Citrus Sinensis ID: 010214
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 515 | 2.2.26 [Sep-21-2011] | |||||||
| Q38997 | 535 | SNF1-related protein kina | yes | no | 0.994 | 0.957 | 0.871 | 0.0 | |
| P92958 | 512 | SNF1-related protein kina | no | no | 0.992 | 0.998 | 0.813 | 0.0 | |
| Q02723 | 502 | Carbon catabolite-derepre | N/A | no | 0.963 | 0.988 | 0.681 | 0.0 | |
| Q5RD00 | 552 | 5'-AMP-activated protein | yes | no | 0.858 | 0.800 | 0.482 | 1e-126 | |
| Q09137 | 552 | 5'-AMP-activated protein | yes | no | 0.848 | 0.791 | 0.477 | 1e-126 | |
| P54646 | 552 | 5'-AMP-activated protein | yes | no | 0.858 | 0.800 | 0.480 | 1e-125 | |
| Q28948 | 552 | 5'-AMP-activated protein | yes | no | 0.858 | 0.800 | 0.480 | 1e-125 | |
| Q5RDH5 | 554 | 5'-AMP-activated protein | no | no | 0.860 | 0.799 | 0.489 | 1e-125 | |
| Q13131 | 559 | 5'-AMP-activated protein | no | no | 0.860 | 0.792 | 0.489 | 1e-125 | |
| P54645 | 559 | 5'-AMP-activated protein | no | no | 0.860 | 0.792 | 0.489 | 1e-125 |
| >sp|Q38997|KIN10_ARATH SNF1-related protein kinase catalytic subunit alpha KIN10 OS=Arabidopsis thaliana GN=KIN10 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 944 bits (2439), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/515 (87%), Positives = 479/515 (93%), Gaps = 3/515 (0%)
Query: 1 MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
MDG+ S SGV+ LPNYKLG+TLGIGSFG+VKIAEHALTGHKVAIKILNRRKIKNMEM
Sbjct: 24 MDGSGTGSRSGVESILPNYKLGRTLGIGSFGRVKIAEHALTGHKVAIKILNRRKIKNMEM 83
Query: 61 EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
EEKVRREIKILRLFMHPHIIRLYEVIETP+DIY+VMEYV SGELFDYIVEKGRLQEDEAR
Sbjct: 84 EEKVRREIKILRLFMHPHIIRLYEVIETPTDIYLVMEYVNSGELFDYIVEKGRLQEDEAR 143
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSP
Sbjct: 144 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSP 203
Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct: 204 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 263
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKE 300
SPGARDLIPRML+VDPMKR+TIPEIRQHPWFQAHLPRYLAVPPPDT+QQAKKIDEEIL+E
Sbjct: 264 SPGARDLIPRMLVVDPMKRVTIPEIRQHPWFQAHLPRYLAVPPPDTVQQAKKIDEEILQE 323
Query: 301 VVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPI 360
V+ MGFD+N L+ESLRNR QN+ TV YYL+LDNRFR SSGYLGAEFQETME G R+HP
Sbjct: 324 VINMGFDRNHLIESLRNRTQNDGTVTYYLILDNRFRASSGYLGAEFQETME-GTPRMHPA 382
Query: 361 EPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGW 420
E SPV+HR PG M+YQG+GLR Q P ERKWALGLQSRAHPREIMTEVLKALQ+LNV W
Sbjct: 383 ESVASPVSHRLPGLMEYQGVGLRSQYPVERKWALGLQSRAHPREIMTEVLKALQDLNVCW 442
Query: 421 KKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLY 480
KKIGHYNMKCRW+P S +GM++N +H N+YFGDES+IIEN+ VKSPNVVKFE+QLY
Sbjct: 443 KKIGHYNMKCRWVPNSSA--DGMLSNSMHDNNYFGDESSIIENEAAVKSPNVVKFEIQLY 500
Query: 481 KTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL 515
KTRD+KYLLDLQRVQGPQFLFLDLCAAFLAQLRVL
Sbjct: 501 KTRDDKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL 535
|
Catalytic subunit of the probable trimeric SNF1-related protein kinase (SnRK) complex, which may play a role in a signal transduction cascade regulating gene expression and carbohydrate metabolism in higher plants. The SnRK complex may also be involved in the regulation of fatty acid synthesis by phosphorylation of acetyl-CoA carboxylase and in assimilation of nitrogen by phosphorylating nitrate reductase. In vitro, KIN10 exhibits kinase activity on sucrose phosphate synthase and the kinase activity is inhibited by PRL1. May be a subunit of a SCF ubiquitin ligase complex and thus be involved in proteasomal ubiquitination. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P92958|KIN11_ARATH SNF1-related protein kinase catalytic subunit alpha KIN11 OS=Arabidopsis thaliana GN=KIN11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 871 bits (2250), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/516 (81%), Positives = 458/516 (88%), Gaps = 5/516 (0%)
Query: 1 MDGASNR-SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME 59
MD +SNR ++GV+ LPNYKLGKTLGIGSFGKVKIAEH +TGHKVAIKILNRRKIKNME
Sbjct: 1 MDHSSNRFGNNGVESILPNYKLGKTLGIGSFGKVKIAEHVVTGHKVAIKILNRRKIKNME 60
Query: 60 MEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA 119
MEEKVRREIKILRLFMHPHIIR YEVIET SDIYVVMEYVKSGELFDYIVEKGRLQEDEA
Sbjct: 61 MEEKVRREIKILRLFMHPHIIRQYEVIETTSDIYVVMEYVKSGELFDYIVEKGRLQEDEA 120
Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS 179
RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS+ N+KIADFGLSN+MRDGHFLKTSCGS
Sbjct: 121 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSRCNIKIADFGLSNVMRDGHFLKTSCGS 180
Query: 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH 239
PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH
Sbjct: 181 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH 240
Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILK 299
LS ARDLIPRMLIVDP+KRITIPEIRQH WFQ HLPRYLAV PPDT++QAKKI+EEI++
Sbjct: 241 LSSEARDLIPRMLIVDPVKRITIPEIRQHRWFQTHLPRYLAVSPPDTVEQAKKINEEIVQ 300
Query: 300 EVVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHP 359
EVV MGFD+NQ++ESLRNR QN+ATV YYLLLDNRFRV SGYL +EFQET +SG N +
Sbjct: 301 EVVNMGFDRNQVLESLRNRTQNDATVTYYLLLDNRFRVPSGYLESEFQETTDSGSNPMRT 360
Query: 360 IEPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVG 419
E SPV H P +D+ G+G R Q+P +RKWALGLQS AHPREIM EVLKALQELNV
Sbjct: 361 PEAGASPVGHWIPAHVDHYGLGARSQVPVDRKWALGLQSHAHPREIMNEVLKALQELNVC 420
Query: 420 WKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQL 479
WKKIGHYNMKCRW+PG++ MVNN LH F DES+IIE+D + SP V+KFE+QL
Sbjct: 421 WKKIGHYNMKCRWVPGLADGQNTMVNNQLH----FRDESSIIEDDCAMTSPTVIKFELQL 476
Query: 480 YKTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL 515
YK R+EKYLLD+QRV GPQFLFLDLCAAFL +LRV+
Sbjct: 477 YKAREEKYLLDIQRVNGPQFLFLDLCAAFLTELRVI 512
|
Catalytic subunit of the probable trimeric SNF1-related protein kinase (SnRK) complex, which may play a role in a signal transduction cascade regulating gene expression and carbohydrate metabolism in higher plants. The SnRK complex may also be involved in the regulation of fatty acid synthesis by phosphorylation of acetyl-CoA carboxylase and in assimilation of nitrogen by phosphorylating nitrate reductase. In vitro, KIN11 exhibits kinase activity on sucrose phosphate synthase and the kinase activity is inhibited by PRL1. May be a subunit of a SCF ubiquitin ligase complex and thus be involved in proteasomal ubiquitination. Involved in innate antiviral defenses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q02723|RKIN1_SECCE Carbon catabolite-derepressing protein kinase OS=Secale cereale GN=RKIN1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 694 bits (1791), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/521 (68%), Positives = 402/521 (77%), Gaps = 25/521 (4%)
Query: 1 MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
MDG S + L NY LGK LG+G+F KV IAEH T HKVAIK+LNRR+++ EM
Sbjct: 1 MDGGGEHSEA-----LKNYYLGKILGVGTFAKVIIAEHKHTRHKVAIKVLNRRQMRAPEM 55
Query: 61 EEKVRREIKILRLFM---HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQED 117
EEK +REIKILRLF+ HPHIIR+YEVI TP DI+VVMEY ++G+L DYI+EK RLQED
Sbjct: 56 EEKAKREIKILRLFIDLIHPHIIRVYEVIVTPKDIFVVMEYCQNGDLLDYILEKRRLQED 115
Query: 118 EARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC 177
EAR FQQIIS VEYCHRN VVHRDLKPENLLLDSK+NVK+ADFGLSN+M DGHFLKTSC
Sbjct: 116 EARRTFQQIISAVEYCHRNKVVHRDLKPENLLLDSKYNVKLADFGLSNVMHDGHFLKTSC 175
Query: 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP 237
GS NYAAPEVISGKLYAGPE+DVWSCGVILYALLCG +PFDD+NIPNLFKKIKGG Y LP
Sbjct: 176 GSLNYAAPEVISGKLYAGPEIDVWSCGVILYALLCGAVPFDDDNIPNLFKKIKGGTYILP 235
Query: 238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEI 297
+LS RDLI RMLIVDPMKRITI EIR+H WFQ LPRYLAVPPPD MQQAK IDE+
Sbjct: 236 IYLSDLVRDLISRMLIVDPMKRITIGEIRKHSWFQNRLPRYLAVPPPDMMQQAKMIDEDT 295
Query: 298 LKEVVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRL 357
L++VVK+G+D++ + ESL NRLQNE TVAYYLLLDNRFR +SGYLGA +Q+ MES
Sbjct: 296 LRDVVKLGYDKDHVCESLCNRLQNEETVAYYLLLDNRFRATSGYLGAHYQQPMES----- 350
Query: 358 HPIEPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGL-QSRAHPREIMTEVLKALQEL 416
A PG D QG GLR ERKWALGL QSRA PR IM EVLKAL+EL
Sbjct: 351 -----ASPSTRSYLPGSNDSQGSGLRPYYRVERKWALGLQQSRAPPRAIMIEVLKALKEL 405
Query: 417 NVGWKKIGH-YNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIEN-DGVVKSPNVVK 474
NV WKK G YNMKCRW PG + + L +NH F D+ AI +N D + P V+K
Sbjct: 406 NVCWKKNGDCYNMKCRWCPGFPRVSDML----LDANHSFVDDCAIKDNGDANSRLPAVIK 461
Query: 475 FEVQLYKTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL 515
FE+QLYKT+D+KYLLD+QRV GPQ LFL+ CAAFL LRVL
Sbjct: 462 FEIQLYKTKDDKYLLDMQRVTGPQLLFLEFCAAFLTNLRVL 502
|
Essential for release from glucose repression. Secale cereale (taxid: 4550) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5RD00|AAPK2_PONAB 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Pongo abelii GN=PRKAA2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 451 bits (1160), Expect = e-126, Method: Compositional matrix adjust.
Identities = 238/493 (48%), Positives = 321/493 (65%), Gaps = 51/493 (10%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++ K++REI+ L+LF HP
Sbjct: 15 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 74
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
HII+LY+VI TP+D ++VMEYV GELFDYI + GR++E EAR FQQI+S V+YCHR+M
Sbjct: 75 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 134
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
VVHRDLKPEN+LLD+ N KIADFGLSNIM DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct: 135 VVHRDLKPENVLLDAHMNAKIADFGLSNIMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 194
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+ L+ ML VDP+
Sbjct: 195 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPL 254
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESL- 315
KR TI +IR+H WF+ LP YL P D A ID+E +KEV K +++++ SL
Sbjct: 255 KRATIKDIREHEWFKQDLPSYLF--PEDPSYDANVIDDEAVKEVCEKFECTESEVMNSLY 312
Query: 316 RNRLQNEATVAYYLLLDNRF---RVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAP 372
Q++ VAY+L++DNR + S YL + + +H I P + P R P
Sbjct: 313 SGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPSGSFMDDSAMH-IPPGLKPHPERMP 371
Query: 373 GF----------MDYQGMGLRGQLPYER-KWALGLQSRAHPREIMTEVLKALQELNVGWK 421
+D L ++ KW LG++S++ P +IM EV +A+++L+ WK
Sbjct: 372 PLIADSPKARCPLDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDFEWK 431
Query: 422 KIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYK 481
+ Y+++ R NP+ N+ VK +QLY
Sbjct: 432 VVNAYHLRVRR------------KNPVTGNY--------------------VKMSLQLYL 459
Query: 482 TRDEKYLLDLQRV 494
+ YLLD + +
Sbjct: 460 VDNRSYLLDFKSI 472
|
Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09137|AAPK2_RAT 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Rattus norvegicus GN=Prkaa2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 451 bits (1159), Expect = e-126, Method: Compositional matrix adjust.
Identities = 238/498 (47%), Positives = 323/498 (64%), Gaps = 61/498 (12%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++ K++REI+ L+LF HP
Sbjct: 15 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 74
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
HII+LY+VI TP+D ++VMEYV GELFDYI + GR++E EAR FQQI+S V+YCHR+M
Sbjct: 75 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEVEARRLFQQILSAVDYCHRHM 134
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
VVHRDLKPEN+LLD++ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct: 135 VVHRDLKPENVLLDAQMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 194
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+ L+ ML VDP+
Sbjct: 195 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSIATLLMHMLQVDPL 254
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESL- 315
KR TI +IR+H WF+ LP YL P D A ID+E +KEV K +++++ SL
Sbjct: 255 KRATIKDIREHEWFKQDLPSYLF--PEDPSYDANVIDDEAVKEVCEKFECTESEVMNSLY 312
Query: 316 RNRLQNEATVAYYLLLDNR--------FRVSSGYLGAEFQETMESGFNRLHPIEPAVSPV 367
Q++ VAY+L++DNR F ++S F + M +H I P + P
Sbjct: 313 SGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPTGSFMDDMA-----MH-IPPGLKPH 366
Query: 368 AHRAPGF----------MDYQGMGLRGQLPYER-KWALGLQSRAHPREIMTEVLKALQEL 416
R P +D L ++ KW LG++S++ P +IM EV +A+++L
Sbjct: 367 PERMPPLIADSPKARCPLDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQL 426
Query: 417 NVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFE 476
+ WK + Y+++ R NP+ N+ VK
Sbjct: 427 DFEWKVVNAYHLRVRR------------KNPVTGNY--------------------VKMS 454
Query: 477 VQLYKTRDEKYLLDLQRV 494
+QLY + YLLD + +
Sbjct: 455 LQLYLVDNRSYLLDFKSI 472
|
Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P54646|AAPK2_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Homo sapiens GN=PRKAA2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 449 bits (1156), Expect = e-125, Method: Compositional matrix adjust.
Identities = 237/493 (48%), Positives = 321/493 (65%), Gaps = 51/493 (10%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++ K++REI+ L+LF HP
Sbjct: 15 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 74
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
HII+LY+VI TP+D ++VMEYV GELFDYI + GR++E EAR FQQI+S V+YCHR+M
Sbjct: 75 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 134
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
VVHRDLKPEN+LLD+ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct: 135 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 194
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+ L+ ML VDP+
Sbjct: 195 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPL 254
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESL- 315
KR TI +IR+H WF+ LP YL P D A ID+E +KEV K +++++ SL
Sbjct: 255 KRATIKDIREHEWFKQDLPSYLF--PEDPSYDANVIDDEAVKEVCEKFECTESEVMNSLY 312
Query: 316 RNRLQNEATVAYYLLLDNRF---RVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAP 372
Q++ VAY+L++DNR + S YL + + +H I P + P R P
Sbjct: 313 SGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPSGSFMDDSAMH-IPPGLKPHPERMP 371
Query: 373 GF----------MDYQGMGLRGQLPYER-KWALGLQSRAHPREIMTEVLKALQELNVGWK 421
+D L ++ KW LG++S++ P +IM EV +A+++L+ WK
Sbjct: 372 PLIADSPKARCPLDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDFEWK 431
Query: 422 KIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYK 481
+ Y+++ R NP+ N+ VK +QLY
Sbjct: 432 VVNAYHLRVRR------------KNPVTGNY--------------------VKMSLQLYL 459
Query: 482 TRDEKYLLDLQRV 494
+ YLLD + +
Sbjct: 460 VDNRSYLLDFKSI 472
|
Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q28948|AAPK2_PIG 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Sus scrofa GN=PRKAA2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 449 bits (1155), Expect = e-125, Method: Compositional matrix adjust.
Identities = 237/493 (48%), Positives = 322/493 (65%), Gaps = 51/493 (10%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++ K++REI+ L+LF HP
Sbjct: 15 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 74
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
HII+LY+VI TP+D ++VMEYV GELFDYI + GR++E EAR FQQI+S V+YCHR+M
Sbjct: 75 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 134
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
VVHRDLKPEN+LLD++ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct: 135 VVHRDLKPENVLLDAQMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 194
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+ L+ ML VDP+
Sbjct: 195 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPL 254
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESL- 315
KR TI +IR+H WF+ LP YL P D A ID+E +KEV K +++++ SL
Sbjct: 255 KRATIKDIREHEWFKQDLPSYLF--PEDPSYDANVIDDEAVKEVCEKFECTESEVMNSLY 312
Query: 316 RNRLQNEATVAYYLLLDNRF---RVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAP 372
Q++ VAY+L++DNR + S YL + + +H I P + P R P
Sbjct: 313 SGDPQDQLAVAYHLVIDNRRIMNQASEFYLASSPPTGSFMDDSAMH-IPPGLKPHPERMP 371
Query: 373 GF----------MDYQGMGLRGQLPYER-KWALGLQSRAHPREIMTEVLKALQELNVGWK 421
+D L ++ KW LG++S++ P +IM EV +A+++L+ WK
Sbjct: 372 PLIADSPKARCPLDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDFEWK 431
Query: 422 KIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYK 481
+ Y+++ R NP+ N+ VK +QLY
Sbjct: 432 VVNAYHLRVRR------------KNPVTGNY--------------------VKMSLQLYL 459
Query: 482 TRDEKYLLDLQRV 494
+ YLLD + +
Sbjct: 460 VDNRSYLLDFKSI 472
|
Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1. Sus scrofa (taxid: 9823) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5RDH5|AAPK1_PONAB 5'-AMP-activated protein kinase catalytic subunit alpha-1 (Fragment) OS=Pongo abelii GN=PRKAA1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 448 bits (1153), Expect = e-125, Method: Compositional matrix adjust.
Identities = 238/486 (48%), Positives = 317/486 (65%), Gaps = 43/486 (8%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+Y LG TLG+G+FGKVK+ +H LTGHKVA+KILNR+KI+++++ K+RREI+ L+LF HP
Sbjct: 21 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 80
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
HII+LY+VI TPSDI++VMEYV GELFDYI + GRL E E+R FQQI+SGV+YCHR+M
Sbjct: 81 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 140
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
VVHRDLKPEN+LLD+ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct: 141 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 200
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
VD+WS GVILYALLCGTLPFDD+++P LFKKI GI+ P +L+P L+ ML VDPM
Sbjct: 201 VDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPM 260
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESLR 316
KR TI +IR+H WF+ LP+YL P D + ID+E LKEV K + +++ L
Sbjct: 261 KRATIKDIREHEWFKQDLPKYLF--PEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLY 318
Query: 317 NR-LQNEATVAYYLLLDNRFRVSSG---YLGAEFQETM--ESGFNRLHPIE-PAVSPVAH 369
NR Q+ VAY+L++DNR ++ YL ++ + R HP P +
Sbjct: 319 NRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETP 378
Query: 370 RAPGFMD-YQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNM 428
RA +D + Q + KW LG++S++ P +IM EV +A+++L+ WK + Y +
Sbjct: 379 RARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYL 438
Query: 429 KCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYL 488
+ R NP+ S + K +QLY+ YL
Sbjct: 439 RVRR------------KNPVTSTY--------------------SKMSLQLYQVDSRTYL 466
Query: 489 LDLQRV 494
LD + +
Sbjct: 467 LDFRSI 472
|
Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also has tau-protein kinase activity: in response to amyloid beta A4 protein (APP) exposure, activated by CAMKK2, leading to phosphorylation of MAPT/TAU; however the relevance of such data remains unclear in vivo. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q13131|AAPK1_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-1 OS=Homo sapiens GN=PRKAA1 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 448 bits (1152), Expect = e-125, Method: Compositional matrix adjust.
Identities = 238/486 (48%), Positives = 317/486 (65%), Gaps = 43/486 (8%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+Y LG TLG+G+FGKVK+ +H LTGHKVA+KILNR+KI+++++ K+RREI+ L+LF HP
Sbjct: 26 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 85
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
HII+LY+VI TPSDI++VMEYV GELFDYI + GRL E E+R FQQI+SGV+YCHR+M
Sbjct: 86 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 145
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
VVHRDLKPEN+LLD+ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct: 146 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 205
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
VD+WS GVILYALLCGTLPFDD+++P LFKKI GI+ P +L+P L+ ML VDPM
Sbjct: 206 VDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPM 265
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESLR 316
KR TI +IR+H WF+ LP+YL P D + ID+E LKEV K + +++ L
Sbjct: 266 KRATIKDIREHEWFKQDLPKYLF--PEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLY 323
Query: 317 NR-LQNEATVAYYLLLDNRFRVSSG---YLGAEFQETM--ESGFNRLHPIE-PAVSPVAH 369
NR Q+ VAY+L++DNR ++ YL ++ + R HP P +
Sbjct: 324 NRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETP 383
Query: 370 RAPGFMD-YQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNM 428
RA +D + Q + KW LG++S++ P +IM EV +A+++L+ WK + Y +
Sbjct: 384 RARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYL 443
Query: 429 KCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYL 488
+ R NP+ S + K +QLY+ YL
Sbjct: 444 RVRR------------KNPVTSTY--------------------SKMSLQLYQVDSRTYL 471
Query: 489 LDLQRV 494
LD + +
Sbjct: 472 LDFRSI 477
|
Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also has tau-protein kinase activity: in response to amyloid beta A4 protein (APP) exposure, activated by CAMKK2, leading to phosphorylation of MAPT/TAU; however the relevance of such data remains unclear in vivo. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P54645|AAPK1_RAT 5'-AMP-activated protein kinase catalytic subunit alpha-1 OS=Rattus norvegicus GN=Prkaa1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 447 bits (1151), Expect = e-125, Method: Compositional matrix adjust.
Identities = 238/486 (48%), Positives = 316/486 (65%), Gaps = 43/486 (8%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+Y LG TLG+G+FGKVK+ +H LTGHKVA+KILNR+KI+++++ K+RREI+ L+LF HP
Sbjct: 26 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 85
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
HII+LY+VI TPSDI++VMEYV GELFDYI + GRL E E+R FQQI+SGV+YCHR+M
Sbjct: 86 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 145
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
VVHRDLKPEN+LLD+ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct: 146 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 205
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
VD+WS GVILYALLCGTLPFDD+++P LFKKI GI+ P +L+P L+ ML VDPM
Sbjct: 206 VDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPM 265
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESLR 316
KR TI +IR+H WF+ LP+YL P D + ID+E LKEV K + +++ L
Sbjct: 266 KRATIKDIREHEWFKQDLPKYLF--PEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLY 323
Query: 317 NR-LQNEATVAYYLLLDNRFRVSSG---YLGAEFQETM--ESGFNRLHPIE-PAVSPVAH 369
NR Q+ VAY+L++DNR ++ YL ++ + R HP P +
Sbjct: 324 NRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETP 383
Query: 370 RAPGFMD-YQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNM 428
RA +D + Q + KW LG++S++ P +IM EV +A+++L+ WK + Y +
Sbjct: 384 RARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYL 443
Query: 429 KCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYL 488
+ R NP+ S K +QLY+ YL
Sbjct: 444 RVRR------------KNPVTS--------------------TFSKMSLQLYQVDSRTYL 471
Query: 489 LDLQRV 494
LD + +
Sbjct: 472 LDFRSI 477
|
Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also has tau-protein kinase activity: in response to amyloid beta A4 protein (APP) exposure, activated by CAMKK2, leading to phosphorylation of MAPT/TAU; however the relevance of such data remains unclear in vivo. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 515 | ||||||
| 449454522 | 515 | PREDICTED: SNF1-related protein kinase c | 1.0 | 1.0 | 0.918 | 0.0 | |
| 1743009 | 504 | SNF1-related protein kinase [Cucumis sat | 0.978 | 1.0 | 0.924 | 0.0 | |
| 224080209 | 515 | predicted protein [Populus trichocarpa] | 1.0 | 1.0 | 0.902 | 0.0 | |
| 396924947 | 510 | sucrose non-fermenting 1 [Mesembryanthem | 0.990 | 1.0 | 0.900 | 0.0 | |
| 356568694 | 514 | PREDICTED: SNF1-related protein kinase c | 0.998 | 1.0 | 0.899 | 0.0 | |
| 157383335 | 515 | sucrose non-fermenting-1-related protein | 1.0 | 1.0 | 0.887 | 0.0 | |
| 62857006 | 516 | Ser/Thr protein kinase [Lotus japonicus] | 0.976 | 0.974 | 0.902 | 0.0 | |
| 30678280 | 535 | SNF1-related protein kinase catalytic su | 0.994 | 0.957 | 0.871 | 0.0 | |
| 225452903 | 508 | PREDICTED: SNF1-related protein kinase c | 0.986 | 1.0 | 0.897 | 0.0 | |
| 18395701 | 512 | SNF1-related protein kinase catalytic su | 0.994 | 1.0 | 0.871 | 0.0 |
| >gi|449454522|ref|XP_004145003.1| PREDICTED: SNF1-related protein kinase catalytic subunit alpha KIN10-like [Cucumis sativus] gi|449474166|ref|XP_004154092.1| PREDICTED: SNF1-related protein kinase catalytic subunit alpha KIN10-like [Cucumis sativus] gi|449498915|ref|XP_004160670.1| PREDICTED: SNF1-related protein kinase catalytic subunit alpha KIN10-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 994 bits (2571), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 473/515 (91%), Positives = 494/515 (95%)
Query: 1 MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
MDG + RS G+DM +PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN++M
Sbjct: 1 MDGPTGRSGGGMDMNVPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNLDM 60
Query: 61 EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR
Sbjct: 61 EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSP
Sbjct: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSP 180
Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKE 300
S GAR+LIP ML+VDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE+IL+E
Sbjct: 241 SSGARELIPSMLVVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEDILQE 300
Query: 301 VVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPI 360
VVKMGFD+NQLVESLRNR+QNEATVAYYLLLDNRFRVSSGYLGAEFQETME+GFNR+HP
Sbjct: 301 VVKMGFDRNQLVESLRNRIQNEATVAYYLLLDNRFRVSSGYLGAEFQETMETGFNRMHPS 360
Query: 361 EPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGW 420
+P V HR PG+MDYQGMGLR Q P ERKWALGLQSRAHPREIMTEVLKAL+ELNV W
Sbjct: 361 DPTNPAVGHRLPGYMDYQGMGLRAQFPVERKWALGLQSRAHPREIMTEVLKALRELNVAW 420
Query: 421 KKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLY 480
KKIGHYNMKCRW+PGI GHHEGM+NNP+HSNHYFGDES IIENDGVVKSPNV+KFEVQLY
Sbjct: 421 KKIGHYNMKCRWLPGIPGHHEGMINNPVHSNHYFGDESTIIENDGVVKSPNVIKFEVQLY 480
Query: 481 KTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL 515
KTR+EKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL
Sbjct: 481 KTREEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL 515
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1743009|emb|CAA71142.1| SNF1-related protein kinase [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 980 bits (2533), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/504 (92%), Positives = 487/504 (96%)
Query: 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL 71
+DM +PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN++MEEKVRREIKIL
Sbjct: 1 MDMNVPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNLDMEEKVRREIKIL 60
Query: 72 RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 131
RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE
Sbjct: 61 RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 120
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
YCHRNMVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK
Sbjct: 121 YCHRNMVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 180
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251
LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLS GAR+LIP M
Sbjct: 181 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSSGARELIPSM 240
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQL 311
L+VDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE+IL+EVVKMGFD+NQL
Sbjct: 241 LVVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEDILQEVVKMGFDRNQL 300
Query: 312 VESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRA 371
VESLRNR+QNEATVAYYLLLDNRFRVSSGYLGAEFQETME+GFNR+HP +P V HR
Sbjct: 301 VESLRNRIQNEATVAYYLLLDNRFRVSSGYLGAEFQETMETGFNRMHPSDPTNPAVGHRL 360
Query: 372 PGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCR 431
PG+MDYQGMGLR Q P ERKWALGLQSRAHPREIMTEVLKAL+ELNV WKKIGHYNMKCR
Sbjct: 361 PGYMDYQGMGLRAQFPVERKWALGLQSRAHPREIMTEVLKALRELNVAWKKIGHYNMKCR 420
Query: 432 WIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDL 491
W+PGI GHHEGM+NNP+HSNHYFGD+S IIENDGVVKSPNV+KFEVQLYKTR+EKYLLDL
Sbjct: 421 WLPGIPGHHEGMINNPVHSNHYFGDKSTIIENDGVVKSPNVIKFEVQLYKTREEKYLLDL 480
Query: 492 QRVQGPQFLFLDLCAAFLAQLRVL 515
QRVQGPQFLFLDLCAAFLAQLRVL
Sbjct: 481 QRVQGPQFLFLDLCAAFLAQLRVL 504
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224080209|ref|XP_002306053.1| predicted protein [Populus trichocarpa] gi|222849017|gb|EEE86564.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 974 bits (2519), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 465/515 (90%), Positives = 484/515 (93%)
Query: 1 MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
MDG+S R SS VDM+L NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM+M
Sbjct: 1 MDGSSYRGSSSVDMYLANYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMDM 60
Query: 61 EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
EEKVRREIKILRLFMHPHIIRLYEVIETP+DIYVVMEYVKSGELFDYIVEKGRLQEDEAR
Sbjct: 61 EEKVRREIKILRLFMHPHIIRLYEVIETPTDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP
Sbjct: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKE 300
SPGARDLIPRML+VDPMKR+TIPEIRQH WFQA LPRYLAVPPPDTMQQAKKIDEEIL+E
Sbjct: 241 SPGARDLIPRMLVVDPMKRMTIPEIRQHQWFQARLPRYLAVPPPDTMQQAKKIDEEILQE 300
Query: 301 VVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPI 360
V+KMGFD+NQL+ESLRNR+QNE TVAYYLLLDNRFRVS+GYLGAEFQETME FN +H
Sbjct: 301 VIKMGFDRNQLIESLRNRMQNEGTVAYYLLLDNRFRVSNGYLGAEFQETMECAFNGMHQN 360
Query: 361 EPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGW 420
E + HR PGFMDYQGMGL+ Q ERKWALGLQSRAHPREIMTEVLKALQELNV W
Sbjct: 361 ESSSPAGGHRLPGFMDYQGMGLKSQFLVERKWALGLQSRAHPREIMTEVLKALQELNVSW 420
Query: 421 KKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLY 480
KKIG YNMKCRWIPG GHHEGMVN+P+H+NH+FGDE IIENDGV SPNVVKFEVQLY
Sbjct: 421 KKIGQYNMKCRWIPGTPGHHEGMVNDPVHTNHFFGDEPTIIENDGVTNSPNVVKFEVQLY 480
Query: 481 KTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL 515
KTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL
Sbjct: 481 KTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL 515
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|396924947|gb|AFN89137.1| sucrose non-fermenting 1 [Mesembryanthemum crystallinum] | Back alignment and taxonomy information |
|---|
Score = 958 bits (2476), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/515 (90%), Positives = 484/515 (93%), Gaps = 5/515 (0%)
Query: 1 MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
MDG S R GVD+FL NY LGKTLGIGSFGKVKIAEH LTGHKVAIKILNRRKIKNMEM
Sbjct: 1 MDGQSGR---GVDVFLQNYNLGKTLGIGSFGKVKIAEHKLTGHKVAIKILNRRKIKNMEM 57
Query: 61 EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYV+SGELFDYIVEKGRLQEDEAR
Sbjct: 58 EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVRSGELFDYIVEKGRLQEDEAR 117
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
NFFQQIISGVEYCHRNMVVHRDLKPENLLLDS NVKIADFGLSNIMRDGHFLKTSCGSP
Sbjct: 118 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSHHNVKIADFGLSNIMRDGHFLKTSCGSP 177
Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct: 178 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 237
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKE 300
SPGARDLIPRML+VDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK+DE+IL+E
Sbjct: 238 SPGARDLIPRMLVVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKVDEDILQE 297
Query: 301 VVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPI 360
VV+MGFD+NQL+ESLRNRLQNE TVAYYLL DNRFRVSSGYLGAEFQET+E FNR+H
Sbjct: 298 VVRMGFDRNQLIESLRNRLQNEGTVAYYLLFDNRFRVSSGYLGAEFQETVE--FNRMHLN 355
Query: 361 EPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGW 420
E A A R G +DYQG+GLR Q P ERKWALGLQSRAHPREIMTEVLKALQELNV W
Sbjct: 356 EVAAPAAAQRFHGHVDYQGVGLRSQFPVERKWALGLQSRAHPREIMTEVLKALQELNVSW 415
Query: 421 KKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLY 480
KKIGHYNMKCRWIPGI GHHEGMVNNP+H++HYFGDES+IIENDGV++SPNVVKFEVQLY
Sbjct: 416 KKIGHYNMKCRWIPGIPGHHEGMVNNPVHNDHYFGDESSIIENDGVLRSPNVVKFEVQLY 475
Query: 481 KTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL 515
KTR+EKYLLDLQRVQGPQ LFLDLCAAFLAQLRVL
Sbjct: 476 KTREEKYLLDLQRVQGPQMLFLDLCAAFLAQLRVL 510
|
Source: Mesembryanthemum crystallinum Species: Mesembryanthemum crystallinum Genus: Mesembryanthemum Family: Aizoaceae Order: Caryophyllales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356568694|ref|XP_003552545.1| PREDICTED: SNF1-related protein kinase catalytic subunit alpha KIN10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 957 bits (2473), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/515 (89%), Positives = 484/515 (93%), Gaps = 1/515 (0%)
Query: 1 MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
MDG + R +G+DMFLPNYKLGKTLGIGSFGKVKIAEH LTGHKVAIKILNRRKIKNMEM
Sbjct: 1 MDGPAGRGGAGLDMFLPNYKLGKTLGIGSFGKVKIAEHVLTGHKVAIKILNRRKIKNMEM 60
Query: 61 EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
EEKVRREIKILRLFMHPHIIRLYEVIETP+DIYVVMEYVKSGELFDYIVEKGRLQEDEAR
Sbjct: 61 EEKVRREIKILRLFMHPHIIRLYEVIETPTDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSP
Sbjct: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSP 180
Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKE 300
SPGARDLIP ML+VDPM+R+TIPEIRQHPWFQA LPRYLAVPPPDTMQQAKKIDEEIL+E
Sbjct: 241 SPGARDLIPGMLVVDPMRRMTIPEIRQHPWFQARLPRYLAVPPPDTMQQAKKIDEEILQE 300
Query: 301 VVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPI 360
VVKMGFD+NQLVESL NR+QNE TVAYYLLLDNRFRVSSGYLGAEFQETM+SGFN++H
Sbjct: 301 VVKMGFDRNQLVESLGNRIQNEGTVAYYLLLDNRFRVSSGYLGAEFQETMDSGFNQMHSS 360
Query: 361 EPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGW 420
E A S V +R PG+M+Y G+G R Q P ERKWALGLQSRAHPREIMTEVLKALQELNV W
Sbjct: 361 ELASSVVGNRFPGYMEYPGVGSRQQFPVERKWALGLQSRAHPREIMTEVLKALQELNVCW 420
Query: 421 KKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLY 480
KKIGHYNMKCRW+ GI GHHEGMVNN +HSNHYFGD+S IIEND V S NVVKFEVQLY
Sbjct: 421 KKIGHYNMKCRWVAGIPGHHEGMVNNNVHSNHYFGDDSNIIENDAVSTS-NVVKFEVQLY 479
Query: 481 KTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL 515
KTR+EKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL
Sbjct: 480 KTREEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL 514
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|157383335|gb|ABV49061.1| sucrose non-fermenting-1-related protein kinase 1 [Malus hupehensis] | Back alignment and taxonomy information |
|---|
Score = 956 bits (2472), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/515 (88%), Positives = 482/515 (93%)
Query: 1 MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
MDG R S D +LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN+EM
Sbjct: 1 MDGPVGRGGSSADTYLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNLEM 60
Query: 61 EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR
Sbjct: 61 EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK NVKIADFGLSN+MRDGHFLKTSCGSP
Sbjct: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKCNVKIADFGLSNVMRDGHFLKTSCGSP 180
Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKE 300
SPGARDLIPRML+VDPMKR+TIPEIRQH WFQAHLPRYLAV PPDT+QQAKKIDEEIL+E
Sbjct: 241 SPGARDLIPRMLVVDPMKRMTIPEIRQHAWFQAHLPRYLAVSPPDTIQQAKKIDEEILQE 300
Query: 301 VVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPI 360
VVKMGFD+N LVESLR R+QNE TVAYYLLLD RFRVSSGYLGAEFQET++ GFNR+
Sbjct: 301 VVKMGFDRNLLVESLRGRVQNEGTVAYYLLLDIRFRVSSGYLGAEFQETVDCGFNRMQQS 360
Query: 361 EPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGW 420
E A SPV HR PG+M+YQGMG R Q P ERKWALGLQSRAHPREIMTEVLKALQEL V W
Sbjct: 361 ETAASPVGHRLPGYMEYQGMGFRPQFPVERKWALGLQSRAHPREIMTEVLKALQELQVCW 420
Query: 421 KKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLY 480
KKIGHYNMKCRW+PG GH+EGM++N +HSN+YFGDES+IIENDGV++ PNVVKFEVQL+
Sbjct: 421 KKIGHYNMKCRWVPGTPGHNEGMIDNSVHSNNYFGDESSIIENDGVMRMPNVVKFEVQLF 480
Query: 481 KTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL 515
KTR+EKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL
Sbjct: 481 KTREEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL 515
|
Source: Malus hupehensis Species: Malus hupehensis Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|62857006|dbj|BAD95888.1| Ser/Thr protein kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 946 bits (2445), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 456/505 (90%), Positives = 479/505 (94%), Gaps = 2/505 (0%)
Query: 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL 71
+D++LPNYKLGKTLGIGSFGKVKIAEH LTGHKVAIKILNRRKIKNMEMEEKVRREIKIL
Sbjct: 13 LDIYLPNYKLGKTLGIGSFGKVKIAEHVLTGHKVAIKILNRRKIKNMEMEEKVRREIKIL 72
Query: 72 RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 131
RLFMHPHIIRLYEVIETP+DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE
Sbjct: 73 RLFMHPHIIRLYEVIETPTDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 132
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
YCHRNMVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK
Sbjct: 133 YCHRNMVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 192
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251
LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM
Sbjct: 193 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 252
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQL 311
L+VDPMKR+TIPEIRQHPWFQA LPRYLAVPPPDTMQQAKKIDEE+++EVV MGFD+NQL
Sbjct: 253 LVVDPMKRMTIPEIRQHPWFQARLPRYLAVPPPDTMQQAKKIDEEVVQEVVNMGFDRNQL 312
Query: 312 VESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRA 371
+ESLRNR+QNE TVAYYLLLDNRFRVSSGYLGAEFQETM+SGFN++HP E A S V HR
Sbjct: 313 IESLRNRIQNEGTVAYYLLLDNRFRVSSGYLGAEFQETMDSGFNQMHPGEVASSVVGHRI 372
Query: 372 PGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCR 431
PG++DY G+G+R Q P ERKWALGLQSRAHPREIMTEVLKALQELNV WKKIGHYNMKCR
Sbjct: 373 PGYIDYPGVGMRPQFPVERKWALGLQSRAHPREIMTEVLKALQELNVCWKKIGHYNMKCR 432
Query: 432 WIPGISGHHEGMV-NNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLD 490
W+ GI GHHEGMV NN HSNHYFGD+S+IIEND V S NVVKFEVQLYKTR+EKYLLD
Sbjct: 433 WVAGIPGHHEGMVNNNTAHSNHYFGDDSSIIENDA-VPSSNVVKFEVQLYKTREEKYLLD 491
Query: 491 LQRVQGPQFLFLDLCAAFLAQLRVL 515
LQRVQG QFLFLDLCAAFLAQLRVL
Sbjct: 492 LQRVQGAQFLFLDLCAAFLAQLRVL 516
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30678280|ref|NP_850488.1| SNF1-related protein kinase catalytic subunit alpha KIN10 [Arabidopsis thaliana] gi|38503401|sp|Q38997.2|KIN10_ARATH RecName: Full=SNF1-related protein kinase catalytic subunit alpha KIN10; Short=AKIN10; AltName: Full=AKIN alpha-2; Short=AKINalpha2 gi|20260542|gb|AAM13169.1| putative SNF1-related protein kinase [Arabidopsis thaliana] gi|34098893|gb|AAQ56829.1| At3g01090 [Arabidopsis thaliana] gi|332640087|gb|AEE73608.1| SNF1-related protein kinase catalytic subunit alpha KIN10 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 944 bits (2439), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/515 (87%), Positives = 479/515 (93%), Gaps = 3/515 (0%)
Query: 1 MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
MDG+ S SGV+ LPNYKLG+TLGIGSFG+VKIAEHALTGHKVAIKILNRRKIKNMEM
Sbjct: 24 MDGSGTGSRSGVESILPNYKLGRTLGIGSFGRVKIAEHALTGHKVAIKILNRRKIKNMEM 83
Query: 61 EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
EEKVRREIKILRLFMHPHIIRLYEVIETP+DIY+VMEYV SGELFDYIVEKGRLQEDEAR
Sbjct: 84 EEKVRREIKILRLFMHPHIIRLYEVIETPTDIYLVMEYVNSGELFDYIVEKGRLQEDEAR 143
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSP
Sbjct: 144 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSP 203
Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct: 204 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 263
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKE 300
SPGARDLIPRML+VDPMKR+TIPEIRQHPWFQAHLPRYLAVPPPDT+QQAKKIDEEIL+E
Sbjct: 264 SPGARDLIPRMLVVDPMKRVTIPEIRQHPWFQAHLPRYLAVPPPDTVQQAKKIDEEILQE 323
Query: 301 VVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPI 360
V+ MGFD+N L+ESLRNR QN+ TV YYL+LDNRFR SSGYLGAEFQETME G R+HP
Sbjct: 324 VINMGFDRNHLIESLRNRTQNDGTVTYYLILDNRFRASSGYLGAEFQETME-GTPRMHPA 382
Query: 361 EPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGW 420
E SPV+HR PG M+YQG+GLR Q P ERKWALGLQSRAHPREIMTEVLKALQ+LNV W
Sbjct: 383 ESVASPVSHRLPGLMEYQGVGLRSQYPVERKWALGLQSRAHPREIMTEVLKALQDLNVCW 442
Query: 421 KKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLY 480
KKIGHYNMKCRW+P S +GM++N +H N+YFGDES+IIEN+ VKSPNVVKFE+QLY
Sbjct: 443 KKIGHYNMKCRWVPNSSA--DGMLSNSMHDNNYFGDESSIIENEAAVKSPNVVKFEIQLY 500
Query: 481 KTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL 515
KTRD+KYLLDLQRVQGPQFLFLDLCAAFLAQLRVL
Sbjct: 501 KTRDDKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL 535
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452903|ref|XP_002283999.1| PREDICTED: SNF1-related protein kinase catalytic subunit alpha KIN10 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 942 bits (2436), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 462/515 (89%), Positives = 481/515 (93%), Gaps = 7/515 (1%)
Query: 1 MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
MDG + R GVDMFL NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM
Sbjct: 1 MDGPTGRGGGGVDMFLSNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
Query: 61 EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
EEKVRREIKILRLFMHPHIIRLYEVIETPSDI+VVMEYVKSGELFDYIVEKGRLQE+EAR
Sbjct: 61 EEKVRREIKILRLFMHPHIIRLYEVIETPSDIFVVMEYVKSGELFDYIVEKGRLQEEEAR 120
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSP
Sbjct: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSP 180
Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
NYAAPEVISG+LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct: 181 NYAAPEVISGRLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKE 300
S GARDLIPRMLIVDPMKR+TIPEIRQHPWFQAHLPRYLAVPPPDT+QQAKKIDEEIL+E
Sbjct: 241 STGARDLIPRMLIVDPMKRMTIPEIRQHPWFQAHLPRYLAVPPPDTIQQAKKIDEEILQE 300
Query: 301 VVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPI 360
VVKMGFD+N LVESLRNR+QN+ATVAYYLLLDNRFRVSSGYLGAEFQE++E FNR
Sbjct: 301 VVKMGFDRNLLVESLRNRVQNDATVAYYLLLDNRFRVSSGYLGAEFQESLEYQFNR---- 356
Query: 361 EPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGW 420
V R PG++DYQGMGLR Q P ERKWALGLQSRA PR+IMTEVLKALQELNV W
Sbjct: 357 -SEAGAVGQRFPGYVDYQGMGLRTQFPAERKWALGLQSRAQPRQIMTEVLKALQELNVCW 415
Query: 421 KKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLY 480
KKIGHYNMKCRWIPGI GHHEGMVNNP+HSNH+FGDE AI+ENDGV S NVVKFEVQLY
Sbjct: 416 KKIGHYNMKCRWIPGIPGHHEGMVNNPVHSNHFFGDEPAIVENDGV--SRNVVKFEVQLY 473
Query: 481 KTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL 515
KTR+EKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL
Sbjct: 474 KTREEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL 508
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18395701|ref|NP_566130.1| SNF1-related protein kinase catalytic subunit alpha KIN10 [Arabidopsis thaliana] gi|186509642|ref|NP_001118546.1| SNF1-related protein kinase catalytic subunit alpha KIN10 [Arabidopsis thaliana] gi|6714479|gb|AAF26165.1|AC008261_22 putative SNF1-related protein kinase [Arabidopsis thaliana] gi|166600|gb|AAA32736.1| SNF1-related protein kinase [Arabidopsis thaliana] gi|1742969|emb|CAA64384.1| ser/thr protein kinase [Arabidopsis thaliana] gi|111609954|gb|ABH11527.1| SNR2 [Arabidopsis thaliana] gi|332640086|gb|AEE73607.1| SNF1-related protein kinase catalytic subunit alpha KIN10 [Arabidopsis thaliana] gi|332640088|gb|AEE73609.1| SNF1-related protein kinase catalytic subunit alpha KIN10 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 942 bits (2436), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/515 (87%), Positives = 479/515 (93%), Gaps = 3/515 (0%)
Query: 1 MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
MDG+ S SGV+ LPNYKLG+TLGIGSFG+VKIAEHALTGHKVAIKILNRRKIKNMEM
Sbjct: 1 MDGSGTGSRSGVESILPNYKLGRTLGIGSFGRVKIAEHALTGHKVAIKILNRRKIKNMEM 60
Query: 61 EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
EEKVRREIKILRLFMHPHIIRLYEVIETP+DIY+VMEYV SGELFDYIVEKGRLQEDEAR
Sbjct: 61 EEKVRREIKILRLFMHPHIIRLYEVIETPTDIYLVMEYVNSGELFDYIVEKGRLQEDEAR 120
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSP
Sbjct: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSP 180
Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKE 300
SPGARDLIPRML+VDPMKR+TIPEIRQHPWFQAHLPRYLAVPPPDT+QQAKKIDEEIL+E
Sbjct: 241 SPGARDLIPRMLVVDPMKRVTIPEIRQHPWFQAHLPRYLAVPPPDTVQQAKKIDEEILQE 300
Query: 301 VVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPI 360
V+ MGFD+N L+ESLRNR QN+ TV YYL+LDNRFR SSGYLGAEFQETME G R+HP
Sbjct: 301 VINMGFDRNHLIESLRNRTQNDGTVTYYLILDNRFRASSGYLGAEFQETME-GTPRMHPA 359
Query: 361 EPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGW 420
E SPV+HR PG M+YQG+GLR Q P ERKWALGLQSRAHPREIMTEVLKALQ+LNV W
Sbjct: 360 ESVASPVSHRLPGLMEYQGVGLRSQYPVERKWALGLQSRAHPREIMTEVLKALQDLNVCW 419
Query: 421 KKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLY 480
KKIGHYNMKCRW+P S +GM++N +H N+YFGDES+IIEN+ VKSPNVVKFE+QLY
Sbjct: 420 KKIGHYNMKCRWVPNSSA--DGMLSNSMHDNNYFGDESSIIENEAAVKSPNVVKFEIQLY 477
Query: 481 KTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL 515
KTRD+KYLLDLQRVQGPQFLFLDLCAAFLAQLRVL
Sbjct: 478 KTRDDKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL 512
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 515 | ||||||
| TAIR|locus:2102132 | 535 | KIN10 "AT3G01090" [Arabidopsis | 0.994 | 0.957 | 0.844 | 1.5e-239 | |
| TAIR|locus:2094672 | 512 | KIN11 "SNF1 kinase homolog 11" | 0.959 | 0.964 | 0.813 | 1.4e-220 | |
| TAIR|locus:2175663 | 494 | SnRK1.3 "SNF1-related protein | 0.864 | 0.900 | 0.654 | 1.4e-170 | |
| DICTYBASE|DDB_G0277905 | 727 | snfA "AMP-activated protein ki | 0.633 | 0.448 | 0.630 | 8.2e-126 | |
| UNIPROTKB|Q5RD00 | 552 | PRKAA2 "5'-AMP-activated prote | 0.821 | 0.766 | 0.515 | 3.2e-119 | |
| RGD|620893 | 552 | Prkaa2 "protein kinase, AMP-ac | 0.817 | 0.762 | 0.520 | 4.1e-119 | |
| FB|FBgn0023169 | 582 | SNF1A "SNF1A/AMP-activated pro | 0.704 | 0.623 | 0.567 | 5.7e-119 | |
| UNIPROTKB|P54646 | 552 | PRKAA2 "5'-AMP-activated prote | 0.821 | 0.766 | 0.513 | 6.7e-119 | |
| UNIPROTKB|Q28948 | 552 | PRKAA2 "5'-AMP-activated prote | 0.821 | 0.766 | 0.513 | 6.7e-119 | |
| UNIPROTKB|F1MBG5 | 559 | PRKAA1 "Uncharacterized protei | 0.8 | 0.737 | 0.536 | 1.4e-118 |
| TAIR|locus:2102132 KIN10 "AT3G01090" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2309 (817.9 bits), Expect = 1.5e-239, P = 1.5e-239
Identities = 435/515 (84%), Positives = 465/515 (90%)
Query: 1 MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
MDG+ S SGV+ LPNYKLG+TLGIGSFG+VKIAEHALTGHKVAIKILNRRKIKNMEM
Sbjct: 24 MDGSGTGSRSGVESILPNYKLGRTLGIGSFGRVKIAEHALTGHKVAIKILNRRKIKNMEM 83
Query: 61 EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
EEKVRREIKILRLFMHPHIIRLYEVIETP+DIY+VMEYV SGELFDYIVEKGRLQEDEAR
Sbjct: 84 EEKVRREIKILRLFMHPHIIRLYEVIETPTDIYLVMEYVNSGELFDYIVEKGRLQEDEAR 143
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSP
Sbjct: 144 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSP 203
Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL
Sbjct: 204 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 263
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKE 300
SPGARDLIPRML+VDPMKR+TIPEIRQHPWFQAHLPRYLAVPPPDT+QQAKKIDEEIL+E
Sbjct: 264 SPGARDLIPRMLVVDPMKRVTIPEIRQHPWFQAHLPRYLAVPPPDTVQQAKKIDEEILQE 323
Query: 301 VVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPI 360
V+ MGFD+N L+ESLRNR QN+ TV YYL+LDNRFR SSGYLGAEFQETME G R+HP
Sbjct: 324 VINMGFDRNHLIESLRNRTQNDGTVTYYLILDNRFRASSGYLGAEFQETME-GTPRMHPA 382
Query: 361 EPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGW 420
E SPV+HR PG M+YQG+GLR Q P ERKWALGLQSRAHPREIMTEVLKALQ+LNV W
Sbjct: 383 ESVASPVSHRLPGLMEYQGVGLRSQYPVERKWALGLQSRAHPREIMTEVLKALQDLNVCW 442
Query: 421 KKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLY 480
KKIGHYNMKCRW+P S +GM++N +H N+YFGDES+IIEN+ VKSPNVVKFE+QLY
Sbjct: 443 KKIGHYNMKCRWVPNSSA--DGMLSNSMHDNNYFGDESSIIENEAAVKSPNVVKFEIQLY 500
Query: 481 KTRDEKYLLDLQRVQGPQXXXXXXXXXXXXXXRVL 515
KTRD+KYLLDLQRVQGPQ RVL
Sbjct: 501 KTRDDKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL 535
|
|
| TAIR|locus:2094672 KIN11 "SNF1 kinase homolog 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2130 (754.9 bits), Expect = 1.4e-220, P = 1.4e-220
Identities = 406/499 (81%), Positives = 442/499 (88%)
Query: 1 MDGASNR-SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME 59
MD +SNR ++GV+ LPNYKLGKTLGIGSFGKVKIAEH +TGHKVAIKILNRRKIKNME
Sbjct: 1 MDHSSNRFGNNGVESILPNYKLGKTLGIGSFGKVKIAEHVVTGHKVAIKILNRRKIKNME 60
Query: 60 MEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA 119
MEEKVRREIKILRLFMHPHIIR YEVIET SDIYVVMEYVKSGELFDYIVEKGRLQEDEA
Sbjct: 61 MEEKVRREIKILRLFMHPHIIRQYEVIETTSDIYVVMEYVKSGELFDYIVEKGRLQEDEA 120
Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS 179
RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS+ N+KIADFGLSN+MRDGHFLKTSCGS
Sbjct: 121 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSRCNIKIADFGLSNVMRDGHFLKTSCGS 180
Query: 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH 239
PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH
Sbjct: 181 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH 240
Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILK 299
LS ARDLIPRMLIVDP+KRITIPEIRQH WFQ HLPRYLAV PPDT++QAKKI+EEI++
Sbjct: 241 LSSEARDLIPRMLIVDPVKRITIPEIRQHRWFQTHLPRYLAVSPPDTVEQAKKINEEIVQ 300
Query: 300 EVVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHP 359
EVV MGFD+NQ++ESLRNR QN+ATV YYLLLDNRFRV SGYL +EFQET +SG N +
Sbjct: 301 EVVNMGFDRNQVLESLRNRTQNDATVTYYLLLDNRFRVPSGYLESEFQETTDSGSNPMRT 360
Query: 360 IEPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVG 419
E SPV H P +D+ G+G R Q+P +RKWALGLQS AHPREIM EVLKALQELNV
Sbjct: 361 PEAGASPVGHWIPAHVDHYGLGARSQVPVDRKWALGLQSHAHPREIMNEVLKALQELNVC 420
Query: 420 WKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQL 479
WKKIGHYNMKCRW+PG++ MVNN LH F DES+IIE+D + SP V+KFE+QL
Sbjct: 421 WKKIGHYNMKCRWVPGLADGQNTMVNNQLH----FRDESSIIEDDCAMTSPTVIKFELQL 476
Query: 480 YKTRDEKYLLDLQRVQGPQ 498
YK R+EKYLLD+QRV GPQ
Sbjct: 477 YKAREEKYLLDIQRVNGPQ 495
|
|
| TAIR|locus:2175663 SnRK1.3 "SNF1-related protein kinase 1.3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1558 (553.5 bits), Expect = 1.4e-170, Sum P(2) = 1.4e-170
Identities = 303/463 (65%), Positives = 363/463 (78%)
Query: 1 MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
MDG+S ++++ + LPNY++GKTLG GSF KVK+A H TGHKVAIKILNR KIKNM +
Sbjct: 1 MDGSSEKTTNKLVSILPNYRIGKTLGHGSFAKVKLALHVATGHKVAIKILNRSKIKNMGI 60
Query: 61 EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
E KV+REIKILR MHPHIIR YEVIETP+DIYVVMEYVKSGELFDYIVEKG+LQEDEAR
Sbjct: 61 EIKVQREIKILRFLMHPHIIRQYEVIETPNDIYVVMEYVKSGELFDYIVEKGKLQEDEAR 120
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
+ FQQIISGVEYCHRNM+VHRDLKPEN+LLDS+ N+KI DFGLSN+M DGHFLKTSCGSP
Sbjct: 121 HLFQQIISGVEYCHRNMIVHRDLKPENVLLDSQCNIKIVDFGLSNVMHDGHFLKTSCGSP 180
Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 240
NYAAPEVISGK Y GP+VD+WSCGVILYALLCGTLPFDDENIPN+F+KIK G+YTLP+HL
Sbjct: 181 NYAAPEVISGKPY-GPDVDIWSCGVILYALLCGTLPFDDENIPNVFEKIKRGMYTLPNHL 239
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKE 300
S ARDLIPRML+VDP RI+I EIRQHPWF HLP YL++PP DT+ QAKKI+EEI++
Sbjct: 240 SHFARDLIPRMLMVDPTMRISITEIRQHPWFNNHLPLYLSIPPLDTIDQAKKIEEEIIQN 299
Query: 301 VVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFR--VSSGYLGAEFQETMESGFNRLH 358
VV +GFD+N +V+SL NR+QNEATVAY+L+LDNR + V + ++F+E + FN
Sbjct: 300 VVNIGFDRNHVVDSLANRIQNEATVAYHLILDNRNQNSVPNDPFQSKFKEISDGIFNSTL 359
Query: 359 PIEPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNV 418
P++ S V H Y GL+ + ++ W LGLQS+ P +IMTE+ KALQ L +
Sbjct: 360 PVQNITSHVGHSFSAL--Y---GLKSNVKDDKTWTLGLQSQGSPYDIMTEIFKALQNLKI 414
Query: 419 GWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAII 461
WKKIG YN+KCRW+ + + NH DE AII
Sbjct: 415 CWKKIGLYNIKCRWVRSFA----------YYKNHTIEDECAII 447
|
|
| DICTYBASE|DDB_G0277905 snfA "AMP-activated protein kinase alpha subunit" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 1099 (391.9 bits), Expect = 8.2e-126, Sum P(3) = 8.2e-126
Identities = 210/333 (63%), Positives = 266/333 (79%)
Query: 9 SSGVD---MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR 65
S G++ + NY+L KTLGIGSFGKVK+AEH TG KVAIKILNR KIKN++M+EK+R
Sbjct: 18 SGGIEKSSQIIGNYRLDKTLGIGSFGKVKLAEHIRTGVKVAIKILNRTKIKNLKMDEKIR 77
Query: 66 REIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQ 125
REI+ ++LF HPHII+LYEVIET +DI++VMEYV GELF+YIV+ G+L EDE+R FQQ
Sbjct: 78 REIQNMKLFRHPHIIKLYEVIETTTDIFMVMEYVTGGELFEYIVKNGKLLEDESRRLFQQ 137
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAA 184
+ISGV+YCH +MVVHRDLKPENLLLD +KIADFGLSN+M+DG FLKTSCGSPNYAA
Sbjct: 138 MISGVDYCHHHMVVHRDLKPENLLLDPINKCIKIADFGLSNMMQDGDFLKTSCGSPNYAA 197
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGA 244
PEVISGKLYAGPEVDVWSCGVILYA LC LPFDDE+IP LFKKI+ G++++P +SP
Sbjct: 198 PEVISGKLYAGPEVDVWSCGVILYAFLCAKLPFDDESIPMLFKKIREGVFSIPDFVSPSC 257
Query: 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKM 304
DLI +ML+VDP+KRITI EIR HPWFQ LP+YL+ P + + I+ IL E+V++
Sbjct: 258 ADLIKKMLVVDPVKRITIHEIRNHPWFQVKLPKYLSSPHTFLSKSIQTINNSILNEMVQV 317
Query: 305 --GFDQNQLVESLRNRLQ-NEATVAYYLLLDNR 334
D+ +++E L+ + N+ V+Y+LL+D++
Sbjct: 318 YAPIDRERIIEELQKSGEVNDLIVSYHLLVDSK 350
|
|
| UNIPROTKB|Q5RD00 PRKAA2 "5'-AMP-activated protein kinase catalytic subunit alpha-2" [Pongo abelii (taxid:9601)] | Back alignment and assigned GO terms |
|---|
Score = 1142 (407.1 bits), Expect = 3.2e-119, Sum P(2) = 3.2e-119
Identities = 228/442 (51%), Positives = 310/442 (70%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++ K++REI+ L+LF HP
Sbjct: 15 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 74
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
HII+LY+VI TP+D ++VMEYV GELFDYI + GR++E EAR FQQI+S V+YCHR+M
Sbjct: 75 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 134
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
VVHRDLKPEN+LLD+ N KIADFGLSNIM DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct: 135 VVHRDLKPENVLLDAHMNAKIADFGLSNIMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 194
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+ L+ ML VDP+
Sbjct: 195 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPL 254
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESLR 316
KR TI +IR+H WF+ LP YL P D A ID+E +KEV K +++++ SL
Sbjct: 255 KRATIKDIREHEWFKQDLPSYLF--PEDPSYDANVIDDEAVKEVCEKFECTESEVMNSLY 312
Query: 317 NR-LQNEATVAYYLLLDNRF---RVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAP 372
+ Q++ VAY+L++DNR + S YL + + +H I P + P R P
Sbjct: 313 SGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPSGSFMDDSAMH-IPPGLKPHPERMP 371
Query: 373 GF----------MDYQGMGLRGQLPYER-KWALGLQSRAHPREIMTEVLKALQELNVGWK 421
+D L ++ KW LG++S++ P +IM EV +A+++L+ WK
Sbjct: 372 PLIADSPKARCPLDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDFEWK 431
Query: 422 KIGHYNMKCRWIPGISGHHEGM 443
+ Y+++ R ++G++ M
Sbjct: 432 VVNAYHLRVRRKNPVTGNYVKM 453
|
|
| RGD|620893 Prkaa2 "protein kinase, AMP-activated, alpha 2 catalytic subunit" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1141 (406.7 bits), Expect = 4.1e-119, Sum P(2) = 4.1e-119
Identities = 231/444 (52%), Positives = 316/444 (71%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++ K++REI+ L+LF HP
Sbjct: 15 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 74
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
HII+LY+VI TP+D ++VMEYV GELFDYI + GR++E EAR FQQI+S V+YCHR+M
Sbjct: 75 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEVEARRLFQQILSAVDYCHRHM 134
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
VVHRDLKPEN+LLD++ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct: 135 VVHRDLKPENVLLDAQMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 194
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+ L+ ML VDP+
Sbjct: 195 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSIATLLMHMLQVDPL 254
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESLR 316
KR TI +IR+H WF+ LP YL P D A ID+E +KEV K +++++ SL
Sbjct: 255 KRATIKDIREHEWFKQDLPSYLF--PEDPSYDANVIDDEAVKEVCEKFECTESEVMNSLY 312
Query: 317 NR-LQNEATVAYYLLLDNRF---RVSSGYLGAE-----FQETMESGFN---RLHP--IEP 362
+ Q++ VAY+L++DNR + S YL + F + M + HP + P
Sbjct: 313 SGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPTGSFMDDMAMHIPPGLKPHPERMPP 372
Query: 363 AV--SPVAHRAPGFMDYQGMGLRGQLPYER-KWALGLQSRAHPREIMTEVLKALQELNVG 419
+ SP A R P +D L ++ KW LG++S++ P +IM EV +A+++L+
Sbjct: 373 LIADSPKA-RCP--LDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDFE 429
Query: 420 WKKIGHYNMKCRWIPGISGHHEGM 443
WK + Y+++ R ++G++ M
Sbjct: 430 WKVVNAYHLRVRRKNPVTGNYVKM 453
|
|
| FB|FBgn0023169 SNF1A "SNF1A/AMP-activated protein kinase" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 1051 (375.0 bits), Expect = 5.7e-119, Sum P(3) = 5.7e-119
Identities = 210/370 (56%), Positives = 270/370 (72%)
Query: 8 SSSGVDMF-LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR 66
S++G + + +Y LG TLG G+FGKVKI EH +T KVA+KILNR+KIK++++ K+RR
Sbjct: 16 SANGQPLVKIGHYLLGATLGTGTFGKVKIGEHQITRVKVAVKILNRQKIKSLDVVGKIRR 75
Query: 67 EIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQI 126
EI+ L+LF HPHII+LY+VI TPSDI+++MEYV GELFDYIV+ G+LQE +AR FFQQI
Sbjct: 76 EIQNLKLFRHPHIIKLYQVISTPSDIFMIMEYVSGGELFDYIVKHGKLQEHQARRFFQQI 135
Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
ISGV+YCHR+M+VHRDLKPENLLLD +VKIADFGLSN+M DG FL+TSCGSPNYAAPE
Sbjct: 136 ISGVDYCHRHMIVHRDLKPENLLLDHNMHVKIADFGLSNMMLDGEFLRTSCGSPNYAAPE 195
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARD 246
VISGKLYAGPEVD+WSCGVILYALLCGTLPFDDE++P LF+KIK GI+ +P +L+ +
Sbjct: 196 VISGKLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFRKIKSGIFPIPEYLNKQVVN 255
Query: 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEV-VKMG 305
L+ +ML VDP+KR I EI++H WFQ LP YL P Q + ID + EV K G
Sbjct: 256 LVCQMLQVDPLKRANIEEIKKHEWFQKDLPAYLF--PSSIEQDSNVIDTYAVAEVCTKFG 313
Query: 306 FDQNQLVESLRNR-LQNEATVAYYLLLDN-RFRVSSGYLGAEFQETMESGFNRLHPIEPA 363
+ ++ SL + ++ +AY+L++DN RF + E +G P P
Sbjct: 314 VKETEVHNSLLSGDPHDQLAIAYHLIIDNKRFADDAANQINEINNFFVAGSPPPPPPPPV 373
Query: 364 V-SPVAHRAP 372
S + H+AP
Sbjct: 374 PQSSMDHQAP 383
|
|
| UNIPROTKB|P54646 PRKAA2 "5'-AMP-activated protein kinase catalytic subunit alpha-2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1139 (406.0 bits), Expect = 6.7e-119, Sum P(2) = 6.7e-119
Identities = 227/442 (51%), Positives = 310/442 (70%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++ K++REI+ L+LF HP
Sbjct: 15 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 74
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
HII+LY+VI TP+D ++VMEYV GELFDYI + GR++E EAR FQQI+S V+YCHR+M
Sbjct: 75 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 134
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
VVHRDLKPEN+LLD+ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct: 135 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 194
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+ L+ ML VDP+
Sbjct: 195 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPL 254
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESLR 316
KR TI +IR+H WF+ LP YL P D A ID+E +KEV K +++++ SL
Sbjct: 255 KRATIKDIREHEWFKQDLPSYLF--PEDPSYDANVIDDEAVKEVCEKFECTESEVMNSLY 312
Query: 317 NR-LQNEATVAYYLLLDNRF---RVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAP 372
+ Q++ VAY+L++DNR + S YL + + +H I P + P R P
Sbjct: 313 SGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPSGSFMDDSAMH-IPPGLKPHPERMP 371
Query: 373 GF----------MDYQGMGLRGQLPYER-KWALGLQSRAHPREIMTEVLKALQELNVGWK 421
+D L ++ KW LG++S++ P +IM EV +A+++L+ WK
Sbjct: 372 PLIADSPKARCPLDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDFEWK 431
Query: 422 KIGHYNMKCRWIPGISGHHEGM 443
+ Y+++ R ++G++ M
Sbjct: 432 VVNAYHLRVRRKNPVTGNYVKM 453
|
|
| UNIPROTKB|Q28948 PRKAA2 "5'-AMP-activated protein kinase catalytic subunit alpha-2" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 1139 (406.0 bits), Expect = 6.7e-119, Sum P(2) = 6.7e-119
Identities = 227/442 (51%), Positives = 311/442 (70%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++ K++REI+ L+LF HP
Sbjct: 15 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 74
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
HII+LY+VI TP+D ++VMEYV GELFDYI + GR++E EAR FQQI+S V+YCHR+M
Sbjct: 75 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 134
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
VVHRDLKPEN+LLD++ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct: 135 VVHRDLKPENVLLDAQMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 194
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+ L+ ML VDP+
Sbjct: 195 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPL 254
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESLR 316
KR TI +IR+H WF+ LP YL P D A ID+E +KEV K +++++ SL
Sbjct: 255 KRATIKDIREHEWFKQDLPSYLF--PEDPSYDANVIDDEAVKEVCEKFECTESEVMNSLY 312
Query: 317 NR-LQNEATVAYYLLLDNRF---RVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAP 372
+ Q++ VAY+L++DNR + S YL + + +H I P + P R P
Sbjct: 313 SGDPQDQLAVAYHLVIDNRRIMNQASEFYLASSPPTGSFMDDSAMH-IPPGLKPHPERMP 371
Query: 373 GF----------MDYQGMGLRGQLPYER-KWALGLQSRAHPREIMTEVLKALQELNVGWK 421
+D L ++ KW LG++S++ P +IM EV +A+++L+ WK
Sbjct: 372 PLIADSPKARCPLDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDFEWK 431
Query: 422 KIGHYNMKCRWIPGISGHHEGM 443
+ Y+++ R ++G++ M
Sbjct: 432 VVNAYHLRVRRKNPVTGNYVKM 453
|
|
| UNIPROTKB|F1MBG5 PRKAA1 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1144 (407.8 bits), Expect = 1.4e-118, Sum P(2) = 1.4e-118
Identities = 227/423 (53%), Positives = 300/423 (70%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+Y LG TLG+G+FGKVK+ +H LTGHKVA+KILNR+KI+++++ K+RREI+ L+LF HP
Sbjct: 26 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 85
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
HII+LY+VI TPSDI++VMEYV GELFDYI + GRL E E+R FQQI+SGV+YCHR+M
Sbjct: 86 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 145
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
VVHRDLKPEN+LLD+ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct: 146 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 205
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
VD+WS GVILYALLCGTLPFDD+++P LFKKI GI+ P +L+P L+ ML VDPM
Sbjct: 206 VDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPM 265
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESLR 316
KR TI +IR+H WF+ LP+YL P D + ID+E LKEV K + +++ L
Sbjct: 266 KRATIKDIREHEWFKQDLPKYLF--PEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLY 323
Query: 317 NRL-QNEATVAYYLLLDNRFRVSSG---YLGAEFQETM--ESGFNRLHPIE-PAVSPVAH 369
NR Q+ VAY+L++DNR ++ YL ++ + R HP P +
Sbjct: 324 NRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETP 383
Query: 370 RAPGFMD-YQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNM 428
RA +D + Q + KW LG++S++ P +IM EV +A+++L+ WK + Y +
Sbjct: 384 RARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYL 443
Query: 429 KCR 431
+ R
Sbjct: 444 RVR 446
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q5RD00 | AAPK2_PONAB | 2, ., 7, ., 1, 1, ., 1 | 0.4827 | 0.8582 | 0.8007 | yes | no |
| P54646 | AAPK2_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.4807 | 0.8582 | 0.8007 | yes | no |
| Q95ZQ4 | AAPK2_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.5303 | 0.7980 | 0.6565 | yes | no |
| Q28948 | AAPK2_PIG | 2, ., 7, ., 1, 1, ., 1 | 0.4807 | 0.8582 | 0.8007 | yes | no |
| Q8BRK8 | AAPK2_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.4787 | 0.8582 | 0.8007 | yes | no |
| Q02723 | RKIN1_SECCE | 2, ., 7, ., 1, 1, ., 1 | 0.6813 | 0.9631 | 0.9880 | N/A | no |
| P92958 | KIN11_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8139 | 0.9922 | 0.9980 | no | no |
| Q38997 | KIN10_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8718 | 0.9941 | 0.9570 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.994 |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 515 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-114 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-104 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-82 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-78 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-74 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-71 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-70 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-66 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-66 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-66 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-60 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-60 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-59 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-56 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-54 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-53 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-53 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-53 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-53 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-51 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-51 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-50 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-50 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-49 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-49 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-48 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-48 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-47 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-46 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-46 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-46 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-46 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-46 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-45 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-45 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-45 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-45 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-45 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-44 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-44 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-44 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-44 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-44 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-44 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-44 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-44 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-43 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-43 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-43 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-43 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-42 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-42 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-42 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-41 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-41 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-41 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-41 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-41 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-41 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-41 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-40 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-40 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-40 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-40 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-39 | |
| cd12122 | 132 | cd12122, AMPKA_C, C-terminal regulatory domain of | 3e-39 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-39 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-38 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-38 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-37 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-37 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-37 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-37 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-37 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-36 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-36 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-36 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-36 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-36 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-35 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-35 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-35 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-35 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-35 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-35 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-35 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-35 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-35 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-35 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-35 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-35 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-35 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-35 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-35 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-35 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-35 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-34 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-34 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-34 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-34 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-34 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-34 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-33 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-33 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-33 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-32 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-32 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-32 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-32 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-32 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-32 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-32 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-31 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-31 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-31 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-31 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-31 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-31 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-31 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-31 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-31 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-31 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-31 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-31 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-31 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-30 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-30 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-30 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-30 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-30 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-30 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-30 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-30 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-30 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-30 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-29 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-29 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-29 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-29 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-28 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-28 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-28 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-28 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-28 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-28 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-28 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-27 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-27 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-27 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-27 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-27 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-27 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-26 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-26 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-26 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-26 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-26 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-26 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-26 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-25 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-25 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-25 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-25 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-25 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-25 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-25 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-25 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-25 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-25 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-24 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-24 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-24 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-24 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-24 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-24 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-24 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-23 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-23 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-23 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-23 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-23 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-23 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-23 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-22 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-22 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-22 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-21 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-21 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-21 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-20 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-19 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-19 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-19 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-18 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-18 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-17 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-16 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-14 | |
| pfam02149 | 46 | pfam02149, KA1, Kinase associated domain 1 | 3e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-14 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-12 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-12 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-11 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-11 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-09 | |
| cd12200 | 102 | cd12200, AMPKA2_C, C-terminal regulatory domain of | 9e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-08 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-07 | |
| cd12199 | 96 | cd12199, AMPKA1_C, C-terminal regulatory domain of | 5e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-06 | |
| pfam00627 | 37 | pfam00627, UBA, UBA/TS-N domain | 5e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| smart00165 | 37 | smart00165, UBA, Ubiquitin associated domain | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-05 | |
| cd00194 | 38 | cd00194, UBA, Ubiquitin Associated domain | 4e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 9e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 3e-04 | |
| cd12120 | 95 | cd12120, AMPKA_C_like, C-terminal regulatory domai | 5e-04 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 7e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.001 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.001 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 337 bits (868), Expect = e-114
Identities = 128/257 (49%), Positives = 172/257 (66%), Gaps = 7/257 (2%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
Y++ + LG GSFGKV +A TG VAIK++ ++KIK + E++ REIKIL+ HP+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK--KDRERILREIKILKKLKHPN 58
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
I+RLY+V E +Y+VMEY + G+LFD + ++GRL EDEAR + +QI+S +EY H +
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
VHRDLKPEN+LLD +VK+ADFGL+ + G L T G+P Y APEV+ GK Y G V
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGY-GKAV 177
Query: 199 DVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSH---LSPGARDLIPRMLIV 254
D+WS GVILY LL G PF D+ + LFKKI P +SP A+DLI ++L+
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVK 237
Query: 255 DPMKRITIPEIRQHPWF 271
DP KR+T E QHP+F
Sbjct: 238 DPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 313 bits (803), Expect = e-104
Identities = 127/261 (48%), Positives = 162/261 (62%), Gaps = 9/261 (3%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
Y+L + LG GSFG V A+H TG VA+KIL +R K + ++ RREI+ILR HP+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEK-SKKDQTARREIRILRRLSHPN 59
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
I+RL + E +Y+VMEY + G+LFDY+ G L EDEA+ QI+ G+EY H N +
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
+HRDLKPEN+LLD VKIADFGL+ +++ L T G+P Y APEV+ G GP+
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPN---LFKKIKGGIYTLP----SHLSPGARDLIPR 250
VDVWS GVILY LL G PF ENI + L ++I G S S A+DLI +
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239
Query: 251 MLIVDPMKRITIPEIRQHPWF 271
L DP KR T EI QHPWF
Sbjct: 240 CLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 255 bits (654), Expect = 3e-82
Identities = 104/251 (41%), Positives = 149/251 (59%), Gaps = 5/251 (1%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
LG GSFGKV + TG A+K+L ++KI + E E IL HP I++L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 85 VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
+T +Y+V+EY GELF ++ ++GR E+ AR + +I+ +EY H +++RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 145 PENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
PEN+LLD+ ++K+ DFGL+ + +G T CG+P Y APEV+ GK Y G VD WS
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWWSL 179
Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT-- 261
GV+LY +L G PF E+ +++KI P LSP ARDLI +L DP KR+
Sbjct: 180 GVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSG 239
Query: 262 -IPEIRQHPWF 271
EI+ HP+F
Sbjct: 240 GAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 245 bits (628), Expect = 8e-78
Identities = 108/261 (41%), Positives = 158/261 (60%), Gaps = 8/261 (3%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+++ KTLG GSFG+V + H +G A+KIL++ KI ++ E V E +IL+ HP
Sbjct: 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHP 61
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
++ LY + S++Y+VMEYV GELF ++ + GR E AR + Q++ +EY H
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD 121
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
+V+RDLKPENLLLDS +KI DFG + ++ + T CG+P Y APE+I K Y G
Sbjct: 122 IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY--TLCGTPEYLAPEIILSKGY-GKA 178
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
VD W+ G+++Y +L G PF D+N +++KI G PS SP A+DLI +L VD
Sbjct: 179 VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLT 238
Query: 258 KRI-----TIPEIRQHPWFQA 273
KR+ + +I+ HPWF
Sbjct: 239 KRLGNLKNGVNDIKNHPWFAG 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 234 bits (599), Expect = 1e-74
Identities = 105/248 (42%), Positives = 138/248 (55%), Gaps = 36/248 (14%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
LG G FG V +A TG KVAIKI+ K + + E++ REI+IL+ HP+I++LY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIK--KEDSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 85 VIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
V E + +Y+VMEY + G L D + E G+L EDE QI+ G+EY H N ++HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 144 KPENLLLDSK-WNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVW 201
KPEN+LLDS VK+ADFGLS ++ LKT G+P Y APEV+ GK Y + D+W
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178
Query: 202 SCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT 261
S GVILY L P +DLI +ML DP KR +
Sbjct: 179 SLGVILYEL-------------------------------PELKDLIRKMLQKDPEKRPS 207
Query: 262 IPEIRQHP 269
EI +H
Sbjct: 208 AKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 2e-71
Identities = 90/260 (34%), Positives = 138/260 (53%), Gaps = 12/260 (4%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK--VRREIKILRLFM 75
Y++ K +G GSFGKV + G +K ++ + NM +E+ E+KIL+
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID---LSNMSEKEREDALNEVKILKKLN 57
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI----VEKGRLQEDEARNFFQQIISGVE 131
HP+II+ YE E + +VMEY G+L I E E++ ++F Q+ ++
Sbjct: 58 HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISG 190
Y H ++HRD+KP+N+ L S VK+ DFG+S ++ KT G+P Y +PE+
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN 177
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIP 249
K Y + D+WS G +LY L PF+ EN+ L KI G Y +PS S R+L+
Sbjct: 178 KPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236
Query: 250 RMLIVDPMKRITIPEIRQHP 269
+L DP +R +I +I Q P
Sbjct: 237 SLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 226 bits (579), Expect = 1e-70
Identities = 95/280 (33%), Positives = 154/280 (55%), Gaps = 27/280 (9%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMH 76
++K GK +G GSF V +A+ T + AIKIL++R++ + + V+ E ++L RL H
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
P II+LY + ++Y V+EY +GEL YI + G L E R + +I+ +EY H
Sbjct: 62 PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIM---------------------RDGHFLKT 175
++HRDLKPEN+LLD ++KI DFG + ++ ++ +
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181
Query: 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT 235
G+ Y +PE+++ K AG D+W+ G I+Y +L G PF N F+KI Y+
Sbjct: 182 FVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240
Query: 236 LPSHLSPGARDLIPRMLIVDPMKRITI----PEIRQHPWF 271
P + P A+DLI ++L++DP R+ + E++ HP+F
Sbjct: 241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 2e-66
Identities = 93/258 (36%), Positives = 143/258 (55%), Gaps = 15/258 (5%)
Query: 28 GSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE 87
G++G+V +A+ TG AIK++ + + ++V E IL P++++LY +
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPEN 147
++Y+VMEY+ G+L + G L ED AR + +I+ +EY H N ++HRDLKP+N
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123
Query: 148 LLLDSKWNVKIADFGLS-------NIMRDGHFLKTS--CGSPNYAAPEVISGKLYAGPEV 198
+L+DS ++K+ DFGLS I + + G+P+Y APEVI G+ + V
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTV 182
Query: 199 DVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRMLIVDP 256
D WS G ILY L G PF E +F+ I G P +S A DLI ++L+ DP
Sbjct: 183 DWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDP 242
Query: 257 MKRI---TIPEIRQHPWF 271
KR+ +I EI+ HP+F
Sbjct: 243 EKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 213 bits (545), Expect = 7e-66
Identities = 94/264 (35%), Positives = 141/264 (53%), Gaps = 14/264 (5%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK--ILNRRKIKNMEMEEKVRREIKILRLFM 75
+ G+ LG GSFG V +A TG +A+K L+ + +E + REI+IL
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELE---ALEREIRILSSLQ 57
Query: 76 HPHIIRLY--EVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
HP+I+R Y E E + + + +EYV G L + + G+L E R + +QI+ G+ Y
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD---GHFLKTSCGSPNYAAPEVISG 190
H N +VHRD+K N+L+DS VK+ADFG + + D G + G+P + APEVI G
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLFKKIKGGIYT-LPSHLSPGARDL 247
+ Y G D+WS G + + G P+ + + L+K G +P HLS A+D
Sbjct: 178 EEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236
Query: 248 IPRMLIVDPMKRITIPEIRQHPWF 271
+ + L DP KR T E+ QHP+
Sbjct: 237 LRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 8e-66
Identities = 94/257 (36%), Positives = 143/257 (55%), Gaps = 10/257 (3%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
LG+G FG+V++ + A+K + +R I +E + E +IL HP I++LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 85 VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
+ IY++MEY GEL+ + ++G E AR + ++ EY H +++RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 145 PENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG 204
PENLLLDS VK+ DFG + ++ G T CG+P Y APE+I K Y VD WS G
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGY-DFSVDYWSLG 179
Query: 205 VILYALLCGTLPF--DDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIVDPMKRI 260
++LY LL G PF DDE+ ++ I G L P+++ A+DLI ++L +P +R+
Sbjct: 180 ILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERL 239
Query: 261 -----TIPEIRQHPWFQ 272
I +I++H WF
Sbjct: 240 GNLKGGIKDIKKHKWFN 256
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 203 bits (516), Expect = 2e-60
Identities = 98/282 (34%), Positives = 144/282 (51%), Gaps = 30/282 (10%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LFMH 76
+Y++ + LG GSFG+V +A VA+K+L ++ + E+ REI+IL L
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE---KGRLQEDEARNFFQQIISGVEYC 133
P+I++LY+ + +Y+VMEYV G L D + + KG L E EA QI+S +EY
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 134 HRNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDG-------HFLKTSCGSPNYAAP 185
H ++HRD+KPEN+LLD VK+ DFGL+ ++ D TS G+P Y AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 186 EVISGKL--YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----- 238
EV+ G YA D+WS G+ LY LL G PF+ E + + I LP+
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 239 --------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
+S A DL+ ++L DP R++ H
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 201 bits (512), Expect = 3e-60
Identities = 105/279 (37%), Positives = 160/279 (57%), Gaps = 13/279 (4%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L ++++G+TLG GSFG+V+IA+H TG AIK L +R+I M+ + V +E IL
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
HP I+ + + + +Y ++E+V GELF ++ + GR D A+ + +++ EY H
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
+++RDLKPENLLLD+K +VK+ DFG + + D F T CG+P Y APEVI K + G
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF--TLCGTPEYLAPEVIQSKGH-G 193
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
VD W+ GV+LY + G PF D+ +++KI G P+ ARDL+ +L D
Sbjct: 194 KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTD 253
Query: 256 PMKRI-TIP----EIRQHPWFQAH-----LPRYLAVPPP 284
KR+ T+ +++ HP+F RY P P
Sbjct: 254 HTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIP 292
|
Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 1e-59
Identities = 92/260 (35%), Positives = 151/260 (58%), Gaps = 8/260 (3%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+ + KT+G G+FG+V + ++ H A+K++ ++ ++ E+ V E ++L+ HP
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
IIRL+ +Y++MEYV GELF Y+ GR + +I+ +EY H
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE 121
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
+V+RDLKPEN+LLD + ++K+ DFG + +RD + T CG+P Y APEVI K +
Sbjct: 122 IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW--TLCGTPEYLAPEVIQSKGH-NKA 178
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
VD W+ G+++Y +L G PF D+N +++KI G P HL A+DLI ++L+VD
Sbjct: 179 VDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRT 238
Query: 258 KRI-----TIPEIRQHPWFQ 272
+R+ +++ H WF+
Sbjct: 239 RRLGNMKNGADDVKNHRWFK 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 2e-56
Identities = 95/297 (31%), Positives = 142/297 (47%), Gaps = 62/297 (20%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFM 75
KL K LG G++G V A TG VA+K KI+ EE + REI +L+
Sbjct: 3 KLEK-LGEGTYGVVYKARDKKTGEIVALK-----KIRLDNEEEGIPSTALREISLLKELK 56
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCH 134
HP+I++L +VI T +Y+V EY +L Y+ G L + ++ Q++ G+ YCH
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YA 183
+ ++HRDLKP+N+L++ +K+ADFGL+ + G P Y
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLA----------RAFGIPLRTYTHEVVTLWYR 165
Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFK--KIKG--------G 232
APE++ G + VD+WS G I ++ G F D I LFK +I G G
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPG 225
Query: 233 IYTLPSH------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
+ LP + L P DL+ +ML +P KRI+ E +HP+F
Sbjct: 226 VTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 8e-54
Identities = 86/264 (32%), Positives = 135/264 (51%), Gaps = 15/264 (5%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
Y++ +T+G GSFG V+ G + K ++ + E ++ V E+ ILR HP+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS-EVNILRELKHPN 60
Query: 79 IIRLY--EVIETPSDIYVVMEYVKSGELFDYI----VEKGRLQEDEARNFFQQIISGVEY 132
I+R Y + + +Y+VMEY + G+L I E+ ++E+ Q++ +
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 133 CHR-----NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC-GSPNYAAPE 186
CH N V+HRDLKP N+ LD+ NVK+ DFGL+ I+ + G+P Y +PE
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPE 180
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGAR 245
++ Y + D+WS G ++Y L + PF N L KIK G + +P S
Sbjct: 181 QLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELN 239
Query: 246 DLIPRMLIVDPMKRITIPEIRQHP 269
++I ML VDP KR + E+ Q P
Sbjct: 240 EVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 2e-53
Identities = 102/308 (33%), Positives = 162/308 (52%), Gaps = 16/308 (5%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIR 81
K LG GSFGKV +AE T A+K+L + I + E E ++L L HP + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
L+ +T ++ VMEYV G+L +I GR E AR + +I+ G+++ H +++R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 142 DLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
DLK +N+LLDS+ ++KIADFG+ + G T CG+P+Y APE++S + Y GP VD
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDW 179
Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
W+ GV+LY +L G PF+ ++ LF+ I P LS A+ ++ L +P KR+
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRL 239
Query: 261 TIP-----EIRQHPWFQ----AHLPRYLAVPPPDTMQQAKK----IDEEILKEVVKMGFD 307
+I+ HP+F+ L R PP + + D+E KE +
Sbjct: 240 GCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVLTPP 299
Query: 308 QNQLVESL 315
++ ++
Sbjct: 300 DEAIIRNI 307
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 3e-53
Identities = 85/256 (33%), Positives = 139/256 (54%), Gaps = 8/256 (3%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
+++ + +G G FG+V A H TG +VAIK++ +++ E +EK+ EI+IL+ HP+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHPN 58
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNM 137
I++ Y ++++VME+ G L D + + L E + ++++ G+EY H N
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
++HRD+K N+LL S VK+ DFGLS + D T G+P + APEVI+GK Y +
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY-DYK 177
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKI-KGGIYTL--PSHLSPGARDLIPRMLIV 254
D+WS G+ L G P+ + KI G L P S +D + + L
Sbjct: 178 ADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK 237
Query: 255 DPMKRITIPEIRQHPW 270
+P KR T ++ +HP+
Sbjct: 238 NPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 3e-53
Identities = 75/259 (28%), Positives = 137/259 (52%), Gaps = 6/259 (2%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+++L + +G G+FGKV I + T A+K +N++K V E +IL+ HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
++ L+ + ++Y+V++ + G+L ++ +K + E++ + + +I+ +EY H
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
++HRD+KP+N+LLD + +V I DF ++ + ++ G+P Y APEV+ + Y
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY-SVA 179
Query: 198 VDVWSCGVILYALLCGTLPF---DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254
VD WS GV Y L G P+ + K + P+ S A D I ++L
Sbjct: 180 VDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLER 239
Query: 255 DPMKRI--TIPEIRQHPWF 271
DP KR+ + +++ HP+F
Sbjct: 240 DPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 4e-53
Identities = 84/258 (32%), Positives = 134/258 (51%), Gaps = 8/258 (3%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
NY+LG +G G+FG V + TG VAIK ++ KIK ++ + +EI +L+ HP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHP 59
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
+I++ IET +Y+++EY ++G L I + G E + Q++ G+ Y H
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
V+HRD+K N+L VK+ADFG++ + + G+P + APEVI G
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS---GA 176
Query: 197 EV--DVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253
D+WS G + LL G P+ D N + LF+ ++ LP +SP +D + +
Sbjct: 177 STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236
Query: 254 VDPMKRITIPEIRQHPWF 271
DP R T ++ +HPW
Sbjct: 237 KDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-51
Identities = 90/268 (33%), Positives = 145/268 (54%), Gaps = 21/268 (7%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILN--------RRKIKNMEMEEKVRREIK 69
N++ GK LG G+FG+V + TG ++A+K + ++++ +E EI+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALE------CEIQ 56
Query: 70 ILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
+L+ H I++ Y + + + MEY+ G + D + G L E R + +QI+ G
Sbjct: 57 LLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEG 116
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFG----LSNIMRDGHFLKTSCGSPNYAAP 185
VEY H NM+VHRD+K N+L DS NVK+ DFG L I G +K+ G+P + +P
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFK-KIKGGIYTLPSHLSPG 243
EVISG+ Y G + DVWS G + +L P+ + E + +FK + LPSH+SP
Sbjct: 177 EVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPD 235
Query: 244 ARDLIPRMLIVDPMKRITIPEIRQHPWF 271
AR+ + R + + KR + E+ +H +
Sbjct: 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 3e-51
Identities = 96/255 (37%), Positives = 137/255 (53%), Gaps = 7/255 (2%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
K LG G+FGKV + TG A+KIL + I + E ++L+ HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
+T + VMEY GELF ++ + ED AR + +I+S + Y H VV+RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 143 LKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVW 201
LK ENL+LD ++KI DFGL + DG +KT CG+P Y APEV+ Y G VD W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 202 SCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI- 260
GV++Y ++CG LPF +++ LF+ I P LSP A+ L+ +L DP +R+
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239
Query: 261 ----TIPEIRQHPWF 271
EI +H +F
Sbjct: 240 GGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 1e-50
Identities = 107/306 (34%), Positives = 164/306 (53%), Gaps = 16/306 (5%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIR 81
K LG GSFGKV +AE T AIK L + + + E E ++L L + HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
L+ +T ++ VMEY+ G+L +I GR E AR + +II G+++ H+ +++R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 142 DLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
DLK +N+LLD ++KIADFG+ N+ +G T CG+P+Y APE++ G+ Y VD
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEGK-ASTFCGTPDYIAPEILKGQKYNE-SVD 178
Query: 200 VWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKR 259
WS GV+LY +L G PF E+ LF I P +S A+D + ++ DP KR
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKR 238
Query: 260 ITIP-EIRQHPWFQA----HLPRYLAVPPP-----DTMQQAKKIDEEILKEVVKMGFDQN 309
+ + +IRQHP+F+ L + +PPP + A D E E V++
Sbjct: 239 LGVDGDIRQHPFFRGIDWERLEKR-EIPPPFKPKVKSPSDASNFDREFTNEKVRLSPVDK 297
Query: 310 QLVESL 315
+L+ S+
Sbjct: 298 KLLASM 303
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 8e-50
Identities = 90/260 (34%), Positives = 135/260 (51%), Gaps = 16/260 (6%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK---NMEMEEKVRREIKILRLFMHPHI 79
K LG GS G V H TG A+K KI + E +++ RE+K LR P++
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALK-----KIHVDGDEEFRKQLLRELKTLRSCESPYV 61
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM-V 138
++ Y +I +V+EY+ G L D + + G++ E +QI+ G++Y H +
Sbjct: 62 VKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI 121
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYAGPE 197
+HRD+KP NLL++SK VKIADFG+S ++ + T G+ Y +PE I G+ Y+
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAA 181
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLF---KKI-KGGIYTLPSHL-SPGARDLIPRML 252
D+WS G+ L G PF P+ F + I G +LP+ SP RD I L
Sbjct: 182 -DIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACL 240
Query: 253 IVDPMKRITIPEIRQHPWFQ 272
DP KR + E+ QHP+ +
Sbjct: 241 QKDPKKRPSAAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 1e-49
Identities = 93/262 (35%), Positives = 137/262 (52%), Gaps = 20/262 (7%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH-----P 77
K + G+FG V +A+ TG AIK+L K +M + +V +K R M P
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVL---KKSDMIAKNQVT-NVKAERAIMMIQGESP 57
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
++ +LY ++ +Y+VMEY+ G+ I G L ED A+ + +++ GVE H+
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
++HRD+KPENLL+D ++K+ DFGLS R+G K G+P+Y APE I G
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGV-GDDKM 173
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH----LSPGARDLIPRMLI 253
D WS G +++ L G PF E +F I P SP A DLI R+L
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC 233
Query: 254 VDPMKRI---TIPEIRQHPWFQ 272
+DP KR+ EI+ HP+F+
Sbjct: 234 MDPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 7e-49
Identities = 90/289 (31%), Positives = 145/289 (50%), Gaps = 39/289 (13%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
YK+ +G G+ G V A+ TG VA+K + R+++ + + REIK L+ HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHP 59
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRN 136
++++L +V S +VMEY+ S L + + ++ R L E + +++ + ++ GV Y H N
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYA 194
++HRDLKP NLL+ + +KIADFGL+ + + S + Y APE++ G
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDEN-------------IPNLFKKIKGGIYTLPSH-- 239
P VD+W+ G I LL G+ F EN PN + G+ +LP +
Sbjct: 179 DPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNE--ETWPGLTSLPDYNK 236
Query: 240 -----------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
SP A DL+ +L+ DP KR++ E +HP+F
Sbjct: 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 4e-48
Identities = 90/290 (31%), Positives = 145/290 (50%), Gaps = 37/290 (12%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
++++ K +G G+FG+V + TG A+K+L + + VR E IL P
Sbjct: 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSP 61
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
I++LY + +Y+VMEY+ G+L + ++ K E+ AR + +++ ++ H+
Sbjct: 62 WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG 121
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-------------------------- 171
+HRD+KP+N+L+D+ ++K+ADFGL M
Sbjct: 122 FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181
Query: 172 ----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFK 227
++ G+P+Y APEV+ G Y G E D WS GVILY +L G PF + + +
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240
Query: 228 KIKGGIYTL--PSH--LSPGARDLIPRMLIVDPMKRIT-IPEIRQHPWFQ 272
KI +L P +SP A DLI R L+ DP R+ EI+ HP+F+
Sbjct: 241 KIINWKESLRFPPDPPVSPEAIDLICR-LLCDPEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 6e-48
Identities = 100/301 (33%), Positives = 141/301 (46%), Gaps = 63/301 (20%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK-------VRREIKI 70
Y+ GK LG G++ V A TG VAIK KIK E +E REIK+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIK-----KIKLGERKEAKDGINFTALREIKL 55
Query: 71 LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISG 129
L+ HP+II L +V S+I +V E++ +L I +K L + +++ + G
Sbjct: 56 LQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRG 114
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-------- 181
+EY H N ++HRDLKP NLL+ S +K+ADFGL+ S GSPN
Sbjct: 115 LEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLA----------RSFGSPNRKMTHQVV 164
Query: 182 ---YAAPEVISGKLYAGPEVDVWSCGVILYALLCGT--LPFD-----------------D 219
Y APE++ G + G VD+WS G I LL LP D +
Sbjct: 165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTE 224
Query: 220 ENIPNL--------FKKIKG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
EN P + FK + + S A DL+ R+L ++P KRIT + +HP+
Sbjct: 225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284
Query: 271 F 271
F
Sbjct: 285 F 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 2e-47
Identities = 91/300 (30%), Positives = 143/300 (47%), Gaps = 72/300 (24%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK-----VRREIKILRLFMHPHI 79
+G G++G+V A + TG VA+K KI+ ME E++ REIK+L+ HP+I
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALK-----KIR-MENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 80 IRLYEVI--ETPSDIYVVMEYVK---SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
+RL E++ + IY+V EY+ +G L V + E + + + +Q++ G++Y H
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEV---KFTESQIKCYMKQLLEGLQYLH 117
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN---------YAAP 185
N ++HRD+K N+L+++ +K+ADFGL+ T S + Y P
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPY-------TKRNSADYTNRVITLWYRPP 170
Query: 186 EVISG-KLYAGPEVDVWSCGVILYAL---------------------LCGTLPFDDENIP 223
E++ G Y GPEVD+WS G IL L LCG+ DEN P
Sbjct: 171 ELLLGATRY-GPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP--TDENWP 227
Query: 224 NLFKKIKGGIYTLPSH------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
+ K + P A DL+ ++L +DP KRI+ + QH +F
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 2e-46
Identities = 93/258 (36%), Positives = 144/258 (55%), Gaps = 9/258 (3%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIR 81
+ LG GSFGKV +A +G A+K+L + I + E E +IL L HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
LY +TP ++ VME+V G+L +I + R E AR + +I S + + H +++R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 142 DLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
DLK +N+LLD + + K+ADFG+ + +G T CG+P+Y APE++ LY GP VD
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSVDW 179
Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
W+ GV+LY +LCG PF+ EN +LF+ I P+ LS A D++ + +P R+
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRL 239
Query: 261 TI------PEIRQHPWFQ 272
I +HP+F+
Sbjct: 240 GSLTLGGEEAILRHPFFK 257
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 2e-46
Identities = 97/256 (37%), Positives = 140/256 (54%), Gaps = 8/256 (3%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
K LG G+FGKV + + TG A+KIL + I + E ++L+ HP + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH-RNMVVHR 141
+T + VMEY GELF ++ + ED AR + +I+S ++Y H VV+R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 142 DLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
DLK ENL+LD ++KI DFGL ++DG +KT CG+P Y APEV+ Y G VD
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 179
Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
W GV++Y ++CG LPF +++ LF+ I P LSP A+ L+ +L DP +R+
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239
Query: 261 -----TIPEIRQHPWF 271
EI QH +F
Sbjct: 240 GGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 3e-46
Identities = 94/301 (31%), Positives = 142/301 (47%), Gaps = 56/301 (18%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE----KVRREIKILRLF 74
Y+L K +G G++G V A TG KVAIK KI N+ + ++ REIK+LR
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIK-----KISNVFDDLIDAKRILREIKLLRHL 56
Query: 75 MHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
H +II L +++ PS D+Y+V E +++ +L I L +D + F QI+ G
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRG 115
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAA 184
++Y H V+HRDLKP N+L++S ++KI DFGL+ + D + + Y A
Sbjct: 116 LKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV-DPDEDEKGFLTEYVVTRWYRA 174
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLCGTLPF----------------------DDENI 222
PE++ +D+WS G I LL F D + I
Sbjct: 175 PELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234
Query: 223 PNLFKKIKGGIYTLPSH-----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
+ +K + + +LP SP A DL+ +ML+ DP KRIT E HP+
Sbjct: 235 TS--EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292
Query: 272 Q 272
Sbjct: 293 A 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 5e-46
Identities = 96/291 (32%), Positives = 141/291 (48%), Gaps = 49/291 (16%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFM 75
KLGK +G G++G V A LTG VAIK KIK E + REIK+L+
Sbjct: 3 KLGK-IGEGTYGVVYKARDKLTGEIVAIK-----KIKLRFESEGIPKTALREIKLLKELN 56
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCH 134
HP+II+L +V D+Y+V E++ + +L+ I ++ R L E +++ Q++ G+ +CH
Sbjct: 57 HPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-YAAPEVISGKLY 193
+ ++HRDLKPENLL++++ +K+ADFGL+ T Y APE++ G
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 194 AGPEVDVWSCGVILYALL------------------CGTL---------------PFDDE 220
VD+WS G I LL TL
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235
Query: 221 NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
+ P KK + L + SP A DL+ +ML DP KRIT + HP+F
Sbjct: 236 SFP---KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 6e-46
Identities = 94/258 (36%), Positives = 143/258 (55%), Gaps = 10/258 (3%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIR 81
LG GSFGKV +AE T AIKIL + I + E E ++L L P + +
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQ 65
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
L+ +T +Y VMEYV G+L +I + G+ +E A + +I G+ + H +++R
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYR 125
Query: 142 DLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
DLK +N++LD++ ++KIADFG+ NI G +T CG+P+Y APE+I+ + Y G VD
Sbjct: 126 DLKLDNVMLDAEGHIKIADFGMCKENIF-GGKTTRTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 200 VWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKR 259
W+ GV+LY +L G PFD E+ LF+ I + P LS A + +L P KR
Sbjct: 184 WWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKR 243
Query: 260 ITI-----PEIRQHPWFQ 272
+ +IR+H +F+
Sbjct: 244 LGCGPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 1e-45
Identities = 88/258 (34%), Positives = 133/258 (51%), Gaps = 10/258 (3%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK--VRREIKILRLFM 75
Y+ + +G G+FG V + V IK + ++ M +E+ + E ++L+L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIP---VEQMTKDERLAAQNECQVLKLLS 57
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYC 133
HP+II YE + +VMEY G L +YI ++ L ED +FF QI+ + +
Sbjct: 58 HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV 117
Query: 134 HRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL 192
H +++HRDLK +N+LLD V KI DFG+S I+ T G+P Y +PE+ GK
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKP 177
Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRM 251
Y + D+W+ G +LY L F+ N+P L KI G + + SP R LI M
Sbjct: 178 Y-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSM 236
Query: 252 LIVDPMKRITIPEIRQHP 269
L +DP KR + +I P
Sbjct: 237 LNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-45
Identities = 103/312 (33%), Positives = 168/312 (53%), Gaps = 15/312 (4%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIR 81
K LG GSFGKV +AE T AIK L + + + E E ++L L + HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
LY +T +++ VMEY+ G+L +I + A + +II G+++ H +V+R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 142 DLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
DLK +N+LLD+ ++KIADFG+ N++ D T CG+P+Y APE++ G+ Y VD
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQKY-NTSVD 178
Query: 200 VWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKR 259
WS GV+LY +L G PF + LF+ I+ P L+ A+D++ ++ + +P +R
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERR 238
Query: 260 ITIP-EIRQHPWFQ----AHLPRYLAVPP-PDTMQQA---KKIDEEILKEVVKMGFDQNQ 310
+ + +IRQHP+F+ + L PP ++ A D+E L E ++
Sbjct: 239 LGVKGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRLSVTDRM 298
Query: 311 LVESL-RNRLQN 321
L+ S+ +N +N
Sbjct: 299 LINSMDQNMFEN 310
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 3e-45
Identities = 99/289 (34%), Positives = 143/289 (49%), Gaps = 42/289 (14%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR-REIKILR-LFMH 76
YK+ K LG G+FG V +A + TG VAIK + ++K + E E + RE+K LR L H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWE--ECMNLREVKSLRKLNEH 57
Query: 77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIV--EKGRLQEDEARNFFQQIISGVEYCH 134
P+I++L EV ++Y V EY++ G L+ + + E R+ QI+ G+ + H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI--SGKL 192
++ HRDLKPENLL+ VKIADFGL+ +R + Y APE++ S
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTS- 175
Query: 193 YAGPEVDVWSCGVI---LYAL---------------LCGTL-PFDDENIPNLFK------ 227
Y+ P VD+W+ G I LY L +C L ++ P +K
Sbjct: 176 YSSP-VDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234
Query: 228 -----KIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
++ L + SP A DLI ML DP KR T + QHP+F
Sbjct: 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 3e-45
Identities = 82/257 (31%), Positives = 131/257 (50%), Gaps = 8/257 (3%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
++K+ K LG GS+G V + A+K ++ + E E+ V EI+IL HP
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHP 59
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYC 133
+II E + + +VMEY G+L I + + + E E F Q++ G++
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
H ++HRDLK N+LL + VKI D G+S +++ + KT G+P+Y APEV G+ Y
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVLK-KNMAKTQIGTPHYMAPEVWKGRPY 178
Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRML 252
+ D+WS G +LY + PF+ ++ +L K++ G Y +P S ++ I ML
Sbjct: 179 SYKS-DIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSML 237
Query: 253 IVDPMKRITIPEIRQHP 269
V P R +I P
Sbjct: 238 QVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 4e-45
Identities = 91/239 (38%), Positives = 132/239 (55%), Gaps = 2/239 (0%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
K LG G+FGKV + TG A+KIL + I + E ++L+ HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
+T + VMEY GELF ++ + E+ AR + +I+S +EY H VV+RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 143 LKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVW 201
+K ENL+LD ++KI DFGL + DG +KT CG+P Y APEV+ Y G VD W
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 202 SCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
GV++Y ++CG LPF +++ LF+ I P LSP A+ L+ +L DP +R+
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 1e-44
Identities = 87/260 (33%), Positives = 135/260 (51%), Gaps = 15/260 (5%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
+G G +G+V +A+ TG VA+K + + + + V E IL +++L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 85 VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
+ +Y+ MEYV G+ + G L ED AR + ++ V+ H +HRDLK
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128
Query: 145 PENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
PEN L+D+ ++K+ DFGLS I+ + + GSP+Y APEV+ GK Y VD WS
Sbjct: 129 PENFLIDASGHIKLTDFGLSKGIVTYAN---SVVGSPDYMAPEVLRGKGY-DFTVDYWSL 184
Query: 204 GVILYALLCGTLPFDD-------ENIPNLFKKIKGGIYTLPSH-LSPGARDLIPRMLIVD 255
G +LY LCG PF EN+ + ++ +Y P LS A DLI ++ I D
Sbjct: 185 GCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKL-IND 243
Query: 256 PMKRI-TIPEIRQHPWFQAH 274
P +R ++ +I+ HP+F+
Sbjct: 244 PSRRFGSLEDIKNHPFFKEV 263
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-44
Identities = 94/263 (35%), Positives = 144/263 (54%), Gaps = 17/263 (6%)
Query: 23 KTLGIGSFGKV----KIAEHALTGHKVAIKILNRRKI-KNMEMEEKVRREIKILRLFMHP 77
K LG G +GKV K+ TG A+K+L + I +N + + E IL HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGAD-TGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
I+ L +T +Y+++EY+ GELF ++ +G ED A + +I +E+ H+
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVI--SGKLYA 194
+++RDLKPEN+LLD++ +VK+ DFGL + +G T CG+ Y APE++ SG
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH--- 177
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254
G VD WS G ++Y +L G PF EN KI G LP +L+P ARDL+ ++L
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237
Query: 255 DPMKRI-----TIPEIRQHPWFQ 272
+P R+ E++ HP+F+
Sbjct: 238 NPSSRLGAGPGDAAEVQSHPFFR 260
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 1e-44
Identities = 95/310 (30%), Positives = 154/310 (49%), Gaps = 14/310 (4%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
+G GSFGKV T A+K + + I + E +L P I+ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 85 VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
++P +Y+V+ ++ GELF ++ +GR AR + +++ +E H+ V++RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 145 PENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
PEN+LLD + ++ + DFGL + M+D T CG+P Y APE++ G Y VD W+
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWWTL 179
Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI- 262
GV+LY +L G PF DEN+ +++KI P A+DL+ +L DP +R+
Sbjct: 180 GVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYN 239
Query: 263 --PEIRQHPWFQAHLPRYL---AVPPP-----DTMQQAKKIDEEILKEV-VKMGFDQNQL 311
EI+ HP+F + L + PP + DEE +E + D + L
Sbjct: 240 GAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTREKPIDSVVDDSHL 299
Query: 312 VESLRNRLQN 321
E+++ +
Sbjct: 300 SETVQQQFGG 309
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 1e-44
Identities = 94/257 (36%), Positives = 137/257 (53%), Gaps = 7/257 (2%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
K LG G+FGKV + +G A+KIL + I + E ++L+ HP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
+T + VMEYV GELF ++ + ED R + +I+S ++Y H +V+RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 143 LKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVW 201
LK ENL+LD ++KI DFGL + D +KT CG+P Y APEV+ Y G VD W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 202 SCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI- 260
GV++Y ++CG LPF +++ LF+ I P LS A+ L+ +LI DP KR+
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLG 239
Query: 261 ----TIPEIRQHPWFQA 273
EI +H +F
Sbjct: 240 GGPDDAKEIMRHSFFTG 256
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 2e-44
Identities = 88/272 (32%), Positives = 144/272 (52%), Gaps = 17/272 (6%)
Query: 18 NYKLGKTLGIGSFGKV----KIAEHALTGHKVAIKILNRRKI-KNMEMEEKVRREIKIL- 71
N++L + LG G++GKV K+ H G A+K+L + I + + E R E ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHD-AGKLYAMKVLKKATIVQKAKTAEHTRTERQVLE 59
Query: 72 RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 131
+ P ++ L+ +T + ++++++YV GELF ++ ++ E E R + +I+ ++
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD 119
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVIS 189
+ H+ +++RD+K EN+LLDS+ +V + DFGLS + CG+ Y APEVI
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179
Query: 190 GKLYA-GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT----LPSHLSPGA 244
G VD WS GV+ + LL G PF + N +I I P +S A
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239
Query: 245 RDLIPRMLIVDPMKRI---TIPEIRQHPWFQA 273
RD I ++L DP KR+ EI+ HP+FQ
Sbjct: 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 2e-44
Identities = 92/264 (34%), Positives = 144/264 (54%), Gaps = 10/264 (3%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
YK + +G G+ G+V A TG +VAIK + RK +N E + EI I++ HP+
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKE---LIINEILIMKDCKHPN 76
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM 137
I+ Y+ +++VVMEY+ G L D I + R+ E + ++++ G+EY H
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGP 196
V+HRD+K +N+LL +VK+ADFG + + + S G+P + APEVI K Y GP
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDY-GP 195
Query: 197 EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 253
+VD+WS G++ + G P+ E + LF GI L P SP +D + + L+
Sbjct: 196 KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLV 255
Query: 254 VDPMKRITIPEIRQHPWFQAHLPR 277
DP KR + E+ QHP+ + P+
Sbjct: 256 KDPEKRPSAEELLQHPFLKKACPK 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 3e-44
Identities = 97/295 (32%), Positives = 142/295 (48%), Gaps = 45/295 (15%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR---EIKILRLFM 75
+K K LG G G+V + TG A+K+L++ K M KV+R E +IL
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDK---KEMIKRNKVKRVLTEQEILATLD 59
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYC 133
HP + LY +T + + +VM+Y GELF + L E+ AR + +++ +EY
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSN--------IMRDGHFLKT---------- 175
H +V+RDLKPEN+LL ++ ++DF LS + +
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 176 -----------SC-GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP 223
S G+ Y APEVISG + G VD W+ G++LY +L GT PF N
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRD 238
Query: 224 NLFKKIKGGIYTLPSH--LSPGARDLIPRMLIVDPMKRI----TIPEIRQHPWFQ 272
F I T P +S ARDLI ++L+ DP KR+ EI+QHP+F+
Sbjct: 239 ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 5e-44
Identities = 96/287 (33%), Positives = 157/287 (54%), Gaps = 21/287 (7%)
Query: 18 NYKLGKTLGIGSFGKV----KIAEHALTGHKVAIKILNRRKI-KNMEMEEKVRREIKILR 72
N++L K LG G++GKV K+ H TG A+K+L + + + + E R E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHD-TGKLYAMKVLQKAALVQKAKTVEHTRTERNVLE 59
Query: 73 LFMH-PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 131
P ++ L+ +T + ++++++YV GE+F ++ ++ EDE R + +II +E
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE 119
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN--IMRDGHFLKTSCGSPNYAAPEVIS 189
+ H+ +V+RD+K EN+LLDS+ +V + DFGLS + + + CG+ Y APE+I
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR 179
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY----TLPSHLSPGAR 245
GK G VD WS G++++ LL G PF E N ++ I PS + P A+
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239
Query: 246 DLIPRMLIVDPMKRI-----TIPEIRQHPWFQAHLPRYLA---VPPP 284
DL+ ++L DP KR+ EI++HP+F+ LA V PP
Sbjct: 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPP 286
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-43
Identities = 87/256 (33%), Positives = 135/256 (52%), Gaps = 9/256 (3%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPHIIR 81
K +G GSFGKV +A+H G A+K+L ++ I + ++ + E +L + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
L+ +T +Y V++YV GELF ++ + E AR + +I S + Y H +++R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 142 DLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
DLKPEN+LLDS+ +V + DFGL I T CG+P Y APEV+ + Y VD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIEHSKT-TSTFCGTPEYLAPEVLRKQPY-DRTVD 178
Query: 200 VWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKR 259
W G +LY +L G PF + ++ I L ++S AR L+ +L D KR
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKR 238
Query: 260 I----TIPEIRQHPWF 271
+ EI+ H +F
Sbjct: 239 LGAKDDFLEIKNHVFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 1e-43
Identities = 95/305 (31%), Positives = 161/305 (52%), Gaps = 14/305 (4%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIR 81
K LG GSFGKV +AE G A+K L + + + E E ++L L + +P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
LY +T ++ VME++ G+L +I +KGR A + +I+ G+++ H +++R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 142 DLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
DLK +N++LD ++KIADFG+ N+ D T CG+P+Y APE++ G Y VD
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDNR-ASTFCGTPDYIAPEILQGLKYTF-SVD 178
Query: 200 VWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKR 259
WS GV+LY +L G PF ++ LF+ I+ P ++ ++D++ ++ DP +R
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRR 238
Query: 260 ITIP-EIRQHPWFQ----AHLPRYLAVPPPDTMQQA----KKIDEEILKEVVKMGFDQNQ 310
+ + IR HP+F+ L + PP ++ D E L E ++ +
Sbjct: 239 LGVVGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRLSYSDKN 298
Query: 311 LVESL 315
L++S+
Sbjct: 299 LIDSM 303
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 2e-43
Identities = 88/259 (33%), Positives = 140/259 (54%), Gaps = 10/259 (3%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIR 81
K LG GSFGKV +AE T AIK+L + I + + E +IL L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
L+ +T ++ VMEYV G+L I + E +R + ++ + + HR+ V++R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 142 DLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
DLK +N+LLD++ + K+ADFG+ + +G T CG+P+Y APE++ Y GP VD
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSVDW 179
Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
W+ GV++Y ++ G PF+ +N +LF+ I P LS A ++ + +P KR+
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRL 239
Query: 261 -------TIPEIRQHPWFQ 272
I+QHP+F+
Sbjct: 240 GCVASQGGEDAIKQHPFFK 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 5e-43
Identities = 84/268 (31%), Positives = 132/268 (49%), Gaps = 15/268 (5%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRLF 74
+ G+ LG G+F A TG +A+K + + + E E E +R+EI+++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
HPHIIR+ S + +E++ G + + + G +E N+ +Q++ G+ Y H
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH 120
Query: 135 RNMVVHRDLKPENLLLDSK-WNVKIADFGL-----SNIMRDGHFLKTSCGSPNYAAPEVI 188
N ++HRD+K NLL+DS ++IADFG + G F G+ + APEV+
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN---LFKKIKGGIYT--LPSHLSPG 243
G+ Y G DVWS G ++ + P++ E N L KI +P HLSPG
Sbjct: 181 RGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239
Query: 244 ARDLIPRMLIVDPMKRITIPEIRQHPWF 271
RD+ R L + P R E+ +HP F
Sbjct: 240 LRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 7e-43
Identities = 81/258 (31%), Positives = 132/258 (51%), Gaps = 14/258 (5%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
LGK LG G+FG+V + G K VA+K L ++ + + E+ RE +I+R
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL--KEDASEQQIEEFLREARIMRKLD 59
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
HP++++L V +Y+VMEY++ G+L Y+ + + +L + +F QI G+EY
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSP-NYAAPEVISGKL 192
+HRDL N L+ VKI+DFGLS ++ D ++ K P + APE +
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 193 YAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIP 249
+ + DVWS GV+L+ + G P+ + + + +K G Y L P + P DL+
Sbjct: 180 F-TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG-YRLPQPPNCPPELYDLML 237
Query: 250 RMLIVDPMKRITIPEIRQ 267
+ DP R T E+ +
Sbjct: 238 QCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 2e-42
Identities = 82/261 (31%), Positives = 132/261 (50%), Gaps = 16/261 (6%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILN--------RRKIKNMEMEEKVRREIKI 70
++ G+ LG GSFG V + G A+K ++ + +K +E +EI +
Sbjct: 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLE------QEIAL 55
Query: 71 LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGV 130
L HP+I++ ++Y+ +E V G L + + G E R + +QI+ G+
Sbjct: 56 LSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGL 115
Query: 131 EYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
EY H VHRD+K N+L+D+ VK+ADFG++ + + F K+ GSP + APEVI+
Sbjct: 116 EYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIY-TLPSHLSPGARDLI 248
+ G D+WS G + + G P+ E + +FK + +P HLS A+D I
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI 235
Query: 249 PRMLIVDPMKRITIPEIRQHP 269
+ L DP R T E+ +HP
Sbjct: 236 LKCLQRDPSLRPTAAELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 2e-42
Identities = 87/269 (32%), Positives = 140/269 (52%), Gaps = 24/269 (8%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKIL----NRRKIKNMEMEEKVRREIKILRLF 74
++ G +G G+FGKV A + TG +A+K + N K +++ E+K+L L
Sbjct: 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPK-----TIKEIADEMKVLELL 56
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA--RNFFQQIISGVEY 132
HP++++ Y V +Y+ MEY G L + ++E GR+ DE R + Q++ G+ Y
Sbjct: 57 KHPNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRI-LDEHVIRVYTLQLLEGLAY 114
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-----GHFLKTSCGSPNYAAPEV 187
H + +VHRD+KP N+ LD +K+ DFG + +++ G +++ G+P Y APEV
Sbjct: 115 LHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 188 ISGKLYAGPE--VDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLPSH--LS 241
I+G G D+WS G ++ + G P+ D +F G +P LS
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLS 234
Query: 242 PGARDLIPRMLIVDPMKRITIPEIRQHPW 270
P +D + R L DP KR T E+ QHP+
Sbjct: 235 PEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 9e-42
Identities = 91/268 (33%), Positives = 141/268 (52%), Gaps = 23/268 (8%)
Query: 28 GSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE 87
G++G V + H T + A+K +N++ + ++V E IL +P ++ ++ E
Sbjct: 12 GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71
Query: 88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPEN 147
T + +VMEYV+ G+ + G L D AR +F + + +EY H +VHRDLKP+N
Sbjct: 72 TKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDN 131
Query: 148 LLLDSKWNVKIADFGLSNI--------MRDGH-------FL-KTSCGSPNYAAPEVISGK 191
LL+ S ++K+ DFGLS I + +GH FL K CG+P Y APEVI +
Sbjct: 132 LLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ 191
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH---LSPGARDLI 248
Y P VD W+ G+ILY L G +PF + LF ++ P L A+DLI
Sbjct: 192 GYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLI 250
Query: 249 PRMLIVDPMKRITIP---EIRQHPWFQA 273
R+L +P++R+ E++QH +F
Sbjct: 251 SRLLRQNPLERLGTGGAFEVKQHRFFLG 278
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-41
Identities = 82/261 (31%), Positives = 126/261 (48%), Gaps = 19/261 (7%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHK------VAIKILNRRKIKNMEMEEKVRREIKILRL 73
LGK LG G+FG+V L G VA+K L ++ + + E+ RE +I+R
Sbjct: 2 TLGKKLGEGAFGEVYKGT--LKGKGDGKEVEVAVKTL--KEDASEQQIEEFLREARIMRK 57
Query: 74 FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVE 131
HP+I++L V + +VMEY+ G+L DY+ + L + +F QI G+E
Sbjct: 58 LDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME 117
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG-SP-NYAAPEVIS 189
Y +HRDL N L+ VKI+DFGLS + D + K G P + APE +
Sbjct: 118 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 190 GKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARD 246
+ + DVWS GV+L+ + G P+ + + + +K G Y L P + P
Sbjct: 178 EGKF-TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG-YRLPKPPNCPPELYK 235
Query: 247 LIPRMLIVDPMKRITIPEIRQ 267
L+ + DP R T E+ +
Sbjct: 236 LMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-41
Identities = 96/274 (35%), Positives = 143/274 (52%), Gaps = 15/274 (5%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
LG G FG+V + TG A K L+++++K + E+ E KIL I+ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 85 VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRNMVVHRD 142
ET D+ +VM + G+L +I G EAR F QII G+E+ H+ +V+RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
LKPEN+LLD NV+I+D GL+ ++ G +K G+P Y APEV+ G++Y VD ++
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS-VDWFA 179
Query: 203 CGVILYALLCGTLPFDD--ENIPN--LFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMK 258
G LY ++ G PF E + L ++ P SP A+DL +L DP K
Sbjct: 180 LGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK 239
Query: 259 RI-----TIPEIRQHPWFQA-HLPRYLA--VPPP 284
R+ + E+R+HP F+ + R A + PP
Sbjct: 240 RLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPP 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 90/295 (30%), Positives = 145/295 (49%), Gaps = 48/295 (16%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
K +G G+FG+V++ + TGH A+K L + ++ E VR E IL +P +++L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
Y + + +Y++MEY+ G++ +++K E+E R + + I ++ H+ +HRD
Sbjct: 67 YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRD 126
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGH---------------FLKTSC---------- 177
+KP+NLLLD+K ++K++DFGL ++ H FL
Sbjct: 127 IKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAE 186
Query: 178 --------------GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP 223
G+P+Y APEV Y E D WS GVI+Y +L G PF +N
Sbjct: 187 TWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCSDNPQ 245
Query: 224 NLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIP---EIRQHPWF 271
++KI TL LSP A+DLI R+ + +R+ EI+ HP+F
Sbjct: 246 ETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF 299
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 87/264 (32%), Positives = 143/264 (54%), Gaps = 17/264 (6%)
Query: 17 PNYKLG--KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
P L +G GS G V IA TG +VA+K ++ RK + E+ + E+ I+R +
Sbjct: 17 PRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL---LFNEVVIMRDY 73
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
HP+I+ +Y +++VVME+++ G L D IV R+ E++ ++ + + H
Sbjct: 74 QHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLH 132
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
V+HRD+K +++LL S VK++DFG + + ++ K+ G+P + APEVIS Y
Sbjct: 133 AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY 192
Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------SPGARDL 247
G EVD+WS G+++ ++ G P+ +E K+I+ LP L SP R
Sbjct: 193 -GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD---NLPPKLKNLHKVSPRLRSF 248
Query: 248 IPRMLIVDPMKRITIPEIRQHPWF 271
+ RML+ DP +R T E+ HP+
Sbjct: 249 LDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 96/255 (37%), Positives = 146/255 (57%), Gaps = 8/255 (3%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP-HIIRLY 83
LG GSFGKV +AE T AIKIL + + + E E ++L L P + +L+
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 84 EVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
+T +Y VMEYV G+L +I + G+ +E +A + +I G+ + HR +++RDL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 144 KPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
K +N++LDS+ ++KIADFG+ M DG +T CG+P+Y APE+I+ + Y G VD W+
Sbjct: 128 KLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWA 186
Query: 203 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI 262
GV+LY +L G PFD E+ LF+ I + P LS A + ++ P KR+
Sbjct: 187 YGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246
Query: 263 -PE----IRQHPWFQ 272
PE IR+H +F+
Sbjct: 247 GPEGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 4e-41
Identities = 82/246 (33%), Positives = 128/246 (52%), Gaps = 6/246 (2%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
++++ +G GSFG V A+K ++ K+ E EE + E ++L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSS 59
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGR-LQEDEARNFFQQIISGVEYCHR 135
+IIR YE + +VMEY ++G+L + +++GR L ED+ FF QI+ G+ + H
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYA 194
++HRD+K NL LD+ NVKI D G++ ++ D +F T G+P Y +PE+ K Y
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY- 178
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLI 253
+ DVW+ GV+LY G PFD N L KI G++ + S LI + L
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLT 238
Query: 254 VDPMKR 259
D +R
Sbjct: 239 KDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 7e-41
Identities = 95/296 (32%), Positives = 140/296 (47%), Gaps = 52/296 (17%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILR-- 72
Y+ +G G++G V A TG VA+K K++ EE + REI +L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALK-----KVRVPLSEEGIPLSTLREIALLKQL 55
Query: 73 -LFMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYI---VEKGRLQEDEARNFF 123
F HP+I+RL +V P + +V E+V +L Y+ + G L + ++
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG-LPPETIKDLM 113
Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC-GSPNY 182
+Q++ GV++ H + +VHRDLKP+N+L+ S VKIADFGL+ I TS + Y
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY-SFEMALTSVVVTLWY 172
Query: 183 AAPEVISGKLYAGPEVDVWSCGVILY------ALLCGT--------------LPFDDENI 222
APEV+ YA P VD+WS G I L GT LP ++E
Sbjct: 173 RAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231
Query: 223 PN-LFKKIKGGIYTLPS------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
N + YT S + DL+ +ML +P KRI+ E QHP+F
Sbjct: 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 1e-40
Identities = 88/260 (33%), Positives = 128/260 (49%), Gaps = 14/260 (5%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR----EIKILRL 73
+Y + LG G+FG+ + V K +N + EK RR EI IL L
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLT-----RLSEKERRDALNEIVILSL 55
Query: 74 FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRL-QEDEARNFFQQIISGVE 131
HP+II Y + + + MEY G L+D IV KG+L +E+ + QI+S V
Sbjct: 56 LQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS 115
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC-GSPNYAAPEVISG 190
Y H+ ++HRD+K N+ L +K+ DFG+S I+ + + + G+P Y +PE+ G
Sbjct: 116 YIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG 175
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIP 249
Y + D+W+ G +LY LL FD N NL KI G YT + S S L+
Sbjct: 176 VKYNF-KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVH 234
Query: 250 RMLIVDPMKRITIPEIRQHP 269
+L DP KR T E+ P
Sbjct: 235 SLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 2e-40
Identities = 95/278 (34%), Positives = 139/278 (50%), Gaps = 26/278 (9%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIR 81
LG G FGKV +AE+ TG AIK L + I + E + E +I HP ++
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
L+ +T + VMEY G+L +I E A + ++ G++Y H N +V+R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 142 DLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTS--CGSPNYAAPEVISGKLYAGPEV 198
DLK +NLLLD++ VKIADFGL M G +TS CG+P + APEV++ Y V
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGLCKEGM--GFGDRTSTFCGTPEFLAPEVLTETSY-TRAV 182
Query: 199 DVWSCGVILYALLCGTLPF--DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256
D W GV++Y +L G PF DDE +F I P LS A ++ R+L +P
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEE--EVFDSIVNDEVRYPRFLSREAISIMRRLLRRNP 240
Query: 257 MKRI-----TIPEIRQHPWF-----QAHLPRYLAVPPP 284
+R+ ++++ P+F L R + PP
Sbjct: 241 ERRLGSGEKDAEDVKKQPFFRDINWDDLLAR--KIKPP 276
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 4e-40
Identities = 85/273 (31%), Positives = 154/273 (56%), Gaps = 19/273 (6%)
Query: 18 NYKLGKTLGIGSFGKV----KIAEHALTGHKVAIKILNRRKI-KNMEMEEKVRREIKILR 72
N++L K LG G++GKV K++ H +G A+K+L + I + + E R E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHD-SGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59
Query: 73 -LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 131
+ P ++ L+ +T + ++++++Y+ GELF ++ ++ R +E E + + +I+ +E
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALE 119
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN--IMRDGHFLKTSCGSPNYAAPEVIS 189
+ H+ +++RD+K EN+LLDS +V + DFGLS + + CG+ Y AP+++
Sbjct: 120 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179
Query: 190 GKLYAGPE-VDVWSCGVILYALLCGTLPF----DDENIPNLFKKIKGGIYTLPSHLSPGA 244
G + VD WS GV++Y LL G PF + + + ++I P +S A
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239
Query: 245 RDLIPRMLIVDPMKRI-----TIPEIRQHPWFQ 272
+D+I R+L+ DP KR+ EI++HP+FQ
Sbjct: 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQ 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 5e-40
Identities = 94/262 (35%), Positives = 144/262 (54%), Gaps = 8/262 (3%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
++ LG GSFGKV +AE T AIKIL + + + E E ++L L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 78 -HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
+ +L+ +T +Y VMEYV G+L I + GR +E A + +I G+ + H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
+++RDLK +N++LDS+ ++KIADFG+ M DG KT CG+P+Y APE+I+ + Y G
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-G 179
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
VD W+ GV+LY +L G PF+ E+ LF+ I P +S A + ++
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH 239
Query: 256 PMKRITI-PE----IRQHPWFQ 272
P KR+ PE I++H +F+
Sbjct: 240 PGKRLGCGPEGERDIKEHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 95/294 (32%), Positives = 149/294 (50%), Gaps = 55/294 (18%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFM 75
K+ K +G G++G V A LTG VA+K KI+ +E V REI +L+
Sbjct: 3 KVEK-IGEGTYGVVYKARDKLTGEIVALK-----KIRLETEDEGVPSTAIREISLLKELN 56
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA--RNFFQQIISGVEYC 133
HP+I+RL +V+ + + +Y+V E++ +L Y+ D +++ Q++ G+ YC
Sbjct: 57 HPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI----MRD-GHFLKTSCGSPNYAAPEVI 188
H + V+HRDLKP+NLL+D + +K+ADFGL+ +R H + T Y APE++
Sbjct: 116 HSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLW----YRAPEIL 171
Query: 189 SG-KLYAGPEVDVWSCGVILYALLCGTLPF--DDENIPNLFK--KIKG--------GIYT 235
G + Y+ P VD+WS G I +A + P D I LF+ + G G+ +
Sbjct: 172 LGSRQYSTP-VDIWSIGCI-FAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229
Query: 236 LPSH------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
LP + L DL+ +ML+ DP KRI+ QHP+F
Sbjct: 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|213378 cd12122, AMPKA_C, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha catalytic subunit | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 3e-39
Identities = 55/143 (38%), Positives = 72/143 (50%), Gaps = 30/143 (20%)
Query: 389 ERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPL 448
ER+W LG++S++HP EIM EV +AL+ L WKKI Y++KCRW + G G
Sbjct: 1 ERRWHLGIRSQSHPHEIMLEVYRALKALGFEWKKISPYHIKCRWKNPVVGKPGGS----- 55
Query: 449 HSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRV-------------- 494
ES+ + G + P VVK E+QLYK D KYLLD Q +
Sbjct: 56 ------SGESSSADGPGAARQPTVVKMELQLYKVDDNKYLLDFQSLDYEEERTGPGESAE 109
Query: 495 -----QGPQFLFLDLCAAFLAQL 512
G FLF DLCA + +L
Sbjct: 110 DAEPQVGSTFLFFDLCAKLITEL 132
|
AMPK, a serine/threonine protein kinase (STK), catalyzes the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. It acts as a sensor for the energy status of the cell and is activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. AMPK is a heterotrimer of three subunits: alpha, beta, and gamma. Co-expression of the three subunits is required for kinase activity; in the absence of one, the other two subunits get degraded. The AMPK alpha subunit is the catalytic subunit and it contains an N-terminal kinase domain and a C-terminal regulatory domain (RD). Vertebrates contain two isoforms of the alpha subunit, alpha1 and alpha2, which are encoded by different genes, PRKAA1 and PRKAA2, respectively. The C-terminal RD of the AMPK alpha subunit is involved in AMPK heterotrimer formation. It mainly interacts with the C-terminal region of the beta subunit to form a tight alpha-beta complex that is associated with the gamma subunit. The AMPK alpha subunit RD also contains an auto-inhibitory region that interacts with the kinase domain; this inhibition is negated by the interaction with the AMPK gamma subunit. AMPK is conserved throughout evolution; the AMPK alpha subunit homologs in yeast and plants are called Snf1 and SnRK1 (Snf1 related kinase), respectively. Length = 132 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 7e-39
Identities = 83/256 (32%), Positives = 139/256 (54%), Gaps = 9/256 (3%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR---LFMHPHIIR 81
+G G+FG+V T A+K+L++++I + E IL L P I+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
L +T SD+Y+V +Y+ GELF ++ ++GR ED A+ + +++ +E+ H+ +V+R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 142 DLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
DLKPEN+LLD+ ++ + DFGLS + D T CG+ Y APEV+ + VD
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180
Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH-LSPGARDLIPRMLIVDPMKR 259
WS GV+++ + CG PF E+ +++ I G P + LS R + +L +P R
Sbjct: 181 WSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240
Query: 260 I----TIPEIRQHPWF 271
+ E+++HP+F
Sbjct: 241 LGAHRDAVELKEHPFF 256
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 6e-38
Identities = 88/256 (34%), Positives = 136/256 (53%), Gaps = 9/256 (3%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPHIIR 81
K +G GSFGKV +A H A+K+L ++ I + E+ + E +L + HP ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
L+ +T +Y V++Y+ GELF ++ + E AR + +I S + Y H +V+R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 142 DLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
DLKPEN+LLDS+ ++ + DFGL NI +G T CG+P Y APEV+ + Y VD
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGT-TSTFCGTPEYLAPEVLHKQPY-DRTVD 178
Query: 200 VWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKR 259
W G +LY +L G PF N ++ I L +++ AR L+ +L D KR
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKR 238
Query: 260 I----TIPEIRQHPWF 271
+ EI+ H +F
Sbjct: 239 LGAKDDFMEIKNHIFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 6e-38
Identities = 109/344 (31%), Positives = 163/344 (47%), Gaps = 63/344 (18%)
Query: 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRL 73
P Y+ +G G++G V A H TG KVAIK KI E + ++ REIKILR
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK-----KISPFEHQTFCQRTLREIKILRR 59
Query: 74 FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
F H +II + ++I PS D+Y+V E +++ +L+ I + L D + F QI+
Sbjct: 60 FKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILR 117
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAA 184
G++Y H V+HRDLKP NLLL++ ++KI DFGL+ I H FL + Y A
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177
Query: 185 PEV-ISGKLYAGPEVDVWSCGVILYALLCGTLPF----------------------DDEN 221
PE+ ++ K Y +D+WS G IL +L F D
Sbjct: 178 PEIMLNSKGYT-KAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236
Query: 222 IPNLFKKIKGGIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
I + + + I +LP + P A DL+ +ML +P KRIT+ E HP+
Sbjct: 237 IIS--LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294
Query: 271 FQA-HLPR---YLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQ 310
+ H P P P + + +E LKE++ F++
Sbjct: 295 LEQYHDPSDEPVAEEPFPFDFELFDDLPKEKLKELI---FEEIM 335
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 84/255 (32%), Positives = 132/255 (51%), Gaps = 7/255 (2%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI-KNMEMEEKVRREIKILRLFMHPHIIR 81
K +G GSFGKV +A+ G A+K+L ++ I K E + +L+ HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
L+ +T +Y V++YV GELF ++ + E AR + ++ S + Y H +++R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 142 DLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
DLKPEN+LLDS+ +V + DFGL + T CG+P Y APEV+ + Y VD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPY-DRTVDW 179
Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
W G +LY +L G PF ++ ++ I LP + A DL+ +L D +R+
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRL 239
Query: 261 ----TIPEIRQHPWF 271
EI+ H +F
Sbjct: 240 GAKADFLEIKNHVFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 2e-37
Identities = 77/251 (30%), Positives = 136/251 (54%), Gaps = 6/251 (2%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
K +G GSFGK + + G + IK +N K+ E EE R+E+ +L HP+I++
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPNIVQY 64
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYI-VEKGRL-QEDEARNFFQQIISGVEYCHRNMVVH 140
E E ++Y+VM+Y + G+L+ I ++G L ED+ ++F QI +++ H ++H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILH 124
Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC-GSPNYAAPEVISGKLYAGPEVD 199
RD+K +N+ L +K+ DFG++ ++ L +C G+P Y +PE+ + Y + D
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNN-KSD 183
Query: 200 VWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMK 258
+W+ G +LY + F+ N+ NL KI G Y + SH S R+L+ ++ +P
Sbjct: 184 IWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRD 243
Query: 259 RITIPEIRQHP 269
R ++ I +
Sbjct: 244 RPSVNSILEKN 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 2e-37
Identities = 87/261 (33%), Positives = 144/261 (55%), Gaps = 12/261 (4%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKIL--NRRKIKNMEMEEKVRREIKILRLFM 75
N++LGK LG G+FG+V + A TG ++A+K + + + + + EI++L+ +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 76 HPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
H I++ Y + P + + + ME++ G + D + G L E+ R + +QI+ GV Y
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFG----LSNIMRDGHFLKTSCGSPNYAAPEVIS 189
H NM+VHRD+K N+L DS NVK+ DFG L I G +K+ G+P + +PEVIS
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFK-KIKGGIYTLPSHLSPGARDL 247
G+ Y G + D+WS G + +L P+ + E + +FK + LP H+S RD
Sbjct: 183 GEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF 241
Query: 248 IPRMLIVDPMKRITIPEIRQH 268
+ R+ V+ R + E+ +H
Sbjct: 242 LKRIF-VEAKLRPSADELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 139 bits (350), Expect = 3e-37
Identities = 88/273 (32%), Positives = 152/273 (55%), Gaps = 14/273 (5%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
+G GS G V IA +G +VA+K+++ RK + E+ + E+ I+R + H +++ +Y+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRREL---LFNEVVIMRDYQHQNVVEMYK 85
Query: 85 VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
+++V+ME+++ G L D IV + RL E++ + ++ + Y H V+HRD+K
Sbjct: 86 SYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144
Query: 145 PENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
+++LL VK++DFG + I +D K+ G+P + APEVIS Y G EVD+WS
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIWSL 203
Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARDLIPRMLIVDPMKRI 260
G+++ ++ G P+ ++ K+++ +SP RD + RML +P +R
Sbjct: 204 GIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERA 263
Query: 261 TIPEIRQHPW-FQAHLPRYLAVPPPDTMQQAKK 292
T E+ HP+ Q LP L VP +QQ +K
Sbjct: 264 TAQELLDHPFLLQTGLPECL-VP---LIQQYRK 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 3e-37
Identities = 87/264 (32%), Positives = 132/264 (50%), Gaps = 9/264 (3%)
Query: 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHK-VAIKILNRRKIKNMEMEEKVRREIKILR 72
M ++ +TLG GSFG+V +A + VAIK + KI + + V E KIL
Sbjct: 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILN 86
Query: 73 LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
HP + LY + S +Y+V+E+V GE F ++ R D + QI+ EY
Sbjct: 87 YINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEY 146
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL 192
+V+RDLKPENLLLD +K+ DFG + ++ + T CG+P Y APE++ +
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY--TLCGTPEYIAPEILL-NV 203
Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 252
G D W+ G+ +Y +L G PF +++KI GI P L + L+ ++L
Sbjct: 204 GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLL 263
Query: 253 IVDPMKRI-----TIPEIRQHPWF 271
D KR +++HPWF
Sbjct: 264 SHDLTKRYGNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 4e-37
Identities = 76/228 (33%), Positives = 113/228 (49%), Gaps = 15/228 (6%)
Query: 20 KLGKTLGIGSFGKVKIA----EHALTGHKVAIKILNRRKIKNMEME-EKVRREIKILRLF 74
+LGK LG G+FG+V + T KVA+K L K E E E+ E I++
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL---KEGASEEEREEFLEEASIMKKL 58
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYC 133
HP+I+RL V +Y+V EY+ G+L D++ + G L + QI G+EY
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG--SPNYAAPEVISG 190
VHRDL N L+ VKI+DFGLS +I D ++ K G + APE +
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKD 178
Query: 191 KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
+ + DVWS GV+L+ + G P+ + + + ++ G Y LP
Sbjct: 179 GKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG-YRLP 224
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 4e-37
Identities = 73/266 (27%), Positives = 129/266 (48%), Gaps = 26/266 (9%)
Query: 23 KTLGIGSFGKVKIAE---HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
K LG G+FG+V + +VA+K L ++ + E + +E ++++ HP++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL--KEDASEEERKDFLKEARVMKKLGHPNV 58
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQ---------QIISGV 130
+RL V +Y+V+EY++ G+L DY+ + + ++ QI G+
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 131 EYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG-SPN-YAAPEV 187
EY VHRDL N L+ VKI+DFGLS ++ D ++ K + G P + APE
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178
Query: 188 ISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN--LFKKIKGGIYTL--PSHLSP 242
+ ++ + DVWS GV+L+ + G P+ + N + + ++ G Y L P +
Sbjct: 179 LKDGIF-TSKSDVWSFGVLLWEIFTLGATPY--PGLSNEEVLEYLRKG-YRLPKPEYCPD 234
Query: 243 GARDLIPRMLIVDPMKRITIPEIRQH 268
+L+ +DP R T E+ +
Sbjct: 235 ELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 83/261 (31%), Positives = 132/261 (50%), Gaps = 13/261 (4%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
LG G+ G V H TG +A+K + R +I +++++ RE+ IL P+I+
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTI-RLEINE-AIQKQILRELDILHKCNSPYIVGF 64
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM-VVH 140
Y DI + MEY+ G L + E +GR+ E ++ G+ Y H ++H
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124
Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
RD+KP N+L++S+ +K+ DFG+S + + KT G+ +Y APE I G Y + D+
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLVNS-LAKTFVGTSSYMAPERIQGNDY-SVKSDI 182
Query: 201 WSCGVILYALLCGTLPFDDENIP-----NLFKKI-KGGIYTLPSH-LSPGARDLIPRMLI 253
WS G+ L L G P+ EN P L + I LPS SP +D + LI
Sbjct: 183 WSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLI 242
Query: 254 VDPMKRITIPEIRQHPWFQAH 274
DP +R + E+ +HP+ + +
Sbjct: 243 KDPRERPSYKELLEHPFIKKY 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 77/263 (29%), Positives = 128/263 (48%), Gaps = 15/263 (5%)
Query: 22 GKTLGIGSFGKVKIAEHALTGHKVAIK------ILNRRKIKNMEMEEKVRREIKILRLFM 75
G +G GSFG V + +A +G +A+K + K + M + + REI +L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
H +I++ + + +EYV G + + G +E RNF +QI+ G+ Y H
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSN-------IMRDGHFLKTSCGSPNYAAPEVI 188
++HRD+K N+L+D+K +KI+DFG+S + + GS + APEV+
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDL 247
Y + D+WS G ++ +L G PF D KI +PS++S A D
Sbjct: 185 KQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDF 243
Query: 248 IPRMLIVDPMKRITIPEIRQHPW 270
+ + +D KR T E+ +HP+
Sbjct: 244 LEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 87/301 (28%), Positives = 131/301 (43%), Gaps = 53/301 (17%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
KT+GIG+FG+V + T A+K L + + V+ E IL + +++L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
Y + ++Y VM+Y+ G++ ++ G +ED AR + ++ +E H+ +HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLK---------------------------- 174
+KP+N+L+D ++K+ DFGL R H K
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 175 ----------TSC------GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFD 218
C G+PNY APEV+ Y D WS GVILY +L G PF
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFL 245
Query: 219 DENIPNLFKKIKGGIYTL--PSH--LSPGARDLIPRMLIVDPMKRI---TIPEIRQHPWF 271
+ K+ TL PS LS A DLI R L R+ EI+ HP+F
Sbjct: 246 ADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKAHPFF 304
Query: 272 Q 272
+
Sbjct: 305 K 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 6e-36
Identities = 83/246 (33%), Positives = 126/246 (51%), Gaps = 7/246 (2%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
Y + + +G GSFG+ + +H + K A+K + R K+ E R+E +L HP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI--RLPKSSSAVEDSRKEAVLLAKMKHP 58
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRL-QEDEARNFFQQIISGVEYCHR 135
+I+ E E +Y+VMEY G+L I +++G+L ED +F Q+ GV++ H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKLYA 194
V+HRD+K +N+ L VK+ DFG + ++ G + T G+P Y PE+ Y
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLI 253
+ D+WS G ILY L PF + NL K+ +G LPSH S R LI +M
Sbjct: 179 N-KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFK 237
Query: 254 VDPMKR 259
+P R
Sbjct: 238 RNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 7e-36
Identities = 77/267 (28%), Positives = 128/267 (47%), Gaps = 16/267 (5%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
Y+L + +G+G+ V A KVAIK ++ K ++E +R+E++ + HP+
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC-QTSVDE-LRKEVQAMSQCNHPN 60
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFD---YIVEKGRLQEDEARNFFQQIISGVEYCHR 135
+++ Y ++++VM Y+ G L D +G L E ++++ G+EY H
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-----HFLKTSCGSPNYAAPEVISG 190
N +HRD+K N+LL +VKIADFG+S + DG KT G+P + APEV+
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTLPSHLSPGA----- 244
+ D+WS G+ L G P+ + L ++ +L +
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSF 240
Query: 245 RDLIPRMLIVDPMKRITIPEIRQHPWF 271
R +I L DP KR T E+ +H +F
Sbjct: 241 RKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 82/263 (31%), Positives = 145/263 (55%), Gaps = 21/263 (7%)
Query: 23 KTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNMEMEEKVR--REIKILRLFMHP 77
K LG GSFGKV + G A+K+L + +K + ++VR E IL HP
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK---VRDRVRTKMERDILAEVNHP 58
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
I++L+ +T +Y+++++++ G+LF + ++ E++ + + ++ +++ H
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGP 196
+++RDLKPEN+LLD + ++K+ DFGLS D S CG+ Y APEV++ + +
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-Q 177
Query: 197 EVDVWSCGVILYALLCGTLPF---DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253
D WS GV+++ +L G+LPF D + + K K G +P LSP A+ L+ +
Sbjct: 178 SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG---MPQFLSPEAQSLLRALFK 234
Query: 254 VDPMKRI-----TIPEIRQHPWF 271
+P R+ + EI++HP+F
Sbjct: 235 RNPANRLGAGPDGVEEIKRHPFF 257
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 89/266 (33%), Positives = 146/266 (54%), Gaps = 14/266 (5%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR---EIKILRLF 74
N++ GK LG G+FG+V + TG ++A K + + ++ E ++V EI++L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQV-QFDPESPETSKEVSALECEIQLLKNL 61
Query: 75 MHPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
H I++ Y + ++ + + MEY+ G + D + G L E R + +QI+ G+ Y
Sbjct: 62 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSY 121
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFG----LSNIMRDGHFLKTSCGSPNYAAPEVI 188
H NM+VHRD+K N+L DS NVK+ DFG L I G +++ G+P + +PEVI
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFK-KIKGGIYTLPSHLSPGARD 246
SG+ Y G + DVWS G + +L P+ + E + +FK + LPSH+S ARD
Sbjct: 182 SGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240
Query: 247 LIPRMLIVDPMKRITIPEIRQHPWFQ 272
+ + V+ R + E+ +HP+ Q
Sbjct: 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 87/300 (29%), Positives = 128/300 (42%), Gaps = 78/300 (26%)
Query: 28 GSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR--------REIKILRLFMHPHI 79
G++G V A TG VA+K K+K EK + REI IL HP+I
Sbjct: 16 GTYGVVYRARDKKTGEIVALK-----KLKM----EKEKEGFPITSLREINILLKLQHPNI 66
Query: 80 IRLYEVI--ETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRN 136
+ + EV+ IY+VMEYV+ +L + K + E + Q++SGV + H N
Sbjct: 67 VTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YAAP 185
++HRDLK NLLL+++ +KI DFGL+ GSP Y AP
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLAR----------EYGSPLKPYTQLVVTLWYRAP 175
Query: 186 EVISGKLYAGPEVDVWSCGVILYALL---------------------CGTLPFDDENIPN 224
E++ G +D+WS G I LL GT P ++ P
Sbjct: 176 ELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGT-P-TEKIWPG 233
Query: 225 LFK--KIKGGIYTLPSHLSPGAR-----------DLIPRMLIVDPMKRITIPEIRQHPWF 271
+ K +T + + DL+ R+L DP KRI+ + +HP+F
Sbjct: 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 82/282 (29%), Positives = 150/282 (53%), Gaps = 22/282 (7%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIR 81
+ +G GS+ KV + E T A+K++ + + + E + V+ E + HP ++
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
L+ +T S ++ V+E+V G+L ++ + +L E+ AR + +I + + H +++R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 142 DLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
DLK +N+LLD++ ++K+ D+G+ +R G T CG+PNY APE++ G+ Y G VD
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 179
Query: 201 WSCGVILYALLCGTLPFD--------DENIPN-LFKKIKGGIYTLPSHLSPGARDLIPRM 251
W+ GV+++ ++ G PFD D+N + LF+ I +P LS A ++
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGF 239
Query: 252 LIVDPMKRI------TIPEIRQHPWFQA----HLPRYLAVPP 283
L DP +R+ +I+ HP+F+ L + +PP
Sbjct: 240 LNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPP 281
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 87/301 (28%), Positives = 144/301 (47%), Gaps = 64/301 (21%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRL 73
N+K + LG G++ V + TG VA+K ++ ++ EE REI +++
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIH------LDAEEGTPSTAIREISLMKE 54
Query: 74 FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI---VEKGRLQEDEARNFFQQIISGV 130
H +I+RL++VI T + + +V EY+ +L Y+ +G L + ++F Q++ G+
Sbjct: 55 LKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGI 113
Query: 131 EYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN--------- 181
+CH N V+HRDLKP+NLL++ + +K+ADFGL+ + G P
Sbjct: 114 AFCHENRVLHRDLKPQNLLINKRGELKLADFGLAR----------AFGIPVNTFSNEVVT 163
Query: 182 --YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF---DDENIPNLFKKIKG----- 231
Y AP+V+ G +D+WS G I+ ++ G F ++E+ +I G
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTES 223
Query: 232 ---GIYTLPS------------------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
GI LP H P DL+ R+L ++P RI+ + QHPW
Sbjct: 224 TWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
Query: 271 F 271
F
Sbjct: 284 F 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 85/261 (32%), Positives = 134/261 (51%), Gaps = 20/261 (7%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
LG G+FGKV A+H TG A KI+ +I++ E E EI IL HP+I+ LYE
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 85 VIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
+ +++++E+ G L ++E R L E + R +Q++ + + H + V+HRDL
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDL 129
Query: 144 KPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP-- 196
K N+LL +VK+ADFG+S + + F+ G+P + APEV++ + +
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI----GTPYWMAPEVVACETFKDNPY 185
Query: 197 --EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRM 251
+ D+WS G+ L L P + N + L K +K TL PS S D +
Sbjct: 186 DYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSC 245
Query: 252 LIVDPMKRITIPEIRQHPWFQ 272
L+ DP R T E+ +HP+
Sbjct: 246 LVKDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 84/318 (26%), Positives = 140/318 (44%), Gaps = 75/318 (23%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK------VRREIK 69
L +Y++ LG G+FG+V A TG VA+K K + EK REIK
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALK-------KILMHNEKDGFPITALREIK 59
Query: 70 ILRLFMHPHIIRLYEVI--------ETPSDIYVVMEYVK---SGELFDYIVEKGRLQEDE 118
IL+ HP+++ L ++ +Y+V Y+ SG L + V +L E +
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV---KLTESQ 116
Query: 119 ARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG 178
+ + Q++ G+ Y H N ++HRD+K N+L+D++ +KIADFGL+ G
Sbjct: 117 IKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 179 SPN------------YAAPEVISGKLYAGPEVDVWSCGVILYAL---------------- 210
Y PE++ G+ VD+W G + +
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236
Query: 211 -----LCGTLPFDDENIPNLFKKIKG--GIYTLPSH----------LSPGARDLIPRMLI 253
LCGT +E P ++ + G G+++ ++ L P DL+ ++L
Sbjct: 237 HLIFKLCGTP--TEETWPG-WRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLS 293
Query: 254 VDPMKRITIPEIRQHPWF 271
+DP KR+T + +HP+F
Sbjct: 294 LDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 84/269 (31%), Positives = 138/269 (51%), Gaps = 23/269 (8%)
Query: 22 GKTLGIGSFGKVKIAEHALTGHKVAIK-------ILNRRKIKNMEMEEKVRREIKILRLF 74
G+ +G G++G+V +A + TG +A+K I R + +M + +R EI+ L+
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
H +I++ T + + +EYV G + + GR +E R F +Q++ G+ Y H
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD--GHFLKTSC-GSPNYAAPEVI--S 189
++HRDLK +NLL+D+ KI+DFG+S D + S GS + APEVI
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLP-------SHLS 241
+ Y+ +VD+WS G ++ + G P+ D+E I +FK G + P +LS
Sbjct: 186 SQGYSA-KVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK--LGNKRSAPPIPPDVSMNLS 242
Query: 242 PGARDLIPRMLIVDPMKRITIPEIRQHPW 270
P A D + ++P R T E+ QHP+
Sbjct: 243 PVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 85/257 (33%), Positives = 138/257 (53%), Gaps = 7/257 (2%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPHIIR 81
K +G GSFGKV +A+ L G A+K+L ++ + N + ++ + E +L + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
L+ +T +Y V+++V GELF ++ + E AR + +I S + Y H +V+R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 142 DLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
DLKPEN+LLDS+ +V + DFGL + T CG+P Y APEVI + Y VD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN-TVDW 179
Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
W G +LY +L G PF ++ ++ I L S A ++ +L D +R+
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRL 239
Query: 261 ----TIPEIRQHPWFQA 273
EI++HP+F++
Sbjct: 240 GAKEDFLEIQEHPFFES 256
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 3e-35
Identities = 87/268 (32%), Positives = 143/268 (53%), Gaps = 24/268 (8%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKIL--------NRRKIKNMEMEEKVRREIK 69
N++LGK LG G+FG+V + A TG ++A+K + +++ +E E I+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECE------IQ 56
Query: 70 ILRLFMHPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII 127
+L+ H I++ Y + P + + + +EY+ G + D + G L E+ R + +QI+
Sbjct: 57 LLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL 116
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS----NIMRDGHFLKTSCGSPNYA 183
GV Y H NM+VHRD+K N+L DS NVK+ DFG S I G +K+ G+P +
Sbjct: 117 QGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFK-KIKGGIYTLPSHLS 241
+PEVISG+ Y G + DVWS + +L P+ + E + +FK + LP +S
Sbjct: 177 SPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVS 235
Query: 242 PGARDLIPRMLIVDPMKRITIPEIRQHP 269
RD + + + V+ +R T + +HP
Sbjct: 236 DACRDFL-KQIFVEEKRRPTAEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 84/284 (29%), Positives = 139/284 (48%), Gaps = 37/284 (13%)
Query: 5 SNRSSSGVDMFLPNYKLGKTLGI--GSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE 62
++S S + FL N ++ K L + G FGKV + +H T K+ ++ IK
Sbjct: 2 MDKSLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQ-----KLFVQKIIKAKNFNA 56
Query: 63 KVRREIKILRLFM--HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
E + +L M +P+ I+LY + T ++M+Y+K G+LFD + ++G+L E E +
Sbjct: 57 I---EPMVHQL-MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVK 112
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSC-- 177
+Q++ + H++ ++H D+K EN+L D +K + + D+GL I+ G SC
Sbjct: 113 KIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII--GT---PSCYD 167
Query: 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFD---DENI------PNLFKK 228
G+ +Y +PE I G Y D W+ GV+ Y LL G PF DE + KK
Sbjct: 168 GTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK 226
Query: 229 IKGGIYTLPSHLSPGARDLIPRMLIVDPMKR-ITIPEIRQHPWF 271
+ ++S A D + ML + R EI +HP+
Sbjct: 227 L-----PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 4e-35
Identities = 92/277 (33%), Positives = 141/277 (50%), Gaps = 18/277 (6%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
LG G FG+V + TG A K LN++++K + E E +IL I+ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 85 VIETPSDIYVVMEYVKSGELFDYIV----EKGRLQEDEARNFFQQIISGVEYCHRNMVVH 140
+T +D+ +VM + G+L +I E E A + QIISG+E+ H+ +++
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVD 199
RDLKPEN+LLD+ NV+I+D GL+ ++DG K G+P + APE++ G+ Y VD
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEY-DFSVD 179
Query: 200 VWSCGVILYALLCGTLPF--DDENIPN--LFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
++ GV LY ++ PF E + N L ++I T P SP ++ +L D
Sbjct: 180 YFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKD 239
Query: 256 PMKRI-----TIPEIRQHPWFQAHLPRYL---AVPPP 284
P KR+ +R HP F+ R L +PPP
Sbjct: 240 PEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 7e-35
Identities = 79/259 (30%), Positives = 136/259 (52%), Gaps = 7/259 (2%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
Y++ K +G GSFGK+ +A+ IK ++ K+ E +E ++E+ +L HP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKE-KEASKKEVILLAKMKHP 59
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRL-QEDEARNFFQQIISGVEYCHR 135
+I+ + + +++VMEY G+L I ++G L ED+ ++F QI G+++ H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 136 NMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSC-GSPNYAAPEVISGKLY 193
++HRD+K +N+ L V K+ DFG++ + D L +C G+P Y +PE+ + Y
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPY 179
Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRML 252
+ D+WS G +LY L PF+ N+ L KI +G + + S R LI ++
Sbjct: 180 NN-KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF 238
Query: 253 IVDPMKRITIPEIRQHPWF 271
V P R +I I + P+
Sbjct: 239 KVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 8e-35
Identities = 84/261 (32%), Positives = 128/261 (49%), Gaps = 29/261 (11%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
LG GS+G V A H TG VAIK++ E +++ +EI IL+ P+I++ Y
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVP-----VEEDLQEIIKEISILKQCDSPYIVKYYG 65
Query: 85 VIETPSDIYVVMEYVKSGELFDY--IVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
+D+++VMEY +G + D I K L E+E Q + G+EY H N +HRD
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNKKIHRD 124
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSPNYAAPEVISGKLYAGPEVDVW 201
+K N+LL+ + K+ADFG+S + D T G+P + APEVI Y + D+W
Sbjct: 125 IKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY-NNKADIW 183
Query: 202 SCGVILYALLCGTLPFDDEN-------IPNL----FKKIKGGIYTLPSHLSPGARDLIPR 250
S G+ + G P+ D + IPN P SP D + +
Sbjct: 184 SLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSD--------PEKWSPEFNDFVKK 235
Query: 251 MLIVDPMKRITIPEIRQHPWF 271
L+ DP +R + ++ QHP+
Sbjct: 236 CLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 8e-35
Identities = 74/260 (28%), Positives = 122/260 (46%), Gaps = 13/260 (5%)
Query: 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLY 83
+G G FG+V++ TG A+K++ + + E E IL + P I +L
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 84 EVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
+ ++Y+VMEY G+L + + + ED A+ + +++ + H+ VHRD
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRD 127
Query: 143 LKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTS-CGSPNYAAPEVI-----SGKLYAG 195
+KPEN+L+D ++K+ADFG + + + G+P+Y APEV+ GK G
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYG 187
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLPSHL--SPGARDLIPRM 251
E D WS GVI Y ++ G PF + + I P S DLI +
Sbjct: 188 VECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLI-QS 246
Query: 252 LIVDPMKRITIPEIRQHPWF 271
L+ +R+ + HP+F
Sbjct: 247 LLCGQKERLGYEGLCCHPFF 266
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 9e-35
Identities = 86/266 (32%), Positives = 140/266 (52%), Gaps = 11/266 (4%)
Query: 17 PNYKLGK--TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
P K + +G G+ G V A TG +VAIK +N ++ +E + EI ++R
Sbjct: 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMREN 73
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
HP+I+ + +++VVMEY+ G L D + E + E + ++ + +E+ H
Sbjct: 74 KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLH 132
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
N V+HRD+K +N+LL +VK+ DFG + I + T G+P + APEV++ K Y
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPR 250
GP+VD+WS G++ ++ G P+ +EN + L+ G L P LS RD + R
Sbjct: 193 -GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251
Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLP 276
L +D KR + E+ QHP+ + P
Sbjct: 252 CLEMDVEKRGSAKELLQHPFLKIAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 9e-35
Identities = 88/272 (32%), Positives = 134/272 (49%), Gaps = 32/272 (11%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR-----EIKI 70
L N+K+ K +G G F V A L G VA+K K++ EM + R EI +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALK-----KVQIFEMMDAKARQDCLKEIDL 55
Query: 71 LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI---VEKGRL-QEDEARNFFQQI 126
L+ HP++I+ +++ +V+E +G+L I ++ RL E +F Q+
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTS-----CGS 179
S +E+ H ++HRD+KP N+ + + VK+ D GL G F KT+ G+
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGL------GRFFSSKTTAAHSLVGT 169
Query: 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKGGIYT-L 236
P Y +PE I Y + D+WS G +LY + PF D N+ +L KKI+ Y L
Sbjct: 170 PYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPL 228
Query: 237 PS-HLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
P+ H S RDL+ R + DP KR I + Q
Sbjct: 229 PADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 99/345 (28%), Positives = 151/345 (43%), Gaps = 73/345 (21%)
Query: 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN----MEMEEKVRREIKILR 72
YK + +G G++G V A +G KVAIK KI + + ++ RE+KILR
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKILR 59
Query: 73 LFMHPHIIRLYEVIETPS----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
F H +II + +++ P D+YVVM+ ++S +L I L E+ R F Q++
Sbjct: 60 HFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLR 118
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL-----SNIMRDGHFLKTSCGSPNYA 183
G++Y H V+HRDLKP NLL++ ++I DFG+ S+ +F+ + Y
Sbjct: 119 GLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178
Query: 184 APEVISGKLYAGPE----VDVWSCGVILYALLCGTLPFDDENIPNLFKKI---------- 229
APE+ L + PE +D+WS G I +L F +N + K I
Sbjct: 179 APEL----LLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234
Query: 230 ----------KGGIYTLPSH-----------LSPGARDLIPRMLIVDPMKRITIPEIRQH 268
+ I LP SP A DL+ +ML DP +RIT+ + QH
Sbjct: 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294
Query: 269 PWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVE 313
P+ + PD DE F+ +L
Sbjct: 295 PFLAQY-------HDPD--------DEPTCPPPFDFDFEAIELSR 324
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 91/298 (30%), Positives = 144/298 (48%), Gaps = 49/298 (16%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR-----REIKILRL 73
Y K +G G++G V A+++ T KVAIK KI N + ++ REIK+LR
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIK-----KIANA-FDNRIDAKRTLREIKLLRH 60
Query: 74 FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
H ++I + +++ P D+Y+V E + + +L I L +D + F Q++
Sbjct: 61 LDHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLR 119
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEV 187
G++Y H V+HRDLKP NLLL++ ++KI DFGL+ + G F+ + Y APE+
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPEL 179
Query: 188 ISGKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLF-K 227
+ +DVWS G I LL F +E++ + +
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239
Query: 228 KIKGGIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274
K + I +LP H +P A DL+ +ML+ DP KRIT+ E HP+ +
Sbjct: 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 4e-34
Identities = 85/301 (28%), Positives = 131/301 (43%), Gaps = 61/301 (20%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRL 73
Y++ +G G++G V + TG VAIK K K E +E V+ RE+K+LR
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIK-----KFKESEDDEDVKKTALREVKVLRQ 56
Query: 74 FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEY 132
H +I+ L E +Y+V EYV+ L + + G L D R++ Q++ + Y
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN---------YA 183
CH + ++HRD+KPEN+L+ +K+ DFG + +R + Y
Sbjct: 116 CHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR-------PASPLTDYVATRWYR 168
Query: 184 APEVISGKLYAGPEVDVWSCGVILYALL---------------------CGTLP------ 216
APE++ G G VDVW+ G I+ LL G LP
Sbjct: 169 APELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL 228
Query: 217 ------FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
F P + + P +S A D + L +DP +R+T E+ QHP+
Sbjct: 229 FSSNPRFAGVAFPEP-SQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287
Query: 271 F 271
F
Sbjct: 288 F 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 5e-34
Identities = 95/296 (32%), Positives = 146/296 (49%), Gaps = 67/296 (22%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPHII 80
+G G++G V + TG VA+K KI+ EE V REI +L+ HP+I+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMK-----KIRLESEEEGVPSTAIREISLLKELQHPNIV 62
Query: 81 RLYEVIETPSDIYVVMEYVKSGELFDYI--VEKGRLQEDE-ARNFFQQIISGVEYCHRNM 137
L +V+ S +Y++ E++ S +L Y+ + KG+ + E +++ QI+ G+ +CH
Sbjct: 63 CLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YAAPE 186
V+HRDLKP+NLL+D+K +K+ADFGL+ + G P Y APE
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLAR----------AFGIPVRVYTHEVVTLWYRAPE 171
Query: 187 VISG-KLYAGPEVDVWSCGVILYAL---------------------LCGTLPFDD----- 219
V+ G Y+ P VD+WS G I + + GT P +D
Sbjct: 172 VLLGSPRYSTP-VDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGT-PTEDVWPGV 229
Query: 220 ENIP---NLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
++P N F K K G + +L DL+ +MLI DP KRI+ + HP+F
Sbjct: 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 6e-34
Identities = 85/262 (32%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
Y + +G G+ G V A TG +VAIK +N +K E+ + EI +++ +P+
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL---IINEILVMKELKNPN 77
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
I+ + +++VVMEY+ G L D + E + E + ++ + +E+ H N V
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC-MDEAQIAAVCRECLQALEFLHANQV 136
Query: 139 VHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
+HRD+K +N+LL +VK+ DFG + I + T G+P + APEV++ K Y GP+
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPK 195
Query: 198 VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIV 254
VD+WS G++ ++ G P+ +EN + L+ G L P LSP RD + R L +
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEM 255
Query: 255 DPMKRITIPEIRQHPWFQAHLP 276
D KR + E+ QHP+ + P
Sbjct: 256 DVEKRGSAKELLQHPFLKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 9e-34
Identities = 89/295 (30%), Positives = 146/295 (49%), Gaps = 52/295 (17%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-NMEME---EKVRREIKILRL 73
N++ + +G G++G V A + LTG VA+K KI+ + E E REI +L+
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKE 55
Query: 74 FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDY--IVEKGRLQEDEARNFFQQIISGVE 131
HP+I++L +VI T + +Y+V E++ +L + + +++ Q++ G+
Sbjct: 56 LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA 114
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI----MRD-GHFLKTSCGSPNYAAPE 186
+CH + V+HRDLKP+NLL++++ +K+ADFGL+ +R H + T Y APE
Sbjct: 115 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW----YRAPE 170
Query: 187 VISGKLYAGPEVDVWSCGVILYALLC--GTLPFDDENIPNLFK----------KIKGGIY 234
++ G Y VD+WS G I ++ P D E I LF+ + G+
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVT 229
Query: 235 TLPSH------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
+LP + L RDL+ +ML DP KRI+ HP+F
Sbjct: 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 91/318 (28%), Positives = 165/318 (51%), Gaps = 26/318 (8%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPHIIR 81
+ +G GS+ KV + T A+K++ + + + E + V+ E + + HP ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
L+ +T S ++ V+EYV G+L ++ + +L E+ AR + +I + Y H +++R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 142 DLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
DLK +N+LLDS+ ++K+ D+G+ +R G T CG+PNY APE++ G+ Y G VD
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 179
Query: 201 WSCGVILYALLCGTLPFD--------DENIPN-LFKKIKGGIYTLPSHLSPGARDLIPRM 251
W+ GV+++ ++ G PFD D+N + LF+ I +P LS A ++
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 239
Query: 252 LIVDPMKRI-TIPE-----IRQHPWFQA----HLPRYLAVPP--PDTMQQ--AKKIDEEI 297
L DP +R+ P+ I+ HP+F+ + + VPP P+ + D +
Sbjct: 240 LNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNFDAQF 299
Query: 298 LKEVVKMGFDQNQLVESL 315
E V++ D + +V +
Sbjct: 300 TNEPVQLTPDDDDIVRKI 317
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 86/280 (30%), Positives = 132/280 (47%), Gaps = 37/280 (13%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
+ +G+G+FG V A LTG VAIK + + + ++ RE+K+L+ H +II L
Sbjct: 16 QPVGMGAFGLVCSARDQLTGQNVAIKKI-MKPFSTPVLAKRTYRELKLLKHLRHENIISL 74
Query: 83 YEVIETPS-DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
++ +P DIY V E + G ++ L++ + F QI+ G++Y H VVHR
Sbjct: 75 SDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHR 132
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVW 201
DLKP N+L++ ++KI DFGL+ I + + Y APE++ EVD+W
Sbjct: 133 DLKPSNILINENCDLKICDFGLARIQD--PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIW 190
Query: 202 SCGVILYAL---------------------LCGTLPFD------DEN----IPNLFKKIK 230
S G I + L GT P D EN + +L K+
Sbjct: 191 SAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREP 250
Query: 231 GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
+ P A DL+ +ML+ DP KRI+ E HP+
Sbjct: 251 VPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 88/287 (30%), Positives = 140/287 (48%), Gaps = 42/287 (14%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
+G G++G+V A TG KVAIK L R ++ ++ RE+++L+ H ++I L +
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKL-SRPFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 85 V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
V +E D+Y+V + G + IV+ +L +D + QI+ G++Y H +
Sbjct: 82 VFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGI 139
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
+HRDLKP N+ ++ +KI DFGL+ D + + Y APE++ ++ V
Sbjct: 140 IHRDLKPSNIAVNEDCELKILDFGLAR-HTD-DEMTGYVATRWYRAPEIMLNWMHYNQTV 197
Query: 199 DVWSCGVILYALLCG-TL-PFDDEN-----I--------PNLFKKI-----KGGIYTLPS 238
D+WS G I+ LL G TL P D I L +KI + I +LP
Sbjct: 198 DIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQ 257
Query: 239 H-----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274
+P A DL+ +ML++DP KRIT E HP+ +
Sbjct: 258 MPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 1e-32
Identities = 82/265 (30%), Positives = 142/265 (53%), Gaps = 15/265 (5%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
+G GS G V IA +G VA+K ++ RK + E+ + E+ I+R + H +++ +Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYN 84
Query: 85 VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
+++VVME+++ G L D IV R+ E++ ++ + H V+HRD+K
Sbjct: 85 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 145 PENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
+++LL VK++DFG + + ++ K+ G+P + APE+IS +L GPEVD+WS
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS-RLPYGPEVDIWSL 202
Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------SPGARDLIPRMLIVDPM 257
G+++ ++ G P+ +E K I+ LP L SP + + R+L+ DP
Sbjct: 203 GIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPKLKNLHKVSPSLKGFLDRLLVRDPA 259
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVP 282
+R T E+ +HP+ P VP
Sbjct: 260 QRATAAELLKHPFLAKAGPPSCIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 86/282 (30%), Positives = 136/282 (48%), Gaps = 35/282 (12%)
Query: 16 LPN----YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL 71
LP+ ++L + +G G++GKV A H TG VAIKI++ + + EE+++ E IL
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNIL 56
Query: 72 RLFM-HPHIIRLYEVIETPSD------IYVVMEYVKSGELFDYI----VEKGRLQEDEAR 120
R + HP+I Y + +++VME G + D + + RL+E+
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKT 175
++ + G+ Y H N V+HRD+K +N+LL VK+ DFG+S + R T
Sbjct: 117 YILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN----T 172
Query: 176 SCGSPNYAAPEVISGKLYAGP----EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIK 230
G+P + APEVI+ DVWS G+ L G P D + + LFK +
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR 232
Query: 231 GGIYTL--PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
TL P + S D I LI + +R + E+ +HP+
Sbjct: 233 NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 82/265 (30%), Positives = 144/265 (54%), Gaps = 15/265 (5%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
+G GS G V IA TG +VA+K ++ RK + E+ + E+ I+R + H +++ +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL---LFNEVVIMRDYHHENVVDMYN 86
Query: 85 VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
+++VVME+++ G L D IV R+ E++ ++ + Y H V+HRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145
Query: 145 PENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
+++LL S +K++DFG + + ++ K+ G+P + APEVIS +L G EVD+WS
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVIS-RLPYGTEVDIWSL 204
Query: 204 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------SPGARDLIPRMLIVDPM 257
G+++ ++ G P+ +E ++I+ LP + S R + ML+ +P
Sbjct: 205 GIMVIEMIDGEPPYFNEPPLQAMRRIRD---NLPPRVKDSHKVSSVLRGFLDLMLVREPS 261
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVP 282
+R T E+ QHP+ + P VP
Sbjct: 262 QRATAQELLQHPFLKLAGPPSCIVP 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 82/262 (31%), Positives = 139/262 (53%), Gaps = 9/262 (3%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
Y + +G G+ G V A TG +VAIK +N ++ +E + EI ++R +P+
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRENKNPN 77
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
I+ + +++VVMEY+ G L D + E + E + ++ + +++ H N V
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQV 136
Query: 139 VHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
+HRD+K +N+LL +VK+ DFG + I + T G+P + APEV++ K Y GP+
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPK 195
Query: 198 VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIV 254
VD+WS G++ ++ G P+ +EN + L+ G L P LS RD + R L +
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEM 255
Query: 255 DPMKRITIPEIRQHPWFQAHLP 276
D +R + E+ QHP+ + P
Sbjct: 256 DVDRRGSAKELLQHPFLKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 85/309 (27%), Positives = 140/309 (45%), Gaps = 57/309 (18%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
++ K +G G+FG+V++ + TG A+K L + ++ + V+ E +L P
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
++ LY + +Y++ME++ G+L +++ ED R + + + +E H+
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG 121
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLS-----------------------------NIMR 168
+HRD+KP+N+L+D ++K++DFGLS ++
Sbjct: 122 FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181
Query: 169 DGHFLKTS-------------------CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYA 209
D L S G+P+Y APE+ + Y G E D WS G I++
Sbjct: 182 DSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFE 240
Query: 210 LLCGTLPFDDENIPNLFKKIKGGIYTL--PS--HLSPGARDLIPRMLIVDPMKRI---TI 262
L G PF EN ++KI TL P HLS A DLI R LI + R+
Sbjct: 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLI-RRLITNAENRLGRGGA 299
Query: 263 PEIRQHPWF 271
EI+ HP+F
Sbjct: 300 HEIKSHPFF 308
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 4e-32
Identities = 86/316 (27%), Positives = 149/316 (47%), Gaps = 45/316 (14%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
K +G G+FG+V++ + TGH A+KIL + + E +R E IL ++++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
+ + ++Y++ME++ G++ +++K L E+ + + + + ++ H+ +HRD
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRD 126
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGH------------------------------- 171
+KP+NLLLD+K +VK++DFGL ++ H
Sbjct: 127 IKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWK 186
Query: 172 -----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF 226
++ G+P+Y APEV Y D WS GVI+Y +L G PF E +
Sbjct: 187 KNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245
Query: 227 KKIKGGIYTL--PSH--LSPGARDLIPRMLIVDPMKRI---TIPEIRQHPWFQAHLPRYL 279
+K+ TL P +S A+DLI R D RI + EI+ HP+F+ ++
Sbjct: 246 RKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGHI 304
Query: 280 AVPPPDTMQQAKKIDE 295
P + K ID+
Sbjct: 305 RERPAAIPIEIKSIDD 320
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 9e-32
Identities = 92/305 (30%), Positives = 138/305 (45%), Gaps = 63/305 (20%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK-----VRREIKILR 72
Y+ + +G G++GKV A TG VA+K K + +EM+E+ REI +L+
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALK-----KTR-LEMDEEGIPPTALREISLLQ 55
Query: 73 LFMH-PHIIRLYEVIETPSD-----IYVVMEYVKSGELFDYIVEKGR-----LQEDEARN 121
+ +I+RL +V +Y+V EY+ S +L ++ GR L ++
Sbjct: 56 MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKS 114
Query: 122 FFQQIISGVEYCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSN-----IMRDGHFLKT 175
F Q++ GV +CH++ V+HRDLKP+NLL+D K +KIAD GL + H + T
Sbjct: 115 FMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVT 174
Query: 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIK---- 230
Y APEV+ G + VD+WS G I + F D + L K
Sbjct: 175 LW----YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230
Query: 231 ------GGI------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIR 266
G+ +P LSP DL+ +ML DP KRI+
Sbjct: 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRISAKAAL 289
Query: 267 QHPWF 271
HP+F
Sbjct: 290 THPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 84/301 (27%), Positives = 135/301 (44%), Gaps = 67/301 (22%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LFMHP 77
YK+ +G G+F +V A+ TG AIK + + ++ REI+ LR L HP
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHP 58
Query: 78 HIIRLYEVI--ETPSDIYVVMEYVKSGELFDYIVEKGR---LQEDEARNFFQQIISGVEY 132
+I+RL EV+ + +V E + L++ I KGR L E +++ Q++ +++
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELMD-MNLYELI--KGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----------- 181
HRN + HRD+KPEN+L+ +K+ADFG SC
Sbjct: 116 MHRNGIFHRDIKPENILIKDD-ILKLADFG-------------SCRGIYSKPPYTEYIST 161
Query: 182 --YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-------IPNL------- 225
Y APE + Y GP++D+W+ G + + +L F N I ++
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAE 221
Query: 226 --------------FKKIKG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
F KG G+ L + S DL+ ++L DP +RIT + +HP+
Sbjct: 222 VLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
Query: 271 F 271
F
Sbjct: 282 F 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 16/271 (5%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
++++ K +G G+FG+V + + T A+KILN+ ++ R E +L
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRN 136
I L+ + + +Y+VM+Y G+L + + + RL ED AR + +++ + H+
Sbjct: 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVIS----G 190
VHRD+KP+N+LLD ++++ADFG M +++S G+P+Y +PE++ G
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHL---SPGAR 245
GPE D WS GV +Y +L G PF E++ + KI + PSH+ S A+
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAK 241
Query: 246 DLIPRMLIVDPMKRI---TIPEIRQHPWFQA 273
DLI R LI +R+ I + ++H +F+
Sbjct: 242 DLIQR-LICSRERRLGQNGIEDFKKHAFFEG 271
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 124 bits (311), Expect = 1e-31
Identities = 83/271 (30%), Positives = 145/271 (53%), Gaps = 16/271 (5%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
++++ K +G G+FG+V + + A+KILN+ ++ R E +L +
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRN 136
I L+ + +++Y+VM+Y G+L + + + RL ED AR + +++ ++ H+
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT-SCGSPNYAAPEVIS----G 190
VHRD+KP+N+L+D ++++ADFG +M DG + + G+P+Y +PE++ G
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPSH---LSPGAR 245
K GPE D WS GV +Y +L G PF E++ + KI + P+ +S A+
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAK 241
Query: 246 DLIPRMLIVDPMKRI---TIPEIRQHPWFQA 273
DLI R LI R+ I + +QHP+F
Sbjct: 242 DLI-RRLICSREHRLGQNGIEDFKQHPFFTG 271
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 2e-31
Identities = 78/260 (30%), Positives = 133/260 (51%), Gaps = 9/260 (3%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
+ L + +G GSFG+V A T VAIK+++ + ++ E+E+ +++EI+ L P+
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED-EIED-IQQEIQFLSQCRSPY 60
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
I + Y S ++++MEY G D +++ G+L E ++++ G+EY H
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHEEGK 119
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGSPNYAAPEVISGKLYAGP 196
+HRD+K N+LL + +VK+ADFG+S + K T G+P + APEVI Y
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTS-TMSKRNTFVGTPFWMAPEVIKQSGYDE- 177
Query: 197 EVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTLPSHL-SPGARDLIPRMLIV 254
+ D+WS G+ L G P D + LF K +L + S +D + L
Sbjct: 178 KADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNK 237
Query: 255 DPMKRITIPEIRQHPWFQAH 274
DP +R + E+ +H + +
Sbjct: 238 DPKERPSAKELLKHKFIKKA 257
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 88/313 (28%), Positives = 140/313 (44%), Gaps = 76/313 (24%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK-----VRREIKILRL 73
Y+ +G G+FG+V A H T VA+K K+ ME E++ REIKIL+L
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALK-----KVL-MENEKEGFPITALREIKILQL 67
Query: 74 FMHPHIIRLYEVIETP--------SDIYVVMEYVK---SGELFDYIVEKGRLQEDEARNF 122
H +++ L E+ T Y+V E+ + +G L + V + E +
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KFTLSEIKKV 124
Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN- 181
+ +++G+ Y HRN ++HRD+K N+L+ +K+ADFGL+ F + PN
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA-----FSLSKNSKPNR 179
Query: 182 ---------YAAPEVISGKLYAGPEVDVWSCGVI---------------------LYALL 211
Y PE++ G+ GP +D+W G I L + L
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239
Query: 212 CGTL-----PFDDENIPNLFKKI---KGGIYTLPSHLSP-----GARDLIPRMLIVDPMK 258
CG++ P + + LFKK+ +G + L P A DLI ++L++DP K
Sbjct: 240 CGSITPEVWP-GVDKLE-LFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAK 297
Query: 259 RITIPEIRQHPWF 271
RI H +F
Sbjct: 298 RIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 85/278 (30%), Positives = 143/278 (51%), Gaps = 9/278 (3%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
Y + +G G+ G V A TG +VAI+ +N ++ +E + EI ++R +P+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPN 78
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
I+ + +++VVMEY+ G L D + E + E + ++ + +E+ H N V
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQV 137
Query: 139 VHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
+HRD+K +N+LL +VK+ DFG + I + T G+P + APEV++ K Y GP+
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPK 196
Query: 198 VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIV 254
VD+WS G++ ++ G P+ +EN + L+ G L P LS RD + R L +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256
Query: 255 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
D KR + E+ QH + + P P ++A K
Sbjct: 257 DVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATK 294
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 78/266 (29%), Positives = 142/266 (53%), Gaps = 12/266 (4%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+Y++ K +G G+FG+V++ H T A+K+L++ ++ E I+ P
Sbjct: 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
+++L+ + +Y+VMEY+ G+L + ++ + E AR + +++ ++ H
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 162
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGSPNYAAPEVIS---GKL 192
+HRD+KP+N+LLD ++K+ADFG M ++ T+ G+P+Y +PEV+ G
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLP--SHLSPGARDLI 248
Y G E D WS GV LY +L G PF +++ + KI T P + +S A++LI
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 282
Query: 249 PRMLIVDPMK--RITIPEIRQHPWFQ 272
L ++ R + EI++H +F+
Sbjct: 283 CAFLTDREVRLGRNGVEEIKRHLFFK 308
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 101/352 (28%), Positives = 153/352 (43%), Gaps = 79/352 (22%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L Y+ K +G G+ G V A +TG VAIK L+R +N+ ++ RE+ +++L
Sbjct: 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSR-PFQNVTHAKRAYRELVLMKLVN 73
Query: 76 HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDY---IVEKGRLQEDEARNFFQQI 126
H +II L V +E D+Y+VME L D V + L + Q+
Sbjct: 74 HKNIIGLLNVFTPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERMSYLLYQM 127
Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
+ G+++ H ++HRDLKP N+++ S +KI DFGL+ + + Y APE
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 187
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLFK 227
VI G Y VD+WS G I+ ++ GT+ F DE + L
Sbjct: 188 VILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246
Query: 228 KIKGGIYTLPSH-------LSPG-----------------ARDLIPRMLIVDPMKRITIP 263
++ + P + L P ARDL+ +ML++DP KRI++
Sbjct: 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306
Query: 264 EIRQHP----WFQAHLPRYLAVPPPDTMQQAKKID----------EEILKEV 301
+ QHP W+ P + PPP ID E I KEV
Sbjct: 307 DALQHPYINVWYD---PSEVEAPPP--APYDHSIDEREHTVEEWKELIYKEV 353
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 5e-31
Identities = 77/211 (36%), Positives = 114/211 (54%), Gaps = 26/211 (12%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVR----REIK 69
+ K K LG G FGKV++ + TG +VA+K LN EE+ R REI+
Sbjct: 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH------SGEEQHRSDFEREIE 58
Query: 70 ILRLFMHPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVEKGRLQEDEAR--NFFQQ 125
ILR H +I++ V E P + ++MEY+ SG L DY+ ++ R Q + R F Q
Sbjct: 59 ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRLLLFSSQ 117
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSP-N 181
I G++Y +HRDL N+L++S+ VKI+DFGL+ ++ +D +++K SP
Sbjct: 118 ICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 182 YAAPEVIS-GKLYAGPEVDVWSCGVILYALL 211
+ APE + K + DVWS GV LY L
Sbjct: 178 WYAPECLRTSKFSS--ASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 6e-31
Identities = 80/280 (28%), Positives = 134/280 (47%), Gaps = 15/280 (5%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
++ + LG G FG+V + TG A K L +++IK + E E +IL
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRN 136
++ L ET + +V+ + G+L +I G DE R F +I G+E HR
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
+V+RDLKPEN+LLD +++I+D GL+ + +G ++ G+ Y APEV+ + Y
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERY-TF 180
Query: 197 EVDVWSCGVILYALLCGTLPFD--DENIP--NLFKKIKGGIYTLPSHLSPGARDLIPRML 252
D W G ++Y ++ G PF E + + +++K S AR + ++L
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL 240
Query: 253 IVDPMKRI-----TIPEIRQHPWFQAHLPRYLA---VPPP 284
DP R+ E++ HP+F+ + L + PP
Sbjct: 241 TKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPP 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 83/295 (28%), Positives = 137/295 (46%), Gaps = 41/295 (13%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
+ +G G+FG V G +VA+K + +N+ ++V RE+K+L F H +++
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPN-VFQNLVSCKRVFRELKMLCFFKHDNVLSA 64
Query: 83 YEVIETP-----SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
++++ P +IYVV E ++S +L IV L D + F QI+ G++Y H
Sbjct: 65 LDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG 123
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNI--MRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
++HRD+KP NLL++S +KI DFGL+ + + + + Y APE++ G +
Sbjct: 124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYT 183
Query: 196 PEVDVWSCGVILYALLCGTLPFD----------------DENIPNLFKKIKGG------- 232
VD+WS G I LL + F ++ + +G
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRG 243
Query: 233 ---------IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY 278
+YTL S + A L+ RML+ DP KRI+ + HP+ RY
Sbjct: 244 PHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRY 298
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 78/277 (28%), Positives = 146/277 (52%), Gaps = 12/277 (4%)
Query: 7 RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR 66
R + M +Y + K +G G+FG+V++ H + A+K+L++ ++
Sbjct: 33 RKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 67 EIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQI 126
E I+ P +++L+ + +Y+VMEY+ G+L + ++ + E A+ + ++
Sbjct: 93 ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEV 151
Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGSPNYAA 184
+ ++ H ++HRD+KP+N+LLD ++K+ADFG M + ++ T+ G+P+Y +
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYIS 211
Query: 185 PEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL----P 237
PEV+ G Y G E D WS GV L+ +L G PF +++ + KI +L
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED 271
Query: 238 SHLSPGARDLIPRMLIVDPMK--RITIPEIRQHPWFQ 272
+S A++LI L ++ R + EI+QHP+F+
Sbjct: 272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK 308
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 9e-31
Identities = 90/297 (30%), Positives = 136/297 (45%), Gaps = 61/297 (20%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE---KVRREIKILRLFMHPHIIR 81
+G G++G+V A TG VA+K + ++ N E E REIKILR H +I+
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALK---KVRLDN-EKEGFPITAIREIKILRQLNHRNIVN 70
Query: 82 LYEVIETPSD----------IYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISG 129
L E++ D Y+V EY+ +L ++E G ED ++F +Q++ G
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMG-LLESGLVHFSEDHIKSFMKQLLEG 128
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR--DGHFLKTSCGSPNYAAPEV 187
+ YCH+ +HRD+K N+LL++K +K+ADFGL+ + + + Y PE+
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPEL 188
Query: 188 ISGKLYAGPEVDVWSCGVILYAL---------------------LCGTLPFDDENIPNLF 226
+ G+ GP +DVWSCG IL L LCG+ P P++
Sbjct: 189 LLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS-P-CPAVWPDVI 246
Query: 227 KKIKGGIYTLP-------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
K T+ S + A DL+ ML +DP KR T E PW
Sbjct: 247 KLP--YFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 85/306 (27%), Positives = 133/306 (43%), Gaps = 55/306 (17%)
Query: 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK-----------VRREIK 69
G LG G++GKV+ A LTG VAIK + +I N +++ RE+K
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 70 ILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
I+ H +I+ L +V I +VM+ + + +L + K RL E + + QI++G
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNG 131
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN------IMRDGHFLKTSCGSPN-- 181
+ H+ +HRDL P N+ ++SK KIADFGL+ +T
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 182 -------YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI----- 229
Y APE++ G VD+WS G I LL G F EN + +I
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLG 251
Query: 230 -----------KGGIYTLPSHLSP------------GARDLIPRMLIVDPMKRITIPEIR 266
K +YT + P A DL+ +L ++P++RI+ E
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311
Query: 267 QHPWFQ 272
+H +F+
Sbjct: 312 KHEYFK 317
|
Length = 335 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 88/290 (30%), Positives = 135/290 (46%), Gaps = 48/290 (16%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPHII 80
+G G+ G V H TG A+K++ E+ VR REI+ILR HP+++
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNH------EDTVRRQICREIEILRDVNHPNVV 135
Query: 81 RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVH 140
+ +++ + +I V++E++ G L + + D AR QI+SG+ Y HR +VH
Sbjct: 136 KCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVH 191
Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKL----YAG 195
RD+KP NLL++S NVKIADFG+S I+ + +S G+ Y +PE I+ L Y G
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDG 251
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL------------PSHLSPG 243
D+WS GV + G PF + + +G +L P+ S
Sbjct: 252 YAGDIWSLGVSILEFYLGRFPF------GVGR--QGDWASLMCAICMSQPPEAPATASRE 303
Query: 244 ARDLIPRMLIVDPMKRITIPEIRQHPWF---------QAHLPRYLAVPPP 284
R I L +P KR + ++ QHP+ L PP
Sbjct: 304 FRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGGPNLHQLLPPPR 353
|
Length = 353 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 1e-30
Identities = 81/265 (30%), Positives = 130/265 (49%), Gaps = 20/265 (7%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
+ LG G FG+V + TG A K L +++IK + E E +IL ++ L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRNMVVH 140
ET + +V+ + G+L +I G +E R F +I G+E H+ +V+
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA-GPEVD 199
RDLKPEN+LLD +++I+D GL+ + +G +K G+ Y APEV+ + Y P D
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP--D 183
Query: 200 VWSCGVILYALLCGTLPFDD-------ENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 252
W+ G +LY ++ G PF E + L K+++ SP AR L +L
Sbjct: 184 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ---EEYSEKFSPDARSLCKMLL 240
Query: 253 IVDPMKRI-----TIPEIRQHPWFQ 272
DP +R+ E+++HP F+
Sbjct: 241 CKDPKERLGCQGGGAREVKEHPLFK 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-30
Identities = 82/264 (31%), Positives = 139/264 (52%), Gaps = 16/264 (6%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
K +G G+FG+V + + TG A+KILN+ ++ R E +L I L
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHR 141
+ + +++Y+VM+Y G+L + + RL ED AR + +++ ++ H+ VHR
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHR 126
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVI----SGKLYAG 195
D+KP+N+LLD ++++ADFG + ++++ G+P+Y +PE++ GK G
Sbjct: 127 DIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYG 186
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLPSH---LSPGARDLIPR 250
PE D WS GV +Y +L G PF E++ + KI + P +S A+DLI R
Sbjct: 187 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLI-R 245
Query: 251 MLIVDPMKRI---TIPEIRQHPWF 271
LI P R+ + + + HP+F
Sbjct: 246 RLICSPETRLGRNGLQDFKDHPFF 269
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 83/276 (30%), Positives = 144/276 (52%), Gaps = 24/276 (8%)
Query: 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR-----REI 68
M ++ + K +G G+FG+V++ H + A+K+L++ EM ++ E
Sbjct: 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK-----FEMIKRSDSAFFWEER 94
Query: 69 KILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
I+ I++L+ + +Y+VMEY+ G+L + ++ + E AR + +++
Sbjct: 95 DIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVL 153
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFL-KTSCGSPNYAAPE 186
++ H +HRD+KP+N+LLD ++K+ADFG M +G T+ G+P+Y +PE
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE 213
Query: 187 VI---SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI---KGGIYTLPS-- 238
V+ G Y G E D WS GV LY +L G PF +++ + KI K + T P
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL-TFPDDI 272
Query: 239 HLSPGARDLIPRMLIVDPMK--RITIPEIRQHPWFQ 272
+S A+DLI L ++ R + EI+ HP+F+
Sbjct: 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 92/297 (30%), Positives = 149/297 (50%), Gaps = 55/297 (18%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLF 74
Y+ + +G G++G V A +T +A+K KI+ + +E V REI +L+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALK-----KIRLEQEDEGVPSTAIREISLLKEM 58
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDE--ARNFFQQIISGVEY 132
H +I+RL +V+ + +Y+V EY+ +L ++ ++ + + QI+ G+ Y
Sbjct: 59 QHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 133 CHRNMVVHRDLKPENLLLDSKWN-VKIADFGLSN-----IMRDGHFLKTSCGSPNYAAPE 186
CH + V+HRDLKP+NLL+D + N +K+ADFGL+ + H + T Y APE
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLW----YRAPE 173
Query: 187 VISG-KLYAGPEVDVWSCGVILYALLCGTLPF--DDENIPNLFK--KIKG--------GI 233
++ G + Y+ P VD+WS G I +A + P D I LFK +I G G+
Sbjct: 174 ILLGSRHYSTP-VDIWSVGCI-FAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231
Query: 234 YTLPSH------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
+LP + L P DL+ +ML +DP KRIT +H +F+
Sbjct: 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 78/280 (27%), Positives = 146/280 (52%), Gaps = 20/280 (7%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPHIIR 81
+ +G GS+ KV + A+K++ + + + E + V+ E + + +P ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
L+ +T S +++V+EYV G+L ++ + +L E+ AR + +I + + H +++R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 142 DLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
DLK +N+LLD+ ++K+ D+G+ + G T CG+PNY APE++ G+ Y G VD
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDW 179
Query: 201 WSCGVILYALLCGTLPFD------DENIPN-LFKKIKGGIYTLPSHLSPGARDLIPRMLI 253
W+ GV+++ ++ G PFD D N + LF+ I +P LS A ++ L
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLN 239
Query: 254 VDPMKRI------TIPEIRQHPWFQA----HLPRYLAVPP 283
DP +R+ +I+ H +F++ L + PP
Sbjct: 240 KDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPP 279
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 104/357 (29%), Positives = 159/357 (44%), Gaps = 76/357 (21%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI----KNMEMEEKVRREIKIL 71
L Y++ + LG G++G V A T VA+K KI +N ++ REI L
Sbjct: 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK-----KIFDAFRNATDAQRTFREIMFL 60
Query: 72 RLFM-HPHIIRLYEVI--ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
+ HP+I++L VI E DIY+V EY+++ +L I L++ R Q++
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVI-RANILEDVHKRYIMYQLLK 118
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN------- 181
++Y H V+HRDLKP N+LL+S VK+ADFGL+ + + L+ + +P
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE---LEENPENPVLTDYVAT 175
Query: 182 --YAAPEVISGKLYAGPEVDVWSCGVILYALLCG--------TL---------------- 215
Y APE++ G VD+WS G IL +L G TL
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235
Query: 216 -------PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
PF + +L + + + L S A DL+ ++L+ +P KR+T E +H
Sbjct: 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295
Query: 269 PWF-QAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQL--VESLRNRLQNE 322
P+ Q H P DE +L + + D N V RN+L E
Sbjct: 296 PYVAQFHNP----------------SDEPVLPYPITIPLDDNVKLSVAEYRNKLYEE 336
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 5e-30
Identities = 78/264 (29%), Positives = 131/264 (49%), Gaps = 17/264 (6%)
Query: 18 NYKLGKTLGIGSFGKV-KIAEHALTGHKVAIKILN-------RRKIKNMEMEEKVRREIK 69
Y + + LG G+FG V K+ + + +A+K +N + K + + + E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 70 ILRLFM-HPHIIRLYEVIETPSDIYVVMEYVKS---GELFDYIVEKG-RLQEDEARNFFQ 124
I++ + HP+I+R Y+ +Y+VM+ ++ GE F+ + EK R E+ N F
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 125 QIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYA 183
Q++ + Y H+ +VHRDL P N++L V I DFGL+ + L + G+ Y+
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYS 180
Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHL-S 241
PE++ + Y G + DVW+ G ILY + PF N+ +L KI +Y LP + S
Sbjct: 181 CPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239
Query: 242 PGARDLIPRMLIVDPMKRITIPEI 265
D+I L D R I ++
Sbjct: 240 EDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 84/269 (31%), Positives = 130/269 (48%), Gaps = 32/269 (11%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
LG G+ G V TG A+K + N ++++++ RE++I + P+I++ Y
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 85 --VIETPSDIYVVMEYVKSGELFDYIVEK-----GRLQEDEARNFFQQIISGVEYCHRNM 137
+ E+ S I + MEY + G L D I +K GR+ E + ++ G+ Y H
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSPNYAAPEVISGKLY 193
++HRD+KP N+LL K VK+ DFG+S G + T G+ Y APE I GK Y
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLAGTFTGTSFYMAPERIQGKPY 180
Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFK-KIKGGIYTLPSHL---SPGA----- 244
+ DVWS G+ L + PF E P L ++ I +P+ PG
Sbjct: 181 S-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWS 239
Query: 245 ---RDLIPRMLIVDPMKRITIPEIRQHPW 270
+D I + L DP +R T ++ +HPW
Sbjct: 240 EEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 9e-30
Identities = 78/269 (28%), Positives = 131/269 (48%), Gaps = 30/269 (11%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE----KVRREIKILRLFMHPHII 80
LG G++G V H TG +A+K +I+ +E++E ++ E+ IL + P+I+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMK-----EIR-LELDESKFNQIIMELDILHKAVSPYIV 62
Query: 81 RLYEVIETPSDIYVVMEYVKSG---ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
Y +Y+ MEY+ +G +L+ V + ED R ++ G+++
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122
Query: 138 -VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
++HRD+KP N+L++ VK+ DFG+S + KT+ G +Y APE I GP
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL-VASLAKTNIGCQSYMAPERIKS---GGP 178
Query: 197 --------EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK----GGIYTLPSHLSPGA 244
+ DVWS G+ + + G P+ E N+F ++ G TLPS S A
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA 238
Query: 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQA 273
+D + + L P +R T ++ +HPW
Sbjct: 239 QDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 87/305 (28%), Positives = 133/305 (43%), Gaps = 55/305 (18%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
KTLGIG+FG+V +A T A+K L ++ + V+ E IL + ++RL
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
Y + ++Y VM+Y+ G++ ++ G ED AR + ++ VE H+ +HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLK----------------------TSC--- 177
+KP+N+L+D ++K+ DFGL R H K +C
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 178 -----------------------GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT 214
G+PNY APEV+ Y D WS GVILY +L G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245
Query: 215 LPFDDEN-IPNLFKKIKGGI---YTLPSHLSPGARDLIPRML--IVDPMKRITIPEIRQH 268
PF + + K I + LSP A DLI ++ D + + EI+ H
Sbjct: 246 PPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAH 305
Query: 269 PWFQA 273
P+F+
Sbjct: 306 PFFKT 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 92/313 (29%), Positives = 135/313 (43%), Gaps = 63/313 (20%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE-----KVRREIKILRLF 74
KL + +G G++G V A +G VA+K K++ M+ E REI +L
Sbjct: 11 KLNR-IGEGTYGIVYRARDTTSGEIVALK-----KVR-MDNERDGIPISSLREITLLLNL 63
Query: 75 MHPHIIRLYEVIETPS--DIYVVMEYVKS--GELFDYIVEKGRLQEDEARNFFQQIISGV 130
HP+I+ L EV+ I++VMEY + L D + E + + Q++ G+
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM--PTPFSESQVKCLMLQLLRGL 121
Query: 131 EYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAP 185
+Y H N ++HRDLK NLLL K +KIADFGL+ G K +P Y AP
Sbjct: 122 QYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPM--TPKVVTLWYRAP 177
Query: 186 EVISGKLYAGPEVDVWSCGVILYALL------------------CGTLPFDDENI-PNLF 226
E++ G +D+W+ G IL LL L +E+I P
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237
Query: 227 KKIKGGIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH- 274
G +TLP LS L+ +L+ DP KR T E + +F+
Sbjct: 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297
Query: 275 LPRYLAVPPPDTM 287
LP P+ M
Sbjct: 298 LPC-----EPEMM 305
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 89/316 (28%), Positives = 152/316 (48%), Gaps = 45/316 (14%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
K +G G+FG+V++ + TGH A+KIL + + E +R E IL ++++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
+ + ++Y++ME++ G++ +++K L E+E + + + + ++ H+ +HRD
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRD 126
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGH---FLK------------------------- 174
+KP+NLLLDSK +VK++DFGL ++ H F +
Sbjct: 127 IKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWK 186
Query: 175 --------TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF 226
++ G+P+Y APEV Y D WS GVI+Y +L G PF E +
Sbjct: 187 RNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245
Query: 227 KKIKGGIYTL--PSH--LSPGARDLIPRMLIVDPMKRITIP---EIRQHPWFQAHLPRYL 279
KK+ TL P +S A+DLI R + RI P EI+ +P+F+ ++
Sbjct: 246 KKVMNWKETLIFPPEVPISEKAKDLILR-FCCEWEHRIGAPGVEEIKTNPFFEGVDWEHI 304
Query: 280 AVPPPDTMQQAKKIDE 295
P + K ID+
Sbjct: 305 RERPAAIPIEIKSIDD 320
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 88/300 (29%), Positives = 134/300 (44%), Gaps = 53/300 (17%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
YK+ + +G GS+G V A TG KVAIK +N +++ ++ REIK+LRL HP
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIND-VFEHVSDATRILREIKLLRLLRHPD 60
Query: 79 IIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
I+ + ++ PS DIYVV E ++S +L I L + + F Q++ ++Y
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--------CGSPNYAAP 185
H V HRDLKP+N+L ++ +KI DFGL+ + F T + Y AP
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFGLARV----AFNDTPTAIFWTDYVATRWYRAP 175
Query: 186 EVISGKLYA--GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL--- 240
E + G ++ P +D+WS G I +L G F +N+ + I + T
Sbjct: 176 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234
Query: 241 ----------------------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
P A L+ R+L DP R T E P+F+
Sbjct: 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 82/301 (27%), Positives = 140/301 (46%), Gaps = 58/301 (19%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
+ LG GS G V A + +VA+K + ++++ REIKI+R H +I+++
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK---HALREIKIIRRLDHDNIVKV 67
Query: 83 YEVI-----ETPSDI---------YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
YEV+ + D+ Y+V EY+++ ++E+G L E+ AR F Q++
Sbjct: 68 YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMYQLLR 125
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHF-----LKTSCGSPNY 182
G++Y H V+HRDLKP N+ ++++ V KI DFGL+ I+ D H+ L + Y
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV-DPHYSHKGYLSEGLVTKWY 184
Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLCG------------------TLPFDDEN--- 221
+P ++ +D+W+ G I +L G ++P E
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRN 244
Query: 222 -----IPNLFKKIKGGIYT-----LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
IP+ + G LP ++P A D + ++L +PM R+T E HP+
Sbjct: 245 ELLNVIPSFVRNDGGEPRRPLRDLLPG-VNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303
Query: 272 Q 272
Sbjct: 304 S 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 89/305 (29%), Positives = 137/305 (44%), Gaps = 55/305 (18%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
KTLGIG+FG+V +A T A+K L ++ + N V+ E IL + +++L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
Y + ++Y VM+Y+ G++ ++ E AR + ++ +E H+ +HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 143 LKPENLLLDSKWNVKIADFGL----------------SNIMRD----------------G 170
+KP+N+L+D ++K+ DFGL S+I +D G
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 171 HFLKT----------SC------GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT 214
LKT C G+PNY APEV+ K Y D WS GVIL+ +L G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245
Query: 215 LPFDDENIPNLFKKIKGGIYTL--PSH--LSPGARDLIPRMLIV--DPMKRITIPEIRQH 268
PF K+ TL P LSP A DLI ++ + + R +I+ H
Sbjct: 246 PPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305
Query: 269 PWFQA 273
P+F
Sbjct: 306 PFFSE 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 83/262 (31%), Positives = 130/262 (49%), Gaps = 16/262 (6%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
Y+L + +G G++G V A TG VAIK++ K++ + E +++EI +L+ HP+
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHPN 61
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFD-YIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
I+ + +++VMEY G L D Y V +G L E + ++ + G+ Y H
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAG- 195
+HRD+K N+LL +VK+ADFG+S + K+ G+P + APEV + + G
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGY 181
Query: 196 -PEVDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYTLPSHL------SPGARDL 247
+ D+W+ G+ L P FD + LF K P L SP D
Sbjct: 182 DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF--PPPKLKDKEKWSPVFHDF 239
Query: 248 IPRMLIVDPMKRITIPEIRQHP 269
I + L DP KR T ++ QHP
Sbjct: 240 IKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 106/362 (29%), Positives = 163/362 (45%), Gaps = 88/362 (24%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALT--GHKVAIK---------ILNRRKIKNMEMEEKVRR 66
Y+L K LG G++G V A +A T VAIK IL +R + R
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL----------R 50
Query: 67 EIKILRLFM-HPHIIRLYEV-IETPS---DIYVVMEYVKSGELFDYIVEKGRLQEDEARN 121
E+K+LR F H +I LY++ I P ++Y+ E +++ +L I L + ++
Sbjct: 51 ELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQS 109
Query: 122 FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----FLKTS 176
F QI+ G++Y H V+HRDLKP NLL+++ +KI DFGL+ + F+
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169
Query: 177 CGSPNYAAPEV-ISGKLYAGPEVDVWSCGVILYALLCGTLPF------------------ 217
+ Y APE+ +S + Y +DVWS G IL LL F
Sbjct: 170 VATRWYRAPEIMLSFQSYT-KAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT 228
Query: 218 -DDE---------------NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT 261
D+E ++PN+ KK I+ + L A DL+ ++L DP KRI+
Sbjct: 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPL---ALDLLEKLLAFDPTKRIS 285
Query: 262 IPEIRQHPWFQAHLPRYLAV-PPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLRNRLQ 320
+ E +HP YLA+ PD DE + ++ F+ +E LR+ +
Sbjct: 286 VEEALEHP--------YLAIWHDPD--------DEPVCQKPFDFSFESEDSMEELRDMII 329
Query: 321 NE 322
E
Sbjct: 330 EE 331
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 81/283 (28%), Positives = 127/283 (44%), Gaps = 41/283 (14%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKIL----NRRKIKNMEMEEKVRREIKILRLFMHPHII 80
+G GS+G V +H TG VAIK + + +K + M REI++L+ H +++
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-----REIRMLKQLRHENLV 63
Query: 81 RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVH 140
L EV +Y+V E+V L D L E R + QI+ G+E+CH + ++H
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIH 123
Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGPEVD 199
RD+KPEN+L+ VK+ DFG + + + T + Y APE++ G G VD
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVD 183
Query: 200 VWSCGVILYALLCGTLPF-DDENIPNLFKKIK------------------GGIYTLPS-- 238
+W+ G ++ +L G F D +I L+ IK LP
Sbjct: 184 IWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVK 243
Query: 239 ----------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
LS DL + L +DP R + ++ H +F
Sbjct: 244 EIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 68/265 (25%), Positives = 137/265 (51%), Gaps = 15/265 (5%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH-- 76
Y+ + +G G++G V +H TG VA+KI+N + ++ + ++RE+ +L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINL-DTPDDDVSD-IQREVALLSQLRQSQ 60
Query: 77 -PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
P+I + Y ++++MEY + G + +++ G + E ++++ ++Y H+
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHK 119
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYA 194
V+HRD+K N+L+ + NVK+ DFG++ ++ + T G+P + APEVI+ Y
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP-----SHLSPGARDLIP 249
+ D+WS G+ +Y + G P+ D + F+ + + P + S R+ +
Sbjct: 180 DTKADIWSLGITIYEMATGNPPYSDV---DAFRAMMLIPKSKPPRLEDNGYSKLLREFVA 236
Query: 250 RMLIVDPMKRITIPEIRQHPWFQAH 274
L +P +R++ E+ + W +AH
Sbjct: 237 ACLDEEPKERLSAEELLKSKWIKAH 261
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 6e-28
Identities = 76/257 (29%), Positives = 134/257 (52%), Gaps = 7/257 (2%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
Y + +G GS+G+V + H G + IK LN R E + +E ++L HP+
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRE-RKAAEQEAQLLSQLKHPN 60
Query: 79 IIRLYEVIETPSD-IYVVMEYVKSGELFDYIVE-KGRL-QEDEARNFFQQIISGVEYCHR 135
I+ E E +Y+VM + + G+L+ + E KG+L E++ +F QI ++Y H
Sbjct: 61 IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYA 194
++HRDLK +N+ L +K+ D G++ ++ + T G+P Y +PE+ S K Y
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPY- 179
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNL-FKKIKGGIYTLPSHLSPGARDLIPRMLI 253
+ DVW+ G +Y + F+ +++ +L ++ I+G + +P SP +LI ML
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLS 239
Query: 254 VDPMKRITIPEIRQHPW 270
P KR ++ I + P+
Sbjct: 240 KRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 86/285 (30%), Positives = 135/285 (47%), Gaps = 42/285 (14%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-MEEKVRREIKILR---LFMHPHII 80
+G+G++G V A +GH VA+K + R N + + RE+ +L+ F HP+I+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALK--SVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 81 RLYEVIET-----PSDIYVVMEYVKSGELFDYI--VEKGRLQEDEARNFFQQIISGVEYC 133
RL +V T + + +V E+V +L Y+ V L + ++ +Q + G+++
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
H N +VHRDLKPEN+L+ S VK+ADFGL+ I L + Y APEV+ Y
Sbjct: 125 HANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTY 184
Query: 194 AGPEVDVWSCGVILY------ALLCGT--------------LPFDDE-----NIP--NLF 226
A P VD+WS G I L CG LP +D+ +P
Sbjct: 185 ATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFS 243
Query: 227 KKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
+ + ++ + L+ ML +P KRI+ QHP+F
Sbjct: 244 PRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 4e-27
Identities = 95/329 (28%), Positives = 147/329 (44%), Gaps = 56/329 (17%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L Y+ K +G G+ G V A A+ VAIK L+R +N ++ RE+ +++
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 76 HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
H +II L V +E D+Y+VME + + L I + L + Q++ G
Sbjct: 82 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCG 138
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
+++ H ++HRDLKP N+++ S +KI DFGL+ + + Y APEVI
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIY 234
G Y VD+WS G I+ ++ G + F D N P KK++ +
Sbjct: 199 GMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
T P L P ARDL+ +ML++D KRI++ E Q
Sbjct: 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 268 HPWFQA-HLPRYLAVPPPDTMQQAKKIDE 295
HP+ + P PPP K++DE
Sbjct: 318 HPYINVWYDPSEAEAPPPKIPD--KQLDE 344
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 75/262 (28%), Positives = 128/262 (48%), Gaps = 14/262 (5%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
+ LG G FG+V + TG A K L +++IK + E E +IL ++ L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRNMVVH 140
ET + +V+ + G+L +I G DE R F ++ G+E R +V+
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA-GPEVD 199
RDLKPEN+LLD + +++I+D GL+ + +G ++ G+ Y APEVI+ + Y P D
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSP--D 183
Query: 200 VWSCGVILYALLCGTLPFD--DENIP--NLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
W G ++Y ++ G PF E + + +++K S A+ + +L +
Sbjct: 184 WWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKN 243
Query: 256 PMKRITI-----PEIRQHPWFQ 272
P +R+ ++QHP F+
Sbjct: 244 PKERLGCRGNGAAGVKQHPIFK 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 78/276 (28%), Positives = 135/276 (48%), Gaps = 15/276 (5%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
+ LG G FG+V + TG A K L +++IK + E E +IL ++ L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRNMVVH 140
ET + +V+ + G+L +I G +E R F +I+ G+E HR V+
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
RDLKPEN+LLD +++I+D GL+ + +G ++ G+ Y APEV++ + Y D
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-TLSPDY 184
Query: 201 WSCGVILYALLCGTLPF--DDENIP--NLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256
W G ++Y ++ G PF E + + +++ + S A+ + +L DP
Sbjct: 185 WGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDP 244
Query: 257 MKRITIP-----EIRQHPWFQ-AHLPRYLA--VPPP 284
+R+ E+++HP+F+ + R A + PP
Sbjct: 245 KQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPP 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 85/294 (28%), Positives = 142/294 (48%), Gaps = 55/294 (18%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFM 75
KL K +G G++G V A++ T VA+K +++ + +E V REI +L+
Sbjct: 4 KLEK-IGEGTYGTVFKAKNRETHEIVALK-----RVRLDDDDEGVPSSALREICLLKELK 57
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
H +I+RLY+V+ + + +V EY + FD G + + ++F Q++ G+ +C
Sbjct: 58 HKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFC 115
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVI 188
H + V+HRDLKP+NLL++ +K+ADFGL+ + C S Y P+V+
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLAR----AFGIPVRCYSAEVVTLWYRPPDVL 171
Query: 189 SG-KLYAGPEVDVWSCGVILYALLCGTLPF----DDENIPNLFKKIKG--------GIYT 235
G KLY+ +D+WS G I L P D ++ ++ G G+
Sbjct: 172 FGAKLYS-TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230
Query: 236 LP------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
LP L+ RDL+ +L+ +P++RI+ E QHP+F
Sbjct: 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 85/311 (27%), Positives = 146/311 (46%), Gaps = 44/311 (14%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
+G G++G V A TG +VA+K L+R +++ ++ RE+++L+ H ++I L +
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83
Query: 85 V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
V +E +D+Y+V + G + IV+ +L +D + QI+ G++Y H +
Sbjct: 84 VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 141
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
+HRDLKP NL ++ +KI DFGL+ D + + Y APE++ ++ V
Sbjct: 142 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTV 199
Query: 199 DVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------------------ 240
D+WS G I+ LL G F + + K I + T + L
Sbjct: 200 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 259
Query: 241 -------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP-D 285
+P A DL+ +ML++D KRIT + H +F Q H P V P D
Sbjct: 260 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYD 319
Query: 286 TMQQAKKIDEE 296
+++ + +
Sbjct: 320 QSFESRDLLID 330
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 77/246 (31%), Positives = 127/246 (51%), Gaps = 6/246 (2%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
+G GSFG+V T VAIKI++ + ++ E+E+ +++EI +L P+I R Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-EIED-IQQEITVLSQCDSPYITRYYG 69
Query: 85 VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
+ ++++MEY+ G D +++ G L+E ++I+ G++Y H +HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 145 PENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
N+LL + +VK+ADFG++ + D + T G+P + APEVI Y + D+WS
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF-KADIWSL 187
Query: 204 GVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI 262
G+ L G P D + LF K TL S ++ + L DP R T
Sbjct: 188 GITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTA 247
Query: 263 PEIRQH 268
E+ +H
Sbjct: 248 KELLKH 253
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 86/282 (30%), Positives = 132/282 (46%), Gaps = 31/282 (10%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH---PHIIR 81
+G G FG+V A TG A+K L++++IK + E E +L L P I+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
+ TP + +++ + G+L ++ + G E E R + +II G+E+ H VV+R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK----TSCGSPNYAAPEVISGKLYAGPE 197
DLKP N+LLD +V+I+D GL+ F K S G+ Y APEV+ +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS 176
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT----LPSHLSPGARDLIPRMLI 253
D +S G +L+ LL G PF + +I T LP SP R L+ +L
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235
Query: 254 VDPMKRITI-----PEIRQHP------WFQAHLPRYLAVPPP 284
D +R+ E+++HP W L +Y PPP
Sbjct: 236 RDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKY---PPP 274
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 77/274 (28%), Positives = 135/274 (49%), Gaps = 15/274 (5%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
LG G FG+V + TG A K L+++++K E+ E +IL P I+ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 85 VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF--QQIISGVEYCHRNMVVHRD 142
E+ + + +VM + G+L +I G + R QI G+ + H +V+RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 202
+KPEN+LLD + N +++D GL+ ++DG + G+ Y APE++ + Y+ P VD ++
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYP-VDWFA 179
Query: 203 CGVILYALLCGTLPFDD--ENIPN---LFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
G +Y ++ G PF D E + + ++ + + + ++D+ L P
Sbjct: 180 MGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPE 239
Query: 258 KRITIPEI----RQHPWFQA-HLPRYLA--VPPP 284
R+ E R+H +F+ + PR A +PPP
Sbjct: 240 DRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPP 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 21 LGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
K LG G FG V + + G VAIK++ + E+ E K++ HP++
Sbjct: 8 FLKELGSGQFGVVHLGK--WRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNL 61
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMV 138
++LY V I++V EY+ +G L +Y+ E KG+L + + + +EY N
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 195
+HRDL N L+ VK++DFGL+ + D + +S G+ +A PEV ++
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 196 PEVDVWSCGVILYALL-CGTLPFD 218
+ DVWS GV+++ + G +P++
Sbjct: 181 -KSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 63/225 (28%), Positives = 112/225 (49%), Gaps = 12/225 (5%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+ L + LG G FG+V E +VAIKIL K ++ ++ ++E++ L+ H
Sbjct: 8 FTLERKLGSGYFGEV--WEGLWKNRVRVAIKIL---KSDDLLKQQDFQKEVQALKRLRHK 62
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYI--VEKGRLQEDEARNFFQQIISGVEYCHR 135
H+I L+ V +Y++ E ++ G L ++ E L + Q+ G+ Y
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYA 194
+HRDL N+L+ K+ADFGL+ ++++ +L + P + APE S ++
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFS 182
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS 238
+ DVWS G++LY + G +P+ N ++ +I G Y +P
Sbjct: 183 T-KSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPC 225
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 83/295 (28%), Positives = 133/295 (45%), Gaps = 56/295 (18%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE-----KVR-REIKILRL 73
KL K +G GS+G V + TG VAIK K +E E+ K+ REI++L+
Sbjct: 5 KLSK-IGEGSYGVVFKCRNRETGQIVAIK-------KFVESEDDPVIKKIALREIRMLKQ 56
Query: 74 FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
HP+++ L EV +++V EY L + + E + Q + V +C
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-YAAPEVISGKL 192
H++ +HRD+KPEN+L+ + +K+ DFG + I+ T + Y APE++ G
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 193 YAGPEVDVWSCGVILYALLCG------------------TLPFDDENIP---NLFKK--- 228
GP VDVW+ G + LL G TL + IP +F
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTL---GDLIPRHQQIFSTNQF 233
Query: 229 IKGGIYTLPS------------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
KG ++P ++S A + L +DP +R++ E+ +HP+F
Sbjct: 234 FKG--LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 92/329 (27%), Positives = 146/329 (44%), Gaps = 56/329 (17%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L Y+ K +G G+ G V A A+ VAIK L+R +N ++ RE+ +++
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74
Query: 76 HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
H +II L V +E D+Y+VME + + L I + L + Q++ G
Sbjct: 75 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCG 131
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
+++ H ++HRDLKP N+++ S +KI DFGL+ + + Y APEVI
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPFDDEN---------------IPNLFKKIKGGIY 234
G Y VD+WS G I+ ++ + F + P KK++ +
Sbjct: 192 GMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 235 T----------------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQ 267
P L P ARDL+ +ML++DP KRI++ E Q
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310
Query: 268 HPWFQA-HLPRYLAVPPPDTMQQAKKIDE 295
HP+ + P + PPP K++DE
Sbjct: 311 HPYINVWYDPAEVEAPPPQIYD--KQLDE 337
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 80/277 (28%), Positives = 128/277 (46%), Gaps = 41/277 (14%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPH 78
LG G+ G V +H TG +A +K+ ++ + VR RE++I+ P+
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMA------KKVVHIGAKSSVRKQILRELQIMHECRSPY 64
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYC---H 134
I+ Y ++I + ME++ G L D I +K G + + ++ G+ Y H
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLS----NIMRDGHFLKTSCGSPNYAAPEVISG 190
R ++HRD+KP N+L++S+ +K+ DFG+S N + D T G+ Y +PE I G
Sbjct: 124 R--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD-----TFVGTSTYMSPERIQG 176
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------------TLPS 238
Y + DVWS G+ + L G PF NI + + GI LPS
Sbjct: 177 GKYT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235
Query: 239 -HLSPGARDLIPRMLIVDPMKRITIPEI-RQHPWFQA 273
RD + L+ DP +R T ++ P+ QA
Sbjct: 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 7e-26
Identities = 74/260 (28%), Positives = 130/260 (50%), Gaps = 10/260 (3%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR--REIKILRLFMH 76
Y L + LG GSFG V + + + +K+L + + E V+ +E ++L H
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEY 132
P I++ + ++ EY + +L + E L E++ +F Q++ GV Y
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGK 191
H+ ++HRDLK +N+ L + +KI DFG+S ++ L T+ G+P Y +PE + +
Sbjct: 122 MHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQ 180
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPR 250
Y + D+WS G ILY + C F+ +N ++ +I +G +LP S ++
Sbjct: 181 GY-DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQS 239
Query: 251 MLIVDPMKRITIPEIRQHPW 270
ML DP R + EI ++P+
Sbjct: 240 MLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 82/292 (28%), Positives = 137/292 (46%), Gaps = 44/292 (15%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
Y+ K +G G++G V A TG KVAIK L R ++ ++ RE+++L+ H +
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHEN 75
Query: 79 IIRLYEVIETP-------SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 131
+I L +V TP D Y+VM ++ G +++ +L ED + Q++ G++
Sbjct: 76 VIGLLDVF-TPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
Y H ++HRDLKP NL ++ +KI DFGL+ + + + Y APEVI
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYVVTRWYRAPEVILNW 190
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--------------------KG 231
++ VD+WS G I+ +L G F + + +I K
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKN 250
Query: 232 GIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
+ LP + +P A +++ +ML++D RIT E HP+F+
Sbjct: 251 YVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 68/225 (30%), Positives = 118/225 (52%), Gaps = 12/225 (5%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
K LG G FG V + + KVAIK +N + EE E K++ HP +++L
Sbjct: 10 KELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQL 64
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
Y V +Y+V E++++G L +Y+ ++ G+L +D + Q + G+EY RN +HR
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPEV 198
DL N L+ S VK++DFG++ + D + +S G+ ++ PEV + Y+ +
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSS-KS 182
Query: 199 DVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSP 242
DVWS GV+++ + G +PF+ ++ + + I G L+
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLAS 227
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 2e-25
Identities = 88/318 (27%), Positives = 149/318 (46%), Gaps = 46/318 (14%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
+G G++G V A KVA+K L+R +++ + RE+++L+ H ++I L +
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 85 V------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
V IE +++Y+V + G + IV+ +L ++ + Q++ G++Y H +
Sbjct: 82 VFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGI 139
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
+HRDLKP N+ ++ ++I DFGL+ D + + Y APE++ ++ V
Sbjct: 140 IHRDLKPSNVAVNEDCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTV 197
Query: 199 DVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKGG-----IYTLPS 238
D+WS G I+ LL G F + P + KKI I +LP
Sbjct: 198 DIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLP- 256
Query: 239 HL------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPR-YLAVPPP 284
H+ +P A DL+ +ML++D KRI+ E HP+F Q H P P
Sbjct: 257 HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEPY 316
Query: 285 DTMQQAKKIDEEILKEVV 302
D + K+ E KE+
Sbjct: 317 DESPENKERTIEEWKELT 334
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 79/259 (30%), Positives = 130/259 (50%), Gaps = 22/259 (8%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR--EIKILRLFMH 76
Y + + LG G+ G V A+ G A+K+++ ++ M +K R E+ L
Sbjct: 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVD---MEGMSEADKNRAQAEVCCLLNCDF 90
Query: 77 PHIIRLYE--VIETPSD------IYVVMEYVKSGELFDYIVEKGR----LQEDEARNFFQ 124
I++ +E + P + I +V++Y +G+L I + + +E EA F
Sbjct: 91 FSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI 150
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD---GHFLKTSCGSPN 181
Q++ V + H ++HRD+K N+LL S VK+ DFG S + +T CG+P
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHL 240
Y APE+ K Y+ + D++S GV+LY LL PFD EN+ + K G Y LP +
Sbjct: 211 YVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSI 269
Query: 241 SPGARDLIPRMLIVDPMKR 259
SP ++++ +L DP +R
Sbjct: 270 SPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 6/252 (2%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
+G GSFG+V T VAIKI++ + ++ E+E+ +++EI +L P++ + Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIED-IQQEITVLSQCDSPYVTKYYG 69
Query: 85 VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
+ ++++MEY+ G D ++ G E + ++I+ G++Y H +HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128
Query: 145 PENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
N+LL + +VK+ADFG++ + D + T G+P + APEVI Y + D+WS
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS-KADIWSL 187
Query: 204 GVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI 262
G+ L G P D + + LF K TL S ++ I L DP R T
Sbjct: 188 GITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTA 247
Query: 263 PEIRQHPWFQAH 274
E+ +H + +
Sbjct: 248 KELLKHKFIVKN 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 78/273 (28%), Positives = 132/273 (48%), Gaps = 19/273 (6%)
Query: 24 TLGIGSFGKVKIAEHALTGHKVAIK----ILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
LG G++G V H TG +A+K +N ++ K + M+ + +R P+
Sbjct: 8 ELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDIS-----MRSVDCPYT 62
Query: 80 IRLYEVIETPSDIYVVMEYVKSG--ELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRN 136
+ Y + D+++ ME + + + + + +KG + ED I+ +EY H
Sbjct: 63 VTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK 122
Query: 137 M-VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL-YA 194
+ V+HRD+KP N+L++ VK+ DFG+S + D G Y APE I+ +L
Sbjct: 123 LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK 182
Query: 195 GPEV--DVWSCGVILYALLCGTLPFDDENIP--NLFKKIKGGIYTLPSH-LSPGARDLIP 249
G +V DVWS G+ + L G P+D P L + ++ LP+ SP +D +
Sbjct: 183 GYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVN 242
Query: 250 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 282
+ L + +R PE+ QHP+F+ HL + V
Sbjct: 243 KCLKKNYKERPNYPELLQHPFFELHLSKNTDVA 275
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 89/318 (27%), Positives = 141/318 (44%), Gaps = 54/318 (16%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L Y+ K +G G+ G V A + G VA+K L+R +N ++ RE+ +L+
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVN 78
Query: 76 HPHIIRLYEV------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
H +II L V +E D+Y+VME + + L I L + Q++ G
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVI--HMELDHERMSYLLYQMLCG 135
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
+++ H ++HRDLKP N+++ S +KI DFGL+ + + Y APEVI
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 195
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPFDD-------------------ENIPNLFKKIK 230
G Y VD+WS G I+ L+ G++ F E + L ++
Sbjct: 196 GMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254
Query: 231 GGIYTLPSH-------LSPG----------------ARDLIPRMLIVDPMKRITIPEIRQ 267
+ P + L P ARDL+ +ML++DP KRI++ E +
Sbjct: 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314
Query: 268 HPWFQA-HLPRYLAVPPP 284
HP+ + P PPP
Sbjct: 315 HPYITVWYDPAEAEAPPP 332
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 78/253 (30%), Positives = 124/253 (49%), Gaps = 10/253 (3%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L N+++ K +G G F +V A L G VA+K + + + + +EI +L+
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI----VEKGRLQEDEARNFFQQIISGVE 131
HP++I+ Y +++ +V+E +G+L I +K + E +F Q+ S +E
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISG 190
+ H V+HRD+KP N+ + + VK+ D GL S G+P Y +PE I
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKGGIY-TLPS-HLSPGARD 246
Y + D+WS G +LY + PF D N+ +L KKI+ Y LPS H S R
Sbjct: 181 NGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239
Query: 247 LIPRMLIVDPMKR 259
L+ + DP KR
Sbjct: 240 LVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 85/282 (30%), Positives = 132/282 (46%), Gaps = 31/282 (10%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH---PHIIR 81
+G G FG+V A TG A+K L++++IK + E E +L L P I+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
+ TP + +++ + G+L ++ + G E E R + +II G+E+ H VV+R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
DLKP N+LLD +V+I+D GL+ + H S G+ Y APEV+ D
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQKGTAYDSSAD 178
Query: 200 VWSCGVILYALLCGTLPF------DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253
+S G +L+ LL G PF D I + + LP SP + L+ +L
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN---VELPDSFSPELKSLLEGLLQ 235
Query: 254 VDPMKRITI-----PEIRQHP------WFQAHLPRYLAVPPP 284
D KR+ E+++H W Q +L +Y PPP
Sbjct: 236 RDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKY---PPP 274
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 96/328 (29%), Positives = 148/328 (45%), Gaps = 58/328 (17%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
K +G G++G V A TG KVAIK L+R ++ ++ RE+ +L+ H ++I L
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQHENVIGL 79
Query: 83 YEVIETPS------DIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHR 135
+V + D Y+VM Y+++ D G L ED+ + Q++ G++Y H
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYMQT----DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHS 135
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG---SPNYAAPEVISGKL 192
++HRDLKP NL ++ +KI DFGL+ H G + Y APEVI +
Sbjct: 136 AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILNWM 190
Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKI-----KGG 232
+ VD+WS G I+ +L G F ++ P +K+ K
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSY 250
Query: 233 IYTLPS-----------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLA 280
I +LP SP A DL+ +ML +D KR+T E +HP+F
Sbjct: 251 IKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET 310
Query: 281 VPPP--DTMQQAKKIDEE----ILKEVV 302
P D+++ K +E I KEV
Sbjct: 311 EQQPYDDSLENEKLSVDEWKKHIYKEVK 338
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 73/248 (29%), Positives = 127/248 (51%), Gaps = 6/248 (2%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
+ +G GSFG+V T VAIKI++ + ++ E+E+ +++EI +L P++ +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-EIED-IQQEITVLSQCDSPYVTKY 67
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
Y + ++++MEY+ G D ++E G L E + ++I+ G++Y H +HRD
Sbjct: 68 YGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRD 126
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGPEVDVW 201
+K N+LL VK+ADFG++ + D + + G+P + APEVI Y + D+W
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS-KADIW 185
Query: 202 SCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
S G+ L G P + + LF K TL + S ++ + L +P R
Sbjct: 186 SLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 245
Query: 261 TIPEIRQH 268
T E+ +H
Sbjct: 246 TAKELLKH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 77/261 (29%), Positives = 130/261 (49%), Gaps = 10/261 (3%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L N+++ K +G G F +V A L VA+K + ++ + + + +EI +L+
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGEL---FDYIVEKGRL-QEDEARNFFQQIISGVE 131
HP++I+ + +++ +V+E +G+L Y ++ RL E +F Q+ S VE
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISG 190
+ H V+HRD+KP N+ + + VK+ D GL S G+P Y +PE I
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKGGIY-TLPS-HLSPGARD 246
Y + D+WS G +LY + PF D N+ +L +KI+ Y LP+ H S R+
Sbjct: 181 NGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239
Query: 247 LIPRMLIVDPMKRITIPEIRQ 267
L+ + DP +R I + Q
Sbjct: 240 LVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 76/251 (30%), Positives = 119/251 (47%), Gaps = 8/251 (3%)
Query: 21 LGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
LG+ +G G FG V + + K+A+ + + + + EK +E I+R F HPHI
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
++L VI +++VME GEL Y+ V K L + Q+ + + Y
Sbjct: 70 VKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRF 128
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGP 196
VHRD+ N+L+ S VK+ DFGLS + D + K S G P + APE I+ + +
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSA 188
Query: 197 EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIV 254
DVW GV ++ +L G PF ++ +I G +P + P L+ +
Sbjct: 189 S-DVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAY 247
Query: 255 DPMKRITIPEI 265
DP KR E+
Sbjct: 248 DPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 28/204 (13%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
KL + LG G FG+V + G KVA+K L K M E ++ E +I++ H
Sbjct: 9 KLERKLGAGQFGEVWMG--TWNGTTKVAVKTL---KPGTMSPEAFLQ-EAQIMKKLRHDK 62
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN--------FFQQIISGV 130
+++LY V IY+V EY+ G L D+ L+ E + QI G+
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDF------LKSGEGKKLRLPQLVDMAAQIAEGM 116
Query: 131 EYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVI 188
Y +HRDL N+L+ KIADFGL+ ++ D + + P + APE
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA 176
Query: 189 SGKLYAGPEV--DVWSCGVILYAL 210
Y + DVWS G++L +
Sbjct: 177 ---NYGRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 83/281 (29%), Positives = 131/281 (46%), Gaps = 36/281 (12%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
+G G++G V H T VAIK + +N E++E RE+K+LR +I+ L E
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSE-ENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 85 VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144
+Y+V EYV+ L + ++ R++ Q+I + +CH+N +VHRD+K
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIK 127
Query: 145 PENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYAGPEVDVWS 202
PENLL+ +K+ DFG + + +G + + Y +PE++ G Y G VD+WS
Sbjct: 128 PENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY-GKAVDMWS 186
Query: 203 CGVILYALLCGTLPFDDEN-IPNLF--KKIKGGI--------YTLP----------SH-- 239
G IL L G F E+ I LF +K+ G + Y+ P +H
Sbjct: 187 VGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQ 246
Query: 240 ---------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
LS DL+ +L ++P R + HP F
Sbjct: 247 SLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 83/262 (31%), Positives = 126/262 (48%), Gaps = 17/262 (6%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGH-----KVAIKILNRRKIKNMEMEEKVRREIKIL- 71
N GKTLG G+FGKV A KVA+K+L + + E + E+KI+
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKML--KPTAHSSEREALMSELKIMS 93
Query: 72 RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISG 129
L H +I+ L I V+ EY G+L +++ K L ++ +F Q+ G
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NYAAPE 186
+ + +HRDL N+LL VKI DFGL+ +IM D +++ K + P + APE
Sbjct: 154 MAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213
Query: 187 VISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGIYTL-PSHLSPG 243
I +Y E DVWS G++L+ + G+ P+ + + F K IK G P H
Sbjct: 214 SIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAE 272
Query: 244 ARDLIPRMLIVDPMKRITIPEI 265
D++ DP+KR T +I
Sbjct: 273 IYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 68/223 (30%), Positives = 116/223 (52%), Gaps = 12/223 (5%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
KL K LG G FG+V + + KVA+K L K M ++ + E +++ H +
Sbjct: 9 KLVKKLGAGQFGEVWMGYYN-NSTKVAVKTL---KPGTMSVQAFLE-EANLMKTLQHDKL 63
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIV--EKGRLQEDEARNFFQQIISGVEYCHRNM 137
+RLY V+ IY++ EY+ G L D++ E G++ + +F QI G+ Y R
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAG 195
+HRDL+ N+L+ KIADFGL+ ++ D + + P + APE I+ +
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT- 182
Query: 196 PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
+ DVWS G++LY ++ G +P+ + ++ ++ G Y +P
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMP 224
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 81/296 (27%), Positives = 132/296 (44%), Gaps = 62/296 (20%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPH 78
+ LG GS+ V + G VA+K+++ M+ EE V RE +L+ H +
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVIS------MKTEEGVPFTAIREASLLKGLKHAN 64
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNM 137
I+ L+++I T + V EY+ + +L Y+++ G L R F Q++ G+ Y H
Sbjct: 65 IVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAA---------PEVI 188
++HRDLKP+NLL+ +K+ADFGL+ S S Y++ P+V+
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLAR--------AKSIPSQTYSSEVVTLWYRPPDVL 175
Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKG-----------GIYTL 236
G +D+W G I +L G F ++ +KI G+ L
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235
Query: 237 PSH-------------------LS--PGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
P++ LS P A DL +ML++ P RI+ + HP+F
Sbjct: 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 80/259 (30%), Positives = 129/259 (49%), Gaps = 20/259 (7%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
LG G+FGKV A++ TG A K+++ K+ E E EI IL HP+I++L +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVID---TKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 85 VIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
+++++++E+ G + ++E R L E + R +Q + + Y H N ++HRDL
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129
Query: 144 KPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKTSCGSPNYAAPEVI----SGKLYA 194
K N+L ++K+ADFG+S I R F+ G+P + APEV+ S
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMCETSKDRPY 185
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-KGGIYTL--PSHLSPGARDLIPRM 251
+ DVWS G+ L + P + N + KI K TL PS S +D + +
Sbjct: 186 DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKC 245
Query: 252 LIVDPMKRITIPEIRQHPW 270
L + R T ++ QHP+
Sbjct: 246 LEKNVDARWTTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 80/303 (26%), Positives = 133/303 (43%), Gaps = 52/303 (17%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFM 75
KL K LG G++ V LT + VA+K + +E EE RE+ +L+
Sbjct: 10 KLDK-LGEGTYATVYKGRSKLTDNLVALKEIR------LEHEEGAPCTAIREVSLLKDLK 62
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRL-QEDEARNFFQQIISGVEYCH 134
H +I+ L+++I T + +V EY+ +L Y+ + G + F Q++ G+ YCH
Sbjct: 63 HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH 121
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVIS 189
R V+HRDLKP+NLL++ + +K+ADFGL+ + T S Y P+++
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR----AKSIPTKTYSNEVVTLWYRPPDILL 177
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLFKKIK 230
G ++D+W G I Y + G F +E P + +
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237
Query: 231 GGIYTLPSH-----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL 279
Y P + L +L+ ++L + KRI+ E +HP+F R
Sbjct: 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIH 297
Query: 280 AVP 282
+P
Sbjct: 298 KLP 300
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 76/269 (28%), Positives = 122/269 (45%), Gaps = 15/269 (5%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFMHPHIIRLY 83
+G G+ G+V TGH +A+K + R+ N E +++ ++ + L+ P+I++ Y
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQM--RRTGNKEENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 84 EVIETPSDIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNM-VVH 140
T SD+++ ME D +++ +G + ED I+ + Y V+H
Sbjct: 81 GYFITDSDVFICME--LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIH 138
Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP---E 197
RD+KP N+LLD+ NVK+ DFG+S + D S G Y APE I
Sbjct: 139 RDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIR 198
Query: 198 VDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLPSH--LSPGARDLIPRMLI 253
DVWS G+ L L G P+ L K ++ +LP + SP + L
Sbjct: 199 ADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLT 258
Query: 254 VDPMKRITIPEIRQHPWFQAHLPRYLAVP 282
D KR E+ QHP+ + + + V
Sbjct: 259 KDHRKRPKYRELLQHPFIRRYETAEVDVA 287
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 44/144 (30%), Positives = 84/144 (58%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
K + G+FGKV + A+K++ + + N M +V+ E L L P I+ L
Sbjct: 10 KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL 69
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
Y +++ +++Y+VMEY+ G++ + G E+ A + ++ ++Y HR+ ++HRD
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRD 129
Query: 143 LKPENLLLDSKWNVKIADFGLSNI 166
LKP+N+L+ ++ ++K+ DFGLS +
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 3e-23
Identities = 62/230 (26%), Positives = 114/230 (49%), Gaps = 12/230 (5%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
L + +G G FG V + + L KVAIK + + EE E +++ HP +
Sbjct: 7 TLVQEIGSGQFGLVWLG-YWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKL 61
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
++LY V S I +V E+++ G L DY+ ++G+ ++ + G+ Y + V
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNV 121
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 195
+HRDL N L+ VK++DFG++ + D + +S G+ +++PEV S Y+
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 196 PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGA 244
+ DVWS GV+++ + G P+++ + + + I G L+ +
Sbjct: 181 -KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQS 229
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 3e-23
Identities = 77/258 (29%), Positives = 124/258 (48%), Gaps = 18/258 (6%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
LG G++G V A T ++AIK + ++ + + EI + H +I++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEI---PERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 85 VIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFF--QQIISGVEYCHRNMVVHR 141
+ ME V G L + K G L+++E F +QI+ G++Y H N +VHR
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 142 DLKPENLLLDSKWNV-KIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVIS-GKLYAGPEV 198
D+K +N+L+++ V KI+DFG S + +T G+ Y APEVI G G
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPA 192
Query: 199 DVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYT----LPSHLSPGARDLIPRML 252
D+WS G + + G PF + P +FK G++ +P LS A++ I R
Sbjct: 193 DIWSLGCTIVEMATGKPPFIELGEPQAAMFKV---GMFKIHPEIPESLSAEAKNFILRCF 249
Query: 253 IVDPMKRITIPEIRQHPW 270
DP KR + ++ Q P+
Sbjct: 250 EPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 4e-23
Identities = 77/259 (29%), Positives = 130/259 (50%), Gaps = 20/259 (7%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
LG G+FGKV A++ TG A K++ + K+ E E EI+IL HP+I++L
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 85 VIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
+++++E+ G + ++E R L E + + +Q++ ++Y H ++HRDL
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDL 136
Query: 144 KPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKTSCGSPNYAAPEVISGK-LYAGP- 196
K N+LL ++K+ADFG+S + R F+ G+P + APEV+ + + P
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI----GTPYWMAPEVVMCETMKDTPY 192
Query: 197 --EVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-KGGIYTL--PSHLSPGARDLIPRM 251
+ D+WS G+ L + P + N + KI K TL PS S RD +
Sbjct: 193 DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTA 252
Query: 252 LIVDPMKRITIPEIRQHPW 270
L P R + ++ +HP+
Sbjct: 253 LDKHPETRPSAAQLLEHPF 271
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 6e-23
Identities = 76/273 (27%), Positives = 131/273 (47%), Gaps = 22/273 (8%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LFMH 76
+++ +T+G G++GKV + G A+KIL+ +++E++ E IL+ L H
Sbjct: 23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNH 78
Query: 77 PHIIRLYEVIETPS-----DIYVVMEYVKSG---ELFDYIVEKG-RLQEDEARNFFQQII 127
P++++ Y + +++V+E G EL ++ G RL E +
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPE 186
G+++ H N ++HRD+K N+LL ++ VK+ DFG+S + + TS G+P + APE
Sbjct: 139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198
Query: 187 VISGK----LYAGPEVDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYTL--PSH 239
VI+ + DVWS G+ L G P FD + LFK + TL P
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEK 258
Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
I + LI D R ++ + +HP+ +
Sbjct: 259 WCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 67/268 (25%), Positives = 109/268 (40%), Gaps = 64/268 (23%)
Query: 66 REIKILRLFMHPHIIRLYEVIETPSD--IYVVMEYVKS--GELFDYIVEKGRLQEDEA-- 119
REI +LR H +++ L EV +D +Y++ +Y + ++ + + R+ +
Sbjct: 51 REIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN----VKIADFGLSNIMRDGHFLKT 175
++ QI++GV Y H N V+HRDLKP N+L+ + VKI D GL+ + LK
Sbjct: 111 KSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP--LKP 168
Query: 176 SCGSPN------YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF----DDENIPNL 225
Y APE++ G + +D+W+ G I LL F N
Sbjct: 169 LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP 228
Query: 226 FK--------KIKG--------GIYTLPSH--------------------------LSPG 243
F+ ++ G I +P +
Sbjct: 229 FQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQ 288
Query: 244 ARDLIPRMLIVDPMKRITIPEIRQHPWF 271
DL+ ++L DP KRIT E +HP+F
Sbjct: 289 GFDLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 8e-23
Identities = 71/255 (27%), Positives = 127/255 (49%), Gaps = 19/255 (7%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
KL +T+G G FG V + ++ G+KVA+K IKN + E ++ H ++
Sbjct: 9 KLLQTIGKGEFGDVMLGDY--RGNKVAVKC-----IKNDATAQAFLAEASVMTQLRHSNL 61
Query: 80 IRLYEVI-ETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRN 136
++L VI E +Y+V EY+ G L DY+ +GR L D F + +EY N
Sbjct: 62 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYAG 195
VHRDL N+L+ K++DFGL+ ++ + + P + APE + K ++
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFS- 177
Query: 196 PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRML 252
+ DVWS G++L+ + G +P+ + ++ +++ G Y + P P D++ +
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPVVYDVMKQCW 236
Query: 253 IVDPMKRITIPEIRQ 267
+D R + ++R+
Sbjct: 237 HLDAATRPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 9e-23
Identities = 74/249 (29%), Positives = 123/249 (49%), Gaps = 9/249 (3%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
+G G+FG+V VA+K + R+ +++ K +E +IL+ + HP+I+RL
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 85 VIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
V IY+VME V+ G+ ++ +G RL+ E + +G+EY +HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 144 KPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPEVDV 200
N L+ K +KI+DFG+S DG + T + APE ++ Y+ E DV
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS-ESDV 179
Query: 201 WSCGVILY-ALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGA-RDLIPRMLIVDPMK 258
WS G++L+ A G +P+ + + + I+ G+ L P A L+ R DP +
Sbjct: 180 WSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQ 239
Query: 259 RITIPEIRQ 267
R + + Q
Sbjct: 240 RPSFSTVHQ 248
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 9e-23
Identities = 72/254 (28%), Positives = 114/254 (44%), Gaps = 17/254 (6%)
Query: 23 KTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
K LG G+FG V + + K VA+K L + I + E RE ++ HP I
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKE--FLREASVMAQLDHPCI 58
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVV 139
+RL V + + +VME G L Y+ ++ + + + Q+ G+ Y V
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSCGS-P-NYAAPEVIS-GKLYA 194
HRDL N+LL ++ KI+DFG+S + G ++ T+ G P + APE I+ GK +
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSS 177
Query: 195 GPEVDVWSCGVILY-ALLCGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRM 251
+ DVWS GV L+ A G P+ + + ++ G L P ++
Sbjct: 178 --KSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-ERLPRPEECPQEIYSIMLSC 234
Query: 252 LIVDPMKRITIPEI 265
P R T E+
Sbjct: 235 WKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-22
Identities = 78/270 (28%), Positives = 132/270 (48%), Gaps = 26/270 (9%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LFMHP 77
+++ +T+G G++GKV + G K A+KIL+ +++E++ E IL+ L HP
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHP 75
Query: 78 HIIRLYEV-----IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN------FFQQI 126
++++ Y + ++ +++V+E G + D + KG L+ E +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV--KGFLKRGERMEEPIIAYILHEA 133
Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAP 185
+ G+++ H N +HRD+K N+LL ++ VK+ DFG+S + TS G+P + AP
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193
Query: 186 EVISGKLYAGP----EVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTL--PS 238
EVI+ + DVWS G+ L G P D + LFK + TL P
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPE 253
Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
S D I + L D KR T+ ++ QH
Sbjct: 254 LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 77/274 (28%), Positives = 120/274 (43%), Gaps = 35/274 (12%)
Query: 18 NYKLGKTLGIGSFGKV--KIAEHALTGH---KVAIKILNRRKIKNMEMEEKVR--REIKI 70
L + LG GSFG V +A+ + G +VAIK +N +N M E++ E +
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN----ENASMRERIEFLNEASV 62
Query: 71 LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQ------ 124
++ F H++RL V+ T VVME + G+L Y+ + R E E
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQK 120
Query: 125 ------QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSC 177
+I G+ Y VHRDL N ++ VKI DFG++ +I ++ K
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 178 GS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPF---DDENIPNLFKKIKG 231
G P + APE + ++ + DVWS GV+L+ + P+ +E + I G
Sbjct: 181 GLLPVRWMAPESLKDGVFT-TKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV--IDG 237
Query: 232 GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEI 265
G LP + +L+ +P R T EI
Sbjct: 238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 2e-22
Identities = 74/270 (27%), Positives = 124/270 (45%), Gaps = 31/270 (11%)
Query: 22 GKTLGIGSFGKVKIAEHALTGHKVAIK--ILNRRKIKNMEME-EKVRREIKILRLFMHPH 78
G+ LG G++G V G +A+K L+ + E E EK++ E+ +L+ H +
Sbjct: 5 GEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
I++ + I + ME+V G + + G L E + +QI+ GV Y H N V
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 139 VHRDLKPENLLLDSKWNVKIADFGL-------------SNIMRDGHFLKTSCGSPNYAAP 185
VHRD+K N++L +K+ DFG SN+++ H G+P + AP
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH------GTPYWMAP 177
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-----KGGIYTLPSHL 240
EVI+ Y G + D+WS G ++ + G P ++ L +G + LP
Sbjct: 178 EVINESGY-GRKSDIWSIGCTVFEMATGKPPL--ASMDRLAAMFYIGAHRGLMPRLPDSF 234
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
S A D + L D +R + ++ +H +
Sbjct: 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 2e-22
Identities = 70/203 (34%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 20 KLGKTLGIGSFGKVKI----AEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
K + LG G FGKV + + TG VA+K L R + ++EI IL+
Sbjct: 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY 64
Query: 76 HPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
H +I++ + ++MEYV G L DY+ K +L + F QQI G+ Y
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYL 123
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNY-AAPEVI- 188
H +HRDL N+LLD+ VKI DFGL+ + +GH ++ SP + A E +
Sbjct: 124 HSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 189 SGKLYAGPEVDVWSCGVILYALL 211
K DVWS GV LY LL
Sbjct: 184 ENKFSYAS--DVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 13/185 (7%)
Query: 41 TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD-IYVVMEYV 99
TGH+VAIK+L + + RRE + HP+I+ L + E P ++ V EYV
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 100 KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL---DSKWNV 156
L + + G L E Q++ + H +VHRDLKP+N+++ + +
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 157 KIADFGLSNIMRDGHFLKTS--------CGSPNYAAPEVISGKLYAGPEVDVWSCGVILY 208
K+ DFG+ ++ + G+P Y APE + G+ P D+++ G+I
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT-PNSDLYAWGLIFL 180
Query: 209 ALLCG 213
L G
Sbjct: 181 ECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 4e-22
Identities = 78/292 (26%), Positives = 128/292 (43%), Gaps = 52/292 (17%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFM 75
KL K LG G++ V LT + VA+K + +E EE RE+ +L+
Sbjct: 9 KLDK-LGEGTYATVFKGRSKLTENLVALKEIR------LEHEEGAPCTAIREVSLLKNLK 61
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQE-DEARNFFQQIISGVEYCH 134
H +I+ L+++I T + +V EY+ S +L Y+ G L + F Q++ G+ YCH
Sbjct: 62 HANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH 120
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVIS 189
+ ++HRDLKP+NLL++ K +K+ADFGL+ + T S Y P+V+
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLAR----AKSVPTKTYSNEVVTLWYRPPDVLL 176
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLFKKIK 230
G +D+W G ILY + G F +E P + +
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236
Query: 231 GGIYTLPSHLSPGARDLIPR-----------MLIVDPMKRITIPEIRQHPWF 271
Y P + + + PR +L+ + RI+ +H +F
Sbjct: 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 65/197 (32%), Positives = 107/197 (54%), Gaps = 15/197 (7%)
Query: 25 LGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
LG G+FG V++ + TG VA+K L +++ E REI+IL+ H +I+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFE---REIEILKSLQHDNIV 68
Query: 81 RLYEVIETPS--DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM 137
+ V + ++ +VMEY+ G L DY+ + + RL + + QI G+EY
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLY 193
VHRDL N+L++S+ VKI DFGL+ ++ ++ + ++ SP + APE ++ +
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF 188
Query: 194 AGPEVDVWSCGVILYAL 210
+ DVWS GV+LY L
Sbjct: 189 S-VASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 6e-22
Identities = 69/225 (30%), Positives = 114/225 (50%), Gaps = 14/225 (6%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM-EEKVRREIKILRLFMHPHIIR 81
K LG G FG VK + + VAIK+ IK M E++ E K++ H +++
Sbjct: 10 KELGTGQFGVVKYGKWR-GQYDVAIKM-----IKEGSMSEDEFIEEAKVMMKLSHEKLVQ 63
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVH 140
LY V IY+V EY+ +G L +Y+ E G R Q + + + G+ Y +H
Sbjct: 64 LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIH 123
Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAGPE 197
RDL N L+D + VK++DFGLS + D + +S GS ++ PEV+ ++ +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSS-K 181
Query: 198 VDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLS 241
DVW+ GV+++ + G +P++ N +K+ G+ HL+
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLA 226
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 7e-22
Identities = 71/254 (27%), Positives = 123/254 (48%), Gaps = 17/254 (6%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
KLG T+G G FG V + ++ G KVA+K L + + E ++ HP++
Sbjct: 9 KLGATIGKGEFGDVMLGDYR--GQKVAVKCLKD----DSTAAQAFLAEASVMTTLRHPNL 62
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNM 137
++L V+ + +Y+V EY+ G L DY+ +GR + + F + G+EY
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYAGP 196
VHRDL N+L+ K++DFGL+ G S P + APE + K ++
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---DSGKLPVKWTAPEALREKKFST- 178
Query: 197 EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 253
+ DVWS G++L+ + G +P+ + ++ ++ G Y + P P ++
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAPEGCPPEVYKVMKDCWE 237
Query: 254 VDPMKRITIPEIRQ 267
+DP KR T ++R+
Sbjct: 238 LDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 62/186 (33%), Positives = 95/186 (51%), Gaps = 11/186 (5%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
+G GSFG V A T VAIK ++ ++ E + + +E++ L+ HP+ I
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 85 VIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
++VMEY G D + V K LQE E + G+ Y H + +HRD+
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDI 141
Query: 144 KPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI----SGKLYAGPEVD 199
K N+LL VK+ADFG ++++ + + G+P + APEVI G+ Y G +VD
Sbjct: 142 KAGNILLTEPGTVKLADFGSASLVSPAN---SFVGTPYWMAPEVILAMDEGQ-YDG-KVD 196
Query: 200 VWSCGV 205
VWS G+
Sbjct: 197 VWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 8e-22
Identities = 79/303 (26%), Positives = 135/303 (44%), Gaps = 52/303 (17%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFM 75
KL K LG G++ V LT + VA+K + +E EE RE+ +L+
Sbjct: 10 KLEK-LGEGTYATVFKGRSKLTENLVALKEIR------LEHEEGAPCTAIREVSLLKDLK 62
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQE-DEARNFFQQIISGVEYCH 134
H +I+ L++++ T + +V EY+ +L Y+ + G + + F QI+ G+ YCH
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH 121
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVIS 189
R V+HRDLKP+NLL++ + +K+ADFGL+ + T S Y P+V+
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR----AKSVPTKTYSNEVVTLWYRPPDVLL 177
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLFKKIK 230
G ++D+W G I + + G F +E P + +
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237
Query: 231 GGIYTLPSH-----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL 279
Y P + L +L+ + L + KRI+ E +H +F++ R
Sbjct: 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIH 297
Query: 280 AVP 282
++P
Sbjct: 298 SLP 300
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 9e-22
Identities = 63/221 (28%), Positives = 108/221 (48%), Gaps = 16/221 (7%)
Query: 20 KLGKTLGIGSFGKVK----IAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
+ K LG G+FG V I E VAIK+L R+ + + +++ E ++
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL--REETSPKANKEILDEAYVMASVD 67
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
HPH++RL + + + ++ + + G L DY+ K + N+ QI G+ Y
Sbjct: 68 HPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
+VHRDL N+L+ + +VKI DFGL+ ++ + + P + A E I +
Sbjct: 127 EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR 186
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFDDEN---IPNLFKK 228
+Y + DVWS GV ++ L+ G P++ IP+L +K
Sbjct: 187 IYTH-KSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK 226
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 86/299 (28%), Positives = 130/299 (43%), Gaps = 63/299 (21%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFM 75
KL K LG GS+ V LTG VA+K + +E EE RE +L+
Sbjct: 9 KLDK-LGEGSYATVYKGRSKLTGQLVALKEIR------LEHEEGAPFTAIREASLLKDLK 61
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCH 134
H +I+ L+++I T + +V EY+ + +L Y+ + G L R F Q++ G+ YCH
Sbjct: 62 HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYA---------AP 185
+ V+HRDLKP+NLL+ + +K+ADFGL+ S S Y+ P
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLAR--------AKSVPSKTYSNEVVTLWYRPP 172
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPF--------------------DDENIPNL 225
+V+ G +D+W G I Y + G F +E P +
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232
Query: 226 -----FKKIKGGIYT---LPSHLS-----PGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
FK Y L +H P +L + L +P KRI+ E +HP+F
Sbjct: 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-21
Identities = 77/279 (27%), Positives = 133/279 (47%), Gaps = 20/279 (7%)
Query: 65 RREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR----LQEDEAR 120
R E+ L H I++ ++ ++ + ++MEY G+L I ++ + QE E
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS---C 177
F QI+ ++ H ++HRDLK N+ L +K+ DFG S D L + C
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232
Query: 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-L 236
G+P Y APE+ K Y+ + D+WS GVILY LL PF + + +++ G Y
Sbjct: 233 GTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF 291
Query: 237 PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKID-- 294
P +S G + L+ +L +P R T ++ +Y+A D ++ ++ I
Sbjct: 292 PCPVSSGMKALLDPLLSKNPALRPTTQQL-----LHTEFLKYVANLFQDIVRHSETISPH 346
Query: 295 --EEILKEVVKMGFDQNQLVESLR-NRLQNEATVAYYLL 330
EEIL+++ + G ++ S+R + ++ T YL
Sbjct: 347 DREEILRQLQESG-ERAPPPSSIRYGVVTSDVTHGGYLY 384
|
Length = 478 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 3e-21
Identities = 70/230 (30%), Positives = 115/230 (50%), Gaps = 13/230 (5%)
Query: 17 PNY-KLGKTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILR 72
P+Y + K +G G FG+V L G VAIK L ++ E I+
Sbjct: 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD--FLTEASIMG 60
Query: 73 LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVE 131
F HP+IIRL V+ + ++ EY+++G L ++ E G+ + + I SG++
Sbjct: 61 QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMK 120
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG--SP-NYAAPEVI 188
Y VHRDL N+L++S K++DFGLS + D T+ G P + APE I
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI 180
Query: 189 SGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
+ + + DVWS G++++ ++ G P+ D + ++ K ++ G Y LP
Sbjct: 181 AYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-YRLP 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 72/268 (26%), Positives = 113/268 (42%), Gaps = 29/268 (10%)
Query: 25 LGIGSFGKVKIAE--HALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
LG G+FGKV + E H VA+K L ++ + + + RE ++L F H +I
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTL--KETASNDARKDFEREAELLTNFQHENI 70
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYI--------------VEKGRLQEDEARNFFQQ 125
++ Y V +V EY++ G+L ++ G L + Q
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NY 182
I SG+ Y VHRDL N L+ VKI DFG+S + D + + P +
Sbjct: 131 IASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRW 190
Query: 183 AAPE-VISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHL 240
PE ++ K E DVWS GV+L+ + G P+ + + + I G
Sbjct: 191 MPPESIMYRKFTT--ESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRT 248
Query: 241 SP-GARDLIPRMLIVDPMKRITIPEIRQ 267
P D++ DP +RI I +I +
Sbjct: 249 CPSEVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 84/283 (29%), Positives = 128/283 (45%), Gaps = 39/283 (13%)
Query: 18 NYKLGKTLGIGSFGKV-KIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILR 72
N LGKTLG G FGKV K L G VA+K+L ++ + + E +L+
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKML--KENASSSELRDLLSEFNLLK 58
Query: 73 LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-----VEKGRLQEDEARN------ 121
HPH+I+LY + +++EY K G L ++ V L D RN
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 122 -------------FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIM 167
F QI G++Y +VHRDL N+L+ +KI+DFGLS ++
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178
Query: 168 RDGHFLKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN 224
+ ++K S G + A E + +Y + DVWS GV+L+ ++ G P+
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237
Query: 225 LFKKIKGGIYTL--PSHLSPGARDLIPRMLIVDPMKRITIPEI 265
LF +K G Y + P + S +L+ +P KR T +I
Sbjct: 238 LFNLLKTG-YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-21
Identities = 74/296 (25%), Positives = 132/296 (44%), Gaps = 40/296 (13%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+Y+ + LG GS+ V + + G VA+K++ ++ + RE +L+ H
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPF--TAIREASLLKGLKHA 63
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRN 136
+I+ L+++I T + +V EYV + +L Y+ + G L + + F Q++ G+ Y H+
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAG 195
++HRDLKP+NLL+ +K+ADFGL+ H + Y P+V+ G
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 196 PEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKI-----------KGGIYTLPSHLSP- 242
+D+W G I ++ G F ++I + ++I G+++LP H P
Sbjct: 183 TCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP-HFKPE 241
Query: 243 ---------------------GARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
A DL ++L P R++ H +F PR
Sbjct: 242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPPR 297
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 7e-21
Identities = 67/235 (28%), Positives = 121/235 (51%), Gaps = 28/235 (11%)
Query: 1 MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
+D ++ R +G+ ++L + +G G++G+V H TG AIK+++ + +
Sbjct: 6 IDLSALRDPAGI------FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DE 55
Query: 61 EEKVRREIKILRLFMHPHIIRLYE---VIETPS----DIYVVMEYVKSGELFDYIVE-KG 112
EE+++ EI +L+ + H I Y + ++P +++VME+ +G + D + KG
Sbjct: 56 EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG 115
Query: 113 R-LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDG 170
L+ED ++I+ G+ + H + V+HRD+K +N+LL VK+ DFG+S + R
Sbjct: 116 NALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175
Query: 171 HFLKTSCGSPNYAAPEVISGKLYAGPEV------DVWSCGVILYALLCGTLPFDD 219
T G+P + APEVI+ P+ D+WS G+ + G P D
Sbjct: 176 GRRNTFIGTPYWMAPEVIACD--ENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 7e-21
Identities = 72/227 (31%), Positives = 118/227 (51%), Gaps = 17/227 (7%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEME-EKVRREIKILRLFM 75
KL K LG G FG+V + + GH KVAIK L K M E E +++
Sbjct: 7 TLKLVKKLGAGQFGEVWMGYY--NGHTKVAIKSL-----KQGSMSPEAFLAEANLMKQLQ 59
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIV--EKGRLQEDEARNFFQQIISGVEYC 133
HP ++RLY V+ T IY++ EY+++G L D++ E +L ++ + QI G+ +
Sbjct: 60 HPRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGK 191
R +HRDL+ N+L+ KIADFGL+ ++ D + + P + APE I+
Sbjct: 119 ERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 178
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
+ + DVWS G++L ++ G +P+ P + + ++ G Y +P
Sbjct: 179 TFT-IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRMP 223
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 7e-21
Identities = 69/272 (25%), Positives = 120/272 (44%), Gaps = 28/272 (10%)
Query: 20 KLGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
KLGK LG G FG V ++++ + KVA+K + E+EE + E ++ F H
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLS-EAACMKDFDH 60
Query: 77 PHIIRLYEVIETPSDI------YVVMEYVKSGELFDYIVEKGRLQEDEAR-------NFF 123
P++++L V S + V++ ++K G+L +++ RL + F
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLKFM 119
Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP--- 180
I G+EY +HRDL N +L V +ADFGLS + G + + +
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPF---DDENIPNLFKKIKGGIYTL 236
+ A E ++ ++Y + DVW+ GV ++ + G P+ ++ I + G
Sbjct: 180 KWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL--RHGNRLKQ 236
Query: 237 PSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
P DL+ DP R T ++R+
Sbjct: 237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 65/224 (29%), Positives = 119/224 (53%), Gaps = 15/224 (6%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
KL K LG G FG+V +A + H KVA+K + K +M +E + E +++ H
Sbjct: 9 KLEKKLGAGQFGEVWMATY--NKHTKVAVKTM---KPGSMSVEAFLA-EANVMKTLQHDK 62
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIV--EKGRLQEDEARNFFQQIISGVEYCHRN 136
+++L+ V+ T IY++ E++ G L D++ E + + +F QI G+ + +
Sbjct: 63 LVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 194
+HRDL+ N+L+ + KIADFGL+ ++ D + + P + APE I+ +
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 181
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
+ DVWS G++L ++ G +P+ + P + + ++ G Y +P
Sbjct: 182 -IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMP 223
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 70/202 (34%), Positives = 108/202 (53%), Gaps = 18/202 (8%)
Query: 23 KTLGIGSFGKVKIA----EHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
+ LG G FGKV++ E TG +VA+K L N + +++EI+ILR H +
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD--LKKEIEILRNLYHEN 67
Query: 79 IIRLYEVI---ETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
I++ Y+ I + + I ++ME++ SG L +Y+ K ++ + + QI G++Y
Sbjct: 68 IVK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNY-AAPE-VIS 189
VHRDL N+L++S+ VKI DFGL+ + + +K SP + APE +I
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 190 GKLYAGPEVDVWSCGVILYALL 211
K Y DVWS GV LY LL
Sbjct: 187 SKFYIAS--DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 7e-20
Identities = 60/203 (29%), Positives = 89/203 (43%), Gaps = 29/203 (14%)
Query: 23 KTLGIGSFGKVKIAE-HALTGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
K LG GSFG V+ E G VA+K L K+ ++ + +E I+ H ++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD--FLKEAAIMHSLDHENL 58
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR--------NFFQQIISGVE 131
IRLY V+ T + +V E G L D RL++D ++ QI +G+
Sbjct: 59 IRLYGVVLTHP-LMMVTELAPLGSLLD------RLRKDALGHFLISTLCDYAVQIANGMR 111
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN------YAAP 185
Y +HRDL N+LL S VKI DFGL + + + AP
Sbjct: 112 YLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM--EEHLKVPFAWCAP 169
Query: 186 EVISGKLYAGPEVDVWSCGVILY 208
E + + ++ DVW GV L+
Sbjct: 170 ESLRTRTFSHAS-DVWMFGVTLW 191
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 8e-20
Identities = 73/275 (26%), Positives = 126/275 (45%), Gaps = 34/275 (12%)
Query: 19 YKLGKTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
+ LG+ LG G FG V+ A+ + KVA+K+L + ++EE +R E ++ F
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLR-EAACMKEFD 59
Query: 76 HPHIIRLYEV---------IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR------ 120
HP++I+L V + P V++ ++K G+L +++ R+ E+
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIP---MVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTL 115
Query: 121 -NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS 179
F I SG+EY +HRDL N +L+ V +ADFGLS + G + + C S
Sbjct: 116 VRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 180 P---NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPF---DDENIPNLFKKIKGG 232
+ A E ++ +Y DVW+ GV ++ ++ G P+ ++ I N IKG
Sbjct: 176 KLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL--IKGN 232
Query: 233 IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
P +L+ + +P R + +R
Sbjct: 233 RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-19
Identities = 72/251 (28%), Positives = 121/251 (48%), Gaps = 15/251 (5%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
LG G +G+V VA+K L K ME+EE ++ E +++ HP++++L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLK-EAAVMKEIKHPNLVQLLG 69
Query: 85 VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQ---QIISGVEYCHRNMVVHR 141
V Y++ E++ G L DY+ E R QE A QI S +EY + +HR
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKNFIHR 128
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGPEVD 199
DL N L+ VK+ADFGLS +M + + P + APE ++ ++ + D
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI-KSD 187
Query: 200 VWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIVDP 256
VW+ GV+L+ + G P+ ++ +++ ++ G Y + P P +L+ +P
Sbjct: 188 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-YRMERPEGCPPKVYELMRACWQWNP 246
Query: 257 MKRITIPEIRQ 267
R + EI Q
Sbjct: 247 SDRPSFAEIHQ 257
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 66/202 (32%), Positives = 110/202 (54%), Gaps = 18/202 (8%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHK-VAIKILNRRKIKNME--MEEKVRREIKILR--- 72
Y+ +G G++GKV A G + VA+K R +++ E M RE+ +LR
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALK---RVRVQTGEEGMPLSTIREVAVLRHLE 59
Query: 73 LFMHPHIIRLYEV-----IETPSDIYVVMEYVKSGELFDYI--VEKGRLQEDEARNFFQQ 125
F HP+++RL++V + + + +V E+V +L Y+ V + + + ++ Q
Sbjct: 60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ 118
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAP 185
++ G+++ H + VVHRDLKP+N+L+ S +K+ADFGL+ I L + + Y AP
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178
Query: 186 EVISGKLYAGPEVDVWSCGVIL 207
EV+ YA P VD+WS G I
Sbjct: 179 EVLLQSSYATP-VDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-19
Identities = 83/291 (28%), Positives = 130/291 (44%), Gaps = 34/291 (11%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
+ +G GSFG V A T VAIK ++ ++ E + + +E+K L+ HP+ I
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 83 YEVIETPSDIYVVMEYV--KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVH 140
++VMEY + +L + V K LQE E + G+ Y H + ++H
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMIH 148
Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI----SGKLYAGP 196
RD+K N+LL VK+ADFG ++I + + G+P + APEVI G+ Y G
Sbjct: 149 RDIKAGNILLTEPGQVKLADFGSASIASPAN---SFVGTPYWMAPEVILAMDEGQ-YDG- 203
Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFK-KIKGGIYTLPSHLSPGA---------RD 246
+VDVWS G+ L E P LF +Y + + SP R+
Sbjct: 204 KVDVWSLGITCIELA--------ERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN 255
Query: 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEI 297
+ L P R T E+ +H + P + + D +Q+ K E+
Sbjct: 256 FVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLI---DLIQRTKDAVREL 303
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-19
Identities = 54/209 (25%), Positives = 103/209 (49%), Gaps = 30/209 (14%)
Query: 77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
P+++ L++ I + +++V+++ + G+L+ +I + + E+ + + +++ ++ HR
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----YAAPEVISGKL 192
+V RDL P N+LLD + ++++ F + + D SC Y APEV G
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED------SCDGEAVENMYCAPEV-GGIS 157
Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-----LPSHLSPGARDL 247
D WS G IL+ LL G L + GI T +P +S AR L
Sbjct: 158 EETEACDWWSLGAILFELLTGK---------TLVECHPSGINTHTTLNIPEWVSEEARSL 208
Query: 248 IPRMLIVDPMKRI-----TIPEIRQHPWF 271
+ ++L +P +R+ + +I+ HP+F
Sbjct: 209 LQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 8/194 (4%)
Query: 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLY 83
LG G+ G V A H LT +A+K++ +E+++++ E++IL P+II Y
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 84 EVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
+ I + E++ G L Y ++ E ++ G+ Y ++HRD+
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDV 121
Query: 144 KPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 203
KP N+L++++ VK+ DFG+S + + KT G+ Y APE ISG+ Y G DVWS
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQY-GIHSDVWSL 179
Query: 204 GVILYALLCGTLPF 217
G+ L G P+
Sbjct: 180 GISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
L + + LG G+FGKV E L+ VAIK L ++ +++++ R+E ++
Sbjct: 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL--KENAEPKVQQEFRQEAEL 61
Query: 71 LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE----------------KGRL 114
+ HP+I+ L V ++ EY+ G+L +++V K L
Sbjct: 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121
Query: 115 QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174
+ + QI +G+EY + VHRDL N L+ VKI+DFGLS + + +
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181
Query: 175 TSCGSP---NYAAPEVI-SGKLYAGPEVDVWSCGVILYAL 210
S + PE I GK E D+WS GV+L+ +
Sbjct: 182 VQSKSLLPVRWMPPEAILYGKF--TTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 4e-19
Identities = 72/237 (30%), Positives = 118/237 (49%), Gaps = 18/237 (7%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEK-VRREIKILRLFM 75
K+ K +G G FG+V L G + VAIK L K E + + E I+ F
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL---KAGYTEKQRRDFLSEASIMGQFD 63
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYC 133
HP+II L V+ + +V EY+++G L D + K G+ + + I SG++Y
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYL 122
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD---GHFLKTSCGSP-NYAAPEVIS 189
VHRDL N+L++S K++DFGLS ++ D + P + APE I+
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 190 GKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLS-PGA 244
+ + DVWS G++++ ++ G P+ + + ++ K I+ G Y LP+ + P A
Sbjct: 183 YRKFTSAS-DVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPMDCPAA 237
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 72/267 (26%), Positives = 124/267 (46%), Gaps = 23/267 (8%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+++L + +G G++G V A + TG AIK++ K++ E V++EI +++ H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKHS 66
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
+I+ + +++ ME+ G L D G L E + ++ + G+ Y H
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
+HRD+K N+LL +VK+ADFG+S I K+ G+P + APEV + + G
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY 186
Query: 197 E--VDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYTLPSHLSPGARD------- 246
D+W+ G+ L P FD + LF + T + P +D
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMTKSNFQPPKLKDKMKWSNS 240
Query: 247 ---LIPRMLIVDPMKRITIPEIRQHPW 270
+ L +P KR T ++ QHP+
Sbjct: 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-19
Identities = 68/229 (29%), Positives = 111/229 (48%), Gaps = 21/229 (9%)
Query: 23 KTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKILRLFM 75
K +G G FG+V + G K VAIK L EK R+ E I+ F
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK------PGYTEKQRQDFLSEASIMGQFS 64
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCH 134
H +IIRL V+ ++ EY+++G L Y+ + G + + I +G++Y
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD---GHFLKTSCGSP-NYAAPEVISG 190
VHRDL N+L++S K++DFGLS ++ D G + + P + APE I+
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 191 KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS 238
+ + DVWS G++++ ++ G P+ D + + K I G + LP+
Sbjct: 185 RKFTSAS-DVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLPA 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 61/187 (32%), Positives = 96/187 (51%), Gaps = 13/187 (6%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
+G GSFG V A ++ T VA+K ++ + E + + +E+K L+ HP+ I
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 85 VIETPSDIYVVMEYV--KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
++VMEY + +L + V K LQE E + G+ Y H + ++HRD
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI----SGKLYAGPEV 198
+K N+LL VK+ADFG ++ + + G+P + APEVI G+ Y G +V
Sbjct: 147 IKAGNILLTEPGQVKLADFGSASKSSPAN---SFVGTPYWMAPEVILAMDEGQ-YDG-KV 201
Query: 199 DVWSCGV 205
DVWS G+
Sbjct: 202 DVWSLGI 208
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-18
Identities = 62/217 (28%), Positives = 112/217 (51%), Gaps = 22/217 (10%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
++L + +G G++G+V H TG AIK+++ + EE++++EI +L+ + H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 79 IIRLYE---VIETP----SDIYVVMEYVKSGELFDYI--VEKGRLQEDEARNFFQQIISG 129
I Y + + P +++VME+ +G + D I + L+E+ ++I+ G
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVI 188
+ + H++ V+HRD+K +N+LL VK+ DFG+S + R T G+P + APEVI
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183
Query: 189 SGKLYAGPEV------DVWSCGVILYALLCGTLPFDD 219
+ P+ D+WS G+ + G P D
Sbjct: 184 ACD--ENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 73/292 (25%), Positives = 135/292 (46%), Gaps = 53/292 (18%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPHII 80
LG G+ G V H +G +A RK+ ++E++ +R RE+K+L P+I+
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMA------RKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62
Query: 81 RLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNM-V 138
Y + +I + ME++ G L D +++K GR+ E+ ++ G+ Y +
Sbjct: 63 GFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKI 121
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
+HRD+KP N+L++S+ +K+ DFG+S + D + G+ +Y +PE + G Y +
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYT-VQS 179
Query: 199 DVWSCGVILYALLCGTLPF---DDENIPNLF-KKIKGG---------------------I 233
D+WS G+ L + G P D + + +F + + G I
Sbjct: 180 DIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAI 239
Query: 234 Y------------TLPS-HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
+ LPS S +D + + L +P +R + E+ +HP+ +
Sbjct: 240 FELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 58/189 (30%), Positives = 91/189 (48%), Gaps = 10/189 (5%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
+G G+FG V +VA+K R +++ K +E +IL+ + HP+I++L
Sbjct: 3 IGKGNFGDVYKGVLK-GNTEVAVKTC--RSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 85 VIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
V IY+VME V G L ++ +K RL + +G+EY +HRDL
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDL 119
Query: 144 KPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----YAAPEVISGKLYAGPEVD 199
N L+ +KI+DFG+S G + S G + APE ++ Y E D
Sbjct: 120 AARNCLVGENNVLKISDFGMSREEEGGIY-TVSDGLKQIPIKWTAPEALNYGRYTS-ESD 177
Query: 200 VWSCGVILY 208
VWS G++L+
Sbjct: 178 VWSYGILLW 186
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 18/231 (7%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPHII 80
LG G+ G V H +G +A RK+ ++E++ +R RE+++L P+I+
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 81 RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVV 139
Y + +I + ME++ G L + + GR+ E +I G+ Y ++ ++
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 126
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
HRD+KP N+L++S+ +K+ DFG+S + D + G+ +Y +PE + G Y+ + D
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQSD 184
Query: 200 VWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
+WS G+ L + G P IP K ++ P P + PR
Sbjct: 185 IWSMGLSLVEMAIGRYP-----IPPPDAKELELMFGCPVEGDPAESETSPR 230
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 4e-18
Identities = 65/262 (24%), Positives = 119/262 (45%), Gaps = 22/262 (8%)
Query: 23 KTLGIGSFGKV---KIAEHALTGHK--VAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
TLG G FG+V K G + V +K L + K +N++ E RRE+ + R H
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE--FRRELDMFRKLSHK 68
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARN--------FFQQIIS 128
+++RL + Y+++EY G+L ++ K + ++ + QI
Sbjct: 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSPNYAAPE 186
G+++ VHRDL N L+ S+ VK++ LS + + + L+ + + APE
Sbjct: 129 GMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 187 VISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI--YTLPSHLSPG 243
+ ++ + DVWS GV+++ + G LPF + + +++ G +P
Sbjct: 189 AVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSR 247
Query: 244 ARDLIPRMLIVDPMKRITIPEI 265
L+ R V+P R + E+
Sbjct: 248 LYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 4e-18
Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
+L + LG G FG+V T VA+K L K M+ ++ + E +I++ HP +
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTT-PVAVKTL---KPGTMDPKDFLA-EAQIMKKLRHPKL 63
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGR-LQEDEARNFFQQIISGVEYCHRNM 137
I+LY V IY+V E +K G L +Y+ GR L+ + + Q+ SG+ Y
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN 123
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSP-NYAAPEVISGKLYAG 195
+HRDL N+L+ K+ADFGL+ I D + + P + APE ++
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFS- 182
Query: 196 PEVDVWSCGVILYALLC-GTLPF 217
+ DVWS G++L ++ G +P+
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-18
Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 14/231 (6%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L LG+ +G G FG V E+ TG KVA+K IK + E ++
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKN-----IKCDVTAQAFLEETAVMTKLH 57
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR--NFFQQIISGVEYC 133
H +++RL VI + +Y+VME + G L +++ +GR + F + G+EY
Sbjct: 58 HKNLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL 116
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
+VHRDL N+L+ K++DFGL+ + G + S + APE + K +
Sbjct: 117 ESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHKKF 174
Query: 194 AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPG 243
+ + DVWS GV+L+ + G P+ ++ + + ++ G P P
Sbjct: 175 SS-KSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPA 224
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-18
Identities = 75/266 (28%), Positives = 123/266 (46%), Gaps = 24/266 (9%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK-VRREIK-ILRLFMHPHIIRL 82
+G G+FG V H +G +A+K R + E E+K + ++ ++R P+I++
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVK---RIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 83 YEVIETPSDIYVVMEYVK-SGELFD---YIVEKGRLQEDEARNFFQQIISGVEYCHRNM- 137
Y + D ++ ME + S + F Y V K + E+ + + Y +
Sbjct: 69 YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK 128
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT-SCGSPNYAAPEVISGKLYAGP 196
++HRD+KP N+LLD N+K+ DFG+S + D KT G Y APE I G
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERIDPSARDGY 187
Query: 197 EV--DVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--------TLPSHLSPGARD 246
+V DVWS G+ LY + G P+ N ++F ++ + + SP +
Sbjct: 188 DVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPILSNSEEREFSPSFVN 245
Query: 247 LIPRMLIVDPMKRITIPEIRQHPWFQ 272
I LI D KR E+ +HP+ +
Sbjct: 246 FINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-18
Identities = 75/292 (25%), Positives = 135/292 (46%), Gaps = 53/292 (18%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
Y + + +G G G+V +A + +VA+K + +N ++++ RE KI +HP
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 79 IIRLYEVIETPSD-IYVVMEYVKSGELFDYIVEKGRLQEDEARNF------------FQQ 125
I+ +Y I + D +Y M Y++ G +++ +E ++ F +
Sbjct: 64 IVPVYS-ICSDGDPVYYTMPYIE-GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----FLKTS---- 176
I + +EY H V+HRDLKP+N+LL V I D+G + I + +
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA-IFKKLEEEDLLDIDVDERNI 180
Query: 177 -----------CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL 225
G+P+Y APE + G A D+++ GVILY +L + P+ +
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRKK---- 235
Query: 226 FKKI--KGGIYTLPSHLSPGARDLIP-------RMLIVDPMKRI-TIPEIRQ 267
+KI + I + P ++P R++ P + L VDP +R ++ E++Q
Sbjct: 236 GRKISYRDVILS-PIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285
|
Length = 932 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 56/197 (28%), Positives = 104/197 (52%), Gaps = 13/197 (6%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRLFMHPHII 80
LG G+ G V +H +G +A RK+ ++E++ +R RE+++L P+I+
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 81 RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVV 139
Y + +I + ME++ G L + E R+ E+ ++ G+ Y ++ ++
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIM 126
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
HRD+KP N+L++S+ +K+ DFG+S + D + G+ +Y +PE + G Y+ + D
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQSD 184
Query: 200 VWSCGVILYALLCGTLP 216
+WS G+ L L G P
Sbjct: 185 IWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-18
Identities = 61/189 (32%), Positives = 96/189 (50%), Gaps = 13/189 (6%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
+ +G GSFG V A VAIK ++ ++ E + + +E++ L+ HP+ I+
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 83 YEVIETPSDIYVVMEYV--KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVH 140
++VMEY + +L + V K LQE E + G+ Y H + ++H
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 138
Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI----SGKLYAGP 196
RD+K N+LL VK+ DFG ++IM + G+P + APEVI G+ Y G
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDEGQ-YDG- 193
Query: 197 EVDVWSCGV 205
+VDVWS G+
Sbjct: 194 KVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 76/251 (30%), Positives = 126/251 (50%), Gaps = 19/251 (7%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
+L K LG G FG+V + KVA+K L K M E E +I++ H +
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNGNT-KVAVKTL---KPGTMS-PESFLEEAQIMKKLRHDKL 63
Query: 80 IRLYEVI-ETPSDIYVVMEYVKSGELFDYIVE-KGR-LQEDEARNFFQQIISGVEYCHRN 136
++LY V+ E P IY+V EY+ G L D++ + +GR L+ + Q+ +G+ Y R
Sbjct: 64 VQLYAVVSEEP--IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLY 193
+HRDL+ N+L+ KIADFGL+ ++ D + + P + APE + G+
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 194 AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPR 250
+ DVWS G++L L+ G +P+ N + ++++ G Y + P +L+ +
Sbjct: 182 I--KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMPCPQDCPISLHELMLQ 238
Query: 251 MLIVDPMKRIT 261
DP +R T
Sbjct: 239 CWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-17
Identities = 68/250 (27%), Positives = 117/250 (46%), Gaps = 35/250 (14%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L Y++ K +G G FG+V + +H T K ++ R +K E + V E+ ++R
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI-EVNVMRELK 70
Query: 76 HPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISG 129
H +I+R + ++ +Y++ME+ +G+L I + G+++E + +Q++
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130
Query: 130 VEYCHR-------NMVVHRDLKPENLLLDSKWN-----------------VKIADFGLSN 165
+ YCH V+HRDLKP+N+ L + KI DFGLS
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
Query: 166 IMRDGHFLKTSCGSPNYAAPEVI--SGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENI 222
+ + G+P Y +PE++ K Y + D+W+ G I+Y L G PF N
Sbjct: 191 NIGIESMAHSCVGTPYYWSPELLLHETKSY-DDKSDMWALGCIIYELCSGKTPFHKANNF 249
Query: 223 PNLFKKIKGG 232
L ++K G
Sbjct: 250 SQLISELKRG 259
|
Length = 1021 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 14/196 (7%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
Y + KTL GS G+V +A V +KI + E +L+ HP
Sbjct: 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI---------GQKGTTLIEAMLLQNVNHP 117
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRN 136
+IR+ + + + + +V+ + S +L+ Y+ L D+A +QI+ G+ Y H
Sbjct: 118 SVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ 176
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
++HRD+K EN+ ++ V I D G + + FL + G+ APEV++ Y
Sbjct: 177 RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA-GTVETNAPEVLARDKY-N 234
Query: 196 PEVDVWSCGVILYALL 211
+ D+WS G++L+ +L
Sbjct: 235 SKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 67/216 (31%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 25 LGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIR 81
+G G FG V + + A+K LNR I ++E E+ +E I++ F HP+++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 82 LYEVIETPSD--IYVVMEYVKSGELFDYIVEKGRLQEDEARN--------FFQQIISGVE 131
L I PS+ VV+ Y+K G+L ++I E N F Q+ G+E
Sbjct: 61 LLG-ICLPSEGSPLVVLPYMKHGDLRNFI-------RSETHNPTVKDLIGFGLQVAKGME 112
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPE 186
Y VHRDL N +LD + VK+ADFGL+ + D + T P + A E
Sbjct: 113 YLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 187 VISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDEN 221
+ + + + DVWS GV+L+ L+ G P+ D +
Sbjct: 173 SLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVD 207
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRR----EIKILR 72
K+ + +G G FG+V L G + VAIK L EK RR E I+
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLK------SGYTEKQRRDFLSEASIMG 60
Query: 73 LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVE 131
F HP+II L V+ + ++ E++++G L ++ + G+ + + I +G++
Sbjct: 61 QFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-----P-NYAAP 185
Y VHRDL N+L++S K++DFGLS + D T S P + AP
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDD 219
E I+ + + DVWS G++++ ++ G P+ D
Sbjct: 181 EAIAYRKFTSAS-DVWSYGIVMWEVMSYGERPYWD 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 69/208 (33%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
+L LG G FG+V + T +VAIK L K M E +E ++++ H +
Sbjct: 9 RLEVKLGQGCFGEVWMGTWNGTT-RVAIKTL---KPGTMS-PEAFLQEAQVMKKLRHEKL 63
Query: 80 IRLYEVI-ETPSDIYVVMEYVKSGELFDYIVEKGR----LQEDEARNFFQQIISGVEYCH 134
++LY V+ E P IY+V EY+ G L D++ KG L+ + + QI SG+ Y
Sbjct: 64 VQLYAVVSEEP--IYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVE 119
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKL 192
R VHRDL+ N+L+ K+ADFGL+ ++ D + + P + APE L
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE---AAL 176
Query: 193 YAGPEV--DVWSCGVILYALLC-GTLPF 217
Y + DVWS G++L L G +P+
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 75/248 (30%), Positives = 112/248 (45%), Gaps = 49/248 (19%)
Query: 21 LGKTLGIGSFGKVKIAEH-ALTGHK----VAIKILNRRK--------IKNMEMEEKVRRE 67
LGK LG G+FG+V AE L VA+K+L + MEM + + +
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK- 74
Query: 68 IKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDY----------------IVEK 111
H +II L V +YVV+EY G L D+ +
Sbjct: 75 --------HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126
Query: 112 GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171
L + + +F Q+ G+E+ +HRDL N+L+ +KIADFGL+ RD H
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA---RDIH 183
Query: 172 ----FLKTSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN 224
+ KT+ G P + APE + ++Y + DVWS GV+L+ + G P+ +
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242
Query: 225 LFKKIKGG 232
LFK +K G
Sbjct: 243 LFKLLKEG 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 72/269 (26%), Positives = 123/269 (45%), Gaps = 27/269 (10%)
Query: 21 LGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
LGKTLG G FG V E L KVA+K + EME+ + E ++ F H
Sbjct: 3 LGKTLGEGEFGSV--MEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLS-EAVCMKEFDH 59
Query: 77 PHIIRL----YEVIET---PSDIYVVMEYVKSGELFDYIV------EKGRLQEDEARNFF 123
P+++RL + +E+ PS + V++ ++K G+L +++ L F
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPV-VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118
Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP--- 180
I SG+EY +HRDL N +L+ NV +ADFGLS + +G + + +
Sbjct: 119 TDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK-GGIYTLPS 238
+ A E ++ ++Y + DVWS GV ++ + G P+ ++ ++ G P
Sbjct: 179 KWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP 237
Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
G L+ +++P R + +R
Sbjct: 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 54/192 (28%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 23 KTLGIGSFGKVKIAEHAL--TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
LG G+FG VK + + + VA+KIL + + +++++ RE +++ +P+I+
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIV 59
Query: 81 RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVH 140
R+ + E S +VME + G L ++ + + E Q+ G++Y VH
Sbjct: 60 RMIGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118
Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYAGP 196
RDL N+LL ++ KI+DFGLS + D ++ K + APE ++ ++
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS- 177
Query: 197 EVDVWSCGVILY 208
+ DVWS GV+++
Sbjct: 178 KSDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 12/216 (5%)
Query: 25 LGIGSFGKVKIAEHALTGHK--VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
LG G+FG VK + + + VAIK+L K++ +++ RE +I+ +P+I+R+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVR--DEMMREAEIMHQLDNPYIVRM 60
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
V E + + +VME G L ++ +K + Q+ G++Y VHR
Sbjct: 61 IGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGS-P-NYAAPEVISGKLYAGPE 197
DL N+LL ++ KI+DFGLS + D ++ S G P + APE I+ + ++
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS-R 178
Query: 198 VDVWSCGVILY-ALLCGTLPFDDENIPNLFKKIKGG 232
DVWS G+ ++ A G P+ P + I+ G
Sbjct: 179 SDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG 214
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-16
Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 18/206 (8%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
+L LG G FG+V + T KVAIK L + M E +E +I++ H +
Sbjct: 9 RLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKL 63
Query: 80 IRLYEVI-ETPSDIYVVMEYVKSGELFDYIVE-KGR-LQEDEARNFFQQIISGVEYCHRN 136
+ LY V+ E P IY+V E++ G L D++ E G+ L+ + + QI G+ Y R
Sbjct: 64 VPLYAVVSEEP--IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM 121
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 194
+HRDL+ N+L+ KIADFGL+ ++ D + + P + APE LY
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE---AALYG 178
Query: 195 GPEV--DVWSCGVILYALLC-GTLPF 217
+ DVWS G++L L+ G +P+
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 69/261 (26%), Positives = 118/261 (45%), Gaps = 15/261 (5%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+Y+L + +G G++G V A + TG A+KI+ + + +++EI +++ H
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL---IQQEIFMVKECKHC 66
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
+I+ + + +++ MEY G L D G L E + ++ + G+ Y H
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
+HRD+K N+LL +VK+ADFG+ + I K+ G+P + APEV + + G
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186
Query: 197 E--VDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYTLPSHL------SPGARDL 247
D+W+ G+ L P FD + LF K P L S +
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ--PPKLKDKTKWSSTFHNF 244
Query: 248 IPRMLIVDPMKRITIPEIRQH 268
+ L +P KR T + H
Sbjct: 245 VKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 5e-16
Identities = 84/293 (28%), Positives = 130/293 (44%), Gaps = 19/293 (6%)
Query: 23 KTLGIGSFGKVK----IAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
K LG G+FG V + E VAIKILN +E E I+ HPH
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE--FMDEALIMASMDHPH 70
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM 137
++RL V +P+ I +V + + G L DY+ E K + N+ QI G+ Y
Sbjct: 71 LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 194
+VHRDL N+L+ S +VKI DFGL+ ++ + G + A E I + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189
Query: 195 GPEVDVWSCGVILYALLC-GTLPFD---DENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
+ DVWS GV ++ L+ G P+D IP+L + KG P + ++ +
Sbjct: 190 H-QSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE--KGERLPQPPICTIDVYMVMVK 246
Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLP-RYLAVPPPDTMQQAKKIDEEILKEVV 302
++D R E+ A P RYL + D M+ D + + ++
Sbjct: 247 CWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPSPNDSKFFQNLL 299
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 6e-16
Identities = 90/334 (26%), Positives = 136/334 (40%), Gaps = 68/334 (20%)
Query: 1 MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNME 59
+D NRS + +YKLG +G GSFG V A T KVAIK +L + KN
Sbjct: 56 IDNDINRSPN------KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN-- 107
Query: 60 MEEKVRREIKILRLFMHPHIIRLYEVIETPS------DIY--VVMEYVKSGELFDYIVEK 111
RE+ I++ H +II L + T +I+ VVME++ + Y+
Sbjct: 108 ------RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHY 160
Query: 112 GR----LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN-VKIADFGLSNI 166
R L + + Q+ + Y H + HRDLKP+NLL+D + +K+ DFG +
Sbjct: 161 ARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220
Query: 167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVIL------YALLCGTLPFD-- 218
+ G + S Y APE++ G +D+WS G I+ Y + G D
Sbjct: 221 LLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL 280
Query: 219 -----------------------DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
D P++ K K P A + I + L +
Sbjct: 281 VRIIQVLGTPTEDQLKEMNPNYADIKFPDV--KPKDLKKVFPKGTPDDAINFISQFLKYE 338
Query: 256 PMKRITIPEIRQHPWFQA------HLPRYLAVPP 283
P+KR+ E P+F LP+Y+ P
Sbjct: 339 PLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLP 372
|
Length = 440 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 21 LGKTLGIGSFGKVKIAE-HALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L + LG G+FGKV +AE + L+ K VA+K L K + + +RE ++L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQ 65
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI----------------VEKGRLQEDEA 119
H HI++ Y V + +V EY+K G+L ++ KG L +
Sbjct: 66 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS 179
+ QI SG+ Y VHRDL N L+ + VKI DFG+S + + + +
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 180 P---NYAAPEVISGKLYAGPEVDVWSCGVILYALL 211
+ PE I + + E DVWS GVIL+ +
Sbjct: 186 MLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 8e-16
Identities = 56/189 (29%), Positives = 93/189 (49%), Gaps = 11/189 (5%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84
LG G+FG+V K + + ++ E++ K E +IL+ + HP+I++L
Sbjct: 3 LGKGNFGEVF---KGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 85 VIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDL 143
V IY+VME V G+ ++ +K L+ + F +G+ Y +HRDL
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDL 119
Query: 144 KPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----YAAPEVISGKLYAGPEVD 199
N L+ +KI+DFG+S DG + +S G + APE ++ Y+ E D
Sbjct: 120 AARNCLVGENNVLKISDFGMSRQEDDGIY--SSSGLKQIPIKWTAPEALNYGRYSS-ESD 176
Query: 200 VWSCGVILY 208
VWS G++L+
Sbjct: 177 VWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 74/244 (30%), Positives = 119/244 (48%), Gaps = 39/244 (15%)
Query: 21 LGKTLGIGSFGKVKIAEHALTGHK--------VAIKILNRRKIKNMEMEEKVRREIKILR 72
LGK LG G FG+V +AE A+ K VA+K+L + + ++ + V E+++++
Sbjct: 16 LGKPLGEGCFGQVVMAE-AIGIDKDKPNKPVTVAVKML-KDDATDKDLSDLVS-EMEMMK 72
Query: 73 LF-MHPHIIRLYEVIETPSDIYVVMEYVKSGEL-----------FDYIVEKGRLQEDEAR 120
+ H +II L +YV++EY G L DY + +L E++
Sbjct: 73 MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132
Query: 121 -----NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---- 171
+ Q+ G+EY +HRDL N+L+ +KIADFGL+ RD H
Sbjct: 133 FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA---RDVHNIDY 189
Query: 172 FLKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKK 228
+ KT+ G + APE + ++Y + DVWS GV+L+ + G P+ + LFK
Sbjct: 190 YKKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248
Query: 229 IKGG 232
+K G
Sbjct: 249 LKEG 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 73/249 (29%), Positives = 114/249 (45%), Gaps = 49/249 (19%)
Query: 21 LGKTLGIGSFGKVKIAE---------HALTGHKVAIKILNRRK--------IKNMEMEEK 63
LGK LG G FG+V +AE + +T KVA+K+L I MEM +
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVT--KVAVKMLKSDATEKDLSDLISEMEMMKM 79
Query: 64 VRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI--------------- 108
+ + H +II L +YV++EY G L +Y+
Sbjct: 80 IGK---------HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPT 130
Query: 109 -VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NI 166
V + +L + + Q+ G+EY +HRDL N+L+ +KIADFGL+ +I
Sbjct: 131 QVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 167 MRDGHFLKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP 223
++ KT+ G + APE + ++Y + DVWS GV+L+ + G P+ +
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPVE 249
Query: 224 NLFKKIKGG 232
LFK +K G
Sbjct: 250 ELFKLLKEG 258
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 71/241 (29%), Positives = 116/241 (48%), Gaps = 33/241 (13%)
Query: 21 LGKTLGIGSFGKVKIAEHALTGHK--------VAIKILNRRKIKNMEMEEKVRREIKILR 72
LGK LG G FG+V +AE AL K VA+K+L + ++ + V E+++++
Sbjct: 19 LGKPLGEGCFGQVVMAE-ALGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMK 75
Query: 73 LF-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQ----------EDEARN 121
+ H +II L +YV++EY G L +Y+ + DE
Sbjct: 76 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135
Query: 122 FFQ------QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLK 174
F Q+ G+EY +HRDL N+L+ +KIADFGL+ ++ ++ K
Sbjct: 136 FKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 175 TSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKG 231
T+ G + APE + ++Y + DVWS GV+++ + G P+ + LFK +K
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 254
Query: 232 G 232
G
Sbjct: 255 G 255
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 74/292 (25%), Positives = 114/292 (39%), Gaps = 57/292 (19%)
Query: 21 LGKTLGIGSFGKVKIAE-----------HALTGHK-----VAIKILNRRKIKNMEMEEKV 64
+ LG G FG+V + E A + VA+K+L R + E
Sbjct: 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL--RPDASDNAREDF 66
Query: 65 RREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQ 124
+E+KIL P+I RL V + ++MEY+++G+L + LQ+ A
Sbjct: 67 LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQF------LQKHVAETSGL 120
Query: 125 -----------------QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167
QI SG+ Y VHRDL N L+ + +KIADFG+S +
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 168 RDGHFLKTSCGSP----NYAAPEVISGKLYAGPEVDVWSCGVILYAL--LCGTLPFDD-- 219
+ + G + A E + + + DVW+ GV L+ + LC P++
Sbjct: 181 YSSDYYRVQ-GRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYEHLT 238
Query: 220 -----ENIPNLFKKIKGGIYTLPSHLSP-GARDLIPRMLIVDPMKRITIPEI 265
EN + F+ IY P +L+ D R T EI
Sbjct: 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 13/209 (6%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLF 74
+K K LG G+FG V G K VAIK L R+ + + +++ E ++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASV 66
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYC 133
+PH+ RL + T S + ++ + + G L DY+ E K + N+ QI G+ Y
Sbjct: 67 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 125
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISG 190
+VHRDL N+L+ + +VKI DFGL+ ++ + G + A E I
Sbjct: 126 EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH 185
Query: 191 KLYAGPEVDVWSCGVILYALLC-GTLPFD 218
++Y + DVWS GV ++ L+ G+ P+D
Sbjct: 186 RIYTH-QSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 18 NYKLGKTLGIGSFGKVKIAE-HALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILR 72
N L + LG G+FGKV +AE + L + VA+K L K + + RE ++L
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL---KDASDNARKDFHREAELLT 62
Query: 73 LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-------------RLQEDEA 119
H HI++ Y V + +V EY+K G+L ++ G L + +
Sbjct: 63 NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQM 122
Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS 179
+ QQI +G+ Y VHRDL N L+ VKI DFG+S + + + +
Sbjct: 123 LHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 180 P---NYAAPEVISGKLYAGPEVDVWSCGVILYALL 211
+ PE I + + E DVWS GV+L+ +
Sbjct: 183 MLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 68/243 (27%), Positives = 118/243 (48%), Gaps = 37/243 (15%)
Query: 21 LGKTLGIGSFGKVKIAE----------HALTGHKVAIKILNRRKIKNMEMEEKVRREIKI 70
LGK LG G FG+V AE +T VA+K+L + + ++ + + E+++
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVT---VAVKML-KDNATDKDLADLIS-EMEL 70
Query: 71 LRLF-MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI----------------VEKGR 113
++L H +II L V +YV++EY G L +++ V + +
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130
Query: 114 LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHF 172
L + + Q+ G+EY +HRDL N+L+ +KIADFGL+ + D ++
Sbjct: 131 LSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY 190
Query: 173 LKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI 229
KTS G + APE + ++Y + DVWS G++++ + G P+ + LFK +
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTH-QSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL 249
Query: 230 KGG 232
+ G
Sbjct: 250 REG 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 53/232 (22%), Positives = 97/232 (41%), Gaps = 19/232 (8%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
+GK V +A+H T VA+K +N + E + +++EI R HP+
Sbjct: 4 TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPN 60
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRN 136
I+ S++YVV + G D + L E + +++ ++Y H
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK 120
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSN---IMRDGHFLKTSCGSP-------NYAAPE 186
+HR +K ++LL V ++ GL +++ G + P + +PE
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 187 VISGKLYA-GPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTL 236
V+ L + D++S G+ L G +PF D L +K++G + L
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCL 230
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|190228 pfam02149, KA1, Kinase associated domain 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 3e-14
Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 1/46 (2%)
Query: 470 PNVVKFEVQLYKTR-DEKYLLDLQRVQGPQFLFLDLCAAFLAQLRV 514
P+VVKFE+++ K Y +D +R+ GPQ+ + DL A L++LR+
Sbjct: 1 PSVVKFEIEVCKLPRLGLYGVDFKRLSGPQWQYKDLAAKILSELRL 46
|
Length = 46 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 25 LGIGSFGKVKIAE-HALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
LG G+FGKV +AE H L + VA+K L K + + +RE ++L + H HI
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTVLQHQHI 69
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYI---------------VEKGRLQEDEARNFFQ 124
+R Y V + +V EY++ G+L ++ V G+L +
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---N 181
QI SG+ Y VHRDL N L+ VKI DFG+S + + + +
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALL 211
+ PE I + + E D+WS GV+L+ +
Sbjct: 190 WMPPESILYRKFT-TESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 6e-14
Identities = 73/290 (25%), Positives = 120/290 (41%), Gaps = 47/290 (16%)
Query: 20 KLGKTLGIGSFGKVKIAE------------HALTGHKVAIKILNRRKIKNMEMEEKVRRE 67
+L + LG G FG+V + E G V + + R +E
Sbjct: 8 RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKE 67
Query: 68 IKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARN----- 121
IKI+ +P+IIRL V + + ++ EY+++G+L ++ ++ A N
Sbjct: 68 IKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 122 ------FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175
QI SG++Y VHRDL N L+ + + +KIADFG+S + G + +
Sbjct: 128 IANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187
Query: 176 SCGSP---NYAAPE-VISGKLYAGPEVDVWSCGVILYAL--LCGTLPF----DDENIPN- 224
+ + A E ++ GK DVW+ GV L+ + LC P+ D++ I N
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTAS--DVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENT 245
Query: 225 --LFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
F+ IY + L P + M R +I+ P F
Sbjct: 246 GEFFRNQGRQIYLSQTPLCPSP--------VFKLMMRCWSRDIKDRPTFN 287
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 25/229 (10%)
Query: 25 LGIGSFGKVKIAEHALTGHKV--AIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
+G G+FG+V A G K+ AIK+L +N + E+ + +L HP+II L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEV-LCKLGHHPNIINL 68
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA----------------RNFFQQI 126
E +Y+ +EY G L D++ + L+ D A F +
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAA 184
+G++Y +HRDL N+L+ KIADFGLS + ++K + G + A
Sbjct: 129 ATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGRLPVRWMA 186
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
E ++ +Y + DVWS GV+L+ ++ G P+ L++K+ G
Sbjct: 187 IESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 56/222 (25%), Positives = 105/222 (47%), Gaps = 26/222 (11%)
Query: 13 DMFLPNYKLGKTLGIGSFGKVKI-AEHALTGHKVAIKILNRRKIKNMEMEEKVRR----- 66
D FL ++++ L G+FGK+ I A A T A + +N + E + +
Sbjct: 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAG 203
Query: 67 ---------EIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-----KG 112
EI L H +I+++ E++ + ++ Y++ + +L+ ++ + K
Sbjct: 204 SRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKD 262
Query: 113 RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171
R + R +Q++ VEY H ++HRD+K EN+ L+ + + DFG +
Sbjct: 263 RPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322
Query: 172 -FLKTSCGSPNYAAPEVISGKLYAGPEV-DVWSCGVILYALL 211
F G+ +PE+++G Y E+ D+WSCG+IL +L
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGYC--EITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 62/232 (26%), Positives = 107/232 (46%), Gaps = 21/232 (9%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPH 78
K +G G+FG+V A G ++ I ++ + + E+++L +L HP+
Sbjct: 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 69
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA----------------RNF 122
II L E +Y+ +EY G L D++ + L+ D A +F
Sbjct: 70 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-N 181
+ G++Y + +HRDL N+L+ + KIADFGLS ++ + KT P
Sbjct: 130 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPVR 188
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
+ A E ++ +Y DVWS GV+L+ ++ G P+ L++K+ G
Sbjct: 189 WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 16/218 (7%)
Query: 23 KTLGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
K LG G+FG V G VAIK+L R+ + + +++ E ++ P+
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVL--RENTSPKANKEILDEAYVMAGVGSPY 70
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM 137
+ RL + T S + +V + + G L DY+ E K R+ + N+ QI G+ Y
Sbjct: 71 VCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 194
+VHRDL N+L+ S +VKI DFGL+ ++ + + P + A E I + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDD---ENIPNLFKK 228
+ DVWS GV ++ L+ G P+D IP+L +K
Sbjct: 190 H-QSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK 226
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 25/229 (10%)
Query: 25 LGIGSFGKVKIAEHALTGHKV--AIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
+G G+FG+V A G ++ AIK + K+ + E+ + +L HP+II L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNIINL 61
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA----------------RNFFQQI 126
E +Y+ +EY G L D++ + L+ D A +F +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAA 184
G++Y + +HRDL N+L+ + KIADFGLS ++K + G + A
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMA 179
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232
E ++ +Y DVWS GV+L+ ++ G P+ L++K+ G
Sbjct: 180 IESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 227
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 20 KLGKTLGIGSFGKVK----IAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
+ K LG G FG V I E VAIK + R + E + + +
Sbjct: 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQE--ITDHMLAMGSLD 67
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
H +I+RL + S + +V + G L D++ + + L N+ QI G+ Y
Sbjct: 68 HAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGK 191
+ +VHR+L N+LL S V+IADFG+++++ D + + +P + A E I
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFDD---ENIPNLFKK 228
Y + DVWS GV ++ ++ G P+ +P+L +K
Sbjct: 187 RYTH-QSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK 226
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 68/286 (23%), Positives = 124/286 (43%), Gaps = 69/286 (24%)
Query: 53 RKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVE 110
++I+ + REI +LR HP++I L +V + +D ++++ +Y + +L+ +I++
Sbjct: 34 KQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLW-HIIK 91
Query: 111 KGR----------LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL----DSKWNV 156
R L ++ QI+ G+ Y H N V+HRDLKP N+L+ + V
Sbjct: 92 FHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 151
Query: 157 KIADFGLSNI----MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC 212
KIAD G + + ++ L + Y APE++ G + +D+W+ G I LL
Sbjct: 152 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
Query: 213 G-------------TLPFDDENIPNLFK-------KIKGGIYTLPSH------------- 239
+ P+ + + +F K I +P H
Sbjct: 212 SEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYT 271
Query: 240 ------------LSPGAR--DLIPRMLIVDPMKRITIPEIRQHPWF 271
+ P ++ L+ ++L +DP+KRIT + Q P+F
Sbjct: 272 NCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 79/287 (27%), Positives = 117/287 (40%), Gaps = 78/287 (27%)
Query: 20 KLGKTLGIGSFGKVKIA-----EHALTGHKVAIKILNRRKIKNMEMEEK-VRREIKIL-R 72
KLGK LG G+FGKV A E + + VA+K+L K E K + E+KIL
Sbjct: 10 KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKML---KEGATASEYKALMTELKILIH 66
Query: 73 LFMHPHIIRLYEVIETPSD-IYVVMEYVKSGELFDY------------------------ 107
+ H +++ L P + V++EY K G L +Y
Sbjct: 67 IGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQK 126
Query: 108 IVEKGRL-----QEDEARNFFQ--------------------------------QIISGV 130
+K RL + A + F Q+ G+
Sbjct: 127 EGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGM 186
Query: 131 EYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NYAAPEV 187
E+ +HRDL N+LL VKI DFGL+ +I +D ++ K P + APE
Sbjct: 187 EFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246
Query: 188 ISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGG 232
I K+Y + DVWS GV+L+ + G P+ I F +++K G
Sbjct: 247 IFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG 292
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 64/255 (25%), Positives = 113/255 (44%), Gaps = 40/255 (15%)
Query: 25 LGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
LG +FGK+ L G VAIK L + I N + + ++E ++ HP+I+
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 81 RLYEVIETPSDIYVVMEYVKSGELFDYIVE-----------------KGRLQEDEARNFF 123
L V+ + ++ EY+ G+L ++++ K L + +
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS---P 180
QI +G+EY + VH+DL N+L+ + +VKI+D GLS + + + S
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLP---FDDENIPNLFKKIKGGIYTL 236
+ PE I ++ + D+WS GV+L+ + G P F ++ + + +K
Sbjct: 191 RWMPPEAIMYGKFSS-DSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK-------- 241
Query: 237 PSHLSPGARDLIPRM 251
L P + D PRM
Sbjct: 242 -RQLLPCSEDCPPRM 255
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 72/285 (25%), Positives = 122/285 (42%), Gaps = 67/285 (23%)
Query: 53 RKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIV- 109
++I+ + REI +LR HP++I L +V + SD ++++ +Y + +L+ I
Sbjct: 34 KQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKF 92
Query: 110 --------EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL----DSKWNVK 157
+ +L ++ QI+ G+ Y H N V+HRDLKP N+L+ + VK
Sbjct: 93 HRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 152
Query: 158 IADFGLSNI----MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG 213
IAD G + + ++ L + Y APE++ G + +D+W+ G I LL
Sbjct: 153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212
Query: 214 -------------TLPF------------------DDENI------PNLFKKIKGGIYTL 236
+ PF D E+I P L K + Y
Sbjct: 213 EPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYAN 272
Query: 237 PS--------HLSPGARD--LIPRMLIVDPMKRITIPEIRQHPWF 271
S + P ++ L+ ++L +DP KRIT + Q P+F
Sbjct: 273 SSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 40/151 (26%), Positives = 77/151 (50%), Gaps = 8/151 (5%)
Query: 67 EIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQI 126
E ILR HP II+L +++ K+ +L+ Y+ K + + + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSV 191
Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS----NIMRDGHFLKTSCGSPNY 182
+ ++Y H N ++HRD+K EN+ ++ +V + DFG + +I + ++ G+
Sbjct: 192 LRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY--GWAGTIAT 249
Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLCG 213
APE+++ Y GP VD+WS G++L+ +
Sbjct: 250 NAPELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 11/226 (4%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
K+ + LG G FG++ L + VAI L R + + E L F H
Sbjct: 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTL--RAGCSDKQRRGFLAEALTLGQFDH 65
Query: 77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHR 135
+I+RL VI + + +V EY+ +G L ++ + +G+L + + SG++Y
Sbjct: 66 SNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE 125
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFG-LSNIMRDGHFLKTSCGSPN-YAAPEVISGKLY 193
VH+ L +L++S KI+ F L + + S SP +AAPE I +
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185
Query: 194 AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS 238
+ DVWS G++++ ++ G P+ D + ++ K ++ G + LP+
Sbjct: 186 S-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRLPA 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 71/270 (26%), Positives = 120/270 (44%), Gaps = 30/270 (11%)
Query: 23 KTLGIGSFGKV------KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
LG G+FG+V I +VA+K L RK + +++ +E ++ F H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNFNH 58
Query: 77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQE--------DEARNFFQQIIS 128
P+I++L V Y++ME ++ G+L Y+ R++ E + +
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAK 117
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWN-----VKIADFGLS-NIMRDGHFLKTSCGSPN- 181
G Y + +HRDL N L+ K VKI DFGL+ +I + ++ K G
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 182 -YAAPE-VISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK-GGIYTLP 237
+ APE ++ GK + DVWS GV+++ +L G P+ N + + + GG P
Sbjct: 178 RWMAPESLLDGKFTT--QSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP 235
Query: 238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
+ L+ DP +R T I++
Sbjct: 236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 72/278 (25%), Positives = 117/278 (42%), Gaps = 33/278 (11%)
Query: 23 KTLGIGSFGKV--KIAEHALTGH---KVAIKILNRRKIKNMEMEEKVR--REIKILRLFM 75
+ LG GSFG V A + G +VA+K +N ++ + E++ E +++ F
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN----ESASLRERIEFLNEASVMKGFT 67
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIV--------EKGRLQE--DEARNFFQQ 125
H++RL V+ VVME + G+L Y+ GR E +
Sbjct: 68 CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 127
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG--SPNY 182
I G+ Y + VHRDL N ++ + VKI DFG++ +I ++ K G +
Sbjct: 128 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHL 240
APE + ++ D+WS GV+L+ + P+ + + K + GG P +
Sbjct: 188 MAPESLKDGVFT-TSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC 246
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQ------HPWFQ 272
DL+ +P R T EI HP F
Sbjct: 247 PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 47/178 (26%), Positives = 85/178 (47%), Gaps = 7/178 (3%)
Query: 66 REIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQ 125
REI IL+ H II L S + +VM K +LF Y+ G L ++A ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC----GSPN 181
++ + Y H ++HRD+K EN+ LD N + DFG + + D H C G+
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKL-DAHPDTPQCYGWSGTLE 252
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH 239
+PE+++ Y + D+WS G++L+ + + + + + +++ I + H
Sbjct: 253 TNSPELLALDPYCA-KTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVH 309
|
Length = 392 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 69/245 (28%), Positives = 103/245 (42%), Gaps = 49/245 (20%)
Query: 25 LGIGSFGKVKIAE----HAL----------TGHK--VAIKILNRRKIKNMEMEEKVRREI 68
LG G FG+V + E L G VA+KIL KN + +E+
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARND--FLKEV 70
Query: 69 KILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN------- 121
KIL P+IIRL V + ++ EY+++G+L ++ ++E N
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130
Query: 122 ------------FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169
QI SG++Y VHRDL N L+ +KIADFG+S +
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190
Query: 170 GHFLKTSCGSP---NYAAPEVI-SGKLYAGPEVDVWSCGVILYALL--CGTLPF----DD 219
G + + + + A E I GK DVW+ GV L+ +L C P+ D+
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILMGKFTTAS--DVWAFGVTLWEILMLCKEQPYGELTDE 248
Query: 220 ENIPN 224
+ I N
Sbjct: 249 QVIEN 253
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 21 LGKTLGIGSFGKV--KIAEHALTGH---KVAIKILNRRKIKNMEMEEKVR--REIKILRL 73
+ + LG GSFG V IA+ + +VAIK +N + M E++ E +++
Sbjct: 10 MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN----EAASMRERIEFLNEASVMKE 65
Query: 74 FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQ--------- 124
F H++RL V+ V+ME + G+L Y+ L+ + N Q
Sbjct: 66 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS---LRPEMENNPVQAPPSLKKMI 122
Query: 125 ----QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG- 178
+I G+ Y + N VHRDL N ++ + VKI DFG++ +I ++ K G
Sbjct: 123 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 179 -SPNYAAPEVISGKLYAGPEVDVWSCGVILYAL 210
+ +PE + ++ DVWS GV+L+ +
Sbjct: 183 LPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 43/223 (19%)
Query: 23 KTLGIGSFGKV--KIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+ +G G+FG+V A L VA+K+L +M+ + +RE ++ F HP
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD--FQREAALMAEFDHP 68
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYI----------------------VEKGRLQ 115
+I++L V + ++ EY+ G+L +++ + L
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 116 EDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175
E +Q+ +G+ Y VHRDL N L+ VKIADFGLS + + K
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK- 187
Query: 176 SCGSPN------YAAPEVISGKLYA--GPEVDVWSCGVILYAL 210
S N + PE I Y E DVW+ GV+L+ +
Sbjct: 188 --ASENDAIPIRWMPPESI---FYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 71/260 (27%), Positives = 109/260 (41%), Gaps = 48/260 (18%)
Query: 25 LGIGSFGKVKIAEHALTGHK-----------------VAIKILNRRKIKNMEMEEKVRRE 67
LG G FG+V + E A K VA+K+L R+ N +E
Sbjct: 13 LGEGQFGEVHLCE-AEGMEKFMDKDFSLDVSGNQPVLVAVKML--REDANKNARNDFLKE 69
Query: 68 IKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA-------- 119
IKI+ P+IIRL V T + ++ EY+++G+L ++ + QE
Sbjct: 70 IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFL-SRHEPQEAAEKADVVTIS 128
Query: 120 ----RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175
QI SG++Y VHRDL N L+ + +KIADFG+S + G + +
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 176 SCGS--P-NYAAPE-VISGKLYAGPEVDVWSCGVILYALL--CGTLPFDD-------ENI 222
+ P + + E ++ GK DVW+ GV L+ +L C P+ EN
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTAS--DVWAFGVTLWEILTLCKEQPYSQLSDEQVIENT 246
Query: 223 PNLFKKIKGGIYTLPSHLSP 242
F+ +Y L P
Sbjct: 247 GEFFRDQGRQVYLPKPALCP 266
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 4e-12
Identities = 42/152 (27%), Positives = 80/152 (52%), Gaps = 18/152 (11%)
Query: 67 EIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQ 125
E ++LR HP ++ L +V +V+ +S +L+ Y+ + R L + +Q
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS-DLYTYLGARLRPLGLAQVTAVARQ 268
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY--- 182
++S ++Y H ++HRD+K EN+L++ ++ + DFG + F + S +P +
Sbjct: 269 LLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAAC------FARGSWSTPFHYGI 322
Query: 183 ------AAPEVISGKLYAGPEVDVWSCGVILY 208
APEV++G Y P VD+WS G++++
Sbjct: 323 AGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 82/323 (25%), Positives = 131/323 (40%), Gaps = 82/323 (25%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHK-------VAIKILNRRKIKNMEMEEKVRREIKIL- 71
+LGK LG G+FGKV E + G VA+K+L ++ + + E+KIL
Sbjct: 10 RLGKVLGHGAFGKV--VEASAFGIDKKSSCNTVAVKML--KEGATASEHKALMSELKILI 65
Query: 72 RLFMHPHIIRLYEVIETPSD-IYVVMEYVKSGEL------------------------FD 106
+ H +++ L P+ + V++E+ K G L F
Sbjct: 66 HIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFR 125
Query: 107 YIVEKGRL-------QEDEARNFFQ-------------------------------QIIS 128
+VE+ R+ Q + FQ Q+
Sbjct: 126 AMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVAR 185
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NYAAP 185
G+E+ +HRDL N+LL VKI DFGL+ +I +D ++ K S P + AP
Sbjct: 186 GMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSP 242
E I K+Y + DVWS GV+L+ + G P+ I F +++K G P + +P
Sbjct: 246 ESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATP 304
Query: 243 GARDLIPRMLIVDPMKRITIPEI 265
++ DP +R T +
Sbjct: 305 EIYRIMLACWQGDPKERPTFSAL 327
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 58/231 (25%), Positives = 108/231 (46%), Gaps = 21/231 (9%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
++G+ G + V +A H TG V ++I + E + ++ E+ + F HP+I
Sbjct: 5 EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNI 61
Query: 80 IRLYEVIETPSDIYVV---MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
+ + V T S ++V+ M Y + L +G + E N + G+ Y H+N
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQN 120
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNI---MRDGHFLKTSCGSPNYA-------APE 186
+HR++K ++L+ V ++ GLS++ +R+G K P ++ +PE
Sbjct: 121 GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 187 VISGKLYA-GPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYT 235
++ LY + D++S G+ L G +PF D L +K+KG Y+
Sbjct: 179 LLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYS 229
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 54/194 (27%), Positives = 90/194 (46%), Gaps = 25/194 (12%)
Query: 45 VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104
VAIK L + + E+ + E + HP+I+ L V+ + ++ Y +L
Sbjct: 38 VAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 105 FDYIVEK------GRLQED-------EARNFFQ---QIISGVEYCHRNMVVHRDLKPENL 148
+++V + G +D E +F QI +G+E+ + VVH+DL N+
Sbjct: 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNV 155
Query: 149 LLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--P-NYAAPEVIS-GKLYAGPEVDVWSCG 204
L+ K NVKI+D GL + + K S P + +PE I GK + D+WS G
Sbjct: 156 LVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSI--DSDIWSYG 213
Query: 205 VILYALLC-GTLPF 217
V+L+ + G P+
Sbjct: 214 VVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 39/97 (40%), Positives = 56/97 (57%), Gaps = 4/97 (4%)
Query: 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP 237
G+P+Y APE++ GK + GP VD W+ GV L+ L G PF+DE +F+ I P
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 238 ---SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
LS A++ I +L +DP KR + E++QHP F
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 54/171 (31%), Positives = 83/171 (48%), Gaps = 10/171 (5%)
Query: 87 ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPE 146
E+P D Y+ + I E L + F Q+ +G+E+ VHRDL
Sbjct: 210 ESPYDQYLPSAP-ERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268
Query: 147 NLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAGPEVDVWSC 203
N+L+ VKI DFGL+ +IMRD +++ K S P + APE I LY DVWS
Sbjct: 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLS-DVWSF 327
Query: 204 GVILYALLC-GTLPFDDENIPNLF-KKIKGGIYTL--PSHLSPGARDLIPR 250
G++L+ + G P+ + + F IK G Y + P+H S +++ +
Sbjct: 328 GILLWEIFTLGGTPYPELPMNEQFYNAIKRG-YRMAKPAHASDEIYEIMQK 377
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 58/182 (31%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 99 VKSGELFDYIVEKGRLQEDEAR-------NFFQQIISGVEYCHRNMVVHRDLKPENLLLD 151
V+SG D V L+EDE +F Q+ G+ + +HRDL N+LL
Sbjct: 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT 248
Query: 152 SKWNVKIADFGLS-NIMRDGHF-LKTSCGSP-NYAAPEVISGKLYAGPEVDVWSCGVILY 208
KI DFGL+ +I D ++ +K + P + APE I +Y E DVWS G++L+
Sbjct: 249 HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF-ESDVWSYGILLW 307
Query: 209 ALLC-GTLPFDDENIPNLF-KKIKGGIYTL-PSHLSPGARDLIPRMLIVDPMKRITIPEI 265
+ G+ P+ + + F K IK G L P D++ DP+KR T +I
Sbjct: 308 EIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367
Query: 266 RQ 267
Q
Sbjct: 368 VQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 19/214 (8%)
Query: 23 KTLGIGSFGKVKIAE-HALTGH-KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
+G G FGKV + E H +V +K L R + + +E++ R HP+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKEL--RASATPDEQLLFLQEVQPYRELNHPNVL 58
Query: 81 RLYEVIETPSDIYVVMEYVKSGELFDYI-----VEKGRLQEDEARNFFQQIISGVEYCHR 135
+ +V+E+ G+L +Y+ + Q+D + ++ SG+ + H+
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-NYAAPEVISGKL 192
+H DL N L + +VKI D+GL+ + +++ C + P + APE++ +
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 193 YAGPEVD------VWSCGVILYALL-CGTLPFDD 219
D +WS GV ++ L P+ D
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 51/146 (34%), Positives = 75/146 (51%), Gaps = 9/146 (6%)
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCG 178
+F Q+ G+E+ VHRDL N+LL VKI DFGL+ +IM D +++ K S
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTF 300
Query: 179 SP-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGIYT 235
P + APE I LY DVWS G++L+ + G P+ + + F KIK G Y
Sbjct: 301 LPVKWMAPESIFDNLYTTLS-DVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG-YR 358
Query: 236 L--PSHLSPGARDLIPRMLIVDPMKR 259
+ P H + D++ + +P KR
Sbjct: 359 MAKPDHATQEVYDIMVKCWNSEPEKR 384
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 81/332 (24%), Positives = 128/332 (38%), Gaps = 89/332 (26%)
Query: 20 KLGKTLGIGSFGKVKIA-----EHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RL 73
KLGK LG G+FG+V A + T VA+K+L + + E+KIL +
Sbjct: 10 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHI 67
Query: 74 FMHPHIIRLYEVIETPSD-IYVVMEYVK-----------SGELFDYIVEKGRL------- 114
H +++ L P + V++E+ K GE Y + R
Sbjct: 68 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGY 127
Query: 115 ----------------------------------------QEDEARNFFQ---------Q 125
QED + Q
Sbjct: 128 GDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQ 187
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NY 182
+ G+E+ +HRDL N+LL VKI DFGL+ +I +D ++ K P +
Sbjct: 188 VAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 247
Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSH 239
APE I ++Y + DVWS GV+L+ + G P+ I F +++K G P +
Sbjct: 248 MAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 306
Query: 240 LSPGARDLIPRMLIV---DPMKRITIPEIRQH 268
+P ++ ML +P +R T E+ +H
Sbjct: 307 TTP---EMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 38/117 (32%), Positives = 59/117 (50%), Gaps = 6/117 (5%)
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-N 181
QI G+ Y H+ V+H+D+ N ++D + VKI D LS + D H L + P
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
+ A E + K Y+ DVWS GV+L+ L+ G P+ + + + +K G Y L
Sbjct: 185 WMALESLVNKEYSSAS-DVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-YRLA 239
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 51/217 (23%), Positives = 94/217 (43%), Gaps = 18/217 (8%)
Query: 18 NYKLGKTLGIGSFGKVKIAEH---ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
+ L + LG G+FG+V + ++ + + + + + E E I+ F
Sbjct: 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-------GRLQEDEARNFFQQII 127
H +I+RL V ++++E + G+L ++ E L + + +
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCG--SPN 181
G +Y N +HRD+ N LL K KIADFG++ +I R ++ K
Sbjct: 127 KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPF 217
+ PE ++ + DVWS GV+L+ + G +P+
Sbjct: 187 WMPPEAFLDGIFTS-KTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 8e-09
Identities = 52/211 (24%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLFMHPHIIR-L 82
+G G FGKV ++E T VA ++ K + + + + ++ R+ HP+I++ L
Sbjct: 3 IGNGWFGKVLLSE-IYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQ----QIISGVEYCHRNMV 138
+ +E +V EY + G+L Y+ ++ + + Q +I +GV + H++
Sbjct: 62 GQCVEAIP-YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF 120
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS---CGSPNYAAPEVIS---GKL 192
+H DL N L S VK+ D+G+ +++T C + APE++ G L
Sbjct: 121 LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGL 180
Query: 193 YAGPEV---DVWSCGVILYALL-CGTLPFDD 219
+ +VW+ GV L+ L P+
Sbjct: 181 ITAEQTKPSNVWALGVTLWELFENAAQPYSH 211
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|213385 cd12200, AMPKA2_C, C-terminal regulatory domain of 5'-AMP-activated serine/threonine kinase, subunit alpha | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 9e-09
Identities = 33/128 (25%), Positives = 58/128 (45%), Gaps = 38/128 (29%)
Query: 391 KWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHS 450
KW LG++S++ P +IM EV +A+++L+ WK + Y+++ R NP+
Sbjct: 7 KWHLGIRSQSKPYDIMAEVYRAMKQLDFEWKVVNPYHLRVR------------RKNPVTG 54
Query: 451 NHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQFL------FLDL 504
N+ VK +QLY+ + YLLD + + L F ++
Sbjct: 55 NY--------------------VKMSLQLYQVDNRSYLLDFKSIDDEPRLGSHTMDFFEM 94
Query: 505 CAAFLAQL 512
CA+ + L
Sbjct: 95 CASLITTL 102
|
AMPK, a serine/threonine protein kinase (STK), catalyzes the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. It acts as a sensor for the energy status of the cell and is activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. AMPK is a heterotrimer of three subunits: alpha, beta, and gamma. Co-expression of the three subunits is required for kinase activity; in the absence of one, the other two subunits get degraded. The AMPK alpha subunit is the catalytic subunit and it contains an N-terminal kinase domain and a C-terminal regulatory domain (RD). Vertebrates contain two isoforms of the alpha subunit, alpha1 and alpha2, which are encoded by different genes, PRKAA1 and PRKAA2, respectively, and show varying expression patterns. AMPKalpha2 shows cytoplasmic and nuclear localization, whereas AMPKalpha1 is localized only in the cytoplasm. The C-terminal RD of the AMPK alpha 1 subunit is involved in AMPK heterotrimer formation. It mainly interacts with the C-terminal region of the beta subunit to form a tight alpha-beta complex that is associated with the gamma subunit. The AMPK alpha subunit RD also contains an auto-inhibitory region that interacts with the kinase domain; this inhibition is negated by the interaction with the AMPK gamma subunit. Length = 102 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 23 KTLGIGSFGKVKIAE--HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHII 80
K +G G FGKV + E T +V +K L R +++ + K E + R H +++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKEL--RVSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 81 RLYEVIETPSDIYVVMEYVKSGELFDYI--VEKGRLQEDEARNFFQ---QIISGVEYCHR 135
+ + +VME+ G+L Y+ K L + + +I G+ + H+
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLS--NIMRDGHFLKTSCGSP-NYAAPEVIS--- 189
N +H DL N LL + VKI D+GLS D + P + APE++
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 190 GKLYA---GPEVDVWSCGVILYALL-CGTLPF 217
G L E +VWS GV ++ L G+ P+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 88 TPSDIYVVMEYVKS--GELFDYIVEKGR-----LQEDEARNFFQQIISGVEYCHRNMVVH 140
SD YV M V S + D E+ L D+ F Q+ G+++ +H
Sbjct: 176 QGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIH 235
Query: 141 RDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF-LKTSCGSP-NYAAPEVISGKLYAGPE 197
RD+ N+LL KI DFGL+ +IM D ++ +K + P + APE I +Y +
Sbjct: 236 RDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYT-VQ 294
Query: 198 VDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGIYTL--PSHLSPGARDLIPRMLI 253
DVWS G++L+ + G P+ + + F K +K G Y + P P ++
Sbjct: 295 SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG-YQMSRPDFAPPEIYSIMKMCWN 353
Query: 254 VDPMKRITIPEIRQ 267
++P +R T +I Q
Sbjct: 354 LEPTERPTFSQISQ 367
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 48/200 (24%), Positives = 87/200 (43%), Gaps = 16/200 (8%)
Query: 33 VKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92
V +A + TG V ++ +N N EM ++ E+ + +LF HP+I+ +++
Sbjct: 16 VNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 74
Query: 93 YVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL 150
+VV ++ G D I + E Q ++ ++Y H VHR +K ++L+
Sbjct: 75 WVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI 134
Query: 151 DSKWNVKIADFGLSNI---MRDGHFLKTSCGSPNYAA-------PEVISGKLYA-GPEVD 199
V ++ GL + + G L+ P Y+ PEV+ L + D
Sbjct: 135 SVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSD 192
Query: 200 VWSCGVILYALLCGTLPFDD 219
++S G+ L G +PF D
Sbjct: 193 IYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 90/365 (24%), Positives = 137/365 (37%), Gaps = 110/365 (30%)
Query: 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR-----RKIK-NMEMEEKVR 65
+D+ +K+ LG G+FGKV A A+KI+ R K ++ EKVR
Sbjct: 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVR 183
Query: 66 RE--------IKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGE-LFDYIVEKGRLQE 116
+ +KI R F + ET + +VM K G L D+I++ G
Sbjct: 184 QADPADRFPLMKIQRYFQN----------ET-GHMCIVMP--KYGPCLLDWIMKHGPFSH 230
Query: 117 DEARNFFQQIISGVEYCHRNM-VVHRDLKPENLLLDSK----------------WNVKIA 159
Q ++Y H + ++H DLKPEN+L+++ V+I
Sbjct: 231 RHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRIC 290
Query: 160 DFGLSNIMRDGHFLKTSCGSPNYAAPEVI--SGKLYAGPEVDVWSCGVILYALLCGTLPF 217
D G + H + +Y +PEV+ G +Y+ D+WS G I+Y L G L +
Sbjct: 291 DLG--GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYS---TDMWSMGCIIYELYTGKLLY 345
Query: 218 DD-ENIP--NLFKKIKGGI-------------------------YTLPSHLSPGAR---- 245
D +N+ +L +K G + T P HL+ AR
Sbjct: 346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPV 405
Query: 246 ----------DLIPRMLIVDPMKRIT-------------IPEIRQHPWFQAHLPRYLAVP 282
DLI +L D KR+ PE RQHP + +
Sbjct: 406 REVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHP---NYPDNRSMLR 462
Query: 283 PPDTM 287
P M
Sbjct: 463 PTPIM 467
|
Length = 467 |
| >gnl|CDD|213384 cd12199, AMPKA1_C, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha 1 catalytic subunit | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 5e-07
Identities = 31/126 (24%), Positives = 52/126 (41%), Gaps = 36/126 (28%)
Query: 391 KWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHS 450
KW LG++S++ P +IM EV +A+++L+ WK + Y ++ R NP+ S
Sbjct: 3 KWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVR------------RKNPVTS 50
Query: 451 NHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQ----GPQFLFLDLCA 506
K +QLY+ YLLD + + F ++CA
Sbjct: 51 TF--------------------SKMSLQLYQVDSRTYLLDFRSIDDEITSHTIEFFEMCA 90
Query: 507 AFLAQL 512
+ L
Sbjct: 91 NLIKIL 96
|
AMPK, a serine/threonine protein kinase (STK), catalyzes the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. It acts as a sensor for the energy status of the cell and is activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. AMPK is a heterotrimer of three subunits: alpha, beta, and gamma. Co-expression of the three subunits is required for kinase activity; in the absence of one, the other two subunits get degraded. The AMPK alpha subunit is the catalytic subunit and it contains an N-terminal kinase domain and a C-terminal regulatory domain (RD). Vertebrates contain two isoforms of the alpha subunit, alpha1 and alpha2, which are encoded by different genes, PRKAA1 and PRKAA2, respectively, and show varying expression patterns. AMPKalpha1 is the predominant isoform expressed in bone; it plays a role in bone remodeling in response to hormonal regulation. It is selectively regulated by nucleoside diphosphate kinase (NDPK)-A in an AMP-independent manner. AMPKalpha1 impacts the regulation of fat metabolism through its in vivo target, acetyl coenzyme A carboxylase (ACC). It also mediates the vasoprotective effects of estrogen through phosphorylation of another in vivo substrate, RhoA. The C-terminal RD of the AMPK alpha 1 subunit is involved in AMPK heterotrimer formation. It mainly interacts with the C-terminal region of the beta subunit to form a tight alpha-beta complex that is associated with the gamma subunit. The AMPK alpha subunit RD also contains an auto-inhibitory region that interacts with the kinase domain; this inhibition is negated by the interaction with the AMPK gamma subunit. Length = 96 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 27/69 (39%), Positives = 38/69 (55%), Gaps = 2/69 (2%)
Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG- 178
+ +Q+++G+ HR +VHRD+KPENLL+ VKI DFG + M G G
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGM 371
Query: 179 -SPNYAAPE 186
P Y+ PE
Sbjct: 372 LDPRYSPPE 380
|
Length = 507 |
| >gnl|CDD|201355 pfam00627, UBA, UBA/TS-N domain | Back alignment and domain information |
|---|
Score = 42.8 bits (102), Expect = 5e-06
Identities = 13/37 (35%), Positives = 22/37 (59%)
Query: 293 IDEEILKEVVKMGFDQNQLVESLRNRLQNEATVAYYL 329
IDEE++K++ +MGF + + ++LR N YL
Sbjct: 1 IDEELIKQLREMGFSREEAKKALRATNGNVERAVEYL 37
|
This small domain is composed of three alpha helices. This family includes the previously defined UBA and TS-N domains. The UBA-domain (ubiquitin associated domain) is a novel sequence motif found in several proteins having connections to ubiquitin and the ubiquitination pathway. The structure of the UBA domain consists of a compact three helix bundle. This domain is found at the N terminus of EF-TS hence the name TS-N. The structure of EF-TS is known and this domain is implicated in its interaction with EF-TU. The domain has been found in non EF-TS proteins such as alpha-NAC and MJ0280. Length = 37 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 14/97 (14%)
Query: 21 LGKTLGIGSFGKVKIA-----EHALTGHKVAIKILN---RRKIKNMEMEEKVRREIKIL- 71
LG+TLG G+FG+V A H+ + KVA+K+L R K M E +KI+
Sbjct: 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSE-----LKIMS 95
Query: 72 RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI 108
L H +I+ L IY++ EY + G+L DY+
Sbjct: 96 HLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|197551 smart00165, UBA, Ubiquitin associated domain | Back alignment and domain information |
|---|
Score = 41.7 bits (99), Expect = 1e-05
Identities = 13/37 (35%), Positives = 23/37 (62%)
Query: 294 DEEILKEVVKMGFDQNQLVESLRNRLQNEATVAYYLL 330
DEE + ++++MGF + + +++LR N A YLL
Sbjct: 1 DEEKIDQLLEMGFSREEALKALRAANGNVERAAEYLL 37
|
Present in Rad23, SNF1-like kinases. The newly-found UBA in p62 is known to bind ubiquitin. Length = 37 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 59/231 (25%), Positives = 92/231 (39%), Gaps = 61/231 (26%)
Query: 12 VDMFL---------PNYK-----LGKTLGIGSFGKVK----IAEHALTGHKVAIKILNRR 53
VDMF+ P++K LGK LG G+FG V + + + K +K
Sbjct: 113 VDMFVLAPLEGLFRPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEY 172
Query: 54 KIKNMEMEEKVRREI-----KILRLFMHPH---------IIRLYEVIETPSDIYVVMEYV 99
+ M E+VRR + F+ P ++ YE T +D+ +
Sbjct: 173 GAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADL------M 226
Query: 100 KSGELFDYIVEKGRLQE--DEAR----------NFFQQIISGVEYCHRNMVVHRDLKPEN 147
+S E F Y VE L + D + +QI+ ++ H +VHRD+KP+N
Sbjct: 227 QSKE-FPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285
Query: 148 LLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
++ + KI D G + +R G NY E + YA PE
Sbjct: 286 IIFSEGSGSFKIIDLGAAADLRVGI---------NYIPKEFLLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 32/100 (32%), Positives = 50/100 (50%), Gaps = 8/100 (8%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGH-----KVAIKILNRRKIKNMEMEEKVRREIKIL- 71
N + GKTLG G+FGKV A G +VA+K+L + + E + E+KIL
Sbjct: 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS--AHTDEREALMSELKILS 96
Query: 72 RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK 111
L H +I+ L + V+ EY G+L +++ +K
Sbjct: 97 HLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|238116 cd00194, UBA, Ubiquitin Associated domain | Back alignment and domain information |
|---|
Score = 40.5 bits (96), Expect = 4e-05
Identities = 12/37 (32%), Positives = 22/37 (59%)
Query: 294 DEEILKEVVKMGFDQNQLVESLRNRLQNEATVAYYLL 330
DEE L+++++MGF + + ++LR N +LL
Sbjct: 1 DEEKLEQLLEMGFSREEARKALRATNNNVERAVEWLL 37
|
The UBA domain is a commonly occurring sequence motif in some members of the ubiquitination pathway, UV excision repair proteins, and certain protein kinases. Although its specific role is so far unknown, it has been suggested that UBA domains are involved in conferring protein target specificity. The domain, a compact three helix bundle, has a conserved GFP-loop and the proline is thought to be critical for binding. The UBA domain is distinct from the conserved three helical domain seen in the N-terminus of EF-TS and eukaryotic NAC proteins. Length = 38 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 9e-05
Identities = 29/108 (26%), Positives = 44/108 (40%), Gaps = 13/108 (12%)
Query: 114 LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173
L E+E Q + + HR L + LL +V S D +F+
Sbjct: 14 LNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSVAFKTPEQSRP--DPYFM 71
Query: 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN 221
APEVI G+ Y + D++S G+ LY L LP+++E
Sbjct: 72 ----------APEVIQGQSY-TEKADIYSLGITLYEALDYELPYNEER 108
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 40/174 (22%), Positives = 72/174 (41%), Gaps = 32/174 (18%)
Query: 34 KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL--RLFMHPHIIRLYEV-IETPS 90
I G +K ++ ++ E++EK+RRE R+ + + E + P
Sbjct: 11 IIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARI-----LAKAREAGVPVP- 64
Query: 91 DIY--------VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
+Y +VMEY++ GEL +E+ R + +++ V H+ +VH D
Sbjct: 65 IVYDVDPDNGLIVMEYIE-GELLKDALEEARP------DLLREVGRLVGKLHKAGIVHGD 117
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMR-------DGHFLKTSCGSPNYAAPEVIS 189
L N++L + DFGL D H L+ + S + A E+ +
Sbjct: 118 LTTSNIILSGG-RIYFIDFGLGEFSDEVEDKAVDLHVLERALESTHEKAEELFA 170
|
Length = 204 |
| >gnl|CDD|213376 cd12120, AMPKA_C_like, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha subunit and similar domains | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 5e-04
Identities = 22/127 (17%), Positives = 42/127 (33%), Gaps = 39/127 (30%)
Query: 391 KWALGLQSRAHPREIMTEVLKALQELNVGWKK-----IGHYNMKCRWIPGISGHHEGMVN 445
KW L + SR P EI + K L+ GW K I ++ + + +
Sbjct: 3 KWELEIHSRIDPSEIYEGIHKVLE----GWGKNLVFRITNFIITGKLV------------ 46
Query: 446 NPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQFLFLDLC 505
+ + FE+++Y+ +++D ++ G F L
Sbjct: 47 ------------------NDHILFLRSTLFEIEVYEVGPGLFMVDFKKKTGSTKTFTKLA 88
Query: 506 AAFLAQL 512
+L
Sbjct: 89 TKIQIKL 95
|
This family is composed of AMPKs, microtubule-associated protein/microtubule affinity regulating kinases (MARKs), yeast Kcc4p-like proteins, plant calcineurin B-Like (CBL)-interacting protein kinases (CIPKs), and similar proteins. They are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. AMPKs act as sensors for the energy status of the cell and are activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. MARKs phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Kcc4p and related proteins are septin-associated proteins that are involved in septin organization and in the yeast morphogenesis checkpoint coordinating the cell cycle with bud formation. CIPKs interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. All members of this family contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain which is also called kinase associated domain 1 (KA1) in some cases. The C-terminal regulatory domain serves as a protein interaction domain in AMPKs and CIPKs. In MARKs and Kcc4p-like proteins, this domain binds phospholipids and may be involved in membrane localization. Length = 95 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 7e-04
Identities = 38/163 (23%), Positives = 67/163 (41%), Gaps = 29/163 (17%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR------RKIKN--------------M 58
+G +G+G V +A G KVA+K +R RK+K
Sbjct: 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKF-HRLGRTSFRKVKRNRDYLADKEHGSWLY 150
Query: 59 EMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDE 118
RE + L+ +P +++ + I VVMEY++ EL+ + RL +
Sbjct: 151 VSRLAAEREFEALQRL-YPEGVKVPKPIAWNRHA-VVMEYIEGVELY-----RLRLDVEN 203
Query: 119 ARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADF 161
+I+ V +R +VH DL N+L+ ++ + D+
Sbjct: 204 PDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDW 246
|
Length = 304 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 45/203 (22%), Positives = 86/203 (42%), Gaps = 49/203 (24%)
Query: 12 VDMFLPNYKLGKTLGIGSFGKV----KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR- 66
+D+ +K+ K +G G FG V ++H + VA KI+N+E E V
Sbjct: 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVA-------KIENLENETIVMET 59
Query: 67 -------EIKILRLFMHPHII-----------------RLYEVIETPSDIYVVME--YVK 100
+I + L+ + H I R+Y ++++E
Sbjct: 60 LVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYR-------FILLEKLVEN 112
Query: 101 SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160
+ E+F I K + +N + +++ +EY H + + H D+KPEN+++D I D
Sbjct: 113 TKEIFKRIKCKNK---KLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169
Query: 161 FGL-SNIMRDGHFLKTSCGSPNY 182
+G+ S+ + G ++ S +
Sbjct: 170 YGIASHFIIHGKHIEYSKEQKDL 192
|
Length = 294 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 36/202 (17%), Positives = 83/202 (41%), Gaps = 8/202 (3%)
Query: 42 GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD----IYVVME 97
+V I+ + + + + EIK LR +I+++Y I D + +++E
Sbjct: 43 NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102
Query: 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM-VVHRDLKPENLLLDSKWNV 156
Y G L + + ++ L + G+ ++ +++L + L+ + +
Sbjct: 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKL 162
Query: 157 KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV-DVWSCGVILYALLCGTL 215
KI GL I+ F + Y + ++++ D++S GV+L+ + G +
Sbjct: 163 KIICHGLEKILSSPPFKNVNFMV--YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKI 220
Query: 216 PFDDENIPNLFKKIKGGIYTLP 237
PF++ ++ I +L
Sbjct: 221 PFENLTTKEIYDLIINKNNSLK 242
|
Length = 283 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 515 | |||
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.64 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.46 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.46 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.44 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.42 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.29 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.26 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.13 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 99.11 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.03 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.03 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.95 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.89 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.84 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.84 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.72 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.64 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.6 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.59 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.59 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.53 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.5 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.46 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.27 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.24 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.23 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.12 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.09 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.08 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.93 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.92 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.8 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.76 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.71 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.69 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.63 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.45 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.42 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.39 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.38 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.36 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.3 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.12 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.09 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.09 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.9 | |
| PLN02236 | 344 | choline kinase | 96.86 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.64 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.54 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.52 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.47 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.4 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.05 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.73 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.56 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.36 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.28 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.0 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.27 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 93.55 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.43 |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-66 Score=536.13 Aligned_cols=326 Identities=48% Similarity=0.825 Sum_probs=298.1
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
...++-|+++++||.|+.|.|.+|+|..||+.+|||++.+..-........+.+||-+|+.+.||||+++|+++++..++
T Consensus 8 ~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l 87 (786)
T KOG0588|consen 8 KNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL 87 (786)
T ss_pred cccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence 34578999999999999999999999999999999999988555555678899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
|+|.||++||+|++|+.++|+++|.+++++|.||+.|+.|||..+|+||||||||+|||..++|||+|||+|..-.++..
T Consensus 88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccC
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 252 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL 252 (515)
+.|.||+|.|+|||++.|.+|.|.++||||||||||+||+|++||+++++..++.+++.|.+.+|..+|+++++||.+||
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml 247 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRML 247 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHhcCccccccc--CcccCCCCC-----CchhhhhccCHHHHHHHHHcC--CCHHHHHHHHHhcccChh
Q 010214 253 IVDPMKRITIPEIRQHPWFQAHL--PRYLAVPPP-----DTMQQAKKIDEEILKEVVKMG--FDQNQLVESLRNRLQNEA 323 (515)
Q Consensus 253 ~~dP~~Rpt~~eil~hp~f~~~~--~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~~~ 323 (515)
.+||.+|+|.+||++|||++... +.....+++ ........||+.+++-|+-.+ -+.+.+.+.|.....|..
T Consensus 248 ~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~~~~~i~s~ps~~~IDp~Il~~l~iLwc~~d~~kl~~kLls~~~n~E 327 (786)
T KOG0588|consen 248 DVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPPVSVPILSIPSIQEIDPLILQHLCILWCGRDPEKLVEKLLSPDDNDE 327 (786)
T ss_pred ccCccccccHHHHhhCchhhcCCCCChhhhcCCCcccceeecCCcccCCHHHHhhhhheeecCChHHHHHHHcCCCcchh
Confidence 99999999999999999998542 111111122 122234689999999987554 489999999999999999
Q ss_pred HHHHHHHhhcccccc
Q 010214 324 TVAYYLLLDNRFRVS 338 (515)
Q Consensus 324 ~~~y~ll~~~~~~~~ 338 (515)
..-|.||++.+.+.+
T Consensus 328 K~~Y~LLl~~k~r~~ 342 (786)
T KOG0588|consen 328 KTLYFLLLRRKRRDS 342 (786)
T ss_pred HHHHHHHHHhhccch
Confidence 999999999876543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-63 Score=492.56 Aligned_cols=263 Identities=43% Similarity=0.763 Sum_probs=241.1
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCC----hHHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN----MEMEEKVRREIKILRLFMHPHIIRLYEVIE 87 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~----~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~ 87 (515)
...+.+.|.+.++||+|+||.|.+|..+.||+.||||++++.+... ......+.+|+++|++|+|||||+++++|+
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 3446788999999999999999999999999999999999876654 223445789999999999999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC---CceEEeecccc
Q 010214 88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLS 164 (515)
Q Consensus 88 ~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~---~~vKL~DFGls 164 (515)
.++..||||||++||+|++++..++.+.|...+.++.||+.||.|||+.||+||||||+|||+..+ ..+||+|||+|
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 999999999999999999999999999999999999999999999999999999999999999876 78999999999
Q ss_pred cccccCCccccCCCCCCccCCCcccCC--ccCCCcceeehhHHHHHHHHhCCCCCCCCChHH-HHHHHhcCccCCC----
Q 010214 165 NIMRDGHFLKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYALLCGTLPFDDENIPN-LFKKIKGGIYTLP---- 237 (515)
Q Consensus 165 ~~~~~~~~~~~~~gt~~Y~aPE~i~~~--~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~-~~~~i~~~~~~~p---- 237 (515)
+....+.+++|.||||.|.|||++.++ .++..++|+||+||+||.+|+|.+||.+..... +.++|..|.+.+-
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 999999999999999999999999754 344568999999999999999999999876555 8999999988764
Q ss_pred CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 238 ~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..+|.++.+||++||.+||++|||++|+|+||||+..
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 4689999999999999999999999999999999853
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-60 Score=491.63 Aligned_cols=261 Identities=40% Similarity=0.720 Sum_probs=249.8
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
..|..++.||+|||+.||.+++..+|+.||+|++.++.+......+++.+||+|.+.|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 34999999999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCcccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~ 175 (515)
|+|+.++|..++++.+.++|.+++.++.||+.||.|||+++|+|||||..|+|++++.+|||+|||+|.... +++...|
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T 177 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT 177 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence 999999999999999999999999999999999999999999999999999999999999999999999887 5588899
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~d 255 (515)
.||||+|.|||++....+ +.++||||+||+||.||+|++||...+..+.+.+|+...+.+|..+|.++++||.+||+.|
T Consensus 178 lCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~ 256 (592)
T KOG0575|consen 178 LCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPN 256 (592)
T ss_pred ecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCC
Confidence 999999999999997766 8999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHhcCcccc-cccCcc
Q 010214 256 PMKRITIPEIRQHPWFQ-AHLPRY 278 (515)
Q Consensus 256 P~~Rpt~~eil~hp~f~-~~~~~~ 278 (515)
|.+|||+++++.|+||+ ...|..
T Consensus 257 P~~Rpsl~~vL~h~Ff~~g~~p~~ 280 (592)
T KOG0575|consen 257 PSERPSLDEVLDHPFFKSGFTPAR 280 (592)
T ss_pred cccCCCHHHHhcCHhhhCCCcCCC
Confidence 99999999999999994 344443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-59 Score=485.40 Aligned_cols=262 Identities=61% Similarity=1.071 Sum_probs=249.0
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh--HHHHHHHHHHHHHHhCC-CCCccEEEEEEEcC
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM--EMEEKVRREIKILRLFM-HPHIIRLYEVIETP 89 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~--~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~ 89 (515)
....++|.+++.||+|+||+|++|.+..+|..||+|+++++..... ...+.+.||+.++++++ ||||+++++++.++
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 4567899999999999999999999999999999999887644311 35678889999999999 99999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CceEEeeccccccc-
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIM- 167 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~-~~vKL~DFGls~~~- 167 (515)
..+|+|||||.||+|+++|.+.++++|.+++.+|+||++||+|||++||+||||||||||++.+ +++||+|||++...
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 9999999999999999999999999999999999999999999999999999999999999999 99999999999998
Q ss_pred ccCCccccCCCCCCccCCCcccCCc-cCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCC-ChhHH
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL-SPGAR 245 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~-~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~-s~~~~ 245 (515)
..+....+.||||.|+|||++.+.. |.+.++|||||||+||.|++|..||++.+...++.+|..+.+.+|..+ |++++
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~ 252 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEAR 252 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHH
Confidence 5778899999999999999999988 999999999999999999999999999999999999999999999999 99999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+|+.+||..||.+|+|+.+|+.||||+..
T Consensus 253 ~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 253 SLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred HHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 99999999999999999999999999973
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-58 Score=453.15 Aligned_cols=260 Identities=38% Similarity=0.690 Sum_probs=246.6
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
.-.++|+++++||+|+||+|+.++++.|++.||+|+++|..+........+..|..||..++||+||+++..|++++.+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 34689999999999999999999999999999999999999888778899999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc-cccCCc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~-~~~~~~ 172 (515)
+|+||+.||+|+.+|++.+.++|..++.++.+|+.||.|||++||+||||||||||||.+|+++|+|||+++. ...+..
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~ 181 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA 181 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999984 456677
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhccc
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~m 251 (515)
.++.|||+.|||||++.+..| +.++|+||||+++|+|++|.+||.+.+.....++|..+. ...|..+|.+++++|+++
T Consensus 182 t~tfcGT~eYmAPEil~~~gy-~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~L 260 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGY-DKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKL 260 (357)
T ss_pred cccccCCccccChHHHhcCCC-CcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHH
Confidence 888999999999999999988 799999999999999999999999999999999999998 555566999999999999
Q ss_pred CCCCCCCCC----CHHHHhcCcccccc
Q 010214 252 LIVDPMKRI----TIPEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rp----t~~eil~hp~f~~~ 274 (515)
|+.||.+|. ++.+|.+||||...
T Consensus 261 L~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 261 LKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred hccCHHHhcCCCCChHHhhcCcccccC
Confidence 999999996 68999999999865
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-58 Score=464.06 Aligned_cols=318 Identities=40% Similarity=0.722 Sum_probs=285.9
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
.+.+=|.+.++||+|.|++|.+|+|.-||.+||||++++.++... ....+.+|+++|+.++|||||++|+++.+...+|
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 456889999999999999999999999999999999999887654 3467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC-CCCceEEeecccccccccCC
Q 010214 94 VVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~-~~~~vKL~DFGls~~~~~~~ 171 (515)
+|+|.-+||+|++||-++ ..++|+.++++|.||+.|+.|||+..+||||||||||.+- .-|-|||.|||+++.+.+|.
T Consensus 94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999999999764 5799999999999999999999999999999999998765 56899999999999999999
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhccc
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~m 251 (515)
.+.|.||+..|.|||++.|..|+.|++||||||||||.|+||.+||...+..+.+..|....|..|+++|.++++||.+|
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sM 253 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSM 253 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCHHHHhcCcccccccCcccCCCCCCchhhhhccC----HHHHHHHHHcCC-CHHHHHHHHHhcccChhHHH
Q 010214 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKID----EEILKEVVKMGF-DQNQLVESLRNRLQNEATVA 326 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~hp~f~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~ 326 (515)
|+.||.+|.|.+||..|+|++...+.....-|. .....+. ..|++.|+.-.+ +.++|.+.|.+...|..+++
T Consensus 254 LvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iPL---vsr~~L~ee~Ha~IIq~Mv~G~IAs~e~Il~aLe~n~YNhiTAT 330 (864)
T KOG4717|consen 254 LVRDPKKRASLEEIVSTSWLQAGDRGLSTAIPL---VSRHHLPEEAHATIIQQMVAGAIASEEDILRALENNEYNHITAT 330 (864)
T ss_pred HhcCchhhccHHHHhccccccCCCCCccccCce---eehhhCChHHHHHHHHHHhcccccCHHHHHHHHhccccchhhhH
Confidence 999999999999999999999765443222111 1112223 346777776555 78999999999999999999
Q ss_pred HHHHhhccc
Q 010214 327 YYLLLDNRF 335 (515)
Q Consensus 327 y~ll~~~~~ 335 (515)
||||.+.+.
T Consensus 331 YfLLAEr~L 339 (864)
T KOG4717|consen 331 YFLLAERVL 339 (864)
T ss_pred HHHHHHHHH
Confidence 999988653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-58 Score=437.17 Aligned_cols=258 Identities=39% Similarity=0.740 Sum_probs=247.4
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
--+++|+++++||.|+||.|-+++++.+|..+|+|++++.++-.....+...+|..+|+.+.||+++++++.+.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 34789999999999999999999999999999999999999888888999999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|||||++||+|++++.+.++++|..++.++.||+.||+|||+++|++|||||||||+|.+|.+||+|||+|...... .
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T 198 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--T 198 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--E
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999887554 6
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCC
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~ 253 (515)
-|.||||.|+|||++.++.| +.++|.|||||++|||++|.+||.+.+...++++|..+.+.+|+.+++++++||+++|+
T Consensus 199 ~TlCGTPeYLAPEii~sk~y-nkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~ 277 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGY-NKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQ 277 (355)
T ss_pred EEecCCccccChHHhhcCCC-CcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHh
Confidence 78999999999999999988 79999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCC-----CHHHHhcCcccccc
Q 010214 254 VDPMKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 254 ~dP~~Rp-----t~~eil~hp~f~~~ 274 (515)
+|-.+|. ...+|..||||+..
T Consensus 278 vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 278 VDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred hhhHhhhcCcCCCccccccCcccccc
Confidence 9999994 56799999999864
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-58 Score=450.07 Aligned_cols=258 Identities=51% Similarity=0.887 Sum_probs=249.4
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
....+|++.++||+|.||+|.+|.....|+.||||.|.++++++....-.++|||+||..|+||||+++|++|+..+.+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 34568999999999999999999998899999999999999999999999999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|||||..+|+|.|||.+.+.++|.+++.+|+||++|+.|||.++++|||||.||||+|.++++||+|||+++.+.++.++
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFL 209 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCC
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~ 253 (515)
.|+||+|.|++||++.|.+|.++++|-|||||+||.|+.|..||++.+...+.++|..|.|.-|.. +.++.-||+.||-
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gLIRwmLm 288 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDASGLIRWMLM 288 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHHHHHHHHHh
Confidence 999999999999999999999999999999999999999999999999999999999999877754 5678999999999
Q ss_pred CCCCCCCCHHHHhcCcccc
Q 010214 254 VDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~f~ 272 (515)
+||++|.|+.+|..|=|+.
T Consensus 289 VNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 289 VNPERRATIEDIASHWWVN 307 (668)
T ss_pred cCcccchhHHHHhhhheee
Confidence 9999999999999998885
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-56 Score=440.55 Aligned_cols=260 Identities=42% Similarity=0.726 Sum_probs=243.0
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|.+.+.||+|+||+||+|+|+.++..||||.+.++++ .....+.+..||++|+.++|||||++++++++++++|
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 347899999999999999999999999999999999998876 4466788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC------CceEEeeccccccc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK------WNVKIADFGLSNIM 167 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~------~~vKL~DFGls~~~ 167 (515)
+|||||+||+|.+||.+++.++|..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+.+
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999999999999999999999999999999999999999999999999875 45899999999999
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC---CCCCCChhH
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT---LPSHLSPGA 244 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~ 244 (515)
.++....|.||||.|||||++....| +.|+|+||+|+|+|+|++|+.||+..+..+++..+..+... +|..+++..
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~~~Y-dAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~ 244 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMSQQY-DAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPL 244 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHhccc-cchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCch
Confidence 99999999999999999999988888 68999999999999999999999999999999998887643 446788889
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
.+|+...|+.+|..|.+..+-+.|+++....
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 9999999999999999999999999987553
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-56 Score=456.39 Aligned_cols=259 Identities=37% Similarity=0.669 Sum_probs=244.3
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 93 (515)
-..+|.+++.||.|+|++|++|+.+.+++.||||++.|+-+......+.+.+|-.+|.+| .||.|++||..|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 357899999999999999999999999999999999998887777788899999999999 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc-
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF- 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~- 172 (515)
+|+||+++|+|.++|.+.|.++|..++.++.||+.||+|||++|||||||||||||||.+|++||+|||.+..+.+...
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999988753211
Q ss_pred -------------cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCC
Q 010214 173 -------------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH 239 (515)
Q Consensus 173 -------------~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~ 239 (515)
..+.+||..|.+||++..... ++.+|||+||||||.|+.|.+||.+.+...++++|....+.+|+.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~ 309 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEG 309 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCC
Confidence 145789999999999998754 899999999999999999999999999999999999999999999
Q ss_pred CChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 240 ~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+++.++|||+++|..||.+|+|+.+|.+||||...
T Consensus 310 fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 310 FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred CCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 99999999999999999999999999999999864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-55 Score=432.77 Aligned_cols=255 Identities=32% Similarity=0.545 Sum_probs=235.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe-EEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD-IYV 94 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~i 94 (515)
..+.+.++.||+|+.|+||+|.|+.|++.+|+|++. ...+....+++.+|+++++.++||+||++|+.|..+.. ++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~--~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL--LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec--ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 457788999999999999999999999999999994 23355678899999999999999999999999999985 999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
+||||+||+|.+++...++++|.....++.++++||.|||+ ++|+||||||+|||++..|.|||||||.|..+-+. ..
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a 234 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IA 234 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hc
Confidence 99999999999999999999999999999999999999995 99999999999999999999999999999988665 66
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC-----ChHHHHHHHhcC-ccCCCCC-CChhHHH
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-----NIPNLFKKIKGG-IYTLPSH-LSPGARD 246 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~-----~~~~~~~~i~~~-~~~~p~~-~s~~~~~ 246 (515)
++.+||..|||||.+.|..| +.++||||||+.+.|+++|+.||... ..-+++..|..+ ...+|.. +|+++++
T Consensus 235 ~tfvGT~~YMsPERi~g~~Y-s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~ 313 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESY-SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRS 313 (364)
T ss_pred ccccccccccChhhhcCCcC-CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence 89999999999999999988 78999999999999999999999874 677888888884 4577886 9999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
||..||++||.+|||+.|+++|||++..
T Consensus 314 FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 314 FVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred HHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 9999999999999999999999999865
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-55 Score=454.46 Aligned_cols=322 Identities=42% Similarity=0.727 Sum_probs=290.8
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
......+.|.+.++||+|.|++|.+|+|..||..||||++++....... ..++.+|+++|+.++|||||+++.+++++.
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 3455678999999999999999999999999999999999988766544 455999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.+|+||||+.+|++++|+.+++++.+.+++.+|.|+++|++|||+++|||||||++||||+.+.++||+|||+++.+..+
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcc
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 250 (515)
..+.+.||+|.|+|||++.|..|.++++|+||+|+++|.|++|.+||++.+...+..+...+.+.+|-.++.++.++|++
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk 288 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRK 288 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCHHHHhcCcccccccCcccCCCCCCchhhhhccCHHHHHHHHHcCCCHHHHHHHHHhcccChhHHHHHHH
Q 010214 251 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLRNRLQNEATVAYYLL 330 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~y~ll 330 (515)
+|..+|.+|++++++++|.|.......-.-.| ........++..-+..+..+|+....+.++|.+..+++...+|.++
T Consensus 289 ~lvl~Pskr~~~dqim~~~W~n~~~~~~~l~p--~~e~~~~~~~~~r~~~m~~~G~~~~~i~~sL~~~k~d~i~a~y~ll 366 (596)
T KOG0586|consen 289 FLVLNPSKRGPCDQIMKDRWRNDLLEARLLAP--LIERSTPFILAKRILHMNSIGHRRLKIEESLAKQKFDDINATYLLL 366 (596)
T ss_pred hhccCccccCCHHHhhhhcccchhhhhhhhhc--ccccCccchhhHHHHHHHhhccchhhHHHHHhhhhHHHHHHHHhhc
Confidence 99999999999999999999976554411111 1111222334444556778999999999999999999999999887
Q ss_pred hhccc
Q 010214 331 LDNRF 335 (515)
Q Consensus 331 ~~~~~ 335 (515)
-.+..
T Consensus 367 ~~~~~ 371 (596)
T KOG0586|consen 367 GYRKQ 371 (596)
T ss_pred chhhh
Confidence 66543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-54 Score=437.11 Aligned_cols=260 Identities=37% Similarity=0.654 Sum_probs=238.9
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
.-+++|++++.||+|+||.||+|+.+.||+.+|+|+++|+.+......+.++.|-.+|...++|+||++|..|++..++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 34789999999999999999999999999999999999999888888999999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc----
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD---- 169 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~---- 169 (515)
+||||++||++..+|.+.+.|+|+.++.++.+++.||+.+|+.|++||||||+|+|||..|++||+|||+|.....
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999853210
Q ss_pred ------------------CC--------------------------ccccCCCCCCccCCCcccCCccCCCcceeehhHH
Q 010214 170 ------------------GH--------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGV 205 (515)
Q Consensus 170 ------------------~~--------------------------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGv 205 (515)
.. .....+|||.|+|||++.++.| +..+|+|||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY-~~~cDwWSLG~ 376 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY-GKECDWWSLGC 376 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC-CccccHHHHHH
Confidence 00 0123579999999999999987 89999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCCC--CCChhHHHHhcccCCCCCCCCCC---HHHHhcCccccccc
Q 010214 206 ILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPS--HLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAHL 275 (515)
Q Consensus 206 ily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~li~~mL~~dP~~Rpt---~~eil~hp~f~~~~ 275 (515)
|+||||.|.+||.+++..+.+++|.+.. +.+|. .++++++|||.+||. ||.+|.. ++||.+||||+...
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence 9999999999999999999999998876 55554 678999999999999 9999985 89999999998754
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-55 Score=409.40 Aligned_cols=259 Identities=44% Similarity=0.745 Sum_probs=243.3
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
.+.++|++.+.||+|.|+.|+++.+..||+.+|+|+++..++... .-+++.+|++|-+.|+||||+++.+.+.+....|
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 356899999999999999999999999999999999998877765 5688999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCceEEeecccccccccC
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~---~~~vKL~DFGls~~~~~~ 170 (515)
+|+|++.|++|..-|.++..++|..+..+++||+.||.|||.+||||||+||+|+|+.+ ..-+||+|||++....++
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 99999999999999988888999999999999999999999999999999999999964 346999999999998888
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCC----CCChhHHH
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARD 246 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~ 246 (515)
.......|||.|||||++...+| +..+|||++|||||-||.|.+||.+++...+++.|..+.+.+|+ .+++++++
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~ 245 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS 245 (355)
T ss_pred cccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence 88888899999999999999888 78999999999999999999999999999999999999988774 78999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|+++||..||.+|+|+.|+|+|||+.+.
T Consensus 246 LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 246 LIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHhccChhhhccHHHHhCCchhcch
Confidence 9999999999999999999999999753
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-53 Score=441.93 Aligned_cols=259 Identities=36% Similarity=0.623 Sum_probs=245.1
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDI 92 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 92 (515)
.-+++|.+.++||+|+||+|++|..+.+++.||||++.|..+-..+..+.+..|.+|+...+ ||++++++..|++++++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34689999999999999999999999999999999999999988899999999999999887 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc-ccCC
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~-~~~~ 171 (515)
|+||||+.||++.. +.+.+.++|..++.++..++.||.|||++||+|||||.+|||||.+|++||+|||+++.- ..+.
T Consensus 445 ~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~ 523 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD 523 (694)
T ss_pred EEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence 99999999999544 445678999999999999999999999999999999999999999999999999999864 4777
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhccc
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~m 251 (515)
...|.||||.|+|||++.+..| +.++|.|||||+||+||.|..||.+++.+++++.|....+.+|..+|.++.++++++
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Y-t~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~l 602 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSY-TRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRL 602 (694)
T ss_pred ccccccCChhhcChhhhccCcc-cchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHH
Confidence 8899999999999999999998 799999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCH-----HHHhcCcccccc
Q 010214 252 LIVDPMKRITI-----PEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rpt~-----~eil~hp~f~~~ 274 (515)
|.+||++|... ++|..||||+..
T Consensus 603 l~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 603 LRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred hccCcccccCCCCCCchhhhhCCccccC
Confidence 99999999964 789999999875
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-53 Score=423.08 Aligned_cols=260 Identities=41% Similarity=0.737 Sum_probs=233.5
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh-----------HHHHHHHHHHHHHHhCCCCCccEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-----------EMEEKVRREIKILRLFMHPHIIRL 82 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~-----------~~~~~i~~Ei~il~~l~hpnIv~l 82 (515)
..+++|++.+.||+|.||+|.+|++..+++.||||++++...... ...+++++||.+|+++.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 457899999999999999999999999999999999987654321 124789999999999999999999
Q ss_pred EEEEEcC--CeEEEEEeccCCCCHHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEe
Q 010214 83 YEVIETP--SDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIA 159 (515)
Q Consensus 83 ~~~~~~~--~~~~iVmEy~~gg~L~~~i~~~~~-l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~ 159 (515)
+++..++ +.+|||+|||..|.+...= ..+. +++.+++.++..++.||+|||.+||+||||||+|+||+++|.|||+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 9999775 5699999999999885532 2334 9999999999999999999999999999999999999999999999
Q ss_pred eccccccccc------CCccccCCCCCCccCCCcccC---CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHh
Q 010214 160 DFGLSNIMRD------GHFLKTSCGSPNYAAPEVISG---KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK 230 (515)
Q Consensus 160 DFGls~~~~~------~~~~~~~~gt~~Y~aPE~i~~---~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~ 230 (515)
|||.+..... ...+...+|||.|+|||.+.+ ..+.+.+.||||+||+||.|+.|..||-++...+++++|.
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 9999987632 233455789999999999987 5678899999999999999999999999999999999999
Q ss_pred cCccCCCCC--CChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 231 GGIYTLPSH--LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 231 ~~~~~~p~~--~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+....+|.. +.++++|||.+||.+||++|+++.+|..|||....
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 999998875 79999999999999999999999999999999765
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=404.34 Aligned_cols=252 Identities=33% Similarity=0.582 Sum_probs=226.6
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEE-EE-EcCCeE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE-VI-ETPSDI 92 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~-~~-~~~~~~ 92 (515)
-..+|++.++||.|+||.||++.+..+|..+|.|.++-.. .+....+.+..||.+|++|+|||||++|+ -| ++..-+
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 3567999999999999999999999999999999997433 34456778889999999999999999998 34 555559
Q ss_pred EEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCcEEECCCCceEEeecccc
Q 010214 93 YVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHR--NM--VVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~--~g--IvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
+||||||.+|+|...|+. +..++|..+|+++.|++.||..||+ .. |+||||||.||+|+.+|.+||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999999974 4579999999999999999999998 44 999999999999999999999999999
Q ss_pred cccccC-CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-CC-CCCC
Q 010214 165 NIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LP-SHLS 241 (515)
Q Consensus 165 ~~~~~~-~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~-~p-~~~s 241 (515)
+.+... .+..+.+|||.||+||.+.+..| ++++||||+||++|||+.-..||.+.+...+.++|..+.++ +| .++|
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y-~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS 254 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHESGY-NFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYS 254 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhcCCC-CcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhh
Confidence 988654 45567899999999999999988 79999999999999999999999999999999999999876 77 7899
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
.++..+|..|+.+||..||+. +|++++
T Consensus 255 ~~l~~li~~ci~vd~~~RP~t-----~~~v~d 281 (375)
T KOG0591|consen 255 TDLRELINMCIAVDPEQRPDT-----VPYVQD 281 (375)
T ss_pred hHHHHHHHHHccCCcccCCCc-----chHHHH
Confidence 999999999999999999986 555544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-52 Score=426.54 Aligned_cols=255 Identities=33% Similarity=0.610 Sum_probs=241.7
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|.+.+.||+|+||.||+|+.+.|.+.||||.+.|....+ ...+.+.+|++|++.++||||+.+++.|++..++|+|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 68999999999999999999999999999999999876444 45688999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc-c
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-T 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~-~ 175 (515)
|||.| +|+.++...+.++|+.++.++.|+++||.|||+++|+|||+||.|||++.+|.+|+||||+++.+..+..+. .
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts 159 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS 159 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence 99987 999999999999999999999999999999999999999999999999999999999999999998766544 4
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~d 255 (515)
.-|||.|||||++.+..| +..+|+||+|||+|||.+|++||...++.++.+.|.......|...|.++++|++.+|.+|
T Consensus 160 ikGtPlYmAPElv~e~py-d~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kd 238 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEEQPY-DHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKD 238 (808)
T ss_pred ccCcccccCHHHHcCCCc-cchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcC
Confidence 569999999999999988 7899999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHhcCcccccc
Q 010214 256 PMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 256 P~~Rpt~~eil~hp~f~~~ 274 (515)
|.+|+|+.+++.|||.+..
T Consensus 239 P~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 239 PAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred hhhcccHHHHhcChHHhhh
Confidence 9999999999999999865
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-52 Score=398.92 Aligned_cols=256 Identities=26% Similarity=0.498 Sum_probs=224.4
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
+.|+.+..+|+|+||+|++++++.||+.||||++-.+ -.+....+-..|||++|++++|||+|.++++|.....+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 5788999999999999999999999999999998533 234455677789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccc
Q 010214 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~ 174 (515)
|||+. ++.+-+.+ ...++++.++.++.|++.|+.|||+++++||||||||||++.+|.+||||||+|+... ++....
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT 159 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT 159 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence 99987 55555554 3469999999999999999999999999999999999999999999999999999887 677777
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-------------------
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------------- 235 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~------------------- 235 (515)
..+.|.+|+|||.+.|...+++.+||||+||++.||++|.+.|.+.+..++.-.|......
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 8899999999999999666699999999999999999999999998877766555432211
Q ss_pred CC------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 236 LP------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 236 ~p------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+| +.++.-+.||++.||..||.+|+|++|++.||+|...
T Consensus 240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 22 2466778999999999999999999999999999654
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-51 Score=420.69 Aligned_cols=261 Identities=44% Similarity=0.770 Sum_probs=244.3
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCC
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPS 90 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~ 90 (515)
.+.+...|.+.+.||.|.||.||++.++.||+.+|+|++.+.........+.+.+|+.+|+++. ||||+.++++|++..
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 3556778999999999999999999999999999999999988877666789999999999999 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC----CceEEeecccccc
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK----WNVKIADFGLSNI 166 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~----~~vKL~DFGls~~ 166 (515)
.+++|||+|.||+|++.|.+. .++|..+..++.|++.|+.|||+.||+||||||||+|+... +.+|++|||++..
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999999887 59999999999999999999999999999999999999643 4799999999999
Q ss_pred cccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCCCh
Q 010214 167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSP 242 (515)
Q Consensus 167 ~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 242 (515)
...+....+.||||.|+|||++.+..| +.++||||+||++|.|++|..||.+.+....+.+|..+.+.++ +.+|.
T Consensus 189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y-~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAPEVLGGRPY-GDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred ccCCceEeeecCCccccCchhhcCCCC-CcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 988888999999999999999998887 7999999999999999999999999999999999999987665 46799
Q ss_pred hHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 243 ~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.+++||.+||..||.+|+|+.++|+|||++..
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 99999999999999999999999999999764
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=415.32 Aligned_cols=258 Identities=38% Similarity=0.698 Sum_probs=238.0
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
....++|++.+.||+|+||.||+|.++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++.+
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 34468999999999999999999999999999999999876554445567889999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 999999999999999999889999999999999999999999999999999999999999999999999999866443
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccC
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 252 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL 252 (515)
..+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+...+|..++..+++||.+||
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 250 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLL 250 (329)
T ss_pred cceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHh
Confidence 235689999999999988876 7899999999999999999999999888888899999988899999999999999999
Q ss_pred CCCCCCCCC-----HHHHhcCccccc
Q 010214 253 IVDPMKRIT-----IPEIRQHPWFQA 273 (515)
Q Consensus 253 ~~dP~~Rpt-----~~eil~hp~f~~ 273 (515)
+.||.+|++ +++++.||||+.
T Consensus 251 ~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 251 QTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred hcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 999999997 799999999975
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=388.47 Aligned_cols=267 Identities=37% Similarity=0.677 Sum_probs=251.4
Q ss_pred CCCCCCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEE
Q 010214 6 NRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV 85 (515)
Q Consensus 6 ~~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~ 85 (515)
+++...-..-+++|.+++.||+|.||.||+|+.+.++-.||+|++.++.+........++||++|-..|+||||+++|++
T Consensus 11 ~~~~~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~ 90 (281)
T KOG0580|consen 11 FGSRATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY 90 (281)
T ss_pred cccccccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh
Confidence 34444555678999999999999999999999999999999999999998888888999999999999999999999999
Q ss_pred EEcCCeEEEEEeccCCCCHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 86 IETPSDIYVVMEYVKSGELFDYIV--EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 86 ~~~~~~~~iVmEy~~gg~L~~~i~--~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
|-+...+|+++||..+|+|+..+. ...+++|..+..++.|++.|+.|||.++|+||||||+|+|++..|.+||+|||.
T Consensus 91 fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGw 170 (281)
T KOG0580|consen 91 FHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGW 170 (281)
T ss_pred eeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCc
Confidence 999999999999999999999998 567899999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChh
Q 010214 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPG 243 (515)
Q Consensus 164 s~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 243 (515)
+.... ...-.|.|||..|.+||...+..+ +..+|+|++|++.|+++.|.+||...+..+.+++|.+..+.+|+.++.+
T Consensus 171 sV~~p-~~kR~tlcgt~dyl~pEmv~~~~h-d~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~ 248 (281)
T KOG0580|consen 171 SVHAP-SNKRKTLCGTLDYLPPEMVEGRGH-DKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGG 248 (281)
T ss_pred eeecC-CCCceeeecccccCCHhhcCCCCc-cchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChh
Confidence 87765 556689999999999999999987 6899999999999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
++|||.+||.++|.+|.+..|++.|||+...
T Consensus 249 a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 249 AADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 9999999999999999999999999998753
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-52 Score=392.18 Aligned_cols=264 Identities=41% Similarity=0.694 Sum_probs=240.6
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccC-----ChHHHHHHHHHHHHHHhCC-CCCccEEEE
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-----NMEMEEKVRREIKILRLFM-HPHIIRLYE 84 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~-----~~~~~~~i~~Ei~il~~l~-hpnIv~l~~ 84 (515)
..+.+..+|.-.+.||.|..++|.++.++.||+.+|+|++....-. .....+...+|+.||+++. ||+|+++.+
T Consensus 11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 3445678899999999999999999999999999999999643221 2345677789999999886 999999999
Q ss_pred EEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccc
Q 010214 85 VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 85 ~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
+++++..+|+|+|.|+.|+|+||+.+.-.++|.+++++++|++.|++|||.++||||||||||||+|++.++||+|||++
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEecccee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCccccCCCCCCccCCCcccC-----CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC--
Q 010214 165 NIMRDGHFLKTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP-- 237 (515)
Q Consensus 165 ~~~~~~~~~~~~~gt~~Y~aPE~i~~-----~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p-- 237 (515)
+.+..|..++..||||+|.|||.+.. .+.++.++|+|++|||+|.||.|.+||......-+.+.|..|.+.+.
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 99999999999999999999999852 33347899999999999999999999998877778899999988764
Q ss_pred --CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 238 --SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 238 --~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.++|.+++|||++||++||.+|+|++|+|.||||...
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 4789999999999999999999999999999999654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=406.72 Aligned_cols=254 Identities=36% Similarity=0.697 Sum_probs=234.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.++.+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997655444455677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccC
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS 176 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~ 176 (515)
||+++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... ..+.
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~~ 158 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWTL 158 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998866442 2356
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCC
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP 256 (515)
+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+...+|..+++.+++||++||+.||
T Consensus 159 ~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp 237 (291)
T cd05612 159 CGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDR 237 (291)
T ss_pred cCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCH
Confidence 79999999999988776 78999999999999999999999999988889999999889999999999999999999999
Q ss_pred CCCCC-----HHHHhcCccccc
Q 010214 257 MKRIT-----IPEIRQHPWFQA 273 (515)
Q Consensus 257 ~~Rpt-----~~eil~hp~f~~ 273 (515)
.+|++ ++++++||||+.
T Consensus 238 ~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 238 TRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHccCCccCCHHHHhcCccccC
Confidence 99995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-50 Score=409.22 Aligned_cols=251 Identities=38% Similarity=0.625 Sum_probs=230.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG 102 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg 102 (515)
+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765544455667889999999999999999999999999999999999999
Q ss_pred CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc-ccCCccccCCCCCC
Q 010214 103 ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPN 181 (515)
Q Consensus 103 ~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~-~~~~~~~~~~gt~~ 181 (515)
+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++... ..+....+.+||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence 99999998889999999999999999999999999999999999999999999999999998753 23334456789999
Q ss_pred ccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC-
Q 010214 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI- 260 (515)
Q Consensus 182 Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp- 260 (515)
|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+......+|..+++++.+||++||..||.+||
T Consensus 161 y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 161 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred ccChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence 999999988777 789999999999999999999999988888888888888889999999999999999999999999
Q ss_pred ----CHHHHhcCcccccc
Q 010214 261 ----TIPEIRQHPWFQAH 274 (515)
Q Consensus 261 ----t~~eil~hp~f~~~ 274 (515)
++.++++||||+..
T Consensus 240 ~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 240 GGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCCCHHHHHcCCCcCCC
Confidence 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-51 Score=405.12 Aligned_cols=258 Identities=34% Similarity=0.574 Sum_probs=223.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC--eEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS--DIY 93 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~ 93 (515)
..+|..++.||+|+||.||++.+..+|...|||.+..... ...+.+.+|+.+|++++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 5779999999999999999999999999999999876521 12677899999999999999999999754444 699
Q ss_pred EEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCceEEeeccccccccc--
Q 010214 94 VVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRD-- 169 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-~~~vKL~DFGls~~~~~-- 169 (515)
+.|||++||+|.+++.+.+ +++|..++.+.+||+.||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999999877 7999999999999999999999999999999999999999 79999999999887653
Q ss_pred --CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCC-CChHHHHHHHhcC--ccCCCCCCChhH
Q 010214 170 --GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGG--IYTLPSHLSPGA 244 (515)
Q Consensus 170 --~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~-~~~~~~~~~i~~~--~~~~p~~~s~~~ 244 (515)
........|||.|||||++......++++||||+||++.||+||..||.. ....+..-.+... .+.+|..+|+++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 22344678999999999999643445699999999999999999999987 3433433334333 357889999999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
++||.+|+..||.+|||+.++|+|||.+...+
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999999999999987655
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-50 Score=406.46 Aligned_cols=261 Identities=31% Similarity=0.482 Sum_probs=230.7
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP- 89 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~- 89 (515)
++....+.|+.++.||+|.||.||+|++..||+.||+|.+..+.... .......|||.||++|+||||++|.+++.+.
T Consensus 111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l~HpNIikL~eivt~~~ 189 (560)
T KOG0600|consen 111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-GFPITAIREIKILRRLDHPNIIKLEEIVTSKL 189 (560)
T ss_pred ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-cchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence 44455678999999999999999999999999999999997765433 4456778999999999999999999998776
Q ss_pred -CeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 90 -SDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 90 -~~~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
..+|||+|||+. +|.-++... -.+++.+++.++.||++||+|||.+||+|||||.+|||||.+|.+||+|||+|+++
T Consensus 190 ~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 190 SGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred CceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 689999999976 998888763 37999999999999999999999999999999999999999999999999999987
Q ss_pred ccCC--ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc----------C
Q 010214 168 RDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY----------T 235 (515)
Q Consensus 168 ~~~~--~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~----------~ 235 (515)
.... .+...+-|.+|+|||.+.|..-++.++|+||+||||.||+.|++.|.+.+..++.++|.+... .
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 6543 466778899999999999988779999999999999999999999999999888888855321 1
Q ss_pred CC-------------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 236 LP-------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 236 ~p-------------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
+| ..+++.+.+|+..||..||.+|.|+.++|.|+||..
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 22 247888999999999999999999999999999943
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=408.35 Aligned_cols=260 Identities=33% Similarity=0.584 Sum_probs=236.9
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCC-cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTG-HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg-~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.....++|++.+.||+|+||.||+|.++.++ ..||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4445789999999999999999999977665 689999997665544455677889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999866432
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcc
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 250 (515)
..+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.....+.+..+...+|..++++++++|++
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 261 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKK 261 (340)
T ss_pred --cceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 346689999999999988766 78999999999999999999999998888888999999888999999999999999
Q ss_pred cCCCCCCCCC-----CHHHHhcCcccccc
Q 010214 251 MLIVDPMKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 251 mL~~dP~~Rp-----t~~eil~hp~f~~~ 274 (515)
||+.||.+|+ |++++++||||+..
T Consensus 262 ~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 262 LLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999995 89999999999753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-51 Score=411.05 Aligned_cols=260 Identities=34% Similarity=0.527 Sum_probs=230.5
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCC-e
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPS-D 91 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~-~ 91 (515)
.+.++|.+++.||.|+||.||+|+.+.+|..||||.+.++... .+. -.=.||++-|++++ |||||++.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 4568999999999999999999999999999999999765433 222 23358999999999 999999999998877 9
Q ss_pred EEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 92 IYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
+|+|||||+. +|.+.++.+ ..++|..++.|+.||++||+|+|.+|+.|||+||||||+..+..|||+|||+|+.....
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence 9999999965 999999865 46999999999999999999999999999999999999998889999999999999988
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-----------------
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----------------- 233 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~----------------- 233 (515)
......+.|.+|+|||++....+++..+|+|++|||++|+.+-++.|.+.+..+.+-+|..-.
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 888999999999999999888788999999999999999999999999988777777764321
Q ss_pred --cCCC-----------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 234 --YTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 234 --~~~p-----------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
+.+| +..++++.+||.+||.+||.+|||+.|+++||||+...+
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 1222 347899999999999999999999999999999986543
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-50 Score=396.25 Aligned_cols=268 Identities=32% Similarity=0.536 Sum_probs=241.1
Q ss_pred CCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010214 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (515)
Q Consensus 10 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 89 (515)
.+...-.++|++++.||.|.-|+||+|+.+.++..+|+|++++..+.......+++.|-+||+.++||+++.||..|+++
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 44445568899999999999999999999999999999999999888878889999999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
+..|+|||||+||+|....+++ +.+++..++.++.+++.||+|||-.|||+||||||||||.++|+|.|+||.++...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999999988764 46999999999999999999999999999999999999999999999999986432
Q ss_pred c----------------------------------c-C----------------------CccccCCCCCCccCCCcccC
Q 010214 168 R----------------------------------D-G----------------------HFLKTSCGSPNYAAPEVISG 190 (515)
Q Consensus 168 ~----------------------------------~-~----------------------~~~~~~~gt~~Y~aPE~i~~ 190 (515)
. . . ......+||-.|.|||++.|
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 0 0 0 01123468999999999999
Q ss_pred CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCC--CCChhHHHHhcccCCCCCCCCCC----HHH
Q 010214 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRMLIVDPMKRIT----IPE 264 (515)
Q Consensus 191 ~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~mL~~dP~~Rpt----~~e 264 (515)
... +.++|+|+|||.+|||+.|..||.+.+..+.+.+|......+|. .++..++|||+++|.+||.+|.. +.|
T Consensus 310 ~GH-gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e 388 (459)
T KOG0610|consen 310 EGH-GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE 388 (459)
T ss_pred CCC-CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence 876 88999999999999999999999999999999999999888875 57899999999999999999998 999
Q ss_pred HhcCcccccccCcc
Q 010214 265 IRQHPWFQAHLPRY 278 (515)
Q Consensus 265 il~hp~f~~~~~~~ 278 (515)
|.+||||+......
T Consensus 389 IK~HpFF~gVnWaL 402 (459)
T KOG0610|consen 389 IKRHPFFEGVNWAL 402 (459)
T ss_pred hhcCccccCCChhh
Confidence 99999998754433
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-49 Score=400.62 Aligned_cols=249 Identities=33% Similarity=0.604 Sum_probs=228.5
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCH
Q 010214 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (515)
Q Consensus 25 LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L 104 (515)
||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999766554555567788999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCccccCCCCCCcc
Q 010214 105 FDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYA 183 (515)
Q Consensus 105 ~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~~Y~ 183 (515)
.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....+.+||+.|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~ 160 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence 99999888999999999999999999999999999999999999999999999999999875432 23345668999999
Q ss_pred CCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC---
Q 010214 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI--- 260 (515)
Q Consensus 184 aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp--- 260 (515)
|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+......+|..+++++++||.+||..||.+||
T Consensus 161 aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~ 239 (312)
T cd05585 161 APELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYN 239 (312)
T ss_pred CHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 9999998776 789999999999999999999999999999999999988899999999999999999999999997
Q ss_pred CHHHHhcCcccccc
Q 010214 261 TIPEIRQHPWFQAH 274 (515)
Q Consensus 261 t~~eil~hp~f~~~ 274 (515)
++.|++.||||...
T Consensus 240 ~~~e~l~hp~~~~~ 253 (312)
T cd05585 240 GAQEIKNHPFFSQL 253 (312)
T ss_pred CHHHHHcCCCcCCC
Confidence 57999999999753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=374.99 Aligned_cols=256 Identities=34% Similarity=0.557 Sum_probs=226.4
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
.+|...+.||+|.||.||+|++..||+.||||.+......+ .......|||+.|+.++||||+.++++|...+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 57889999999999999999999999999999998765543 33456789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
||++. +|...|+.+ ..++..+++.++.+++.||+|||++.|+||||||+|+|++++|.+||+|||+++.+.......+
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 99976 999999754 4699999999999999999999999999999999999999999999999999999876554443
Q ss_pred -CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-----------CC------
Q 010214 176 -SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-----------LP------ 237 (515)
Q Consensus 176 -~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~-----------~p------ 237 (515)
.+-|.+|+|||.+.|...++..+|+||.|||+.||+-|.+-|.++++-++...|.....+ +|
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~ 239 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ 239 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence 488999999999988776799999999999999999999999999888877777542211 11
Q ss_pred -----------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 238 -----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 238 -----------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+..+.++.||+.+||..||.+|+|+.|+++|+||++.
T Consensus 240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 2457889999999999999999999999999999863
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=389.47 Aligned_cols=258 Identities=34% Similarity=0.562 Sum_probs=225.1
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc-----C
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-----P 89 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-----~ 89 (515)
+...|...+.||+|+||.|+.|.++.||+.||||.+... +...-..++..||+++|+.++|+||+.+++++.. -
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 446677789999999999999999999999999998642 4455667899999999999999999999999855 4
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
+++|+|+|+|+ -+|...|+.+..++++.+..++.||+.||+|+|+.+|+||||||+|+|++.++.+||+|||+|+....
T Consensus 99 ~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred ceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 57999999994 59999998888899999999999999999999999999999999999999999999999999998863
Q ss_pred ---CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-----------
Q 010214 170 ---GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT----------- 235 (515)
Q Consensus 170 ---~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~----------- 235 (515)
...++..+.|.+|.|||++.....++.++||||+|||+.||++|++.|.+.+...+++.|..-..+
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 556677889999999999876555589999999999999999999999988765555554332111
Q ss_pred ------------CC--------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 236 ------------LP--------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 236 ------------~p--------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.| ++.++.+.+|+++||..||.+|+|++|+|.||||...
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 11 4688999999999999999999999999999999864
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-49 Score=392.69 Aligned_cols=256 Identities=27% Similarity=0.467 Sum_probs=226.9
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
.|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48899999999999999999999999999999987665544455677899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 98 y~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
|+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....+.....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 99999999888653 3689999999999999999999999999999999999999999999999999987655555566
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH----HHHHHHhcCccCCCCCCChhHHHHhccc
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP----NLFKKIKGGIYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~----~~~~~i~~~~~~~p~~~s~~~~~li~~m 251 (515)
..||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...... .....+......++..+++++.+|+++|
T Consensus 161 ~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 239 (285)
T cd05631 161 RVGTVGYMAPEVINNEKY-TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRML 239 (285)
T ss_pred CCCCCCccCHhhhcCCCC-CcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHH
Confidence 789999999999998877 78999999999999999999999875432 3344455555667788999999999999
Q ss_pred CCCCCCCCCC-----HHHHhcCcccccc
Q 010214 252 LIVDPMKRIT-----IPEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rpt-----~~eil~hp~f~~~ 274 (515)
|+.||.+||| ++++++||||+..
T Consensus 240 l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 240 LTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred hhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 9999999997 8999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-49 Score=401.28 Aligned_cols=250 Identities=38% Similarity=0.633 Sum_probs=228.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG 102 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg 102 (515)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765544455678889999999999999999999999999999999999999
Q ss_pred CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCCC
Q 010214 103 ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPN 181 (515)
Q Consensus 103 ~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~ 181 (515)
+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... ........+||+.
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 160 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence 999999888899999999999999999999999999999999999999999999999999987532 2233455689999
Q ss_pred ccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC-
Q 010214 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI- 260 (515)
Q Consensus 182 Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp- 260 (515)
|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||++||..||.+|+
T Consensus 161 y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (328)
T cd05593 161 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLG 239 (328)
T ss_pred ccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence 999999988776 789999999999999999999999888888888888888889999999999999999999999997
Q ss_pred ----CHHHHhcCccccc
Q 010214 261 ----TIPEIRQHPWFQA 273 (515)
Q Consensus 261 ----t~~eil~hp~f~~ 273 (515)
++.++++||||..
T Consensus 240 ~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 240 GGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCHHHHhcCCCcCC
Confidence 8999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-49 Score=406.03 Aligned_cols=256 Identities=31% Similarity=0.568 Sum_probs=225.5
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544555678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-----
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----- 171 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~----- 171 (515)
||++||+|.+++.+++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 999999999999988999999999999999999999999999999999999999999999999999987543211
Q ss_pred -------------------------------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC
Q 010214 172 -------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE 220 (515)
Q Consensus 172 -------------------------------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~ 220 (515)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCC-CCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 1124589999999999988876 68999999999999999999999998
Q ss_pred ChHHHHHHHhcC--ccCCCC--CCChhHHHHhcccCCCCCC---CCCCHHHHhcCcccccc
Q 010214 221 NIPNLFKKIKGG--IYTLPS--HLSPGARDLIPRMLIVDPM---KRITIPEIRQHPWFQAH 274 (515)
Q Consensus 221 ~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~mL~~dP~---~Rpt~~eil~hp~f~~~ 274 (515)
+......++... ...+|. .+++++++||.+|+. +|. .||+++|+++||||+..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 888888888763 234443 478999999999775 444 46899999999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-49 Score=399.75 Aligned_cols=251 Identities=37% Similarity=0.623 Sum_probs=229.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG 102 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg 102 (515)
+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+++++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444455667789999999999999999999999999999999999999
Q ss_pred CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCCC
Q 010214 103 ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPN 181 (515)
Q Consensus 103 ~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~ 181 (515)
+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........+||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence 999999888899999999999999999999999999999999999999999999999999987532 2333455689999
Q ss_pred ccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC-
Q 010214 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI- 260 (515)
Q Consensus 182 Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp- 260 (515)
|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||..||.+|+
T Consensus 161 y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05595 161 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred cCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCC
Confidence 999999988776 789999999999999999999999988888888888888889999999999999999999999998
Q ss_pred ----CHHHHhcCcccccc
Q 010214 261 ----TIPEIRQHPWFQAH 274 (515)
Q Consensus 261 ----t~~eil~hp~f~~~ 274 (515)
++.++++||||...
T Consensus 240 ~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 240 GGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CCCCCHHHHHcCCCcCCC
Confidence 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=397.77 Aligned_cols=255 Identities=31% Similarity=0.552 Sum_probs=228.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765544455677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccC
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS 176 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~ 176 (515)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...+.
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~ 158 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSV 158 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999976543 34567
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCCC------CCChhHHHHh
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPS------HLSPGARDLI 248 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~------~~s~~~~~li 248 (515)
+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+.... ...|. .+++++.+||
T Consensus 159 ~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li 237 (333)
T cd05600 159 VGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI 237 (333)
T ss_pred ccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHH
Confidence 89999999999998866 789999999999999999999999988877777665432 12222 4589999999
Q ss_pred cccCCCCCCCCCCHHHHhcCcccccc
Q 010214 249 PRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.+||..+|.+|||+.++++||||+..
T Consensus 238 ~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 238 TKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=396.41 Aligned_cols=255 Identities=36% Similarity=0.591 Sum_probs=231.9
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCC-CccEEEEEEEcCCeEEEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP-HIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~iVm 96 (515)
+|++.+.||+|+||.||+|.++.+++.||+|++.+.........+.+..|+++++.+.|+ +|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876544445567788899999999865 5888999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCcccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~ 175 (515)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence 999999999999988899999999999999999999999999999999999999999999999999986432 2333456
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~d 255 (515)
.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+..+....+......+|..+++++.+++.+||..|
T Consensus 161 ~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (324)
T cd05587 161 FCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKH 239 (324)
T ss_pred ecCCccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 689999999999998877 7899999999999999999999999998889999998888899999999999999999999
Q ss_pred CCCCCCH-----HHHhcCccccc
Q 010214 256 PMKRITI-----PEIRQHPWFQA 273 (515)
Q Consensus 256 P~~Rpt~-----~eil~hp~f~~ 273 (515)
|.+|++. +++++||||+.
T Consensus 240 P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 240 PAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred HHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999987 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=403.29 Aligned_cols=256 Identities=34% Similarity=0.645 Sum_probs=226.4
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||+||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998665444455677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-----
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----- 171 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~----- 171 (515)
||++||+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999986543211
Q ss_pred ----------------------------------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCC
Q 010214 172 ----------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF 217 (515)
Q Consensus 172 ----------------------------------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf 217 (515)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC-CCeeeeecchhHHHHhhcCCCCC
Confidence 1123579999999999988776 78999999999999999999999
Q ss_pred CCCChHHHHHHHhcCc--cCCCC--CCChhHHHHhcccCCCCCCCCCC---HHHHhcCcccccc
Q 010214 218 DDENIPNLFKKIKGGI--YTLPS--HLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAH 274 (515)
Q Consensus 218 ~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~li~~mL~~dP~~Rpt---~~eil~hp~f~~~ 274 (515)
.+.+.......+.... ..+|. .+++++++||.+||. +|.+|++ +.|++.||||+..
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9988877777776543 23333 578999999999996 9999998 9999999999753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-50 Score=385.35 Aligned_cols=260 Identities=37% Similarity=0.621 Sum_probs=247.7
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
+..++|.++++||+|.||+|-+++.+.||+.||||++.++.+...+....-..|-++|+..+||++..+-..|++.+.+|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 35689999999999999999999999999999999999998888888888889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc-cccCCc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~-~~~~~~ 172 (515)
+||||+.||+|+-++.+...++|+.++.+-.+|++||.|||+++||+||||.+|+|+|.+|++||+|||+++. +..+..
T Consensus 245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t 324 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDT 324 (516)
T ss_pred EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccce
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999974 567788
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccC
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 252 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL 252 (515)
.+|.||||.|.|||++....| +.++|.|.+||++|||+||++||...+...++.-|......+|..+|++++.|+..+|
T Consensus 325 ~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL 403 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLL 403 (516)
T ss_pred eccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHh
Confidence 899999999999999998887 8999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCC-----HHHHhcCcccccc
Q 010214 253 IVDPMKRIT-----IPEIRQHPWFQAH 274 (515)
Q Consensus 253 ~~dP~~Rpt-----~~eil~hp~f~~~ 274 (515)
.+||.+|.. +.||..|+||...
T Consensus 404 ~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 404 KKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred hcChHhhcCCCchhHHHHHhhhhhccC
Confidence 999999984 7899999999764
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=397.00 Aligned_cols=251 Identities=37% Similarity=0.654 Sum_probs=227.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999765544444556777888888876 699999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~ 180 (515)
|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .+....+.+||+
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP 160 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence 9999999988899999999999999999999999999999999999999999999999999987542 333445668999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+...+...+..+...+|..+++++.+||++||+.||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 239 (320)
T cd05590 161 DYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRL 239 (320)
T ss_pred cccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence 9999999988776 789999999999999999999999999999999999988889999999999999999999999999
Q ss_pred CH------HHHhcCcccccc
Q 010214 261 TI------PEIRQHPWFQAH 274 (515)
Q Consensus 261 t~------~eil~hp~f~~~ 274 (515)
++ ++++.||||+..
T Consensus 240 ~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 240 GSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 98 999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=398.49 Aligned_cols=251 Identities=39% Similarity=0.632 Sum_probs=229.2
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG 102 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg 102 (515)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+++++.++||||+++++++.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765544455677789999999999999999999999999999999999999
Q ss_pred CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCC
Q 010214 103 ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (515)
Q Consensus 103 ~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~ 180 (515)
+|..++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.... ......+.+||+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 160 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence 999999888899999999999999999999997 799999999999999999999999999987532 333445678999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||.+||+.||.+|+
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~ 239 (325)
T cd05594 161 EYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239 (325)
T ss_pred ccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhC
Confidence 9999999988776 789999999999999999999999988888888888888889999999999999999999999997
Q ss_pred -----CHHHHhcCcccccc
Q 010214 261 -----TIPEIRQHPWFQAH 274 (515)
Q Consensus 261 -----t~~eil~hp~f~~~ 274 (515)
++.++++||||...
T Consensus 240 ~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 240 GGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred CCCCCCHHHHhcCCCcCCC
Confidence 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=403.74 Aligned_cols=255 Identities=31% Similarity=0.581 Sum_probs=223.6
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||+||+|.++.+|+.||||++.+...........+.+|+++++.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997655444455678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-----
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----- 171 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~----- 171 (515)
||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999986321100
Q ss_pred -------------------------------------------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHH
Q 010214 172 -------------------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY 208 (515)
Q Consensus 172 -------------------------------------------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily 208 (515)
...+.+||+.|+|||++.+..+ +.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchhhh
Confidence 0013579999999999988777 78999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcC--ccCCCC--CCChhHHHHhcccCCCCCCCC---CCHHHHhcCccccc
Q 010214 209 ALLCGTLPFDDENIPNLFKKIKGG--IYTLPS--HLSPGARDLIPRMLIVDPMKR---ITIPEIRQHPWFQA 273 (515)
Q Consensus 209 ~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~mL~~dP~~R---pt~~eil~hp~f~~ 273 (515)
+|++|..||.+.+....+..+... ...+|. .++.++++||.+||. +|.+| +|+.|++.||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999988877777777653 234444 579999999999997 67665 59999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=400.22 Aligned_cols=256 Identities=35% Similarity=0.660 Sum_probs=230.3
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|.+.+.||+|+||+||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765544455678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-----
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----- 171 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~----- 171 (515)
||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999987664433
Q ss_pred -------------------------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHH
Q 010214 172 -------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF 226 (515)
Q Consensus 172 -------------------------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~ 226 (515)
......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 2345679999999999998876 78999999999999999999999998877777
Q ss_pred HHHhc--CccCCCCC--CChhHHHHhcccCCCCCCCCCC-HHHHhcCcccccc
Q 010214 227 KKIKG--GIYTLPSH--LSPGARDLIPRMLIVDPMKRIT-IPEIRQHPWFQAH 274 (515)
Q Consensus 227 ~~i~~--~~~~~p~~--~s~~~~~li~~mL~~dP~~Rpt-~~eil~hp~f~~~ 274 (515)
.++.. ....+|.. +++++.+||.+||. ||.+|++ +.++++||||+..
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 77776 44445543 59999999999997 9999999 9999999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-49 Score=405.01 Aligned_cols=256 Identities=32% Similarity=0.572 Sum_probs=229.0
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
..-...|...+.||+|+.|.||.|....+++.||||.++...... .+.+.+|+.+|+..+|+|||++++.|-..+.+
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence 344567889999999999999999999999999999998766544 56789999999999999999999999888999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~- 171 (515)
|+||||++||+|.|.+. ...++|.++..++.+++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+....
T Consensus 346 WVVMEym~ggsLTDvVt-~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVT-KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred EEEEeecCCCchhhhhh-cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999999999999875 4569999999999999999999999999999999999999999999999999998876654
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHH-hcCc--cCCCCCCChhHHHHh
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-KGGI--YTLPSHLSPGARDLI 248 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i-~~~~--~~~p~~~s~~~~~li 248 (515)
.-.+.+|||+|||||++..+.| ++++||||||+++.||+-|.+||-.++.-.....| .++. ...|..+|+.+++||
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL 503 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFL 503 (550)
T ss_pred ccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHH
Confidence 4568899999999999999988 89999999999999999999999866554433333 4444 456789999999999
Q ss_pred cccCCCCCCCCCCHHHHhcCccccc
Q 010214 249 PRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
.+||++|+.+|+|+.|+|+||||+.
T Consensus 504 ~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 504 DRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHHhhcchhcCCCHHHHhcChhhhh
Confidence 9999999999999999999999953
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=395.76 Aligned_cols=250 Identities=31% Similarity=0.574 Sum_probs=223.6
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876655555567788999999988 699999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc-ccCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~-~~~~~~~~~~gt~ 180 (515)
|+|.+++.+.+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++... ..+....+.+||+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence 999999988889999999999999999999999999999999999999999999999999998753 3344455678999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC---------ChHHHHHHHhcCccCCCCCCChhHHHHhccc
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---------NIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~s~~~~~li~~m 251 (515)
.|+|||++.+..+ +.++|+||+||++|+|++|..||+.. ......+.+......+|..++.++.++|.+|
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 239 (329)
T cd05588 161 NYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGF 239 (329)
T ss_pred cccCHHHHcCCCC-CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 9999999998776 78999999999999999999999632 1233566677778888999999999999999
Q ss_pred CCCCCCCCCC------HHHHhcCccccc
Q 010214 252 LIVDPMKRIT------IPEIRQHPWFQA 273 (515)
Q Consensus 252 L~~dP~~Rpt------~~eil~hp~f~~ 273 (515)
|+.||.+|+| ++++++||||..
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 240 LNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred hccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999997 789999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=394.70 Aligned_cols=250 Identities=35% Similarity=0.592 Sum_probs=227.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||.||+|+++.+++.||+|++.+...........+..|+++++.+ +||||+++++++.+++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876544445566778899998866 799999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~ 180 (515)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ......+.+||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence 9999999988899999999999999999999999999999999999999999999999999987543 233345668999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+..+...+|..+++++.++|.+||+.||.+|+
T Consensus 161 ~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~ 239 (321)
T cd05591 161 DYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRL 239 (321)
T ss_pred cccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcC
Confidence 9999999988776 789999999999999999999999999999999999988888999999999999999999999999
Q ss_pred -------CHHHHhcCccccc
Q 010214 261 -------TIPEIRQHPWFQA 273 (515)
Q Consensus 261 -------t~~eil~hp~f~~ 273 (515)
++.++++||||..
T Consensus 240 ~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 240 GCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred CCCCCCCCHHHHhcCCccCC
Confidence 8999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-48 Score=401.89 Aligned_cols=257 Identities=31% Similarity=0.519 Sum_probs=223.3
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
..|++++.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999998766555566778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC------
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG------ 170 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~------ 170 (515)
||++||+|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999987532100
Q ss_pred ------------------------------------------CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHH
Q 010214 171 ------------------------------------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY 208 (515)
Q Consensus 171 ------------------------------------------~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily 208 (515)
....+.+||+.|+|||++.+..+ +.++||||+||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC-CCccceeehhhHHH
Confidence 01124579999999999988776 68999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcC--ccCCCC--CCChhHHHHhcccCC--CCCCCCCCHHHHhcCcccccc
Q 010214 209 ALLCGTLPFDDENIPNLFKKIKGG--IYTLPS--HLSPGARDLIPRMLI--VDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 209 ~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~mL~--~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+|++|..||...+......++... ....|. .+++++++||.+|+. .+|..|+|+.+++.||||+..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 999999999987776666666532 233443 589999999999654 455569999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-48 Score=393.11 Aligned_cols=255 Identities=36% Similarity=0.582 Sum_probs=231.6
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iVm 96 (515)
+|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+. ||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5899999999999999999999999999999998765444445566778888888775 899999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCcccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~ 175 (515)
||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... .+.....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~ 160 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT 160 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999987543 2334456
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~d 255 (515)
.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+...+...+......+|..++.++.+++.+||+.|
T Consensus 161 ~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~ 239 (323)
T cd05616 161 FCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH 239 (323)
T ss_pred CCCChhhcCHHHhcCCCC-CCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccC
Confidence 789999999999998877 7899999999999999999999999998899999999888899999999999999999999
Q ss_pred CCCCCCH-----HHHhcCccccc
Q 010214 256 PMKRITI-----PEIRQHPWFQA 273 (515)
Q Consensus 256 P~~Rpt~-----~eil~hp~f~~ 273 (515)
|.+|+++ .++++||||+.
T Consensus 240 p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 240 PGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred HHhcCCCCCCCHHHHhcCCCcCC
Confidence 9999984 89999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=393.50 Aligned_cols=254 Identities=34% Similarity=0.563 Sum_probs=227.9
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHH---HhCCCCCccEEEEEEEcCCeEEEE
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL---RLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il---~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
|++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|++++ +.++||||+++++++.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999866544444556777777765 466799999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~ 174 (515)
|||++||+|..++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ......
T Consensus 81 ~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05589 81 MEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159 (324)
T ss_pred EcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence 99999999998885 4579999999999999999999999999999999999999999999999999986532 233345
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCC
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~ 254 (515)
+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+..+....|..+++++.++|.+||+.
T Consensus 160 ~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~ 238 (324)
T cd05589 160 TFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRR 238 (324)
T ss_pred ccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhc
Confidence 6789999999999988776 789999999999999999999999998888889998888889999999999999999999
Q ss_pred CCCCCC-----CHHHHhcCcccccc
Q 010214 255 DPMKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 255 dP~~Rp-----t~~eil~hp~f~~~ 274 (515)
||.+|| ++.++++||||+..
T Consensus 239 dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 239 NPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred CHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 999999 79999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=400.98 Aligned_cols=255 Identities=33% Similarity=0.560 Sum_probs=223.3
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 69999999999999999999999999999999987655444566788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc--------
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-------- 169 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-------- 169 (515)
||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 999999999998888899999999999999999999999999999999999999999999999999753210
Q ss_pred ----------------------------------------CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHH
Q 010214 170 ----------------------------------------GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYA 209 (515)
Q Consensus 170 ----------------------------------------~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~ 209 (515)
.....+.+||+.|+|||++.+..+ +.++||||+||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvil~e 240 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYE 240 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC-CCeeeEEechHHHHH
Confidence 001124579999999999988877 689999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcCc--cCCC--CCCChhHHHHhcccCCCCCCCCCC---HHHHhcCcccccc
Q 010214 210 LLCGTLPFDDENIPNLFKKIKGGI--YTLP--SHLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAH 274 (515)
Q Consensus 210 lltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~li~~mL~~dP~~Rpt---~~eil~hp~f~~~ 274 (515)
|++|..||.+.+..+...++.... ...| ..+++++.++|.+|+ .+|.+|++ ++++++||||+..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 999999999887766666665432 2333 468999999999986 59999997 9999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-48 Score=391.65 Aligned_cols=251 Identities=33% Similarity=0.604 Sum_probs=224.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHh-CCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||.||+|.++.+|+.||+|++.+...........+..|..++.. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999999999999999976543323345566778888875 4899999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~ 180 (515)
|+|.+++..++.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....+.+||+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence 99999999888999999999999999999999999999999999999999999999999999875322 23345678999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+...+.+.+......+|..++.++++||.+||..||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 239 (316)
T cd05620 161 DYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRL 239 (316)
T ss_pred CccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 9999999998877 789999999999999999999999998888889888888888889999999999999999999999
Q ss_pred CH-HHHhcCcccccc
Q 010214 261 TI-PEIRQHPWFQAH 274 (515)
Q Consensus 261 t~-~eil~hp~f~~~ 274 (515)
|+ +++++||||+..
T Consensus 240 ~~~~~~~~h~~f~~~ 254 (316)
T cd05620 240 GVVGNIRGHPFFKTI 254 (316)
T ss_pred CChHHHHcCCCcCCC
Confidence 98 589999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=383.29 Aligned_cols=265 Identities=30% Similarity=0.494 Sum_probs=230.1
Q ss_pred CCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010214 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (515)
Q Consensus 10 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 89 (515)
.....-.+.|++...||.|..++||+|++..+++.||||+++.++..+. .+.+++|+..|+.++||||++++..|..+
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 3455567899999999999999999999999999999999998887653 78999999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
..+|+||.||.+|++.+.++.. ..++|..+..++++++.||.|||++|.+|||||+.||||+.+|.|||+|||.+..+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999999999999864 45999999999999999999999999999999999999999999999999987765
Q ss_pred cc-CCc----cccCCCCCCccCCCcc-cCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHH-HHHHHhcCccC-----
Q 010214 168 RD-GHF----LKTSCGSPNYAAPEVI-SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN-LFKKIKGGIYT----- 235 (515)
Q Consensus 168 ~~-~~~----~~~~~gt~~Y~aPE~i-~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~-~~~~i~~~~~~----- 235 (515)
.+ |.. .++.+|||+|||||++ ..-..++.|+||||+|++..||.+|..||....... +..++.+..+.
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~ 256 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG 256 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence 43 221 2677999999999994 333334799999999999999999999998876544 45555554431
Q ss_pred CC----CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 236 LP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 236 ~p----~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
++ ..++..++.+|..||+.||.+|||++++++|+||+....
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 12 246778999999999999999999999999999987543
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=391.97 Aligned_cols=250 Identities=34% Similarity=0.594 Sum_probs=223.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHH-HHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIK-ILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||+||+|.++.+|+.||+|++.+...........+.+|.. +++.++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999997665443334455555555 56889999999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~ 180 (515)
|+|..++.+++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence 9999999988899999999999999999999999999999999999999999999999999987542 223344568999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++|||||||++|+|++|..||...+..++...+......++..+++++.++|.+||+.||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (323)
T cd05575 161 EYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRL 239 (323)
T ss_pred hhcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCC
Confidence 9999999988776 789999999999999999999999998888899998888888888999999999999999999999
Q ss_pred CH----HHHhcCccccc
Q 010214 261 TI----PEIRQHPWFQA 273 (515)
Q Consensus 261 t~----~eil~hp~f~~ 273 (515)
++ .++++||||..
T Consensus 240 ~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 240 GAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCHHHHHcCCCcCC
Confidence 97 69999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=389.86 Aligned_cols=251 Identities=36% Similarity=0.623 Sum_probs=225.8
Q ss_pred eeeecccCceEEEEEEEc---CCCcEEEEEEecccccC-ChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 22 GKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~---~tg~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
++.||+|+||.||+|.+. .+++.||+|++.+.... .......+.+|+.+|+.++||||+++++++.+++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 57899999999765432 22334567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccC
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTS 176 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~ 176 (515)
|++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 99999999999988899999999999999999999999999999999999999999999999999987543 23334456
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCC
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP 256 (515)
+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..+...+|..+++++.+||.+||+.||
T Consensus 161 ~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 239 (323)
T cd05584 161 CGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNP 239 (323)
T ss_pred CCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCH
Confidence 89999999999988766 78999999999999999999999999888888899888889999999999999999999999
Q ss_pred CCCC-----CHHHHhcCccccc
Q 010214 257 MKRI-----TIPEIRQHPWFQA 273 (515)
Q Consensus 257 ~~Rp-----t~~eil~hp~f~~ 273 (515)
.+|| +++++++||||+.
T Consensus 240 ~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 240 SSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred hHcCCCCCCCHHHHhcCCCcCC
Confidence 9999 8999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=391.35 Aligned_cols=251 Identities=31% Similarity=0.566 Sum_probs=222.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.++.++ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876555555667788999998776 799999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~ 180 (515)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .+....+.+||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence 9999999888899999999999999999999999999999999999999999999999999987532 333445678999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCC---------CChHHHHHHHhcCccCCCCCCChhHHHHhccc
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD---------ENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~m 251 (515)
.|+|||++.+..+ +.++|||||||++|+|++|..||.. .......+.+......+|..++.++.+||++|
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~ 239 (329)
T cd05618 161 NYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 239 (329)
T ss_pred cccCHHHHcCCCC-CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence 9999999998876 7899999999999999999999952 12233556677777889999999999999999
Q ss_pred CCCCCCCCCC------HHHHhcCcccccc
Q 010214 252 LIVDPMKRIT------IPEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rpt------~~eil~hp~f~~~ 274 (515)
|+.||.+||| +.++++||||+..
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 240 LNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred hcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 9999999998 5799999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=391.17 Aligned_cols=251 Identities=37% Similarity=0.638 Sum_probs=228.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.+++.+ +||||+++++++++.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876554445567778899999888 699999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~ 180 (515)
|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ......+.+||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~ 160 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence 9999999988899999999999999999999999999999999999999999999999999986532 233344568999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+......+|..++.++.+||++||..||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 239 (318)
T cd05570 161 DYIAPEILSYQPY-GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRL 239 (318)
T ss_pred cccCHHHhcCCCC-CcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcC
Confidence 9999999998877 689999999999999999999999988888888898888888999999999999999999999999
Q ss_pred CH-----HHHhcCcccccc
Q 010214 261 TI-----PEIRQHPWFQAH 274 (515)
Q Consensus 261 t~-----~eil~hp~f~~~ 274 (515)
|+ .++++||||+..
T Consensus 240 s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 240 GCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CCCCCCHHHHhcCCCcCCC
Confidence 99 999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=383.00 Aligned_cols=253 Identities=30% Similarity=0.480 Sum_probs=215.6
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.++.+++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 4799999999999999999999999999999999765332 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--ccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~--~~~ 174 (515)
||++++.+..+....+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 999987776665556679999999999999999999999999999999999999999999999999998764332 223
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-------------------
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------------- 235 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~------------------- 235 (515)
...||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+.......+......
T Consensus 160 ~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 160 EYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred ccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 4579999999999988776 78999999999999999999999876654433332221100
Q ss_pred C-------------CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 236 L-------------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 236 ~-------------p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
. ...+|.++.+||++||++||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 1 12368889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=397.07 Aligned_cols=260 Identities=30% Similarity=0.527 Sum_probs=228.8
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34678999999999999999999999999999999997655444445566789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-- 171 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-- 171 (515)
+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 99999999999998864 468999999999999999999999999999999999999999999999999997764332
Q ss_pred ccccCCCCCCccCCCcccCCc---cCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCCC--CCChhH
Q 010214 172 FLKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPS--HLSPGA 244 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~---~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~ 244 (515)
...+.+||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.+.+....+.++.... ..+|. .+|.++
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence 224568999999999987542 34789999999999999999999999998888888887643 34454 579999
Q ss_pred HHHhcccCCCCCCC--CCCHHHHhcCcccccc
Q 010214 245 RDLIPRMLIVDPMK--RITIPEIRQHPWFQAH 274 (515)
Q Consensus 245 ~~li~~mL~~dP~~--Rpt~~eil~hp~f~~~ 274 (515)
++||.+||+.+|.+ |+|++|+++||||+..
T Consensus 279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 99999999999988 9999999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=399.82 Aligned_cols=256 Identities=31% Similarity=0.541 Sum_probs=222.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
.+|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+|+.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997654444345577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC------
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG------ 170 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~------ 170 (515)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999997432100
Q ss_pred --------------------------------------CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh
Q 010214 171 --------------------------------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC 212 (515)
Q Consensus 171 --------------------------------------~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt 212 (515)
....+.+||+.|+|||++.+..+ +.++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC-Ccceeeeeccceeeehhh
Confidence 00123579999999999988776 789999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcCc--cCCC--CCCChhHHHHhcccCCCCCCCCC---CHHHHhcCcccccc
Q 010214 213 GTLPFDDENIPNLFKKIKGGI--YTLP--SHLSPGARDLIPRMLIVDPMKRI---TIPEIRQHPWFQAH 274 (515)
Q Consensus 213 G~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~li~~mL~~dP~~Rp---t~~eil~hp~f~~~ 274 (515)
|..||.+.+.......+.... ..+| ..+++++.++|.+|+ .+|.+|+ |+.++++||||+..
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 999999888776666665432 2233 368999999999976 5999999 99999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=389.59 Aligned_cols=250 Identities=38% Similarity=0.656 Sum_probs=223.6
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHh-CCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||+||+|.+..+++.||+|++.+.........+.+..|..++.. .+||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999986544333445556667777764 4799999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~ 180 (515)
|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+||+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~ 160 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence 99999999888999999999999999999999999999999999999999999999999999976433 23345668999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+......+|..++.++.+||.+||..||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~ 239 (316)
T cd05592 161 DYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRL 239 (316)
T ss_pred cccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 9999999988776 789999999999999999999999998888888888888888999999999999999999999999
Q ss_pred CHH-HHhcCccccc
Q 010214 261 TIP-EIRQHPWFQA 273 (515)
Q Consensus 261 t~~-eil~hp~f~~ 273 (515)
++. ++++||||+.
T Consensus 240 ~~~~~l~~h~~~~~ 253 (316)
T cd05592 240 GVDGDIRQHPFFRG 253 (316)
T ss_pred CChHHHHcCcccCC
Confidence 874 8999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=397.51 Aligned_cols=256 Identities=31% Similarity=0.603 Sum_probs=225.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997655444456678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-----
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----- 171 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~----- 171 (515)
||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999986542210
Q ss_pred -------------------------------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC
Q 010214 172 -------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE 220 (515)
Q Consensus 172 -------------------------------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~ 220 (515)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC-CCcceeccccceeeecccCCCCCCCC
Confidence 0124579999999999988877 68999999999999999999999998
Q ss_pred ChHHHHHHHhcC--ccCCCC--CCChhHHHHhcccCCCCCCCCC---CHHHHhcCcccccc
Q 010214 221 NIPNLFKKIKGG--IYTLPS--HLSPGARDLIPRMLIVDPMKRI---TIPEIRQHPWFQAH 274 (515)
Q Consensus 221 ~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~mL~~dP~~Rp---t~~eil~hp~f~~~ 274 (515)
+......++... ...+|. .+++++++||.+|+ .||.+|+ ++.|+++||||+..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence 888877777653 233443 47899999999987 4999998 48999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=382.74 Aligned_cols=253 Identities=28% Similarity=0.494 Sum_probs=215.5
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||.|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 57899999999999999999999999999999998654322 2235677999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccc
Q 010214 96 MEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~ 173 (515)
|||+++ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 999975 9999987654 5799999999999999999999999999999999999999999999999998765322 233
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-------------------c
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------------Y 234 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~ 234 (515)
....|++.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+.... .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 456789999999998765444789999999999999999999998877665544432211 0
Q ss_pred CC-----------CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 235 TL-----------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 235 ~~-----------p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.+ ...+++++++||++||+.||.+|||++|+++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 01 13468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=396.15 Aligned_cols=261 Identities=29% Similarity=0.554 Sum_probs=227.4
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
....++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 34468899999999999999999999999999999999765544444556788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 999999999999999864 4689999999999999999999999999999999999999999999999999987643322
Q ss_pred --cccCCCCCCccCCCcccCCc---cCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCCC--CCChh
Q 010214 173 --LKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPS--HLSPG 243 (515)
Q Consensus 173 --~~~~~gt~~Y~aPE~i~~~~---~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~ 243 (515)
..+.+||+.|+|||++.+.. +.+.++||||+||++|+|++|..||.+.+....+.++.... ..+|. .++..
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 277 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH 277 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence 24678999999999997543 24789999999999999999999999988888888877643 44454 56999
Q ss_pred HHHHhcccCCCCCCC--CCCHHHHhcCcccccc
Q 010214 244 ARDLIPRMLIVDPMK--RITIPEIRQHPWFQAH 274 (515)
Q Consensus 244 ~~~li~~mL~~dP~~--Rpt~~eil~hp~f~~~ 274 (515)
+++++.+||..++.+ |+|+.|+++||||+..
T Consensus 278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 999999999866544 8999999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=388.81 Aligned_cols=257 Identities=34% Similarity=0.588 Sum_probs=224.3
Q ss_pred CceEeeeecccCceEEEEEEEc---CCCcEEEEEEecccccC-ChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDI 92 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~---~tg~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 92 (515)
+|++.+.||+|+||+||+|.+. .+++.||+|++.+.... .....+.+.+|+.+++.++ ||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 57899999999764432 2234567889999999995 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~- 171 (515)
|+||||++||+|.+++.+++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 9999999999999999988899999999999999999999999999999999999999999999999999997653322
Q ss_pred -ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC----ChHHHHHHHhcCccCCCCCCChhHHH
Q 010214 172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE----NIPNLFKKIKGGIYTLPSHLSPGARD 246 (515)
Q Consensus 172 -~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~ 246 (515)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||... ........+......+|..+++.+.+
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 2335679999999999987654578999999999999999999999643 33445556666677788889999999
Q ss_pred HhcccCCCCCCCCC-----CHHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rp-----t~~eil~hp~f~~~ 274 (515)
||.+||+.||.+|| +++++++||||+..
T Consensus 241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999999 88899999999753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=388.12 Aligned_cols=256 Identities=36% Similarity=0.584 Sum_probs=230.8
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iVm 96 (515)
+|++.+.||+|+||.||+|.++.+|+.||+|++.+.........+.+..|+.+++.+. ||+|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4889999999999999999999999999999998765444445567788999998886 577889999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCcccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~ 175 (515)
||++||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... +.....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~ 160 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence 9999999999999888999999999999999999999999999999999999999999999999999875432 233456
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~d 255 (515)
.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+......+|..++.++.+++.+||+.|
T Consensus 161 ~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~ 239 (323)
T cd05615 161 FCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKH 239 (323)
T ss_pred ccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccC
Confidence 679999999999988776 7899999999999999999999999988888899998888899999999999999999999
Q ss_pred CCCCCC-----HHHHhcCcccccc
Q 010214 256 PMKRIT-----IPEIRQHPWFQAH 274 (515)
Q Consensus 256 P~~Rpt-----~~eil~hp~f~~~ 274 (515)
|.+|++ ..++++||||+..
T Consensus 240 p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 240 PSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HhhCCCCCCCCHHHHhcCcccCCC
Confidence 999997 4789999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=390.20 Aligned_cols=256 Identities=29% Similarity=0.526 Sum_probs=225.8
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|.+.+.||+|+||+||+|.++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544456678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc--c
Q 010214 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--L 173 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~--~ 173 (515)
||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 999999999999876 6899999999999999999999999999999999999999999999999999987654332 2
Q ss_pred ccCCCCCCccCCCcccC-----CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCC--CCCChhH
Q 010214 174 KTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP--SHLSPGA 244 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~-----~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~ 244 (515)
....||+.|+|||++.+ ....+.++|||||||++|+|++|..||...+....+.++.... ..+| ..+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence 34579999999999863 2233689999999999999999999999888777777776543 2333 3579999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
.+||.+||+ ||.+|||+.+++.||||+.
T Consensus 241 ~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 241 LDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 999999998 9999999999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=383.91 Aligned_cols=256 Identities=26% Similarity=0.460 Sum_probs=212.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||.|+||+||+|.++.+++.||+|++...... .....+.+|+.+++.++||||+++++++.++...|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 47899999999999999999999999999999998754322 2234677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCcc
Q 010214 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~~ 173 (515)
|||+. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 99996 5888888654 5799999999999999999999999999999999999999999999999999875432 2233
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh-HHHHHHHhcCc-----------cC------
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGGI-----------YT------ 235 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~-~~~~~~i~~~~-----------~~------ 235 (515)
...+||+.|+|||++.+....+.++||||+||++|+|++|..||.+... ......+.... ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 4567899999999987765557899999999999999999999987532 22222221100 00
Q ss_pred ------CC---------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 236 ------LP---------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 236 ------~p---------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.| ...++++.+|+.+||+.||.+|||+.|+++||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00 1245788999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=378.46 Aligned_cols=255 Identities=29% Similarity=0.477 Sum_probs=225.5
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999976655444445667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 98 y~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
|++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 99999999988653 4689999999999999999999999999999999999999999999999999987765555556
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHH----HHHHhcCccCCCCCCChhHHHHhccc
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL----FKKIKGGIYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~li~~m 251 (515)
.+|++.|+|||++.+..+ +.++||||+||++|+|++|..||.+...... ...+......+|..+++.+.+|+.+|
T Consensus 161 ~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05605 161 RVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL 239 (285)
T ss_pred ccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHH
Confidence 689999999999987766 7899999999999999999999987655332 33444555566778999999999999
Q ss_pred CCCCCCCCC-----CHHHHhcCccccc
Q 010214 252 LIVDPMKRI-----TIPEIRQHPWFQA 273 (515)
Q Consensus 252 L~~dP~~Rp-----t~~eil~hp~f~~ 273 (515)
|..||.+|| +++++++||||..
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 240 LTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred ccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=386.03 Aligned_cols=251 Identities=35% Similarity=0.606 Sum_probs=223.6
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHh-CCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||+||+|.+..+++.||+|++.+..............|..+++. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999976543323344566678888875 5899999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~ 180 (515)
|+|.+++.....+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....+.+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence 99999998888899999999999999999999999999999999999999999999999999875322 22345567999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+...+.+.+......+|..++.++++||.+||+.||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 239 (316)
T cd05619 161 DYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRL 239 (316)
T ss_pred cccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcC
Confidence 9999999988776 789999999999999999999999988888888888777778888999999999999999999999
Q ss_pred CHH-HHhcCcccccc
Q 010214 261 TIP-EIRQHPWFQAH 274 (515)
Q Consensus 261 t~~-eil~hp~f~~~ 274 (515)
++. +++.||||+..
T Consensus 240 ~~~~~l~~h~~~~~~ 254 (316)
T cd05619 240 GVKGDIRQHPFFREI 254 (316)
T ss_pred CChHHHHcCcccCCC
Confidence 996 89999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=386.20 Aligned_cols=251 Identities=29% Similarity=0.556 Sum_probs=223.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++.++ +||||+++++++++.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876655555667788999999888 599999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc-ccCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~-~~~~~~~~~~gt~ 180 (515)
|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++... ..+....+.+||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP 160 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence 999999988889999999999999999999999999999999999999999999999999998753 2334455678999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCC-------CChHHHHHHHhcCccCCCCCCChhHHHHhcccCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-------ENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~-------~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~ 253 (515)
.|+|||++.+..+ +.++|||||||++|+|++|..||.. .........+......+|..++..+.++|.+||+
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~ 239 (327)
T cd05617 161 NYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLN 239 (327)
T ss_pred ccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999988777 7899999999999999999999953 2233456667777778899999999999999999
Q ss_pred CCCCCCCC------HHHHhcCcccccc
Q 010214 254 VDPMKRIT------IPEIRQHPWFQAH 274 (515)
Q Consensus 254 ~dP~~Rpt------~~eil~hp~f~~~ 274 (515)
.||.+|++ ++++++||||+..
T Consensus 240 ~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 240 KDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred cCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 99999998 5699999999754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=390.14 Aligned_cols=250 Identities=33% Similarity=0.570 Sum_probs=221.6
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC---CCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 25 LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
||+|+||+||+|.++.+|+.||+|++.+..............|..++... +||||+++++++++.+.+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765544433445556677777665 699999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~ 180 (515)
|+|.+++.+++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... ......+.+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 160 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence 9999999988899999999999999999999999999999999999999999999999999987543 233445678999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCC-CCChhHHHHhcccCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS-HLSPGARDLIPRMLIVDPMKR 259 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~-~~s~~~~~li~~mL~~dP~~R 259 (515)
.|+|||++.+....+.++|||||||++|+|++|..||...+.....+.+..+...+|. .+++++++||++||..||.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R 240 (330)
T cd05586 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240 (330)
T ss_pred cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence 9999999987654578999999999999999999999999888888888888777775 479999999999999999999
Q ss_pred C----CHHHHhcCcccccc
Q 010214 260 I----TIPEIRQHPWFQAH 274 (515)
Q Consensus 260 p----t~~eil~hp~f~~~ 274 (515)
| ++.++++||||+..
T Consensus 241 ~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 241 LGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCCCCCHHHHhcCccccCC
Confidence 8 79999999999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=385.76 Aligned_cols=250 Identities=33% Similarity=0.575 Sum_probs=222.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHH-HHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIK-ILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+. +++.++||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999997655433334445555554 67899999999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~ 180 (515)
|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.... ........+||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP 160 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence 9999999888889999999999999999999999999999999999999999999999999987532 223344568999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|...+.++.++|.+||+.||.+|+
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (321)
T cd05603 161 EYLAPEVLRKEPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRL 239 (321)
T ss_pred ccCCHHHhcCCCC-CCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcC
Confidence 9999999988776 689999999999999999999999998888889998888888889999999999999999999999
Q ss_pred CH----HHHhcCccccc
Q 010214 261 TI----PEIRQHPWFQA 273 (515)
Q Consensus 261 t~----~eil~hp~f~~ 273 (515)
++ .++++||||..
T Consensus 240 ~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 240 GAKADFLEIKNHVFFSP 256 (321)
T ss_pred CCCCCHHHHhCCCCcCC
Confidence 75 59999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=387.31 Aligned_cols=249 Identities=31% Similarity=0.591 Sum_probs=225.0
Q ss_pred eeecccCceEEEEEEE---cCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEecc
Q 010214 23 KTLGIGSFGKVKIAEH---ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYV 99 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~---~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~ 99 (515)
+.||+|+||.||++.+ ..+|+.||+|++.+..... .....+.+|++++++++||||+++++++.++..+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 6799999999999986 3578999999997654332 23456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-CccccCCC
Q 010214 100 KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCG 178 (515)
Q Consensus 100 ~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~g 178 (515)
++|+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....+.+|
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 160 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence 99999999988888999999999999999999999999999999999999999999999999998765443 33445689
Q ss_pred CCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCC
Q 010214 179 SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMK 258 (515)
Q Consensus 179 t~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~ 258 (515)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||+.||.+
T Consensus 161 ~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~ 239 (318)
T cd05582 161 TVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPAN 239 (318)
T ss_pred ChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhH
Confidence 999999999988766 7899999999999999999999999888888888888888899999999999999999999999
Q ss_pred CCC-----HHHHhcCccccc
Q 010214 259 RIT-----IPEIRQHPWFQA 273 (515)
Q Consensus 259 Rpt-----~~eil~hp~f~~ 273 (515)
||| +.+++.||||+.
T Consensus 240 R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 240 RLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred cCCCCCCCHHHHhCCCCcCC
Confidence 999 788999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=387.24 Aligned_cols=251 Identities=34% Similarity=0.578 Sum_probs=223.3
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHH-HHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIK-ILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||+||+|.++.+|+.||+|++.+...........+.+|.. +++.++||||++++++++.++.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654433344455556655 56789999999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~ 180 (515)
|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... ........+||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP 160 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence 9999999988899999999999999999999999999999999999999999999999999987532 223345668999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++|||||||++|+|++|..||...+...++..+.......++..+..+.++|.+||..||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~ 239 (325)
T cd05604 161 EYLAPEVIRKQPY-DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRL 239 (325)
T ss_pred hhCCHHHHcCCCC-CCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcC
Confidence 9999999988877 689999999999999999999999998888888888888778888999999999999999999999
Q ss_pred CH----HHHhcCcccccc
Q 010214 261 TI----PEIRQHPWFQAH 274 (515)
Q Consensus 261 t~----~eil~hp~f~~~ 274 (515)
++ .++++||||+..
T Consensus 240 ~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 240 GAKEDFLEIQEHPFFESL 257 (325)
T ss_pred CCCCCHHHHhcCCCcCCC
Confidence 87 589999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=370.63 Aligned_cols=255 Identities=38% Similarity=0.667 Sum_probs=228.6
Q ss_pred CccccCCCceEe-eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEc
Q 010214 11 GVDMFLPNYKLG-KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIET 88 (515)
Q Consensus 11 ~~~~~~~~Y~i~-~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~ 88 (515)
....+.++|.+. ++||-|-.|+|-.+.++.||+++|+|++.- ..+.+||+++.-+.. |||||+++++|+.
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 334478889884 579999999999999999999999998742 357789999876554 9999999999854
Q ss_pred ----CCeEEEEEeccCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCceEEe
Q 010214 89 ----PSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIA 159 (515)
Q Consensus 89 ----~~~~~iVmEy~~gg~L~~~i~~~~~--l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~---~~~vKL~ 159 (515)
...+.+|||.++||+|++.|..++. ++|.++..|+.||..|+.|||+.+|.||||||||+|... +..+||+
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 4568999999999999999998776 999999999999999999999999999999999999975 4579999
Q ss_pred ecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC----hHHHHHHHhcCccC
Q 010214 160 DFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYT 235 (515)
Q Consensus 160 DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~----~~~~~~~i~~~~~~ 235 (515)
|||+++.......+.|.|-||.|+|||++....| +..+|+||+|||+|-||||.+||.... .+.+..+|..+.+.
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKy-dkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYE 285 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHhCchhc-CCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCcc
Confidence 9999998887788999999999999999998887 789999999999999999999998654 45678899999999
Q ss_pred CCC----CCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 236 LPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 236 ~p~----~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+|. .+|.+++|+|+.+|..+|.+|.|+.++++|||+...
T Consensus 286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 984 689999999999999999999999999999999754
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=390.38 Aligned_cols=262 Identities=30% Similarity=0.540 Sum_probs=227.3
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
.....++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34456899999999999999999999999999999999976554444455678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
+|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 9999999999999999865 468999999999999999999999999999999999999999999999999998764332
Q ss_pred --ccccCCCCCCccCCCcccCCc---cCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCC--CCCCh
Q 010214 172 --FLKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP--SHLSP 242 (515)
Q Consensus 172 --~~~~~~gt~~Y~aPE~i~~~~---~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~ 242 (515)
...+.+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||.+.+....+.++.... ..+| ..++.
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 276 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCH
Confidence 224668999999999987543 24789999999999999999999999998888888887643 3344 36899
Q ss_pred hHHHHhcccCCCCCCC--CCCHHHHhcCcccccc
Q 010214 243 GARDLIPRMLIVDPMK--RITIPEIRQHPWFQAH 274 (515)
Q Consensus 243 ~~~~li~~mL~~dP~~--Rpt~~eil~hp~f~~~ 274 (515)
++++||.+||..++.+ |++++++++||||+..
T Consensus 277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 277 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 9999999999844443 7899999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=392.92 Aligned_cols=257 Identities=31% Similarity=0.552 Sum_probs=240.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe-EEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD-IYV 94 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~i 94 (515)
.++|..++.+|+|+||.+++++|+..++.|++|.++........ .....+|+.+++++.|||||.+++.|+.++. ++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 57899999999999999999999999999999999887766644 3478899999999999999999999988887 999
Q ss_pred EEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-
Q 010214 95 VMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~- 171 (515)
||+||+||+|.+.|.+. .-++|+.+..|+.||+.|+.|||++.|+|||||+.||+++.++.|||+|||+|+.+.+..
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 99999999999999764 359999999999999999999999999999999999999999999999999999998776
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcc
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPR 250 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~ 250 (515)
...+..|||.||+||++.+.+| +.++|||||||++|||++-+++|.+.+...+..+|..+. .++|...|.+++.+|+.
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pY-n~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~ 240 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPY-NEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKS 240 (426)
T ss_pred hhheecCCCcccCHHHhCCCCC-CccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHH
Confidence 7889999999999999999998 799999999999999999999999999999999999988 67899999999999999
Q ss_pred cCCCCCCCCCCHHHHhcCcccccc
Q 010214 251 MLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
||..+|..||++.++|.+|.++..
T Consensus 241 ~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 241 MLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HhhcCCccCCCHHHHhhChhhhhH
Confidence 999999999999999999887644
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=385.59 Aligned_cols=250 Identities=34% Similarity=0.581 Sum_probs=221.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHH-HHHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREI-KILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei-~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|. .+++.++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4799999999999999999999999999765433323333444444 457889999999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~ 180 (515)
|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ......+.+||+
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 160 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP 160 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence 9999999988889999999999999999999999999999999999999999999999999987542 233345678999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.......++.+++++.++|.+||+.||.+|+
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (325)
T cd05602 161 EYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL 239 (325)
T ss_pred cccCHHHHcCCCC-CCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence 9999999998776 689999999999999999999999988888888888888888889999999999999999999999
Q ss_pred CHH----HHhcCccccc
Q 010214 261 TIP----EIRQHPWFQA 273 (515)
Q Consensus 261 t~~----eil~hp~f~~ 273 (515)
++. ++++|+||..
T Consensus 240 ~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 240 GAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCHHHHhcCcccCC
Confidence 876 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=371.36 Aligned_cols=257 Identities=32% Similarity=0.438 Sum_probs=223.5
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEE--cCCeEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE--TPSDIY 93 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~ 93 (515)
+++|+.+..|++|+||.||+|+++.|++.||+|.++-++-+. ..--.-.|||.+|.+++|||||.+-++.. +-+.+|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~-GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE-GFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC-CCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 578999999999999999999999999999999987655222 22234579999999999999999999874 456799
Q ss_pred EEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-C
Q 010214 94 VVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-H 171 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~ 171 (515)
||||||+. +|...+..-+ ++.+.+++.++.|++.|++|||.+.|+||||||+|+|++..|.+||+|||+|+.+... .
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 99999987 9999998754 8999999999999999999999999999999999999999999999999999988655 3
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc------------------
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------------ 233 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~------------------ 233 (515)
.....+-|.+|+|||.+.|...++.++|+||+|||+.||+++++.|.+.+..++..+|....
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence 45566889999999999998777999999999999999999999999998888877774321
Q ss_pred -cCCC------------C-CCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 234 -YTLP------------S-HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 234 -~~~p------------~-~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..++ . .+|....+|+..+|..||.+|.|+.|.|+|+||.+.
T Consensus 313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 1111 1 156888999999999999999999999999999863
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=374.27 Aligned_cols=249 Identities=34% Similarity=0.535 Sum_probs=217.7
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCH
Q 010214 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (515)
Q Consensus 25 LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L 104 (515)
||+|+||+||+|.++.+|+.||+|++.+.........+.+..|+.+++.++||||+++++++.+...+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999999766554444456778899999999999999999999999999999999999999
Q ss_pred HHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc-cccCCCC
Q 010214 105 FDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGS 179 (515)
Q Consensus 105 ~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~-~~~~~gt 179 (515)
.+++.. +..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....+.. .....||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 988753 34699999999999999999999999999999999999999999999999999976654332 3445799
Q ss_pred CCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh----HHHHHHHhcCccCCCCCCChhHHHHhcccCCCC
Q 010214 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 180 ~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~d 255 (515)
+.|+|||++.+..+ +.++||||+||++|+|++|..||..... ......+......+|..+++++.+++.+||+.|
T Consensus 161 ~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (280)
T cd05608 161 PGFMAPELLQGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKD 239 (280)
T ss_pred cCccCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCC
Confidence 99999999998877 6899999999999999999999976532 233444555556677889999999999999999
Q ss_pred CCCCC-----CHHHHhcCcccccc
Q 010214 256 PMKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 256 P~~Rp-----t~~eil~hp~f~~~ 274 (515)
|.+|| |++++++||||+..
T Consensus 240 P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 240 PEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HHHhcCCCCCCHHHHhcChhhhcC
Confidence 99999 88999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=380.34 Aligned_cols=257 Identities=30% Similarity=0.572 Sum_probs=221.7
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++++++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997654444445677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc--
Q 010214 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-- 173 (515)
Q Consensus 97 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~-- 173 (515)
||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99999999999976 457999999999999999999999999999999999999999999999999998765443322
Q ss_pred ccCCCCCCccCCCcccC----CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCC---CCCChhH
Q 010214 174 KTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP---SHLSPGA 244 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~----~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~~ 244 (515)
...+||+.|+|||++.+ ....+.++||||+||++|+|++|..||.+.+..+....+.... ..+| ..+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence 23469999999999863 2334789999999999999999999999888777777775432 3333 3479999
Q ss_pred HHHhcccCCCCCCC--CCCHHHHhcCccccc
Q 010214 245 RDLIPRMLIVDPMK--RITIPEIRQHPWFQA 273 (515)
Q Consensus 245 ~~li~~mL~~dP~~--Rpt~~eil~hp~f~~ 273 (515)
++||.+||..++.+ |+++.++++||||..
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 99999998765444 889999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=382.16 Aligned_cols=254 Identities=33% Similarity=0.561 Sum_probs=211.1
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----CeE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP-----SDI 92 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~ 92 (515)
+|++.+.||+|+||.||+|.++.+|+.||||++..... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 59999999999999999999999999999999864322 223345788999999999999999999988543 358
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~- 171 (515)
|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 6999999888889999999999999999999999999999999999999999999999999987643221
Q ss_pred ---ccccCCCCCCccCCCcccC--CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--------------
Q 010214 172 ---FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-------------- 232 (515)
Q Consensus 172 ---~~~~~~gt~~Y~aPE~i~~--~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~-------------- 232 (515)
.....+||+.|+|||++.+ ..+ ++++|||||||++|+|++|+.||.+.+.......+...
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 2234579999999999875 344 78999999999999999999999876543322211100
Q ss_pred ------------ccCC-----CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 233 ------------IYTL-----PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 233 ------------~~~~-----p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.... .+.+++++.++|.+||+.||.+|||++|+++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 0000 12467889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=378.89 Aligned_cols=255 Identities=24% Similarity=0.448 Sum_probs=220.3
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||.||+|.+..+|..||+|++.... .......+.+|+++++.++||||+++++++...+.+++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 589999999999999999999999999999999987542 234567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
|||++||+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...... ...
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 160 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MAN 160 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-ccc
Confidence 99999999999999888899999999999999999999985 6999999999999999999999999998765432 334
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhc-----------------------
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG----------------------- 231 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~----------------------- 231 (515)
...||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......++...+..
T Consensus 161 ~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd06649 161 SFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP 239 (331)
T ss_pred cCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence 5679999999999988776 7899999999999999999999976554443222111
Q ss_pred -----------------------Cc-cCC-CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 232 -----------------------GI-YTL-PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 232 -----------------------~~-~~~-p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.. ... ...+++++++||.+||+.||++|||+.|+++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 00 011 12467899999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-47 Score=371.18 Aligned_cols=257 Identities=30% Similarity=0.494 Sum_probs=224.0
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCC-ccEEEEEEEcCC----
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIRLYEVIETPS---- 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~~~~~~---- 90 (515)
...|..++.||+|+||+||+|+++.+|+.||+|.+..+.-. ........||+.+|+.++|+| |+++++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45688888999999999999999999999999999765432 224466789999999999999 999999998877
Q ss_pred --eEEEEEeccCCCCHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccc
Q 010214 91 --DIYVVMEYVKSGELFDYIVEKG----RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 91 --~~~iVmEy~~gg~L~~~i~~~~----~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
.+++|+||++. +|..|+.... .++...++.++.||+.||+|||+++|+||||||.|||++++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999965 9999998755 5888899999999999999999999999999999999999999999999999
Q ss_pred cccc-cCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---------
Q 010214 165 NIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--------- 234 (515)
Q Consensus 165 ~~~~-~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~--------- 234 (515)
+... +.....+.++|.+|+|||++.|...++..+||||+|||++||+++...|.+.+..++..+|-....
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 9776 445567778999999999999986678999999999999999999999999988777777643211
Q ss_pred ---------CCC------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 ---------TLP------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 ---------~~p------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.+| +..+++..+++.+||+.+|.+|.|+..++.||||+..
T Consensus 248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 111 1234689999999999999999999999999999865
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=383.20 Aligned_cols=258 Identities=31% Similarity=0.507 Sum_probs=215.5
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC---
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS--- 90 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~--- 90 (515)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+.. ........+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 45799999999999999999999999999999999987543 23344567889999999999999999999986543
Q ss_pred ---eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 91 ---DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 91 ---~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
.+|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 57999999975 6777664 35899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC---------------
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--------------- 232 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~--------------- 232 (515)
..........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+...
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 55555556789999999999998877 68999999999999999999999876543322221110
Q ss_pred -------ccC--------------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 233 -------IYT--------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 233 -------~~~--------------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
... .+...++++++||.+||+.||.+|||+.|+++||||+.+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 000 01124678999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=396.60 Aligned_cols=252 Identities=29% Similarity=0.426 Sum_probs=211.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP------ 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~------ 89 (515)
..+|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 457999999999999999999999999999999885432 2345799999999999999999887432
Q ss_pred --CeEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-ceEEeecc
Q 010214 90 --SDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFG 162 (515)
Q Consensus 90 --~~~~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~-~vKL~DFG 162 (515)
..+++||||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 247799999975 78777653 46799999999999999999999999999999999999999664 69999999
Q ss_pred cccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc---------
Q 010214 163 LSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------- 233 (515)
Q Consensus 163 ls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--------- 233 (515)
++.....+....+.+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+......++....
T Consensus 217 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 217 SAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred cchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 99877665555667899999999998876544789999999999999999999999876655444442210
Q ss_pred --------------------cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 234 --------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 234 --------------------~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
..+|...++++++||.+||++||.+|||+.|+++||||+...
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 113445788999999999999999999999999999998653
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=370.68 Aligned_cols=252 Identities=29% Similarity=0.485 Sum_probs=211.0
Q ss_pred CCceEeeeecccCceEEEEEEEcC-CCcEEEEEEecccccCChHHHHHHHHHHHHHHhC---CCCCccEEEEEEE-----
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHAL-TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIRLYEVIE----- 87 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~-tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l~~~~~----- 87 (515)
++|++.+.||+|+||+||+|.+.. +|+.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999854 46889999987544322 2234556777777665 6999999999985
Q ss_pred cCCeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 88 TPSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 88 ~~~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
....+++||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3456899999996 5999999753 358999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-----------
Q 010214 166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY----------- 234 (515)
Q Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~----------- 234 (515)
............||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+..+...++.....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred eccCCcccccccccccccChHHHhCCCC-CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 7665555566789999999999987766 6899999999999999999999998877666665543211
Q ss_pred ----------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 235 ----------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 235 ----------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.+.+.+++.+++|+.+||+.||++|||+.|+++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0113467888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=377.53 Aligned_cols=257 Identities=30% Similarity=0.560 Sum_probs=222.0
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||++.++.+++.||+|++.+...........+.+|+.++..++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997654444444566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc--c
Q 010214 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--L 173 (515)
Q Consensus 97 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~--~ 173 (515)
||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99999999999987 46799999999999999999999999999999999999999999999999999876533222 2
Q ss_pred ccCCCCCCccCCCcccC----CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCC---CCCChhH
Q 010214 174 KTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP---SHLSPGA 244 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~----~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~~ 244 (515)
...+||+.|+|||++.+ ....+.++|||||||++|+|++|+.||...+......++.... ..+| ..+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~ 240 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence 34579999999999862 2233789999999999999999999999988888888876643 2333 3579999
Q ss_pred HHHhcccCCCCCCC--CCCHHHHhcCccccc
Q 010214 245 RDLIPRMLIVDPMK--RITIPEIRQHPWFQA 273 (515)
Q Consensus 245 ~~li~~mL~~dP~~--Rpt~~eil~hp~f~~ 273 (515)
++||.+||..++.+ |+|+.|+++||||+.
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 99999999765544 789999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=368.92 Aligned_cols=255 Identities=42% Similarity=0.748 Sum_probs=234.5
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|++++++++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997765555556678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccC
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS 176 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~ 176 (515)
||+++++|.+++...+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++...... ....
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~ 158 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTL 158 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCC
Confidence 99999999999998889999999999999999999999999999999999999999999999999999876544 3456
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCC
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP 256 (515)
+|++.|+|||.+.+... +.++||||||+++|+|++|..||...+.......+..+...+|..+++.++++|.+||..||
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 237 (290)
T cd05580 159 CGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDL 237 (290)
T ss_pred CCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCH
Confidence 79999999999987755 68999999999999999999999988877778888888888899999999999999999999
Q ss_pred CCCC-----CHHHHhcCcccccc
Q 010214 257 MKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 257 ~~Rp-----t~~eil~hp~f~~~ 274 (515)
.+|+ +++|+++||||+..
T Consensus 238 ~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 238 TKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HHccCcccCCHHHHHcCcccccC
Confidence 9999 99999999999754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=379.51 Aligned_cols=248 Identities=31% Similarity=0.528 Sum_probs=218.4
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcE-EEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-eEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHK-VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-DIY 93 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~-vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~ 93 (515)
.....+.+.||.|+||+||.|.+. |+. ||+|++......... .+.+.+|+.+|++++|||||++++++.++. .++
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 345567778999999999999985 555 999999876655544 789999999999999999999999998887 799
Q ss_pred EEEeccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCcEEECCCC-ceEEeeccccccccc
Q 010214 94 VVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNM-VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRD 169 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~yLH~~g-IvHrDLkpeNILl~~~~-~vKL~DFGls~~~~~ 169 (515)
+||||+++|+|.+++.. +..++...+..++.||+.|++|||+++ ||||||||+|||++.++ ++||+|||+++....
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999999987 678999999999999999999999999 99999999999999998 999999999988765
Q ss_pred C-CccccCCCCCCccCCCccc--CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHh--cCccCCCCCCChhH
Q 010214 170 G-HFLKTSCGSPNYAAPEVIS--GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK--GGIYTLPSHLSPGA 244 (515)
Q Consensus 170 ~-~~~~~~~gt~~Y~aPE~i~--~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~ 244 (515)
. .......||+.|||||++. ...| +.++||||+|+++|||+||..||.+....+....+. .....+|..+++.+
T Consensus 197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~-~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l 275 (362)
T KOG0192|consen 197 SKTSMTSVAGTYRWMAPEVLRGEKSPY-TEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHL 275 (362)
T ss_pred ccccccCCCCCccccChhhhcCCCCcC-CccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence 4 3334468999999999999 4566 799999999999999999999999988755555543 33456778899999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
..|+.+||..||.+||++.+|+.
T Consensus 276 ~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 276 SSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHhCCCCCCcCCCHHHHHH
Confidence 99999999999999999999865
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=377.76 Aligned_cols=257 Identities=30% Similarity=0.538 Sum_probs=222.5
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++++++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999997654444445566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc--
Q 010214 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-- 173 (515)
Q Consensus 97 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~-- 173 (515)
||++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 99999999999987 467999999999999999999999999999999999999999999999999998766443222
Q ss_pred ccCCCCCCccCCCcccCC----ccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCCC---CCChhH
Q 010214 174 KTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPS---HLSPGA 244 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~----~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~~ 244 (515)
...+||+.|+|||++.+. ...+.++||||+||++|+|++|+.||...+......++.... ..+|. .+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~ 240 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence 345799999999998752 223689999999999999999999999888877777776543 33443 468999
Q ss_pred HHHhcccCCCCCCC--CCCHHHHhcCccccc
Q 010214 245 RDLIPRMLIVDPMK--RITIPEIRQHPWFQA 273 (515)
Q Consensus 245 ~~li~~mL~~dP~~--Rpt~~eil~hp~f~~ 273 (515)
+++|.+||..++.+ |++++++++||||+.
T Consensus 241 ~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 241 KDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 99999999876654 579999999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=368.19 Aligned_cols=255 Identities=30% Similarity=0.504 Sum_probs=221.4
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++|++|+++++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999987655554445667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 98 YVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 98 y~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
|++|++|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....+.....
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 999999999986543 589999999999999999999999999999999999999999999999999987655544455
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH----HHHHHHhcCccCCCCCCChhHHHHhccc
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP----NLFKKIKGGIYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~----~~~~~i~~~~~~~p~~~s~~~~~li~~m 251 (515)
..|++.|+|||++.+..+ +.++||||+||++|+|++|..||...... .............+..+++++++|+.+|
T Consensus 161 ~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05630 161 RVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKML 239 (285)
T ss_pred CCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHH
Confidence 689999999999988776 78999999999999999999999864321 1111112223345677899999999999
Q ss_pred CCCCCCCCCC-----HHHHhcCccccc
Q 010214 252 LIVDPMKRIT-----IPEIRQHPWFQA 273 (515)
Q Consensus 252 L~~dP~~Rpt-----~~eil~hp~f~~ 273 (515)
|+.||.+||| +.|+++||||+.
T Consensus 240 l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 240 LCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred hhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=367.83 Aligned_cols=252 Identities=31% Similarity=0.495 Sum_probs=220.0
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--C---
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--S--- 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~--- 90 (515)
.=.|.-.+.+|.|+||.||.|....+++.||||.+-.+.- .-.+|+.+|+.++|||||++..+|... +
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 3468889999999999999999999999999998754432 124799999999999999999988532 2
Q ss_pred eEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CceEEeeccccc
Q 010214 91 DIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLSN 165 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~-~~vKL~DFGls~ 165 (515)
...+||||++. +|.++++. +.+++.-.++-+..||++||.|||+.||+||||||.|+|+|.+ |.+||||||.|+
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 35689999976 99999974 5789999999999999999999999999999999999999976 999999999999
Q ss_pred ccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc------------
Q 010214 166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------ 233 (515)
Q Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~------------ 233 (515)
....++...+...|..|+|||.+.|...++.+.||||+||++.||+-|.+.|.+++...+...|.+-.
T Consensus 175 ~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 175 VLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred eeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 99999988889999999999999987777899999999999999999999999988777666553311
Q ss_pred -----cC------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 234 -----YT------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 234 -----~~------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
.. +....++++.+|+.++|+.+|.+|.|+.|++.||||....
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 11 1245789999999999999999999999999999998653
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=371.08 Aligned_cols=259 Identities=26% Similarity=0.484 Sum_probs=217.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|.+.+.||+|+||.||+|.++.+++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 47899999999999999999999999999999998754322 2234567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccc
Q 010214 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~ 173 (515)
|||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 999975 888888764 45899999999999999999999999999999999999999999999999998765332 223
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-------------------c
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------------Y 234 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~ 234 (515)
....+|+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+.... .
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 445789999999998765545789999999999999999999998876655444332210 0
Q ss_pred CC-----------CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccCc
Q 010214 235 TL-----------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277 (515)
Q Consensus 235 ~~-----------p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~~ 277 (515)
.. ...+++++++||.+||+.||.+|||+.|+++||||+....+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~ 295 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTR 295 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccc
Confidence 11 12468899999999999999999999999999999865433
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=364.29 Aligned_cols=264 Identities=34% Similarity=0.587 Sum_probs=232.3
Q ss_pred CccccCCCceE-eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEc
Q 010214 11 GVDMFLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIET 88 (515)
Q Consensus 11 ~~~~~~~~Y~i-~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~ 88 (515)
....+.+-|++ .+.||+|+++.|-.+....||..||||++.|.. .....++.||++++..++ |+||++++++|++
T Consensus 71 ~~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 71 LSGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred ccchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 33345556776 568999999999999999999999999998763 346789999999999987 9999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---ceEEeeccccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVKIADFGLSN 165 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~---~vKL~DFGls~ 165 (515)
++.+|+|||-+.||.|..+|.++..++|.++.++.++|++||+|||.+||.||||||||||..... -||||||.+..
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred cceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccc
Confidence 999999999999999999999999999999999999999999999999999999999999997654 48999999875
Q ss_pred cccc--------CCccccCCCCCCccCCCccc----CCccCCCcceeehhHHHHHHHHhCCCCCCCCC------------
Q 010214 166 IMRD--------GHFLKTSCGSPNYAAPEVIS----GKLYAGPEVDVWSCGVILYALLCGTLPFDDEN------------ 221 (515)
Q Consensus 166 ~~~~--------~~~~~~~~gt~~Y~aPE~i~----~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~------------ 221 (515)
.+.- ...+.|.||+..|||||+.. ...+++.++|.||||||||-||+|.+||.+.-
T Consensus 228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence 4421 12356789999999999873 23345899999999999999999999996531
Q ss_pred ---hHHHHHHHhcCccCCCC----CCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccCc
Q 010214 222 ---IPNLFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277 (515)
Q Consensus 222 ---~~~~~~~i~~~~~~~p~----~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~~ 277 (515)
...+++.|+.|.|.+|+ ++|.++++|++.+|..|+.+|.++.++++|||++...+.
T Consensus 308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 46789999999999995 799999999999999999999999999999999877655
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=384.35 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=209.3
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
...+|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+++++.++||||+++++++..+...++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 34689999999999999999999999999999996432 346789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC--Cc
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HF 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~--~~ 172 (515)
|||++. ++|..++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 999995 699999988888999999999999999999999999999999999999999999999999998754322 23
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC-------hHHHHHHHhc--------------
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-------IPNLFKKIKG-------------- 231 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~-------~~~~~~~i~~-------------- 231 (515)
....+||+.|+|||++.+..+ ++++||||+||++|+|++|..||.... .......+..
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred cccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 345689999999999988776 789999999999999999998874321 1111111110
Q ss_pred ------------CccCCC---------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 232 ------------GIYTLP---------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 232 ------------~~~~~p---------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.....| ..++.++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 000001 1246689999999999999999999999999999874
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=379.64 Aligned_cols=258 Identities=31% Similarity=0.518 Sum_probs=241.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.+.|+.-++||+|+||.||-++.+.||+.||+|.+.++.++.........+|-.||.+++.++||.+-..|++++.+|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 46788899999999999999999999999999999999988888888889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 96 MEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|..|+||+|.-+|.+.+ .++|..++.++.+|+.||++||+.+||+|||||+|||+|+.|+|+|+|+|+|..+..+...
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence 99999999999998866 7999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC----hHHHHHHHhcCccCCCCCCChhHHHHhc
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLPSHLSPGARDLIP 249 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~~li~ 249 (515)
...+||.+|||||++.+..| +...|.|||||++|+|+.|+.||.... .+++-+.+......+|+.+|++++++.+
T Consensus 344 ~~rvGT~GYMAPEvl~ne~Y-~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~ 422 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEVY-DFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCE 422 (591)
T ss_pred ccccCcccccCHHHHcCCcc-cCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHH
Confidence 99999999999999999887 789999999999999999999997633 3456667777788889999999999999
Q ss_pred ccCCCCCCCCCC-----HHHHhcCcccccc
Q 010214 250 RMLIVDPMKRIT-----IPEIRQHPWFQAH 274 (515)
Q Consensus 250 ~mL~~dP~~Rpt-----~~eil~hp~f~~~ 274 (515)
.+|++||.+|.. ++++.+||||+..
T Consensus 423 ~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 423 GLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred HHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 999999999985 5699999999874
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=365.81 Aligned_cols=249 Identities=28% Similarity=0.473 Sum_probs=213.9
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCH
Q 010214 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (515)
Q Consensus 25 LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L 104 (515)
||+|+||.||++.++.+|+.||+|.+.+...........+..|+++++.++||||++++++++++..+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765554434445667799999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCCCCc
Q 010214 105 FDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY 182 (515)
Q Consensus 105 ~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y 182 (515)
.+++...+ .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.....+.......|++.|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence 99886543 5889999999999999999999999999999999999999999999999999877655544556799999
Q ss_pred cCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh----HHHHHHHhcCccCCC-CCCChhHHHHhcccCCCCCC
Q 010214 183 AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYTLP-SHLSPGARDLIPRMLIVDPM 257 (515)
Q Consensus 183 ~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~----~~~~~~i~~~~~~~p-~~~s~~~~~li~~mL~~dP~ 257 (515)
+|||++.+..+ +.++||||+||++|+|++|..||.+... ......+.......+ ..+++++++|+.+||+.||.
T Consensus 161 ~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 239 (277)
T cd05607 161 MAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPE 239 (277)
T ss_pred cCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHh
Confidence 99999988775 7899999999999999999999976432 233333333333332 46899999999999999999
Q ss_pred CCCCH----HHHhcCcccccc
Q 010214 258 KRITI----PEIRQHPWFQAH 274 (515)
Q Consensus 258 ~Rpt~----~eil~hp~f~~~ 274 (515)
+|||+ ++++.||||+..
T Consensus 240 ~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 240 DRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred hCCCCccchhhhhcChhhcCC
Confidence 99999 678899999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=358.05 Aligned_cols=254 Identities=34% Similarity=0.560 Sum_probs=222.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCC--hHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN--MEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
++|.+.+.||.|++|.||.|.+..+++.||+|.+....... ......+.+|+.+++.++||||+++++++++...+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999999999999999987553322 2234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc--
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-- 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~-- 172 (515)
|+||++|++|.+++...+.+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 999999999999999888899999999999999999999999999999999999999999999999999876533211
Q ss_pred --cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--ccCCCCCCChhHHHHh
Q 010214 173 --LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARDLI 248 (515)
Q Consensus 173 --~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li 248 (515)
.....|++.|+|||++.+..+ +.++||||+|+++|+|++|+.||.+.+......++... ...+|..++..+.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 134568899999999988765 78999999999999999999999876655544444333 4456778899999999
Q ss_pred cccCCCCCCCCCCHHHHhcCccc
Q 010214 249 PRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.+||..+|.+|||+.++++||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=379.99 Aligned_cols=257 Identities=31% Similarity=0.505 Sum_probs=217.1
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC----
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP---- 89 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 89 (515)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 357899999999999999999999999999999999875432 234456788999999999999999999987543
Q ss_pred --CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 90 --SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 90 --~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
..+|+||||+++ +|.+++.. .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 357999999965 78887753 4889999999999999999999999999999999999999999999999999877
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC------------
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------ 235 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~------------ 235 (515)
.......+..||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......++......
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 65555566789999999999988776 78999999999999999999999887765555444321100
Q ss_pred ------------------------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 236 ------------------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 236 ------------------------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
.+...+.++++||.+||+.||.+|||+.|+++||||....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~ 325 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence 0011346789999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=365.53 Aligned_cols=251 Identities=31% Similarity=0.517 Sum_probs=209.5
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC---CCCCccEEEEEEEc-----C
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIRLYEVIET-----P 89 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l~~~~~~-----~ 89 (515)
+|++.+.||+|+||.||+|.++.+|+.||+|.+....... .....+.+|+.+++.+ +||||+++++++.+ .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 5999999999999999999999999999999987543222 1223455677777655 69999999999864 3
Q ss_pred CeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
..+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 458999999975 899988764 34899999999999999999999999999999999999999999999999999877
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-----------c--
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----------Y-- 234 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-----------~-- 234 (515)
..........||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+........++.... .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred cCcccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 65544556678999999999987766 789999999999999999999998876655554443210 0
Q ss_pred --------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 235 --------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 235 --------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
...+.++..+.+||.+||+.||.+|||+.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0112467888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=378.33 Aligned_cols=257 Identities=31% Similarity=0.511 Sum_probs=215.8
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC----
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP---- 89 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 89 (515)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 357899999999999999999999999999999999875432 334456788999999999999999999998643
Q ss_pred --CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 90 --SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 90 --~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
...|+||||+++ +|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 357999999975 77777753 5899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--------------
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------- 233 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------------- 233 (515)
..........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 65555566789999999999988876 689999999999999999999998776443332221100
Q ss_pred -------------c---------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 234 -------------Y---------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 234 -------------~---------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
. ..+...+.++++||.+||..||.+|||+.|+++||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 0 01122456789999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=364.04 Aligned_cols=256 Identities=28% Similarity=0.470 Sum_probs=225.0
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
.|+..+.||.|+||+||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+++++.+.+++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999977665554455667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 98 y~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
|+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence 99999999988654 3699999999999999999999999999999999999999999999999999977655444456
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHH----HHHHhcCccCCCCCCChhHHHHhccc
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL----FKKIKGGIYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~li~~m 251 (515)
..|++.|+|||++.+..+ +.++|+||+||++|+|++|..||.+...... ...+......++..+++++.+|+.+|
T Consensus 161 ~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05632 161 RVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239 (285)
T ss_pred CCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHH
Confidence 689999999999988766 7899999999999999999999987655433 33344444556678899999999999
Q ss_pred CCCCCCCCCC-----HHHHhcCcccccc
Q 010214 252 LIVDPMKRIT-----IPEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rpt-----~~eil~hp~f~~~ 274 (515)
|+.||.+||| +.+++.||||+..
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 240 LTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred ccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999 8899999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=382.43 Aligned_cols=255 Identities=28% Similarity=0.445 Sum_probs=227.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
...|+..+.||+|+||.||+|.+..|++.||||+++.+... +..+.+++|+.+|.++++|||.++|+.+-....++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 35688889999999999999999999999999999877654 4568899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc-cc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~-~~ 174 (515)
||||.||++.+.+.....+.|.++..++++++.|+.|||.++.+|||||+.|||+..+|.+||+|||.+..+..... ..
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 99999999999998887789999999999999999999999999999999999999999999999999988765433 37
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHh-cCccCCCCCCChhHHHHhcccCC
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK-GGIYTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~-~~~~~~p~~~s~~~~~li~~mL~ 253 (515)
|.+|||.|||||++.+..| +.++||||||++.+||++|.+|+.+.......-.|- .....+..++|+.+++||..||.
T Consensus 170 tfvGTPfwMAPEVI~~~~Y-~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~ 248 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGY-DTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLD 248 (467)
T ss_pred cccccccccchhhhccccc-cchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhh
Confidence 8999999999999998777 789999999999999999999998876533222222 22233345789999999999999
Q ss_pred CCCCCCCCHHHHhcCccccc
Q 010214 254 VDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~f~~ 273 (515)
+||+.|||+.++++|+|++.
T Consensus 249 k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 249 KNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred cCcccCcCHHHHhhhHHHHh
Confidence 99999999999999999986
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=382.23 Aligned_cols=255 Identities=31% Similarity=0.550 Sum_probs=218.3
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----eE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-----DI 92 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 92 (515)
+|++.+.||+|+||.||+|.+..+|+.||||++.... .......++.+|+.+++.++||||+++++++..+. .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 5789999999999999999999999999999986432 23344567889999999999999999999998876 79
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC--
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-- 170 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-- 170 (515)
|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99999996 589999988888999999999999999999999999999999999999999999999999999765432
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC------------------
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG------------------ 232 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~------------------ 232 (515)
.......+|+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence 22334568999999999988655578999999999999999999999887765554444221
Q ss_pred -----c---------cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 233 -----I---------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 233 -----~---------~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
. +......++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 1 12234568899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=377.67 Aligned_cols=256 Identities=31% Similarity=0.481 Sum_probs=216.1
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
....+|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+++++.++||||+++++++...+.+|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 34678999999999999999999999999999999986432 3345577899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Cc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~ 172 (515)
+||||+++|+|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 99999999998653 34678888999999999999999999999999999999999999999999999876432 22
Q ss_pred cccCCCCCCccCCCcccC----CccCCCcceeehhHHHHHHHHhCCCCCCCCChHH---HHHHHh-cCccCCCCCCChhH
Q 010214 173 LKTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN---LFKKIK-GGIYTLPSHLSPGA 244 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~----~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~---~~~~i~-~~~~~~p~~~s~~~ 244 (515)
.....||+.|+|||++.. ..+.+.++|||||||++|+|++|+.||....... ....+. ......+..++.++
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 304 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF 304 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence 345679999999999853 2344678999999999999999999997533222 222222 22344567789999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
++||.+||..||.+|||+.|+++||||....
T Consensus 305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 305 RHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 9999999999999999999999999998754
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=391.62 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=208.9
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC------CCccEEEEEEEc
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH------PHIIRLYEVIET 88 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h------pnIv~l~~~~~~ 88 (515)
..++|++.+.||+|+||+||+|.+..+++.||||++.... ........|+.+++.++| ++++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3578999999999999999999999999999999986422 123345667777777654 458899999876
Q ss_pred C-CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCC------------
Q 010214 89 P-SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKW------------ 154 (515)
Q Consensus 89 ~-~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~------------ 154 (515)
+ ..+|+|||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 5 5789999998 77999999988899999999999999999999998 5999999999999998765
Q ss_pred ----ceEEeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHh
Q 010214 155 ----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK 230 (515)
Q Consensus 155 ----~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~ 230 (515)
.+||+|||.+.... ......+||+.|+|||++.+..| +.++|||||||++|+|++|++||++.+..+....+.
T Consensus 282 ~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 358 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME 358 (467)
T ss_pred CCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 49999999875432 23346689999999999998877 789999999999999999999998876554443332
Q ss_pred cCccCCCC------------------------------------------CCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 231 GGIYTLPS------------------------------------------HLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 231 ~~~~~~p~------------------------------------------~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.....+|. ..++.+.|||.+||++||.+|||++|+++|
T Consensus 359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 21111110 114567899999999999999999999999
Q ss_pred cccccccCcc
Q 010214 269 PWFQAHLPRY 278 (515)
Q Consensus 269 p~f~~~~~~~ 278 (515)
|||+...+..
T Consensus 439 p~~~~~~~~~ 448 (467)
T PTZ00284 439 PYVLKYYPEC 448 (467)
T ss_pred ccccccCCcc
Confidence 9999865544
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=372.57 Aligned_cols=256 Identities=24% Similarity=0.443 Sum_probs=218.4
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
..++|++.+.||.|+||.||+|.+..++..+|+|++.... .......+.+|+++++.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 3589999999999999999999999999999999986542 23445778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
||||++||+|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~ 159 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA 159 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-cc
Confidence 999999999999999888899999999999999999999974 7999999999999999999999999998765332 23
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHH------------------------
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI------------------------ 229 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i------------------------ 229 (515)
...+|++.|+|||++.+..+ +.++|+||+||++|+|++|..||.......+...+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL 238 (333)
T ss_pred ccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence 45579999999999988766 78999999999999999999999765433322111
Q ss_pred --------------------hcC-ccCCC-CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 230 --------------------KGG-IYTLP-SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 230 --------------------~~~-~~~~p-~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
... ....+ ..++.++++||.+||+.||.+|||+.|++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000 01111 1357889999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=390.19 Aligned_cols=254 Identities=27% Similarity=0.441 Sum_probs=225.5
Q ss_pred CCCceEeeeecccCceEEEEEEEcCC-CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALT-GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~t-g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
...|.+.+.||+|+||.||+|.+..+ ++.||+|.+... .......+.+|+.+|+.++||||+++++++.+++.+|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34599999999999999999998887 788999977433 33445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 95 VMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
||||++||+|.+++.. ..++++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999998754 346899999999999999999999999999999999999999999999999999876543
Q ss_pred C---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-CCCCCCChhHHH
Q 010214 171 H---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARD 246 (515)
Q Consensus 171 ~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~ 246 (515)
. ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..++...+..+.. ..|..+++++++
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHH
Confidence 2 2345689999999999988776 7899999999999999999999999888888887776654 456788999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
+|.+||..||.+|||+.+++.|||++.
T Consensus 302 li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 999999999999999999999999864
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=391.32 Aligned_cols=262 Identities=29% Similarity=0.485 Sum_probs=230.1
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
......++|++.+.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.++..++|+||+++++.+....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 3345568999999999999999999999999999999999776543 345677889999999999999999998775332
Q ss_pred --------eEEEEEeccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEE
Q 010214 91 --------DIYVVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI 158 (515)
Q Consensus 91 --------~~~iVmEy~~gg~L~~~i~~~----~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL 158 (515)
.+++||||+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEE
Confidence 378999999999999999753 46899999999999999999999999999999999999999999999
Q ss_pred eeccccccccc---CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-
Q 010214 159 ADFGLSNIMRD---GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY- 234 (515)
Q Consensus 159 ~DFGls~~~~~---~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~- 234 (515)
+|||+++.... .....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+..
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~ 263 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD 263 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 99999976543 223456789999999999998776 7899999999999999999999999888888777776654
Q ss_pred CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 ~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.+|..+++++.+++.+||+.||.+|||+.++++|||++..
T Consensus 264 ~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 264 PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 4678899999999999999999999999999999999764
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=360.69 Aligned_cols=251 Identities=41% Similarity=0.698 Sum_probs=216.0
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy 98 (515)
|++++.||+|+||+||+|.+..+++.||+|++........ ......+|+.+++.++||||+++++++.+....++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence 8999999999999999999999999999999987654332 233445699999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc-ccCCccccCC
Q 010214 99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSC 177 (515)
Q Consensus 99 ~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~-~~~~~~~~~~ 177 (515)
+++++|.+++...+.+++..+..++.||+.||++||++||+|+||||+||+++.++.++|+|||.+... ..........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 159 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV 159 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999998889999999999999999999999999999999999999999999999999998763 3344556678
Q ss_pred CCCCccCCCccc-CCccCCCcceeehhHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCccCCC----CCCChhHHHHhc
Q 010214 178 GSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYALLCGTLPFDDENI---PNLFKKIKGGIYTLP----SHLSPGARDLIP 249 (515)
Q Consensus 178 gt~~Y~aPE~i~-~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~---~~~~~~i~~~~~~~p----~~~s~~~~~li~ 249 (515)
+++.|+|||++. +.. .+.++||||||+++|+|++|..||..... .....+........+ ...++++.++|.
T Consensus 160 ~~~~y~aPE~~~~~~~-~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 238 (260)
T PF00069_consen 160 GTPEYMAPEVLQQGKK-YTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIK 238 (260)
T ss_dssp SSGGGSCHHHHTTTSS-BSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHH
T ss_pred cccccccccccccccc-ccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHH
Confidence 999999999998 444 47999999999999999999999998732 333333333222111 122489999999
Q ss_pred ccCCCCCCCCCCHHHHhcCccc
Q 010214 250 RMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~hp~f 271 (515)
+||+.||.+|||+.++++||||
T Consensus 239 ~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 239 KMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=358.11 Aligned_cols=253 Identities=30% Similarity=0.545 Sum_probs=229.5
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|++++++++||||++++++++++...|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 69999999999999999999999999999999987666555567889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCC
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC 177 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~ 177 (515)
|+.|++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++.............
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 160 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS 160 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccC
Confidence 99999999999888899999999999999999999999999999999999999999999999999988776554455677
Q ss_pred CCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC---hHHHHHHHhcCccCCCCCCChhHHHHhcccCCC
Q 010214 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN---IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 178 gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~ 254 (515)
|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+ ...............|..++.++.++|.+||..
T Consensus 161 ~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (258)
T cd05578 161 GTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLER 239 (258)
T ss_pred CChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccC
Confidence 8999999999987765 789999999999999999999998876 344444444466677888999999999999999
Q ss_pred CCCCCCCH--HHHhcCccc
Q 010214 255 DPMKRITI--PEIRQHPWF 271 (515)
Q Consensus 255 dP~~Rpt~--~eil~hp~f 271 (515)
||.+||++ .|+++||||
T Consensus 240 ~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 240 DPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ChhHcCCccHHHHhcCCCC
Confidence 99999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=362.89 Aligned_cols=260 Identities=27% Similarity=0.504 Sum_probs=218.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||.|+||.||+|.++.+++.||+|.+...... .....+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 67899999999999999999999999999999998654322 2234577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccc
Q 010214 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~ 173 (515)
|||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ...
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence 99997 5899988753 56899999999999999999999999999999999999999999999999998764332 223
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-------------------c
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------------Y 234 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~ 234 (515)
....+++.|+|||++.+....+.++|||||||++|+|++|.+||...+..+....+.... .
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence 345678999999998776555789999999999999999999998877655444332210 1
Q ss_pred CCC-----------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccCcc
Q 010214 235 TLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY 278 (515)
Q Consensus 235 ~~p-----------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~~~ 278 (515)
..| ..+++++++||.+||+.||.+|||++|+++||||+....++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~ 296 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERI 296 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchh
Confidence 111 24688999999999999999999999999999998664443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=380.90 Aligned_cols=253 Identities=32% Similarity=0.462 Sum_probs=217.5
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-C-----CCccEEEEEEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-H-----PHIIRLYEVIE 87 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-h-----pnIv~l~~~~~ 87 (515)
.+..+|.+.+.||+|+||+|-+|.+..|++.||||+++... ....+...|+++|..++ | -|+|+++++|.
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 34458999999999999999999999999999999996543 44567778999999998 3 38999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC--CceEEeeccc
Q 010214 88 TPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK--WNVKIADFGL 163 (515)
Q Consensus 88 ~~~~~~iVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~--~~vKL~DFGl 163 (515)
..+++|||+|.++ -+|.++|+.+. +++...++.++.||+.||.+||+.||||+|||||||||... ..|||+|||.
T Consensus 259 fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 259 FRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred cccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccc
Confidence 9999999999995 49999999764 58899999999999999999999999999999999999754 4799999999
Q ss_pred ccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC--------
Q 010214 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-------- 235 (515)
Q Consensus 164 s~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~-------- 235 (515)
|......- .+.+-|..|+|||++.|.+| +.+.||||||||++||++|.+.|.+++..+++..|..-...
T Consensus 338 Sc~~~q~v--ytYiQSRfYRAPEVILGlpY-~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 338 SCFESQRV--YTYIQSRFYRAPEVILGLPY-DTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred ccccCCcc--eeeeeccccccchhhccCCC-CCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 98765543 38889999999999999999 78999999999999999999999999877777666432110
Q ss_pred --------------------------------------------CCC-----------CCChhHHHHhcccCCCCCCCCC
Q 010214 236 --------------------------------------------LPS-----------HLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 236 --------------------------------------------~p~-----------~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|. .-...+.|||++||.+||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 110 0123568999999999999999
Q ss_pred CHHHHhcCcccccc
Q 010214 261 TIPEIRQHPWFQAH 274 (515)
Q Consensus 261 t~~eil~hp~f~~~ 274 (515)
|..++|+||||...
T Consensus 495 tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 495 TPAQALNHPFLTGT 508 (586)
T ss_pred CHHHHhcCcccccc
Confidence 99999999999843
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=367.83 Aligned_cols=261 Identities=37% Similarity=0.584 Sum_probs=244.5
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCe
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSD 91 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 91 (515)
.....+|.++.+||+|+||+|-+|..+.|.+.||||++.++.+...+..+--..|-++|.... -|++++++..|++.+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 345689999999999999999999999999999999999988777777777788999998876 6789999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc-cccC
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~-~~~~ 170 (515)
+|+||||+.||+|-..|++-|++.|..|..++.+|+-||-+||++||++||||..||++|.+|+|||+|||++.. +.++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG 504 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999874 3456
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcc
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 250 (515)
...+|.||||.|+|||++..++| +.++|.||+||+||||+.|.+||++++..+++..|......+|..+|.++.++.+.
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg 583 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKG 583 (683)
T ss_pred cceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHH
Confidence 67889999999999999999988 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCH-----HHHhcCcccccc
Q 010214 251 MLIVDPMKRITI-----PEIRQHPWFQAH 274 (515)
Q Consensus 251 mL~~dP~~Rpt~-----~eil~hp~f~~~ 274 (515)
+|.+.|.+|..+ .+|..||||+..
T Consensus 584 ~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 584 LLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred HhhcCCccccCCCCccccchhhCcchhhc
Confidence 999999999865 689999999864
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=407.37 Aligned_cols=261 Identities=33% Similarity=0.559 Sum_probs=235.3
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|.++++||+|+||.|.+++++.|++.||+|+++|-.........-+..|-.+|.--+.+-|++++..|+++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 34578999999999999999999999999999999998755444445577889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~ 172 (515)
+||||++||+|..++.+.+++||..++.++..|+.||+-||+.|+|||||||+|||||..|+|||+|||.+-.+.. |..
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 9999999999999999988999999999999999999999999999999999999999999999999999887764 433
Q ss_pred c-ccCCCCCCccCCCccc----CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--ccCCC--CCCChh
Q 010214 173 L-KTSCGSPNYAAPEVIS----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLP--SHLSPG 243 (515)
Q Consensus 173 ~-~~~~gt~~Y~aPE~i~----~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~ 243 (515)
. .+.+|||.|.|||++. ++..+|+.+|.||+||++|||++|..||..++..+.+.+|.+- .+.+| ..+|++
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSee 311 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEE 311 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHH
Confidence 2 3568999999999985 3244589999999999999999999999999999999999876 67788 578999
Q ss_pred HHHHhcccCCCCCCCCCC---HHHHhcCccccccc
Q 010214 244 ARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAHL 275 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt---~~eil~hp~f~~~~ 275 (515)
+++||.+++ -+|..|.. ++++..||||...-
T Consensus 312 akdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 312 AKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred HHHHHHHHh-cChhhhcccccHHHHHhCccccCCC
Confidence 999999987 57889998 99999999998653
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=370.63 Aligned_cols=256 Identities=28% Similarity=0.490 Sum_probs=213.8
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC----
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP---- 89 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 89 (515)
.+.++|++.+.||.|+||+||+|.+..+++.||+|++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 346899999999999999999999999999999999875432 223346678999999999999999999987543
Q ss_pred --CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 90 --SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 90 --~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
..+|++||++ +++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 4579999998 779988775 467999999999999999999999999999999999999999999999999999865
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--------------
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------- 233 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------------- 233 (515)
.. ...+.+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 169 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07878 169 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246 (343)
T ss_pred CC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence 43 23456799999999999875445789999999999999999999998766544443332110
Q ss_pred ---------cCCC--------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 234 ---------YTLP--------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 234 ---------~~~p--------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
...| ...++.+.+||.+||+.||.+|||+.|+++||||...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0011 2356778999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=348.98 Aligned_cols=252 Identities=29% Similarity=0.558 Sum_probs=220.8
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc-CCeEEEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-PSDIYVVM 96 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~iVm 96 (515)
+|++.+.||.|++|.||+|.++.+++.||+|.+...... ......+.+|+.+++.++|||++++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 599999999999999999999999999999998754432 2345678899999999999999999998864 44689999
Q ss_pred eccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccc
Q 010214 97 EYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL 173 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~ 173 (515)
||+++++|.+++... ..+++.+++.++.|++.||.+||++|++||||||+||+++.++.++|+|||++...... ...
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence 999999999999763 45899999999999999999999999999999999999999999999999999876432 233
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-CCCCCCChhHHHHhcccC
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRML 252 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~mL 252 (515)
.+..|++.|+|||++.+..+ +.++|+||+||++|+|++|..||+..+.......+..+.. ..+..+++.+.+++.+||
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 238 (257)
T cd08223 160 STLIGTPYYMSPELFSNKPY-NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATML 238 (257)
T ss_pred ccccCCcCccChhHhcCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHh
Confidence 45678999999999988766 6899999999999999999999998877766666655544 556778999999999999
Q ss_pred CCCCCCCCCHHHHhcCccc
Q 010214 253 IVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 253 ~~dP~~Rpt~~eil~hp~f 271 (515)
+.||.+|||+.++++||||
T Consensus 239 ~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 239 SKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ccCcccCCCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=361.38 Aligned_cols=257 Identities=36% Similarity=0.586 Sum_probs=227.6
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+++++.++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998776554456678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC---
Q 010214 97 EYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--- 171 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~--- 171 (515)
||+.|++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998754 569999999999999999999999999999999999999999999999999986543211
Q ss_pred ---------------------------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHH
Q 010214 172 ---------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN 224 (515)
Q Consensus 172 ---------------------------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~ 224 (515)
......||..|+|||++.+..+ +.++||||||+++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 1123468889999999987766 789999999999999999999999888777
Q ss_pred HHHHHhcCccCCCCC--CChhHHHHhcccCCCCCCCCCC----HHHHhcCcccccc
Q 010214 225 LFKKIKGGIYTLPSH--LSPGARDLIPRMLIVDPMKRIT----IPEIRQHPWFQAH 274 (515)
Q Consensus 225 ~~~~i~~~~~~~p~~--~s~~~~~li~~mL~~dP~~Rpt----~~eil~hp~f~~~ 274 (515)
.+.++.......|.. ++.++.++|.+||..||.+||| ++|++.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 777777666555544 6999999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=351.18 Aligned_cols=249 Identities=36% Similarity=0.692 Sum_probs=224.5
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCH
Q 010214 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (515)
Q Consensus 25 LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L 104 (515)
||.|++|.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.++..+|++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999877665555678899999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCCCCccC
Q 010214 105 FDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAA 184 (515)
Q Consensus 105 ~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~a 184 (515)
.+++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.............|++.|+|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 160 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVA 160 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccC
Confidence 99998888899999999999999999999999999999999999999999999999999987765543445678999999
Q ss_pred CCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC--hHHHHHHHh--cCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 185 PEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLFKKIK--GGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 185 PE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~--~~~~~~~i~--~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
||.+.+..+ +.++|+||+|+++|+|++|..||.... ......++. ......|...++++.++|.+||..||.+||
T Consensus 161 PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 239 (262)
T cd05572 161 PEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERL 239 (262)
T ss_pred hhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCc
Confidence 999887665 689999999999999999999998766 556666666 445667777899999999999999999999
Q ss_pred C-----HHHHhcCcccccc
Q 010214 261 T-----IPEIRQHPWFQAH 274 (515)
Q Consensus 261 t-----~~eil~hp~f~~~ 274 (515)
| +.|+++||||++.
T Consensus 240 ~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 240 GNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred CCcccCHHHHhcChhhhCC
Confidence 9 9999999999854
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=359.48 Aligned_cols=254 Identities=25% Similarity=0.475 Sum_probs=217.8
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.+..++..+|+|.+.... .......+.+|+++++.++||||+++++++.+++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999986432 2345567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
||++|++|.+++.+.+.+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++...... ...+
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~ 157 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANS 157 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-cccc
Confidence 999999999999988889999999999999999999997 69999999999999999999999999998765332 2355
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc----------------------
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---------------------- 233 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~---------------------- 233 (515)
.+|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+....
T Consensus 158 ~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06615 158 FVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRP 236 (308)
T ss_pred CCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccch
Confidence 689999999999987765 689999999999999999999997655433322221110
Q ss_pred ---------------cCCC-CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 234 ---------------YTLP-SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 234 ---------------~~~p-~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
...| ..++.++++|+.+||..||++|||+.++++||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 237 MAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred hhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 1111 1367889999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=357.55 Aligned_cols=256 Identities=34% Similarity=0.600 Sum_probs=225.1
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||.|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999987665444445678889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC------
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG------ 170 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~------ 170 (515)
||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999988642110
Q ss_pred ----------CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCC--
Q 010214 171 ----------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS-- 238 (515)
Q Consensus 171 ----------~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~-- 238 (515)
.......|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||.+....+....+..+....|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 01123467889999999987665 78999999999999999999999988877777777766544433
Q ss_pred -CCChhHHHHhcccCCCCCCCCCC---HHHHhcCccccc
Q 010214 239 -HLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQA 273 (515)
Q Consensus 239 -~~s~~~~~li~~mL~~dP~~Rpt---~~eil~hp~f~~ 273 (515)
.++.++.++|.+||+.||.+||| +.++++||||..
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 57899999999999999999998 799999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=349.88 Aligned_cols=253 Identities=30% Similarity=0.524 Sum_probs=220.8
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh------HHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM------EMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~------~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
+|.+.+.||.|+||.||+|.+..+++.||+|.+........ ...+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 57889999999999999999999999999999876543321 234678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
.++||||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999987664211
Q ss_pred -------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC-ccCCCCCCChh
Q 010214 172 -------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-IYTLPSHLSPG 243 (515)
Q Consensus 172 -------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 243 (515)
......|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||.+.+......++... ...+|..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1123468899999999987766 68899999999999999999999876655444444433 34567788999
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
+.++|++||+.||.+|||+.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=345.23 Aligned_cols=252 Identities=31% Similarity=0.518 Sum_probs=224.7
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|.+.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 589999999999999999999999999999998765443 3456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccc
Q 010214 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (515)
Q Consensus 98 y~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~ 174 (515)
|++|++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....... ...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 99999999999764 578999999999999999999999999999999999999999999999999988665432 334
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-CCCCCCChhHHHHhcccCC
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~mL~ 253 (515)
...|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+......++..+.. .++..++.++.+++.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLT 238 (256)
T ss_pred ccccCccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence 5678999999999988766 6899999999999999999999998887777777766543 4455788999999999999
Q ss_pred CCCCCCCCHHHHhcCccc
Q 010214 254 VDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~f 271 (515)
.+|++||++.+++.|||+
T Consensus 239 ~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 239 KDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CCcccCcCHHHHhhCCCC
Confidence 999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=353.41 Aligned_cols=252 Identities=30% Similarity=0.509 Sum_probs=210.9
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||.|++|.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 589999999999999999999999999999998654322 2234677899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cc
Q 010214 98 YVKSGELFDYIVEK---GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (515)
Q Consensus 98 y~~gg~L~~~i~~~---~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~ 173 (515)
|++ ++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++....... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 997 5898888642 468999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC---------------------
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--------------------- 232 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~--------------------- 232 (515)
....+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 34467899999999877654578999999999999999999999876543322211100
Q ss_pred --------ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 233 --------IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 233 --------~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.......+++++.++|.+||..||.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 001123578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=352.91 Aligned_cols=254 Identities=28% Similarity=0.505 Sum_probs=215.2
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.++.+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 5799999999999999999999999999999998654322 123456789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~ 175 (515)
||++++.|..++.....+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++....... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence 999998888887777789999999999999999999999999999999999999999999999999998765443 2334
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-------------------cCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------------YTL 236 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~~~ 236 (515)
..++..|+|||++.+....+.++|+||+||++|+|++|..||.+.+..+....+.... ...
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence 5688999999998775444789999999999999999999998766544333222100 000
Q ss_pred C------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 237 P------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 237 p------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
| +.++..+.+|+.+||+.||.+|||+.|++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 1 2467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=353.57 Aligned_cols=249 Identities=36% Similarity=0.569 Sum_probs=218.6
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCH
Q 010214 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (515)
Q Consensus 25 LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L 104 (515)
||.|+||+||+|.+..+|+.||+|++.+...........+.+|+++++.++||||++++++++..+..|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999876554444556678899999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCCCCc
Q 010214 105 FDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY 182 (515)
Q Consensus 105 ~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y 182 (515)
.+++.+.+ .+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.............++..|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence 99998766 7999999999999999999999999999999999999999999999999998876554444556788999
Q ss_pred cCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh----HHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCC
Q 010214 183 AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMK 258 (515)
Q Consensus 183 ~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~ 258 (515)
+|||++.+..+ +.++|+||+||++|+|++|..||..... ..+...+.......|..+++++.++|.+||+.||.+
T Consensus 161 ~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 239 (277)
T cd05577 161 MAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK 239 (277)
T ss_pred CCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhH
Confidence 99999987765 7899999999999999999999977543 333344444455677788999999999999999999
Q ss_pred CC-----CHHHHhcCcccccc
Q 010214 259 RI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 259 Rp-----t~~eil~hp~f~~~ 274 (515)
|| ++.+++.||||+..
T Consensus 240 R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 240 RLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred ccCCCcccHHHHHhChhhhcC
Confidence 99 88889999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=349.74 Aligned_cols=254 Identities=31% Similarity=0.562 Sum_probs=218.6
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCC---hHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN---MEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
+|+..+.||+|+||.||+|.+..+++.||+|++....... ....+.+.+|+++++.++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 5889999999999999999999999999999987544222 2345788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-ceEEeecccccccccC---
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDG--- 170 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~-~vKL~DFGls~~~~~~--- 170 (515)
||||++|++|.+++.+.+++++..+..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||.+......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999999888999999999999999999999999999999999999998776 5999999998766432
Q ss_pred --CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHH-----hcCccCCCCCCChh
Q 010214 171 --HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-----KGGIYTLPSHLSPG 243 (515)
Q Consensus 171 --~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i-----~~~~~~~p~~~s~~ 243 (515)
.......|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...........+ .......|..++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 12234568899999999987766 78999999999999999999999765433222222 12234566778999
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
+.+++.+||..+|.+|||+.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=363.58 Aligned_cols=249 Identities=28% Similarity=0.470 Sum_probs=206.7
Q ss_pred CCCceEeeeecccCceEEEEEEEc-----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~ 89 (515)
.++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 468999999999999999999752 345789999986432 223456788999999999 899999999988764
Q ss_pred -CeEEEEEeccCCCCHHHHHHHh---------------------------------------------------------
Q 010214 90 -SDIYVVMEYVKSGELFDYIVEK--------------------------------------------------------- 111 (515)
Q Consensus 90 -~~~~iVmEy~~gg~L~~~i~~~--------------------------------------------------------- 111 (515)
..+|+||||+++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4589999999999999999753
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC---ccccCCCCCCcc
Q 010214 112 -----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYA 183 (515)
Q Consensus 112 -----~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~Y~ 183 (515)
.++++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...+..+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 247788899999999999999999999999999999999999999999999997653321 112334678899
Q ss_pred CCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHH-HHHHHhcC-ccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 184 APEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN-LFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 184 aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
|||++.+..+ +.++|||||||++|+|++ |..||.+..... ....+..+ ....|...++++.+++.+||..||.+||
T Consensus 244 aPE~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 244 APESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred CcHHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 9999988776 789999999999999997 999998765433 33444433 3455678899999999999999999999
Q ss_pred CHHHHhc
Q 010214 261 TIPEIRQ 267 (515)
Q Consensus 261 t~~eil~ 267 (515)
|+.|+++
T Consensus 323 s~~el~~ 329 (338)
T cd05102 323 TFSALVE 329 (338)
T ss_pred CHHHHHH
Confidence 9999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=352.77 Aligned_cols=250 Identities=30% Similarity=0.464 Sum_probs=209.2
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHH---hCCCCCccEEEEEEEcCCeEEEEEeccC
Q 010214 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR---LFMHPHIIRLYEVIETPSDIYVVMEYVK 100 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~---~l~hpnIv~l~~~~~~~~~~~iVmEy~~ 100 (515)
.||+|+||.||+|.+..+++.+|+|.+.+.............+|..+++ ..+||||+.+++++.+.+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997765443333333445554444 4479999999999999999999999999
Q ss_pred CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCCC
Q 010214 101 SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180 (515)
Q Consensus 101 gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~ 180 (515)
||+|.+++..++.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... .....|++
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~ 159 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH 159 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCCc
Confidence 99999999988899999999999999999999999999999999999999999999999999987554332 23457999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC---hHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN---IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~ 257 (515)
.|+|||.+.+....+.++||||+||++|+|++|..||.... ..............+|..++++++++|.+||..||.
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 239 (279)
T cd05633 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVS 239 (279)
T ss_pred CccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHH
Confidence 99999998743334789999999999999999999997543 222222333344567778999999999999999999
Q ss_pred CCC-----CHHHHhcCcccccc
Q 010214 258 KRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 258 ~Rp-----t~~eil~hp~f~~~ 274 (515)
+|+ |+.|+++||||+..
T Consensus 240 ~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 240 KRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred HhcCCCCCCHHHHHhCccccCC
Confidence 999 69999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=359.82 Aligned_cols=244 Identities=30% Similarity=0.498 Sum_probs=195.4
Q ss_pred eeeecccCceEEEEEEEc--CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CCeEEEEEe
Q 010214 22 GKTLGIGSFGKVKIAEHA--LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--PSDIYVVME 97 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~iVmE 97 (515)
++.||+|+||.||+|.++ .+++.||+|.+..... ...+.+|+.+++.++||||+++++++.. ...+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999976 4678999999865432 2456789999999999999999999854 456899999
Q ss_pred ccCCCCHHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----CCCCceEEeecccc
Q 010214 98 YVKSGELFDYIVEK---------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL----DSKWNVKIADFGLS 164 (515)
Q Consensus 98 y~~gg~L~~~i~~~---------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl----~~~~~vKL~DFGls 164 (515)
|+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 995 5898888632 258999999999999999999999999999999999999 45678999999999
Q ss_pred cccccC----CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH---------HHHHHHhc
Q 010214 165 NIMRDG----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---------NLFKKIKG 231 (515)
Q Consensus 165 ~~~~~~----~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~---------~~~~~i~~ 231 (515)
...... ......+||+.|+|||++.+....+.++||||+||++|+|++|.+||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 876432 12345678999999999987655588999999999999999999999643311 11111111
Q ss_pred C----------------------------ccC----------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 232 G----------------------------IYT----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 232 ~----------------------------~~~----------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
. ... .....+.++.+||.+||+.||.+|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 000 001235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=342.55 Aligned_cols=252 Identities=34% Similarity=0.600 Sum_probs=224.9
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||.|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 6999999999999999999999999999999998765443 346788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CceEEeecccccccccCCccc
Q 010214 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 98 y~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~-~~vKL~DFGls~~~~~~~~~~ 174 (515)
|++|++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.+||+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence 99999999999764 358999999999999999999999999999999999999865 458999999998776555555
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcccCC
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~ 253 (515)
...|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+.... ..++..+++++.+++.+||.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 238 (256)
T cd08220 160 TVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLN 238 (256)
T ss_pred ccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHcc
Confidence 6678999999999987765 689999999999999999999999888777776665543 35677789999999999999
Q ss_pred CCCCCCCCHHHHhcCccc
Q 010214 254 VDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~f 271 (515)
.||.+|||+.|++.||||
T Consensus 239 ~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 239 LDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CChhhCCCHHHHhhCCCC
Confidence 999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=345.55 Aligned_cols=253 Identities=30% Similarity=0.490 Sum_probs=220.1
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||.|+||.||+|.+..++..+|+|++....... ....+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 57999999999999999999999999999999987554332 5678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc-
Q 010214 97 EYVKSGELFDYIVEK---GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF- 172 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~---~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~- 172 (515)
|+++|++|.+++... +.+++..++.++.||+.||.|||++|++||||+|+||++++++.++|+|||++........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 4589999999999999999999999999999999999999999999999999876654322
Q ss_pred ----cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-CCC-----CCCCh
Q 010214 173 ----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLP-----SHLSP 242 (515)
Q Consensus 173 ----~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p-----~~~s~ 242 (515)
.....|++.|+|||++......+.++|+||+||++|+|++|..||...+......++..... .++ ..+++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 23457899999999988764447899999999999999999999988766655555544322 111 25678
Q ss_pred hHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 243 GARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 243 ~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.+.+++.+||..||.+|||+.++++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=346.88 Aligned_cols=252 Identities=27% Similarity=0.463 Sum_probs=217.1
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccC---ChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK---NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
+|++.+.||.|+||.||+|.+ .+|+.+|+|.+...... .......+.+|+.+++.++||||+++++++.+....|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999986 48899999998654322 12334678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-----
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD----- 169 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~----- 169 (515)
||||++|++|.+++.+.+.+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 999999999999998888899999999999999999999999999999999999999999999999999875421
Q ss_pred --CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC---ccCCCCCCChhH
Q 010214 170 --GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGA 244 (515)
Q Consensus 170 --~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~ 244 (515)
........|+..|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+... ....|..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 112234568999999999988766 68999999999999999999999875544433333322 234667789999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.++|.+||..+|.+|||+.++++||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=394.35 Aligned_cols=267 Identities=26% Similarity=0.443 Sum_probs=223.7
Q ss_pred CCCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010214 9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET 88 (515)
Q Consensus 9 ~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 88 (515)
....+...++|++++.||.|+||+||+|.+..++..||+|++....... .....+.+|+.+++.++||||++++++|..
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 3456677899999999999999999999999999999999997654433 345778999999999999999999998854
Q ss_pred --CCeEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCcEEECC---
Q 010214 89 --PSDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRN-------MVVHRDLKPENLLLDS--- 152 (515)
Q Consensus 89 --~~~~~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~-------gIvHrDLkpeNILl~~--- 152 (515)
...+||||||+++|+|.++|.. .+.+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 4579999999999999999975 35799999999999999999999984 4999999999999964
Q ss_pred --------------CCceEEeecccccccccCCccccCCCCCCccCCCcccCC-ccCCCcceeehhHHHHHHHHhCCCCC
Q 010214 153 --------------KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPF 217 (515)
Q Consensus 153 --------------~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~-~~~~~~~DIwSlGvily~lltG~~Pf 217 (515)
.+.+||+|||++............+||+.|+|||++.+. ...++++||||||||||+|++|..||
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 234899999999877655555667899999999998643 23378999999999999999999999
Q ss_pred CCCCh-HHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 218 DDENI-PNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 218 ~~~~~-~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
..... ..+...+...........+.++.+||..||..+|.+|||+.|+|.|||++...+
T Consensus 244 ~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 244 HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred CcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 76544 344444444332223457899999999999999999999999999999975533
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=356.08 Aligned_cols=252 Identities=29% Similarity=0.548 Sum_probs=210.9
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||.|+||.||+|.++.+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+...+|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 58999999999999999999999999999999875432 22234567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccccc
Q 010214 98 YVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKT 175 (515)
Q Consensus 98 y~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~ 175 (515)
|+++ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA 158 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence 9975 88888765 567999999999999999999999999999999999999999999999999998765432 22334
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCC-CCCChHHHHHHHhcCc---------------------
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGI--------------------- 233 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf-~~~~~~~~~~~i~~~~--------------------- 233 (515)
..+++.|+|||++.+....+.++||||+||++|+|++|..|| .+.+.......+....
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence 567899999999887655578999999999999999998885 4444444433332110
Q ss_pred --------cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 234 --------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 234 --------~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
......+++++++||.+||+.||.+|||+++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00113478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=350.92 Aligned_cols=250 Identities=30% Similarity=0.479 Sum_probs=213.1
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHH---HHHHhCCCCCccEEEEEEEcCCeEEEEEeccC
Q 010214 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREI---KILRLFMHPHIIRLYEVIETPSDIYVVMEYVK 100 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei---~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~ 100 (515)
.||+|+||.||+|.+..+++.||+|++.+..............|. ..++...||+|+++++++.+.+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999999876544322222333343 44555679999999999999999999999999
Q ss_pred CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCCC
Q 010214 101 SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180 (515)
Q Consensus 101 gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~ 180 (515)
||+|.+++...+.+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++...... ...+.+|+.
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~ 159 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTH 159 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCCCc
Confidence 9999999988889999999999999999999999999999999999999999999999999998765332 234568999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC---ChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~ 257 (515)
.|+|||++.+....+.++||||+||++|+|++|..||.+. ........+......+|..+++++.+++.+||..||.
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~ 239 (278)
T cd05606 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 239 (278)
T ss_pred CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHH
Confidence 9999999975533478999999999999999999999876 3344444555556677888899999999999999999
Q ss_pred CCC-----CHHHHhcCcccccc
Q 010214 258 KRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 258 ~Rp-----t~~eil~hp~f~~~ 274 (515)
+|| ++.++++||||+..
T Consensus 240 ~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 240 RRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred hccCCCCCCHHHHHhCccccCC
Confidence 999 99999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=346.12 Aligned_cols=254 Identities=33% Similarity=0.550 Sum_probs=216.8
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccC--ChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CCeE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--NMEMEEKVRREIKILRLFMHPHIIRLYEVIET--PSDI 92 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 92 (515)
.+|++.+.||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3799999999999999999999999999999998755332 22345678999999999999999999999865 3678
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC--
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-- 170 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-- 170 (515)
+++|||+++++|.+++...+.+++...+.++.|++.||+|||+++|+||||||+||+++.++.+||+|||++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 999999999999999988888999999999999999999999999999999999999999999999999998755321
Q ss_pred --CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--ccCCCCCCChhHHH
Q 010214 171 --HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARD 246 (515)
Q Consensus 171 --~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 246 (515)
.......++..|+|||.+.+..+ +.++|+||+||++|+|++|..||..........++... ...+|..+++.+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence 12233568899999999988765 78999999999999999999999876554444443322 24456678899999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
++ +||..+|.+|||++|+++||||+
T Consensus 241 li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhcCcccc
Confidence 99 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=349.06 Aligned_cols=251 Identities=26% Similarity=0.401 Sum_probs=213.4
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 468999999999999999999999999999999986542 22345678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Cccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~~ 174 (515)
|||+++++|.+++...+.+++.+++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++...... ....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK 164 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence 999999999999998889999999999999999999999999999999999999999999999999998765432 1223
Q ss_pred cCCCCCCccCCCccc---CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC-----CCCChhHHH
Q 010214 175 TSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP-----SHLSPGARD 246 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~---~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~~ 246 (515)
...|++.|+|||++. +..+ +.++|+||+||++|+|++|..||...........+.......+ ..++..+.+
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH 243 (267)
T ss_pred cccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence 457899999999974 2334 6899999999999999999999976543333222222222211 246788999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPW 270 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~ 270 (515)
++.+||..||++|||++++++|||
T Consensus 244 li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 244 FVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=351.95 Aligned_cols=240 Identities=18% Similarity=0.265 Sum_probs=211.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc----CCeEEEEEec
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----PSDIYVVMEY 98 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~iVmEy 98 (515)
..||+|++|.||+|.. +|+.||||.+.+.........+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999987 789999999987655454556788899999999999999999999866 4578999999
Q ss_pred cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccCCccccCC
Q 010214 99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC 177 (515)
Q Consensus 99 ~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~ 177 (515)
++||+|.+++.+.+.+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++....... ....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~~~ 181 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FKNV 181 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--cccc
Confidence 9999999999988889999999999999999999998 599999999999999999999999999988664332 3457
Q ss_pred CCCCccCCCcccC--CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--ccCCCCCCChhHHHHhcccCC
Q 010214 178 GSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 178 gt~~Y~aPE~i~~--~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~mL~ 253 (515)
|++.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+...+...+... ...+|...++++.+++.+||+
T Consensus 182 ~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~ 260 (283)
T PHA02988 182 NFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTS 260 (283)
T ss_pred CcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhc
Confidence 8999999999976 444 78999999999999999999999998888877777443 445566789999999999999
Q ss_pred CCCCCCCCHHHHhc
Q 010214 254 VDPMKRITIPEIRQ 267 (515)
Q Consensus 254 ~dP~~Rpt~~eil~ 267 (515)
.||.+|||+.|+++
T Consensus 261 ~dp~~Rps~~ell~ 274 (283)
T PHA02988 261 HDSIKRPNIKEILY 274 (283)
T ss_pred CCcccCcCHHHHHH
Confidence 99999999999985
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=368.19 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=209.6
Q ss_pred cCCCceEeeeecccCceEEEEEEEc--CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHA--LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
+..+|.+++.||.|+||.||+|... .++..||+|.+... ....+|+++|+.++||||+++++++.....+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 4567999999999999999999764 35678999987543 2346899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
|+|||++. ++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 99999995 69999998788899999999999999999999999999999999999999999999999999876544322
Q ss_pred ---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH---HHHHHHhcC--------------
Q 010214 173 ---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---NLFKKIKGG-------------- 232 (515)
Q Consensus 173 ---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~---~~~~~i~~~-------------- 232 (515)
.....||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.... ..+..+...
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred cccccccccccCccCHhHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 234579999999999988877 68999999999999999999999764321 111111110
Q ss_pred ---------------ccCCC-----CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 233 ---------------IYTLP-----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 233 ---------------~~~~p-----~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
.+..| ..++.++.+||.+||..||.+|||+.|++.||||+..-+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 01111 134678899999999999999999999999999986533
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=360.68 Aligned_cols=253 Identities=22% Similarity=0.368 Sum_probs=208.0
Q ss_pred Eeeeeccc--CceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010214 21 LGKTLGIG--SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 21 i~~~LG~G--~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy 98 (515)
++++||+| +||+||++.++.+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 7899999999999999999998765433 34556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CC----
Q 010214 99 VKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GH---- 171 (515)
Q Consensus 99 ~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~---- 171 (515)
+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+..... +.
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9999999999753 4589999999999999999999999999999999999999999999999986543221 11
Q ss_pred ---ccccCCCCCCccCCCcccCC-ccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC------------
Q 010214 172 ---FLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------ 235 (515)
Q Consensus 172 ---~~~~~~gt~~Y~aPE~i~~~-~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~------------ 235 (515)
......++..|+|||++.+. ...+.++||||+||++|+|++|..||..............+..+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 11234577889999999763 22378999999999999999999999875544333222221110
Q ss_pred ----------------------------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 236 ----------------------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 236 ----------------------------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
....+++++.+||.+||+.||.+|||++|+++||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 112356789999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=352.28 Aligned_cols=260 Identities=31% Similarity=0.499 Sum_probs=223.5
Q ss_pred CCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010214 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (515)
Q Consensus 10 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 89 (515)
..+.....+|++.+.||.|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++.+...
T Consensus 13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred cccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 34555678999999999999999999999999999999998764432 346788999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
...|+||||++|++|.+++.+ ..+++.++..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 999999999999999999854 5689999999999999999999999999999999999999999999999999876543
Q ss_pred CC-ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHh-cCc--cCCCCCCChhHH
Q 010214 170 GH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK-GGI--YTLPSHLSPGAR 245 (515)
Q Consensus 170 ~~-~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~-~~~--~~~p~~~s~~~~ 245 (515)
.. ......|++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+. ... ...|..+++.+.
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 247 (296)
T cd06654 169 EQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (296)
T ss_pred cccccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHH
Confidence 32 2234578999999999987765 689999999999999999999998776543332222 222 234567889999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+++.+||..||.+|||+.+++.||||...
T Consensus 248 ~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 99999999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=349.25 Aligned_cols=253 Identities=32% Similarity=0.562 Sum_probs=217.1
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||.|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 5899999999999999999999999999999997654322 345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--ccc
Q 010214 98 YVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLK 174 (515)
Q Consensus 98 y~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~--~~~ 174 (515)
|+ +++|.+++.. ...+++.+++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... ...
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 99 9999999865 4568999999999999999999999999999999999999999999999999988765433 234
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc--------------------
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-------------------- 234 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-------------------- 234 (515)
...|+..|+|||.+.+....++++||||+||++|+|++|.+||.+.........+.....
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 567899999999987665557899999999999999999999987665554444322100
Q ss_pred ----------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 235 ----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 235 ----------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
...+..+.++.+||.+||..||.+|||+++++.||||.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 01124578899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=348.75 Aligned_cols=250 Identities=28% Similarity=0.455 Sum_probs=213.2
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|++++++++||||+++++.+...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 46889999999999999999999999999999986542 2344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccC
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS 176 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~ 176 (515)
||+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++...... .....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~ 153 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTY 153 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCC
Confidence 99999999654 35789999999999999999999999999999999999999999999999999765433 34456
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh-------HHHHHHHhcCc-cCC-CCCCChhHHHH
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-------PNLFKKIKGGI-YTL-PSHLSPGARDL 247 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~-------~~~~~~i~~~~-~~~-p~~~s~~~~~l 247 (515)
+|++.|+|||++.+..+ +.++|+||+||++|+|++|..||..... ......+.... ... ....+++++++
T Consensus 154 ~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (279)
T cd06619 154 VGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF 232 (279)
T ss_pred CCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence 89999999999988766 7899999999999999999999965321 12222222222 122 23578899999
Q ss_pred hcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+.+||+.||.+||+++|+++||||+..
T Consensus 233 i~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 233 ITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHhhCChhhCCCHHHHhcCcccccc
Confidence 999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=351.13 Aligned_cols=256 Identities=31% Similarity=0.446 Sum_probs=222.0
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||.|+||.||+|.+..+++.||+|++... .....+.+.+|+++++.++||||+++++++.++...|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 36799999999999999999999989999999998543 334557788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cc
Q 010214 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~ 173 (515)
|||+++++|.+++.+. ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 9999999999998764 569999999999999999999999999999999999999999999999999887653322 22
Q ss_pred ccCCCCCCccCCCcccCC----ccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---CCCCCCChhHHH
Q 010214 174 KTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGARD 246 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~----~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~ 246 (515)
....|++.|+|||++.+. ...+.++|+||+||++|+|++|..||.+.+......++..+.. ..|..++.++.+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFND 240 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHH
Confidence 345689999999998532 2235789999999999999999999988776666666665532 345678999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+|.+||..||.+|||+.++++||||...
T Consensus 241 li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 241 FLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHhccChhhCcCHHHHhcChhhccc
Confidence 9999999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=342.77 Aligned_cols=252 Identities=34% Similarity=0.603 Sum_probs=223.7
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CCeEEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--PSDIYVV 95 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~iV 95 (515)
+|++.+.||.|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.. ....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 589999999999999999999999999999998765443 3445778899999999999999999998753 4568999
Q ss_pred EeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 96 MEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCH-----RNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 96 mEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH-----~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
|||+++++|.+++.. ..++++..++.++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999975 367999999999999999999999 89999999999999999999999999999987
Q ss_pred cccCCc-cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-CCCCCCChhH
Q 010214 167 MRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGA 244 (515)
Q Consensus 167 ~~~~~~-~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~ 244 (515)
...... ..+..|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.....+.+..+.. .+|...+.++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL 238 (265)
T ss_pred ccCCcccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHH
Confidence 755443 455679999999999988765 6899999999999999999999998887777777776654 4677889999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.+++.+||..+|.+|||+.++++|||+
T Consensus 239 ~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 239 NEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=342.48 Aligned_cols=254 Identities=31% Similarity=0.496 Sum_probs=222.9
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccC--ChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
+|+..+.||+|+||+||+|.+..+++.||+|.+...... ..+....+.+|+.+++.++||||+++++++.+...+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 578889999999999999999989999999998754322 234567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
|||+++++|.+++.+.+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++...........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 160 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS 160 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence 99999999999998888899999999999999999999999999999999999999999999999999887655444556
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhc--CccCCCCCCChhHHHHhcccCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~mL~ 253 (515)
..|++.|+|||.+......+.++|+||+||++|+|++|..||..........++.. ....+|..+++++.+++.+||+
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 240 (258)
T cd06632 161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ 240 (258)
T ss_pred cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhh
Confidence 77999999999987665237899999999999999999999987664444444433 2345667789999999999999
Q ss_pred CCCCCCCCHHHHhcCccc
Q 010214 254 VDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~f 271 (515)
.+|.+|||+.+++.|||+
T Consensus 241 ~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 241 RDPSLRPTAAELLEHPFV 258 (258)
T ss_pred cCcccCcCHHHHhcCCCC
Confidence 999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=343.95 Aligned_cols=254 Identities=33% Similarity=0.569 Sum_probs=217.0
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccc--cCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CeE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRK--IKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDI 92 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 92 (515)
.+|++.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999999999999999886432 22233457889999999999999999999998763 568
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC--
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-- 170 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-- 170 (515)
+++|||++|++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 899999999999999988888999999999999999999999999999999999999999999999999998765321
Q ss_pred --CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--ccCCCCCCChhHHH
Q 010214 171 --HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARD 246 (515)
Q Consensus 171 --~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 246 (515)
.......|+..|+|||++.+..+ +.++|+|||||++|+|++|+.||..........++... ....|..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 12334568999999999987765 78999999999999999999999876544444444332 23456678889999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
+|.+|+. +|.+|||++|+++|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999994 999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=340.66 Aligned_cols=252 Identities=33% Similarity=0.528 Sum_probs=224.7
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||.|+||.||.+.+..+++.+++|.+....... .....+.+|+.++++++||||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999987655443 345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccc
Q 010214 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (515)
Q Consensus 98 y~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~ 174 (515)
|+++++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 99999999999765 468999999999999999999999999999999999999999999999999987664433 334
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-CCCCCChhHHHHhcccCC
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~mL~ 253 (515)
...|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+..+....+..+.+. .+..++.++.+++.+||.
T Consensus 160 ~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQ 238 (256)
T ss_pred ccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence 5678999999999987765 68899999999999999999999998888877777666543 345678999999999999
Q ss_pred CCCCCCCCHHHHhcCccc
Q 010214 254 VDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~f 271 (515)
.+|.+|||+.++++|||+
T Consensus 239 ~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 239 QDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cCcccCCCHHHHhhCcCC
Confidence 999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=352.15 Aligned_cols=260 Identities=31% Similarity=0.514 Sum_probs=224.6
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.......+|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred hcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 334445789999999999999999999999999999999865432 23567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.+|+|+||+++++|.+++.. ..+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred eEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 99999999999999998864 46899999999999999999999999999999999999999999999999998765443
Q ss_pred Cc-cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC---ccCCCCCCChhHHH
Q 010214 171 HF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARD 246 (515)
Q Consensus 171 ~~-~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~ 246 (515)
.. .....|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+... ....|..+++.+.+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247 (296)
T ss_pred cccCCCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHH
Confidence 22 334578999999999987766 68999999999999999999999887665444444332 23346678999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
+|.+||..||.+|||+.+++.||||+...
T Consensus 248 li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 248 FLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 99999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=342.23 Aligned_cols=252 Identities=29% Similarity=0.566 Sum_probs=223.5
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||+|+||.||++.+..+|+.||+|.+....... .....+.+|+.+++.++||||++++++++..+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 5999999999999999999999999999999987654433 345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc-cc
Q 010214 98 YVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LK 174 (515)
Q Consensus 98 y~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~-~~ 174 (515)
|+.+++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 999999999997643 589999999999999999999999999999999999999999999999999876644322 23
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-CCCCCCChhHHHHhcccCC
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~mL~ 253 (515)
...|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+..+.. ..|..++.++.++|.+||+
T Consensus 160 ~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08218 160 TCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFK 238 (256)
T ss_pred hccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhh
Confidence 4468899999999987765 6799999999999999999999998888777777766554 4667889999999999999
Q ss_pred CCCCCCCCHHHHhcCccc
Q 010214 254 VDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~f 271 (515)
.+|.+||++.++++||||
T Consensus 239 ~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 239 RNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CChhhCcCHHHHhhCcCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=347.00 Aligned_cols=252 Identities=24% Similarity=0.352 Sum_probs=213.6
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 4689999999999999999999999999999999864432 2345678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~ 174 (515)
|||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 9999999999999888899999999999999999999999999999999999999999999999999998664322 223
Q ss_pred cCCCCCCccCCCcccCC--ccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCC-----CCCCChhHHHH
Q 010214 175 TSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL-----PSHLSPGARDL 247 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~--~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~-----p~~~s~~~~~l 247 (515)
...|++.|+|||.+.+. ...+.++|+||+||++|+|++|..||...........+....... +..++..+.+|
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNF 244 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHH
Confidence 45789999999998532 222678999999999999999999997654333222222222221 23568899999
Q ss_pred hcccCCCCCCCCCCHHHHhcCcc
Q 010214 248 IPRMLIVDPMKRITIPEIRQHPW 270 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~hp~ 270 (515)
+.+||..||.+|||++++++|+|
T Consensus 245 i~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 245 VKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=342.43 Aligned_cols=250 Identities=30% Similarity=0.455 Sum_probs=218.2
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||.|+||.||+|.+..+++.+|+|++..... ...+.+.+|+.+++.++||||+++++++.....+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 689999999999999999999999999999999975432 24678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccc
Q 010214 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~ 174 (515)
||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence 999999999999876 789999999999999999999999999999999999999999999999999987654332 334
Q ss_pred cCCCCCCccCCCcccCC---ccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-----CCCCCChhHHH
Q 010214 175 TSCGSPNYAAPEVISGK---LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-----LPSHLSPGARD 246 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~---~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~~ 246 (515)
...++..|+|||.+.+. .+ +.++|+||+||++|+|++|..||.+.+.......+....+. .+...+.++.+
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHD 238 (262)
T ss_pred cccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHH
Confidence 55789999999998765 55 67999999999999999999999887655544444433222 23346788999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPW 270 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~ 270 (515)
++.+||..||.+|||+.+++.|||
T Consensus 239 li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 239 FIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=348.03 Aligned_cols=254 Identities=29% Similarity=0.463 Sum_probs=222.4
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||.|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++.++...|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 47999999999999999999999999999999987543 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~ 175 (515)
||+++++|.+++... ++++..++.++.|++.|+.|||+.+++||||+|+||+++.++.++|+|||++...... .....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 999999999999765 8999999999999999999999999999999999999999999999999999876543 23345
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-cCCCCC-CChhHHHHhcccCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSH-LSPGARDLIPRMLI 253 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~-~s~~~~~li~~mL~ 253 (515)
..|++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+.... ...+.. +++++.+++.+||.
T Consensus 158 ~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 236 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLN 236 (274)
T ss_pred ccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhh
Confidence 578899999999988775 789999999999999999999998766555554444443 233444 78999999999999
Q ss_pred CCCCCCCCHHHHhcCcccccc
Q 010214 254 VDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.||++|||++++++||||+..
T Consensus 237 ~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 237 KDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred CChhhCcCHHHHhhChhhcCC
Confidence 999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=348.91 Aligned_cols=256 Identities=27% Similarity=0.403 Sum_probs=219.3
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||.|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++.+..+..+|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 47799999999999999999999999999999998643 334567788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccc
Q 010214 96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~ 173 (515)
|||++|++|..++.+ ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ...
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 167 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR 167 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccccc
Confidence 999999999988765 456899999999999999999999999999999999999999999999999988654322 222
Q ss_pred ccCCCCCCccCCCcccCCc----cCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---CCCCCCChhHHH
Q 010214 174 KTSCGSPNYAAPEVISGKL----YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGARD 246 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~----~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~ 246 (515)
....+++.|+|||++.+.. ..+.++|+|||||++|+|++|..||...+......++..... ..+..++.++.+
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRD 247 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHH
Confidence 3456889999999985321 125789999999999999999999988766555555544322 335678899999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+|.+||..||.+||+++++++||||...
T Consensus 248 li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 248 FLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred HHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 9999999999999999999999999754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=349.98 Aligned_cols=255 Identities=29% Similarity=0.486 Sum_probs=218.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||.|+||.||+|.+..+|+.||+|.+.... .......+.+|+.++++++||||+++++.+..++.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47899999999999999999999999999999886432 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 97 EYVKSGELFDYIVEK---GRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~---~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
||++|++|..++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++...... .
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 157 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-L 157 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-c
Confidence 999999999998763 379999999999999999999997 59999999999999999999999999998765332 3
Q ss_pred cccCCCCCCccCCCcccCCcc-----CCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHH---HhcC-ccCCCCCCChh
Q 010214 173 LKTSCGSPNYAAPEVISGKLY-----AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKK---IKGG-IYTLPSHLSPG 243 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~-----~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~---i~~~-~~~~p~~~s~~ 243 (515)
..+..+++.|+|||.+.+... .+.++|+||+||++|+|++|..||........... +..+ ....|..++++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence 345678999999999865432 26789999999999999999999977655444333 3332 34567778999
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+.+||.+||+.+|.+||++.+++.||||...
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred HHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 9999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=360.24 Aligned_cols=257 Identities=33% Similarity=0.549 Sum_probs=216.0
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----- 89 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 89 (515)
+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+.. ........+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 5689999999999999999999999999999999986543 2334456778899999999999999999998644
Q ss_pred -CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 90 -SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 90 -~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
...|+||||+.+ +|.+++... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999964 888888654 8999999999999999999999999999999999999999999999999998765
Q ss_pred cCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-------------
Q 010214 169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------- 235 (515)
Q Consensus 169 ~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~------------- 235 (515)
......+..+++.|+|||.+.+..+ +.++|||||||++|+|++|+.||...+......++......
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 170 TSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CCCCCCCCcccccccCHHHHhCCCC-CCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 5544456678999999999988776 78999999999999999999999876654443333211000
Q ss_pred -----------------------C-------CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 236 -----------------------L-------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 236 -----------------------~-------p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
. +...++.+++||.+||+.||.+|||+.|++.||||+.+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 0 1124567899999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=363.71 Aligned_cols=246 Identities=27% Similarity=0.407 Sum_probs=202.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
.+|++.+.||+|+||.||+|.+..+++.||+|+..+. ....|+.+++.++||||+++++++......|+||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 4699999999999999999999999999999985432 2346999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
|++. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........+
T Consensus 137 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 215 (357)
T PHA03209 137 PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG 215 (357)
T ss_pred EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccccc
Confidence 9995 588888865 45799999999999999999999999999999999999999999999999999976544444455
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCC-CCCCCChH---------HHHHHHhcC----ccCCC----
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL-PFDDENIP---------NLFKKIKGG----IYTLP---- 237 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~-Pf~~~~~~---------~~~~~i~~~----~~~~p---- 237 (515)
..||+.|+|||++.+..+ +.++||||+||++|+|+++.. +|...... ..+.++... ...+|
T Consensus 216 ~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 294 (357)
T PHA03209 216 LAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG 294 (357)
T ss_pred ccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence 679999999999988877 789999999999999998544 44432110 011111110 00011
Q ss_pred --------------------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 238 --------------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 238 --------------------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
..++.++.+||.+||+.||.+|||+.|+++||||++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 135677888999999999999999999999999975
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=366.02 Aligned_cols=253 Identities=38% Similarity=0.700 Sum_probs=228.0
Q ss_pred CCceE--eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 17 PNYKL--GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 17 ~~Y~i--~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
.-|++ .++||+|-||+||-|.|+.||+.||||+|+|-.+... ....++.|+.||..+.||.||.+-..|++++.+|+
T Consensus 562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFV 640 (888)
T KOG4236|consen 562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFV 640 (888)
T ss_pred HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEE
Confidence 34555 5789999999999999999999999999998877654 34889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC---CceEEeeccccccccc
Q 010214 95 VMEYVKSGELFDYIV--EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRD 169 (515)
Q Consensus 95 VmEy~~gg~L~~~i~--~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~---~~vKL~DFGls~~~~~ 169 (515)
|||-+.| ++.+.|- ++++++|...+.++.||+.||.|||.++|+|+||||||||+.+. -.+||||||+++++..
T Consensus 641 VMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE 719 (888)
T KOG4236|consen 641 VMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE 719 (888)
T ss_pred Eehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence 9999966 6666553 57899999999999999999999999999999999999999765 3699999999999999
Q ss_pred CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCCChhHH
Q 010214 170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGAR 245 (515)
Q Consensus 170 ~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 245 (515)
..+-++.+|||.|.|||++..+.| ...-|+||.|||+|.-|+|..||..+ +++.++|++..+-+| ..+++++.
T Consensus 720 ksFRrsVVGTPAYLaPEVLrnkGy-NrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~Ai 796 (888)
T KOG4236|consen 720 KSFRRSVVGTPAYLAPEVLRNKGY-NRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAI 796 (888)
T ss_pred hhhhhhhcCCccccCHHHHhhccc-cccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHH
Confidence 999999999999999999999988 68899999999999999999999764 345567777766555 47899999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|||..+|++.-.+|.|+++.+.|||+++.
T Consensus 797 dlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 797 DLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 99999999999999999999999999864
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=351.00 Aligned_cols=254 Identities=29% Similarity=0.483 Sum_probs=216.4
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||.|+||.||+|.++.+++.||+|++.+..... ...+.+.+|+++++.++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999999999999999987644332 34567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~ 175 (515)
||++++.|..++...+.+++..+..++.||+.||.|||+.|++|+||+|+||++++++.++|+|||++....... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD 159 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence 999999998887777779999999999999999999999999999999999999999999999999987654432 2334
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-------------------c--
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------------Y-- 234 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~-- 234 (515)
..++..|+|||++.+....+.++||||+||++|+|++|.+||..........++.... .
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence 5688999999998765545789999999999999999999998765444333322100 0
Q ss_pred ----------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 235 ----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 235 ----------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
..++.++..+.+|+.+||..+|.+|||+.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0123568889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=346.23 Aligned_cols=253 Identities=28% Similarity=0.454 Sum_probs=218.1
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
.|++.+.||.|+||.||+|.+..++..+|+|.+.... ....+.+.+|+++++.++||||+++++++......|+|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 4788999999999999999999999999999985432 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccccc
Q 010214 98 YVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKT 175 (515)
Q Consensus 98 y~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~ 175 (515)
|+++++|..++.+ ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++...... .....
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence 9999999998865 457999999999999999999999999999999999999999999999999998765332 22345
Q ss_pred CCCCCCccCCCccc-----CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc---cCCCCCCChhHHHH
Q 010214 176 SCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDL 247 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~-----~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~l 247 (515)
..|++.|+|||++. +..+ +.++|+||+||++|+|++|..||...+......++.... ...|..++.++.+|
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241 (282)
T ss_pred ccccccccCHhhccccCCCCCCC-CccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence 57899999999984 2223 578999999999999999999998877666555554432 23456788999999
Q ss_pred hcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|.+||..||.+|||+.++++||||+..
T Consensus 242 i~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 242 LKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHccCChhhCcCHHHHhcCCCEecc
Confidence 999999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=348.64 Aligned_cols=254 Identities=36% Similarity=0.697 Sum_probs=230.7
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iV 95 (515)
.+|.+.+.||.|+||.||+|.+..+|+.||+|++.++..........+.+|+.+++.++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998766655555678899999999999 99999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC----
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---- 171 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~---- 171 (515)
|||+++++|.+++.+.+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 9999999999999988899999999999999999999999999999999999999999999999999987654321
Q ss_pred -----------------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc
Q 010214 172 -----------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY 234 (515)
Q Consensus 172 -----------------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~ 234 (515)
......|+..|+|||++.+..+ +.++|+||||++++++++|..||...+....+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 1223457899999999887655 7899999999999999999999998887777788888888
Q ss_pred CCCCCCChhHHHHhcccCCCCCCCCCCH----HHHhcCccc
Q 010214 235 TLPSHLSPGARDLIPRMLIVDPMKRITI----PEIRQHPWF 271 (515)
Q Consensus 235 ~~p~~~s~~~~~li~~mL~~dP~~Rpt~----~eil~hp~f 271 (515)
.+|..+++.+.+||.+||+.||.+|||+ .++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 8999999999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=352.44 Aligned_cols=261 Identities=31% Similarity=0.508 Sum_probs=223.3
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.......+|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 89 (297)
T cd06656 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD 89 (297)
T ss_pred ccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 445566899999999999999999999999999999999865432 23467889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
..|+||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred EEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 99999999999999999864 56899999999999999999999999999999999999999999999999998765443
Q ss_pred C-ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhc-C--ccCCCCCCChhHHH
Q 010214 171 H-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG-G--IYTLPSHLSPGARD 246 (515)
Q Consensus 171 ~-~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~-~--~~~~p~~~s~~~~~ 246 (515)
. ......+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+.. + ....|..++..+++
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD 247 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHH
Confidence 2 2234578999999999988766 7899999999999999999999987654333222222 1 12345678899999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
|+.+||..||.+|||+.++++||||+...+
T Consensus 248 li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=350.87 Aligned_cols=256 Identities=33% Similarity=0.501 Sum_probs=218.3
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccC--ChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
+|++.+.||.|+||.||+|.+..+|+.||+|.+...... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999999765543 123456678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccc
Q 010214 96 MEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~ 173 (515)
|||+ +++|.+++.... .+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++...... ...
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 889999998766 7999999999999999999999999999999999999999999999999999876543 223
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-------------------
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------------------- 234 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~------------------- 234 (515)
....+++.|+|||.+.+....+.++|+||+||++|+|++|.+||.+.+......++.....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence 3446788999999987654457899999999999999999999987766555444432110
Q ss_pred ---------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 ---------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 ---------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
......+.++.++|.+||..||.+|||+.|++.||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 0113457889999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=343.30 Aligned_cols=249 Identities=37% Similarity=0.645 Sum_probs=224.3
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCH
Q 010214 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (515)
Q Consensus 25 LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L 104 (515)
||.|+||.||+|.+..+|+.+|+|++.............+.+|+.++++++||||+++++.+.+....|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999776554455678899999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC---------cccc
Q 010214 105 FDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---------FLKT 175 (515)
Q Consensus 105 ~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~---------~~~~ 175 (515)
.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 9999887889999999999999999999999999999999999999999999999999987653321 2234
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCC--ChhHHHHhcccCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL--SPGARDLIPRMLI 253 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~--s~~~~~li~~mL~ 253 (515)
..+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||........+..+..+....|... +..+.+++.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 568889999999987764 7899999999999999999999999888888888887777777665 9999999999999
Q ss_pred CCCCCCCCH---HHHhcCcccccc
Q 010214 254 VDPMKRITI---PEIRQHPWFQAH 274 (515)
Q Consensus 254 ~dP~~Rpt~---~eil~hp~f~~~ 274 (515)
.+|.+|||+ .++++||||++.
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccCC
Confidence 999999999 999999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=369.59 Aligned_cols=260 Identities=33% Similarity=0.614 Sum_probs=246.6
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
..+.+.+.+.+||.|+||.|-++..+.....+|+|++++..+.+....+.+..|-.||..++.|+||++|..|.+..++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 44678889999999999999999877665669999999999988888999999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
+.||-|-||+|+..+..++.+.+..++.++.-+++|++|||++||++|||||||.++|.+|-+||.|||+++.+..+...
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCCCCCChhHHHHhccc
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~m 251 (515)
-|.||||.|.|||++..+.. +.++|.||||+++||||+|.+||.+.+....+..|.+|. ..+|..++..+.+||+++
T Consensus 577 wTFcGTpEYVAPEIILnKGH-D~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~L 655 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGH-DRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKL 655 (732)
T ss_pred eeecCCcccccchhhhccCc-chhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHH
Confidence 99999999999999998876 789999999999999999999999999999999999986 678999999999999999
Q ss_pred CCCCCCCCCC-----HHHHhcCcccccc
Q 010214 252 LIVDPMKRIT-----IPEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rpt-----~~eil~hp~f~~~ 274 (515)
...+|.+|.. +.+|.+|.||...
T Consensus 656 Cr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 656 CRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 9999999986 8999999999765
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=347.06 Aligned_cols=254 Identities=31% Similarity=0.538 Sum_probs=217.1
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||.|+||.||+|.+..+++.||+|++..... .....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 479999999999999999999999999999999865432 2334578899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--ccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~--~~~ 174 (515)
||++++.+..++.+...+++.++..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 999987777777666779999999999999999999999999999999999999999999999999988765443 334
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc---------------------
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------------------- 233 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--------------------- 233 (515)
...+++.|+|||++.+....+.++|+||+|+++|+|++|..||.+.+..+....+....
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence 56788999999999887444789999999999999999999998765544333222100
Q ss_pred -----------cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 234 -----------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 234 -----------~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
...|..+++++++||.+||..+|++|||++++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 01233458899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=351.85 Aligned_cols=258 Identities=29% Similarity=0.459 Sum_probs=216.3
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CeE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDI 92 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 92 (515)
-.++|++.+.||.|+||.||+|.++.+|+.||+|++....... .....+.+|+.++++++||||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 3678999999999999999999999999999999986543322 2233456899999999999999999998654 568
Q ss_pred EEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|+||||+.+ +|.+++.. ...+++.+++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999965 89888875 4679999999999999999999999999999999999999999999999999998765432
Q ss_pred -ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-----------------
Q 010214 172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----------------- 233 (515)
Q Consensus 172 -~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~----------------- 233 (515)
......+++.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence 22333568889999998775545789999999999999999999999888777666554321
Q ss_pred --cCCC-----------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 234 --YTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 234 --~~~p-----------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+..+ ...++++.+||.+||+.||.+|||+.+++.||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 1111 1258889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=347.03 Aligned_cols=252 Identities=30% Similarity=0.534 Sum_probs=212.3
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||.|++|.||+|.+..+|+.||||.+..... .......+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 58999999999999999999999999999999865432 22334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccc
Q 010214 98 YVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (515)
Q Consensus 98 y~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~ 174 (515)
|+. ++|.+++.. ...+++..++.++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++....... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence 996 589998865 3568999999999999999999999999999999999999999999999999987654322 223
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc---------------------
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------------------- 233 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--------------------- 233 (515)
...+++.|+|||++.+....+.++|||||||++|+|++|..||...+......++....
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence 44678899999998876655788999999999999999999998766544333222100
Q ss_pred --------cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 234 --------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 234 --------~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
......++++++++|.+||+.||.+|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 01123478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=343.91 Aligned_cols=252 Identities=27% Similarity=0.439 Sum_probs=211.5
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC-----
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP----- 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~----- 89 (515)
.+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 467999999999999999999999999999999986543 2235678999999998 699999999998642
Q ss_pred -CeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 90 -SDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 90 -~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
..+|+||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 4689999999999999999863 3689999999999999999999999999999999999999999999999999876
Q ss_pred cccC-CccccCCCCCCccCCCcccCC----ccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCCCC
Q 010214 167 MRDG-HFLKTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPSH 239 (515)
Q Consensus 167 ~~~~-~~~~~~~gt~~Y~aPE~i~~~----~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~ 239 (515)
.... ....+..|++.|+|||++.+. ...+.++|+||+||++|+|++|..||...........+.... ...+..
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCC
Confidence 5432 233456799999999998632 123678999999999999999999998765444333333222 122346
Q ss_pred CChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 240 ~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
++.++.+|+.+||..||.+|||+.++++||||
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 78899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=344.99 Aligned_cols=249 Identities=31% Similarity=0.521 Sum_probs=209.0
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcC--CeEEEE
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETP--SDIYVV 95 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~iV 95 (515)
|++.+.||.|+||.||+|.+..+++.||+|++.+... .... ....+|+.+++++. ||||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 7889999999999999999999999999999865432 2222 23457888888886 99999999999887 889999
Q ss_pred EeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
|||+++ +|.+++.. .+.+++..++.++.||+.||.|||+.|++||||+|+||+++. +.+||+|||++..........
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence 999975 88888875 457899999999999999999999999999999999999999 999999999998765544445
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC------------------ccCC
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG------------------IYTL 236 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~------------------~~~~ 236 (515)
...+++.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+... .+.+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 5678999999998765445578999999999999999999999887665544443221 1111
Q ss_pred C-----------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 237 P-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 237 p-----------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
| ..++.++.++|.+||++||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1 2568999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=340.54 Aligned_cols=248 Identities=35% Similarity=0.579 Sum_probs=213.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHH-HHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||.|+||.||+|.+..+|+.||+|++.+...........+..|..+ ....+|||+++++++++..+.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999999999999999999976544333333344455444 4556899999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN 181 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~ 181 (515)
++|.+++...+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.+||+|||++..... .....|++.
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~ 158 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTPD 158 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCcC
Confidence 99999999888899999999999999999999999999999999999999999999999999875433 234568899
Q ss_pred ccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCC----CCCCChhHHHHhcccCCCCCC
Q 010214 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL----PSHLSPGARDLIPRMLIVDPM 257 (515)
Q Consensus 182 Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~li~~mL~~dP~ 257 (515)
|+|||.+.+..+ +.++||||+|+++|+|++|..||...+....+..+....... +..+++++.+++.+||+.||.
T Consensus 159 y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 237 (260)
T cd05611 159 YLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPA 237 (260)
T ss_pred ccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHH
Confidence 999999988765 789999999999999999999999888877777776554332 335789999999999999999
Q ss_pred CCC---CHHHHhcCcccccc
Q 010214 258 KRI---TIPEIRQHPWFQAH 274 (515)
Q Consensus 258 ~Rp---t~~eil~hp~f~~~ 274 (515)
+|| +++|++.||||++.
T Consensus 238 ~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 238 KRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred HccCCCcHHHHHcChHhhcC
Confidence 999 45799999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=342.80 Aligned_cols=255 Identities=27% Similarity=0.471 Sum_probs=210.2
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHH-HHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
++|++.+.||+|+||.||+|.++.+|+.||+|.+....... ....+..|+.+ ++.++||||+++++++..++.+|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 47999999999999999999999999999999987653322 23445556554 6778899999999999999999999
Q ss_pred EeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 96 MEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 96 mEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
|||++ |+|.+++.. +..+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99996 588888764 34689999999999999999999997 9999999999999999999999999999876544
Q ss_pred CccccCCCCCCccCCCcccCC---ccCCCcceeehhHHHHHHHHhCCCCCCCCC--hHHHHHHHhcCccCCC-CCCChhH
Q 010214 171 HFLKTSCGSPNYAAPEVISGK---LYAGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLFKKIKGGIYTLP-SHLSPGA 244 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~---~~~~~~~DIwSlGvily~lltG~~Pf~~~~--~~~~~~~i~~~~~~~p-~~~s~~~ 244 (515)
.......|+..|+|||++.+. ...+.++|+||+||++|+|++|..||.... ...+...+......+| ..+|.++
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF 237 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHH
Confidence 333445789999999998652 123678999999999999999999997532 2333333333333343 3578999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.++|.+||..+|.+|||+.++++||||+..
T Consensus 238 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 238 QDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=340.74 Aligned_cols=249 Identities=32% Similarity=0.517 Sum_probs=217.7
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||.|+||.||+|.+..+++.||+|.+.... ..+.+.+|+++++.++||||+++++++.+....|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 68999999999999999999999889999999986432 2578899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccc
Q 010214 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~ 174 (515)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++....... ...
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN 157 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence 99999999999975 4568999999999999999999999999999999999999999999999999988765443 233
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC---ccCCCCCCChhHHHHhccc
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~m 251 (515)
...|+..|+|||++.+..+ +.++||||+|+++|+|++|..||...........+... ....+..++.++.+++.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred cccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence 4568899999999988766 78999999999999999999999876554433333222 2234456788999999999
Q ss_pred CCCCCCCCCCHHHHhcCccc
Q 010214 252 LIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~hp~f 271 (515)
|+.||.+|||+.|++.||||
T Consensus 237 l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 237 LVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=343.51 Aligned_cols=258 Identities=26% Similarity=0.447 Sum_probs=216.5
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP 89 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~ 89 (515)
......++|.+.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred cCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 33445789999999999999999999999999999999986432 2345678899999988 799999999998653
Q ss_pred -----CeEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEee
Q 010214 90 -----SDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160 (515)
Q Consensus 90 -----~~~~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~D 160 (515)
...|+||||++|++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEee
Confidence 358999999999999998863 45789999999999999999999999999999999999999999999999
Q ss_pred cccccccccCC-ccccCCCCCCccCCCcccCCc----cCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--
Q 010214 161 FGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKL----YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-- 233 (515)
Q Consensus 161 FGls~~~~~~~-~~~~~~gt~~Y~aPE~i~~~~----~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-- 233 (515)
||++....... ......|+..|+|||++.... ..+.++||||+||++|+|++|..||...........+....
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 251 (291)
T cd06639 172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP 251 (291)
T ss_pred cccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC
Confidence 99987654332 223457899999999986432 13689999999999999999999998776554444444332
Q ss_pred -cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 234 -YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 234 -~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
...+...+..+.+||.+||+.||.+|||+.|+++||||+
T Consensus 252 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 252 TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 223556778899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=344.57 Aligned_cols=254 Identities=31% Similarity=0.532 Sum_probs=220.1
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||.|+||.||+|.++.+++.||+|.+..... ......+.+|+++++.++||||+++++++...+..|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 478899999999999999999999999999999876532 245677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+........ .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 157 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-K 157 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-h
Confidence 999999999999876 789999999999999999999999 9999999999999999999999999999876643322 2
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC-----ChHHHHHHHhcC-ccCCCCC-CChhHHHH
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-----NIPNLFKKIKGG-IYTLPSH-LSPGARDL 247 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~-----~~~~~~~~i~~~-~~~~p~~-~s~~~~~l 247 (515)
...++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||... ......+.+... ....+.. ++++++++
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236 (265)
T ss_pred cccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence 2678999999999988766 78999999999999999999999754 233334444333 2334444 88999999
Q ss_pred hcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|.+||..||.+|||+.+++.||||+..
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 237 VNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=348.32 Aligned_cols=259 Identities=28% Similarity=0.460 Sum_probs=211.0
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.+....++|++.+.||.|+||.||+|.+..+++.||||.+....... .....+.+|+.++++++||||+++++++....
T Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 6 PFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred cccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 45556789999999999999999999999999999999986543222 22345678999999999999999999986643
Q ss_pred --------eEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeec
Q 010214 91 --------DIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADF 161 (515)
Q Consensus 91 --------~~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DF 161 (515)
..|+||||+.+ +|.+++... ..+++.+++.++.||+.||.|||++|++|+||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred ccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcC
Confidence 46999999964 888888654 37899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC-----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc--
Q 010214 162 GLSNIMRDGH-----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-- 234 (515)
Q Consensus 162 Gls~~~~~~~-----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-- 234 (515)
|++....... ......++..|+|||.+.+....+.++||||+|+++|+|++|..||.+.+.......+.....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9997654322 123346788999999987755447899999999999999999999987765443332222110
Q ss_pred -----------------CCC-------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 235 -----------------TLP-------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 235 -----------------~~p-------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.+| ...+..+.+||.+||..||.+|||++|+++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 011 1235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=337.26 Aligned_cols=253 Identities=31% Similarity=0.571 Sum_probs=218.3
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++.+.+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 689999999999999999999999999999999765443 3467889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc-----
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----- 172 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~----- 172 (515)
|+++++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 999999999998887899999999999999999999999999999999999999999999999999887644322
Q ss_pred cccCCCCCCccCCCcccCCc--cCCCcceeehhHHHHHHHHhCCCCCCCCC-hHHHHHHHhc-CccCCCCCC--ChhHHH
Q 010214 173 LKTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKG-GIYTLPSHL--SPGARD 246 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~--~~~~~~DIwSlGvily~lltG~~Pf~~~~-~~~~~~~i~~-~~~~~p~~~--s~~~~~ 246 (515)
.....+++.|+|||++.+.. ..+.++||||+|+++|+|++|..||.... .......+.. ....+|... ++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 22457889999999998664 13689999999999999999999997653 2222222332 233455544 899999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
+|.+||+.+|.+|||+.+++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=337.85 Aligned_cols=248 Identities=33% Similarity=0.554 Sum_probs=219.4
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||.|+||.||++.+..+++.||+|.+..... ....+.+.+|+.+++.++||||+++++.+++.+.+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999865432 2345778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Cccc
Q 010214 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLK 174 (515)
Q Consensus 98 y~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~~ 174 (515)
|+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+...... ....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 99999999998753 35899999999999999999999999999999999999999999999999998766432 2334
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-CCCCCCChhHHHHhcccCC
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~mL~ 253 (515)
...|++.|+|||++.+..+ ++++|+||+|+++|+|++|..||...+.......+..+.. ..|..++..+.+||.+||+
T Consensus 159 ~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFK 237 (255)
T ss_pred cccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHh
Confidence 5678999999999987765 7899999999999999999999998887777777766544 4677889999999999999
Q ss_pred CCCCCCCCHHHHhcC
Q 010214 254 VDPMKRITIPEIRQH 268 (515)
Q Consensus 254 ~dP~~Rpt~~eil~h 268 (515)
.||.+|||+.+++.-
T Consensus 238 ~~P~~Rp~~~~il~~ 252 (255)
T cd08219 238 RNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCCCHHHHhhc
Confidence 999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=348.79 Aligned_cols=254 Identities=33% Similarity=0.481 Sum_probs=215.3
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CeEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDIY 93 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 93 (515)
.++|++.+.||.|+||.||+|.+..+++.+|+|.+...... ......+.+|+.++++++||||+++++++... ...|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 46899999999999999999999999999999999755433 22334567899999999999999999998777 8899
Q ss_pred EEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-C
Q 010214 94 VVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-H 171 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~ 171 (515)
+||||+++ +|.+++.... .+++.+++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++...... .
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 99999975 9999887644 5899999999999999999999999999999999999999999999999998876543 2
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc------------------
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------------ 233 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~------------------ 233 (515)
......+++.|+|||.+.+....+.++|+||+|+++|+|++|..||..........++....
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 33445688999999998876555789999999999999999999998876655544432211
Q ss_pred -------------cCCCCC-CChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 234 -------------YTLPSH-LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 234 -------------~~~p~~-~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
..+|.. +++.+.++|.+||+.||++|||+.|++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 112222 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=341.20 Aligned_cols=254 Identities=30% Similarity=0.492 Sum_probs=215.0
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccC-------ChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-------NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~-------~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+...... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 688999999999999999999999999999988543211 1123457889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.+++||||++|++|.+++.+.+.+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998765432
Q ss_pred ---CccccCCCCCCccCCCcccCCc-cCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--ccCCC----CCC
Q 010214 171 ---HFLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLP----SHL 240 (515)
Q Consensus 171 ---~~~~~~~gt~~Y~aPE~i~~~~-~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p----~~~ 240 (515)
.......|+..|+|||.+.+.. ..+.++|+||||+++|++++|..||...........+... ...++ ..+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 1223456889999999987654 2378999999999999999999999765544433333222 22223 245
Q ss_pred ChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 241 s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
+.++.++|.+||..+|.+|||++++++||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=341.52 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=214.3
Q ss_pred CCCceEeeeecccCceEEEEEEEc---CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
..+|++.+.||+|+||.||+|.++ .++..||+|.+.... .......+.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 367999999999999999999875 456789999986542 233456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|+||||+++|+|.+++... +.+++..++.++.||+.||+|||++|++||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999999764 578999999999999999999999999999999999999999999999999876543322
Q ss_pred ccc--cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHH
Q 010214 172 FLK--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL 247 (515)
Q Consensus 172 ~~~--~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 247 (515)
... ...++..|+|||++.+..+ +.++||||+||++|++++ |..||.+.+.....+.+..+. .+.|..++..+.++
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQL 240 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 222 2345678999999988766 789999999999999775 999999888887777776653 45677889999999
Q ss_pred hcccCCCCCCCCCCHHHHhc
Q 010214 248 IPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~ 267 (515)
+.+||+.+|.+|||+.+|++
T Consensus 241 i~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 241 MLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHcCCCchhCCCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=343.33 Aligned_cols=256 Identities=29% Similarity=0.464 Sum_probs=214.1
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEE--
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIE-- 87 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~-- 87 (515)
......++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 44456789999999999999999999999999999999875432 1235678899999999 6999999999873
Q ss_pred ---cCCeEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEee
Q 010214 88 ---TPSDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160 (515)
Q Consensus 88 ---~~~~~~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~D 160 (515)
.....|+||||++|++|.+++.. ...+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEcc
Confidence 44579999999999999998753 35689999999999999999999999999999999999999999999999
Q ss_pred cccccccccCC-ccccCCCCCCccCCCcccC-----CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-
Q 010214 161 FGLSNIMRDGH-FLKTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI- 233 (515)
Q Consensus 161 FGls~~~~~~~-~~~~~~gt~~Y~aPE~i~~-----~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~- 233 (515)
||++....... ......|++.|+|||++.+ ..+ +.++||||+||++|+|++|..||..........++....
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~ 246 (286)
T cd06638 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP 246 (286)
T ss_pred CCceeecccCCCccccccCCCcccChhhhchhhhccccc-cchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC
Confidence 99987654322 2345579999999999853 223 679999999999999999999998766544443333222
Q ss_pred --cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 234 --YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 234 --~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
...|..++..+.+|+.+||+.||.+|||+.|+++|+||
T Consensus 247 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 247 PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 22355678899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=337.22 Aligned_cols=255 Identities=34% Similarity=0.562 Sum_probs=224.7
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
.+|++.+.||.|++|.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4799999999999999999999999999999998765432 45678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccCCcc-c
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-K 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~-~ 174 (515)
||+++++|.+++.....+++..+..++.|++.|+.|||+ .|++||||+|+||+++.++.++|+|||++......... .
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN 158 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence 999999999999888899999999999999999999999 99999999999999999999999999998876543332 2
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC---ChHHHHHHHhcC-ccCCCCC-CChhHHHHhc
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---NIPNLFKKIKGG-IYTLPSH-LSPGARDLIP 249 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~---~~~~~~~~i~~~-~~~~p~~-~s~~~~~li~ 249 (515)
...++..|+|||.+.+..+ +.++|+||||+++|+|++|..||... ...+....+... ....+.. ++..+.++|.
T Consensus 159 ~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 237 (264)
T cd06623 159 TFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS 237 (264)
T ss_pred ceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHH
Confidence 5568899999999987755 78999999999999999999999876 444555555543 3344555 8899999999
Q ss_pred ccCCCCCCCCCCHHHHhcCcccccc
Q 010214 250 RMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+||..+|.+|||+.++++||||+..
T Consensus 238 ~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 238 ACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHccCChhhCCCHHHHHhCHHHHhc
Confidence 9999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=340.13 Aligned_cols=252 Identities=32% Similarity=0.488 Sum_probs=213.7
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC----
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPS---- 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~---- 90 (515)
.++|++.+.||.|++|.||+|.++.+++.+|+|++..... ..+.+.+|+.+++++ .||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 5899999999999999999999999999999999875432 346788999999999 6999999999996644
Q ss_pred --eEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccc
Q 010214 91 --DIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 91 --~~~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
.+|+||||+++++|.+++.. +..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 48999999999999999865 357999999999999999999999999999999999999999999999999998
Q ss_pred cccccC-CccccCCCCCCccCCCcccCC----ccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---CC
Q 010214 165 NIMRDG-HFLKTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TL 236 (515)
Q Consensus 165 ~~~~~~-~~~~~~~gt~~Y~aPE~i~~~----~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~---~~ 236 (515)
...... .......|++.|+|||++.+. ...+.++|||||||++|+|++|..||...........+..... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS 240 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCc
Confidence 765432 223455689999999988542 2236789999999999999999999987665555455544422 22
Q ss_pred CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 237 PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 237 p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
+..++.++++||.+||..||.+|||+.++++|||+
T Consensus 241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 241 PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 33477899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=358.27 Aligned_cols=244 Identities=30% Similarity=0.536 Sum_probs=215.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
..+++++.||+|-||.||+|.+. ...+||+|.+....... +.+.+|+++|++|+|+|||++++++..+..+||||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 34567889999999999999986 33489999987654433 56679999999999999999999999988999999
Q ss_pred eccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 97 EYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
||++.|+|.+|+.. ++.++..+...++.||++|++||+++++|||||-..|||+++++.+||+|||+++...++....
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 99999999999987 5579999999999999999999999999999999999999999999999999999666555433
Q ss_pred cCC--CCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcc
Q 010214 175 TSC--GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPR 250 (515)
Q Consensus 175 ~~~--gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~ 250 (515)
..- -..-|.|||.+....+ +.++||||+||+||||+| |+.||.+.+..+..+.+..|. .+-|..+|+++-+++..
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~F-S~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~ 439 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKF-SSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKS 439 (468)
T ss_pred cCCCCCCceecCHHHHhhCCc-ccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHH
Confidence 322 2346999999998877 789999999999999999 999999999999999998875 57788999999999999
Q ss_pred cCCCCCCCCCCHHHHh
Q 010214 251 MLIVDPMKRITIPEIR 266 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil 266 (515)
||..+|++|||++.+.
T Consensus 440 CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 440 CWHEDPEDRPTFETLR 455 (468)
T ss_pred HhhCCcccCCCHHHHH
Confidence 9999999999999664
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=344.30 Aligned_cols=250 Identities=26% Similarity=0.429 Sum_probs=218.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCC-----cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTG-----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 468999999999999999999986655 689999986432 3345577899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC
Q 010214 91 DIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW 154 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~ 154 (515)
..|++|||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 999999999999999999764 4578899999999999999999999999999999999999999
Q ss_pred ceEEeecccccccccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 010214 155 NVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK 230 (515)
Q Consensus 155 ~vKL~DFGls~~~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~ 230 (515)
.+||+|||++....... ......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999987654332 2234467889999999887766 789999999999999998 999999888888887776
Q ss_pred cCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 231 GGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 231 ~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.+. ...|..+++++.+|+.+||+.||.+|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 654 35577899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=350.48 Aligned_cols=244 Identities=29% Similarity=0.480 Sum_probs=194.3
Q ss_pred eeeecccCceEEEEEEEcC--CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEE--cCCeEEEEEe
Q 010214 22 GKTLGIGSFGKVKIAEHAL--TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE--TPSDIYVVME 97 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~iVmE 97 (515)
+..||+|+||.||+|.++. ++..||+|.+..... ...+.+|+.+++.++||||+++++++. ....+|+|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 4689999999999999764 568999999865432 245678999999999999999999984 4567899999
Q ss_pred ccCCCCHHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----CCCCceEEeecccc
Q 010214 98 YVKSGELFDYIVEK---------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL----DSKWNVKIADFGLS 164 (515)
Q Consensus 98 y~~gg~L~~~i~~~---------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl----~~~~~vKL~DFGls 164 (515)
|+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9964 888887532 248899999999999999999999999999999999999 56678999999999
Q ss_pred cccccCC----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH---------HHHHHHhc
Q 010214 165 NIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---------NLFKKIKG 231 (515)
Q Consensus 165 ~~~~~~~----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~---------~~~~~i~~ 231 (515)
....... ......||+.|+|||++.+....+.++||||+||++|+|++|.+||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 8764322 2334578999999999987555578999999999999999999999653211 00100000
Q ss_pred ----------------------------Ccc----------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 232 ----------------------------GIY----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 232 ----------------------------~~~----------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
... ......+..+.+||.+||+.||.+|||+.|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=343.62 Aligned_cols=253 Identities=31% Similarity=0.546 Sum_probs=208.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||.|++|.||+|.++.+++.||+|.+....... ....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 589999999999999999999999999999999986543221 223466899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccc
Q 010214 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~ 173 (515)
|||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ...
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 999975 999988764 46899999999999999999999999999999999999999999999999998654321 112
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC-hHHHHHHHhcCc-------------------
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGI------------------- 233 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~-~~~~~~~i~~~~------------------- 233 (515)
....+++.|+|||++.+....+.++||||+||++|+|++|..||.+.. ..+....+....
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 234578899999998765544789999999999999999999997654 222222221100
Q ss_pred c-----------CCCCCCC--hhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 234 Y-----------TLPSHLS--PGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 234 ~-----------~~p~~~s--~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
. .....++ .++.+++.+||+.||.+|||+.|++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 0001234 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=342.32 Aligned_cols=258 Identities=29% Similarity=0.563 Sum_probs=239.7
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~i 94 (515)
+++|.++++||+|+|++|.+++++.|.+.||+|++.++-..+.+..+-++.|..+..+. +||++|-++.+|+++..+|+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 68999999999999999999999999999999999998888877788888998888765 59999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc-cccCCcc
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFL 173 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~-~~~~~~~ 173 (515)
|.||++||+|--++++..+++|+.++.+..+|+.||.|||++||++||||..|+|+|..|++||+|+|+++. +.++...
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~t 408 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTT 408 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999874 5678889
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCC--------CChHHHHHHHhcCccCCCCCCChhHH
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD--------ENIPNLFKKIKGGIYTLPSHLSPGAR 245 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~--------~~~~~~~~~i~~~~~~~p~~~s~~~~ 245 (515)
.|.||||+|.|||++.|..| +..+|.|+|||+++||+.|+.||+- .+..-+++-|......+|..+|-.+.
T Consensus 409 stfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas 487 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKAS 487 (593)
T ss_pred ccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhH
Confidence 99999999999999999998 8999999999999999999999962 23445788888889999999999999
Q ss_pred HHhcccCCCCCCCCCC------HHHHhcCcccccc
Q 010214 246 DLIPRMLIVDPMKRIT------IPEIRQHPWFQAH 274 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt------~~eil~hp~f~~~ 274 (515)
.+++..|++||.+|.. +.++..|+||+..
T Consensus 488 ~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 488 HVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred HHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 9999999999999975 5899999999854
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=345.82 Aligned_cols=248 Identities=26% Similarity=0.389 Sum_probs=206.6
Q ss_pred CCCceEeeeecccCceEEEEEEEcC----------------CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHAL----------------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~----------------tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI 79 (515)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++++++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence 4689999999999999999998642 34579999986543 23445678899999999999999
Q ss_pred cEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 010214 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-------------------RLQEDEARNFFQQIISGVEYCHRNMVVH 140 (515)
Q Consensus 80 v~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~-------------------~l~e~~~~~i~~qil~aL~yLH~~gIvH 140 (515)
+++++++.+.+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999996532 3677889999999999999999999999
Q ss_pred ccCCCCcEEECCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh--CCC
Q 010214 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC--GTL 215 (515)
Q Consensus 141 rDLkpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt--G~~ 215 (515)
|||||+|||++.++.+||+|||++.....+.. .....++..|+|||++.+..+ +.++|||||||++|+|++ +..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999976644322 223456789999999887766 789999999999999986 678
Q ss_pred CCCCCChHHHHHHHhc--------CccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHh
Q 010214 216 PFDDENIPNLFKKIKG--------GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIR 266 (515)
Q Consensus 216 Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil 266 (515)
||...+..+....+.. .....|+.++..+.+|+.+||+.||.+|||+.+|.
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 8887665555443321 11234567889999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=366.54 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=226.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
+.|.|+..||.|+||+||+|.++.++-..|-|+|.. +..+..+.+.-||.||..+.||+|+++++.|..++.++|+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 568899999999999999999999999999999854 34456777888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccc
Q 010214 97 EYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~ 174 (515)
|||.||-....+..-+ .++|.++..+++|++.||.|||+++|+|||||..|||++-+|.|+|+|||.+.... .-..-.
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD 188 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD 188 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence 9999999999888754 69999999999999999999999999999999999999999999999999986543 233446
Q ss_pred cCCCCCCccCCCccc-----CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC---CCCCCChhHHH
Q 010214 175 TSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT---LPSHLSPGARD 246 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~-----~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~ 246 (515)
++.|||+|||||++. ..+| +.++||||||++|.+|..+.+|-...+....+-+|.+...+ -|++.+..+.|
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PY-DykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D 267 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD 267 (1187)
T ss_pred cccCCcccccchheeeccccCCCc-hhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence 789999999999874 4555 78999999999999999999999999888888888766543 47889999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|+++||.+||..||+++++++||||++.
T Consensus 268 fLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 268 FLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 9999999999999999999999999754
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=366.83 Aligned_cols=248 Identities=25% Similarity=0.413 Sum_probs=205.8
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
...+|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+++|++++||||+++++++...+..|+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 35689999999999999999999999999999996321 235689999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--
Q 010214 95 VMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-- 171 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-- 171 (515)
|||++. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 999995 6899988764 469999999999999999999999999999999999999999999999999997654322
Q ss_pred -ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCC-C-------ChHHHHHHHhcCcc---CCC--
Q 010214 172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-E-------NIPNLFKKIKGGIY---TLP-- 237 (515)
Q Consensus 172 -~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~-~-------~~~~~~~~i~~~~~---~~p-- 237 (515)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..|+-. . ....+.+.+..... .+|
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1234579999999999998876 7899999999999999998765422 1 12222232222111 011
Q ss_pred -----------------------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 238 -----------------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 238 -----------------------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
..++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 134668999999999999999999999999999974
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=347.09 Aligned_cols=250 Identities=26% Similarity=0.440 Sum_probs=211.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcE--EEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHK--VAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~--vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 92 (515)
.++|++.+.||+|+||.||+|.++.++.. +|+|.+.. .........+.+|+.++.++ +||||+++++++.+.+.+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 46899999999999999999999888765 57766542 22334567788999999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCce
Q 010214 93 YVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNV 156 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~v 156 (515)
|+||||+++++|.+++.+.+ .+++..++.++.||+.||+|||++|++||||||+|||++.++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence 99999999999999997543 47899999999999999999999999999999999999999999
Q ss_pred EEeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-c
Q 010214 157 KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-Y 234 (515)
Q Consensus 157 KL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~ 234 (515)
||+|||++.............++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+..+. .
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 242 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcC
Confidence 9999999864322111122234667999999987765 789999999999999998 999998887777777776542 3
Q ss_pred CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 235 ~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..|...++++.+|+.+||+.+|.+|||+++++.+
T Consensus 243 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 243 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4566788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=341.59 Aligned_cols=250 Identities=30% Similarity=0.537 Sum_probs=209.8
Q ss_pred ccccCCCceEeeee--cccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEc
Q 010214 12 VDMFLPNYKLGKTL--GIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET 88 (515)
Q Consensus 12 ~~~~~~~Y~i~~~L--G~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~ 88 (515)
...+.++|.+.+.+ |.|+||.||++.++.++..+|+|++.+...... |+.....+ +||||+++++.+..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEec
Confidence 34456788888777 999999999999999999999999876543221 22222222 69999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-ceEEeeccccccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIM 167 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~-~vKL~DFGls~~~ 167 (515)
++..|+||||++|++|.+++..++.+++.+++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++...
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 999999999999999999998888999999999999999999999999999999999999999988 9999999998765
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHH----HHHHHhcCccCCCCCCChh
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN----LFKKIKGGIYTLPSHLSPG 243 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~~ 243 (515)
... ....|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||....... ............+..+++.
T Consensus 161 ~~~---~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T PHA03390 161 GTP---SCYDGTLDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKN 236 (267)
T ss_pred CCC---ccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHH
Confidence 432 23468999999999988776 689999999999999999999997543322 1222223344566689999
Q ss_pred HHHHhcccCCCCCCCCCC-HHHHhcCccccc
Q 010214 244 ARDLIPRMLIVDPMKRIT-IPEIRQHPWFQA 273 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt-~~eil~hp~f~~ 273 (515)
+.+||.+||+.||.+||+ ++++++||||++
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 237 ANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 999999999999999996 699999999963
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=335.46 Aligned_cols=246 Identities=42% Similarity=0.718 Sum_probs=225.9
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCH
Q 010214 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (515)
Q Consensus 25 LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L 104 (515)
||.|+||.||++.+..+++.+|+|++.+...........+.+|+.+++.++||||+++++.++.+...|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999989999999999887666656678899999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-CccccCCCCCCcc
Q 010214 105 FDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYA 183 (515)
Q Consensus 105 ~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~Y~ 183 (515)
.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... .......++..|+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL 160 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence 999998888999999999999999999999999999999999999999999999999998776443 2344567899999
Q ss_pred CCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCCH-
Q 010214 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI- 262 (515)
Q Consensus 184 aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~- 262 (515)
|||.+.+... +.++|+||||+++|+|++|..||...........+......+|..++.++.+++++||..||.+|||+
T Consensus 161 ~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 161 APEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred ChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcc
Confidence 9999987665 78999999999999999999999888877778888877888899999999999999999999999999
Q ss_pred --HHHhcCccc
Q 010214 263 --PEIRQHPWF 271 (515)
Q Consensus 263 --~eil~hp~f 271 (515)
.++++||||
T Consensus 240 ~~~~l~~~~~f 250 (250)
T cd05123 240 GAEEIKAHPFF 250 (250)
T ss_pred cHHHHHhCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.53 Aligned_cols=252 Identities=36% Similarity=0.579 Sum_probs=223.9
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CeEEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDIYVV 95 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~iV 95 (515)
+|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+... ..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999999999999998765543 34568889999999999999999999999888 899999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc---
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--- 172 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~--- 172 (515)
+||+++++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999987765543
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC-hHHHHHHHh--cCccCCCCCCChhHHHHhc
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIK--GGIYTLPSHLSPGARDLIP 249 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~-~~~~~~~i~--~~~~~~p~~~s~~~~~li~ 249 (515)
.....++..|+|||.+.+..+ +.++||||+|+++|+|++|..||.... .......+. .....+|..++..+.+++.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 456678999999999987765 789999999999999999999998765 233333333 2345677788999999999
Q ss_pred ccCCCCCCCCCCHHHHhcCccc
Q 010214 250 RMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~hp~f 271 (515)
+||..||.+|||+.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=341.48 Aligned_cols=254 Identities=27% Similarity=0.436 Sum_probs=211.9
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEE----
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIE---- 87 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~---- 87 (515)
..-.+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 12 RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred cChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 344689999999999999999999999999999999986532 2345678899999988 6999999999984
Q ss_pred --cCCeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 88 --TPSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 88 --~~~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
....+|++|||+++|+|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence 346789999999999999999753 4588999999999999999999999999999999999999999999999999
Q ss_pred ccccccC-CccccCCCCCCccCCCcccC-----CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc--C
Q 010214 164 SNIMRDG-HFLKTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--T 235 (515)
Q Consensus 164 s~~~~~~-~~~~~~~gt~~Y~aPE~i~~-----~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~--~ 235 (515)
+...... .......|++.|+|||++.. ..+ +.++|+|||||++|+|++|..||...........+..... .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd06636 168 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246 (282)
T ss_pred hhhhhccccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence 8765321 22345678999999999863 233 6789999999999999999999977654443333332221 1
Q ss_pred CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 236 ~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.+..++.++.+||.+||+.||.+|||+.|+++||||
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=332.28 Aligned_cols=252 Identities=34% Similarity=0.611 Sum_probs=225.2
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|.+.+.||.|+||.||+|.+..+++.||+|++...... ......+.+|+++++.++|||++++++.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 689999999999999999999999999999999765432 3456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-c
Q 010214 98 YVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-F 172 (515)
Q Consensus 98 y~~gg~L~~~i~~~----~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~ 172 (515)
|+++++|.+++.+. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 99999999999864 679999999999999999999999999999999999999999999999999988765443 3
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhccc
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~m 251 (515)
....+|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||+..+.......+... ...+|..++.++.+++.+|
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSL 238 (258)
T ss_pred ecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 445678999999999887765 68999999999999999999999988777776666554 3456678899999999999
Q ss_pred CCCCCCCCCCHHHHhcCccc
Q 010214 252 LIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~hp~f 271 (515)
|..+|.+|||+.++++||||
T Consensus 239 l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 239 LQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred cCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=344.13 Aligned_cols=254 Identities=28% Similarity=0.477 Sum_probs=218.3
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||+||+|.+..+|+.||+|++.... .......+.+|+++++.++||||+++++++.....+|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 478999999999999999999999999999999986542 233467889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
|||+++++|.+++...+.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++...... ...
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~~~ 160 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-IAD 160 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-ccC
Confidence 9999999999999888889999999999999999999997 69999999999999999999999999998655332 223
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH-----------HHHHHHhcCc-cCCCC-CCC
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-----------NLFKKIKGGI-YTLPS-HLS 241 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~-----------~~~~~i~~~~-~~~p~-~~s 241 (515)
..+|+..|+|||++.+..+ +.++||||+||++|+|++|..||...... .....+.... ..++. .++
T Consensus 161 ~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239 (284)
T ss_pred ccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence 5679999999999987655 78999999999999999999999865432 2333333222 22333 377
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
.++.+|+.+||+.||.+|||+.|+++||||..
T Consensus 240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 89999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=342.09 Aligned_cols=253 Identities=28% Similarity=0.490 Sum_probs=207.3
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||.||+|.++.+|+.||+|++...... .....+.+|+.+++.++|+||+++++++.++...|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 47899999999999999999999999999999998654322 2234567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCcc
Q 010214 96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~~ 173 (515)
|||+. ++|.+++.. .+.+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++..... ....
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 99996 577777654 35688999999999999999999999999999999999999999999999999875432 2223
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH-HHHHHHhcCc-------------------
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGI------------------- 233 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~-~~~~~i~~~~------------------- 233 (515)
....+++.|+|||++.+....+.++||||+||++|+|++|..||.+.+.. +...++....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence 44567999999999976554478899999999999999999999865432 2222211000
Q ss_pred --c--CCC---------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 234 --Y--TLP---------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 234 --~--~~p---------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
. ..+ -..++++.+++.+||..||.+|||+.|++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 000 0125688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=343.02 Aligned_cols=254 Identities=31% Similarity=0.474 Sum_probs=209.8
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCe----
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSD---- 91 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~---- 91 (515)
++|++.+.||.|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 479999999999999999999999999999999865432 2223456788999999996 6999999999877665
Q ss_pred -EEEEEeccCCCCHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCceEEeecccc
Q 010214 92 -IYVVMEYVKSGELFDYIVEK-----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLS 164 (515)
Q Consensus 92 -~~iVmEy~~gg~L~~~i~~~-----~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-~~~vKL~DFGls 164 (515)
.|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 899988653 35799999999999999999999999999999999999998 889999999998
Q ss_pred cccccC-CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---------
Q 010214 165 NIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--------- 234 (515)
Q Consensus 165 ~~~~~~-~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~--------- 234 (515)
...... .......+++.|+|||++.+....+.++||||+|+++|+|++|..||.+.+......++.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T cd07837 159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238 (295)
T ss_pred eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 755322 2223346788999999987654447899999999999999999999987765554443322100
Q ss_pred -------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 235 -------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 235 -------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
...+.+++++.+||.+||..||.+|||+.|++.||||+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00134788999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=350.13 Aligned_cols=257 Identities=36% Similarity=0.593 Sum_probs=211.1
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----- 89 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 89 (515)
+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 4579999999999999999999999999999999986422 223456678899999999999999999987544
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
...|+|+||+.+ +|.+++. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred ceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 358999999964 8888774 45799999999999999999999999999999999999999999999999999876543
Q ss_pred CC----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc------------
Q 010214 170 GH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------ 233 (515)
Q Consensus 170 ~~----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~------------ 233 (515)
.. .....+|++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 22 12345789999999987654444789999999999999999999998765433222221100
Q ss_pred --------------cC-----CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 234 --------------YT-----LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 234 --------------~~-----~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
.. ..+..++++.++|.+||+.||.+|||+.|+++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00 1134678899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=341.43 Aligned_cols=254 Identities=28% Similarity=0.460 Sum_probs=220.4
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
..|+..+.||.|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 468889999999999999999999999999999875432 234678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~ 175 (515)
||++|++|.+++.. +++++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence 99999999999864 579999999999999999999999999999999999999999999999999987664433 2234
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhcccCCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~mL~~ 254 (515)
..++..|+|||++.+..+ +.++|+||+||++|+|++|..||...........+... ...++..++..+.+++.+||..
T Consensus 161 ~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNK 239 (277)
T ss_pred ccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHccc
Confidence 468889999999987765 78999999999999999999999877655554444333 2344556788999999999999
Q ss_pred CCCCCCCHHHHhcCcccccc
Q 010214 255 DPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 255 dP~~Rpt~~eil~hp~f~~~ 274 (515)
+|.+|||+.+++.||||...
T Consensus 240 ~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 240 DPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred CcccCcCHHHHHhChHhhhc
Confidence 99999999999999999654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=358.72 Aligned_cols=249 Identities=28% Similarity=0.462 Sum_probs=207.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCC-----cEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTG-----HKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~ 89 (515)
.++|++.+.||+|+||.||+|.+..+| ..||+|++.... ..+....+.+|+.+++.+ +||||+++++++...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 357999999999999999999865444 579999987543 223456788999999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHh----------------------------------------------------------
Q 010214 90 SDIYVVMEYVKSGELFDYIVEK---------------------------------------------------------- 111 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~---------------------------------------------------------- 111 (515)
..+|+|||||++|+|.+++..+
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999998642
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc---cccC
Q 010214 112 ------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTS 176 (515)
Q Consensus 112 ------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~ 176 (515)
.++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....+.. ..+.
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 2478889999999999999999999999999999999999999999999999876543321 1223
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC--ccCCCCCCChhHHHHhcccCC
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~mL~ 253 (515)
.+++.|+|||++.+..+ +.++||||+||++|+|++ |..||..........++... ....|..+++++.+++.+||+
T Consensus 275 ~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 353 (374)
T cd05106 275 RLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWN 353 (374)
T ss_pred CCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence 35668999999987766 789999999999999997 99999876544433333322 334566789999999999999
Q ss_pred CCCCCCCCHHHHhc
Q 010214 254 VDPMKRITIPEIRQ 267 (515)
Q Consensus 254 ~dP~~Rpt~~eil~ 267 (515)
.||.+|||+.++++
T Consensus 354 ~dp~~RPs~~~l~~ 367 (374)
T cd05106 354 LEPTERPTFSQISQ 367 (374)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=340.63 Aligned_cols=251 Identities=32% Similarity=0.561 Sum_probs=213.4
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||.|++|.||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 689999999999999999999999999999998754322 224567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cc
Q 010214 98 YVKSGELFDYIVEKG---RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (515)
Q Consensus 98 y~~gg~L~~~i~~~~---~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~ 173 (515)
|+++ +|.+++...+ .+++..+..++.||+.||.|||+.|++||||||+||++++++.++|+|||++....... ..
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 9975 8999887643 58999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc------------------cC
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------------YT 235 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~------------------~~ 235 (515)
....+++.|+|||++.+....+.++|+||+||++|+|++|..||.+.+..+...++.... ..
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 345678999999998776555789999999999999999999998877665544433210 00
Q ss_pred -----------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 236 -----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 236 -----------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
+.+.+++.+++++.+||+.||.+|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 112457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=350.51 Aligned_cols=258 Identities=33% Similarity=0.527 Sum_probs=215.5
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----- 89 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 89 (515)
+..+|.+.+.||+|+||+||+|.+..+++.||||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 45789999999999999999999999999999999875432 223345677899999999999999999988654
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
..+|+|+||+. ++|.+++...+++++..++.++.||+.||.|||+++++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 35899999995 69999998888999999999999999999999999999999999999999999999999999876644
Q ss_pred C-CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC----------------
Q 010214 170 G-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---------------- 232 (515)
Q Consensus 170 ~-~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~---------------- 232 (515)
. ....+..++..|+|||.+.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence 3 33445678999999999875433578999999999999999999999876543322221100
Q ss_pred -------c--------cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 233 -------I--------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 233 -------~--------~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
. ....+.+++++.+||.+||+.||.+|||+.++++||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 01124578999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=339.89 Aligned_cols=254 Identities=27% Similarity=0.503 Sum_probs=218.1
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC---CCCccEEEEEEEcCCeEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM---HPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~i 94 (515)
.|++.+.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++ |||++++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 58889999999999999999999999999999865432 234567889999999997 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cc
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~ 173 (515)
||||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence 9999999999999865 579999999999999999999999999999999999999999999999999987765433 23
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-cCCCC-CCChhHHHHhccc
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPS-HLSPGARDLIPRM 251 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~-~~s~~~~~li~~m 251 (515)
....|+..|+|||.+.+....+.++|+||+||++|+|++|..||.+.........+.... ..++. .++.++.+++.+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC 238 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHH
Confidence 345789999999998765555789999999999999999999998876555444433322 22333 3788999999999
Q ss_pred CCCCCCCCCCHHHHhcCcccccc
Q 010214 252 LIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|+.||.+|||+.+++.||||++.
T Consensus 239 l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 239 LDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred cCCCcccCcCHHHHhhChHhhcc
Confidence 99999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=334.37 Aligned_cols=253 Identities=33% Similarity=0.573 Sum_probs=218.3
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccc--cCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CeE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRK--IKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDI 92 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 92 (515)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... .........+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999885432 12234557889999999999999999999998764 468
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc---
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD--- 169 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~--- 169 (515)
+++|||+++++|.+++...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999876532
Q ss_pred -CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--ccCCCCCCChhHHH
Q 010214 170 -GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARD 246 (515)
Q Consensus 170 -~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 246 (515)
........|+..|+|||.+.+... +.++|+|||||++|+|++|..||.+........++... ...+|..+++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 122234568999999999988765 78999999999999999999999887655555554433 24568889999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
++.+||+ +|.+|||+.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=335.76 Aligned_cols=252 Identities=29% Similarity=0.488 Sum_probs=216.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||.|+||.||+|.++.+++.||||.+......+......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 36899999999999999999999999999999998765555555667788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 96 MEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 96 mEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999998853 3458999999999999999999999999999999999999999999999999988764432
Q ss_pred -ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC--hHHHHHHHhcCcc-CC-CCCCChhHHH
Q 010214 172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLFKKIKGGIY-TL-PSHLSPGARD 246 (515)
Q Consensus 172 -~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~--~~~~~~~i~~~~~-~~-p~~~s~~~~~ 246 (515)
......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.... .......+..... +. +...+..+.+
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred HHHhcCCCCccccChhhhccCCC-CchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 2234578999999999987765 689999999999999999999996543 3344555544332 22 2357788999
Q ss_pred HhcccCCCCCCCCCCHHHHhcC
Q 010214 247 LIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~h 268 (515)
++.+||..+|.+|||+.++++.
T Consensus 240 li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHCCCCcccCcCHHHHHHH
Confidence 9999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=350.91 Aligned_cols=257 Identities=32% Similarity=0.512 Sum_probs=215.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc----CCe
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----PSD 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----~~~ 91 (515)
.++|++.+.||.|+||.||+|.++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 4799999999999999999999999999999999875432 22345677889999999999999999998753 356
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG- 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~- 170 (515)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 899999995 599999988888999999999999999999999999999999999999999999999999998765332
Q ss_pred ----CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--------------
Q 010214 171 ----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-------------- 232 (515)
Q Consensus 171 ----~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~-------------- 232 (515)
....+..|+..|+|||.+.+....+.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 12234578999999999876444578999999999999999999999876544332221110
Q ss_pred ------------ccCC-----CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 233 ------------IYTL-----PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 233 ------------~~~~-----p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.... ....++++.++|.+||+.||.+|||+.+++.||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 0001 13468899999999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=329.89 Aligned_cols=252 Identities=33% Similarity=0.552 Sum_probs=223.7
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+.+|++++++++|||++++++++.+....+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999999999999999876543 2455789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc-cccC
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTS 176 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~-~~~~ 176 (515)
|+++++|.+++...+.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++........ ....
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV 159 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence 999999999999888999999999999999999999999999999999999999999999999999987654432 2345
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHH-HhcCccCCCCCCChhHHHHhcccCCCC
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKK-IKGGIYTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~-i~~~~~~~p~~~s~~~~~li~~mL~~d 255 (515)
.++..|+|||...+..+ +.++|+||+|+++|+|++|..||..........+ .......+|..++..+.+++.+||..+
T Consensus 160 ~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 238 (254)
T cd06627 160 VGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKD 238 (254)
T ss_pred ccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCC
Confidence 78999999999887764 7899999999999999999999987654433333 334455677888999999999999999
Q ss_pred CCCCCCHHHHhcCccc
Q 010214 256 PMKRITIPEIRQHPWF 271 (515)
Q Consensus 256 P~~Rpt~~eil~hp~f 271 (515)
|++|||+.+++.||||
T Consensus 239 p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 239 PNLRPTAKQLLKHPWI 254 (254)
T ss_pred hhhCcCHHHHhcCCCC
Confidence 9999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=346.43 Aligned_cols=255 Identities=29% Similarity=0.519 Sum_probs=218.8
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
..+.|.....||.|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l 96 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV 96 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence 3456666788999999999999999999999999985432 3345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccc
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL 173 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~ 173 (515)
||||+++++|.+++. .+.+++.++..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... ...
T Consensus 97 v~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 97 VMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred EEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 999999999999875 457999999999999999999999999999999999999999999999999998755322 223
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc---cCCCCCCChhHHHHhcc
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLIPR 250 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~ 250 (515)
....|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+.... ...+...+..+.+++.+
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred ceeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence 44578999999999987766 689999999999999999999998877665555544332 22233578899999999
Q ss_pred cCCCCCCCCCCHHHHhcCcccccc
Q 010214 251 MLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
||..||.+|||++++++||||+..
T Consensus 255 ~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 255 MLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred HccCChhHCcCHHHHhhChhhhcc
Confidence 999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=339.69 Aligned_cols=249 Identities=28% Similarity=0.432 Sum_probs=216.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcC-----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.++|.+.+.||+|+||.||+|.+.. ++..||+|++.... ..+..+.+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4679999999999999999998753 46789999986442 2234578899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCce
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG--------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNV 156 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~--------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~v 156 (515)
..|+||||++|++|.+++...+ .+++..+..++.||+.||.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999997643 47889999999999999999999999999999999999999999
Q ss_pred EEeecccccccccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC
Q 010214 157 KIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232 (515)
Q Consensus 157 KL~DFGls~~~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~ 232 (515)
||+|||++....... ......+++.|+|||++.+..+ ++++|||||||++|+|++ |..||.+.+.......+..+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 999999987543322 1223456788999999988776 789999999999999998 99999888888888888776
Q ss_pred ccC-CCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 233 IYT-LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 233 ~~~-~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
... .|..++..+.+++.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 553 45678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=334.18 Aligned_cols=252 Identities=29% Similarity=0.574 Sum_probs=219.3
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|.+.+.||.|+||.||+|.++.+|..||+|.+....... ...+.+.+|+.+++.++||||+++++.+.+....|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 6899999999999999999999999999999987654322 334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc-eEEeecccccccccCC-cc
Q 010214 98 YVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN-VKIADFGLSNIMRDGH-FL 173 (515)
Q Consensus 98 y~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~-vKL~DFGls~~~~~~~-~~ 173 (515)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||++++++. +||+|||.+....... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 999999999997643 4799999999999999999999999999999999999998864 6999999987765432 22
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcccC
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRML 252 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL 252 (515)
....|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+.... ...+..++.++.++|.+||
T Consensus 160 ~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 238 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF 238 (257)
T ss_pred cccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHh
Confidence 34468999999999887665 689999999999999999999999877766666555443 2345677899999999999
Q ss_pred CCCCCCCCCHHHHhcCccc
Q 010214 253 IVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 253 ~~dP~~Rpt~~eil~hp~f 271 (515)
..+|++|||+.++++||||
T Consensus 239 ~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 239 KVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ccChhhCcCHHHHhhCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=353.68 Aligned_cols=258 Identities=28% Similarity=0.413 Sum_probs=212.8
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCC
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPS 90 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~ 90 (515)
+.+....|++++.||+||.++||++.... .+.||+|.+... ..+.....-+.+||..|.+|+ |.+||++|+|-.+++
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 44456789999999999999999998654 456677765432 335567888999999999997 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCH-HHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQE-DEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e-~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
.+||||||-+ .+|..+|.+++...+ -..+.+..||+.|+.++|.+||||.||||.|+|+-. |.+||+|||.|+.+..
T Consensus 434 ~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 434 YLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 9999999875 599999988766444 588999999999999999999999999999999854 6999999999998865
Q ss_pred CC---ccccCCCCCCccCCCcccCCcc----------CCCcceeehhHHHHHHHHhCCCCCCCCC-hHHHHHHHhcCc--
Q 010214 170 GH---FLKTSCGSPNYAAPEVISGKLY----------AGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGI-- 233 (515)
Q Consensus 170 ~~---~~~~~~gt~~Y~aPE~i~~~~~----------~~~~~DIwSlGvily~lltG~~Pf~~~~-~~~~~~~i~~~~-- 233 (515)
.. ...+.+||++|||||.+....+ .++++||||||||||+|+.|+.||..-. ..+-+..|....
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE 591 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence 43 2357799999999998853222 2678999999999999999999997632 344455555543
Q ss_pred cCCCCCCChh-HHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 234 YTLPSHLSPG-ARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 234 ~~~p~~~s~~-~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
.++|..-+.. +.++++.||..||++|||+.|+|+|||++-
T Consensus 592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 3566655555 999999999999999999999999999874
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=342.02 Aligned_cols=257 Identities=28% Similarity=0.365 Sum_probs=218.5
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
.....|.+.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..|
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 34577999999999999999999999999999999987655445455677899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 94 VVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
+||||+. |+|.+++.. .+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++......
T Consensus 92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9999997 477777754 457999999999999999999999999999999999999999999999999998765432
Q ss_pred cccCCCCCCccCCCcccC--CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC-ccCC-CCCCChhHHHHh
Q 010214 173 LKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-IYTL-PSHLSPGARDLI 248 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~--~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~-~~~~-p~~~s~~~~~li 248 (515)
.+..+++.|+|||++.+ ....+.++||||+|+++|+|++|..||.+.+.......+... .... +..++.+++++|
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFV 247 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHH
Confidence 34578899999998842 222368999999999999999999999887765544444332 2222 235688999999
Q ss_pred cccCCCCCCCCCCHHHHhcCcccccc
Q 010214 249 PRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.+||..||.+|||+.+++.||||...
T Consensus 248 ~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 248 DSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHHhcCChhhCcCHHHHhcChhhccc
Confidence 99999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=332.91 Aligned_cols=245 Identities=29% Similarity=0.524 Sum_probs=212.5
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.++ ++..+|+|.+...... ...+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 56999999999999999999876 4568999988644322 356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc-
Q 010214 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK- 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~- 174 (515)
||+++|+|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||.+..........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 99999999999975 3568999999999999999999999999999999999999999999999999987654333222
Q ss_pred -cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCcc-CCCCCCChhHHHHhccc
Q 010214 175 -TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRM 251 (515)
Q Consensus 175 -~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~m 251 (515)
...++..|+|||++.+..+ +.++|+||+|+++|+|++ |..||...+..+....+..+.. ..|...+..+.+++.+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSC 237 (256)
T ss_pred CCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 2234568999999987766 689999999999999999 9999999888888888776543 34667788999999999
Q ss_pred CCCCCCCCCCHHHHhc
Q 010214 252 LIVDPMKRITIPEIRQ 267 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~ 267 (515)
|..||.+|||+.++++
T Consensus 238 ~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 238 WHEKPEGRPTFAELLR 253 (256)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=333.42 Aligned_cols=253 Identities=30% Similarity=0.441 Sum_probs=211.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++......||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 345555678999999999999999999999999886443 23456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCceEEeecccccccccCC
Q 010214 96 MEYVKSGELFDYIVEK-GRL--QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-~~l--~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-~~~vKL~DFGls~~~~~~~ 171 (515)
+||+++++|.+++... +.+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 9999999999999764 455 88899999999999999999999999999999999986 6799999999987654322
Q ss_pred -ccccCCCCCCccCCCcccCCc-cCCCcceeehhHHHHHHHHhCCCCCCCCChHH--HHHH-HhcCccCCCCCCChhHHH
Q 010214 172 -FLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENIPN--LFKK-IKGGIYTLPSHLSPGARD 246 (515)
Q Consensus 172 -~~~~~~gt~~Y~aPE~i~~~~-~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~--~~~~-i~~~~~~~p~~~s~~~~~ 246 (515)
......|++.|+|||++.+.. ..+.++|+||+|+++|+|++|..||....... .... .......+|..+++++++
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKN 243 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHH
Confidence 233446889999999986543 23689999999999999999999997643221 1111 223334567788999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
++.+||..+|.+|||+.|++.||||
T Consensus 244 li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 244 FILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHcCCCchhCCCHHHHHhCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=356.59 Aligned_cols=250 Identities=29% Similarity=0.471 Sum_probs=208.6
Q ss_pred CCCceEeeeecccCceEEEEEEE-----cCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEH-----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~-----~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~ 89 (515)
.++|++.+.||+|+||.||+|.+ ..++..||+|++..... ....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 35899999999999999999974 35677899999864432 23456788999999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhC---------------------------------------------------------
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKG--------------------------------------------------------- 112 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~--------------------------------------------------------- 112 (515)
...|+|||||+||+|.+++.+..
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999996532
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc--
Q 010214 113 ------------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-- 172 (515)
Q Consensus 113 ------------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~-- 172 (515)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 467888999999999999999999999999999999999999999999999976543321
Q ss_pred -cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChH-HHHHHHhcCc-cCCCCCCChhHHHHh
Q 010214 173 -LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP-NLFKKIKGGI-YTLPSHLSPGARDLI 248 (515)
Q Consensus 173 -~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~-~~~~~i~~~~-~~~p~~~s~~~~~li 248 (515)
..+..++..|+|||++.+..+ +.++|||||||++|+|++ |..||...... ...+.+..+. ...|...+.++.+|+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence 122345667999999988776 789999999999999998 99999876543 3344444432 234566788999999
Q ss_pred cccCCCCCCCCCCHHHHhcC
Q 010214 249 PRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~h 268 (515)
.+||+.||.+|||+.|+++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=334.56 Aligned_cols=247 Identities=25% Similarity=0.443 Sum_probs=216.5
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
..+|.+.+.||.|+||.||+|.++.+++.||+|++.... .....+.+|+++++.++||||+++++++.....++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 467999999999999999999999999999999986432 2346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 96 MEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999999999764 35899999999999999999999999999999999999999999999999999876543322
Q ss_pred c--cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhc
Q 010214 174 K--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIP 249 (515)
Q Consensus 174 ~--~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~ 249 (515)
. ...+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+....+....+..+ ....|..+++++.+++.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMR 239 (263)
T ss_pred ccCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 1 2234568999999987766 689999999999999998 99999988887777777654 45567788999999999
Q ss_pred ccCCCCCCCCCCHHHHhc
Q 010214 250 RMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~ 267 (515)
+||+.||++|||+.++++
T Consensus 240 ~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 240 ACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHccCCcccCCCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=344.89 Aligned_cols=253 Identities=30% Similarity=0.486 Sum_probs=207.6
Q ss_pred CceEeeeecccCceEEEEEEEcC--CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CeEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHAL--TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDIY 93 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 93 (515)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.............+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 8999999999875433333456778999999999999999999999888 8899
Q ss_pred EEEeccCCCCHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC----CCceEEeecccc
Q 010214 94 VVMEYVKSGELFDYIVEK-----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS----KWNVKIADFGLS 164 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~-----~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~----~~~vKL~DFGls 164 (515)
+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 787777532 36899999999999999999999999999999999999999 899999999998
Q ss_pred cccccCCc----cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHH---------HHHHHh-
Q 010214 165 NIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN---------LFKKIK- 230 (515)
Q Consensus 165 ~~~~~~~~----~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~---------~~~~i~- 230 (515)
........ ....++++.|+|||++.+....+.++|||||||++|+|++|..||.+..... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 86543221 2345688999999998775544789999999999999999999997644321 000000
Q ss_pred -------------------------cCccCCC-----------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 231 -------------------------GGIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 231 -------------------------~~~~~~p-----------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
......+ ...+.++.+++.+||+.||.+|||+.|++.||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0000111 1567789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=331.73 Aligned_cols=243 Identities=28% Similarity=0.486 Sum_probs=216.0
Q ss_pred eeecccCceEEEEEEEcCC---CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEecc
Q 010214 23 KTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYV 99 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~ 99 (515)
+.||+|+||.||+|.+... +..||+|++....... ....+.+|+++++.++||||+++++++.+...+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999866 8999999987654322 4678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 100 KSGELFDYIVEK---------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 100 ~gg~L~~~i~~~---------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 78999999999999999999999999999999999999999999999999999877543
Q ss_pred C---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHH
Q 010214 171 H---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGAR 245 (515)
Q Consensus 171 ~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (515)
. ......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+..+ ....|..+++++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 2 2344567889999999987755 789999999999999999 69999998888888877754 3456778899999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcC
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+++.+||..||.+|||+.|++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=340.25 Aligned_cols=257 Identities=29% Similarity=0.489 Sum_probs=212.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||.|++|.||+|.++.+|+.||+|.+...... ......+.+|+++++.++||||+++++++.+....|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999998654322 23346678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCceEEeecccccccccC-C
Q 010214 96 MEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDG-H 171 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~--l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-~~~vKL~DFGls~~~~~~-~ 171 (515)
|||++ ++|.+++..... +++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++...... .
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 99996 588888865443 578899999999999999999999999999999999985 567999999999765332 2
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc------------------
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------------ 233 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~------------------ 233 (515)
......+++.|+|||++.+....+.++||||+||++|+|++|..||......+...++....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 22345678999999998775545789999999999999999999998766544444332100
Q ss_pred ---c--------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 234 ---Y--------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 234 ---~--------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
. .....+++++.+++.+||+.||.+|||+.++++||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0 0123568899999999999999999999999999999753
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=339.47 Aligned_cols=251 Identities=31% Similarity=0.542 Sum_probs=211.2
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy 98 (515)
|++.+.||.|++|.||+|.++.+|..||+|++...... ......+.+|+.+++.++|||++++++++.+....|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 67889999999999999999999999999998765422 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cccc
Q 010214 99 VKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (515)
Q Consensus 99 ~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~ 175 (515)
++ ++|.+++.... .+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++....... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 95 69999998765 78999999999999999999999999999999999999999999999999987653221 2233
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc----------------------
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---------------------- 233 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~---------------------- 233 (515)
..+++.|+|||++.+....+.++|+||+|+++|+|++|..||...+......++....
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence 4578899999998765444789999999999999999999998765543332221110
Q ss_pred -------cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 234 -------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 234 -------~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
......++.++.++|.+||+.||.+|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01124577899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=357.15 Aligned_cols=235 Identities=28% Similarity=0.464 Sum_probs=211.7
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
++-||.|+.|.||+|+. .++.||||.++ +.-..+|+.|++|+|||||.+.++|...-.+|||||||..
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~----------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVR----------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHh----------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 56699999999999986 57889999764 2224689999999999999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN 181 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~ 181 (515)
|.|...++....++......|..+|+.|+.|||.+.|+|||||.-||||+.+..|||+|||-++...+....-.++||..
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVa 276 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVA 276 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHh
Confidence 99999999999999999999999999999999999999999999999999999999999999998877766678899999
Q ss_pred ccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCCCCCChhHHHHhcccCCCCCCCC
Q 010214 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPSHLSPGARDLIPRMLIVDPMKR 259 (515)
Q Consensus 182 Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~mL~~dP~~R 259 (515)
|||||+|...+. +.++||||+||+|||||||..||.+-+..+++.-+-... .+.|+.++..++=||++||+-.|..|
T Consensus 277 WMAPEvIrnePc-sEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNR 355 (904)
T KOG4721|consen 277 WMAPEVIRNEPC-SEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNR 355 (904)
T ss_pred hhCHHHhhcCCc-ccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCC
Confidence 999999998876 799999999999999999999999876665544433332 46688999999999999999999999
Q ss_pred CCHHHHhcCc
Q 010214 260 ITIPEIRQHP 269 (515)
Q Consensus 260 pt~~eil~hp 269 (515)
|++.+|+.|-
T Consensus 356 PSFrqil~Hl 365 (904)
T KOG4721|consen 356 PSFRQILLHL 365 (904)
T ss_pred ccHHHHHHHH
Confidence 9999999994
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=337.71 Aligned_cols=252 Identities=32% Similarity=0.557 Sum_probs=218.9
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
.|...+.||.|++|.||+|.+..+++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++...+..|+++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4566689999999999999999999999999885332 2335668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccccC
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTS 176 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~ 176 (515)
|++|++|.+++.. +++++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... .....
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence 9999999999876 679999999999999999999999999999999999999999999999999887553322 22345
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCC---CCCCChhHHHHhcccCC
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL---PSHLSPGARDLIPRMLI 253 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~li~~mL~ 253 (515)
.|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+....... +..++..+.+++.+||+
T Consensus 176 ~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 254 (285)
T cd06648 176 VGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLV 254 (285)
T ss_pred cCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcc
Confidence 68999999999988766 689999999999999999999998877666666666553222 33478899999999999
Q ss_pred CCCCCCCCHHHHhcCcccccc
Q 010214 254 VDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.+|.+|||+.++++||||+..
T Consensus 255 ~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 255 RDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred cChhhCcCHHHHccCcccccC
Confidence 999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=338.92 Aligned_cols=257 Identities=32% Similarity=0.589 Sum_probs=220.5
Q ss_pred CceEeeeecccCceEEEEEEEc---CCCcEEEEEEecccccC-ChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~---~tg~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 92 (515)
+|++.+.||.|+||.||+|.+. .+|..||+|++...... .....+.+.+|+++++.+ +||||++++++++.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999875 47899999998754322 223456788999999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~- 171 (515)
|+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999987664432
Q ss_pred -ccccCCCCCCccCCCcccCC-ccCCCcceeehhHHHHHHHHhCCCCCCCCC----hHHHHHHHhcCccCCCCCCChhHH
Q 010214 172 -FLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLPSHLSPGAR 245 (515)
Q Consensus 172 -~~~~~~gt~~Y~aPE~i~~~-~~~~~~~DIwSlGvily~lltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~ 245 (515)
......|+..|+|||.+.+. ...+.++||||+|+++|+|++|..||.... .......+.......|..+++.+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHH
Confidence 22345689999999998753 233678999999999999999999997432 344445555556667788999999
Q ss_pred HHhcccCCCCCCCCC-----CHHHHhcCcccccc
Q 010214 246 DLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 246 ~li~~mL~~dP~~Rp-----t~~eil~hp~f~~~ 274 (515)
+++.+||+.||.+|| ++.+++.||||+..
T Consensus 241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 999999999999997 89999999999765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=347.44 Aligned_cols=256 Identities=35% Similarity=0.555 Sum_probs=221.0
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----eE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-----DI 92 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 92 (515)
+|++.+.||.|+||.||+|.+..+|+.||||.+.... ......+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 6899999999999999999999999999999987543 22345578899999999999999999999987775 79
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~- 171 (515)
|++|||++ ++|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999997 4899999887899999999999999999999999999999999999999999999999999998765543
Q ss_pred ---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-------------
Q 010214 172 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------- 235 (515)
Q Consensus 172 ---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~------------- 235 (515)
......+++.|+|||++.+....+.++|+||+|+++|+|++|..||.+.+..+....+......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 2445568999999999988744588999999999999999999999888766655554432111
Q ss_pred ------------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 236 ------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 236 ------------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
....+++++.++|.+||+.||.+|||+++++.||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 1134678899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=347.52 Aligned_cols=260 Identities=32% Similarity=0.444 Sum_probs=216.7
Q ss_pred cCCCceE-eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChH-----------HHHHHHHHHHHHHhCCCCCccEE
Q 010214 15 FLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-----------MEEKVRREIKILRLFMHPHIIRL 82 (515)
Q Consensus 15 ~~~~Y~i-~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~-----------~~~~i~~Ei~il~~l~hpnIv~l 82 (515)
+.++|.. .+.||.|+||+||+|.+..+++.||+|++......... ....+.+|+++++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 4577865 57799999999999999999999999998654322200 11257799999999999999999
Q ss_pred EEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecc
Q 010214 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFG 162 (515)
Q Consensus 83 ~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFG 162 (515)
++++...+..|+||||+. |+|.+++.....+++..+..++.|++.||.|||+.||+||||+|+||+++.++.+||+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 999999999999999997 5999999888889999999999999999999999999999999999999999999999999
Q ss_pred cccccccC---------------CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHH
Q 010214 163 LSNIMRDG---------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFK 227 (515)
Q Consensus 163 ls~~~~~~---------------~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~ 227 (515)
++...... .......+++.|+|||.+.+....+.++|+|||||++|+|++|..||.+.+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 98765411 112234578899999999876555789999999999999999999998877665544
Q ss_pred HHhcCcc----------------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 228 KIKGGIY----------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 228 ~i~~~~~----------------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
.+..... ......+.++.++|.+||+.+|.+|||++|++.||||+...
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 4422110 01124578899999999999999999999999999998663
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=336.59 Aligned_cols=254 Identities=28% Similarity=0.459 Sum_probs=220.2
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
+-|++.+.||.|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 347888999999999999999999999999999865432 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~ 175 (515)
||+++++|.+++. .+.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 82 e~~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 82 EYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred EeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcc
Confidence 9999999999986 4578999999999999999999999999999999999999999999999999987654332 2234
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcccCCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~~ 254 (515)
..++..|+|||.+.+... +.++|+||+||++|+|++|..||...+.......+.... ..++..++.++.+++.+||..
T Consensus 161 ~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred ccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 568899999999987655 689999999999999999999998876655555554432 335567889999999999999
Q ss_pred CCCCCCCHHHHhcCcccccc
Q 010214 255 DPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 255 dP~~Rpt~~eil~hp~f~~~ 274 (515)
+|.+||++.++++||||...
T Consensus 240 ~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 240 EPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ChhhCcCHHHHHhCHHHhhh
Confidence 99999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=348.99 Aligned_cols=259 Identities=31% Similarity=0.493 Sum_probs=218.5
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
...+.++|++.+.||.|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++...+.
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 4456789999999999999999999999999999999986542 222345677889999999999999999998866554
Q ss_pred ------EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 92 ------IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 92 ------~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
.|+|+||+ |++|.+++.. .++++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999999 6699998865 579999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC----------
Q 010214 166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT---------- 235 (515)
Q Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~---------- 235 (515)
..... .....+++.|+|||.+.+....+.++||||+||++|+|++|..||.+.+.......+......
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 65432 345578899999999876545578999999999999999999999877665555444332110
Q ss_pred ---------------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 236 ---------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 236 ---------------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
....+++++.++|.+||+.||.+|||+.+++.||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 1124588999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=342.52 Aligned_cols=254 Identities=29% Similarity=0.454 Sum_probs=218.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
..|+..+.||+|+||.||+|.+..+++.||+|.+..... ....+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 457788999999999999999999999999999865432 234578899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~ 175 (515)
||+++++|.+++. .+.+++..++.++.||+.|+.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 82 e~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 82 EYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred EccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence 9999999999885 4578999999999999999999999999999999999999999999999999987664432 2234
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhcccCCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~mL~~ 254 (515)
..|+..|+|||++.+..+ +.++|+||+||++|+|++|..||...........+... ...++...+.++.+++.+||..
T Consensus 161 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNK 239 (277)
T ss_pred ccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 468899999999988766 68999999999999999999999876555444444333 2234456788999999999999
Q ss_pred CCCCCCCHHHHhcCcccccc
Q 010214 255 DPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 255 dP~~Rpt~~eil~hp~f~~~ 274 (515)
+|.+|||+.++++||||...
T Consensus 240 ~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 240 DPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred CcccCcCHHHHHHhHHHHHH
Confidence 99999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=340.08 Aligned_cols=249 Identities=26% Similarity=0.436 Sum_probs=211.6
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCc--EEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 93 (515)
++|++.+.||.|+||.||+|..+.++. .+++|.+.. .......+.+.+|+.+++++ +||||+++++++.....+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE--FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc--cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 589999999999999999999887765 478887752 22334456788999999999 6999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceE
Q 010214 94 VVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK 157 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vK 157 (515)
+||||+++++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999997532 488899999999999999999999999999999999999999999
Q ss_pred EeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cC
Q 010214 158 IADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YT 235 (515)
Q Consensus 158 L~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~ 235 (515)
|+|||++..............+..|+|||++.+..+ +.++|||||||++|+|++ |..||..........++..+. ..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME 238 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 999999864322111112233557999999987766 789999999999999997 999999888887777776653 34
Q ss_pred CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 236 ~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.|..++.++.+|+.+||..+|.+|||++++++.
T Consensus 239 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 239 KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 567789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=331.27 Aligned_cols=242 Identities=29% Similarity=0.501 Sum_probs=207.1
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG 102 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg 102 (515)
+.||+|+||.||+|.++.+++.||+|.+.... ..+....+.+|+++++.++||||+++++++......|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46899999999999999999999999875432 3345678899999999999999999999999999999999999999
Q ss_pred CHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc---cCCC
Q 010214 103 ELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK---TSCG 178 (515)
Q Consensus 103 ~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~---~~~g 178 (515)
+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....+.... ...+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 9999997644 68999999999999999999999999999999999999999999999999987654332111 1122
Q ss_pred CCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhcccCCCCC
Q 010214 179 SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDP 256 (515)
Q Consensus 179 t~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~mL~~dP 256 (515)
+..|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+... ....|...+..+.+|+.+||+.||
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 456999999988776 789999999999999998 99999877766655555443 345667789999999999999999
Q ss_pred CCCCCHHHHhc
Q 010214 257 MKRITIPEIRQ 267 (515)
Q Consensus 257 ~~Rpt~~eil~ 267 (515)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=338.20 Aligned_cols=248 Identities=29% Similarity=0.454 Sum_probs=214.3
Q ss_pred CCCceEeeeecccCceEEEEEEEc-----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
..+|.+.+.||.|+||+||++.+. .++..+|+|.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 368999999999999999999863 34567999988643 2334567899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceE
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG-------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK 157 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~-------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vK 157 (515)
..|+||||+++++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+||+++.++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 9999999999999999997543 489999999999999999999999999999999999999999999
Q ss_pred EeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc
Q 010214 158 IADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI 233 (515)
Q Consensus 158 L~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~ 233 (515)
|+|||++........ .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999876543221 123345778999999987765 789999999999999998 999999888777777777765
Q ss_pred -cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 234 -YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 234 -~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
...+..+++++.+|+.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3456678999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=349.16 Aligned_cols=255 Identities=29% Similarity=0.506 Sum_probs=210.4
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----- 89 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 89 (515)
+.++|.+.+.||.|+||.||+|.++.+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 45899999999999999999999999999999999865443 3456788999999999999999999876543
Q ss_pred ---------CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCceEEe
Q 010214 90 ---------SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIA 159 (515)
Q Consensus 90 ---------~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-~~~vKL~ 159 (515)
...|+||||++ ++|.+++. .+.+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35899999997 58988885 457999999999999999999999999999999999999974 5678999
Q ss_pred ecccccccccC----CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--
Q 010214 160 DFGLSNIMRDG----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-- 233 (515)
Q Consensus 160 DFGls~~~~~~----~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-- 233 (515)
|||++...... .......++..|+|||.+.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99998765322 122334688899999987654445789999999999999999999998766544443332211
Q ss_pred -----------------------c-----CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 234 -----------------------Y-----TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 234 -----------------------~-----~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
. .....++.++.+||.+||+.||.+|||+.+++.||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0 0123578899999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=336.17 Aligned_cols=251 Identities=23% Similarity=0.376 Sum_probs=212.8
Q ss_pred cCCCceEeeeecccCceEEEEEEEcC-----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 89 (515)
..++|++.+.||+|+||+||+|.++. ++..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 45789999999999999999998752 35689999985432 223456688999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEe
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKG----------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIA 159 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~----------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~ 159 (515)
...++||||+++++|.+++.+.. .++...+..++.|++.||.|||+.|++||||||+||++++++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999999997532 35678889999999999999999999999999999999999999999
Q ss_pred ecccccccccCCcc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-c
Q 010214 160 DFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-Y 234 (515)
Q Consensus 160 DFGls~~~~~~~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~ 234 (515)
|||++......... ....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99998765432221 22355788999999987766 789999999999999999 799999887777666655543 4
Q ss_pred CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 235 ~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..|...+..+.+++.+||+.||.+|||+.|++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5677889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=326.09 Aligned_cols=249 Identities=34% Similarity=0.572 Sum_probs=217.5
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|.+.+.||.|++|.||+|.+..+++.+++|++..... .....+.+|+.+++.++|||++++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58899999999999999999998999999999876443 346788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccC
Q 010214 98 YVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS 176 (515)
Q Consensus 98 y~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~ 176 (515)
|++|++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+............
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 157 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM 157 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence 99999999999876 68999999999999999999999999999999999999999999999999999877655434566
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhc-CccCCCC--CCChhHHHHhcccCC
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG-GIYTLPS--HLSPGARDLIPRMLI 253 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~-~~~~~p~--~~s~~~~~li~~mL~ 253 (515)
.++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+.. .....+. .++..+.++|.+||+
T Consensus 158 ~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (253)
T cd05122 158 VGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQ 236 (253)
T ss_pred ecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHcc
Confidence 78999999999987764 7899999999999999999999988744443333332 2223333 348899999999999
Q ss_pred CCCCCCCCHHHHhcCcc
Q 010214 254 VDPMKRITIPEIRQHPW 270 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~ 270 (515)
.||.+|||+.++++|||
T Consensus 237 ~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 237 KNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CChhhCCCHHHHhcCCC
Confidence 99999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=348.42 Aligned_cols=258 Identities=30% Similarity=0.472 Sum_probs=216.4
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC--
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-- 90 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-- 90 (515)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+.. ........+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 346789999999999999999999999999999999986532 23334567889999999999999999999987654
Q ss_pred ----eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 91 ----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 91 ----~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
.+++||||+ |++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 469999999 779988875 46799999999999999999999999999999999999999999999999999876
Q ss_pred cccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc------------
Q 010214 167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------------ 234 (515)
Q Consensus 167 ~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~------------ 234 (515)
.... .....+++.|+|||++.+....+.++|+||+||++|+|++|..||.+.+......++.....
T Consensus 168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 168 TDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred cccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 5432 23456789999999987644457899999999999999999999987765444443322111
Q ss_pred -------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 235 -------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 235 -------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
.....+++++.++|.+||..||.+|||+.+++.||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 11235788899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=331.68 Aligned_cols=249 Identities=27% Similarity=0.441 Sum_probs=215.0
Q ss_pred CCceEeeeecccCceEEEEEEEcCC---CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
++|++.+.||+|+||+||+|.++.+ ...||+|++.... .......+.+|+.+++.++||||+++++++...+..|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 6799999999999999999998754 4589999886543 2334567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-C
Q 010214 94 VVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-H 171 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~ 171 (515)
+||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... .
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 999999999999999764 47899999999999999999999999999999999999999999999999999877421 1
Q ss_pred ccc--cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHH
Q 010214 172 FLK--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDL 247 (515)
Q Consensus 172 ~~~--~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 247 (515)
... ...+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+ ..+.+...++.+.++
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQL 240 (266)
T ss_pred ceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 111 2345678999999987766 789999999999999998 99999887777777777655 334566789999999
Q ss_pred hcccCCCCCCCCCCHHHHhcC
Q 010214 248 IPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~h 268 (515)
+.+||+.+|.+|||+.+++++
T Consensus 241 i~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 241 MLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=330.41 Aligned_cols=250 Identities=30% Similarity=0.511 Sum_probs=216.1
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||.|+||.||+|.+..+|+.||+|.+...........+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999987655555555678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-
Q 010214 97 EYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (515)
Q Consensus 97 Ey~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~- 171 (515)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999999864 3458999999999999999999999999999999999999999999999999987654332
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC--hHHHHHHHhcCcc-CCCC-CCChhHHHH
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLFKKIKGGIY-TLPS-HLSPGARDL 247 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~--~~~~~~~i~~~~~-~~p~-~~s~~~~~l 247 (515)
......+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||.... .......+..+.. +.|. .++.++.++
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDL 240 (267)
T ss_pred ccceecCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHH
Confidence 2334578999999999988776 689999999999999999999996543 3344445444433 3444 678899999
Q ss_pred hcccCCCCCCCCCCHHHHhc
Q 010214 248 IPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~ 267 (515)
|.+||..+|.+|||+.++++
T Consensus 241 i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 241 VSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=336.31 Aligned_cols=251 Identities=31% Similarity=0.537 Sum_probs=213.9
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CeEEEEE
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDIYVVM 96 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~iVm 96 (515)
|++.+.||.|+||.||+|.+..+|+.+|+|++.... ........+.+|+.+++.++|||++++++++... ...|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 789999999999999999999999999999998654 2223446678999999999999999999999888 8899999
Q ss_pred eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--cc
Q 010214 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FL 173 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~--~~ 173 (515)
||+++ +|.+++... ..+++..++.++.||+.||+|||+.|++|+||+|+||++++++.+||+|||++....... ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence 99975 899988765 579999999999999999999999999999999999999999999999999998765433 23
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC------------------
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------------ 235 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~------------------ 235 (515)
....++..|+|||.+.+....++++||||+|+++|+|++|..||...+.......+......
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL 238 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence 34467889999998876544578999999999999999999999987766655554332100
Q ss_pred -------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 236 -------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 236 -------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
+...+++.+.+++.+||+.||.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 011138889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=334.34 Aligned_cols=251 Identities=29% Similarity=0.504 Sum_probs=215.7
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
+++|++.+.||.|+||.||+|.+..+++.+|||.+......+......+.+|+.+++.++||||+++++++..++..+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 36899999999999999999999999999999998765555555567888999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 96 MEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 96 mEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|||++|++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999999864 3568999999999999999999999999999999999999999999999999987664432
Q ss_pred -ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh--HHHHHHHhcCccC-C-CCCCChhHHH
Q 010214 172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI--PNLFKKIKGGIYT-L-PSHLSPGARD 246 (515)
Q Consensus 172 -~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~--~~~~~~i~~~~~~-~-p~~~s~~~~~ 246 (515)
......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.+... ....+.+....+. . +..+++.+.+
T Consensus 161 ~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred cccccccCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 2345579999999999987766 6899999999999999999999976543 3444444433322 2 2457889999
Q ss_pred HhcccCCCCCCCCCCHHHHhc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~ 267 (515)
++.+||..||.+|||+.++++
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHH
Confidence 999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=329.88 Aligned_cols=251 Identities=32% Similarity=0.532 Sum_probs=224.3
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||.|+||.||++.+..+++.+|+|.+....... .....+.+|+++++.++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999987655433 345677889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 98 YVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 98 y~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|+++++|.+++.+ ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~ 158 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MA 158 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Cc
Confidence 9999999999876 356899999999999999999999999999999999999999999999999999877554 44
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-CCCCCCChhHHHHhcccC
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRML 252 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~mL 252 (515)
....+++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.+ ..+..++.++++++.+||
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSML 237 (256)
T ss_pred ccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHc
Confidence 55678999999999988776 6899999999999999999999998887777666665553 456678999999999999
Q ss_pred CCCCCCCCCHHHHhcCccc
Q 010214 253 IVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 253 ~~dP~~Rpt~~eil~hp~f 271 (515)
+.+|.+|||+.++++||++
T Consensus 238 ~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 238 QVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCCcccCCCHHHHhcCCCC
Confidence 9999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=334.66 Aligned_cols=254 Identities=30% Similarity=0.464 Sum_probs=212.7
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CCeEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--PSDIYV 94 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~i 94 (515)
++|...+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|+++++.++||||+++++++.+ ...+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 478999999999999999999999999999999875432 2455778999999999999999999998854 347899
Q ss_pred EEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 95 VMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
||||++|++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999988753 345899999999999999999999999999999999999999999999999998765432
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC-----hHHHHHHHhcCc-cCCC------C
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-----IPNLFKKIKGGI-YTLP------S 238 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~-----~~~~~~~i~~~~-~~~p------~ 238 (515)
. .....++..|+|||.+.+..+ +.++|||||||++|+|++|..||.... ..+....+.... ..++ .
T Consensus 159 ~-~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd06621 159 L-AGTFTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236 (287)
T ss_pred c-cccccCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence 2 234568889999999987776 689999999999999999999998652 233333333311 1122 1
Q ss_pred CCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 239 ~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..++.+.+|+.+||..||.+|||+.|++.||||+..
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 345789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=359.98 Aligned_cols=245 Identities=36% Similarity=0.587 Sum_probs=217.9
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 92 (515)
.+.+.|.+...+|.|+|+.|..+.+..+++..++|++.+... ...+|+.++.+. +||||+++++++.+..+.
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCcee
Confidence 357889999999999999999999999999999999987632 234577665555 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE-CCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL-DSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl-~~~~~vKL~DFGls~~~~~~~ 171 (515)
|+|||.+.|+.|.+.|..+..+. .++..|+.||+.|+.|||++|||||||||+|||+ ++.|+++|+|||.+......
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999999999999998776665 8888999999999999999999999999999999 58899999999999877654
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh-HHHHHHHhcCccCCCCCCChhHHHHhcc
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGGIYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~-~~~~~~i~~~~~~~p~~~s~~~~~li~~ 250 (515)
..+.|-|..|.|||++....| ++++||||||++||+||+|..||..... .++...|..+.+. ..+|..+++||++
T Consensus 470 -~~tp~~t~~y~APEvl~~~~y-t~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~~ 545 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAIQEY-TEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQQ 545 (612)
T ss_pred -hcccchhhcccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHHHH
Confidence 567788999999999998877 7999999999999999999999976544 4677777766554 7899999999999
Q ss_pred cCCCCCCCCCCHHHHhcCccc
Q 010214 251 MLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~hp~f 271 (515)
||++||.+|+++.+++.||||
T Consensus 546 LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 546 LLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred hccCChhhCcChhhhccCcch
Confidence 999999999999999999999
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=338.70 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=210.3
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iV 95 (515)
++|...+.||+|+||.||++.+..+++.||+|.+.+.... .....+.+|+.++.++. ||||+++++++..+...+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 5677888999999999999999999999999998754432 44567889999999996 99999999999999999999
Q ss_pred EeccCCCCHHHHH---H--HhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 96 MEYVKSGELFDYI---V--EKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 96 mEy~~gg~L~~~i---~--~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
|||+.+ +|.++. . ..+.+++..+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999864 555433 2 24679999999999999999999997 4999999999999999999999999999976654
Q ss_pred CCccccCCCCCCccCCCcccCC--ccCCCcceeehhHHHHHHHHhCCCCCCCCCh-HHHHHHHhcCc-cCC----CCCCC
Q 010214 170 GHFLKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGGI-YTL----PSHLS 241 (515)
Q Consensus 170 ~~~~~~~~gt~~Y~aPE~i~~~--~~~~~~~DIwSlGvily~lltG~~Pf~~~~~-~~~~~~i~~~~-~~~----p~~~s 241 (515)
........|++.|+|||++.+. ...+.++||||+||++|+|++|..||..... .+....+..+. ..+ +..++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFS 240 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccC
Confidence 4444455789999999999866 2347899999999999999999999976542 12222222221 122 22478
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.++.+|+.+||+.||.+|||++++++||||+..
T Consensus 241 ~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 241 PSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 899999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=338.83 Aligned_cols=260 Identities=32% Similarity=0.513 Sum_probs=221.0
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
..+...++|.+.+.||.|+||.||++.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 13 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred eccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 34445689999999999999999999999899999999986432 233567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
..|+|+||+++++|.+++.+ ..+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred cEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 99999999999999999865 46889999999999999999999999999999999999999999999999988765433
Q ss_pred C-ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhc-Cc--cCCCCCCChhHHH
Q 010214 171 H-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG-GI--YTLPSHLSPGARD 246 (515)
Q Consensus 171 ~-~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~-~~--~~~p~~~s~~~~~ 246 (515)
. ......|++.|+|||.+.+..+ +.++|+||+||++|++++|..||...+.......+.. +. ...+..++..+++
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 247 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 247 (293)
T ss_pred ccccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHH
Confidence 2 2334568899999999987766 6899999999999999999999987655443332221 11 2234567889999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
++.+||..+|.+|||+.+++.||||+...
T Consensus 248 li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 248 FLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 99999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=335.57 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=215.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcC-----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.++|++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 5789999999999999999997653 34589999876433 2233456788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEee
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG----------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~----------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~D 160 (515)
..|+||||+++|+|.+++...+ .++...+..++.||+.||.|||++||+||||||+||+++.++.++|+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 9999999999999999997532 245678899999999999999999999999999999999999999999
Q ss_pred cccccccccCCcc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccC
Q 010214 161 FGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYT 235 (515)
Q Consensus 161 FGls~~~~~~~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~ 235 (515)
||+++........ ....++..|+|||.+.+..+ +.++|+||+||++|+|++ |..||.+.......+.+..+ ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 241 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9998765432221 22345678999999987766 789999999999999998 89999988877777766554 345
Q ss_pred CCCCCChhHHHHhcccCCCCCCCCCCHHHHhc------Cccccc
Q 010214 236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ------HPWFQA 273 (515)
Q Consensus 236 ~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~------hp~f~~ 273 (515)
.|...++.+.+++.+||+.||.+|||+.++++ ||||..
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 242 QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 66778899999999999999999999999987 888864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=332.75 Aligned_cols=249 Identities=26% Similarity=0.379 Sum_probs=215.0
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCC-----cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTG-----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.++|++.+.||.|+||.||+|.++..+ ..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 578999999999999999999986444 789999986432 2234567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEee
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG----------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~----------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~D 160 (515)
..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECC
Confidence 9999999999999999997532 367889999999999999999999999999999999999999999999
Q ss_pred cccccccccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccC
Q 010214 161 FGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYT 235 (515)
Q Consensus 161 FGls~~~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~ 235 (515)
||+++...... ......++..|+|||.+.+..+ +.++|||||||++|++++ |..||.+.+.....+.+..+ ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence 99987654332 2234457889999999987665 789999999999999998 99999988877777766654 346
Q ss_pred CCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 236 ~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.|...+.++.+++.+||+.+|.+|||+.++++
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 242 LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 67888999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=334.33 Aligned_cols=250 Identities=23% Similarity=0.420 Sum_probs=213.3
Q ss_pred CCCceEeeeecccCceEEEEEEEc----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
.++|++.+.||+|+||+||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 468999999999999999999853 456789999986432 23445678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHh-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC
Q 010214 92 IYVVMEYVKSGELFDYIVEK-----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW 154 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~-----------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~ 154 (515)
.|+||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 99999999999999999633 2478889999999999999999999999999999999999999
Q ss_pred ceEEeecccccccccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 010214 155 NVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK 230 (515)
Q Consensus 155 ~vKL~DFGls~~~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~ 230 (515)
.+||+|||++....... ......++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999997654332 2234456778999999987765 789999999999999998 999998877666666555
Q ss_pred cCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 231 GGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 231 ~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
... ...|..+++.+.+++.+||+.||.+||++.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 443 45667889999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=341.33 Aligned_cols=254 Identities=29% Similarity=0.502 Sum_probs=209.0
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP------ 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~------ 89 (515)
.++|++.+.||.|+||.||+|.++.+++.||+|++......+ .....+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 689999999999999999999999999999999987544332 1234567899999999999999999987443
Q ss_pred --CeEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 90 --SDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 90 --~~~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
..+|+||||+.+ +|...+.. ...+++..++.++.||++||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 347999999965 77777764 45799999999999999999999999999999999999999999999999999876
Q ss_pred cccCCc------------cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc
Q 010214 167 MRDGHF------------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY 234 (515)
Q Consensus 167 ~~~~~~------------~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~ 234 (515)
...... .....+++.|+|||.+.+....+.++||||+||++|+|++|.+||.+.+.......+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 543221 12235688899999987655457899999999999999999999998776665554432110
Q ss_pred C-----------------------CC-------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 235 T-----------------------LP-------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 235 ~-----------------------~p-------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
. .+ ..+++++.++|.+||+.||.+|||+.|++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 00 2345788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=334.56 Aligned_cols=250 Identities=23% Similarity=0.368 Sum_probs=213.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcC-----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 4789999999999999999999987 78899999876432 2334466888999999999999999999999888
Q ss_pred eEEEEEeccCCCCHHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---ceEEee
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG-------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVKIAD 160 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~-------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~---~vKL~D 160 (515)
..|+||||++|++|.+++...+ .+++..+..++.||+.||.|||+++++||||||+||+++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 9999999999999999997653 489999999999999999999999999999999999998765 599999
Q ss_pred cccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccC
Q 010214 161 FGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYT 235 (515)
Q Consensus 161 FGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~ 235 (515)
||++........ ......+..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+... ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 999986633221 112233568999999987776 789999999999999997 99999988777766665543 345
Q ss_pred CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 236 ~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.|..++..+.+++.+||+.||.+|||+.++++|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 677889999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=341.48 Aligned_cols=254 Identities=30% Similarity=0.541 Sum_probs=218.3
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
...|.....||.|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence 3455666789999999999999999999999999865432 2346688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~ 174 (515)
|||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ...
T Consensus 97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 999999999987754 578999999999999999999999999999999999999999999999999987554322 234
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc---cCCCCCCChhHHHHhccc
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~m 251 (515)
..+|++.|+|||++.+..+ +.++||||+||++|+|++|..||...........+.... ...+..++..+.++|.+|
T Consensus 176 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred ceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence 5678999999999987766 789999999999999999999998776666555554432 223346788999999999
Q ss_pred CCCCCCCCCCHHHHhcCcccccc
Q 010214 252 LIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|+.+|.+|||+.++++||||.+.
T Consensus 255 l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 255 LTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred hcCCcccCcCHHHHhhChhhccC
Confidence 99999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=339.78 Aligned_cols=256 Identities=31% Similarity=0.528 Sum_probs=213.1
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC---
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS--- 90 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~--- 90 (515)
...++|++.+.||.|+||.||+|.++.+|+.||+|++....... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 45689999999999999999999999999999999987543222 23356778999999999999999999987655
Q ss_pred -------eEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecc
Q 010214 91 -------DIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFG 162 (515)
Q Consensus 91 -------~~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFG 162 (515)
.+|+|+||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||++++++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 79999999976 777777653 468999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC--ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc------
Q 010214 163 LSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------ 234 (515)
Q Consensus 163 ls~~~~~~~--~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~------ 234 (515)
++....... ......+++.|+|||.+.+....+.++||||+||++|+|++|..||...+.......+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 988664432 122335678899999987654457899999999999999999999987765554444433110
Q ss_pred ------------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 235 ------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 235 ------------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.....+++.+.+++.+||+.||.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0112468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=329.45 Aligned_cols=241 Identities=25% Similarity=0.423 Sum_probs=207.9
Q ss_pred eecccCceEEEEEEE--cCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 24 TLGIGSFGKVKIAEH--ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~~--~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
.||+|+||.||+|.+ +.++..+|+|++.... ......+.+.+|+.+++.++||||++++++++ ....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 689999999999964 4678899999986443 33445678899999999999999999999885 4567899999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc----cccCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSC 177 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~~~ 177 (515)
|+|.+++...+.+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||++........ .....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 99999998888899999999999999999999999999999999999999999999999999987643321 12233
Q ss_pred CCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcccCCCC
Q 010214 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 178 gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~~d 255 (515)
+++.|+|||.+.+..+ +.++|+|||||++|+|++ |..||.+.+.......+..+. ...|..+++++.++|.+||+.|
T Consensus 160 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 4678999999876655 689999999999999998 999999887777777777654 4667789999999999999999
Q ss_pred CCCCCCHHHHhc
Q 010214 256 PMKRITIPEIRQ 267 (515)
Q Consensus 256 P~~Rpt~~eil~ 267 (515)
|.+|||+.+|..
T Consensus 239 p~~Rp~~~~i~~ 250 (257)
T cd05116 239 VDERPGFAVVEL 250 (257)
T ss_pred chhCcCHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=332.64 Aligned_cols=250 Identities=33% Similarity=0.509 Sum_probs=211.5
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC---CCCCccEEEEEEEcCCe----
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIRLYEVIETPSD---- 91 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l~~~~~~~~~---- 91 (515)
|++.+.||.|+||.||+|.++.+++.||+|++..... .......+.+|+.+++.+ +||||+++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7899999999999999999998999999999975433 222345566788877666 59999999999988776
Q ss_pred -EEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 92 -IYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 92 -~~iVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
++++|||+.+ +|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 8999887643 58999999999999999999999999999999999999999999999999998775
Q ss_pred cCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-----C--------
Q 010214 169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-----T-------- 235 (515)
Q Consensus 169 ~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-----~-------- 235 (515)
.........+++.|+|||++.+..+ +.++|+||+||++|+|++|.+||.+.+..+...++..... .
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred CCcccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 5544455568899999999988766 6899999999999999999999998877666655533110 0
Q ss_pred ---C-----------CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 236 ---L-----------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 236 ---~-----------p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
+ .+.+++.+.++|.+||+.||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 02356788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=342.40 Aligned_cols=251 Identities=28% Similarity=0.464 Sum_probs=220.2
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
-|.++.+||+|+||.||+|.|+.+|+.+|||.+..+. ..+.+..||.+|+++..|++|++|+.+-...++|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3788999999999999999999999999999886543 46788999999999999999999999989999999999
Q ss_pred ccCCCCHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cccc
Q 010214 98 YVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (515)
Q Consensus 98 y~~gg~L~~~i~-~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~ 175 (515)
||..|+..+.+. ++++++|+++..+++.-+.||+|||...-+|||||..|||++.+|..||+|||.+..+.+.- .-+|
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT 188 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT 188 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence 999999999997 46789999999999999999999999999999999999999999999999999998775532 3467
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC---ccCCCCCCChhHHHHhcccC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARDLIPRML 252 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~mL 252 (515)
..|||.|||||++..-.| +.++||||||++..||.-|++||.+-......--|-.. .+.-|...|.++.||+++||
T Consensus 189 VIGTPFWMAPEVI~EIGY-~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CL 267 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGY-DTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCL 267 (502)
T ss_pred cccCcccccHHHHHHhcc-chhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHh
Confidence 899999999999998777 67999999999999999999999876543221111111 12335567899999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccc
Q 010214 253 IVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 253 ~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.++|++|.|+.++++|||+++.
T Consensus 268 iK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 268 IKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred cCCHHHHHHHHHHhhhhhhcCC
Confidence 9999999999999999999864
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=329.27 Aligned_cols=246 Identities=26% Similarity=0.490 Sum_probs=212.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+..|++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 478999999999999999999875 567899998764332 346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc-
Q 010214 96 MEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF- 172 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~- 172 (515)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++........
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999999999753 4688999999999999999999999999999999999999999999999999987654322
Q ss_pred -cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhc
Q 010214 173 -LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIP 249 (515)
Q Consensus 173 -~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 249 (515)
.....++..|+|||.+.+..+ ++++|||||||++|+|++ |..||...........+..+. .+.+..++.++.+++.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMK 238 (261)
T ss_pred ccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 122345678999999987766 789999999999999998 999998887777777766542 3344568899999999
Q ss_pred ccCCCCCCCCCCHHHHhc
Q 010214 250 RMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~ 267 (515)
+||..+|++|||++++.+
T Consensus 239 ~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 239 TCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=330.13 Aligned_cols=246 Identities=25% Similarity=0.478 Sum_probs=211.6
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
.+|++.+.||+|+||.||+|.++ ++..+|+|++.+.... ...+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 46899999999999999999886 5678999998654332 246778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc-
Q 010214 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK- 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~- 174 (515)
||++|++|.+++..+ +.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++...+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999999999999763 468999999999999999999999999999999999999999999999999987654332211
Q ss_pred -cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhccc
Q 010214 175 -TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 175 -~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~m 251 (515)
...++..|+|||.+.+..+ +.++|+||+|+++|+|++ |..||...+..+....+..+ ....|...+..+.+++.+|
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSC 237 (256)
T ss_pred CCCCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHH
Confidence 1123457999999988776 689999999999999999 89999887777777777655 3455677899999999999
Q ss_pred CCCCCCCCCCHHHHhcC
Q 010214 252 LIVDPMKRITIPEIRQH 268 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~h 268 (515)
|..+|++|||+.|+++.
T Consensus 238 l~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 238 WHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred hcCChhhCcCHHHHHHH
Confidence 99999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=366.98 Aligned_cols=246 Identities=31% Similarity=0.514 Sum_probs=209.5
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEE-EE---cC--
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEV-IE---TP-- 89 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~-~~---~~-- 89 (515)
-++++.+.|.+|||+.||+|.+...|..||+|++-. .+......+.+||.+|++|. |||||.+++. .. ..
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 456889999999999999999998889999998753 36677899999999999998 9999999993 21 11
Q ss_pred -CeEEEEEeccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCceEEeecccc
Q 010214 90 -SDIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 90 -~~~~iVmEy~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
-.++|.||||+||.|-|++.+ ..+|+|.++.+||.|+++||.+||... |+|||||-|||||+.+|++||||||.+
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 248899999999999999984 456999999999999999999999987 999999999999999999999999987
Q ss_pred cccccCC-c------c---ccCCCCCCccCCCccc---CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhc
Q 010214 165 NIMRDGH-F------L---KTSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG 231 (515)
Q Consensus 165 ~~~~~~~-~------~---~~~~gt~~Y~aPE~i~---~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~ 231 (515)
....... . + -...-|+.|+|||++. |.. .++|+|||+|||+||.|+....||++... -.|.+
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~p-I~eKsDIWALGclLYkLCy~t~PFe~sg~----laIln 268 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLP-IGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILN 268 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCC-CcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEe
Confidence 6432111 0 0 1224689999999984 444 48999999999999999999999988643 35788
Q ss_pred CccCCCC--CCChhHHHHhcccCCCCCCCCCCHHHHhcCcc
Q 010214 232 GIYTLPS--HLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270 (515)
Q Consensus 232 ~~~~~p~--~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~ 270 (515)
+.|.+|+ .++..+++||..||+.||.+||++-+++.+-+
T Consensus 269 g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 269 GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 8998886 68999999999999999999999999887643
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=329.99 Aligned_cols=247 Identities=26% Similarity=0.465 Sum_probs=212.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||+||+|.+.. +..+|+|.+...... ...+.+|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 3579999999999999999998753 456999988654322 35688999999999999999999999998899999
Q ss_pred EeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
|||+.+|+|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||.+..........
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999999999764 468999999999999999999999999999999999999999999999999987654433221
Q ss_pred --cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCcc-CCCCCCChhHHHHhcc
Q 010214 175 --TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPR 250 (515)
Q Consensus 175 --~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 250 (515)
...++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+.. ..+...+..+.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred cCCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 1234567999999987766 689999999999999998 9999998877777777766543 3456678999999999
Q ss_pred cCCCCCCCCCCHHHHhcC
Q 010214 251 MLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~h 268 (515)
||..||.+|||+.+++.+
T Consensus 237 cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 237 CWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HcCCCcccCCCHHHHHHh
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=329.84 Aligned_cols=248 Identities=26% Similarity=0.452 Sum_probs=211.1
Q ss_pred ceEeeeecccCceEEEEEEEcCC---CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe----
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD---- 91 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~---- 91 (515)
|++.+.||+|+||.||.|.+..+ +..||+|.+...... ......+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 67889999999999999987654 478999998754332 3445778999999999999999999998865443
Q ss_pred --EEEEEeccCCCCHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 92 --IYVVMEYVKSGELFDYIVEK------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 92 --~~iVmEy~~gg~L~~~i~~~------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
.+++|||+++|+|..++... ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999998542 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCC
Q 010214 164 SNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPS 238 (515)
Q Consensus 164 s~~~~~~~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 238 (515)
+......... ....++..|+|||.+.+..+ +.++||||+||++|+|++ |..||.+....+....+..+ ....|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 9876443321 12335678999999987766 789999999999999999 99999888777777777654 345678
Q ss_pred CCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 239 ~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.++.++.+++.+||+.||.+|||+.|++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=346.31 Aligned_cols=259 Identities=29% Similarity=0.472 Sum_probs=214.1
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC---
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--- 89 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--- 89 (515)
..+.++|.+.+.||+|+||.||+|.+..+|+.||+|++.+... .....+.+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 3456899999999999999999999999999999999875422 223356788999999999999999999988543
Q ss_pred ---CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 90 ---SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 90 ---~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
...|++++++ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 3478899987 7799887754 4699999999999999999999999999999999999999999999999999876
Q ss_pred cccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc------------
Q 010214 167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------------ 234 (515)
Q Consensus 167 ~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~------------ 234 (515)
... ......+++.|+|||++.+....+.++||||+||++|+|++|..||...+.......+.....
T Consensus 170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 170 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred ccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 533 234457899999999987744447899999999999999999999987665444333322110
Q ss_pred -----------CCC--------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 235 -----------TLP--------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 235 -----------~~p--------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
..| ...++++++||.+||+.||.+|||+.+++.||||++...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 011 135788999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=353.72 Aligned_cols=251 Identities=30% Similarity=0.417 Sum_probs=222.2
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy 98 (515)
|.=++.||.|+||.||.|++..|.+.||||.++-+.-...+-...+..|++.|++++|||+|.+-++|-.+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 66788999999999999999999999999999877766666778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCC
Q 010214 99 VKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC 177 (515)
Q Consensus 99 ~~gg~L~~~i~-~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~ 177 (515)
|-| +-.|++. .++++.|.++..|+.+.+.||.|||+++.+|||||..|||+++.|.|||+|||.+..+.+ .++++
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---AnsFv 183 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---ANSFV 183 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---hhccc
Confidence 965 8888775 467899999999999999999999999999999999999999999999999999987754 46789
Q ss_pred CCCCccCCCccc---CCccCCCcceeehhHHHHHHHHhCCCCCCCCC-hHHHHHHHhcCccCCCC-CCChhHHHHhcccC
Q 010214 178 GSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPS-HLSPGARDLIPRML 252 (515)
Q Consensus 178 gt~~Y~aPE~i~---~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~-~~~~~~~i~~~~~~~p~-~~s~~~~~li~~mL 252 (515)
|||+|||||+|. ...| +-++||||||++..+|.-.++|+-..+ ...++.-..+..+.+++ ..|..+++||..||
T Consensus 184 GTPywMAPEVILAMDEGqY-dgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CL 262 (948)
T KOG0577|consen 184 GTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL 262 (948)
T ss_pred CCccccchhHheecccccc-CCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHH
Confidence 999999999985 3456 569999999999999999999966554 45566555666666653 67899999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccc
Q 010214 253 IVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 253 ~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
++-|.+|||.++++.|+|+...
T Consensus 263 qKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 263 QKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred hhCcccCCcHHHHhhcchhccC
Confidence 9999999999999999998643
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=333.19 Aligned_cols=255 Identities=33% Similarity=0.535 Sum_probs=222.4
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|++.+.||.|++|.||+|.+..++..||+|++..... ....+.+|+++++.++||||+++++++......|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 456789999999999999999999998999999999865432 4567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-
Q 010214 94 VVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~- 171 (515)
+|+||++|++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 9999999999999998876 89999999999999999999999999999999999999999999999999887554322
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-cC--CCCCCChhHHHHh
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YT--LPSHLSPGARDLI 248 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-~~--~p~~~s~~~~~li 248 (515)
......+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+.... .. .+..++.++.++|
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 250 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL 250 (286)
T ss_pred hhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHH
Confidence 2234568899999999987766 789999999999999999999998876655555443332 22 2234788999999
Q ss_pred cccCCCCCCCCCCHHHHhcCccccc
Q 010214 249 PRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
.+||+.+|.+|||+.+++.||||+.
T Consensus 251 ~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 251 NKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHhccChhhCcCHHHHhhChHhhc
Confidence 9999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=339.96 Aligned_cols=249 Identities=26% Similarity=0.409 Sum_probs=211.0
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcE----EEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~----vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
..+|++.+.||+|+||+||+|.+..+++. ||+|++... ......+.+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 36799999999999999999998766654 899998643 2334557788999999999999999999998764 5
Q ss_pred EEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 92 IYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.++++||+++|+|.+++.++ ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 78999999999999999874 46899999999999999999999999999999999999999999999999999876543
Q ss_pred Ccc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHH
Q 010214 171 HFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGAR 245 (515)
Q Consensus 171 ~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (515)
... ....++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+..+ ..+.|..++.++.
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 241 (316)
T ss_pred CcceeccCCccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 322 22334678999999988776 789999999999999997 99999987766655444433 2345667889999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcC
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+++.+||..||.+|||+.+++.+
T Consensus 242 ~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 242 MIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=333.75 Aligned_cols=253 Identities=28% Similarity=0.480 Sum_probs=216.4
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCC-----cEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTG-----HKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVI 86 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~ 86 (515)
..-.++|++.+.||+|+||.||+|.+...+ ..+|+|.+.... .......+.+|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344578999999999999999999986443 789999987542 223456788999999999 799999999999
Q ss_pred EcCCeEEEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 010214 87 ETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL 150 (515)
Q Consensus 87 ~~~~~~~iVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl 150 (515)
.....++++|||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 9999999999999999999999642 358899999999999999999999999999999999999
Q ss_pred CCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHH
Q 010214 151 DSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF 226 (515)
Q Consensus 151 ~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~ 226 (515)
+.++.+||+|||++........ .....++..|+|||++.+..+ +.++||||+||++|+|++ |..||.+....+..
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 9999999999999987654322 122235678999999887766 789999999999999997 99999988887777
Q ss_pred HHHhcCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 227 KKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 227 ~~i~~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..+..+. ...|...+.++.+|+.+||..||.+|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 245 KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 7776654 35567788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=372.83 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=209.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||.||+|.+..+|+.||+|++...........+++.+|+++++.++||||+++++++.+.+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 47899999999999999999999999999999999765444445567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccc
Q 010214 96 MEYVKSGELFDYIVEK-----------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-----------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
|||++||+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999998642 23556778899999999999999999999999999999999999999999999
Q ss_pred cccccC-------------------CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHH
Q 010214 165 NIMRDG-------------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL 225 (515)
Q Consensus 165 ~~~~~~-------------------~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~ 225 (515)
...... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 765210 01123479999999999988876 7899999999999999999999987554333
Q ss_pred HHHH-hcCccC--CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 226 FKKI-KGGIYT--LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 226 ~~~i-~~~~~~--~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.... ...... ....+++.+.+++.+||..||.+|++..+.+.+
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2221 111111 123678899999999999999999887666554
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=342.44 Aligned_cols=255 Identities=32% Similarity=0.515 Sum_probs=209.9
Q ss_pred CceEeeeecccCceEEEEEEEcCC--CcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEc----CC
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALT--GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIET----PS 90 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~t--g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~----~~ 90 (515)
+|++.+.||.|+||.||+|.+..+ +..||+|.+.... ........+.+|+.+++.+. ||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999988 9999999986432 22234566788999999994 9999999987532 24
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.+|++|||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6899999995 599999988888999999999999999999999999999999999999999999999999999765432
Q ss_pred C-----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc------------
Q 010214 171 H-----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------ 233 (515)
Q Consensus 171 ~-----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~------------ 233 (515)
. ......||+.|+|||++.+....+.++||||+||++|+|++|..||...+.......+....
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 1 22345789999999988764444789999999999999999999998766443333222110
Q ss_pred ----------------c---CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 234 ----------------Y---TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 234 ----------------~---~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
. ......+..+.+|+.+||+.||.+|||+.+++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 0 0112357899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=330.49 Aligned_cols=248 Identities=27% Similarity=0.476 Sum_probs=209.6
Q ss_pred ceEeeeecccCceEEEEEEEcCCCc--EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------C
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP------S 90 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~------~ 90 (515)
|.+++.||+|+||.||+|.+..++. .||+|.+.... ......+.+.+|+.+++.++||||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4578899999999999999887775 69999886543 2334567888999999999999999999986322 2
Q ss_pred eEEEEEeccCCCCHHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccc
Q 010214 91 DIYVVMEYVKSGELFDYIVE------KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
..+++|||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 47899999999999998853 234889999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCC
Q 010214 165 NIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSH 239 (515)
Q Consensus 165 ~~~~~~~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~ 239 (515)
.....+... ....+++.|+|||.+.+..+ ++++||||+||++|+|++ |..||...........+..+. ...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 876543321 23346778999999988766 789999999999999999 899998877777777777654 355677
Q ss_pred CChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 240 LSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 240 ~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
++..+.+++.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=326.80 Aligned_cols=246 Identities=25% Similarity=0.440 Sum_probs=211.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||.|++|.||+|.+. +++.||+|.+...... .+.+.+|+.++++++||||+++++++...+..|+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 467999999999999999999975 4578999998654322 35688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 96 MEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999999997654 6899999999999999999999999999999999999999999999999999876533221
Q ss_pred cc--CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhc
Q 010214 174 KT--SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIP 249 (515)
Q Consensus 174 ~~--~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~ 249 (515)
.. ...+..|+|||++.+..+ +.++||||||+++|+|++ |+.||.+.+.......+... ....+...+..+.+++.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIML 238 (261)
T ss_pred ccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence 11 122357999999987765 789999999999999999 99999988877777776554 23456678999999999
Q ss_pred ccCCCCCCCCCCHHHHhc
Q 010214 250 RMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~ 267 (515)
+||+.+|.+|||+.++++
T Consensus 239 ~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 239 DCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHhhcCcccCCCHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=342.80 Aligned_cols=251 Identities=22% Similarity=0.351 Sum_probs=204.8
Q ss_pred eeeccc--CceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccC
Q 010214 23 KTLGIG--SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVK 100 (515)
Q Consensus 23 ~~LG~G--~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~ 100 (515)
..||.| +||+||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++..++..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 99999999999999999999987654333 445788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Cc-----
Q 010214 101 SGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HF----- 172 (515)
Q Consensus 101 gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~----- 172 (515)
+++|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||+.+...... ..
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 999999998643 5899999999999999999999999999999999999999999999999865433211 11
Q ss_pred --cccCCCCCCccCCCcccCCc-cCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---------------
Q 010214 173 --LKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--------------- 234 (515)
Q Consensus 173 --~~~~~gt~~Y~aPE~i~~~~-~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~--------------- 234 (515)
.....++..|+|||++.+.. ..+.++||||+||++|+|++|..||...........+.....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 01123566799999997642 237899999999999999999999987654443333222111
Q ss_pred --------------------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 --------------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 --------------------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..+..+++.+.+|+.+||+.||.+|||+.|+++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 0112356789999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=365.69 Aligned_cols=260 Identities=24% Similarity=0.423 Sum_probs=199.6
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCC-CcEEEEEE--------------ecccccCChHHHHHHHHHHHHHHhCCCC
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALT-GHKVAIKI--------------LNRRKIKNMEMEEKVRREIKILRLFMHP 77 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~t-g~~vAiK~--------------i~~~~~~~~~~~~~i~~Ei~il~~l~hp 77 (515)
+.+.++|++++.||+|+||+||+|.++.. +...+.|. +.+...........+.+|+.+|+.++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 34668999999999999999999876533 22223221 1111112223456788999999999999
Q ss_pred CccEEEEEEEcCCeEEEEEeccCCCCHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC
Q 010214 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS 152 (515)
Q Consensus 78 nIv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~-----~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~ 152 (515)
||+++++++++.+..|+|+|++. ++|.+++... .......++.++.||+.||.|||++||+||||||+|||++.
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 99999999999999999999995 5888887542 23456778899999999999999999999999999999999
Q ss_pred CCceEEeecccccccccCC--ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCC-CCCCC--hHHHHH
Q 010214 153 KWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP-FDDEN--IPNLFK 227 (515)
Q Consensus 153 ~~~vKL~DFGls~~~~~~~--~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~P-f~~~~--~~~~~~ 227 (515)
++.+||+|||++..+.... ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..+ |.... ......
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 9999999999998765432 2234679999999999998877 7899999999999999998754 43221 111111
Q ss_pred HHhcCc----cCCC----------------------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 228 KIKGGI----YTLP----------------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 228 ~i~~~~----~~~p----------------------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
++.... ..+| ..++.++.++|.+||+.||.+|||+.|++.||||+..
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 111100 0000 1356678889999999999999999999999999753
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=333.73 Aligned_cols=249 Identities=25% Similarity=0.360 Sum_probs=212.4
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCC----------------cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTG----------------HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg----------------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI 79 (515)
.++|++++.||+|+||.||+|.+..++ ..||+|.+..... ....+.+.+|++++++++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCE
Confidence 478999999999999999999877644 4589999875432 2456788999999999999999
Q ss_pred cEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 010214 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-----------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL 148 (515)
Q Consensus 80 v~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~-----------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNI 148 (515)
+++++++..+...+++|||+++++|.+++.+.. .+++..++.++.|++.||.|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999998765 689999999999999999999999999999999999
Q ss_pred EECCCCceEEeecccccccccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh--CCCCCCCCChH
Q 010214 149 LLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC--GTLPFDDENIP 223 (515)
Q Consensus 149 Ll~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt--G~~Pf~~~~~~ 223 (515)
+++.++.++|+|||++....... ......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 99999999999999987654332 1224456788999999987665 789999999999999998 78999887766
Q ss_pred HHHHHHhcC--------ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 224 NLFKKIKGG--------IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 224 ~~~~~i~~~--------~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.....+... ....|..++.++.+++.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 665555432 12345567899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=336.06 Aligned_cols=254 Identities=27% Similarity=0.457 Sum_probs=215.6
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcC-------CCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEE
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHAL-------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLY 83 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~-------tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~ 83 (515)
.....++|.+.+.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++.+ +||||++++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 33445889999999999999999998743 33579999987542 223456788899999999 799999999
Q ss_pred EEEEcCCeEEEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010214 84 EVIETPSDIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPEN 147 (515)
Q Consensus 84 ~~~~~~~~~~iVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeN 147 (515)
+++......|+||||+++|+|.+++.... .+++.++..++.||+.||+|||++|++||||||+|
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 99999999999999999999999997642 47889999999999999999999999999999999
Q ss_pred EEECCCCceEEeecccccccccCCcc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChH
Q 010214 148 LLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP 223 (515)
Q Consensus 148 ILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~ 223 (515)
|+++.++.+||+|||++......... ....+++.|+|||++.+..+ +.++|+|||||++|+|++ |..||.+....
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999999998765432211 12234578999999987766 789999999999999998 99999988877
Q ss_pred HHHHHHhcCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 224 NLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 224 ~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+....+..+. ...|...+.++.+|+.+||..+|.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 250 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 7777776654 35677889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=325.78 Aligned_cols=243 Identities=28% Similarity=0.549 Sum_probs=213.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||.|+||.||+|... |+.||+|.+..... ..+++.+|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 578999999999999999999864 78999999865432 457889999999999999999999999989999999
Q ss_pred EeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 96 MEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||.+.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 99999999999998765 69999999999999999999999999999999999999999999999999998763322
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhccc
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~m 251 (515)
....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+...+...+..+ ....|..+++++.++|.+|
T Consensus 157 ~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05039 157 DSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDC 235 (256)
T ss_pred ccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHH
Confidence 23445668999999987665 689999999999999997 99999988877777666554 3455677899999999999
Q ss_pred CCCCCCCCCCHHHHhc
Q 010214 252 LIVDPMKRITIPEIRQ 267 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~ 267 (515)
|..+|.+|||+.++++
T Consensus 236 l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 236 WELDPAKRPTFKQLRE 251 (256)
T ss_pred hccChhhCcCHHHHHH
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=334.99 Aligned_cols=256 Identities=29% Similarity=0.379 Sum_probs=218.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
...|...+.||+|+||.||+|.+..++..||+|++.............+.+|+++++.++|||++++++++.++...|+|
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 45589999999999999999999999999999999766555555667889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
|||+.| +|.+.+.. ..++++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++..... ..
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~ 179 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---AN 179 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---cc
Confidence 999975 78777754 56799999999999999999999999999999999999999999999999999875433 23
Q ss_pred cCCCCCCccCCCccc---CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-C-CCCCCChhHHHHhc
Q 010214 175 TSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-T-LPSHLSPGARDLIP 249 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~---~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~-~p~~~s~~~~~li~ 249 (515)
...|++.|+|||.+. +..+ +.++|+||+||++|+|++|..||...+.......+..... . .+...++.+++++.
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 258 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 258 (317)
T ss_pred cccCCccccChhhhhcCCCCCC-CccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHH
Confidence 557899999999974 2333 7899999999999999999999987765555555544332 2 23467889999999
Q ss_pred ccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 250 RMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
+||+.+|.+|||+.++++|+|+....+
T Consensus 259 ~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 259 SCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HHccCCcccCcCHHHHHhChhhhccCc
Confidence 999999999999999999999965533
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=330.62 Aligned_cols=247 Identities=25% Similarity=0.489 Sum_probs=215.4
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
..+|++.+.||.|+||.||+|.+.. +..+|+|++..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3579999999999999999999987 88999999865432 2346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 96 MEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||.+.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999999999753 46899999999999999999999999999999999999999999999999999776443222
Q ss_pred -ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhcc
Q 010214 174 -KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 174 -~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~ 250 (515)
....++..|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+.+..+..+ ....|..+++.+.+++.+
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLE 239 (261)
T ss_pred ccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHH
Confidence 23345678999999987766 689999999999999998 89999988877777777654 345567889999999999
Q ss_pred cCCCCCCCCCCHHHHhc
Q 010214 251 MLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~ 267 (515)
||+.||.+|||+.++++
T Consensus 240 ~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 240 CWAAEPEDRPSFKALRE 256 (261)
T ss_pred HcCCCchhCcCHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=331.51 Aligned_cols=250 Identities=36% Similarity=0.532 Sum_probs=211.5
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEEEe
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iVmE 97 (515)
|++.+.||.|++|+||+|....+++.||||.+...... .......+|+..+++++ ||||+++++++.+++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 78899999999999999999999999999998654322 12234567999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 98 YVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 98 y~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
|+ +|+|.+++.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence 99 779999998765 789999999999999999999999999999999999999999999999999987765544455
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-------------------cC-
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------------YT- 235 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~~- 235 (515)
..++..|+|||++.+....+.++|+||+|+++++|++|..||...+......++.... ..
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF 237 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence 6789999999998654444789999999999999999999998776554443332110 00
Q ss_pred ----------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 236 ----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 236 ----------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.....+.++.++|.+||+.||.+|||+.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 012336889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=332.99 Aligned_cols=248 Identities=29% Similarity=0.451 Sum_probs=213.3
Q ss_pred CCCceEeeeecccCceEEEEEEEc-----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.++|.+.+.||+|+||.||+|.+. .++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 467999999999999999999864 345679999875432 234467889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW 154 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~ 154 (515)
..++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999997643 388999999999999999999999999999999999999999
Q ss_pred ceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 010214 155 NVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK 230 (515)
Q Consensus 155 ~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~ 230 (515)
.++|+|||++........ .....+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||...+..+..+.+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 999999999876543321 233456789999999988766 789999999999999998 999998888777777776
Q ss_pred cCcc-CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 231 GGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 231 ~~~~-~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.+.. ..+...+..+.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 6554 345667899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=325.67 Aligned_cols=241 Identities=26% Similarity=0.452 Sum_probs=207.0
Q ss_pred eeecccCceEEEEEEEcCCC---cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEecc
Q 010214 23 KTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYV 99 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~ 99 (515)
+.||+|+||.||+|....++ ..||+|.+...... ...+.+.+|+.+++.+.||||++++++++. ...++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence 47999999999999876555 78999998765543 455778999999999999999999998764 5689999999
Q ss_pred CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc-c---c
Q 010214 100 KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-K---T 175 (515)
Q Consensus 100 ~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~-~---~ 175 (515)
++|+|.+++...+.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++......... . .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 99999999998888999999999999999999999999999999999999999999999999999866443221 1 1
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcccCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~ 253 (515)
..++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+.... ...|..++..+.+++.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 123457999999987766 789999999999999998 999999887777766665553 35667789999999999999
Q ss_pred CCCCCCCCHHHHhc
Q 010214 254 VDPMKRITIPEIRQ 267 (515)
Q Consensus 254 ~dP~~Rpt~~eil~ 267 (515)
.||.+|||+.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=369.65 Aligned_cols=150 Identities=29% Similarity=0.591 Sum_probs=142.0
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
+++|.+.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57999999999999999999999999999999999876666666678899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
|||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999888889999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=334.02 Aligned_cols=250 Identities=24% Similarity=0.406 Sum_probs=215.6
Q ss_pred CCCceEeeeecccCceEEEEEEEcCC-----CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALT-----GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~t-----g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
..+|++.+.||.|+||.||+|.+..+ ++.||+|++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 45688999999999999999987643 5789999987443 2234567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC
Q 010214 91 DIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW 154 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~ 154 (515)
..++++||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 999999999999999998632 3478889999999999999999999999999999999999999
Q ss_pred ceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 010214 155 NVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK 230 (515)
Q Consensus 155 ~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~ 230 (515)
.+||+|||+++....... .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999876543322 234456789999999987766 789999999999999998 899999888888888877
Q ss_pred cCcc-CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 231 GGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 231 ~~~~-~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.... ..|..++..+.+|+.+||+.+|.+|||+.+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 7654 4577899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=334.34 Aligned_cols=254 Identities=27% Similarity=0.363 Sum_probs=215.4
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
+-|...+.||.|+||+||+|.+..+|+.||+|++.............+.+|+.+++.++|||++++++++.+....|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 34777888999999999999999999999999997665555555677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
||+. |+|.+++.. ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++.... ....
T Consensus 101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~~~ 176 (313)
T cd06633 101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANS 176 (313)
T ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CCCC
Confidence 9996 478887765 4578999999999999999999999999999999999999999999999999886432 2345
Q ss_pred CCCCCCccCCCcccC--CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-C-CCCCCChhHHHHhccc
Q 010214 176 SCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-T-LPSHLSPGARDLIPRM 251 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~--~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~-~p~~~s~~~~~li~~m 251 (515)
..|+..|+|||++.+ ....+.++||||+||++|+|++|..||...+......++..... . ....++..+++|+.+|
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 256 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYC 256 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHH
Confidence 678999999999842 22236799999999999999999999988765554444443322 1 2235678899999999
Q ss_pred CCCCCCCCCCHHHHhcCcccccc
Q 010214 252 LIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|+.+|.+|||+.+++.||||+..
T Consensus 257 l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 257 LQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred ccCChhhCcCHHHHhcCcccCCC
Confidence 99999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=332.70 Aligned_cols=251 Identities=34% Similarity=0.560 Sum_probs=214.1
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy 98 (515)
|++.+.||.|++|.||+|.+..+|+.+|+|.+...... ......+.+|+.+++.++||||+++++++.++...|+|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999999999999998765433 23457888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccccC
Q 010214 99 VKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTS 176 (515)
Q Consensus 99 ~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~ 176 (515)
+++ +|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+....... .....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~ 158 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY 158 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence 975 88888876 4589999999999999999999999999999999999999999999999999987765543 23345
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-------------------C--
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-------------------T-- 235 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-------------------~-- 235 (515)
.++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+..+...++..... .
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP 238 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence 6888999999998764447899999999999999999999988776555444322100 0
Q ss_pred ---------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 236 ---------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 236 ---------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
..+.++.+++++|.+||..||.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 112467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=327.59 Aligned_cols=245 Identities=27% Similarity=0.483 Sum_probs=209.0
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||.||+|.+..+ ..||+|++...... .+.+.+|+.+++.++||||+++++++.. ...|+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence 46899999999999999999998755 46999998754332 3568899999999999999999998754 568999
Q ss_pred EeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 96 MEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||.+.....+...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999999999763 35899999999999999999999999999999999999999999999999999766443321
Q ss_pred --ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhc
Q 010214 174 --KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIP 249 (515)
Q Consensus 174 --~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 249 (515)
....++..|+|||++.+..+ +.++||||+||++|+|++ |..||.+.........+..+. ...+..++..+.+++.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 237 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 237 (262)
T ss_pred cccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 23346678999999887766 789999999999999999 899998887777666665542 3445678999999999
Q ss_pred ccCCCCCCCCCCHHHHhc
Q 010214 250 RMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~ 267 (515)
+||+.||.+|||+.++++
T Consensus 238 ~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 238 QCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHccCCcccCCCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=326.33 Aligned_cols=246 Identities=27% Similarity=0.482 Sum_probs=210.2
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
..++|++.+.||+|+||.||+|.+. ++..+|+|.+...... .+.+.+|+.++++++|||++++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 3578999999999999999999876 5677999998764432 356889999999999999999999885 456899
Q ss_pred EEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 95 VMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
+|||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999999999999753 3589999999999999999999999999999999999999999999999999987644322
Q ss_pred c--ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHh
Q 010214 173 L--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLI 248 (515)
Q Consensus 173 ~--~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li 248 (515)
. ....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+ ..+.|...+..+.+|+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELM 236 (260)
T ss_pred ccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 1 12235567999999887765 689999999999999999 99999888777777777654 3456677899999999
Q ss_pred cccCCCCCCCCCCHHHHhc
Q 010214 249 PRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~ 267 (515)
.+||..||.+|||+.++.+
T Consensus 237 ~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 237 LQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHcccCcccCcCHHHHHH
Confidence 9999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=342.55 Aligned_cols=258 Identities=34% Similarity=0.516 Sum_probs=214.2
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC--C
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP--S 90 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~--~ 90 (515)
.+.++|++.+.||.|+||.||+|.+..+|+.+|+|.+.+... .......+.+|+.+++++ +||||+++++++... .
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 356899999999999999999999999999999999865322 223345677899999999 999999999998653 4
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
..|+||||++ ++|.+++..+ .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 6899999997 4999998765 7899999999999999999999999999999999999999999999999998765432
Q ss_pred C------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc----------
Q 010214 171 H------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---------- 234 (515)
Q Consensus 171 ~------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~---------- 234 (515)
. ......|++.|+|||++.+....+.++|+||+|+++|+|++|..||.+........++.....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 2 223456899999999987655557899999999999999999999987655444333221110
Q ss_pred ---------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 ---------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 ---------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.....++.++.++|.+||+.||.+|||+.++++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0112368899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=333.83 Aligned_cols=252 Identities=29% Similarity=0.520 Sum_probs=215.2
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy 98 (515)
|.....||+|+||.||+|.+..+|+.||+|.+... .......+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 33346799999999999999999999999987532 223456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccccCC
Q 010214 99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSC 177 (515)
Q Consensus 99 ~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~ 177 (515)
+++++|.+++. .+.+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++....... ......
T Consensus 99 ~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 99 LEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred CCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence 99999999774 4578999999999999999999999999999999999999999999999999887654322 223456
Q ss_pred CCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc---cCCCCCCChhHHHHhcccCCC
Q 010214 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 178 gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~mL~~ 254 (515)
|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...........+.... ......+++++.+++.+||..
T Consensus 178 ~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 256 (292)
T cd06657 178 GTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR 256 (292)
T ss_pred cCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhC
Confidence 8999999999887665 789999999999999999999998876655544443322 222346789999999999999
Q ss_pred CCCCCCCHHHHhcCccccccc
Q 010214 255 DPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 255 dP~~Rpt~~eil~hp~f~~~~ 275 (515)
||.+|||+.+++.||||....
T Consensus 257 ~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 257 DPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred CcccCcCHHHHhcChHHhccC
Confidence 999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=331.57 Aligned_cols=258 Identities=33% Similarity=0.563 Sum_probs=219.3
Q ss_pred CceEeeeecccCceEEEEEEEc---CCCcEEEEEEecccccC-ChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~---~tg~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 92 (515)
+|++.+.||+|++|.||+|.+. .+++.||+|++.+.... .....+.+.+|+.+++.+ +||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5899999999999999999864 46789999998754332 223456788999999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
|+||||+++|+|.+++.....+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999876543321
Q ss_pred --cccCCCCCCccCCCcccCCc-cCCCcceeehhHHHHHHHHhCCCCCCCCC----hHHHHHHHhcCccCCCCCCChhHH
Q 010214 173 --LKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLPSHLSPGAR 245 (515)
Q Consensus 173 --~~~~~gt~~Y~aPE~i~~~~-~~~~~~DIwSlGvily~lltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~ 245 (515)
....+|++.|+|||.+.+.. ..+.++|+||+|+++|+|++|..||.... .....+.+.......|..+++++.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 240 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR 240 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHH
Confidence 22346899999999987654 24689999999999999999999996432 234445556666777888999999
Q ss_pred HHhcccCCCCCCCCCC---HHHHhcCccccccc
Q 010214 246 DLIPRMLIVDPMKRIT---IPEIRQHPWFQAHL 275 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt---~~eil~hp~f~~~~ 275 (515)
+++.+||+.||++||| +.++++||||+...
T Consensus 241 ~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 241 DFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 9999999999999998 56789999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=334.60 Aligned_cols=250 Identities=27% Similarity=0.453 Sum_probs=212.8
Q ss_pred cCCCceEeeeecccCceEEEEEEEcC-------CCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHAL-------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVI 86 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~-------tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~ 86 (515)
-.++|.+.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 35789999999999999999998642 34579999986432 233456788999999999 599999999999
Q ss_pred EcCCeEEEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 010214 87 ETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL 150 (515)
Q Consensus 87 ~~~~~~~iVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl 150 (515)
.....+|++|||+++|+|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 9999999999999999999999753 347889999999999999999999999999999999999
Q ss_pred CCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHH
Q 010214 151 DSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF 226 (515)
Q Consensus 151 ~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~ 226 (515)
+.++.+||+|||+++....... .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+......+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999976643221 122234568999999987766 789999999999999999 99999988877777
Q ss_pred HHHhcCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 227 KKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 227 ~~i~~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
..+..+. ...|..++.++.+++.+||..||.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 247 KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7776654 3556778899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=326.41 Aligned_cols=249 Identities=27% Similarity=0.451 Sum_probs=212.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCc---EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
..+|++.+.||+|+||.||+|.++.++. .+|+|.+.... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3689999999999999999999875543 79999886532 223456889999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|+||||+++++|.+++... +.+++.++..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999765 468999999999999999999999999999999999999999999999999998764432
Q ss_pred c-c---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHH
Q 010214 172 F-L---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (515)
Q Consensus 172 ~-~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 245 (515)
. . ....++..|+|||.+.+..+ +.++|+|||||++|++++ |..||.+....+....+..+. .+.+..+++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 1 1 11223568999999987766 789999999999999886 999998877777767666552 344556789999
Q ss_pred HHhcccCCCCCCCCCCHHHHhc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+++.+||+.+|.+|||+.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=327.96 Aligned_cols=248 Identities=26% Similarity=0.389 Sum_probs=210.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCc----EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
..+|++.+.||.|+||+||+|.+..+|+ .||+|++.... .......+.+|+.+++.+.||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 4689999999999999999999877776 48999986432 334457788999999999999999999998754 5
Q ss_pred EEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 92 IYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.++++||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 7899999999999999976 456999999999999999999999999999999999999999999999999999876432
Q ss_pred Ccc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHH
Q 010214 171 HFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (515)
Q Consensus 171 ~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 245 (515)
... ....+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+..+. .+.+...+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHH
Confidence 221 12235678999999987766 689999999999999998 999998877666665555543 345667899999
Q ss_pred HHhcccCCCCCCCCCCHHHHhc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+++.+||..||.+|||+.+++.
T Consensus 242 ~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 242 MIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=327.67 Aligned_cols=242 Identities=26% Similarity=0.442 Sum_probs=204.2
Q ss_pred eeecccCceEEEEEEEcCCCc--EEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEecc
Q 010214 23 KTLGIGSFGKVKIAEHALTGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYV 99 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iVmEy~ 99 (515)
+.||+|+||.||+|.+..++. .+|+|.+... ......+.+.+|+.+++++ +||||+++++++...+..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999988876 4688877532 2334556788999999999 7999999999999999999999999
Q ss_pred CCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 100 KSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 100 ~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
++|+|.+++.... .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999997543 478999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCC
Q 010214 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLS 241 (515)
Q Consensus 164 s~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s 241 (515)
+..............+..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 237 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCC
Confidence 864322111112234567999999977665 789999999999999997 99999888777777776654 334566788
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.++.+++.+||..||.+|||+.+++.
T Consensus 238 ~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 238 DEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHHHHHHHHHcccChhhCCCHHHHHH
Confidence 99999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=324.66 Aligned_cols=242 Identities=27% Similarity=0.522 Sum_probs=208.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEE-EcCCeEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVI-ETPSDIYV 94 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~-~~~~~~~i 94 (515)
..+|++.+.||+|+||.||+|.. .|..||+|.+.... ..+.+.+|+.++++++|||++++++++ ......|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 46899999999999999999976 47889999875432 245788999999999999999999975 55667999
Q ss_pred EEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 95 VMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
+|||+++++|.+++.+.+ .+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 999999999999998654 38899999999999999999999999999999999999999999999999987553322
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhcc
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~ 250 (515)
.+..++..|+|||++.+..+ +.++||||+||++|+|++ |..||...+.......+..+ ....++.+++.+.+++.+
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 234 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQ 234 (256)
T ss_pred -CCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 33455678999999987766 689999999999999997 99999988877777777654 334567789999999999
Q ss_pred cCCCCCCCCCCHHHHhc
Q 010214 251 MLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~ 267 (515)
||+.+|.+|||+.++++
T Consensus 235 ~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 235 CWHLDAATRPSFLQLRE 251 (256)
T ss_pred HhcCChhhCcCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=329.52 Aligned_cols=248 Identities=28% Similarity=0.450 Sum_probs=212.4
Q ss_pred CCCceEeeeecccCceEEEEEEEc-----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
..+|.+.+.||+|+||.||+|... .++..+|+|.+... .....+.+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 367899999999999999999743 35678999987543 2345678899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG---------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN 155 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~---------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~ 155 (515)
..+++|||+++++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 9999999999999999997643 4889999999999999999999999999999999999999999
Q ss_pred eEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhc
Q 010214 156 VKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKG 231 (515)
Q Consensus 156 vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~ 231 (515)
+||+|||++........ .....+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...........+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 99999999876543221 123345788999999988776 789999999999999998 9999988777766666655
Q ss_pred Cc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 232 GI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 232 ~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+. ...|..+++.+.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 43 4556788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=330.86 Aligned_cols=251 Identities=32% Similarity=0.558 Sum_probs=213.8
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy 98 (515)
|++.+.||.|++|.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999997654 2223346778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccccC
Q 010214 99 VKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTS 176 (515)
Q Consensus 99 ~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~ 176 (515)
++ ++|.+++.+. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++....... .....
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence 97 5999999876 589999999999999999999999999999999999999999999999999987664432 33345
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc------------------cCC--
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------------YTL-- 236 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~------------------~~~-- 236 (515)
.++..|+|||.+.+....+.++|+||+||++|+|++|..||...+......++.... ..+
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK 238 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence 667889999998776444789999999999999999999998877655544433210 000
Q ss_pred ---------CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 237 ---------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 237 ---------p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.+.++.++.++|.+||..||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 12347889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.76 Aligned_cols=249 Identities=29% Similarity=0.456 Sum_probs=206.0
Q ss_pred CCceEeeeecccCceEEEEEEEcC-----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEc-C
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET-P 89 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~-~ 89 (515)
++|++.+.||.|+||.||+|.+.. +++.||+|++.... .....+.+.+|+.+++++ +||||+++++++.. .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 589999999999999999997543 45789999986432 223456778899999999 79999999998764 4
Q ss_pred CeEEEEEeccCCCCHHHHHHHh----------------------------------------------------------
Q 010214 90 SDIYVVMEYVKSGELFDYIVEK---------------------------------------------------------- 111 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~---------------------------------------------------------- 111 (515)
..++++|||+++++|.++|...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5689999999999999998642
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc---cccCCCCCCccCC
Q 010214 112 ---GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAP 185 (515)
Q Consensus 112 ---~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aP 185 (515)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... ..+..++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 2578899999999999999999999999999999999999999999999999987543221 1233456789999
Q ss_pred CcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHH-HHHHHhcCc-cCCCCCCChhHHHHhcccCCCCCCCCCCH
Q 010214 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN-LFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITI 262 (515)
Q Consensus 186 E~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~-~~~~i~~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~ 262 (515)
|++.+..+ +.++||||+||++|+|++ |..||.+....+ +...+..+. ...|...++++.+++.+||+.+|.+|||+
T Consensus 245 E~~~~~~~-~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 323 (337)
T cd05054 245 ESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTF 323 (337)
T ss_pred HHhcCCCC-CccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 99988877 789999999999999998 999998754333 333443332 34466788999999999999999999999
Q ss_pred HHHhcC
Q 010214 263 PEIRQH 268 (515)
Q Consensus 263 ~eil~h 268 (515)
.|+++|
T Consensus 324 ~ell~~ 329 (337)
T cd05054 324 SELVEI 329 (337)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=324.52 Aligned_cols=246 Identities=28% Similarity=0.507 Sum_probs=211.0
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
..++|++.+.||+|+||.||+|... +++.||+|.+...... ...+.+|+.++++++||||+++++++. .+..|+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 4578999999999999999999865 6788999998755432 357889999999999999999999874 457899
Q ss_pred EEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 95 VMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
+|||+.+++|.+++... ..+++.++..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999999998753 3689999999999999999999999999999999999999999999999999976653222
Q ss_pred --cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHh
Q 010214 173 --LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLI 248 (515)
Q Consensus 173 --~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 248 (515)
.....++..|+|||++.+..+ +.++||||+|+++|+|++ |++||.+.+..+....+..+. ...+...+.++.+++
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELM 236 (260)
T ss_pred ccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 122345678999999987765 789999999999999999 999999888777777665543 355677889999999
Q ss_pred cccCCCCCCCCCCHHHHhc
Q 010214 249 PRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~ 267 (515)
.+||..+|++|||++++++
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 237 RLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHccCChhhCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=302.57 Aligned_cols=256 Identities=29% Similarity=0.524 Sum_probs=221.1
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
.+|.-.++||+|.||+||+|+++.|++.||+|.+..+.- +........|||-+|+.++|.|||+++++..+++.+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 467778899999999999999999999999999876542 2234567789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccc
Q 010214 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~ 174 (515)
|||.. +|..|... +|.++.+.++.++.|++.||.+||++++.|||+||.|+||+.+|.+|++|||+++.+.-.- ...
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 99976 89888865 7889999999999999999999999999999999999999999999999999998775432 334
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCcc-----------CCC-----
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY-----------TLP----- 237 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~~-----------~~p----- 237 (515)
..+-|.+|.+|.++.|...++...|+||.|||+.|+.. |.+.|.+.+...+.++|..... .+|
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 55678999999999987777899999999999999986 8888999988888877753211 111
Q ss_pred -------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 238 -------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 238 -------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+.++..-+||++++|.-+|.+|++++++++||||.+.
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 2345566899999999999999999999999999765
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=339.57 Aligned_cols=256 Identities=32% Similarity=0.496 Sum_probs=211.6
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC----
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP---- 89 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 89 (515)
.+.++|.+.+.||+|+||.||+|.+..+|+.||+|++.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 3468999999999999999999999999999999998754322 23345678999999999999999999998654
Q ss_pred --CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 90 --SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 90 --~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
..+|+|+||+.. +|..++ ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 91 EFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred CCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 346999999964 777765 346899999999999999999999999999999999999999999999999998754
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--------------
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------- 233 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------------- 233 (515)
.. ......+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+....
T Consensus 168 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 168 DA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred CC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence 32 22345678999999998764444789999999999999999999998876544444332210
Q ss_pred ---------cCC--------CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 234 ---------YTL--------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 234 ---------~~~--------p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
... .+..++++.+||.+||+.||.+|||+++++.||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 000 124678899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=325.21 Aligned_cols=249 Identities=26% Similarity=0.430 Sum_probs=212.6
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCc---EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
...|++.+.||+|+||.||+|.++.++. .||+|++.... .......+.+|+.+++.++||||+++++++.+....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4579999999999999999999987765 59999986432 344567899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
++||||+++++|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999999763 568999999999999999999999999999999999999999999999999987654322
Q ss_pred cccc---CC---CCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChh
Q 010214 172 FLKT---SC---GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPG 243 (515)
Q Consensus 172 ~~~~---~~---gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 243 (515)
.... .. .+..|+|||.+.+..+ +.++||||+||++|+|++ |..||...+.......+... ..+.+..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 1111 11 2357999999987776 689999999999999886 99999988777777766543 23445678899
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+.+++.+||..+|.+|||+.+++.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=346.57 Aligned_cols=251 Identities=28% Similarity=0.453 Sum_probs=209.1
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCC-----CcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALT-----GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIE 87 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~t-----g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~ 87 (515)
.-.++|++++.||+|+||.||+|.+... +..||||++.... .....+.+.+|+++++.+. ||||+++++++.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3367899999999999999999987533 3579999986542 2334577899999999996 999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHHh--------------------------------------------------------
Q 010214 88 TPSDIYVVMEYVKSGELFDYIVEK-------------------------------------------------------- 111 (515)
Q Consensus 88 ~~~~~~iVmEy~~gg~L~~~i~~~-------------------------------------------------------- 111 (515)
+...+|+|||||++|+|.++|.++
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 999999999999999999998653
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC
Q 010214 112 ----------------------------------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD 151 (515)
Q Consensus 112 ----------------------------------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~ 151 (515)
..+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 1377888899999999999999999999999999999999
Q ss_pred CCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChH-HHH
Q 010214 152 SKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP-NLF 226 (515)
Q Consensus 152 ~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~-~~~ 226 (515)
.++.+||+|||++........ .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...... ...
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 999999999999876543221 223456788999999988766 789999999999999997 99999875433 334
Q ss_pred HHHhcC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 227 KKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 227 ~~i~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
..+..+ ....|..++.++.+++.+||+.||++|||+.++.+
T Consensus 351 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 444443 24456778999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=331.97 Aligned_cols=257 Identities=25% Similarity=0.448 Sum_probs=218.1
Q ss_pred CCCccccCCCceEeeeecccCceEEEEEEEc-------CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCcc
Q 010214 9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHA-------LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHII 80 (515)
Q Consensus 9 ~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~-------~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv 80 (515)
........++|.+.+.||+|+||.||+|++. .++..||+|.+.... .......+.+|+.+++.+ +||||+
T Consensus 7 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~ 84 (304)
T cd05101 7 DPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNII 84 (304)
T ss_pred CCcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCch
Confidence 3445666899999999999999999999753 234579999886432 223457789999999999 799999
Q ss_pred EEEEEEEcCCeEEEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 010214 81 RLYEVIETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144 (515)
Q Consensus 81 ~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLk 144 (515)
++++++......|+||||+++|+|.+++.+. ..++...+..++.||+.||.|||++||+|||||
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlk 164 (304)
T cd05101 85 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLA 164 (304)
T ss_pred heeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence 9999999999999999999999999999764 246788899999999999999999999999999
Q ss_pred CCcEEECCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCC
Q 010214 145 PENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDE 220 (515)
Q Consensus 145 peNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~ 220 (515)
|+||+++.++.+||+|||++........ .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred cceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999999986643221 223346778999999987766 689999999999999998 89999998
Q ss_pred ChHHHHHHHhcCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 221 NIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 221 ~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+..++...+..+. ...|..++.++.+|+.+||..+|.+|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 244 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 8888888776554 34567789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=335.32 Aligned_cols=255 Identities=27% Similarity=0.360 Sum_probs=215.4
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
...|...+.||.|+||.||+|.++.+++.+|+|.+.............+.+|+++++.++|||++++++++......|+|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 45688899999999999999999999999999998765444444556788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
|||+. |+|.+++.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... .
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~ 169 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---N 169 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---c
Confidence 99996 588877754 456899999999999999999999999999999999999999999999999998765432 3
Q ss_pred cCCCCCCccCCCcccC--CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-C-CCCCCChhHHHHhcc
Q 010214 175 TSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-T-LPSHLSPGARDLIPR 250 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~--~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~-~p~~~s~~~~~li~~ 250 (515)
...|++.|+|||.+.+ ....+.++|||||||++|+|++|..||...+.......+..+.. . .+..++..+.+||.+
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 249 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHH
Confidence 4568899999999752 12236799999999999999999999987655444444433322 2 234678899999999
Q ss_pred cCCCCCCCCCCHHHHhcCcccccc
Q 010214 251 MLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
||..+|.+|||+.++++|||+...
T Consensus 250 cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 250 CLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HhhCCcccCCCHHHHhhCcccccc
Confidence 999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=323.69 Aligned_cols=247 Identities=27% Similarity=0.477 Sum_probs=213.9
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
..++|++.+.||.|+||.||+|.+. +++.||+|.+...... .+.+.+|+.+++.++||||+++++++.+....++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 3578999999999999999999976 5578999998754432 3568899999999999999999999999899999
Q ss_pred EEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 95 VMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
||||+++++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999999997643 689999999999999999999999999999999999999999999999999876643221
Q ss_pred --cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHh
Q 010214 173 --LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLI 248 (515)
Q Consensus 173 --~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 248 (515)
.....++..|+|||.+.+..+ ++++|+||+||++|+|++ |+.||.+.+.......+..+. ...|...+.++.+++
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLM 237 (261)
T ss_pred hhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 112234578999999987765 789999999999999998 999999888777777776553 355667789999999
Q ss_pred cccCCCCCCCCCCHHHHhc
Q 010214 249 PRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~ 267 (515)
.+||+.+|.+|||++++++
T Consensus 238 ~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 238 LQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHcccCcccCCCHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=327.02 Aligned_cols=248 Identities=29% Similarity=0.404 Sum_probs=201.4
Q ss_pred CCCc-eEeeeecccCceEEEEEE----EcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc--
Q 010214 16 LPNY-KLGKTLGIGSFGKVKIAE----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-- 88 (515)
Q Consensus 16 ~~~Y-~i~~~LG~G~fg~Vy~a~----~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-- 88 (515)
.++| ++.+.||+|+||+||++. ...++..||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3556 999999999999998865 34578899999986542 22345678899999999999999999998765
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
...+|+||||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 3468999999999999999965 469999999999999999999999999999999999999999999999999998765
Q ss_pred cCCc----cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH--H-------------HHHHH
Q 010214 169 DGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP--N-------------LFKKI 229 (515)
Q Consensus 169 ~~~~----~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~--~-------------~~~~i 229 (515)
.+.. .....++..|+|||.+.+..+ +.++||||||+++|+|++|..||...... . ....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 4321 122345677999999987765 78999999999999999999998643211 0 11111
Q ss_pred hc-CccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 230 KG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 230 ~~-~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.. ...+.|..++.++.+++.+||+.||++|||+++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11 112345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=317.35 Aligned_cols=254 Identities=30% Similarity=0.415 Sum_probs=210.5
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEE----
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE---- 87 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~---- 87 (515)
+-.-..+|++.+.||.|||+.||++++..+++.||+|.+.... .+..+...+||+..++++|||+++++++.-
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 3344578999999999999999999999999999999986544 456789999999999999999999988752
Q ss_pred -cCCeEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCceEEee
Q 010214 88 -TPSDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKIAD 160 (515)
Q Consensus 88 -~~~~~~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDLkpeNILl~~~~~vKL~D 160 (515)
.....|++++|...|+|.+.|.. +..++|.++..|+.+|++||++||... ++||||||.|||+.+.+.++|.|
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence 23459999999999999999975 236999999999999999999999998 99999999999999999999999
Q ss_pred cccccccccC---C-------ccccCCCCCCccCCCcccCCcc--CCCcceeehhHHHHHHHHhCCCCCCCCC--hHHHH
Q 010214 161 FGLSNIMRDG---H-------FLKTSCGSPNYAAPEVISGKLY--AGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLF 226 (515)
Q Consensus 161 FGls~~~~~~---~-------~~~~~~gt~~Y~aPE~i~~~~~--~~~~~DIwSlGvily~lltG~~Pf~~~~--~~~~~ 226 (515)
||.++...-. . .......|..|+|||.+.-+.+ .+.++|||||||+||+|+.|..||+..- ...+.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 9998765311 0 1122346889999999864433 3689999999999999999999997421 11122
Q ss_pred HHHhcCccCCC--CCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 227 KKIKGGIYTLP--SHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 227 ~~i~~~~~~~p--~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
-.+.++.+.+| ..+|..+.+||+.||++||.+||++.+++.+
T Consensus 253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 23455566666 3589999999999999999999999999874
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=319.02 Aligned_cols=256 Identities=27% Similarity=0.426 Sum_probs=218.4
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~i 94 (515)
+++.+++..||.|+.|+|++++++.+|...|||.+.+.. +.+..+++...+.++.... .|+||+.+++|-++.+++|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 345667888999999999999999999999999998655 4456788888888876655 8999999999999999999
Q ss_pred EEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 95 VMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
.||.+.. .+..++.+ +++++|..+-++...++.||.||-. +||+|||+||+|||+|+.|+|||||||+|..+-++..
T Consensus 169 cMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 169 CMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 9999843 45555543 5689999999999999999999995 6999999999999999999999999999999988887
Q ss_pred cccCCCCCCccCCCcccCC--ccCCCcceeehhHHHHHHHHhCCCCCCCCC-hHHHHHHHhcCcc-CCCC--CCChhHHH
Q 010214 173 LKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIY-TLPS--HLSPGARD 246 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~--~~~~~~~DIwSlGvily~lltG~~Pf~~~~-~~~~~~~i~~~~~-~~p~--~~s~~~~~ 246 (515)
.....|.+.|||||.+.-. .-++.++||||||+.++||.||..||.+-+ .-+...++.+... .+|. .+|+++.+
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~ 327 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQS 327 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHH
Confidence 7888999999999998632 223789999999999999999999998833 3345556655433 3332 48999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|+..||++|+.+||...++|+|||+...
T Consensus 328 fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 328 FVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred HHHHHhhcCcccCcchHHHhcCcceeec
Confidence 9999999999999999999999999754
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=330.63 Aligned_cols=258 Identities=29% Similarity=0.434 Sum_probs=212.2
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDI 92 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 92 (515)
...++|++.+.||.|+||.||+|.+..+++.||||.+.+.... .....+.+|+.++.... ||||+++++++.+....
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence 3468999999999999999999999999999999999754322 23455666777666554 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
|++|||+. ++|.+++.. .+.+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++......
T Consensus 90 ~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 90 FICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred EEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 99999985 478777765 4578999999999999999999997 69999999999999999999999999999876554
Q ss_pred CccccCCCCCCccCCCcccCCc---cCCCcceeehhHHHHHHHHhCCCCCCCCCh-HHHHHHHhcCc-cCCC--CCCChh
Q 010214 171 HFLKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGGI-YTLP--SHLSPG 243 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~---~~~~~~DIwSlGvily~lltG~~Pf~~~~~-~~~~~~i~~~~-~~~p--~~~s~~ 243 (515)
.......+++.|+|||.+.+.. ..+.++||||||+++|+|++|+.||..... .+....+.... ...+ ..++.+
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD 248 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHH
Confidence 4444456888999999987653 236789999999999999999999976332 23333333332 2233 246889
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+.+|+.+||..||.+|||+.+++.||||+..
T Consensus 249 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 249 FCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred HHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 9999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=321.12 Aligned_cols=246 Identities=31% Similarity=0.512 Sum_probs=214.4
Q ss_pred ceEeeeecccCceEEEEEEEcCCC----cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTG----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
+++.+.||.|+||.||+|.+..++ ..||+|++..... ......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 457889999999999999998776 8999999865432 2256788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 95 VMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~--l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
+|||+++++|.+++..... +++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976554 99999999999999999999999999999999999999999999999999987655432
Q ss_pred ccc--CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHh
Q 010214 173 LKT--SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLI 248 (515)
Q Consensus 173 ~~~--~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 248 (515)
... ..+++.|+|||.+.+..+ +.++|+||+|+++|+|++ |..||...+.......+.... ...+...+.++.+++
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLM 237 (258)
T ss_pred cccccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence 222 336789999999976655 789999999999999998 899999888777777776554 345667899999999
Q ss_pred cccCCCCCCCCCCHHHHhc
Q 010214 249 PRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~ 267 (515)
.+||..||.+|||+.|+++
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 238 LQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHCcCChhhCcCHHHHHh
Confidence 9999999999999999975
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=331.99 Aligned_cols=250 Identities=30% Similarity=0.462 Sum_probs=209.9
Q ss_pred cCCCceEeeeecccCceEEEEEEE-----cCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEc
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEH-----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET 88 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~-----~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~ 88 (515)
..++|.+.+.||+|+||.||+|.+ ..++..||+|.+.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 346899999999999999999975 3345689999986542 233456789999999999 79999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
.+..|+||||+++|+|.+++.... .+++.++..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999999997643 389999999999999999999999999999999999999999999999999876
Q ss_pred cccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhc-C-ccCCCCCC
Q 010214 167 MRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKG-G-IYTLPSHL 240 (515)
Q Consensus 167 ~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~-~-~~~~p~~~ 240 (515)
..... ......+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||........+.+... + ....|...
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHA 269 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCC
Confidence 54322 1123346788999999988776 789999999999999998 9999987765554433332 2 22345677
Q ss_pred ChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 241 SPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 241 s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
++++.+++.+||..+|++|||+.|+++
T Consensus 270 ~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 270 PAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=334.92 Aligned_cols=256 Identities=32% Similarity=0.515 Sum_probs=211.9
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc-CCeE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-PSDI 92 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-~~~~ 92 (515)
.+.++|++.+.||.|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 457899999999999999999999999999999999865432 22345677899999999999999999999865 5678
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
|++|||+ +++|.+++. ..++++..+..++.||++||.|||+.||+||||+|+||+++.++.++|+|||.+..... .
T Consensus 86 ~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~ 161 (328)
T cd07856 86 YFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--Q 161 (328)
T ss_pred EEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--C
Confidence 9999999 568988875 45689999999999999999999999999999999999999999999999999875432 2
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--------------------
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-------------------- 232 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~-------------------- 232 (515)
..+..+++.|+|||.+.+....++++||||+||++|+|++|..||...........+.+.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 345568899999999876444478999999999999999999999876543222111100
Q ss_pred ------ccCC-----CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 233 ------IYTL-----PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 233 ------~~~~-----p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.... ...+++++.++|.+||+.+|.+|||+++++.||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 0011 13467899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=329.18 Aligned_cols=245 Identities=37% Similarity=0.560 Sum_probs=207.0
Q ss_pred eEeeeecccCceEEEEEEEc----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 20 KLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 20 ~i~~~LG~G~fg~Vy~a~~~----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.+.+.||.|+||.||+|.+. ..+..|+||++.. .......+.+.+|++.+++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP--SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST--TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc--ccccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999988 4567899999943 23344578899999999999999999999999988889999
Q ss_pred EeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--
Q 010214 96 MEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-- 171 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-- 171 (515)
|||+++|+|.+++... ..+++.....++.||+.||.|||+++++|+||+++|||++.++.+||+|||++.......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999986 689999999999999999999999999999999999999999999999999998763221
Q ss_pred -ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCcc-CCCCCCChhHHHHh
Q 010214 172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLI 248 (515)
Q Consensus 172 -~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 248 (515)
......+...|+|||.+.+..+ +.++||||||+++|||++ |..||.+.+......++..+.. ..|..++..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 1233456778999999987766 789999999999999999 7899999888888888766544 45677899999999
Q ss_pred cccCCCCCCCCCCHHHHhc
Q 010214 249 PRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~ 267 (515)
.+||..||.+|||+.++++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=320.91 Aligned_cols=246 Identities=26% Similarity=0.488 Sum_probs=212.3
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
.+|++.+.||.|+||.||+|.+. ++..+|+|++...... ...+.+|+++++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 57999999999999999999875 4778999998654332 346788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc--
Q 010214 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-- 173 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~-- 173 (515)
||+++++|.+++... +.++++.++.++.|++.|++|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999999999764 56899999999999999999999999999999999999999999999999998765432211
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhccc
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~m 251 (515)
....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+. ...|...+..+.+|+.+|
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 237 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHC 237 (256)
T ss_pred CCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence 12235568999999987766 689999999999999998 999999888777777776653 334666799999999999
Q ss_pred CCCCCCCCCCHHHHhcC
Q 010214 252 LIVDPMKRITIPEIRQH 268 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~h 268 (515)
|..+|.+|||+.+++++
T Consensus 238 l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 238 WKERPEDRPSFSLLLHQ 254 (256)
T ss_pred cccChhhCCCHHHHHHh
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=351.48 Aligned_cols=251 Identities=29% Similarity=0.553 Sum_probs=222.4
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEeccccc-CChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe--EEEEE
Q 010214 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI-KNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD--IYVVM 96 (515)
Q Consensus 20 ~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~--~~iVm 96 (515)
++...||+|+|-+||+|.+..+|..||.--+....+ +.....+++..|+.+|+.|+||||+++|+.+.+... +-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 556789999999999999999999999776654433 344567999999999999999999999999987655 88999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCcEEECCC-CceEEeecccccccccCCcc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN--MVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~--gIvHrDLkpeNILl~~~-~~vKL~DFGls~~~~~~~~~ 173 (515)
|.+.+|+|..|+++.++++...++.|++||+.||.|||++ .|+|||||.+||+|+.+ |.|||+|+|+|..+......
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ak 202 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAK 202 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccc
Confidence 9999999999999999999999999999999999999987 59999999999999864 89999999999998766544
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCC-CChHHHHHHHhcCccC--CCCCCChhHHHHhcc
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYT--LPSHLSPGARDLIPR 250 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~ 250 (515)
...|||.|||||+.. ..| +..+||||||+++.||+|+..||.. .+..++++++..|.-+ +..--.+++++||.+
T Consensus 203 -svIGTPEFMAPEmYE-E~Y-nE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIek 279 (632)
T KOG0584|consen 203 -SVIGTPEFMAPEMYE-ENY-NELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEK 279 (632)
T ss_pred -eeccCccccChHHHh-hhc-chhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHH
Confidence 478999999999997 446 7899999999999999999999986 7778889999888642 233447999999999
Q ss_pred cCCCCCCCCCCHHHHhcCcccccc
Q 010214 251 MLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
||.. ...|+|+.|+|+||||...
T Consensus 280 Cl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 280 CLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HhcC-chhccCHHHHhhChhhccc
Confidence 9999 9999999999999999875
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=322.85 Aligned_cols=245 Identities=29% Similarity=0.484 Sum_probs=208.4
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|.+.+.||.|++|.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. .+..|++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 46799999999999999999988655 4699998765432 2356788999999999999999999885 4568999
Q ss_pred EeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 96 MEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|||+.+++|.+++.+.. .+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++.....+...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999999997643 4789999999999999999999999999999999999999999999999999766443221
Q ss_pred --ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhc
Q 010214 174 --KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIP 249 (515)
Q Consensus 174 --~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~ 249 (515)
....++..|+|||.+.+..+ +.++||||+|+++|+|++ |..||.+....+....+..+ ....|...+..+.++++
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMK 237 (260)
T ss_pred ccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHH
Confidence 22345678999999887765 789999999999999999 99999988777777776654 33456678999999999
Q ss_pred ccCCCCCCCCCCHHHHhc
Q 010214 250 RMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~ 267 (515)
+||..||.+|||++++++
T Consensus 238 ~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 238 LCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=328.74 Aligned_cols=247 Identities=30% Similarity=0.463 Sum_probs=209.7
Q ss_pred CceEeeeecccCceEEEEEEEcC-----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 23579999886433 223456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHh------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 010214 93 YVVMEYVKSGELFDYIVEK------------------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL 148 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~------------------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNI 148 (515)
|++|||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998642 2478889999999999999999999999999999999
Q ss_pred EECCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHH
Q 010214 149 LLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN 224 (515)
Q Consensus 149 Ll~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~ 224 (515)
|+++++.+||+|||++........ .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999876533221 123346778999999887765 789999999999999998 999999888777
Q ss_pred HHHHHhcC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 225 LFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 225 ~~~~i~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+...+... ....|..++.++.+++.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 77666554 33456778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=329.85 Aligned_cols=249 Identities=25% Similarity=0.373 Sum_probs=207.3
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCC--------------cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTG--------------HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIR 81 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg--------------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~ 81 (515)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|++++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 368999999999999999999875432 359999986542 2345567899999999999999999
Q ss_pred EEEEEEcCCeEEEEEeccCCCCHHHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 010214 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKG------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLL 149 (515)
Q Consensus 82 l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNIL 149 (515)
+++++......|+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999996532 3678899999999999999999999999999999999
Q ss_pred ECCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh--CCCCCCCCChHH
Q 010214 150 LDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC--GTLPFDDENIPN 224 (515)
Q Consensus 150 l~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt--G~~Pf~~~~~~~ 224 (515)
++.++.+||+|||++........ .....+++.|+|||++.+..+ +.++|+|||||++|+|++ |..||...+..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999876543322 122345678999999887766 789999999999999988 778998876655
Q ss_pred HHHHHhc--------CccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 225 LFKKIKG--------GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 225 ~~~~i~~--------~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
....+.. .....+...++.+.+|+.+||+.||.+|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5444321 112345567899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=325.56 Aligned_cols=252 Identities=28% Similarity=0.510 Sum_probs=215.6
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCC--hHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN--MEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
+|.+.+.||+|+||.||+|.+..++..+++|++....... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5899999999999999999998888888888775433221 12345677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-
Q 010214 96 MEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG- 170 (515)
Q Consensus 96 mEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~- 170 (515)
|||+++++|.+++.+ ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999998864 356999999999999999999999999999999999999975 57999999998766433
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhc
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIP 249 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 249 (515)
.......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...........+..+. ...|..++.++.++|.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGY-DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHH
Confidence 23345668999999999877665 678999999999999999999998877766666665443 3456678899999999
Q ss_pred ccCCCCCCCCCCHHHHhcCccc
Q 010214 250 RMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~hp~f 271 (515)
+||..||.+||++.|+++||||
T Consensus 239 ~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 239 SMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=321.17 Aligned_cols=241 Identities=28% Similarity=0.458 Sum_probs=207.6
Q ss_pred eeecccCceEEEEEEEcC-CCc--EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEecc
Q 010214 23 KTLGIGSFGKVKIAEHAL-TGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYV 99 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~-tg~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~ 99 (515)
+.||+|++|.||+|.+.. +++ .||+|.+...... ...+.+.+|+.++++++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999766543 567889999999999999999999999988 8899999999
Q ss_pred CCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC----cc
Q 010214 100 KSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FL 173 (515)
Q Consensus 100 ~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~----~~ 173 (515)
++++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ..
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999999998754 68999999999999999999999999999999999999999999999999998764321 11
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC--ccCCCCCCChhHHHHhcc
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~ 250 (515)
....++..|+|||.+.+..+ +.++||||+||++|+|++ |..||...+..+....+... ....|...+..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 23457789999999987766 789999999999999998 99999888777776666532 234456778999999999
Q ss_pred cCCCCCCCCCCHHHHhc
Q 010214 251 MLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~ 267 (515)
||..+|.+|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=322.39 Aligned_cols=249 Identities=26% Similarity=0.436 Sum_probs=212.6
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCc---EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
..+|+..+.||+|+||.||+|.++.++. .+|+|.+.... .....+.+.+|+++++.++||||+++.+++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 4689999999999999999999886665 79999886432 223456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|+||||+++++|.+++..+ +.+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999999764 578999999999999999999999999999999999999999999999999987654322
Q ss_pred cc--c--cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHH
Q 010214 172 FL--K--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (515)
Q Consensus 172 ~~--~--~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 245 (515)
.. . ....++.|+|||++.+..+ +.++||||+||++|+|++ |..||...+.......+..+. .+.+...+.++.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 240 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 11 1 1123457999999987766 789999999999999997 999998887777777776542 334456789999
Q ss_pred HHhcccCCCCCCCCCCHHHHhc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+++.+||+.+|.+||++.++++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=324.01 Aligned_cols=248 Identities=25% Similarity=0.410 Sum_probs=213.7
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCc----EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
.++|++.+.||+|+||+||+|.++.+|. .+|+|.+..... ......+.+|+.+++.++||||+++++++.+ ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 4789999999999999999999877765 589998765432 3455778899999999999999999999987 78
Q ss_pred EEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 92 IYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.++||||+++|+|.+++.+. +.+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 89999999999999999864 46999999999999999999999999999999999999999999999999999876433
Q ss_pred Ccc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHH
Q 010214 171 HFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (515)
Q Consensus 171 ~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 245 (515)
... ....++..|+|||.+.+..+ +.++|+||+||++|++++ |..||.+....++...+..+. .+.|...+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 221 11223568999999877665 689999999999999998 999999988777777776553 456677889999
Q ss_pred HHhcccCCCCCCCCCCHHHHhc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+++.+||..||.+|||+.++++
T Consensus 242 ~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 242 MVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=318.06 Aligned_cols=241 Identities=27% Similarity=0.464 Sum_probs=206.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG 102 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg 102 (515)
+.||+|+||.||+|.+. ++..+|+|++.... .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 46899999999999865 68899999986543 2334557889999999999999999999999999999999999999
Q ss_pred CHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc--ccCCCC
Q 010214 103 ELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGS 179 (515)
Q Consensus 103 ~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~~~gt 179 (515)
+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....+... ....++
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 999998753 46899999999999999999999999999999999999999999999999998765433221 122446
Q ss_pred CCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcccCCCCCC
Q 010214 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPM 257 (515)
Q Consensus 180 ~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~~dP~ 257 (515)
..|+|||++.+..+ +.++||||+|+++|++++ |..||...........+..+. ...|..++..+.+++.+||..+|+
T Consensus 158 ~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (250)
T cd05085 158 IKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPE 236 (250)
T ss_pred ccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence 67999999987765 689999999999999998 999998877776666665543 355677899999999999999999
Q ss_pred CCCCHHHHhc
Q 010214 258 KRITIPEIRQ 267 (515)
Q Consensus 258 ~Rpt~~eil~ 267 (515)
+|||+.|+++
T Consensus 237 ~Rp~~~~l~~ 246 (250)
T cd05085 237 NRPKFSELQK 246 (250)
T ss_pred cCCCHHHHHH
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=321.67 Aligned_cols=240 Identities=26% Similarity=0.444 Sum_probs=203.1
Q ss_pred eecccCceEEEEEEEc--CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 24 TLGIGSFGKVKIAEHA--LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||++++++++. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999775 445679999986542 23445778999999999999999999999864 578999999999
Q ss_pred CCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc-c---ccC
Q 010214 102 GELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-L---KTS 176 (515)
Q Consensus 102 g~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~-~---~~~ 176 (515)
++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++........ . ...
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999999975 45799999999999999999999999999999999999999999999999999976543321 1 112
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcccCCC
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~~ 254 (515)
.+++.|+|||.+.+..+ +.++|||||||++|++++ |..||.+.........+..+. ...|...++++.+++.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 23578999999887665 789999999999999996 999999887777766666543 456778899999999999999
Q ss_pred CCCCCCCHHHHhc
Q 010214 255 DPMKRITIPEIRQ 267 (515)
Q Consensus 255 dP~~Rpt~~eil~ 267 (515)
||.+||++.++.+
T Consensus 238 ~~~~Rp~~~~i~~ 250 (257)
T cd05115 238 KWEDRPNFAKVEE 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=327.61 Aligned_cols=249 Identities=26% Similarity=0.430 Sum_probs=212.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcC-----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.++|++.+.||.|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 4689999999999999999998753 67899999986432 2344567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG----------------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL 148 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~----------------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNI 148 (515)
..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++|++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 9999999999999999997432 367888999999999999999999999999999999
Q ss_pred EECCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHH
Q 010214 149 LLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN 224 (515)
Q Consensus 149 Ll~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~ 224 (515)
+++.++.++|+|||++........ .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999876533221 122345667999999987776 789999999999999997 889998887777
Q ss_pred HHHHHhcCcc-CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 225 LFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 225 ~~~~i~~~~~-~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
....+..+.. ..|..++.++.+|+.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7777766543 446778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=322.15 Aligned_cols=229 Identities=24% Similarity=0.395 Sum_probs=196.4
Q ss_pred cCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCHHHH
Q 010214 28 GSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDY 107 (515)
Q Consensus 28 G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~ 107 (515)
|.+|+||+|.++.+++.||+|.+.+.. ...+|...+....||||+++++++......|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999986543 123455555666799999999999999999999999999999999
Q ss_pred HHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCCCCccCCCc
Q 010214 108 IVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187 (515)
Q Consensus 108 i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~ 187 (515)
+.+...+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+...... .....++..|+|||.
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~ 153 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEV 153 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcc
Confidence 988888999999999999999999999999999999999999999999999999987665432 234556788999999
Q ss_pred ccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCCH-----
Q 010214 188 ISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI----- 262 (515)
Q Consensus 188 i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~----- 262 (515)
+.+..+ ++++|+||+|+++|+|++|..||........ ......+|..+++.++++|.+||+.||.+|||+
T Consensus 154 ~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~ 228 (237)
T cd05576 154 GGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGIN----THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGV 228 (237)
T ss_pred cCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhcc----cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccch
Confidence 987766 6899999999999999999998865332110 112235677899999999999999999999985
Q ss_pred HHHhcCccc
Q 010214 263 PEIRQHPWF 271 (515)
Q Consensus 263 ~eil~hp~f 271 (515)
+++++||||
T Consensus 229 ~~~~~h~~~ 237 (237)
T cd05576 229 EDIKSHPFF 237 (237)
T ss_pred HHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=324.45 Aligned_cols=248 Identities=24% Similarity=0.359 Sum_probs=207.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCc----EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
.++|++.+.||.|+||+||+|.+..+++ ++++|.+... ........+..|+.+++.++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 3689999999999999999999987776 4677776432 122334677889999999999999999998754 45
Q ss_pred EEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 92 IYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.++++||+++|+|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 7899999999999999976 457899999999999999999999999999999999999999999999999999865433
Q ss_pred Cc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHH
Q 010214 171 HF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (515)
Q Consensus 171 ~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 245 (515)
.. .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.......+.+..+. ...|...+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVY 241 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHH
Confidence 21 223456778999999987766 789999999999999998 999998877666555555443 344556788999
Q ss_pred HHhcccCCCCCCCCCCHHHHhc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+++.+||..||.+|||+.|+++
T Consensus 242 ~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 242 MVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=324.04 Aligned_cols=249 Identities=25% Similarity=0.448 Sum_probs=214.1
Q ss_pred CCceEeeeecccCceEEEEEEEcCC-----CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALT-----GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~t-----g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
.+|++.+.||.|+||.||+|+++.+ .+.||+|.+.... .....+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 6899999999999999999997643 4679999876432 22355778999999999999999999999999899
Q ss_pred EEEEEeccCCCCHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecc
Q 010214 92 IYVVMEYVKSGELFDYIVEKG---------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFG 162 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~---------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFG 162 (515)
.|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.++++|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999999998765 68999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC--ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCcc--CCC
Q 010214 163 LSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY--TLP 237 (515)
Q Consensus 163 ls~~~~~~~--~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~~--~~p 237 (515)
++....... ......+++.|+|||.+.+... ++++||||||+++|+|++ |..||.+.........+..+.. ..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence 986543222 2234456778999999887665 689999999999999998 8999988777777777765553 345
Q ss_pred CCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 238 ~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..++..+.+++.+||+.||.+|||+.|++.+
T Consensus 242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 6788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=332.68 Aligned_cols=245 Identities=23% Similarity=0.357 Sum_probs=199.7
Q ss_pred CceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCHHHHH
Q 010214 29 SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI 108 (515)
Q Consensus 29 ~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~i 108 (515)
++|.||++++..+++.||+|++..... .......+.+|+.+++.++||||+++++++...+..|++|||+++|+|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 556677777778999999999976533 3345678999999999999999999999999999999999999999999999
Q ss_pred HHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--------ccccCCC
Q 010214 109 VEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--------FLKTSCG 178 (515)
Q Consensus 109 ~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~--------~~~~~~g 178 (515)
... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+....... ......+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 763 468999999999999999999999999999999999999999999999999886543211 1234457
Q ss_pred CCCccCCCcccCC-ccCCCcceeehhHHHHHHHHhCCCCCCCCChHHH-HHHHhcCc-----------------------
Q 010214 179 SPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL-FKKIKGGI----------------------- 233 (515)
Q Consensus 179 t~~Y~aPE~i~~~-~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~-~~~i~~~~----------------------- 233 (515)
+..|+|||++.+. ...+.++|+||+||++|+|++|..||........ ..++....
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
T cd08216 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN 250 (314)
T ss_pred cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence 7889999998763 2236899999999999999999999987543332 22221110
Q ss_pred ----------cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 234 ----------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 234 ----------~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
...+..++.++.+|+.+||..||.+|||+.++++||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00112345678999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=351.42 Aligned_cols=248 Identities=30% Similarity=0.494 Sum_probs=216.4
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCC
Q 010214 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGE 103 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~ 103 (515)
+||+|.||+||.|++..|...+|||.+..+. ....+-+.+||.+.+.++|.|||++++.+..++++-|.||.++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 6999999999999999999999999986433 3456788999999999999999999999999999999999999999
Q ss_pred HHHHHHHh-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCceEEeeccccccccc-CCccccCCC
Q 010214 104 LFDYIVEK-GRL--QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRD-GHFLKTSCG 178 (515)
Q Consensus 104 L~~~i~~~-~~l--~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-~~~vKL~DFGls~~~~~-~~~~~~~~g 178 (515)
|.+.+..+ |++ +|..+-.+.+||++||.|||++.|||||||=.|||++. .|.+||+|||-++.... .....|..|
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG 738 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG 738 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence 99999864 667 88899999999999999999999999999999999975 68999999999876643 345678899
Q ss_pred CCCccCCCccc-CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHH--HHHH-HhcCccCCCCCCChhHHHHhcccCCC
Q 010214 179 SPNYAAPEVIS-GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN--LFKK-IKGGIYTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 179 t~~Y~aPE~i~-~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~--~~~~-i~~~~~~~p~~~s~~~~~li~~mL~~ 254 (515)
|..|||||++. |...+++++|||||||++.||.||++||.....++ +++- +.+.-.++|..+|.+++.||.+|+.+
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFep 818 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEP 818 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCC
Confidence 99999999995 44445899999999999999999999997654332 2221 22334678899999999999999999
Q ss_pred CCCCCCCHHHHhcCcccccc
Q 010214 255 DPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 255 dP~~Rpt~~eil~hp~f~~~ 274 (515)
||..||++.++|..||++..
T Consensus 819 d~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 819 DPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CcccCccHHHhccCcccccC
Confidence 99999999999999999754
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=333.36 Aligned_cols=256 Identities=26% Similarity=0.448 Sum_probs=215.5
Q ss_pred CCccccCCCceEeeeecccCceEEEEEEEcCC-------CcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccE
Q 010214 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALT-------GHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIR 81 (515)
Q Consensus 10 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~t-------g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~ 81 (515)
........+|++++.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++++ +||||++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 34445567899999999999999999986432 2369999876432 223457888999999999 7999999
Q ss_pred EEEEEEcCCeEEEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 010214 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKP 145 (515)
Q Consensus 82 l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkp 145 (515)
+++++.....+|++|||+++|+|.+++.+.. .++...+..++.||+.||.|||++|++||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 9999999999999999999999999997532 367788899999999999999999999999999
Q ss_pred CcEEECCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCC
Q 010214 146 ENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDEN 221 (515)
Q Consensus 146 eNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~ 221 (515)
+|||++.++.+||+|||+++....... .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc-CchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999999999876544321 122234567999999988776 689999999999999998 899999988
Q ss_pred hHHHHHHHhcCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 222 IPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 222 ~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..+....+.... ...|...+.++.+++.+||..+|.+|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 242 VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 888887776653 35667788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=318.33 Aligned_cols=241 Identities=27% Similarity=0.447 Sum_probs=207.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG 102 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg 102 (515)
+.||.|+||.||+|.+.. ++.||+|.+...... .....+.+|+++++.++||||+++++++.+....|+||||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 468999999999999887 999999998654432 35678899999999999999999999999999999999999999
Q ss_pred CHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc---ccCCC
Q 010214 103 ELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCG 178 (515)
Q Consensus 103 ~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~g 178 (515)
+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....+... ....+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99999976 356899999999999999999999999999999999999999999999999998765432211 12234
Q ss_pred CCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhcccCCCCC
Q 010214 179 SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDP 256 (515)
Q Consensus 179 t~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~mL~~dP 256 (515)
+..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...........+... ....|...+..+.+++.+||+.+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999987765 789999999999999998 89999887766666666554 345567889999999999999999
Q ss_pred CCCCCHHHHhc
Q 010214 257 MKRITIPEIRQ 267 (515)
Q Consensus 257 ~~Rpt~~eil~ 267 (515)
.+|||+.|+++
T Consensus 237 ~~Rp~~~ell~ 247 (251)
T cd05041 237 ENRPSFSEIYN 247 (251)
T ss_pred hhCcCHHHHHH
Confidence 99999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=327.40 Aligned_cols=249 Identities=25% Similarity=0.385 Sum_probs=206.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcC----------------CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHAL----------------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~----------------tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI 79 (515)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 3679999999999999999986543 34579999986442 23455788999999999999999
Q ss_pred cEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 010214 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-----------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL 148 (515)
Q Consensus 80 v~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~-----------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNI 148 (515)
+++++++...+..|+||||+++++|.+++.... .+++..+..++.||+.||+|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999997643 366788999999999999999999999999999999
Q ss_pred EECCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh--CCCCCCCCChH
Q 010214 149 LLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC--GTLPFDDENIP 223 (515)
Q Consensus 149 Ll~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt--G~~Pf~~~~~~ 223 (515)
|++.++.++|+|||++..+..... .....+++.|+|||+..+..+ +.++|+|||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999876543321 122344678999998877666 789999999999999998 78999876655
Q ss_pred HHHHHHh--------cCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 224 NLFKKIK--------GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 224 ~~~~~i~--------~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+...... ....+.|..+++.+.+|+.+||+.||.+|||+.++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5443321 1123445678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=325.49 Aligned_cols=239 Identities=20% Similarity=0.295 Sum_probs=200.3
Q ss_pred eeecccCceEEEEEEEcCCCcE-------EEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 23 KTLGIGSFGKVKIAEHALTGHK-------VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~-------vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
+.||.|+||.||+|.++.++.. ||+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 4689999999999998765544 8888875432 23456788999999999999999999999998999999
Q ss_pred EeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc--------eEEeecccccc
Q 010214 96 MEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN--------VKIADFGLSNI 166 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~--------vKL~DFGls~~ 166 (515)
|||+++|+|.+++..++ .+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997654 5899999999999999999999999999999999999987765 69999999865
Q ss_pred cccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhC-CCCCCCCChHHHHHHHhcCccCCCCCCChhHH
Q 010214 167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR 245 (515)
Q Consensus 167 ~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 245 (515)
.... ....+++.|+|||++.+....+.++||||+||++|+|++| ..||......... .+......+|...+.++.
T Consensus 158 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 233 (258)
T cd05078 158 VLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWTELA 233 (258)
T ss_pred cCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcHHHH
Confidence 5432 3456888999999998755447899999999999999998 5677665544332 333445667777889999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcC
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+|+.+||+.||.+|||++++++.
T Consensus 234 ~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 234 NLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=345.03 Aligned_cols=257 Identities=30% Similarity=0.538 Sum_probs=223.3
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
..-|..++.||-|+||.|.++...+|...||+|.+.|...-.......++.|-.||...+.+-||+||..|++.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 35688899999999999999999999999999999988877777788889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-------
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR------- 168 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~------- 168 (515)
|||++||++-.+|.+.+-++|+.++.++.++.+|+++.|..|+|||||||.|||||.+|+|||+|||++.-++
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999986431
Q ss_pred --cCC----------------------------------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh
Q 010214 169 --DGH----------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC 212 (515)
Q Consensus 169 --~~~----------------------------------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt 212 (515)
.++ .....+||++|+|||++....| +..+|.||.|||||+|+.
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~-~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY-TQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc-cccchhhHhhHHHHHHhh
Confidence 000 0124579999999999998877 689999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcCc----cCCCCCCChhHHHHhcccCCCCCCCCCC---HHHHhcCcccccc
Q 010214 213 GTLPFDDENIPNLFKKIKGGI----YTLPSHLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAH 274 (515)
Q Consensus 213 G~~Pf~~~~~~~~~~~i~~~~----~~~p~~~s~~~~~li~~mL~~dP~~Rpt---~~eil~hp~f~~~ 274 (515)
|..||-+.+.-+...++.+-. +..-..+|+++.++|.++. .+++.|.. ++|+..||||+..
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCcccccc
Confidence 999998876655444444321 2233578999999998854 67788874 6789999999864
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=320.33 Aligned_cols=249 Identities=29% Similarity=0.476 Sum_probs=211.6
Q ss_pred CCCceEeeeecccCceEEEEEEEcCC---CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
..+|.+.+.||.|+||.||+|.+..+ ...||||.+.... .....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 46799999999999999999987644 3579999875432 23456788999999999999999999999876 457
Q ss_pred EEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|+||||+++|+|.+++.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 89999999999999998644 58999999999999999999999999999999999999999999999999987664433
Q ss_pred ccc--cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHH
Q 010214 172 FLK--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL 247 (515)
Q Consensus 172 ~~~--~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 247 (515)
... ...+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+. ...|..++.++.++
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 240 (270)
T ss_pred ceecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence 222 2234568999999987766 789999999999999986 999999887777666666553 45677889999999
Q ss_pred hcccCCCCCCCCCCHHHHhcC
Q 010214 248 IPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~h 268 (515)
+.+|+..+|.+|||+.+++..
T Consensus 241 i~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 241 MTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=379.16 Aligned_cols=260 Identities=29% Similarity=0.491 Sum_probs=225.4
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
..+.-+++-+.+||.|.||+||.|.+..||+-.|+|-+.-.... ......+.+|.+++..++|||+|++|++-.+.+.+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 34455777888999999999999999999999999988655443 34457788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC--
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-- 170 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-- 170 (515)
+|.||||+||+|.+.+...+-.+|...+.+..|++.|+.|||++|||||||||+||+++.+|.+|++|||.|......
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 999999999999999987777888899999999999999999999999999999999999999999999999876543
Q ss_pred ---CccccCCCCCCccCCCcccCCc--cCCCcceeehhHHHHHHHHhCCCCCCCCC-hHH-HHHHHhcCccCCCCCCChh
Q 010214 171 ---HFLKTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVILYALLCGTLPFDDEN-IPN-LFKKIKGGIYTLPSHLSPG 243 (515)
Q Consensus 171 ---~~~~~~~gt~~Y~aPE~i~~~~--~~~~~~DIwSlGvily~lltG~~Pf~~~~-~~~-~~~~i~~~~~~~p~~~s~~ 243 (515)
..++...|||.|||||++.|.. ..+-+.|||||||++.||+||+.||...+ .-+ +++--..-.+++|..+|++
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence 2356678999999999998654 23568999999999999999999997532 223 3433344467899999999
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
.++||.+||..||++|.++.|+++|-|-+.
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 999999999999999999999999988654
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=316.86 Aligned_cols=246 Identities=26% Similarity=0.475 Sum_probs=209.8
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
..++|++.+.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|+.+++.++|+||+++++++.. ...|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 4689999999999999999999865 55679999876432 234678899999999999999999999887 77899
Q ss_pred EEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 95 VMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
+|||+++++|.+++.+. ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||.+.....+..
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999999763 3578889999999999999999999999999999999999999999999999876544322
Q ss_pred c--ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHh
Q 010214 173 L--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLI 248 (515)
Q Consensus 173 ~--~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 248 (515)
. ....++..|+|||++.+..+ +.++|+|||||++|++++ |..||.+.+.......+..+. ...+...+.++.+++
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 236 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM 236 (260)
T ss_pred ccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHH
Confidence 1 12335677999999987665 789999999999999998 999999887777777666543 344567889999999
Q ss_pred cccCCCCCCCCCCHHHHhc
Q 010214 249 PRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~ 267 (515)
.+||+.+|.+|||+.++++
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 237 MRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHcccCcccCcCHHHHHH
Confidence 9999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=321.60 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=212.5
Q ss_pred cCCCceEeeeecccCceEEEEEEEcC----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc-C
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-P 89 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-~ 89 (515)
-.++|++.+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.+++.++||||+++++++.. +
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 35789999999999999999999876 3588999987532 244556788999999999999999999998755 5
Q ss_pred CeEEEEEeccCCCCHHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeec
Q 010214 90 SDIYVVMEYVKSGELFDYIVEK--------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADF 161 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~--------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DF 161 (515)
...++++||+++++|.+++... ..+++..+..++.||+.||+|||+++++||||||+||+++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 6789999999999999999753 45899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCcc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCC
Q 010214 162 GLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTL 236 (515)
Q Consensus 162 Gls~~~~~~~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~ 236 (515)
|+++.+..+... ....++..|+|||++.+..+ +.++|||||||++|++++ |..||...+...+...+..+. ...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ 240 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCC
Confidence 999866443221 22345678999999987766 789999999999999998 999999887777666665543 244
Q ss_pred CCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 237 PSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 237 p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+..+++++.+++.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 241 PINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 5567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=322.60 Aligned_cols=249 Identities=27% Similarity=0.430 Sum_probs=204.5
Q ss_pred CCceEeeeecccCceEEEEEEE----cCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--C
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEH----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--S 90 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~----~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~ 90 (515)
..|++.+.||+|+||.||+|.. +.++..||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 4578999999999999999974 4678899999986442 234457889999999999999999999998775 5
Q ss_pred eEEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
..++||||++|++|.+++.+.. .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 6899999999999999997653 589999999999999999999999999999999999999999999999999886643
Q ss_pred CC----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC---------------hHHHHHHHh
Q 010214 170 GH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN---------------IPNLFKKIK 230 (515)
Q Consensus 170 ~~----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~---------------~~~~~~~i~ 230 (515)
.. ......++..|+|||++.+..+ ++++||||+||++|+|+++..|+.... .......+.
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 32 1234456778999999987766 689999999999999999877653211 111112222
Q ss_pred cC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 231 GG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 231 ~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.+ ..+.+..++..+.+|+.+||+.||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 22 234466789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=334.25 Aligned_cols=250 Identities=28% Similarity=0.455 Sum_probs=205.2
Q ss_pred CCCceEeeeecccCceEEEEEEE-----cCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEc-
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEH-----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET- 88 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~-----~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~- 88 (515)
.++|++.+.||+|+||.||+|.+ ..+++.||||++..... ......+.+|+.++..+ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 46899999999999999999984 35678999999865432 23456788999999999 58999999998754
Q ss_pred CCeEEEEEeccCCCCHHHHHHHh---------------------------------------------------------
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEK--------------------------------------------------------- 111 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~--------------------------------------------------------- 111 (515)
...+++||||+++|+|.+++..+
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 45689999999999999998653
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc---cccCCC
Q 010214 112 ----------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCG 178 (515)
Q Consensus 112 ----------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~g 178 (515)
..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 1367788889999999999999999999999999999999999999999999876533211 122345
Q ss_pred CCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChH-HHHHHHhcC-ccCCCCCCChhHHHHhcccCCCC
Q 010214 179 SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP-NLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 179 t~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~li~~mL~~d 255 (515)
++.|+|||++.+..+ +.++||||||+++|+|++ |..||...... .....+..+ ....|...++++.+++.+||+.|
T Consensus 244 ~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 244 PLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred CcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence 678999999988766 789999999999999997 99999875433 333333333 34556678899999999999999
Q ss_pred CCCCCCHHHHhcC
Q 010214 256 PMKRITIPEIRQH 268 (515)
Q Consensus 256 P~~Rpt~~eil~h 268 (515)
|.+|||+.|+++|
T Consensus 323 p~~Rps~~eil~~ 335 (343)
T cd05103 323 PSQRPTFSELVEH 335 (343)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=319.66 Aligned_cols=239 Identities=21% Similarity=0.304 Sum_probs=197.0
Q ss_pred eeecccCceEEEEEEEcC------------CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 23 KTLGIGSFGKVKIAEHAL------------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~------------tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
+.||+|+||.||+|.... ....||+|++.... ......+.+|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999998542 23368999875432 234567888999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc-------eEEeecc
Q 010214 91 DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN-------VKIADFG 162 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~-------vKL~DFG 162 (515)
..++||||+++|+|..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999999875 456999999999999999999999999999999999999987664 8999999
Q ss_pred cccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHH-hCCCCCCCCChHHHHHHHhcCccCCCCCCC
Q 010214 163 LSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLPSHLS 241 (515)
Q Consensus 163 ls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~ll-tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 241 (515)
++...... ....++..|+|||++.+....+.++||||+||++|+|+ +|..||......+.. .+...........+
T Consensus 158 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (262)
T cd05077 158 IPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVTPSC 233 (262)
T ss_pred CCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCCCCh
Confidence 98654322 23467889999999875444478999999999999998 589999876554432 33334444444567
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+++.+|+.+||+.||.+||++.+|+.+
T Consensus 234 ~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 234 KELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=340.10 Aligned_cols=251 Identities=28% Similarity=0.434 Sum_probs=209.1
Q ss_pred cCCCceEeeeecccCceEEEEEEEc-----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEc
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIET 88 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~ 88 (515)
-.++|.+.+.||+|+||.||+|.+. .++..||+|++..... ....+.+.+|+++|.++. ||||+++++++.+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 3467889999999999999999864 3456899999975432 233457889999999998 9999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhC--------------------------------------------------------
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKG-------------------------------------------------------- 112 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~-------------------------------------------------------- 112 (515)
.+.+|+||||+++|+|.+++.+.+
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 999999999999999999996532
Q ss_pred ------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 010214 113 ------------------------------------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL 150 (515)
Q Consensus 113 ------------------------------------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl 150 (515)
.+++..+..++.||+.||.|||+.+++||||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 25667788999999999999999999999999999999
Q ss_pred CCCCceEEeecccccccccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHH-
Q 010214 151 DSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNL- 225 (515)
Q Consensus 151 ~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~- 225 (515)
+.++.+||+|||++....... ...+..+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||......+.
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 999999999999997653221 1223467889999999987766 789999999999999998 8999987554444
Q ss_pred HHHHhcC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 226 FKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 226 ~~~i~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
...+..+ ....|..++.++.+|+.+||..+|.+||++.+|+..
T Consensus 352 ~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 352 YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3334433 234567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=321.44 Aligned_cols=258 Identities=31% Similarity=0.488 Sum_probs=210.2
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCc----EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc-C
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-P 89 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-~ 89 (515)
....|++.+.||+|.||.||+|..+.++. .+|||.+..++-.+ ..-...-||+.+++.++|||++.+..++-+ +
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 36789999999999999999997665543 68999887653221 233566799999999999999999999866 8
Q ss_pred CeEEEEEeccCCCCHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC----CceEEee
Q 010214 90 SDIYVVMEYVKSGELFDYIVE-----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK----WNVKIAD 160 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~-----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~----~~vKL~D 160 (515)
..+++++||.+. +|+..|+- ...++...++.++.||+.|+.|||++-|+||||||.|||+..+ |.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 889999999986 99999963 2358999999999999999999999999999999999999887 8999999
Q ss_pred cccccccccCC----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC---------hHHHHH
Q 010214 161 FGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN---------IPNLFK 227 (515)
Q Consensus 161 FGls~~~~~~~----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~---------~~~~~~ 227 (515)
||+++.+.+.- .....+-|.+|+|||.+.|...+++++|||++|||+.||++-.+.|.+.. ..+...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999876531 23445678999999999998877999999999999999999998886532 112222
Q ss_pred HHhcCcc-----------CCC--------------------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcc
Q 010214 228 KIKGGIY-----------TLP--------------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270 (515)
Q Consensus 228 ~i~~~~~-----------~~p--------------------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~ 270 (515)
+|..-.. .+| ..-++.+.+|+.+||+.||.+|+|++++++|+|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 3321110 011 113556889999999999999999999999999
Q ss_pred cccc
Q 010214 271 FQAH 274 (515)
Q Consensus 271 f~~~ 274 (515)
|...
T Consensus 340 F~~d 343 (438)
T KOG0666|consen 340 FTED 343 (438)
T ss_pred cccC
Confidence 9865
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=317.55 Aligned_cols=250 Identities=29% Similarity=0.499 Sum_probs=214.3
Q ss_pred CceEeeeecccCceEEEEEEEcC-CCcEEEEEEeccccc-------CChHHHHHHHHHHHHHHh-CCCCCccEEEEEEEc
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHAL-TGHKVAIKILNRRKI-------KNMEMEEKVRREIKILRL-FMHPHIIRLYEVIET 88 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~-tg~~vAiK~i~~~~~-------~~~~~~~~i~~Ei~il~~-l~hpnIv~l~~~~~~ 88 (515)
+|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.+++. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 58899999999999999999987 688999998864321 222345667788888864 799999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeeccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
.+..|++|||++|++|.+++.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999998743 3468999999999999999999996 7899999999999999999999999999
Q ss_pred ccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCC-CC-CCC
Q 010214 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL-PS-HLS 241 (515)
Q Consensus 164 s~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~-p~-~~s 241 (515)
+.............|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...........+....... +. ..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCC
Confidence 987665544556678999999999987765 789999999999999999999999887777777766655432 22 578
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+++.+++.+||+.||++|||+.|+..+
T Consensus 240 ~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 240 EDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=341.90 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=214.0
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
+.-.+...+...||+|+||+||+|.+-. .||||+++...... +..+.+++|+.++++-+|.||+-+.+++..+..
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 3445677889999999999999999742 59999998877665 478999999999999999999999999988877
Q ss_pred EEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc---
Q 010214 93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR--- 168 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~--- 168 (515)
.||+-+|+|.+|..+|.- ..++.....+.|++||++|+.|||.++|+|||||..||++.+++.|||+|||++....
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 999999999999999963 4578899999999999999999999999999999999999999999999999987542
Q ss_pred cCCccccCCCCCCccCCCcccC--CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-----CCCCCCC
Q 010214 169 DGHFLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-----TLPSHLS 241 (515)
Q Consensus 169 ~~~~~~~~~gt~~Y~aPE~i~~--~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-----~~p~~~s 241 (515)
....+....|+..|||||++.. ....++.+||||+|+++|||+||.+||...+..+++-.+-.|.. ......+
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~p 622 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCP 622 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCH
Confidence 3344566779999999999963 22337899999999999999999999997776666555555522 1224567
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.++++|+..||..++++||++.+|+.
T Consensus 623 k~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 623 KAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHHhcCcccCccHHHHHH
Confidence 79999999999999999999999987
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=321.15 Aligned_cols=238 Identities=21% Similarity=0.280 Sum_probs=196.2
Q ss_pred eecccCceEEEEEEEcCC------------------------CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc
Q 010214 24 TLGIGSFGKVKIAEHALT------------------------GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~~~~t------------------------g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI 79 (515)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 699999999999975322 2458999886432 2345678889999999999999
Q ss_pred cEEEEEEEcCCeEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC----
Q 010214 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---- 154 (515)
Q Consensus 80 v~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~---- 154 (515)
+++++++.+....|+||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999875 56789999999999999999999999999999999999997654
Q ss_pred ---ceEEeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHH-hCCCCCCCCChHHHHHHHh
Q 010214 155 ---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIK 230 (515)
Q Consensus 155 ---~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~ll-tG~~Pf~~~~~~~~~~~i~ 230 (515)
.+|++|||++...... ....++..|+|||.+.+....++++|||||||++|+|+ +|..||.......... ..
T Consensus 159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~ 234 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FY 234 (274)
T ss_pred ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HH
Confidence 3899999987544222 23457888999999876544478999999999999985 6999998766544333 22
Q ss_pred cCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 231 GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 231 ~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
......|...++++.++|.+||+.+|.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 235 EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 33445566677899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=314.72 Aligned_cols=241 Identities=27% Similarity=0.502 Sum_probs=206.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||.||++. .+++.||+|.+.... ....+.+|+.+++.++||||+++++++..+ ..|+|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 4679999999999999999986 478899999985432 235788999999999999999999998654 57999
Q ss_pred EeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 96 MEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~ 154 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--V 154 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--C
Confidence 99999999999997654 4899999999999999999999999999999999999999999999999998764332 2
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhccc
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~m 251 (515)
.....+..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...+.......+..+. ...+..+++.+.+++.+|
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 233 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSC 233 (254)
T ss_pred CCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHH
Confidence 23344678999999987766 689999999999999997 999999888777777766553 334567889999999999
Q ss_pred CCCCCCCCCCHHHHhc
Q 010214 252 LIVDPMKRITIPEIRQ 267 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~ 267 (515)
|+.+|.+|||+++++.
T Consensus 234 l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 234 WETEPKKRPSFHKLRE 249 (254)
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=318.97 Aligned_cols=247 Identities=29% Similarity=0.447 Sum_probs=201.2
Q ss_pred CCceEeeeecccCceEEEEEE----EcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CC
Q 010214 17 PNYKLGKTLGIGSFGKVKIAE----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--PS 90 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~----~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~ 90 (515)
.+|++.+.||+|+||.||+|. +..++..||+|.+... .......+.+|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 589999999999999999997 4457889999998643 23445778999999999999999999998744 34
Q ss_pred eEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 91 DIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
.+++||||+++++|.+++.+. +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 689999999999999999764 4689999999999999999999999999999999999999999999999999987644
Q ss_pred CCcc----ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH----------------HHHHHH
Q 010214 170 GHFL----KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP----------------NLFKKI 229 (515)
Q Consensus 170 ~~~~----~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~----------------~~~~~i 229 (515)
+... ....++..|+|||++.+..+ +.++||||+||++|+|++|..|+...... .+...+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 3221 11223456999999987766 78999999999999999988776433211 011111
Q ss_pred hcC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 230 KGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 230 ~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
... ..+.+..++.++.+|+.+||..+|.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111 23445678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=317.48 Aligned_cols=242 Identities=26% Similarity=0.440 Sum_probs=205.2
Q ss_pred eeecccCceEEEEEEEcCCC------cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 23 KTLGIGSFGKVKIAEHALTG------HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
+.||+|+||.||+|.++.++ +.+|+|.+.+.. .......+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999986544 689999886432 1233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-----ceEEeecccc
Q 010214 97 EYVKSGELFDYIVEK-------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-----NVKIADFGLS 164 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~-------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~-----~vKL~DFGls 164 (515)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999999742 2478899999999999999999999999999999999999887 8999999998
Q ss_pred cccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCC
Q 010214 165 NIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSH 239 (515)
Q Consensus 165 ~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 239 (515)
........ .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+..+ ....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 76543322 123345788999999987766 789999999999999998 99999887777766666543 3456778
Q ss_pred CChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 240 LSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 240 ~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
++..+.+++.+||..+|.+|||+.++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=337.72 Aligned_cols=251 Identities=28% Similarity=0.426 Sum_probs=218.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCc---E-EEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH---K-VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~---~-vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
..+-.+.+.||+|+||.||+|..+..+. . ||+|....+..........+.+|.++|++++|||||++||+......
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 4556677999999999999998876432 3 89999876554566778999999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 92 IYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
+|+|||+|+||+|.+|+.+++ .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||+++.-..-
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY 315 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence 999999999999999999877 4999999999999999999999999999999999999999999999999998765421
Q ss_pred CccccCC-CCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc--cCCCCCCChhHHH
Q 010214 171 HFLKTSC-GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI--YTLPSHLSPGARD 246 (515)
Q Consensus 171 ~~~~~~~-gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~ 246 (515)
......+ -...|+|||.+....| ++++||||+||++||+.+ |..||.+....+...+|.... .+.|...+.++..
T Consensus 316 ~~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~ 394 (474)
T KOG0194|consen 316 VMKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAK 394 (474)
T ss_pred eeccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHH
Confidence 2222122 4568999999998877 799999999999999998 899999999999999995443 3456677889999
Q ss_pred HhcccCCCCCCCCCCHHHHhc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~ 267 (515)
++.+|+..||++|||+.++.+
T Consensus 395 ~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 395 VMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHhccCChhhccCHHHHHH
Confidence 999999999999999998864
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=313.76 Aligned_cols=243 Identities=27% Similarity=0.402 Sum_probs=200.7
Q ss_pred eeecccCceEEEEEEEcC---CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEE-cCCeEEEEEec
Q 010214 23 KTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE-TPSDIYVVMEY 98 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~---tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~iVmEy 98 (515)
+.||+|+||.||+|.+.. ++..||+|.+... ......+.+.+|+.+++.++||||+++++++. .+...++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998654 3457999987532 23345678889999999999999999999765 45568999999
Q ss_pred cCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-----c
Q 010214 99 VKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----F 172 (515)
Q Consensus 99 ~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-----~ 172 (515)
+.+|+|.+++.+. ..+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||++....... .
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9999999999764 356788889999999999999999999999999999999999999999999987653321 1
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcc
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPR 250 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~ 250 (515)
.....+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+...+...+..+. ...|..+++.+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 123346778999999887766 789999999999999999 577788777666666665543 34456678999999999
Q ss_pred cCCCCCCCCCCHHHHhcC
Q 010214 251 MLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~h 268 (515)
||..+|++|||+.++++.
T Consensus 238 cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 238 CWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HcCCChhhCCCHHHHHHH
Confidence 999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=314.39 Aligned_cols=236 Identities=21% Similarity=0.282 Sum_probs=196.1
Q ss_pred eeecccCceEEEEEEEcCCC----------cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 23 KTLGIGSFGKVKIAEHALTG----------HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg----------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
+.||+|+||.||+|.+..++ ..+++|++..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999998777 3588887654321 15778899999999999999999999887 778
Q ss_pred EEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-------ceEEeecccc
Q 010214 93 YVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-------NVKIADFGLS 164 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~-------~vKL~DFGls 164 (515)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998766 799999999999999999999999999999999999999887 7999999998
Q ss_pred cccccCCccccCCCCCCccCCCcccCC-ccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCccCCCCCCCh
Q 010214 165 NIMRDGHFLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSP 242 (515)
Q Consensus 165 ~~~~~~~~~~~~~gt~~Y~aPE~i~~~-~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 242 (515)
..... .....++..|+|||++.+. ...+.++||||+||++|+|++ |..||...+......... .....|...+.
T Consensus 156 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (259)
T cd05037 156 ITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPDCA 231 (259)
T ss_pred ccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCCCch
Confidence 76543 2334577889999999876 234789999999999999999 688887765433333222 22223333458
Q ss_pred hHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 243 GARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 243 ~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.+.+++.+||..+|.+|||+.++++
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 232 ELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 8999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=314.46 Aligned_cols=242 Identities=24% Similarity=0.354 Sum_probs=194.4
Q ss_pred eeecccCceEEEEEEEc--CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccC
Q 010214 23 KTLGIGSFGKVKIAEHA--LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVK 100 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~ 100 (515)
+.||+|+||.||+|... .++..+|+|.+.... .......+.+|+.+++.++||||+++++++.+...+++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999864 355789999886543 22334578889999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc---
Q 010214 101 SGELFDYIVEKG-----RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--- 172 (515)
Q Consensus 101 gg~L~~~i~~~~-----~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~--- 172 (515)
+|+|.+++.... ..++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999999997532 456778889999999999999999999999999999999999999999999875433322
Q ss_pred cccCCCCCCccCCCcccCCc------cCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHH-HhcCccCCC-----CC
Q 010214 173 LKTSCGSPNYAAPEVISGKL------YAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKK-IKGGIYTLP-----SH 239 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~------~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~-i~~~~~~~p-----~~ 239 (515)
.....+++.|+|||++.+.. ..+.++||||+||++|+|++ |..||......+.... +.......+ ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 12346788899999986432 12679999999999999996 9999987665544332 222222222 24
Q ss_pred CChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 240 LSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 240 ~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.++.+.+++++|+ .+|++|||++|++.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6788999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.84 Aligned_cols=249 Identities=28% Similarity=0.421 Sum_probs=208.7
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCc----EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
..+|+..+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++..+ .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 4678999999999999999999987776 57888876433 223345688999999999999999999998754 4
Q ss_pred EEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 92 IYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 679999999999999997654 6899999999999999999999999999999999999999999999999999876433
Q ss_pred Cc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHH
Q 010214 171 HF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (515)
Q Consensus 171 ~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 245 (515)
.. .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+. ...+...+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY 241 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 22 123345778999999987766 789999999999999997 999998876555555444432 344566789999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcC
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+++.+||..+|.+|||+.++++.
T Consensus 242 ~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=314.11 Aligned_cols=248 Identities=26% Similarity=0.455 Sum_probs=207.0
Q ss_pred ceEeeeecccCceEEEEEEEc---CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 010214 19 YKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS----- 90 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~----- 90 (515)
|.+.++||+|+||.||+|.++ .+++.||||++..+.. .....+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 678899999999999999865 3578999999865433 3344677889999999999999999999885532
Q ss_pred -eEEEEEeccCCCCHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 91 -DIYVVMEYVKSGELFDYIVEK------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 91 -~~~iVmEy~~gg~L~~~i~~~------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
..++++||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 247899999999999887532 2478999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCC
Q 010214 164 SNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPS 238 (515)
Q Consensus 164 s~~~~~~~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~ 238 (515)
+.....+... ....+++.|++||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+....+.... ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 8866433221 23345678999999987766 689999999999999999 999998887777766665543 34556
Q ss_pred CCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 239 ~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..+..+.+++.+||+.+|.+|||+.+++.+
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=314.25 Aligned_cols=242 Identities=22% Similarity=0.344 Sum_probs=193.9
Q ss_pred eeecccCceEEEEEEEcC--CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccC
Q 010214 23 KTLGIGSFGKVKIAEHAL--TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVK 100 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~ 100 (515)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999996533 34578888775432 23345677889999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc---
Q 010214 101 SGELFDYIVEKG-----RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--- 172 (515)
Q Consensus 101 gg~L~~~i~~~~-----~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~--- 172 (515)
+|+|.+++.... ..++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999999997643 246788899999999999999999999999999999999999999999999865433221
Q ss_pred cccCCCCCCccCCCcccCC------ccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHh-cCccC-----CCCC
Q 010214 173 LKTSCGSPNYAAPEVISGK------LYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK-GGIYT-----LPSH 239 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~------~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~-~~~~~-----~p~~ 239 (515)
.....+++.|+|||++... ...+.++||||+||++|+|++ |..||......+....+. ..... .+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 1233456789999987531 223679999999999999999 889998776555544433 33222 3346
Q ss_pred CChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 240 LSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 240 ~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+++.+.+++..|+ .||.+|||++++++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7888999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=317.76 Aligned_cols=252 Identities=18% Similarity=0.207 Sum_probs=196.6
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCC---CcEEEEEEecccccCChHH--------HHHHHHHHHHHHhCCCCCccE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEM--------EEKVRREIKILRLFMHPHIIR 81 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~--------~~~i~~Ei~il~~l~hpnIv~ 81 (515)
+...++|++.+.||+|+||+||+|.+..+ +..+|+|+........... ......+...+..+.|++|++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 44558999999999999999999999877 6778888654322111000 011223444566778999999
Q ss_pred EEEEEEcCC----eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceE
Q 010214 82 LYEVIETPS----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK 157 (515)
Q Consensus 82 l~~~~~~~~----~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vK 157 (515)
+++.+.... ..++++|++. .++.+.+......++..++.++.|++.||.|||+++|+||||||+|||++.++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEE
Confidence 999765443 4578899884 47777777666678999999999999999999999999999999999999999999
Q ss_pred EeecccccccccCC--------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh-HH----
Q 010214 158 IADFGLSNIMRDGH--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PN---- 224 (515)
Q Consensus 158 L~DFGls~~~~~~~--------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~-~~---- 224 (515)
|+|||+++...... ......||+.|+|||+..+..+ +.++||||+||++|+|++|.+||.+... ..
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999997653221 1233469999999999998877 7999999999999999999999987632 22
Q ss_pred ----HHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 225 ----LFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 225 ----~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
....+..+...+ ...++.+.++++.|+..+|++||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 246 AKCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hHHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 223344333333 356889999999999999999999999875
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=314.29 Aligned_cols=249 Identities=30% Similarity=0.459 Sum_probs=206.0
Q ss_pred CCCceEeeeecccCceEEEEEEEcC----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc--C
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--P 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~ 89 (515)
.++|++.+.||+|+||.||+|.+.. ++..||+|++...... .....+.+|+++++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 3578899999999999999998653 4789999998755432 356789999999999999999999999877 5
Q ss_pred CeEEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
...++||||+++++|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 67999999999999999997654 69999999999999999999999999999999999999999999999999998765
Q ss_pred cCCcc----ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH---------------HHHHHH
Q 010214 169 DGHFL----KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---------------NLFKKI 229 (515)
Q Consensus 169 ~~~~~----~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~---------------~~~~~i 229 (515)
..... ....++..|+|||.+.+..+ +.++||||+|+++|+|++|..||...... .+...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 32211 12344567999999887765 78999999999999999999998653221 122222
Q ss_pred hcC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 230 KGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 230 ~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
... ..+.+..++.++.+++.+||+.+|.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 222 23345567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=343.54 Aligned_cols=248 Identities=29% Similarity=0.484 Sum_probs=219.2
Q ss_pred CCCceEeeeecccCceEEEEEEEc-----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
..+-++.+.||+|+||+||+|+.. .....||||.++... +......|+||+++|..++|||||++++++..++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 456778899999999999999754 234579999986443 4457789999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCce
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG--------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNV 156 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~--------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~v 156 (515)
.+|||+|||..|||.+++...+ +++..+...++.||+.|+.||-++.+|||||-..|+|+.++..|
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence 9999999999999999997432 27889999999999999999999999999999999999999999
Q ss_pred EEeecccccccccCCcccc---CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC
Q 010214 157 KIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232 (515)
Q Consensus 157 KL~DFGls~~~~~~~~~~~---~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~ 232 (515)
||+|||+++..-..++.+- ..-...|||||.|....+ +.++||||+||+|||+++ |..||.+.+..+..+-|..+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF-TteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF-TTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc-cchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 9999999987655444332 234568999999998888 789999999999999998 99999999999999999888
Q ss_pred c-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHh
Q 010214 233 I-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIR 266 (515)
Q Consensus 233 ~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil 266 (515)
. .+-|...+.++.+|+..||+.+|.+|||+.||-
T Consensus 722 ~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 722 QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 6 466889999999999999999999999999984
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=319.93 Aligned_cols=255 Identities=31% Similarity=0.496 Sum_probs=209.2
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC--C----CccEEEEE
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH--P----HIIRLYEV 85 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h--p----nIv~l~~~ 85 (515)
.|.+..+|.+++++|+|.||+|-.+.+..++..||||++..-. ...+..+-||++|.++.+ | -++++.++
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 3456889999999999999999999999999999999985321 234566779999999953 3 37888899
Q ss_pred EEcCCeEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-----------
Q 010214 86 IETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS----------- 152 (515)
Q Consensus 86 ~~~~~~~~iVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~----------- 152 (515)
|+-.+++|||+|.+ |-++++++.+++ +++...++.+..|++.+++|||+.+++|-||||||||+.+
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence 99999999999998 669999998765 5889999999999999999999999999999999999832
Q ss_pred ---------CCceEEeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH
Q 010214 153 ---------KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP 223 (515)
Q Consensus 153 ---------~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~ 223 (515)
+..|+|+|||.|+...... .+.+.|..|.|||++.|-.+ +..+||||+||||+|+.+|...|......
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGw-S~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGW-SQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCc-CCccCceeeeeEEEEeeccceecccCCcH
Confidence 2359999999998754433 67789999999999999887 68999999999999999999999765433
Q ss_pred H---HHHHHhcCc------------------cCCCC-------------------------CCChhHHHHhcccCCCCCC
Q 010214 224 N---LFKKIKGGI------------------YTLPS-------------------------HLSPGARDLIPRMLIVDPM 257 (515)
Q Consensus 224 ~---~~~~i~~~~------------------~~~p~-------------------------~~s~~~~~li~~mL~~dP~ 257 (515)
+ +.+.|.... ...|. .-..++.|||++||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 3 344443211 11110 0113467999999999999
Q ss_pred CCCCHHHHhcCcccccc
Q 010214 258 KRITIPEIRQHPWFQAH 274 (515)
Q Consensus 258 ~Rpt~~eil~hp~f~~~ 274 (515)
+|+|+.|++.||||+..
T Consensus 396 ~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 396 RRITLREALSHPFFARL 412 (415)
T ss_pred ccccHHHHhcCHHhhcC
Confidence 99999999999999753
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=324.41 Aligned_cols=249 Identities=28% Similarity=0.419 Sum_probs=201.0
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-eE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-DI 92 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-~~ 92 (515)
...++|.-...||+|+||.||+|.... |..||||.+....... ...+.+|+.++.+++|||+|+++++|.+.+ ..
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~ 147 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHR 147 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceE
Confidence 345788888999999999999999764 4899999876544332 345999999999999999999999999888 59
Q ss_pred EEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 93 YVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNM---VVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~g---IvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
++|+||+++|+|.+++.... .+++....+|+.+++.||+|||... |+||||||+|||||++++.||+|||+|...
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence 99999999999999998654 8999999999999999999999854 999999999999999999999999999766
Q ss_pred cc-CCccccC-CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC------hHHHHH-HHhcCc-----
Q 010214 168 RD-GHFLKTS-CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN------IPNLFK-KIKGGI----- 233 (515)
Q Consensus 168 ~~-~~~~~~~-~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~------~~~~~~-~i~~~~----- 233 (515)
.. .....+. .||.+|+|||.+..... +.++||||+||+|.|++||+.|.+... ...+.. .+..+.
T Consensus 228 ~~~~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii 306 (361)
T KOG1187|consen 228 PEGDTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV 306 (361)
T ss_pred CccccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence 54 4444444 89999999999976544 789999999999999999998887532 222211 222211
Q ss_pred -cCCC-CCCC--hh---HHHHhcccCCCCCCCCCCHHHHhc
Q 010214 234 -YTLP-SHLS--PG---ARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 234 -~~~p-~~~s--~~---~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
..+. ...+ .. +..+..+|++.+|.+||++.|+++
T Consensus 307 D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 307 DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111 1222 22 456778999999999999999744
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=307.89 Aligned_cols=242 Identities=22% Similarity=0.334 Sum_probs=194.0
Q ss_pred eeecccCceEEEEEEEcCCC--cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccC
Q 010214 23 KTLGIGSFGKVKIAEHALTG--HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVK 100 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg--~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~ 100 (515)
+.||+|+||.||+|....++ ..+++|.+.... .....+.+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 36999999999999754332 356677665432 22345788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC---cc
Q 010214 101 SGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FL 173 (515)
Q Consensus 101 gg~L~~~i~~~----~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~---~~ 173 (515)
+|+|.+++.+. ...++..++.++.||+.||+|||+.+++||||||+|||++.++.+||+|||++....... ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999999764 246677888999999999999999999999999999999999999999999976432221 12
Q ss_pred ccCCCCCCccCCCcccCCc------cCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc------cCCCCCC
Q 010214 174 KTSCGSPNYAAPEVISGKL------YAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI------YTLPSHL 240 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~------~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~------~~~p~~~ 240 (515)
...++++.|+|||++.+.. ..+.++|||||||++|+|++ |..||...+..+....+..+. ..++..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 3457889999999985321 12578999999999999996 678998777666665543332 2233457
Q ss_pred ChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 241 SPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 241 s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
++.+.+++..|| .+|.+|||++++++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 888999999999 68999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=352.49 Aligned_cols=253 Identities=32% Similarity=0.557 Sum_probs=208.6
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc------
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET------ 88 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------ 88 (515)
...+|+.++.||+||||.||+++++.+|..||||.|.... ......++.+|++.|.+|+|||||++|..+.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 5667889999999999999999999999999999998665 44567889999999999999999998742100
Q ss_pred --------------------------------------------------------------------------------
Q 010214 89 -------------------------------------------------------------------------------- 88 (515)
Q Consensus 89 -------------------------------------------------------------------------------- 88 (515)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CeEEEEEeccCCCCHHHHHHHhCCC-CHHHHHHHHHHHHHHHHHHH
Q 010214 89 -------------------------P--------SDIYVVMEYVKSGELFDYIVEKGRL-QEDEARNFFQQIISGVEYCH 134 (515)
Q Consensus 89 -------------------------~--------~~~~iVmEy~~gg~L~~~i~~~~~l-~e~~~~~i~~qil~aL~yLH 134 (515)
+ ..+||-||||+...|.++|.++... ....++++|+||++||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 1368999999987777777665544 57899999999999999999
Q ss_pred HCCceeccCCCCcEEECCCCceEEeecccccccc------------------cC-CccccCCCCCCccCCCcccCCc--c
Q 010214 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR------------------DG-HFLKTSCGSPNYAAPEVISGKL--Y 193 (515)
Q Consensus 135 ~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~------------------~~-~~~~~~~gt~~Y~aPE~i~~~~--~ 193 (515)
+.|||||||||.||++|+++.|||+|||+++... .+ ....+.+||..|+|||++.+.. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999998621 01 1345668999999999998766 3
Q ss_pred CCCcceeehhHHHHHHHHhCCCCCCCC-ChHHHHHHHhcCccCCCCCC----ChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 194 AGPEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIYTLPSHL----SPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 194 ~~~~~DIwSlGvily~lltG~~Pf~~~-~~~~~~~~i~~~~~~~p~~~----s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
++.++|+||||+||+||+. ||... .......++.++..+.|..+ -+.-..+|..||+.||.+|||+.|+|++
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 4789999999999999994 57543 34456677777777666322 3456789999999999999999999999
Q ss_pred cccc
Q 010214 269 PWFQ 272 (515)
Q Consensus 269 p~f~ 272 (515)
.||.
T Consensus 872 ~llp 875 (1351)
T KOG1035|consen 872 ELLP 875 (1351)
T ss_pred cCCC
Confidence 9985
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=310.01 Aligned_cols=253 Identities=32% Similarity=0.531 Sum_probs=216.6
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc------C
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET------P 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------~ 89 (515)
..+|.-++.+|.|+- .|..|.+..+++.||+|..... ..+.....+..||..++..++|+||++++.+|.- .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 468999999999999 8899999999999999998776 4444567889999999999999999999999843 2
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
..+|+|||++.. +|...+. -.++.+.++.++.|++.|++|||+.||+||||||+||++..++.+||.|||+++....
T Consensus 94 ~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 94 QEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred HhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence 458999999965 9999887 4578899999999999999999999999999999999999999999999999988766
Q ss_pred CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---------------
Q 010214 170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--------------- 234 (515)
Q Consensus 170 ~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~--------------- 234 (515)
.-.+...+.|..|.|||++.|..| .+.+||||+|||+.||++|+..|.+.+.-..+.++.....
T Consensus 171 ~~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 171 DFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred ccccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 656677789999999999999886 7899999999999999999999998765555555432111
Q ss_pred ------------C----CCC-----------CCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 ------------T----LPS-----------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 ------------~----~p~-----------~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
. +|+ .-+..+++|+.+||..||++|.|++++|.||||+.+
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw 316 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW 316 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence 0 111 123468899999999999999999999999999844
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=335.57 Aligned_cols=242 Identities=32% Similarity=0.498 Sum_probs=200.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC------
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS------ 90 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~------ 90 (515)
..+...+.||+|+||.||+++++.||+.||||.+++.. .....++.-+|+++|++++|||||+++++-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 56778889999999999999999999999999998755 3345678889999999999999999999866544
Q ss_pred eEEEEEeccCCCCHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC--C--ceEEeeccc
Q 010214 91 DIYVVMEYVKSGELFDYIVE---KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK--W--NVKIADFGL 163 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~---~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~--~--~vKL~DFGl 163 (515)
.-.+|||||.||+|..++.+ ...++|.+.+.++..+..||.|||++||+||||||+||++-.. | ..||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 35799999999999999974 3479999999999999999999999999999999999998432 3 479999999
Q ss_pred ccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH----HHHHHHhcC-------
Q 010214 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP----NLFKKIKGG------- 232 (515)
Q Consensus 164 s~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~----~~~~~i~~~------- 232 (515)
|+...++....+.+||+.|.+||+.....+++..+|.||+||++|++.||.+||-....+ +....+...
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 999999999999999999999999986445588999999999999999999999643222 122222111
Q ss_pred --------------ccCCCCCCChhH----HHHhcccCCCCCCCCC
Q 010214 233 --------------IYTLPSHLSPGA----RDLIPRMLIVDPMKRI 260 (515)
Q Consensus 233 --------------~~~~p~~~s~~~----~~li~~mL~~dP~~Rp 260 (515)
.++.|-++++.+ ..++..+|..+|.+|-
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 123344555544 3567788999999998
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=297.36 Aligned_cols=240 Identities=51% Similarity=0.873 Sum_probs=214.1
Q ss_pred CceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCHHHHH
Q 010214 29 SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI 108 (515)
Q Consensus 29 ~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~i 108 (515)
+||.||+|.+..+|+.+|+|++........ .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999999999999999876543321 578899999999999999999999999999999999999999999999
Q ss_pred HHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCCCCccCCCcc
Q 010214 109 VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI 188 (515)
Q Consensus 109 ~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i 188 (515)
.....+++..+..++.+++.++.|||+.+++|+||+|.||+++.++.++|+|||.+.............++..|+|||.+
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 87767999999999999999999999999999999999999999999999999999887665556677899999999999
Q ss_pred cCCccCCCcceeehhHHHHHHHHhCCCCCCC-CChHHHHHHHhcCccCCCCC---CChhHHHHhcccCCCCCCCCCCHHH
Q 010214 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTLPSH---LSPGARDLIPRMLIVDPMKRITIPE 264 (515)
Q Consensus 189 ~~~~~~~~~~DIwSlGvily~lltG~~Pf~~-~~~~~~~~~i~~~~~~~p~~---~s~~~~~li~~mL~~dP~~Rpt~~e 264 (515)
.+..+ ++++||||+|+++|+|++|..||.. .........+.......+.. ++.++.+++.+||..+|.+|||+.+
T Consensus 159 ~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 237 (244)
T smart00220 159 LGKGY-GKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEE 237 (244)
T ss_pred ccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHH
Confidence 87666 6799999999999999999999988 66666666666665554433 8899999999999999999999999
Q ss_pred HhcCccc
Q 010214 265 IRQHPWF 271 (515)
Q Consensus 265 il~hp~f 271 (515)
+++||||
T Consensus 238 ~~~~~~~ 244 (244)
T smart00220 238 ALQHPFF 244 (244)
T ss_pred HhhCCCC
Confidence 9999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=335.14 Aligned_cols=253 Identities=23% Similarity=0.283 Sum_probs=180.0
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCC----CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEE-----
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALT----GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV----- 85 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~t----g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~----- 85 (515)
..++|.+.+.||+|+||.||+|.+..+ +..||+|.+....... ....| .++...+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-----~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-----IWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-----HHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 467999999999999999999999988 9999999875432111 11111 1111222222222111
Q ss_pred -EEcCCeEEEEEeccCCCCHHHHHHHhCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 010214 86 -IETPSDIYVVMEYVKSGELFDYIVEKGR--------------------LQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144 (515)
Q Consensus 86 -~~~~~~~~iVmEy~~gg~L~~~i~~~~~--------------------l~e~~~~~i~~qil~aL~yLH~~gIvHrDLk 144 (515)
......+++||||+.+++|.+++..... ..+..+..++.||+.||.|||++||+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 2456679999999999999999875421 1234567899999999999999999999999
Q ss_pred CCcEEECC-CCceEEeecccccccccC--CccccCCCCCCccCCCcccCCcc---------------------CCCccee
Q 010214 145 PENLLLDS-KWNVKIADFGLSNIMRDG--HFLKTSCGSPNYAAPEVISGKLY---------------------AGPEVDV 200 (515)
Q Consensus 145 peNILl~~-~~~vKL~DFGls~~~~~~--~~~~~~~gt~~Y~aPE~i~~~~~---------------------~~~~~DI 200 (515)
|+|||++. ++.+||+|||++..+..+ ....+.++|+.|+|||.+..... .+.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 579999999999865432 23346689999999997643221 1345699
Q ss_pred ehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---------------------CCCCCCChhHHHHhcccCCCCCCCC
Q 010214 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---------------------TLPSHLSPGARDLIPRMLIVDPMKR 259 (515)
Q Consensus 201 wSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~---------------------~~p~~~s~~~~~li~~mL~~dP~~R 259 (515)
||+||++|+|+++..|++... ......+..... ......+....+||.+||++||.+|
T Consensus 363 wSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 999999999999887765431 111111111110 0111123345589999999999999
Q ss_pred CCHHHHhcCccccccc
Q 010214 260 ITIPEIRQHPWFQAHL 275 (515)
Q Consensus 260 pt~~eil~hp~f~~~~ 275 (515)
||+.|+++||||+...
T Consensus 442 ~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 442 ISAKAALAHPYFDREG 457 (566)
T ss_pred CCHHHHhCCcCcCCCC
Confidence 9999999999998653
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=318.50 Aligned_cols=264 Identities=31% Similarity=0.482 Sum_probs=219.3
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCC----hHHHHHHHHHHHHHHhCCCCCccEEEEEE
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN----MEMEEKVRREIKILRLFMHPHIIRLYEVI 86 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~----~~~~~~i~~Ei~il~~l~hpnIv~l~~~~ 86 (515)
+-..+.++|-++.+||+|||+.||+|.+....+.||+|+-...+... ....+..-||.+|.+.|+||.||++|++|
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 34456789999999999999999999999899999999976543322 12345567999999999999999999999
Q ss_pred Ec-CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCcEEECC---CCceEEee
Q 010214 87 ET-PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN--MVVHRDLKPENLLLDS---KWNVKIAD 160 (515)
Q Consensus 87 ~~-~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~--gIvHrDLkpeNILl~~---~~~vKL~D 160 (515)
.- .+.+|-|+|||+|.+|.-|++++.-++|.+++.|+.||+.||.||... .|+|-||||.|||+-. .|.+||+|
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence 64 556899999999999999999999999999999999999999999975 6999999999999953 57899999
Q ss_pred cccccccccCCc--------cccCCCCCCccCCCccc-C--CccCCCcceeehhHHHHHHHHhCCCCCCCCChHH-H--H
Q 010214 161 FGLSNIMRDGHF--------LKTSCGSPNYAAPEVIS-G--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN-L--F 226 (515)
Q Consensus 161 FGls~~~~~~~~--------~~~~~gt~~Y~aPE~i~-~--~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~-~--~ 226 (515)
||++.++.+... .....||.+|++||.+. + .+-.+.++||||+|||+|.++.|+.||....... + .
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 999999865432 34557999999999874 3 2234679999999999999999999998654322 1 1
Q ss_pred HHH-hcCccCCC--CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 227 KKI-KGGIYTLP--SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 227 ~~i-~~~~~~~p--~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..| ......+| +.+++++++||++||+.--+.|..+.++..||+|...
T Consensus 697 NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 697 NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 122 22334454 5789999999999999999999999999999999654
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=342.20 Aligned_cols=249 Identities=27% Similarity=0.455 Sum_probs=217.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCc-----EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH-----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~-----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
-.+-++.+.||+|+||.||.|....-.. .||||.+. +..+......+.+|..+|+.++||||+++++++-+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~--~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLK--RLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecc--ccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 3567889999999999999998754332 48888875 4456677899999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 91 DIYVVMEYVKSGELFDYIVEK-------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~-------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
..+|++|||+||+|..||.+. ..++..+...++.||+.|++||+++++|||||...|+||+....|||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999999865 3488999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccccC-C--CCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHH-HHhcCccCCCC
Q 010214 164 SNIMRDGHFLKTS-C--GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFK-KIKGGIYTLPS 238 (515)
Q Consensus 164 s~~~~~~~~~~~~-~--gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~-~i~~~~~~~p~ 238 (515)
|+.+.+.++.+.. . -...|||||.+....+ +.++|||||||++||+++ |..||.+.+..+... -...+....|.
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~ 927 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS 927 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC
Confidence 9955444433222 1 2357999999998777 789999999999999999 999999988777777 55666788899
Q ss_pred CCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 239 ~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+++..+.+++..||+.+|++||++..|++
T Consensus 928 ~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 928 YCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 99999999999999999999999999987
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=304.26 Aligned_cols=257 Identities=28% Similarity=0.478 Sum_probs=212.4
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP------ 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~------ 89 (515)
.+.|.-..+||+|.||.||+|+++.+|++||+|++--+.-+ ...-....+|+++|..+.|+|++.+++++.+.
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK-eGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc-cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 46788888999999999999999999999999976432111 12234567999999999999999999887432
Q ss_pred --CeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 90 --SDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 90 --~~~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
..+|+|+.+|+. +|.-.+... .+++..++++++++++.||.|+|+..|+|||+||+|+||+.+|.+||+|||+++.
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 348999999976 899888754 6899999999999999999999999999999999999999999999999999977
Q ss_pred cccCC-----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-------c
Q 010214 167 MRDGH-----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------Y 234 (515)
Q Consensus 167 ~~~~~-----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------~ 234 (515)
+.... .....+-|.+|.+||.+.|...+++..|||..|||+.+|++|.+.|.+.+......-|..-. +
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 64322 23344569999999999998877999999999999999999999999887666655543211 1
Q ss_pred C---------------CC-------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 T---------------LP-------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 ~---------------~p-------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+ +| ..-++++.+|+.+||..||.+|++++++++|.||...
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 0 11 1124588999999999999999999999999999754
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=292.04 Aligned_cols=251 Identities=27% Similarity=0.503 Sum_probs=212.3
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCC--e
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPS--D 91 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~--~ 91 (515)
..++|++.+.+|+|.++.||.|.+..++++++||++.+-+ .+++.||++||..|+ ||||++++++..++. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 3689999999999999999999999999999999986533 578999999999998 999999999997764 4
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CceEEeecccccccccC
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~-~~vKL~DFGls~~~~~~ 170 (515)
.-+|+||+++.+.... -..++..+++.++.|++.||.|||+.||.|||+||.|++||.. ..++|+|+|++.+..++
T Consensus 110 paLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred chhHhhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 6799999987554433 3458889999999999999999999999999999999999964 57999999999999999
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCC-CCChHHHHHHHhc-------------CccCC
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKG-------------GIYTL 236 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~-~~~~~~~~~~i~~-------------~~~~~ 236 (515)
...+-.+.+..|--||.+..-..++..-|+||+||++..|+..+.||- +.+...+.-+|.+ -...+
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 888888999999999999877767889999999999999999999983 3333333322211 01111
Q ss_pred C------------------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 237 P------------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 237 p------------------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+ ...++++.||+.++|..|..+|+|+.|++.||||...
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 1 1357999999999999999999999999999999754
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=296.52 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=209.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHH-HhCCCCCccEEEEEEEcCCeEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
++.+-+..||.|+||+|++-.|+.+|+..|||.|..... .....++..|.... +.-+.||||++|+..-.++..||.
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC 141 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC 141 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence 344556789999999999999999999999999976554 33456777777754 555699999999999999999999
Q ss_pred EeccCCCCHHHHH-----HHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 96 MEYVKSGELFDYI-----VEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 96 mEy~~gg~L~~~i-----~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
||.|+- +|..+- .++..++|+..-.+..-.+.||+||-. ..|+|||+||+|||++..|.|||||||.+..+.+
T Consensus 142 MELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 142 MELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 999954 665433 356789999999999999999999995 5899999999999999999999999999988766
Q ss_pred CCccccCCCCCCccCCCcccC--CccCCCcceeehhHHHHHHHHhCCCCCCCC-ChHHHHHHHhcCccCC---CC---CC
Q 010214 170 GHFLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIYTL---PS---HL 240 (515)
Q Consensus 170 ~~~~~~~~gt~~Y~aPE~i~~--~~~~~~~~DIwSlGvily~lltG~~Pf~~~-~~~~~~~~i~~~~~~~---p~---~~ 240 (515)
+-......|...|||||.+.. ..| +.++|+||||++|||+.||..|+.+- +.-++...+..+.++. +. ++
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gy-DiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~ 299 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGY-DIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHY 299 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCc-chhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccccc
Confidence 655566689999999999963 334 78999999999999999999999763 3334444455554332 22 47
Q ss_pred ChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 241 s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|..++.+|..||.+|-..||...+++++||++..
T Consensus 300 s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 300 SFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred CHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 8999999999999999999999999999999754
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=322.09 Aligned_cols=254 Identities=28% Similarity=0.467 Sum_probs=217.5
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEE-----cC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIE-----TP 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~-----~~ 89 (515)
.+.|+|.++||.|.+|+||+++++.+|+..|+|+.+... +..+.++-|.++|+... |||++.+|++|. .+
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 477999999999999999999999999999999987544 34577888999998876 999999999984 34
Q ss_pred CeEEEEEeccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
+.+|+|||||.||+.-|+++. ..++.|+.+..|+..++.|+.+||++.++|||||=.|||++.+|.|||+|||++...
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 679999999999999999975 457999999999999999999999999999999999999999999999999999877
Q ss_pred ccC-CccccCCCCCCccCCCcccCCc----cCCCcceeehhHHHHHHHHhCCCCCCCCChHHH-HHHHhcCccC--CCCC
Q 010214 168 RDG-HFLKTSCGSPNYAAPEVISGKL----YAGPEVDVWSCGVILYALLCGTLPFDDENIPNL-FKKIKGGIYT--LPSH 239 (515)
Q Consensus 168 ~~~-~~~~~~~gt~~Y~aPE~i~~~~----~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~-~~~i~~~~~~--~p~~ 239 (515)
... ..-.|..|||.|||||++.... -++.++|+||||++..||.-|.+|+-+...... |.-..+.... -|..
T Consensus 174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~k 253 (953)
T KOG0587|consen 174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKK 253 (953)
T ss_pred ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhh
Confidence 543 3456889999999999996422 125689999999999999999999988765543 3333332222 2456
Q ss_pred CChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 240 ~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
.+.++.+||..||.+|-.+||+..++++|||++.
T Consensus 254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 254 WSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred HHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 7899999999999999999999999999999973
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=315.05 Aligned_cols=260 Identities=22% Similarity=0.303 Sum_probs=192.6
Q ss_pred ccCCCceEeeeecccCceEEEEEEEc----------------CCCcEEEEEEecccccCCh-----------HHHHHHHH
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHA----------------LTGHKVAIKILNRRKIKNM-----------EMEEKVRR 66 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~----------------~tg~~vAiK~i~~~~~~~~-----------~~~~~i~~ 66 (515)
.-.++|.+.+.||+|+||+||+|.+. ..++.||||.+........ ...+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 34689999999999999999999752 2356799999864321110 01122345
Q ss_pred HHHHHHhCCCCCc-----cEEEEEEEc--------CCeEEEEEeccCCCCHHHHHHHhC---------------------
Q 010214 67 EIKILRLFMHPHI-----IRLYEVIET--------PSDIYVVMEYVKSGELFDYIVEKG--------------------- 112 (515)
Q Consensus 67 Ei~il~~l~hpnI-----v~l~~~~~~--------~~~~~iVmEy~~gg~L~~~i~~~~--------------------- 112 (515)
|+.++.+++|.++ +++++++.. ....++||||+++++|.+++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777776554 666666642 356899999999999999886421
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccC--CCCCCccCCCc
Q 010214 113 ---RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEV 187 (515)
Q Consensus 113 ---~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~--~gt~~Y~aPE~ 187 (515)
.+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++..+..+....+. .+|+.|+|||+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 2356778899999999999999999999999999999999999999999999766544333333 34899999999
Q ss_pred ccCCc--------------------cC-CCcceeehhHHHHHHHHhCCC-CCCCCC-----------hHHHHHHHhcCcc
Q 010214 188 ISGKL--------------------YA-GPEVDVWSCGVILYALLCGTL-PFDDEN-----------IPNLFKKIKGGIY 234 (515)
Q Consensus 188 i~~~~--------------------~~-~~~~DIwSlGvily~lltG~~-Pf~~~~-----------~~~~~~~i~~~~~ 234 (515)
+.... |. ...+|+||+||++|+|++|.+ ||.+.. ....++.+....+
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~ 461 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY 461 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence 86422 11 135799999999999999986 775421 1111222333333
Q ss_pred CC--CCCCChhHHHHhcccCCCCC---CCCCCHHHHhcCccccc
Q 010214 235 TL--PSHLSPGARDLIPRMLIVDP---MKRITIPEIRQHPWFQA 273 (515)
Q Consensus 235 ~~--p~~~s~~~~~li~~mL~~dP---~~Rpt~~eil~hp~f~~ 273 (515)
.+ ....++.+.||+.+||..+| .+|+|++|+|+||||..
T Consensus 462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 33 35678999999999999876 68999999999999953
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=308.13 Aligned_cols=244 Identities=31% Similarity=0.507 Sum_probs=212.5
Q ss_pred eEeeeecccCceEEEEEEEcCC--C--cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 20 KLGKTLGIGSFGKVKIAEHALT--G--HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 20 ~i~~~LG~G~fg~Vy~a~~~~t--g--~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.+.+.||.|-||.||.|....- | -.||||..+.+. +.+..+++..|..+|+.++|||||++++++.+ ...|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 4467899999999999976433 3 358899876433 34557899999999999999999999999965 468999
Q ss_pred EeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
||.++-|+|..|++.+ ..++......++.||..||.|||+..+|||||-..|||+.+.--|||+|||+|+.+.+....+
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence 9999999999999864 479999999999999999999999999999999999999999899999999999998887766
Q ss_pred cCCCC--CCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhcc
Q 010214 175 TSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 175 ~~~gt--~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~ 250 (515)
...|. .-|||||.+.-..+ +.++|||-|||++||++. |..||.+-...+..-.|.+| ..+.|+.+++.+..|+.+
T Consensus 549 aS~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmsk 627 (974)
T KOG4257|consen 549 ASRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSK 627 (974)
T ss_pred ccccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHH
Confidence 65554 46999999998877 689999999999999987 99999987766666667666 468899999999999999
Q ss_pred cCCCCCCCCCCHHHHhc
Q 010214 251 MLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~ 267 (515)
||..+|.+||++.+|..
T Consensus 628 cWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 628 CWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HhccCcccCCcHHHHHH
Confidence 99999999999988743
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=305.95 Aligned_cols=255 Identities=28% Similarity=0.479 Sum_probs=215.3
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC------CCccEEEEE
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH------PHIIRLYEV 85 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h------pnIv~l~~~ 85 (515)
.+.+-.+|.+....|+|-|++|..|.+...|+.||||+|.... -+.+.=..|+++|++|+. -|+++++..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 3455688999999999999999999999999999999997543 344566789999999973 489999999
Q ss_pred EEcCCeEEEEEeccCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CceEEeec
Q 010214 86 IETPSDIYVVMEYVKSGELFDYIVEKG---RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADF 161 (515)
Q Consensus 86 ~~~~~~~~iVmEy~~gg~L~~~i~~~~---~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~-~~vKL~DF 161 (515)
|...+++|||+|-+. .+|.+.+++-| .|....++.+++|++.||..|-..||+|.||||.|||+++. ..+|||||
T Consensus 503 F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred hhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccC
Confidence 999999999999994 59999998755 58889999999999999999999999999999999999875 46899999
Q ss_pred ccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCC---
Q 010214 162 GLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS--- 238 (515)
Q Consensus 162 Gls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~--- 238 (515)
|.|......+ +....-+..|.|||++.|.+| +...|+||.||+||||.||+..|.+.+...+++-.......+|.
T Consensus 582 GSA~~~~ene-itPYLVSRFYRaPEIiLG~~y-d~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 582 GSASFASENE-ITPYLVSRFYRAPEIILGLPY-DYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred cccccccccc-ccHHHHHHhccCcceeecCcc-cCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 9998776544 445566778999999999998 68899999999999999999999998766665544332222220
Q ss_pred --------------------------------------------------CCC-------hhHHHHhcccCCCCCCCCCC
Q 010214 239 --------------------------------------------------HLS-------PGARDLIPRMLIVDPMKRIT 261 (515)
Q Consensus 239 --------------------------------------------------~~s-------~~~~~li~~mL~~dP~~Rpt 261 (515)
.++ ..+++|+.+||..||.+|.|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 011 35789999999999999999
Q ss_pred HHHHhcCccccc
Q 010214 262 IPEIRQHPWFQA 273 (515)
Q Consensus 262 ~~eil~hp~f~~ 273 (515)
+.++|.||||+.
T Consensus 740 ~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 740 VNQALKHPFITE 751 (752)
T ss_pred HHHHhcCCcccC
Confidence 999999999963
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=290.90 Aligned_cols=256 Identities=30% Similarity=0.520 Sum_probs=215.5
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----e
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-----D 91 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-----~ 91 (515)
.+.+-.+-||-|+||+||.+++..+|+.||+|.+.. ...+...-+++.+|+++|..++|.|++..+++.+-+. .
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 344557889999999999999999999999998853 3344455688999999999999999999999876553 4
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
+|+++|.+.. +|...|..-..++.+.++-+..||+.||+|||+.+|.||||||.|+|++++..+||||||+++.....+
T Consensus 132 iYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 132 LYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 7899999965 999999988899999999999999999999999999999999999999999999999999999875443
Q ss_pred c--cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhc------------------
Q 010214 172 F--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG------------------ 231 (515)
Q Consensus 172 ~--~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~------------------ 231 (515)
. +...+-|.+|.|||++.|...++.++||||.|||+.|++..+..|...+..+..+-|..
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 2 33446788999999999877778999999999999999999999988766555544422
Q ss_pred -----CccCCC-----------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 232 -----GIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 232 -----~~~~~p-----------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+....| ..-..+..+++..||..||.+|++.++++.|++..+.
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 111111 2344578899999999999999999999999998754
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=303.64 Aligned_cols=247 Identities=26% Similarity=0.453 Sum_probs=211.5
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
+.-.+++.||+|-||.|.+++-. .+.+||+|+++..... +....+.+||++|.+|+||||++++++|..++.+++|+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 34578999999999999999854 4689999999765433 45688999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 97 EYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
||++.|+|.+|+.++. .+......+++.||++|++||.+.++|||||.+.|+|++.++++||+|||+++.+-.+...+
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 9999999999998873 33456677899999999999999999999999999999999999999999999776665443
Q ss_pred c---CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHH--hCCCCCCCCChHHHHHHHhcC--------ccCCCCCCC
Q 010214 175 T---SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL--CGTLPFDDENIPNLFKKIKGG--------IYTLPSHLS 241 (515)
Q Consensus 175 ~---~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~ll--tG~~Pf~~~~~~~~~~~i~~~--------~~~~p~~~s 241 (515)
. .+-...|||||.+.-..+ +.++|+|++|+++||++ |...||...+.++..++...- ....|.-++
T Consensus 695 vqgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp 773 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACP 773 (807)
T ss_pred eecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence 2 245678999999877667 68999999999999975 689999988777766655332 235577889
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.++.+++-+||..|..+|||++++..
T Consensus 774 ~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 774 QGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 99999999999999999999999844
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=307.86 Aligned_cols=252 Identities=28% Similarity=0.427 Sum_probs=219.8
Q ss_pred CCceEeeeecccCceEEEEEEEcCCC---cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
++..+.++||+|+||+|++|.++..+ ..||||++....... ....|.+|+.+|.+|+|||+++||+++-+ ..+.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 45667889999999999999987543 369999997665443 56889999999999999999999999987 6789
Q ss_pred EEEeccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 94 VVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
||||.+++|+|.+.+.+ +..+.......++.||+.|+.||..+++|||||-..|+|+.....|||+|||+.+.+..++
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999999999986 4568889999999999999999999999999999999999999999999999999886654
Q ss_pred ccccCC----CCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHH
Q 010214 172 FLKTSC----GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (515)
Q Consensus 172 ~~~~~~----gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 245 (515)
...... -...|+|||.+....+ +.++|+|++||++|||++ |..||.+-....++++|..+. .+-|..++.++.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kF-ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY 345 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKF-SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIY 345 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccc-cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHH
Confidence 333222 2346999999998888 789999999999999998 999999999999999987653 567889999999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
+++..||..+|.+|||+..|.+.-+..
T Consensus 346 ~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 346 QIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHHhccCCccccccHHHHHHhHHHH
Confidence 999999999999999999998665544
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=305.50 Aligned_cols=204 Identities=33% Similarity=0.583 Sum_probs=186.1
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChH-----HHHHHHHHHHHHHhCC---CCCccEEEEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-----MEEKVRREIKILRLFM---HPHIIRLYEVI 86 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~-----~~~~i~~Ei~il~~l~---hpnIv~l~~~~ 86 (515)
....|...+.+|.|+||+|++|.|+.+...|+||.|.|+++--.. ....+-.||.||..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 356699999999999999999999999999999999887654221 2345678999999998 99999999999
Q ss_pred EcCCeEEEEEecc-CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 87 ETPSDIYVVMEYV-KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 87 ~~~~~~~iVmEy~-~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
++++++|++||-- +|-+|+++|..+.+++|.+++.||.|++.|+++||+.||||||||-||+.++.+|-+||+|||.+.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence 9999999999975 567999999999999999999999999999999999999999999999999999999999999988
Q ss_pred ccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCC
Q 010214 166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD 219 (515)
Q Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~ 219 (515)
....| ...+.+||..|+|||++.|..|.+..-|||+||++||.++....||..
T Consensus 719 ~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 YTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 77665 457889999999999999999999999999999999999999999864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=336.48 Aligned_cols=239 Identities=21% Similarity=0.297 Sum_probs=190.5
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
+...|...+.||+|+||.||+|.+..+|..||+|.+..... ...+|++++++++||||+++++++.+....|+
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence 34567778899999999999999999999999999864321 11346889999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH---RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH---~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
||||+++|+|.+++. .+++..+..++.||+.|++||| +.+|+||||||+||+++.++..++. ||.......
T Consensus 761 v~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 761 IHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred EEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 999999999999995 3889999999999999999999 6699999999999999998888776 665543321
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC-----hHHHHHHHhc---------Ccc---
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-----IPNLFKKIKG---------GIY--- 234 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~-----~~~~~~~i~~---------~~~--- 234 (515)
..+..||+.|+|||++.+..+ +.++||||+||++|||++|+.||+... .....+.... ...
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred -CCCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 123468899999999988777 789999999999999999999996432 1111111100 000
Q ss_pred -CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 235 -TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 235 -~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..+.....++.+++.+||+.||.+|||+.|+++.
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0011112356789999999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=310.58 Aligned_cols=249 Identities=28% Similarity=0.478 Sum_probs=219.2
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCc---EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
..-.|.++||.|.||.|+.|+.+..|+ .||||.++.-. .......+..|..||-+++||||++|.++....+.+.
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 345788999999999999999987774 69999985432 3345678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 94 VVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
||+|||++|+|..+|.+ .+.++..+..-+++-|++|++||-+.|+|||||-..|||++.+..+|++|||+|+...++..
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 99999999999999986 46799999999999999999999999999999999999999999999999999998866542
Q ss_pred --cccCCC--CCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHH
Q 010214 173 --LKTSCG--SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARD 246 (515)
Q Consensus 173 --~~~~~g--t~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 246 (515)
..+.-| ...|.|||.|....+ +.++||||+|++|||.++ |..||-+.+..+.++.|..+. .+.|..++..+.+
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~q 865 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQ 865 (996)
T ss_pred ccccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHH
Confidence 122222 358999999998888 689999999999999886 999999999999999988764 5667799999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcC
Q 010214 247 LIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~h 268 (515)
|+..||++|-.+||.+.+|+.+
T Consensus 866 LMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 866 LMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHhhcCCCHHHHHHH
Confidence 9999999999999999998774
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=297.40 Aligned_cols=268 Identities=26% Similarity=0.463 Sum_probs=227.1
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
.+.....+||-|-||.||.|.++...-.||||.+..+.+ ..+.+..|..+|+.+.|||+|+++++|..+-.+|||+
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence 345567889999999999999999989999998854432 3688999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 97 EYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
|||..|+|.+|+.+.. .++.-....++.||.+|++||..++++||||-..|+|+.++..||++|||+++.+....+.
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT- 421 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT- 421 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee-
Confidence 9999999999998744 4677788899999999999999999999999999999999999999999999998655432
Q ss_pred cCCC---CCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhc
Q 010214 175 TSCG---SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIP 249 (515)
Q Consensus 175 ~~~g---t~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 249 (515)
...| ..-|.|||.+.-..+ +.++|||+|||+|||+.| |-.||.+-+..+.+.-+.++. ..-|..+++.+.+|+.
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMr 500 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMR 500 (1157)
T ss_pred cccCccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHH
Confidence 2233 346999999987766 789999999999999998 999999999888888776653 4668899999999999
Q ss_pred ccCCCCCCCCCCHHHHhcCcccccccCcccCCCCCCchhhhhccCHHHHHHHHHcC
Q 010214 250 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMG 305 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (515)
.||+++|..||++.|+-+ -|.. +...+.|.+|+-+++.+.+
T Consensus 501 aCW~WsPsDRPsFaeiHq--afEt-------------mf~~sSisdEV~keLgk~~ 541 (1157)
T KOG4278|consen 501 ACWNWSPSDRPSFAEIHQ--AFET-------------MFSSSSISDEVQKELGKNN 541 (1157)
T ss_pred HHhcCCcccCccHHHHHH--HHHH-------------HhccccccHHHHHHHhhcc
Confidence 999999999999999843 2322 2334456677777776544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=315.46 Aligned_cols=243 Identities=33% Similarity=0.488 Sum_probs=200.0
Q ss_pred eEeeeecccCce-EEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEEEe
Q 010214 20 KLGKTLGIGSFG-KVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 20 ~i~~~LG~G~fg-~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iVmE 97 (515)
.-.+.+|.|+-| .||+|.. .|+.||||.+-.+ -...+.|||..|+..+ |||||++|+.-.+....||+.|
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred ccHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 335678999888 6788976 6889999986432 3467889999999987 9999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---C--CceEEeecccccccc
Q 010214 98 YVKSGELFDYIVEKGR----LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---K--WNVKIADFGLSNIMR 168 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~----l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~---~--~~vKL~DFGls~~~~ 168 (515)
.|.. +|.+++...+. ......+.+..|+++||++||+.+||||||||.||||+. + ..++|+|||++..+.
T Consensus 584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 9965 99999987421 122456889999999999999999999999999999976 2 479999999999876
Q ss_pred cCC----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhC-CCCCCCCChHHHHHHHhcCccCCCC---CC
Q 010214 169 DGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPNLFKKIKGGIYTLPS---HL 240 (515)
Q Consensus 169 ~~~----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG-~~Pf~~~~~~~~~~~i~~~~~~~p~---~~ 240 (515)
.+. ...+..||-+|+|||++.+... ..++||||+||++|+.++| .+||.+.-.. ..+|..+.+.+-. ..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~~ 739 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPLP 739 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeeccCc
Confidence 542 2456789999999999987765 5799999999999999985 9999875433 3567777665432 22
Q ss_pred ChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 241 s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..++++||.+||.+||..|||+.++|.||+|...
T Consensus 740 d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 740 DCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred hHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 2289999999999999999999999999999754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=290.85 Aligned_cols=136 Identities=27% Similarity=0.448 Sum_probs=117.9
Q ss_pred CccccC-CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-----C---CCccE
Q 010214 11 GVDMFL-PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-----H---PHIIR 81 (515)
Q Consensus 11 ~~~~~~-~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----h---pnIv~ 81 (515)
-.+.+. ++|.+.++||+|.|++||+|.+..+.+.||+|+..... ...+....||++|++++ | .+||+
T Consensus 71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 345566 89999999999999999999999999999999986433 34577789999999886 2 47999
Q ss_pred EEEEEEc----CCeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEC
Q 010214 82 LYEVIET----PSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLD 151 (515)
Q Consensus 82 l~~~~~~----~~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~ 151 (515)
|++.|.. ..++|||+|++ |.+|..+|... ..++...+++|++||+.||.|||+ .||+|-||||||||+.
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 9999964 46799999999 77999999864 469999999999999999999996 5999999999999983
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=297.16 Aligned_cols=248 Identities=31% Similarity=0.523 Sum_probs=211.6
Q ss_pred CCceEeeeecccCceEEEEEEEc---C----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEc
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHA---L----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIET 88 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~---~----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~ 88 (515)
.+..+.+.||.|+||+|++|.-. . ....||||.+...... ...+.+..|+++|+.+. ||||+.+++++..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 34467779999999999999643 1 1457999988654332 56788999999999987 9999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS 152 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~ 152 (515)
...+++|+||+..|+|.+++.++. .++..+...++.||+.|++||++.+++||||-..|||+..
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 999999999999999999998765 3889999999999999999999999999999999999999
Q ss_pred CCceEEeecccccccccCCccc--cCCCC--CCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCC-hHHHH
Q 010214 153 KWNVKIADFGLSNIMRDGHFLK--TSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDEN-IPNLF 226 (515)
Q Consensus 153 ~~~vKL~DFGls~~~~~~~~~~--~~~gt--~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~-~~~~~ 226 (515)
+..+||+|||+++...+..... ...|+ ..|||||.+....| +.++||||+||+|||+++ |..||.+-. ..++.
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 9999999999998655443332 22332 34999999998766 789999999999999998 999998854 56667
Q ss_pred HHHhcCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 227 KKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 227 ~~i~~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+.+..|. ...|.++++++.++++.||+.+|++||++.++.+
T Consensus 533 ~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 533 EFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 7777775 4788999999999999999999999999999865
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=249.51 Aligned_cols=212 Identities=49% Similarity=0.817 Sum_probs=188.8
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCH
Q 010214 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (515)
Q Consensus 25 LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L 104 (515)
||.|++|.||++.+..+++.+++|++....... ....+.+|+..++.+.|++|+++++++......++++|++.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987654322 357889999999999999999999999999999999999999999
Q ss_pred HHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCceEEeecccccccccCC-ccccCCCCCC
Q 010214 105 FDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGH-FLKTSCGSPN 181 (515)
Q Consensus 105 ~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-~~~vKL~DFGls~~~~~~~-~~~~~~gt~~ 181 (515)
.+++... ..+++..++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+....... ......++..
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence 9999875 57899999999999999999999999999999999999999 8999999999998665432 2334568889
Q ss_pred ccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCC
Q 010214 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT 261 (515)
Q Consensus 182 Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt 261 (515)
|++||.+......+.+.|+|++|+++++| ..+.+++.+|+..||.+|||
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R~~ 207 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKRPS 207 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccCcC
Confidence 99999998762347899999999999999 67899999999999999999
Q ss_pred HHHHhcCc
Q 010214 262 IPEIRQHP 269 (515)
Q Consensus 262 ~~eil~hp 269 (515)
+.++++|+
T Consensus 208 ~~~l~~~~ 215 (215)
T cd00180 208 AKEILEHL 215 (215)
T ss_pred HHHHhhCC
Confidence 99999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=250.00 Aligned_cols=216 Identities=24% Similarity=0.434 Sum_probs=178.5
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHh-CCCCCccEEEEEEEcCC
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIRLYEVIETPS 90 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~-l~hpnIv~l~~~~~~~~ 90 (515)
++.-.+...-+..||+|++|.|-+.+|..+|+..|+|.+...- . ....+++.+|+.+..+ ...|++|.+|+......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-N-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-C-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 4444566666788999999999999999999999999986543 3 3445677788887654 45999999999999999
Q ss_pred eEEEEEeccCCCCHHHHH----HHhCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCceEEeeccccc
Q 010214 91 DIYVVMEYVKSGELFDYI----VEKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i----~~~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
+++|.||.+.- +|..+- .+.+.++|..+-+++..++.||.|||++ .++|||+||+|||++.+|+||+||||.|.
T Consensus 119 dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999999964 776554 3467899999999999999999999975 89999999999999999999999999998
Q ss_pred ccccCCccccCCCCCCccCCCcccC----CccCCCcceeehhHHHHHHHHhCCCCCCCC-ChHHHHHHHhc
Q 010214 166 IMRDGHFLKTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKG 231 (515)
Q Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~i~~----~~~~~~~~DIwSlGvily~lltG~~Pf~~~-~~~~~~~~i~~ 231 (515)
.+.++-......|...|||||.+.. +.| +-++||||||+.+.||.+++.||+.- +.-++++++..
T Consensus 198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY-~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGY-SVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred eehhhhHHHHhcCCCccCChhhcCcccCcccc-eeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 8876655555778899999999863 234 78999999999999999999999763 33344555544
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-31 Score=252.66 Aligned_cols=215 Identities=49% Similarity=0.812 Sum_probs=189.3
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy 98 (515)
|.+.+.||.|++|.||+|.+..+++.+|+|.+...... ...+.+.+|++.++.++|+|++++++.+......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999988999999999765433 2467889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--cccc
Q 010214 99 VKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKT 175 (515)
Q Consensus 99 ~~gg~L~~~i~~~~~-l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~ 175 (515)
+++++|.+++..... +++..+..++.|++.++.+||+++++|+||+|.||+++.++.++|+|||.+....... ....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 999999999987766 8999999999999999999999999999999999999999999999999998775543 4456
Q ss_pred CCCCCCccCCCcc-cCCccCCCcceeehhHHHHHHHHhCCCCCCC--CChHHHHHHHhcCccCC
Q 010214 176 SCGSPNYAAPEVI-SGKLYAGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGIYTL 236 (515)
Q Consensus 176 ~~gt~~Y~aPE~i-~~~~~~~~~~DIwSlGvily~lltG~~Pf~~--~~~~~~~~~i~~~~~~~ 236 (515)
..++..|++||.+ .+..+ +.++|+||||+++++|++|+.||+. .+...+.+.+..+....
T Consensus 159 ~~~~~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLL 221 (225)
T ss_pred eeccCCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccc
Confidence 6788999999998 54444 5699999999999999999999987 55557778887776443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=273.28 Aligned_cols=254 Identities=28% Similarity=0.465 Sum_probs=203.3
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcC---CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEE
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIE 87 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~---tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~ 87 (515)
+..+...|..+..||.|+|++||+|.+.. .++.||+|.+..... ..++.+|+++|..+. +.||+++.+++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhc
Confidence 44567789999999999999999999887 788999999875442 367899999999987 899999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCceEEeecccccc
Q 010214 88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNI 166 (515)
Q Consensus 88 ~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-~~~vKL~DFGls~~ 166 (515)
.++.+.+|+||++..+-.++.. .++-.+++.++..++.||.++|.+|||||||||+|+|.+. .+.-.|+|||++..
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred cCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 9999999999999877777764 4678999999999999999999999999999999999985 46789999999861
Q ss_pred cc-----------------c--C---------------Cc-----------cccCCCCCCccCCCcccCCccCCCcceee
Q 010214 167 MR-----------------D--G---------------HF-----------LKTSCGSPNYAAPEVISGKLYAGPEVDVW 201 (515)
Q Consensus 167 ~~-----------------~--~---------------~~-----------~~~~~gt~~Y~aPE~i~~~~~~~~~~DIw 201 (515)
.. . + .. .....|||+|.|||++..-.-.++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 10 0 0 00 01235999999999998777678899999
Q ss_pred hhHHHHHHHHhCCCCCCCCC--hHHHHH--HH-----------hcCc---------------------------cC----
Q 010214 202 SCGVILYALLCGTLPFDDEN--IPNLFK--KI-----------KGGI---------------------------YT---- 235 (515)
Q Consensus 202 SlGvily~lltG~~Pf~~~~--~~~~~~--~i-----------~~~~---------------------------~~---- 235 (515)
|.|||+..++++..||-... ...+.+ .| .-+. ..
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 99999999999999993211 000000 00 0000 00
Q ss_pred ------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 236 ------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 236 ------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
..+..+..+.+|+.+||..||.+|+|++++|+||||..
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 01234558899999999999999999999999999973
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-33 Score=289.37 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=219.7
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|.+...+|.|++|-||+|+++.+++..|+|+++.. ..+...-+++||-+++.++||||+.+++-+-....++++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 58999999999999999999999999999999999644 334567788999999999999999999999888999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Cccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~~ 174 (515)
||||.||+|.+.-.-.++++|.++....+..+.|++|||+.|=+|||||=.|||+++.|.+|++|||.+..+... ..-+
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk 170 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK 170 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence 999999999998777889999999999999999999999999999999999999999999999999998766432 2235
Q ss_pred cCCCCCCccCCCccc---CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC-----CCCChhHHH
Q 010214 175 TSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP-----SHLSPGARD 246 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~---~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~~ 246 (515)
...|||.|||||+-. ...| ...+|||++|+...|+---.+|.-+........-..+..+..| ...++.+-+
T Consensus 171 sfiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~ 249 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHN 249 (829)
T ss_pred cccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHH
Confidence 678999999999863 2234 6899999999999999887777555444443333334444433 457889999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
|++.+|.++|++|||++.+|.|||....+.
T Consensus 250 fvK~altknpKkRptaeklL~h~fvs~~l~ 279 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQHPFVSQTLS 279 (829)
T ss_pred HHHHHhcCCCccCCChhhheeceeeccchh
Confidence 999999999999999999999999976543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=258.52 Aligned_cols=252 Identities=31% Similarity=0.505 Sum_probs=198.7
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEE-EEcCCe
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEV-IETPSD 91 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~-~~~~~~ 91 (515)
.+.+.|.|.+.||+|.||++.+|+|+.+++.+++|.+++... ....+.+|...--.|. |.||+.-|++ |++.+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 356889999999999999999999999999999999987653 3467788877654444 8999999886 788889
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC--CCceEEeeccccccccc
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS--KWNVKIADFGLSNIMRD 169 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~--~~~vKL~DFGls~~~~~ 169 (515)
++++|||++.|+|.+-+.. ..+-|...+.++.|+++||.|+|++++||||||.+||||-. ..+|||||||+++..
T Consensus 97 YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~-- 173 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV-- 173 (378)
T ss_pred EEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc--
Confidence 9999999999999887754 45889999999999999999999999999999999999942 348999999998754
Q ss_pred CCccccCCCCCCccCCCccc----CCccCCCcceeehhHHHHHHHHhCCCCCCCCCh-----HHHHHHHhcCccCCCC--
Q 010214 170 GHFLKTSCGSPNYAAPEVIS----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-----PNLFKKIKGGIYTLPS-- 238 (515)
Q Consensus 170 ~~~~~~~~gt~~Y~aPE~i~----~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~-----~~~~~~i~~~~~~~p~-- 238 (515)
+......-.+..|.+||++. ++....+.+|+|.||+++|.+++|.+||..... .+..+-........|.
T Consensus 174 g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F 253 (378)
T KOG1345|consen 174 GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF 253 (378)
T ss_pred CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence 33333444566899999874 333346889999999999999999999964321 1222222233334553
Q ss_pred -CCChhHHHHhcccCCCCCCCC---CCHHHHhcCcccc
Q 010214 239 -HLSPGARDLIPRMLIVDPMKR---ITIPEIRQHPWFQ 272 (515)
Q Consensus 239 -~~s~~~~~li~~mL~~dP~~R---pt~~eil~hp~f~ 272 (515)
.+|+.+..+.++-|..+|++| -++...+...|..
T Consensus 254 ~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 254 NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 578999999999999999999 4444455555543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=281.78 Aligned_cols=245 Identities=27% Similarity=0.432 Sum_probs=210.2
Q ss_pred ceEeeeecccCceEEEEEEEcCCCc----EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
.+-.++||+|+||+||+|.+--.|+ +||||++...... .....+.+|+-+|.+++|||++++++++.... +.|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 3456789999999999998865554 6888988654433 34578889999999999999999999997765 889
Q ss_pred EEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-c
Q 010214 95 VMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-F 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~ 172 (515)
|++|+++|.|.+|++. ++.+.......|..||++|+.|||.+.+|||||-..|||+.+-..+||.|||+++...... .
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999999985 5678999999999999999999999999999999999999999999999999999875433 2
Q ss_pred cccCCC--CCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHh
Q 010214 173 LKTSCG--SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLI 248 (515)
Q Consensus 173 ~~~~~g--t~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 248 (515)
..+..| .+-|||-|.+....| +.++||||+||++||++| |..|+++....++-+.+..+. .+-|+..+-++--++
T Consensus 855 y~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM 933 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence 222222 457999999988888 789999999999999998 999999988888777776654 566888999999999
Q ss_pred cccCCCCCCCCCCHHHHhc
Q 010214 249 PRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~ 267 (515)
.+||..|++.||+++++..
T Consensus 934 vkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 934 VKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHhccCcccCccHHHHHH
Confidence 9999999999999998754
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=264.54 Aligned_cols=254 Identities=25% Similarity=0.436 Sum_probs=194.9
Q ss_pred CCCCCCCccc-----cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHH--HhCCCC
Q 010214 5 SNRSSSGVDM-----FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL--RLFMHP 77 (515)
Q Consensus 5 ~~~~~~~~~~-----~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il--~~l~hp 77 (515)
++||.++..- +.++-++.+.||+|.||.||+|.+ .|+.||||++.... +....||.+|. ..|+|+
T Consensus 194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHE 265 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHE 265 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccc
Confidence 4455555553 457789999999999999999998 58999999986432 34455555555 578999
Q ss_pred CccEEEEEEEcC----CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCC
Q 010214 78 HIIRLYEVIETP----SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN--------MVVHRDLKP 145 (515)
Q Consensus 78 nIv~l~~~~~~~----~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~--------gIvHrDLkp 145 (515)
||+.+++.-..+ ..+|+|++|.+.|+|+||+.+ ..++.+...+++..+++||++||.. .|.|||||.
T Consensus 266 NILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS 344 (513)
T KOG2052|consen 266 NILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS 344 (513)
T ss_pred hhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence 999998875333 359999999999999999987 6799999999999999999999942 499999999
Q ss_pred CcEEECCCCceEEeecccccccccCC-----ccccCCCCCCccCCCcccCCcc----C-CCcceeehhHHHHHHHHhC--
Q 010214 146 ENLLLDSKWNVKIADFGLSNIMRDGH-----FLKTSCGSPNYAAPEVISGKLY----A-GPEVDVWSCGVILYALLCG-- 213 (515)
Q Consensus 146 eNILl~~~~~vKL~DFGls~~~~~~~-----~~~~~~gt~~Y~aPE~i~~~~~----~-~~~~DIwSlGvily~lltG-- 213 (515)
.|||+..+|.+-|+|+|+|-...... ..+..+||..|||||++..... . -..+||||||.++||++..
T Consensus 345 KNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~ 424 (513)
T KOG2052|consen 345 KNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE 424 (513)
T ss_pred ccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence 99999999999999999997665431 3467799999999999965321 1 1468999999999999852
Q ss_pred --------CCCCCC-----CChHHHHHHHhcC--ccCCCCCC--Ch---hHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 214 --------TLPFDD-----ENIPNLFKKIKGG--IYTLPSHL--SP---GARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 214 --------~~Pf~~-----~~~~~~~~~i~~~--~~~~p~~~--s~---~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.+||.+ .+.+++.+-+... ...+|... .+ .+..+++.||..||.-|.|+--|.+
T Consensus 425 ~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 425 SGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred cCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 578864 3444444433322 23444332 22 3456789999999999999876643
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=263.34 Aligned_cols=240 Identities=24% Similarity=0.385 Sum_probs=189.5
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHH--hCCCCCccEEEEEEEcCC---
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR--LFMHPHIIRLYEVIETPS--- 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~--~l~hpnIv~l~~~~~~~~--- 90 (515)
...-++.+.||+|.||.||+|.. +++.||||+++.. ..+.+..|-.|.+ .+.|+||++++++-+..+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 67888999999999999999975 5699999998643 3456666666665 456999999999876555
Q ss_pred -eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCcEEECCCCceEEee
Q 010214 91 -DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN---------MVVHRDLKPENLLLDSKWNVKIAD 160 (515)
Q Consensus 91 -~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~---------gIvHrDLkpeNILl~~~~~vKL~D 160 (515)
.+++|+||.+.|+|.+|++.+ .+++.+..+++..|+.||+|||+. .|+|||||..|||+.+++..-|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 799999999999999999765 689999999999999999999952 499999999999999999999999
Q ss_pred cccccccccCCc---cccCCCCCCccCCCcccCCccCC-----CcceeehhHHHHHHHHhCCC------------CCCC-
Q 010214 161 FGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAG-----PEVDVWSCGVILYALLCGTL------------PFDD- 219 (515)
Q Consensus 161 FGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~-----~~~DIwSlGvily~lltG~~------------Pf~~- 219 (515)
||+|..+..+.. ....+||..|||||++.|...-. .+.||||+|.+||||++... ||..
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 999998865533 34478999999999998754321 36899999999999997432 3321
Q ss_pred ----CChHHHHHHH--hcCccCCCCC-----CChhHHHHhcccCCCCCCCCCCHHH
Q 010214 220 ----ENIPNLFKKI--KGGIYTLPSH-----LSPGARDLIPRMLIVDPMKRITIPE 264 (515)
Q Consensus 220 ----~~~~~~~~~i--~~~~~~~p~~-----~s~~~~~li~~mL~~dP~~Rpt~~e 264 (515)
.+..++...+ .+....+|+. .-..+++.+..||..||+-|.|+.=
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 1233333332 2333445532 2356789999999999999999753
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=294.74 Aligned_cols=196 Identities=17% Similarity=0.219 Sum_probs=147.1
Q ss_pred CCC-CCccEEEEEE-------EcCCeEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 010214 74 FMH-PHIIRLYEVI-------ETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144 (515)
Q Consensus 74 l~h-pnIv~l~~~~-------~~~~~~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLk 144 (515)
++| +||.++++.+ .....++.++|++ +++|.++|.. ...+++.+++.++.||+.||+|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 345 5777777776 2234577889988 5699999975 3469999999999999999999999999999999
Q ss_pred CCcEEECC-------------------CCceEEeecccccccccC-----------------CccccCCCCCCccCCCcc
Q 010214 145 PENLLLDS-------------------KWNVKIADFGLSNIMRDG-----------------HFLKTSCGSPNYAAPEVI 188 (515)
Q Consensus 145 peNILl~~-------------------~~~vKL~DFGls~~~~~~-----------------~~~~~~~gt~~Y~aPE~i 188 (515)
|+||||+. ++.+|++|||+++..... ......+||+.|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 99999965 345666666666532110 001124689999999999
Q ss_pred cCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-CCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 189 ~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.+..| +.++|||||||+||||++|..|+.... .....+.....+ .+....+...+++.+||.+||.+|||+.|+++
T Consensus 188 ~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 188 NGSSS-NCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred ccCCC-CchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 98887 789999999999999999999876432 122222221111 11122456789999999999999999999999
Q ss_pred Cccccc
Q 010214 268 HPWFQA 273 (515)
Q Consensus 268 hp~f~~ 273 (515)
||||..
T Consensus 265 h~~~~~ 270 (793)
T PLN00181 265 SEFINE 270 (793)
T ss_pred chhhhh
Confidence 999975
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=283.31 Aligned_cols=258 Identities=35% Similarity=0.558 Sum_probs=210.8
Q ss_pred CCCc-eEeeeecccCceEEEEEEEcCCCcEEEEEEeccc---ccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 16 LPNY-KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRR---KIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 16 ~~~Y-~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~---~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
.+.| .....+|.|++|.|+.+......+.++.|.+... ..........+..|..+-..+.|||++.....+.+...
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 4556 5678899999999999988877777777765421 11222223337778888889999999887777766655
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG- 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~- 170 (515)
.+-.||||++ +|+..+...+.++..++..+++|++.||+|||..||.|||+||+|++++.+|.+||+|||.+.....+
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 5566999999 99999998889999999999999999999999999999999999999999999999999998876533
Q ss_pred ----CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHH---------HHHHhcCccCCC
Q 010214 171 ----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL---------FKKIKGGIYTLP 237 (515)
Q Consensus 171 ----~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~---------~~~i~~~~~~~p 237 (515)
......+|+..|+|||++.+..|....+||||+|+++..|.+|+.||........ ..++..+...+-
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 2345678999999999999999999999999999999999999999975433221 112222333344
Q ss_pred CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 238 ~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..++...+.+|.+||++||.+|+|+++|++.+||+..
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 5678899999999999999999999999999999875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=232.48 Aligned_cols=252 Identities=39% Similarity=0.650 Sum_probs=214.4
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCC-CccEEEEEEEcCCeEEEEEe
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP-HIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~iVmE 97 (515)
|.+.+.||.|+||.||.+.+. ..+|+|.+.............+.+|+.+++.+.|+ +|+++++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999987 78999999877655544678899999999999988 79999999988888999999
Q ss_pred ccCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-ceEEeecccccccccCC--
Q 010214 98 YVKSGELFDYIVEKG---RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGH-- 171 (515)
Q Consensus 98 y~~gg~L~~~i~~~~---~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~-~vKL~DFGls~~~~~~~-- 171 (515)
++.++++.+++.... .+++..+..++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998887665 799999999999999999999999999999999999999988 79999999987654432
Q ss_pred -----ccccCCCCCCccCCCcccCC--ccCCCcceeehhHHHHHHHHhCCCCCCCCCh----HHHHHHHhcCccC-CCCC
Q 010214 172 -----FLKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYT-LPSH 239 (515)
Q Consensus 172 -----~~~~~~gt~~Y~aPE~i~~~--~~~~~~~DIwSlGvily~lltG~~Pf~~~~~----~~~~~~i~~~~~~-~p~~ 239 (515)
.....+||+.|+|||.+.+. .+.+...|+||+|++++++++|..||..... ......+...... ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 34677899999999999874 3557899999999999999999999887763 4455555444433 2222
Q ss_pred CC--------hhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 240 LS--------PGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 240 ~s--------~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
.. ..+.+++.+++..+|..|.+..+...+++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 22 47899999999999999999999999866653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=228.17 Aligned_cols=158 Identities=24% Similarity=0.297 Sum_probs=130.9
Q ss_pred CCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCCC
Q 010214 102 GELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~ 180 (515)
|+|.+++... ..+++.+++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...||+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcc
Confidence 6899999874 46999999999999999999999999 999999999999999 9998876442 236899
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh-HHHHHHHhcCccCC-------CCCCCh--hHHHHhcc
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGGIYTL-------PSHLSP--GARDLIPR 250 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~-~~~~~~i~~~~~~~-------p~~~s~--~~~~li~~ 250 (515)
.|+|||++.+..+ +.++||||+||++|+|++|..||..... ......+....... +..++. ++.+++.+
T Consensus 69 ~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 147 (176)
T smart00750 69 YFMAPEVIQGQSY-TEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV 147 (176)
T ss_pred cccChHHhcCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence 9999999998877 6899999999999999999999976533 23333333322211 122333 69999999
Q ss_pred cCCCCCCCCCCHHHHhcCcccc
Q 010214 251 MLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
||..||.+|||+.|+++|+|+.
T Consensus 148 cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 148 CASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-29 Score=258.58 Aligned_cols=242 Identities=31% Similarity=0.553 Sum_probs=214.7
Q ss_pred eecccCceEEEEEE---EcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEEEecc
Q 010214 24 TLGIGSFGKVKIAE---HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVMEYV 99 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~---~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iVmEy~ 99 (515)
++|.|+||+|+++. -.+.|+-+|+|+..+......... .-..|-.++...+ ||++++++..++++...++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 47999999999864 335678899999987766554433 5566778888887 999999999999999999999999
Q ss_pred CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCC
Q 010214 100 KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS 179 (515)
Q Consensus 100 ~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt 179 (515)
.||+|+..+.+...+.+...+.+...++-|++++|+.||+|||+|++||+++.+|++++.|||+++..-+.... |||
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt 156 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGT 156 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccc
Confidence 99999999988888999999999999999999999999999999999999999999999999999877554433 999
Q ss_pred CCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCC
Q 010214 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKR 259 (515)
Q Consensus 180 ~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~R 259 (515)
..|||||++.|. ..++|.||+|+++++|++|..||.. +..+.|......+|..++..+++++..++..+|.+|
T Consensus 157 ~eymApEI~~gh---~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nr 229 (612)
T KOG0603|consen 157 YEYRAPEIINGH---LSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENR 229 (612)
T ss_pred hhhhhhHhhhcc---CCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHH
Confidence 999999999843 5789999999999999999999988 677888888999999999999999999999999999
Q ss_pred CCH-----HHHhcCcccccccC
Q 010214 260 ITI-----PEIRQHPWFQAHLP 276 (515)
Q Consensus 260 pt~-----~eil~hp~f~~~~~ 276 (515)
... .|+++|+||+....
T Consensus 230 Lg~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 230 LGAGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred hccCcchhHHHhccchheeeeH
Confidence 854 79999999987643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=237.63 Aligned_cols=170 Identities=18% Similarity=0.194 Sum_probs=136.4
Q ss_pred CCccccCCCceEeeeecccCceEEEEEEEcC-CCcEEEEEEeccccc--CChHHHHHHHHHHHHHHhCCCCCccE-EEEE
Q 010214 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHAL-TGHKVAIKILNRRKI--KNMEMEEKVRREIKILRLFMHPHIIR-LYEV 85 (515)
Q Consensus 10 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~-tg~~vAiK~i~~~~~--~~~~~~~~i~~Ei~il~~l~hpnIv~-l~~~ 85 (515)
+....+.++|.+.+.||+|+||+||+|.++. +++.||||++..... ........+.+|+++|+.++|+|++. +++.
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 3455677899999999999999999999876 678889998753311 12334677999999999999999985 5442
Q ss_pred EEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCcEEECCCCceEEeecccc
Q 010214 86 IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDL-KPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 86 ~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDL-kpeNILl~~~~~vKL~DFGls 164 (515)
...|+||||++|++|.. +. ... ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||++
T Consensus 91 ----~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred ----CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 45799999999999963 21 111 2578899999999999999999999 999999999999999999999
Q ss_pred cccccCC---------ccccCCCCCCccCCCcccC
Q 010214 165 NIMRDGH---------FLKTSCGSPNYAAPEVISG 190 (515)
Q Consensus 165 ~~~~~~~---------~~~~~~gt~~Y~aPE~i~~ 190 (515)
....... ...+.++++.|+|||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 8664332 1245678899999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=233.18 Aligned_cols=251 Identities=19% Similarity=0.287 Sum_probs=208.6
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCC-----cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEE-E
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTG-----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVI-E 87 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~-~ 87 (515)
....++++...+-+|.||.||.|.+++.. +.|-+|.+... ...-....+..|...+..+.|||+..+.++. +
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 34566888889999999999999776443 33555554321 2233567788999999999999999999986 5
Q ss_pred cCCeEEEEEeccCCCCHHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEe
Q 010214 88 TPSDIYVVMEYVKSGELFDYIVEK--------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIA 159 (515)
Q Consensus 88 ~~~~~~iVmEy~~gg~L~~~i~~~--------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~ 159 (515)
+...-++++.+..-|+|..++... ..++..+...++.|+..|++|||++||+|.||-..|.+||+...+||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 556678889999889999999731 237788889999999999999999999999999999999999999999
Q ss_pred ecccccccccCCccc---cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-c
Q 010214 160 DFGLSNIMRDGHFLK---TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-Y 234 (515)
Q Consensus 160 DFGls~~~~~~~~~~---~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~ 234 (515)
|=.+|+-..++++.. ..-....||+||.+....| +.++|+|||||+||||+| |+.|+.+-+..++..-+++|. .
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~y-ssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRl 517 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHY-SSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL 517 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhh-cchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcccee
Confidence 999998776654321 1123457999999999988 789999999999999998 999999998888888888774 4
Q ss_pred CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 235 ~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.-|-++++++..++..||..+|++||+++|+..
T Consensus 518 aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 518 AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 667899999999999999999999999998754
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-25 Score=224.35 Aligned_cols=246 Identities=23% Similarity=0.310 Sum_probs=191.2
Q ss_pred CceEeeeecccCceEEEEEEEcCCC-cEEEEEEecccccCChHHHHHHHHHHHHHHhCCC----CCccEEEEEE-EcCCe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTG-HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH----PHIIRLYEVI-ETPSD 91 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg-~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h----pnIv~l~~~~-~~~~~ 91 (515)
+|.+.+.||+|+||.||+|.+..++ ..+|+|+........ . ..+..|+.+++.+.. +++.++++.. ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--P-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--C-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999988775 679999876543222 1 157788888888873 6999999999 58888
Q ss_pred EEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-----CceEEeecccc
Q 010214 92 IYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-----WNVKIADFGLS 164 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~-----~~vKL~DFGls 164 (515)
-|+||+.+ |.+|.++.... +.++...+..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 78999988554 579999999999999999999999999999999999999765 46999999999
Q ss_pred cccc---cCC----c----cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHH---HHh
Q 010214 165 NIMR---DGH----F----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFK---KIK 230 (515)
Q Consensus 165 ~~~~---~~~----~----~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~---~i~ 230 (515)
+... ... . .....||..|+++.+..+... +++.|+||++.++.+++.|.+||.......... +..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8322 111 1 123459999999999998876 899999999999999999999997654322222 222
Q ss_pred cCccC--CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 231 GGIYT--LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 231 ~~~~~--~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..... .....+.++..+...+-..+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 21111 223345667777766666777888877666543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-25 Score=213.54 Aligned_cols=247 Identities=24% Similarity=0.363 Sum_probs=199.1
Q ss_pred CCCCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEE
Q 010214 8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVI 86 (515)
Q Consensus 8 ~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~ 86 (515)
+++++-++.-+|+++++||+|+||..+.|.+..+++.||||.-..+. ..-.++.|.+..+.|. .++|...|.+.
T Consensus 19 s~s~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFG 93 (449)
T KOG1165|consen 19 SSSGVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFG 93 (449)
T ss_pred CCCCceEecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeec
Confidence 44566688899999999999999999999999999999999765433 2356778888888887 79999999999
Q ss_pred EcCCeEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-----CceEEee
Q 010214 87 ETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-----WNVKIAD 160 (515)
Q Consensus 87 ~~~~~~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~-----~~vKL~D 160 (515)
....+-.+|||.+ |-+|.|+..- ..+++...+..++.|++.-++|+|++.+|+|||||+|+||..- ..|-|+|
T Consensus 94 qeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 94 QEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred cccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEe
Confidence 9999999999999 7788888764 4469999999999999999999999999999999999999643 4599999
Q ss_pred cccccccccCCc--------cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC---ChHHHHHHH
Q 010214 161 FGLSNIMRDGHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---NIPNLFKKI 229 (515)
Q Consensus 161 FGls~~~~~~~~--------~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~---~~~~~~~~i 229 (515)
||+++.+.+... .++..||..||+-....|+.. +.+.|+-|||.++++.|-|.+||.+. +..+-+++|
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 999998866532 346679999999999988876 78999999999999999999999764 445556666
Q ss_pred hcCccCCC-----CCCChhHHHHhcccCCCCCCCCCC
Q 010214 230 KGGIYTLP-----SHLSPGARDLIPRMLIVDPMKRIT 261 (515)
Q Consensus 230 ~~~~~~~p-----~~~s~~~~~li~~mL~~dP~~Rpt 261 (515)
-......| ..++.++...+.-.-..+-.+-|.
T Consensus 252 Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PD 288 (449)
T KOG1165|consen 252 GETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPD 288 (449)
T ss_pred ccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCC
Confidence 54433322 345555555554444444444444
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=201.75 Aligned_cols=244 Identities=23% Similarity=0.286 Sum_probs=194.0
Q ss_pred CCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC-CCccEEEEEEEc
Q 010214 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH-PHIIRLYEVIET 88 (515)
Q Consensus 10 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h-pnIv~l~~~~~~ 88 (515)
...-...++|.+++.||+|+||-+|+|.+..+|+.||||+-.... .. ..+..|.++.+.|++ ..|..+..+..+
T Consensus 8 ~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e 82 (341)
T KOG1163|consen 8 LEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KH----PQLLYESKVYRILQGGVGIPHIRHYGTE 82 (341)
T ss_pred hhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CC----cchhHHHHHHHHhccCCCCchhhhhccc
Confidence 334456799999999999999999999999999999999865432 22 356678888888884 678888888888
Q ss_pred CCeEEEEEeccCCCCHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCceEEeecccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIADFGLS 164 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~-~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~---~~~vKL~DFGls 164 (515)
..+-.+|||.. |-+|.+... ....++...+.-++.|++.-++|+|.++++||||||+|+|+.- ...+.++|||+|
T Consensus 83 ~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 83 KDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred cccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccch
Confidence 88999999999 779988876 3557999999999999999999999999999999999999863 357999999999
Q ss_pred cccccCC--------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC---ChHHHHHHHhcCc
Q 010214 165 NIMRDGH--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---NIPNLFKKIKGGI 233 (515)
Q Consensus 165 ~~~~~~~--------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~---~~~~~~~~i~~~~ 233 (515)
+.+.+.. .-+...||..|++-....|... +.+.|+-|+|.+|.++.-|.+||.+- +..+-+++|....
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 8875432 2235579999999888877655 78999999999999999999999874 3344556666555
Q ss_pred cCCC-----CCCChhHHHHhcccCCCCCCCCC
Q 010214 234 YTLP-----SHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 234 ~~~p-----~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.+.| ..++.++.-.+.-|-..--.+-|
T Consensus 241 ~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~P 272 (341)
T KOG1163|consen 241 MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKP 272 (341)
T ss_pred cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCC
Confidence 5444 45677777777766554433333
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-25 Score=240.61 Aligned_cols=219 Identities=36% Similarity=0.634 Sum_probs=179.5
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
.-.+|..+++|..|++|.||+++|+.|.+.+|+ .++++.+. .|- ++.....|++|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li--------lRn--ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI--------LRN--ILTFAGNPFVV-------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhh-cccccchh--------hhc--cccccCCccee--------------
Confidence 457899999999999999999999999999999 45554321 111 44444455554
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc------
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR------ 168 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~------ 168 (515)
|+=...++.-+.++.+. +.+++|||+.||+|||+||+|++|+.-|++|+.|||++....
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 34444555555666554 789999999999999999999999999999999999986421
Q ss_pred --cC-------Ccc-ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCC
Q 010214 169 --DG-------HFL-KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS 238 (515)
Q Consensus 169 --~~-------~~~-~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~ 238 (515)
.+ ++. +..||||.|.|||++..+.| +.-+|+|++|+|+|+.+.|..||.+++.++++..+.......|.
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 11 112 34599999999999998888 89999999999999999999999999999999999888877774
Q ss_pred ---CCChhHHHHhcccCCCCCCCCC---CHHHHhcCcccccc
Q 010214 239 ---HLSPGARDLIPRMLIVDPMKRI---TIPEIRQHPWFQAH 274 (515)
Q Consensus 239 ---~~s~~~~~li~~mL~~dP~~Rp---t~~eil~hp~f~~~ 274 (515)
.+++++++++.++|+.+|..|. .+-++.+|+||+..
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 5789999999999999999996 46789999999864
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=204.48 Aligned_cols=176 Identities=15% Similarity=0.143 Sum_probs=138.1
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHH------HHHHHHHHHhCCCCCccEEEEEE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK------VRREIKILRLFMHPHIIRLYEVI 86 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~------i~~Ei~il~~l~hpnIv~l~~~~ 86 (515)
+.+.++|++.+.||.|+||.||++.. ++..+|+|++............. +.+|+..+.++.||+|..+.+++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 34568999999999999999999765 47789999997665544444344 68999999999999999999986
Q ss_pred EcC--------CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEE
Q 010214 87 ETP--------SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI 158 (515)
Q Consensus 87 ~~~--------~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL 158 (515)
... +..++||||++|.+|.++. .+++ ....+++.+|..||+.|++|||+||+||+++.+| ++|
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence 543 3578999999999998873 2333 2456999999999999999999999999999988 999
Q ss_pred eecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHH
Q 010214 159 ADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL 211 (515)
Q Consensus 159 ~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~ll 211 (515)
+|||.+......... ...+....|. .++|+||||+++....
T Consensus 176 iDfg~~~~~~e~~a~-----------d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRKAK-----------DRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchhhH-----------HHHHHHhHhc-ccccccceeEeehHHH
Confidence 999988655322111 1133445564 7899999999876654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=201.46 Aligned_cols=142 Identities=22% Similarity=0.245 Sum_probs=113.9
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChH-----------------------HHHHHHHHHHHHHhCCCCC
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-----------------------MEEKVRREIKILRLFMHPH 78 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~-----------------------~~~~i~~Ei~il~~l~hpn 78 (515)
...||+|+||.||+|.+. +|+.||||++......... ......+|++++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999997 8999999999765321111 0123456999999999887
Q ss_pred ccEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCcEEECCCCceE
Q 010214 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVVHRDLKPENLLLDSKWNVK 157 (515)
Q Consensus 79 Iv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yL-H~~gIvHrDLkpeNILl~~~~~vK 157 (515)
+.....+... ..++||||++|+++...+...+.+++..+..++.|++.+|.+| |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 7544333222 2389999999988876655567899999999999999999999 799999999999999998 47899
Q ss_pred Eeeccccccc
Q 010214 158 IADFGLSNIM 167 (515)
Q Consensus 158 L~DFGls~~~ 167 (515)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-25 Score=242.08 Aligned_cols=240 Identities=27% Similarity=0.388 Sum_probs=193.0
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccc-cCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRK-IKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
+..+|...+.||.+.|=+|.+|+|. .|. |+||++-+.. .-......+..+|++ .+.+++||++.+..+.++....|
T Consensus 21 ~~~e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAy 97 (1431)
T KOG1240|consen 21 LSVECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAY 97 (1431)
T ss_pred CccceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHH
Confidence 3448899999999999999999986 444 9999987654 223333444455666 78889999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc--cc--
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RD-- 169 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~--~~-- 169 (515)
||-+|+.. +|+|.|..+..+..-+.+.|+.||+.||.-||+.||+|||||.|||||+.-+-+.|+||..-+.. ..
T Consensus 98 lvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 98 LVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 99999965 99999998888999999999999999999999999999999999999999999999999865432 11
Q ss_pred ----CCccccCCCCCCccCCCcccCCc----------cCCCcceeehhHHHHHHHHh-CCCCCCCC-----------ChH
Q 010214 170 ----GHFLKTSCGSPNYAAPEVISGKL----------YAGPEVDVWSCGVILYALLC-GTLPFDDE-----------NIP 223 (515)
Q Consensus 170 ----~~~~~~~~gt~~Y~aPE~i~~~~----------~~~~~~DIwSlGvily~llt-G~~Pf~~~-----------~~~ 223 (515)
.-+..|...-.+|.|||.+.... .-.++-||||+||+++||++ |.+||+-. +.+
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e 256 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPE 256 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHH
Confidence 12345666667999999875421 12578999999999999998 89999521 222
Q ss_pred HHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 224 NLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 224 ~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.+.++| -+..+++||..|++.||++|.++++.|+.
T Consensus 257 ~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 257 QLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 223332 24578999999999999999999999886
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-23 Score=193.51 Aligned_cols=143 Identities=17% Similarity=0.210 Sum_probs=116.0
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh-----------------------HHHHHHHHHHHHHHhCCCCC
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-----------------------EMEEKVRREIKILRLFMHPH 78 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~-----------------------~~~~~i~~Ei~il~~l~hpn 78 (515)
.+.||+|+||+||+|.+. +|+.||||+++....... .......+|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 899999999986532100 01233468999999999998
Q ss_pred ccEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceE
Q 010214 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVK 157 (515)
Q Consensus 79 Iv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vK 157 (515)
+.....+.... .|+||||++|+++.........+++.++..++.|++.++.+||+ .||+||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 85554443332 48999999988665544455678999999999999999999999 9999999999999999 78999
Q ss_pred Eeecccccccc
Q 010214 158 IADFGLSNIMR 168 (515)
Q Consensus 158 L~DFGls~~~~ 168 (515)
|+|||++....
T Consensus 158 liDFG~a~~~~ 168 (190)
T cd05145 158 IIDVSQAVELD 168 (190)
T ss_pred EEEcccceecC
Confidence 99999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-24 Score=209.63 Aligned_cols=236 Identities=23% Similarity=0.303 Sum_probs=155.8
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC----------CCccEEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH----------PHIIRLYEVI 86 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h----------pnIv~l~~~~ 86 (515)
.....++.||.|+++.||.++|..||+.+|+|++...........+.+++|.-....+.+ -.++-.++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 456778899999999999999999999999999876654444456777777765555433 1233333332
Q ss_pred E---------cC---C-----eEEEEEeccCCCCHHHHHHH---hCCC----CHHHHHHHHHHHHHHHHHHHHCCceecc
Q 010214 87 E---------TP---S-----DIYVVMEYVKSGELFDYIVE---KGRL----QEDEARNFFQQIISGVEYCHRNMVVHRD 142 (515)
Q Consensus 87 ~---------~~---~-----~~~iVmEy~~gg~L~~~i~~---~~~l----~e~~~~~i~~qil~aL~yLH~~gIvHrD 142 (515)
. .. + ..+++|+-+. ++|.+.+.. .... .......+..|++..+++||+.|++|+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 1 11 1 2477888885 589887652 2222 1222345569999999999999999999
Q ss_pred CCCCcEEECCCCceEEeecccccccccCCccccCCCCCCccCCCcccCC-------ccCCCcceeehhHHHHHHHHhCCC
Q 010214 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK-------LYAGPEVDVWSCGVILYALLCGTL 215 (515)
Q Consensus 143 LkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~-------~~~~~~~DIwSlGvily~lltG~~ 215 (515)
|+|+|++++.+|.++|+||+....... .......+..|.+||..... ...+.+.|.|+||+++|.|+||.+
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 999999999999999999987654433 22223455789999976431 223678999999999999999999
Q ss_pred CCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCC
Q 010214 216 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKR 259 (515)
Q Consensus 216 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~R 259 (515)
||+.......... .+..-..++..+++||..||+.||.+|
T Consensus 249 Pf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9986543322111 222223788999999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.3e-22 Score=187.12 Aligned_cols=190 Identities=17% Similarity=0.125 Sum_probs=144.2
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChH-HHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEEE
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-MEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~-~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iVm 96 (515)
..+...|++|+||+|+++.. .+.+++.+.+.-....... ....+.+|+++|+++. |+++++++++ ...|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34678899999999998875 6788888877544432111 1236889999999996 5889999886 3569999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCcEEECCCCceEEeecccccccccCCcc--
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDL-KPENLLLDSKWNVKIADFGLSNIMRDGHFL-- 173 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDL-kpeNILl~~~~~vKL~DFGls~~~~~~~~~-- 173 (515)
||+.|.+|...+.. . ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||++.........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99999998754321 1 2457899999999999999999999 799999999999999999999855432210
Q ss_pred --c----------cCCCCCCccCCCcccCCc-cCCCcceeehhHHHHHHHHhCCCCCCCCC
Q 010214 174 --K----------TSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDEN 221 (515)
Q Consensus 174 --~----------~~~gt~~Y~aPE~i~~~~-~~~~~~DIwSlGvily~lltG~~Pf~~~~ 221 (515)
. -...++.|++|+...--. ..-.+.+.++.|.-+|.++|+.+|+-+++
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 112678888888654321 11257889999999999999999876543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=185.76 Aligned_cols=134 Identities=26% Similarity=0.371 Sum_probs=108.8
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-----CCCCccEEEEEEEcCC---eEE
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-----MHPHIIRLYEVIETPS---DIY 93 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-----~hpnIv~l~~~~~~~~---~~~ 93 (515)
.+.||+|+||.||. |+.++.. +||++..... ...+.+.+|+++++.+ .||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 56899999999995 8878776 6999865432 2346789999999999 5799999999999874 434
Q ss_pred -EEEec--cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCcEEECC----CCceEEeecccc
Q 010214 94 -VVMEY--VKSGELFDYIVEKGRLQEDEARNFFQQIISGV-EYCHRNMVVHRDLKPENLLLDS----KWNVKIADFGLS 164 (515)
Q Consensus 94 -iVmEy--~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL-~yLH~~gIvHrDLkpeNILl~~----~~~vKL~DFGls 164 (515)
+|||| +.+|+|.+++.+ +.+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+-+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 557999999965 456666 35678888777 9999999999999999999974 347999995433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-23 Score=225.67 Aligned_cols=257 Identities=33% Similarity=0.562 Sum_probs=217.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcC-CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHAL-TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~-tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 93 (515)
...|.+.+.||+|+|+.|-++.... +...+|.|.+.... ........+..|..+-+.+. |+|++++++....++..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 5789999999999999999988743 44567888776554 34455677778888888888 999999999999999999
Q ss_pred EEEeccCCCCHHHHH-HHhC-CCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEECCCC-ceEEeeccccccccc
Q 010214 94 VVMEYVKSGELFDYI-VEKG-RLQEDEARNFFQQIISGVEYCH-RNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRD 169 (515)
Q Consensus 94 iVmEy~~gg~L~~~i-~~~~-~l~e~~~~~i~~qil~aL~yLH-~~gIvHrDLkpeNILl~~~~-~vKL~DFGls~~~~~ 169 (515)
++++|..|+++++.+ .... ..+...+..++.|+..++.|+| ..++.|||+||+|.+++..+ .++++|||+|.....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 5554 6888899999999999999999 99999999999999999999 999999999987765
Q ss_pred -C---CccccCCC-CCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHH-H-HHhc---CccCCCCC
Q 010214 170 -G---HFLKTSCG-SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF-K-KIKG---GIYTLPSH 239 (515)
Q Consensus 170 -~---~~~~~~~g-t~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~-~-~i~~---~~~~~p~~ 239 (515)
. ......+| ++.|+|||...+..|.++..|+||+|+++..+++|..|++........ . .+.. ........
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 2 23456688 999999999999888899999999999999999999999764332211 1 1111 12344567
Q ss_pred CChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 240 ~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
++..+.+++.+++..+|..|.+.+++..+||+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 8999999999999999999999999999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=8e-21 Score=185.32 Aligned_cols=145 Identities=19% Similarity=0.204 Sum_probs=117.4
Q ss_pred CceEeeeecccCceEEEEEE-EcCCCcEEEEEEecccccCC---------------------hHHHHHHHHHHHHHHhCC
Q 010214 18 NYKLGKTLGIGSFGKVKIAE-HALTGHKVAIKILNRRKIKN---------------------MEMEEKVRREIKILRLFM 75 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~-~~~tg~~vAiK~i~~~~~~~---------------------~~~~~~i~~Ei~il~~l~ 75 (515)
.|.+.+.||+|+||.||+|. +..+|+.||+|++....... ......+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999999 77799999999987543210 001234678999999998
Q ss_pred CC--CccEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCcEEECC
Q 010214 76 HP--HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM-VVHRDLKPENLLLDS 152 (515)
Q Consensus 76 hp--nIv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~g-IvHrDLkpeNILl~~ 152 (515)
+. .+.++++. . ..++||||++|++|.........+.+.++..++.||+.++.+||++| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 63 34455543 2 34899999999888776655566777788999999999999999999 99999999999999
Q ss_pred CCceEEeeccccccc
Q 010214 153 KWNVKIADFGLSNIM 167 (515)
Q Consensus 153 ~~~vKL~DFGls~~~ 167 (515)
++.++|+|||.+...
T Consensus 184 ~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCCEEEEEChhhhcc
Confidence 789999999988654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.3e-21 Score=190.67 Aligned_cols=187 Identities=27% Similarity=0.447 Sum_probs=142.4
Q ss_pred CCCCccEEEEEEEc---------------------------CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHH
Q 010214 75 MHPHIIRLYEVIET---------------------------PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII 127 (515)
Q Consensus 75 ~hpnIv~l~~~~~~---------------------------~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil 127 (515)
+|||||++..+|.+ +..+|+||...+. +|..|+-.+ ..+....+-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 59999999887632 3358999998865 999999654 467788899999999
Q ss_pred HHHHHHHHCCceeccCCCCcEEEC--CC--CceEEeecccccccccC----Cc---cccCCCCCCccCCCcccCCc----
Q 010214 128 SGVEYCHRNMVVHRDLKPENLLLD--SK--WNVKIADFGLSNIMRDG----HF---LKTSCGSPNYAAPEVISGKL---- 192 (515)
Q Consensus 128 ~aL~yLH~~gIvHrDLkpeNILl~--~~--~~vKL~DFGls~~~~~~----~~---~~~~~gt~~Y~aPE~i~~~~---- 192 (515)
+|+.|||++||.|||+|.+|||+. ++ -.+.|+|||.+-.-..- .+ .-..-|...-||||+....+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999983 33 35899999976432210 01 11224677889999976322
Q ss_pred -cCCCcceeehhHHHHHHHHhCCCCCCCCChHHH--HHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCCHH
Q 010214 193 -YAGPEVDVWSCGVILYALLCGTLPFDDENIPNL--FKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIP 263 (515)
Q Consensus 193 -~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~--~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~ 263 (515)
.+-.++|.|++|.+.||+++...||.......+ ..--......+|+.+++.+++|+..+|+.||++|++..
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 112479999999999999999999987432222 11112334678899999999999999999999999853
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.8e-20 Score=207.46 Aligned_cols=199 Identities=25% Similarity=0.337 Sum_probs=164.0
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
+..-...|.|.+.||.|+||+||+|.+.. |+.||+|+=..........-.++..-++ ..--+.|+.+...+.-.+.
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk---~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK---PQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc---hhhhcchHHHHHHHccCCc
Confidence 33446789999999999999999999886 9999999976665544333333333222 1113556666666666677
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-------CCceEEeecccc
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-------KWNVKIADFGLS 164 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-------~~~vKL~DFGls 164 (515)
.++|+||.+.|+|.+++...+.+++..+..+..||+..|+.||..+|||+||||.|+||.. .--++|+|||.|
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 8899999999999999998889999999999999999999999999999999999999943 235999999998
Q ss_pred ccc---ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCC
Q 010214 165 NIM---RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL 215 (515)
Q Consensus 165 ~~~---~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~ 215 (515)
--+ .++...+..++|-.+-.+|+..|+++ +..+|.|.++.+++.||.|+.
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpW-tYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPW-TYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCC-chhhhhHHHHHHHHHHHHHHH
Confidence 654 46667788899999999999999998 789999999999999999963
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3e-19 Score=170.67 Aligned_cols=137 Identities=25% Similarity=0.359 Sum_probs=116.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChH-----HHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-----MEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~-----~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+.||+|++|.||+|.+ +|..+++|+.......... ...++.+|+.++..+.|+++.....++...+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 7788999987654332221 23567889999999999998877777777778899999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
|++|++|.+++..... ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999865432 8889999999999999999999999999999999 78999999998865
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-20 Score=193.89 Aligned_cols=245 Identities=23% Similarity=0.315 Sum_probs=170.1
Q ss_pred CCceEeeeecccCceEEEEEEEcCC---CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEE-------EE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE-------VI 86 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~-------~~ 86 (515)
.-+.+.+..+..+++.+....-..+ .+.++-+.. ...+........+++-.+....|-+..-+.+ .+
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~---~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~ 320 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRA---DVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESS 320 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhh---hccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhc
Confidence 3445555556666665554433222 222222222 1222223345556666655555443333332 11
Q ss_pred -----EcCCeEEEEEeccCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEE
Q 010214 87 -----ETPSDIYVVMEYVKSGELFDYIVEKG---RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI 158 (515)
Q Consensus 87 -----~~~~~~~iVmEy~~gg~L~~~i~~~~---~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL 158 (515)
....++||.|++|..++|.++|..+. ..+......++.|+..|++| +|.+|||+||.||+...+..+||
T Consensus 321 ~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 321 KRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred cccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhh
Confidence 11235899999999999999997543 36677889999999999999 99999999999999999999999
Q ss_pred eecccccccccCC-------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 010214 159 ADFGLSNIMRDGH-------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK 230 (515)
Q Consensus 159 ~DFGls~~~~~~~-------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~ 230 (515)
.|||+........ ......||..||+||.+.|..| +.++||||||+||+|++. -..+|. ....+..+.
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y-~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r 473 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY-SEKVDIYALGLILAELLIQFSTQFE---RIATLTDIR 473 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhh-hhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhh
Confidence 9999988776554 4566789999999999999988 799999999999999997 232322 223344555
Q ss_pred cCccCCC-CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 231 GGIYTLP-SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 231 ~~~~~~p-~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.+.++.- ..-.++-.+|+.+||...|.+||++.+.--|+|.
T Consensus 474 ~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 474 DGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred cCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 5554311 1123455689999999999999988888777775
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=165.42 Aligned_cols=134 Identities=22% Similarity=0.294 Sum_probs=108.9
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEecccccCCh-----HHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010214 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-----EMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~-----~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy 98 (515)
.||+|+||.||+|.+ +|..+++|+......... ....++.+|+++++.+.|+++....-++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 678999998654432221 1246778999999999988765554445556667899999
Q ss_pred cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 99 ~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
++|++|.+++..... .++.|++.+|.+||+.|++|||++|+||+++ ++.++++|||++...
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999998764321 8899999999999999999999999999999 789999999988653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.2e-19 Score=166.15 Aligned_cols=141 Identities=21% Similarity=0.297 Sum_probs=111.7
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh-------------------HHHHHHHHHHHHHHhCCCC-
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-------------------EMEEKVRREIKILRLFMHP- 77 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~-------------------~~~~~i~~Ei~il~~l~hp- 77 (515)
.|.+.+.||.|+||.||+|.+. +|+.||||++........ .......+|+.++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888999999999999999875 899999999765331000 0112367899999999887
Q ss_pred -CccEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCce
Q 010214 78 -HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNV 156 (515)
Q Consensus 78 -nIv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~v 156 (515)
.++..++. ...++||||++|++|..... ......++.+++.++.++|+.||+||||||+||+++.++.+
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 44555442 34589999999999876532 14567899999999999999999999999999999999999
Q ss_pred EEeeccccccccc
Q 010214 157 KIADFGLSNIMRD 169 (515)
Q Consensus 157 KL~DFGls~~~~~ 169 (515)
+|+|||++.....
T Consensus 165 ~liDfg~~~~~~~ 177 (198)
T cd05144 165 YIIDWPQMVSTDH 177 (198)
T ss_pred EEEECCccccCCC
Confidence 9999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.2e-20 Score=173.94 Aligned_cols=241 Identities=23% Similarity=0.373 Sum_probs=191.3
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
....+..+|.....|..|+|++. |..++.|+++...... ..-..+.+|.--|+-+.||||+.+++.+.++..+.++.
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 45566778999999999999985 5567888887655443 22345778888899999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCceEEe--ecccccccccC
Q 010214 97 EYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKIA--DFGLSNIMRDG 170 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~--l~e~~~~~i~~qil~aL~yLH~~g--IvHrDLkpeNILl~~~~~vKL~--DFGls~~~~~~ 170 (515)
.|++.|+|+..+..... .+..++.+++.+|+.|++|||+.. |.---|....+++|++...+|+ |--+|..
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq---- 342 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---- 342 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee----
Confidence 99999999999986543 677899999999999999999853 4444688899999998766654 3222211
Q ss_pred CccccCCCCCCccCCCcccCCccC--CCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHH--hcCccCCCCCCChhHHH
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYA--GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--KGGIYTLPSHLSPGARD 246 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~--~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~ 246 (515)
.....-+|.||+||.++.++.+ -.++|+||+++++||+.|...||.+-+..+.--+| ......+|+.+|+....
T Consensus 343 --e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~k 420 (448)
T KOG0195|consen 343 --EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNK 420 (448)
T ss_pred --ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHH
Confidence 0123457899999999876542 35799999999999999999999987665543333 33456889999999999
Q ss_pred HhcccCCCCCCCCCCHHHHh
Q 010214 247 LIPRMLIVDPMKRITIPEIR 266 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil 266 (515)
|++-|+..||.+||.++.+.
T Consensus 421 lm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 421 LMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHhcCCCCcCCCcceeh
Confidence 99999999999999877653
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.3e-18 Score=182.90 Aligned_cols=140 Identities=21% Similarity=0.259 Sum_probs=114.0
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCC-----hHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-----MEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
..|...+.||+|+||.||+|.+. +..+++|+........ ....+++.+|+++++.++|++++....+..+...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 44566889999999999999874 3345555433222211 1234678899999999999999988877777777
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
.++||||++|++|.+++. ....++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||+++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 899999999999999885 457899999999999999999999999999999 5779999999998653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.7e-18 Score=157.14 Aligned_cols=140 Identities=21% Similarity=0.306 Sum_probs=102.3
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHH---------------------HHHHHHHHHhCCCCC--
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK---------------------VRREIKILRLFMHPH-- 78 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~---------------------i~~Ei~il~~l~hpn-- 78 (515)
.+.||+|+||+||+|.+. +|+.||||++............. ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999987 89999999987643222111111 145677776665443
Q ss_pred ccEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceE
Q 010214 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVK 157 (515)
Q Consensus 79 Iv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vK 157 (515)
+.+++++ ...++||||++|+.+.......... ..+++.++.+++.++.++|. .||+||||||+||+++ ++.++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence 5555543 2358999999985432211111111 16789999999999999999 9999999999999999 88999
Q ss_pred Eeecccccccc
Q 010214 158 IADFGLSNIMR 168 (515)
Q Consensus 158 L~DFGls~~~~ 168 (515)
|+|||.+....
T Consensus 155 liDfg~a~~~~ 165 (187)
T cd05119 155 IIDVPQAVEID 165 (187)
T ss_pred EEECccccccc
Confidence 99999986553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2e-17 Score=173.67 Aligned_cols=197 Identities=29% Similarity=0.480 Sum_probs=157.4
Q ss_pred HHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCCcE
Q 010214 71 LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMV-VHRDLKPENL 148 (515)
Q Consensus 71 l~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gI-vHrDLkpeNI 148 (515)
|+.+.|.|+.++++.+-++...++|.+||..|+|.|.+.. .-.++..-...++++|+.||.|||+..| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4578899999999999999999999999999999999986 4467777888899999999999998766 9999999999
Q ss_pred EECCCCceEEeecccccccccC---CccccCCCCCCccCCCcccCCcc------CCCcceeehhHHHHHHHHhCCCCCCC
Q 010214 149 LLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLY------AGPEVDVWSCGVILYALLCGTLPFDD 219 (515)
Q Consensus 149 Ll~~~~~vKL~DFGls~~~~~~---~~~~~~~gt~~Y~aPE~i~~~~~------~~~~~DIwSlGvily~lltG~~Pf~~ 219 (515)
++|....+||+|||+....... .......-...|.|||.+.+... .+.+.||||+|++++|+++...||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 9999999999999998776421 11111223456899999987422 25679999999999999999999976
Q ss_pred CC----hHHHHHHHhc-CccC-CCC-----CCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 220 EN----IPNLFKKIKG-GIYT-LPS-----HLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 220 ~~----~~~~~~~i~~-~~~~-~p~-----~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.. ..++...+.+ +... .|. ...+++..++..||..+|.+||+++++..
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 32 2345555555 2211 121 34557899999999999999999999865
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.3e-16 Score=155.97 Aligned_cols=138 Identities=19% Similarity=0.259 Sum_probs=106.8
Q ss_pred eeec-ccCceEEEEEEEcCCCcEEEEEEeccccc-----C-----ChHHHHHHHHHHHHHHhCCCCCc--cEEEEEEEcC
Q 010214 23 KTLG-IGSFGKVKIAEHALTGHKVAIKILNRRKI-----K-----NMEMEEKVRREIKILRLFMHPHI--IRLYEVIETP 89 (515)
Q Consensus 23 ~~LG-~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~-----~-----~~~~~~~i~~Ei~il~~l~hpnI--v~l~~~~~~~ 89 (515)
..|| .||.|+||.+... +..+++|.+.+... . +.....++.+|+.++..+.|++| ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 7888888888763 77899998865322 1 11234678899999999998875 7777765432
Q ss_pred C-e---EEEEEeccCC-CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccc
Q 010214 90 S-D---IYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 90 ~-~---~~iVmEy~~g-g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
. . .++|||+++| .+|.+++.. ..+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 2 2599999997 689888754 4566543 578999999999999999999999999999889999999988
Q ss_pred ccc
Q 010214 165 NIM 167 (515)
Q Consensus 165 ~~~ 167 (515)
...
T Consensus 190 ~~~ 192 (239)
T PRK01723 190 ELR 192 (239)
T ss_pred ccC
Confidence 653
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.7e-16 Score=138.60 Aligned_cols=132 Identities=23% Similarity=0.293 Sum_probs=113.2
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC--CCccEEEEEEEcCCeEEEEEec
Q 010214 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH--PHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~iVmEy 98 (515)
+++.||.|.++.||++.... ..+++|....... ...+.+|+..++.+++ +++++++.+....+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 46789999999999999743 7899999865432 4578899999999987 5999999998888889999999
Q ss_pred cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCcEEECCCCceEEeecccccc
Q 010214 99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN---MVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 99 ~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~---gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
++|+++..+ +......++.+++.++.++|.. +++|+|++|+||+++..+.++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 998877654 5567788899999999999984 799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2e-17 Score=181.75 Aligned_cols=262 Identities=27% Similarity=0.410 Sum_probs=214.0
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
.-.+.+.+.+-+-+|+++.++.+.-..+|...++|+..+...-.....+.+.++-.++-...+|.++....-+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 45678888899999999999999988889888888765433222222344445555544455676666555445566789
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-----
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR----- 168 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~----- 168 (515)
++++|..|++|...+..-+..+++-++..+..+..+++|||...+.|||++|.|+|...+|+.+++|||......
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 999999999999999988889999999999999999999999999999999999999999999999998322110
Q ss_pred ----------------c---------C--CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC
Q 010214 169 ----------------D---------G--HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN 221 (515)
Q Consensus 169 ----------------~---------~--~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~ 221 (515)
. + .......||+.|.+||...+... +..+|+|+.|+++++.++|..||....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 0 01223468999999999998876 789999999999999999999999999
Q ss_pred hHHHHHHHhcCccCCC---CCCChhHHHHhcccCCCCCCCCCCHH---HHhcCcccccccC
Q 010214 222 IPNLFKKIKGGIYTLP---SHLSPGARDLIPRMLIVDPMKRITIP---EIRQHPWFQAHLP 276 (515)
Q Consensus 222 ~~~~~~~i~~~~~~~p---~~~s~~~~~li~~mL~~dP~~Rpt~~---eil~hp~f~~~~~ 276 (515)
....+++|.++..+.| ...++++++++.++|..+|.+|..+. +...||||+..-.
T Consensus 1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 9999999999887766 46799999999999999999999987 8999999986533
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-16 Score=167.21 Aligned_cols=261 Identities=22% Similarity=0.243 Sum_probs=203.9
Q ss_pred CCCccccCCCceEeeeecc--cCceEEEEEEE--cCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEE
Q 010214 9 SSGVDMFLPNYKLGKTLGI--GSFGKVKIAEH--ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLY 83 (515)
Q Consensus 9 ~~~~~~~~~~Y~i~~~LG~--G~fg~Vy~a~~--~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~ 83 (515)
+.....+...+.+.+.+|. |.+|.||.+.. ..++..+|+|.-... .........=.+|+...+.++ |++.++.+
T Consensus 106 S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~ 184 (524)
T KOG0601|consen 106 SPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDS 184 (524)
T ss_pred CCccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccC
Confidence 3444556677888999999 99999999998 889999999973221 111111222345666666666 99999999
Q ss_pred EEEEcCCeEEEEEeccCCCCHHHHHHHhCC-CCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCCcEEECCC-CceE
Q 010214 84 EVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIIS----GVEYCHRNMVVHRDLKPENLLLDSK-WNVK 157 (515)
Q Consensus 84 ~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~-l~e~~~~~i~~qil~----aL~yLH~~gIvHrDLkpeNILl~~~-~~vK 157 (515)
..++..+..|+-+|+|. .+|..+...... +++..++..+.+..+ ||.++|..+++|-|+||.||++..+ ...+
T Consensus 185 ~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 185 PAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred cccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceee
Confidence 99999999999999995 699999887655 899999999999999 9999999999999999999999998 8999
Q ss_pred EeecccccccccCCccc------cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC--ChHHHHHHH
Q 010214 158 IADFGLSNIMRDGHFLK------TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE--NIPNLFKKI 229 (515)
Q Consensus 158 L~DFGls~~~~~~~~~~------~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~--~~~~~~~~i 229 (515)
++|||+...+.++.+.. ...|...|++||...+.. +...|++|+|.+..+..+|..++... +.-..++..
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 99999998887766432 225788999999998753 78999999999999988887666543 111111111
Q ss_pred hcCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 230 KGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 230 ~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
. ...++-...+.++...+..|+..+|..|++++.++.|+++...
T Consensus 342 ~-ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 342 Y-IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred c-CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 1 1111223456677779999999999999999999999998744
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=7e-15 Score=158.03 Aligned_cols=148 Identities=23% Similarity=0.346 Sum_probs=103.9
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccC---------------------------Ch----HHH
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK---------------------------NM----EME 61 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~---------------------------~~----~~~ 61 (515)
+.+...|.. +-||+|++|+||+|+.+.+|+.||||+..+.-.. .. +..
T Consensus 116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 116 EEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 444566776 7899999999999999988999999999754210 00 111
Q ss_pred HH------HHHHHHHHHhCC----CCCccEEEEEEEc-CCeEEEEEeccCCCCHHHH--HHHhC----CCCHHHHHHHHH
Q 010214 62 EK------VRREIKILRLFM----HPHIIRLYEVIET-PSDIYVVMEYVKSGELFDY--IVEKG----RLQEDEARNFFQ 124 (515)
Q Consensus 62 ~~------i~~Ei~il~~l~----hpnIv~l~~~~~~-~~~~~iVmEy~~gg~L~~~--i~~~~----~l~e~~~~~i~~ 124 (515)
+. +.+|...+.+++ +...+.+-.++.+ .+..++||||++|+.+.++ +...+ .+.+..+..++.
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 22 334555554443 4444444444432 4556899999999999874 33333 255555666666
Q ss_pred HHHHHHHHHHHCCceeccCCCCcEEECCCC----ceEEeecccccccc
Q 010214 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKW----NVKIADFGLSNIMR 168 (515)
Q Consensus 125 qil~aL~yLH~~gIvHrDLkpeNILl~~~~----~vKL~DFGls~~~~ 168 (515)
|++ ..|++|+|+||.||+++.+| .++++|||++....
T Consensus 275 Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 275 QVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 665 59999999999999999888 99999999987653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.4e-13 Score=145.98 Aligned_cols=142 Identities=23% Similarity=0.304 Sum_probs=98.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCCh---------------------------HH----------HHHHH
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---------------------------EM----------EEKVR 65 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~---------------------------~~----------~~~i~ 65 (515)
+.||+|++|+||+|+.+ +|+.||||+..+.-.... .. +-.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999975 799999999854311100 00 01234
Q ss_pred HHHHHHHhCC----CCCccEEEEEE-EcCCeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHH-HHHHHHHCCc
Q 010214 66 REIKILRLFM----HPHIIRLYEVI-ETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIIS-GVEYCHRNMV 138 (515)
Q Consensus 66 ~Ei~il~~l~----hpnIv~l~~~~-~~~~~~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~-aL~yLH~~gI 138 (515)
+|.+.+.+++ |.+-+.+-.++ +..+..++||||++|++|.++.... ... ....++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence 5666665553 22223333333 2234568999999999998876532 122 23456666665 4678999999
Q ss_pred eeccCCCCcEEECCCCceEEeecccccccc
Q 010214 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 139 vHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
+|+|+||.||+++.+|.++++|||++..+.
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999986653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=6.8e-13 Score=141.13 Aligned_cols=185 Identities=21% Similarity=0.313 Sum_probs=141.2
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
-|.+ ...+-++.+..-.|..+.++.+|.|.++..+.- ...+.+.+-++-|+.++||||+++++.+++.+.+|+|+|
T Consensus 14 pY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTE 89 (690)
T KOG1243|consen 14 PYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTE 89 (690)
T ss_pred Cccc-ccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEee
Confidence 3555 334444444222467778899999999865432 456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEECCCCceEEeecccccccccCCc-ccc
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH-RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKT 175 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH-~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~-~~~ 175 (515)
.+. .|..++++.+ .......+.||+.||.||| +.+++|++|.-..|+++..|..||++|.++........ ...
T Consensus 90 rV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~ 164 (690)
T KOG1243|consen 90 RVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKS 164 (690)
T ss_pred ccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccccc
Confidence 984 6788887654 7788888999999999998 67899999999999999999999999998754432211 111
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT 214 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~ 214 (515)
..---.|..|+.+.... -..|.|-|||++++++.|.
T Consensus 165 ~~~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 165 LYLIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred chhhhcccChhhcCccc---cchhhhhHHHHHHHHhCcc
Confidence 11222456666654322 3579999999999999993
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=7.3e-13 Score=124.77 Aligned_cols=142 Identities=18% Similarity=0.215 Sum_probs=105.0
Q ss_pred eeeecccCceEEEEEEEcC------CCcEEEEEEeccccc--CC-----------------hHHHHHH----HHHHHHHH
Q 010214 22 GKTLGIGSFGKVKIAEHAL------TGHKVAIKILNRRKI--KN-----------------MEMEEKV----RREIKILR 72 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~------tg~~vAiK~i~~~~~--~~-----------------~~~~~~i----~~Ei~il~ 72 (515)
...||.|.-+.||.|.... .+..+|||++..... ++ ......+ ++|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998643 357999999753211 00 1112233 38999999
Q ss_pred hCCC--CCccEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCcEE
Q 010214 73 LFMH--PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVVHRDLKPENLL 149 (515)
Q Consensus 73 ~l~h--pnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yL-H~~gIvHrDLkpeNIL 149 (515)
++.. -++.+++++ ..-++||||+.++.+..-..+...+++.++..++.|++.+|..| |+.|++|+||++.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8873 567777765 34579999997654433222344566777888999999999999 8999999999999999
Q ss_pred ECCCCceEEeecccccccc
Q 010214 150 LDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 150 l~~~~~vKL~DFGls~~~~ 168 (515)
++. +.+.|+|||.+....
T Consensus 158 ~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred EEC-CcEEEEECCCceeCC
Confidence 974 689999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.1e-13 Score=145.60 Aligned_cols=254 Identities=18% Similarity=0.156 Sum_probs=192.8
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEc-CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcC
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHA-LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETP 89 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~-~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~ 89 (515)
......+|..+..||.|.|+.|+..... .++..|++|-..+......+. ..-..|+.+...+. |.|++..+..+...
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh-hcchhhhhHhhHhhcccccCCCCCCcccc
Confidence 3345688999999999999999987755 678899999876544443332 33345555555554 99999999998888
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CceEEeecccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIMR 168 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~-~~vKL~DFGls~~~~ 168 (515)
...|+--|||+++++...+.....+.+...+++..|++.++.++|+..++|+|+||+||++..+ +..++.|||....+.
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 8889999999999988887666678999999999999999999999999999999999999886 789999999886421
Q ss_pred cCCccccCCCCCCcc-CCCcccCCccCCCcceeehhHHHHHHHHhCCCC-CCCCChHHHHHHHhcCccCCCCCCChhHHH
Q 010214 169 DGHFLKTSCGSPNYA-APEVISGKLYAGPEVDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYTLPSHLSPGARD 246 (515)
Q Consensus 169 ~~~~~~~~~gt~~Y~-aPE~i~~~~~~~~~~DIwSlGvily~lltG~~P-f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 246 (515)
-. .......-.+. .+|++........+.|++|||.-+++..+|... .... ....|..+...........+..
T Consensus 419 ~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~~~~~~~~q~ 492 (524)
T KOG0601|consen 419 FS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNLPGLKLQLQV 492 (524)
T ss_pred ee--cccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccccCCCchHHhhhh
Confidence 11 11112233344 355555444447899999999999999988643 2222 2234555655555555588899
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
+.+.++..++..|+.+.++..|.=|-
T Consensus 493 ~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 493 LLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhcCCccccchhhhhhcccchhh
Confidence 99999999999999999998886553
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.2e-14 Score=139.23 Aligned_cols=204 Identities=17% Similarity=0.255 Sum_probs=149.1
Q ss_pred HHHHHHHHhCCCCCccEEEEEEEcCC-----eEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHH
Q 010214 65 RREIKILRLFMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHR 135 (515)
Q Consensus 65 ~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~ 135 (515)
+.-...|-++-|.||++++.|+.+.+ ...++.||+..|+|..++++ ...+.....++|+.||++||.|||+
T Consensus 115 ~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs 194 (458)
T KOG1266|consen 115 RAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS 194 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc
Confidence 33344566677999999999985543 47889999999999999975 3458888999999999999999997
Q ss_pred C--CceeccCCCCcEEECCCCceEEeeccccccccc-----CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHH
Q 010214 136 N--MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-----GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY 208 (515)
Q Consensus 136 ~--gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-----~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily 208 (515)
. -|+|+++...-|++..+|-||+.--........ ........+-++|.|||.=.-... .-++|||++|....
T Consensus 195 ~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 195 CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCAL 273 (458)
T ss_pred cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHH
Confidence 6 599999999999999999888864332221110 011122346789999997544433 45899999999999
Q ss_pred HHHhCCCCC-CCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 209 ALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 209 ~lltG~~Pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
+|..|..-- ...+....-..|.+..+.+. .+.-++++.+||+-.|..||++.+++-||.+-
T Consensus 274 emailEiq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 274 EMAILEIQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred HHHHheeccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 999887542 33333333334433333222 22346799999999999999999999999764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.42 E-value=8.2e-13 Score=121.39 Aligned_cols=127 Identities=20% Similarity=0.218 Sum_probs=96.6
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc-cEEEEEEEcCCeEEEEEeccC
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVVMEYVK 100 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~iVmEy~~ 100 (515)
++.|+.|.++.||+++.. +..|++|+...... ......+|+.+++.+.+.++ .+++.+.. ..-++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999864 78899998754421 12245789999988875443 45665543 23479999999
Q ss_pred CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCcEEECCCCceEEeeccccc
Q 010214 101 SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV-----VHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 101 gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gI-----vHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
|.++.+. .......+.+++.+|..||+.++ +|+|++|+||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887643 11224567899999999999885 9999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.2e-11 Score=109.77 Aligned_cols=135 Identities=22% Similarity=0.325 Sum_probs=101.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHH-----HHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM-----EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~-----~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
..+++|+-+.++.+.. -|.++.+|.=.++....+.. ..+..+|.+++..+.--.|.-.+=+..++....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4578999999999966 34457777654444444443 3555689999988875555444444456677789999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
|++|..|.+++... ...++..+=.-+.-||..||+|+||.++||++..+ ++.++|||++...
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~s 141 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFS 141 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCccccc
Confidence 99998888888765 24566667777788999999999999999999876 4999999998643
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.4e-10 Score=105.96 Aligned_cols=145 Identities=21% Similarity=0.253 Sum_probs=109.4
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh-----HHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-----EMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~-----~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
....|-+|+-+.|+++.. .|+.+.||.=..+....+ -...+..+|++.|.++.--.|.-..=++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567889999999999976 688888886444333332 2456778999999988855554444455566666799
Q ss_pred EeccCC-CCHHHHHHHhC-CCCHHH-HHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---ceEEeeccccccc
Q 010214 96 MEYVKS-GELFDYIVEKG-RLQEDE-ARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVKIADFGLSNIM 167 (515)
Q Consensus 96 mEy~~g-g~L~~~i~~~~-~l~e~~-~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~---~vKL~DFGls~~~ 167 (515)
|||++| .++.+++.... .-.+++ ...++.+|-+.+.-||.++|+|+||..+||++..++ .+.++|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999987 47888887543 223333 378999999999999999999999999999997654 3589999998643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.2e-11 Score=113.41 Aligned_cols=140 Identities=21% Similarity=0.312 Sum_probs=107.3
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC--CCccEEEEEEEcCC---eEEEEEe
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH--PHIIRLYEVIETPS---DIYVVME 97 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h--pnIv~l~~~~~~~~---~~~iVmE 97 (515)
+.||.|..+.||++... +|..+++|+....... .....+.+|.++++.+.+ ..+.+++.+..... ..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 56899999999999875 3688999997654321 124567899999999986 44677887765532 5689999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR------------------------------------------ 135 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~------------------------------------------ 135 (515)
|++|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888775432 456777777778888888888873
Q ss_pred --------------CCceeccCCCCcEEECC--CCceEEeecccccc
Q 010214 136 --------------NMVVHRDLKPENLLLDS--KWNVKIADFGLSNI 166 (515)
Q Consensus 136 --------------~gIvHrDLkpeNILl~~--~~~vKL~DFGls~~ 166 (515)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 66789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.2e-10 Score=116.03 Aligned_cols=211 Identities=16% Similarity=0.280 Sum_probs=158.5
Q ss_pred ceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc----CCeEEEEEeccCC-CCH
Q 010214 30 FGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----PSDIYVVMEYVKS-GEL 104 (515)
Q Consensus 30 fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~iVmEy~~g-g~L 104 (515)
-.+.|++....+|..|++|.++-.+.... .+...-.+.++++.|+|+|++.+++.+ +..+++|++|.++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 45789999999999999999954443322 233345778899999999999999864 3458999999876 467
Q ss_pred HHHHHH---------------hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 105 FDYIVE---------------KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 105 ~~~i~~---------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
.++--. +...+|+..|.++.|+..||.++|+.|+.-+-|.|.+||++.+.+++|+..|.......
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 664421 22478999999999999999999999999999999999999999999999888776644
Q ss_pred CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCC-CCChHHH-HHHHhcCccCCCCCCChhHHHH
Q 010214 170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNL-FKKIKGGIYTLPSHLSPGARDL 247 (515)
Q Consensus 170 ~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~-~~~~~~~-~~~i~~~~~~~p~~~s~~~~~l 247 (515)
.. + |-+.+. .+-|.=-||.++..|.||..--. .+..... .+.| -..+|.+++++
T Consensus 446 d~------~-------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------~~~yS~D~rn~ 501 (655)
T KOG3741|consen 446 DP------T-------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------TTTYSTDLRNV 501 (655)
T ss_pred CC------C-------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------hhhhhHHHHHH
Confidence 32 0 112222 35688899999999999964321 1111221 2222 24578999999
Q ss_pred hcccCCCCCCCCCCHHHHhcC
Q 010214 248 IPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~h 268 (515)
|.-+...++.+ -++.+++.|
T Consensus 502 v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 502 VEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHhcCccc-ccHHHHHHH
Confidence 99999998887 788888875
|
|
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.11 E-value=1e-10 Score=83.42 Aligned_cols=44 Identities=36% Similarity=0.697 Sum_probs=39.6
Q ss_pred ceEEEEEEEeeec-CCceeEEeecccCCceehHHHHHHHHHHHhc
Q 010214 471 NVVKFEVQLYKTR-DEKYLLDLQRVQGPQFLFLDLCAAFLAQLRV 514 (515)
Q Consensus 471 ~~~k~~lQLyk~~-~~~yllDf~~~~g~~~~f~~~c~~~i~~l~~ 514 (515)
..++||||+||++ .+.|.|||||++|+++.|.++|++++++|+.
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~il~~l~L 47 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSKILNELRL 47 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHHHHHHTT-
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHHHHHHccC
Confidence 4699999999999 8999999999999999999999999999974
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=7.2e-09 Score=102.82 Aligned_cols=134 Identities=15% Similarity=0.137 Sum_probs=96.6
Q ss_pred eEEEEEEEcCCCcEEEEEEecccccCC----h----HHHHHHHHHHHHHHhCCCCC--ccEEEEEEEc-----CCeEEEE
Q 010214 31 GKVKIAEHALTGHKVAIKILNRRKIKN----M----EMEEKVRREIKILRLFMHPH--IIRLYEVIET-----PSDIYVV 95 (515)
Q Consensus 31 g~Vy~a~~~~tg~~vAiK~i~~~~~~~----~----~~~~~i~~Ei~il~~l~hpn--Iv~l~~~~~~-----~~~~~iV 95 (515)
..|..+.. .|+.|.||......... . .....+.+|...+..+..-+ .+.+..+.+. ....++|
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 33555543 67789999764333110 0 01124778999988875333 3344445443 2357899
Q ss_pred EeccCCC-CHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-------CCceEEeeccccc
Q 010214 96 MEYVKSG-ELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-------KWNVKIADFGLSN 165 (515)
Q Consensus 96 mEy~~gg-~L~~~i~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-------~~~vKL~DFGls~ 165 (515)
||++++. +|.+++.. ....++.....++.+++..+.-||.+||+|+|+++.|||++. ++.+.++||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999875 79998864 345677788899999999999999999999999999999975 4689999999875
Q ss_pred c
Q 010214 166 I 166 (515)
Q Consensus 166 ~ 166 (515)
.
T Consensus 194 ~ 194 (268)
T PRK15123 194 I 194 (268)
T ss_pred c
Confidence 3
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.2e-09 Score=102.47 Aligned_cols=128 Identities=25% Similarity=0.345 Sum_probs=86.1
Q ss_pred EEEEEEEcCCCcEEEEEEeccccc-----------------------CChHHHHHHHHHHHHHHhCCCC--CccEEEEEE
Q 010214 32 KVKIAEHALTGHKVAIKILNRRKI-----------------------KNMEMEEKVRREIKILRLFMHP--HIIRLYEVI 86 (515)
Q Consensus 32 ~Vy~a~~~~tg~~vAiK~i~~~~~-----------------------~~~~~~~~i~~Ei~il~~l~hp--nIv~l~~~~ 86 (515)
.||.|... .|..+|+|+...... .........++|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38888864 678999999753210 1111345678999999999865 577777653
Q ss_pred EcCCeEEEEEeccC--CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHH-HHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 87 ETPSDIYVVMEYVK--SGELFDYIVEKGRLQEDEARNFFQQIISGVEY-CHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 87 ~~~~~~~iVmEy~~--gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~y-LH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
.-++||||++ |..+..+.. ..++.+....++.+++..+.. +|+.||+|+||.+.|||++++ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~--~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKD--VDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHH--CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHh--ccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2369999998 655544332 122355678888899886665 579999999999999999987 999999998
Q ss_pred cccc
Q 010214 164 SNIM 167 (515)
Q Consensus 164 s~~~ 167 (515)
+...
T Consensus 153 av~~ 156 (188)
T PF01163_consen 153 AVDS 156 (188)
T ss_dssp EEET
T ss_pred ceec
Confidence 7654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.2e-10 Score=121.41 Aligned_cols=150 Identities=22% Similarity=0.379 Sum_probs=114.1
Q ss_pred HHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccCCcc-----c-----cCCCCCCccCCCcccCCc
Q 010214 124 QQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-----K-----TSCGSPNYAAPEVISGKL 192 (515)
Q Consensus 124 ~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~-----~-----~~~gt~~Y~aPE~i~~~~ 192 (515)
.+...|+.|+|+ .++||++|.|++|.++.+|.+||+.|+++.....+... . ...-...|.|||++.+..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 344499999996 58999999999999999999999999987654332110 0 112356899999999854
Q ss_pred cCCCcceeehhHHHHHHHH-hCCCCCCCCChHHHHHH----HhcCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 193 YAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKK----IKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 193 ~~~~~~DIwSlGvily~ll-tG~~Pf~~~~~~~~~~~----i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
. ++++|++|+||++|.+. .|+..+...+....... ...+....+..+++++++=+.++|..++..||++.++..
T Consensus 186 ~-~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 186 N-TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred c-cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 4 79999999999999999 56666655432221111 112234455788999999999999999999999999999
Q ss_pred Ccccccc
Q 010214 268 HPWFQAH 274 (515)
Q Consensus 268 hp~f~~~ 274 (515)
-|||++-
T Consensus 265 ~~ff~D~ 271 (700)
T KOG2137|consen 265 IPFFSDP 271 (700)
T ss_pred ccccCCc
Confidence 9999864
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.2e-08 Score=95.66 Aligned_cols=127 Identities=17% Similarity=0.223 Sum_probs=95.4
Q ss_pred CCcEEEEEEecccccCC----hHHHHHHHHHHHHHHhCCCC--CccEEEEEEEcC----CeEEEEEeccCCC-CHHHHHH
Q 010214 41 TGHKVAIKILNRRKIKN----MEMEEKVRREIKILRLFMHP--HIIRLYEVIETP----SDIYVVMEYVKSG-ELFDYIV 109 (515)
Q Consensus 41 tg~~vAiK~i~~~~~~~----~~~~~~i~~Ei~il~~l~hp--nIv~l~~~~~~~----~~~~iVmEy~~gg-~L~~~i~ 109 (515)
.++.+-+|.....-..+ .-...+..+|...+..|..- .+.+.+.+.+.. ...++|+|+++|. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 45566666543221111 12345678898888777633 345666666543 2468999999884 7999998
Q ss_pred HhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---ceEEeeccccccc
Q 010214 110 EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVKIADFGLSNIM 167 (515)
Q Consensus 110 ~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~---~vKL~DFGls~~~ 167 (515)
.....+......++.++...+.-||.+||+|+|++|.|||++.++ .+.++||+-+...
T Consensus 111 ~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 755678888999999999999999999999999999999999887 8999999977643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.7e-08 Score=96.59 Aligned_cols=138 Identities=23% Similarity=0.333 Sum_probs=105.4
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccc------------------cC-ChHHHHHHHHHHHHHHhCCCC--
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRK------------------IK-NMEMEEKVRREIKILRLFMHP-- 77 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~------------------~~-~~~~~~~i~~Ei~il~~l~hp-- 77 (515)
+.++..||.|.-|.||.|.+. .|.++|||.-..-. .. -.-.....++|.++|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 467889999999999999976 78999999742100 00 011235568999999998755
Q ss_pred CccEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceE
Q 010214 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK 157 (515)
Q Consensus 78 nIv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vK 157 (515)
.+.+.+++ +.-.+|||+++|-.|... +++.+.+..++..|+.-+.-.-+.||||+|+.+-||+++++|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 67776664 345799999999777542 234666777788888877777799999999999999999999999
Q ss_pred Eeecccccc
Q 010214 158 IADFGLSNI 166 (515)
Q Consensus 158 L~DFGls~~ 166 (515)
++||--+..
T Consensus 243 vIDwPQ~v~ 251 (304)
T COG0478 243 VIDWPQAVP 251 (304)
T ss_pred EEeCccccc
Confidence 999976543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.8e-08 Score=99.36 Aligned_cols=235 Identities=18% Similarity=0.188 Sum_probs=156.6
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccE--------EEEEEEcCCe
Q 010214 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIR--------LYEVIETPSD 91 (515)
Q Consensus 20 ~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~--------l~~~~~~~~~ 91 (515)
..++.||+|+-+.+|..-.. ...+-|++.+..... ..+... .+-+--.||-+-. +++- .....
T Consensus 14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~---~aqk~a--~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAA---QAQKVA--ELAATPDAPLLNYRVAWPQATLHGG-RRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchh---hchhheeecCCCchH---HHHHHH--HhccCCCCcchhhhhcccHHHhhCC-Cccce
Confidence 45678999999999965422 224568877654221 111111 1122234554332 1111 11223
Q ss_pred EEEEEeccCCCCHH-HHHH---Hh---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccc
Q 010214 92 IYVVMEYVKSGELF-DYIV---EK---GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 92 ~~iVmEy~~gg~L~-~~i~---~~---~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
+-+.|..++|..-- ++.. +. ....++-+.+.++.|+.+.+-||..|.+-+|++++|+|+++++.|.|+|-..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 78899998875322 2221 11 23667888999999999999999999999999999999999999999997665
Q ss_pred cccccCCccccCCCCCCccCCCcccCCc----cCCCcceeehhHHHHHHHHhC-CCCCCCCC----hH-HHHHHHhcCcc
Q 010214 165 NIMRDGHFLKTSCGSPNYAAPEVISGKL----YAGPEVDVWSCGVILYALLCG-TLPFDDEN----IP-NLFKKIKGGIY 234 (515)
Q Consensus 165 ~~~~~~~~~~~~~gt~~Y~aPE~i~~~~----~~~~~~DIwSlGvily~lltG-~~Pf~~~~----~~-~~~~~i~~~~~ 234 (515)
....++......+|.+.|.+||...-.. ..+...|.|.|||+++++|.| ++||.+-. .+ -.-..|..+.+
T Consensus 165 qi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 165 QINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred eeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 5556677777889999999999765211 125679999999999999986 99997631 11 11123433332
Q ss_pred C-----------CC-----CCCChhHHHHhcccCCC--CCCCCCCHH
Q 010214 235 T-----------LP-----SHLSPGARDLIPRMLIV--DPMKRITIP 263 (515)
Q Consensus 235 ~-----------~p-----~~~s~~~~~li~~mL~~--dP~~Rpt~~ 263 (515)
. .| +-+++++..|..+|+.. ++.-|||++
T Consensus 245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 1 11 24678888999888875 466899875
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.72 E-value=1e-07 Score=90.77 Aligned_cols=141 Identities=21% Similarity=0.261 Sum_probs=95.2
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHH------HHHHHHHHHHHhCC---CCCccEEEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME------EKVRREIKILRLFM---HPHIIRLYE 84 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~------~~i~~Ei~il~~l~---hpnIv~l~~ 84 (515)
.+.++|.+.+.+-......|.+.. .+|+.+++|............. ....+++..+..++ -.....++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 456789999999988888787775 3678999998754322111111 11234444444443 233333333
Q ss_pred EEE-----cCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEe
Q 010214 85 VIE-----TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIA 159 (515)
Q Consensus 85 ~~~-----~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~ 159 (515)
+.+ -....+++|||++|.+|.+... +++ .+...|.+++.-+|+.|++|+|.+|.|++++.+ .++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iI 176 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRII 176 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEE
Confidence 332 2345678999999988876532 333 345677788999999999999999999999965 59999
Q ss_pred eccccc
Q 010214 160 DFGLSN 165 (515)
Q Consensus 160 DFGls~ 165 (515)
||+..+
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=6.2e-07 Score=85.09 Aligned_cols=138 Identities=11% Similarity=0.148 Sum_probs=100.8
Q ss_pred cccCceEEEEEEEcCCCcEEEEEEeccc---ccCChHHHHHHHHHHHHHHhCCCCC--ccEEEEEEE---cC--CeEEEE
Q 010214 26 GIGSFGKVKIAEHALTGHKVAIKILNRR---KIKNMEMEEKVRREIKILRLFMHPH--IIRLYEVIE---TP--SDIYVV 95 (515)
Q Consensus 26 G~G~fg~Vy~a~~~~tg~~vAiK~i~~~---~~~~~~~~~~i~~Ei~il~~l~hpn--Iv~l~~~~~---~~--~~~~iV 95 (515)
|+||-+.|+.... .|+.+-+|.-... ...-......+.+|+..+..+..-+ +.++. ++. .+ -.-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 6688888998765 3456888865311 1111224577889999998886322 44444 222 11 236899
Q ss_pred EeccCC-CCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc--eEEeecccccc
Q 010214 96 MEYVKS-GELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN--VKIADFGLSNI 166 (515)
Q Consensus 96 mEy~~g-g~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~--vKL~DFGls~~ 166 (515)
+|-+.| -+|.+++.+. .+.++.....++.++..++.-||+.|+.|+|+.+.|||++.+|. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997754 5888888653 35678888999999999999999999999999999999987777 99999987653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.5e-08 Score=107.68 Aligned_cols=250 Identities=19% Similarity=0.151 Sum_probs=176.1
Q ss_pred CCCCCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCC-ccEEEEE
Q 010214 7 RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIRLYEV 85 (515)
Q Consensus 7 ~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~ 85 (515)
...........-|.....+++|+++++++.+...+...+ .+++... ....-++++|.+++||| .+..++-
T Consensus 232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d 302 (829)
T KOG0576|consen 232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLED 302 (829)
T ss_pred CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCccccccc
Confidence 344455566667778888999999999998876555444 5555322 34456889999999999 6666666
Q ss_pred EEcCCeEEEEEeccCCC-CHHH-HHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 86 IETPSDIYVVMEYVKSG-ELFD-YIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 86 ~~~~~~~~iVmEy~~gg-~L~~-~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
++.+...+++|+++.++ +-.. .-...-.+.+-+...+.+.=+.+++++|+.-=+||| ||+..+ +..|..||+.
T Consensus 303 ~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v 377 (829)
T KOG0576|consen 303 YDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAV 377 (829)
T ss_pred CCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccC
Confidence 67778899999999887 2111 111112234445556667778899999998778998 888766 5899999999
Q ss_pred ccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCC-----
Q 010214 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----- 238 (515)
Q Consensus 164 s~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~----- 238 (515)
...+.....-++..+++.++|||+..+..+ ....|.||+|+-..+|.-|.+|-... ......+-.+. ..|.
T Consensus 378 ~~~L~~~~~~~t~~~~~~~~~pev~~~~~~-~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~p-~s~~L~~~~ 453 (829)
T KOG0576|consen 378 PPQLTRTMKPRTAIGTPEPLAPEVIQENTI-DGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNGP-NSPMLTDKS 453 (829)
T ss_pred CcccCcccccccCCCCCCCCCchhhccccc-ccCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCCC-Cccccchhh
Confidence 887776666678899999999999988877 57899999998777777787775441 11000111110 0010
Q ss_pred CCChhH-HHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 239 HLSPGA-RDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 239 ~~s~~~-~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..++.. .++...|+..-|..|++...++.|.+|...
T Consensus 454 aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 454 AWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred hcCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 011111 257888999999999999999999999754
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.4e-07 Score=101.39 Aligned_cols=138 Identities=23% Similarity=0.351 Sum_probs=91.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccccc---------------------------CChHH----------HHHHH
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI---------------------------KNMEM----------EEKVR 65 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~---------------------------~~~~~----------~~~i~ 65 (515)
+-|+.++-|+||.|+.+ +|+.||||+..+.-. .-... +-.+.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56899999999999987 599999999753210 00011 11134
Q ss_pred HHHHHHHhCC-----CCCccEEEEEE-EcCCeEEEEEeccCCCCHHHHHH-HhCCCCHH-----HHHHHHHHHHHHHHHH
Q 010214 66 REIKILRLFM-----HPHIIRLYEVI-ETPSDIYVVMEYVKSGELFDYIV-EKGRLQED-----EARNFFQQIISGVEYC 133 (515)
Q Consensus 66 ~Ei~il~~l~-----hpnIv~l~~~~-~~~~~~~iVmEy~~gg~L~~~i~-~~~~l~e~-----~~~~i~~qil~aL~yL 133 (515)
+|...+.+++ .|++ ++=.++ +-.+.-.++|||++|-.+.+... +....+.. -+..++.|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~------- 281 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQL------- 281 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHH-------
Confidence 5666665554 2333 333333 33455679999999988888742 22334422 223333333
Q ss_pred HHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 134 H~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
=..|++|.|.+|.||+++.+|.+-+.|||+.....+
T Consensus 282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 348999999999999999999999999999876543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.2e-07 Score=87.54 Aligned_cols=138 Identities=20% Similarity=0.237 Sum_probs=97.9
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEecccccCChHH---------------------HHHHHHHHHHHHhCC--CCCcc
Q 010214 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM---------------------EEKVRREIKILRLFM--HPHII 80 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~---------------------~~~i~~Ei~il~~l~--hpnIv 80 (515)
.|+.|.-+.||+|.. .++..+|+|++......-... ..-...|...|+++. +-.+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 677788889999875 468899999986433221111 122356888888876 44556
Q ss_pred EEEEEEEcCCeEEEEEeccCCCCH-HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEE
Q 010214 81 RLYEVIETPSDIYVVMEYVKSGEL-FDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKI 158 (515)
Q Consensus 81 ~l~~~~~~~~~~~iVmEy~~gg~L-~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL 158 (515)
+.+.+. .-.+||||+..... .-.+ +.-++..+++..+..+++..+.-|-. .++||+||..-|||+. ++.+.|
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i 207 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI 207 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence 666664 34699999954311 1111 12234444899999999999998877 9999999999999999 779999
Q ss_pred eecccccccc
Q 010214 159 ADFGLSNIMR 168 (515)
Q Consensus 159 ~DFGls~~~~ 168 (515)
+|||-|....
T Consensus 208 ID~~QaV~~~ 217 (268)
T COG1718 208 IDVSQAVTID 217 (268)
T ss_pred EECccccccC
Confidence 9999886554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.2e-06 Score=84.87 Aligned_cols=133 Identities=15% Similarity=0.174 Sum_probs=85.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCC--CccEEEEEEEcCCeEEEEEeccC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP--HIIRLYEVIETPSDIYVVMEYVK 100 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~~~~~~~~~~~iVmEy~~ 100 (515)
..||.|..+.||+. .|..+++|...... ....+.+|.++++.+..- .+.+.+.+.+..+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 46899999999974 25568899875422 234578999999988743 35788888888888899999999
Q ss_pred CCC-HH--------------HHHHH-----h----CCCCHHH-HHHHHHH----------HHH-HHHHHH----HCCcee
Q 010214 101 SGE-LF--------------DYIVE-----K----GRLQEDE-ARNFFQQ----------IIS-GVEYCH----RNMVVH 140 (515)
Q Consensus 101 gg~-L~--------------~~i~~-----~----~~l~e~~-~~~i~~q----------il~-aL~yLH----~~gIvH 140 (515)
|.+ +. ..+.+ + ...+... ...+..+ +.. ...+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 11 11111 0 0111000 0111000 111 112222 124789
Q ss_pred ccCCCCcEEECCCCceEEeeccccc
Q 010214 141 RDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 141 rDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
+|+.|.||++++++ +.|+||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999888 9999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.50 E-value=9.8e-07 Score=99.82 Aligned_cols=204 Identities=19% Similarity=0.216 Sum_probs=152.2
Q ss_pred HHHHHHHHHHHHhCCCCCccEEEEEEEcCCe----EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC
Q 010214 61 EEKVRREIKILRLFMHPHIIRLYEVIETPSD----IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136 (515)
Q Consensus 61 ~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~----~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~ 136 (515)
.....-|+..+....|+|++.++.+--.... ..+..|+|.+.++.+.+...+..+.+..+.+..++++|+.|+|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 4445667788889999999999988644333 335568999999999999999999999999999999999999998
Q ss_pred CceeccCCCC---cEEECCCCceEEe--ecccccccccCCccccCCCCCCccCCCcccCCccC-CCcceeehhHHHHHHH
Q 010214 137 MVVHRDLKPE---NLLLDSKWNVKIA--DFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA-GPEVDVWSCGVILYAL 210 (515)
Q Consensus 137 gIvHrDLkpe---NILl~~~~~vKL~--DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~-~~~~DIwSlGvily~l 210 (515)
...|.-+... +-..+..+.+.++ ||+.+....+........-+..+.+||......+. +...|+|.+|..+..+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence 7666655555 4445566777777 99988877666555555667778888888765542 2236999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 211 LCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 211 ltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
..|..+-..... ...+ ++.....+..+++.+|+.-++++|+++.+++.|||.+.
T Consensus 386 ~~~~~i~~~~~~---~~~~------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 386 SQGEDISEKSAV---PVSL------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred hhcCcccccccc---hhhh------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence 987654221111 1111 11111226788999999999999999999999999864
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.1e-06 Score=82.34 Aligned_cols=137 Identities=22% Similarity=0.308 Sum_probs=83.4
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCC--CccEEEEEE---EcCCeEEEEE
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP--HIIRLYEVI---ETPSDIYVVM 96 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~~~~---~~~~~~~iVm 96 (515)
++.|+.|..+.||.+.... ..+++|+.... .....+.+|..+++.+... .+.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4679999999999998754 48999986543 3457788899998887633 356676644 2334579999
Q ss_pred eccCCCCHHH----------------HHH---Hh----CCCCHHH------HHHH---------------HHHHHH-HHH
Q 010214 97 EYVKSGELFD----------------YIV---EK----GRLQEDE------ARNF---------------FQQIIS-GVE 131 (515)
Q Consensus 97 Ey~~gg~L~~----------------~i~---~~----~~l~e~~------~~~i---------------~~qil~-aL~ 131 (515)
++++|..+.. .+. +. ....... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988777 111 11 0001000 0000 111222 233
Q ss_pred HHHH-------CCceeccCCCCcEEEC-CCCceEEeeccccc
Q 010214 132 YCHR-------NMVVHRDLKPENLLLD-SKWNVKIADFGLSN 165 (515)
Q Consensus 132 yLH~-------~gIvHrDLkpeNILl~-~~~~vKL~DFGls~ 165 (515)
.+++ ..++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3332 3599999999999999 66777899999774
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.27 E-value=8.8e-06 Score=79.56 Aligned_cols=133 Identities=14% Similarity=0.071 Sum_probs=82.8
Q ss_pred ecccCc-eEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEEEeccCCC
Q 010214 25 LGIGSF-GKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVMEYVKSG 102 (515)
Q Consensus 25 LG~G~f-g~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iVmEy~~gg 102 (515)
|..|.. +.||++... +..+.+|+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 344444 789998753 4688999875432 235678898888875 344668888877766789999999997
Q ss_pred CHHHHH---------H-------H--hC-----CCCHH------HHHHHHH----------------HHHHHHHHHH---
Q 010214 103 ELFDYI---------V-------E--KG-----RLQED------EARNFFQ----------------QIISGVEYCH--- 134 (515)
Q Consensus 103 ~L~~~i---------~-------~--~~-----~l~e~------~~~~i~~----------------qil~aL~yLH--- 134 (515)
+|.... . + .- ++... .....+. .+...+..|-
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 776431 0 0 00 01100 0000000 0111122221
Q ss_pred ----HCCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 135 ----RNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 135 ----~~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2348999999999999998778899999774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=4.8e-06 Score=89.43 Aligned_cols=139 Identities=19% Similarity=0.302 Sum_probs=87.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCCh-----------------------------HHHHH------HHHH
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-----------------------------EMEEK------VRRE 67 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~-----------------------------~~~~~------i~~E 67 (515)
+.||.-+.|+|++|+.+. |+.||||+-++. +... +..+. +.+|
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 579999999999999875 999999985432 1110 00111 2234
Q ss_pred HHHHH----hCCCCC------ccEEEEEEEcCCeEEEEEeccCCCCHHH--HHHHhCCCCHHHHHHHHHHHHHHHHHHHH
Q 010214 68 IKILR----LFMHPH------IIRLYEVIETPSDIYVVMEYVKSGELFD--YIVEKGRLQEDEARNFFQQIISGVEYCHR 135 (515)
Q Consensus 68 i~il~----~l~hpn------Iv~l~~~~~~~~~~~iVmEy~~gg~L~~--~i~~~~~l~e~~~~~i~~qil~aL~yLH~ 135 (515)
.+... .+.|-+ |.++|--+ .+.-.++||||+|..+.| +|.+. .++...+..-+.+...- -+=.
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~~--qIf~ 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYLE--QIFK 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHHH--HHHh
Confidence 44333 333444 44444333 334679999999986654 44443 35555443333332221 1225
Q ss_pred CCceeccCCCCcEEECC----CCceEEeecccccccc
Q 010214 136 NMVVHRDLKPENLLLDS----KWNVKIADFGLSNIMR 168 (515)
Q Consensus 136 ~gIvHrDLkpeNILl~~----~~~vKL~DFGls~~~~ 168 (515)
.|++|+|-+|.||+++. ++.+.+.|||+.....
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 78999999999999983 6789999999986553
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.4e-05 Score=74.11 Aligned_cols=130 Identities=24% Similarity=0.382 Sum_probs=94.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccccc-------------CChHHHHHHHHHHHHHHhCC------CCCccEEE
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI-------------KNMEMEEKVRREIKILRLFM------HPHIIRLY 83 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~-------------~~~~~~~~i~~Ei~il~~l~------hpnIv~l~ 83 (515)
..||+|+.-.|| .|.. .....||+...... ..........+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy--~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCY--QHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEE--ECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 468999999999 4553 34578999876650 01112456677777776666 78999999
Q ss_pred EEEEcCCeEEEEEeccCC------CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---
Q 010214 84 EVIETPSDIYVVMEYVKS------GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW--- 154 (515)
Q Consensus 84 ~~~~~~~~~~iVmEy~~g------g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~--- 154 (515)
++.+|+....+|+|.+.. -+|.+++. .+.+++ ..+. .+-.-..||-+++|+.+|++|.||++....
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK-EGGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH-cCCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999999998632 36888884 445665 4343 344455688899999999999999996432
Q ss_pred -ceEEee
Q 010214 155 -NVKIAD 160 (515)
Q Consensus 155 -~vKL~D 160 (515)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 577887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.1e-05 Score=89.03 Aligned_cols=144 Identities=19% Similarity=0.349 Sum_probs=92.4
Q ss_pred EeeeecccCceEEEEEEEcCCC--cEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCc--cEEEEEEEcC---CeE
Q 010214 21 LGKTLGIGSFGKVKIAEHALTG--HKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHI--IRLYEVIETP---SDI 92 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~tg--~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnI--v~l~~~~~~~---~~~ 92 (515)
-++.++.|.+..+|+......+ ..+++|+........ ....+.+|+++|+.+. |+++ .+++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3577899999999998765433 468888765432211 2356889999999996 6665 7888887664 457
Q ss_pred EEEEeccCCCCHHH--------------------HHHH-hC------CC---------CHHHHHHHHHH-----------
Q 010214 93 YVVMEYVKSGELFD--------------------YIVE-KG------RL---------QEDEARNFFQQ----------- 125 (515)
Q Consensus 93 ~iVmEy~~gg~L~~--------------------~i~~-~~------~l---------~e~~~~~i~~q----------- 125 (515)
|+||||++|..+.+ .+.. +. .+ ...++..|..|
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 89999998864321 1110 00 00 11233332222
Q ss_pred ----HHHHHHHHHH-----------CCceeccCCCCcEEECCC-Cc-eEEeecccccc
Q 010214 126 ----IISGVEYCHR-----------NMVVHRDLKPENLLLDSK-WN-VKIADFGLSNI 166 (515)
Q Consensus 126 ----il~aL~yLH~-----------~gIvHrDLkpeNILl~~~-~~-vKL~DFGls~~ 166 (515)
+...+.+|.. ..+||+|+++.|||++.+ +. +-|.||+++..
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 2234566632 249999999999999853 33 57999998765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.6e-05 Score=72.94 Aligned_cols=130 Identities=23% Similarity=0.325 Sum_probs=92.5
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc-cEEEEEEEcCCeEEEEEec
Q 010214 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 20 ~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~iVmEy 98 (515)
+..+.||+|.+|.||++.+ .|..+|+|+-..+. ....+..|.++|..+...++ .++|.+.+ .++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhh
Confidence 4567899999999999997 46689999854433 34678899999999987665 45565543 3456999
Q ss_pred cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC-CCcEEECCCCceEEeeccccccc
Q 010214 99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK-PENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 99 ~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLk-peNILl~~~~~vKL~DFGls~~~ 167 (515)
+.|-+|.+.-... -++-...++++---|...||-|+.|. |...++-.++.+.|+||.-++..
T Consensus 94 i~G~~L~~~~~~~-------~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 94 IDGRPLGKLEIGG-------DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hcCcchhhhhhcc-------cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 9998887654211 13334445555555778899999986 44444445559999999988744
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.08 E-value=6e-05 Score=71.13 Aligned_cols=129 Identities=21% Similarity=0.247 Sum_probs=90.8
Q ss_pred CCCceEeeeecccCc-eEEEEEEEcCCCcEEEEEEecc---ccc-------CCh--------HHHHHHHHHHHHHHhCC-
Q 010214 16 LPNYKLGKTLGIGSF-GKVKIAEHALTGHKVAIKILNR---RKI-------KNM--------EMEEKVRREIKILRLFM- 75 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~f-g~Vy~a~~~~tg~~vAiK~i~~---~~~-------~~~--------~~~~~i~~Ei~il~~l~- 75 (515)
..++++++.||.|+- |.||+++. .|+.||+|++.. ... ... ....-+..|.+..-+|+
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 378999999999999 99999986 688999999321 110 000 12234566777655554
Q ss_pred --CCCc--cEEEEEEEcC------------------CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHH
Q 010214 76 --HPHI--IRLYEVIETP------------------SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133 (515)
Q Consensus 76 --hpnI--v~l~~~~~~~------------------~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yL 133 (515)
+.++ ++++++..-. ...-||.||++... .++ ..-+.+|++-+..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHH
Confidence 5566 9999987211 12467888887643 222 23356677778889
Q ss_pred HHCCceeccCCCCcEEECCCCceEEeecccc
Q 010214 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 134 H~~gIvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
|..||+-+|+++.|.. .=||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999987 3489999864
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=2.8e-07 Score=105.92 Aligned_cols=208 Identities=19% Similarity=0.101 Sum_probs=152.2
Q ss_pred HHHHHHHHHhCCCCCccEEEEEEE--cCCeEEEEEeccCCCCHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC-
Q 010214 64 VRREIKILRLFMHPHIIRLYEVIE--TPSDIYVVMEYVKSGELFDYIVEKG----RLQEDEARNFFQQIISGVEYCHRN- 136 (515)
Q Consensus 64 i~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~iVmEy~~gg~L~~~i~~~~----~l~e~~~~~i~~qil~aL~yLH~~- 136 (515)
+..|..-++...|+++...+.-+. +....|.+++|+.+|.+++.|.+.- .+.+.-+....++.+.+..-+|+.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 344555556678998877666553 3345789999999999999997532 344444555555558888888854
Q ss_pred C----ceeccCCCCcEEECCCCceEEeeccccccc-ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHH
Q 010214 137 M----VVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL 211 (515)
Q Consensus 137 g----IvHrDLkpeNILl~~~~~vKL~DFGls~~~-~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~ll 211 (515)
+ .+|+++|+-|.+|..+.++|++++|+.++. ..........+++.|++|++...-.+ +.++|+|+.|+-+|...
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~-t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKF-TKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhh-hhHHHHHHHHHHHHHHh
Confidence 2 689999999999999999999999999833 33445667789999999999887666 45699999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 212 CGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 212 tG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
.|..+|.....+.+...+.++. ..++...|.++-.....+|-+.-..||.-...+.-+.|.
T Consensus 1435 ~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1435 DGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred cccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 9998886655555544444443 344444455555556666777778899988888877764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.92 E-value=5.2e-05 Score=73.82 Aligned_cols=73 Identities=10% Similarity=0.073 Sum_probs=46.7
Q ss_pred eeecccCce-EEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCC---CccEEEEEEEcCC---eEEEE
Q 010214 23 KTLGIGSFG-KVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP---HIIRLYEVIETPS---DIYVV 95 (515)
Q Consensus 23 ~~LG~G~fg-~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp---nIv~l~~~~~~~~---~~~iV 95 (515)
+.|+.|+.. .||... ..+++|+..... ....+.+|.++++.+... -+.++++..+..+ ..|++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 457777776 488762 357788754321 235788999999887632 3455555443322 34889
Q ss_pred EeccCCCCHH
Q 010214 96 MEYVKSGELF 105 (515)
Q Consensus 96 mEy~~gg~L~ 105 (515)
||+++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00038 Score=70.36 Aligned_cols=77 Identities=8% Similarity=0.068 Sum_probs=55.7
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC---CCccEEEEEEEc---CCeEEE
Q 010214 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH---PHIIRLYEVIET---PSDIYV 94 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h---pnIv~l~~~~~~---~~~~~i 94 (515)
-.+.||.|..+.||..... +..+.+|... ... ....+.+|...|+.+.. ..+.++++++.. .+.-++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~-~~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 18 RVECISEQPYAALWALYDS--QGNPMPLMAR-SFS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeeecCCccceeEEEEEcC--CCCEEEEEec-ccc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 3567999999999998643 2357777742 211 12577899999988863 467888887754 356899
Q ss_pred EEeccCCCCH
Q 010214 95 VMEYVKSGEL 104 (515)
Q Consensus 95 VmEy~~gg~L 104 (515)
|||+++|+++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998754
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00066 Score=71.14 Aligned_cols=80 Identities=16% Similarity=0.153 Sum_probs=56.5
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccccc--CC--hHHHHHHHHHHHHHHhCC---CCCccEEEEEEEcCCeEEE
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI--KN--MEMEEKVRREIKILRLFM---HPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~--~~--~~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~i 94 (515)
.+.||.|.+..||++.....++.|+||.-..... .. .-..++...|.+.|+.+. ..++++++.+ ++...++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4679999999999999864446899998542211 01 123467778888888764 3568888887 3455789
Q ss_pred EEeccCCCC
Q 010214 95 VMEYVKSGE 103 (515)
Q Consensus 95 VmEy~~gg~ 103 (515)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00046 Score=66.87 Aligned_cols=75 Identities=16% Similarity=0.225 Sum_probs=48.9
Q ss_pred eeeecccCceEEEEEEEcC-CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCC-CccEEEEEEEcCCeEEEEEecc
Q 010214 22 GKTLGIGSFGKVKIAEHAL-TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP-HIIRLYEVIETPSDIYVVMEYV 99 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~-tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~iVmEy~ 99 (515)
++.|..|-...+|++.... .++.|++|+....... .-...+|..+++.+... -.++++.... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4567888888999987543 3578999987543211 12234788888888533 3455554432 2 3799999
Q ss_pred CCCCH
Q 010214 100 KSGEL 104 (515)
Q Consensus 100 ~gg~L 104 (515)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00012 Score=68.95 Aligned_cols=99 Identities=17% Similarity=0.230 Sum_probs=79.5
Q ss_pred HHHHHHHHhCCC-CCccEEEEEEEcCCeEEEEEeccCCCCHHH---HHHHhCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 010214 65 RREIKILRLFMH-PHIIRLYEVIETPSDIYVVMEYVKSGELFD---YIVEKGRLQEDEARNFFQQIISGVEYCHR---NM 137 (515)
Q Consensus 65 ~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~iVmEy~~gg~L~~---~i~~~~~l~e~~~~~i~~qil~aL~yLH~---~g 137 (515)
..|.-+|+.+.+ +++++++|.+ .-++|.||...+++.. .+.+-...++....+++.+++..+++++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888999986 6999999998 2367999998765542 12222346899999999999999999997 44
Q ss_pred ceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 138 IvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
+.-.|++|+|+-++++|++|++|.......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 677999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00018 Score=70.91 Aligned_cols=132 Identities=16% Similarity=0.158 Sum_probs=76.7
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc-cEEEEEEEcCCeEEEEEeccCCC
Q 010214 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVVMEYVKSG 102 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~iVmEy~~gg 102 (515)
.+..|-.+.+|+.. .++..+++|+....... ..-...+|..+++.+....+ .+++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKA---LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccccc---ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 35667788899887 35678899976432111 00124678888888864333 44444432 26899999986
Q ss_pred CHHHH----------H----HH---h----CCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCceeccC
Q 010214 103 ELFDY----------I----VE---K----GRLQE-DEARNFFQQI---------ISGVEYCHR--------NMVVHRDL 143 (515)
Q Consensus 103 ~L~~~----------i----~~---~----~~l~e-~~~~~i~~qi---------l~aL~yLH~--------~gIvHrDL 143 (515)
.+..- + .+ . .+++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 65321 1 11 0 01111 1222222122 111222222 24899999
Q ss_pred CCCcEEECCCCceEEeeccccc
Q 010214 144 KPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 144 kpeNILl~~~~~vKL~DFGls~ 165 (515)
.|.||++++++ +.|+||+.+.
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccC
Confidence 99999999876 8999999774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0015 Score=66.42 Aligned_cols=147 Identities=12% Similarity=0.168 Sum_probs=78.6
Q ss_pred CccccCCCceE-----eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCC--CccEEE
Q 010214 11 GVDMFLPNYKL-----GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP--HIIRLY 83 (515)
Q Consensus 11 ~~~~~~~~Y~i-----~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~ 83 (515)
.+..+...|.+ .+.|+.|....+|..... + ..+++|++.. . . .+.+..|+.+++.|... .+.+++
T Consensus 11 ~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~-~-g~~vLK~~~~--~-~---~~~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 11 ELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTT-Q-GEYVLTLFER--L-T---AEDLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred HHHHHHHhcCCchhhccchhccccccceEEEEeC-C-CcEEEEEecc--C-C---hHHhHHHHHHHHHHHHCCCCCCcce
Confidence 33334455544 345667777889988743 3 3689998751 1 1 12333455555444311 133433
Q ss_pred E------EEEcCCeEEEEEeccCCCCHH-----------HHHH---H-hCCC--------C--H--HHHH----------
Q 010214 84 E------VIETPSDIYVVMEYVKSGELF-----------DYIV---E-KGRL--------Q--E--DEAR---------- 120 (515)
Q Consensus 84 ~------~~~~~~~~~iVmEy~~gg~L~-----------~~i~---~-~~~l--------~--e--~~~~---------- 120 (515)
. +....+..++++||++|..+. ..+. . ...+ . . ....
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 2 123355679999999986431 1111 0 0000 0 0 0000
Q ss_pred -HHHHH-HHHHHHHHH-------HCCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 121 -NFFQQ-IISGVEYCH-------RNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 121 -~i~~q-il~aL~yLH-------~~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
..+.+ +-..++.+. ..++||+|+.|.||+++.+...-|+||+.+.
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 11111 111222222 2479999999999999976556899999763
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00051 Score=72.48 Aligned_cols=159 Identities=21% Similarity=0.296 Sum_probs=105.4
Q ss_pred HHHHHHHHHHhCCCCCccEEEEEEEcC-CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 010214 63 KVRREIKILRLFMHPHIIRLYEVIETP-SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141 (515)
Q Consensus 63 ~i~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHr 141 (515)
++.-...+++.+.|+|....+++.+.. ....+|||++ +.+|.+++..+. +-.... . .+++.|-
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~---~-----------~~~~~~~ 91 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESL---L-----------AHGVLHL 91 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhh---c-----------cccccee
Confidence 445567788999999999999987543 3478999999 569999887653 211111 0 1222221
Q ss_pred cCCCCcEEECCCCceEEeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC
Q 010214 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN 221 (515)
Q Consensus 142 DLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~ 221 (515)
| .++.+| ..+.. | |- ..++++||||+|.++.++.-|...+....
T Consensus 92 -----~-------~~~~td----~~~t~------------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~~~~ 135 (725)
T KOG1093|consen 92 -----N-------IIYITD----HFLTK------------Y--PS------PIGPKSDVWSLGFIILELYLGISLEAELT 135 (725)
T ss_pred -----h-------hhhccc----ccccc------------C--CC------CCCcchhhhhHHHHHHHHHHhhHHHHHHH
Confidence 2 233333 00000 0 11 11369999999999999999988876655
Q ss_pred hHHHHHHHhcCccCCC-------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 222 IPNLFKKIKGGIYTLP-------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 222 ~~~~~~~i~~~~~~~p-------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..+....+.+-. ..+ -.++.....+..+|+...|..||...++++++-|.+.
T Consensus 136 ~s~~l~~i~k~~-~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 136 ESEYLEILLKYY-TDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHhc-cCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 555555444322 111 1345667889999999999999999999999998765
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0023 Score=64.27 Aligned_cols=136 Identities=12% Similarity=0.091 Sum_probs=82.7
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCC--CccEEEE------EEEcCCeEE
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP--HIIRLYE------VIETPSDIY 93 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~~------~~~~~~~~~ 93 (515)
.+.|..|....+|++.. ++..+++|+... .. ...+..|++++..+.+- .+.+++. +....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~---~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK---VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC---CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 56677888889998864 345799998754 11 24566788887777532 2445443 223345678
Q ss_pred EEEeccCCCCHHH----HH----------HHh-CCCC--------HHHH------------HHHHHHHHHHHHHHHH---
Q 010214 94 VVMEYVKSGELFD----YI----------VEK-GRLQ--------EDEA------------RNFFQQIISGVEYCHR--- 135 (515)
Q Consensus 94 iVmEy~~gg~L~~----~i----------~~~-~~l~--------e~~~------------~~i~~qil~aL~yLH~--- 135 (515)
+|+++++|..+.. .. +.. ..+. .... ......+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999866421 11 000 0000 0000 0011122334444443
Q ss_pred ----CCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 136 ----NMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 136 ----~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998777899999763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0012 Score=66.96 Aligned_cols=137 Identities=14% Similarity=0.152 Sum_probs=79.6
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCC--ccEEEEE------EEcCCeEE
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH--IIRLYEV------IETPSDIY 93 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn--Iv~l~~~------~~~~~~~~ 93 (515)
.+.++.|....+|++.. .+ ..+++|+..... . ...+..|.+++..|.... +.+++.. ....+..+
T Consensus 27 i~~~~~G~~n~~y~v~t-~~-~~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-DV-GRYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ccccCCccccceEEEEe-CC-CcEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 55677777789998864 23 468889875421 1 234556677776664222 4444432 12245678
Q ss_pred EEEeccCCCCHH----H-------HH---HH-hCCCCH-------HHHH----------------HHHHHHHHHHHHHHH
Q 010214 94 VVMEYVKSGELF----D-------YI---VE-KGRLQE-------DEAR----------------NFFQQIISGVEYCHR 135 (515)
Q Consensus 94 iVmEy~~gg~L~----~-------~i---~~-~~~l~e-------~~~~----------------~i~~qil~aL~yLH~ 135 (515)
+++||++|.++. + .+ +. ...++. ...+ .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999885431 1 11 11 000100 0000 001123334555542
Q ss_pred -------CCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 136 -------NMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 136 -------~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 689999999999999988777899999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0014 Score=66.10 Aligned_cols=76 Identities=14% Similarity=0.138 Sum_probs=49.2
Q ss_pred eeeecccCceEEEEEEEcC------CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCC-ccEEEEEEEcCCeEEE
Q 010214 22 GKTLGIGSFGKVKIAEHAL------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIRLYEVIETPSDIYV 94 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~------tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~i 94 (515)
++.|..|-...||++.... +++.+++|+...... ......+|.++++.+.... ..+++.++.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3556677777899887543 267899999754321 1234567888888776333 3455655532 35
Q ss_pred EEeccCCCCHH
Q 010214 95 VMEYVKSGELF 105 (515)
Q Consensus 95 VmEy~~gg~L~ 105 (515)
|+||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00023 Score=71.29 Aligned_cols=134 Identities=13% Similarity=0.240 Sum_probs=96.1
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccC-----------------ChH--HHHHHHHHHHHHHhCCC--C
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-----------------NME--MEEKVRREIKILRLFMH--P 77 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~-----------------~~~--~~~~i~~Ei~il~~l~h--p 77 (515)
|.++..||-|.-+-||.+-+. .|++.++|+-..-... ..- ..-...+|...|+.|.. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 567889999999999999875 6888999963211000 000 11224578888887763 2
Q ss_pred CccEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceE
Q 010214 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK 157 (515)
Q Consensus 78 nIv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vK 157 (515)
-+.+.+++ +.-++|||++.|-.|...-. ...+..+...++.-+.-|-++|+||+|..--||++++++.++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 34455544 34579999999977755321 234556677777778889999999999999999999999999
Q ss_pred Eeeccc
Q 010214 158 IADFGL 163 (515)
Q Consensus 158 L~DFGl 163 (515)
++||--
T Consensus 243 vIDFPQ 248 (465)
T KOG2268|consen 243 VIDFPQ 248 (465)
T ss_pred EeechH
Confidence 999964
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0041 Score=64.08 Aligned_cols=76 Identities=16% Similarity=0.046 Sum_probs=50.8
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEeccccc----CChHHHHHHHHHHHHHHhCC--CC-CccEEEEEEEcCCeEEEEE
Q 010214 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKI----KNMEMEEKVRREIKILRLFM--HP-HIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~i~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~iVm 96 (515)
.||.|....||++.....++.|+||.-...-. .-.-..++..-|...|+... -| +++++|.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57999999999999764446899996432111 11223466677888887765 34 56666665 444556999
Q ss_pred eccCC
Q 010214 97 EYVKS 101 (515)
Q Consensus 97 Ey~~g 101 (515)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0049 Score=62.54 Aligned_cols=144 Identities=17% Similarity=0.311 Sum_probs=83.7
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCC--ccEEEEEEEcCC--eEEEE
Q 010214 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH--IIRLYEVIETPS--DIYVV 95 (515)
Q Consensus 20 ~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn--Iv~l~~~~~~~~--~~~iV 95 (515)
.+++.+..|..-.+|.... +++++++. .+. ............+|..+++.+.--- +...++++.+.. ..|.|
T Consensus 28 ~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGD--TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred ceeeeccCCcccceEEEec--CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 3444454444444555543 38889888 332 2333445677889999998876422 344555555444 56999
Q ss_pred EeccCCCCHHH----------HHH--------H-h----------CC---CCHHHHHHHHHHH--------------HHH
Q 010214 96 MEYVKSGELFD----------YIV--------E-K----------GR---LQEDEARNFFQQI--------------ISG 129 (515)
Q Consensus 96 mEy~~gg~L~~----------~i~--------~-~----------~~---l~e~~~~~i~~qi--------------l~a 129 (515)
|+|++|..+.+ ++. . + +. ....+...+..+. ..-
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 99998842211 111 1 0 00 0111111111111 122
Q ss_pred HHHHHHC--------CceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 130 VEYCHRN--------MVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 130 L~yLH~~--------gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
..+|+.+ .++|+|+.+.|++++.++-+-++||+++..-
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 3444432 2899999999999999989999999998643
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0025 Score=64.98 Aligned_cols=143 Identities=21% Similarity=0.237 Sum_probs=97.1
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEecccccC----------------------ChHH-HHHHHHHHHHHHhCCCC
Q 010214 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK----------------------NMEM-EEKVRREIKILRLFMHP 77 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~----------------------~~~~-~~~i~~Ei~il~~l~hp 77 (515)
+-..|..|.-+.||.|... +|..+|||++..+-+. ...+ .--...|++.|++++.-
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3456788999999999854 7888999998533111 1111 12245788888888765
Q ss_pred CccEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEECCCCce
Q 010214 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH-RNMVVHRDLKPENLLLDSKWNV 156 (515)
Q Consensus 78 nIv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH-~~gIvHrDLkpeNILl~~~~~v 156 (515)
.|.-.--+. -. .-.+||+|+.+...-.-.-+...++...++.+-.|++.-+.-|- ..++||.||.--|+|+-. |.+
T Consensus 227 GIP~PePIl-Lk-~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~l 303 (520)
T KOG2270|consen 227 GIPCPEPIL-LK-NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GKL 303 (520)
T ss_pred CCCCCCcee-ee-cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CEE
Confidence 543221111 11 23589999954222221223456888899999999998888775 579999999999999965 589
Q ss_pred EEeeccccccc
Q 010214 157 KIADFGLSNIM 167 (515)
Q Consensus 157 KL~DFGls~~~ 167 (515)
.|+|-+-|...
T Consensus 304 yiIDVSQSVE~ 314 (520)
T KOG2270|consen 304 YIIDVSQSVEH 314 (520)
T ss_pred EEEEccccccC
Confidence 99998877543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.01 Score=62.18 Aligned_cols=77 Identities=21% Similarity=0.118 Sum_probs=53.6
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh----HHHHHHHHHHHHHHhCC---CCCccEEEEEEEcCCeEE
Q 010214 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM----EMEEKVRREIKILRLFM---HPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~----~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~ 93 (515)
-.+.||.|....||+..+. +..++||.-........ ....+...|...|+.+. ..++.+++.+.++ ..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence 4678899999999998863 45699997652211110 13456666777777665 3578889988763 457
Q ss_pred EEEeccCC
Q 010214 94 VVMEYVKS 101 (515)
Q Consensus 94 iVmEy~~g 101 (515)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0084 Score=61.92 Aligned_cols=139 Identities=17% Similarity=0.168 Sum_probs=81.8
Q ss_pred ceEeeeecccCceEEEEEEEcC----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc-cEEEEEEEcCCeEE
Q 010214 19 YKLGKTLGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIY 93 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~ 93 (515)
..-.+.|-.|-...+|++.... +++.|.+|+..... .....+ .+|..+++.+..-++ .++++.+...
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g---- 109 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG---- 109 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----
Confidence 3344556668888999987532 34789999876532 112222 678888888874443 3556665332
Q ss_pred EEEeccCCCCHHHH-------H-------H---HhC------CCCHHHHHHHHHHH-----------------HHHHHHH
Q 010214 94 VVMEYVKSGELFDY-------I-------V---EKG------RLQEDEARNFFQQI-----------------ISGVEYC 133 (515)
Q Consensus 94 iVmEy~~gg~L~~~-------i-------~---~~~------~l~e~~~~~i~~qi-----------------l~aL~yL 133 (515)
.|.||++|.+|..- + . +.. ....+++..+..++ ...+..|
T Consensus 110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L 189 (344)
T PLN02236 110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL 189 (344)
T ss_pred eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence 58999987665321 1 0 000 01122333333222 1111122
Q ss_pred ----H----HCCceeccCCCCcEEECC-CCceEEeeccccc
Q 010214 134 ----H----RNMVVHRDLKPENLLLDS-KWNVKIADFGLSN 165 (515)
Q Consensus 134 ----H----~~gIvHrDLkpeNILl~~-~~~vKL~DFGls~ 165 (515)
. ...++|+|+++.|||+++ ++.+.++||..+.
T Consensus 190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 235899999999999986 4689999998774
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.024 Score=57.25 Aligned_cols=28 Identities=29% Similarity=0.411 Sum_probs=25.1
Q ss_pred CCceeccCCCCcEEECCCCceEEeecccc
Q 010214 136 NMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 136 ~gIvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
.+++|+|+.+.||+++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 57899999999999988 67899999965
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.013 Score=60.09 Aligned_cols=136 Identities=12% Similarity=0.180 Sum_probs=78.3
Q ss_pred eeeecccCceEEEEEEEcCC---CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc-cEEEEEEEcCCeEEEEEe
Q 010214 22 GKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVVME 97 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~iVmE 97 (515)
.+.|..|=...+|++..... +..|.+|+.....- .. -.-.+|..+++.+..-++ .++++++. +. +|.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~-IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YV-IDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eE-echHHHHHHHHHHHhcCCCCceeEEeC--Cc--Eeeh
Confidence 44555577788998875432 34899998754321 11 122578888888875444 45666653 22 5899
Q ss_pred ccCCCCHHH-------HH---HH------hCC------C-CHHHHHHHHHHH----------------------HHHHHH
Q 010214 98 YVKSGELFD-------YI---VE------KGR------L-QEDEARNFFQQI----------------------ISGVEY 132 (515)
Q Consensus 98 y~~gg~L~~-------~i---~~------~~~------l-~e~~~~~i~~qi----------------------l~aL~y 132 (515)
|++|..|.. .+ .+ ... . ....+..++.++ ...+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 998765521 11 10 011 1 122233333222 111222
Q ss_pred HH----HC----CceeccCCCCcEEECC-CCceEEeeccccc
Q 010214 133 CH----RN----MVVHRDLKPENLLLDS-KWNVKIADFGLSN 165 (515)
Q Consensus 133 LH----~~----gIvHrDLkpeNILl~~-~~~vKL~DFGls~ 165 (515)
+. .. -++|+|+.+.|||+++ ++.++++||..|.
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 21 12 2799999999999974 5789999999774
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.015 Score=58.44 Aligned_cols=74 Identities=12% Similarity=0.179 Sum_probs=48.4
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC---CCCccEEEEEEEcCCeEEEEEe
Q 010214 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM---HPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~iVmE 97 (515)
-.+.++.|....+|... .+++.+.+|+-... ....+..|..-|+.|. .-.+.+++.+.+..+.-|+|||
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle 92 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE 92 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence 35678999999999887 67889999986522 1245677888888774 4467899999888777899999
Q ss_pred ccCCC
Q 010214 98 YVKSG 102 (515)
Q Consensus 98 y~~gg 102 (515)
|++.+
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 99766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.024 Score=56.74 Aligned_cols=30 Identities=27% Similarity=0.568 Sum_probs=25.1
Q ss_pred CceeccCCCCcEEECCCCc-eEEeecccccc
Q 010214 137 MVVHRDLKPENLLLDSKWN-VKIADFGLSNI 166 (515)
Q Consensus 137 gIvHrDLkpeNILl~~~~~-vKL~DFGls~~ 166 (515)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.022 Score=59.55 Aligned_cols=78 Identities=21% Similarity=0.190 Sum_probs=53.6
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccc-c--CChHHHHHHHHHHHHHHhCC--CC-CccEEEEEEEcCCeEEEE
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRK-I--KNMEMEEKVRREIKILRLFM--HP-HIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~-~--~~~~~~~~i~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~iV 95 (515)
.+.||.|.-.-||++.+...++.|+||--...- . .-.-..++..-|.+.|+... -| +++++|.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 678999999999999985445689999643211 1 11224577788888888765 34 57777765 44456789
Q ss_pred EeccCC
Q 010214 96 MEYVKS 101 (515)
Q Consensus 96 mEy~~g 101 (515)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999854
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.1 Score=52.84 Aligned_cols=29 Identities=21% Similarity=0.328 Sum_probs=26.9
Q ss_pred CceeccCCCCcEEECCCCceEEeeccccc
Q 010214 137 MVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 137 gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
+++|+|+.+.|+|++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.016 Score=55.17 Aligned_cols=30 Identities=33% Similarity=0.641 Sum_probs=21.3
Q ss_pred CceeccCCCCcEEE-CCCCceEEeecccccc
Q 010214 137 MVVHRDLKPENLLL-DSKWNVKIADFGLSNI 166 (515)
Q Consensus 137 gIvHrDLkpeNILl-~~~~~vKL~DFGls~~ 166 (515)
.++|+|+.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8889999999998754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.035 Score=56.78 Aligned_cols=86 Identities=24% Similarity=0.310 Sum_probs=62.9
Q ss_pred CCCccEEEEEE-EcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCC
Q 010214 76 HPHIIRLYEVI-ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSK 153 (515)
Q Consensus 76 hpnIv~l~~~~-~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDLkpeNILl~~~ 153 (515)
-++..+.+-+- ....+.|++|++- |+.|.. ++ --..+++..++.+.++.++-+..+ ..-|||+...||||+ +
T Consensus 284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~-ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~ 357 (488)
T COG5072 284 SVFLETLKVVSLDETLYLYLHFKDH-GTPISI-IK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E 357 (488)
T ss_pred chhhhcceEEecCCceEEEEEEecC-Cceeee-ee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c
Confidence 44444444443 3345678888886 545532 22 234678889999988888887754 689999999999999 8
Q ss_pred CceEEeeccccccc
Q 010214 154 WNVKIADFGLSNIM 167 (515)
Q Consensus 154 ~~vKL~DFGls~~~ 167 (515)
|+|.|+||-+++.-
T Consensus 358 GnvtLIDfklsRl~ 371 (488)
T COG5072 358 GNVTLIDFKLSRLS 371 (488)
T ss_pred CceEEEEeeeeecc
Confidence 99999999999843
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.053 Score=56.34 Aligned_cols=61 Identities=20% Similarity=0.272 Sum_probs=46.1
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEECC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH-RNMVVHRDLKPENLLLDS 152 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH-~~gIvHrDLkpeNILl~~ 152 (515)
...++-+|..|-++..+++.. ..+|...+.++.-...|+--+- -.+++|.|++|.||++--
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 356788899999999988654 3566667777776666665443 578999999999999853
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.13 Score=53.94 Aligned_cols=78 Identities=15% Similarity=0.123 Sum_probs=46.8
Q ss_pred eEeeeecccCceEEEEEEEcCC-CcE-----EEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc-cEEEEEEEcCCeE
Q 010214 20 KLGKTLGIGSFGKVKIAEHALT-GHK-----VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDI 92 (515)
Q Consensus 20 ~i~~~LG~G~fg~Vy~a~~~~t-g~~-----vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~ 92 (515)
...+.|..|-...+|++..... +.. |.+++.... . ...-.-.+|+++++.+..-++ .++++.+..
T Consensus 53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~---- 124 (383)
T PTZ00384 53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---N-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD---- 124 (383)
T ss_pred EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC---C-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----
Confidence 3445666688889999875433 122 444443211 1 111122568999998875544 566666632
Q ss_pred EEEEeccCCCCHH
Q 010214 93 YVVMEYVKSGELF 105 (515)
Q Consensus 93 ~iVmEy~~gg~L~ 105 (515)
+++.||++|.+|.
T Consensus 125 g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 FTIQEWVEGNTMG 137 (383)
T ss_pred EEEEEEeccccCC
Confidence 5999999987653
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.43 Score=48.87 Aligned_cols=70 Identities=9% Similarity=0.061 Sum_probs=41.2
Q ss_pred CceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCC--ccEEE---E--EEEcCCeEEEEEeccCC
Q 010214 29 SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH--IIRLY---E--VIETPSDIYVVMEYVKS 101 (515)
Q Consensus 29 ~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn--Iv~l~---~--~~~~~~~~~iVmEy~~g 101 (515)
.-..||.+.. .+|..+++|+...... ....+..|...+..|.... ++... + +...++..+.++++++|
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 3456888864 3567899998754332 2345667777776554211 22211 1 22335678889999987
Q ss_pred CC
Q 010214 102 GE 103 (515)
Q Consensus 102 g~ 103 (515)
..
T Consensus 112 ~~ 113 (325)
T PRK11768 112 RA 113 (325)
T ss_pred CC
Confidence 54
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.27 E-value=1.2 Score=52.68 Aligned_cols=31 Identities=29% Similarity=0.457 Sum_probs=26.2
Q ss_pred CCceeccCCCCcEEECCCC--ceE-Eeecccccc
Q 010214 136 NMVVHRDLKPENLLLDSKW--NVK-IADFGLSNI 166 (515)
Q Consensus 136 ~gIvHrDLkpeNILl~~~~--~vK-L~DFGls~~ 166 (515)
.++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5799999999999999875 555 999998753
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=93.55 E-value=0.34 Score=48.57 Aligned_cols=74 Identities=19% Similarity=0.216 Sum_probs=44.8
Q ss_pred cccCceEEEEEEEcC----CC----cEEEEEEecccccC--ChHHHHHHHHHHHHHHhCC-------------CCCccEE
Q 010214 26 GIGSFGKVKIAEHAL----TG----HKVAIKILNRRKIK--NMEMEEKVRREIKILRLFM-------------HPHIIRL 82 (515)
Q Consensus 26 G~G~fg~Vy~a~~~~----tg----~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~-------------hpnIv~l 82 (515)
|.|-.|.+|++.-.. ++ ..+.||........ .......+.+|+...+.+- ...+.++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 677788888876533 22 35888887522211 1123456677887765442 1245677
Q ss_pred EEEEEcCCeEEEEEecc
Q 010214 83 YEVIETPSDIYVVMEYV 99 (515)
Q Consensus 83 ~~~~~~~~~~~iVmEy~ 99 (515)
+..-..+...+||||-+
T Consensus 82 ~~~~~~~~~~~lvlEDL 98 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDL 98 (294)
T ss_pred EEeccCCCceeeehhhh
Confidence 77666666788999865
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.43 E-value=0.91 Score=43.99 Aligned_cols=75 Identities=17% Similarity=0.186 Sum_probs=50.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC---CCccEEEEEEEcCCeEEEEEecc
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH---PHIIRLYEVIETPSDIYVVMEYV 99 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h---pnIv~l~~~~~~~~~~~iVmEy~ 99 (515)
+.+..|.--..|...+ ...++-+|+=. ......+..|+.-|+.+.- -.+.+++.+..+.++.|+||||.
T Consensus 22 ~~v~gG~inea~~v~d--g~~~~FvK~n~------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 22 EEVSGGDINEAWRLRD--GTDPFFVKCNQ------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred cccCCccccceeEeec--CCcceEEEecc------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence 3445555555555543 34578888632 2345667777777776654 45778888889999999999999
Q ss_pred CCCCHH
Q 010214 100 KSGELF 105 (515)
Q Consensus 100 ~gg~L~ 105 (515)
+-|.+.
T Consensus 94 ~~~~~d 99 (286)
T COG3001 94 PTGPLD 99 (286)
T ss_pred cCCCCC
Confidence 876554
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 515 | ||||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-124 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-109 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-109 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-108 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-103 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-102 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-102 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-102 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-79 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-78 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-77 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-77 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-76 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-76 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-76 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-76 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-75 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-73 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-65 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-59 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-58 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-57 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-57 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-57 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-54 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-54 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-54 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-54 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-53 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-53 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-52 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-52 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-52 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-52 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-52 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-52 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-52 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-51 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-51 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-51 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-50 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-50 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-50 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-50 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-49 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-49 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-49 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-49 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-49 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-49 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-48 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-48 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-48 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-48 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-47 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-47 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-47 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-47 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-47 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-47 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-47 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-47 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-46 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-46 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-46 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-46 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-46 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-46 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-46 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-46 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-46 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-46 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-46 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-46 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-46 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-46 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-46 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-46 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-46 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-46 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-46 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-46 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-46 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-46 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-46 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-46 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-45 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-45 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-45 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-45 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-45 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-45 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-45 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-45 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-45 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-45 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-45 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-45 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-45 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-45 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-45 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-44 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-44 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-44 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-44 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-44 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-44 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-44 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-44 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-44 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-44 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-44 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-44 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-44 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-44 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-44 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-44 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-44 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-44 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-44 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-44 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-44 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-44 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-44 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-44 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-44 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-43 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-43 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-43 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-43 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-43 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-43 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-43 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-43 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-43 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-43 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-43 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-43 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-43 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-43 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-43 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-43 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-43 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-43 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-43 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-43 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-43 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-43 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-43 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-43 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-43 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-43 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-43 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-43 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-43 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-43 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-43 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-43 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-43 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-43 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-43 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-43 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-43 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-43 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-43 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-43 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-43 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-43 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-43 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-43 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-43 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-43 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-43 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-42 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-42 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-42 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-42 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-42 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-42 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-42 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-42 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-42 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-42 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-42 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-42 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-42 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-42 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-42 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-42 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-42 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-42 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-42 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-42 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-42 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-42 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-42 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-42 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-42 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-41 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-41 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-41 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-41 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-41 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-41 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-41 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-41 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-41 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-41 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-41 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-41 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-41 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-40 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-40 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-40 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-40 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-40 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-40 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-40 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-40 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-40 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-40 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-40 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-40 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-40 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-40 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-40 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-40 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-40 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-40 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-40 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-40 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-40 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-40 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-40 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-40 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-40 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-40 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-40 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-39 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-39 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-39 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-39 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-39 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-39 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-39 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-39 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-39 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-39 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-39 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-39 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-39 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-38 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-38 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-38 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-38 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-38 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-38 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-38 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-38 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-37 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-36 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-36 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-36 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-34 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-34 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-34 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-34 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-33 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-33 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-33 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-33 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-33 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-33 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-32 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-32 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-32 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-32 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-32 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-32 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-32 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-32 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-32 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-32 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-32 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-32 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-32 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-32 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-32 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-32 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-32 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-32 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-32 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-32 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-32 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-32 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-32 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-32 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-32 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-32 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-32 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-32 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-32 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-32 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-32 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-32 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-32 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-32 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-32 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-32 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-32 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-32 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-32 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-31 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-31 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-31 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-31 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-31 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-31 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-31 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-31 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-31 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-31 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-30 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-30 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-30 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-30 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-30 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-30 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-29 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-29 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-29 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-29 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-29 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-29 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-29 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-29 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-29 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-29 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-29 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-29 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-29 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-29 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-29 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-28 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-28 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-28 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-28 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-28 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-28 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-28 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-27 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-27 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-27 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-27 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-27 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-27 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-27 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-27 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-27 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-27 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-27 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-27 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-27 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-27 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-27 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-26 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-26 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-26 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-26 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-26 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-26 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-26 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-26 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-26 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-26 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-26 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-26 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-26 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-26 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-26 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-26 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-26 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-26 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-26 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-26 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-26 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-26 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-26 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-26 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-26 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-26 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-26 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-26 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-26 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-26 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-25 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-25 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-25 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-25 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-25 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-25 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-25 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-25 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-25 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-25 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-25 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-25 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-25 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-25 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-25 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-25 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-25 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-25 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-25 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-25 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-25 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-25 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-25 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-25 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-25 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-25 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-25 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-24 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-24 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-24 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-24 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-24 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-24 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-24 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-24 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-24 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-24 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-24 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-24 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-24 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-24 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-24 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-24 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-24 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-24 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-24 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-24 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-24 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-24 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-24 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-24 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-24 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-24 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-24 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-24 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-24 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-24 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-24 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-24 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-24 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-24 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-24 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-24 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-24 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-24 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-24 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-24 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-24 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-24 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-24 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-24 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-24 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-24 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-24 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-24 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-24 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-24 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-24 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-24 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-24 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-24 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-24 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-24 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-24 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-24 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-24 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-23 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-23 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-23 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-23 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-23 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-23 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-23 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-23 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-23 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-23 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-23 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-23 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-23 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-23 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-23 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-23 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-23 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-23 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-23 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-23 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-23 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-23 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-23 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-23 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-23 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-23 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-23 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-23 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-23 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-23 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-23 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-23 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-23 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-23 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-23 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-23 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-23 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-23 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-23 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-23 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-23 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-23 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-23 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-23 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-23 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-22 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-22 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-22 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-22 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-22 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-22 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-22 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-22 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-22 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-22 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-22 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-22 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-22 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-22 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-22 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-22 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-22 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-22 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-22 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-22 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-22 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-22 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-21 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-21 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-21 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-21 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-21 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-21 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-21 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-21 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-21 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-21 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-21 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-21 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-21 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-21 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-21 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-21 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-21 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-21 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-21 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-21 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-21 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-21 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-21 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-21 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-20 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-20 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-20 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-20 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-20 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-20 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-20 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-20 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-20 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-20 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-20 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-20 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-20 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-20 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-20 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-20 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-20 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-20 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-20 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-20 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-20 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-20 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-20 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-20 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-20 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-20 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-20 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-20 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-20 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-20 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-20 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-20 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-20 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-20 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-20 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-19 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-19 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-19 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-19 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-19 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-19 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-19 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-19 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-19 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-18 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-18 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-18 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-18 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-18 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-18 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-18 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-18 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-18 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-18 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-17 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-17 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-17 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-17 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-17 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-17 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-17 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-17 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-17 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-17 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-17 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-17 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-17 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-17 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-16 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-16 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-16 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-16 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-16 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-16 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-16 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-16 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-16 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-15 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-15 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-15 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-15 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-15 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-15 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-15 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-15 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-15 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-15 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-15 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-15 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-15 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-14 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-14 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-13 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-13 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-13 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-13 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-12 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-12 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-12 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-12 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-12 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-12 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 8e-12 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-11 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-11 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-11 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 |
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 693 bits (1790), Expect = 0.0
Identities = 231/507 (45%), Positives = 313/507 (61%), Gaps = 43/507 (8%)
Query: 5 SNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKV 64
+ + + + +Y LG TLG+G+FGKVK+ +H LTGHKVA+KILNR+KI+++++ K+
Sbjct: 4 AEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKI 63
Query: 65 RREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQ 124
RREI+ L+LF HPHII+LY+VI TPSDI++VMEYV GELFDYI + GRL E E+R FQ
Sbjct: 64 RREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ 123
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAA 184
QI+SGV+YCHR+MVVHRDLKPEN+LLD+ N KIADFGLSN+M DG FL+TSCGSPNYAA
Sbjct: 124 QILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAA 183
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGA 244
PEVISG+LYAGPEVD+WS GVILYALLCGTLPFDD+++P LFKKI GI+ P +L+P
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSV 243
Query: 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-K 303
L+ ML VDPMKR TI +IR+H WF+ LP+YL P D + ID+E LKEV K
Sbjct: 244 ISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLF--PEDPSYSSTMIDDEALKEVCEK 301
Query: 304 MGFDQNQLVESLRNR-LQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEP 362
+ +++ L NR Q+ VAY+L++DNR ++ +S + H P
Sbjct: 302 FECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRP 361
Query: 363 -------AVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQE 415
V+ + + Q + KW LG++S++ P +IM EV +A+++
Sbjct: 362 HPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQ 421
Query: 416 LNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKF 475
L+ WK + Y ++ R + + K
Sbjct: 422 LDYEWKVVNPYYLRVRRKNPV--------------------------------TSTFSKM 449
Query: 476 EVQLYKTRDEKYLLDLQRVQGPQFLFL 502
+QLY+ YLLD + + L
Sbjct: 450 SLQLYQVDSRTYLLDFRSIDDEILEVL 476
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 594 bits (1533), Expect = 0.0
Identities = 192/323 (59%), Positives = 237/323 (73%), Gaps = 5/323 (1%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
Y + +TLG GSFGKVK+A H T KVA+K ++R+ +K +M +V REI L+L HP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
HII+LY+VI TP+DI +V+EY GELFDYIVEK R+ EDE R FFQQII +EYCHR+
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
+VHRDLKPENLLLD NVKIADFGLSNIM DG+FLKTSCGSPNYAAPEVI+GKLYAGPE
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPE 188
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
VDVWSCG++LY +L G LPFDDE IPNLFKK+ +Y +P LSPGA+ LI RM++ DPM
Sbjct: 189 VDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPM 248
Query: 258 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVK-MGFDQNQLVESLR 316
+RITI EIR+ PWF +LP YL P Q D I+ ++ + MGF ++ +VE+LR
Sbjct: 249 QRITIQEIRRDPWFNVNLPDYL---RPMEEVQGSYADSRIVSKLGEAMGFSEDYIVEALR 305
Query: 317 NRLQNEATVAYYLLLDNRFRVSS 339
+ NE AY LL +N+
Sbjct: 306 SDENNEVKEAYNLLHENQVIQEK 328
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 579 bits (1495), Expect = 0.0
Identities = 144/330 (43%), Positives = 213/330 (64%), Gaps = 3/330 (0%)
Query: 3 GASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE 62
G S S + + NY+L KT+G G+F KVK+A H LTG +VAIKI+++ ++ ++
Sbjct: 1 GNSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ- 59
Query: 63 KVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNF 122
K+ RE++I+++ HP+I++L+EVIET +Y++MEY GE+FDY+V GR++E EAR+
Sbjct: 60 KLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK 119
Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY 182
F+QI+S V+YCH+ +VHRDLK ENLLLD+ N+KIADFG SN G L CG+P Y
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPY 179
Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSP 242
AAPE+ GK Y GPEVDVWS GVILY L+ G+LPFD +N+ L +++ G Y +P ++S
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 239
Query: 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV 302
+L+ R L+++P+KR T+ +I + W A P + D++ + +V
Sbjct: 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDE--LKPFVEPELDISDQKRIDIMV 297
Query: 303 KMGFDQNQLVESLRNRLQNEATVAYYLLLD 332
MG+ Q ++ ESL +E T Y LL
Sbjct: 298 GMGYSQEEIQESLSKMKYDEITATYLLLGR 327
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 554 bits (1429), Expect = 0.0
Identities = 124/332 (37%), Positives = 175/332 (52%), Gaps = 13/332 (3%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
Y K +G G+FG ++ LT VA+K + R ++E V+REI R
Sbjct: 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLR 74
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
HP+I+R EVI TP+ + ++MEY GEL++ I GR EDEAR FFQQ++SGV YCH
Sbjct: 75 HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS 134
Query: 136 NMVVHRDLKPENLLLDSKW--NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
+ HRDLK EN LLD +KI DFG S K++ G+P Y APEV+ + Y
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEY 194
Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKK----IKGGIYTLPS--HLSPGARDL 247
G DVWSCGV LY +L G PF+D P ++K I Y++P +SP L
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL 254
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFD 307
I R+ + DP RI+IPEI+ H WF +LP L + +T Q ++ ++ + M
Sbjct: 255 ISRIFVADPATRISIPEIKTHSWFLKNLPADL-MNESNTGSQFQEPEQPMQSLDTIMQII 313
Query: 308 QNQLVESLRNRLQNEATVAYYLLLDNRFRVSS 339
+ ++RNR ++ L D+ S
Sbjct: 314 SEATIPAVRNRCLDDFMTDNLDLDDDMDDFDS 345
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 548 bits (1414), Expect = 0.0
Identities = 178/262 (67%), Positives = 222/262 (84%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+Y LG TLG+G+FGKVKI EH LTGHKVA+KILNR+KI+++++ K++REI+ L+LF HP
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
HII+LY+VI TP+D ++VMEYV GELFDYI + GR++E EAR FQQI+S V+YCHR+M
Sbjct: 72 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
VVHRDLKPEN+LLD+ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGPE
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 191
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
VD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+ L+ ML VDP+
Sbjct: 192 VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPL 251
Query: 258 KRITIPEIRQHPWFQAHLPRYL 279
KR TI +IR+H WF+ LP YL
Sbjct: 252 KRATIKDIREHEWFKQDLPSYL 273
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 519 bits (1340), Expect = 0.0
Identities = 94/309 (30%), Positives = 166/309 (53%), Gaps = 10/309 (3%)
Query: 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
F+ ++ L +TLG G++G+V++A + +T VA+KI++ ++ ++ E +++EI I ++
Sbjct: 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 62
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
H ++++ Y + Y+ +EY GELFD I + E +A+ FF Q+++GV Y H
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGK 191
+ HRD+KPENLLLD + N+KI+DFGL+ + R L CG+ Y APE++ +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGIYTLP-SHLSPGARDLI 248
+ VDVWSCG++L A+L G LP+D ++ + Y P + L+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQ 308
++L+ +P RITIP+I++ W+ L + P + ++ D
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKKGA--KRPRVTSGGVSESPSGFSKHIQSNLDF 300
Query: 309 NQLVESLRN 317
+ + + R
Sbjct: 301 SPVNSASRT 309
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 515 bits (1330), Expect = 0.0
Identities = 92/274 (33%), Positives = 158/274 (57%), Gaps = 8/274 (2%)
Query: 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
F+ ++ L +TLG G++G+V++A + +T VA+KI++ ++ ++ E +++EI I ++
Sbjct: 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML 62
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
H ++++ Y + Y+ +EY GELFD I + E +A+ FF Q+++GV Y H
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGK 191
+ HRD+KPENLLLD + N+KI+DFGL+ + R L CG+ Y APE++ +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGIYTLP-SHLSPGARDLI 248
+ VDVWSCG++L A+L G LP+D ++ + Y P + L+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 282
++L+ +P RITIP+I++ W+ L + P
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 509 bits (1312), Expect = 0.0
Identities = 105/289 (36%), Positives = 163/289 (56%), Gaps = 14/289 (4%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-MEEKVRREIKILRLFMH 76
Y +G LG GS+GKVK + T + A+KIL ++K++ + E V++EI++LR H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 77 PHIIRLYEVI--ETPSDIYVVMEYVKSG--ELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
++I+L +V+ E +Y+VMEY G E+ D + + R +A +F Q+I G+EY
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEY 124
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNYAAPEVIS 189
H +VH+D+KP NLLL + +KI+ G++ + +TS GSP + PE+ +
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 190 G-KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLI 248
G ++G +VD+WS GV LY + G PF+ +NI LF+ I G Y +P P DL+
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLL 244
Query: 249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPP----PDTMQQAKKI 293
ML +P KR +I +IRQH WF+ P A P PDT + + +
Sbjct: 245 KGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSM 293
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 492 bits (1269), Expect = e-174
Identities = 102/280 (36%), Positives = 144/280 (51%), Gaps = 8/280 (2%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
Y G+ LG G F K A T A KI+ + + EK+ EI I R H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
H++ + E ++VV+E + L + + L E EAR + +QI+ G +Y HRN
Sbjct: 76 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 135
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
V+HRDLK NL L+ VKI DFGL+ + DG K CG+PNY APEV+S K +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-SF 194
Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256
EVDVWS G I+Y LL G PF+ + + +IK Y++P H++P A LI +ML DP
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 254
Query: 257 MKRITIPEIRQHPWFQAHL------PRYLAVPPPDTMQQA 290
R TI E+ +F + L +PP ++ +
Sbjct: 255 TARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPS 294
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 480 bits (1237), Expect = e-169
Identities = 105/293 (35%), Positives = 146/293 (49%), Gaps = 7/293 (2%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
Y G+ LG G F K A T A KI+ + + EK+ EI I R H
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
H++ + E ++VV+E + L + + L E EAR + +QI+ G +Y HRN
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 161
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
V+HRDLK NL L+ VKI DFGL+ + DG K CG+PNY APEV+S K +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-SF 220
Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256
EVDVWS G I+Y LL G PF+ + + +IK Y++P H++P A LI +ML DP
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 280
Query: 257 MKRITIPEIRQHPWFQAH-----LPRYLAVPPPDTMQQAKKIDEEILKEVVKM 304
R TI E+ +F + LP PP +D K + +
Sbjct: 281 TARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVL 333
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 471 bits (1214), Expect = e-166
Identities = 104/297 (35%), Positives = 161/297 (54%), Gaps = 31/297 (10%)
Query: 6 NRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI---------- 55
+ SSG + L Y L +G GS+G VK+A + A+K+L+++K+
Sbjct: 2 SSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRP 61
Query: 56 -------------KNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD--IYVVMEYVK 100
+ E+V +EI IL+ HP++++L EV++ P++ +Y+V E V
Sbjct: 62 PPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVN 121
Query: 101 SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160
G + + + L ED+AR +FQ +I G+EY H ++HRD+KP NLL+ ++KIAD
Sbjct: 122 QGPVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 161 FGLSNIMRDGH-FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPF 217
FG+SN + L + G+P + APE +S K+++G +DVW+ GV LY + G PF
Sbjct: 181 FGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240
Query: 218 DDENIPNLFKKIKGGIYTLPSH--LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
DE I L KIK P ++ +DLI RML +P RI +PEI+ HPW
Sbjct: 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 471 bits (1214), Expect = e-165
Identities = 84/291 (28%), Positives = 134/291 (46%), Gaps = 14/291 (4%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-----NMEMEEKVRREIKILR 72
Y LG G+FG V A +V +K + + K+ KV EI IL
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 73 LFMHPHIIRLYEVIETPSDIYVVMEYVKSG-ELFDYIVEKGRLQEDEARNFFQQIISGVE 131
H +II++ ++ E +VME SG +LF +I RL E A F+Q++S V
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
Y ++HRD+K EN+++ + +K+ DFG + + G T CG+ Y APEV+ G
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGN 204
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251
Y GPE+++WS GV LY L+ PF + ++ P +S L+ +
Sbjct: 205 PYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVSKELMSLVSGL 258
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV 302
L P +R T+ ++ PW + LA + + + K + +L
Sbjct: 259 LQPVPERRTTLEKLVTDPWVTQPVN--LADYTWEEVFRVNKPESGVLSAAS 307
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 466 bits (1202), Expect = e-164
Identities = 88/296 (29%), Positives = 143/296 (48%), Gaps = 15/296 (5%)
Query: 1 MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN--- 57
+ + Y++G LG G FG V VAIK + + +I +
Sbjct: 27 LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 86
Query: 58 MEMEEKVRREIKILRLFMH--PHIIRLYEVIETPSDIYVVMEYVK-SGELFDYIVEKGRL 114
+ +V E+ +L+ +IRL + E P +++E + +LFD+I E+G L
Sbjct: 87 LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 146
Query: 115 QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGHFL 173
QE+ AR+FF Q++ V +CH V+HRD+K EN+L+D + +K+ DFG +++D
Sbjct: 147 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-Y 205
Query: 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI 233
G+ Y+ PE I Y G VWS G++LY ++CG +PF+ + ++I G
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQ 259
Query: 234 YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ-AHLPRYLAVPPPDTMQ 288
+S + LI L + P R T EI+ HPW Q LP+ A ++
Sbjct: 260 VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLS 315
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 463 bits (1193), Expect = e-163
Identities = 98/270 (36%), Positives = 155/270 (57%), Gaps = 3/270 (1%)
Query: 9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREI 68
++ + + ++K+G LG GSF V AE TG +VAIK+++++ + M ++V+ E+
Sbjct: 3 ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 69 KILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQII 127
KI HP I+ LY E + +Y+V+E +GE+ Y+ + E+EAR+F QII
Sbjct: 63 KIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII 122
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPE 186
+G+ Y H + ++HRDL NLLL N+KIADFGL+ + T CG+PNY +PE
Sbjct: 123 TGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE 182
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARD 246
+ + + G E DVWS G + Y LL G PFD + + N K+ Y +PS LS A+D
Sbjct: 183 IATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKD 241
Query: 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276
LI ++L +P R+++ + HP+ +
Sbjct: 242 LIHQLLRRNPADRLSLSSVLDHPFMSRNSS 271
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 459 bits (1184), Expect = e-161
Identities = 91/286 (31%), Positives = 136/286 (47%), Gaps = 16/286 (5%)
Query: 8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN---MEMEEKV 64
+ F Y+LG LG G FG V +VAIK++ R ++ +
Sbjct: 22 GGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTC 81
Query: 65 RREIKILRL----FMHPHIIRLYEVIETPSDIYVVMEYVKSG-ELFDYIVEKGRLQEDEA 119
E+ +L HP +IRL + ET +V+E +LFDYI EKG L E +
Sbjct: 82 PLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS 141
Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCG 178
R FF Q+++ +++CH VVHRD+K EN+L+D + K+ DFG ++ D + G
Sbjct: 142 RCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY-TDFDG 200
Query: 179 SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS 238
+ Y+ PE IS Y VWS G++LY ++CG +PF+ + ++I P+
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPA 254
Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
H+SP LI R L P R ++ EI PW Q P
Sbjct: 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSK 300
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 440 bits (1135), Expect = e-154
Identities = 94/276 (34%), Positives = 154/276 (55%), Gaps = 4/276 (1%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
+ ++ +G+ LG G FG V +A +A+K+L + +++ +E ++RREI+I
Sbjct: 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
HP+I+R+Y IY+++E+ GEL+ + + GR E + F +++ + YCH
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
V+HRD+KPENLL+ K +KIADFG S + +T CG+ +Y PE+I GK +
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRTMCGTLDYLPPEMIEGKTH-D 190
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
+VD+W GV+ Y L G PFD + ++I P LS G++DLI ++L
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYH 250
Query: 256 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAK 291
P +R+ + + +HPW +A+ R L PP Q+K
Sbjct: 251 PPQRLPLKGVMEHPWVKANSRRVL--PPVYQSTQSK 284
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 436 bits (1124), Expect = e-152
Identities = 70/332 (21%), Positives = 135/332 (40%), Gaps = 47/332 (14%)
Query: 6 NRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME------ 59
N+ D ++ +Y++ +TL G F K+ + E A+K + ++
Sbjct: 20 NKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSN 77
Query: 60 --------MEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK 111
+ + E++I+ + + + +I ++Y++ EY+++ + +
Sbjct: 78 NDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYF 137
Query: 112 GRLQ--------EDEARNFFQQIISGVEYCHRNM-VVHRDLKPENLLLDSKWNVKIADFG 162
L + + +++ Y H + HRD+KP N+L+D VK++DFG
Sbjct: 138 FVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFG 197
Query: 163 LSNIMRDGHFLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDE- 220
S M D +K S G+ + PE S + Y G +VD+WS G+ LY + +PF +
Sbjct: 198 ESEYMVDKK-IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
Query: 221 NIPNLFKKIKGGIYTLP-------------------SHLSPGARDLIPRMLIVDPMKRIT 261
++ LF I+ P + LS D + L +P +RIT
Sbjct: 257 SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT 316
Query: 262 IPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKI 293
+ +H W L + ++ KK+
Sbjct: 317 SEDALKHEWLADTNIEDLREFSKELYKKRKKL 348
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 432 bits (1112), Expect = e-150
Identities = 106/273 (38%), Positives = 152/273 (55%), Gaps = 16/273 (5%)
Query: 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI-----KNMEMEEKVRREIK 69
Y + KTLG G+ G+VK+A T KVAIKI+++RK + + V EI+
Sbjct: 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 70 ILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
IL+ HP II++ + D Y+V+E ++ GELFD +V RL+E + +F Q++
Sbjct: 68 ILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126
Query: 130 VEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
V+Y H N ++HRDLKPEN+LL S+ +KI DFG S I+ + ++T CG+P Y APE
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 186
Query: 187 VISGKLYA--GPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTLPS----H 239
V+ A VD WS GVIL+ L G PF + +L +I G Y
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246
Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
+S A DL+ ++L+VDP R T E +HPW Q
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 425 bits (1094), Expect = e-148
Identities = 87/274 (31%), Positives = 153/274 (55%), Gaps = 2/274 (0%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L ++++G+ LG G FG V +A + +A+K+L + +++ +E ++RRE++I
Sbjct: 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
HP+I+RLY + +Y+++EY G ++ + + + E + ++ + + YCH
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
V+HRD+KPENLLL S +KIADFG S + CG+ +Y PE+I G+++
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMH-D 185
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
+VD+WS GV+ Y L G PF+ +K+I +T P ++ GARDLI R+L +
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 245
Query: 256 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQ 289
P +R + E+ +HPW A+ + ++ +
Sbjct: 246 PSQRPMLREVLEHPWITANSSKPSNCQNKESASK 279
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 410 bits (1057), Expect = e-142
Identities = 113/279 (40%), Positives = 159/279 (56%), Gaps = 9/279 (3%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
NY + + LG G+F V+ H TG + A KI+N +K+ + + K+ RE +I R HP
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHP 65
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
+I+RL++ I+ S Y+V + V GELF+ IV + E +A + QQI+ + YCH N
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 138 VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
+VHR+LKPENLLL SK VK+ADFGL+ + D G+P Y +PEV+ Y
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY- 184
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 250
VD+W+CGVILY LL G PF DE+ L+ +IK G Y PS ++P A+ LI
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244
Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQ 289
ML V+P KRIT + + PW A+ DT+
Sbjct: 245 MLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDC 283
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 411 bits (1059), Expect = e-142
Identities = 103/273 (37%), Positives = 149/273 (54%), Gaps = 15/273 (5%)
Query: 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-----MEMEEKVRREIK 69
F Y +G G V+ H TGH+ A+KI+ + E+ E RRE
Sbjct: 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151
Query: 70 ILR-LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
ILR + HPHII L + E+ S +++V + ++ GELFDY+ EK L E E R+ + ++
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE 211
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI 188
V + H N +VHRDLKPEN+LLD ++++DFG S + G L+ CG+P Y APE++
Sbjct: 212 AVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271
Query: 189 SGKLYA-----GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----H 239
+ G EVD+W+CGVIL+ LL G+ PF + + I G Y S
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD 331
Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
S +DLI R+L VDP R+T + QHP+F+
Sbjct: 332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 413 bits (1063), Expect = e-141
Identities = 107/287 (37%), Positives = 155/287 (54%), Gaps = 16/287 (5%)
Query: 1 MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI----- 55
D + S Y + KTLG G+ G+VK+A T KVAI+I+++RK
Sbjct: 119 FDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA 178
Query: 56 KNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQ 115
+ + V EI+IL+ HP II++ + D Y+V+E ++ GELFD +V RL+
Sbjct: 179 READPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLK 237
Query: 116 EDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHF 172
E + +F Q++ V+Y H N ++HRDLKPEN+LL S+ +KI DFG S I+ +
Sbjct: 238 EATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297
Query: 173 LKTSCGSPNYAAPEVISGKLYA--GPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKI 229
++T CG+P Y APEV+ A VD WS GVIL+ L G PF + +L +I
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 357
Query: 230 KGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
G Y +S A DL+ ++L+VDP R T E +HPW Q
Sbjct: 358 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 406 bits (1046), Expect = e-141
Identities = 104/269 (38%), Positives = 154/269 (57%), Gaps = 12/269 (4%)
Query: 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
Y L T+G GS+G+VKIA T + A K + + +++ ++ ++EI+I++
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSL 63
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
HP+IIRLYE E +DIY+VME GELF+ +V K +E +A + ++S V YCH
Sbjct: 64 DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH 123
Query: 135 RNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
+ V HRDLKPEN L + +K+ DFGL+ + G ++T G+P Y +P+V+ G
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL 183
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDL 247
Y GPE D WS GV++Y LLCG PF + KI+ G +T P ++SP A L
Sbjct: 184 -Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLP 276
I R+L P +RIT + +H WF+ L
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWFEKQLS 270
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 405 bits (1042), Expect = e-140
Identities = 102/281 (36%), Positives = 150/281 (53%), Gaps = 16/281 (5%)
Query: 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN------MEMEEKVRREI 68
F NY+ + LG G V+ H T + A+KI++ + E+ E +E+
Sbjct: 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 69 KILR-LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII 127
ILR + HP+II+L + ET + ++V + +K GELFDY+ EK L E E R + ++
Sbjct: 75 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 134
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187
+ H+ +VHRDLKPEN+LLD N+K+ DFG S + G L+ CG+P+Y APE+
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194
Query: 188 ISGKLYA-----GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS---- 238
I + G EVD+WS GVI+Y LL G+ PF + + I G Y S
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 254
Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL 279
S +DL+ R L+V P KR T E HP+FQ ++ +
Sbjct: 255 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 397 bits (1022), Expect = e-136
Identities = 116/285 (40%), Positives = 162/285 (56%), Gaps = 9/285 (3%)
Query: 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
F NY + + LG G+F V+ H TG + A KI+N +K+ + + K+ RE +I R
Sbjct: 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKL 85
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
HP+I+RL++ I+ S Y+V + V GELF+ IV + E +A + QQI+ + YCH
Sbjct: 86 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 145
Query: 135 RNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
N +VHR+LKPENLLL SK VK+ADFGL+ + D G+P Y +PEV+
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 205
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDL 247
Y VD+W+CGVILY LL G PF DE+ L+ +IK G Y PS ++P A+ L
Sbjct: 206 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
I ML V+P KRIT + + PW A+ DT+ KK
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKK 309
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 388 bits (999), Expect = e-134
Identities = 84/264 (31%), Positives = 138/264 (52%), Gaps = 14/264 (5%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
+ + LG G+FG V + E +G + IK +N+ + + E++ EI++L+ HP+
Sbjct: 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPN 81
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCH 134
II+++EV E ++Y+VME + GEL + IV L E +Q+++ + Y H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 135 RNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
VVH+DLKPEN+L +KI DFGL+ + + + G+ Y APEV
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD 201
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS---HLSPGARDLI 248
+ + D+WS GV++Y LL G LPF ++ + +K L+P A DL+
Sbjct: 202 V--TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLL 259
Query: 249 PRMLIVDPMKRITIPEIRQHPWFQ 272
+ML DP +R + ++ H WF+
Sbjct: 260 KQMLTKDPERRPSAAQVLHHEWFK 283
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 374 bits (962), Expect = e-127
Identities = 89/357 (24%), Positives = 146/357 (40%), Gaps = 27/357 (7%)
Query: 2 DGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME 61
D AS+ ++ + + Y + K +G G KV + AIK +N + N ++
Sbjct: 41 DKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD 99
Query: 62 EKVRREIKILRLFMHP--HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA 119
R EI L IIRLY+ T IY+VME +L ++ +K + E
Sbjct: 100 -SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWER 157
Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTS 176
+++++ ++ V H++ +VH DLKP N L+ +K+ DFG++N M+ +
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 177 CGSPNYAAPEVISG----------KLYAGPEVDVWSCGVILYALLCGTLPFDD--ENIPN 224
G+ NY PE I K P+ DVWS G ILY + G PF I
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276
Query: 225 LFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPP 283
L I P +D++ L DP +RI+IPE+ HP+ Q P
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH-----PV 331
Query: 284 PDTMQQAKKIDEEILKEVVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSG 340
+ + + +L ++V + + L + ++ F G
Sbjct: 332 NQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRG 388
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 384 bits (986), Expect = e-127
Identities = 92/396 (23%), Positives = 153/396 (38%), Gaps = 52/396 (13%)
Query: 7 RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRR 66
RS S +++ + LG G FG V H TG +VAIK + + E+
Sbjct: 4 RSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP--KNRERWCL 61
Query: 67 EIKILRLFMHPHIIRLYEVIETPSDI------YVVMEYVKSGELFDYIVEKGR---LQED 117
EI+I++ HP+++ EV + + + MEY + G+L Y+ + L+E
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 118 EARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLK 174
R I S + Y H N ++HRDLKPEN++L KI D G + + G
Sbjct: 122 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 181
Query: 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF-KKIKGGI 233
G+ Y APE++ K Y VD WS G + + + G PF P + K++
Sbjct: 182 EFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKS 240
Query: 234 Y-------------------TLPSHLSPGARDLIPR----MLIVDPMKRITIPEIRQHPW 270
P+HLS + R ML+ +R T P+
Sbjct: 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300
Query: 271 FQA-HLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLRNRLQNEATVAY-- 327
FQA L + M + + +N+ +++L++ LQ + +
Sbjct: 301 FQALDSILSLKLLSVMNMVSGRVHTYPV---------TENENLQNLKSWLQQDTGIPEEE 351
Query: 328 -YLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEP 362
LL + ++S ++ R +
Sbjct: 352 QELLQASGLALNSAQPLTQYVIDCTVIDGRQGEGDL 387
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 371 bits (954), Expect = e-126
Identities = 68/306 (22%), Positives = 114/306 (37%), Gaps = 47/306 (15%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+ L LG G+ V H TG AIK+ N + RE ++L+ H
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHK 67
Query: 78 HIIRLYEVIE--TPSDIYVVMEYVKSGELFDYIVEKGR---LQEDEARNFFQQIISGVEY 132
+I++L+ + E T ++ME+ G L+ + E L E E + ++ G+ +
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 133 CHRNMVVHRDLKPENLLL----DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI 188
N +VHR++KP N++ D + K+ DFG + + D + G+ Y P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 189 SGKLYA-------GPEVDVWSCGVILYALLCGTLPFDDENIP----NLFKKIKGGIYT-- 235
+ G VD+WS GV Y G+LPF P + KI G +
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 236 -------------------LPSHLSPGARD----LIPRMLIVDPMKRITIPEIRQHPWFQ 272
+ LS G + ++ +L D K +
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307
Query: 273 AHLPRY 278
H
Sbjct: 308 LHRGNS 313
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 369 bits (949), Expect = e-126
Identities = 105/267 (39%), Positives = 158/267 (59%), Gaps = 10/267 (3%)
Query: 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
F Y + LG GSFG+V + +T + A+K++N+ KN + + RE+++L+
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKL 78
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
HP+I++L+E++E S Y+V E GELFD I+++ R E +A +Q+ SG+ Y H
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 135 RNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
++ +VHRDLKPEN+LL+SK ++KI DFGLS + +K G+ Y APEV+ G
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDL 247
Y + DVWS GVILY LL GT PF +N ++ K+++ G Y +S A+DL
Sbjct: 199 -Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274
I +ML P RIT + +HPW Q +
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 368 bits (948), Expect = e-126
Identities = 85/297 (28%), Positives = 128/297 (43%), Gaps = 30/297 (10%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
Y + K +G G KV + AIK +N + N ++ R EI L
Sbjct: 29 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQH 86
Query: 78 --HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
IIRLY+ T IY+VME + +L ++ +K + E +++++ ++ V H+
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISG-- 190
+ +VH DLKP N L+ +K+ DFG++N M+ + G+ NY PE I
Sbjct: 146 HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 191 --------KLYAGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGI-YTLPSH 239
K P+ DVWS G ILY + G PF I L I P
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEE 296
+D++ L DP +RI+IPE+ HP+ Q + Q AK EE
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ--------IQTHPVNQMAKGTTEE 313
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 366 bits (942), Expect = e-124
Identities = 85/341 (24%), Positives = 139/341 (40%), Gaps = 27/341 (7%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
Y + K +G G KV + AIK +N + N ++ R EI L
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQH 67
Query: 78 --HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
IIRLY+ T IY+VME + +L ++ +K + E +++++ ++ V H+
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKL 192
+ +VH DLKP N L+ +K+ DFG++N M+ + G+ NY PE I
Sbjct: 127 HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 193 YA----------GPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGI-YTLPSH 239
+ P+ DVWS G ILY + G PF I L I P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILK 299
+D++ L DP +RI+IPE+ HP+ Q P + + + +L
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH-----PVNQMAKGTTEEMKYVLG 300
Query: 300 EVVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSG 340
++V + + L + ++ F G
Sbjct: 301 QLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRG 341
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 361 bits (927), Expect = e-121
Identities = 68/305 (22%), Positives = 115/305 (37%), Gaps = 47/305 (15%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+ L LG G+ V H TG AIK+ N + + RE ++L+ H
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHK 67
Query: 78 HIIRLYEVIE--TPSDIYVVMEYVKSGELFDYIVEKGR---LQEDEARNFFQQIISGVEY 132
+I++L+ + E T ++ME+ G L+ + E L E E + ++ G+ +
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 133 CHRNMVVHRDLKPENLLL----DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI 188
N +VHR++KP N++ D + K+ DFG + + D + G+ Y P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 189 SGKLYA-------GPEVDVWSCGVILYALLCGTLPFDDENIP----NLFKKIKGGIYT-- 235
+ G VD+WS GV Y G+LPF P + KI G +
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 236 -------------------LPSHLSPGARD----LIPRMLIVDPMKRITIPEIRQHPWFQ 272
+ LS G + ++ +L D K +
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307
Query: 273 AHLPR 277
H
Sbjct: 308 LHRMV 312
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 353 bits (907), Expect = e-119
Identities = 102/262 (38%), Positives = 147/262 (56%), Gaps = 12/262 (4%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+ + LG G+F +V + + LTG A+K + + + + EI +L+ H
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHE 66
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
+I+ L ++ E+ + Y+VM+ V GELFD I+E+G E +A QQ++S V+Y H N
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 138 VVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
+VHRDLKPENLL + + I DFGLS + ++G + T+CG+P Y APEV++ K Y
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPY- 184
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 250
VD WS GVI Y LLCG PF +E LF+KIK G Y S +S A+D I
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICH 244
Query: 251 MLIVDPMKRITIPEIRQHPWFQ 272
+L DP +R T + HPW
Sbjct: 245 LLEKDPNERYTCEKALSHPWID 266
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 357 bits (918), Expect = e-119
Identities = 109/265 (41%), Positives = 156/265 (58%), Gaps = 10/265 (3%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
Y+L + LG G+F V+ L G + A I+N +K+ + +K+ RE +I RL HP
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLKHP 70
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
+I+RL++ I Y++ + V GELF+ IV + E +A + QQI+ V +CH+
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 138 VVHRDLKPENLLLDSKWN---VKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLY 193
VVHR+LKPENLLL SK VK+ADFGL+ + + G+P Y +PEV+ Y
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190
Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIP 249
G VD+W+CGVILY LL G PF DE+ L+++IK G Y PS ++P A+DLI
Sbjct: 191 -GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 249
Query: 250 RMLIVDPMKRITIPEIRQHPWFQAH 274
+ML ++P KRIT E +HPW
Sbjct: 250 KMLTINPSKRITAAEALKHPWISHR 274
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 346 bits (891), Expect = e-117
Identities = 97/268 (36%), Positives = 150/268 (55%), Gaps = 12/268 (4%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRLF 74
+Y++G+ LG G F V+ TG + A K + +R++ + E++ RE+ ILR
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
HP+II L+++ E +D+ +++E V GELFD++ EK L EDEA F +QI+ GV Y H
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 135 RNMVVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190
+ H DLKPEN++L K +K+ DFG+++ + G+ K G+P + APE+++
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY 185
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARD 246
+ G E D+WS GVI Y LL G PF E I Y + S A+D
Sbjct: 186 EPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKD 244
Query: 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274
I R+L+ DP +R+TI + +H W +A
Sbjct: 245 FIRRLLVKDPKRRMTIAQSLEHSWIKAI 272
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 346 bits (890), Expect = e-117
Identities = 77/323 (23%), Positives = 135/323 (41%), Gaps = 57/323 (17%)
Query: 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
+ +++ LG G+FG+V A +AL AIK + + E + E+ +L
Sbjct: 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASL 59
Query: 75 MHPHIIRLYEV-------------IETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEAR 120
H +++R Y ++ S +++ MEY ++G L+D I + Q DE
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS---------------N 165
F+QI+ + Y H ++HRDLKP N+ +D NVKI DFGL+ N
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL 225
+ L ++ G+ Y A EV+ G + ++D++S G+I + ++ N+
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNI 237
Query: 226 FKKIKGGIYTLPSHL----SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAV 281
KK++ P + +I ++ DP KR + W
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP--------- 288
Query: 282 PPPDTMQQAKKIDEEILKEVVKM 304
K +E++KE +K
Sbjct: 289 ---------VKHQDEVIKEALKS 302
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 352 bits (906), Expect = e-117
Identities = 109/274 (39%), Positives = 161/274 (58%), Gaps = 9/274 (3%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
YK + LG GSFG+V + + +TG + A+K++++R++K +E + RE+++L+ HP
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
+I++LYE E Y+V E GELFD I+ + R E +A +Q++SG+ Y H+N
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 138 VVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
+VHRDLKPENLLL+SK N++I DFGLS +K G+ Y APEV+ G Y
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-Y- 204
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 250
+ DVWS GVILY LL G PF+ N ++ KK++ G YT +S A+DLI +
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264
Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
ML P RI+ + H W Q + ++V P
Sbjct: 265 MLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 298
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 346 bits (891), Expect = e-116
Identities = 100/288 (34%), Positives = 156/288 (54%), Gaps = 16/288 (5%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME--MEEKVRREIKILRLFMH 76
Y+L + +G G F V+ + TG + A+KI++ K + E ++RE I + H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQ----EDEARNFFQQIISGVEY 132
PHI+ L E + +Y+V E++ +L IV++ E A ++ +QI+ + Y
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 133 CHRNMVVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVI 188
CH N ++HRD+KP +LL SK N VK+ FG++ + G G+P++ APEV+
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGA 244
+ Y G VDVW CGVIL+ LL G LPF LF+ I G Y + H+S A
Sbjct: 206 KREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESA 263
Query: 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
+DL+ RML++DP +RIT+ E HPW + + P+T++Q +K
Sbjct: 264 KDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRK 311
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 345 bits (888), Expect = e-116
Identities = 106/357 (29%), Positives = 168/357 (47%), Gaps = 21/357 (5%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRLFM 75
Y +G+ LG G F VK TG + A K + +R+ + E++ RE+ ILR +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
HP+II L++V E +D+ +++E V GELFD++ +K L E+EA +F +QI+ GV Y H
Sbjct: 74 HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 136 NMVVHRDLKPENLLLDSK----WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
+ H DLKPEN++L K ++K+ DFGL++ + DG K G+P + APE+++ +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDL 247
G E D+WS GVI Y LL G PF + I Y S A+D
Sbjct: 194 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDF 252
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMG-F 306
I ++L+ + KR+TI E +HPW +++ ++ E K+ +
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPWITPV------DTQQAMVRRESVVNLENFKKQYVRRRW 306
Query: 307 DQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPA 363
+ + SL N L +L R E + +
Sbjct: 307 KLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCES--DTEENIARRKALHPRRRSSTS 361
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 343 bits (881), Expect = e-115
Identities = 97/284 (34%), Positives = 150/284 (52%), Gaps = 12/284 (4%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRLFM 75
Y +G+ LG G F VK TG + A K + +R+ + E++ RE+ ILR +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
H ++I L++V E +D+ +++E V GELFD++ +K L E+EA +F +QI+ GV Y H
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 136 NMVVHRDLKPENLLLDSK----WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
+ H DLKPEN++L K ++K+ DFGL++ + DG K G+P + APE+++ +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDL 247
G E D+WS GVI Y LL G PF + I Y H S A+D
Sbjct: 194 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDF 252
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAK 291
I ++L+ + KR+TI E +HPW + V +
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLEN 296
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 343 bits (881), Expect = e-115
Identities = 102/308 (33%), Positives = 158/308 (51%), Gaps = 23/308 (7%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME---EKVRREIKILRLFM 75
Y G+ LG G F VK TG + A K + +R+ K+ E + RE+ IL+
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
HP++I L+EV E +D+ +++E V GELFD++ EK L E+EA F +QI++GV Y H
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 136 NMVVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
+ H DLKPEN++L + +KI DFGL++ + G+ K G+P + APE+++ +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDL 247
G E D+WS GVI Y LL G PF + + Y + S A+D
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 251
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQ-----AHLPRYLAVPPPDTMQQ------AKKIDEE 296
I R+L+ DP KR+TI + QHPW + L R + + ++ +
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKSNNGSGG 311
Query: 297 ILKEVVKM 304
L ++ +
Sbjct: 312 GLNDIFEA 319
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 342 bits (880), Expect = e-115
Identities = 94/271 (34%), Positives = 141/271 (52%), Gaps = 21/271 (7%)
Query: 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RL 73
F Y++ + +G+GS+ K H T + A+KI+++ K EI+IL R
Sbjct: 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRY 72
Query: 74 FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
HP+II L +V + +YVV E +K GEL D I+ + E EA I VEY
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYL 132
Query: 134 HRNMVVHRDLKPENLLLDSK----WNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVI 188
H VVHRDLKP N+L + +++I DFG + +R + L T C + N+ APEV+
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 192
Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFD---DENIPNLFKKIKGGIYTLPS----HLS 241
+ Y D+WS GV+LY +L G PF D+ + +I G ++L +S
Sbjct: 193 ERQGY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251
Query: 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
A+DL+ +ML VDP +R+T + +HPW
Sbjct: 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 346 bits (890), Expect = e-114
Identities = 105/289 (36%), Positives = 160/289 (55%), Gaps = 17/289 (5%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
Y + LG GSFG+V + +T + A+K++N+ KN + + RE+++L+ HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHP 81
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
+I++L+E++E S Y+V E GELFD I+++ R E +A +Q+ SG+ Y H++
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 138 VVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
+VHRDLKPEN+LL+SK ++KI DFGLS + +K G+ Y APEV+ G Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-Y- 199
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 250
+ DVWS GVILY LL GT PF +N ++ K+++ G Y +S A+DLI +
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259
Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILK 299
ML P RIT + +HPW Q + + E +
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSETPTISD-------LPSLESAMT 301
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 341 bits (876), Expect = e-114
Identities = 110/266 (41%), Positives = 155/266 (58%), Gaps = 14/266 (5%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
+++ LG G+ V + T A+K+L + ++ VR EI +L HP+
Sbjct: 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPN 109
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
II+L E+ ETP++I +V+E V GELFD IVEKG E +A + +QI+ V Y H N +
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169
Query: 139 VHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
VHRDLKPENLL + +KIADFGLS I+ +KT CG+P Y APE++ G Y G
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-G 228
Query: 196 PEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 250
PEVD+WS G+I Y LLCG PF DE +F++I Y S +S A+DL+ +
Sbjct: 229 PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRK 288
Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLP 276
++++DP KR+T + QHPW
Sbjct: 289 LIVLDPKKRLTTFQALQHPWVTGKAA 314
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 341 bits (875), Expect = e-114
Identities = 90/311 (28%), Positives = 137/311 (44%), Gaps = 54/311 (17%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--NMEMEEKVRREIKILRLFM 75
Y L +G GS+G V++A T AIKI+N+ KI+ N + E+++ E+++++
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQ-------------------- 115
HP+I RLYEV E I +VME G L D +
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 116 --------------------EDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-- 153
E N +QI S + Y H + HRD+KPEN L +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 154 WNVKIADFGLSNIMR-----DGHFLKTSCGSPNYAAPEVISGKLYA-GPEVDVWSCGVIL 207
+ +K+ DFGLS + + + T G+P + APEV++ + GP+ D WS GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 208 YALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIP 263
+ LL G +PF N + ++ + LSP ARDL+ +L + +R
Sbjct: 267 HLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326
Query: 264 EIRQHPWFQAH 274
QHPW
Sbjct: 327 RALQHPWISQF 337
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 334 bits (858), Expect = e-112
Identities = 87/285 (30%), Positives = 133/285 (46%), Gaps = 13/285 (4%)
Query: 19 YKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LFMH 76
Y L K LG G F V+ TG + A K L +R+ + ++ EI +L
Sbjct: 30 YILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSC 88
Query: 77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCH 134
P +I L+EV E S+I +++EY GE+F + + + E++ +QI+ GV Y H
Sbjct: 89 PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 135 RNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
+N +VH DLKP+N+LL S ++KI DFG+S + L+ G+P Y APE+++
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD 208
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDL 247
D+W+ G+I Y LL T PF E+ + I +S A D
Sbjct: 209 PI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDF 267
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
I +L+ +P KR T H W Q L P + +
Sbjct: 268 IQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQ 312
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 334 bits (858), Expect = e-112
Identities = 101/321 (31%), Positives = 150/321 (46%), Gaps = 33/321 (10%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHP 77
K LG GSF + H + A+KI+++R E ++EI L HP
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHP 66
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
+I++L+EV ++VME + GELF+ I +K E EA ++++S V + H
Sbjct: 67 NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG 126
Query: 138 VVHRDLKPENLLLDSKW---NVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLY 193
VVHRDLKPENLL + +KI DFG + + D LKT C + +YAAPE+++ Y
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGY 186
Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDEN-------IPNLFKKIKGGIYTLPS----HLSP 242
D+WS GVILY +L G +PF + + KKIK G ++ ++S
Sbjct: 187 -DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ 245
Query: 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV 302
A+DLI +L VDP KR+ + +R + W Q P + V
Sbjct: 246 EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ---LSSNPLMTPDILGSSGAAVHTCV 302
Query: 303 KMGFDQNQLVESLRNRLQNEA 323
K F N+ + E
Sbjct: 303 KATF-------HAFNKYKREG 316
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 338 bits (870), Expect = e-111
Identities = 104/279 (37%), Positives = 161/279 (57%), Gaps = 10/279 (3%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
Y+ K LG G++G+V + +T + AIKI+ + + K+ E+ +L+L HP+
Sbjct: 39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDHPN 97
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
I++LY+ E + Y+VME K GELFD I+ + + E +A +Q++SGV Y H++ +
Sbjct: 98 IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI 157
Query: 139 VHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
VHRDLKPENLLL+SK +KI DFGLS + + +K G+ Y APEV+ K Y
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK-Y-D 215
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRM 251
+ DVWS GVIL+ LL G PF + + +K++ G YT S ++S GA+DLI +M
Sbjct: 216 EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQM 275
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQA 290
L D +RI+ + +HPW + + + ++ A
Sbjct: 276 LQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANA 314
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 338 bits (870), Expect = e-111
Identities = 97/284 (34%), Positives = 155/284 (54%), Gaps = 19/284 (6%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM----------EMEEKVRRE 67
+Y + LG G++G+V + + + AIK++ + + + E++ E
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 68 IKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII 127
I +L+ HP+II+L++V E Y+V E+ + GELF+ I+ + + E +A N +QI+
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAA 184
SG+ Y H++ +VHRD+KPEN+LL++K N+KI DFGLS+ + L+ G+ Y A
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIA 216
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HL 240
PEV+ K Y + DVWSCGVI+Y LLCG PF +N ++ KK++ G Y ++
Sbjct: 217 PEVLKKK-Y-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNI 274
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
S A++LI ML D KR T E W + +
Sbjct: 275 SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQK 318
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 331 bits (850), Expect = e-111
Identities = 69/267 (25%), Positives = 127/267 (47%), Gaps = 12/267 (4%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
Y + + LG G FG V + K + + + V++EI IL + H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHR 61
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRN 136
+I+ L+E E+ ++ ++ E++ ++F+ I L E E ++ Q+ +++ H +
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 137 MVVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
+ H D++PEN++ ++ + +KI +FG + ++ G + +P Y APEV +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV- 180
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 250
D+WS G ++Y LL G PF E + + I YT +S A D + R
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240
Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLPR 277
+L+ + R+T E QHPW + + R
Sbjct: 241 LLVKERKSRMTASEALQHPWLKQKIER 267
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 332 bits (854), Expect = e-110
Identities = 80/282 (28%), Positives = 141/282 (50%), Gaps = 11/282 (3%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
Y + + LG G+FG V TG K +N + V+ EI I+ HP
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHP 108
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRN 136
+I L++ E ++ +++E++ GELFD I + ++ E E N+ +Q G+++ H +
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 137 MVVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
+VH D+KPEN++ ++K VKI DFGL+ + +K + + +AAPE++ +
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV- 227
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 250
G D+W+ GV+ Y LL G PF E+ + +K + +SP A+D I
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 287
Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
+L +P KR+T+ + +HPW + + P + ++
Sbjct: 288 LLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQ 329
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 325 bits (836), Expect = e-109
Identities = 91/310 (29%), Positives = 147/310 (47%), Gaps = 42/310 (13%)
Query: 3 GASNRSSSGVDMFLPNYKLGK-TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME 61
G+++ S F Y+L + LG G+ +V+ + +T + A+KI+ ++ +
Sbjct: 1 GSTDSFSGR---FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIR 54
Query: 62 EKVRREIKIL-RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR 120
+V RE+++L + H +++ L E E Y+V E ++ G + +I ++ E EA
Sbjct: 55 SRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS 114
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHF----- 172
Q + S +++ H + HRDLKPEN+L + VKI DF L + ++
Sbjct: 115 VVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 173 ---LKTSCGSPNYAAPEVISGKLYA----GPEVDVWSCGVILYALLCGTLPFDDENIPN- 224
L T CGS Y APEV+ D+WS GVILY LL G PF +
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234
Query: 225 --------------LFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIR 266
LF+ I+ G Y P H+S A+DLI ++L+ D +R++ ++
Sbjct: 235 GWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294
Query: 267 QHPWFQAHLP 276
QHPW Q P
Sbjct: 295 QHPWVQGCAP 304
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 327 bits (839), Expect = e-108
Identities = 96/265 (36%), Positives = 147/265 (55%), Gaps = 13/265 (4%)
Query: 19 YKLGKT--LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
Y + KT LG G FG+V E TG K+A KI+ R +K+ +E+V+ EI ++ H
Sbjct: 89 YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQLDH 145
Query: 77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHR 135
++I+LY+ E+ +DI +VMEYV GELFD I+++ L E + F +QI G+ + H+
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 136 NMVVHRDLKPENLLLDSK--WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
++H DLKPEN+L ++ +KI DFGL+ + LK + G+P + APEV++ +
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYD-F 264
Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIP 249
D+WS GVI Y LL G PF +N I + L +S A++ I
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFIS 324
Query: 250 RMLIVDPMKRITIPEIRQHPWFQAH 274
++LI + RI+ E +HPW H
Sbjct: 325 KLLIKEKSWRISASEALKHPWLSDH 349
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 331 bits (851), Expect = e-107
Identities = 85/293 (29%), Positives = 146/293 (49%), Gaps = 21/293 (7%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
Y + + LG G+FG V TG+ A K + + +E VR+EI+ + + HP
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPT 215
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNM 137
++ L++ E +++ ++ E++ GELF+ + E ++ EDEA + +Q+ G+ + H N
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 138 VVHRDLKPENLLLDSKW--NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
VH DLKPEN++ +K +K+ DFGL+ + +K + G+ +AAPEV GK G
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-G 334
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRM 251
D+WS GV+ Y LL G PF EN + +K + + +S +D I ++
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 394
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKM 304
L+ DP R+TI + +HPW + + +I ++
Sbjct: 395 LLADPNTRMTIHQALEHPWLTPG----------NAPGRDSQIPSSRYTKIRDS 437
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 319 bits (819), Expect = e-105
Identities = 92/272 (33%), Positives = 133/272 (48%), Gaps = 27/272 (9%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHP 77
+ LG+G GKV + T K A+K+L K RRE+++ R P
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCP 115
Query: 78 HIIRLYEVIETPSD----IYVVMEYVKSGELFDYIVEKGRLQ--EDEARNFFQQIISGVE 131
HI+R+ +V E + +VME + GELF I ++G E EA + I ++
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 132 YCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI 188
Y H + HRD+KPENLL SK +K+ DFG + + L T C +P Y APEV+
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 235
Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYTLPS----HL 240
+ Y D+WS GVI+Y LLCG PF + P + +I+ G Y P+ +
Sbjct: 236 GPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
S + LI +L +P +R+TI E HPW
Sbjct: 295 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 319 bits (820), Expect = e-105
Identities = 80/294 (27%), Positives = 125/294 (42%), Gaps = 50/294 (17%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LFMHP 77
K LG GS G V + + G VA+K + + + EIK+L HP
Sbjct: 17 VVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLI------DFCDIALMEIKLLTESDDHP 69
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-------RLQEDEARNFFQQIISGV 130
++IR Y T +Y+ +E + L D + K +E + +QI SGV
Sbjct: 70 NVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 131 EYCHRNMVVHRDLKPENLLLDSK-------------WNVKIADFGLSNIMRDGHF----- 172
+ H ++HRDLKP+N+L+ + + I+DFGL + G
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 173 LKTSCGSPNYAAPEVISG------KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNL 225
L G+ + APE++ K +D++S G + Y +L G PF D+
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247
Query: 226 FKKIKGGIYTLPS-------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
I GI++L L A DLI +M+ DP+KR T ++ +HP F
Sbjct: 248 -SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = e-104
Identities = 101/321 (31%), Positives = 154/321 (47%), Gaps = 34/321 (10%)
Query: 15 FLPNYKLGK-TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-R 72
+Y+L K LG+G GKV H TG K A+K+L K R+E+ +
Sbjct: 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQ 77
Query: 73 LFMHPHIIRLYEVIETPSD----IYVVMEYVKSGELFDYIVEKGRLQ--EDEARNFFQQI 126
PHI+ + +V E + ++ME ++ GELF I E+G E EA + I
Sbjct: 78 ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 137
Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYA 183
+ +++ H + + HRD+KPENLL SK +K+ DFG + L+T C +P Y
Sbjct: 138 GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPYYV 196
Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLPS- 238
APEV+ + Y D+WS GVI+Y LLCG PF P + ++I+ G Y P+
Sbjct: 197 APEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255
Query: 239 ---HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ-----AHLPRYLAVPPPDTMQQA 290
+S A+ LI +L DP +R+TI + HPW P + A +
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHW 315
Query: 291 KKIDEEILKEVVKMGFDQNQL 311
++ EE+ + M D +Q+
Sbjct: 316 DEVKEEMTSALATMRVDYDQV 336
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = e-101
Identities = 81/326 (24%), Positives = 137/326 (42%), Gaps = 43/326 (13%)
Query: 3 GASNRSSSG-----VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN 57
GAS R S V++ ++ + L G F V A+ +G + A+K L
Sbjct: 9 GASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL---SNE 65
Query: 58 MEMEEKVRREIKILR-LFMHPHIIRLY-------EVIETPSDIYVVMEYVKSGELFDYIV 109
E + +E+ ++ L HP+I++ E +T ++++ + G+L +++
Sbjct: 66 EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK 125
Query: 110 E---KGRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKIADFGLS 164
+ +G L D F Q V++ HR ++HRDLK ENLLL ++ +K+ DFG +
Sbjct: 126 KMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185
Query: 165 NIMRDGHFLK-------------TSCGSPNYAAPEVIS--GKLYAGPEVDVWSCGVILYA 209
+ T +P Y PE+I G + D+W+ G ILY
Sbjct: 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL 245
Query: 210 LLCGTLPFDDENIPNLFKKIKGGIYTLPSHL--SPGARDLIPRMLIVDPMKRITIPEIRQ 267
L PF+D +I G Y++P H LI ML V+P +R++I E+
Sbjct: 246 LCFRQHPFEDGAK----LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVH 301
Query: 268 HPWFQAHLPRY-LAVPPPDTMQQAKK 292
A P + ++Q
Sbjct: 302 QLQEIAAARNVNPKSPITELLEQNGG 327
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = 2e-99
Identities = 71/280 (25%), Positives = 111/280 (39%), Gaps = 26/280 (9%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+Y + LG G F V + E GH A+K + + E+ +RE + RLF HP
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL---CHEQQDREEAQREADMHRLFNHP 86
Query: 78 HIIRLYEVIETPSD----IYVVMEYVKSGELFDYI----VEKGRLQEDEARNFFQQIISG 129
+I+RL ++++ + K G L++ I + L ED+ I G
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----------LKTSCGS 179
+E H HRDLKP N+LL + + D G N +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 180 PNYAAPEVISGKLYA--GPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTL 236
+Y APE+ S + + DVWS G +LYA++ G P+D + ++
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 237 P--SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274
P S L+ M+ VDP +R IP +
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = 3e-98
Identities = 75/338 (22%), Positives = 135/338 (39%), Gaps = 31/338 (9%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LFMH 76
++ LG G+ G + + VA+K + RE+++LR H
Sbjct: 25 SFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEH 77
Query: 77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHR 135
P++IR + + Y+ +E + L +Y+ +K E QQ SG+ + H
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 136 NMVVHRDLKPENLLLDSKWN-----VKIADFGLSNIMRDGH----FLKTSCGSPNYAAPE 186
+VHRDLKP N+L+ I+DFGL + G G+ + APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 187 VISGKLYA--GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS---HL 240
++S VD++S G + Y ++ G+ PF + H
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKE 300
AR+LI +M+ +DP KR + + +HP+F + + + + +D I+K+
Sbjct: 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQ 316
Query: 301 VVKMGFD------QNQLVESLRNRLQNEATVAYYLLLD 332
+ + G + + L+ L+ T + D
Sbjct: 317 LERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRD 354
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 6e-95
Identities = 87/274 (31%), Positives = 141/274 (51%), Gaps = 15/274 (5%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+Y++ T+G GS+G+ + G + K L+ + E ++ + E+ +LR HP
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKHP 65
Query: 78 HIIRLYEVI--ETPSDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVE 131
+I+R Y+ I T + +Y+VMEY + G+L I + + L E+ Q+ ++
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 132 YCHR-----NMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAP 185
CHR + V+HRDLKP N+ LD K NVK+ DFGL+ I+ D F KT G+P Y +P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGA 244
E ++ Y + D+WS G +LY L PF + L KI+ G + +P S
Sbjct: 186 EQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 244
Query: 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY 278
++I RML + R ++ EI ++P H +
Sbjct: 245 NEIITRMLNLKDYHRPSVEEILENPLILEHHHHH 278
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 5e-94
Identities = 48/309 (15%), Positives = 93/309 (30%), Gaps = 50/309 (16%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-- 75
G LG A TG + + + ++++ E+ LRL
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 76 -----------------------HPHIIRLYEVIETPS--DIYVVMEYVKS------GEL 104
+IR+ + + ++S L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 105 FDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164
+ L Q+I + H +VH L+P +++LD + V + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 165 NIMRDGHFLKTSCGSPNYAAPEVIS----------GKLYAGPEVDVWSCGVILYALLCGT 214
+RDG S S + PE+ + + D W+ G+++Y + C
Sbjct: 254 --VRDGAR-VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 215 LPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274
LP + + I+ ++ R L+ L R+ + + P ++
Sbjct: 311 LPITKDAALGGSEW----IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366
Query: 275 LPRYLAVPP 283
A P
Sbjct: 367 RTELSAALP 375
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 3e-92
Identities = 86/272 (31%), Positives = 122/272 (44%), Gaps = 48/272 (17%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHP 77
+ LG+G GKV + T K A+K+L K RRE+++ R P
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCP 71
Query: 78 HIIRLYEVIETPSD----IYVVMEYVKSGELFDYIVEKGRLQ--EDEARNFFQQIISGVE 131
HI+R+ +V E + +VME + GELF I ++G E EA + I ++
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 132 YCHRNMVVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI 188
Y H + HRD+KPENLL SK +K+ DFG A E
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKETT 171
Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYTLPS----HL 240
K Y D+WS GVI+Y LLCG PF + P + +I+ G Y P+ +
Sbjct: 172 GEK-Y-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 229
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
S + LI +L +P +R+TI E HPW
Sbjct: 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 6e-90
Identities = 75/269 (27%), Positives = 137/269 (50%), Gaps = 6/269 (2%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
+ Y + +G GSFGK + + G + IK +N ++ + E EE RRE+ +L
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE-SRREVAVLANMK 81
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYC 133
HP+I++ E E +Y+VM+Y + G+LF I QED+ ++F QI +++
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKL 192
H ++HRD+K +N+ L V++ DFG++ ++ + G+P Y +PE+ K
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRM 251
Y + D+W+ G +LY L F+ ++ NL KI G + + H S R L+ ++
Sbjct: 202 Y-NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL 260
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLA 280
+P R ++ I + + + ++L+
Sbjct: 261 FKRNPRDRPSVNSILEKGFIAKRIEKFLS 289
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 9e-86
Identities = 75/280 (26%), Positives = 122/280 (43%), Gaps = 30/280 (10%)
Query: 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
F ++K + +G G FG+V A+H + G IK + EK RE+K L
Sbjct: 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKL 61
Query: 75 MHPHIIRLYEVIETPSD----------------IYVVMEYVKSGELFDYIVEK--GRLQE 116
H +I+ + +++ ME+ G L +I ++ +L +
Sbjct: 62 DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 117 DEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS 176
A F+QI GV+Y H +++RDLKP N+ L VKI DFGL +++ S
Sbjct: 122 VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS 181
Query: 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL 236
G+ Y +PE IS + Y G EVD+++ G+IL LL + + F ++ GI +
Sbjct: 182 KGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDGI--I 236
Query: 237 PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276
+ L+ ++L P R EI + P
Sbjct: 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 4e-85
Identities = 87/264 (32%), Positives = 137/264 (51%), Gaps = 10/264 (3%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
++K GK LG GSF V +A T + AIKIL +R I V RE ++ HP
Sbjct: 31 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
++LY + +Y + Y K+GEL YI + G E R + +I+S +EY H
Sbjct: 91 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYA 194
++HRDLKPEN+LL+ +++I DFG + ++ + G+ Y +PE+++ K
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA- 209
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254
D+W+ G I+Y L+ G PF N +F+KI Y P P ARDL+ ++L++
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 269
Query: 255 DPMKRITIP------EIRQHPWFQ 272
D KR+ ++ HP+F+
Sbjct: 270 DATKRLGCEEMEGYGPLKAHPFFE 293
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 2e-83
Identities = 64/270 (23%), Positives = 104/270 (38%), Gaps = 7/270 (2%)
Query: 5 SNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKV 64
S F +++ LG GS+G+V G A+K + K+
Sbjct: 45 GYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL 104
Query: 65 RREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFF 123
++ HP +RL + E +Y+ E L + G L E + +
Sbjct: 105 AEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYL 163
Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYA 183
+ + + + H +VH D+KP N+ L + K+ DFGL + + G P Y
Sbjct: 164 RDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYM 223
Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPNLFKKIKGGIYTLPSHLSP 242
APE++ G Y G DV+S G+ + + C LP E L + + LS
Sbjct: 224 APELLQGS-Y-GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPP--EFTAGLSS 279
Query: 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
R ++ ML DP R T + P +
Sbjct: 280 ELRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 258 bits (660), Expect = 7e-82
Identities = 45/297 (15%), Positives = 79/297 (26%), Gaps = 44/297 (14%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
KL + L +G V + A+K+ + E++ +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 78 HIIRLYEV--IETPSDI------------------------YVVMEYVKS------GELF 105
+ + PSD ++M L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 106 DYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165
V +G Q+I +VH P+NL + + + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 166 IMRDGHFLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPFDDEN--- 221
+ G S YA E ++ ++ W G+ +Y + C LPF
Sbjct: 243 --KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 222 ------IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
+ + L + LI R L D +R+ E + P F
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 8e-80
Identities = 94/262 (35%), Positives = 146/262 (55%), Gaps = 8/262 (3%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L + KTLG GSFG+V + +H +G+ A+KIL+++K+ ++ E E +IL+
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
P +++L + S++Y+VMEYV GE+F ++ GR E AR + QI+ EY H
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
+++RDLKPENLL+D + +++ DFG + R T CG+P APE+I K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGY-N 216
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
VD W+ GV++Y + G PF + +++KI G PSH S +DL+ +L VD
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 256 PMKRI-----TIPEIRQHPWFQ 272
KR + +I+ H WF
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 2e-79
Identities = 76/264 (28%), Positives = 125/264 (47%), Gaps = 10/264 (3%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L N+++ K +G G F +V A L G VA+K + + + + +EI +L+
Sbjct: 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR----LQEDEARNFFQQIISGVE 131
HP++I+ Y +++ +V+E +G+L I + + E +F Q+ S +E
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISG 190
+ H V+HRD+KP N+ + + VK+ D GL + G+P Y +PE I
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 210
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKGGIYT-LPS-HLSPGARD 246
Y + D+WS G +LY + PF D N+ +L KKI+ Y LPS H S R
Sbjct: 211 NGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269
Query: 247 LIPRMLIVDPMKRITIPEIRQHPW 270
L+ + DP KR + +
Sbjct: 270 LVNMCINPDPEKRPDVTYVYDVAK 293
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 2e-78
Identities = 68/256 (26%), Positives = 131/256 (51%), Gaps = 6/256 (2%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
+ +G GSFGKV I + T A+K +N++K V +E++I++ HP ++ L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
+ + D+++V++ + G+L ++ + +E+ + F +++ ++Y ++HRD
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG--PEVDV 200
+KP+N+LLD +V I DF ++ ++ + T G+ Y APE+ S + AG VD
Sbjct: 141 MKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDW 200
Query: 201 WSCGVILYALLCGTLPF---DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
WS GV Y LL G P+ + + + + T PS S L+ ++L +P
Sbjct: 201 WSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPD 260
Query: 258 KRI-TIPEIRQHPWFQ 272
+R + +++ P+
Sbjct: 261 QRFSQLSDVQNFPYMN 276
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 3e-78
Identities = 84/262 (32%), Positives = 144/262 (54%), Gaps = 8/262 (3%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L ++++ +TLG GSFG+V + G A+K+L + + ++ E E +L +
Sbjct: 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
HP IIR++ + I+++M+Y++ GELF + + R A+ + ++ +EY H
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
+++RDLKPEN+LLD ++KI DFG + + D T CG+P+Y APEV+S K Y
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPY-N 181
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
+D WS G+++Y +L G PF D N ++KI P + +DL+ R++ D
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 241
Query: 256 PMKRI-----TIPEIRQHPWFQ 272
+R+ +++ HPWF+
Sbjct: 242 LSQRLGNLQNGTEDVKNHPWFK 263
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 8e-78
Identities = 74/289 (25%), Positives = 123/289 (42%), Gaps = 38/289 (13%)
Query: 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME-EKVRREIKILRL 73
+L +++ + LG G FG V A++ + AIK + ++ N E+ EKV RE+K L
Sbjct: 3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI---RLPNRELAREKVMREVKALAK 59
Query: 74 FMHPHIIRLYEVIET------------PSDIYVVMEYVKSGELFDYIVEKGRLQ---EDE 118
HP I+R + +Y+ M+ + L D++ + ++
Sbjct: 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 119 ARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK---- 174
+ F QI VE+ H ++HRDLKP N+ VK+ DFGL M +
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 175 ---------TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN- 224
G+ Y +PE I G Y +VD++S G+IL+ LL PF +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELLY---PFSTQMERVR 235
Query: 225 LFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
++ + L + P ++ ML PM+R I ++ F+
Sbjct: 236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 241 bits (615), Expect = 1e-74
Identities = 49/313 (15%), Positives = 93/313 (29%), Gaps = 48/313 (15%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM--- 75
G LG A TG + + + ++++ E+ LRL
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 76 -------------------HPHIIRLYEVIETPSDIYVVMEYV-----------KSGELF 105
P ++ V D++V+ + L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 106 DYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165
+ L Q+I + H +VH L+P +++LD + V + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL- 258
Query: 166 IMRDGHFLKTSC----GSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPF 217
+RDG + P A ++ D W+ G+ +Y + C LP
Sbjct: 259 -VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317
Query: 218 DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
D+ + I+ ++ R L+ L R+ + + P ++ L
Sbjct: 318 TDDAALGGSEW----IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE-QLRT 372
Query: 278 YLAVPPPDTMQQA 290
L+ P
Sbjct: 373 ELSAALPLYQTDG 385
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 3e-73
Identities = 93/271 (34%), Positives = 146/271 (53%), Gaps = 4/271 (1%)
Query: 5 SNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKV 64
R S + + + ++ L K LG GSFGKV +AE T AIK L + + + E
Sbjct: 5 KERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT 64
Query: 65 RREIKILRLFM-HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF 123
E ++L L HP + ++ +T +++ VMEY+ G+L +I + A +
Sbjct: 65 MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA 124
Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNY 182
+II G+++ H +V+RDLK +N+LLD ++KIADFG+ M T CG+P+Y
Sbjct: 125 AEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDY 184
Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSP 242
APE++ G+ Y VD WS GV+LY +L G PF ++ LF I+ P L
Sbjct: 185 IAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEK 243
Query: 243 GARDLIPRMLIVDPMKRI-TIPEIRQHPWFQ 272
A+DL+ ++ + +P KR+ +IRQHP F+
Sbjct: 244 EAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 1e-72
Identities = 94/263 (35%), Positives = 141/263 (53%), Gaps = 7/263 (2%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
+ ++ K LG G+FGKV + TG A+KIL + I + E ++L+
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
HP + L +T + VMEY GELF ++ + E+ AR + +I+S +EY H
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYA 194
VV+RD+K ENL+LD ++KI DFGL + DG +KT CG+P Y APEV+ Y
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY- 182
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254
G VD W GV++Y ++CG LPF +++ LF+ I P LSP A+ L+ +L
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 242
Query: 255 DPMKRI-----TIPEIRQHPWFQ 272
DP +R+ E+ +H +F
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFFL 265
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 3e-72
Identities = 85/256 (33%), Positives = 133/256 (51%), Gaps = 7/256 (2%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIR 81
K +G GSFGKV +A H A+K+L ++ I + E+ + E +L + HP ++
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
L+ +T +Y V++Y+ GELF ++ + E AR + +I S + Y H +V+R
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 163
Query: 142 DLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
DLKPEN+LLDS+ ++ + DFGL + T CG+P Y APEV+ + Y VD
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDW 222
Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
W G +LY +L G PF N ++ I L +++ AR L+ +L D KR+
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL 282
Query: 261 TIP----EIRQHPWFQ 272
EI+ H +F
Sbjct: 283 GAKDDFMEIKSHVFFS 298
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 2e-71
Identities = 84/260 (32%), Positives = 134/260 (51%), Gaps = 11/260 (4%)
Query: 23 KTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKI-KNMEMEEKVRREIKILRLFMHPH 78
+ LG G +GKV TG A+K+L + I +N + + E IL HP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
I+ L +T +Y+++EY+ GELF + +G ED A + +I + + H+ +
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
++RDLKPEN++L+ + +VK+ DFGL + DG T CG+ Y APE++ +
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH-NRA 201
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257
VD WS G ++Y +L G PF EN KI LP +L+ ARDL+ ++L +
Sbjct: 202 VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAA 261
Query: 258 KRI-----TIPEIRQHPWFQ 272
R+ E++ HP+F+
Sbjct: 262 SRLGAGPGDAGEVQAHPFFR 281
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 4e-71
Identities = 93/265 (35%), Positives = 147/265 (55%), Gaps = 9/265 (3%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
+ N++ + LG GSFGKV +A TG A+K+L + I + E E +IL L
Sbjct: 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR 81
Query: 76 -HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
HP + +L+ +TP ++ VME+V G+L +I + R E AR + +IIS + + H
Sbjct: 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLY 193
+++RDLK +N+LLD + + K+ADFG+ + +G T CG+P+Y APE++ LY
Sbjct: 142 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY 201
Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253
GP VD W+ GV+LY +LCG PF+ EN +LF+ I P+ L A ++ +
Sbjct: 202 -GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMT 260
Query: 254 VDPMKRI------TIPEIRQHPWFQ 272
+P R+ I +HP+F+
Sbjct: 261 KNPTMRLGSLTQGGEHAILRHPFFK 285
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 1e-70
Identities = 74/259 (28%), Positives = 139/259 (53%), Gaps = 11/259 (4%)
Query: 23 KTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
K LG GSFGKV + + A+K+L + +K + + + E IL HP I
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFI 88
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVV 139
++L+ +T +Y+++++++ G+LF + ++ E++ + + ++ +++ H ++
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 148
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
+RDLKPEN+LLD + ++K+ DFGLS + + CG+ Y APEV++ + +
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSA 207
Query: 199 DVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMK 258
D WS GV+++ +L GTLPF ++ I +P LSP A+ L+ + +P
Sbjct: 208 DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPAN 267
Query: 259 RI-----TIPEIRQHPWFQ 272
R+ + EI++H +F
Sbjct: 268 RLGAGPDGVEEIKRHSFFS 286
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 2e-70
Identities = 47/290 (16%), Positives = 98/290 (33%), Gaps = 37/290 (12%)
Query: 18 NYKLGKTLGIGSFGKVKIAEH-----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
+ LG G+F +V A A K +K+ + + ++ L+
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG---TQLMERLK 122
Query: 73 LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-----LQEDEARNFFQQII 127
M ++ Y + +V E G L + I + + +F +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 128 SGVEYCHRNMVVHRDLKPENLLL-----------DSKWNVKIADFGLS---NIMRDGHFL 173
+E H ++H D+KP+N +L D + + D G S + G
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGG 232
C + + E++S K + ++D + +Y +L GT +E + +
Sbjct: 243 TAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
Query: 233 IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHP---WFQAHLPRYL 279
+ L + ML + + ++ + FQ H +
Sbjct: 302 LPHLDM-----WNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKI 346
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 4e-70
Identities = 96/257 (37%), Positives = 139/257 (54%), Gaps = 8/257 (3%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
K LG G+FGKV + + TG A+KIL + I + E ++L+ HP + L
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH-RNMVVHR 141
+T + VMEY GELF ++ + ED AR + +I+S ++Y H VV+R
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273
Query: 142 DLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
DLK ENL+LD ++KI DFGL ++DG +KT CG+P Y APEV+ Y G VD
Sbjct: 274 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 332
Query: 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260
W GV++Y ++CG LPF +++ LF+ I P L P A+ L+ +L DP +R+
Sbjct: 333 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRL 392
Query: 261 -----TIPEIRQHPWFQ 272
EI QH +F
Sbjct: 393 GGGSEDAKEIMQHRFFA 409
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 4e-70
Identities = 89/264 (33%), Positives = 144/264 (54%), Gaps = 8/264 (3%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L ++ LG GSFGKV ++E T A+KIL + + + E E ++L L
Sbjct: 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78
Query: 76 -HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
P + +L+ +T +Y VMEYV G+L +I + GR +E A + +I G+ +
Sbjct: 79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
+++RDLK +N++LDS+ ++KIADFG+ + DG KT CG+P+Y APE+I+ + Y
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY 198
Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253
G VD W+ GV+LY +L G PF+ E+ LF+ I P +S A + ++
Sbjct: 199 -GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 257
Query: 254 VDPMKRI-----TIPEIRQHPWFQ 272
P KR+ +I++H +F+
Sbjct: 258 KHPGKRLGCGPEGERDIKEHAFFR 281
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 6e-70
Identities = 73/262 (27%), Positives = 133/262 (50%), Gaps = 14/262 (5%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
K +G G+FG+V++ H T A+K+L++ ++ E I+ P +++L
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRD 142
+ + +Y+VMEY+ G+L ++ + E AR + +++ ++ H +HRD
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD 193
Query: 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYA---GPE 197
+KP+N+LLD ++K+ADFG M ++ G+P+Y +PEV+ + G E
Sbjct: 194 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 253
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH----LSPGARDLIPRMLI 253
D WS GV LY +L G PF +++ + KI +L +S A++LI +
Sbjct: 254 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI-CAFL 312
Query: 254 VDPMKRIT---IPEIRQHPWFQ 272
D R+ + EI++H +F+
Sbjct: 313 TDREVRLGRNGVEEIKRHLFFK 334
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 5e-69
Identities = 81/274 (29%), Positives = 144/274 (52%), Gaps = 18/274 (6%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L ++ L + +G GS+ KV + T A+K++ + + + E + V+ E +
Sbjct: 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 76 -HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
HP ++ L+ +T S ++ V+EYV G+L ++ + +L E+ AR + +I + Y H
Sbjct: 68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLY 193
+++RDLK +N+LLDS+ ++K+ D+G+ +R G T CG+PNY APE++ G+ Y
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 187
Query: 194 AGPEVDVWSCGVILYALLCGTLPF---------DDENIPNLFKKIKGGIYTLPSHLSPGA 244
G VD W+ GV+++ ++ G PF D LF+ I +P LS A
Sbjct: 188 -GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 246
Query: 245 RDLIPRMLIVDPMKRI------TIPEIRQHPWFQ 272
++ L DP +R+ +I+ HP+F+
Sbjct: 247 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 7e-69
Identities = 82/264 (31%), Positives = 132/264 (50%), Gaps = 15/264 (5%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
+ LG G FG+V + TG A K LN++++K + + E KIL I+ L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIV----EKGRLQEDEARNFFQQIISGVEYCHRNMV 138
ET +D+ +VM + G++ +I + QE A + QI+SG+E+ H+ +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
++RDLKPEN+LLD NV+I+D GL+ + K G+P + APE++ G+ Y
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY-DFS 369
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPN----LFKKIKGGIYTLPSHLSPGARDLIPRMLI 253
VD ++ GV LY ++ PF L +++ T P SP ++D +L
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQ 429
Query: 254 VDPMKRI-----TIPEIRQHPWFQ 272
DP KR+ + +R HP F+
Sbjct: 430 KDPEKRLGFRDGSCDGLRTHPLFR 453
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 1e-68
Identities = 77/261 (29%), Positives = 128/261 (49%), Gaps = 12/261 (4%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
+ LG G FG+V + TG A K L +++IK + E E +IL ++ L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYI--VEKGRLQEDEARNFFQQIISGVEYCHRNMVVH 140
ET + +V+ + G+L +I + + E A + +I G+E HR +V+
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV 200
RDLKPEN+LLD +++I+D GL+ + +G +K G+ Y APEV+ + Y D
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY-TFSPDW 368
Query: 201 WSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256
W+ G +LY ++ G PF + + +K SP AR L ++L DP
Sbjct: 369 WALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDP 428
Query: 257 MKRI-----TIPEIRQHPWFQ 272
+R+ + E+++HP F+
Sbjct: 429 AERLGCRGGSAREVKEHPLFK 449
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 5e-68
Identities = 80/274 (29%), Positives = 144/274 (52%), Gaps = 18/274 (6%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L ++ L + +G GS+ KV + T A++++ + + + E + V+ E +
Sbjct: 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110
Query: 76 -HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
HP ++ L+ +T S ++ V+EYV G+L ++ + +L E+ AR + +I + Y H
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
+++RDLK +N+LLDS+ ++K+ D+G+ +R G T CG+PNY APE++ G+ Y
Sbjct: 171 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 194 AGPEVDVWSCGVILYALLCGTLPF---------DDENIPNLFKKIKGGIYTLPSHLSPGA 244
G VD W+ GV+++ ++ G PF D LF+ I +P LS A
Sbjct: 231 -GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 289
Query: 245 RDLIPRMLIVDPMKRI------TIPEIRQHPWFQ 272
++ L DP +R+ +I+ HP+F+
Sbjct: 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 5e-68
Identities = 82/267 (30%), Positives = 143/267 (53%), Gaps = 17/267 (6%)
Query: 23 KTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKI-KNMEMEEKVRREIKILRLFMH-P 77
K LG G++GKV + TG A+K+L + I + + E R E ++L P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
++ L+ +T + ++++++Y+ GELF ++ ++ R E E + + +I+ +E+ H+
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 179
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLS--NIMRDGHFLKTSCGSPNYAAPEVISGKLYA- 194
+++RD+K EN+LLDS +V + DFGLS + + CG+ Y AP+++ G
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH 239
Query: 195 GPEVDVWSCGVILYALLCGTLPF----DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250
VD WS GV++Y LL G PF + + + ++I P +S A+DLI R
Sbjct: 240 DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQR 299
Query: 251 MLIVDPMKRI-----TIPEIRQHPWFQ 272
+L+ DP KR+ EI++H +FQ
Sbjct: 300 LLMKDPKKRLGCGPRDADEIKEHLFFQ 326
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 2e-67
Identities = 89/264 (33%), Positives = 144/264 (54%), Gaps = 8/264 (3%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L ++ LG GSFGKV ++E T A+KIL + + + E E ++L L
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399
Query: 76 -HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
P + +L+ +T +Y VMEYV G+L +I + GR +E A + +I G+ +
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
+++RDLK +N++LDS+ ++KIADFG+ + DG KT CG+P+Y APE+I+ + Y
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY 519
Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253
G VD W+ GV+LY +L G PF+ E+ LF+ I P +S A + ++
Sbjct: 520 -GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 578
Query: 254 VDPMKRI-----TIPEIRQHPWFQ 272
P KR+ +I++H +F+
Sbjct: 579 KHPGKRLGCGPEGERDIKEHAFFR 602
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 5e-67
Identities = 76/265 (28%), Positives = 135/265 (50%), Gaps = 16/265 (6%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
K +G G+FG+V + + A+KILN+ ++ R E +L I L
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141
+ + +++Y+VM+Y G+L + + RL E+ AR + +++ ++ H+ VHR
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHR 199
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYA----G 195
D+KP+N+L+D ++++ADFG + + +++S G+P+Y +PE++ G
Sbjct: 200 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYG 259
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP-----SHLSPGARDLIPR 250
PE D WS GV +Y +L G PF E++ + KI + +S A+DLI R
Sbjct: 260 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLI-R 318
Query: 251 MLIVDPMKRIT---IPEIRQHPWFQ 272
LI R+ I + ++HP+F
Sbjct: 319 RLICSREHRLGQNGIEDFKKHPFFS 343
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 5e-67
Identities = 62/295 (21%), Positives = 110/295 (37%), Gaps = 36/295 (12%)
Query: 3 GASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEE 62
GA S + + + +G G FG V L G AIK + +++ E+
Sbjct: 1 GAMGMKSR----YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQ 55
Query: 63 KVRREIKIL-RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR----LQED 117
RE+ L H H++R + + + EY G L D I E R +E
Sbjct: 56 NALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEA 115
Query: 118 EARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD-------------------SKWNVKI 158
E ++ Q+ G+ Y H +VH D+KP N+ + +K KI
Sbjct: 116 ELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI 175
Query: 159 ADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFD 218
D G + + G + A EV+ P+ D+++ + +
Sbjct: 176 GDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232
Query: 219 DENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
+ + + +I+ G +P LS +L+ M+ DP +R + + +H
Sbjct: 233 NG---DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 5e-67
Identities = 75/267 (28%), Positives = 128/267 (47%), Gaps = 18/267 (6%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRL 82
K +G G+F +V + + TG A+KI+N+ + R E +L I +L
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHR 141
+ + + +Y+VMEY G+L + + G R+ + AR + +I+ ++ HR VHR
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHR 186
Query: 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYA----- 194
D+KP+N+LLD ++++ADFG +R +++ G+P+Y +PE++
Sbjct: 187 DIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGS 246
Query: 195 -GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP-----SHLSPGARDLI 248
GPE D W+ GV Y + G PF ++ + KI L + ARD I
Sbjct: 247 YGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFI 306
Query: 249 PRMLIVDPMKRIT---IPEIRQHPWFQ 272
+ L+ P R+ + R HP+F
Sbjct: 307 -QRLLCPPETRLGRGGAGDFRTHPFFF 332
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 2e-65
Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 12/261 (4%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL---FMHPHI 79
+ +G G FG+V A TG A+K L++++IK + E E +L L P I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVV 139
+ + TP + +++ + G+L ++ + G E + R + +II G+E+ H VV
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314
Query: 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 199
+RDLKP N+LLD +V+I+D GL+ S G+ Y APEV+ + D
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSAD 373
Query: 200 VWSCGVILYALLCGTLPFDDENIPN---LFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256
+S G +L+ LL G PF + + + LP SP R L+ +L D
Sbjct: 374 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV 433
Query: 257 MKRI-----TIPEIRQHPWFQ 272
+R+ E+++ P+F+
Sbjct: 434 NRRLGCLGRGAQEVKESPFFR 454
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 3e-64
Identities = 69/274 (25%), Positives = 113/274 (41%), Gaps = 19/274 (6%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
+G GSFG+V + TG + A+K + +E E+ P
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK--------VRLEVFRVEELVACAGLSSPR 111
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
I+ LY + + + ME ++ G L I + G L ED A + Q + G+EY H +
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 139 VHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSC------GSPNYAAPEVISGK 191
+H D+K +N+LL S + DFG + ++ K+ G+ + APEV+ GK
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGG--IYTLPSHLSPGARDLI 248
+VD+WS ++ +L G P+ P K I +P +P I
Sbjct: 232 PC-DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 290
Query: 249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 282
L +P+ R + E+R+ L P
Sbjct: 291 QEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP 324
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 3e-61
Identities = 66/264 (25%), Positives = 127/264 (48%), Gaps = 14/264 (5%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
K +G GSF V T +VA L RK+ ++ + E ++L+ HP+
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPN 86
Query: 79 IIRLY----EVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
I+R Y ++ I +V E + SG L Y+ ++ R++ +QI+ G+++ H
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 135 RN--MVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
++HRDLK +N+ + +VKI D GL+ + R F K G+P + APE+ K
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEEK 205
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGI--YTLPSHLSPGARDLI 248
VDV++ G+ + + P+ + +N +++++ G+ + P +++I
Sbjct: 206 --YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 263
Query: 249 PRMLIVDPMKRITIPEIRQHPWFQ 272
+ + +R +I ++ H +FQ
Sbjct: 264 EGCIRQNKDERYSIKDLLNHAFFQ 287
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-60
Identities = 68/280 (24%), Positives = 122/280 (43%), Gaps = 12/280 (4%)
Query: 2 DGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME 61
+G D LG G++G V ++AIK + ++
Sbjct: 7 EGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYS 63
Query: 62 EKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEA- 119
+ + EI + + H +I++ I + ME V G L + K G L+++E
Sbjct: 64 QPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT 123
Query: 120 -RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSC 177
+ +QI+ G++Y H N +VHRD+K +N+L+++ +KI+DFG S + + +
Sbjct: 124 IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF 183
Query: 178 -GSPNYAAPEVISGKLY-AGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGI 233
G+ Y APE+I G D+WS G + + G PF + E +FK +
Sbjct: 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV 243
Query: 234 Y-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
+ +P +S A+ I + DP KR ++ + +
Sbjct: 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK 283
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 1e-60
Identities = 65/331 (19%), Positives = 120/331 (36%), Gaps = 77/331 (23%)
Query: 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAI-------KILNRRKI------------ 55
+L +++ + +G G FG V A++ + AI + L R K+
Sbjct: 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH 63
Query: 56 ------------------------------------KNMEMEEKVRREIKILRLFMHPHI 79
+ + +I+ + F +
Sbjct: 64 PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDE---ARNFFQQIISGVEYCHRN 136
+ + +Y+ M+ + L D++ + L++ E + F QI VE+ H
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT-------------SCGSPNYA 183
++HRDLKP N+ VK+ DFGL M +T G+ Y
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243
Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIYT-LPSHLS 241
+PE I G Y +VD++S G+IL+ LL F + + ++ + L +
Sbjct: 244 SPEQIHGNNY-SHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFPLLFTQKY 299
Query: 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
P ++ ML P +R +I ++ F+
Sbjct: 300 PQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 2e-59
Identities = 76/316 (24%), Positives = 129/316 (40%), Gaps = 66/316 (20%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----REIKILRL 73
Y+ +G GS+G V + TG VAIK K E + ++ REI++L+
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLKQ 58
Query: 74 FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEY 132
HP+++ L EV +++V EY + + R + E ++ Q + V +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----------- 181
CH++ +HRD+KPEN+L+ +K+ DFG + R P+
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFA---R-------LLTGPSDYYDDEVATRW 167
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK----------KI 229
Y +PE++ G GP VDVW+ G + LL G P + + L+ +
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD-VDQLYLIRKTLGDLIPRH 226
Query: 230 KGGIYTLP--------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHP 269
+ T ++S A L+ L +DP +R+T ++ HP
Sbjct: 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286
Query: 270 WFQA-HLPRYLAVPPP 284
+F+ LA
Sbjct: 287 YFENIREIEDLAKEHD 302
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 4e-59
Identities = 87/328 (26%), Positives = 136/328 (41%), Gaps = 73/328 (22%)
Query: 1 MDGASNRSSSGVDMFLP--------NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR 52
M + SSGVD+ Y+ +G GS+G V + TG VAIK
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK---- 56
Query: 53 RKIKNMEMEEKVR----REIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI 108
K + ++ V+ REIK+L+ H +++ L EV + Y+V E+V + D +
Sbjct: 57 -KFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL 114
Query: 109 -VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167
+ L + + QII+G+ +CH + ++HRD+KPEN+L+ VK+ DFG +
Sbjct: 115 ELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA--- 171
Query: 168 RDGHFLKTSCGSPN-----------YAAPEVISGKLYAGPEVDVWSCGVILYALLCGT-- 214
R + +P Y APE++ G + G VDVW+ G ++ + G
Sbjct: 172 R-------TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPL 224
Query: 215 LPFDDENIPNLFK--KIKG--------GIYTLP--------------------SHLSPGA 244
P D + I L+ G P LS
Sbjct: 225 FPGDSD-IDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVV 283
Query: 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
DL + L +DP KR E+ H +FQ
Sbjct: 284 IDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 3e-58
Identities = 80/328 (24%), Positives = 136/328 (41%), Gaps = 71/328 (21%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKV----RREIKILRL 73
Y LG G++ V + LT + VA+K +I+ +E EE RE+ +L+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALK-----EIR-LEHEEGAPCTAIREVSLLKD 56
Query: 74 FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEY 132
H +I+ L+++I T + +V EY+ +L Y+ + + F Q++ G+ Y
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----------- 181
CHR V+HRDLKP+NLL++ + +K+ADFGL+ R + P
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLA---R-------AKSIPTKTYDNEVVTLW 165
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK--KIKG------ 231
Y P+++ G ++D+W G I Y + G P L +I G
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV-EEQLHFIFRILGTPTEET 224
Query: 232 --GIYTLP-------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270
GI + L DL+ ++L + RI+ + +HP+
Sbjct: 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
Query: 271 F------QAHLPRYLAVPPPDTMQQAKK 292
F LP ++ +Q K+
Sbjct: 285 FLSLGERIHKLPDTTSIFALKEIQLQKE 312
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 6e-57
Identities = 88/305 (28%), Positives = 133/305 (43%), Gaps = 69/305 (22%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR--------REIK 69
Y+ LG G F V A T VAIK KIK + + + REIK
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIK-----KIK-LGHRSEAKDGINRTALREIK 64
Query: 70 ILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIIS 128
+L+ HP+II L + S+I +V +++++ +L I L + + +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN------- 181
G+EY H++ ++HRDLKP NLLLD +K+ADFGL+ S GSPN
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA----------KSFGSPNRAYTHQV 173
Query: 182 ----YAAPEVISG-KLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK--KIKG- 231
Y APE++ G ++Y G VD+W+ G IL LL LP D + + L + + G
Sbjct: 174 VTRWYRAPELLFGARMY-GVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGT 231
Query: 232 -------GIYTLP-----------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
+ +LP S DLI + + +P RIT + +
Sbjct: 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291
Query: 268 HPWFQ 272
+F
Sbjct: 292 MKYFS 296
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 8e-57
Identities = 79/315 (25%), Positives = 140/315 (44%), Gaps = 73/315 (23%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK-----VRREIKILR 72
Y+ + +G G++G V A++ T VA+K +++ ++ +++ REI +L+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALK-----RVR-LDDDDEGVPSSALREICLLK 56
Query: 73 LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVE 131
H +I+RL++V+ + + +V E+ +L Y G L + ++F Q++ G+
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN---------- 181
+CH V+HRDLKP+NLL++ +K+A+FGL+ R + G P
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLA---R-------AFGIPVRCYSAEVVTL 165
Query: 182 -YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF---DDENIPNLFK--KIKG---- 231
Y P+V+ G +D+WS G I L P +D L + ++ G
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTE 224
Query: 232 ----GIYTLP------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHP 269
+ LP L+ RDL+ +L +P++RI+ E QHP
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284
Query: 270 WFQAHLPRYLAVPPP 284
+F PP
Sbjct: 285 YFS-------DFCPP 292
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 5e-56
Identities = 86/322 (26%), Positives = 147/322 (45%), Gaps = 67/322 (20%)
Query: 4 ASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK 63
+S R + + Y+ + +G G++G V A+ + G VA+K +I+ ++ E++
Sbjct: 8 SSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALK-----RIR-LDAEDE 60
Query: 64 -----VRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQED 117
REI +L+ HP+I+ L +VI + + +V E+++ +L + K LQ+
Sbjct: 61 GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS 119
Query: 118 EARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC 177
+ + + Q++ GV +CH++ ++HRDLKP+NLL++S +K+ADFGL+ R +
Sbjct: 120 QIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA---R-------AF 169
Query: 178 GSPN-----------YAAPEVISGKLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPN 224
G P Y AP+V+ G VD+WS G I ++ G P +
Sbjct: 170 GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD-DDQ 228
Query: 225 LFK--KIKG--------GIYTLP-------------------SHLSPGARDLIPRMLIVD 255
L K I G + LP DL+ ML D
Sbjct: 229 LPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFD 288
Query: 256 PMKRITIPEIRQHPWFQAHLPR 277
P KRI+ + HP+F+ P+
Sbjct: 289 PNKRISARDAMNHPYFKDLDPQ 310
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 7e-56
Identities = 91/303 (30%), Positives = 146/303 (48%), Gaps = 68/303 (22%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK-----VRREIKILR 72
Y + +G G++G V A++ G A+K KI+ +E E++ REI IL+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALK-----KIR-LEKEDEGIPSTTIREISILK 55
Query: 73 LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVE 131
H +I++LY+VI T + +V E++ +L + V +G L+ A++F Q+++G+
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN---------- 181
YCH V+HRDLKP+NLL++ + +KIADFGL+ R + G P
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLA---R-------AFGIPVRKYTHEIVTL 164
Query: 182 -YAAPEVISG-KLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK--KIKG---- 231
Y AP+V+ G K Y +D+WS G I ++ GT P E L + +I G
Sbjct: 165 WYRAPDVLMGSKKY-STTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNS 222
Query: 232 ----GIYTLP------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHP 269
+ LP L DL+ +ML +DP +RIT + +H
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282
Query: 270 WFQ 272
+F+
Sbjct: 283 YFK 285
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-55
Identities = 95/336 (28%), Positives = 150/336 (44%), Gaps = 80/336 (23%)
Query: 1 MDGASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM 60
M ++ S++ +D + ++ K LG G++G+V A +T VAIK +I+ +E
Sbjct: 22 MSVSAAPSATSIDRYR---RITK-LGEGTYGEVYKAIDTVTNETVAIK-----RIR-LEH 71
Query: 61 EEK-----VRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQ 115
EE+ RE+ +L+ H +II L VI ++++ EY ++ +L Y+ + +
Sbjct: 72 EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVS 130
Query: 116 EDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-----NVKIADFGLSNIMRDG 170
++F Q+I+GV +CH +HRDLKP+NLLL +KI DFGL+ R
Sbjct: 131 MRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA---R-- 185
Query: 171 HFLKTSCGSPN-----------YAAPEVISGKLYAGPEVDVWSCGVILYALLCGT--LPF 217
+ G P Y PE++ G + VD+WS I +L T P
Sbjct: 186 -----AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG 240
Query: 218 DDENIPNLFK--KIKG--------GIYTLP-------------------SHLSPGARDLI 248
D E I LFK ++ G G+ LP + L DL+
Sbjct: 241 DSE-IDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLL 299
Query: 249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
ML +DP+KRI+ +HP+F H P
Sbjct: 300 TAMLEMDPVKRISAKNALEHPYFS-HND-----FDP 329
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 3e-55
Identities = 80/328 (24%), Positives = 141/328 (42%), Gaps = 75/328 (22%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKV----RREIKILRL 73
+K + LG G++ V + TG VA+K ++K ++ EE REI +++
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALK-----EVK-LDSEEGTPSTAIREISLMKE 59
Query: 74 FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI------VEKGRLQEDEARNFFQQII 127
H +I+RLY+VI T + + +V E++ + +L Y+ L+ + + F Q++
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN------ 181
G+ +CH N ++HRDLKP+NLL++ + +K+ DFGL+ R + G P
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA---R-------AFGIPVNTFSSE 168
Query: 182 -----YAAPEVISGKLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK--KIKG- 231
Y AP+V+ G +D+WSCG IL ++ G P ++ L I G
Sbjct: 169 VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-EEQLKLIFDIMGT 227
Query: 232 -------GIYTLP-----------------------SHLSPGARDLIPRMLIVDPMKRIT 261
+ LP L D + +L ++P R++
Sbjct: 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS 287
Query: 262 IPEIRQHPWFQAHLPRYLAVPPPDTMQQ 289
+ HPWF + ++ +
Sbjct: 288 AKQALHHPWFA-EYYHHASMGGSRSHHH 314
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-54
Identities = 77/311 (24%), Positives = 123/311 (39%), Gaps = 75/311 (24%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR--------REIK 69
Y+ +G+G++G V A +GH VA+K ++ + RE+
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALK-----SVR-VPNGGGGGGGLPISTVREVA 63
Query: 70 ILR---LFMHPHIIRLYEVI-----ETPSDIYVVMEYVKSGELFDYI--VEKGRLQEDEA 119
+LR F HP+++RL +V + + +V E+V +L Y+ L +
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI 122
Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS 179
++ +Q + G+++ H N +VHRDLKPEN+L+ S VK+ADFGL+ R
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA---R-------IYSY 172
Query: 180 PN----------YAAPEVISGKLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK 227
Y APEV+ Y VD+WS G I + + E L K
Sbjct: 173 QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQLGK 230
Query: 228 --KIKG--------GIYTLP----------------SHLSPGARDLIPRMLIVDPMKRIT 261
+ G +LP + L+ ML +P KRI+
Sbjct: 231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290
Query: 262 IPEIRQHPWFQ 272
QH +
Sbjct: 291 AFRALQHSYLH 301
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-54
Identities = 77/259 (29%), Positives = 121/259 (46%), Gaps = 28/259 (10%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
++ + +G G+FG V A+ VAIK +I++ + E++ L HP+I
Sbjct: 11 EVEEVVGRGAFGVVCKAKW--RAKDVAIK-----QIESESERKAFIVELRQLSRVNHPNI 63
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR---LQEDEARNFFQQIISGVEYCHR- 135
++LY P + +VMEY + G L++ + A ++ Q GV Y H
Sbjct: 64 VKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 136 --NMVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGK 191
++HRDLKP NLLL + V KI DFG + D T+ GS + APEV G
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTA---CDIQTHMTNNKGSAAWMAPEVFEGS 178
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-----TLPSHLSPGARD 246
Y + DV+S G+IL+ ++ PFD+ I +I ++ L +L
Sbjct: 179 NY-SEKCDVFSWGIILWEVITRRKPFDE--IGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235
Query: 247 LIPRMLIVDPMKRITIPEI 265
L+ R DP +R ++ EI
Sbjct: 236 LMTRCWSKDPSQRPSMEEI 254
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-54
Identities = 74/258 (28%), Positives = 121/258 (46%), Gaps = 20/258 (7%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
+ + +G GSFG V AE G VA+KIL + + E RE+ I++ HP+I
Sbjct: 40 NIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNE-FLREVAIMKRLRHPNI 96
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYI---VEKGRLQEDEARNFFQQIISGVEYCHRN 136
+ + P ++ +V EY+ G L+ + + +L E + + G+ Y H
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 137 --MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLY 193
+VHR+LK NLL+D K+ VK+ DFGLS + S G+P + APEV+ +
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------TLPSHLSPGARDL 247
+ DV+S GVIL+ L P+ N+ ++ + +P +L+P +
Sbjct: 217 -NEKSDVYSFGVILWELATLQQPW--GNLNPA--QVVAAVGFKCKRLEIPRNLNPQVAAI 271
Query: 248 IPRMLIVDPMKRITIPEI 265
I +P KR + I
Sbjct: 272 IEGCWTNEPWKRPSFATI 289
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-53
Identities = 86/332 (25%), Positives = 129/332 (38%), Gaps = 55/332 (16%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
+Y K +G GSFG V A+ +G VAIK +L ++ KN RE++I+R H
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 106
Query: 77 PHIIRLYEVIETPSD------IYVVMEYVKS---GELFDYIVEKGRLQEDEARNFFQQII 127
+I+RL + + + +V++YV Y K L + + Q+
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPE 186
+ Y H + HRD+KP+NLLLD +K+ DFG + + G + S Y APE
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 226
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNL-- 225
+I G +DVWS G +L LL G F E I +
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286
Query: 226 ------FKKIKGG--IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ----- 272
F +IK P A L R+L P R+T E H +F
Sbjct: 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 346
Query: 273 -AHLPRYLAVPPP-DTMQQAKKIDEEILKEVV 302
LP P + Q + + ++
Sbjct: 347 NVKLPNGRDTPALFNFTTQELSSNPPLATILI 378
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-52
Identities = 79/324 (24%), Positives = 134/324 (41%), Gaps = 76/324 (23%)
Query: 18 NY-KLGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNMEMEEK-----VRREIKI 70
Y + + +G G++GKV K + G VA+K +++ ++ E+ RE+ +
Sbjct: 12 QYECVAE-IGEGAYGKVFKARDLKNGGRFVALK-----RVR-VQTGEEGMPLSTIREVAV 64
Query: 71 LR---LFMHPHIIRLYEVIETPSD-----IYVVMEYVKSGELFDYI--VEKGRLQEDEAR 120
LR F HP+++RL++V + +V E+V +L Y+ V + + + +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK 123
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
+ Q++ G+++ H + VVHRDLKP+N+L+ S +K+ADFGL+ R
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA---R-------IYSFQ 173
Query: 181 N----------YAAPEVISGKLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK- 227
Y APEV+ Y VD+WS G I + + + L K
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKI 231
Query: 228 -KIKG--------GIYTLPSH----------------LSPGARDLIPRMLIVDPMKRITI 262
+ G LP + +DL+ + L +P KRI+
Sbjct: 232 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 291
Query: 263 PEIRQHPWFQAHLPRYLAVPPPDT 286
HP+FQ L R
Sbjct: 292 YSALSHPYFQD-LERCKENLDSHL 314
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 4e-52
Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 21/263 (7%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
+G+ +G GSFG V VA+K+LN + + + E+ +LR H +I
Sbjct: 27 TVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNI 82
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
+ T + +V ++ + L+ ++ + + + + + +Q G++Y H +
Sbjct: 83 LLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRD---GHFLKTSCGSPNYAAPEVISGKLYA- 194
+HRDLK N+ L VKI DFGL+ H + GS + APEVI +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 195 -GPEVDVWSCGVILYALLCGTLPFDDENIPNL--------FKKIKGGIYTLPSHLSPGAR 245
+ DV++ G++LY L+ G LP+ NI N + + + S+ +
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPY--SNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 259
Query: 246 DLIPRMLIVDPMKRITIPEIRQH 268
L+ L +R + P I
Sbjct: 260 RLMAECLKKKRDERPSFPRILAE 282
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-51
Identities = 50/256 (19%), Positives = 102/256 (39%), Gaps = 17/256 (6%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
L G++ G+ + +K+L R + + E LR+F HP++
Sbjct: 13 NFLTKLNENHSGELWKGR--WQGNDIVVKVLKVRDWSTRKSRD-FNEECPRLRIFSHPNV 69
Query: 80 IRLYEVIETP--SDIYVVMEYVKSGELFDYIVEKGRLQEDEAR--NFFQQIISGVEYCH- 134
+ + ++P ++ ++ G L++ + E D+++ F + G+ + H
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 135 -RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
++ L ++++D +I+ + + +P + APE + K
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPE 185
Query: 194 AGPE--VDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIY-TLPSHLSPGARDLIP 249
D+WS V+L+ L+ +PF D N+ K G+ T+P +SP L+
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMK 245
Query: 250 RMLIVDPMKRITIPEI 265
+ DP KR I
Sbjct: 246 ICMNEDPAKRPKFDMI 261
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 5e-51
Identities = 75/268 (27%), Positives = 117/268 (43%), Gaps = 25/268 (9%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN----MEMEEKVRREIKILRLFM 75
+ K +G G FG V VAIK L + +E ++ +RE+ I+
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCH 134
HP+I++LY ++ P +VME+V G+L+ +++K ++ I G+EY
Sbjct: 82 HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 135 RN--MVVHRDLKPENLLLDSKW-----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187
+VHRDL+ N+ L S K+ADFGLS + G+ + APE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPET 197
Query: 188 ISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-----TLPSHL 240
I + Y + D +S +ILY +L G PFD+ + K I T+P
Sbjct: 198 IGAEEESY-TEKADTYSFAMILYTILTGEGPFDEYS-YGKIKFINMIREEGLRPTIPEDC 255
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQH 268
P R++I DP KR I +
Sbjct: 256 PPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 8e-51
Identities = 85/283 (30%), Positives = 144/283 (50%), Gaps = 14/283 (4%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
Y + +G G+ G V A TG +VAI+ +N ++ +E + EI ++R +P+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPN 78
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
I+ + +++VVMEY+ G L D +V + + E + ++ + +E+ H N V
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
+HRD+K +N+LL +VK+ DFG I + T G+P + APEV++ K Y GP+
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPK 196
Query: 198 VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIV 254
VD+WS G++ ++ G P+ +EN + L+ G L P LS RD + R L +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 256
Query: 255 DPMKRITIPEIRQHPWFQ-AHLPRYLAVPPPDTMQQAKKIDEE 296
D KR + E+ QH + + A L + AK+ +
Sbjct: 257 DVEKRGSAKELLQHQFLKIAKPLSSLT----PLIAAAKEATKN 295
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-50
Identities = 83/279 (29%), Positives = 148/279 (53%), Gaps = 14/279 (5%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
+G GS G V +A +G +VA+K+++ ++ + E + E+ I+R + H +
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHFN 103
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
++ +Y+ +++V+ME+++ G L D IV + RL E++ + ++ + Y H V
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
+HRD+K +++LL VK++DFG I +D K+ G+P + APEVIS LY E
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY-ATE 221
Query: 198 VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIV 254
VD+WS G+++ ++ G P+ ++ + + + L +SP RD + RML+
Sbjct: 222 VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR 281
Query: 255 DPMKRITIPEIRQHPWF-QAHLPRYLAVPPPDTMQQAKK 292
DP +R T E+ HP+ Q LP L +Q +K
Sbjct: 282 DPQERATAQELLDHPFLLQTGLPECLV----PLIQLYRK 316
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-50
Identities = 77/263 (29%), Positives = 120/263 (45%), Gaps = 19/263 (7%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRLFMHPH 78
L + +GIG FGKV A G +VA+K +++ + E VR+E K+ + HP+
Sbjct: 10 TLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN-- 136
II L V ++ +VME+ + G L + K R+ D N+ QI G+ Y H
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 137 -MVVHRDLKPENLLLDSK--------WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187
++HRDLK N+L+ K +KI DFGL+ ++ G+ + APEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEV 185
Query: 188 ISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIY-TLPSHLSPGAR 245
I ++ DVWS GV+L+ LL G +PF + + + + +PS
Sbjct: 186 IRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFA 244
Query: 246 DLIPRMLIVDPMKRITIPEIRQH 268
L+ DP R + I
Sbjct: 245 KLMEDCWNPDPHSRPSFTNILDQ 267
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-50
Identities = 58/263 (22%), Positives = 111/263 (42%), Gaps = 22/263 (8%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
++G+ +G G FG+V H +VAI++++ + +++ +RE+ R H ++
Sbjct: 36 EIGELIGKGRFGQVY---HGRWHGEVAIRLIDIERDNEDQLKA-FKREVMAYRQTRHENV 91
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
+ +P + ++ K L+ + K L ++ R Q+I+ G+ Y H +
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIM------RDGHFLKTSCGSPNYAAPEVISGKL 192
+H+DLK +N+ D V I DFGL +I R L+ G + APE+I
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 193 YAGPE--------VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL--PSHLSP 242
E DV++ G I Y L PF + + ++ G+ +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK 270
Query: 243 GARDLIPRMLIVDPMKRITIPEI 265
D++ + +R T ++
Sbjct: 271 EISDILLFCWAFEQEERPTFTKL 293
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-50
Identities = 87/333 (26%), Positives = 143/333 (42%), Gaps = 60/333 (18%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMHP 77
Y K +G GSFG V A+ + +VAIK +L ++ KN RE++I+R+ HP
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKN--------RELQIMRIVKHP 92
Query: 78 HIIRLYEVIETPS------DIYVVMEYVKS---GELFDYIVEKGRLQEDEARNFFQQIIS 128
+++ L + + +V+EYV Y K + + + Q++
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 129 GVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAP 185
+ Y H + HRD+KP+NLLLD +K+ DFG + I+ G S C S Y AP
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN-VSYIC-SRYYRAP 210
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNL- 225
E+I G +D+WS G ++ L+ G F E I +
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270
Query: 226 -------FKKIKGGIYT--LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF----- 271
F +I+ ++ P A DLI R+L P R+T E HP+F
Sbjct: 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330
Query: 272 -QAHLPRYLAVPPP-DTMQQAKKIDEEILKEVV 302
+A +P +PP + ++ + +++ +V
Sbjct: 331 GEARMPNGRELPPLFNWTKEELSVRPDLISRLV 363
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-50
Identities = 87/331 (26%), Positives = 144/331 (43%), Gaps = 68/331 (20%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME-EKVR----REIKILRLF 74
KL K +G G+FG+V A H TG KVA+K K+ ME E E REIKIL+L
Sbjct: 21 KLAK-IGQGTFGEVFKARHRKTGQKVALK-----KVL-MENEKEGFPITALREIKILQLL 73
Query: 75 MHPHIIRLYEVI--------ETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQ 125
H +++ L E+ IY+V ++ + +L + + E + Q
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN---- 181
+++G+ Y HRN ++HRD+K N+L+ +K+ADFGL+ + + +
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 192
Query: 182 -YAAPEVISGKLYAGPEVDVWSCGVILYAL---------------------LCGTLPFDD 219
Y PE++ G+ GP +D+W G I+ + LCG+
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS-I-TP 250
Query: 220 ENIPN-----LFKKIKGGIY-------TLPSH-LSPGARDLIPRMLIVDPMKRITIPEIR 266
E PN L++K++ L ++ P A DLI ++L++DP +RI +
Sbjct: 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310
Query: 267 QHPWFQ-----AHLPRYLAVPPPDTMQQAKK 292
H +F + L L+ +
Sbjct: 311 NHDFFWSDPMPSDLKGMLSTHLTSMFEYLAP 341
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 3e-50
Identities = 70/265 (26%), Positives = 120/265 (45%), Gaps = 23/265 (8%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
G+ LG G FG+ H TG + +K L R + E + +E+K++R HP++
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNV 69
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
++ V+ + + EY+K G L I + + +F + I SG+ Y H +
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---------------KTSCGSPNYA 183
+HRDL N L+ NV +ADFGL+ +M D T G+P +
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF--KKIKGGI-YTLPSHL 240
APE+I+G+ Y +VDV+S G++L ++ D + ++G + P +
Sbjct: 190 APEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNC 248
Query: 241 SPGARDLIPRMLIVDPMKRITIPEI 265
P + R +DP KR + ++
Sbjct: 249 PPSFFPITVRCCDLDPEKRPSFVKL 273
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 4e-50
Identities = 75/248 (30%), Positives = 124/248 (50%), Gaps = 8/248 (3%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
YK+ LG G V +AE + KVAIK + + E ++ RE+ H +
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
I+ + +V E Y+VMEY++ L +YI G L D A NF QI+ G+++ H +
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC--GSPNYAAPEVISGKLYAGP 196
VHRD+KP+N+L+DS +KI DFG++ + + +T+ G+ Y +PE G+
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDE 191
Query: 197 EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSHLSPG----ARDLIPRM 251
D++S G++LY +L G PF+ E + K I+ + + + + ++I R
Sbjct: 192 CTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRA 251
Query: 252 LIVDPMKR 259
D R
Sbjct: 252 TEKDKANR 259
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-49
Identities = 69/298 (23%), Positives = 127/298 (42%), Gaps = 53/298 (17%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-H 76
+Y+L + LG G + +V A + KV +KIL ++K++REIKIL
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILENLRGG 90
Query: 77 PHIIRLYEVIETPS---DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
P+II L ++++ P V E+V + + L + + R + +I+ ++YC
Sbjct: 91 PNIITLADIVKDPVSRTPALVF-EHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 146
Query: 134 HRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL 192
H ++HRD+KP N+++D + +++ D+GL+ G S + PE++
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 193 YAGPEVDVWSCGVILYALLCGTLPF--------------------DDENIPNLF--KKIK 230
+D+WS G +L +++ PF D + + + +
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266
Query: 231 GGIYTLPSH----------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
L H +SP A D + ++L D R+T E +HP+F
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-48
Identities = 86/341 (25%), Positives = 140/341 (41%), Gaps = 65/341 (19%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEK-VRREIKIL 71
L Y+ K +G G+ G V A A+ VAIK K+ + K RE+ ++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK-----KLSRPFQNQTHAKRAYRELVLM 115
Query: 72 RLFMHPHIIRLYEVIETPS------DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQ 125
+ H +II L V D+Y+VME + + L I + L + Q
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQ 172
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAP 185
++ G+++ H ++HRDLKP N+++ S +KI DFGL+ + + Y AP
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLF 226
EVI G Y VD+WS G I+ ++ + F E + L
Sbjct: 233 EVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291
Query: 227 KKIKGGIYTLP-----------------------SHLSPGARDLIPRMLIVDPMKRITIP 263
++ + P + ARDL+ +ML++DP KRI++
Sbjct: 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351
Query: 264 EIRQHPWFQA-HLPRYLAVPPPDTMQQA---KKIDEEILKE 300
+ QHP+ + P + PPP + ++ E KE
Sbjct: 352 DALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKE 392
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 6e-48
Identities = 98/363 (26%), Positives = 153/363 (42%), Gaps = 78/363 (21%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR---REIKILR 72
+++L LG G++G V A H TG VAIK KI+ + REIKIL+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK-----KIEPFDKPLFALRTLREIKILK 64
Query: 73 LFMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFD--YIVEKGRLQEDEARNFFQQ 125
F H +II ++ + S ++Y++ E +++ D ++ L +D + F Q
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVYIIQELMQT----DLHRVISTQMLSDDHIQYFIYQ 120
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN---- 181
+ V+ H + V+HRDLKP NLL++S ++K+ DFGL+ I+ + +
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 182 -------YAAPEVISGKLYAGPEVDVWSCGVILYALL---------------------CG 213
Y APEV+ +DVWSCG IL L G
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240
Query: 214 TLPFDDENIPNLF-KKIKGGIYTLP-----------SHLSPGARDLIPRMLIVDPMKRIT 261
T P D ++ + + + I +LP ++P DL+ RML+ DP KRIT
Sbjct: 241 T-PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT 299
Query: 262 IPEIRQHPWFQA-HLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQL-VESLRNRL 319
E +HP+ Q H P P I + + L + L+ +
Sbjct: 300 AKEALEHPYLQTYHDPNDEPEGEP------------IPPSFFEFDHYKEALTTKDLKKLI 347
Query: 320 QNE 322
NE
Sbjct: 348 WNE 350
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} Length = 130 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 7e-48
Identities = 32/125 (25%), Positives = 57/125 (45%), Gaps = 4/125 (3%)
Query: 390 RKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNN--P 447
KW LG++S++ P +IM EV +A++ L+ WK I Y+++ R +G M
Sbjct: 6 AKWHLGIRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQ 65
Query: 448 LHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQFLFLDLCAA 507
+ + Y D ++ + V+ + V E ++ LQ F ++CAA
Sbjct: 66 VDAKSYLLDFKSL--TNDEVEQGDDVIMESLTPPPLSVSGVMPLQPTGHHTMEFFEMCAA 123
Query: 508 FLAQL 512
+ QL
Sbjct: 124 LIIQL 128
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 8e-48
Identities = 81/284 (28%), Positives = 137/284 (48%), Gaps = 16/284 (5%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME-EKVRREIKILRLFMHP 77
+ + +G GSFG+V T VAIKI++ ++ E E E +++EI +L P
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID---LEEAEDEIEDIQQEITVLSQCDSP 80
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
++ + Y + ++++MEY+ G D ++E G L E + ++I+ G++Y H
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYAGP 196
+HRD+K N+LL VK+ADFG++ + D + T G+P + APEVI Y
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY-DS 198
Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254
+ D+WS G+ L G P + + P LF K TL + S ++ + L
Sbjct: 199 KADIWSLGITAIELARGEPPHSELH-PMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 257
Query: 255 DPMKRITIPEIRQHPWF--QAHLPRYLAVPPPDTMQQAKKIDEE 296
+P R T E+ +H + A YL + + + K+ E
Sbjct: 258 EPSFRPTAKELLKHKFILRNAKKTSYLT----ELIDRYKRWKAE 297
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-47
Identities = 88/341 (25%), Positives = 140/341 (41%), Gaps = 65/341 (19%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEK-VRREIKIL 71
L Y+ K +G G+ G V A A+ VAIK K+ + K RE+ ++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK-----KLSRPFQNQTHAKRAYRELVLM 78
Query: 72 RLFMHPHIIRLYEVI------ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQ 125
+ H +II L V E D+Y+VME + + L I + L + Q
Sbjct: 79 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI--QMELDHERMSYLLYQ 135
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAP 185
++ G+++ H ++HRDLKP N+++ S +KI DFGL+ + + Y AP
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLF 226
EVI G Y VD+WS G I+ ++ G + F E + L
Sbjct: 196 EVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 227 KKIKGGIYTLP-----------------------SHLSPGARDLIPRMLIVDPMKRITIP 263
++ + P + ARDL+ +ML++D KRI++
Sbjct: 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314
Query: 264 EIRQHPWFQA-HLPRYLAVPPPDTMQQA---KKIDEEILKE 300
E QHP+ + P PPP + ++ E KE
Sbjct: 315 EALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKE 355
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-47
Identities = 67/274 (24%), Positives = 119/274 (43%), Gaps = 15/274 (5%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
Y+L + +G G G V AE + VA+K+++ + +++RE + PH
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
++ +++ E +YV M + +L + +G L A +QI S ++ H
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC--GSPNYAAPEVISGKLYAGP 196
HRD+KPEN+L+ + + DFG+++ D + G+ Y APE S +A
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES-HATY 214
Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPG----ARDLIPRML 252
D+++ +LY L G+ P+ + + + I I PS + PG +I R +
Sbjct: 215 RADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAI-PRPSTVRPGIPVAFDAVIARGM 273
Query: 253 IVDPMKR-ITIPEIRQHPWFQAHLPRYLAVPPPD 285
+P R +T + A LA D
Sbjct: 274 AKNPEDRYVTCGD------LSAAAHAALATADQD 301
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 8e-47
Identities = 70/263 (26%), Positives = 123/263 (46%), Gaps = 13/263 (4%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFMHPHIIR 81
LG G++G V+ H +G +A+K + R N + ++++ ++ I +R P +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVT 70
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDY---IVEKGRLQEDEARNFFQQIISGVEYCHRNM- 137
Y + D+++ ME + + Y I + + ED I+ +E+ H +
Sbjct: 71 FYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP- 196
V+HRD+KP N+L+++ VK+ DFG+S + D G Y APE I+ +L
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGY 190
Query: 197 --EVDVWSCGVILYALLCGTLPFDDENIP--NLFKKIKGGIYTLPS-HLSPGARDLIPRM 251
+ D+WS G+ + L P+D P L + ++ LP+ S D +
Sbjct: 191 SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQC 250
Query: 252 LIVDPMKRITIPEIRQHPWFQAH 274
L + +R T PE+ QHP+F H
Sbjct: 251 LKKNSKERPTYPELMQHPFFTLH 273
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-46
Identities = 73/348 (20%), Positives = 125/348 (35%), Gaps = 71/348 (20%)
Query: 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR----------- 65
Y + + + GS+G V + G VAIK ++ N + +
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIK-----RVFNTVSDGRTVNILSDSFLCKR 75
Query: 66 --REIKILRLFMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIV-EKGRLQED 117
REI++L F HP+I+ L ++ +Y+V E +++ +L I ++ +
Sbjct: 76 VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQ 134
Query: 118 EARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC 177
+ F I+ G+ H VVHRDL P N+LL ++ I DF L+
Sbjct: 135 HIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV 194
Query: 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL---------------------CGTLP 216
Y APE++ VD+WS G ++ + GT
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254
Query: 217 FDD-ENIPN----------LFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEI 265
+D + L + P A DLI +ML +P +RI+ +
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 266 RQHPWFQA-HLPRYLAVPPP---------DTMQQAKKIDEEILKEVVK 303
+HP+F++ P L + + EV +
Sbjct: 315 LRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDMH---KIFTAEVER 359
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-46
Identities = 83/311 (26%), Positives = 132/311 (42%), Gaps = 64/311 (20%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI--KNMEMEEKVRREIKILRL 73
Y K LG G G V A +VAIK KI + + + REIKI+R
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQSVKHALREIKIIRR 64
Query: 74 FMHPHIIRLYEVIETPS--------------DIYVVMEYVKSGELFD--YIVEKGRLQED 117
H +I++++E++ +Y+V EY+++ D ++E+G L E+
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGPLLEE 120
Query: 118 EARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTS 176
AR F Q++ G++Y H V+HRDLKP NL ++++ +KI DFGL+ IM D H+
Sbjct: 121 HARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIM-DPHYSHKG 179
Query: 177 CGSPN-----YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF-------------- 217
S Y +P ++ +D+W+ G I +L G F
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239
Query: 218 -----DDENIPNLFKKIKGGIYTLPS-----------HLSPGARDLIPRMLIVDPMKRIT 261
+E+ L I I + +S A D + ++L PM R+T
Sbjct: 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299
Query: 262 IPEIRQHPWFQ 272
E HP+
Sbjct: 300 AEEALSHPYMS 310
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-46
Identities = 66/266 (24%), Positives = 119/266 (44%), Gaps = 12/266 (4%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHP 77
+ +G G+ G+V TGH +A+K + R+ N E +++ ++ ++ + P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
+I++ + T +D+++ ME + + +G + E I+ + Y
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 138 -VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
V+HRD+KP N+LLD + +K+ DFG+S + D S G Y APE I P
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKP 204
Query: 197 E----VDVWSCGVILYALLCGTLPFDDENIP--NLFKKIKGGIYTLPSHL--SPGARDLI 248
+ DVWS G+ L L G P+ + L K ++ LP H+ S + +
Sbjct: 205 DYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFV 264
Query: 249 PRMLIVDPMKRITIPEIRQHPWFQAH 274
L D KR ++ +H + + +
Sbjct: 265 KDCLTKDHRKRPKYNKLLEHSFIKRY 290
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 5e-46
Identities = 97/353 (27%), Positives = 151/353 (42%), Gaps = 72/353 (20%)
Query: 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVR---REIKILRL 73
P Y +G G++G V A L +VAIK KI E + + REIKIL
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 81
Query: 74 FMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFD--YIVEKGRLQEDEARNFFQQI 126
F H +II + ++I P+ D+Y+V + +++ D +++ L D F QI
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQI 137
Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNY 182
+ G++Y H V+HRDLKP NLLL++ ++KI DFGL+ + H FL + Y
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLC---------------------GTLPFDDEN 221
APE++ +D+WS G IL +L G+ +D N
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257
Query: 222 ----------IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
+ +L K K L + A DL+ +ML +P KRI + + HP+
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 272 QA-HLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQL-VESLRNRLQNE 322
+ + P DE I + K + + L E L+ + E
Sbjct: 318 EQYYDPS----------------DEPIAEAPFKFDMELDDLPKEKLKELIFEE 354
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 8e-46
Identities = 90/347 (25%), Positives = 148/347 (42%), Gaps = 65/347 (18%)
Query: 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
Y +G G++G V A +G KVAIK L+R ++ ++ RE+ +L+ H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKHMQH 82
Query: 77 PHIIRLYEVIETPS------DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGV 130
++I L +V S D Y+VM ++++ +L + + E++ + Q++ G+
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM--GLKFSEEKIQYLVYQMLKGL 139
Query: 131 EYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSCGSPNYAAPEVI 188
+Y H VVHRDLKP NL ++ +KI DFGL+ ++ T Y APEVI
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW----YRAPEVI 195
Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLF-KK 228
++ VD+WS G I+ +L G F E + L K
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255
Query: 229 IKGGIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA-HLP 276
K I +LP SP A DL+ +ML +D KR+T + HP+F+ P
Sbjct: 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 315
Query: 277 RYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQL-VESLRNRLQNE 322
+E ++ + +L V+ + + E
Sbjct: 316 E----------------EETEAQQPFDDSLEHEKLTVDEWKQHIYKE 346
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-45
Identities = 80/345 (23%), Positives = 135/345 (39%), Gaps = 64/345 (18%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLF 74
+ +++ + G G+FG V++ + TG VAIK ++ + +N E+ + ++ L +
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-----QIMQDLAVL 76
Query: 75 MHPHIIRLYEVIETPS-----DIY--VVMEYVKS---GELFDYIVEKGRLQEDEARNFFQ 124
HP+I++L T DIY VVMEYV +Y + + F
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 125 QIISGVEYCHRNM--VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTS--CGS 179
Q+I + H V HRD+KP N+L++ + +K+ DFG + + + C S
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-VAYIC-S 194
Query: 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF-------------------DDE 220
Y APE+I G + VD+WS G I ++ G F E
Sbjct: 195 RYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254
Query: 221 NIPNL--------FKKIKG-----GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
+ L KG + A DL+ +L P +R+ E
Sbjct: 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314
Query: 268 HPWFQ------AHLPRYLAVPPPD---TMQQAKKIDEEILKEVVK 303
HP+F LP +P + + + E ++V+
Sbjct: 315 HPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVR 359
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-45
Identities = 80/285 (28%), Positives = 132/285 (46%), Gaps = 28/285 (9%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+Y+L + +G G+ V+ A A KVAIK +N K + M+E + +EI+ + HP
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT-SMDE-LLKEIQAMSQCHHP 73
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYI--------VEKGRLQEDEARNFFQQIISG 129
+I+ Y ++++VM+ + G + D I + G L E ++++ G
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL------KTSCGSPNYA 183
+EY H+N +HRD+K N+LL +V+IADFG+S + G + KT G+P +
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTL----- 236
APEV+ + D+WS G+ L G P+ P L ++ +L
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP-PMKVLMLTLQNDPPSLETGVQ 252
Query: 237 ----PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
R +I L DP KR T E+ +H +FQ +
Sbjct: 253 DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-45
Identities = 81/285 (28%), Positives = 136/285 (47%), Gaps = 16/285 (5%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+ + + LG GS+G V A H TG VAIK + +++ +EI I++ P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ-----VPVESDLQEIIKEISIMQQCDSP 84
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFD-YIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
H+++ Y +D+++VMEY +G + D + L EDE Q + G+EY H
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYAG 195
+HRD+K N+LL+++ + K+ADFG++ + D + T G+P + APEVI Y
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY-N 203
Query: 196 PEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRML 252
D+WS G+ + G P+ D + + +F T P S D + + L
Sbjct: 204 CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCL 263
Query: 253 IVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPDTMQQAKKIDEE 296
+ P +R T ++ QHP+ A L D + +A + +
Sbjct: 264 VKSPEQRATATQLLQHPFVRSAKGVSILR----DLINEAMDVKLK 304
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 72/273 (26%), Positives = 130/273 (47%), Gaps = 15/273 (5%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
+++ LG G+FGKV A++ TG A K++ K+ E E EI+IL HP+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCDHPY 77
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM 137
I++L +++++E+ G + ++E L E + + +Q++ + + H
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYA-- 194
++HRDLK N+L+ + ++++ADFG+S + + G+P + APEV+ +
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197
Query: 195 --GPEVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTL--PSHLSPGARDLI 248
+ D+WS G+ L + P + N P L K K TL PS S RD +
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSDPPTLLTPSKWSVEFRDFL 256
Query: 249 PRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLA 280
L +P R + ++ +HP+ + L
Sbjct: 257 KIALDKNPETRPSAAQLLEHPFVSSITSNKALR 289
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-45
Identities = 84/349 (24%), Positives = 149/349 (42%), Gaps = 69/349 (19%)
Query: 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
Y+ +G G++G V A TG +VA+K L R +++ ++ RE+++L+ H
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 77 PHIIRLYEVIETPS------DIYVVMEYVKSGELFD--YIVEKGRLQEDEARNFFQQIIS 128
++I L +V D+Y+V + + D IV+ +L +D + QI+
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI 188
G++Y H ++HRDLKP NL ++ +KI DFGL+ D + + Y APE++
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD--EMTGYVATRWYRAPEIM 201
Query: 189 SGKLYAGPEVDVWSCGVILYALL---------------------CGTLPFDD-ENIPNLF 226
++ VD+WS G I+ LL GT + + I +
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS-- 259
Query: 227 KKIKGGIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 274
+ + I +L +P A DL+ +ML++D KRIT + H +F H
Sbjct: 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319
Query: 275 LPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQL-VESLRNRLQNE 322
P D+E + + + L ++ ++ +E
Sbjct: 320 DP-----------------DDEPVADPYDQSLESRDLLIDEWKSLTYDE 351
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-45
Identities = 65/253 (25%), Positives = 114/253 (45%), Gaps = 13/253 (5%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
Y+LG+ LG G +V +A VA+K+L ++ + RRE + HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 79 IIRLYEVIETPSDI----YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
I+ +Y+ E + Y+VMEYV L D + +G + A + + H
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC----GSPNYAAPEVISG 190
+N ++HRD+KP N+++ + VK+ DFG++ + D T G+ Y +PE G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSH---LSPGARD 246
DV+S G +LY +L G PF ++ + ++ ++ + LS
Sbjct: 194 D-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDA 252
Query: 247 LIPRMLIVDPMKR 259
++ + L +P R
Sbjct: 253 VVLKALAKNPENR 265
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-44
Identities = 87/353 (24%), Positives = 148/353 (41%), Gaps = 77/353 (21%)
Query: 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEK-VRREIKILR 72
Y+ + +G G++G V A TG KVAIK K+ E+ K RE+++L+
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK-----KLYRPFQSELFAKRAYRELRLLK 79
Query: 73 LFMHPHIIRLYEVIETPS------DIYVVMEYVKSGELFD--YIVEKGRLQEDEARNFFQ 124
H ++I L +V D Y+VM ++ + D +++ +L ED +
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT----DLGKLMKHEKLGEDRIQFLVY 135
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSCGSPNY 182
Q++ G+ Y H ++HRDLKP NL ++ +KI DFGL+ ++ T Y
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----Y 191
Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI------------- 229
APEVI + VD+WS G I+ ++ G F + + K+I
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251
Query: 230 -------KGGIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271
K + LP ++ SP A +L+ +ML++D +R+T E HP+F
Sbjct: 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311
Query: 272 QA-HLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQL-VESLRNRLQNE 322
++ H ++E + FD ++ + E
Sbjct: 312 ESLHDT-----------------EDEPQVQKYDDSFDDVDRTLDEWKRVTYKE 347
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-44
Identities = 75/284 (26%), Positives = 119/284 (41%), Gaps = 14/284 (4%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
+ + +G GSFG V A VAIK ++ ++ E + + +E++ L+ HP+
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
I+ ++VMEY V K LQE E + G+ Y H + +
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 175
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG--P 196
+HRD+K N+LL VK+ DFG ++IM + G+P + APEVI
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDG 232
Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTL-PSHLSPGARDLIPRMLI 253
+VDVWS G+ L P + N L+ + L H S R+ + L
Sbjct: 233 KVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 291
Query: 254 VDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPDTMQQAKKIDEE 296
P R T + +H + + P + D +Q+ K E
Sbjct: 292 KIPQDRPTSEVLLKHRFVLRERPPTVIM----DLIQRTKDAVRE 331
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 78/324 (24%), Positives = 124/324 (38%), Gaps = 80/324 (24%)
Query: 20 KLGKTLGIGSFGKVKIA--EHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
G +G G++G V A + A+K +I+ + REI +LR HP
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALK-----QIEGTGISMSACREIALLRELKHP 78
Query: 78 HIIRLYEVIETPSD--IYVVMEYV--------KSGELFDYIVEKGRLQEDEARNFFQQII 127
++I L +V + +D ++++ +Y K + +L ++ QI+
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWN----VKIADFGLSNIMRDGHFLKTSCGSPN-- 181
G+ Y H N V+HRDLKP N+L+ + VKIAD G + + LK
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVV 196
Query: 182 ----YAAPEVISG-KLYAGPEVDVWSCGVILYALL------------------------- 211
Y APE++ G + Y +D+W+ G I LL
Sbjct: 197 VTFWYRAPELLLGARHY-TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255
Query: 212 -----CGTLPFDDE--------NIPNLFKKIKGGIYTLPS----------HLSPGARDLI 248
G P D + L K + YT S A L+
Sbjct: 256 RIFNVMGF-PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL 314
Query: 249 PRMLIVDPMKRITIPEIRQHPWFQ 272
++L +DP+KRIT + Q P+F
Sbjct: 315 QKLLTMDPIKRITSEQAMQDPYFL 338
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 6e-44
Identities = 63/301 (20%), Positives = 123/301 (40%), Gaps = 49/301 (16%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
++ LG G+ G V H +G +A K+++ + ++ RE+++L P+
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPY 92
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM- 137
I+ Y + +I + ME++ G L + + GR+ E +I G+ Y
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 197
++HRD+KP N+L++S+ +K+ DFG+S + D + G+ +Y +PE + G Y +
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHY-SVQ 210
Query: 198 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG-------------------------- 231
D+WS G+ L + G P + L
Sbjct: 211 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270
Query: 232 -----GIYTLPSHL-------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273
I+ L ++ S +D + + LI +P +R + ++ H + +
Sbjct: 271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330
Query: 274 H 274
Sbjct: 331 S 331
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 82/352 (23%), Positives = 128/352 (36%), Gaps = 85/352 (24%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIK-ILNRRKIKNMEMEEKVRREIKILRLFMH 76
Y LGKTLG GSFG V +G + A+K +L + KN RE+ I+++ H
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN--------RELDIMKVLDH 59
Query: 77 PHIIRLYEVIETPS--------------------------------------DIYVVMEY 98
+II+L + T + V+MEY
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 99 VKS---GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-W 154
V L +I + + + Q+ V + H + HRD+KP+NLL++SK
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 155 NVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC 212
+K+ DFG + + + C S Y APE++ G P +D+WS G + L+
Sbjct: 180 TLKLCDFGSAKKLIPSEPS-VAYIC-SRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237
Query: 213 GTLPF-------------------DDENIPNL--------FKKIKGGIYT--LPSHLSPG 243
G F E + + F +K + LP
Sbjct: 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSL 297
Query: 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-HLPRYLAVPPPDTMQQAKKID 294
A DL+ ++L +P RI E HP+F V +
Sbjct: 298 AIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQN 349
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-43
Identities = 86/390 (22%), Positives = 149/390 (38%), Gaps = 110/390 (28%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEKVR--REIKI 70
L Y+L K LG G++G V + TG VA+K KI + + + R REI I
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK-----KIFDAFQNSTDAQ-RTFREIMI 61
Query: 71 LRLF-MHPHIIRLYEVIETPS--DIYVVMEYVKSGELFD--YIVEKGRLQEDEARNFFQQ 125
L H +I+ L V+ + D+Y+V +Y+++ D ++ L+ + Q
Sbjct: 62 LTELSGHENIVNLLNVLRADNDRDVYLVFDYMET----DLHAVIRANILEPVHKQYVVYQ 117
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN---- 181
+I ++Y H ++HRD+KP N+LL+++ +VK+ADFGLS + + +
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 182 ------------------YAAPEVI-SGKLYAGPEVDVWSCGVILYALLC---------- 212
Y APE++ Y +D+WS G IL +LC
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKY-TKGIDMWSLGCILGEILCGKPIFPGSST 236
Query: 213 -----------GTLPFDD-------------ENIP--------NLFKKIKGGIYTLPSHL 240
+D E++ N L
Sbjct: 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKIN 296
Query: 241 -----SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA-HLPRYLAVPPPDTMQQAKKID 294
+ A DL+ ++L +P KRI+ + +HP+ H P +
Sbjct: 297 PKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN----------------E 340
Query: 295 EEILKEVVKMGFDQNQL--VESLRNRLQNE 322
E ++ + + N ++ RN + +E
Sbjct: 341 EPNCDHIITIPINDNVKHSIDDYRNLVYSE 370
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 8e-43
Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 17/267 (6%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFMHPHIIR 81
+G G++G V H +G +A+K + R + + ++++ ++ + +R P+I++
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ 85
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDY----IVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
Y + D ++ ME + + Y V + E+ + + + N+
Sbjct: 86 FYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 138 -VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
++HRD+KP N+LLD N+K+ DFG+S + D G Y APE I
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 197 ---EVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTLPSHL----SPGARDL 247
DVWS G+ LY L G P+ N L + +KG L + SP +
Sbjct: 206 YDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINF 265
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274
+ L D KR E+ +HP+ +
Sbjct: 266 VNLCLTKDESKRPKYKELLKHPFILMY 292
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-42
Identities = 59/292 (20%), Positives = 110/292 (37%), Gaps = 51/292 (17%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
L + +G G +G+V G VA+KI + R K+ E E+ + H +I
Sbjct: 11 TLLECVGKGRYGEVWRGS--WQGENVAVKIFSSRDEKSWFRE----TELYNTVMLRHENI 64
Query: 80 IRLY----EVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH- 134
+ + + ++++ Y + G L+DY+ + L I SG+ + H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 135 -------RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-----KTSCGSPNY 182
+ + HRDLK +N+L+ IAD GL+ + G+ Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 183 AAPEVISGKLYAGPE-----VDVWSCGVILYALLCGT----------LPFDDENIPNL-F 226
APEV+ + VD+W+ G++L+ + PF D + F
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 227 KKIKGGIY------TLPSHLS-----PGARDLIPRMLIVDPMKRITIPEIRQ 267
+ ++ + +P+ L+ +P R+T I++
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-42
Identities = 71/361 (19%), Positives = 126/361 (34%), Gaps = 79/361 (21%)
Query: 5 SNRSSSGVDMFLPN---YKLGKTLGIG--SFGKVKIAEHALTGHKVAIKILNRRKIKNME 59
N G+ FLP Y+L +G G V +A + TG V ++ +N N E
Sbjct: 10 ENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-E 68
Query: 60 MEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE--KGRLQED 117
M ++ E+ + +LF HP+I+ ++++VV ++ G D I + E
Sbjct: 69 MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL 128
Query: 118 EARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-------- 169
Q ++ ++Y H VHR +K ++L+ V ++ + M
Sbjct: 129 AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188
Query: 170 GHFLKTSCGSPNYAAPEVISGKLYA-GPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFK 227
F K S + +PEV+ L + D++S G+ L G +PF D L +
Sbjct: 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 248
Query: 228 KIKGGIYTL---------------------------------------------PSHLSP 242
K+ G + L SP
Sbjct: 249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSP 308
Query: 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV 302
+ + L +P R + + H +F +Q K+ E L E++
Sbjct: 309 HFHHFVEQCLQRNPDARPSASTLLNHSFF----------------KQIKRRASEALPELL 352
Query: 303 K 303
+
Sbjct: 353 R 353
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-42
Identities = 73/296 (24%), Positives = 137/296 (46%), Gaps = 23/296 (7%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LFMHP 77
++L + +G G++G+V H TG AIK+++ + EE++++EI +L+ H
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHR 81
Query: 78 HIIRLYE------VIETPSDIYVVMEYVKSGELFDYI--VEKGRLQEDEARNFFQQIISG 129
+I Y +++VME+ +G + D I + L+E+ ++I+ G
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC-GSPNYAAPEVI 188
+ + H++ V+HRD+K +N+LL VK+ DFG+S + + + G+P + APEVI
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 189 SGKLYA----GPEVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTL-PSHLS 241
+ + D+WS G+ + G P D + P LF + L S
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKWS 260
Query: 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPDTMQQAKKIDEE 296
+ I L+ + +R ++ +HP+ R + + D + + KK E
Sbjct: 261 KKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRGE 316
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-41
Identities = 83/401 (20%), Positives = 128/401 (31%), Gaps = 116/401 (28%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEK-VRREIKIL 71
NY + +G GS+G V +A T VAIK K+ M ++ K + REI IL
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK-----KVNRMFEDLIDCKRILREITIL 79
Query: 72 RLFMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQI 126
+IIRLY++I ++Y+V+E S +L L E+ + +
Sbjct: 80 NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNL 138
Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----- 181
+ G + H + ++HRDLKP N LL+ +VK+ DFGL+ +
Sbjct: 139 LLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 182 ------------------YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP 223
Y APE+I + +D+WS G I LL ++
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
Query: 224 N--LFK---------KIKGGIYTLPSHL----------------------SPGARDLIPR 250
LF S+ P I
Sbjct: 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKL 318
Query: 251 M--------------------------LIVDPMKRITIPEIRQHPWFQA-HLPRYLAVPP 283
L +P KRITI + HP+ + +
Sbjct: 319 FPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK------ 372
Query: 284 PDTMQQAKKIDEEILKEVVKMGFDQNQL--VESLRNRLQNE 322
E + + + FD + LR E
Sbjct: 373 ----------LENFSTKKIILPFDDWMVLSETQLRYIFLKE 403
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-40
Identities = 63/315 (20%), Positives = 120/315 (38%), Gaps = 56/315 (17%)
Query: 2 DGASNRSSSGVDMFLPNY-----KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK 56
S+ S SG+ + + ++ K +G G +G+V + + G KVA+K+ +
Sbjct: 17 QSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTEEA 74
Query: 57 NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD----IYVVMEYVKSGELFDYIVEKG 112
+ E EI L H +I+ + +Y++ +Y ++G L+DY+
Sbjct: 75 SWFRE----TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST- 129
Query: 113 RLQEDEARNFFQQIISGVEYCH--------RNMVVHRDLKPENLLLDSKWNVKIADFGLS 164
L +SG+ + H + + HRDLK +N+L+ IAD GL+
Sbjct: 130 TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189
Query: 165 NIMRDGHFL-----KTSCGSPNYAAPEVISGKLYAGPE-----VDVWSCGVILYALLCGT 214
T G+ Y PEV+ L D++S G+IL+ +
Sbjct: 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249
Query: 215 ----------LPFDDENIPNL-FKKIKGGIY------TLPSHLS-----PGARDLIPRML 252
LP+ D + ++ ++ + + P+ S L+
Sbjct: 250 VSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECW 309
Query: 253 IVDPMKRITIPEIRQ 267
+P R+T +++
Sbjct: 310 AHNPASRLTALRVKK 324
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-39
Identities = 56/248 (22%), Positives = 101/248 (40%), Gaps = 24/248 (9%)
Query: 19 YKLGKTLGIGSFGKVKIAE-HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
Y++ + G G + +A + G V +K L + E + E + L +HP
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGL--VHSGDAEAQAMAMAERQFLAEVVHP 139
Query: 78 HIIRLYEVIETPSDI-----YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
I++++ +E Y+VMEYV L +L EA + +I+ + Y
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSY 197
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGK 191
H +V+ DLKPEN++L + +K+ D G + + G+ G+P + APE++
Sbjct: 198 LHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY----GTPGFQAPEIVRTG 252
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251
D+++ G L AL + + L + L+ R
Sbjct: 253 --PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPED------DPVLKTYDSYGRLLRRA 304
Query: 252 LIVDPMKR 259
+ DP +R
Sbjct: 305 IDPDPRQR 312
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 2e-39
Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 43/228 (18%)
Query: 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEK-VRREIKILR 72
Y++ +G GS+G V A L VAIK KI + ++ K + REI IL
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK-----KILRVFEDLIDCKRILREIAILN 107
Query: 73 LFMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII 127
H H++++ +++ ++YVV+E S + L E + ++
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLL 166
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN------ 181
GV+Y H ++HRDLKP N L++ +VK+ DFGL+ + +
Sbjct: 167 VGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 182 ----------------------YAAPEVISGKLYAGPEVDVWSCGVIL 207
Y APE+I + +DVWS G I
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF 274
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 25/104 (24%), Positives = 36/104 (34%), Gaps = 19/104 (18%)
Query: 222 IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA-HLPRYLA 280
I K+ + S A L+ RML+ +P KRITI E HP+F+ +
Sbjct: 351 IRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE--- 407
Query: 281 VPPPDTMQQAKKIDEEILKEVVKMGFDQNQL--VESLRNRLQNE 322
E E V++ F+ LR E
Sbjct: 408 -------------VETNATEKVRLPFNDWMNMDEPQLRYAFVKE 438
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 58/316 (18%), Positives = 120/316 (37%), Gaps = 56/316 (17%)
Query: 1 MDGASNRSSSGVDMFLPNY-----KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI 55
D ++ S SG+ + + L +++G G FG+V + G +VA+KI + R+
Sbjct: 21 YDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREE 78
Query: 56 KNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD----IYVVMEYVKSGELFDYIVEK 111
++ E EI + H +I+ + +++V +Y + G LFDY+ +
Sbjct: 79 RSWFRE----AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NR 133
Query: 112 GRLQEDEARNFFQQIISGVEYCHRNM--------VVHRDLKPENLLLDSKWNVKIADFGL 163
+ + SG+ + H + + HRDLK +N+L+ IAD GL
Sbjct: 134 YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193
Query: 164 SNIMRDGH-----FLKTSCGSPNYAAPEVISGKLYAGPE-----VDVWSCGVILYALLCG 213
+ G+ Y APEV+ + D+++ G++ + +
Sbjct: 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
Query: 214 T----------LPFDDENIPNL-FKKIKGGIY------TLPSHLS-----PGARDLIPRM 251
LP+ D + ++++ + +P+ ++
Sbjct: 254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMREC 313
Query: 252 LIVDPMKRITIPEIRQ 267
+ R+T I++
Sbjct: 314 WYANGAARLTALRIKK 329
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 63/294 (21%), Positives = 116/294 (39%), Gaps = 47/294 (15%)
Query: 1 MDGASNRSSSGVDMFLP-------NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRR 53
M + SSGVD+ +L + G FG V A+ VA+KI +
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQ 58
Query: 54 KIKNMEMEEKVRREIKILRLFMHPHIIRLY----EVIETPSDIYVVMEYVKSGELFDYIV 109
++ + E E+ L H +I++ D++++ + + G L D++
Sbjct: 59 DKQSWQNE----YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL- 113
Query: 110 EKGRLQEDEARNFFQQIISGVEYCHRNM----------VVHRDLKPENLLLDSKWNVKIA 159
+ + +E + + + G+ Y H ++ + HRD+K +N+LL + IA
Sbjct: 114 KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 160 DFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPE----VDVWSCGVILYALLC 212
DFGL+ G G+ Y APEV+ G + + +D+++ G++L+ L
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 213 GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM--LIVDPMKRITIPE 264
D Y LP G + M ++V KR + +
Sbjct: 234 RCTAADGPVDE----------YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD 277
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 39/248 (15%), Positives = 77/248 (31%), Gaps = 36/248 (14%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
Y+L G + A +VA+ ++ + + ++ ++ L P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
+ R+ +V+ T + VV E+++ G L + A Q + + + HR V
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAGV 150
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 198
P + + +V +A A P+
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA-------------------TMPD--------ANPQD 183
Query: 199 DVWSCGVILYALLCGTLPFDDENIPNLFK---KIKGGIYTLPSHLSPGA----RDLIPRM 251
D+ G LYALL P + + + + G P+ + + R
Sbjct: 184 DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARS 243
Query: 252 LIVDPMKR 259
+ D R
Sbjct: 244 VQGDGGIR 251
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 71/256 (27%), Positives = 118/256 (46%), Gaps = 13/256 (5%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
LG+ +G G+FG+V VA+K R+ +++ K +E +IL+ + HP+I
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSC--RETLPPDLKAKFLQEARILKQYSHPNI 174
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMV 138
+RL V IY+VME V+ G+ ++ +G L+ +G+EY
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY----AAPEVISGKLYA 194
+HRDL N L+ K +KI+DFG+S DG + S G APE ++ Y+
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVY-AASGGLRQVPVKWTAPEALNYGRYS 293
Query: 195 GPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRM 251
E DVWS G++L+ G P+ + + + ++ G L P L+ +
Sbjct: 294 -SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRLPCPELCPDAVFRLMEQC 351
Query: 252 LIVDPMKRITIPEIRQ 267
+P +R + I Q
Sbjct: 352 WAYEPGQRPSFSTIYQ 367
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 9e-36
Identities = 55/223 (24%), Positives = 102/223 (45%), Gaps = 11/223 (4%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
+ LG G +G+V VA+K L K ME E+ +E +++ HP++
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTME-VEEFLKEAAVMKEIKHPNL 278
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYI--VEKGRLQEDEARNFFQQIISGVEYCHRNM 137
++L V Y++ E++ G L DY+ + + QI S +EY +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY--AAPEVISGKLYAG 195
+HR+L N L+ VK+ADFGLS +M + + APE ++ ++
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS- 397
Query: 196 PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
+ DVW+ GV+L+ + G P+ ++ +++ ++ Y +
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRME 439
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-35
Identities = 64/224 (28%), Positives = 112/224 (50%), Gaps = 19/224 (8%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
KL +T+G G FG V + + G+KVA+K + KN + E ++ H ++
Sbjct: 24 KLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-----KNDATAQAFLAEASVMTQLRHSNL 76
Query: 80 IRLYEVI--ETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHR 135
++L VI E +Y+V EY+ G L DY+ +GR L D F + +EY
Sbjct: 77 VQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYA 194
N VHRDL N+L+ K++DFGL+ ++ + + P + APE + K ++
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFS 192
Query: 195 GPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
+ DVWS G++L+ + G +P+ + ++ +++ G Y +
Sbjct: 193 -TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMD 234
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 64/223 (28%), Positives = 112/223 (50%), Gaps = 17/223 (7%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
KL +T+G G FG V + + G+KVA+K + KN + E ++ H ++
Sbjct: 196 KLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-----KNDATAQAFLAEASVMTQLRHSNL 248
Query: 80 IRLYEVI-ETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRN 136
++L VI E +Y+V EY+ G L DY+ +GR L D F + +EY N
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYAG 195
VHRDL N+L+ K++DFGL+ ++ + + P + APE + K ++
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFST 365
Query: 196 PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
+ DVWS G++L+ + G +P+ + ++ +++ G Y +
Sbjct: 366 -KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMD 406
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 57/223 (25%), Positives = 104/223 (46%), Gaps = 11/223 (4%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
+ LG G +G+V VA+K L K ME E+ +E +++ HP++
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTME-VEEFLKEAAVMKEIKHPNL 71
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYI--VEKGRLQEDEARNFFQQIISGVEYCHRNM 137
++L V Y++ E++ G L DY+ + + QI S +EY +
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 195
+HRDL N L+ VK+ADFGLS +M + + P + APE ++ ++
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS- 190
Query: 196 PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
+ DVW+ GV+L+ + G P+ ++ +++ ++ Y +
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRME 232
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 68/225 (30%), Positives = 109/225 (48%), Gaps = 17/225 (7%)
Query: 20 KLGKTLGIGSFGKVKIAE----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
K + LG G+FG V++ TG VA+K L + E REI+IL+
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQ 69
Query: 76 HPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEY 132
H +I++ V + + ++MEY+ G L DY+ + K R+ + + QI G+EY
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSP-NYAAPEVI 188
+HRDL N+L++++ VKI DFGL+ ++ K SP + APE +
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI 233
+ ++ DVWS GV+LY L T ++ P F ++ G
Sbjct: 190 TESKFS-VASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIGND 231
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 17/225 (7%)
Query: 20 KLGKTLGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
K + LG G+FG V++ + TG VA+K L + E REI+IL+
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQ 100
Query: 76 HPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEY 132
H +I++ V + + ++MEY+ G L DY+ + K R+ + + QI G+EY
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 160
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCG-SP-NYAAPEVI 188
+HRDL N+L++++ VKI DFGL+ ++ + G SP + APE +
Sbjct: 161 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220
Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI 233
+ ++ DVWS GV+LY L T ++ P F ++ G
Sbjct: 221 TESKFS-VASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIGND 262
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 20/230 (8%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVR---REIKILR 72
K K LG G+FG V G K VAIK L + + + E ++
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-----REATSPKANKEILDEAYVMA 72
Query: 73 LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVE 131
+PH+ RL + T + + ++ + + G L DY+ E K + N+ QI G+
Sbjct: 73 SVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--P-NYAAPEVI 188
Y +VHRDL N+L+ + +VKI DFGL+ ++ + G P + A E I
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 189 SGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
++Y + DVWS GV ++ L+ G+ P+D + ++ G LP
Sbjct: 192 LHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLP 239
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* Length = 106 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-34
Identities = 28/134 (20%), Positives = 50/134 (37%), Gaps = 40/134 (29%)
Query: 387 PYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNN 446
KW LG++S++ P +IM EV +A+++L+ WK + Y ++ R ++
Sbjct: 3 HMGAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTF------ 56
Query: 447 PLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQ--------GPQ 498
K +QLY+ YLLD + +
Sbjct: 57 --------------------------SKMSLQLYQVDSRTYLLDFRSIDDGGGGGGGSHT 90
Query: 499 FLFLDLCAAFLAQL 512
F ++CA + L
Sbjct: 91 IEFFEMCANLIKIL 104
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 1e-33
Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 13/223 (5%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
+L LG G FG+V + +VAIK L K M E +E ++++ H +
Sbjct: 270 RLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL---KPGTMS-PEAFLQEAQVMKKLRHEKL 324
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNM 137
++LY V+ + IY+V EY+ G L D++ + L+ + + QI SG+ Y R
Sbjct: 325 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 195
VHRDL+ N+L+ K+ADFGL+ ++ D + P + APE +
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT- 442
Query: 196 PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
+ DVWS G++L L G +P+ + +++ G Y +P
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 484
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 13/223 (5%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
+L LG G FG+V + +VAIK L E +E ++++ H +
Sbjct: 187 RLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHEKL 241
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNM 137
++LY V+ + IY+V EY+ G L D++ + L+ + + QI SG+ Y R
Sbjct: 242 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 195
VHRDL+ N+L+ K+ADFGL+ ++ D + P + APE +
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT- 359
Query: 196 PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
+ DVWS G++L L G +P+ + +++ G Y +P
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 401
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-33
Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 20 KLGKTLGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
K + LG G FGKV++ + TG +VA+K L + +++EI+ILR
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEILRNLY 81
Query: 76 HPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEY 132
H +I++ + I ++ME++ SG L +Y+ K ++ + + QI G++Y
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 141
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSP-NYAAPEVI 188
VHRDL N+L++S+ VKI DFGL+ + +K SP + APE +
Sbjct: 142 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201
Query: 189 SGKLYAGPEVDVWSCGVILY 208
+ DVWS GV L+
Sbjct: 202 MQSKFY-IASDVWSFGVTLH 220
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 67/200 (33%), Positives = 105/200 (52%), Gaps = 15/200 (7%)
Query: 20 KLGKTLGIGSFGKVKIAE----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
K LG G+FG V++ TG VA+K L + + + +REI+IL+
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILKALH 82
Query: 76 HPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEY 132
I++ V P + +VMEY+ SG L D++ + RL + QI G+EY
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 142
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR--DGHFLKTSCG-SP-NYAAPEVI 188
VHRDL N+L++S+ +VKIADFGL+ ++ +++ G SP + APE +
Sbjct: 143 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 189 SGKLYAGPEVDVWSCGVILY 208
S +++ + DVWS GV+LY
Sbjct: 203 SDNIFS-RQSDVWSFGVVLY 221
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-33
Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 11/222 (4%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
+ +G G FG V + L KVAIK + + M EE E +++ HP +
Sbjct: 11 TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTI---REGAMS-EEDFIEEAEVMMKLSHPKL 65
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMV 138
++LY V + I +V E+++ G L DY+ +G + + G+ Y V
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGP 196
+HRDL N L+ +K++DFG++ + D + ++ P +A+PEV S Y+
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-S 184
Query: 197 EVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
+ DVWS GV+++ + G +P+++ + + + I G + L
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLY 225
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-33
Identities = 58/222 (26%), Positives = 110/222 (49%), Gaps = 11/222 (4%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
L K LG G FG VK+ + + VA+K++ + E++ +E + + HP +
Sbjct: 11 TLLKELGSGQFGVVKLGK-WKGQYDVAVKMIK----EGSMSEDEFFQEAQTMMKLSHPKL 65
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMV 138
++ Y V IY+V EY+ +G L +Y+ G+ L+ + + G+ + +
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF 125
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGP 196
+HRDL N L+D VK++DFG++ + D ++ + P ++APEV Y+
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS-S 184
Query: 197 EVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
+ DVW+ G++++ + G +P+D + K+ G + L
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-HRLY 225
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 65/281 (23%), Positives = 106/281 (37%), Gaps = 48/281 (17%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L N KL + +G G +G V L VA+K+ + +N E + I + L
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQNFINE----KNIYRVPLME 65
Query: 76 HPHIIRLYEVIETPSDI-----YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGV 130
H +I R E + +VMEY +G L Y+ + + G+
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGL 124
Query: 131 EYCH---------RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS----- 176
Y H + + HRDL N+L+ + I+DFGLS + ++
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 177 ----CGSPNYAAPEVISGKL------YAGPEVDVWSCGVILYALLCG-TLPFDDENIPNL 225
G+ Y APEV+ G + A +VD+++ G+I + + T F E++P
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE- 243
Query: 226 FKKIKGGIYTLPSHLSPGARDLIPRM--LIVDPMKRITIPE 264
Y + G M L+ +R PE
Sbjct: 244 --------YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE 276
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 63/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
KL + LG G FG+V + KVA+K L K +M + E +++ H +
Sbjct: 16 KLVERLGAGQFGEVWMGY-YNGHTKVAVKSL---KQGSMS-PDAFLAEANLMKQLQHQRL 70
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNM 137
+RLY V+ T IY++ EY+++G L D++ L ++ + QI G+ +
Sbjct: 71 VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 195
+HRDL+ N+L+ + KIADFGL+ ++ D + P + APE I+ +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT- 188
Query: 196 PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
+ DVWS G++L ++ G +P+ P + + ++ G Y +
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMV 230
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 66/227 (29%), Positives = 109/227 (48%), Gaps = 14/227 (6%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
K K LG G+FG V G K VAIK L R+ + + +++ E ++
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD 75
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
+PH+ RL + T + + ++ + + G L DY+ E K + N+ QI G+ Y
Sbjct: 76 NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--P-NYAAPEVISGK 191
+VHRDL N+L+ + +VKI DFGL+ ++ + G P + A E I +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 192 LYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
+Y + DVWS GV ++ L+ G+ P+D + ++ G LP
Sbjct: 195 IYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLP 239
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 16/228 (7%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEME-EKVRREIKILRLF 74
+ K LG G FG V G V IK++ + K+ + V + +
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI---EDKSGRQSFQAVTDHMLAIGSL 72
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYC 133
H HI+RL + S + +V +Y+ G L D++ + +G L N+ QI G+ Y
Sbjct: 73 DHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--P-NYAAPEVISG 190
+ +VHR+L N+LL S V++ADFG+++++ + P + A E I
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 191 KLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
Y + DVWS GV ++ L+ G P+ + + ++ G L
Sbjct: 192 GKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-ERLA 237
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 86/351 (24%), Positives = 132/351 (37%), Gaps = 86/351 (24%)
Query: 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-MEEKVRREIKIL 71
D Y++ K +G GSFG+V A VA+K+ ++N + + EI+IL
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKM-----VRNEKRFHRQAAEEIRIL 147
Query: 72 RLFMH------PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQ---EDEARNF 122
++I + E + I + E + S L++ I +K + Q R F
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELI-KKNKFQGFSLPLVRKF 205
Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLL--DSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
I+ ++ H+N ++H DLKPEN+LL + +K+ DFG S + T S
Sbjct: 206 AHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY--TYIQSR 263
Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYAL---------------------LCGTLP--- 216
Y APEVI G Y G +D+WS G IL L L G
Sbjct: 264 FYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322
Query: 217 ----------FDDENIPN--LFKKIKGGIYTLPSHLS--------PGAR----------- 245
+ P + G L S P +R
Sbjct: 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDD 382
Query: 246 ----DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292
D + + L DP R+T + +HPW + LP+ PP + + K
Sbjct: 383 PLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPK-----PPTGEKTSVK 428
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 72/200 (36%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
K + LG G FGKV + + T VA+K L + + ++EI ILR
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADAGPQHRSGWKQEIDILRTLY 91
Query: 76 HPHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
H HII+ E + +VMEYV G L DY+ + + + F QQI G+ Y
Sbjct: 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYL 150
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCG-SP-NYAAPEVIS 189
H +HRDL N+LLD+ VKI DFGL+ + +GH + G SP + APE +
Sbjct: 151 HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210
Query: 190 -GKLYAGPEVDVWSCGVILY 208
K Y DVWS GV LY
Sbjct: 211 EYKFYY--ASDVWSFGVTLY 228
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-32
Identities = 70/225 (31%), Positives = 109/225 (48%), Gaps = 12/225 (5%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
+LG+ +G G FG V + + VAIK + + + EK +E +R F H
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQFDH 75
Query: 77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHR 135
PHI++L VI T + ++++ME GEL ++ K L + Q+ + + Y
Sbjct: 76 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG-SP-NYAAPEVISGKLY 193
VHRD+ N+L+ S VK+ DFGLS M D + K S G P + APE I+ + +
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 194 AGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
DVW GV ++ +L G PF ++ +I+ G LP
Sbjct: 195 T-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLP 237
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-32
Identities = 56/222 (25%), Positives = 105/222 (47%), Gaps = 11/222 (4%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
K LG G FG VK + + VAIK++ + E++ E K++ H +
Sbjct: 27 TFLKELGTGQFGVVKYGK-WRGQYDVAIKMIK----EGSMSEDEFIEEAKVMMNLSHEKL 81
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
++LY V I+++ EY+ +G L +Y+ + R Q + + + +EY
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGP 196
+HRDL N L++ + VK++DFGLS + D + + P ++ PEV+ ++
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS-S 200
Query: 197 EVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
+ D+W+ GV+++ + G +P++ + I G L
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLY 241
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 78/339 (23%), Positives = 128/339 (37%), Gaps = 82/339 (24%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-MEEKVRREIKILRL---- 73
Y L + LG G F V +A+ + VA+KI ++ + E EIK+L+
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKI-----VRGDKVYTEAAEDEIKLLQRVNDA 75
Query: 74 -------FMHPHIIRLYE--VIETPSDIYV--VMEYVKSGELFDYIV--EKGRLQEDEAR 120
HI++L + + P+ ++V V E V L I E + +
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVK 134
Query: 121 NFFQQIISGVEYCHRNM-VVHRDLKPENLLLD------SKWNVKIADFGLSNIMRDGHFL 173
+Q++ G++Y HR ++H D+KPEN+L++ + +KIAD G +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHY 192
Query: 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL----------------------- 210
S + Y +PEV+ G + G D+WS +++ L
Sbjct: 193 TNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251
Query: 211 ----LCGTLP-------------FDDE----NIPNL-FKKIKGGIYTLPSHLSPGAR--- 245
L G LP F+ NI L F ++ + A+
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
D + ML +DP KR + HPW + L P
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPD 350
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 63/223 (28%), Positives = 114/223 (51%), Gaps = 13/223 (5%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79
KL K LG G FG+V +A KVA+K + K +M +E + E +++ H +
Sbjct: 191 KLEKKLGAGQFGEVWMAT-YNKHTKVAVKTM---KPGSMSVEAFLA-EANVMKTLQHDKL 245
Query: 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNM 137
++L+ V+ T IY++ E++ G L D++ + +F QI G+ + +
Sbjct: 246 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 195
+HRDL+ N+L+ + KIADFGL+ ++ D + P + APE I+ +
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT- 363
Query: 196 PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
+ DVWS G++L ++ G +P+ + P + + ++ G Y +P
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMP 405
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 11/209 (5%)
Query: 20 KLGKTLGIGSFGKVKIAE---HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
+L + LG GSFG V+ E + VA+K L + E + RE+ + H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHR 135
++IRLY V+ TP + +V E G L D + + +G + Q+ G+ Y
Sbjct: 81 RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSP---NYAAPEVISGK 191
+HRDL NLLL ++ VKI DFGL + ++ + APE + +
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 192 LYAGPEVDVWSCGVILYALL-CGTLPFDD 219
++ D W GV L+ + G P+
Sbjct: 200 TFS-HASDTWMFGVTLWEMFTYGQEPWIG 227
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 66/225 (29%), Positives = 103/225 (45%), Gaps = 12/225 (5%)
Query: 20 KLGKTLGIGSFGKVKIAE---HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
L + LG G FG+V H VA+K +K ++ +EK E I++ H
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHR 135
PHI++L +IE +++ME GEL Y+ K L+ + QI + Y
Sbjct: 73 PHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLY 193
VHRD+ N+L+ S VK+ DFGLS + D + K S P + +PE I+ + +
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 194 AGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
DVW V ++ +L G PF ++ ++ G LP
Sbjct: 192 T-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-DRLP 234
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 61/228 (26%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 21 LGKTLGIGSFGKVKIAEHALTGH--KVAIKILNRRKIKNMEMEEKVR----REIKILRLF 74
K LG G+FG VK + + VA+KIL KN + ++ E +++
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-----KNEANDPALKDELLAEANVMQQL 75
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
+P+I+R+ + E S +VME + G L Y+ + +++ Q+ G++Y
Sbjct: 76 DNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 134
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--P-NYAAPEVISG 190
+ VHRDL N+LL ++ KI+DFGLS + D ++ K P + APE I+
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 191 KLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
++ + DVWS GV+++ G P+ + ++ G +
Sbjct: 195 YKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMG 240
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-31
Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 12/225 (5%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
+LG+ +G G FG V + VAIK + + + EK +E +R F H
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREKFLQEALTMRQFDH 450
Query: 77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHR 135
PHI++L VI T + ++++ME GEL ++ K L + Q+ + + Y
Sbjct: 451 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG-SP-NYAAPEVISGKLY 193
VHRD+ N+L+ S VK+ DFGLS M D + K S G P + APE I+ + +
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 194 AGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
DVW GV ++ +L G PF ++ +I+ G LP
Sbjct: 570 T-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLP 612
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 9e-31
Identities = 68/230 (29%), Positives = 110/230 (47%), Gaps = 19/230 (8%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVR---REIKILRL 73
+ K +G G G+V + G VAIK L K E + R E I+
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-----KAGYTERQRRDFLSEASIMGQ 106
Query: 74 FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEY 132
F HP+IIRL V+ +V EY+++G L ++ G+ + + + +G+ Y
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGS--P-NYAAPEVI 188
VHRDL N+L+DS K++DFGLS ++ D T+ G P + APE I
Sbjct: 167 LSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 189 SGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
+ + ++ DVWS GV+++ +L G P+ + ++ ++ G Y LP
Sbjct: 227 AFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLP 274
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 67/228 (29%), Positives = 112/228 (49%), Gaps = 15/228 (6%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEME-EKVRREIKILRLFM 75
+ K +G G FG+V L K VAIK L K+ E + E I+ F
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL---KVGYTEKQRRDFLGEASIMGQFD 104
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCH 134
HP+IIRL V+ + +V EY+++G L ++ + + + + I SG++Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGS--P-NYAAPEVISG 190
VHRDL N+L++S K++DFGL ++ D T+ G P + +PE I+
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 191 KLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
+ + DVWS G++L+ ++ G P+ + + ++ K + G Y LP
Sbjct: 225 RKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} PDB: 3tdh_A* 3te5_A* 2qlv_A Length = 179 | Back alignment and structure |
|---|
Score = 114 bits (285), Expect = 9e-30
Identities = 34/195 (17%), Positives = 66/195 (33%), Gaps = 50/195 (25%)
Query: 344 AEFQETMESGFNRLHPIEPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPR 403
+ +++ S P + +A +P + + + +W G++SR++P
Sbjct: 6 YKEEDSTVSILPTSLPQIHRANMLAQGSPAASKISPLVTKKS---KTRWHFGIRSRSYPL 62
Query: 404 EIMTEVLKALQELNVGWKKIGH---YNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAI 460
++M E+ AL+ L W K + +K RW I N
Sbjct: 63 DVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTN---TNE------------- 106
Query: 461 IENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQ---------------------F 499
K P+++K +QL++ YL+D + +
Sbjct: 107 -------KIPDLMKMVIQLFQIETNNYLVDFKFDGWESSYGDDTTVSNISEDEMSTFSAY 159
Query: 500 LFLDLCAAFLAQLRV 514
FL L + +L V
Sbjct: 160 PFLHLTTKLIMELAV 174
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 67/229 (29%), Positives = 107/229 (46%), Gaps = 16/229 (6%)
Query: 20 KLGKTLGIGSFGKVK----IAEHALTGHKVAIKILNRRKIKNMEME-EKVRREIKILRLF 74
K +G G FG+V VAIK L K E + E I+ F
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL---KAGYTEKQRVDFLGEAGIMGQF 103
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYC 133
H +IIRL VI + ++ EY+++G L ++ E G + + I +G++Y
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGS--P-NYAAPEVIS 189
VHRDL N+L++S K++DFGLS ++ D T+ G P + APE IS
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 190 GKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
+ + DVWS G++++ ++ G P+ + + + K I G + LP
Sbjct: 224 YRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLP 270
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 59/339 (17%), Positives = 119/339 (35%), Gaps = 88/339 (25%)
Query: 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-MEEKVRREIKIL 71
+ + + + +G G+FG+V + +H A+K+ ++N++ + E IL
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKV-----VRNIKKYTRSAKIEADIL 85
Query: 72 R-LFMHP----HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQ 124
+ + +I++ + + ++ E L++ I ++ + +
Sbjct: 86 KKIQNDDINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCI 144
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDS-------------------------KWNVKIA 159
+I+ + Y + + H DLKPEN+LLD +K+
Sbjct: 145 EILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 160 DFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL--------- 210
DFG + D H + + Y APEVI + D+WS G +L L
Sbjct: 205 DFGCATFKSDYHGSIIN--TRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRT 261
Query: 211 ------------LCGTLP--------------FDDENIPNLF--------KKIKGGIYTL 236
+ +P + +++ L IK L
Sbjct: 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCL 321
Query: 237 PSHLS---PGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
P + D + +L +DP R + E+ +H + +
Sbjct: 322 PLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 77/351 (21%), Positives = 124/351 (35%), Gaps = 84/351 (23%)
Query: 13 DMFLPNYKLGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNME-MEEKVRREIKI 70
D Y++ LG G+FGKV + +HA +VA+KI I+N+ E R EI +
Sbjct: 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKI-----IRNVGKYREAARLEINV 69
Query: 71 LRLFMHP------HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNF 122
L+ + + + + + E + F+++ E R+
Sbjct: 70 LKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHM 128
Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDS-------------------KWNVKIADFGL 163
Q+ + + H N + H DLKPEN+L + ++++ADFG
Sbjct: 129 AYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL------------- 210
+ D T + +Y PEVI +A P DVWS G IL+
Sbjct: 189 A--TFDHEHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENR 245
Query: 211 --------LCGTLP------------FDDENIPNLFKKIKGGIYTLPSHLSPGAR----- 245
+ G +P F + G Y + +
Sbjct: 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSD-GRYVKENCKPLKSYMLQDS 304
Query: 246 -------DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQ 289
DL+ RML DP +RIT+ E HP+F P + +
Sbjct: 305 LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPSR 355
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 46/237 (19%), Positives = 89/237 (37%), Gaps = 28/237 (11%)
Query: 20 KLGKTLGIGSFGKV-------KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
++LG G+F K+ L +V +K+L + E ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL---DKAHRNYSESFFEAASMMS 67
Query: 73 LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVE 131
H H++ Y V + +V E+VK G L Y+ K + +Q+ + +
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 132 YCHRNMVVHRDLKPENLLLDSKWN--------VKIADFGLSNIMRDGHFLKTSCGSP-NY 182
+ N ++H ++ +N+LL + + +K++D G+S + L+ +
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ----ERIPW 183
Query: 183 AAPEVIS-GKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
PE I K D WS G L+ + G P + + + + LP
Sbjct: 184 VPPECIENPKNLN-LATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR-HQLP 238
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* Length = 173 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 4e-29
Identities = 26/125 (20%), Positives = 47/125 (37%), Gaps = 33/125 (26%)
Query: 375 MDYQGMGLRGQLPYER-KWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWI 433
M + G +P W LG++S++ P +IM EV +A+++L+ WK + Y ++ R
Sbjct: 1 MSHHHHHHSGLVPRGSMAWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRK 60
Query: 434 PGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQR 493
++ K +QLY+ YLLD +
Sbjct: 61 NPVTSTF--------------------------------SKMSLQLYQVDSRTYLLDFRS 88
Query: 494 VQGPQ 498
+
Sbjct: 89 IDDEI 93
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 36/294 (12%)
Query: 20 KLGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
LG+ LG G FG V ++ + + KVA+K+L I + ++EE +R E ++ F H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR-EAACMKEFDH 84
Query: 77 PHIIRLYEV------IETPSDIYVVMEYVKSGELFDYI------VEKGRLQEDEARNFFQ 124
PH+ +L V V++ ++K G+L ++ L F
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-N 181
I G+EY +HRDL N +L V +ADFGLS I ++ + P
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PS 238
+ A E ++ LY DVW+ GV ++ ++ G P+ ++ + GG L P
Sbjct: 205 WLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG-NRLKQPP 262
Query: 239 HLSPGARDLIPRML---IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQ 289
DL M DP +R + +R L L + Q
Sbjct: 263 ECMEEVYDL---MYQCWSADPKQRPSFTCLRM------ELENILGHLSVLSTSQ 307
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 69/272 (25%), Positives = 113/272 (41%), Gaps = 29/272 (10%)
Query: 20 KLGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
LGK LG G FG V + + T KVA+K + E+EE + E ++ F H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS-EAACMKDFSH 95
Query: 77 PHIIRLYEVI-----ETPSDIYVVMEYVKSGELFDYI------VEKGRLQEDEARNFFQQ 125
P++IRL V + V++ ++K G+L Y+ + F
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-NY 182
I G+EY +HRDL N +L V +ADFGLS I ++ + P +
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSH 239
A E ++ ++Y + DVW+ GV ++ + G P+ ++ + G + L P
Sbjct: 216 IAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG-HRLKQPED 273
Query: 240 LSPGARDLIPRML---IVDPMKRITIPEIRQH 268
++ M DP+ R T +R
Sbjct: 274 CLDELYEI---MYSCWRTDPLDRPTFSVLRLQ 302
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 14/227 (6%)
Query: 20 KLGKT-LGIGSFGKVKIAEHALTG--HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
+ LG G+FG V+ + + VAIK+L ++ E++ RE +I+ +
Sbjct: 12 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLDN 69
Query: 77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHR 135
P+I+RL V + + + +VME G L ++ ++ + Q+ G++Y
Sbjct: 70 PYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 128
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--P-NYAAPEVISGK 191
VHRDL N+LL ++ KI+DFGLS + D + P + APE I+ +
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 192 LYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
++ DVWS GV ++ L G P+ P + I+ G +
Sbjct: 189 KFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRME 233
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 65/273 (23%), Positives = 112/273 (41%), Gaps = 31/273 (11%)
Query: 20 KLGKTLGIGSFGKV-----KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
+ + LG GSFG V K +VAIK +N + +M + E +++ F
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMKEF 85
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR----------NFFQ 124
H++RL V+ V+ME + G+L Y+ +
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-N 181
+I G+ Y + N VHRDL N ++ + VKI DFG++ +I ++ K G P
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PS 238
+ +PE + ++ DVWS GV+L+ + P+ + + + + G L P
Sbjct: 206 WMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG-GLLDKPD 263
Query: 239 HLSPGARDLIPRMLI---VDPMKRITIPEIRQH 268
+ +L M + +P R + EI
Sbjct: 264 NCPDMLFEL---MRMCWQYNPKMRPSFLEIISS 293
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 88/332 (26%), Positives = 128/332 (38%), Gaps = 82/332 (24%)
Query: 13 DMFLPNYKLGKTLGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKNME-MEEKVRREIKI 70
D+ Y++ TLG G+FGKV + +H G VA+KI +KN++ E R EI++
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKI-----VKNVDRYCEAARSEIQV 64
Query: 71 LRLFMHP------HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNF 122
L +++ E E I +V E + +D+I E G + D R
Sbjct: 65 LEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKM 123
Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDS-------------------KWNVKIADFGL 163
QI V + H N + H DLKPEN+L ++K+ DFG
Sbjct: 124 AYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL------------- 210
+ + H S + +Y APEVI ++ P DVWS G IL
Sbjct: 184 ATYDDEHHSTLVS--TRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSK 240
Query: 211 --------LCGTLP------------FDDENIPNLFKKIKGGIY-----TLPSHLSP--- 242
+ G LP F + + G L +
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300
Query: 243 ---GARDLIPRMLIVDPMKRITIPEIRQHPWF 271
DLI +ML DP KRIT+ E +HP+F
Sbjct: 301 EHERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 63/230 (27%), Positives = 105/230 (45%), Gaps = 17/230 (7%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
+ +G G FG V E+ + AIK L+ +I M+ E RE ++R H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS--RITEMQQVEAFLREGLLMRGLNH 81
Query: 77 PHIIRLYEVIETPSD--IYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYC 133
P+++ L ++ P + +V++ Y+ G+L +I + + +F Q+ G+EY
Sbjct: 82 PNVLALIGIM-LPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVI 188
VHRDL N +LD + VK+ADFGL+ + D + + A E +
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 189 SGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
+ + DVWS GV+L+ LL G P+ + +L + G LP
Sbjct: 201 QTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-RRLP 248
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 13/225 (5%)
Query: 21 LGKTLGIGSFGKVKIAEHALTGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
LG G+FG V+ + + VAIK+L ++ E++ RE +I+ +P+
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLDNPY 397
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNM 137
I+RL V + + + +VME G L ++V + + Q+ G++Y
Sbjct: 398 IVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--P-NYAAPEVISGKLY 193
VHR+L N+LL ++ KI+DFGLS + D + P + APE I+ + +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 194 AGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 237
+ DVWS GV ++ L G P+ P + I+ G +
Sbjct: 517 S-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRME 559
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 75/280 (26%), Positives = 122/280 (43%), Gaps = 39/280 (13%)
Query: 20 KLGKTLGIGSFGKVKIAE-HALTGH----KVAIKILNRRKIKNMEMEEK-VRREIKILRL 73
+ GKTLG G+FGKV A L KVA+K+L K E++ + E+KI+
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML---KSTAHADEKEALMSELKIMSH 105
Query: 74 FM-HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN----------- 121
H +I+ L + V+ EY G+L +++ K R+ E +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 122 ---FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSC 177
F Q+ G+ + +HRD+ N+LL + KI DFGL+ +IM D +++
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 178 GS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPF-DDENIPNLFKKIKGGI 233
P + APE I +Y + DVWS G++L+ + G P+ +K +K G
Sbjct: 226 ARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG- 283
Query: 234 YTL--PSHLSPGARDLIPRMLI---VDPMKRITIPEIRQH 268
Y + P+ + M ++P R T +I
Sbjct: 284 YQMAQPAFAPKNIYSI---MQACWALEPTHRPTFQQICSF 320
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* Length = 157 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 3e-27
Identities = 23/109 (21%), Positives = 42/109 (38%), Gaps = 32/109 (29%)
Query: 390 RKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLH 449
W LG++S++ P +IM EV +A+++L+ WK + Y ++ R ++
Sbjct: 3 MAWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTF--------- 53
Query: 450 SNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQ 498
K +QLY+ YLLD + +
Sbjct: 54 -----------------------SKMSLQLYQVDSRTYLLDFRSIDDEI 79
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 17/230 (7%)
Query: 20 KLGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
+ +G G FG V + ++ A+K LN +I ++ + E I++ F H
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFSH 85
Query: 77 PHIIRLYEVIETPSD--IYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYC 133
P+++ L + S+ VV+ Y+K G+L ++I E + F Q+ G++Y
Sbjct: 86 PNVLSLLGIC-LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVI 188
VHRDL N +LD K+ VK+ADFGL+ M D + + + A E +
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 189 SGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
+ + + DVWS GV+L+ L+ G P+ D N ++ + G L
Sbjct: 205 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLL 252
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 63/302 (20%), Positives = 119/302 (39%), Gaps = 31/302 (10%)
Query: 20 KLGKTLGIGSFGKV-----KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
L + LG G+FG+V + + +VA+K L ++ + + E E I+ F
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKF 90
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEAR-------NFFQQII 127
H +I+R V +++ME + G+L ++ E + + + I
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGS-P-N 181
G +Y N +HRD+ N LL KI DFG++ +I R ++ K C P
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PS 238
+ PE ++ + D WS GV+L+ + G +P+ ++ + + + G + P
Sbjct: 211 WMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG-GRMDPPK 268
Query: 239 HLSPGARDLIPRML---IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 295
+ + M P R I + + P + P + +E
Sbjct: 269 NCPGPVYRI---MTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEE 325
Query: 296 EI 297
++
Sbjct: 326 KV 327
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 17/230 (7%)
Query: 20 KLGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
+ +G G FG V + ++ A+K LN +I ++ + E I++ F H
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFSH 149
Query: 77 PHIIRLYEVIETPSD--IYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYC 133
P+++ L + S+ VV+ Y+K G+L ++I E + F Q+ G+++
Sbjct: 150 PNVLSLLGIC-LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVI 188
VHRDL N +LD K+ VK+ADFGL+ M D F + + A E +
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 189 SGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 237
+ + + DVWS GV+L+ L+ G P+ D N ++ + G L
Sbjct: 269 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLL 316
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 32/217 (14%)
Query: 20 KLGKTLGIGSFGKVKIAE-HALTGH----KVAIKILNRRKIKNMEMEEK-VRREIKILRL 73
GKTLG G+FGKV A + L VA+K+L K E + + E+K+L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML---KPSAHLTEREALMSELKVLSY 82
Query: 74 FM-HPHIIRLYEVIETPSDIYVVMEYVKSGELFDY------------------IVEKGRL 114
H +I+ L V+ EY G+L ++ ++ L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 115 QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL 173
++ +F Q+ G+ + +HRDL N+LL KI DFGL+ +I D +++
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 174 KTSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILY 208
P + APE I +Y E DVWS G+ L+
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLW 238
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 5e-26
Identities = 82/294 (27%), Positives = 123/294 (41%), Gaps = 44/294 (14%)
Query: 20 KLGKTLGIGSFGKVKIAE-HALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLF 74
L + LG G+FGKV +AE + L+ K VA+K L K + + +RE ++L
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNL 74
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDY----------------IVEKGRLQEDE 118
H HI++ Y V + +V EY+K G+L + KG L +
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 119 ARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSC 177
+ QI SG+ Y VHRDL N L+ + VKI DFG+S ++ ++
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 178 GS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIY 234
P + PE I + + E DVWS GVIL+ + G P+ + + + I G
Sbjct: 195 TMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG-R 252
Query: 235 TL--PSHLSPGARDLIPRML---IVDPMKRITIPEIRQHPWFQAHLPRYLAVPP 283
L P D+ ML +P +R+ I EI L P
Sbjct: 253 VLERPRVCPKEVYDV---MLGCWQREPQQRLNIKEI------YKILHALGKATP 297
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 73/278 (26%), Positives = 115/278 (41%), Gaps = 37/278 (13%)
Query: 20 KLGKTLGIGSFGKVKIAE-HALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLF 74
L LG G+FGKV +AE H L + VA+K L K + + +RE ++L +
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTML 100
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN------------- 121
H HI+R + V + +V EY++ G+L ++ G + A
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 122 --FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG 178
Q+ +G+ Y VHRDL N L+ VKI DFG+S +I ++
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 179 S-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYT 235
P + PE I + + E DVWS GV+L+ + G P+ + I G
Sbjct: 221 MLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG-RE 278
Query: 236 L--PSHLSPGARDLIPRMLI---VDPMKRITIPEIRQH 268
L P P + M +P +R +I ++
Sbjct: 279 LERPRACPPEVYAI---MRGCWQREPQQRHSIKDVHAR 313
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* Length = 137 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 5e-26
Identities = 29/142 (20%), Positives = 43/142 (30%), Gaps = 37/142 (26%)
Query: 390 RKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLH 449
KW G++ R EI+ V +ALQ + N K R
Sbjct: 11 NKWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDM--------------- 55
Query: 450 SNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQ-------------- 495
Y I + E+QLY+ ++LD++
Sbjct: 56 ---YTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLDVKSNGYKDIYSHPERTADH 112
Query: 496 -----GPQFLFLDLCAAFLAQL 512
F FLDLCA + +L
Sbjct: 113 GMDDLKSSFPFLDLCAMLVCKL 134
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 82/288 (28%), Positives = 127/288 (44%), Gaps = 47/288 (16%)
Query: 20 KLGKTLGIGSFGKVKIAE-HALTGH----KVAIKILNRRKIKNMEMEEK-VRREIKILRL 73
LGKTLG G FGKV A L G VA+K+L K E + + E +L+
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML---KENASPSELRDLLSEFNVLKQ 82
Query: 74 FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDY------------------------IV 109
HPH+I+LY + +++EY K G L +
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 110 EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMR 168
++ L + +F QI G++Y +VHRDL N+L+ +KI+DFGLS ++
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 169 DGHFLKTSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNL 225
+ ++K S G P + A E + +Y + DVWS GV+L+ ++ G P+ L
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261
Query: 226 FKKIKGGIYTL--PSHLSPGARDLIPRMLI---VDPMKRITIPEIRQH 268
F +K G + + P + S L ML +P KR +I +
Sbjct: 262 FNLLKTG-HRMERPDNCSEEMYRL---MLQCWKQEPDKRPVFADISKD 305
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 62/289 (21%), Positives = 115/289 (39%), Gaps = 31/289 (10%)
Query: 20 KLGKTLGIGSFGKV-----KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
L + LG G+FG+V + + +VA+K L ++ + + E E I+ F
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP--EVCSEQDELDFLMEALIISKF 131
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDY-------IVEKGRLQEDEARNFFQQII 127
H +I+R V ++++E + G+L + + L + + + I
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCG-SP-N 181
G +Y N +HRD+ N LL KI DFG++ +I R G++ K C P
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PS 238
+ PE ++ + D WS GV+L+ + G +P+ ++ + + + G + P
Sbjct: 252 WMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG-GRMDPPK 309
Query: 239 HLSPGARDLIPRML---IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284
+ + M P R I + + P + P
Sbjct: 310 NCPGPVYRI---MTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 355
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 72/282 (25%), Positives = 128/282 (45%), Gaps = 40/282 (14%)
Query: 20 KLGKTLGIGSFGKVKIAE-------HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
LGK LG G FG+V +AE VA+K+L + + + E+++++
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEMEMMK 141
Query: 73 LFM-HPHIIRLYEVIETPSDIYVVMEYVKSGELFDY----------------IVEKGRLQ 115
+ H +II L +YV++EY G L +Y V + ++
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 116 EDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLK 174
+ + Q+ G+EY +HRDL N+L+ +KIADFGL+ +I ++ K
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 175 TSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKG 231
T+ G P + APE + ++Y + DVWS GV+++ + G P+ + LFK +K
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 320
Query: 232 GIYTL--PSHLSPGARDLIPRMLI---VDPMKRITIPEIRQH 268
G + + P++ + + M P +R T ++ +
Sbjct: 321 G-HRMDKPANCTNELYMM---MRDCWHAVPSQRPTFKQLVED 358
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 65/241 (26%), Positives = 109/241 (45%), Gaps = 22/241 (9%)
Query: 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-MEEKVRREIKIL 71
+ ++ Y++ +G GSFG+V A + VAIKI IKN + + + E+++L
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKI-----IKNKKAFLNQAQIEVRLL 104
Query: 72 RLFMHP------HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFF 123
L +I+ L + + +V E + S L+D + + + R F
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFA 163
Query: 124 QQIISGVEYCHRNM--VVHRDLKPENLLL--DSKWNVKIADFGLSNIMRDGHFLKTSCGS 179
QQ+ + + + ++H DLKPEN+LL + +KI DFG S + + S
Sbjct: 164 QQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QYIQS 221
Query: 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH 239
Y +PEV+ G Y +D+WS G IL + G F N + KI + P+H
Sbjct: 222 RFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH 280
Query: 240 L 240
+
Sbjct: 281 I 281
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 13/27 (48%), Positives = 15/27 (55%)
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQ 272
DLI RML DP RI QH +F+
Sbjct: 351 DLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 33/217 (15%)
Query: 20 KLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
KLGK LG G+FG+V A+ T VA+K+L + + E+KIL
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--EGATHSEHRALMSELKILIHI 87
Query: 75 M-HPHIIRLYEV---IETPSDIYVVMEYVKSGELFDYI----------------VEKGRL 114
H +++ L P + V++E+ K G L Y+ + K L
Sbjct: 88 GHHLNVVNLLGACTKPGGP--LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 115 QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL 173
+ + Q+ G+E+ +HRDL N+LL K VKI DFGL+ +I +D ++
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205
Query: 174 KTSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILY 208
+ P + APE I ++Y + DVWS GV+L+
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLW 241
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 73/280 (26%), Positives = 115/280 (41%), Gaps = 44/280 (15%)
Query: 20 KLGKTLGIGSFGKVKIAEHALTGHK--VAIKILNRRKIKNMEMEEKVR---REIKILRLF 74
K +G G+FG+V A G + AIK + K ++ R E+++L
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-----KEYASKDDHRDFAGELEVLCKL 82
Query: 75 M-HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN------------ 121
HP+II L E +Y+ +EY G L D++ + L+ D A
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 122 ----FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC 177
F + G++Y + +HRDL N+L+ + KIADFGLS R
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS---RGQEVYVKKT 199
Query: 178 GS--P-NYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGI 233
P + A E ++ +Y DVWS GV+L+ ++ G P+ L++K+ G
Sbjct: 200 MGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 257
Query: 234 YTL--PSHLSPGARDLIPRMLI---VDPMKRITIPEIRQH 268
Y L P + DL M P +R + +I
Sbjct: 258 YRLEKPLNCDDEVYDL---MRQCWREKPYERPSFAQILVS 294
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 72/282 (25%), Positives = 129/282 (45%), Gaps = 40/282 (14%)
Query: 20 KLGKTLGIGSFGKVKIAE-------HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
LGK LG G+FG+V +AE VA+K+L + + + E+++++
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEMEMMK 95
Query: 73 LFM-HPHIIRLYEVIETPSDIYVVMEYVKSGELFDY----------------IVEKGRLQ 115
+ H +II L +YV++EY G L +Y V + ++
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 116 EDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLK 174
+ + Q+ G+EY +HRDL N+L+ +KIADFGL+ +I ++ K
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 175 TSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKG 231
T+ G P + APE + ++Y + DVWS GV+++ + G P+ + LFK +K
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 232 GIYTL--PSHLSPGARDLIPRMLI---VDPMKRITIPEIRQH 268
G + + P++ + + M P +R T ++ +
Sbjct: 275 G-HRMDKPANCTNELYMM---MRDCWHAVPSQRPTFKQLVED 312
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 75/282 (26%), Positives = 128/282 (45%), Gaps = 40/282 (14%)
Query: 20 KLGKTLGIGSFGKVKIAE-------HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
LGK LG G+FG+V +AE KVA+K+L + + E+++++
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK--SDATEKDLSDLISEMEMMK 129
Query: 73 LFM-HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN---------- 121
+ H +II L +YV++EY G L +Y+ + + + N
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 122 ------FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLK 174
Q+ G+EY +HRDL N+L+ +KIADFGL+ +I ++ K
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 175 TSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKG 231
T+ G P + APE + ++Y + DVWS GV+L+ + G P+ + LFK +K
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 308
Query: 232 GIYTL--PSHLSPGARDLIPRMLI---VDPMKRITIPEIRQH 268
G + + PS+ + + M P +R T ++ +
Sbjct: 309 G-HRMDKPSNCTNELYMM---MRDCWHAVPSQRPTFKQLVED 346
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 20 KLGKTLGIGSFGKVKIAE-HALTGH----KVAIKILNRRKIKNMEMEEK-VRREIKILRL 73
+ GK LG G+FGKV A + ++ +VA+K+L K K E + + E+K++
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML---KEKADSSEREALMSELKMMTQ 104
Query: 74 FM-HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQ-------- 124
H +I+ L IY++ EY G+L +Y+ K ++ +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 125 ---------------QIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMR 168
Q+ G+E+ VHRDL N+L+ VKI DFGL+ +IM
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 169 DGHFLKTSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILY 208
D +++ P + APE + +Y + DVWS G++L+
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLW 265
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 29/243 (11%)
Query: 20 KLGKTLGIGSFGKV-----KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
+ + LG FGKV VAIK L + + E+ R E +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAMLRARL 69
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN------------- 121
HP+++ L V+ + ++ Y G+L +++V + + + +
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 122 ---FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSC 177
QI +G+EY + VVH+DL N+L+ K NVKI+D GL + ++
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 178 GS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIY 234
P + APE I ++ + D+WS GV+L+ + G P+ + ++ + I+
Sbjct: 190 SLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR-Q 247
Query: 235 TLP 237
LP
Sbjct: 248 VLP 250
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 66/287 (22%), Positives = 117/287 (40%), Gaps = 45/287 (15%)
Query: 20 KLGKTLGIGSFGKVKIAE-HALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLF 74
+ + +G G+FG+V A L ++ VA+K+L ++ + +M+ +RE ++ F
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEF 107
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARN------------- 121
+P+I++L V + ++ EY+ G+L +++ +
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 122 -----------FFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRD 169
+Q+ +G+ Y VHRDL N L+ VKIADFGLS NI
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 170 GHFLKTSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLF 226
++ + P + PE I Y E DVW+ GV+L+ + G P+ +
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI 286
Query: 227 KKIKGGIYTL--PSHLSPGARDLIPRML---IVDPMKRITIPEIRQH 268
++ G L P + +L M P R + I +
Sbjct: 287 YYVRDG-NILACPENCPLELYNL---MRLCWSKLPADRPSFCSIHRI 329
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 42/223 (18%)
Query: 25 LGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIR 81
+G G FGKV + + G KVA+K ++ + E+ EI+ L HPH++
Sbjct: 47 IGHGVFGKVYKGVLRD----GAKVALKRRTP---ESSQGIEEFETEIETLSFCRHPHLVS 99
Query: 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKG----------RLQ--EDEARNFFQQIISG 129
L + +++ ++ +Y+++G L ++ RL+ AR G
Sbjct: 100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR--------G 151
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPE 186
+ Y H ++HRD+K N+LLD + KI DFG+S + H G+ Y PE
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPE 211
Query: 187 -VISGKLYAGPEVDVWSCGVILYALLCG------TLPFDDENI 222
I G+L + DV+S GV+L+ +LC +LP + N+
Sbjct: 212 YFIKGRLTE--KSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 35/213 (16%)
Query: 25 LGIGSFGKV-KIAEHALTGHKVAIKILNRRKIKN-MEMEEKVRREIKILRLFMHPHIIRL 82
+G G FG V K + VA+K L E++++ +EIK++ H +++ L
Sbjct: 39 MGEGGFGVVYK---GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQ-----------EDEARNFFQQIISGVE 131
D+ +V Y+ +G L D + + A G+
Sbjct: 96 LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN--------GIN 147
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS------CGSPNYAAP 185
+ H N +HRD+K N+LLD + KI+DFGL+ R + G+ Y AP
Sbjct: 148 FLHENHHIHRDIKSANILLDEAFTAKISDFGLA---RASEKFAQTVMTSRIVGTTAYMAP 204
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPFD 218
E + G++ + D++S GV+L ++ G D
Sbjct: 205 EALRGEITP--KSDIYSFGVVLLEIITGLPAVD 235
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 55/270 (20%), Positives = 94/270 (34%), Gaps = 72/270 (26%)
Query: 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
D+F Y + + LG G F V ++ VA+K++ + E EI++L+
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLK 88
Query: 73 LFM-----HP---HIIRLYE--VIETPSDIYVVMEYVKSGE-LFDYIV--EKGRLQEDEA 119
P +++L + I + ++ M + G L +I+ L
Sbjct: 89 SVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCV 148
Query: 120 RNFFQQIISGVEYCHRNM-VVHRDLKPENLLL---------------------------- 150
+ QQ++ G++Y H ++H D+KPEN+LL
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 151 ---------------------DSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-YAAPEVI 188
K VKIAD G + + T Y + EV+
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---TEDIQTRQYRSLEVL 265
Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFD 218
G Y D+WS + + L G F+
Sbjct: 266 IGSGY-NTPADIWSTACMAFELATGDYLFE 294
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 31/228 (13%)
Query: 13 DMFLPNYKLGKTLGIGSFGKV---KIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIK 69
D F LG+ G FGKV ++A G VA+K L + + E++ + E++
Sbjct: 30 DNFSNKNILGR----GGFGKVYKGRLA----DGTLVAVKRLKEERTQGGELQFQT--EVE 79
Query: 70 ILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQED---EARNFFQQI 126
++ + +H +++RL TP++ +V Y+ +G + + E+ Q R Q+I
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR---QRI 136
Query: 127 ISGV----EYCHRNM---VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSC 177
G Y H + ++HRD+K N+LLD ++ + DFGL+ +M H
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 178 GSPNYAAPE-VISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN 224
G+ + APE + +GK + DV+ GV+L L+ G FD + N
Sbjct: 197 GTIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAFDLARLAN 242
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 32/228 (14%)
Query: 9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREI 68
S GV M PN+++GK +G G+FG++++ ++ T VAIK+ + E
Sbjct: 1 SMGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLH-----LEY 55
Query: 69 KILRLFMH-PHIIRLYEVIETPSDIYVVMEYV-KSGE-LFDYIVEKGRLQEDEARNFFQQ 125
+ + I ++Y +V+E + S E LFD Q
Sbjct: 56 RFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDL--CDRTFSLKTVLMIAIQ 113
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWN-----VKIADFGLSNIMRDG----HFL--- 173
+IS +EY H +++RD+KPEN L+ N + I DF L+ D H
Sbjct: 114 LISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173
Query: 174 -KTSCGSPNYAAPEVISGKLYAGPEV----DVWSCGVILYALLCGTLP 216
K+ G+ Y + I+ L G E D+ + G + L G+LP
Sbjct: 174 HKSLTGTARYMS---INTHL--GKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 53/228 (23%), Positives = 96/228 (42%), Gaps = 32/228 (14%)
Query: 9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREI 68
S ++ +YK+G+ +G GSFG + + L +VAIK R+ ++ R E
Sbjct: 2 SGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQL----RDEY 56
Query: 69 KILRLFMH-PHIIRLYEVIETPSDIYVVMEYV-KS-GELFDYIVEKGRLQEDEARNFFQQ 125
+ +L I +Y + +V++ + S +L D + +Q
Sbjct: 57 RTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQ 114
Query: 126 IISGVEYCHRNMVVHRDLKPENLLLDSKWN-----VKIADFGLSNIMRDG----HFL--- 173
+++ V+ H +V+RD+KP+N L+ + + + DFG+ RD H
Sbjct: 115 MLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 174
Query: 174 -KTSCGSPNYAAPEVISGKLYAGPEV----DVWSCGVILYALLCGTLP 216
K G+ Y + I+ L G E D+ + G + L G+LP
Sbjct: 175 KKNLSGTARYMS---INTHL--GREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 51/238 (21%), Positives = 85/238 (35%), Gaps = 45/238 (18%)
Query: 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
DM + LGK +G G FG + +A K A ++ +N + E+K +
Sbjct: 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF----SELKFYQ 88
Query: 73 LFMHPHIIRLYEVIETPSDI-------------------YVVMEYV-KSGELFDYIVEKG 112
I+ + + + ++VME + L + G
Sbjct: 89 RVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID--LQKISGQNG 146
Query: 113 RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI--ADFGLSNIMRDG 170
++ +++ +EY H N VH D+K NLLL K ++ AD+GLS
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206
Query: 171 ----HFL----KTSCGSPNYAAPEVISGKLYAGPEV----DVWSCGVILYALLCGTLP 216
+ K G+ + S + G + DV G + LCG LP
Sbjct: 207 GNHKQYQENPRKGHNGTIEFT-----SLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 6e-16
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM- 75
++LG+ +G GSFG++ + + T +VAIK+ N + + E KI R+
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----LLYESKIYRILQG 61
Query: 76 HPHIIRLYEVIETPSDIYVVMEYV-KS-GELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
I + +VM+ + S +LF++ +L Q+I+ VE+
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFV 119
Query: 134 HRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFL--------KTSCGSPNY 182
H +HRD+KP+N L+ V I DFGL+ RD K G+ Y
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 183 AAPEVISGKLYAGPEV----DVWSCGVILYALLCGTLP 216
A+ ++ L G E D+ S G +L L G+LP
Sbjct: 180 AS---VNTHL--GIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 13/159 (8%)
Query: 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
Y+LG+ +G GSFG + + G +VAIK+ K K+ ++ E KI ++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQL----HIESKIYKMMQG 63
Query: 77 -PHIIRLYEVIETPSDIYVVMEYV-KS-GELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
I + +VME + S +LF++ + Q+IS +EY
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYI 121
Query: 134 HRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRD 169
H +HRD+KP+N L+ V I DFGL+ RD
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 75.7 bits (185), Expect = 3e-15
Identities = 35/228 (15%), Positives = 65/228 (28%), Gaps = 49/228 (21%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME-----EKVRREIKILR 72
+ + +G G FG+V VAIKI+ + E++ EI I +
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 73 LF---------MHPHIIRLYEV------------------------------IETPSDIY 93
I L V ++
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM-VVHRDLKPENLLLDS 152
+V+E+ G + + K A++ Q+ + + ++ HRDL N+LL
Sbjct: 139 IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 153 KWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVD 199
K+ L+ S + E ++ +D
Sbjct: 198 TSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMD 245
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 45/245 (18%), Positives = 82/245 (33%), Gaps = 56/245 (22%)
Query: 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
DM +K+G +G G FG + +A+ + V K++ + + E+K +
Sbjct: 31 DMAAAAWKVGLPIGQGGFGCIYLADM-NSSESVGSDAPCVVKVEPSD-NGPLFTELKFYQ 88
Query: 73 LFMHPHIIRLYEVIETPSDI-------------------YVVMEYV-KSGELFDYIVEKG 112
P I+ + + +++M+ L
Sbjct: 89 RAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSD--LQKIYEANA 146
Query: 113 R-------LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN--VKIADFGL 163
+ LQ +I+ +EY H + VH D+K NLLL+ K V + D+GL
Sbjct: 147 KRFSRKTVLQ------LSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGL 200
Query: 164 SNIMRDG----HFL----KTSCGSPNYAAPEVISGKLYAGPEV----DVWSCGVILYALL 211
+ + + G+ + S + G D+ G + L
Sbjct: 201 AYRYCPEGVHKAYAADPKRCHDGTIEFT-----SIDAHNGVAPSRRGDLEILGYCMIQWL 255
Query: 212 CGTLP 216
G LP
Sbjct: 256 TGHLP 260
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 32/237 (13%), Positives = 76/237 (32%), Gaps = 40/237 (16%)
Query: 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
D +KL + G + A T + + +K + ++ E +
Sbjct: 38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQ 97
Query: 73 LFMHPHIIRLYEVIETPSDIYV--VMEYVKSGELFDYIV--------EKGRLQEDEARNF 122
P + ++ + + + + M + + + ++V + + ++
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQS--ALDVSPKHV 155
Query: 123 F---------QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI--ADFGLSNIMRDGH 171
+++ +E+ H N VH ++ EN+ +D + ++ A +G +
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 172 --------FLKTSCGSPNYAAPEVISGKLYAGPEV----DVWSCGVILYALLCGTLP 216
G + S L+ G D+ S G + L G LP
Sbjct: 216 KHVAYVEGSRSPHEGDLEFI-----SMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 15/174 (8%)
Query: 105 FDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164
+ K L + + Q+ G+E+ +HRDL N+LL K VKI DFGL+
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
Query: 165 -NIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDD- 219
+I +D +++ P + APE I ++Y + DVWS GV+L+ + G P+
Sbjct: 241 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGV 299
Query: 220 ENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI---VDPMKRITIPEIRQH 268
+ +++K G + P + +P ML +P +R T E+ +H
Sbjct: 300 KIDEEFCRRLKEG-TRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVEH 349
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 37/159 (23%), Positives = 62/159 (38%), Gaps = 21/159 (13%)
Query: 20 KLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
KLGK LG G+FG+V A+ T VA+K+L ++ + E+KIL
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHI 82
Query: 75 M-HPHIIRLY-EVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
H +++ L + + V++E+ K G L Y+ K RN F +
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK--------RNEFVPYKTKGAR 134
Query: 133 CHRNMV----VHRDLKPENLLLDSKWNVKIADFGLSNIM 167
+ + DLK + S + + F +
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 5e-08
Identities = 84/578 (14%), Positives = 166/578 (28%), Gaps = 169/578 (29%)
Query: 6 NRSSSGVDMFL-----PNYK-LGKTLGIGSFGKVKIAEHALTGHKV---AIKILNRRKIK 56
++ V F+ NYK L + + + ++ + +
Sbjct: 73 SKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS 132
Query: 57 NMEMEEKVRREIKILR----LFMH-----------PHIIRLYEVIET-PSDIYVVMEYVK 100
++ K+R+ + LR + + + Y+V I+ ++
Sbjct: 133 RLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF----WLN 188
Query: 101 SGE-------------LFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPEN 147
L I + D + N +I S R ++ +
Sbjct: 189 LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL-RRLLKSKPY-ENC 246
Query: 148 LL-LDSKWNVKIAD-FGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGV 205
LL L + N K + F LS K + + +S +D S
Sbjct: 247 LLVLLNVQNAKAWNAFNLS--------CKILLTTRFKQVTDFLSAATTTHISLDHHSMT- 297
Query: 206 ILYALLCGTLPFDDENIPNLF-KKIKGGIYTLPS---HLSPGARDLIPRMLIVDPM---- 257
+ + +L K + LP +P +I +
Sbjct: 298 -----------LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDN 346
Query: 258 -KRITIPEIR---------QHPWFQAHLPRYLAVPPPDTMQQAKKIDEEIL--------K 299
K + ++ P + L+V PP I +L K
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA-----HIPTILLSLIWFDVIK 401
Query: 300 EVVKMGFDQNQLVE-SLRNRLQNEATVAYY-LLLDNRFRVSSGYLGAEFQETMESGFNRL 357
V + N+L + SL + E+T++ + L+ + ++ + Y L
Sbjct: 402 SDVMV--VVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEY--------------AL 445
Query: 358 HP--IE----PAVSPVAHRAPGFMD---YQGMG--LRGQLPYERKWALGLQSRAHPREIM 406
H ++ P P ++D Y +G L+ ER +
Sbjct: 446 HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERM------------TLF 493
Query: 407 TEVLKALQELNVGW--KKIGHYNMKCRWIPGISGHHEGMVNNPLHS-NHYFGDESAIIEN 463
V L+ + +KI H + + G + N L Y + I +N
Sbjct: 494 RMVF-----LDFRFLEQKIRH--------DSTAWNASGSILNTLQQLKFY---KPYICDN 537
Query: 464 DG----VVKS--PNVVKFEVQLYKTRDEKYLLDLQRVQ 495
D +V + + K E L ++ DL ++
Sbjct: 538 DPKYERLVNAILDFLPKIEENLICSKY----TDL--LR 569
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 6e-04
Identities = 32/273 (11%), Positives = 71/273 (26%), Gaps = 96/273 (35%)
Query: 291 KKIDEEILKEVVKMGFDQNQLVESLRNRLQNE-----------ATVAYYL---LLDN--- 333
K I V FD + + ++ L E + L LL
Sbjct: 19 KDILSVFEDAFVD-NFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEE 77
Query: 334 ---RF-----RVSSGYLGAEFQ----------ETMESGFNRLHPIEPAVSP--VAHRAPG 373
+F R++ +L + + +RL+ + V+ R
Sbjct: 78 MVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS-RLQP 136
Query: 374 FMDYQ---------------GMGLRGQLPYERKWALGLQS-RAHPREIMTEVLKALQELN 417
++ + G+ G K + L ++ + +
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGSG------KTWVALDVCLSYKVQCK-------MDFK 183
Query: 418 VGWKKIGHYN-----MK-----CRWI-PGISGHHEGMVNNPLHSN-------HYFGDE-- 457
+ W + + N ++ I P + + N L + +
Sbjct: 184 IFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243
Query: 458 --SAIIENDGVVKSPNVVK-FEVQ---LYKTRD 484
++ + V++ F + L TR
Sbjct: 244 ENCLLVLLN--VQNAKAWNAFNLSCKILLTTRF 274
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} PDB: 1ul7_A Length = 120 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 2e-06
Identities = 18/123 (14%), Positives = 44/123 (35%), Gaps = 33/123 (26%)
Query: 392 WALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSN 451
W++ S P ++M E+ K L N +++ + + C
Sbjct: 29 WSMKTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVH------------------- 69
Query: 452 HYFGDESAIIENDGVVKSPNVVKFEVQLYK-TRDEKYLLDLQRVQGPQFLFLDLCAAFLA 510
G + ++V++E+++ K R + +R+ G F ++ +
Sbjct: 70 -------------GDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASKIAN 116
Query: 511 QLR 513
+L+
Sbjct: 117 ELK 119
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 515 | |||
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 100.0 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 100.0 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 100.0 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 99.84 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.43 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.15 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.03 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.8 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.62 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.61 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.43 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.36 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.33 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.14 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.07 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.8 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.76 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.44 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.41 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.35 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.3 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.26 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.2 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.18 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.07 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.9 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.85 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.8 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.28 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 96.23 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 95.38 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.36 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.72 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.37 |
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-88 Score=724.80 Aligned_cols=455 Identities=51% Similarity=0.898 Sum_probs=347.2
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
......++|.+++.||+|+||+||+|.+..+|+.||||++.+......+....+.+|+.+++.++||||+++++++.+.+
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 34456799999999999999999999999999999999998765444345678999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.+|+||||++||+|.+++.+++.+++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.....+
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999988877
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcc
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 250 (515)
....+.+||+.|+|||++.+..+.++++|||||||++|+|++|..||.+.+...+..++..+.+..|..+++++.+||.+
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 249 (476)
T 2y94_A 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKH 249 (476)
T ss_dssp CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHH
T ss_pred ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHH
Confidence 77888999999999999999887788999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCHHHHhcCcccccccCcccCCCCCCchhhhhccCHHHHHHHH-HcCCCHHHHHHHHHhc-ccChhHHHHH
Q 010214 251 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESLRNR-LQNEATVAYY 328 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~-~~~~~~~~y~ 328 (515)
||+.||.+|||+.|+++||||+...+.++....+ ......++++.++++. +++++.+++.++|.+. ..+..+++|+
T Consensus 250 ~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~y~ 327 (476)
T 2y94_A 250 MLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDP--SYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYH 327 (476)
T ss_dssp HTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSS--CSSCSHHHHHHHHSCCCC--------------------------
T ss_pred HcCCCchhCcCHHHHHhCHHhhhcCccccCCCCc--ccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHHHHHH
Confidence 9999999999999999999999887766543221 1223345566666654 6788888999888775 5788999999
Q ss_pred HHhhcccccccc---chhhhHHHh-hh-hccCCCCCCCCCC--CCCCC---CCCCcccccccCCCCCCCCCCceeEeecc
Q 010214 329 LLLDNRFRVSSG---YLGAEFQET-ME-SGFNRLHPIEPAV--SPVAH---RAPGFMDYQGMGLRGQLPYERKWALGLQS 398 (515)
Q Consensus 329 ll~~~~~~~~~~---~~~~~~~~~-~~-~~~~~~~~~~~~~--~~~~~---~~~~~~~~~~~~~~~~~~~~~~w~lgi~s 398 (515)
+++++++..... +........ .+ ......+|...++ +..|. +.++. ......+..++++||||||||
T Consensus 328 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~w~lgi~s 404 (476)
T 2y94_A 328 LIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDEL---NPQKSKHQGVRKAKWHLGIRS 404 (476)
T ss_dssp -----CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCTTT---SSSTTTCSCCCCCCEEESEEE
T ss_pred HHHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCccccccccc---ccccccccccccceeeecCcc
Confidence 999998753321 111111110 00 0111111111000 00110 11111 111233445789999999999
Q ss_pred cCCHHHHHHHHHHHHHhcCcEEEEecceeEEEEeecCCCCCCCCccCCCCCCCCCCCCcccccccCCccCCCceEEEEEE
Q 010214 399 RAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQ 478 (515)
Q Consensus 399 ~~~p~~im~ev~~~l~~l~~~wk~~~~y~~kcr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~lQ 478 (515)
|++|.|||+||||||++||++||++++|+|+|||+++.+ ++.+||+||
T Consensus 405 ~~~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~--------------------------------~~~~k~~lq 452 (476)
T 2y94_A 405 QSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVT--------------------------------STFSKMSLQ 452 (476)
T ss_dssp CSCHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTT--------------------------------CCEEEEEEE
T ss_pred CCCHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCC--------------------------------CceEEEEEE
Confidence 999999999999999999999999999999999997532 458999999
Q ss_pred EeeecCCceeEEeecccCCceehH
Q 010214 479 LYKTRDEKYLLDLQRVQGPQFLFL 502 (515)
Q Consensus 479 Lyk~~~~~yllDf~~~~g~~~~f~ 502 (515)
|||+++++||||||+++|++|+||
T Consensus 453 ly~~~~~~~llDf~~~~~~~~~~~ 476 (476)
T 2y94_A 453 LYQVDSRTYLLDFRSIDDEILEVL 476 (476)
T ss_dssp EEECSSSCEEEEEEEECCC-----
T ss_pred EEEecCCcEEEEeeecCCCccccC
Confidence 999999999999999999999996
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-68 Score=526.81 Aligned_cols=264 Identities=67% Similarity=1.154 Sum_probs=229.8
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
.+++|++.+.||+|+||+||+|.++.+|+.||||++++..........++.+|+++|++++|||||++++++++++.+|+
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46899999999999999999999999999999999998776666667889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
||||| +|+|.+++.+++++++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+...+.....
T Consensus 91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~ 169 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK 169 (275)
T ss_dssp EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccC
Confidence 99999 67999999999999999999999999999999999999999999999999999999999999999887777778
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCC
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~ 254 (515)
+.+||+.|||||++.+..|.++++||||+||++|+|+||+.||.+.+...+++.+..+.+.+|..+|+++++||.+||++
T Consensus 170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 249 (275)
T 3hyh_A 170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIV 249 (275)
T ss_dssp -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCS
T ss_pred CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccC
Confidence 89999999999999999887899999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHhcCcccccccCccc
Q 010214 255 DPMKRITIPEIRQHPWFQAHLPRYL 279 (515)
Q Consensus 255 dP~~Rpt~~eil~hp~f~~~~~~~~ 279 (515)
||.+|||++|+++||||+..+|.++
T Consensus 250 dP~~R~s~~eil~hpw~k~~~p~~L 274 (275)
T 3hyh_A 250 NPLNRISIHEIMQDDWFKVDLPEYL 274 (275)
T ss_dssp SGGGSCCHHHHHHCHHHHTTCCGGG
T ss_pred ChhHCcCHHHHHcCcccccCCChhh
Confidence 9999999999999999998877764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-67 Score=526.87 Aligned_cols=258 Identities=34% Similarity=0.633 Sum_probs=242.3
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++++.||+|+||+||+|+++.||+.||||++++....+....+.+.+|+++|+.++|||||++++++++++.+|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46799999999999999999999999999999999876655445568899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC---Cc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HF 172 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~---~~ 172 (515)
||||+||+|.++|.+.+.++|.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+... ..
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~ 190 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCC
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999877532 34
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccC
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 252 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL 252 (515)
..+.|||+.|||||++.+..| +.++|||||||++|+|+||.+||.+.+..+++.+|..+.+.+|..+|+++++||.+||
T Consensus 191 ~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~lL 269 (311)
T 4aw0_A 191 ANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLL 269 (311)
T ss_dssp BCCCCSCGGGCCHHHHHHSCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHHS
T ss_pred ccCcccCcccCCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHHc
Confidence 567899999999999998887 7899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHH------HhcCcccccc
Q 010214 253 IVDPMKRITIPE------IRQHPWFQAH 274 (515)
Q Consensus 253 ~~dP~~Rpt~~e------il~hp~f~~~ 274 (515)
++||.+|||++| |++||||+..
T Consensus 270 ~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 270 VLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp CSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred cCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 999999999987 6899999865
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-64 Score=515.82 Aligned_cols=260 Identities=28% Similarity=0.555 Sum_probs=232.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++++.||+|+||+||+|+++.+|+.||||++.+..... ...+.+.+|+++|++++|||||++++++++++.+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 479999999999999999999999999999999998776543 4568899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-c
Q 010214 96 MEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-F 172 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~ 172 (515)
||||+||+|.++|...+ .++|.+++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+...... .
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 99999999999997643 57999999999999999999999999999999999999999999999999998875543 3
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-CCCCCCChhHHHHhccc
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRM 251 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~m 251 (515)
..+.+||+.|||||++.+..| +.++|||||||++|+|+||..||.+.+..+++.+|..+.+ ..+..+|+++++||.+|
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~ 260 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPY-NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL 260 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccCCCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHH
Confidence 456789999999999999887 7899999999999999999999999999999999988765 56778999999999999
Q ss_pred CCCCCCCCCCHHHHhcCcccccccCc
Q 010214 252 LIVDPMKRITIPEIRQHPWFQAHLPR 277 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~hp~f~~~~~~ 277 (515)
|++||.+|||++|+++||||+.....
T Consensus 261 L~~dP~~R~s~~e~l~hp~~~~~~~~ 286 (350)
T 4b9d_A 261 FKRNPRDRPSVNSILEKGFIAKRIEK 286 (350)
T ss_dssp TCSSGGGSCCHHHHHTSHHHHTTGGG
T ss_pred ccCChhHCcCHHHHhcCHHhhcCCCc
Confidence 99999999999999999999876443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-63 Score=509.38 Aligned_cols=255 Identities=29% Similarity=0.508 Sum_probs=233.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
...|++.+.||+|+||+||+|.++.||+.||||++++..... .+.+.+|+.+|+.++|||||++++++++++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999999999999999998665443 35678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~~~ 174 (515)
||||+||+|.+++.+ +++++.+++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.... .....
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence 999999999998864 6799999999999999999999999999999999999999999999999999987754 34567
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---CCCCCCChhHHHHhccc
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGARDLIPRM 251 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~m 251 (515)
+.|||+.|||||++.+..| +.++|||||||++|+|++|.+||.+.+..+.+..|..... ..+..+|+++++||.+|
T Consensus 229 ~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 307 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 307 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred ccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence 8899999999999998888 7999999999999999999999999998888888877643 33457899999999999
Q ss_pred CCCCCCCCCCHHHHhcCccccccc
Q 010214 252 LIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
|++||.+|||++|+++||||++..
T Consensus 308 L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 308 LVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred cCCChhHCcCHHHHhcCHhhcCCC
Confidence 999999999999999999998753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-64 Score=505.46 Aligned_cols=256 Identities=30% Similarity=0.565 Sum_probs=229.7
Q ss_pred CCceEeeeecccCceEEEEEEEc---CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
++|++++.||+|+||+||+|++. .+++.||||++++....... ..++.+|+++|++++|||||++++++++++.+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 57999999999999999999984 46889999999876543322 346788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~ 172 (515)
+|||||+||+|.++|.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+...+ ...
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 182 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 182 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CC
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCcc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999986543 345
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccC
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 252 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL 252 (515)
..+.+||+.|||||++.+..| +.++|||||||++|+|+||..||.+.+..++..+|..+.+.+|..+|+++++||.+||
T Consensus 183 ~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 261 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLF 261 (304)
T ss_dssp CCSCCCCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccccCcccCCHHHhccCCC-CCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHc
Confidence 567899999999999999887 7899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCC-----HHHHhcCcccccc
Q 010214 253 IVDPMKRIT-----IPEIRQHPWFQAH 274 (515)
Q Consensus 253 ~~dP~~Rpt-----~~eil~hp~f~~~ 274 (515)
++||.+||| ++|+++||||+..
T Consensus 262 ~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 262 KRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp CSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred ccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 999999998 5799999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-62 Score=510.01 Aligned_cols=254 Identities=29% Similarity=0.520 Sum_probs=233.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
...|++.+.||+|+||+||+|.++.||+.||||++++..... .+.+.+|+.+|+.++|||||++++++++++.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 367999999999999999999999999999999998665433 35688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~~~ 174 (515)
||||+||+|.+++. .+++++.+++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|..+.. .....
T Consensus 227 mEy~~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 305 (423)
T 4fie_A 227 MEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 305 (423)
T ss_dssp EECCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred EeCCCCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence 99999999999886 56799999999999999999999999999999999999999999999999999987654 34567
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc---cCCCCCCChhHHHHhccc
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~m 251 (515)
+.|||+.|||||++.+..| +.++|||||||++|+|++|..||.+.+..+.+..|.... ...+..+|+++++||.+|
T Consensus 306 ~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 384 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 384 (423)
T ss_dssp CCEECTTTCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHH
T ss_pred ccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHH
Confidence 8899999999999999888 799999999999999999999999999888888887764 334567899999999999
Q ss_pred CCCCCCCCCCHHHHhcCcccccc
Q 010214 252 LIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|++||.+|||+.|+|+||||+..
T Consensus 385 L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 385 LVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGC
T ss_pred cCCChhHCcCHHHHhcCHHhcCC
Confidence 99999999999999999999865
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-61 Score=485.43 Aligned_cols=253 Identities=26% Similarity=0.517 Sum_probs=224.7
Q ss_pred CCc-eEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc----CCe
Q 010214 17 PNY-KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----PSD 91 (515)
Q Consensus 17 ~~Y-~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----~~~ 91 (515)
++| ++.+.||+|+||+||+|.++.++..||+|++.+..... ...+.+.+|+++|++++|||||++++++++ +..
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 455 78889999999999999999999999999998765443 456789999999999999999999999875 356
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECC-CCceEEeecccccccc
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDS-KWNVKIADFGLSNIMR 168 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDLkpeNILl~~-~~~vKL~DFGls~~~~ 168 (515)
+|||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++. +|.+||+|||+|+..
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~- 182 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK- 182 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC-
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC-
Confidence 8999999999999999999999999999999999999999999998 999999999999984 789999999999764
Q ss_pred cCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC-ChHHHHHHHhcCcc--CCCCCCChhHH
Q 010214 169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIY--TLPSHLSPGAR 245 (515)
Q Consensus 169 ~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~s~~~~ 245 (515)
......+.+|||.|||||++.+. | +.++|||||||++|+|+||..||.+. +...+...+..+.. .++...+++++
T Consensus 183 ~~~~~~~~~GTp~YmAPE~~~~~-y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 260 (290)
T 3fpq_A 183 RASFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260 (290)
T ss_dssp CTTSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred CCCccCCcccCccccCHHHcCCC-C-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHH
Confidence 34456788999999999999864 5 79999999999999999999999764 45566777776643 34567899999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
+||.+||+.||.+|||++|+++||||++
T Consensus 261 ~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 261 EIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHccCChhHCcCHHHHhcCccccC
Confidence 9999999999999999999999999975
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-60 Score=486.04 Aligned_cols=325 Identities=44% Similarity=0.773 Sum_probs=286.5
Q ss_pred CCCCCCCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEE
Q 010214 5 SNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84 (515)
Q Consensus 5 ~~~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~ 84 (515)
+-.+.+......++|++.+.||+|+||+||+|.+..+|+.||||++.+... .....+++.+|+++|+.++||||+++++
T Consensus 3 s~~s~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~ 81 (328)
T 3fe3_A 3 SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFE 81 (328)
T ss_dssp --------CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 334556667778999999999999999999999999999999999987654 3355678899999999999999999999
Q ss_pred EEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccc
Q 010214 85 VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 85 ~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
++.+.+.+|+||||++||+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||++
T Consensus 82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 161 (328)
T 3fe3_A 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS 161 (328)
T ss_dssp EEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCC
T ss_pred EEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhH
Q 010214 165 NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGA 244 (515)
Q Consensus 165 ~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 244 (515)
.....+....+.+||+.|+|||++.+..+.++++||||+||++|+|++|..||.+.+...+...+..+.+.+|..+++++
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 241 (328)
T 3fe3_A 162 NEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDC 241 (328)
T ss_dssp GGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred eecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Confidence 98877777788899999999999999888778999999999999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcCcccccccCcccCCCCCCchhhhhccCHHHHHHHHHcCCCHHHHHHHHHhcccChhH
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLRNRLQNEAT 324 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 324 (515)
.+||.+||+.||.+|||++|+++||||+.........| .........++..+..+..+|++.+++.+.|.+...++.+
T Consensus 242 ~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 319 (328)
T 3fe3_A 242 ENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKP--FVEPELDISDQKRIDIMVGMGYSQEEIQESLSKMKYDEIT 319 (328)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTTCCCCC--CCCCCCCCCCHHHHHHHHHTTCCHHHHHHHHHTTCCSHHH
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcccccCc--ccCCCcCcccHHHHHHHHHCCCCHHHHHHHHHcCCCCHHH
Confidence 99999999999999999999999999986532211111 1111123346777888889999999999999999999999
Q ss_pred HHHHHHhh
Q 010214 325 VAYYLLLD 332 (515)
Q Consensus 325 ~~y~ll~~ 332 (515)
.+|+||.+
T Consensus 320 ~~y~ll~~ 327 (328)
T 3fe3_A 320 ATYLLLGR 327 (328)
T ss_dssp HHHHHHTC
T ss_pred HHHHHhcC
Confidence 99998864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-61 Score=491.40 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=225.4
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.+.|++.+.||+|+||+||+|+++.+|+.||||+++++... .+|+.+|+.++|||||++++++++++.+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46799999999999999999999999999999999865433 4799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-ceEEeecccccccccCCc--
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHF-- 172 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~-~vKL~DFGls~~~~~~~~-- 172 (515)
||||+||+|.++|.+.+.+++.+++.++.||+.||+|||++||+||||||+||||+.+| ++||+|||+|+.......
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999999999999999999999999999999999999999999999999999999987 699999999987754322
Q ss_pred ----cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---CCCCCCChhHH
Q 010214 173 ----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGAR 245 (515)
Q Consensus 173 ----~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~ 245 (515)
..+.+||+.|||||++.+..| +.++|||||||++|+|+||.+||.+.+...+..+|..... .+|+.+|++++
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 287 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred ceecCCccccCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence 234689999999999999887 7899999999999999999999999888777888877654 46789999999
Q ss_pred HHhcccCCCCCCCCCCHHHH-------------hcCcccccc
Q 010214 246 DLIPRMLIVDPMKRITIPEI-------------RQHPWFQAH 274 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~ei-------------l~hp~f~~~ 274 (515)
+||.+||++||.+|||+.|+ ++|||+++.
T Consensus 288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 99999999999999999997 579998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-60 Score=486.39 Aligned_cols=320 Identities=60% Similarity=1.021 Sum_probs=289.9
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
...+++|++.+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 34578999999999999999999999999999999999765443333446789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
|+||||+ +|+|.+++.+.+++++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....+..
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 9999999 679999999999999999999999999999999999999999999999999999999999999998888888
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccC
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 252 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL 252 (515)
..+.+||+.|+|||++.+..+.++++|||||||++|+|++|..||++.....+..++..+.+.+|..+|+++.+||.+||
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 243 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMI 243 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTS
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHc
Confidence 88899999999999999988878899999999999999999999999888888888888888899999999999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccccCcccCCCCCCchhhhhccCHHHHHHHH-HcCCCHHHHHHHHHhcccChhHHHHHHHh
Q 010214 253 IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESLRNRLQNEATVAYYLLL 331 (515)
Q Consensus 253 ~~dP~~Rpt~~eil~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~~y~ll~ 331 (515)
+.||.+|||++|+++||||+...+.+..+... ......+..++..+. .+|++.+.+.++|.++..++.+.+|+||.
T Consensus 244 ~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~y~ll~ 320 (336)
T 3h4j_B 244 VADPMQRITIQEIRRDPWFNVNLPDYLRPMEE---VQGSYADSRIVSKLGEAMGFSEDYIVEALRSDENNEVKEAYNLLH 320 (336)
T ss_dssp CSSGGGSCCHHHHTTCHHHHTTCCGGGSCCCC---CCCCCCCHHHHHHHHHTTCCCHHHHHHHTTSSSCCSSTTHHHHHH
T ss_pred CCChhHCcCHHHHHhChhhccCCccccCCchh---cccccCCHHHHHHHHHHcCCCHHHHHHHHhcCCCCHHHHHHHHHH
Confidence 99999999999999999999887776553322 223456777877774 68999999999999999999999999999
Q ss_pred hcccc
Q 010214 332 DNRFR 336 (515)
Q Consensus 332 ~~~~~ 336 (515)
+++..
T Consensus 321 ~~~~~ 325 (336)
T 3h4j_B 321 ENQVI 325 (336)
T ss_dssp HHHHH
T ss_pred hChhh
Confidence 88753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-59 Score=489.50 Aligned_cols=258 Identities=29% Similarity=0.471 Sum_probs=228.5
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc------
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET------ 88 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------ 88 (515)
+.++|++++.||+|+||+||+|.++.||+.||||++.+... .....+++.+|+++|+.++|||||++++++.+
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 34689999999999999999999999999999999976543 33456788999999999999999999999864
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
.+.+|||||||+ |+|.+++.+++++++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+.
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 367999999996 6899999999999999999999999999999999999999999999999999999999999998764
Q ss_pred c-----CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCC-------
Q 010214 169 D-----GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL------- 236 (515)
Q Consensus 169 ~-----~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~------- 236 (515)
. .....+.+||+.|||||++.+..+++.++||||+|||+|+|++|.+||.+.+..+++..|.......
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 3 2345678999999999999987777899999999999999999999999999888888775432221
Q ss_pred ------------------------CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 237 ------------------------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 237 ------------------------p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.+.+|+++++||.+||++||.+|||++|+|+||||+..
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 13578999999999999999999999999999999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-58 Score=504.84 Aligned_cols=261 Identities=28% Similarity=0.472 Sum_probs=232.1
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHH---HHHHHHHHhCCCCCccEEEEEEEcC
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKV---RREIKILRLFMHPHIIRLYEVIETP 89 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i---~~Ei~il~~l~hpnIv~l~~~~~~~ 89 (515)
..-+++|+++++||+|+||+||+|+++.||+.||||++.+..+........+ ++++.+++.++|||||+++++|+++
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 3457899999999999999999999999999999999987654333323333 3446667778999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
+.+|+|||||+||+|.++|.+.+.++|..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|.....
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999987654
Q ss_pred CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC---ChHHHHHHHhcCccCCCCCCChhHHH
Q 010214 170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---NIPNLFKKIKGGIYTLPSHLSPGARD 246 (515)
Q Consensus 170 ~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~ 246 (515)
. ...+.||||.|||||++.+...++.++|||||||++|+|++|.+||.+. +...+...+......+|..+|+++++
T Consensus 345 ~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~d 423 (689)
T 3v5w_A 345 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 423 (689)
T ss_dssp C-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred C-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHH
Confidence 3 4567899999999999975433489999999999999999999999764 34566778888889999999999999
Q ss_pred HhcccCCCCCCCCCC-----HHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRIT-----IPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rpt-----~~eil~hp~f~~~ 274 (515)
||.+||++||.+|++ ++||++||||+..
T Consensus 424 LI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp HHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred HHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 999999999999998 7999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-59 Score=466.95 Aligned_cols=253 Identities=28% Similarity=0.456 Sum_probs=205.5
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS----- 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~----- 90 (515)
+.+|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+++|++++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 467999999999999999999999999999999997543 3345678999999999999999999999986544
Q ss_pred -------eEEEEEeccCCCCHHHHHHHhCCC---CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEee
Q 010214 91 -------DIYVVMEYVKSGELFDYIVEKGRL---QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160 (515)
Q Consensus 91 -------~~~iVmEy~~gg~L~~~i~~~~~l---~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~D 160 (515)
.+|+|||||+||+|.+++...+.+ ++..++.++.||++||+|||++||+||||||+|||++.+|.+||+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence 479999999999999999876654 4567899999999999999999999999999999999999999999
Q ss_pred cccccccccCC-------------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh-HHHH
Q 010214 161 FGLSNIMRDGH-------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLF 226 (515)
Q Consensus 161 FGls~~~~~~~-------------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~-~~~~ 226 (515)
||+|+...... ...+.+||+.|||||++.+..| +.++|||||||++|+|++ ||..... ....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC-CCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 99998765432 1234689999999999999887 799999999999999996 8875432 2233
Q ss_pred HHHhcCccC-CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 227 KKIKGGIYT-LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 227 ~~i~~~~~~-~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..+....++ .+...++.+.+||.+||++||.+|||+.|+++||||++.
T Consensus 238 ~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 444443321 223457788999999999999999999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=469.54 Aligned_cols=254 Identities=24% Similarity=0.426 Sum_probs=212.6
Q ss_pred cccCCCceEeeeecccCceEEEEEEEc---CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEc
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET 88 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~ 88 (515)
..+.++|++.+.||+|+||+||+|+++ .+++.||+|++.+.. ...++.+|+++|+.+ +||||+++++++++
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 456788999999999999999999885 467899999986543 235688999999988 59999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CceEEeeccccccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIM 167 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~-~~vKL~DFGls~~~ 167 (515)
.+.+|+|||||+||+|.+++ +.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CCEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 99999999999999999998 369999999999999999999999999999999999999876 89999999999754
Q ss_pred ccC-----------------------------CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCC
Q 010214 168 RDG-----------------------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFD 218 (515)
Q Consensus 168 ~~~-----------------------------~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~ 218 (515)
.+. ....+.+||+.|+|||++.+..+++.++||||+|||+|+|++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 322 123456899999999999887666899999999999999999999995
Q ss_pred CC-ChHHHHHHHhc--------------------------------------Ccc----------------CCCCCCChh
Q 010214 219 DE-NIPNLFKKIKG--------------------------------------GIY----------------TLPSHLSPG 243 (515)
Q Consensus 219 ~~-~~~~~~~~i~~--------------------------------------~~~----------------~~p~~~s~~ 243 (515)
.. +..+.+..|.. ... .....+|++
T Consensus 249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~ 328 (361)
T 4f9c_A 249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE 328 (361)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence 43 33333333211 000 112457899
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
++|||++||++||.+|||++|+|+||||++.
T Consensus 329 a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 329 AYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999853
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-57 Score=494.81 Aligned_cols=259 Identities=33% Similarity=0.627 Sum_probs=239.9
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
-+.++++|++++.||+|+||+||+|.++.+|+.||+|++.+.. ....+.+.+|+.+|+.++|||||+++++|++++.
T Consensus 152 ~~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 228 (573)
T 3uto_A 152 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 228 (573)
T ss_dssp SSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE
T ss_pred CCcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3456789999999999999999999999999999999997643 3346788999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC--CceEEeecccccccc
Q 010214 92 IYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK--WNVKIADFGLSNIMR 168 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~--~~vKL~DFGls~~~~ 168 (515)
+|||||||+||+|+++|.. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 9999999999999999964 5689999999999999999999999999999999999999854 899999999999988
Q ss_pred cCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCCChhH
Q 010214 169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGA 244 (515)
Q Consensus 169 ~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 244 (515)
......+.|||+.|||||++.+..| +.++|||||||++|+|++|..||.+.+..+.+.+|....+.++ ..+|+++
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred CCCceeeeEECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 8888888999999999999999888 7899999999999999999999999999999999998877665 4689999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
++||.+||++||.+|||+.|+|+||||+..
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence 999999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=457.29 Aligned_cols=251 Identities=29% Similarity=0.444 Sum_probs=222.9
Q ss_pred CCceEeeeecccCceEEEEEEEc-----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
++|.+.+.||+|+||+||+|++. .++..||||+++.. .....+.+.+|+++|++++|||||++++++.+++.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 67999999999999999999875 35789999999643 34456789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEE
Q 010214 92 IYVVMEYVKSGELFDYIVEK-------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI 158 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~-------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL 158 (515)
+|+|||||+||+|.++|.+. ..+++.++..++.||++||.|||+++|+||||||+|||++.++.+||
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEE
Confidence 99999999999999999764 36999999999999999999999999999999999999999999999
Q ss_pred eecccccccccCCcc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-
Q 010214 159 ADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI- 233 (515)
Q Consensus 159 ~DFGls~~~~~~~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~- 233 (515)
+|||+|+........ ...+||+.|||||++.+..| +.++|||||||++|||+| |+.||.+.+..++...+..+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~ 248 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 248 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999876544322 23469999999999998887 789999999999999998 999999999999988888775
Q ss_pred cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 234 YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 234 ~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
...|..+|+++.+|+.+||+.||.+|||+.|+ |+|+++
T Consensus 249 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 249 LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 46788999999999999999999999999999 567764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-56 Score=451.45 Aligned_cols=248 Identities=27% Similarity=0.426 Sum_probs=215.4
Q ss_pred CCceEeeeecccCceEEEEEEEc-----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
.+|.+.+.||+|+||+||+|+++ .+++.||||+++.. .....+.+.+|+++|++++|||||++++++.+++.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 57899999999999999999875 36889999999643 34556789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHh---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCce
Q 010214 92 IYVVMEYVKSGELFDYIVEK---------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNV 156 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~---------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~v 156 (515)
+|||||||++|+|.+++.+. +++++.++..++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcE
Confidence 99999999999999999753 458999999999999999999999999999999999999999999
Q ss_pred EEeecccccccccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC
Q 010214 157 KIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232 (515)
Q Consensus 157 KL~DFGls~~~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~ 232 (515)
||+|||+|+...... ...+.+||+.|||||++.+..| +.++|||||||++|||+| |+.||.+.+..+....+..+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g 276 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCC-CccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999998764433 2245689999999999999887 799999999999999999 99999999988888888776
Q ss_pred -ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 233 -IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 233 -~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
....|..+++++.+|+.+||+.||.+|||+.|++++
T Consensus 277 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 277 RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 467788999999999999999999999999999764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=446.51 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=222.1
Q ss_pred CCCceEeeeecccCceEEEEEEEc-----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
..++++.+.||+|+||+||+|.+. .+++.||||++.... .....+.+.+|+.+|++++|||||++++++.+++
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 578999999999999999999863 467899999996543 2234578999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC
Q 010214 91 DIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW 154 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~ 154 (515)
.+|+|||||++|+|.++|... +.+++.++..++.||+.||+|||+++|+||||||+|||+++++
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC
Confidence 999999999999999999653 3589999999999999999999999999999999999999999
Q ss_pred ceEEeecccccccccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 010214 155 NVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK 230 (515)
Q Consensus 155 ~vKL~DFGls~~~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~ 230 (515)
.+||+|||+|+...... ...+.+||+.|||||++.+..| +.++|||||||++|||+| |..||.+.+..++...+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~-s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~ 261 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 261 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999998764432 3445689999999999998877 799999999999999998 899999999999888888
Q ss_pred cCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 231 GGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 231 ~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.+. .+.|..+++++.+|+.+||+.||.+|||+.||+++
T Consensus 262 ~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 262 NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 765 46788999999999999999999999999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-55 Score=442.42 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=207.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.+++++.+.||+|+||+||+|++. ..||||+++... ......+.+.+|+.+|++++|||||++++++. ++.+|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEE
Confidence 578999999999999999999864 359999986543 33456688999999999999999999999875 4568999
Q ss_pred EeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC---C
Q 010214 96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---H 171 (515)
Q Consensus 96 mEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~---~ 171 (515)
||||+||+|.++|.. ++++++.++..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+|+..... .
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 999999999999975 467999999999999999999999999999999999999999999999999999876432 3
Q ss_pred ccccCCCCCCccCCCcccCCc--cCCCcceeehhHHHHHHHHhCCCCCCCCChHHH-HHHHhcCcc-----CCCCCCChh
Q 010214 172 FLKTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVILYALLCGTLPFDDENIPNL-FKKIKGGIY-----TLPSHLSPG 243 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~--~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~-~~~i~~~~~-----~~p~~~s~~ 243 (515)
...+.+||+.|||||++.+.. .++.++|||||||++|||+||+.||.+.+.... ...+..+.. ..+..++++
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 269 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA 269 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHH
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHH
Confidence 345679999999999996532 137899999999999999999999988665444 334443321 245678999
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+.+|+.+||+.||.+|||+.|++++
T Consensus 270 l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 270 MKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999988665
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=445.98 Aligned_cols=261 Identities=36% Similarity=0.630 Sum_probs=234.1
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCe
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSD 91 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 91 (515)
....++|++.+.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 34568999999999999999999999999999999999876544444567788999999988 69999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cC
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~ 170 (515)
+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.... .+
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998643 33
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcc
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 250 (515)
....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..+++.+|..+...+|..+++++.+||++
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 257 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKS 257 (353)
T ss_dssp -------CCGGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCcCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 45567799999999999988777 78999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCH------HHHhcCcccccc
Q 010214 251 MLIVDPMKRITI------PEIRQHPWFQAH 274 (515)
Q Consensus 251 mL~~dP~~Rpt~------~eil~hp~f~~~ 274 (515)
||+.||.+||++ .|+++||||+..
T Consensus 258 lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 258 FMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 999999999998 899999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-54 Score=438.53 Aligned_cols=258 Identities=36% Similarity=0.616 Sum_probs=239.6
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++++.||+|+||+||+|.++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 57999999999999999999999999999999999765433334457788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc-ccCCccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~-~~~~~~~ 174 (515)
|||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++... ..+....
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~ 163 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999864 3444566
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCC
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~ 254 (515)
+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+...+......+|..+++++++||.+||+.
T Consensus 164 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~ 242 (337)
T 1o6l_A 164 TFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 242 (337)
T ss_dssp CCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred ccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhc
Confidence 7899999999999998877 789999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCC-----CHHHHhcCcccccc
Q 010214 255 DPMKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 255 dP~~Rp-----t~~eil~hp~f~~~ 274 (515)
||.+|| |+.|+++||||+..
T Consensus 243 dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 243 DPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp STTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred CHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 999999 99999999999754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=437.46 Aligned_cols=261 Identities=38% Similarity=0.667 Sum_probs=240.5
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh---HHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEKVRREIKILRLFMHPHIIRLYEVIET 88 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 88 (515)
...+.++|++.+.||+|+||+||+|.++.+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++++
T Consensus 7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN 86 (361)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence 34567899999999999999999999999999999999987654321 135678999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC----ceEEeecccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW----NVKIADFGLS 164 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~----~vKL~DFGls 164 (515)
.+.+|+||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999999999998888999999999999999999999999999999999999998877 7999999999
Q ss_pred cccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCC
Q 010214 165 NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHL 240 (515)
Q Consensus 165 ~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~ 240 (515)
.....+....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+.+.++ ..+
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (361)
T 2yab_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245 (361)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred eEcCCCCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCC
Confidence 98877766778899999999999998777 7899999999999999999999999999999999998887765 578
Q ss_pred ChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 241 s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
++++++||.+||..||.+|||+.|+++||||+.
T Consensus 246 s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 999999999999999999999999999999974
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=437.76 Aligned_cols=265 Identities=34% Similarity=0.578 Sum_probs=238.4
Q ss_pred CCCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 010214 9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIE 87 (515)
Q Consensus 9 ~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~ 87 (515)
+.......++|++.+.||+|+||+||+|+++.+|+.||||++.+...........+.+|..+++.+ +||||+++++++.
T Consensus 9 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~ 88 (345)
T 1xjd_A 9 SLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ 88 (345)
T ss_dssp -------CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CccCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence 344456689999999999999999999999999999999999865433333456788899999876 8999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 88 ~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
+.+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++...
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999999999999899999999999999999999999999999999999999999999999999999864
Q ss_pred cc-CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHH
Q 010214 168 RD-GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARD 246 (515)
Q Consensus 168 ~~-~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 246 (515)
.. .....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...++.++......+|..+++++++
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 247 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 247 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred ccCCCcccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHH
Confidence 32 334567899999999999998877 7899999999999999999999999999999999999988999999999999
Q ss_pred HhcccCCCCCCCCCCHH-HHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRITIP-EIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~-eil~hp~f~~~ 274 (515)
||.+||+.||.+|||+. ++++||||+..
T Consensus 248 li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 248 LLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 99999999999999998 99999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-53 Score=429.77 Aligned_cols=256 Identities=33% Similarity=0.688 Sum_probs=238.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||+||+|.++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 57899999999999999999999999999999999765443333457788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
|||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ...+
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--~~~~ 162 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYT 162 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CBCC
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--cccc
Confidence 99999999999999989999999999999999999999999999999999999999999999999999986543 3456
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~d 255 (515)
.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......++......+|..+++++++||.+||+.|
T Consensus 163 ~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~d 241 (318)
T 1fot_A 163 LCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 241 (318)
T ss_dssp CCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSC
T ss_pred ccCCccccCHhHhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccC
Confidence 789999999999998877 7899999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCC-----CHHHHhcCcccccc
Q 010214 256 PMKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 256 P~~Rp-----t~~eil~hp~f~~~ 274 (515)
|.+|| +++|+++||||+..
T Consensus 242 p~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 242 LSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp TTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHcCCCcCCCHHHHhcCccccCC
Confidence 99999 99999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-54 Score=441.46 Aligned_cols=250 Identities=28% Similarity=0.444 Sum_probs=216.7
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCC-----cEEEEEEecccccCChHHHHHHHHHHHHHHhCCC-CCccEEEEEEEc-
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTG-----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH-PHIIRLYEVIET- 88 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h-pnIv~l~~~~~~- 88 (515)
.++|++++.||+|+||+||+|.+..++ +.||||++.... .....+.+.+|+++|++++| ||||++++++.+
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 368999999999999999999986543 689999987543 33446779999999999976 899999999865
Q ss_pred CCeEEEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS 152 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~ 152 (515)
.+.+|||||||++|+|.++|.+. ..+++.++..++.||+.||+|||+++|+||||||+|||+++
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 45699999999999999999753 34899999999999999999999999999999999999999
Q ss_pred CCceEEeecccccccccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCCh-HHHHH
Q 010214 153 KWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENI-PNLFK 227 (515)
Q Consensus 153 ~~~vKL~DFGls~~~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~-~~~~~ 227 (515)
++.+||+|||+|+...... ...+.+||+.|||||++.+..| +.++|||||||++|||+| |..||.+.+. ..+..
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y-~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC-CCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999998764432 2235679999999999998887 799999999999999998 9999988664 44455
Q ss_pred HHhcC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 228 KIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 228 ~i~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.+..+ ....|..+++++.+|+.+||+.||.+|||+.||++|
T Consensus 300 ~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 55554 467788999999999999999999999999999987
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=430.37 Aligned_cols=259 Identities=31% Similarity=0.564 Sum_probs=237.9
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 93 (515)
-.++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 367999999999999999999999999999999999988777777778899999999987 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc-ccCCc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~-~~~~~ 172 (515)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++... ..+..
T Consensus 87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~ 166 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCc
Confidence 99999999999999999899999999999999999999999999999999999999999999999999999864 34445
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCC---------CChHHHHHHHhcCccCCCCCCChh
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD---------ENIPNLFKKIKGGIYTLPSHLSPG 243 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~ 243 (515)
..+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.. .....+...+......+|..++++
T Consensus 167 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~ 245 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 245 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHH
Confidence 667899999999999998877 7999999999999999999999975 344556778888888899999999
Q ss_pred HHHHhcccCCCCCCCCCCH------HHHhcCcccccc
Q 010214 244 ARDLIPRMLIVDPMKRITI------PEIRQHPWFQAH 274 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~------~eil~hp~f~~~ 274 (515)
+++||.+||+.||.+|||+ .|+++||||+..
T Consensus 246 ~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp HHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred HHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 9999999999999999995 899999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-53 Score=441.90 Aligned_cols=259 Identities=31% Similarity=0.567 Sum_probs=235.0
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 93 (515)
-.++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|..+++++ +||||+++++++.+.+.+|
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 467899999999999999999999999999999999887666655667788999999876 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc-cccCCc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~-~~~~~~ 172 (515)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.. ...+..
T Consensus 130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~ 209 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 209 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999986 344556
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC---------ChHHHHHHHhcCccCCCCCCChh
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---------NIPNLFKKIKGGIYTLPSHLSPG 243 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~s~~ 243 (515)
..+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||... ....+...+......+|..++++
T Consensus 210 ~~~~~gt~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~ 288 (396)
T 4dc2_A 210 TSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 288 (396)
T ss_dssp BCCCCBCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred cccccCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHH
Confidence 678899999999999998877 79999999999999999999999632 34457788888889999999999
Q ss_pred HHHHhcccCCCCCCCCCCH------HHHhcCcccccc
Q 010214 244 ARDLIPRMLIVDPMKRITI------PEIRQHPWFQAH 274 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~------~eil~hp~f~~~ 274 (515)
+++||++||+.||.+||++ +|+++||||+..
T Consensus 289 ~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 289 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp HHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred HHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 9999999999999999995 799999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-53 Score=433.80 Aligned_cols=261 Identities=34% Similarity=0.561 Sum_probs=238.6
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCe
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSD 91 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 91 (515)
....++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|..+++.+ +||||+++++++++.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 34578999999999999999999999999999999999876443334457788999999887 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cC
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~ 170 (515)
+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.... .+
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 99999999999999999998999999999999999999999999999999999999999999999999999998643 34
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcc
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 250 (515)
....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+++.+|......+|..+++++++||.+
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 254 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG 254 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 45667899999999999998877 78999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCC-----HHHHhcCcccccc
Q 010214 251 MLIVDPMKRIT-----IPEIRQHPWFQAH 274 (515)
Q Consensus 251 mL~~dP~~Rpt-----~~eil~hp~f~~~ 274 (515)
||..||.+||+ +.++++||||+..
T Consensus 255 lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 255 LMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp HTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 99999999995 6999999999853
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=415.17 Aligned_cols=273 Identities=66% Similarity=1.167 Sum_probs=237.5
Q ss_pred CCCCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010214 8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE 87 (515)
Q Consensus 8 ~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~ 87 (515)
|........++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.
T Consensus 2 s~~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 81 (276)
T 2h6d_A 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81 (276)
T ss_dssp -----CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CcccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 34455667899999999999999999999999999999999997654433344678899999999999999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 88 ~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
+.+..|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 82 TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 99999999999999999999999899999999999999999999999999999999999999999999999999999887
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHH
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDL 247 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 247 (515)
.........+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+.......+..+...+|..++.++.++
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 241 (276)
T 2h6d_A 162 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATL 241 (276)
T ss_dssp CC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred CCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHH
Confidence 76666667789999999999998776678999999999999999999999999998999999988888999999999999
Q ss_pred hcccCCCCCCCCCCHHHHhcCcccccccCcccC
Q 010214 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLA 280 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~hp~f~~~~~~~~~ 280 (515)
|.+||+.||.+|||+.|+++||||++.++.++.
T Consensus 242 i~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~~ 274 (276)
T 2h6d_A 242 LMHMLQVDPLKRATIKDIREHEWFKQDLPSYLF 274 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHHSHHHHTTCCGGGC
T ss_pred HHHHccCChhhCCCHHHHHhChhhccCchhccC
Confidence 999999999999999999999999988776643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=431.39 Aligned_cols=258 Identities=36% Similarity=0.644 Sum_probs=239.7
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|++++.||+|+||.||+|.++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34689999999999999999999999999999999997665433344577889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~ 195 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--T 195 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--B
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--c
Confidence 99999999999999999899999999999999999999999999999999999999999999999999999876433 3
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCC
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~ 253 (515)
.+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......++..+...+|..+++++.+||.+||+
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~ 274 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ 274 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSC
T ss_pred ccccCCccccCHHHhcCCCC-CCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 56789999999999998877 78999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCC-----HHHHhcCcccccc
Q 010214 254 VDPMKRIT-----IPEIRQHPWFQAH 274 (515)
Q Consensus 254 ~dP~~Rpt-----~~eil~hp~f~~~ 274 (515)
.||.+||+ ++|+++||||+..
T Consensus 275 ~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 275 VDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp SCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred cCHHhccCCccCCHHHHHhCcCcCCC
Confidence 99999998 9999999999753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=431.42 Aligned_cols=259 Identities=43% Similarity=0.723 Sum_probs=237.7
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
.+.++|++.+.||+|+||.||+|.++.+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 4456899999999999999999999999999999999876543 345678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---ceEEeecccccccccC
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDG 170 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~---~vKL~DFGls~~~~~~ 170 (515)
+||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999999999999998888999999999999999999999999999999999999998654 5999999999887766
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCC----CCChhHHH
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARD 246 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~ 246 (515)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+...+..+.+.+|. .+++++++
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 263 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 263 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHH
T ss_pred cccccCCCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 66677899999999999998777 78999999999999999999999999999999999888777663 57999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
||.+||+.||.+|||+.|+++||||+..
T Consensus 264 li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 264 LIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=423.82 Aligned_cols=257 Identities=26% Similarity=0.512 Sum_probs=236.6
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
.+.++|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.+++.++||||+++++++++.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 45789999999999999999999999999999999986432 34567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC--CCceEEeecccccccccC
Q 010214 94 VVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS--KWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~--~~~vKL~DFGls~~~~~~ 170 (515)
+|||||+||+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....+
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999999999765 47999999999999999999999999999999999999987 789999999999988777
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCCChhHHH
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARD 246 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~ 246 (515)
......+||+.|+|||++.+..+ ++++|||||||++|+|++|..||.+.+.......+..+.+.++ ..+|+++.+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred CccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence 66777889999999999988766 7899999999999999999999999999999999988887766 478999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
||.+||..||.+|||+.|+++||||+...
T Consensus 237 li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 237 FVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 99999999999999999999999998653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=433.24 Aligned_cols=263 Identities=25% Similarity=0.499 Sum_probs=239.3
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
.+...++|++.+.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34557899999999999999999999999999999999987654444456788999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....+.
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999999887777
Q ss_pred ccccCCCCCCccCCCcccCCc--cCCCcceeehhHHHHHHHHhCCCCCCC---CChHHHHHHHhcCccCCCCCCChhHHH
Q 010214 172 FLKTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVILYALLCGTLPFDD---ENIPNLFKKIKGGIYTLPSHLSPGARD 246 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~--~~~~~~DIwSlGvily~lltG~~Pf~~---~~~~~~~~~i~~~~~~~p~~~s~~~~~ 246 (515)
...+.+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||.. .........+......+|..+++++.+
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~ 249 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVS 249 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHH
Confidence 778889999999999997432 237899999999999999999999974 445566777788888899999999999
Q ss_pred HhcccCCCCCCCCCC-HHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRIT-IPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rpt-~~eil~hp~f~~~ 274 (515)
||.+||+.||.+||+ ++++++||||+..
T Consensus 250 li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 250 LLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp HHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred HHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 999999999999998 8999999999754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=432.02 Aligned_cols=261 Identities=33% Similarity=0.551 Sum_probs=231.2
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHH-HHhCCCCCccEEEEEEEcCCe
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~i-l~~l~hpnIv~l~~~~~~~~~ 91 (515)
....++|++.+.||+|+||+||+|+++.+++.||||++.+...........+.+|..+ ++.++||||+++++++.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 3456899999999999999999999999999999999988776655556677778877 577899999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cC
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~ 170 (515)
+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.... ..
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 99999999999999999998999999999999999999999999999999999999999999999999999998643 34
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcc
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 250 (515)
....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+++.+|......+|..+++++++||.+
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 272 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEG 272 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHH
T ss_pred CccccccCCccccCHHHhCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Confidence 45667899999999999998877 78999999999999999999999999999999999999889999999999999999
Q ss_pred cCCCCCCCCCCH----HHHhcCcccccc
Q 010214 251 MLIVDPMKRITI----PEIRQHPWFQAH 274 (515)
Q Consensus 251 mL~~dP~~Rpt~----~eil~hp~f~~~ 274 (515)
||+.||.+||++ .++++||||+..
T Consensus 273 lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 273 LLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 999999999997 699999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=422.30 Aligned_cols=262 Identities=38% Similarity=0.658 Sum_probs=238.1
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh---HHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEKVRREIKILRLFMHPHIIRLYEVIE 87 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~hpnIv~l~~~~~ 87 (515)
..+.+.++|++.+.||+|+||.||+|.++.+|+.||+|++.+...... ...+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 84 (326)
T 2y0a_A 5 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 84 (326)
T ss_dssp BCSCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccCCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 345567889999999999999999999999999999999987544321 13577899999999999999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC----ceEEeeccc
Q 010214 88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW----NVKIADFGL 163 (515)
Q Consensus 88 ~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~----~vKL~DFGl 163 (515)
+...+|+||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 85 NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999999999998888999999999999999999999999999999999999999887 899999999
Q ss_pred ccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CC
Q 010214 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SH 239 (515)
Q Consensus 164 s~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~ 239 (515)
+.....+......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....+.++ ..
T Consensus 165 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (326)
T 2y0a_A 165 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243 (326)
T ss_dssp CEECCTTSCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred CeECCCCCccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence 988776666677889999999999988776 7899999999999999999999999988888888877766554 57
Q ss_pred CChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 240 ~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
+++.+.+||.+||+.||.+|||+.|+++||||+.
T Consensus 244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 8999999999999999999999999999999974
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-52 Score=438.75 Aligned_cols=261 Identities=41% Similarity=0.720 Sum_probs=235.9
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
...+.++|++.+.||+|+||+||+|.++.+|+.||+|++.+..... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 84 (444)
T 3soa_A 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEGH 84 (444)
T ss_dssp -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence 3456689999999999999999999999999999999998765433 346778999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC---CCCceEEeecccccccc
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD---SKWNVKIADFGLSNIMR 168 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~---~~~~vKL~DFGls~~~~ 168 (515)
.|+|||||+||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999999999999999999999999999999999999999999999999999999998 46789999999998765
Q ss_pred cCC-ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCC----CCChh
Q 010214 169 DGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPG 243 (515)
Q Consensus 169 ~~~-~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 243 (515)
... ...+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+.......+..+.+.+|. .++++
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 243 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE 243 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred CCCceeecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHH
Confidence 433 3456789999999999998877 78999999999999999999999999999999999988876653 68999
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+++||.+||+.||.+|||+.|+++||||+..
T Consensus 244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 244 AKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 9999999999999999999999999999754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=425.43 Aligned_cols=261 Identities=43% Similarity=0.751 Sum_probs=220.2
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
....++|++.+.||+|+||+||+|.++.+|+.||||++.+..... +.+.+|+.+++.++||||+++++++.+++.+
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 344689999999999999999999999999999999997654333 5678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc--eEEeecccccccccC
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDG 170 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~--vKL~DFGls~~~~~~ 170 (515)
|+||||++||+|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999999999999999899999999999999999999999999999999999999987765 999999999865555
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC----hHHHHHHHhcCccCCCC--CCChhH
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLPS--HLSPGA 244 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~----~~~~~~~i~~~~~~~p~--~~s~~~ 244 (515)
......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.. .......+....+.+|. .+++++
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 251 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC 251 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHH
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHH
Confidence 555677899999999999888876666999999999999999999998743 34555666666666665 689999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcCcccccccCc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~~ 277 (515)
.+||.+||+.||.+|||+.|+++||||...++.
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 284 (361)
T 3uc3_A 252 CHLISRIFVADPATRISIPEIKTHSWFLKNLPA 284 (361)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCCC
T ss_pred HHHHHHHccCChhHCcCHHHHHhCcchhcCCch
Confidence 999999999999999999999999999876544
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=417.57 Aligned_cols=262 Identities=32% Similarity=0.547 Sum_probs=226.9
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEc---CCCcEEEEEEecccccC-ChHHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLFMHPHIIRLYEVIE 87 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~---~tg~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~ 87 (515)
.....++|++.+.||+|+||.||+|.+. .+|+.||+|++.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 3445689999999999999999999985 68999999999876432 2234566789999999999999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 88 ~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999999999899999999999999999999999999999999999999999999999999998764
Q ss_pred c-cCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHH
Q 010214 168 R-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARD 246 (515)
Q Consensus 168 ~-~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 246 (515)
. .+....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......++......+|..+++++.+
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 250 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 250 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred ccCCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 3 3344556789999999999988776 7899999999999999999999999999999999999999999999999999
Q ss_pred HhcccCCCCCCCCC-----CHHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rp-----t~~eil~hp~f~~~ 274 (515)
||.+||..||.+|| |+.|+++||||+..
T Consensus 251 li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 99999999999999 88999999999754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=409.97 Aligned_cols=258 Identities=31% Similarity=0.497 Sum_probs=229.6
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
+....++|++.+.||+|+||+||+|.+..+|+.||+|++....... .+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 91 (297)
T 3fxz_A 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDE 91 (297)
T ss_dssp SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCE
Confidence 4456789999999999999999999999999999999997654433 4678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
+|+||||++||+|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999999999999754 69999999999999999999999999999999999999999999999999988765433
Q ss_pred -ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC---ccCCCCCCChhHHHH
Q 010214 172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARDL 247 (515)
Q Consensus 172 -~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~l 247 (515)
...+.+||+.|+|||++.+..+ ++++|||||||++|+|++|..||.+.+.......+... ....|..+++.+.+|
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHH
T ss_pred cccCCccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHH
Confidence 3456689999999999998877 78999999999999999999999988776655554332 334567889999999
Q ss_pred hcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|.+||+.||.+|||+.|+++||||+..
T Consensus 250 i~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 250 LNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHccCChhHCcCHHHHhhChhhccc
Confidence 999999999999999999999999865
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=438.12 Aligned_cols=260 Identities=37% Similarity=0.612 Sum_probs=229.1
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|++.+.||+|+||.||+|.++.+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 34578999999999999999999999999999999998765545455677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccc-cCC
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGH 171 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~ 171 (515)
+||||++||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||++.... .+.
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence 999999999999999999999999999999999999999998 999999999999999999999999999998643 344
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhccc
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~m 251 (515)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+...+......+|..+++++.+||.+|
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~ 383 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL 383 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence 5567899999999999988877 789999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCC-----CHHHHhcCcccccc
Q 010214 252 LIVDPMKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rp-----t~~eil~hp~f~~~ 274 (515)
|+.||.+|| |+.|+++||||+..
T Consensus 384 L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 384 LKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred cccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 999999999 99999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-51 Score=406.95 Aligned_cols=258 Identities=28% Similarity=0.513 Sum_probs=221.7
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
+++|++.+.||+|+||+||+|.++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 4689999999999999999999999999999999976553 334567788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccc
Q 010214 96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~ 173 (515)
|||+++ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 999976 66665554 678999999999999999999999999999999999999999999999999999876533 344
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCC-CCCCChHHHHHHHhcCcc------------------
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIY------------------ 234 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~P-f~~~~~~~~~~~i~~~~~------------------ 234 (515)
...+||+.|+|||++.+....+.++||||+||++|+|++|..| |.+.+.......+.....
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 5668999999999998876558999999999999999988777 566666666665533111
Q ss_pred -----------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 235 -----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 235 -----------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
..+..+++++++||.+||+.||.+|||++|+++||||++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 12235789999999999999999999999999999998753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=413.54 Aligned_cols=269 Identities=28% Similarity=0.473 Sum_probs=222.4
Q ss_pred CCCCCCCCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEE
Q 010214 4 ASNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLY 83 (515)
Q Consensus 4 ~~~~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~ 83 (515)
+++.+....+.+.++|++.+.||+|+||+||+|.+. +|+.||+|++..... .......+.+|+++++.++||||++++
T Consensus 8 ~~~~~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~ 85 (311)
T 3niz_A 8 SSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLI 85 (311)
T ss_dssp -------CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeee
Confidence 344556688889999999999999999999999986 589999999975432 233457788999999999999999999
Q ss_pred EEEEcCCeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecc
Q 010214 84 EVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFG 162 (515)
Q Consensus 84 ~~~~~~~~~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFG 162 (515)
+++.+++.+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 164 (311)
T 3niz_A 86 DVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFG 164 (311)
T ss_dssp EEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCc
Confidence 999999999999999975 888888764 459999999999999999999999999999999999999999999999999
Q ss_pred cccccccC-CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-------
Q 010214 163 LSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------- 234 (515)
Q Consensus 163 ls~~~~~~-~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~------- 234 (515)
++...... ......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+.....
T Consensus 165 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 165 LARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp TCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred CceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence 99876533 3345568999999999998755458999999999999999999999988776665555533111
Q ss_pred -----------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 235 -----------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 235 -----------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
...+.+++++.+||.+||+.||.+|||+.|+++||||++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 01235788999999999999999999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=399.52 Aligned_cols=259 Identities=42% Similarity=0.722 Sum_probs=238.4
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
.+.++|++.+.||+|+||.||+|.++.+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..|
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 4578999999999999999999999999999999999766543 345678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc---eEEeecccccccccC
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDG 170 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~---vKL~DFGls~~~~~~ 170 (515)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++......
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999999999999999999999999999999999999999999999999999999987655 999999999887776
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCCChhHHH
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARD 246 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~ 246 (515)
.......||+.|+|||++.+..+ +.++||||+|+++|+|++|..||.+.+.......+..+....| ..+++++.+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred ccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence 66677889999999999998877 7899999999999999999999999998888888888776655 468999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
||.+||+.||.+|||+.|+++||||+..
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 241 LIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred HHHHHcccChhhCCCHHHHhcCccccCC
Confidence 9999999999999999999999999865
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=405.82 Aligned_cols=261 Identities=33% Similarity=0.689 Sum_probs=236.4
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
....++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 44578999999999999999999999999999999999765544444467789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~ 163 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-R 163 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-c
Confidence 999999999999999999899999999999999999999999999999999999999999999999999998655433 3
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccC
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 252 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL 252 (515)
....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+......+|..+++++.+||.+||
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 242 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 242 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHC
T ss_pred ccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHh
Confidence 345689999999999988766 7899999999999999999999999999999999999899999999999999999999
Q ss_pred CCCCCCCCCHHHHhcCccccccc
Q 010214 253 IVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 253 ~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
+.||.+|||+.|+++||||+...
T Consensus 243 ~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 243 KHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp CSSGGGSCCHHHHHHCHHHHHHC
T ss_pred ccChhhCCCHHHHhhCccccCCc
Confidence 99999999999999999998763
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=410.19 Aligned_cols=262 Identities=39% Similarity=0.692 Sum_probs=223.5
Q ss_pred CCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCC-----------------------hHHHHHHHH
Q 010214 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-----------------------MEMEEKVRR 66 (515)
Q Consensus 10 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~-----------------------~~~~~~i~~ 66 (515)
++.....++|++.+.||+|+||.||+|.+..+|+.||||++.+..... ....+.+.+
T Consensus 6 ~~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (298)
T 2zv2_A 6 SGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQ 85 (298)
T ss_dssp ----CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHH
T ss_pred CCCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHH
Confidence 344455799999999999999999999999999999999997654322 112466889
Q ss_pred HHHHHHhCCCCCccEEEEEEEc--CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 010214 67 EIKILRLFMHPHIIRLYEVIET--PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144 (515)
Q Consensus 67 Ei~il~~l~hpnIv~l~~~~~~--~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLk 144 (515)
|+++++.++||||+++++++.+ ...+|+||||+++++|.+++ ..+.+++.+++.++.||+.||.|||++||+|||||
T Consensus 86 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 164 (298)
T 2zv2_A 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIK 164 (298)
T ss_dssp HHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 9999999999999999999987 56899999999999998865 34679999999999999999999999999999999
Q ss_pred CCcEEECCCCceEEeecccccccccCC-ccccCCCCCCccCCCcccCCcc--CCCcceeehhHHHHHHHHhCCCCCCCCC
Q 010214 145 PENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLY--AGPEVDVWSCGVILYALLCGTLPFDDEN 221 (515)
Q Consensus 145 peNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~Y~aPE~i~~~~~--~~~~~DIwSlGvily~lltG~~Pf~~~~ 221 (515)
|+|||++.++.+||+|||++....... .....+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+.+
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999999998765433 3456689999999999986542 3678999999999999999999999988
Q ss_pred hHHHHHHHhcCccCCC--CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 222 IPNLFKKIKGGIYTLP--SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 222 ~~~~~~~i~~~~~~~p--~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
...+...+.......| ..+++++.+||.+||+.||.+|||+.|+++||||+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 8888888877766555 47899999999999999999999999999999996
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-52 Score=433.82 Aligned_cols=260 Identities=30% Similarity=0.549 Sum_probs=230.5
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|++.+.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 34679999999999999999999999999999999997643322222345789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc-
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF- 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~- 172 (515)
+|||||+||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++........
T Consensus 146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 99999999999999864 5799999999999999999999999999999999999999999999999999987655432
Q ss_pred -cccCCCCCCccCCCcccCCc---cCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCC--CCCChhH
Q 010214 173 -LKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP--SHLSPGA 244 (515)
Q Consensus 173 -~~~~~gt~~Y~aPE~i~~~~---~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~ 244 (515)
..+.+||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.+.+....+.+|.... ..+| ..+|+++
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 304 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 304 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHH
Confidence 34779999999999998654 13689999999999999999999999999999999887653 3444 4799999
Q ss_pred HHHhcccCCCCCCC--CCCHHHHhcCcccccc
Q 010214 245 RDLIPRMLIVDPMK--RITIPEIRQHPWFQAH 274 (515)
Q Consensus 245 ~~li~~mL~~dP~~--Rpt~~eil~hp~f~~~ 274 (515)
++||.+||+.+|.+ |+|++||++||||+..
T Consensus 305 ~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 305 KNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 99999999999988 9999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=400.82 Aligned_cols=259 Identities=40% Similarity=0.758 Sum_probs=238.7
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
..+.++|++.+.||+|+||.||+|.+..++..||+|++.+..... .+.+.+|+++++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI 81 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence 345688999999999999999999999999999999997654433 46788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---CCCCceEEeeccccccccc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL---DSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl---~~~~~vKL~DFGls~~~~~ 169 (515)
|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999999999999999999999999999999999999999999999999999999 7889999999999988877
Q ss_pred CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCC----CCChhHH
Q 010214 170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGAR 245 (515)
Q Consensus 170 ~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~ 245 (515)
.....+.+||+.|+|||++.+. + ++++||||||+++|+|++|..||...+.......+..+....|. .+++++.
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 162 GKMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp TSCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred ccchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence 7777788999999999999775 4 78999999999999999999999999988888999888877774 7899999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
+||.+||+.||.+|||+.++++||||++...
T Consensus 240 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence 9999999999999999999999999987543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=419.91 Aligned_cols=258 Identities=38% Similarity=0.693 Sum_probs=226.7
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCC--hHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN--MEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
+.++|++.+.||+|+||+||+|.++.+|+.||||++....... ....+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4578999999999999999999999999999999997543221 11356789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc---eEEeeccccc
Q 010214 93 YVVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSN 165 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~----~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~---vKL~DFGls~ 165 (515)
|+|||||+|++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999999888653 25899999999999999999999999999999999999987655 9999999998
Q ss_pred ccccCCc-cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCC
Q 010214 166 IMRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHL 240 (515)
Q Consensus 166 ~~~~~~~-~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~ 240 (515)
....... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. ...+...+..+.+..+ ..+
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~ 259 (351)
T 3c0i_A 182 QLGESGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHI 259 (351)
T ss_dssp ECCTTSCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTS
T ss_pred EecCCCeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccC
Confidence 7755433 456789999999999998877 78999999999999999999999875 4566677777766554 578
Q ss_pred ChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 241 s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
++++++||.+||..||.+|||+.|+++||||+..
T Consensus 260 s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 9999999999999999999999999999999753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=414.50 Aligned_cols=262 Identities=35% Similarity=0.678 Sum_probs=226.0
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
.+.++|++.+.||+|+||+||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 3578999999999999999999999999999999999755432 23467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC---
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--- 170 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~--- 170 (515)
+||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999999999988888999999999999999999999999999999999999999999999999999866432
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH-HHHHHHhcCccCC--CCCCChhHHHH
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTL--PSHLSPGARDL 247 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~-~~~~~i~~~~~~~--p~~~s~~~~~l 247 (515)
......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...... ............. ...+++++.+|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 23456789999999999988877678999999999999999999999876543 2333333333222 25689999999
Q ss_pred hcccCCCCCCCCCCHHHHhcCcccccccCc
Q 010214 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~hp~f~~~~~~ 277 (515)
|.+||+.||.+|||+.|+++||||+.....
T Consensus 242 i~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 271 (323)
T 3tki_A 242 LHKILVENPSARITIPDIKKDRWYNKPLKK 271 (323)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred HHHHccCChhhCcCHHHHhhChhhcccccc
Confidence 999999999999999999999999876443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=402.53 Aligned_cols=263 Identities=34% Similarity=0.685 Sum_probs=239.7
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
....++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 34568999999999999999999999999999999999765433333457789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 168 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-R 168 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-C
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-c
Confidence 999999999999999999899999999999999999999999999999999999999999999999999998765432 3
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccC
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 252 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL 252 (515)
....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+......+|..+++++.+||.+||
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 247 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLL 247 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHS
T ss_pred cccccCCCCcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHh
Confidence 356689999999999998776 7899999999999999999999999988888888888888899999999999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccccCc
Q 010214 253 IVDPMKRITIPEIRQHPWFQAHLPR 277 (515)
Q Consensus 253 ~~dP~~Rpt~~eil~hp~f~~~~~~ 277 (515)
..||.+|||+.++++||||+....+
T Consensus 248 ~~~p~~Rps~~~ll~h~~~~~~~~~ 272 (284)
T 2vgo_A 248 RYHPPQRLPLKGVMEHPWVKANSRR 272 (284)
T ss_dssp CSSGGGSCCHHHHHTCHHHHHHCCC
T ss_pred hcCHhhCCCHHHHhhCHHHHhhccc
Confidence 9999999999999999999876443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=434.53 Aligned_cols=261 Identities=37% Similarity=0.678 Sum_probs=235.5
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh----------HHHHHHHHHHHHHHhCCCCCccEE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM----------EMEEKVRREIKILRLFMHPHIIRL 82 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~----------~~~~~i~~Ei~il~~l~hpnIv~l 82 (515)
+.+.++|++++.||+|+||+||+|.++.+++.||+|++.+...... ...+.+.+|+.+++.++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 4567899999999999999999999999999999999987554321 235678999999999999999999
Q ss_pred EEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---ceEEe
Q 010214 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVKIA 159 (515)
Q Consensus 83 ~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~---~vKL~ 159 (515)
++++++...+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999999999999999999999999999999999999999999999999999999776 69999
Q ss_pred ecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC--
Q 010214 160 DFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP-- 237 (515)
Q Consensus 160 DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p-- 237 (515)
|||++............+||+.|+|||++.+. + +.++||||+||++|+|++|..||.+.+...+...+..+.+.++
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 269 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKK-Y-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-B-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhccC-C-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 99999988777677788999999999998754 5 7899999999999999999999999999999999998887665
Q ss_pred --CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 238 --SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 238 --~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
..+|+++++||.+||+.||.+|||+.|+++||||+...
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 67899999999999999999999999999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=432.36 Aligned_cols=260 Identities=28% Similarity=0.556 Sum_probs=229.4
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|++.+.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 34579999999999999999999999999999999997643322223345789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 94 VVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 99999999999999987 57899999999999999999999999999999999999999999999999999976654332
Q ss_pred --cccCCCCCCccCCCccc-----CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--ccCCCC---CC
Q 010214 173 --LKTSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPS---HL 240 (515)
Q Consensus 173 --~~~~~gt~~Y~aPE~i~-----~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~---~~ 240 (515)
..+.+||+.|+|||++. +..| +.++|||||||++|+|++|..||.+.+..+.+.+|... .+.+|. .+
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 309 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred cccccccCCcCeeChHHHhhcccCCCCC-CCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence 23468999999999986 3444 78999999999999999999999999998888888754 244554 48
Q ss_pred ChhHHHHhcccCCCCCCC--CCCHHHHhcCcccccc
Q 010214 241 SPGARDLIPRMLIVDPMK--RITIPEIRQHPWFQAH 274 (515)
Q Consensus 241 s~~~~~li~~mL~~dP~~--Rpt~~eil~hp~f~~~ 274 (515)
|+++++||++||..+|.+ |++++|+++||||+..
T Consensus 310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 999999999999999888 9999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=413.19 Aligned_cols=246 Identities=21% Similarity=0.330 Sum_probs=195.7
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC----e
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS----D 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~----~ 91 (515)
.++|.+.+.||+|+||+||+|++ +|+.||||+++... ......++|+..+.+++|||||++++++.+++ .
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 46799999999999999999987 68999999986542 12233445777778899999999999997653 5
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCcEEECCCCceEEeeccc
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN--------MVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~--------gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
+|||||||+||+|.+++.+ .+++++.+.+++.|++.||+|||++ +|+||||||+|||++.++++||+|||+
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 8999999999999999965 5699999999999999999999987 999999999999999999999999999
Q ss_pred ccccccCCc-----cccCCCCCCccCCCcccCCcc-----CCCcceeehhHHHHHHHHhCCCCCCCC-------------
Q 010214 164 SNIMRDGHF-----LKTSCGSPNYAAPEVISGKLY-----AGPEVDVWSCGVILYALLCGTLPFDDE------------- 220 (515)
Q Consensus 164 s~~~~~~~~-----~~~~~gt~~Y~aPE~i~~~~~-----~~~~~DIwSlGvily~lltG~~Pf~~~------------- 220 (515)
|+....... ..+.+||+.|||||++.+... .+.++|||||||++|||+||..||...
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 987654322 234589999999999976521 257899999999999999998766321
Q ss_pred --ChHHHHHHHhcCcc--CCCCC-----CChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 221 --NIPNLFKKIKGGIY--TLPSH-----LSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 221 --~~~~~~~~i~~~~~--~~p~~-----~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
....+...+..... .+|.. .+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 22334444433332 33332 22467899999999999999999999763
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=420.43 Aligned_cols=265 Identities=22% Similarity=0.345 Sum_probs=224.5
Q ss_pred CCCCccccCCCceEeeeeccc--CceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEE
Q 010214 8 SSSGVDMFLPNYKLGKTLGIG--SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV 85 (515)
Q Consensus 8 ~~~~~~~~~~~Y~i~~~LG~G--~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~ 85 (515)
+.+.+-...++|++++.||+| +||.||+|.++.+|+.||||++...... ......+.+|+.+++.++||||++++++
T Consensus 16 ~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp --CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 344444557899999999999 9999999999999999999999876543 4567889999999999999999999999
Q ss_pred EEcCCeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 86 IETPSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 86 ~~~~~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
+.+.+.+|+||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~ 174 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS 174 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGG
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccc
Confidence 99999999999999999999999876 6799999999999999999999999999999999999999999999999998
Q ss_pred ccccccC--------CccccCCCCCCccCCCcccC--CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc
Q 010214 164 SNIMRDG--------HFLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI 233 (515)
Q Consensus 164 s~~~~~~--------~~~~~~~gt~~Y~aPE~i~~--~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~ 233 (515)
+...... ......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+.......+..+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 253 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred ceeeccccccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 8654322 12234579999999999987 445 789999999999999999999998866555444333221
Q ss_pred c----------------------------------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 234 Y----------------------------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 234 ~----------------------------------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
. ..+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1 234568899999999999999999999999999
Q ss_pred Ccccccc
Q 010214 268 HPWFQAH 274 (515)
Q Consensus 268 hp~f~~~ 274 (515)
||||+..
T Consensus 334 hp~f~~~ 340 (389)
T 3gni_B 334 HSFFKQI 340 (389)
T ss_dssp SGGGGGC
T ss_pred CHHHHHH
Confidence 9999865
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-51 Score=427.11 Aligned_cols=259 Identities=30% Similarity=0.526 Sum_probs=228.7
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|++.+.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.++..++||||+++++++.+.+.+|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 34689999999999999999999999999999999997654333333456789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 94 VVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++........
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 9999999999999998764 799999999999999999999999999999999999999999999999999987654433
Q ss_pred --cccCCCCCCccCCCccc-------CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCC---C
Q 010214 173 --LKTSCGSPNYAAPEVIS-------GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP---S 238 (515)
Q Consensus 173 --~~~~~gt~~Y~aPE~i~-------~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p---~ 238 (515)
..+.+||+.|+|||++. +..| +.++|||||||++|+|++|..||.+.+..+.+.+|.... ..+| .
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 296 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE 296 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence 23568999999999997 2344 789999999999999999999999999888888887632 3344 5
Q ss_pred CCChhHHHHhcccCCCCCCCC---CCHHHHhcCcccccc
Q 010214 239 HLSPGARDLIPRMLIVDPMKR---ITIPEIRQHPWFQAH 274 (515)
Q Consensus 239 ~~s~~~~~li~~mL~~dP~~R---pt~~eil~hp~f~~~ 274 (515)
.+|+++++||++||. +|.+| +|++|+++||||+..
T Consensus 297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 799999999999999 99998 599999999999865
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=438.65 Aligned_cols=262 Identities=40% Similarity=0.727 Sum_probs=240.7
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
..+.++|++.+.||+|+||.||+|.++.+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 45667899999999999999999999999999999999877655445568899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---CCCCceEEeeccccccccc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL---DSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl---~~~~~vKL~DFGls~~~~~ 169 (515)
|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999999999998999999999999999999999999999999999999999 5678999999999988877
Q ss_pred CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCCChhHH
Q 010214 170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGAR 245 (515)
Q Consensus 170 ~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 245 (515)
.......+||+.|+|||++.+. + ++++|||||||++|+|++|.+||.+.+.......+..+.+.++ ..+|++++
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 259 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHGT-Y-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred ccccccCCCCccccCceeecCC-C-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence 7667778899999999999874 5 7899999999999999999999999999999999988876554 46899999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
+||.+||+.||.+|||+.|+++||||+....
T Consensus 260 ~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 260 DLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred HHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 9999999999999999999999999987644
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=408.65 Aligned_cols=261 Identities=37% Similarity=0.660 Sum_probs=237.7
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh---HHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 89 (515)
..+.++|++.+.||+|+||.||+|.++.+|+.||+|++.+...... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 3456789999999999999999999999999999999986544321 1357789999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC----ceEEeeccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW----NVKIADFGLSN 165 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~----~vKL~DFGls~ 165 (515)
+.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999999999888899999999999999999999999999999999999999888 79999999998
Q ss_pred ccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCCC
Q 010214 166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLS 241 (515)
Q Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 241 (515)
....+......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+ ..++
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (321)
T 2a2a_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246 (321)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred ecCccccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence 8776666677789999999999988776 7899999999999999999999999998888888888776655 5789
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+.+.+||.+||..||.+|||+.|+++||||+..
T Consensus 247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 999999999999999999999999999999743
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=434.09 Aligned_cols=263 Identities=39% Similarity=0.711 Sum_probs=235.5
Q ss_pred CCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010214 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (515)
Q Consensus 10 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 89 (515)
..-..+.++|++.+.||+|+||+||+|.++.+|+.||||++.+..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 15 ~~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 93 (486)
T 3mwu_A 15 YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDS 93 (486)
T ss_dssp TTCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC
Confidence 344567899999999999999999999999999999999997654332 2346788999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC---CCCceEEeecccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD---SKWNVKIADFGLSNI 166 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~---~~~~vKL~DFGls~~ 166 (515)
..+|+|||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999999999999999999999999999999999999999999999999999995 456799999999988
Q ss_pred cccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCCCh
Q 010214 167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSP 242 (515)
Q Consensus 167 ~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 242 (515)
..........+||+.|+|||++.+. | +.++||||+||++|+|++|..||.+.+.......+..+.+.++ ..+|+
T Consensus 174 ~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 251 (486)
T 3mwu_A 174 FQQNTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (486)
T ss_dssp BCCC----CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCH
T ss_pred CCCCCccCCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCH
Confidence 8777667788999999999999875 4 7899999999999999999999999999999999988776544 46899
Q ss_pred hHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 243 ~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
++++||.+||+.||.+|||+.|+++||||+...
T Consensus 252 ~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 999999999999999999999999999998653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=399.13 Aligned_cols=260 Identities=38% Similarity=0.592 Sum_probs=241.6
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|.+.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 34678999999999999999999999999999999998776666677788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~ 172 (515)
+||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... +..
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence 9999999999999999888999999999999999999999999999999999999999999999999999987653 333
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccC
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 252 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL 252 (515)
....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||......+....+......+|..+++.+.++|.+||
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 250 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML 250 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHc
Confidence 455689999999999988766 7899999999999999999999999998888888988888899999999999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccc
Q 010214 253 IVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 253 ~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+.||.+|||+.|+++||||+..
T Consensus 251 ~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 251 QTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp CSSGGGSCCGGGGGGSHHHHTS
T ss_pred ccChhhCcCHHHHhhChheecC
Confidence 9999999999999999999865
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=418.31 Aligned_cols=258 Identities=31% Similarity=0.575 Sum_probs=233.6
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
..+.++|++.+.||+|+||.||+|.++.+|+.||+|++.... ......+.+|+.+|+.++||||+++++++.+...+
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence 456689999999999999999999999999999999997543 23456789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC--CCceEEeeccccccccc
Q 010214 93 YVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS--KWNVKIADFGLSNIMRD 169 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~--~~~vKL~DFGls~~~~~ 169 (515)
|+||||++||+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999999999997654 7999999999999999999999999999999999999974 47899999999998776
Q ss_pred CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCCChhHH
Q 010214 170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGAR 245 (515)
Q Consensus 170 ~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 245 (515)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....+.++ ..++++++
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 204 DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred CcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 666667789999999999998776 7899999999999999999999999988888888877765544 46899999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+||.+||+.||.+|||+.|+++||||+..
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 99999999999999999999999999865
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=440.43 Aligned_cols=260 Identities=30% Similarity=0.498 Sum_probs=236.7
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|++.+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+|+.++||||+++++++++.+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34578999999999999999999999999999999998765443344567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 94 VVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~--l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
+||||++||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.....+.
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 99999999999999987544 9999999999999999999999999999999999999999999999999998887766
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC----hHHHHHHHhcCccCCCCCCChhHHHH
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLPSHLSPGARDL 247 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~~l 247 (515)
...+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+ ...+...+......+|..+|+++++|
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~-~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dL 419 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSL 419 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEE-SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred cccccCCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHH
Confidence 6677899999999999998877 789999999999999999999998753 45667777777788889999999999
Q ss_pred hcccCCCCCCCCC-----CHHHHhcCcccccc
Q 010214 248 IPRMLIVDPMKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 248 i~~mL~~dP~~Rp-----t~~eil~hp~f~~~ 274 (515)
|.+||+.||.+|| |++|+++||||+..
T Consensus 420 I~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp HHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred HHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 9999999999999 78999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=450.12 Aligned_cols=260 Identities=35% Similarity=0.567 Sum_probs=239.8
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 92 (515)
...++|++++.||+|+||+||+|.++.+++.||||++.+.........+.+.+|..++..+ +||+|+++++++++.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 3468999999999999999999999999999999999865443334457788999999887 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc-ccCC
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~-~~~~ 171 (515)
|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++... ..+.
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 497 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999864 3445
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhccc
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~m 251 (515)
...+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..+++..|......+|..+++++++||.+|
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~l 576 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 576 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence 5667899999999999998887 799999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCH-----HHHhcCcccccc
Q 010214 252 LIVDPMKRITI-----PEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rpt~-----~eil~hp~f~~~ 274 (515)
|+.||.+||++ +||++||||+..
T Consensus 577 L~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 577 MTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp SCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred ccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 99999999998 999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=412.79 Aligned_cols=258 Identities=43% Similarity=0.724 Sum_probs=213.2
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
.+.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 122 (349)
T 2w4o_A 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE 122 (349)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCe
Confidence 3456678999999999999999999999999999999997543 23567899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCceEEeecccccccc
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIADFGLSNIMR 168 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~---~~~vKL~DFGls~~~~ 168 (515)
+|+||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999999999998888999999999999999999999999999999999999975 8899999999998876
Q ss_pred cCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHH-HHHHHhcCccCCC----CCCChh
Q 010214 169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN-LFKKIKGGIYTLP----SHLSPG 243 (515)
Q Consensus 169 ~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~-~~~~i~~~~~~~p----~~~s~~ 243 (515)
......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+..... ....+.......+ ..++.+
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 281 (349)
T 2w4o_A 203 HQVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281 (349)
T ss_dssp ----------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred cccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence 6656667889999999999998776 789999999999999999999998765443 6677776655443 468999
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
+.+||.+||+.||.+|||+.|+++||||+...
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 99999999999999999999999999998653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=400.96 Aligned_cols=261 Identities=38% Similarity=0.673 Sum_probs=209.3
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
....++|++.+.||+|+||.||+|.+..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 34568899999999999999999999999999999999765433333457889999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-
Q 010214 93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG- 170 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~- 170 (515)
|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999999865 57999999999999999999999999999999999999999999999999999876432
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcc
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 250 (515)
......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........+....+..|..++.++.+||.+
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 245 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQ 245 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHH
Confidence 23345679999999999988766 78999999999999999999999988777777777777778888999999999999
Q ss_pred cCCCCCCCCCCHHHHhcCcccccc
Q 010214 251 MLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
||+.||.+|||+.++++||||+..
T Consensus 246 ~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 246 LLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HcccCHhhCCCHHHHhcCccccCC
Confidence 999999999999999999999754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=414.77 Aligned_cols=253 Identities=36% Similarity=0.656 Sum_probs=225.7
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 92 (515)
.+.++|++.+.||+|+||+||+|.++.+|+.||+|++.+.... ..+|++++.++ +||||+++++++++.+.+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 4568899999999999999999999999999999999765432 24688888777 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC----CceEEeecccccccc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK----WNVKIADFGLSNIMR 168 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~----~~vKL~DFGls~~~~ 168 (515)
|+|||||+||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||+... +.+||+|||++....
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999999999999988899999999999999999999999999999999999998543 359999999998765
Q ss_pred cC-CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCC---CChHHHHHHHhcCccCCC----CCC
Q 010214 169 DG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD---ENIPNLFKKIKGGIYTLP----SHL 240 (515)
Q Consensus 169 ~~-~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~---~~~~~~~~~i~~~~~~~p----~~~ 240 (515)
.. ....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+ .+..++...+..+.+.++ ..+
T Consensus 172 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 250 (342)
T 2qr7_A 172 AENGLLMTPCYTANFVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250 (342)
T ss_dssp CTTCCBCCSSCCSSCCCHHHHHHHHH-HHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred CCCCceeccCCCccccCHHHhcCCCC-CCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence 43 34567899999999999987766 6899999999999999999999986 456677888888777655 568
Q ss_pred ChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 241 s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|+++++||.+||..||.+|||+.|+++||||...
T Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 9999999999999999999999999999999754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=402.48 Aligned_cols=259 Identities=27% Similarity=0.503 Sum_probs=219.6
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 3689999999999999999999999999999999986653 334456778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCcc
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFL 173 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~~ 173 (515)
||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... ....
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc
Confidence 999999999999988888899999999999999999999999999999999999999999999999999987653 3344
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-------------------
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------------------- 234 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~------------------- 234 (515)
...+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+.....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 5678999999999998755558999999999999999999999998877665554432110
Q ss_pred CCC------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 TLP------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 ~~p------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..| +.+++++.+||.+||+.||.+|||++|+++||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 011 3578899999999999999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=431.67 Aligned_cols=259 Identities=39% Similarity=0.712 Sum_probs=231.0
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
+.+.++|++++.||+|+||+||+|.++.++..||+|++.+..... .....+.+|+.+++.++||||+++++++++...+
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 111 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 345567999999999999999999999999999999998655332 2246788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC---CceEEeeccccccccc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRD 169 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~---~~vKL~DFGls~~~~~ 169 (515)
|+|||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||++.....
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 9999999999999999999999999999999999999999999999999999999999764 4599999999998877
Q ss_pred CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCCChhHH
Q 010214 170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGAR 245 (515)
Q Consensus 170 ~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 245 (515)
.....+.+||+.|+|||++.+. | +.++||||+||++|+|++|..||.+.+..++...+..+.+.++ ..+|++++
T Consensus 192 ~~~~~~~~gt~~y~aPE~l~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 269 (494)
T 3lij_A 192 QKKMKERLGTAYYIAPEVLRKK-Y-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269 (494)
T ss_dssp TBCBCCCCSCTTTCCHHHHTTC-B-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred CccccccCCCcCeeCHHHHccc-C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence 7777788999999999998753 5 7899999999999999999999999999999999988877654 46899999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+||.+||+.||.+|||+.|+++||||+..
T Consensus 270 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 270 DLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 99999999999999999999999999865
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=418.86 Aligned_cols=258 Identities=31% Similarity=0.512 Sum_probs=213.3
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCC--
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPS-- 90 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~-- 90 (515)
.+.++|++++.||+|+||.||+|.++.+|+.||||++.+. ........++.+|+.+++.+. ||||+++++++..++
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 4568999999999999999999999999999999998654 334456678889999999998 999999999997654
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD- 169 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~- 169 (515)
.+|+||||++ ++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 7999999997 589998865 5799999999999999999999999999999999999999999999999999976532
Q ss_pred ---------------------CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHH
Q 010214 170 ---------------------GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKK 228 (515)
Q Consensus 170 ---------------------~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~ 228 (515)
.......+||+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 12234568999999999998754458999999999999999999999999887777766
Q ss_pred HhcCcc-----------------------------------------------CCCCCCChhHHHHhcccCCCCCCCCCC
Q 010214 229 IKGGIY-----------------------------------------------TLPSHLSPGARDLIPRMLIVDPMKRIT 261 (515)
Q Consensus 229 i~~~~~-----------------------------------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt 261 (515)
+..... ..+..+++++.+||.+||+.||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 643111 012267899999999999999999999
Q ss_pred HHHHhcCcccccc
Q 010214 262 IPEIRQHPWFQAH 274 (515)
Q Consensus 262 ~~eil~hp~f~~~ 274 (515)
++|+++||||+..
T Consensus 323 ~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 323 ANDALKHPFVSIF 335 (388)
T ss_dssp HHHHTTSTTTTTT
T ss_pred HHHHhCCHHHHHh
Confidence 9999999999764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=406.76 Aligned_cols=259 Identities=38% Similarity=0.596 Sum_probs=241.3
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 45789999999999999999999999999999999987766666777889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCcc
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFL 173 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~~ 173 (515)
||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... +...
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 198 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence 999999999999999889999999999999999999999999999999999999999999999999999987653 3344
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCC
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~ 253 (515)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+......+|..+++++.+||.+||+
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 277 (335)
T 2owb_A 199 KVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 277 (335)
T ss_dssp CCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHTC
T ss_pred cccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcc
Confidence 56789999999999988776 78999999999999999999999999888888888888888999999999999999999
Q ss_pred CCCCCCCCHHHHhcCcccccc
Q 010214 254 VDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.||.+|||+.|+++||||+..
T Consensus 278 ~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 278 TDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp SSGGGSCCGGGGGGSHHHHTS
T ss_pred CChhHCcCHHHHhcCccccCC
Confidence 999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=410.95 Aligned_cols=263 Identities=29% Similarity=0.441 Sum_probs=215.2
Q ss_pred CCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010214 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (515)
Q Consensus 10 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 89 (515)
.......++|++.+.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++.+.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (329)
T 3gbz_A 27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHN 105 (329)
T ss_dssp -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 3445567899999999999999999999999999999999976543 223456778999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC-----CCCceEEeecccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD-----SKWNVKIADFGLS 164 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~-----~~~~vKL~DFGls 164 (515)
+.+|+||||++| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 106 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 106 HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp TEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred CEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 999999999975 9999999988999999999999999999999999999999999999994 4556999999999
Q ss_pred cccccC-CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCC-------
Q 010214 165 NIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL------- 236 (515)
Q Consensus 165 ~~~~~~-~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~------- 236 (515)
...... ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+......++.......
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 876432 334556789999999999876555899999999999999999999999988777666654321100
Q ss_pred -----------------------CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 237 -----------------------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 237 -----------------------p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+..+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 11268899999999999999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=401.81 Aligned_cols=259 Identities=34% Similarity=0.616 Sum_probs=220.6
Q ss_pred cccCCCceEe-eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 010214 13 DMFLPNYKLG-KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPS 90 (515)
Q Consensus 13 ~~~~~~Y~i~-~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~ 90 (515)
+.+.+.|++. +.||+|+||.||+|.+..+++.||||++.+... .....+.+|+.+++++ +||||+++++++.+.+
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~ 84 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEED 84 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 4467899995 789999999999999999999999999976532 2356788999999884 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc---eEEeeccccccc
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIM 167 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~---vKL~DFGls~~~ 167 (515)
.+|+||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999999999999899999999999999999999999999999999999999998776 999999998765
Q ss_pred ccC--------CccccCCCCCCccCCCcccC-----CccCCCcceeehhHHHHHHHHhCCCCCCCCC-------------
Q 010214 168 RDG--------HFLKTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYALLCGTLPFDDEN------------- 221 (515)
Q Consensus 168 ~~~--------~~~~~~~gt~~Y~aPE~i~~-----~~~~~~~~DIwSlGvily~lltG~~Pf~~~~------------- 221 (515)
... ....+.+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 321 12335579999999999875 334 789999999999999999999998754
Q ss_pred --hHHHHHHHhcCccCCC----CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 222 --IPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 222 --~~~~~~~i~~~~~~~p----~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
...+...+..+.+.+| ..+++++++||.+||+.||.+|||+.|+++||||+...
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 2446677777777776 46899999999999999999999999999999998653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=400.43 Aligned_cols=255 Identities=30% Similarity=0.506 Sum_probs=216.4
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||+||+|.+ .+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 36899999999999999999998 68999999999755422 22346778999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccc
Q 010214 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~ 173 (515)
|||+++ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 999976 999998763 67999999999999999999999999999999999999999999999999999876432 233
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-------------------
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------------------- 234 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~------------------- 234 (515)
...+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 4568999999999998765458999999999999999999999998877666555532110
Q ss_pred ----------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 235 ----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 235 ----------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
..+..+++++.+||.+||+.||.+|||+.|+++||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 112457899999999999999999999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=406.68 Aligned_cols=258 Identities=28% Similarity=0.503 Sum_probs=210.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||.||+|.++.+|+.||+|++...... .....+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 47899999999999999999999999999999999765422 2335778999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 96 MEYVKSGELFDYIVEK------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
|||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99998 5999999764 3599999999999999999999999999999999999999999999999999987643
Q ss_pred C-CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc--------------
Q 010214 170 G-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-------------- 234 (515)
Q Consensus 170 ~-~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-------------- 234 (515)
. ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (317)
T 2pmi_A 161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240 (317)
T ss_dssp CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence 2 3345668999999999998754458899999999999999999999999887776666543110
Q ss_pred --------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 235 --------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 235 --------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
..+..+++++.+||.+||+.||.+|||+.|+++||||++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 112357889999999999999999999999999999987643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=397.07 Aligned_cols=258 Identities=33% Similarity=0.608 Sum_probs=222.7
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
-..+.++|.+.+.||+|+||.||+|.++.++..||+|++...... ...+.+.+|+++++.++||||+++++++.+...
T Consensus 17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 94 (285)
T 3is5_A 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN 94 (285)
T ss_dssp SSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence 345678999999999999999999999999999999999765432 235778999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---CCCCceEEeecccc
Q 010214 92 IYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL---DSKWNVKIADFGLS 164 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl---~~~~~vKL~DFGls 164 (515)
.|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 9999999999999999864 3679999999999999999999999999999999999999 45678999999999
Q ss_pred cccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC---CCCC
Q 010214 165 NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP---SHLS 241 (515)
Q Consensus 165 ~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p---~~~s 241 (515)
............+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.+.......+.......+ ..++
T Consensus 175 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (285)
T 3is5_A 175 ELFKSDEHSTNAAGTALYMAPEVFKRD-V-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLT 252 (285)
T ss_dssp CC----------CTTGGGCCHHHHTTC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCC
T ss_pred eecCCcccCcCcccccCcCChHHhccC-C-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCC
Confidence 887766666777899999999998754 4 6899999999999999999999999888887777765554433 3478
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
+++.+||.+||+.||.+|||+.|+++||||++
T Consensus 253 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 99999999999999999999999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=402.95 Aligned_cols=260 Identities=30% Similarity=0.468 Sum_probs=218.8
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCC--hHHHHHHHHHHHHHHhCC---CCCccEEEEEEE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN--MEMEEKVRREIKILRLFM---HPHIIRLYEVIE 87 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~ 87 (515)
+.+.++|++.+.||+|+||+||+|.+..+|+.||+|++....... ......+.+|+.+++.++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 345789999999999999999999999999999999997543221 112245567777776665 999999999998
Q ss_pred cCC-----eEEEEEeccCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEee
Q 010214 88 TPS-----DIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160 (515)
Q Consensus 88 ~~~-----~~~iVmEy~~gg~L~~~i~~~~~--l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~D 160 (515)
+.. .+++||||+. ++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence 765 5899999997 599999987654 99999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-----
Q 010214 161 FGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT----- 235 (515)
Q Consensus 161 FGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~----- 235 (515)
||++............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......++......
T Consensus 164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (308)
T 3g33_A 164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242 (308)
T ss_dssp CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CccccccCCCcccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 999988776666677899999999999988877 78999999999999999999999998887777766442111
Q ss_pred ----------------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 236 ----------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 236 ----------------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..+.+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 243 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred ccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 113578899999999999999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=434.40 Aligned_cols=260 Identities=32% Similarity=0.482 Sum_probs=235.0
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|.+.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++++.+.+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 34688999999999999999999999999999999998765444344577889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 94 VVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~----~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999999763 3699999999999999999999999999999999999999999999999999987765
Q ss_pred CCc-cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC----ChHHHHHHHhcCccCCCCCCChhH
Q 010214 170 GHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE----NIPNLFKKIKGGIYTLPSHLSPGA 244 (515)
Q Consensus 170 ~~~-~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~ 244 (515)
+.. ..+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+. ....+...+......+|..+++++
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~ 420 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred CCcccccccCCccccChhhhcCCCC-ChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHH
Confidence 443 345699999999999998877 78999999999999999999999875 346777888888888999999999
Q ss_pred HHHhcccCCCCCCCCCC-----HHHHhcCcccccc
Q 010214 245 RDLIPRMLIVDPMKRIT-----IPEIRQHPWFQAH 274 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt-----~~eil~hp~f~~~ 274 (515)
++||.+||+.||.+||+ ++++++||||+..
T Consensus 421 ~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp HHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred HHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 99999999999999996 4899999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=394.90 Aligned_cols=260 Identities=38% Similarity=0.683 Sum_probs=230.7
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh---HHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
+.++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 45789999999999999999999999999999999977644321 135788999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC----ceEEeeccccccc
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW----NVKIADFGLSNIM 167 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~----~vKL~DFGls~~~ 167 (515)
.|+||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++...
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999999999999999888999999999999999999999999999999999999999877 8999999999887
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCCChh
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPG 243 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 243 (515)
..........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.......+ ..+++.
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241 (283)
T ss_dssp C--------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred cCCCcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence 66655667789999999999988776 7899999999999999999999999988888888877766554 578999
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
+.+||.+||..||.+|||+.|+++||||+...
T Consensus 242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 99999999999999999999999999998653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=417.72 Aligned_cols=254 Identities=37% Similarity=0.640 Sum_probs=214.3
Q ss_pred ccccCCCceEe-eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHH-HhCCCCCccEEEEEEEc-
Q 010214 12 VDMFLPNYKLG-KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPHIIRLYEVIET- 88 (515)
Q Consensus 12 ~~~~~~~Y~i~-~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il-~~l~hpnIv~l~~~~~~- 88 (515)
...+.++|.+. +.||+|+||+||+|.++.+|+.||||++... ..+.+|+.++ +..+||||++++++++.
T Consensus 56 ~~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~ 127 (400)
T 1nxk_A 56 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 127 (400)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence 34567889887 7899999999999999999999999998632 3567888887 55689999999999876
Q ss_pred ---CCeEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCceEEee
Q 010214 89 ---PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIAD 160 (515)
Q Consensus 89 ---~~~~~iVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~---~~~vKL~D 160 (515)
...+|+|||||+||+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence 567999999999999999998643 5999999999999999999999999999999999999997 78999999
Q ss_pred cccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH----HHHHHHhcCccCC
Q 010214 161 FGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP----NLFKKIKGGIYTL 236 (515)
Q Consensus 161 FGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~----~~~~~i~~~~~~~ 236 (515)
||++..........+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+.. .....+..+.+.+
T Consensus 208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~ 286 (400)
T 1nxk_A 208 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286 (400)
T ss_dssp CTTCEECC-----------CTTCCGGGSCCCCS-SSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred cccccccCCCCccccCCCCCCccCHhhcCCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence 999987766666678899999999999988877 78999999999999999999999875432 2556666666665
Q ss_pred C----CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 237 P----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 237 p----~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
| ..+++++.+||.+||+.||.+|||+.|+++||||...
T Consensus 287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 5 4689999999999999999999999999999999764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=407.47 Aligned_cols=267 Identities=26% Similarity=0.477 Sum_probs=219.5
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
+++|++++.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 36899999999999999999999999999999998654321 1122445799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccc
Q 010214 96 MEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~ 173 (515)
|||++| +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 999974 9999988754 5999999999999999999999999999999999999999999999999999765432 334
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC------------------
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------------ 235 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~------------------ 235 (515)
...+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+......
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 55689999999999987555589999999999999999999999998877776665442111
Q ss_pred ------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccCcccCCCCCC
Q 010214 236 ------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 285 (515)
Q Consensus 236 ------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~~~~~~~~~~ 285 (515)
.+..+++++.+||.+||+.||.+|||+.|+++||||+.........+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~ 299 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTT 299 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTS
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCC
Confidence 12357889999999999999999999999999999998766554444443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=428.77 Aligned_cols=256 Identities=31% Similarity=0.527 Sum_probs=215.8
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----- 89 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 89 (515)
+.++|++++.||+|+||+||+|.+..+|+.||||++.+.. .......++.+|+.+|+.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 4689999999999999999999999999999999997653 3445677889999999999999999999999654
Q ss_pred -CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 90 -SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 90 -~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
..+|+||||+++ +|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 468999999976 5777664 459999999999999999999999999999999999999999999999999999887
Q ss_pred cCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCC------------
Q 010214 169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL------------ 236 (515)
Q Consensus 169 ~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~------------ 236 (515)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..+...+|.......
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 216 TSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp -CCCC----CCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred CCcccCCCcccccccCHHHHcCCCC-CHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 7666778899999999999998877 789999999999999999999999988777766664321110
Q ss_pred -------------------CCC-----------CChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 237 -------------------PSH-----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 237 -------------------p~~-----------~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
|.. .++++++||.+||+.||.+|||++|+++||||+...
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 000 156799999999999999999999999999998653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=407.62 Aligned_cols=253 Identities=39% Similarity=0.693 Sum_probs=207.0
Q ss_pred cCCCceEe---eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCC
Q 010214 15 FLPNYKLG---KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPS 90 (515)
Q Consensus 15 ~~~~Y~i~---~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~ 90 (515)
+.++|.+. +.||+|+||.||+|.++.+|+.||||++.+. ....+.+|+.+++.+. ||||+++++++.+..
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 34678875 7899999999999999999999999999653 2456789999999998 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---ceEEeeccccccc
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVKIADFGLSNIM 167 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~---~vKL~DFGls~~~ 167 (515)
..|+||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999999999999999999999999999999999999999999999999998765 8999999999866
Q ss_pred ccC-CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC-------hHHHHHHHhcCccCCCC-
Q 010214 168 RDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-------IPNLFKKIKGGIYTLPS- 238 (515)
Q Consensus 168 ~~~-~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~-------~~~~~~~i~~~~~~~p~- 238 (515)
... ....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+ ..+....+..+.+.++.
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLNQNGY-DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238 (325)
T ss_dssp CC----------------------CCC-CHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred CCCCCcccccCCCcCccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence 443 34567789999999999988877 789999999999999999999997643 35677888888776653
Q ss_pred ---CCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 239 ---HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 239 ---~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.+++++++||.+||+.||.+|||+.|+++||||+..
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 689999999999999999999999999999999865
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=414.29 Aligned_cols=255 Identities=31% Similarity=0.546 Sum_probs=229.2
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh-----HHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-----EMEEKVRREIKILRLFMHPHIIRLYEVIET 88 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~-----~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 88 (515)
.+.++|++.+.||+|+||.||+|.++.+|+.||||++.+...... .....+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 456789999999999999999999999999999999987654321 123466789999999999999999999999
Q ss_pred CCeEEEEEeccCCC-CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 89 PSDIYVVMEYVKSG-ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 89 ~~~~~iVmEy~~gg-~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
.+.+++||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999999766 99999998889999999999999999999999999999999999999999999999999999988
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHH
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDL 247 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 247 (515)
..+....+.+||+.|+|||++.+..+.++++|||||||++|+|++|..||.... .........|..+++++.+|
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~l~~l 254 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKELMSL 254 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHHHHHH
T ss_pred CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHHHHHH
Confidence 777667778899999999999988877889999999999999999999997632 23344556677899999999
Q ss_pred hcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|.+||+.||.+|||+.++++||||+..
T Consensus 255 i~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 255 VSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHccCChhhCcCHHHHhcCccccCC
Confidence 999999999999999999999999754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=420.52 Aligned_cols=259 Identities=29% Similarity=0.443 Sum_probs=202.5
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----c
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE-----T 88 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~-----~ 88 (515)
.+.++|++++.||+|+||+||+|.++.+|+.||||++.+. .......+++.+|+++|+.++||||+++++++. .
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 3568899999999999999999999999999999999654 344456688999999999999999999999984 3
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
...+|+||||+ +++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 129 FDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred CceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 35799999998 56999999888889999999999999999999999999999999999999999999999999998764
Q ss_pred cC----------------------------CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh--------
Q 010214 169 DG----------------------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-------- 212 (515)
Q Consensus 169 ~~----------------------------~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-------- 212 (515)
.. ......+||+.|+|||++.+....+.++||||||||+|+|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 22 123456899999999987544444899999999999999998
Q ss_pred ---CCCCCCCCCh--------------------HHHHHHHhcCc-------------------------------cCCCC
Q 010214 213 ---GTLPFDDENI--------------------PNLFKKIKGGI-------------------------------YTLPS 238 (515)
Q Consensus 213 ---G~~Pf~~~~~--------------------~~~~~~i~~~~-------------------------------~~~p~ 238 (515)
|.++|.+.+. ......|.... ....+
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 7777766431 11111111100 01123
Q ss_pred CCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 239 ~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 568999999999999999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=412.70 Aligned_cols=259 Identities=30% Similarity=0.442 Sum_probs=213.4
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC----
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP---- 89 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 89 (515)
.+.++|++.+.||+|+||.||+|.++.+|+.||||++.+. .......+++.+|+++|+.++||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 4678999999999999999999999999999999999754 34445678899999999999999999999999766
Q ss_pred -CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 90 -SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 90 -~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
..+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred CCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 57999999996 5999999988889999999999999999999999999999999999999999999999999998764
Q ss_pred cCC-----------------------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhC-----------C
Q 010214 169 DGH-----------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-----------T 214 (515)
Q Consensus 169 ~~~-----------------------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG-----------~ 214 (515)
... ...+.+||+.|+|||++.+....+.++||||+||++|+|++| .
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 322 246778999999999975444448999999999999999984 4
Q ss_pred CCCCCCCh-----------------HHHHHHH------------------------hcCccCC-------CCCCChhHHH
Q 010214 215 LPFDDENI-----------------PNLFKKI------------------------KGGIYTL-------PSHLSPGARD 246 (515)
Q Consensus 215 ~Pf~~~~~-----------------~~~~~~i------------------------~~~~~~~-------p~~~s~~~~~ 246 (515)
++|.+.+. ......| ....... .+.+++++.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 44444320 1111111 1111111 1458999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
||.+||+.||.+|||++|+++||||+..
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred HHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 9999999999999999999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=407.75 Aligned_cols=264 Identities=27% Similarity=0.453 Sum_probs=223.9
Q ss_pred CCCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010214 9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET 88 (515)
Q Consensus 9 ~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 88 (515)
........++|++.+.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++.+
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 9 ECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRT 87 (351)
T ss_dssp CCTTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cccccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeec
Confidence 3344445789999999999999999999999999999999987654332 234567799999999999999999999977
Q ss_pred --------CCeEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEe
Q 010214 89 --------PSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIA 159 (515)
Q Consensus 89 --------~~~~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~ 159 (515)
.+.+|+||||+++ +|.+.+.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 88 KASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp C--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEEC
T ss_pred cccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEc
Confidence 4468999999975 78777765 3679999999999999999999999999999999999999999999999
Q ss_pred eccccccccc-----CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc
Q 010214 160 DFGLSNIMRD-----GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY 234 (515)
Q Consensus 160 DFGls~~~~~-----~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~ 234 (515)
|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 246 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999987642 22335568999999999998765558999999999999999999999999888777776655433
Q ss_pred CCCCC--------------------------------CChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 TLPSH--------------------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 ~~p~~--------------------------------~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..+.. .++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 33221 26779999999999999999999999999999754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=392.79 Aligned_cols=263 Identities=38% Similarity=0.636 Sum_probs=234.0
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCC------hHHHHHHHHHHHHHHhCC-CCCccEEEE
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN------MEMEEKVRREIKILRLFM-HPHIIRLYE 84 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~------~~~~~~i~~Ei~il~~l~-hpnIv~l~~ 84 (515)
...+.++|++.+.||+|+||.||+|.++.+|+.||||++....... ....+.+.+|+.+++++. ||||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 4557899999999999999999999999999999999997654211 233567889999999996 999999999
Q ss_pred EEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccc
Q 010214 85 VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 85 ~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
++.+.+..|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999999999999889999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCccccCCCCCCccCCCcccC-----CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC--
Q 010214 165 NIMRDGHFLKTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP-- 237 (515)
Q Consensus 165 ~~~~~~~~~~~~~gt~~Y~aPE~i~~-----~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p-- 237 (515)
.....+......+||+.|+|||++.+ ....+.++||||||+++|+|++|..||...+.......+..+....+
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1phk_A 172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 251 (298)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred hhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence 88776666677889999999999852 22237899999999999999999999999888888888877766554
Q ss_pred --CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 238 --SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 238 --~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..+++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus 252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 252 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 3578999999999999999999999999999999865
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=410.78 Aligned_cols=255 Identities=37% Similarity=0.630 Sum_probs=225.4
Q ss_pred CCCceE--eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 16 LPNYKL--GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 16 ~~~Y~i--~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
.+.|.+ .+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 162 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV 162 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 345666 678999999999999999999999999997643 244678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE--CCCCceEEeecccccccccC
Q 010214 94 VVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL--DSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl--~~~~~vKL~DFGls~~~~~~ 170 (515)
+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 163 lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 163 LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp EEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 999999999999998754 469999999999999999999999999999999999999 66789999999999988776
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCCChhHHH
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARD 246 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~ 246 (515)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....+.++ ..+++++++
T Consensus 243 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 321 (373)
T 2x4f_A 243 EKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKE 321 (373)
T ss_dssp CBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHH
T ss_pred cccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHH
Confidence 66677789999999999987766 7899999999999999999999999998888888887766554 468999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
||.+||+.||.+|||+.|+++||||+..
T Consensus 322 li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 322 FISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 9999999999999999999999999854
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=395.58 Aligned_cols=256 Identities=39% Similarity=0.716 Sum_probs=229.9
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence 456899999999999999999999999999999999975432 23457889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---CCCCceEEeecccccccccC
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL---DSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl---~~~~~vKL~DFGls~~~~~~ 170 (515)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.....+
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 999999999999999988999999999999999999999999999999999999999 78899999999998765433
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCCChhHHH
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARD 246 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~ 246 (515)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+...+...+..+.+.++ ..+++++.+
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD 240 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred -ccccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence 3445679999999999988776 7899999999999999999999999988888888888765543 568999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
||.+||..||.+|||+.|+++||||+..
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 241 FICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 9999999999999999999999999865
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=405.19 Aligned_cols=258 Identities=40% Similarity=0.710 Sum_probs=232.1
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCC-----hHHHHHHHHHHHHHHhC-CCCCccEEEEEEEc
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-----MEMEEKVRREIKILRLF-MHPHIIRLYEVIET 88 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~ 88 (515)
+.++|++.+.||+|+||.||+|.++.+|+.||||++....... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 4467999999999999999999999999999999997653211 12356788999999999 79999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
.+..|+||||++|++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++....
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999998887
Q ss_pred cCCccccCCCCCCccCCCcccCC-----ccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CC
Q 010214 169 DGHFLKTSCGSPNYAAPEVISGK-----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SH 239 (515)
Q Consensus 169 ~~~~~~~~~gt~~Y~aPE~i~~~-----~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~ 239 (515)
........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.+.+.......+..+.+..+ ..
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 331 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD 331 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSS
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence 76667788999999999998632 1237899999999999999999999999888888888877766554 47
Q ss_pred CChhHHHHhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 240 ~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
+++++.+||.+||+.||.+|||+.|+++||||+
T Consensus 332 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 889999999999999999999999999999996
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=407.40 Aligned_cols=270 Identities=33% Similarity=0.544 Sum_probs=228.7
Q ss_pred CCCCCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccC--ChHHHHHHHHHHHHHHhCCCCCccEEEE
Q 010214 7 RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--NMEMEEKVRREIKILRLFMHPHIIRLYE 84 (515)
Q Consensus 7 ~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~hpnIv~l~~ 84 (515)
.....+..+.++|++.+.||+|+||.||+|.+..+++.||+|++.+.... .....+.+.+|+.+++.++||||+++++
T Consensus 16 ~q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 95 (345)
T 3hko_A 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE 95 (345)
T ss_dssp CCCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeeh
Confidence 34445566789999999999999999999999999999999999765432 2345678999999999999999999999
Q ss_pred EEEcCCeEEEEEeccCCCCHHHHHHH----------------------------------------hCCCCHHHHHHHHH
Q 010214 85 VIETPSDIYVVMEYVKSGELFDYIVE----------------------------------------KGRLQEDEARNFFQ 124 (515)
Q Consensus 85 ~~~~~~~~~iVmEy~~gg~L~~~i~~----------------------------------------~~~l~e~~~~~i~~ 124 (515)
++.+.+..|+||||++||+|.+++.. ...+++..++.++.
T Consensus 96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 175 (345)
T 3hko_A 96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175 (345)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred hhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence 99999999999999999999998842 11246788999999
Q ss_pred HHHHHHHHHHHCCceeccCCCCcEEECCCC--ceEEeecccccccccCC-----ccccCCCCCCccCCCcccCC-ccCCC
Q 010214 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKW--NVKIADFGLSNIMRDGH-----FLKTSCGSPNYAAPEVISGK-LYAGP 196 (515)
Q Consensus 125 qil~aL~yLH~~gIvHrDLkpeNILl~~~~--~vKL~DFGls~~~~~~~-----~~~~~~gt~~Y~aPE~i~~~-~~~~~ 196 (515)
||+.||.|||++||+||||||+|||++.++ .+||+|||++....... .....+||+.|+|||++.+. ...+.
T Consensus 176 qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 176 QIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 999999999999999999999999998776 89999999998654321 23566899999999999752 23378
Q ss_pred cceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCC----CCChhHHHHhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 197 ~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
++|||||||++|+|++|..||.+.+.......+......++. .+++++.+||.+||+.||.+|||+.|+++||||+
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~ 335 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWIS 335 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhc
Confidence 999999999999999999999998888888888776654432 4799999999999999999999999999999998
Q ss_pred cccC
Q 010214 273 AHLP 276 (515)
Q Consensus 273 ~~~~ 276 (515)
....
T Consensus 336 ~~~~ 339 (345)
T 3hko_A 336 QFSD 339 (345)
T ss_dssp TTSS
T ss_pred cChH
Confidence 7643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=389.98 Aligned_cols=260 Identities=35% Similarity=0.675 Sum_probs=227.2
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 457899999999999999999999999999999999755432 345788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC---C
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---H 171 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~---~ 171 (515)
||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 9999999999999987788999999999999999999999999999999999999999999999999999866432 2
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH-HHHHHHhcCccC--CCCCCChhHHHHh
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYT--LPSHLSPGARDLI 248 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~-~~~~~i~~~~~~--~p~~~s~~~~~li 248 (515)
.....+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...... .....+...... .+..+++++.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 3456689999999999988776677999999999999999999999876543 233334333322 2346899999999
Q ss_pred cccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 249 PRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
.+||+.||.+|||+.|+++||||+....
T Consensus 243 ~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 243 HKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHCCCCchhCCCHHHHhcCccccChhh
Confidence 9999999999999999999999987643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=402.57 Aligned_cols=264 Identities=25% Similarity=0.418 Sum_probs=227.0
Q ss_pred CCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010214 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (515)
Q Consensus 10 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 89 (515)
.....+.++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp CCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred CCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 34456789999999999999999999999999999999999877666667778899999999999999999999998665
Q ss_pred C----eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 90 S----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 90 ~----~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
. ..|+||||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 85 TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp ETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred CCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 4 359999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred ccccCC----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCC----C
Q 010214 166 IMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL----P 237 (515)
Q Consensus 166 ~~~~~~----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~----p 237 (515)
...... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....... +
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence 764432 2234579999999999998876 789999999999999999999999988777666655544332 2
Q ss_pred CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 238 ~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..+++++.+||.+||..||.+||+..+++.|+|++..
T Consensus 244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 5689999999999999999999999999999999854
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=407.37 Aligned_cols=256 Identities=30% Similarity=0.488 Sum_probs=217.7
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC----
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP---- 89 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 89 (515)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+++.+|+++++.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 45689999999999999999999999999999999986543 3445567899999999999999999999999765
Q ss_pred --CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 90 --SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 90 --~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
..+|+||||+ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 3469999999 7899999875 67999999999999999999999999999999999999999999999999999875
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-------------
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------------- 234 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~------------- 234 (515)
.. .....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+.....
T Consensus 179 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 256 (367)
T 1cm8_A 179 DS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256 (367)
T ss_dssp CS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred cc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence 43 345678999999999998744448999999999999999999999999887766665543211
Q ss_pred ------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 ------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 ------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..+...++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 1234678999999999999999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=402.75 Aligned_cols=255 Identities=22% Similarity=0.394 Sum_probs=221.9
Q ss_pred CCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-----CCCccEEEE
Q 010214 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-----HPHIIRLYE 84 (515)
Q Consensus 10 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----hpnIv~l~~ 84 (515)
.....+.++|++.+.||+|+||+||+|.+..+++.||||++... ........+|+.+++.+. ||||+++++
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 34456679999999999999999999999999999999998642 234567788999999997 999999999
Q ss_pred EEEcCCeEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC----------
Q 010214 85 VIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---------- 152 (515)
Q Consensus 85 ~~~~~~~~~iVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~---------- 152 (515)
++...+..|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence 999999999999999 889999998754 5999999999999999999999999999999999999975
Q ss_pred ---------------CCceEEeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCC
Q 010214 153 ---------------KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF 217 (515)
Q Consensus 153 ---------------~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf 217 (515)
++.+||+|||++..... ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSC
T ss_pred hcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCC-CCccchHHHHHHHHHHHHCCCCC
Confidence 78999999999976543 3456789999999999998877 78999999999999999999999
Q ss_pred CCCChHHHHHHHhcCccCCCC----------------------------------------------CCChhHHHHhccc
Q 010214 218 DDENIPNLFKKIKGGIYTLPS----------------------------------------------HLSPGARDLIPRM 251 (515)
Q Consensus 218 ~~~~~~~~~~~i~~~~~~~p~----------------------------------------------~~s~~~~~li~~m 251 (515)
...+..+....+.......|. ..++.+.+||.+|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 339 (360)
T 3llt_A 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI 339 (360)
T ss_dssp CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence 988777666655443332221 1236788999999
Q ss_pred CCCCCCCCCCHHHHhcCcccc
Q 010214 252 LIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~hp~f~ 272 (515)
|+.||.+|||+.|+++||||+
T Consensus 340 L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 340 LQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CCSSGGGSCCHHHHTTSGGGC
T ss_pred hcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999995
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=396.63 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=210.2
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHH-HhCCCCCccEEEEEEEcCCeE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il-~~l~hpnIv~l~~~~~~~~~~ 92 (515)
.+.++|++.+.||+|+||+||+|.+..+|+.||||++.......... ....+|+..+ +..+||||+++++++.+.+.+
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH-HHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 34478999999999999999999999999999999987654433333 3444455444 555899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|+||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999999 669999887654 69999999999999999999999999999999999999999999999999998776666
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc--CCCCCCChhHHHHhc
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--TLPSHLSPGARDLIP 249 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~ 249 (515)
.....+||+.|+|||++.+ .+ +.++||||+||++|+|++|..||.+.. ....+..+.. .++..+++++.+||.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~ 286 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLSSELRSVLV 286 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred CCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCCHHHHHHHH
Confidence 6667789999999999987 34 789999999999999999976665432 2333333322 235678999999999
Q ss_pred ccCCCCCCCCCCHHHHhcCccccc
Q 010214 250 RMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
+||+.||.+|||+.|+++||||++
T Consensus 287 ~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 287 MMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHcCCChhhCcCHHHHHhCccccC
Confidence 999999999999999999999974
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=402.44 Aligned_cols=265 Identities=33% Similarity=0.532 Sum_probs=229.0
Q ss_pred CCCccccCCCceEe-eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEE
Q 010214 9 SSGVDMFLPNYKLG-KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVI 86 (515)
Q Consensus 9 ~~~~~~~~~~Y~i~-~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~ 86 (515)
-...+.+.++|.+. +.||+|+||.||+|.++.+|+.||+|++.+..... .....+.+|+.+++.+. ||||+++++++
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 34555677889998 89999999999999999999999999997654332 33567889999999996 69999999999
Q ss_pred EcCCeEEEEEeccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCceEEeec
Q 010214 87 ETPSDIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIADF 161 (515)
Q Consensus 87 ~~~~~~~iVmEy~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~---~~~vKL~DF 161 (515)
.+.+.+|+||||++||+|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 999999999999999999999854 367999999999999999999999999999999999999998 789999999
Q ss_pred ccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----
Q 010214 162 GLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP---- 237 (515)
Q Consensus 162 Gls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p---- 237 (515)
|++............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+
T Consensus 179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 257 (327)
T 3lm5_A 179 GMSRKIGHACELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETF 257 (327)
T ss_dssp GGCEEC---------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred ccccccCCccccccccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhh
Confidence 99988776666667789999999999988876 7899999999999999999999999888888777776554443
Q ss_pred CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 238 ~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
..+++.+.+||.+||+.||.+|||++++++||||+...
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 258 SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 46889999999999999999999999999999998753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=408.84 Aligned_cols=255 Identities=29% Similarity=0.427 Sum_probs=218.1
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc---
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--- 88 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--- 88 (515)
++...++|++++.||+|+||+||+|.+..+|+.||||++...... ..+|+.+++.++||||+++++++.+
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~ 74 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGD 74 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCc
Confidence 345578999999999999999999999999999999998654322 2479999999999999999999843
Q ss_pred -----------------------------------CCeEEEEEeccCCCCHHHHHH----HhCCCCHHHHHHHHHHHHHH
Q 010214 89 -----------------------------------PSDIYVVMEYVKSGELFDYIV----EKGRLQEDEARNFFQQIISG 129 (515)
Q Consensus 89 -----------------------------------~~~~~iVmEy~~gg~L~~~i~----~~~~l~e~~~~~i~~qil~a 129 (515)
...+++||||++| +|.+.+. ..+.+++..++.++.||+.|
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a 153 (383)
T 3eb0_A 75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRA 153 (383)
T ss_dssp -----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence 3458999999985 7777665 35789999999999999999
Q ss_pred HHHHHHCCceeccCCCCcEEEC-CCCceEEeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHH
Q 010214 130 VEYCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY 208 (515)
Q Consensus 130 L~yLH~~gIvHrDLkpeNILl~-~~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily 208 (515)
|.|||++||+||||||+|||++ .++.+||+|||++............+||+.|+|||++.+....+.++||||+||++|
T Consensus 154 L~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 154 VGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 9999999999999999999998 688999999999998777766777889999999999987664589999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcCc-----------------------------cCCCCCCChhHHHHhcccCCCCCCCC
Q 010214 209 ALLCGTLPFDDENIPNLFKKIKGGI-----------------------------YTLPSHLSPGARDLIPRMLIVDPMKR 259 (515)
Q Consensus 209 ~lltG~~Pf~~~~~~~~~~~i~~~~-----------------------------~~~p~~~s~~~~~li~~mL~~dP~~R 259 (515)
+|++|..||.+.+..+....+.... ..+|...++++.+||.+||+.||.+|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 9999999999988777666654311 01455688999999999999999999
Q ss_pred CCHHHHhcCcccccc
Q 010214 260 ITIPEIRQHPWFQAH 274 (515)
Q Consensus 260 pt~~eil~hp~f~~~ 274 (515)
||+.|+++||||+..
T Consensus 314 ~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 314 INPYEAMAHPFFDHL 328 (383)
T ss_dssp CCHHHHHTSGGGHHH
T ss_pred CCHHHHhcCHHHHHH
Confidence 999999999999865
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=391.29 Aligned_cols=260 Identities=28% Similarity=0.432 Sum_probs=225.0
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
.+.+.++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++++.+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC 85 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence 44567899999999999999999999999999999999987766666777899999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
+|+||||++|++|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998765433
Q ss_pred --ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-----CCCCCCChhH
Q 010214 172 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-----TLPSHLSPGA 244 (515)
Q Consensus 172 --~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-----~~p~~~s~~~ 244 (515)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......+...... ..+..+++.+
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL 244 (294)
T ss_dssp ---------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHH
T ss_pred ccccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHH
Confidence 2344679999999999998876 7899999999999999999999999887665554444332 2356789999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
.++|.+||..||.+||+..+.+.+.|..
T Consensus 245 ~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 245 SNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 9999999999999999766666666653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=394.55 Aligned_cols=252 Identities=30% Similarity=0.545 Sum_probs=224.7
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
.|...+.||+|+||.||+|.++.+|+.||||++...... ..+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 488889999999999999999999999999999765432 34678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-CccccC
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTS 176 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~ 176 (515)
|++|++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 123 ~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 201 (321)
T 2c30_A 123 FLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 201 (321)
T ss_dssp CCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred cCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence 999999999885 457999999999999999999999999999999999999999999999999998876543 234566
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---CCCCCCChhHHHHhcccCC
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~mL~ 253 (515)
+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..... ..+..+++++.+||.+||+
T Consensus 202 ~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 280 (321)
T 2c30_A 202 VGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLV 280 (321)
T ss_dssp CSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSC
T ss_pred cCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHcc
Confidence 89999999999988776 7899999999999999999999999888777777765543 2234678999999999999
Q ss_pred CCCCCCCCHHHHhcCcccccc
Q 010214 254 VDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.||.+|||+.|+++||||+..
T Consensus 281 ~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 281 RDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp SSTTTSCCHHHHHTSGGGGGC
T ss_pred CChhhCcCHHHHhcChhhccC
Confidence 999999999999999999754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=394.27 Aligned_cols=263 Identities=37% Similarity=0.694 Sum_probs=229.3
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCC-hHHHHHHHHHHHHHHhCCCCCccEEEEEE--EcCC
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-MEMEEKVRREIKILRLFMHPHIIRLYEVI--ETPS 90 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~-~~~~~~i~~Ei~il~~l~hpnIv~l~~~~--~~~~ 90 (515)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.+..... ......+.+|+.+++.++||||+++++++ .+..
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 35789999999999999999999999999999999997654321 23467899999999999999999999998 4456
Q ss_pred eEEEEEeccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 91 DIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
..|+||||++++ |.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 799999999876 8888775 4579999999999999999999999999999999999999999999999999998764
Q ss_pred c---CCccccCCCCCCccCCCcccCCc-cCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhH
Q 010214 169 D---GHFLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGA 244 (515)
Q Consensus 169 ~---~~~~~~~~gt~~Y~aPE~i~~~~-~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 244 (515)
. ........||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.+.+.......+..+...+|..+++++
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 240 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHH
Confidence 3 22334667999999999997643 3367999999999999999999999999999999999999889999999999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcCcccccccCc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~~ 277 (515)
.+||.+||..||.+|||+.|+++||||+...+.
T Consensus 241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred HHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 999999999999999999999999999876543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=415.79 Aligned_cols=260 Identities=40% Similarity=0.694 Sum_probs=214.7
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCC-----hHHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-----MEMEEKVRREIKILRLFMHPHIIRLYEVIET 88 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 88 (515)
.+.++|.+.+.||+|+||+||+|.+..+++.||+|++.+..... ......+.+|+.+|++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34689999999999999999999999999999999998764321 1223457899999999999999999999865
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---ceEEeeccccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVKIADFGLSN 165 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~---~vKL~DFGls~ 165 (515)
+..|+||||+++|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 45899999999999999998888999999999999999999999999999999999999997554 59999999999
Q ss_pred ccccCCccccCCCCCCccCCCcccC--CccCCCcceeehhHHHHHHHHhCCCCCCCCCh-HHHHHHHhcCccCCC----C
Q 010214 166 IMRDGHFLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGGIYTLP----S 238 (515)
Q Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~i~~--~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~-~~~~~~i~~~~~~~p----~ 238 (515)
.........+.+||+.|+|||++.+ ....+.++|||||||++|+|++|..||..... ..+...+..+.+..+ .
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 370 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 370 (419)
T ss_dssp SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHT
T ss_pred ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhc
Confidence 8877666778899999999999864 22236799999999999999999999986543 345566666665543 4
Q ss_pred CCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 239 ~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 371 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 689999999999999999999999999999999753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=400.25 Aligned_cols=260 Identities=29% Similarity=0.471 Sum_probs=221.8
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 35789999999999999999999999999999999986554 33445677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~ 172 (515)
+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... +..
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 9999999999999888788899999999999999999999999999999999999999999999999999976644 334
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc------------------
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------------------ 234 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~------------------ 234 (515)
....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 45678999999999998765558999999999999999999999998876665554432110
Q ss_pred -CC------------CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 -TL------------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 -~~------------p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.. .+.+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 11 13578999999999999999999999999999999753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=403.84 Aligned_cols=256 Identities=32% Similarity=0.522 Sum_probs=211.5
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC----
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS---- 90 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~---- 90 (515)
+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 5689999999999999999999999999999999997643 34455678899999999999999999999997665
Q ss_pred --eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 91 --DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 91 --~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
.+|+||||+++ +|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 78999999975 7888885 569999999999999999999999999999999999999999999999999998776
Q ss_pred cCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCC------------
Q 010214 169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL------------ 236 (515)
Q Consensus 169 ~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~------------ 236 (515)
......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 179 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 179 TSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp -----------CTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred cccccCCceecCCccCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 6555667789999999999998876 789999999999999999999999988777766665432111
Q ss_pred ------------------------CC------CCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 237 ------------------------PS------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 237 ------------------------p~------~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
|. ..++++++||.+||+.||.+|||++|+++||||+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 00 0156789999999999999999999999999998653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=384.29 Aligned_cols=254 Identities=22% Similarity=0.366 Sum_probs=218.7
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 92 (515)
.+.++|++.+.||+|+||+||+|.+..+++.||+|++....... .....+.+|+..+..+ +||||+++++++.+++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 45688999999999999999999999999999999998654433 3457788999999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC---------------
Q 010214 93 YVVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK--------------- 153 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~----~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~--------------- 153 (515)
|+||||++|++|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999999865 679999999999999999999999999999999999999844
Q ss_pred ----CceEEeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHH
Q 010214 154 ----WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI 229 (515)
Q Consensus 154 ----~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i 229 (515)
..+||+|||++...... ....||+.|+|||++.+....++++|||||||++|+|++|..|+.... ....+
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~ 240 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEI 240 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHH
T ss_pred cCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHH
Confidence 47999999999876543 345699999999999876555689999999999999999998875543 23334
Q ss_pred hcC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 230 KGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 230 ~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..+ ...+|..+++++.+||.+||..||.+|||+.|+++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 241 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 433 346778899999999999999999999999999999999854
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=397.33 Aligned_cols=259 Identities=32% Similarity=0.535 Sum_probs=223.1
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC----
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP---- 89 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 89 (515)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+++++.++||||+++++++...
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 34579999999999999999999999999999999997432 344567889999999999999999999999665
Q ss_pred -CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 90 -SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 90 -~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
...|+||||+.| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 102 ~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 102 MKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp CCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 469999999974 99998864 579999999999999999999999999999999999999999999999999998765
Q ss_pred cCC----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC---------
Q 010214 169 DGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT--------- 235 (515)
Q Consensus 169 ~~~----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~--------- 235 (515)
... .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 332 2345689999999999876554588999999999999999999999988877766665421110
Q ss_pred ----------------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 236 ----------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 236 ----------------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
.+..+++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 12467899999999999999999999999999999987643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=400.88 Aligned_cols=263 Identities=29% Similarity=0.423 Sum_probs=216.5
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh--HHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM--EMEEKVRREIKILRLFMHPHIIRLYEVIET 88 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~--~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 88 (515)
.+....++|++.+.||+|+||.||+|.+..+|+.||||++........ .....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp ---------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 345567899999999999999999999999999999999975433221 123467899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
.+..|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999999986 898888754 36999999999999999999999999999999999999999999999999999876
Q ss_pred ccC-CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-----------
Q 010214 168 RDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT----------- 235 (515)
Q Consensus 168 ~~~-~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~----------- 235 (515)
... ......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+......++......
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 433 34456789999999999977654578999999999999999999999998877776666432110
Q ss_pred -----------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 236 -----------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 236 -----------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
....+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 014567899999999999999999999999999999865
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=383.18 Aligned_cols=258 Identities=26% Similarity=0.486 Sum_probs=223.6
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc----
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET---- 88 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~---- 88 (515)
......|++.+.||+|+||.||+|.+..++..||+|++...... ....+.+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCC
Confidence 33456699999999999999999999999999999999765543 3456889999999999999999999999865
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEC-CCCceEEeeccccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLD-SKWNVKIADFGLSN 165 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDLkpeNILl~-~~~~vKL~DFGls~ 165 (515)
...+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 4568999999999999999998899999999999999999999999999 99999999999998 78999999999997
Q ss_pred ccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC-ChHHHHHHHhcCcc--CCCCCCCh
Q 010214 166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIY--TLPSHLSP 242 (515)
Q Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~s~ 242 (515)
.... ......+||+.|+|||++.+. + +.++|||||||++|+|++|..||... +.......+..+.. ..+...++
T Consensus 181 ~~~~-~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (290)
T 1t4h_A 181 LKRA-SFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp GCCT-TSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred cccc-cccccccCCcCcCCHHHHhcc-C-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence 5543 334566899999999998865 4 78999999999999999999999874 44455555555432 34567789
Q ss_pred hHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 243 ~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
++.+||.+||+.||.+|||+.|+++||||++.
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 99999999999999999999999999999753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=388.25 Aligned_cols=259 Identities=41% Similarity=0.742 Sum_probs=233.1
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
+.+.++|++.+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.++++++||||+++++++.+.+.+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 456689999999999999999999999999999999997654432 2356788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC---CceEEeeccccccccc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRD 169 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~---~~vKL~DFGls~~~~~ 169 (515)
|+||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 9999999999999999988899999999999999999999999999999999999999764 4699999999987766
Q ss_pred CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCCChhHH
Q 010214 170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGAR 245 (515)
Q Consensus 170 ~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 245 (515)
........||+.|+|||++.+. + +.++||||||+++|+|++|..||.+.+.......+..+.+..+ ..+++++.
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T 2wei_A 177 NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (287)
T ss_dssp CSSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred CCccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence 5555566789999999999875 4 7899999999999999999999999988888888887765443 56899999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+||.+||..||.+|||+.|+++||||++.
T Consensus 255 ~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 255 DLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999999999865
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=408.39 Aligned_cols=258 Identities=29% Similarity=0.442 Sum_probs=219.1
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC------CCCCccEEEEE
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF------MHPHIIRLYEV 85 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l------~hpnIv~l~~~ 85 (515)
.+.+..+|++.+.||+|+||+||+|.+..+++.||||++... ......+.+|+++++.+ +||||++++++
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 345678899999999999999999999999999999998643 23456778899888877 57799999999
Q ss_pred EEcCCeEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc--eEEeec
Q 010214 86 IETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN--VKIADF 161 (515)
Q Consensus 86 ~~~~~~~~iVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~--vKL~DF 161 (515)
+...+.+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 999999999999996 59999998754 4999999999999999999999999999999999999999887 999999
Q ss_pred ccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC------
Q 010214 162 GLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------ 235 (515)
Q Consensus 162 Gls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~------ 235 (515)
|++.... ....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 247 G~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 247 GSSCYEH--QRVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323 (429)
T ss_dssp TTCEETT--CCCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccceecC--CcccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 9997543 33456789999999999998877 79999999999999999999999998877665554421100
Q ss_pred -----------------------------------------------------CCCCCChhHHHHhcccCCCCCCCCCCH
Q 010214 236 -----------------------------------------------------LPSHLSPGARDLIPRMLIVDPMKRITI 262 (515)
Q Consensus 236 -----------------------------------------------------~p~~~s~~~~~li~~mL~~dP~~Rpt~ 262 (515)
++...++++.+||.+||+.||.+|||+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 112347889999999999999999999
Q ss_pred HHHhcCcccccccCc
Q 010214 263 PEIRQHPWFQAHLPR 277 (515)
Q Consensus 263 ~eil~hp~f~~~~~~ 277 (515)
.|+++||||+...+.
T Consensus 404 ~e~L~Hpw~~~~~~~ 418 (429)
T 3kvw_A 404 GQALRHPWLRRRLPK 418 (429)
T ss_dssp HHHHTSTTTC-----
T ss_pred HHHhCChhhccCCCC
Confidence 999999999976543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=390.49 Aligned_cols=250 Identities=27% Similarity=0.486 Sum_probs=215.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEc--CCeE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIET--PSDI 92 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~--~~~~ 92 (515)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.+++.++ ||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 478999999999999999999999999999999986432 367889999999998 9999999999988 6679
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-ceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~-~vKL~DFGls~~~~~~~ 171 (515)
++||||+++++|.+++. .+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....+.
T Consensus 109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999999874 489999999999999999999999999999999999999776 89999999998877776
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC-hHHHHHH-------------HhcCccCC-
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKK-------------IKGGIYTL- 236 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~-~~~~~~~-------------i~~~~~~~- 236 (515)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.... ....... +.......
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 67778999999999999874445899999999999999999999995432 2222111 11111111
Q ss_pred -----------------------CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 237 -----------------------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 237 -----------------------p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 12379999999999999999999999999999999865
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=395.70 Aligned_cols=253 Identities=28% Similarity=0.387 Sum_probs=223.4
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
+.|++.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999998765555556678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 97 EYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~-~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
||+. |+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~~ 209 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANS 209 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCC
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---CCc
Confidence 9997 58888875 456799999999999999999999999999999999999999999999999999976643 245
Q ss_pred CCCCCCccCCCccc---CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC--CCCCCChhHHHHhcc
Q 010214 176 SCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT--LPSHLSPGARDLIPR 250 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~---~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~ 250 (515)
.+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+.......+...... .+..+++.+.+||.+
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 288 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 288 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 68999999999985 3444 78999999999999999999999988776666666554332 245789999999999
Q ss_pred cCCCCCCCCCCHHHHhcCcccccc
Q 010214 251 MLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
||+.||.+|||+.++++||||...
T Consensus 289 ~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 289 CLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HcccChhhCcCHHHHhhChhhhcc
Confidence 999999999999999999999754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=398.44 Aligned_cols=255 Identities=27% Similarity=0.434 Sum_probs=212.6
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC---
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS--- 90 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~--- 90 (515)
.+.++|++.+.||+|+||.||+|.++.+|+.||||++.... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 35678999999999999999999999999999999997544 2345678999999999999999999999985543
Q ss_pred ------------------------------------------------------eEEEEEeccCCCCHHHHHHHhCC---
Q 010214 91 ------------------------------------------------------DIYVVMEYVKSGELFDYIVEKGR--- 113 (515)
Q Consensus 91 ------------------------------------------------------~~~iVmEy~~gg~L~~~i~~~~~--- 113 (515)
.+|+|||||+|++|.+++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 38999999999999999987543
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-------------ccccCCCCC
Q 010214 114 LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-------------FLKTSCGSP 180 (515)
Q Consensus 114 l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-------------~~~~~~gt~ 180 (515)
.++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....+||+
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 5666799999999999999999999999999999999999999999999998765432 234457999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-CCCCCChhHHHHhcccCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLIVDPMKR 259 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~mL~~dP~~R 259 (515)
.|+|||++.+..+ +.++|||||||++|+|++|..|+.. .......+.....+ .+...++++.+||.+||+.||.+|
T Consensus 241 ~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 241 LYMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp GGSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred CccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence 9999999998877 7899999999999999998777532 12233333333221 123457889999999999999999
Q ss_pred CCHHHHhcCccccc
Q 010214 260 ITIPEIRQHPWFQA 273 (515)
Q Consensus 260 pt~~eil~hp~f~~ 273 (515)
||+.|+++||||++
T Consensus 318 ps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 318 PEATDIIENAIFEN 331 (332)
T ss_dssp CCHHHHHHSTTCCC
T ss_pred CCHHHHhhchhhhc
Confidence 99999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=398.72 Aligned_cols=257 Identities=25% Similarity=0.441 Sum_probs=222.6
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 44688999999999999999999999999999999997643 3455678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
+||||++|++|.+++...+.+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++...... .
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 186 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M 186 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-c
Confidence 9999999999999999989999999999999999999999985 9999999999999999999999999998765432 3
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHH------------------------
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKK------------------------ 228 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~------------------------ 228 (515)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred ccCCCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 345689999999999998876 7899999999999999999999987665443221
Q ss_pred ------------------HhcCc-cCC-CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 229 ------------------IKGGI-YTL-PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 229 ------------------i~~~~-~~~-p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+.... ... +..++.++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 11111 111 23478899999999999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=394.40 Aligned_cols=258 Identities=41% Similarity=0.716 Sum_probs=219.3
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccC-----ChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-----NMEMEEKVRREIKILRLFMHPHIIRLYEVIET 88 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~-----~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 88 (515)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 4567899999999999999999999999999999999765432 12234568899999999999999999999977
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc---eEEeeccccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSN 165 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~---vKL~DFGls~ 165 (515)
+. .|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred Cc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 65 8999999999999999988889999999999999999999999999999999999999987665 9999999998
Q ss_pred ccccCCccccCCCCCCccCCCccc---CCccCCCcceeehhHHHHHHHHhCCCCCCCCChH-HHHHHHhcCccCCC----
Q 010214 166 IMRDGHFLKTSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTLP---- 237 (515)
Q Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~i~---~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~-~~~~~i~~~~~~~p---- 237 (515)
...........+||+.|+|||++. +..+ +.++|||||||++|+|++|..||...... .+...+..+....+
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244 (322)
T ss_dssp ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTC-TTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred ecccccccccccCCcCccCchhhccCCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence 876655556678999999999974 3334 78999999999999999999999865433 44455555554432
Q ss_pred CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 238 ~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
..+++++.+||.+||..||.+|||+.++++||||+.
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 568999999999999999999999999999999964
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=386.19 Aligned_cols=259 Identities=26% Similarity=0.414 Sum_probs=206.1
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
+...++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.++...++.++||||+++++++.+++..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 4456899999999999999999999999999999999975432 223344555666668889999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 93 YVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
|+||||++| +|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999975 88887754 56799999999999999999999998 9999999999999999999999999999887
Q ss_pred ccCCccccCCCCCCccCCCcc----cCCccCCCcceeehhHHHHHHHHhCCCCCCCC-Ch-HHHHHHHhcCccCCC-CCC
Q 010214 168 RDGHFLKTSCGSPNYAAPEVI----SGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-NI-PNLFKKIKGGIYTLP-SHL 240 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i----~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~-~~-~~~~~~i~~~~~~~p-~~~ 240 (515)
.........+||+.|+|||++ .+..+ +.++||||+||++|+|++|..||... .. ......+.......+ ..+
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF 239 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--C-CHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTS
T ss_pred cccccccccCCCccccChhhcChhhcCcCC-CcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccC
Confidence 666555667899999999997 33334 78999999999999999999999863 32 333333444433333 468
Q ss_pred ChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 241 s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 9999999999999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=400.32 Aligned_cols=259 Identities=32% Similarity=0.572 Sum_probs=225.2
Q ss_pred CCCceEeeeecccCceEEEEEEEc---CCCcEEEEEEecccccC-ChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~---~tg~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~ 90 (515)
.++|++.+.||+|+||.||+|.+. .+|+.||||++.+.... .....+.+.+|+.+++.+ .||||+++++++.+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 479999999999999999999984 58999999999764321 112234567899999999 6999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.+|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 99999999999999999999899999999999999999999999999999999999999999999999999999865432
Q ss_pred --CccccCCCCCCccCCCcccCC-ccCCCcceeehhHHHHHHHHhCCCCCCCC----ChHHHHHHHhcCccCCCCCCChh
Q 010214 171 --HFLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPFDDE----NIPNLFKKIKGGIYTLPSHLSPG 243 (515)
Q Consensus 171 --~~~~~~~gt~~Y~aPE~i~~~-~~~~~~~DIwSlGvily~lltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~ 243 (515)
......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... ....+...+......+|..+++.
T Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (355)
T 1vzo_A 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 292 (355)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCHH
Confidence 223456899999999999863 33478999999999999999999999743 34556666777777888999999
Q ss_pred HHHHhcccCCCCCCCCC-----CHHHHhcCcccccc
Q 010214 244 ARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rp-----t~~eil~hp~f~~~ 274 (515)
+.+||.+||..||.+|| |+.|+++||||+..
T Consensus 293 ~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 293 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp HHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 99999999999999999 99999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=401.78 Aligned_cols=256 Identities=30% Similarity=0.447 Sum_probs=217.7
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC--CCCccEEEEEEEcCCeE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM--HPHIIRLYEVIETPSDI 92 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~--hpnIv~l~~~~~~~~~~ 92 (515)
...+|++.+.||+|+||+||+|.+.. ++.||||++..... .....+.+.+|+.+|+.++ ||||+++++++...+.+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34569999999999999999999864 89999999976554 3455688999999999997 59999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~- 171 (515)
|+||| +.+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 99999 55789999999988999999999999999999999999999999999999996 5799999999998765432
Q ss_pred --ccccCCCCCCccCCCcccCC----------ccCCCcceeehhHHHHHHHHhCCCCCCCCC-hHHHHHHHhcCc--cCC
Q 010214 172 --FLKTSCGSPNYAAPEVISGK----------LYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGI--YTL 236 (515)
Q Consensus 172 --~~~~~~gt~~Y~aPE~i~~~----------~~~~~~~DIwSlGvily~lltG~~Pf~~~~-~~~~~~~i~~~~--~~~ 236 (515)
...+.+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.... .......+.... ..+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 289 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCC
Confidence 23567899999999998752 223789999999999999999999998753 334445555443 356
Q ss_pred CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 237 PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 237 p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|...+.++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 290 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 77778999999999999999999999999999999854
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=402.82 Aligned_cols=254 Identities=30% Similarity=0.421 Sum_probs=214.6
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC--
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-- 90 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-- 90 (515)
+....+|++.+.||+|+||+||+|.+..+++ ||+|++...... ..+|+++++.++||||+++++++....
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 3445789999999999999999999987766 888887544322 237999999999999999999985543
Q ss_pred ----eEEEEEeccCCCCHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC-CCCceEEeec
Q 010214 91 ----DIYVVMEYVKSGELFDYIV----EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD-SKWNVKIADF 161 (515)
Q Consensus 91 ----~~~iVmEy~~gg~L~~~i~----~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~-~~~~vKL~DF 161 (515)
.+|+||||+++ ++.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 108 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp SSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 38999999987 4444433 356899999999999999999999999999999999999999 7899999999
Q ss_pred ccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--------
Q 010214 162 GLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------- 233 (515)
Q Consensus 162 Gls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------- 233 (515)
|++.....+......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+....
T Consensus 187 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 187 GSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp TTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999987776666778899999999999876555899999999999999999999999988766655554311
Q ss_pred ---------c------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 234 ---------Y------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 234 ---------~------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
. .++..+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 0 12345889999999999999999999999999999998653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=394.20 Aligned_cols=258 Identities=30% Similarity=0.456 Sum_probs=216.4
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC--CCccEEEEEEEcCC
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH--PHIIRLYEVIETPS 90 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h--pnIv~l~~~~~~~~ 90 (515)
....++|++.+.||+|+||.||+|.+. +++.||||++..... .....+.+.+|+.+|+.++| |||+++++++.+..
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 445678999999999999999999984 689999999976543 33456788999999999987 99999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.+|+|||+ .+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 83 ~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 83 YIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99999995 5789999999999999999999999999999999999999999999999997 578999999999876543
Q ss_pred C---ccccCCCCCCccCCCcccC----------CccCCCcceeehhHHHHHHHHhCCCCCCCCCh-HHHHHHHhc--Ccc
Q 010214 171 H---FLKTSCGSPNYAAPEVISG----------KLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKG--GIY 234 (515)
Q Consensus 171 ~---~~~~~~gt~~Y~aPE~i~~----------~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~-~~~~~~i~~--~~~ 234 (515)
. ...+.+||+.|+|||++.+ ....+.++|||||||++|+|++|..||..... ......+.. ...
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence 2 2346689999999999864 12337899999999999999999999987433 233344433 234
Q ss_pred CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 ~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.+|...++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 5677888999999999999999999999999999999854
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=412.78 Aligned_cols=252 Identities=16% Similarity=0.213 Sum_probs=211.6
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHH---HHHHhCCCCCccEEE-------
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREI---KILRLFMHPHIIRLY------- 83 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei---~il~~l~hpnIv~l~------- 83 (515)
...++|++.+.||+|+||+||+|.++.+|+.||||++.+.........+.+.+|+ ++++.++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 3357899999999999999999999999999999999876555556778899999 455566799999998
Q ss_pred EEEEcCCe-----------------EEEEEeccCCCCHHHHHHHhCCCCH-------HHHHHHHHHHHHHHHHHHHCCce
Q 010214 84 EVIETPSD-----------------IYVVMEYVKSGELFDYIVEKGRLQE-------DEARNFFQQIISGVEYCHRNMVV 139 (515)
Q Consensus 84 ~~~~~~~~-----------------~~iVmEy~~gg~L~~~i~~~~~l~e-------~~~~~i~~qil~aL~yLH~~gIv 139 (515)
+++++++. .|+||||+ +|+|.+++...+.+++ ..++.++.||+.||+|||++||+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 88876643 89999999 6799999987666666 78888999999999999999999
Q ss_pred eccCCCCcEEECCCCceEEeecccccccccCCccccCCCCCCccCCCcccCC-----------ccCCCcceeehhHHHHH
Q 010214 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK-----------LYAGPEVDVWSCGVILY 208 (515)
Q Consensus 140 HrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~-----------~~~~~~~DIwSlGvily 208 (515)
||||||+|||++.++.+||+|||++... +....+.+| +.|+|||++.+. .+ +.++|||||||++|
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~--~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il~ 304 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRD--GARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVIY 304 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEET--TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheec--CCcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHHH
Confidence 9999999999999999999999999853 334556778 999999999876 55 78999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 209 ALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 209 ~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+|++|..||.+.+.......+. ..+..+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 305 elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 9999999998765444333332 3346789999999999999999999999999999999754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=383.91 Aligned_cols=259 Identities=33% Similarity=0.574 Sum_probs=228.3
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEE--cCCeE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE--TPSDI 92 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~--~~~~~ 92 (515)
..++|++.+.||+|+||.||+|.++.+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++. ....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 467999999999999999999999999999999999765543 345678999999999999999999999874 46789
Q ss_pred EEEEeccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCcEEECCCCceEEeeccc
Q 010214 93 YVVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNM-----VVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~----~~l~e~~~~~i~~qil~aL~yLH~~g-----IvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
|+||||++|++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999999999753 34999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCC-ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-CCCCCCC
Q 010214 164 SNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLS 241 (515)
Q Consensus 164 s~~~~~~~-~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s 241 (515)
+....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+..+.. .+|..++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSC
T ss_pred heeeccccccccccCCCccccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccC
Confidence 97765432 2345679999999999988776 7899999999999999999999999888888888877765 6777899
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
+++.++|.+||+.||.+|||+.|+++|+|+....
T Consensus 242 ~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 242 DELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 9999999999999999999999999999998653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=405.14 Aligned_cols=252 Identities=30% Similarity=0.407 Sum_probs=213.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP------ 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~------ 89 (515)
..+|++.+.||+|+||+||+|.+..+|+.||||++..... ...+|+++|+.++||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 3479999999999999999999999999999999865432 234799999999999999999998432
Q ss_pred CeEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CceEEeecccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLS 164 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~-~~vKL~DFGls 164 (515)
..+++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 237799999976 67666643 5679999999999999999999999999999999999999965 57899999999
Q ss_pred cccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC------------
Q 010214 165 NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG------------ 232 (515)
Q Consensus 165 ~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~------------ 232 (515)
+....+......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+......++...
T Consensus 205 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 205 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp EECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred hhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 88766666667789999999999987644489999999999999999999999998766655554321
Q ss_pred -----ccC------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 233 -----IYT------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 233 -----~~~------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
.+. ++..+++++.+||.+||..||.+|||+.|+++||||+...
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 111 2346789999999999999999999999999999998653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=401.88 Aligned_cols=256 Identities=30% Similarity=0.478 Sum_probs=204.3
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC----
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP---- 89 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 89 (515)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......++.+|+++++.++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 34589999999999999999999999999999999986543 3445567889999999999999999999999654
Q ss_pred --CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 90 --SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 90 --~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
..+|+|||++ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp GCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred cCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 5689999999 6799998865 67999999999999999999999999999999999999999999999999999865
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC------------
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------ 235 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~------------ 235 (515)
.. .....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+......
T Consensus 183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 183 AD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred cc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 43 2455689999999999987444589999999999999999999999998877666655432110
Q ss_pred -------------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 236 -------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 236 -------------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.....++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 113568899999999999999999999999999999865
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=388.63 Aligned_cols=260 Identities=30% Similarity=0.540 Sum_probs=218.1
Q ss_pred CCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010214 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (515)
Q Consensus 10 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 89 (515)
...+...++|++.+.||+|+||+||+|.+ +|+.||+|++..... .....+.+.+|++++++++||||+++++++.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 34455678999999999999999999987 688999999976544 334567889999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCceEEeecccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGR---LQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~---l~e~~~~~i~~qil~aL~yLH~~g--IvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
..+|+||||++||+|.+++...+. +++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999999999999986553 999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCC-ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHh--cCccCCCCCCC
Q 010214 165 NIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK--GGIYTLPSHLS 241 (515)
Q Consensus 165 ~~~~~~~-~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s 241 (515)
....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+. .....+|..++
T Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (309)
T 3p86_A 187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN 265 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSC
T ss_pred ccccccccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCC
Confidence 7654432 2345689999999999998876 789999999999999999999999988877776663 44567788999
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhc--Cccccc
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQ--HPWFQA 273 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~--hp~f~~ 273 (515)
+++.+||.+||+.||.+|||+.++++ +++++.
T Consensus 266 ~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 266 PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999999987 455543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=399.90 Aligned_cols=260 Identities=25% Similarity=0.504 Sum_probs=230.2
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChH--------------HHHHHHHHHHHHHhCCCC
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME--------------MEEKVRREIKILRLFMHP 77 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~--------------~~~~i~~Ei~il~~l~hp 77 (515)
.+...++|++.+.||+|+||.||+|.+ +|+.||+|++......... ..+.+.+|+.+++.++||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 103 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence 345578999999999999999999998 8999999999765433211 127889999999999999
Q ss_pred CccEEEEEEEcCCeEEEEEeccCCCCHHHH------HHH--hCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcE
Q 010214 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDY------IVE--KGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENL 148 (515)
Q Consensus 78 nIv~l~~~~~~~~~~~iVmEy~~gg~L~~~------i~~--~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNI 148 (515)
||+++++++.+.+..|+||||++||+|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999999999999999999999999998 655 5679999999999999999999999 9999999999999
Q ss_pred EECCCCceEEeecccccccccCCccccCCCCCCccCCCcccCC-ccCCCcceeehhHHHHHHHHhCCCCCCCCCh-HHHH
Q 010214 149 LLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLF 226 (515)
Q Consensus 149 Ll~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~-~~~~~~~DIwSlGvily~lltG~~Pf~~~~~-~~~~ 226 (515)
+++.++.+||+|||++...... ......||+.|+|||++.+. .+.+.++|||||||++|+|++|..||..... ....
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 9999999999999999876443 44567899999999999877 5533499999999999999999999998776 7788
Q ss_pred HHHhcCccCCC-------------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 227 KKIKGGIYTLP-------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 227 ~~i~~~~~~~p-------------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..+..+...+| ..+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 88888877777 6789999999999999999999999999999999753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=391.58 Aligned_cols=254 Identities=26% Similarity=0.417 Sum_probs=215.9
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC--e
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS--D 91 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~--~ 91 (515)
...++|++.+.||+|+||+||+|.+..+|+.||||++....... ..+.+.+|+++++.++||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 34688999999999999999999999999999999997544322 2466789999999999999999999998765 7
Q ss_pred EEEEEeccCCCCHHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----CCCCceEEeecccc
Q 010214 92 IYVVMEYVKSGELFDYIVEKGR---LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL----DSKWNVKIADFGLS 164 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~---l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl----~~~~~vKL~DFGls 164 (515)
.|+||||++|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 8999999999999999986443 9999999999999999999999999999999999999 78888999999999
Q ss_pred cccccCCccccCCCCCCccCCCccc--------CCccCCCcceeehhHHHHHHHHhCCCCCCCCC----hHHHHHHHhcC
Q 010214 165 NIMRDGHFLKTSCGSPNYAAPEVIS--------GKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGG 232 (515)
Q Consensus 165 ~~~~~~~~~~~~~gt~~Y~aPE~i~--------~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~----~~~~~~~i~~~ 232 (515)
..........+.+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.... ..+...++..+
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred eecCCCCceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 9887766667788999999999985 3444 789999999999999999999997432 23344444433
Q ss_pred cc-------------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcc
Q 010214 233 IY-------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270 (515)
Q Consensus 233 ~~-------------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~ 270 (515)
.. .++..+++.+.+||.+||+.||.+|||++|+++||-
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 21 111234567889999999999999999999999983
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=395.54 Aligned_cols=260 Identities=26% Similarity=0.365 Sum_probs=210.3
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
.....++|++.+.||+|+||.||+|.+..+|+.||||++....... ....+|++.++.++||||+++++++.+...
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 3456789999999999999999999999999999999986543222 345678888899999999999999865433
Q ss_pred -------EEEEEeccCCCCHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCcEEECC-CCceE
Q 010214 92 -------IYVVMEYVKSGELFDYIV----EKGRLQEDEARNFFQQIISGVEYCH--RNMVVHRDLKPENLLLDS-KWNVK 157 (515)
Q Consensus 92 -------~~iVmEy~~gg~L~~~i~----~~~~l~e~~~~~i~~qil~aL~yLH--~~gIvHrDLkpeNILl~~-~~~vK 157 (515)
+++||||+++ +|.+.+. ....+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+|
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEE
Confidence 8999999986 5554443 4567999999999999999999999 999999999999999996 89999
Q ss_pred EeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---
Q 010214 158 IADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--- 234 (515)
Q Consensus 158 L~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~--- 234 (515)
|+|||++............+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 99999999887766666778999999999997766558999999999999999999999999887777666643211
Q ss_pred -----------------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 235 -----------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 235 -----------------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
..+...++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 111235678999999999999999999999999999987643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=387.78 Aligned_cols=260 Identities=33% Similarity=0.525 Sum_probs=219.4
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP-- 89 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~-- 89 (515)
...+.++|++.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSF 83 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence 345678999999999999999999999999999999999643 3344567788999999999999999999998654
Q ss_pred ---CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 90 ---SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 90 ---~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
...|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 84 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 84 ENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 67999999997 599998875 6799999999999999999999999999999999999999999999999999987
Q ss_pred cccCC-----------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--
Q 010214 167 MRDGH-----------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-- 233 (515)
Q Consensus 167 ~~~~~-----------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-- 233 (515)
..... .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 64321 12345789999999998654444789999999999999999999999887655544332110
Q ss_pred ----------------------c--------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 234 ----------------------Y--------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 234 ----------------------~--------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
. ..++.+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 0 01246889999999999999999999999999999998753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=387.25 Aligned_cols=262 Identities=29% Similarity=0.456 Sum_probs=200.0
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
......++|++.+.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+++.++||||+++++++...+
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSS
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 3445578999999999999999999999999999999998654322 23567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHH--------hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecc
Q 010214 91 DIYVVMEYVKSGELFDYIVE--------KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFG 162 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~--------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFG 162 (515)
..|+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 99999999999999999974 4569999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc--
Q 010214 163 LSNIMRDGH------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-- 234 (515)
Q Consensus 163 ls~~~~~~~------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-- 234 (515)
++.....+. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence 987654321 234567999999999987633347899999999999999999999988766555444333221
Q ss_pred --------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 --------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 --------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..+..+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 1234678999999999999999999999999999999764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=386.92 Aligned_cols=256 Identities=32% Similarity=0.478 Sum_probs=219.0
Q ss_pred CccccCCCceEeeeecccCceEEEEEEE-cCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCC------ccEEE
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEH-ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH------IIRLY 83 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~-~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn------Iv~l~ 83 (515)
..+.+.++|++.+.||+|+||+||+|.+ ..+|+.||+|++... ....+.+.+|+.+++.++|++ +++++
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 3456678999999999999999999998 568899999998643 244577889999999887664 99999
Q ss_pred EEEEcCCeEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---------
Q 010214 84 EVIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS--------- 152 (515)
Q Consensus 84 ~~~~~~~~~~iVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~--------- 152 (515)
+++.+.+.+|+||||+ +++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999999999 889999998765 6899999999999999999999999999999999999987
Q ss_pred ----------CCceEEeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh
Q 010214 153 ----------KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI 222 (515)
Q Consensus 153 ----------~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~ 222 (515)
++.+||+|||++..... ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 66899999999976433 3356689999999999998776 7899999999999999999999998876
Q ss_pred HHHHHHHhcCccCCC--------------------------------------------CCCChhHHHHhcccCCCCCCC
Q 010214 223 PNLFKKIKGGIYTLP--------------------------------------------SHLSPGARDLIPRMLIVDPMK 258 (515)
Q Consensus 223 ~~~~~~i~~~~~~~p--------------------------------------------~~~s~~~~~li~~mL~~dP~~ 258 (515)
.+....+......+| ...++++.+||.+||..||.+
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 665544433222111 123467889999999999999
Q ss_pred CCCHHHHhcCcccccc
Q 010214 259 RITIPEIRQHPWFQAH 274 (515)
Q Consensus 259 Rpt~~eil~hp~f~~~ 274 (515)
|||+.|+++||||+..
T Consensus 320 Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 320 RITLREALKHPFFDLL 335 (339)
T ss_dssp SCCHHHHTTSGGGGGG
T ss_pred ccCHHHHhcCHHHHHH
Confidence 9999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=380.21 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=228.8
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
..+.|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 456799999999999999999999999999999999765433 245788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cc
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~ 173 (515)
||||++|++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus 98 v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 98 IMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp EEECCTTEEHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred EEEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 999999999999985 4679999999999999999999999999999999999999999999999999998765433 33
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcccC
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRML 252 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL 252 (515)
....||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........+.... ..++..++..+.+||.+||
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 255 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL 255 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHC
T ss_pred CccCCCcCccCHHHHhcCCC-CchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHc
Confidence 45679999999999988776 689999999999999999999999887776666655443 3566788999999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccc
Q 010214 253 IVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 253 ~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..||.+|||+.++++||||...
T Consensus 256 ~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 256 NKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp CSSGGGSCCHHHHTTCHHHHHH
T ss_pred CCChhhCcCHHHHhhChhhhcC
Confidence 9999999999999999999764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=380.60 Aligned_cols=255 Identities=30% Similarity=0.476 Sum_probs=219.2
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|++.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 456789999999999999999999999999999999976432 356889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-
Q 010214 94 VVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~-~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~- 171 (515)
+||||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999999999999997 45689999999999999999999999999999999999999999999999999997765432
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc---cCCCCCCChhHHHHh
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLI 248 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li 248 (515)
......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.... ...|..+++++.+||
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 259 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGY-NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFV 259 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCB-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred ccCccCCCCCccChhhcCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHH
Confidence 3345679999999999988776 789999999999999999999999877665554444332 234566899999999
Q ss_pred cccCCCCCCCCCCHHHHhcCcccccc
Q 010214 249 PRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.+||..||.+|||+.++++||||+..
T Consensus 260 ~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 260 KQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHHccCChhhCcCHHHHHhCHHHhcC
Confidence 99999999999999999999999854
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=393.48 Aligned_cols=254 Identities=31% Similarity=0.488 Sum_probs=216.7
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE--
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI-- 92 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~-- 92 (515)
+.++|.+.+.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 5589999999999999999999999999999999997643 3345568889999999999999999999999877654
Q ss_pred ----EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 93 ----YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 93 ----~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
|+||||+. ++|.+++ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred ceeEEEEEcccc-ccHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999997 5888877 3459999999999999999999999999999999999999999999999999998654
Q ss_pred cCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc--------------
Q 010214 169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-------------- 234 (515)
Q Consensus 169 ~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-------------- 234 (515)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 196 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 196 A--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred c--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 3 345668999999999998744458999999999999999999999999887666655533110
Q ss_pred -----------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 -----------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 -----------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..+..+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 1124678999999999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=382.40 Aligned_cols=259 Identities=26% Similarity=0.436 Sum_probs=217.6
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEc-
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET- 88 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~- 88 (515)
.+....++|++.+.||+|+||.||+|.+..+|+.||||++...... ...+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 4555678999999999999999999999999999999999754322 36788999999998 79999999999976
Q ss_pred -----CCeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeec
Q 010214 89 -----PSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADF 161 (515)
Q Consensus 89 -----~~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DF 161 (515)
...+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence 46899999999999999999864 57999999999999999999999999999999999999999999999999
Q ss_pred ccccccccC-CccccCCCCCCccCCCccc-----CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC
Q 010214 162 GLSNIMRDG-HFLKTSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT 235 (515)
Q Consensus 162 Gls~~~~~~-~~~~~~~gt~~Y~aPE~i~-----~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~ 235 (515)
|++...... ......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+.......+......
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 252 (326)
T 2x7f_A 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 252 (326)
T ss_dssp TTTC-------------CCGGGCCHHHHC--------C-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred cCceecCcCccccccccCCccccChhhhccccccCcCC-CccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence 998876432 2334567999999999987 3334 78999999999999999999999988776665555444322
Q ss_pred --CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 236 --LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 236 --~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.+..+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 245689999999999999999999999999999999754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=380.97 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=219.8
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|++.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 92 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence 456899999999999999999999999999999999875432 23567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CC
Q 010214 94 VVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GH 171 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~ 171 (515)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... ..
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 99999999999999876 46799999999999999999999999999999999999999999999999998764322 12
Q ss_pred ccccCCCCCCccCCCccc-----CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---CCCCCCChh
Q 010214 172 FLKTSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPG 243 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~-----~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~ 243 (515)
......||+.|+|||++. +..+ +.++|||||||++|+|++|..||...+.......+..... ..+..++.+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVE 251 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHH
T ss_pred ccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHH
Confidence 234567999999999983 4444 7899999999999999999999999887777666655543 235678899
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+.+||.+||..||.+|||+.++++||||+..
T Consensus 252 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 252 FRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred HHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 9999999999999999999999999999754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=395.48 Aligned_cols=253 Identities=26% Similarity=0.461 Sum_probs=211.6
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC--------CCCccEEEE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM--------HPHIIRLYE 84 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~--------hpnIv~l~~ 84 (515)
+.+.++|++.+.||+|+||+||+|.+..+++.||||++... ....+.+.+|+.+++.++ ||||+++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 45678999999999999999999999999999999998643 345678889999999986 788999999
Q ss_pred EEE----cCCeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCC---
Q 010214 85 VIE----TPSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKW--- 154 (515)
Q Consensus 85 ~~~----~~~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDLkpeNILl~~~~--- 154 (515)
++. ....+|+||||+ +++|.+++... +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence 987 566899999999 56777777654 4699999999999999999999998 999999999999999775
Q ss_pred ----------------------------------------------ceEEeecccccccccCCccccCCCCCCccCCCcc
Q 010214 155 ----------------------------------------------NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI 188 (515)
Q Consensus 155 ----------------------------------------------~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i 188 (515)
.+||+|||++...... ....+||+.|+|||++
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhh
Confidence 7999999999876432 4556899999999999
Q ss_pred cCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCc-----------------------------
Q 010214 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI------PNLFKKIKGGI----------------------------- 233 (515)
Q Consensus 189 ~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~------~~~~~~i~~~~----------------------------- 233 (515)
.+..+ +.++|||||||++|+|++|..||...+. ......+....
T Consensus 266 ~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 266 IGSGY-NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred cCCCC-CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 98876 7899999999999999999999976542 11222221100
Q ss_pred -------------cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 234 -------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 234 -------------~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
+..+...++++.+||.+||+.||.+|||+.|+++||||++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 1122233567889999999999999999999999999963
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=382.79 Aligned_cols=260 Identities=29% Similarity=0.453 Sum_probs=221.3
Q ss_pred cccCCCceEeeeecccCceEEEEEEEc-CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC---CCCCccEEEEEEE-
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHA-LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIRLYEVIE- 87 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~-~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l~~~~~- 87 (515)
....++|++.+.||+|+||.||+|.+. .+|+.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 345689999999999999999999995 678999999997544321 1123455777777666 8999999999987
Q ss_pred ----cCCeEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeec
Q 010214 88 ----TPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADF 161 (515)
Q Consensus 88 ----~~~~~~iVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DF 161 (515)
....+++||||++ |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence 5567999999997 59999998754 4999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--------
Q 010214 162 GLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------- 233 (515)
Q Consensus 162 Gls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------- 233 (515)
|++............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....
T Consensus 165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 165 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred cccccccCCCCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence 99987765555667789999999999988776 789999999999999999999999988777666654311
Q ss_pred -------------------cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 234 -------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 234 -------------------~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
..++..+++.+.+||.+||..||.+|||+.|+++||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 112356889999999999999999999999999999998653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=399.95 Aligned_cols=255 Identities=16% Similarity=0.162 Sum_probs=199.5
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC--CCCCccEEE-------EEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF--MHPHIIRLY-------EVI 86 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l--~hpnIv~l~-------~~~ 86 (515)
..+|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34599999999999999999999999999999999887665556677888886555544 699988865 566
Q ss_pred EcC-----------------CeEEEEEeccCCCCHHHHHHHhC-CCCHHHH------HHHHHHHHHHHHHHHHCCceecc
Q 010214 87 ETP-----------------SDIYVVMEYVKSGELFDYIVEKG-RLQEDEA------RNFFQQIISGVEYCHRNMVVHRD 142 (515)
Q Consensus 87 ~~~-----------------~~~~iVmEy~~gg~L~~~i~~~~-~l~e~~~------~~i~~qil~aL~yLH~~gIvHrD 142 (515)
..+ ..+|+||||++ |+|.+++...+ .+++... ..++.||+.||+|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 543 33899999998 79999998643 3444444 57779999999999999999999
Q ss_pred CCCCcEEECCCCceEEeecccccccccCCccccCCCCCCccCCCcccC--CccCCCcceeehhHHHHHHHHhCCCCCCCC
Q 010214 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDE 220 (515)
Q Consensus 143 LkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~--~~~~~~~~DIwSlGvily~lltG~~Pf~~~ 220 (515)
|||+|||++.+|.+||+|||++..... ......+|+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CCHHHEEECCCCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999986643 2225567799999999987 555 79999999999999999999999876
Q ss_pred ChHHH--HHH-----HhcCcc--CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 221 NIPNL--FKK-----IKGGIY--TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 221 ~~~~~--~~~-----i~~~~~--~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..... +.. ...... ..+..+++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 43211 110 111122 2235789999999999999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=392.85 Aligned_cols=262 Identities=26% Similarity=0.415 Sum_probs=212.8
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEeccccc--------CChHHHHHHHHHHHHHHhCCCCCccEEE
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI--------KNMEMEEKVRREIKILRLFMHPHIIRLY 83 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~--------~~~~~~~~i~~Ei~il~~l~hpnIv~l~ 83 (515)
...+.++|++.+.||+|+||.||+|.+.. |+.||||++..... ......+.+.+|+.+++.++||||++++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 95 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence 34567999999999999999999999864 99999999865432 2333457899999999999999999999
Q ss_pred EEEEc-----CCeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceE
Q 010214 84 EVIET-----PSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK 157 (515)
Q Consensus 84 ~~~~~-----~~~~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vK 157 (515)
+++.. ...+|+||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred eeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEE
Confidence 99843 346899999997 5888888754 4799999999999999999999999999999999999999999999
Q ss_pred EeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc----
Q 010214 158 IADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---- 233 (515)
Q Consensus 158 L~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~---- 233 (515)
|+|||++............+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 9999999876665556677899999999999874445899999999999999999999999988766666553211
Q ss_pred --------------------c--------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 234 --------------------Y--------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 234 --------------------~--------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
. ..++..++.+.+||.+||+.||.+|||+.|+++||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 0 11245688999999999999999999999999999998754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=381.11 Aligned_cols=257 Identities=30% Similarity=0.473 Sum_probs=214.0
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE----- 87 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~----- 87 (515)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++... +....+.+.+|+++++.++||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 34678999999999999999999999999999999998643 3455678899999999999999999999974
Q ss_pred ---------cCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC-CCCceE
Q 010214 88 ---------TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD-SKWNVK 157 (515)
Q Consensus 88 ---------~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~-~~~~vK 157 (515)
+....|+||||++ |+|.+++. .+++++..++.++.||+.||+|||++||+||||||+|||++ .++.+|
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp CCC----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred cccccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence 3467999999997 59999885 46799999999999999999999999999999999999997 567999
Q ss_pred EeecccccccccC----CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc
Q 010214 158 IADFGLSNIMRDG----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI 233 (515)
Q Consensus 158 L~DFGls~~~~~~----~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~ 233 (515)
|+|||++...... .......+|+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999876432 223455689999999998764444789999999999999999999999888766665554322
Q ss_pred c------------------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 234 Y------------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 234 ~------------------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
. ..+..+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 1 1124689999999999999999999999999999999854
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=383.91 Aligned_cols=263 Identities=27% Similarity=0.450 Sum_probs=206.0
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCc---EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE 87 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~ 87 (515)
......++|++.+.||+|+||.||+|.+..++. .||+|++....... ...+.+.+|+.+++.++||||+++++++.
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 444556889999999999999999999887775 89999997654333 44678999999999999999999999998
Q ss_pred cCCeE------EEEEeccCCCCHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc
Q 010214 88 TPSDI------YVVMEYVKSGELFDYIVEKG------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN 155 (515)
Q Consensus 88 ~~~~~------~iVmEy~~gg~L~~~i~~~~------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~ 155 (515)
..... ++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC
Confidence 77665 99999999999999997543 5999999999999999999999999999999999999999999
Q ss_pred eEEeecccccccccCCcc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhc
Q 010214 156 VKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKG 231 (515)
Q Consensus 156 vKL~DFGls~~~~~~~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~ 231 (515)
+||+|||++.....+... ....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 999999999876554332 23456788999999988776 789999999999999999 9999999888888777766
Q ss_pred Cc-cCCCCCCChhHHHHhcccCCCCCCCCCC-------HHHHhcCccccccc
Q 010214 232 GI-YTLPSHLSPGARDLIPRMLIVDPMKRIT-------IPEIRQHPWFQAHL 275 (515)
Q Consensus 232 ~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt-------~~eil~hp~f~~~~ 275 (515)
+. ...|..+++++.+|+.+||+.||.+||| +++++.|||+....
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 54 5677889999999999999999999999 78899999997653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=384.93 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=219.7
Q ss_pred CCCCccccCCCceEeeeecccCceEEEEEEEcCCC-cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCC------cc
Q 010214 8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTG-HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH------II 80 (515)
Q Consensus 8 ~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg-~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn------Iv 80 (515)
...-.+.+.++|++.+.||+|+||+||+|.+..++ +.||+|++... ....+.+.+|+.+++.++|++ ++
T Consensus 10 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~ 85 (355)
T 2eu9_A 10 VCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCV 85 (355)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBC
T ss_pred ccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEE
Confidence 33445567899999999999999999999998877 68999998643 244577889999999998766 99
Q ss_pred EEEEEEEcCCeEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE--------
Q 010214 81 RLYEVIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL-------- 150 (515)
Q Consensus 81 ~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl-------- 150 (515)
.+++++...+.+|+||||+ +++|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 86 LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEE
T ss_pred EeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccc
Confidence 9999999999999999999 668888887654 69999999999999999999999999999999999999
Q ss_pred -----------CCCCceEEeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCC
Q 010214 151 -----------DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD 219 (515)
Q Consensus 151 -----------~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~ 219 (515)
+.++.+||+|||++..... ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCC-CCccchHHHHHHHHHHHhCCCCCCC
Confidence 5678999999999976433 3356689999999999988877 7899999999999999999999998
Q ss_pred CChHHHHHHHhcCccCCCC--------------------------------------------CCChhHHHHhcccCCCC
Q 010214 220 ENIPNLFKKIKGGIYTLPS--------------------------------------------HLSPGARDLIPRMLIVD 255 (515)
Q Consensus 220 ~~~~~~~~~i~~~~~~~p~--------------------------------------------~~s~~~~~li~~mL~~d 255 (515)
.+.......+.......|. ..++++.+||.+||..|
T Consensus 242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 8766655444332222221 12357889999999999
Q ss_pred CCCCCCHHHHhcCccccccc
Q 010214 256 PMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 256 P~~Rpt~~eil~hp~f~~~~ 275 (515)
|.+|||+.|+++||||+...
T Consensus 322 P~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 322 PAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp TTTSCCHHHHTTSGGGGGCC
T ss_pred hhhCcCHHHHhcChhhcCCC
Confidence 99999999999999998753
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=388.37 Aligned_cols=257 Identities=33% Similarity=0.614 Sum_probs=224.9
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh---HHHHHHHHHHHHHHhCC--CCCccEEEEE
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEKVRREIKILRLFM--HPHIIRLYEV 85 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~--hpnIv~l~~~ 85 (515)
..+.+.++|++.+.||+|+||.||+|.+..+|+.||||++........ .....+.+|+.+++.++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 345577899999999999999999999999999999999976644321 12245678999999997 5999999999
Q ss_pred EEcCCeEEEEEeccCC-CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC-CCCceEEeeccc
Q 010214 86 IETPSDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD-SKWNVKIADFGL 163 (515)
Q Consensus 86 ~~~~~~~~iVmEy~~g-g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~-~~~~vKL~DFGl 163 (515)
+.+++..++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 9999999999999976 89999999999999999999999999999999999999999999999999 788999999999
Q ss_pred ccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChh
Q 010214 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPG 243 (515)
Q Consensus 164 s~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 243 (515)
+...... ......||+.|+|||++.+..+.+.++|||||||++|+|++|..||.... .+......++..++++
T Consensus 197 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~ 269 (320)
T 3a99_A 197 GALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSE 269 (320)
T ss_dssp CEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHH
T ss_pred ccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCCHH
Confidence 9876543 34456799999999999877766788999999999999999999997642 3444556677889999
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+.+||.+||..||.+|||+.|+++||||++.
T Consensus 270 ~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 270 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 9999999999999999999999999999865
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=377.15 Aligned_cols=257 Identities=24% Similarity=0.384 Sum_probs=213.8
Q ss_pred CCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010214 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (515)
Q Consensus 10 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 89 (515)
+......++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.++
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 2h34_A 27 SREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID 106 (309)
T ss_dssp -------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred cCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence 35556689999999999999999999999999999999999876666666678899999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
+.+|+||||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999999999999989999999999999999999999999999999999999999999999999999877654
Q ss_pred CC--ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---CCCCCCChhH
Q 010214 170 GH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGA 244 (515)
Q Consensus 170 ~~--~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~ 244 (515)
.. ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+..... ..+..+++++
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 265 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAF 265 (309)
T ss_dssp ----------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHH
T ss_pred cccccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHH
Confidence 32 2345679999999999988766 7899999999999999999999998876655555544332 3456789999
Q ss_pred HHHhcccCCCCCCCCC-CHHHHhc
Q 010214 245 RDLIPRMLIVDPMKRI-TIPEIRQ 267 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rp-t~~eil~ 267 (515)
.++|.+||..||.+|| |++++++
T Consensus 266 ~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 266 DAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHhccCCHHHHHHhHHHHHH
Confidence 9999999999999999 7877765
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=389.53 Aligned_cols=251 Identities=26% Similarity=0.460 Sum_probs=221.8
Q ss_pred cCCCceEeeeecccCceEEEEEEEc-------CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHA-------LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVI 86 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~-------~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~ 86 (515)
..++|++.+.||+|+||+||+|.+. .++..||+|++.... .......+.+|+.+++.+ +||||+++++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 4578999999999999999999975 345689999996542 344567899999999999 899999999999
Q ss_pred EcCCeEEEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 010214 87 ETPSDIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL 150 (515)
Q Consensus 87 ~~~~~~~iVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl 150 (515)
.+.+.+|+||||++||+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 99999999999999999999998753 47899999999999999999999999999999999999
Q ss_pred CCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHH
Q 010214 151 DSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF 226 (515)
Q Consensus 151 ~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~ 226 (515)
+.++.+||+|||++........ .....+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....++.
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999999986654322 234467889999999988776 789999999999999999 99999998888888
Q ss_pred HHHhcCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 227 KKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 227 ~~i~~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..+..+. ...|..+++++.+||.+||..||.+|||+.|++++
T Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 316 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8777664 46778899999999999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=386.29 Aligned_cols=259 Identities=35% Similarity=0.613 Sum_probs=190.0
Q ss_pred CCCCccccCCCceEee-eecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEE
Q 010214 8 SSSGVDMFLPNYKLGK-TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVI 86 (515)
Q Consensus 8 ~~~~~~~~~~~Y~i~~-~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~ 86 (515)
.......+.++|.+.+ .||+|+||+||+|.++.+|+.||||++.... ....+....++.++||||+++++++
T Consensus 19 p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~ 91 (336)
T 3fhr_A 19 PEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVY 91 (336)
T ss_dssp -CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred CCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHH
Confidence 3445556789999965 6999999999999999999999999986431 1222333446778999999999999
Q ss_pred Ec----CCeEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC---CceE
Q 010214 87 ET----PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK---WNVK 157 (515)
Q Consensus 87 ~~----~~~~~iVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~---~~vK 157 (515)
.. ...+|+||||++||+|.+++.+.+ .+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+|
T Consensus 92 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~k 171 (336)
T 3fhr_A 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLK 171 (336)
T ss_dssp EEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEE
T ss_pred hhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEE
Confidence 76 455899999999999999998754 69999999999999999999999999999999999999864 4599
Q ss_pred EeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHH----HHHHhcCc
Q 010214 158 IADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL----FKKIKGGI 233 (515)
Q Consensus 158 L~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~----~~~i~~~~ 233 (515)
|+|||++..... ....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ...+....
T Consensus 172 l~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (336)
T 3fhr_A 172 LTDFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ 249 (336)
T ss_dssp ECCCTTCEEC-----------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred Eeccccceeccc-cccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc
Confidence 999999986643 33456789999999999987776 6899999999999999999999977654433 23333333
Q ss_pred cCCC----CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 234 YTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 234 ~~~p----~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
...| ..+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 250 YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp -CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 3333 47899999999999999999999999999999998753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=386.49 Aligned_cols=255 Identities=31% Similarity=0.489 Sum_probs=216.4
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe---
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD--- 91 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~--- 91 (515)
+.++|.+.+.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+++.++||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 4689999999999999999999999999999999997643 344556788999999999999999999999987654
Q ss_pred ---EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 92 ---IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 92 ---~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
+|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred ceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 599999997 58888774 459999999999999999999999999999999999999999999999999997654
Q ss_pred cCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC----------------
Q 010214 169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---------------- 232 (515)
Q Consensus 169 ~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~---------------- 232 (515)
.. ....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 178 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 178 AE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred CC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 32 345689999999999987444588999999999999999999999988766655554321
Q ss_pred ---------------ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 233 ---------------IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 233 ---------------~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
....+..+++++.+||.+||..||.+|||+.|+++||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 0122346789999999999999999999999999999998653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=390.83 Aligned_cols=256 Identities=29% Similarity=0.424 Sum_probs=217.2
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CC-----CccEEEE
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HP-----HIIRLYE 84 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hp-----nIv~l~~ 84 (515)
..+.+.++|++.+.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.++ |+ +|+++++
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 3455679999999999999999999999999999999999643 234567788999998886 55 4999999
Q ss_pred EEEcCCeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCcEEEC--CCCceEE
Q 010214 85 VIETPSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCH--RNMVVHRDLKPENLLLD--SKWNVKI 158 (515)
Q Consensus 85 ~~~~~~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH--~~gIvHrDLkpeNILl~--~~~~vKL 158 (515)
++...+.+|+||||+++ +|.+++... +.+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||
T Consensus 124 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 124 HFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred eeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence 99999999999999964 999999875 46999999999999999999999 57999999999999995 4788999
Q ss_pred eecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC-
Q 010214 159 ADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP- 237 (515)
Q Consensus 159 ~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p- 237 (515)
+|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.......|
T Consensus 203 ~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 279 (382)
T 2vx3_A 203 VDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA 279 (382)
T ss_dssp CCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred EeccCceeccc--ccccccCCccccChHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999987643 3456789999999999998876 7899999999999999999999999887777666654211110
Q ss_pred -----------------C------------------C----------------------------CChhHHHHhcccCCC
Q 010214 238 -----------------S------------------H----------------------------LSPGARDLIPRMLIV 254 (515)
Q Consensus 238 -----------------~------------------~----------------------------~s~~~~~li~~mL~~ 254 (515)
. . .++++++||.+||+.
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 359 (382)
T 2vx3_A 280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY 359 (382)
T ss_dssp HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence 0 0 013689999999999
Q ss_pred CCCCCCCHHHHhcCcccccc
Q 010214 255 DPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 255 dP~~Rpt~~eil~hp~f~~~ 274 (515)
||.+|||+.|+++||||+..
T Consensus 360 dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 360 DPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp CTTTSCCHHHHTTSGGGCC-
T ss_pred ChhhCCCHHHHhcCcccccC
Confidence 99999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=394.74 Aligned_cols=262 Identities=21% Similarity=0.330 Sum_probs=226.0
Q ss_pred ccCCCceEeeeecccCceEEEEEE-----EcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET 88 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~-----~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 88 (515)
...++|++.+.||+|+||+||+|. +..+++.||||++... ........+.+|+.+++.++||||+++++++.+
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 345789999999999999999999 4567889999998643 234456678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---ceEE
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKG-------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVKI 158 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~-------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~---~vKL 158 (515)
....|+||||++||+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999999998753 589999999999999999999999999999999999999655 4999
Q ss_pred eecccccccccC---CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-
Q 010214 159 ADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI- 233 (515)
Q Consensus 159 ~DFGls~~~~~~---~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~- 233 (515)
+|||++...... .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+.
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999765332 22334578999999999987776 789999999999999998 999999999888888887764
Q ss_pred cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccCcc
Q 010214 234 YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY 278 (515)
Q Consensus 234 ~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~~~ 278 (515)
...|..+++.+.+|+.+||+.||.+|||+.++++|.++-...+..
T Consensus 305 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~ 349 (367)
T 3l9p_A 305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349 (367)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence 456778999999999999999999999999999998876544433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=383.56 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=221.2
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCc---EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET 88 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 88 (515)
.+...++|++.+.||+|+||.||+|.+..+++ .||||++.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 34456899999999999999999999986665 49999996532 33456789999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
.+..|+||||++||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999999754 57999999999999999999999999999999999999999999999999999876
Q ss_pred ccCC----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCC
Q 010214 168 RDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLS 241 (515)
Q Consensus 168 ~~~~----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s 241 (515)
.... ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+ ....|..++
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP 280 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence 5432 1223356788999999987776 789999999999999999 99999999888888887766 456677899
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+++.+||.+||..||.+|||+.++++
T Consensus 281 ~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=374.03 Aligned_cols=255 Identities=26% Similarity=0.407 Sum_probs=214.3
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|.....||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 34444559999999999999999999999999997543 234577899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCceEEeecccccccccCC-
Q 010214 97 EYVKSGELFDYIVEKG---RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGH- 171 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~---~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-~~~vKL~DFGls~~~~~~~- 171 (515)
||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999999998652 4679999999999999999999999999999999999987 8999999999998765432
Q ss_pred ccccCCCCCCccCCCcccCCc-cCCCcceeehhHHHHHHHHhCCCCCCCCChHH--HHH-HHhcCccCCCCCCChhHHHH
Q 010214 172 FLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENIPN--LFK-KIKGGIYTLPSHLSPGARDL 247 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~-~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~--~~~-~i~~~~~~~p~~~s~~~~~l 247 (515)
......||+.|+|||++.+.. ..+.++||||||+++|+|++|..||....... ... ........+|..+++++.+|
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 258 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHH
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHH
Confidence 344668999999999997543 23789999999999999999999997643322 111 22334456778899999999
Q ss_pred hcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|.+||..||.+|||+.++++||||+..
T Consensus 259 i~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 259 ILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp HHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred HHHHccCChhhCCCHHHHhcChhhhhc
Confidence 999999999999999999999999754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=378.85 Aligned_cols=250 Identities=28% Similarity=0.470 Sum_probs=215.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||+||+|.+..+++.||+|++... +....+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 57999999999999999999999999999999998542 345678899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc-
Q 010214 96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL- 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~- 173 (515)
|||++||+|.+++.. .+.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 999999999999987 567999999999999999999999999999999999999999999999999999876433221
Q ss_pred --------------ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHH-----HHHHhcCcc
Q 010214 174 --------------KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL-----FKKIKGGIY 234 (515)
Q Consensus 174 --------------~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~-----~~~i~~~~~ 234 (515)
.+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ..... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--~~ 242 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--DR 242 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH--HH
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc--cc
Confidence 25689999999999998877 7899999999999999999999875322110 01111 12
Q ss_pred CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 235 ~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
..|..+++++.+++.+||+.||.+|||+.++++ |++.
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~ 279 (310)
T 3s95_A 243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLET 279 (310)
T ss_dssp TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHH
Confidence 346788999999999999999999999999986 5543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=397.13 Aligned_cols=254 Identities=28% Similarity=0.459 Sum_probs=196.2
Q ss_pred cCCCceE-eeeecccCceEEEEEEEc--CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEE--cC
Q 010214 15 FLPNYKL-GKTLGIGSFGKVKIAEHA--LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE--TP 89 (515)
Q Consensus 15 ~~~~Y~i-~~~LG~G~fg~Vy~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~--~~ 89 (515)
+.+.|.+ ++.||+|+||+||+|.++ .+++.||||++...... ..+.+|+.+|+.++||||+++++++. ..
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHAD 92 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence 3456777 568999999999999976 56889999999755432 46789999999999999999999995 46
Q ss_pred CeEEEEEeccCCCCHHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----CCCCce
Q 010214 90 SDIYVVMEYVKSGELFDYIVEK---------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL----DSKWNV 156 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~---------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl----~~~~~v 156 (515)
..+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 93 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp TEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred CeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 789999999965 898888632 249999999999999999999999999999999999999 677899
Q ss_pred EEeecccccccccC----CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH---------
Q 010214 157 KIADFGLSNIMRDG----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP--------- 223 (515)
Q Consensus 157 KL~DFGls~~~~~~----~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~--------- 223 (515)
||+|||++...... ....+.+||+.|+|||++.+....+.++|||||||++|+|++|..||.+....
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 99999999876532 23456789999999999988655589999999999999999999999765431
Q ss_pred HHHHHHhcCccC--------------------------------------CCCCCChhHHHHhcccCCCCCCCCCCHHHH
Q 010214 224 NLFKKIKGGIYT--------------------------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEI 265 (515)
Q Consensus 224 ~~~~~i~~~~~~--------------------------------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~ei 265 (515)
.....+...... .....++++.+||.+||+.||.+|||++|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 222222211100 011237889999999999999999999999
Q ss_pred hcCcccccc
Q 010214 266 RQHPWFQAH 274 (515)
Q Consensus 266 l~hp~f~~~ 274 (515)
++||||+..
T Consensus 332 L~hp~f~~~ 340 (405)
T 3rgf_A 332 MQDPYFLED 340 (405)
T ss_dssp HTSGGGTSS
T ss_pred hcChhhccC
Confidence 999999865
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=371.05 Aligned_cols=247 Identities=24% Similarity=0.459 Sum_probs=220.5
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 578999999999999999999987 5778999999765433 35688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--c
Q 010214 96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--F 172 (515)
Q Consensus 96 mEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~--~ 172 (515)
|||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 999999999999975 4569999999999999999999999999999999999999999999999999998664432 2
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhcc
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~ 250 (515)
.....+|+.|+|||++.+..+ ++++||||+|+++|+|++ |..||...+.......+..+ ....|...++++.+++.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 242 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 242 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred ccCcccccccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHH
Confidence 234567888999999987766 789999999999999999 99999999988888888776 345567789999999999
Q ss_pred cCCCCCCCCCCHHHHhcC
Q 010214 251 MLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~h 268 (515)
||+.||.+|||+.++++|
T Consensus 243 ~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 243 CWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCcccCcCHHHHHHH
Confidence 999999999999999876
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=383.83 Aligned_cols=258 Identities=35% Similarity=0.626 Sum_probs=215.3
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh---HHHHHHHHHHHHHHhC----CCCCccEEE
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEKVRREIKILRLF----MHPHIIRLY 83 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l----~hpnIv~l~ 83 (515)
..+.+.++|++.+.||+|+||.||+|.+..+|+.||+|++........ .....+.+|+.+++++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 456678899999999999999999999999999999999976544321 1234456799999998 899999999
Q ss_pred EEEEcCCeEEEEEec-cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC-CCCceEEeec
Q 010214 84 EVIETPSDIYVVMEY-VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD-SKWNVKIADF 161 (515)
Q Consensus 84 ~~~~~~~~~~iVmEy-~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~-~~~~vKL~DF 161 (515)
+++.+.+..++|||+ +.+++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 999999999999999 78999999999989999999999999999999999999999999999999999 8899999999
Q ss_pred ccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCC
Q 010214 162 GLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLS 241 (515)
Q Consensus 162 Gls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 241 (515)
|++...... ......||+.|+|||++.+..+.+.++|||||||++|+|++|..||... ..+......++..++
T Consensus 185 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~~~~~ 257 (312)
T 2iwi_A 185 GSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVS 257 (312)
T ss_dssp SSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHTCCCCCTTSC
T ss_pred chhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhhccCCcccCC
Confidence 999876543 3456679999999999987766566899999999999999999999763 234455667888999
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
+++.+||.+||..||.+|||+.|+++||||+...
T Consensus 258 ~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 258 PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 9999999999999999999999999999998653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=375.78 Aligned_cols=252 Identities=29% Similarity=0.520 Sum_probs=209.9
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc------
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET------ 88 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------ 88 (515)
+.++|++.+.||+|+||.||+|.+..+|+.||||++... ......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 357899999999999999999999999999999998642 2456788999999999999999999998754
Q ss_pred -------CCeEEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEee
Q 010214 89 -------PSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160 (515)
Q Consensus 89 -------~~~~~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~D 160 (515)
....|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 456899999999999999998644 588999999999999999999999999999999999999999999999
Q ss_pred cccccccccC---------------CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCC-CChHH
Q 010214 161 FGLSNIMRDG---------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPN 224 (515)
Q Consensus 161 FGls~~~~~~---------------~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~-~~~~~ 224 (515)
||++...... ......+||+.|+|||++.+....+.++|||||||++|+|++ ||.. .+...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 9998765421 223456799999999999876444789999999999999998 6653 33345
Q ss_pred HHHHHhcCccCCCC----CCChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 225 LFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 225 ~~~~i~~~~~~~p~----~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
....+......+|. ..++.+.++|.+||+.||.+|||+.++++||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 56666665555554 45667899999999999999999999999999964
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=367.28 Aligned_cols=250 Identities=25% Similarity=0.467 Sum_probs=221.1
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
+...++|++.+.||+|+||.||+|.++ ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 445689999999999999999999876 6778999999765433 35688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|+||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999999998754 59999999999999999999999999999999999999999999999999998765443
Q ss_pred cc--ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHH
Q 010214 172 FL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL 247 (515)
Q Consensus 172 ~~--~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 247 (515)
.. ....+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+.......+..+. ...|...++++.++
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQI 237 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEE-ETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred hhcccCCCcCcccCCHHHHhccCC-chhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHH
Confidence 22 23456778999999988776 789999999999999999 999999988888877777664 34566789999999
Q ss_pred hcccCCCCCCCCCCHHHHhcC
Q 010214 248 IPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~h 268 (515)
+.+||+.||.+|||+.|++++
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 238 MYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=387.52 Aligned_cols=257 Identities=26% Similarity=0.478 Sum_probs=212.5
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-----------CCCcc
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-----------HPHII 80 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----------hpnIv 80 (515)
.....++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.++++++ ||||+
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~ 89 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 89 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHH
Confidence 3344689999999999999999999999999999999986432 34567889999999887 89999
Q ss_pred EEEEEEEcCC----eEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEC--
Q 010214 81 RLYEVIETPS----DIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLD-- 151 (515)
Q Consensus 81 ~l~~~~~~~~----~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDLkpeNILl~-- 151 (515)
++++++...+ .+++||||+ +++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 90 KLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp CCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred HHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEecc
Confidence 9999987654 799999999 88999999863 4599999999999999999999998 999999999999994
Q ss_pred ----CCCceEEeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh-----
Q 010214 152 ----SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI----- 222 (515)
Q Consensus 152 ----~~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~----- 222 (515)
..+.+||+|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CCCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 445899999999987643 2345689999999999998877 7899999999999999999999986541
Q ss_pred -HHHHHHHh------------------------------------------cCccCCCCCCChhHHHHhcccCCCCCCCC
Q 010214 223 -PNLFKKIK------------------------------------------GGIYTLPSHLSPGARDLIPRMLIVDPMKR 259 (515)
Q Consensus 223 -~~~~~~i~------------------------------------------~~~~~~p~~~s~~~~~li~~mL~~dP~~R 259 (515)
......+. .....++...++++.+||.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 11222221 11223344556789999999999999999
Q ss_pred CCHHHHhcCcccccccC
Q 010214 260 ITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 260 pt~~eil~hp~f~~~~~ 276 (515)
||+.|+++||||++...
T Consensus 326 pt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 326 ADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp BCHHHHHTCGGGTTCTT
T ss_pred CCHHHHhhChhhhcccC
Confidence 99999999999997643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=372.72 Aligned_cols=257 Identities=27% Similarity=0.465 Sum_probs=212.0
Q ss_pred CCCCccccCCCceEeeeecccCceEEEEEEEcCC---CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEE
Q 010214 8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84 (515)
Q Consensus 8 ~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~ 84 (515)
+....+...++|++.+.||+|+||.||+|.+..+ +..||+|++... ......+.+.+|+.+++.++||||+++++
T Consensus 6 s~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 83 (281)
T 1mp8_A 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIG 83 (281)
T ss_dssp ---CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEE
Confidence 4456667789999999999999999999998754 457999998643 23455678999999999999999999999
Q ss_pred EEEcCCeEEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 85 VIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 85 ~~~~~~~~~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
++. .+..|+||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 84 VIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp EEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred EEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccc
Confidence 984 567899999999999999998654 699999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCc--cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCC
Q 010214 164 SNIMRDGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSH 239 (515)
Q Consensus 164 s~~~~~~~~--~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~ 239 (515)
+........ .....+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+. ...|..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 241 (281)
T 1mp8_A 163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 241 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred ccccCcccccccccCCCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCC
Confidence 987654432 233457789999999987766 789999999999999996 999999988888877776654 567788
Q ss_pred CChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 240 LSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 240 ~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+++++.+++.+||..||.+|||+.|++++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=382.13 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=223.1
Q ss_pred cccCCCceEeeeecccCceEEEEEEEc-----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE 87 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~ 87 (515)
+...++|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 445689999999999999999999997 456899999997543 3445678999999999999999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHHh------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 010214 88 TPSDIYVVMEYVKSGELFDYIVEK------------------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDL 143 (515)
Q Consensus 88 ~~~~~~iVmEy~~gg~L~~~i~~~------------------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDL 143 (515)
+.+..|+||||+++|+|.+++... ..+++.+++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 999999999999999999999864 57999999999999999999999999999999
Q ss_pred CCCcEEECCCCceEEeecccccccccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCC
Q 010214 144 KPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDD 219 (515)
Q Consensus 144 kpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~ 219 (515)
||+|||++.++.+||+|||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhcCCCcCCC
Confidence 9999999999999999999997654332 2334568899999999987766 789999999999999999 9999999
Q ss_pred CChHHHHHHHhcCcc-CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 220 ENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 220 ~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.+..+....+..+.. ..|..+++++.+|+.+||+.||.+|||+.+++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 988888888776654 5678899999999999999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=376.03 Aligned_cols=255 Identities=29% Similarity=0.443 Sum_probs=224.3
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEc-----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEE
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV 85 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~ 85 (515)
..+...++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+++++.++||||++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 34445689999999999999999999983 456899999987543 34556789999999999999999999999
Q ss_pred EEcCCeEEEEEeccCCCCHHHHHHHhCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCceec
Q 010214 86 IETPSDIYVVMEYVKSGELFDYIVEKGR------------------------LQEDEARNFFQQIISGVEYCHRNMVVHR 141 (515)
Q Consensus 86 ~~~~~~~~iVmEy~~gg~L~~~i~~~~~------------------------l~e~~~~~i~~qil~aL~yLH~~gIvHr 141 (515)
+.+.+..|+||||++||+|.+++..... +++.+++.++.||+.||.|||++||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 9999999999999999999999987543 8999999999999999999999999999
Q ss_pred cCCCCcEEECCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCC
Q 010214 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPF 217 (515)
Q Consensus 142 DLkpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf 217 (515)
||||+|||++.++.+||+|||++........ .....+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987644322 234467889999999988766 789999999999999999 99999
Q ss_pred CCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 218 DDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 218 ~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.+.....+...+..+. ...|..+++++.++|.+||+.||.+|||+.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 254 PGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp TTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9988888887777654 45677899999999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=369.90 Aligned_cols=250 Identities=24% Similarity=0.428 Sum_probs=218.9
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
..-.++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+++++.++||||+++++++.+.+.+
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 344679999999999999999999886 6778999999765433 35688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999999999986 5679999999999999999999999999999999999999999999999999998664432
Q ss_pred --ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHH
Q 010214 172 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL 247 (515)
Q Consensus 172 --~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 247 (515)
......+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+.......+..+. ...|...++.+.++
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 253 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTI 253 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHH
Confidence 2234457788999999987766 789999999999999998 999999988888888887764 44567789999999
Q ss_pred hcccCCCCCCCCCCHHHHhcC
Q 010214 248 IPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~h 268 (515)
|.+||+.||.+|||+.++++|
T Consensus 254 i~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 254 MYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999876
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=374.55 Aligned_cols=260 Identities=25% Similarity=0.368 Sum_probs=201.8
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
....++|++.+.||+|+||.||+|.++.+|+.||||++...... ......+.++..+++.++||||+++++++.+++.+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 34567899999999999999999999999999999999765422 23344555666678999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
|+||||+ ++.+..+... .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 9999999 5566665544 56899999999999999999999995 9999999999999999999999999999877665
Q ss_pred CccccCCCCCCccCCCcccC----CccCCCcceeehhHHHHHHHHhCCCCCCC-CChHHHHHHHhcCcc-CCC--CCCCh
Q 010214 171 HFLKTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIY-TLP--SHLSP 242 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~----~~~~~~~~DIwSlGvily~lltG~~Pf~~-~~~~~~~~~i~~~~~-~~p--~~~s~ 242 (515)
.......||+.|+|||++.+ ....+.++|||||||++|+|++|..||.. .........+..... ..| ..+++
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T 2dyl_A 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSG 258 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCH
T ss_pred ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCH
Confidence 55566789999999999852 22237899999999999999999999987 344455555554433 233 35899
Q ss_pred hHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 243 ~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
++.+||.+||..||.+|||+.++++||||+..
T Consensus 259 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 99999999999999999999999999999754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=367.24 Aligned_cols=256 Identities=29% Similarity=0.430 Sum_probs=214.4
Q ss_pred CCCCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHH----HHHHHHHHHHHhCCCCCccEEE
Q 010214 8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME----EKVRREIKILRLFMHPHIIRLY 83 (515)
Q Consensus 8 ~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~----~~i~~Ei~il~~l~hpnIv~l~ 83 (515)
.+.-.....++|++.+.||+|+||.||+|.+..+++.||+|++........... +.+.+|+.+++.++||||++++
T Consensus 10 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 89 (287)
T 4f0f_A 10 KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLY 89 (287)
T ss_dssp --CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred chhhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence 333344557899999999999999999999999999999999976544332221 6789999999999999999999
Q ss_pred EEEEcCCeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCc-----
Q 010214 84 EVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWN----- 155 (515)
Q Consensus 84 ~~~~~~~~~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDLkpeNILl~~~~~----- 155 (515)
+++.+.. ++||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.
T Consensus 90 ~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 90 GLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp EEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred eeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCcee
Confidence 9997666 6999999999999988754 47999999999999999999999999 999999999999988876
Q ss_pred eEEeecccccccccCCccccCCCCCCccCCCcccCC-ccCCCcceeehhHHHHHHHHhCCCCCCCCChHHH--HHHHhcC
Q 010214 156 VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL--FKKIKGG 232 (515)
Q Consensus 156 vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~-~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~--~~~i~~~ 232 (515)
+||+|||++..... ......||+.|+|||++.+. ...++++|||||||++|+|++|..||...+.... ...+...
T Consensus 168 ~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 245 (287)
T 4f0f_A 168 AKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245 (287)
T ss_dssp EEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred EEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence 99999999975433 34567899999999998432 2237899999999999999999999987654333 3333322
Q ss_pred --ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 233 --IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 233 --~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
....|..+++++.+||.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 34567889999999999999999999999999976
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=383.93 Aligned_cols=254 Identities=27% Similarity=0.452 Sum_probs=224.6
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCC-------CcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEE
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALT-------GHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLY 83 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~t-------g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~ 83 (515)
.....++|++.+.||+|+||.||+|.+..+ +..||+|++.... .......+.+|+++++.+ +||||++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 344568999999999999999999997543 3579999997542 344567899999999999 899999999
Q ss_pred EEEEcCCeEEEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010214 84 EVIETPSDIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPEN 147 (515)
Q Consensus 84 ~~~~~~~~~~iVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeN 147 (515)
+++.+.+..|+||||+++|+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 99999999999999999999999998754 49999999999999999999999999999999999
Q ss_pred EEECCCCceEEeecccccccccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChH
Q 010214 148 LLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP 223 (515)
Q Consensus 148 ILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~ 223 (515)
||++.++.+||+|||++....... ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999998765432 2334567889999999988776 789999999999999999 99999999988
Q ss_pred HHHHHHhcC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 224 NLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 224 ~~~~~i~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
++...+..+ ....|..+++++.+||.+||+.||.+|||+.|++++
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 301 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 888888766 456678899999999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=380.73 Aligned_cols=248 Identities=23% Similarity=0.335 Sum_probs=214.0
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPS 90 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~ 90 (515)
.-.+.++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.+ +||||+++++++.+.+
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 78 (330)
T 2izr_A 4 VLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGK 78 (330)
T ss_dssp CCEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred eEEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence 345678999999999999999999999999999999998755422 3578999999999 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc-----eEEeecccc
Q 010214 91 DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN-----VKIADFGLS 164 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~-----vKL~DFGls 164 (515)
..|+||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred ccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999999999 8999999987 468999999999999999999999999999999999999999887 999999999
Q ss_pred cccccCCc--------cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC---ChHHHHHHHhcCc
Q 010214 165 NIMRDGHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---NIPNLFKKIKGGI 233 (515)
Q Consensus 165 ~~~~~~~~--------~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~---~~~~~~~~i~~~~ 233 (515)
........ ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. ...+.+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~ 236 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK 236 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence 87644322 246789999999999998877 78999999999999999999999874 3444455554444
Q ss_pred cCCC-----CCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 234 YTLP-----SHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 234 ~~~p-----~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
...| ..++ ++.+++.+||..||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 237 RATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 3333 2244 9999999999999999999998875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=385.10 Aligned_cols=252 Identities=29% Similarity=0.467 Sum_probs=215.7
Q ss_pred ccCCCceEeeeecccCceEEEEEE-----EcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIE 87 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~-----~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~ 87 (515)
...++|++.+.||+|+||.||+|. +..+++.||||++.... .......+.+|+++++.+ +||||+++++++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 346899999999999999999999 55677999999997543 334567889999999999 7899999999998
Q ss_pred cCCe-EEEEEeccCCCCHHHHHHHhCC-----------------------------------------------------
Q 010214 88 TPSD-IYVVMEYVKSGELFDYIVEKGR----------------------------------------------------- 113 (515)
Q Consensus 88 ~~~~-~~iVmEy~~gg~L~~~i~~~~~----------------------------------------------------- 113 (515)
+.+. +++||||++||+|.+++.....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 7654 9999999999999999986543
Q ss_pred -------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC---ccccCC
Q 010214 114 -------------LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSC 177 (515)
Q Consensus 114 -------------l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~ 177 (515)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 8999999999999999999999999999999999999999999999999998664322 234556
Q ss_pred CCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHH-HHHHHhcC-ccCCCCCCChhHHHHhcccCCC
Q 010214 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN-LFKKIKGG-IYTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 178 gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~li~~mL~~ 254 (515)
||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+..... ....+..+ ....|..+++++.+++.+||+.
T Consensus 257 ~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 335 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 335 (359)
T ss_dssp ECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCceeEChhhhcCCCC-CchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 8899999999987776 789999999999999998 999998866443 33444433 4567788999999999999999
Q ss_pred CCCCCCCHHHHhcC
Q 010214 255 DPMKRITIPEIRQH 268 (515)
Q Consensus 255 dP~~Rpt~~eil~h 268 (515)
||.+|||+.|+++|
T Consensus 336 dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 336 EPSQRPTFSELVEH 349 (359)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCCCHHHHHHH
Confidence 99999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=371.64 Aligned_cols=247 Identities=19% Similarity=0.290 Sum_probs=213.5
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCC-------cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTG-------HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE 87 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg-------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~ 87 (515)
..++|++.+.||+|+||+||+|.+..++ ..||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 3579999999999999999999998877 479999986543 234577899999999999999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc--------eEE
Q 010214 88 TPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN--------VKI 158 (515)
Q Consensus 88 ~~~~~~iVmEy~~gg~L~~~i~~~~~-l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~--------vKL 158 (515)
+++..|+||||++||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++. +||
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence 99999999999999999999987654 999999999999999999999999999999999999998887 999
Q ss_pred eecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhC-CCCCCCCChHHHHHHHhcCccCCC
Q 010214 159 ADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPNLFKKIKGGIYTLP 237 (515)
Q Consensus 159 ~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG-~~Pf~~~~~~~~~~~i~~~~~~~p 237 (515)
+|||++...... ....||+.|+|||++.+....+.++|||||||++|+|++| .+||....... ...+.......|
T Consensus 163 ~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (289)
T 4fvq_A 163 SDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYEDRHQLP 238 (289)
T ss_dssp CCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTTCCCC
T ss_pred ccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhccCCCC
Confidence 999998755332 3345889999999998744458999999999999999995 45555544443 444445566778
Q ss_pred CCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 238 ~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
...++++.+|+.+||+.||.+|||+.|+++|
T Consensus 239 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 239 APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8889999999999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=366.85 Aligned_cols=249 Identities=20% Similarity=0.280 Sum_probs=214.8
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCe
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSD 91 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 91 (515)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++...... ..+.+|+.+++.+ +|||++++++++.+...
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 45678899999999999999999999999999999998654322 3577899999999 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc-----eEEeeccccc
Q 010214 92 IYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN-----VKIADFGLSN 165 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~-----vKL~DFGls~ 165 (515)
.|+||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999999 899999998754 5999999999999999999999999999999999999987776 9999999998
Q ss_pred ccccCC--------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC---ChHHHHHHHhcCcc
Q 010214 166 IMRDGH--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---NIPNLFKKIKGGIY 234 (515)
Q Consensus 166 ~~~~~~--------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~---~~~~~~~~i~~~~~ 234 (515)
...... .....+||+.|+|||++.+..+ ++++|||||||++|+|++|..||.+. ........+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 765432 2345679999999999988876 78999999999999999999999874 33444444433322
Q ss_pred -----CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 235 -----TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 235 -----~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..+..+++++.+|+.+||+.||.+|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 2235789999999999999999999999998763
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=376.29 Aligned_cols=259 Identities=25% Similarity=0.416 Sum_probs=195.3
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHH-HHHhCCCCCccEEEEEEEcCC
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIK-ILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~hpnIv~l~~~~~~~~ 90 (515)
.+...++|++.+.||+|+||.||+|.++.+|+.||||++.... .......+.+|+. +++.++||||+++++++.+++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG 94 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence 4455689999999999999999999999999999999997543 2233445555655 778889999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCceEEeecccc
Q 010214 91 DIYVVMEYVKSGELFDYIVE-----KGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~-----~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
..|+||||+++ +|.+++.. ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 99999999975 88888764 56799999999999999999999998 9999999999999999999999999999
Q ss_pred cccccCCccccCCCCCCccCCCccc----CCccCCCcceeehhHHHHHHHHhCCCCCCCCCh-HHHHHHHhcCcc-CCC-
Q 010214 165 NIMRDGHFLKTSCGSPNYAAPEVIS----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGGIY-TLP- 237 (515)
Q Consensus 165 ~~~~~~~~~~~~~gt~~Y~aPE~i~----~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~-~~~~~~i~~~~~-~~p- 237 (515)
.............||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+. ......+..+.. .++
T Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3aln_A 174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN 252 (327)
T ss_dssp CC------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCC
T ss_pred eecccccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCC
Confidence 8776555555568999999999983 4444 7899999999999999999999987432 222222222221 222
Q ss_pred ---CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 238 ---SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 238 ---~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..+++++.+||.+||..||.+|||+.++++||||...
T Consensus 253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 3588999999999999999999999999999999754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=368.81 Aligned_cols=253 Identities=24% Similarity=0.412 Sum_probs=225.1
Q ss_pred CCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010214 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (515)
Q Consensus 10 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 89 (515)
...+...++|++.+.||+|+||.||+|.++.++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 455566789999999999999999999999999999999986533 3457788999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
+..|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999999999874 45999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCc--cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChh
Q 010214 168 RDGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPG 243 (515)
Q Consensus 168 ~~~~~--~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 243 (515)
..... .....+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+... ....|..++++
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 240 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred cCCccccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHH
Confidence 54332 233457889999999987766 789999999999999999 99999998888877777665 45667889999
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+.+|+.+||..||.+|||+.++++
T Consensus 241 l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 241 VYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhCCChhhCcCHHHHHH
Confidence 999999999999999999999976
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=364.67 Aligned_cols=250 Identities=30% Similarity=0.475 Sum_probs=206.1
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCC-hHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-MEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~-~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
.-.++|++.+.||+|+||.||+|.+. |+.||+|++....... ....+.+.+|+++++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 34689999999999999999999974 8899999987654322 22357789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCcEEECC--------CCceEEeec
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM---VVHRDLKPENLLLDS--------KWNVKIADF 161 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~g---IvHrDLkpeNILl~~--------~~~vKL~DF 161 (515)
|+||||++|++|.+++. .+++++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999885 568999999999999999999999999 899999999999986 678999999
Q ss_pred ccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCCCC
Q 010214 162 GLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPSH 239 (515)
Q Consensus 162 Gls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~ 239 (515)
|++....... .....||+.|+|||++.+..+ ++++||||||+++|+|++|..||.+.+.......+.... ...|..
T Consensus 161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3dtc_A 161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238 (271)
T ss_dssp CC--------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTT
T ss_pred Cccccccccc-ccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcc
Confidence 9998665433 235679999999999987766 789999999999999999999999988777666665543 456778
Q ss_pred CChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 240 LSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 240 ~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+++++.+++.+||+.||.+|||+.|+++|
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 99999999999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=377.56 Aligned_cols=250 Identities=26% Similarity=0.438 Sum_probs=218.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEE--EEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKV--AIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~v--AiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 92 (515)
.++|++.+.||+|+||.||+|.++.+|..+ |+|.+.... .......+.+|+.+++++ +||||+++++++.+.+.+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 489999999999999999999999898865 999886432 233456789999999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCce
Q 010214 93 YVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNV 156 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~v 156 (515)
|+||||+++|+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeE
Confidence 99999999999999997654 69999999999999999999999999999999999999999999
Q ss_pred EEeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-cc
Q 010214 157 KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IY 234 (515)
Q Consensus 157 KL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~ 234 (515)
||+|||++.............+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..
T Consensus 182 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~ 260 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 260 (327)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC
T ss_pred EEcccCcCccccccccccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCC
Confidence 9999999975544333445567899999999987766 789999999999999998 99999999988888887766 34
Q ss_pred CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 235 ~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..|..+++++.+||.+||..||.+|||+.|++++
T Consensus 261 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 261 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5677889999999999999999999999999886
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=387.05 Aligned_cols=249 Identities=27% Similarity=0.468 Sum_probs=219.4
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||.||+|.++.+++.||||++... ........+.+|+++|+.++||||+++++++.+.+.+|+|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 46899999999999999999999999999999998643 2334556788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 96 MEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
|||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....+....
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 99999999999998654 69999999999999999999999999999999999999999999999999998654432221
Q ss_pred ---cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhc
Q 010214 175 ---TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIP 249 (515)
Q Consensus 175 ---~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~ 249 (515)
...+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++++.+|+.
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 349 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLME 349 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 1235678999999987766 789999999999999998 99999998887777766655 35667889999999999
Q ss_pred ccCCCCCCCCCCHHHHhc
Q 010214 250 RMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~ 267 (515)
+||+.||.+|||+.++++
T Consensus 350 ~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 350 QCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCchhCcCHHHHHH
Confidence 999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=370.28 Aligned_cols=262 Identities=29% Similarity=0.441 Sum_probs=217.0
Q ss_pred CCCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC--CCCccEEEEEE
Q 010214 9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM--HPHIIRLYEVI 86 (515)
Q Consensus 9 ~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~--hpnIv~l~~~~ 86 (515)
...+....++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.+++.++ ||||+++++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3445556678999999999999999999986 589999999976543 3355678899999999998 59999999999
Q ss_pred EcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 87 ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 87 ~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
.+.+.+|+||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++..
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeecccccc
Confidence 99999999999 557899999999889999999999999999999999999999999999999975 7999999999987
Q ss_pred cccCC---ccccCCCCCCccCCCcccCC----------ccCCCcceeehhHHHHHHHHhCCCCCCCCCh-HHHHHHHhcC
Q 010214 167 MRDGH---FLKTSCGSPNYAAPEVISGK----------LYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGG 232 (515)
Q Consensus 167 ~~~~~---~~~~~~gt~~Y~aPE~i~~~----------~~~~~~~DIwSlGvily~lltG~~Pf~~~~~-~~~~~~i~~~ 232 (515)
..... .....+||+.|+|||++.+. ...+.++|||||||++|+|++|..||..... ......+...
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 255 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 255 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc
Confidence 65432 23456799999999998752 2336799999999999999999999987532 2333344333
Q ss_pred --ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 233 --IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 233 --~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
...+|...+.++.+||.+||..||.+|||+.|+++||||+..
T Consensus 256 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 256 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 235667789999999999999999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=371.80 Aligned_cols=255 Identities=23% Similarity=0.369 Sum_probs=223.6
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEc-----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEE
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV 85 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~ 85 (515)
......++|++.+.||+|+||.||+|.++ .+++.||+|++.... .......+.+|+.+++.++||||++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 34555689999999999999999999887 467899999987543 33455678999999999999999999999
Q ss_pred EEcCCeEEEEEeccCCCCHHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc
Q 010214 86 IETPSDIYVVMEYVKSGELFDYIVEK----------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN 155 (515)
Q Consensus 86 ~~~~~~~~iVmEy~~gg~L~~~i~~~----------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~ 155 (515)
+.+.+..|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 99999999999999999999999753 45799999999999999999999999999999999999999999
Q ss_pred eEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhc
Q 010214 156 VKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKG 231 (515)
Q Consensus 156 vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~ 231 (515)
+||+|||++........ .....||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence 99999999986644322 234467899999999987766 789999999999999999 8999999888888777766
Q ss_pred Cc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 232 GI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 232 ~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+. ...|..+++++.+||.+||..||.+|||+.|+++|
T Consensus 256 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 256 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 54 45678899999999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=360.76 Aligned_cols=247 Identities=24% Similarity=0.459 Sum_probs=219.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence 478999999999999999999987 6789999999765433 35788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--c
Q 010214 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--F 172 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~--~ 172 (515)
|||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 9999999999999865 568999999999999999999999999999999999999999999999999998664322 2
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcc
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPR 250 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~ 250 (515)
.....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+..+. ...|...++.+.+++.+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 240 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 240 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred cccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHH
Confidence 234567889999999987766 789999999999999999 999999998888888887764 44567789999999999
Q ss_pred cCCCCCCCCCCHHHHhcC
Q 010214 251 MLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~h 268 (515)
||+.||.+|||+.+++++
T Consensus 241 ~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 241 CWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCChhhCcCHHHHHHH
Confidence 999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=368.68 Aligned_cols=251 Identities=26% Similarity=0.418 Sum_probs=209.5
Q ss_pred cccCCCceEeeeecccCceEEEEEE----EcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAE----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET 88 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~----~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 88 (515)
....++|++.+.||+|+||+||+|. +..+++.||+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3456899999999999999999998 5678999999998643 34456788999999999999999999999854
Q ss_pred --CCeEEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 89 --PSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 89 --~~~~~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
...+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 356899999999999999998754 59999999999999999999999999999999999999999999999999998
Q ss_pred ccccCC----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH----------------HH
Q 010214 166 IMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP----------------NL 225 (515)
Q Consensus 166 ~~~~~~----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~----------------~~ 225 (515)
...... ......+++.|+|||++.+..+ +.++|||||||++|+|++|..||...... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 765432 2234457778999999988776 78999999999999999999998653211 12
Q ss_pred HHHHh-cCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 226 FKKIK-GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 226 ~~~i~-~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
...+. ......|..+++++.+||.+||..||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22222 2345667889999999999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=366.06 Aligned_cols=248 Identities=29% Similarity=0.475 Sum_probs=217.8
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc-----
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----- 88 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----- 88 (515)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... +.+.+|+++++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 35578999999999999999999999999999999997543 356789999999999999999999864
Q ss_pred -----------CCeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc
Q 010214 89 -----------PSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN 155 (515)
Q Consensus 89 -----------~~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~ 155 (515)
...+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC
Confidence 44589999999999999999764 57999999999999999999999999999999999999999999
Q ss_pred eEEeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC
Q 010214 156 VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT 235 (515)
Q Consensus 156 vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~ 235 (515)
+||+|||++.............||+.|+|||++.+..+ +.++||||||+++|+|++|..||... ......+..+ .
T Consensus 161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--~ 235 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG--I 235 (284)
T ss_dssp EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--C
T ss_pred EEECcchhheeccccccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--c
Confidence 99999999988766655667789999999999988776 78999999999999999999988532 2334444443 3
Q ss_pred CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 236 ~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
++..+++++.++|.+||..||.+|||+.|+++|++.-.
T Consensus 236 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 236 ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 56778999999999999999999999999999988643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=364.56 Aligned_cols=254 Identities=29% Similarity=0.492 Sum_probs=209.8
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 35678999999999999999999999999999999998766666667788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 94 VVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999999975 45699999999999999999999999999999999999999999999999999877644
Q ss_pred CC-ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC--ChHHHHHHHhcCccC-C-CCCCChhH
Q 010214 170 GH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE--NIPNLFKKIKGGIYT-L-PSHLSPGA 244 (515)
Q Consensus 170 ~~-~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~--~~~~~~~~i~~~~~~-~-p~~~s~~~ 244 (515)
.. ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+. +.......+...... . +..+++++
T Consensus 189 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (310)
T 2wqm_A 189 KTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267 (310)
T ss_dssp ----------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred CCccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence 32 2345679999999999988766 78999999999999999999999764 334555555554432 2 25689999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcC
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.+||.+||..||.+|||+.+++++
T Consensus 268 ~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 268 RQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=371.83 Aligned_cols=255 Identities=25% Similarity=0.455 Sum_probs=222.1
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEc-------CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEE
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHA-------LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRL 82 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~-------~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l 82 (515)
......++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.+ +||||+++
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 33445689999999999999999999986 467889999987543 334567889999999999 89999999
Q ss_pred EEEEEcCCeEEEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 010214 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPE 146 (515)
Q Consensus 83 ~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpe 146 (515)
++++.+.+.+|+||||+++|+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 999999999999999999999999998654 3899999999999999999999999999999999
Q ss_pred cEEECCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCCh
Q 010214 147 NLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENI 222 (515)
Q Consensus 147 NILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~ 222 (515)
|||++.++.+||+|||++........ .....+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 99999999999999999987654332 233457889999999987766 789999999999999999 9999999888
Q ss_pred HHHHHHHhcCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 223 PNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 223 ~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.++...+..+. ...|..+++++.++|.+||..||.+|||+.|++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 266 EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 88887776654 45677899999999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=376.71 Aligned_cols=252 Identities=27% Similarity=0.431 Sum_probs=214.3
Q ss_pred cCCCceEeeeecccCceEEEEEEE-----cCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEc
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEH-----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET 88 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~-----~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~ 88 (515)
-.++|++.+.||+|+||.||+|.+ ..++..||+|++.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 457899999999999999999997 3466789999997543 223457889999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKG-----------------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKP 145 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~-----------------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkp 145 (515)
.+..|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 999999999999999999998643 379999999999999999999999999999999
Q ss_pred CcEEECCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCC
Q 010214 146 ENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDEN 221 (515)
Q Consensus 146 eNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~ 221 (515)
+|||++.++.+||+|||++........ .....||+.|+|||++.+..+ ++++|||||||++|+|++ |..||.+..
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999999999987654322 234467889999999987766 789999999999999998 999998876
Q ss_pred hHHHHHHHh-cC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCc
Q 010214 222 IPNLFKKIK-GG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHP 269 (515)
Q Consensus 222 ~~~~~~~i~-~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp 269 (515)
.......+. .+ ....|..+++++.+||.+||..||.+|||+.++++|.
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 280 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 554444433 33 3455778899999999999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=360.45 Aligned_cols=247 Identities=19% Similarity=0.344 Sum_probs=216.7
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--Ce
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SD 91 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 91 (515)
...++|++.+.||+|+||.||+|.+. |+.||+|++...... ....+.+.+|+.+++.++||||+++++++.++ ..
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 34689999999999999999999984 889999999765433 34567899999999999999999999999887 78
Q ss_pred EEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 92 IYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
.++||||++||+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999999999999998765 4899999999999999999999999 999999999999999999999999987553
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCC--cceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--ccCCCCCCChh
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGP--EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHLSPG 243 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~--~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~ 243 (515)
.. ....||+.|+|||++.+..+... ++|||||||++|+|++|..||.+.+.......+... ....|..++++
T Consensus 164 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3kmu_A 164 QS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239 (271)
T ss_dssp SC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHH
T ss_pred cc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 22 34578999999999987665332 799999999999999999999998877776665543 34667889999
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+.++|.+||+.||.+|||+.++++
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=376.55 Aligned_cols=249 Identities=25% Similarity=0.395 Sum_probs=214.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcE----EEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~----vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
.++|++.+.||+|+||+||+|.+..+++. ||+|++...... .....+.+|+.+++.++||||+++++++. ...
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 88 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS 88 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence 57899999999999999999999888876 777776533211 12345678999999999999999999986 456
Q ss_pred EEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 92 IYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.++||||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 89999999999999999764 57999999999999999999999999999999999999999999999999999876543
Q ss_pred C---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHH
Q 010214 171 H---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGAR 245 (515)
Q Consensus 171 ~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (515)
. ......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+ ....|..+++++.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVY 247 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTT
T ss_pred cccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHH
Confidence 2 2344568889999999987776 789999999999999999 99999998887777777765 4566778899999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcC
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+++.+||..||.+|||+.++++|
T Consensus 248 ~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 248 MVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999886
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=369.15 Aligned_cols=254 Identities=29% Similarity=0.460 Sum_probs=218.0
Q ss_pred ccccCCCceEeeeecccCceEEEEEEE-----cCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEE
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEH-----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEV 85 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~-----~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~ 85 (515)
.+...++|++.+.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|+.+++++ +||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 334457999999999999999999985 4578899999997543 334567899999999999 89999999999
Q ss_pred EEcCCeEEEEEeccCCCCHHHHHHHhC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010214 86 IETPSDIYVVMEYVKSGELFDYIVEKG------------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPEN 147 (515)
Q Consensus 86 ~~~~~~~~iVmEy~~gg~L~~~i~~~~------------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeN 147 (515)
+.+.+..|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 999999999999999999999998754 48999999999999999999999999999999999
Q ss_pred EEECCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChH
Q 010214 148 LLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP 223 (515)
Q Consensus 148 ILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~ 223 (515)
||++.++.+||+|||++........ .....||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 9999999999999999987654332 234557889999999987766 789999999999999998 99999887654
Q ss_pred HHHHHH-hcC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 224 NLFKKI-KGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 224 ~~~~~i-~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.....+ ... ....+..+++++.++|.+||..||.+|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 443333 322 234467889999999999999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=373.96 Aligned_cols=249 Identities=26% Similarity=0.414 Sum_probs=210.6
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEE----EEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKV----AIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~v----AiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
.++|++.+.||+|+||+||+|.+..+++.+ |+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 478999999999999999999998888765 777664322 2234578899999999999999999999998765
Q ss_pred EEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 92 IYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.++|+||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++......
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 7899999999999999987 467999999999999999999999999999999999999999999999999999876543
Q ss_pred Cc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHH
Q 010214 171 HF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (515)
Q Consensus 171 ~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 245 (515)
.. .....||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. ...|..++.++.
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 249 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHH
T ss_pred cccccccCCCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence 32 223456889999999988776 789999999999999999 999999988887777776554 566778999999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcC
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+++.+||+.||.+|||+.|++++
T Consensus 250 ~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 250 MIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999999876
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=364.23 Aligned_cols=251 Identities=24% Similarity=0.381 Sum_probs=216.9
Q ss_pred ccCCCceEee-eecccCceEEEEEE--EcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 14 MFLPNYKLGK-TLGIGSFGKVKIAE--HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 14 ~~~~~Y~i~~-~LG~G~fg~Vy~a~--~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.-.++|++.+ .||+|+||.||+|. +..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 3357899998 99999999999995 456788999999976532 334567899999999999999999999999 556
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
..|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 78999999999999999998888999999999999999999999999999999999999999999999999999876543
Q ss_pred Cc----cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhH
Q 010214 171 HF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGA 244 (515)
Q Consensus 171 ~~----~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 244 (515)
.. .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+. ...|..+++++
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM 249 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CCcccccccCCCCceeeChHHhccCCC-ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 22 223456789999999987766 689999999999999999 999999988888777776654 45678899999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.++|.+||+.||.+|||+.++++
T Consensus 250 ~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 250 YDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999976
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=373.46 Aligned_cols=258 Identities=22% Similarity=0.336 Sum_probs=219.7
Q ss_pred ccCCCceEeeeecccCceEEEEEE-----EcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAE-----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET 88 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~-----~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 88 (515)
...++|++.+.||+|+||.||+|. +..++..||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 345899999999999999999999 56788899999986432 33456788999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCceEE
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKG-------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKI 158 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~-------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~---~~~vKL 158 (515)
....|+||||++|++|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999999998753 4899999999999999999999999999999999999994 446999
Q ss_pred eecccccccccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-
Q 010214 159 ADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI- 233 (515)
Q Consensus 159 ~DFGls~~~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~- 233 (515)
+|||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+.
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 9999987654332 2234568999999999987766 789999999999999998 999999988888777776653
Q ss_pred cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 234 YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 234 ~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
...+..+++.+.++|.+||+.||.+|||+.++++|.|+-..
T Consensus 264 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 45677899999999999999999999999999999987544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=361.51 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=216.2
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcC---CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE 87 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~---tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~ 87 (515)
..+...++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 345557899999999999999999998754 34569999987543 3345688999999999999999999999986
Q ss_pred cCCeEEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 88 TPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 88 ~~~~~~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
++ ..|+||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 54 5689999999999999997654 599999999999999999999999999999999999999999999999999987
Q ss_pred cccCCc--cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCCh
Q 010214 167 MRDGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSP 242 (515)
Q Consensus 167 ~~~~~~--~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 242 (515)
...... .....+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||...........+..+ ....|..+++
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPP 241 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCH
T ss_pred cccccccccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCH
Confidence 654332 234467889999999987766 789999999999999998 99999887777766666554 3556778999
Q ss_pred hHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 243 GARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 243 ~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.+.++|.+||..||.+|||+.|++++
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 242 VLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCchhCcCHHHHHHH
Confidence 99999999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=361.67 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=219.3
Q ss_pred cCCCceEee-eecccCceEEEEEEEc--CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 15 FLPNYKLGK-TLGIGSFGKVKIAEHA--LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 15 ~~~~Y~i~~-~LG~G~fg~Vy~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
..++|.+.+ .||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+++++.++||||+++++++. .+.
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~ 83 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEA 83 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSS
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCC
Confidence 357788877 9999999999999864 467889999997542 3456788999999999999999999999994 456
Q ss_pred EEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 92 IYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 89999999999999999653 56999999999999999999999999999999999999999999999999999876433
Q ss_pred Cc----cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhH
Q 010214 171 HF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGA 244 (515)
Q Consensus 171 ~~----~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 244 (515)
.. .....||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+. ...|..+++++
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 242 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 242 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred cceeeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHH
Confidence 22 233457899999999987766 789999999999999998 999999988888877777654 56778899999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcCcc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQHPW 270 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~hp~ 270 (515)
.++|.+||..||.+|||+.++++|.+
T Consensus 243 ~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 243 YALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 99999999999999999999998754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=368.11 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=214.6
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCC----cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTG----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET 88 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 88 (515)
+....+|++.+.||+|+||.||+|.++.++ ..||+|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 344578999999999999999999987654 459999986543 33456678999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
.+..|+||||+++|+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999999999865 67999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCc----cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCC
Q 010214 168 RDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLS 241 (515)
Q Consensus 168 ~~~~~----~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s 241 (515)
..... .....+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....|..++
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 276 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred ccccccccccCCCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCC
Confidence 54321 123346789999999987776 789999999999999998 99999998888888887766 345677899
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+.+.+++.+||+.||.+|||+.+++++
T Consensus 277 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 277 SAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=360.35 Aligned_cols=247 Identities=24% Similarity=0.301 Sum_probs=210.0
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEE-EEcCCeE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV-IETPSDI 92 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~-~~~~~~~ 92 (515)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++...... ..+.+|+.+++.++|++++..+.. .......
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 3568999999999999999999999999999999998765432 357899999999998886665555 4677889
Q ss_pred EEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---CCCCceEEeecccccccc
Q 010214 93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL---DSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl---~~~~~vKL~DFGls~~~~ 168 (515)
|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999999 8899999974 5579999999999999999999999999999999999999 478899999999998765
Q ss_pred cCCc--------cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC---hHHHHHHHhcCccCCC
Q 010214 169 DGHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN---IPNLFKKIKGGIYTLP 237 (515)
Q Consensus 169 ~~~~--------~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~---~~~~~~~i~~~~~~~p 237 (515)
.... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.. .......+.......|
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred ccccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 4322 245689999999999998876 789999999999999999999998633 2334444444333333
Q ss_pred -----CCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 238 -----SHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 238 -----~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
..+++++.+|+.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 678999999999999999999999999876
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=369.94 Aligned_cols=254 Identities=26% Similarity=0.435 Sum_probs=217.9
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCc-----EEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEE
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGH-----KVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEV 85 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~-----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~ 85 (515)
.....++|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34456889999999999999999999987665 79999987543 334567899999999999 89999999999
Q ss_pred EEcCCeEEEEEeccCCCCHHHHHHHh--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC
Q 010214 86 IETPSDIYVVMEYVKSGELFDYIVEK--------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD 151 (515)
Q Consensus 86 ~~~~~~~~iVmEy~~gg~L~~~i~~~--------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~ 151 (515)
+.+.+.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 99999999999999999999999753 3589999999999999999999999999999999999999
Q ss_pred CCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHH
Q 010214 152 SKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFK 227 (515)
Q Consensus 152 ~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~ 227 (515)
.++.+||+|||++........ .....||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 999999999999986644322 234457889999999987766 789999999999999998 999998876555444
Q ss_pred HHhcC--ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 228 KIKGG--IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 228 ~i~~~--~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.+... ....|...++++.++|.+||+.||.+|||+.|++++
T Consensus 278 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 44332 234567789999999999999999999999999873
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=385.44 Aligned_cols=252 Identities=26% Similarity=0.427 Sum_probs=212.7
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC--e
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS--D 91 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~--~ 91 (515)
...++|++.+.||+|+||+||+|.+..+|+.||||++....... ..+.+.+|+++++.++||||+++++++.... .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 34678999999999999999999999999999999997544322 2467789999999999999999999998765 7
Q ss_pred EEEEEeccCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----CCCCceEEeecccc
Q 010214 92 IYVVMEYVKSGELFDYIVEKG---RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL----DSKWNVKIADFGLS 164 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~---~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl----~~~~~vKL~DFGls 164 (515)
.|+||||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 899999999999999997543 39999999999999999999999999999999999999 77888999999999
Q ss_pred cccccCCccccCCCCCCccCCCcccC--------CccCCCcceeehhHHHHHHHHhCCCCCCC----CChHHHHHHHhcC
Q 010214 165 NIMRDGHFLKTSCGSPNYAAPEVISG--------KLYAGPEVDVWSCGVILYALLCGTLPFDD----ENIPNLFKKIKGG 232 (515)
Q Consensus 165 ~~~~~~~~~~~~~gt~~Y~aPE~i~~--------~~~~~~~~DIwSlGvily~lltG~~Pf~~----~~~~~~~~~i~~~ 232 (515)
..........+.+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.. ....+...++..+
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred eEccCCCccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 88777666677889999999999864 333 6799999999999999999999964 2233444555443
Q ss_pred ccC-------------------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 233 IYT-------------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 233 ~~~-------------------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
... ++..+++.+.++|.+||..||.+|||+.|++++
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 321 112245678899999999999999999998654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=363.59 Aligned_cols=249 Identities=27% Similarity=0.421 Sum_probs=209.6
Q ss_pred CCCceEeeeecccCceEEEEEE----EcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAE----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP-- 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~----~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~-- 89 (515)
..+|++.+.||+|+||.||+|. +..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 4669999999999999999999 567899999999975542 22357789999999999999999999999876
Q ss_pred CeEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
..+|+||||+++|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 679999999999999999954 4579999999999999999999999999999999999999999999999999998765
Q ss_pred cCC----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC---------------ChHHHHHHH
Q 010214 169 DGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---------------NIPNLFKKI 229 (515)
Q Consensus 169 ~~~----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~---------------~~~~~~~~i 229 (515)
... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..|+... ........+
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKF-YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCC-CcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 443 2345578889999999988776 68999999999999999999886432 112222333
Q ss_pred hcC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 230 KGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 230 ~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
..+ ....|..+++++.+||.+||..||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 332 34567889999999999999999999999999975
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=383.47 Aligned_cols=244 Identities=27% Similarity=0.518 Sum_probs=214.5
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-eE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-DI 92 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-~~ 92 (515)
...++|++.+.||+|+||.||+|.+. |+.||||++.... ..+.+.+|+.+|++++||||+++++++.... .+
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 34578999999999999999999874 7899999997543 2467889999999999999999999987655 79
Q ss_pred EEEEeccCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 93 YVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~--l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
|+||||+++|+|.+++...+. +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 999999999999999987654 799999999999999999999999999999999999999999999999999854332
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHh
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLI 248 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li 248 (515)
..+..+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+ ....|..+++++.+||
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 419 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVM 419 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred --ccCCCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 234467899999999988877 789999999999999998 99999988877777777665 4567788999999999
Q ss_pred cccCCCCCCCCCCHHHHhc
Q 010214 249 PRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~ 267 (515)
.+||..||.+|||+.++++
T Consensus 420 ~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 420 KNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHH
Confidence 9999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=366.52 Aligned_cols=255 Identities=26% Similarity=0.413 Sum_probs=210.8
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcC---CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET 88 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~---tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 88 (515)
+....++|.+.+.||+|+||.||+|.+.. ++..||+|++..... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 33445789999999999999999998765 556899999876543 33456788999999999999999999999977
Q ss_pred CC-----eEEEEEeccCCCCHHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceE
Q 010214 89 PS-----DIYVVMEYVKSGELFDYIVE------KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK 157 (515)
Q Consensus 89 ~~-----~~~iVmEy~~gg~L~~~i~~------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vK 157 (515)
.. ..|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence 55 35999999999999999953 35699999999999999999999999999999999999999999999
Q ss_pred EeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-
Q 010214 158 IADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG- 232 (515)
Q Consensus 158 L~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~- 232 (515)
|+|||++........ .....+++.|+|||++.+..+ ++++|||||||++|+|++ |..||.+.........+..+
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 266 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH 266 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence 999999987654322 233467889999999988776 789999999999999999 99999998888877777665
Q ss_pred ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 233 IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 233 ~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
....|..+++++.++|.+||..||.+|||+.+++++
T Consensus 267 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 267 RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 356678899999999999999999999999999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=358.98 Aligned_cols=238 Identities=35% Similarity=0.608 Sum_probs=200.2
Q ss_pred CCCCccccCCCceEe-eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHH-HhCCCCCccEEEEE
Q 010214 8 SSSGVDMFLPNYKLG-KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPHIIRLYEV 85 (515)
Q Consensus 8 ~~~~~~~~~~~Y~i~-~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il-~~l~hpnIv~l~~~ 85 (515)
.....+.+.++|.+. +.||+|+||.||+|.++.+++.||+|++... ....+|+.++ +..+||||++++++
T Consensus 8 ~~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~ 79 (299)
T 3m2w_A 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDV 79 (299)
T ss_dssp CCCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred ccCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhh
Confidence 444567788999998 7899999999999999999999999998532 3567888888 77789999999999
Q ss_pred EEc----CCeEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCce
Q 010214 86 IET----PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNV 156 (515)
Q Consensus 86 ~~~----~~~~~iVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~---~~~v 156 (515)
+.. ...+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~ 159 (299)
T 3m2w_A 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL 159 (299)
T ss_dssp EEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCE
T ss_pred hhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcE
Confidence 977 677999999999999999998754 6999999999999999999999999999999999999998 7899
Q ss_pred EEeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHH----HHhcC
Q 010214 157 KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFK----KIKGG 232 (515)
Q Consensus 157 KL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~----~i~~~ 232 (515)
||+|||++..... ..+ +.++|||||||++|+|++|..||.+.+...... .+..+
T Consensus 160 kl~Dfg~a~~~~~---------------------~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 217 (299)
T 3m2w_A 160 KLTDFGFAKETTG---------------------EKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 217 (299)
T ss_dssp EECCCTTCEECTT---------------------CGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTT
T ss_pred EEecccccccccc---------------------ccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhc
Confidence 9999999865421 223 679999999999999999999998765443322 22223
Q ss_pred ccCCC----CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 233 IYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 233 ~~~~p----~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
....| ..+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 33444 57899999999999999999999999999999998653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=362.81 Aligned_cols=257 Identities=25% Similarity=0.437 Sum_probs=201.4
Q ss_pred CCCCCCCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEE
Q 010214 5 SNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84 (515)
Q Consensus 5 ~~~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~ 84 (515)
+.......+...++|++.+.||+|+||.||+|.+. ..||+|++..... .....+.+.+|+.+++.++||||+++++
T Consensus 12 ~~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (289)
T 3og7_A 12 SRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMG 87 (289)
T ss_dssp ------CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CCCCCCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEe
Confidence 33444556677789999999999999999999854 3599999976543 3455688999999999999999999999
Q ss_pred EEEcCCeEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 85 VIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 85 ~~~~~~~~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
+. .....++||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (289)
T 3og7_A 88 YS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL 166 (289)
T ss_dssp EE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred ec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEcccee
Confidence 65 55678999999999999999964 45699999999999999999999999999999999999999999999999999
Q ss_pred cccccc---CCccccCCCCCCccCCCccc---CCccCCCcceeehhHHHHHHHHhCCCCCCCCChH-HHHHHHhcCccC-
Q 010214 164 SNIMRD---GHFLKTSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYT- 235 (515)
Q Consensus 164 s~~~~~---~~~~~~~~gt~~Y~aPE~i~---~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~-~~~~~i~~~~~~- 235 (515)
+..... ........||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.... .....+..+...
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP 245 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc
Confidence 976543 22334567999999999986 3444 67999999999999999999999875544 344444443322
Q ss_pred ----CCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 236 ----LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 236 ----~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.+..+++++.+||.+||..||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 23578899999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=379.17 Aligned_cols=249 Identities=25% Similarity=0.420 Sum_probs=207.6
Q ss_pred CCCceEeeeecccCceEEEEEEEc---CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
.++|.+.+.||+|+||.||+|.++ .++..||||++.... .......+.+|+.++++++||||+++++++.+.+.+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 468999999999999999999987 467789999986542 334567899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|+||||++||+|.+++.+.+ .+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 99999999999999998654 69999999999999999999999999999999999999999999999999998765432
Q ss_pred c----cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHH
Q 010214 172 F----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (515)
Q Consensus 172 ~----~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 245 (515)
. .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. ...|..++..+.
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 280 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKF-TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY 280 (373)
T ss_dssp ------------CTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHH
T ss_pred ccceeccCCCcCCCccChhhhccCCc-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHH
Confidence 1 122345778999999987776 789999999999999998 999999988888887777653 445667899999
Q ss_pred HHhcccCCCCCCCCCCHHHHhc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+|+.+||+.||.+|||+.++++
T Consensus 281 ~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 281 QLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhCcChhhCcCHHHHHH
Confidence 9999999999999999999876
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=364.04 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=209.4
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcC-CCc--EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHAL-TGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~-tg~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 89 (515)
....++|++.+.||+|+||.||+|.+.. +++ .||+|++...........+.+.+|+++++.++||||+++++++.++
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 3445789999999999999999998653 333 6999999876555556678899999999999999999999999876
Q ss_pred CeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
. .++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 5 88999999999999999864 579999999999999999999999999999999999999999999999999998765
Q ss_pred cCCc----cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc--cCCCCCCC
Q 010214 169 DGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI--YTLPSHLS 241 (515)
Q Consensus 169 ~~~~----~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s 241 (515)
.... .....+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+.... ...+..++
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 251 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence 4322 234467889999999987766 689999999999999999 999999998888888876654 34557889
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+++.++|.+||..||.+|||+.++++
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=367.22 Aligned_cols=250 Identities=28% Similarity=0.393 Sum_probs=207.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEE----cCCe
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE----TPSD 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~----~~~~ 91 (515)
.++|++.+.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 46799999999999999999999999999999998653 3455678899999999999999999999986 3457
Q ss_pred EEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 92 IYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
.|+||||+++|+|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 8999999999999999986 467999999999999999999999999999999999999999999999999988764
Q ss_pred ccCC----------ccccCCCCCCccCCCcccCCcc--CCCcceeehhHHHHHHHHhCCCCCCCCC--hHHHHHHHhc-C
Q 010214 168 RDGH----------FLKTSCGSPNYAAPEVISGKLY--AGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLFKKIKG-G 232 (515)
Q Consensus 168 ~~~~----------~~~~~~gt~~Y~aPE~i~~~~~--~~~~~DIwSlGvily~lltG~~Pf~~~~--~~~~~~~i~~-~ 232 (515)
.... ......||+.|+|||++.+... .++++|||||||++|+|++|..||.... .......+.. .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 3211 1123468999999999976542 3789999999999999999999995411 1111222222 2
Q ss_pred ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 233 IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 233 ~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..+.+..+++++.++|.+||+.||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 233446789999999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=371.05 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=210.9
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEE----EEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKV----AIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~v----AiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
..++|++.+.||+|+||.||+|.+..+++.+ |+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 3588999999999999999999999888765 666654322 2234578899999999999999999999998765
Q ss_pred eEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 91 DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
.++|+||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 7899999999999999987 45799999999999999999999999999999999999999999999999999987644
Q ss_pred CCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhH
Q 010214 170 GHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGA 244 (515)
Q Consensus 170 ~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 244 (515)
... .....+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+. ...|..+++++
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred ccccccccCCCccccccCHHHHcCCCC-ChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence 322 233456889999999988776 789999999999999999 999999988888777776654 56677899999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcC
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.++|.+||..||.+|||+.|+++.
T Consensus 249 ~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 249 YMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999999873
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=359.62 Aligned_cols=246 Identities=26% Similarity=0.505 Sum_probs=209.0
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-C
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP-S 90 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~-~ 90 (515)
.....++|++.+.||+|+||.||+|.+ +|+.||+|++.... ..+.+.+|+.+++.++||||+++++++.+. +
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred ccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence 344568999999999999999999987 48899999986543 346788999999999999999999997544 5
Q ss_pred eEEEEEeccCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~--l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
.+|+||||+++++|.+++...+. +++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 78999999999999999986543 8999999999999999999999999999999999999999999999999987654
Q ss_pred cCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHH
Q 010214 169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARD 246 (515)
Q Consensus 169 ~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (515)
.. .....+++.|+|||++.+..+ ++++||||||+++|+|++ |..||...+.......+..+ ....|..+++.+.+
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 245 (278)
T 1byg_A 169 ST--QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 245 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHH
T ss_pred cc--ccCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHH
Confidence 32 234568899999999987766 789999999999999998 99999998888887777665 35667889999999
Q ss_pred HhcccCCCCCCCCCCHHHHhc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~ 267 (515)
+|.+||..||.+|||+.|+++
T Consensus 246 li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 246 VMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCChhhCCCHHHHHH
Confidence 999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=356.51 Aligned_cols=248 Identities=26% Similarity=0.493 Sum_probs=216.9
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
....++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+++++.++||||+++++++.. +..
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 82 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCc
Confidence 344589999999999999999999976 6778999999754422 4678899999999999999999999864 568
Q ss_pred EEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 93 YVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
|+||||++|++|.+++.... .+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999999999999997543 7999999999999999999999999999999999999999999999999999876544
Q ss_pred Cc--cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHH
Q 010214 171 HF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARD 246 (515)
Q Consensus 171 ~~--~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 246 (515)
.. .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+..+....+..+. ...|..+++++.+
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 241 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHH
Confidence 32 234457889999999987766 789999999999999999 999999988888887776653 4556788999999
Q ss_pred HhcccCCCCCCCCCCHHHHhc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~ 267 (515)
++.+||..||.+|||+.++++
T Consensus 242 li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 242 LMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccChhhCCCHHHHHH
Confidence 999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=368.02 Aligned_cols=250 Identities=21% Similarity=0.308 Sum_probs=202.7
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
+...-.++|++.+.||+|+||+||+|.+. ++.||||++.... .......+|+.+++.++||||+++++++....
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred ccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 33344678999999999999999999875 7899999986432 23455667999999999999999999997744
Q ss_pred ----eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC----------CceeccCCCCcEEECCCCce
Q 010214 91 ----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN----------MVVHRDLKPENLLLDSKWNV 156 (515)
Q Consensus 91 ----~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~----------gIvHrDLkpeNILl~~~~~v 156 (515)
.+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred CCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 47999999999999999965 5699999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccccCCc---cccCCCCCCccCCCcccCCc----cCCCcceeehhHHHHHHHHhCCCCCCCCC--------
Q 010214 157 KIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKL----YAGPEVDVWSCGVILYALLCGTLPFDDEN-------- 221 (515)
Q Consensus 157 KL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~----~~~~~~DIwSlGvily~lltG~~Pf~~~~-------- 221 (515)
||+|||++........ ....+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||.+..
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 9999999987654332 33467999999999998732 22568899999999999999999997642
Q ss_pred --------hHHHHHHHhcCcc--CCCC-----CCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 222 --------IPNLFKKIKGGIY--TLPS-----HLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 222 --------~~~~~~~i~~~~~--~~p~-----~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.......+..... .++. ..++++.+||.+||+.||.+|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1222222222211 1111 12345999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=358.69 Aligned_cols=247 Identities=24% Similarity=0.307 Sum_probs=205.0
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEE-EcCCeE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVI-ETPSDI 92 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~-~~~~~~ 92 (515)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.++|++++..+..+ ...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 3468999999999999999999999999999999987654432 3578899999999988766665554 778889
Q ss_pred EEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---CCCCceEEeecccccccc
Q 010214 93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL---DSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl---~~~~~vKL~DFGls~~~~ 168 (515)
++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999999 8899999985 5679999999999999999999999999999999999999 788999999999998765
Q ss_pred cCCc--------cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCccCCC
Q 010214 169 DGHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI---PNLFKKIKGGIYTLP 237 (515)
Q Consensus 169 ~~~~--------~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~---~~~~~~i~~~~~~~p 237 (515)
.... .....||+.|+|||++.+..+ ++++|||||||++|+|++|..||.+.+. ......+.......|
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 4322 235689999999999998876 7899999999999999999999976432 233334333333333
Q ss_pred -----CCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 238 -----SHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 238 -----~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
..+++++.+||.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 678999999999999999999999999976
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=367.24 Aligned_cols=252 Identities=29% Similarity=0.463 Sum_probs=215.6
Q ss_pred ccCCCceEeeeecccCceEEEEEEE-----cCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEH-----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIE 87 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~-----~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~ 87 (515)
...++|++.+.||+|+||.||+|.+ ..+++.||+|++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 4467999999999999999999985 4577899999997543 334557889999999999 6999999999987
Q ss_pred cCC-eEEEEEeccCCCCHHHHHHHhCC----------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 010214 88 TPS-DIYVVMEYVKSGELFDYIVEKGR----------------LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL 150 (515)
Q Consensus 88 ~~~-~~~iVmEy~~gg~L~~~i~~~~~----------------l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl 150 (515)
..+ .+|+||||++||+|.+++..... +++..++.++.||+.||.|||++||+||||||+||++
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 654 49999999999999999987543 8999999999999999999999999999999999999
Q ss_pred CCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChH-HH
Q 010214 151 DSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP-NL 225 (515)
Q Consensus 151 ~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~-~~ 225 (515)
+.++.+||+|||++........ .....||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.... ..
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 9999999999999986643321 234567899999999987776 789999999999999998 99999876543 33
Q ss_pred HHHHhcC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 226 FKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 226 ~~~i~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
...+..+ ....|..+++++.++|.+||..||.+|||+.|+++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 261 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4444433 356677899999999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=373.22 Aligned_cols=252 Identities=20% Similarity=0.227 Sum_probs=203.2
Q ss_pred cCCCceEeeeecccCceEEEEEEEcC---CCcEEEEEEecccccCChH--------HHHHHHHHHHHHHhCCCCCccEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNME--------MEEKVRREIKILRLFMHPHIIRLY 83 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~---tg~~vAiK~i~~~~~~~~~--------~~~~i~~Ei~il~~l~hpnIv~l~ 83 (515)
..++|++.+.||+|+||.||+|.+.. ++..||+|++......... ....+.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 35789999999999999999999987 7889999998765321111 112356788999999999999999
Q ss_pred EEEEc----CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC--ceE
Q 010214 84 EVIET----PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW--NVK 157 (515)
Q Consensus 84 ~~~~~----~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~--~vK 157 (515)
+++.+ ....|+||||+ |++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 99987 77899999999 999999998888999999999999999999999999999999999999999877 999
Q ss_pred EeecccccccccCC--------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC--ChHHHHH
Q 010214 158 IADFGLSNIMRDGH--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE--NIPNLFK 227 (515)
Q Consensus 158 L~DFGls~~~~~~~--------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~--~~~~~~~ 227 (515)
|+|||++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. +......
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 99999997764322 1245689999999999998766 78999999999999999999999652 2222222
Q ss_pred HHhcCccCCC---------CCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 228 KIKGGIYTLP---------SHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 228 ~i~~~~~~~p---------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
........+| ..+++++.++|.+||..||.+|||+.++++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 2222122222 2789999999999999999999999999863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=366.59 Aligned_cols=249 Identities=28% Similarity=0.439 Sum_probs=213.5
Q ss_pred CCCceEeeeecccCceEEEEEE----EcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEE--cC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAE----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE--TP 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~----~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~--~~ 89 (515)
.++|++.+.||+|+||.||+|. +..+++.||+|++... .....+.+.+|+++++.++||||+++++++. ..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 4789999999999999999999 5678999999998654 3445677999999999999999999999986 45
Q ss_pred CeEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
..+|+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 679999999999999999987 4569999999999999999999999999999999999999999999999999998765
Q ss_pred cCC----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH---------------HHHHHH
Q 010214 169 DGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---------------NLFKKI 229 (515)
Q Consensus 169 ~~~----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~---------------~~~~~i 229 (515)
... ......||+.|+|||++.+..+ ++++|||||||++|+|++|..||...... .....+
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 432 2234568889999999988776 78999999999999999999999654321 222233
Q ss_pred hcC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 230 KGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 230 ~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..+ ....|..+++++.+||.+||..||.+|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 322 345677899999999999999999999999999765
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=387.92 Aligned_cols=249 Identities=24% Similarity=0.424 Sum_probs=221.0
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
....+|++.+.||+|+||.||+|.++.++..||||++..... ..+.+.+|+.+|++++||||+++++++.+...+|
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 345689999999999999999999999999999999975432 2467899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 94 VVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999999999864 458999999999999999999999999999999999999999999999999998765432
Q ss_pred c--cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHH
Q 010214 172 F--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL 247 (515)
Q Consensus 172 ~--~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 247 (515)
. .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. ...|..+++++.+|
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 451 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eeecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 2 223456788999999987776 789999999999999999 999999988888777776553 45678899999999
Q ss_pred hcccCCCCCCCCCCHHHHhc
Q 010214 248 IPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~ 267 (515)
|.+||+.||.+|||+.++++
T Consensus 452 i~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCcChhHCcCHHHHHH
Confidence 99999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=382.68 Aligned_cols=248 Identities=25% Similarity=0.480 Sum_probs=217.0
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
....++|++.+.||+|+||.||+|.+. ++..||||++..... ..+.+.+|+.+|+.++||||+++++++. .+.+
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 334578999999999999999999986 577899999976442 2567899999999999999999999986 5678
Q ss_pred EEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 93 YVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999999999999753 37899999999999999999999999999999999999999999999999999876443
Q ss_pred Cc--cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHH
Q 010214 171 HF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARD 246 (515)
Q Consensus 171 ~~--~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (515)
.. .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+ ....|..+++++.+
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 416 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 416 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred ceeccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 21 223456788999999987766 789999999999999999 99999998888888777665 34567789999999
Q ss_pred HhcccCCCCCCCCCCHHHHhc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~ 267 (515)
||.+||..||.+|||+.++++
T Consensus 417 li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 417 IMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHHH
Confidence 999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=356.02 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=213.4
Q ss_pred CceEeeeecccCceEEEEEEEcCCCc---EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE-E
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI-Y 93 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~-~ 93 (515)
.|.+.+.||+|+||.||+|.+..+++ .||+|++... ......+.+.+|+.+++.++||||+++++++.+.+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 46667999999999999999866655 7999998643 3445668889999999999999999999999876665 9
Q ss_pred EEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-
Q 010214 94 VVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~- 171 (515)
+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999976 4568999999999999999999999999999999999999999999999999997654322
Q ss_pred ----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHH
Q 010214 172 ----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (515)
Q Consensus 172 ----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 245 (515)
......+|+.|+|||.+.+..+ ++++|||||||++|+|++ |.+||...+.......+..+. ...|..+++++.
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 258 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY 258 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccCcCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHH
Confidence 2344568899999999988776 789999999999999999 566677777777766666554 456778999999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcC
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+|+.+||..||.+|||+.++++.
T Consensus 259 ~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 259 QVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999863
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=363.83 Aligned_cols=248 Identities=27% Similarity=0.424 Sum_probs=190.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEE-------
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIE------- 87 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~------- 87 (515)
..+|++.+.||+|+||.||+|.+..+|+.||+|++... .......+.+|+.+++.+. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 45899999999999999999999999999999998543 3345678899999999996 999999999984
Q ss_pred -cCCeEEEEEeccCCCCHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCceEEeec
Q 010214 88 -TPSDIYVVMEYVKSGELFDYIVE---KGRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKIADF 161 (515)
Q Consensus 88 -~~~~~~iVmEy~~gg~L~~~i~~---~~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDLkpeNILl~~~~~vKL~DF 161 (515)
....+++||||+. |+|.+++.. .+.+++.+++.++.||+.||.|||++| |+||||||+|||++.++.+||+||
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecC
Confidence 3445899999996 699998875 567999999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCc-------------cccCCCCCCccCCCcc---cCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHH
Q 010214 162 GLSNIMRDGHF-------------LKTSCGSPNYAAPEVI---SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL 225 (515)
Q Consensus 162 Gls~~~~~~~~-------------~~~~~gt~~Y~aPE~i---~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~ 225 (515)
|++........ ..+.+||+.|+|||++ .+..+ +.++|||||||++|+|++|..||.+......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 99987654321 1255799999999998 34444 7899999999999999999999987654433
Q ss_pred HHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcc
Q 010214 226 FKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270 (515)
Q Consensus 226 ~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~ 270 (515)
..... ....+...++.+.+||.+||+.||.+|||+.|+++|.+
T Consensus 262 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 262 VNGKY--SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ----C--CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hcCcc--cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 22221 22344567889999999999999999999999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=364.92 Aligned_cols=253 Identities=31% Similarity=0.432 Sum_probs=211.6
Q ss_pred CccccCCCc-eEeeeecccCceEEEEEEE----cCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEE
Q 010214 11 GVDMFLPNY-KLGKTLGIGSFGKVKIAEH----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV 85 (515)
Q Consensus 11 ~~~~~~~~Y-~i~~~LG~G~fg~Vy~a~~----~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~ 85 (515)
....+.++| ++++.||+|+||+||+|.. ..+|+.||||++.... .......+.+|+++++.++||||++++++
T Consensus 24 ~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (318)
T 3lxp_A 24 DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGC 101 (318)
T ss_dssp CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEE
Confidence 334566777 9999999999999988754 4578999999997542 34556789999999999999999999999
Q ss_pred EEc--CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 86 IET--PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 86 ~~~--~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
+.+ ...+|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 102 CEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGL 180 (318)
T ss_dssp EEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred EecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccc
Confidence 987 46799999999999999999654 599999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH---------------H
Q 010214 164 SNIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---------------N 224 (515)
Q Consensus 164 s~~~~~~~----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~---------------~ 224 (515)
+....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKF-YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence 98775543 2334568889999999988776 68999999999999999999999754221 1
Q ss_pred HHHHHhcC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 225 LFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 225 ~~~~i~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
....+..+ ....|..+++++.+||.+||+.||.+|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 12222222 34567789999999999999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=373.04 Aligned_cols=255 Identities=22% Similarity=0.347 Sum_probs=211.5
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.+....++|++.+.||+|+||.||+|.+. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 45567799999999999999999999965 78999999986543 234678899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG----RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~----~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
..|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999999999986543 589999999999999999999999999999999999999999999999999976
Q ss_pred cccC---CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHH---H----HHHhcCcc--
Q 010214 167 MRDG---HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL---F----KKIKGGIY-- 234 (515)
Q Consensus 167 ~~~~---~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~---~----~~i~~~~~-- 234 (515)
.... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ . .....+..
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred cccccccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 5332 22334568999999999987766 7899999999999999999999976432211 0 11111110
Q ss_pred --------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcc
Q 010214 235 --------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270 (515)
Q Consensus 235 --------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~ 270 (515)
..+...+..+.+++.+||+.||.+|||+.|+++|..
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 112233567889999999999999999999998643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=374.00 Aligned_cols=250 Identities=17% Similarity=0.225 Sum_probs=201.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcCC-----CcEEEEEEecccccCChHH--------HHHHHHHHHHHHhCCCCCccEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALT-----GHKVAIKILNRRKIKNMEM--------EEKVRREIKILRLFMHPHIIRL 82 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~t-----g~~vAiK~i~~~~~~~~~~--------~~~i~~Ei~il~~l~hpnIv~l 82 (515)
.++|++.+.||+|+||.||+|.+..+ ++.||||++.......... ...+.+|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 34899999999999999999999765 5889999987653211110 1123456667778889999999
Q ss_pred EEEEEcC----CeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC--CCCc
Q 010214 83 YEVIETP----SDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD--SKWN 155 (515)
Q Consensus 83 ~~~~~~~----~~~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~--~~~~ 155 (515)
++++... ...|+||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 9998664 4589999999 99999999876 6799999999999999999999999999999999999999 8899
Q ss_pred eEEeecccccccccCCc--------cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH-HHH
Q 010214 156 VKIADFGLSNIMRDGHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-NLF 226 (515)
Q Consensus 156 vKL~DFGls~~~~~~~~--------~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~-~~~ 226 (515)
+||+|||++........ ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.... ...
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 99999999977643321 234569999999999998876 79999999999999999999999863222 211
Q ss_pred HHHhc----Ccc------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 227 KKIKG----GIY------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 227 ~~i~~----~~~------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
..... ... -.+..+++++.+++..||..||.+|||+.++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 11110 000 112577999999999999999999999999876
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=379.17 Aligned_cols=249 Identities=32% Similarity=0.495 Sum_probs=197.0
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 93 (515)
+.+.|.+.+.||+|+||+||.+ ...+|+.||||++.... .+.+.+|+.+++.+ +||||+++++++.+.+.+|
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 85 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY 85 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence 4456667899999999999875 45689999999986432 34678899999876 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCC-------CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-------------
Q 010214 94 VVMEYVKSGELFDYIVEKGRL-------QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK------------- 153 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l-------~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~------------- 153 (515)
+|||||+ |+|.+++...+.. ++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence 9999996 5999999865433 233457899999999999999999999999999999754
Q ss_pred CceEEeecccccccccCC-----ccccCCCCCCccCCCcccC------CccCCCcceeehhHHHHHHHHh-CCCCCCCCC
Q 010214 154 WNVKIADFGLSNIMRDGH-----FLKTSCGSPNYAAPEVISG------KLYAGPEVDVWSCGVILYALLC-GTLPFDDEN 221 (515)
Q Consensus 154 ~~vKL~DFGls~~~~~~~-----~~~~~~gt~~Y~aPE~i~~------~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~ 221 (515)
+.+||+|||++.....+. .....+||+.|+|||++.+ ....+.++|||||||++|+|++ |..||.+..
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 489999999998765432 2335689999999999976 1234789999999999999999 999998765
Q ss_pred hHHHHHHHhcCccCCCC-------CCChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 222 IPNLFKKIKGGIYTLPS-------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 222 ~~~~~~~i~~~~~~~p~-------~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
... ..+..+....+. .+++++.+||.+||+.||.+|||+.|+++||||..
T Consensus 245 ~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 245 SRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp THH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 443 334444433322 23578999999999999999999999999999964
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=358.09 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=212.4
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCC---cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEE-EcC
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVI-ETP 89 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~-~~~ 89 (515)
....+|++.+.||+|+||.||+|.+..++ ..||+|.+... ......+.+.+|+.++++++||||+++++++ ..+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 33467999999999999999999976443 36899998753 3445667899999999999999999999985 556
Q ss_pred CeEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
+..|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 678999999999999999975 4568999999999999999999999999999999999999999999999999998664
Q ss_pred cCC-----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCcc-CCCCCCC
Q 010214 169 DGH-----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY-TLPSHLS 241 (515)
Q Consensus 169 ~~~-----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s 241 (515)
... ......||+.|+|||++.+..+ ++++||||||+++|+|++ |.+||.+.+.......+..+.. ..|..++
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 258 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCC
T ss_pred ccchhccccccCCCCCccccChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCC
Confidence 432 1234467889999999987776 789999999999999999 7788888777776666665544 4467889
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+.+.+++.+||..||.+|||+.|+++
T Consensus 259 ~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 259 DPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=358.56 Aligned_cols=246 Identities=24% Similarity=0.403 Sum_probs=199.0
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHh--CCCCCccEEEEEEEc--
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL--FMHPHIIRLYEVIET-- 88 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~--l~hpnIv~l~~~~~~-- 88 (515)
..+.++|++.+.||+|+||+||+|.+ +|+.||||++.... .....+|.+++.. ++||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 45678999999999999999999987 68999999986432 3455667777766 889999999998643
Q ss_pred --CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCcEEECCCCceEE
Q 010214 89 --PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH--------RNMVVHRDLKPENLLLDSKWNVKI 158 (515)
Q Consensus 89 --~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH--------~~gIvHrDLkpeNILl~~~~~vKL 158 (515)
...+|+||||+++|+|.+++. ...+++..++.++.||+.||.||| ++||+||||||+|||++.++.+||
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 356899999999999999994 567999999999999999999999 999999999999999999999999
Q ss_pred eecccccccccCCc-----cccCCCCCCccCCCcccCCccC-----CCcceeehhHHHHHHHHhC----------CCCCC
Q 010214 159 ADFGLSNIMRDGHF-----LKTSCGSPNYAAPEVISGKLYA-----GPEVDVWSCGVILYALLCG----------TLPFD 218 (515)
Q Consensus 159 ~DFGls~~~~~~~~-----~~~~~gt~~Y~aPE~i~~~~~~-----~~~~DIwSlGvily~lltG----------~~Pf~ 218 (515)
+|||++........ ..+.+||+.|+|||++.+.... ++++|||||||++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 99999976654322 2345899999999999876321 3689999999999999999 88986
Q ss_pred CCC----hHHHHHHHhcCc---cCCCC-----CCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 219 DEN----IPNLFKKIKGGI---YTLPS-----HLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 219 ~~~----~~~~~~~i~~~~---~~~p~-----~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
... ............ ...|. ..++++.+|+.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 532 122222222211 12221 24467999999999999999999999976
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=379.99 Aligned_cols=249 Identities=27% Similarity=0.415 Sum_probs=198.3
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iV 95 (515)
.+|.+.+.||+|+||+|+. ....+|+.||||++.+.... .+.+|+.+|+.+ +||||+++++++.+....|+|
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 3599999999999999764 44568999999999764432 246899999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-----CCceEEeeccccccccc
Q 010214 96 MEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-----KWNVKIADFGLSNIMRD 169 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-----~~~vKL~DFGls~~~~~ 169 (515)
||||. |+|.+++.... ..++..++.++.||+.||.|||++||+||||||+|||++. ...+||+|||++.....
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 99996 59999997654 4666778899999999999999999999999999999953 23588999999987654
Q ss_pred C----CccccCCCCCCccCCCcccCC--ccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCccC---CCCC
Q 010214 170 G----HFLKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYT---LPSH 239 (515)
Q Consensus 170 ~----~~~~~~~gt~~Y~aPE~i~~~--~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~~~---~p~~ 239 (515)
+ ....+.+||+.|+|||++.+. ...+.++|||||||++|+|++ |..||...........+...... .+..
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCH
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcccc
Confidence 3 233456899999999999742 223679999999999999999 99999776554433322222211 1223
Q ss_pred CChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 240 ~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
.+..+.+||.+||+.||.+|||+.|+++||||..
T Consensus 256 ~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 4566899999999999999999999999999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=378.03 Aligned_cols=254 Identities=26% Similarity=0.468 Sum_probs=214.7
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|+.++||||+++++++.+ +.+|
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 445789999999999999999999874 467999999765422 3578999999999999999999999866 6789
Q ss_pred EEEeccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 94 VVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
+||||+++|+|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999999999974 3569999999999999999999999999999999999999999999999999998765432
Q ss_pred c--cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHH
Q 010214 172 F--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDL 247 (515)
Q Consensus 172 ~--~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 247 (515)
. .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+..+ ....|..+++.+.+|
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 413 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 413 (452)
T ss_dssp --------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred eecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 2 223457789999999987766 789999999999999999 99999998888888877765 345678899999999
Q ss_pred hcccCCCCCCCCCCHHHHhcC--cccccc
Q 010214 248 IPRMLIVDPMKRITIPEIRQH--PWFQAH 274 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~h--p~f~~~ 274 (515)
|.+||+.||.+|||++++++. .++...
T Consensus 414 i~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 414 MCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 999999999999999999872 444433
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=368.49 Aligned_cols=242 Identities=15% Similarity=0.161 Sum_probs=203.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCC--------CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccE------
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALT--------GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIR------ 81 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~t--------g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~------ 81 (515)
.++|++.+.||+|+||.||+|.+..| ++.||+|++... +.+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 47999999999999999999999874 889999998754 35789999999999999987
Q ss_pred ---------EEEEEEc-CCeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 010214 82 ---------LYEVIET-PSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLL 149 (515)
Q Consensus 82 ---------l~~~~~~-~~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNIL 149 (515)
+++++.. ....|+||||+ +++|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6777765 78899999999 99999999875 78999999999999999999999999999999999999
Q ss_pred ECCCC--ceEEeecccccccccCC--------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCC
Q 010214 150 LDSKW--NVKIADFGLSNIMRDGH--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD 219 (515)
Q Consensus 150 l~~~~--~vKL~DFGls~~~~~~~--------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~ 219 (515)
++.++ .+||+|||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCccc
Confidence 99998 99999999997664322 1234589999999999998776 7899999999999999999999987
Q ss_pred CC--hHHHHHHH---hcCccCCC------CCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 220 EN--IPNLFKKI---KGGIYTLP------SHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 220 ~~--~~~~~~~i---~~~~~~~p------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.. ........ ......++ ..+++++.+||.+||..||.+|||+.++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 53 22222222 22222222 256899999999999999999999999976
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=400.89 Aligned_cols=261 Identities=30% Similarity=0.423 Sum_probs=212.4
Q ss_pred CCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc-
Q 010214 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET- 88 (515)
Q Consensus 10 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~- 88 (515)
.-.....++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~ 84 (676)
T 3qa8_A 7 SLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL 84 (676)
T ss_dssp ----------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred CCCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence 444556799999999999999999999999999999999986542 34556789999999999999999999999765
Q ss_pred -----CCeEEEEEeccCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc---eE
Q 010214 89 -----PSDIYVVMEYVKSGELFDYIVEKG---RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VK 157 (515)
Q Consensus 89 -----~~~~~iVmEy~~gg~L~~~i~~~~---~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~---vK 157 (515)
.+..|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vK 164 (676)
T 3qa8_A 85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHK 164 (676)
T ss_dssp CCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEE
T ss_pred ccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEE
Confidence 677899999999999999998644 6999999999999999999999999999999999999997765 99
Q ss_pred EeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHH---------
Q 010214 158 IADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKK--------- 228 (515)
Q Consensus 158 L~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~--------- 228 (515)
|+|||++.....+......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...........
T Consensus 165 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 165 IIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243 (676)
T ss_dssp ECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred EcccccccccccccccccccCCcccCChHHhccCCC-CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence 999999998877666677889999999999998877 7899999999999999999999976533221100
Q ss_pred -----HhcCcc------CCC----CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 229 -----IKGGIY------TLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 229 -----i~~~~~------~~p----~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
...+.. +.| ..+++.+.+||.+||..||.+|||+.|+++||||+.
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 011111 111 235678999999999999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=356.30 Aligned_cols=241 Identities=29% Similarity=0.482 Sum_probs=200.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||+||+|.+. ++.||+|++... ...+.+.+|++++++++||||+++++++.+ ..|+|
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence 478999999999999999999874 789999998533 345778999999999999999999998764 47899
Q ss_pred EeccCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCCCcEEECCCCc-eEEeecccccccc
Q 010214 96 MEYVKSGELFDYIVEKG---RLQEDEARNFFQQIISGVEYCHR---NMVVHRDLKPENLLLDSKWN-VKIADFGLSNIMR 168 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~---~l~e~~~~~i~~qil~aL~yLH~---~gIvHrDLkpeNILl~~~~~-vKL~DFGls~~~~ 168 (515)
|||++||+|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 99999999999998655 37899999999999999999999 89999999999999998886 7999999997654
Q ss_pred cCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH--HHHHHHhc-CccCCCCCCChhHH
Q 010214 169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP--NLFKKIKG-GIYTLPSHLSPGAR 245 (515)
Q Consensus 169 ~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~--~~~~~i~~-~~~~~p~~~s~~~~ 245 (515)
.. .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .....+.. .....+..+++.+.
T Consensus 158 ~~--~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
T 2eva_A 158 TH--MTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHH
T ss_pred cc--cccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHH
Confidence 32 344579999999999998776 78999999999999999999999864332 23333333 34456678999999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcC
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+++.+||+.||.+|||+.+++++
T Consensus 235 ~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 235 SLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=389.32 Aligned_cols=243 Identities=25% Similarity=0.413 Sum_probs=210.7
Q ss_pred eeeecccCceEEEEEEE--cCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEecc
Q 010214 22 GKTLGIGSFGKVKIAEH--ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYV 99 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~--~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~ 99 (515)
.+.||+|+||.||+|.+ +.+++.||||++.... ......+.+.+|+++|+.++||||++++++++. +.+++||||+
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~ 451 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 451 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence 34899999999999955 4567899999997543 233446789999999999999999999999975 4588999999
Q ss_pred CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc----ccc
Q 010214 100 KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKT 175 (515)
Q Consensus 100 ~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~ 175 (515)
++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ...
T Consensus 452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 9999999999888999999999999999999999999999999999999999999999999999987654321 223
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcccCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~ 253 (515)
..+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+. ...|..+++++.+||.+||.
T Consensus 532 ~~~t~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~ 610 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT 610 (635)
T ss_dssp ---CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCceeeeChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 456789999999988776 789999999999999998 999999998888888887664 45778899999999999999
Q ss_pred CCCCCCCCHHHHhc
Q 010214 254 VDPMKRITIPEIRQ 267 (515)
Q Consensus 254 ~dP~~Rpt~~eil~ 267 (515)
.||.+|||+.++++
T Consensus 611 ~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 611 YDVENRPGFAAVEL 624 (635)
T ss_dssp SSTTTSCCHHHHHH
T ss_pred CCHhHCcCHHHHHH
Confidence 99999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=364.47 Aligned_cols=244 Identities=17% Similarity=0.267 Sum_probs=200.9
Q ss_pred ccCCCceEeeeecccCceEEEEE-----EEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC---CCCccEEEEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIA-----EHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM---HPHIIRLYEV 85 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a-----~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---hpnIv~l~~~ 85 (515)
...++|.+.+.||+|+||+||+| .+..+++.||+|++.... ...+.+|+.+++.++ |+||++++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 34577999999999999999999 467789999999986542 346778888888887 9999999999
Q ss_pred EEcCCeEEEEEeccCCCCHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC--------
Q 010214 86 IETPSDIYVVMEYVKSGELFDYIVE-----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-------- 152 (515)
Q Consensus 86 ~~~~~~~~iVmEy~~gg~L~~~i~~-----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-------- 152 (515)
+...+..|+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999999974 457999999999999999999999999999999999999998
Q ss_pred ---CCceEEeecccccccc---cCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHH
Q 010214 153 ---KWNVKIADFGLSNIMR---DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF 226 (515)
Q Consensus 153 ---~~~vKL~DFGls~~~~---~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~ 226 (515)
++.+||+|||++..+. .+....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~- 293 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGEC- 293 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCCEEEETTEE-
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCccccCCCCce-
Confidence 8999999999996543 3445567789999999999998876 7999999999999999999999965322110
Q ss_pred HHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 227 KKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 227 ~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.+. ..+. ....++.+.+++..||+.+|.+|++..+.+.+
T Consensus 294 -~~~-~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 294 -KPE-GLFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp -EEC-SCCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred -eec-hhcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 000 0111 11246788999999999999999765554443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=364.27 Aligned_cols=257 Identities=25% Similarity=0.375 Sum_probs=209.1
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
......++|++.+.||+|+||.||+|.+. +|+.||||++....... ....+.+|+++++.++||||+++++++.+++
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPT 100 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence 44556789999999999999999999854 68999999987654221 1236889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCcEEECCCCceEEeeccc
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG----RLQEDEARNFFQQIISGVEYCHRN---MVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~----~l~e~~~~~i~~qil~aL~yLH~~---gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 180 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence 9999999999999999998643 499999999999999999999999 999999999999999999999999999
Q ss_pred ccccccC--CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC-----ChHHHHHHHhc---Cc
Q 010214 164 SNIMRDG--HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-----NIPNLFKKIKG---GI 233 (515)
Q Consensus 164 s~~~~~~--~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~-----~~~~~~~~i~~---~~ 233 (515)
+...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||+.. ........+.. ..
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 3uim_A 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259 (326)
T ss_dssp CEECCSSSSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred ccccCcccccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence 9876433 23345569999999999987776 78999999999999999999999521 11111111111 00
Q ss_pred -----------cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 234 -----------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 234 -----------~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
...+...++.+.+++.+||+.||.+|||+.|+++|-.-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 01112234678999999999999999999999998653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=369.12 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=204.1
Q ss_pred CCceEeeeecccCceEEEEEEEcCCC---cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEE-cCCeE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE-TPSDI 92 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~-~~~~~ 92 (515)
..|++.+.||+|+||+||+|.+..++ ..||+|.+... ......+.+.+|+.+++.++||||+++++++. .++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 35888999999999999999976443 46899998643 33456688999999999999999999999864 45678
Q ss_pred EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|+||||+++|+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999999764 458999999999999999999999999999999999999999999999999998664332
Q ss_pred c-----cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhH
Q 010214 172 F-----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGA 244 (515)
Q Consensus 172 ~-----~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 244 (515)
. .....+|+.|+|||++.+..+ +.++|||||||++|+|++ |.+||.+.+..+....+..+. ...|..+++.+
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l 325 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 325 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccCCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 1 223457889999999987776 789999999999999999 788998877666666666554 34567899999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcC
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.+++.+||..||.+|||+.|++++
T Consensus 326 ~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 326 YEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=354.39 Aligned_cols=246 Identities=26% Similarity=0.409 Sum_probs=204.7
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccc-cCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRK-IKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
|...+.||+|+||.||+|.+ +++.||+|++.... .......+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44458999999999999986 68899999987543 2334557889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC---
Q 010214 98 YVKSGELFDYIVE---KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--- 171 (515)
Q Consensus 98 y~~gg~L~~~i~~---~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~--- 171 (515)
|+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 9999999999974 3469999999999999999999999999999999999999999999999999987654322
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHH----HHHHHhcCc-----------cCC
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN----LFKKIKGGI-----------YTL 236 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~----~~~~i~~~~-----------~~~ 236 (515)
.....+||+.|+|||++.+. + +.++||||||+++|+|++|..||....... +...+.... ...
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred cccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 23345799999999998865 4 789999999999999999999998754332 222222211 112
Q ss_pred CCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 237 PSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 237 p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+...+..+.+++.+||..||.+|||+.+++++
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 23345678999999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=380.27 Aligned_cols=249 Identities=27% Similarity=0.468 Sum_probs=217.4
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
....++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+++|+.++||||+++++++.+ +.+
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 3445789999999999999999999874 467999999765432 3578999999999999999999999866 678
Q ss_pred EEEEeccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 93 YVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
|+||||+++|+|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 999999999999999974 356999999999999999999999999999999999999999999999999999876533
Q ss_pred Cc--cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHH
Q 010214 171 HF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARD 246 (515)
Q Consensus 171 ~~--~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 246 (515)
.. .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+..+. ...|..+++++.+
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 495 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 495 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ceecccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 21 223456788999999987766 789999999999999999 999999988888888877653 4567889999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcC
Q 010214 247 LIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~h 268 (515)
||.+||..||.+|||+.++++.
T Consensus 496 li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 496 LMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999873
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=356.65 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=210.6
Q ss_pred ccCCCceEeeeecccCceEEEEEE----EcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAE----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~----~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 89 (515)
...++|++++.||+|+||.||+|. +..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 345779999999999999999998 4668999999998753 334567899999999999999999999998654
Q ss_pred C--eEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 90 S--DIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 90 ~--~~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
+ .+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 3 689999999999999999875 4699999999999999999999999999999999999999999999999999987
Q ss_pred cccCCc----cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH----------------HHH
Q 010214 167 MRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP----------------NLF 226 (515)
Q Consensus 167 ~~~~~~----~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~----------------~~~ 226 (515)
...... .....+++.|+|||++.+..+ +.++|||||||++|+|++|..||...... .+.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 654322 234467888999999987766 68999999999999999999998643110 112
Q ss_pred HHHhc-CccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 227 KKIKG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 227 ~~i~~-~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
..+.. ...+.|..+++++.+||.+||..||.+|||+.|+++
T Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22222 234567789999999999999999999999999975
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=356.72 Aligned_cols=247 Identities=23% Similarity=0.399 Sum_probs=197.4
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHh--CCCCCccEEEEEEEcC-
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL--FMHPHIIRLYEVIETP- 89 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~--l~hpnIv~l~~~~~~~- 89 (515)
..+.++|++.+.||+|+||.||+|.++ |+.||||++.... .....+|.+++.. ++||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 345679999999999999999999875 8999999985432 2334455555544 4899999999999877
Q ss_pred ---CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCcEEECCCCceEE
Q 010214 90 ---SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN--------MVVHRDLKPENLLLDSKWNVKI 158 (515)
Q Consensus 90 ---~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~--------gIvHrDLkpeNILl~~~~~vKL 158 (515)
..+|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 789999999999999999965 5799999999999999999999998 9999999999999999999999
Q ss_pred eecccccccccCCc-----cccCCCCCCccCCCcccCCccCCC-----cceeehhHHHHHHHHhC----------CCCCC
Q 010214 159 ADFGLSNIMRDGHF-----LKTSCGSPNYAAPEVISGKLYAGP-----EVDVWSCGVILYALLCG----------TLPFD 218 (515)
Q Consensus 159 ~DFGls~~~~~~~~-----~~~~~gt~~Y~aPE~i~~~~~~~~-----~~DIwSlGvily~lltG----------~~Pf~ 218 (515)
+|||++........ ..+.+||+.|+|||++.+..+... ++|||||||++|+|++| ..||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 99999976543321 235689999999999987765322 38999999999999999 77775
Q ss_pred CCC-----hHHHHHHHhcC--ccCCCC-----CCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 219 DEN-----IPNLFKKIKGG--IYTLPS-----HLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 219 ~~~-----~~~~~~~i~~~--~~~~p~-----~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
... .......+... ...+|. .+++++.+||.+||+.||.+|||+.|+++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 431 12222222221 122332 345679999999999999999999999876
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=383.52 Aligned_cols=248 Identities=27% Similarity=0.440 Sum_probs=211.1
Q ss_pred CCCceEee-eecccCceEEEEEEEcC--CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 16 LPNYKLGK-TLGIGSFGKVKIAEHAL--TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 16 ~~~Y~i~~-~LG~G~fg~Vy~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
.+++.+.+ .||+|+||.||+|.++. ++..||||++.... .....+.+.+|+++|+.++||||+++++++.+ +.+
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence 35566666 89999999999998763 55679999997543 22345788999999999999999999999976 569
Q ss_pred EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|+||||+++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 9999999999999999754 469999999999999999999999999999999999999999999999999998764332
Q ss_pred c----cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHH
Q 010214 172 F----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (515)
Q Consensus 172 ~----~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 245 (515)
. .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+. ...|..+++++.
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 569 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 569 (613)
T ss_dssp -----------CCTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ceeeeccCCCCccceeCHhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 1 122345689999999987776 789999999999999998 999999988888888887664 467788999999
Q ss_pred HHhcccCCCCCCCCCCHHHHhc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+||.+||..||.+|||+.++++
T Consensus 570 ~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 570 ALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999854
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=369.34 Aligned_cols=247 Identities=24% Similarity=0.303 Sum_probs=209.9
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC-CCccEEEEEEEcCCeE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH-PHIIRLYEVIETPSDI 92 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h-pnIv~l~~~~~~~~~~ 92 (515)
.+.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+++++.++| ++|..+..++...+..
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 4568999999999999999999999999999999998765433 246789999999997 5666677777888899
Q ss_pred EEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---CCCCceEEeecccccccc
Q 010214 93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL---DSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl---~~~~~vKL~DFGls~~~~ 168 (515)
|+||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 8899999985 5679999999999999999999999999999999999999 588999999999998765
Q ss_pred cCCc--------cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCc----
Q 010214 169 DGHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI---PNLFKKIKGGI---- 233 (515)
Q Consensus 169 ~~~~--------~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~---~~~~~~i~~~~---- 233 (515)
.... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+... ...+.++....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 4332 226689999999999998877 7899999999999999999999987443 33333333222
Q ss_pred -cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 234 -YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 234 -~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
..++..+++++.+||.+||..||.+||++.+|++
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2233678999999999999999999999998765
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=372.24 Aligned_cols=249 Identities=17% Similarity=0.194 Sum_probs=198.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC-CCc---------------
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH-PHI--------------- 79 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h-pnI--------------- 79 (515)
..+|.+.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.++| +|.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3458899999999999999999999999999999875444433446789999999999987 221
Q ss_pred ------cEEEEEEEc-----CCeEEEEEeccCCCCHHHHHHH-------hCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 010214 80 ------IRLYEVIET-----PSDIYVVMEYVKSGELFDYIVE-------KGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141 (515)
Q Consensus 80 ------v~l~~~~~~-----~~~~~iVmEy~~gg~L~~~i~~-------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHr 141 (515)
..+..++.. ...++++|+++ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 111122222 23478888877 5799998852 2347788999999999999999999999999
Q ss_pred cCCCCcEEECCCCceEEeecccccccccCCccccCCCCCCccCCCcc----------cCCccCCCcceeehhHHHHHHHH
Q 010214 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI----------SGKLYAGPEVDVWSCGVILYALL 211 (515)
Q Consensus 142 DLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i----------~~~~~~~~~~DIwSlGvily~ll 211 (515)
||||+|||++.++.+||+|||++...... ..+.+| +.|+|||++ .+..+ +.++|||||||++|+|+
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHHHH
Confidence 99999999999999999999998765433 566788 999999999 44444 78999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 212 CGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 212 tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
+|..||...+.......+.. ....+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 312 tg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HSSCCCCTTGGGSCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HCCCCCCCcchhhhHHHHHh----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 99999988765544444332 23467899999999999999999999999999999964
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=352.53 Aligned_cols=245 Identities=23% Similarity=0.398 Sum_probs=204.8
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHh--CCCCCccEEEEEEEcCC--
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL--FMHPHIIRLYEVIETPS-- 90 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~--l~hpnIv~l~~~~~~~~-- 90 (515)
+.++|++.+.||+|+||.||+|.+ +|+.||||++.... ...+.+|+++++. ++||||+++++++....
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 457899999999999999999998 58999999986432 3567789999987 78999999999998876
Q ss_pred --eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCcEEECCCCceEEee
Q 010214 91 --DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH--------RNMVVHRDLKPENLLLDSKWNVKIAD 160 (515)
Q Consensus 91 --~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH--------~~gIvHrDLkpeNILl~~~~~vKL~D 160 (515)
.+|+||||+++|+|.+++.+ ..+++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+|
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred cceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 79999999999999999965 57999999999999999999999 89999999999999999999999999
Q ss_pred cccccccccCC-----ccccCCCCCCccCCCcccCCccC-----CCcceeehhHHHHHHHHhC----------CCCCCCC
Q 010214 161 FGLSNIMRDGH-----FLKTSCGSPNYAAPEVISGKLYA-----GPEVDVWSCGVILYALLCG----------TLPFDDE 220 (515)
Q Consensus 161 FGls~~~~~~~-----~~~~~~gt~~Y~aPE~i~~~~~~-----~~~~DIwSlGvily~lltG----------~~Pf~~~ 220 (515)
||++....... .....+||+.|+|||++.+.... +.++|||||||++|+|++| ..||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 99998765443 23456899999999999875321 2689999999999999999 8899764
Q ss_pred -----ChHHHHHHHhcCcc--CCCC-----CCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 221 -----NIPNLFKKIKGGIY--TLPS-----HLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 221 -----~~~~~~~~i~~~~~--~~p~-----~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
....+...+..... .+|. ..+..+.+|+.+||+.||.+|||+.++++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 23444444433322 2222 223578899999999999999999999876
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=356.46 Aligned_cols=251 Identities=22% Similarity=0.370 Sum_probs=211.1
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
.+...++|++.+.||+|+||.||+|.+.. .||+|++....... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 34456899999999999999999999853 49999987653322 223557789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-
Q 010214 92 IYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD- 169 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~- 169 (515)
+++||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 999999999999999997654 699999999999999999999999999999999999998 67999999999875431
Q ss_pred -----CCccccCCCCCCccCCCcccCC--------ccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCC
Q 010214 170 -----GHFLKTSCGSPNYAAPEVISGK--------LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL 236 (515)
Q Consensus 170 -----~~~~~~~~gt~~Y~aPE~i~~~--------~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~ 236 (515)
........||+.|+|||++.+. ...+.++|||||||++|+|++|..||...........+..+....
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 262 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence 2233455689999999998752 223789999999999999999999999988888877777665432
Q ss_pred --CCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 237 --PSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 237 --p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+..++.++.+++.+||..||.+|||+.++++
T Consensus 263 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2368899999999999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=354.76 Aligned_cols=247 Identities=23% Similarity=0.329 Sum_probs=190.6
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc-----
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----- 88 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----- 88 (515)
.-.++|++.+.||+|+||.||+|.+ +++.||||++..... .......|+..++.++||||+++++.+..
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR----QNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch----hhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 3468999999999999999999976 789999999864331 11222344444556899999999986532
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCcEEECCCCceEEe
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN---------MVVHRDLKPENLLLDSKWNVKIA 159 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~---------gIvHrDLkpeNILl~~~~~vKL~ 159 (515)
...+|+||||+++|+|.+++... ..++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred CceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 23679999999999999999654 569999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccCC---------ccccCCCCCCccCCCcccCC------ccCCCcceeehhHHHHHHHHhCCCCCCC-CCh-
Q 010214 160 DFGLSNIMRDGH---------FLKTSCGSPNYAAPEVISGK------LYAGPEVDVWSCGVILYALLCGTLPFDD-ENI- 222 (515)
Q Consensus 160 DFGls~~~~~~~---------~~~~~~gt~~Y~aPE~i~~~------~~~~~~~DIwSlGvily~lltG~~Pf~~-~~~- 222 (515)
|||++....... .....+||+.|+|||++.+. ...++++|||||||++|+|++|..||.. ...
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 999998764321 22355799999999999873 1225789999999999999999776532 211
Q ss_pred ----------------HHHHHHHh--cCccCCCCC------CChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 223 ----------------PNLFKKIK--GGIYTLPSH------LSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 223 ----------------~~~~~~i~--~~~~~~p~~------~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
......+. .....+|.. .++++.+||.+||..||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 11111111 112233333 2347999999999999999999999954
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=372.17 Aligned_cols=243 Identities=19% Similarity=0.227 Sum_probs=198.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccC-----ChHHHHHHHHHHHHHHhCC---------CCCccE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-----NMEMEEKVRREIKILRLFM---------HPHIIR 81 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~-----~~~~~~~i~~Ei~il~~l~---------hpnIv~ 81 (515)
.++|++.+.||+|+||+||+|++ +|+.||||++.+.... .....+.+.+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 47899999999999999999998 7899999999876432 2223467889999998886 888888
Q ss_pred EEEEEE------------------------------cCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHH
Q 010214 82 LYEVIE------------------------------TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 131 (515)
Q Consensus 82 l~~~~~------------------------------~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~ 131 (515)
+.+++. ..+.+|+|||||++|++.+.+.+ +.+++.+++.++.||+.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 877643 26789999999999987776643 67899999999999999999
Q ss_pred HHH-HCCceeccCCCCcEEECCCC--------------------ceEEeecccccccccCCccccCCCCCCccCCCcccC
Q 010214 132 YCH-RNMVVHRDLKPENLLLDSKW--------------------NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 190 (515)
Q Consensus 132 yLH-~~gIvHrDLkpeNILl~~~~--------------------~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~ 190 (515)
||| ++||+||||||+|||++.++ .+||+|||+|+....+ +.+||+.|+|||++.+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence 999 99999999999999999887 8999999999877543 4589999999999997
Q ss_pred CccCCCcceeehhHHH-HHHHHhCCCCCCCCCh-HHHHHHHhcC-ccC------CCCCCChhHHHHhcccCCCCCCCCCC
Q 010214 191 KLYAGPEVDVWSCGVI-LYALLCGTLPFDDENI-PNLFKKIKGG-IYT------LPSHLSPGARDLIPRMLIVDPMKRIT 261 (515)
Q Consensus 191 ~~~~~~~~DIwSlGvi-ly~lltG~~Pf~~~~~-~~~~~~i~~~-~~~------~p~~~s~~~~~li~~mL~~dP~~Rpt 261 (515)
.. +.++||||+|++ .+++++|..||.+... ......+... ... .+..+|+++++||.+||+.| |
T Consensus 252 ~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s 324 (336)
T 2vuw_A 252 DG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S 324 (336)
T ss_dssp CS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred CC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence 75 689999998776 7788999999965321 1222333311 111 12246889999999999987 9
Q ss_pred HHHHh-cCcccc
Q 010214 262 IPEIR-QHPWFQ 272 (515)
Q Consensus 262 ~~eil-~hp~f~ 272 (515)
+.|++ +||||+
T Consensus 325 a~e~l~~Hp~f~ 336 (336)
T 2vuw_A 325 ATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHCGGGC
T ss_pred HHHHHhcCCCcC
Confidence 99999 999995
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=380.66 Aligned_cols=251 Identities=27% Similarity=0.474 Sum_probs=216.1
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCC---CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 89 (515)
....++|++.+.||+|+||.||+|.+..+ +..||+|++... ......+.+.+|+.+++.++||||+++++++. .
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 34457899999999999999999998654 457999988643 23455678999999999999999999999984 5
Q ss_pred CeEEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
+..|+||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 66899999999999999998654 69999999999999999999999999999999999999999999999999998765
Q ss_pred cCCcc--ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhH
Q 010214 169 DGHFL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGA 244 (515)
Q Consensus 169 ~~~~~--~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 244 (515)
..... ....+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+. ...|..+++.+
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l 621 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 621 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 44322 23457789999999987766 789999999999999997 999999988888887776654 56788999999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.+||.+||..||.+|||+.++++
T Consensus 622 ~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 622 YSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999976
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=339.05 Aligned_cols=225 Identities=17% Similarity=0.163 Sum_probs=193.1
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++.+.+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 45688999999999999999999999999999999998776666667788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
+||||++|++|.+++.+ + ..+.++..++.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999999999999853 3 4667889999999999999999999999999999999999999998543
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHH---HHhcCcc----CCCCCCChhHHH
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFK---KIKGGIY----TLPSHLSPGARD 246 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~---~i~~~~~----~~p~~~s~~~~~ 246 (515)
|++| .+.++|||||||++|+|++|..||.+.+...... +...+.. ..+..+++++.+
T Consensus 175 --------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (286)
T 3uqc_A 175 --------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238 (286)
T ss_dssp --------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHH
T ss_pred --------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHH
Confidence 3332 3789999999999999999999998865432110 1111111 223578999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcC
Q 010214 247 LIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~h 268 (515)
||.+||+.||.+| |+.|+++.
T Consensus 239 li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 239 VAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHcccCCccC-CHHHHHHH
Confidence 9999999999999 99999873
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=381.23 Aligned_cols=243 Identities=23% Similarity=0.333 Sum_probs=203.7
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcC-CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe-
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHAL-TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD- 91 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~-tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~- 91 (515)
.+.++|++.+.||+|+||.||+|.+.. +|+.||||++... ........+.+|+.+++.++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 456899999999999999999999976 7899999998653 234556788999999999999999999999987655
Q ss_pred ----EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 92 ----IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 92 ----~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
.|+||||++|++|.+++.. .+++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++...
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999998754 79999999999999999999999999999999999999986 9999999999876
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHH
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDL 247 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 247 (515)
... ...+||+.|+|||++.+.. +.++|||||||++|+|++|..||.+.....+. ........++.+.+|
T Consensus 232 ~~~---~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------~~~~~~~~~~~l~~l 300 (681)
T 2pzi_A 232 NSF---GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------EDDPVLKTYDSYGRL 300 (681)
T ss_dssp TCC---SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------TTCHHHHHCHHHHHH
T ss_pred ccC---CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCccccccccc------ccccccccCHHHHHH
Confidence 543 5568999999999987653 68999999999999999999998763211100 000001235789999
Q ss_pred hcccCCCCCCCCCCHHHHhcCcccc
Q 010214 248 IPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
|.+||..||.+||+..+.+.|+|+.
T Consensus 301 i~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 301 LRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HhhhccCChhhCCCHHHHHHHHHHH
Confidence 9999999999999999999999875
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=278.24 Aligned_cols=96 Identities=29% Similarity=0.653 Sum_probs=87.4
Q ss_pred CCCCCceeEeecccCCHHHHHHHHHHHHHhcCcEEEEecceeEEEEeecCCCCCCCCccCCCCCCCCCCCCcccccccCC
Q 010214 386 LPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDG 465 (515)
Q Consensus 386 ~~~~~~w~lgi~s~~~p~~im~ev~~~l~~l~~~wk~~~~y~~kcr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (515)
+.+++||||||||+++|.|||+||||||++||++||+++||+|||||+++.+
T Consensus 2 ~~~~~kW~LGIrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~---------------------------- 53 (106)
T 4eai_A 2 PHMGAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVT---------------------------- 53 (106)
T ss_dssp ----CEEEESEEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTT----------------------------
T ss_pred CCcCccceEcceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCC----------------------------
Confidence 3568999999999999999999999999999999999999999999997532
Q ss_pred ccCCCceEEEEEEEeeecCCceeEEeecccC--------CceehHHHHHHHHHHHh
Q 010214 466 VVKSPNVVKFEVQLYKTRDEKYLLDLQRVQG--------PQFLFLDLCAAFLAQLR 513 (515)
Q Consensus 466 ~~~~~~~~k~~lQLyk~~~~~yllDf~~~~g--------~~~~f~~~c~~~i~~l~ 513 (515)
++++||+|||||+++++||||||+++| ++|+|||+||+||++|+
T Consensus 54 ----~~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~~~~~~~F~d~ca~li~~la 105 (106)
T 4eai_A 54 ----STFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGGGSHTIEFFEMCANLIKILA 105 (106)
T ss_dssp ----CCEEEEEEEEEECSSSCEEEEEEECCSSCCCSSSCHHHHHHHHHHHHHHHCC
T ss_pred ----CceeEEEEEEEEecCCcEEEEEEeccCCCCCCCCcCcEeHHHHHHHHHHHHh
Confidence 357999999999999999999999999 69999999999999997
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=301.90 Aligned_cols=129 Identities=26% Similarity=0.505 Sum_probs=104.3
Q ss_pred CCCCCCCCCCCCcccccc----------cCCCCCCCCCCceeEeecccCCHHHHHHHHHHHHHhcCcEEEEec---ceeE
Q 010214 362 PAVSPVAHRAPGFMDYQG----------MGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIG---HYNM 428 (515)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~w~lgi~s~~~p~~im~ev~~~l~~l~~~wk~~~---~y~~ 428 (515)
++.+..|+|+|+++.+.| .++.+..++++|||||||||++|.|||.|||||||+||++||+++ +|||
T Consensus 11 sti~ilpsslp~~h~~~m~~~~~~~~~~~~~~~~~~~~~kW~LGIrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~I 90 (179)
T 3t4n_A 11 STVSILPTSLPQIHRANMLAQGSPAASKISPLVTKKSKTRWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTI 90 (179)
T ss_dssp CCCEECGGGSHHHHHHHHHHHTCTHHHHCCCCCCCCCCCCCEESEEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEE
T ss_pred cceeecCCcchHHHHHHHHhcCCccccccCCCCCCcccceeeeccccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEE
Confidence 455668899999886666 123334567899999999999999999999999999999999998 9999
Q ss_pred EEEeecCCCCCCCCccCCCCCCCCCCCCcccccccCCccCCCceEEEEEEEeeecCCceeEEeecccC------------
Q 010214 429 KCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQG------------ 496 (515)
Q Consensus 429 kcr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~lQLyk~~~~~yllDf~~~~g------------ 496 (515)
||||+++.+++.+ ..+..++.+||+|||||+++++|||||| ++|
T Consensus 91 kcRw~~~~~~~~~-----------------------~~~~~p~~vKmeLQLYkv~~~~YLLDfk-~~G~e~~~~~~~~~~ 146 (179)
T 3t4n_A 91 KLRWKYDIGNKTN-----------------------TNEKIPDLMKMVIQLFQIETNNYLVDFK-FDGWESSYGDDTTVS 146 (179)
T ss_dssp EEEECC----------------------------------CCCEEEEEEEEEEEETTEEEEEEE-EEEEECC--------
T ss_pred EEEEeCCCCcccc-----------------------cccCCCceeEEEEEEEEecCCceEEEEE-ecccccccccccccc
Confidence 9999986543210 0123367899999999999999999999 777
Q ss_pred ----------CceehHHHHHHHHHHHhc
Q 010214 497 ----------PQFLFLDLCAAFLAQLRV 514 (515)
Q Consensus 497 ----------~~~~f~~~c~~~i~~l~~ 514 (515)
++|+|||||++||++|++
T Consensus 147 ~~~~~e~~~~s~~pFLdlca~LI~eLa~ 174 (179)
T 3t4n_A 147 NISEDEMSTFSAYPFLHLTTKLIMELAV 174 (179)
T ss_dssp --------CCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccCCccHHHHHHHHHHHHHh
Confidence 789999999999999986
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=291.94 Aligned_cols=102 Identities=27% Similarity=0.462 Sum_probs=88.3
Q ss_pred CCCCCceeEeecccCCHHHHHHHHHHHHHhcCcEEEEe---------cceeEEEEeecCCCCCCCCccCCCCCCCCCCCC
Q 010214 386 LPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKI---------GHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGD 456 (515)
Q Consensus 386 ~~~~~~w~lgi~s~~~p~~im~ev~~~l~~l~~~wk~~---------~~y~~kcr~~~~~~~~~~~~~~~~~~~~~~~~~ 456 (515)
.++++|||||||||++|.|||.|||||||+||++||++ ++|+|||||+++.++.
T Consensus 7 ~~~~~kWhlGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~----------------- 69 (137)
T 2qrd_A 7 KSRRNKWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKR----------------- 69 (137)
T ss_dssp ----CCCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHH-----------------
T ss_pred CcccCccccccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCcc-----------------
Confidence 45799999999999999999999999999999999999 9999999998752100
Q ss_pred cccccccCCccCCCceEEEEEEEeeecCCceeEEeecccCC---------------c----eehHHHHHHHHHHHhc
Q 010214 457 ESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGP---------------Q----FLFLDLCAAFLAQLRV 514 (515)
Q Consensus 457 ~~~~~~~~~~~~~~~~~k~~lQLyk~~~~~yllDf~~~~g~---------------~----~~f~~~c~~~i~~l~~ 514 (515)
+..+..|||+||||||++++||||||+++|+ . |+|||+|++||+||++
T Consensus 70 ----------~~~~~~vkm~iQLYqv~~~~YLlDFk~~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~Li~eLa~ 136 (137)
T 2qrd_A 70 ----------EGKNTYAYIELQLYEVMPGCFMLDVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLFS 136 (137)
T ss_dssp ----------TTCCEEEEEEEEEEEEETTEEEEEEEEEEEEESCC-------------CCCTTHHHHHHHHHHHHHH
T ss_pred ----------ccCCceEEEEEEEEEecCCcEEEEEEecCCccccccCccccccCCccccccccHHHHHHHHHHHHhc
Confidence 1125689999999999999999999999998 6 9999999999999986
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=281.39 Aligned_cols=77 Identities=30% Similarity=0.676 Sum_probs=71.6
Q ss_pred CCceeEeecccCCHHHHHHHHHHHHHhcCcEEEEecceeEEEEeecCCCCCCCCccCCCCCCCCCCCCcccccccCCccC
Q 010214 389 ERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVK 468 (515)
Q Consensus 389 ~~~w~lgi~s~~~p~~im~ev~~~l~~l~~~wk~~~~y~~kcr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (515)
++|||||||||++|.|||.|||||||+||+|||+++||||||||+++.+
T Consensus 2 ~~kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~------------------------------- 50 (157)
T 2v8q_A 2 SMAWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVT------------------------------- 50 (157)
T ss_dssp CCEEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTT-------------------------------
T ss_pred CccceeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCC-------------------------------
Confidence 5899999999999999999999999999999999999999999997532
Q ss_pred CCceEEEEEEEeeecCCceeEEeecccCC
Q 010214 469 SPNVVKFEVQLYKTRDEKYLLDLQRVQGP 497 (515)
Q Consensus 469 ~~~~~k~~lQLyk~~~~~yllDf~~~~g~ 497 (515)
+..+||+|||||+++++||||||+++|+
T Consensus 51 -~~~vKm~LQLYkv~~~~YLLDFk~l~g~ 78 (157)
T 2v8q_A 51 -STFSKMSLQLYQVDSRTYLLDFRSIDDE 78 (157)
T ss_dssp -CCEEEEEEEEEECSSSCEEEEEEEECCC
T ss_pred -CceEEEEEEEEEecCCCEEEEEEecCCC
Confidence 3479999999999999999999998875
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=270.55 Aligned_cols=95 Identities=33% Similarity=0.660 Sum_probs=84.4
Q ss_pred CCCCceeEeecccCCHHHHHHHHHHHHHhcCcEEEEecceeEEEEeecCCCCCCCCccCCCCCCCCCCCCcccccccCCc
Q 010214 387 PYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGV 466 (515)
Q Consensus 387 ~~~~~w~lgi~s~~~p~~im~ev~~~l~~l~~~wk~~~~y~~kcr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (515)
.+++|||||||||++|.|||.|||||||+||++||+++||+|||||+++..
T Consensus 3 ~k~~kW~LGIrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~----------------------------- 53 (130)
T 4eag_A 3 HMGAKWHLGIRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKT----------------------------- 53 (130)
T ss_dssp ---CCEEESBCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTT-----------------------------
T ss_pred ccccceeeeeecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCC-----------------------------
Confidence 468999999999999999999999999999999999999999999987521
Q ss_pred cCCCceEEEEEEEeeecCCceeEEeecccCCc--------------------------------eehHHHHHHHHHHHh
Q 010214 467 VKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQ--------------------------------FLFLDLCAAFLAQLR 513 (515)
Q Consensus 467 ~~~~~~~k~~lQLyk~~~~~yllDf~~~~g~~--------------------------------~~f~~~c~~~i~~l~ 513 (515)
+.++||+||||||++++||||||+++|+. |+||||||+||++|+
T Consensus 54 ---~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~tmeffemc~~li~~la 129 (130)
T 4eag_A 54 ---GKFSKMSLQLYQVDAKSYLLDFKSLTNDEVEQGDDVIMESLTPPPLSVSGVMPLQPTGHHTMEFFEMCAALIIQLA 129 (130)
T ss_dssp ---CCEEEEEEEEEESSSSCEEEEEEECC---------------------------CCCSCCHHHHHHHHHHHHHHHHH
T ss_pred ---CceeEEEEEEEEecCCcEEEEeccCCcchhhccCCccccccCCCcccccCCCCCCCCCcccChHHHHHHHHHHHHh
Confidence 35799999999999999999999998752 999999999999997
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=281.38 Aligned_cols=80 Identities=29% Similarity=0.621 Sum_probs=72.1
Q ss_pred CCCCCceeEeecccCCHHHHHHHHHHHHHhcCcEEEEecceeEEEEeecCCCCCCCCccCCCCCCCCCCCCcccccccCC
Q 010214 386 LPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDG 465 (515)
Q Consensus 386 ~~~~~~w~lgi~s~~~p~~im~ev~~~l~~l~~~wk~~~~y~~kcr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (515)
.++++|||||||||++|.|||+|||||||+||+|||+++||+|||||+++..
T Consensus 13 ~~k~~kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~---------------------------- 64 (173)
T 2y8l_A 13 PRGSMAWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVT---------------------------- 64 (173)
T ss_dssp ---CCEEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTT----------------------------
T ss_pred ccccceeeeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCC----------------------------
Confidence 4579999999999999999999999999999999999999999999997532
Q ss_pred ccCCCceEEEEEEEeeecCCceeEEeecccCC
Q 010214 466 VVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGP 497 (515)
Q Consensus 466 ~~~~~~~~k~~lQLyk~~~~~yllDf~~~~g~ 497 (515)
+..+||+|||||+++++||||||+++|+
T Consensus 65 ----~~~vKmeLQLYKv~~~~YLLDFk~l~Gd 92 (173)
T 2y8l_A 65 ----STFSKMSLQLYQVDSRTYLLDFRSIDDE 92 (173)
T ss_dssp ----CCEEEEEEEEEECSSSCEEEEEEEECCC
T ss_pred ----CeeEEEEEEEEEEcCCCEEEEEEecCCC
Confidence 3479999999999999999999998875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.81 Aligned_cols=233 Identities=13% Similarity=0.061 Sum_probs=165.9
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCC-------hHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEE
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-------MEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~-------~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 93 (515)
....+.|++|.+..++...+|+.||+|++.+..... ....+.+.+|+++|+++ .|+||+++++++++++.+|
T Consensus 239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y 318 (569)
T 4azs_A 239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW 318 (569)
T ss_dssp ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence 345678888888888888899999999998653221 22346799999999999 5999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~ 172 (515)
||||||+|++|.++|.+.+++++. +|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.... ...
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence 999999999999999999988875 4889999999999999999999999999999999999999999987643 345
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccC
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 252 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL 252 (515)
..+.+||+.|+|||++.+.. ..++|+||+|++++.+.++..||. ..+. ..|.. ...+.++...+.
T Consensus 396 ~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~~~--------~~l~----~~~~~-~~~~~~l~~~l~ 460 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSNWL--------YAVW----QEPVE-RWNFVLLLALFE 460 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTTHHHHH--------HHHH----TSCGG-GCSHHHHHHHHH
T ss_pred ccCceechhhccHHHhCCCC--CCcccccccccchhhhccccchhH--------HHhh----cCCCC-CCcHHHHHHHHh
Confidence 56789999999999998864 568999999999988876644331 1111 11111 123566777778
Q ss_pred CCCCCCCCCHHHHhcCcccc
Q 010214 253 IVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 253 ~~dP~~Rpt~~eil~hp~f~ 272 (515)
..+|..|++......|+|..
T Consensus 461 ~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 461 KKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp TGGGSCCGGGSSCCHHHHHH
T ss_pred CCCCCCCCChhhhccchhHH
Confidence 88888888877777777764
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-29 Score=268.78 Aligned_cols=185 Identities=21% Similarity=0.218 Sum_probs=145.8
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChH-----HHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-----MEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~-----~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
..+.||+|+||.||+|. ..+..+|+|........... ..+++.+|++++++++||||+++..++...+..|+|
T Consensus 340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 46689999999999994 46789999987665443322 245689999999999999999444444466677999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc---
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--- 172 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~--- 172 (515)
|||++|++|.+++.+ +..++.||+.||.|||++||+||||||+|||++. ++||+|||+++.......
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 999999999999865 6799999999999999999999999999999998 999999999988754322
Q ss_pred -----cccCCCCCCccCCCcccC--CccCCCcceeehhHHHHHHHHhCCCCCC
Q 010214 173 -----LKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFD 218 (515)
Q Consensus 173 -----~~~~~gt~~Y~aPE~i~~--~~~~~~~~DIwSlGvily~lltG~~Pf~ 218 (515)
..+.+||+.|+|||++.+ ..| +..+|+||..+-..+..-++-+|.
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y-~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWERFLEGY-KSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHH-HHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred chhhhhhhhcCCCCcCCHHHHHHHHHHH-HHHHhHHHHHHHHHHHHHhccccC
Confidence 246789999999999986 445 567899999888887777666653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.2e-26 Score=225.95 Aligned_cols=147 Identities=19% Similarity=0.186 Sum_probs=117.5
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh---------------HHHHHHHHHHHHHHhCCCCCccEEE
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---------------EMEEKVRREIKILRLFMHPHIIRLY 83 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~---------------~~~~~i~~Ei~il~~l~hpnIv~l~ 83 (515)
|.+++.||+|+||.||+|.+ .+|+.||+|++........ .....+.+|+.+|+.++| ++++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcC
Confidence 44559999999999999999 7899999999964322110 135678999999999994 5555
Q ss_pred EEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 84 EVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 84 ~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
+++.. +..|+||||++|++|.+ +. ......++.||+.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 55544 45699999999999987 41 234568999999999999999999999999999999 99999999999
Q ss_pred ccccccCCccccCCCCCCccCCCcccC
Q 010214 164 SNIMRDGHFLKTSCGSPNYAAPEVISG 190 (515)
Q Consensus 164 s~~~~~~~~~~~~~gt~~Y~aPE~i~~ 190 (515)
+.. +..++|||.+.+
T Consensus 239 a~~------------~~~~~a~e~l~r 253 (282)
T 1zar_A 239 SVE------------VGEEGWREILER 253 (282)
T ss_dssp CEE------------TTSTTHHHHHHH
T ss_pred CeE------------CCCCCHHHHHHH
Confidence 863 345788988753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7e-22 Score=193.93 Aligned_cols=140 Identities=19% Similarity=0.269 Sum_probs=111.0
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcE--EEEEEecccccCC---------------------hHHHHHHHHHHHHHHhCC
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHK--VAIKILNRRKIKN---------------------MEMEEKVRREIKILRLFM 75 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~--vAiK~i~~~~~~~---------------------~~~~~~i~~Ei~il~~l~ 75 (515)
|.+.+.||+|+||.||+|.+..+|+. ||||++....... ......+.+|+.+|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999778999 9999975432110 012246889999999998
Q ss_pred CCCc--cEEEEEEEcCCeEEEEEeccCC-C----CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCc
Q 010214 76 HPHI--IRLYEVIETPSDIYVVMEYVKS-G----ELFDYIVEKGRLQEDEARNFFQQIISGVEYCH-RNMVVHRDLKPEN 147 (515)
Q Consensus 76 hpnI--v~l~~~~~~~~~~~iVmEy~~g-g----~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH-~~gIvHrDLkpeN 147 (515)
|+++ +.++++ ...++||||+.+ | +|.++... .++..+..++.||+.||.||| ++||+||||||+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 8754 445543 246899999942 3 67665432 345678899999999999999 9999999999999
Q ss_pred EEECCCCceEEeeccccccc
Q 010214 148 LLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 148 ILl~~~~~vKL~DFGls~~~ 167 (515)
||++. .++|+|||+|...
T Consensus 202 ILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EEESS--SEEECCCTTCEET
T ss_pred EEEcC--cEEEEECcccccC
Confidence 99998 9999999999654
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=99.84 E-value=4.3e-21 Score=164.42 Aligned_cols=88 Identities=18% Similarity=0.321 Sum_probs=80.5
Q ss_pred ecccCCHHHHHHHHHHHHHhcCcEEEEecceeEEEEeecCCCCCCCCccCCCCCCCCCCCCcccccccCCccCCCceEEE
Q 010214 396 LQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKF 475 (515)
Q Consensus 396 i~s~~~p~~im~ev~~~l~~l~~~wk~~~~y~~kcr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 475 (515)
++|+.+|.+||.||+|+|+++|++||+.++|+++|||.++.. ...|+|
T Consensus 33 tTSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~--------------------------------~~~vkf 80 (126)
T 1v5s_A 33 QGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHA--------------------------------ENLVQW 80 (126)
T ss_dssp CCCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSST--------------------------------TTCEEE
T ss_pred eecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCC--------------------------------CceEEE
Confidence 899999999999999999999999999999999999965311 236999
Q ss_pred EEEEeeec-CCceeEEeecccCCceehHHHHHHHHHHHhcC
Q 010214 476 EVQLYKTR-DEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL 515 (515)
Q Consensus 476 ~lQLyk~~-~~~yllDf~~~~g~~~~f~~~c~~~i~~l~~~ 515 (515)
|||+||++ .+.|.|||||++|+.+.|.++|++|+++|+++
T Consensus 81 EiEVcKvp~l~l~GI~fKRisGd~w~YK~lc~~IL~eLkL~ 121 (126)
T 1v5s_A 81 EMEVCKLPRLSLNGVRFKRISGTSIAFKNIASKIANELKLS 121 (126)
T ss_dssp EEECCCCTTTCSCCCEEEEEESCHHHHHHHHHHHHHHTTCC
T ss_pred EEEEEEecCCCceeEEEeeccCchhHHHHHHHHHHHHHhcc
Confidence 99999995 88999999999999999999999999999863
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=99.80 E-value=9.2e-20 Score=156.60 Aligned_cols=95 Identities=17% Similarity=0.359 Sum_probs=86.7
Q ss_pred CCCceeEeecccCCHHHHHHHHHHHHHhcCcEEEEecceeEEEEeecCCCCCCCCccCCCCCCCCCCCCcccccccCCcc
Q 010214 388 YERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVV 467 (515)
Q Consensus 388 ~~~~w~lgi~s~~~p~~im~ev~~~l~~l~~~wk~~~~y~~kcr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (515)
-+..|.+|..|+.+|.+||.||.+||+++|++|++.|+|+++|+|..+..
T Consensus 25 lk~~~~v~tTS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~------------------------------ 74 (120)
T 3ose_A 25 LRFTWSMKTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQ------------------------------ 74 (120)
T ss_dssp CCCCTTCCCEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTT------------------------------
T ss_pred EeceeeecCcccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCC------------------------------
Confidence 47899999999999999999999999999999999999999999964311
Q ss_pred CCCceEEEEEEEeeec-CCceeEEeecccCCceehHHHHHHHHHHHhc
Q 010214 468 KSPNVVKFEVQLYKTR-DEKYLLDLQRVQGPQFLFLDLCAAFLAQLRV 514 (515)
Q Consensus 468 ~~~~~~k~~lQLyk~~-~~~yllDf~~~~g~~~~f~~~c~~~i~~l~~ 514 (515)
...++||+|+||++ .+.|+|||||++|+++.|.++|++|+.+|+.
T Consensus 75 --~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~lc~~il~~L~L 120 (120)
T 3ose_A 75 --DSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASKIANELKL 120 (120)
T ss_dssp --TCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHHHHHHHHHCCC
T ss_pred --CccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHHHHHHHHHhcC
Confidence 24699999999996 7899999999999999999999999999973
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=2.4e-18 Score=177.22 Aligned_cols=137 Identities=15% Similarity=0.234 Sum_probs=103.1
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccC------------C---hH----HHHHHHHHHHHHHhCCCCCc
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK------------N---ME----MEEKVRREIKILRLFMHPHI 79 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~------------~---~~----~~~~i~~Ei~il~~l~hpnI 79 (515)
|.+++.||.|+||.||+|.+. +|+.||||++...... . .. ..-...+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999985 7999999998643211 0 00 01123468888888865554
Q ss_pred --cEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---
Q 010214 80 --IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW--- 154 (515)
Q Consensus 80 --v~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~--- 154 (515)
...+++ .. .++||||++|++|..+. ..+.+..++.||+.+|.+||++|||||||||+|||++.+|
T Consensus 176 ~vp~p~~~--~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQ--SR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEE--ET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeec--cC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 233332 22 27999999998886542 2335678899999999999999999999999999998876
Q ss_pred -------ceEEeecccccc
Q 010214 155 -------NVKIADFGLSNI 166 (515)
Q Consensus 155 -------~vKL~DFGls~~ 166 (515)
.+.|+||+-+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 389999997643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=4.3e-13 Score=130.71 Aligned_cols=142 Identities=14% Similarity=0.107 Sum_probs=115.1
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDI 92 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 92 (515)
..++.|++...+|.|+.+.||++.. .+..+++|+........ ...+.+|+.+++.+. +..+.++++++.+.+..
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 3467899999999999999999974 36899999986532111 235889999999885 67788999999998999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR------------------------------------- 135 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~------------------------------------- 135 (515)
|+||||++|.+|.+.+ .+......++.++..+|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 9999999999987652 1223445788999999999998
Q ss_pred ----------------------CCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 136 ----------------------NMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 136 ----------------------~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876566799999774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.28 E-value=1.1e-11 Score=119.79 Aligned_cols=140 Identities=13% Similarity=0.055 Sum_probs=105.4
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCC--ccEEEEEEEcC
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH--IIRLYEVIETP 89 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn--Iv~l~~~~~~~ 89 (515)
+.....+|.+....+.|..+.||++.. .+|..+++|+..... ...+.+|+.+++.+.+.+ +.+++.+....
T Consensus 15 l~~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 15 WVERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp GTTTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred HHHhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 455567788866656777799999964 467789999976431 135678999998886544 56799998888
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------------------
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM-------------------------------- 137 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~g-------------------------------- 137 (515)
+..|+||||++|.+|. . ...+ ...++.++...|..||+..
T Consensus 88 ~~~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp SCEEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred CCCEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 8899999999998884 1 1122 2356677777777777643
Q ss_pred --------------------------ceeccCCCCcEEECCCCceEEeecccccc
Q 010214 138 --------------------------VVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 138 --------------------------IvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
++|+|++|.|||++.++.+.|+|||.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999998743
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.15 E-value=8.3e-11 Score=120.13 Aligned_cols=141 Identities=16% Similarity=0.289 Sum_probs=107.2
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEec--ccccCChHHHHHHHHHHHHHHhCC--CCCccEEEEEEEcC---CeE
Q 010214 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILN--RRKIKNMEMEEKVRREIKILRLFM--HPHIIRLYEVIETP---SDI 92 (515)
Q Consensus 20 ~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~--~~~~~~~~~~~~i~~Ei~il~~l~--hpnIv~l~~~~~~~---~~~ 92 (515)
.-.+.|+.|.++.||++... +..+++|+.. ..... .....+.+|..+++.+. +..+++++.++.+. +..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 34677999999999998753 4688999875 32211 12357889999999998 45688999988766 448
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR------------------------------------- 135 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~------------------------------------- 135 (515)
|+||||++|..+.+.. -..+++.+...++.+++.+|..||+
T Consensus 117 ~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999999998774421 2347788899999999999999997
Q ss_pred ---------------------CCceeccCCCCcEEECCCCc--eEEeecccccc
Q 010214 136 ---------------------NMVVHRDLKPENLLLDSKWN--VKIADFGLSNI 166 (515)
Q Consensus 136 ---------------------~gIvHrDLkpeNILl~~~~~--vKL~DFGls~~ 166 (515)
..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999997753 69999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.03 E-value=1.1e-10 Score=116.43 Aligned_cols=186 Identities=15% Similarity=0.162 Sum_probs=124.8
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCC--ccEEEEEEEcCC---eEEEE
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPH--IIRLYEVIETPS---DIYVV 95 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpn--Iv~l~~~~~~~~---~~~iV 95 (515)
.+.++.|....||++. ..+++|+.... .....+.+|..+|+.+. +.. +.+++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3458999999999863 45899986422 34578899999998874 332 455555543333 34889
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR---------------------------------------- 135 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~---------------------------------------- 135 (515)
||+++|.+|.+... ..++.++...++.|+...+..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988876433 357888888999999999999986
Q ss_pred ------------------CCceeccCCCCcEEECC--CCceEEeecccccccccCCccccCCCCCCccCCCcccC--Ccc
Q 010214 136 ------------------NMVVHRDLKPENLLLDS--KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG--KLY 193 (515)
Q Consensus 136 ------------------~gIvHrDLkpeNILl~~--~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~--~~~ 193 (515)
..++|+|++|.||+++. ++.+.|+||+.+..-.....+........-..|+.... ..|
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 13699999999999998 55689999998865432111111111000012221110 011
Q ss_pred CC-----------CcceeehhHHHHHHHHhCCCCCCC
Q 010214 194 AG-----------PEVDVWSCGVILYALLCGTLPFDD 219 (515)
Q Consensus 194 ~~-----------~~~DIwSlGvily~lltG~~Pf~~ 219 (515)
.. ...+.|++|.++|.+.+|..+|..
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 01 125899999999999999887643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=3.3e-07 Score=89.13 Aligned_cols=140 Identities=19% Similarity=0.248 Sum_probs=102.5
Q ss_pred CCCceEeeeecccCce-EEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEE
Q 010214 16 LPNYKLGKTLGIGSFG-KVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg-~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 93 (515)
...|+... +..|..| .||+......+..+.+|+-.. .....+.+|...|+.+. +--+.+++.++++++..|
T Consensus 24 l~g~~~~~-~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~ 96 (272)
T 4gkh_A 24 LYGYRWAR-DNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAW 96 (272)
T ss_dssp HTTCEEEE-EECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred ccCCeEEE-ccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEE
Confidence 44555543 4445444 799988777788899998643 23567889999998876 334778899999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------------------
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM------------------------------------ 137 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~g------------------------------------ 137 (515)
+|||+++|.++.+..... ......+..++...|.-||+..
T Consensus 97 lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 97 LLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp EEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred EEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 999999998887765431 2233456666666677776421
Q ss_pred ----------------------ceeccCCCCcEEECCCCceEEeecccccc
Q 010214 138 ----------------------VVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 138 ----------------------IvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 68999999999999877778999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=5.9e-07 Score=89.57 Aligned_cols=133 Identities=18% Similarity=0.212 Sum_probs=96.6
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCC---CccEEEEEEE-cCCeEEEEEe
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP---HIIRLYEVIE-TPSDIYVVME 97 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp---nIv~l~~~~~-~~~~~~iVmE 97 (515)
.+.++.|....||+. |..+++|+.. .......+.+|..+|+.+.+. .+.+++.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456789999999988 5678899842 223457889999999999753 3667777764 4556789999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN----------------------------------------- 136 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~----------------------------------------- 136 (515)
+++|..|.+.. -..++..+...++.|+...|..||+.
T Consensus 94 ~i~G~~l~~~~--~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDG--MAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHH--HTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhh--hhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 99998887632 12345555666666666666666642
Q ss_pred -------------------CceeccCCCCcEEECC---CCc-eEEeecccccc
Q 010214 137 -------------------MVVHRDLKPENLLLDS---KWN-VKIADFGLSNI 166 (515)
Q Consensus 137 -------------------gIvHrDLkpeNILl~~---~~~-vKL~DFGls~~ 166 (515)
.++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999997 455 48999997753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=7.3e-07 Score=91.99 Aligned_cols=80 Identities=16% Similarity=0.042 Sum_probs=51.4
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEeccccc-CCh---HHHHHHHHHHHHHHhCCC--C-CccEEEEEEEcCCeEE
Q 010214 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI-KNM---EMEEKVRREIKILRLFMH--P-HIIRLYEVIETPSDIY 93 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~-~~~---~~~~~i~~Ei~il~~l~h--p-nIv~l~~~~~~~~~~~ 93 (515)
-.+.||.|.++.||++....+++.+++|....... ... ....++.+|.++++.+.. | .+.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 35689999999999997666678999998653211 000 123456789999887742 3 44566654 344468
Q ss_pred EEEeccCCC
Q 010214 94 VVMEYVKSG 102 (515)
Q Consensus 94 iVmEy~~gg 102 (515)
+|||+++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=1.2e-06 Score=88.76 Aligned_cols=81 Identities=12% Similarity=0.181 Sum_probs=55.7
Q ss_pred Eeeee-cccCceEEEEEEEc--C----CCcEEEEEEecccc---cCChHHHHHHHHHHHHHHhCCC---CCccEEEEEEE
Q 010214 21 LGKTL-GIGSFGKVKIAEHA--L----TGHKVAIKILNRRK---IKNMEMEEKVRREIKILRLFMH---PHIIRLYEVIE 87 (515)
Q Consensus 21 i~~~L-G~G~fg~Vy~a~~~--~----tg~~vAiK~i~~~~---~~~~~~~~~i~~Ei~il~~l~h---pnIv~l~~~~~ 87 (515)
..+.| +.|....+|++... . ++..+++|+..... ... ...+.+|..+++.+.. ..+.+++.+..
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~ 100 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIET 100 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence 45678 88999999988653 1 16689999865432 101 1356788888887752 35778888876
Q ss_pred cC---CeEEEEEeccCCCCH
Q 010214 88 TP---SDIYVVMEYVKSGEL 104 (515)
Q Consensus 88 ~~---~~~~iVmEy~~gg~L 104 (515)
+. ...|+|||+++|..+
T Consensus 101 ~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 101 TGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp SSTTTSSCEEEEECCCCBCC
T ss_pred CCCccCCceEEEEecCCCCh
Confidence 55 346899999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.07 E-value=4e-05 Score=76.55 Aligned_cols=135 Identities=13% Similarity=0.088 Sum_probs=77.5
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-----CCCccEEE-E--EEEcCCeEE
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-----HPHIIRLY-E--VIETPSDIY 93 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~~~~ 93 (515)
.+.|+.|..+.||++... +..+++|+.... . ..+..|..+++.+. .|.++... + +....+..+
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 445677788999998753 345999998652 1 23344555554443 34444310 0 123467789
Q ss_pred EEEeccCCCCHH--------------HHHHH-hCCC--C-----------HH--------H-------------------
Q 010214 94 VVMEYVKSGELF--------------DYIVE-KGRL--Q-----------ED--------E------------------- 118 (515)
Q Consensus 94 iVmEy~~gg~L~--------------~~i~~-~~~l--~-----------e~--------~------------------- 118 (515)
++|||++|.++. ..++. ...+ + .. .
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986542 11111 1111 1 00 0
Q ss_pred ----HHHHHHHHHHHHHHHH-------------HCCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 119 ----ARNFFQQIISGVEYCH-------------RNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 119 ----~~~i~~qil~aL~yLH-------------~~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
...+..++..++.+|+ ..+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1112223344566665 2579999999999999888899999999763
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.80 E-value=8.6e-05 Score=77.10 Aligned_cols=77 Identities=16% Similarity=0.107 Sum_probs=46.2
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEecccc--cCCh----HHHHHHHHHHHHHH-hCCCCCccEEEEEEEcCCeEE
Q 010214 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRK--IKNM----EMEEKVRREIKILR-LFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~--~~~~----~~~~~i~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~ 93 (515)
-.+.||.|..+.||++.. ++..++||...... .... .....+..|+..+. ......+.+++.+. +...+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 456789999999999963 56789999432211 0000 01223333333222 22334677777765 45678
Q ss_pred EEEecc-CC
Q 010214 94 VVMEYV-KS 101 (515)
Q Consensus 94 iVmEy~-~g 101 (515)
+|||++ +|
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 77
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00016 Score=72.13 Aligned_cols=76 Identities=16% Similarity=0.238 Sum_probs=61.0
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC---CCCccEEEEEEEcCCeEEEEEe
Q 010214 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM---HPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~iVmE 97 (515)
-.+.|+.|....+|+... ++..+++|+.... ....+.+|...|+.+. ...+++++.+....+..|+|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 356789999999999874 5678999987542 2466788999888875 3678899999888889999999
Q ss_pred ccCCCCH
Q 010214 98 YVKSGEL 104 (515)
Q Consensus 98 y~~gg~L 104 (515)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00025 Score=69.98 Aligned_cols=71 Identities=14% Similarity=0.044 Sum_probs=44.8
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc-cEEEEEEEcCCeEEEEEecc-
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVVMEYV- 99 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~iVmEy~- 99 (515)
.+.|+.|....+|++ ..+++|+....... .....+|..+++.+....+ .+++.+. ++.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 678999999999998 45899987643111 1112467777776652222 4666543 33346899999
Q ss_pred CCCCH
Q 010214 100 KSGEL 104 (515)
Q Consensus 100 ~gg~L 104 (515)
+|.+|
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 66544
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00065 Score=63.67 Aligned_cols=122 Identities=20% Similarity=0.142 Sum_probs=81.6
Q ss_pred CCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCC
Q 010214 102 GELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS 179 (515)
Q Consensus 102 g~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt 179 (515)
-+|.+.+.. +.+++|+++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|+|-+.+ +.+. ...
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~ 100 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGE 100 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------ccc
Confidence 478998875 5689999999999999999877622 2212334557899999999987764 2111 123
Q ss_pred CCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCC
Q 010214 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 180 ~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~ 254 (515)
..+.|||.... ..+.+.=|||||+++|..+--.+|=+ -+..+|+.+.+||..|..-
T Consensus 101 ~~~~~pe~~~~--~~te~~~IysLG~tLY~ALDygL~e~-----------------eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 101 PPPVAGKLGYS--QCMETEVIESLGIIIYKALDYGLKEN-----------------EERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ------CCSSS--SSCHHHHHHHHHHHHHHHHTTTCCTT-----------------EEECCCHHHHHHHHHHTTC
T ss_pred cCCCChhhccc--cchHHHHHHHHHHHHHHHhhcCCCcc-----------------cchhhCHHHHHHHHHHHhc
Confidence 35678887642 23567789999999999985433311 2346899999999999866
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.35 E-value=8.2e-05 Score=73.96 Aligned_cols=138 Identities=11% Similarity=0.085 Sum_probs=77.1
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCC--ccEEEE------EEEcCCeE
Q 010214 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH--IIRLYE------VIETPSDI 92 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn--Iv~l~~------~~~~~~~~ 92 (515)
-.+.|+.|....+|++... +| .+++|+..... ....+..|..+++.+.... +.+++. +....+..
T Consensus 26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 3556778888999998753 33 68899986521 1234556777776554211 233321 11234567
Q ss_pred EEEEeccCCCCHH----H----------HHHHh-CCC--------CHHHHHHH---------------HHHHHHHHHHHH
Q 010214 93 YVVMEYVKSGELF----D----------YIVEK-GRL--------QEDEARNF---------------FQQIISGVEYCH 134 (515)
Q Consensus 93 ~iVmEy~~gg~L~----~----------~i~~~-~~l--------~e~~~~~i---------------~~qil~aL~yLH 134 (515)
+++|++++|..+. . .++.. ..+ ....-... -..+...++.++
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 9999999986431 0 11111 011 11100000 011344455555
Q ss_pred H-------CCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 135 R-------NMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 135 ~-------~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
. .+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 2 368999999999999987656899999764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00048 Score=68.86 Aligned_cols=136 Identities=14% Similarity=0.172 Sum_probs=72.1
Q ss_pred eeeecccCceE-EEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC--CCccEEEEEEEcCCeEEEEEec
Q 010214 22 GKTLGIGSFGK-VKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH--PHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 22 ~~~LG~G~fg~-Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~iVmEy 98 (515)
.+.|+.|+... +|+... .+|..+++|....... ..+..|+.+++.+.. -.+.+++.+.... . +++||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~-g-~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHAR-G-LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTT-T-EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCC-C-EEEEee
Confidence 34565555444 666653 2367788886543321 233456777666642 2356677663333 3 789999
Q ss_pred cCCCCHHHHHHHh--------------------------CCCCHHHHH-------HHH-------------HHHHHHHHH
Q 010214 99 VKSGELFDYIVEK--------------------------GRLQEDEAR-------NFF-------------QQIISGVEY 132 (515)
Q Consensus 99 ~~gg~L~~~i~~~--------------------------~~l~e~~~~-------~i~-------------~qil~aL~y 132 (515)
+.+..+.+++... ..++..... .+. ..+...+..
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9776665544211 011221110 000 011122233
Q ss_pred H------HHCCceeccCCCCcEEECCC----CceEEeecccccc
Q 010214 133 C------HRNMVVHRDLKPENLLLDSK----WNVKIADFGLSNI 166 (515)
Q Consensus 133 L------H~~gIvHrDLkpeNILl~~~----~~vKL~DFGls~~ 166 (515)
+ +...++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3 13469999999999999874 6899999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0035 Score=61.18 Aligned_cols=79 Identities=16% Similarity=0.041 Sum_probs=56.2
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC---CCccEEEEEEEcCCeEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH---PHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h---pnIv~l~~~~~~~~~~~i 94 (515)
...-++.+|.|..+.||+++.. +|+.|.+|+........ ...+.+|...|+.+.. --+.+++.+. .-++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 4556788999999999999864 78999999865433222 2457789999988852 2355666542 2378
Q ss_pred EEeccCCCCH
Q 010214 95 VMEYVKSGEL 104 (515)
Q Consensus 95 VmEy~~gg~L 104 (515)
||||++++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00085 Score=69.93 Aligned_cols=74 Identities=18% Similarity=0.187 Sum_probs=50.5
Q ss_pred EeeeecccCceEEEEEEEcC-------CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCC-ccEEEEEEEcCCeE
Q 010214 21 LGKTLGIGSFGKVKIAEHAL-------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIRLYEVIETPSDI 92 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~-------tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~ 92 (515)
-.+.|+.|....||++.... ++..+.+|+..... . ...+.+|..+++.+...+ ..++++.+. +
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~-- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFS--G-- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--
Confidence 35678889999999998653 35789999984321 1 134457888888776333 367777653 2
Q ss_pred EEEEeccCCCC
Q 010214 93 YVVMEYVKSGE 103 (515)
Q Consensus 93 ~iVmEy~~gg~ 103 (515)
.+|+||++|.+
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 38999998743
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.00079 Score=66.90 Aligned_cols=135 Identities=13% Similarity=0.177 Sum_probs=77.2
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCC--CccEEEEE-----EEcCCeEEEE
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP--HIIRLYEV-----IETPSDIYVV 95 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~~~-----~~~~~~~~iV 95 (515)
..++ |....||++.. .+|+.+++|+....... ...+.+|..+++.+... .+++++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 3466 78889998764 34667999998643221 24566788877766421 23333332 2235567899
Q ss_pred EeccCCCCHH-----H------H---HHH---hC------CCCHHHH----H------------------HHHHHHHHHH
Q 010214 96 MEYVKSGELF-----D------Y---IVE---KG------RLQEDEA----R------------------NFFQQIISGV 130 (515)
Q Consensus 96 mEy~~gg~L~-----~------~---i~~---~~------~l~e~~~----~------------------~i~~qil~aL 130 (515)
||+++|..+. . . ++. .. ..+.... . ..+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999875431 1 1 111 00 1111110 1 1112222222
Q ss_pred HHH----HHCCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 131 EYC----HRNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 131 ~yL----H~~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
.-+ ....++|+|++|.|||++ + .+.|+||+.+.
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 221 124589999999999999 4 89999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00067 Score=69.53 Aligned_cols=136 Identities=15% Similarity=0.150 Sum_probs=82.1
Q ss_pred eeeecccCceEEEEEEEcC-------CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEE
Q 010214 22 GKTLGIGSFGKVKIAEHAL-------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~-------tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 93 (515)
.+.|..|-...+|++.... +++.+.+|+.... .. ....+.+|.++++.+. +.-..+++.++.. .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQ---GVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 3567778888899988642 3578999986331 11 1345568999988776 3233667766543 2
Q ss_pred EEEeccCCCCHHH----------HH----HH--h-----C-CC--CHHHHHHHHHHHHH-------------------HH
Q 010214 94 VVMEYVKSGELFD----------YI----VE--K-----G-RL--QEDEARNFFQQIIS-------------------GV 130 (515)
Q Consensus 94 iVmEy~~gg~L~~----------~i----~~--~-----~-~l--~e~~~~~i~~qil~-------------------aL 130 (515)
+||||++|..|.. .+ .+ . + .. -..++.++..++-. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8999998855421 11 11 0 1 11 13556666655432 23
Q ss_pred HHHH----H----CCceeccCCCCcEEECCC----CceEEeeccccc
Q 010214 131 EYCH----R----NMVVHRDLKPENLLLDSK----WNVKIADFGLSN 165 (515)
Q Consensus 131 ~yLH----~----~gIvHrDLkpeNILl~~~----~~vKL~DFGls~ 165 (515)
..|. . ..++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3333 2 248999999999999876 789999999874
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0066 Score=63.72 Aligned_cols=76 Identities=14% Similarity=0.143 Sum_probs=49.9
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc-cEEEEEEEcCCeEEEEEecc
Q 010214 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVVMEYV 99 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~iVmEy~ 99 (515)
-.+.|+.|-...+|++....++..+++|+.....-.- . ...+|..+++.+...++ .++++++. +. +||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---I-NREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---S-CHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---c-CHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEee
Confidence 4567888999999999876545789999875422110 0 11579999988875444 57777762 32 599999
Q ss_pred CCCCH
Q 010214 100 KSGEL 104 (515)
Q Consensus 100 ~gg~L 104 (515)
+|.+|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0011 Score=67.33 Aligned_cols=75 Identities=9% Similarity=0.015 Sum_probs=45.0
Q ss_pred EeeeecccCceEEEEEEEcC--------CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCC-ccEEEEEEEcCCe
Q 010214 21 LGKTLGIGSFGKVKIAEHAL--------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIRLYEVIETPSD 91 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~--------tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~~~~~~~ 91 (515)
-.+.|+.|....+|++.... .+..+++|+.....- ......+|..+++.+...+ +.+++... ++
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~- 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG- 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence 35678888889999998653 136899998754211 0112357888887775333 45676654 22
Q ss_pred EEEEEeccCCCC
Q 010214 92 IYVVMEYVKSGE 103 (515)
Q Consensus 92 ~~iVmEy~~gg~ 103 (515)
++||||++|..
T Consensus 110 -~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 -GRIEEWLYGDP 120 (369)
T ss_dssp -EEEEECCCSEE
T ss_pred -cEEEEEecCCc
Confidence 68999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0036 Score=62.91 Aligned_cols=31 Identities=19% Similarity=0.393 Sum_probs=27.2
Q ss_pred CCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 136 ~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4589999999999999888899999987653
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.23 E-value=0.018 Score=50.22 Aligned_cols=84 Identities=12% Similarity=0.299 Sum_probs=65.9
Q ss_pred cccCCHHHHHHHHHHHHHhcCcEEEEecceeEEEEeecCCCCCCCCccCCCCCCCCCCCCcccccccCCccCCCceEEEE
Q 010214 397 QSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFE 476 (515)
Q Consensus 397 ~s~~~p~~im~ev~~~l~~l~~~wk~~~~y~~kcr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~ 476 (515)
-|+.+|.+||..|-.+.+.+|+.+++.+ |.+|+--.. .+ +...+-+.
T Consensus 39 ~s~~~a~~ii~klEe~a~~lg~~V~kk~-~~vkl~~~~--~g------------------------------rkG~l~v~ 85 (143)
T 2ehb_D 39 VSRREPSEIIANIEAVANSMGFKSHTRN-FKTRLEGLS--SI------------------------------KAGQLAVV 85 (143)
T ss_dssp EECSCHHHHHHHHHHHHHHTTEEEEESS-SEEEEEECC--SS------------------------------GGGCCEEE
T ss_pred EeCCCHHHHHHHHHHHHHhcCcEEEEcC-cEEEEEEec--CC------------------------------CcceEEEE
Confidence 3888999999999999999999999865 555543211 00 01135577
Q ss_pred EEEeeecCCceeEEeecccCCceehHHHHHHHHHHHh
Q 010214 477 VQLYKTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLR 513 (515)
Q Consensus 477 lQLyk~~~~~yllDf~~~~g~~~~f~~~c~~~i~~l~ 513 (515)
+.+|.|.+.-+||||++-.|+.++|-.+|..|-..|.
T Consensus 86 ~EVfevapsl~vVEvrks~GD~lEy~k~~~~Lr~~L~ 122 (143)
T 2ehb_D 86 IEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKLE 122 (143)
T ss_dssp EEEEEEETTEEEEEEEEEESCHHHHHHHHHHHHHHST
T ss_pred EEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHhh
Confidence 7889999999999999999999999998887777665
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.38 E-value=0.056 Score=45.87 Aligned_cols=81 Identities=12% Similarity=0.090 Sum_probs=58.8
Q ss_pred cccCCHHHHHHHHHHHHHhcCcEEEEecceeEEEEeecCCCCCCCCccCCCCCCCCCCCCcccccccCCccCCCceEEEE
Q 010214 397 QSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFE 476 (515)
Q Consensus 397 ~s~~~p~~im~ev~~~l~~l~~~wk~~~~y~~kcr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~ 476 (515)
-|+.+|.+|+..|=.+.+.+|+.|++.+. . .+.. .+ +...+-+.
T Consensus 37 ~S~~~a~~ii~klEe~a~~lg~~v~kk~~-~-~~~~-~g---------------------------------~kG~l~v~ 80 (123)
T 2zfd_B 37 VSAWTAERVVERLEEIVSAENLTVAKKET-W-GMKI-EG---------------------------------QKGNFAMV 80 (123)
T ss_dssp EESSCHHHHHHHHHHHHHHTTCEEEEEET-T-EEEE-EE---------------------------------GGGTEEEE
T ss_pred EeCCCHHHHHHHHHHHHHHCCCEEEEcCC-c-cccc-cC---------------------------------CCccEEEE
Confidence 38889999999999999999999987543 2 1111 00 01136678
Q ss_pred EEEeeecCCceeEEeecccCCceehHHHHH-HHHHHHh
Q 010214 477 VQLYKTRDEKYLLDLQRVQGPQFLFLDLCA-AFLAQLR 513 (515)
Q Consensus 477 lQLyk~~~~~yllDf~~~~g~~~~f~~~c~-~~i~~l~ 513 (515)
+.+|.|.+.-+|+|+++-.|+.++|-.+|. .|-..|.
T Consensus 81 ~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~ 118 (123)
T 2zfd_B 81 VEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFV 118 (123)
T ss_dssp EEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHH
T ss_pred EEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHh
Confidence 888999999999999999999999888776 4555553
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.36 E-value=0.029 Score=58.11 Aligned_cols=76 Identities=11% Similarity=0.118 Sum_probs=48.8
Q ss_pred EeeeecccCceEEEEEEEcCC-------CcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeE
Q 010214 21 LGKTLGIGSFGKVKIAEHALT-------GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDI 92 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~t-------g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 92 (515)
-++.+..|-...+|++..... +..|++++..... .. .-...+|..+++.+. +.-..++++.+ .+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~---~idR~~E~~~l~~L~~~gi~P~l~~~~--~~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GK---FYDSKVELDVFRYLSNINIAPNIIADF--PE-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--C---CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-ch---hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence 356677888889999987521 6789999865422 11 112357888887775 33345666543 22
Q ss_pred EEEEeccCCCCH
Q 010214 93 YVVMEYVKSGEL 104 (515)
Q Consensus 93 ~iVmEy~~gg~L 104 (515)
+.||||++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 689999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.72 E-value=0.25 Score=50.52 Aligned_cols=29 Identities=31% Similarity=0.485 Sum_probs=24.9
Q ss_pred ceeccCCCCcEEE------CCCCceEEeecccccc
Q 010214 138 VVHRDLKPENLLL------DSKWNVKIADFGLSNI 166 (515)
Q Consensus 138 IvHrDLkpeNILl------~~~~~vKL~DFGls~~ 166 (515)
++|+|+.+.|||+ ++++.+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567899999998753
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.37 E-value=3.9 Score=38.04 Aligned_cols=85 Identities=16% Similarity=0.139 Sum_probs=63.8
Q ss_pred CCCCccEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHH-HHHHCCceeccCCCCcEEECCC
Q 010214 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE-YCHRNMVVHRDLKPENLLLDSK 153 (515)
Q Consensus 75 ~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~-yLH~~gIvHrDLkpeNILl~~~ 153 (515)
.||++ -..+-++++.+.+.++.-+++.=+..+. .++..+.++++.+|+.... ++ ..-+|--|+|+||++|.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence 58888 5555577888877777765554455553 4788899999999887665 43 445677899999999999
Q ss_pred CceEEeecccccc
Q 010214 154 WNVKIADFGLSNI 166 (515)
Q Consensus 154 ~~vKL~DFGls~~ 166 (515)
+.++|.-.|+-..
T Consensus 121 ~~p~i~hRGi~~~ 133 (219)
T 4ano_A 121 LEPFFLHVGVKES 133 (219)
T ss_dssp CCEEESCCEETTT
T ss_pred CcEEEEEcCCccc
Confidence 9999998887543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 515 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-95 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-91 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-89 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-88 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-87 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-87 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-87 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-87 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-87 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-86 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-85 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-84 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-82 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-81 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-80 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-80 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-80 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-78 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-78 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-78 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-76 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-74 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-73 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-73 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-71 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-71 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-70 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-69 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-68 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-67 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-67 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-67 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-66 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-66 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-65 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-65 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-65 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-65 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-64 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-64 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-64 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-64 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-64 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-63 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-62 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-60 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-57 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-56 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-55 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-52 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-45 | |
| d2qrda1 | 127 | d.129.6.2 (A:450-576) Snf1-like protein kinase ssp | 1e-29 | |
| d2v8qa1 | 153 | d.129.6.2 (A:396-548) 5'-AMP-activated protein kin | 6e-29 | |
| d2qlva1 | 171 | d.129.6.2 (A:460-630) Carbon catabolite-derepressi | 8e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-22 | |
| d1ul7a_ | 102 | d.129.6.1 (A:) Map/microtubule affinity-regulating | 2e-19 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 288 bits (739), Expect = 1e-95
Identities = 88/259 (33%), Positives = 149/259 (57%), Gaps = 2/259 (0%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L ++++G+ LG G FG V +A + +A+K+L + +++ +E ++RRE++I
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
HP+I+RLY + +Y+++EY G ++ + + + E + ++ + + YCH
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
V+HRD+KPENLLL S +KIADFG S T CG+ +Y PE+I G+++
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMH-D 182
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
+VD+WS GV+ Y L G PF+ +K+I +T P ++ GARDLI R+L +
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 242
Query: 256 PMKRITIPEIRQHPWFQAH 274
P +R + E+ +HPW A+
Sbjct: 243 PSQRPMLREVLEHPWITAN 261
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 278 bits (712), Expect = 2e-91
Identities = 91/269 (33%), Positives = 155/269 (57%), Gaps = 8/269 (2%)
Query: 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
F+ ++ L +TLG G++G+V++A + +T VA+KI++ ++ + E +++EI I ++
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 60
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
H ++++ Y + Y+ +EY GELFD I + E +A+ FF Q+++GV Y H
Sbjct: 61 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGK 191
+ HRD+KPENLLLD + N+KI+DFGL+ + R L CG+ Y APE++ +
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLP--SHLSPGARDLI 248
+ VDVWSCG++L A+L G LP+D + + K L + L+
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240
Query: 249 PRMLIVDPMKRITIPEIRQHPWFQAHLPR 277
++L+ +P RITIP+I++ W+ L +
Sbjct: 241 HKILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 273 bits (698), Expect = 3e-89
Identities = 87/264 (32%), Positives = 137/264 (51%), Gaps = 10/264 (3%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
++K GK LG GSF V +A T + AIKIL +R I V RE ++ HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
++LY + +Y + Y K+GEL YI + G E R + +I+S +EY H
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLYA 194
++HRDLKPEN+LL+ +++I DFG + ++ + G+ Y +PE+++ K
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA- 187
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254
D+W+ G I+Y L+ G PF N +F+KI Y P P ARDL+ ++L++
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 247
Query: 255 DPMKRITI------PEIRQHPWFQ 272
D KR+ ++ HP+F+
Sbjct: 248 DATKRLGCEEMEGYGPLKAHPFFE 271
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 271 bits (694), Expect = 5e-88
Identities = 101/313 (32%), Positives = 160/313 (51%), Gaps = 12/313 (3%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-H 76
++ L K LG GSFGKV +AE T AIK L + + + E E ++L L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
P + ++ +T +++ VMEY+ G+L +I + A + +II G+++ H
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAG 195
+V+RDLK +N+LLD ++KIADFG+ G + CG+P+Y APE++ G+ Y
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY-N 181
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
VD WS GV+LY +L G PF ++ LF I+ P L A+DL+ ++ + +
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVRE 241
Query: 256 PMKRITIP-EIRQHPWFQ----AHLPRYLAVPP----PDTMQQAKKIDEEILKEVVKMGF 306
P KR+ + +IRQHP F+ L R PP + D+E L E ++ F
Sbjct: 242 PEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSF 301
Query: 307 DQNQLVESLRNRL 319
L+ S+ +
Sbjct: 302 ADRALINSMDQNM 314
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 268 bits (687), Expect = 1e-87
Identities = 102/277 (36%), Positives = 149/277 (53%), Gaps = 16/277 (5%)
Query: 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM------EMEEKVRREI 68
F NY+ + LG G V+ H T + A+KI++ + E+ E +E+
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 69 KILR-LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII 127
ILR + HP+II+L + ET + ++V + +K GELFDY+ EK L E E R + ++
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 120
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187
+ H+ +VHRDLKPEN+LLD N+K+ DFG S + G L+ CG+P+Y APE+
Sbjct: 121 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 188 ISGKLYA-----GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS---- 238
I + G EVD+WS GVI+Y LL G+ PF + + I G Y S
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275
S +DL+ R L+V P KR T E HP+FQ ++
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 277
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 271 bits (693), Expect = 2e-87
Identities = 92/320 (28%), Positives = 161/320 (50%), Gaps = 18/320 (5%)
Query: 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
D L +Y + + LG G+FG V TG+ A K + + +E VR+EI+ +
Sbjct: 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKEIQTMS 78
Query: 73 LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVE 131
+ HP ++ L++ E +++ ++ E++ GELF+ + ++ ++ EDEA + +Q+ G+
Sbjct: 79 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138
Query: 132 YCHRNMVVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
+ H N VH DLKPEN++ +K + +K+ DFGL+ + +K + G+ +AAPEV
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 198
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGAR 245
GK G D+WS GV+ Y LL G PF EN + +K + + S +S +
Sbjct: 199 GKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMG 305
D I ++L+ DP R+TI + +HPW P Q +++ +K
Sbjct: 258 DFIRKLLLADPNTRMTIHQALEHPWLT-------PGNAPGRDSQIPSSRYTKIRDSIKTK 310
Query: 306 FDQNQLVESLRNRLQNEATV 325
+D R+ N +++
Sbjct: 311 YDAWPEPLPPLGRISNYSSL 330
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 268 bits (686), Expect = 5e-87
Identities = 110/292 (37%), Positives = 152/292 (52%), Gaps = 10/292 (3%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
Y LG G+F +V +AE T VAIK + ++ ++ E + EI +L HP+
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKHPN 68
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
I+ L ++ E+ +Y++M+ V GELFD IVEKG E +A Q++ V+Y H +
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 128
Query: 139 VHRDLKPENLLL---DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
VHRDLKPENLL D + I+DFGLS + G L T+CG+P Y APEV++ K Y
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY-S 187
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRM 251
VD WS GVI Y LLCG PF DEN LF++I Y S +S A+D I +
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 247
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVK 303
+ DP KR T + QHPW + + Q K + K+
Sbjct: 248 MEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQAFN 299
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 269 bits (689), Expect = 6e-87
Identities = 82/290 (28%), Positives = 146/290 (50%), Gaps = 11/290 (3%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
Y + + LG G+FG V TG K +N + + V+ EI I+ HP
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHP 86
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRN 136
+I L++ E ++ +++E++ GELFD I + ++ E E N+ +Q G+++ H +
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 137 MVVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
+VH D+KPEN++ ++K VKI DFGL+ + +K + + +AAPE++ +
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV- 205
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPR 250
G D+W+ GV+ Y LL G PF E+ + +K + S +SP A+D I
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 265
Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKE 300
+L +P KR+T+ + +HPW + + P + ++ +E +
Sbjct: 266 LLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 315
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 268 bits (685), Expect = 6e-87
Identities = 74/295 (25%), Positives = 125/295 (42%), Gaps = 8/295 (2%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
+ + +G GSFG V A VAIK ++ ++ E + + +E++ L+ HP+
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 138
I+ ++VMEY V K LQE E + G+ Y H + +
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY--AGP 196
+HRD+K N+LL VK+ DFG ++IM + + G+P + APEVI
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILAMDEGQYDG 193
Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIV 254
+VDVWS G+ L P + N + I H S R+ + L
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253
Query: 255 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQA-KKIDEEILKEVVKMGFDQ 308
P R T + +H + P + + + A +++D +++ K+ F +
Sbjct: 254 IPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQE 308
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 265 bits (679), Expect = 4e-86
Identities = 82/277 (29%), Positives = 140/277 (50%), Gaps = 9/277 (3%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
Y + +G G+ G V A TG +VAI+ + ++ +E + EI ++R +P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNP 77
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
+I+ + +++VVMEY+ G L D + + + E + ++ + +E+ H N
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
V+HRD+K +N+LL +VK+ DFG I + T G+P + APEV++ K Y GP
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GP 195
Query: 197 EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 253
+VD+WS G++ ++ G P+ +EN + L+ G L P LS RD + R L
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255
Query: 254 VDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQA 290
+D KR + E+ QH + + P P ++A
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEA 292
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 263 bits (674), Expect = 2e-85
Identities = 75/283 (26%), Positives = 133/283 (46%), Gaps = 16/283 (5%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+++ LG G+FGKV A++ T A K+++ K+ E E EI IL HP
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT---KSEEELEDYMVEIDILASCDHP 69
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRN 136
+I++L + +++++++E+ G + ++E R L E + + +Q + + Y H N
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYA- 194
++HRDLK N+L ++K+ADFG+S R + G+P + APEV+ +
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189
Query: 195 ---GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARDLI 248
+ DVWS G+ L + P + N + KI PS S +D +
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249
Query: 249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAK 291
+ L + R T ++ QHP+ + P + + +AK
Sbjct: 250 KKCLEKNVDARWTTSQLLQHPFVTVDSNK----PIRELIAEAK 288
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 262 bits (670), Expect = 2e-84
Identities = 72/291 (24%), Positives = 137/291 (47%), Gaps = 13/291 (4%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
Y + + LG G FG V + K + + + V++EI IL + H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHR 61
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRN 136
+I+ L+E E+ ++ ++ E++ ++F+ I L E E ++ Q+ +++ H +
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 137 MVVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
+ H D++PEN++ ++ + +KI +FG + ++ G + +P Y APEV +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV- 180
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 250
D+WS G ++Y LL G PF E + + I YT +S A D + R
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240
Query: 251 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEV 301
+L+ + R+T E QHPW + + R ++ T++ + I K++
Sbjct: 241 LLVKERKSRMTASEALQHPWLKQKIER-VSTKVIRTLKHRRYYHTLIKKDL 290
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 255 bits (653), Expect = 1e-82
Identities = 86/266 (32%), Positives = 137/266 (51%), Gaps = 15/266 (5%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+Y++ T+G GS+G+ + G + K L+ + E + + E+ +LR HP
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM-LVSEVNLLRELKHP 63
Query: 78 HIIRLYEVI--ETPSDIYVVMEYVKSGELFDYIV----EKGRLQEDEARNFFQQIISGVE 131
+I+R Y+ I T + +Y+VMEY + G+L I E+ L E+ Q+ ++
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 132 YCHR-----NMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAP 185
CHR + V+HRDLKP N+ LD K NVK+ DFGL+ I+ D F K G+P Y +P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 186 EVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGA 244
E ++ Y + D+WS G +LY L PF + L KI+ G + +P S
Sbjct: 184 EQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 242
Query: 245 RDLIPRMLIVDPMKRITIPEIRQHPW 270
++I RML + R ++ EI ++P
Sbjct: 243 NEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 253 bits (647), Expect = 1e-81
Identities = 68/264 (25%), Positives = 127/264 (48%), Gaps = 14/264 (5%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
K +G GSF V T +VA L RK+ E + + E ++L+ HP+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEMLKGLQHPN 69
Query: 79 IIRLYEVIETPSD----IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
I+R Y+ E+ I +V E + SG L Y+ ++ R++ +QI+ G+++ H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 135 RN--MVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
++HRDLK +N+ + +VKI D GL+ + R F K G+P + APE+ K
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEEK 188
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIY--TLPSHLSPGARDLI 248
VDV++ G+ + + P+ + N +++++ G+ + P +++I
Sbjct: 189 Y--DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246
Query: 249 PRMLIVDPMKRITIPEIRQHPWFQ 272
+ + +R +I ++ H +FQ
Sbjct: 247 EGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 252 bits (644), Expect = 1e-80
Identities = 84/262 (32%), Positives = 144/262 (54%), Gaps = 8/262 (3%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L ++++ +TLG GSFG+V + G A+K+L + + ++ E E +L +
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
HP IIR++ + I+++M+Y++ GELF + + R A+ + ++ +EY H
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
+++RDLKPEN+LLD ++KI DFG + + D T CG+P+Y APEV+S K Y
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--YTLCGTPDYIAPEVVSTKPY-N 179
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
+D WS G+++Y +L G PF D N ++KI P + +DL+ R++ D
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239
Query: 256 PMKRI-----TIPEIRQHPWFQ 272
+R+ +++ HPWF+
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFK 261
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 251 bits (643), Expect = 2e-80
Identities = 61/300 (20%), Positives = 122/300 (40%), Gaps = 49/300 (16%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+++ LG G+ G V H +G +A K++ + ++ RE+++L P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHECNSP 64
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH-RN 136
+I+ Y + +I + ME++ G L + + GR+ E +I G+ Y ++
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
++HRD+KP N+L++S+ +K+ DFG+S + D + G+ +Y +PE + G Y
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHY-SV 182
Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS------------------ 238
+ D+WS G+ L + G P + L + +
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242
Query: 239 --------------------------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
S +D + + LI +P +R + ++ H + +
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (637), Expect = 5e-80
Identities = 101/265 (38%), Positives = 148/265 (55%), Gaps = 12/265 (4%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM 75
Y G+ LG G F VK TG + A K + +R+ K+ E + RE+ IL+
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
HP++I L+EV E +D+ +++E V GELFD++ EK L E+EA F +QI++GV Y H
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 136 NMVVHRDLKPENLLLDS----KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
+ H DLKPEN++L K +KI DFGL++ + G+ K G+P + APE+++ +
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDL 247
G E D+WS GVI Y LL G PF + + Y S+ S A+D
Sbjct: 192 PL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 250
Query: 248 IPRMLIVDPMKRITIPEIRQHPWFQ 272
I R+L+ DP KR+TI + QHPW +
Sbjct: 251 IRRLLVKDPKKRMTIQDSLQHPWIK 275
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 248 bits (633), Expect = 2e-78
Identities = 73/266 (27%), Positives = 128/266 (48%), Gaps = 12/266 (4%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRRE---IKILRLF 74
++ + + +G G FG+V A TG A+K L++++IK + E E + ++
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
P I+ + TP + +++ + G+L ++ + G E + R + +II G+E+ H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
VV+RDLKP N+LLD +V+I+D GL+ S G+ Y APEV+ +
Sbjct: 125 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAY 183
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPN---LFKKIKGGIYTLPSHLSPGARDLIPRM 251
D +S G +L+ LL G PF + + + LP SP R L+ +
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 243
Query: 252 LIVDPMKRITIP-----EIRQHPWFQ 272
L D +R+ E+++ P+F+
Sbjct: 244 LQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (630), Expect = 2e-78
Identities = 101/323 (31%), Positives = 154/323 (47%), Gaps = 33/323 (10%)
Query: 13 DMFLPNYK-LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL 71
+ + +YK + LG+G GKV + T K A+K+L K RRE+++
Sbjct: 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELH 58
Query: 72 -RLFMHPHIIRLYEVIETPSD----IYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQ 124
R PHI+R+ +V E + +VME + GELF I ++G E EA +
Sbjct: 59 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118
Query: 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPN 181
I ++Y H + HRD+KPENLL SK +K+ DFG + + L T C +P
Sbjct: 119 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 178
Query: 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP 237
Y APEV+ + Y D+WS GVI+Y LLCG PF + P + +I+ G Y P
Sbjct: 179 YVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237
Query: 238 ----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL-----PRYLAVPPPDTMQ 288
S +S + LI +L +P +R+TI E HPW P + + + +
Sbjct: 238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 297
Query: 289 QAKKIDEEILKEVVKMGFDQNQL 311
+ + + EE+ + M D Q+
Sbjct: 298 RWEDVKEEMTSALATMRVDYEQI 320
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (628), Expect = 4e-78
Identities = 101/320 (31%), Positives = 155/320 (48%), Gaps = 15/320 (4%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
++ K LG G+FGKV + TG A+KIL + I + E ++L+ HP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
+ L +T + VMEY GELF ++ + E+ AR + +I+S +EY H
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
VV+RD+K ENL+LD ++KI DFGL + DG +KT CG+P Y APEV+ Y G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GR 184
Query: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256
VD W GV++Y ++CG LPF +++ LF+ I P LSP A+ L+ +L DP
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 244
Query: 257 MKRI-----TIPEIRQHPWFQ-----AHLPRYLA---VPPPDTMQQAKKIDEEILKEVVK 303
+R+ E+ +H +F + + L P + + D+E + +
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSIT 304
Query: 304 MGFDQNQLVESLRNRLQNEA 323
+ L Q E
Sbjct: 305 ITPPDRYDSLGLLELDQREE 324
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (612), Expect = 2e-76
Identities = 85/261 (32%), Positives = 136/261 (52%), Gaps = 14/261 (5%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN---MEMEEKVRREIKILRLF- 74
Y++G LG G FG V VAIK + + +I + + +V E+ +L+
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 75 -MHPHIIRLYEVIETPSDIYVVMEYVK-SGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
+IRL + E P +++E + +LFD+I E+G LQE+ AR+FF Q++ V +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 133 CHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
CH V+HRD+K EN+L+D ++ +K+ DFG +++D + G+ Y+ PE I
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYH 184
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251
Y G VWS G++LY ++CG +PF+ + +I G +S + LI
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIRWC 238
Query: 252 LIVDPMKRITIPEIRQHPWFQ 272
L + P R T EI+ HPW Q
Sbjct: 239 LALRPSDRPTFEEIQNHPWMQ 259
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 235 bits (600), Expect = 8e-74
Identities = 93/262 (35%), Positives = 148/262 (56%), Gaps = 8/262 (3%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L + KTLG GSFG+V + +H +G+ A+KIL+++K+ ++ E E +IL+
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
P +++L + S++Y+VMEYV GE+F ++ GR E AR + QI+ EY H
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 195
+++RDLKPENLL+D + +++ DFG + ++ + T CG+P APE+I K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEALAPEIILSKGY-N 216
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255
VD W+ GV++Y + G PF + +++KI G PSH S +DL+ +L VD
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 256 PMKRI-----TIPEIRQHPWFQ 272
KR + +I+ H WF
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 2e-73
Identities = 67/273 (24%), Positives = 122/273 (44%), Gaps = 18/273 (6%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+G+ +G GSFG V + VA+K+LN +++ + E+ +LR H
Sbjct: 9 QITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHV 64
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRN 136
+I+ T + +V ++ + L+ ++ + + + + + + +Q G++Y H
Sbjct: 65 NILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLY 193
++HRDLK N+ L VKI DFGL+ + H + GS + APEVI +
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 194 A--GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP------SHLSPGAR 245
+ DV++ G++LY L+ G LP+ + N + + G Y P S+ +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243
Query: 246 DLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPR 277
L+ L +R P+I LP+
Sbjct: 244 RLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 230 bits (587), Expect = 8e-73
Identities = 67/268 (25%), Positives = 115/268 (42%), Gaps = 13/268 (4%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
Y+LG+ LG G +V +A VA+K+L ++ + RRE + HP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 79 IIRLYEVIETPSD----IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
I+ +Y+ E + Y+VMEYV L D + +G + A + + H
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 128
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG----HFLKTSCGSPNYAAPEVISG 190
+N ++HRD+KP N+++ + VK+ DFG++ + D G+ Y +PE G
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARD 246
DV+S G +LY +L G PF ++ ++ + PS LS
Sbjct: 189 DSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDA 247
Query: 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274
++ + L +P R + + H
Sbjct: 248 VVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 3e-71
Identities = 74/294 (25%), Positives = 117/294 (39%), Gaps = 34/294 (11%)
Query: 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME--MEEKVRREIKILRLFMHPHII 80
LG G F V A T VAIK + + + REIK+L+ HP+II
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 81 RLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVH 140
L + S+I +V +++++ L + + + G+EY H++ ++H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT-SCGSPNYAAPEVISGKLYAGPEVD 199
RDLKP NLLLD +K+ADFGL+ + T + Y APE++ G G VD
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVD 183
Query: 200 VWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------------------ 235
+W+ G IL LL ++ + +I + T
Sbjct: 184 MWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGI 243
Query: 236 ----LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 285
+ S DLI + + +P RIT + + +F R P
Sbjct: 244 PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS---NRPGPTPGCQ 294
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 3e-71
Identities = 84/328 (25%), Positives = 143/328 (43%), Gaps = 45/328 (13%)
Query: 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH 76
P Y +G G++G V A + +VAIK + ++ ++ REIKIL F H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRH 65
Query: 77 PHIIRLYEVIETPS----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
+II + ++I P+ ++ ++ +L+ + + L D F QI+ G++Y
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKY 124
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVI 188
H V+HRDLKP NLLL++ ++KI DFGL+ + H FL + Y APE++
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------- 235
+D+WS G IL +L F ++ + I G + +
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 236 ------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH--- 274
L + A DL+ +ML +P KRI + + HP+ + +
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304
Query: 275 LPRYLAVPPPDTMQQAKKIDEEILKEVV 302
+A P + + +E LKE++
Sbjct: 305 SDEPIAEAPFKFDMELDDLPKEKLKELI 332
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 3e-70
Identities = 69/256 (26%), Positives = 119/256 (46%), Gaps = 15/256 (5%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
KL +T+G G FG V + ++ G+KVA+K IKN + E ++ H
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKC-----IKNDATAQAFLAEASVMTQLRHS 60
Query: 78 HIIRLYEV-IETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCH 134
++++L V +E +Y+V EY+ G L DY+ +GR L D F + +EY
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 194
N VHRDL N+L+ K++DFGL+ T + APE + K +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKF- 177
Query: 195 GPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRML 252
+ DVWS G++L+ + G +P+ + ++ ++ KG P P +++
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW 237
Query: 253 IVDPMKRITIPEIRQH 268
+D R + ++R+
Sbjct: 238 HLDAAMRPSFLQLREQ 253
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 2e-69
Identities = 73/308 (23%), Positives = 124/308 (40%), Gaps = 47/308 (15%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
Y+ +G G+FG+V A H TG KVA+K + K REIKIL+L H
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHE 69
Query: 78 HIIRLYEVIETPS--------DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
+++ L E+ T + IY+V ++ + + E + Q +++G
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-----HFLKTSCGSPNYAA 184
+ Y HRN ++HRD+K N+L+ +K+ADFGL+ + + Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH----- 239
PE++ G+ GP +D+W G I+ + + + I ++
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 240 ---------------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
P A DLI ++L++DP +RI + H +F
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309
Query: 273 -AHLPRYL 279
+P L
Sbjct: 310 SDPMPSDL 317
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 218 bits (555), Expect = 6e-68
Identities = 78/287 (27%), Positives = 133/287 (46%), Gaps = 32/287 (11%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
+ Y + +G G++G V A++ G A+K + K ++ + REI IL+
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKELK 58
Query: 76 HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 135
H +I++LY+VI T + +V E++ V +G L+ A++F Q+++G+ YCH
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYA 194
V+HRDLKP+NLL++ + +KIADFGL+ + Y AP+V+ G
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 195 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------------- 235
+D+WS G I ++ GT F + + +I + T
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 236 ----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
L DL+ +ML +DP +RIT + +H +F+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 2e-67
Identities = 65/273 (23%), Positives = 121/273 (44%), Gaps = 17/273 (6%)
Query: 14 MFLPNYKLG---KTLGIGSFGKVKIAEHAL--TGHKVAIKILNRRKIKNMEMEEKVRREI 68
++L L K LG G+FG VK + + VA+KIL + + + +++++ E
Sbjct: 1 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEA 59
Query: 69 KILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIIS 128
+++ +P+I+R+ + E S +VME + G L Y+ + +++ Q+
Sbjct: 60 NVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 118
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS----CGSPNYAA 184
G++Y + VHRDL N+LL ++ KI+DFGLS +R + + A
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 185 PEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSP 242
PE I+ + + DVWS GV+++ G P+ + + KG P+
Sbjct: 179 PECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR 237
Query: 243 GARDLIPRMLIVDPMKRITIPEIR---QHPWFQ 272
DL+ D R + ++ ++
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 6e-67
Identities = 77/286 (26%), Positives = 135/286 (47%), Gaps = 32/286 (11%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
N++ + +G G++G V A + LTG VA+K + R + + REI +L+ HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHP 61
Query: 78 HIIRLYEVIETPSDIYVVMEYV-KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
+I++L +VI T + +Y+V E++ + + F + +++ Q++ G+ +CH +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAG 195
V+HRDLKP+NLL++++ +K+ADFGL+ + Y APE++ G Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 196 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-------------------- 235
VD+WS G I ++ F ++ + +I + T
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 236 ---------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
+ L R L+ +ML DP KRI+ HP+FQ
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 7e-67
Identities = 79/322 (24%), Positives = 122/322 (37%), Gaps = 46/322 (14%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+Y K +G GSFG V A+ +G VAIK + + K RE++I+R H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHC 73
Query: 78 HIIRLYEVIETPSD------IYVVMEYVKSG---ELFDYIVEKGRLQEDEARNFFQQIIS 128
+I+RL + + + +V++YV Y K L + + Q+
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 129 GVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187
+ Y H + HRD+KP+NLLLD +K+ DFG + + G + S Y APE+
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 188 ISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------ 235
I G +DVWS G +L LL G F ++ + +I + T
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 236 -----------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY 278
P A L R+L P R+T E H +F
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313
Query: 279 LAVPPPDTMQQAKKIDEEILKE 300
+ +P + L
Sbjct: 314 VKLPNGRDTPALFNFTTQELSS 335
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 8e-67
Identities = 92/300 (30%), Positives = 155/300 (51%), Gaps = 20/300 (6%)
Query: 5 SNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKI-KNMEM 60
+N + + + N++L K LG G++GKV + TG A+K+L + I + +
Sbjct: 12 ANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT 71
Query: 61 EEKVRREIKILRLFMH-PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEA 119
E R E ++L P ++ L+ +T + ++++++Y+ GELF ++ ++ R E E
Sbjct: 72 TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV 131
Query: 120 RNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSC 177
+ + +I+ +E+ H+ +++RD+K EN+LLDS +V + DFGLS + C
Sbjct: 132 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 191
Query: 178 GSPNYAAPEVISGKLYA-GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT- 235
G+ Y AP+++ G VD WS GV++Y LL G PF + N +I I
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251
Query: 236 ---LPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAHLPRYLA---VPPP 284
P +S A+DLI R+L+ DP KR+ EI++H +FQ LA VP P
Sbjct: 252 EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP 311
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 2e-66
Identities = 58/256 (22%), Positives = 113/256 (44%), Gaps = 11/256 (4%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+ K LG G FG VK + + VAIK++ + E++ E K++ H
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHE 59
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRN 136
+++LY V I+++ EY+ +G L +Y+ + R Q + + + +EY
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYA 194
+HRDL N L++ + VK++DFGLS + D + + ++ PEV+ +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF- 178
Query: 195 GPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRML 252
+ D+W+ GV+++ + G +P++ + I G+ P S ++
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238
Query: 253 IVDPMKRITIPEIRQH 268
+R T + +
Sbjct: 239 HEKADERPTFKILLSN 254
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 7e-66
Identities = 85/328 (25%), Positives = 143/328 (43%), Gaps = 49/328 (14%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
Y+ + +G G++G V A TG KVAIK L R ++ ++ RE+++L+ H +
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMRHEN 78
Query: 79 IIRLYEVIETPS------DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132
+I L +V D Y+VM ++ G +++ +L ED + Q++ G+ Y
Sbjct: 79 VIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL 192
H ++HRDLKP NL ++ +KI DFGL+ + + Y APEVI +
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA--DSEMTGYVVTRWYRAPEVILNWM 194
Query: 193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS-------------- 238
VD+WS G I+ ++ G F + + K+I T P+
Sbjct: 195 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 254
Query: 239 -----------------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ-AHLPRYLA 280
+ SP A +L+ +ML++D +R+T E HP+F+ H
Sbjct: 255 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP 314
Query: 281 VPPP--DTMQQAKKIDEE----ILKEVV 302
D+ + +E KEV+
Sbjct: 315 QVQKYDDSFDDVDRTLDEWKRVTYKEVL 342
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 9e-66
Identities = 70/269 (26%), Positives = 122/269 (45%), Gaps = 15/269 (5%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+ +L LG G FG+V + T +VAIK L E +E ++++ H
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK----PGTMSPEAFLQEAQVMKKLRHE 72
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHR 135
+++LY V+ + IY+V EY+ G L D++ + L+ + + QI SG+ Y R
Sbjct: 73 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLY 193
VHRDL+ N+L+ K+ADFGL+ ++ D + + APE +
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 194 AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM 251
+ DVWS G++L L G +P+ + +++ G P DL+ +
Sbjct: 192 -TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 250
Query: 252 LIVDPMKRITIPEIRQ--HPWFQAHLPRY 278
+P +R T ++ +F + P+Y
Sbjct: 251 WRKEPEERPTFEYLQAFLEDYFTSTEPQY 279
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 1e-65
Identities = 62/270 (22%), Positives = 111/270 (41%), Gaps = 20/270 (7%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMH 76
+ K +G G+FG+V A G ++ I ++ + + E+++L +L H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQEDEAR 120
P+II L E +Y+ +EY G L D++ + L +
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 121 NFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180
+F + G++Y + +HRDL N+L+ + KIADFGLS
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 190
Query: 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKI-KGGIYTLPS 238
+ A E ++ DVWS GV+L+ ++ G P+ L++K+ +G P
Sbjct: 191 RWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 249
Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
+ DL+ + P +R + +I
Sbjct: 250 NCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 2e-65
Identities = 68/286 (23%), Positives = 116/286 (40%), Gaps = 38/286 (13%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGH-----KVAIKILNRRKIKNMEMEEKVRREIKIL- 71
N + GK LG G+FGKV A +VA+K+L + + E + E+K++
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMT 95
Query: 72 RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-------------------- 111
+L H +I+ L IY++ EY G+L +Y+ K
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 112 ---GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168
L ++ F Q+ G+E+ VHRDL N+L+ VKI DFGL+ +
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 169 DG---HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPN 224
+ + APE + +Y + DVWS G++L+ + G P+ +
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 225 LFKKIKGGIYTL--PSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
F K+ + + P + + ++ D KR + P +
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 6e-65
Identities = 68/262 (25%), Positives = 105/262 (40%), Gaps = 13/262 (4%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLF 74
+ +L + LG GSFG V+ E K VA+K L + E + RE+ +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYC 133
H ++IRLY V+ TP + +V E G L D + + G + Q+ G+ Y
Sbjct: 69 DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVIS 189
+HRDL NLLL ++ VKI DFGL + + + APE +
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 190 GKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARD 246
+ + D W GV L+ + G P+ N + KI L P +
Sbjct: 188 TRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN 246
Query: 247 LIPRMLIVDPMKRITIPEIRQH 268
++ + P R T +R
Sbjct: 247 VMVQCWAHKPEDRPTFVALRDF 268
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 6e-65
Identities = 85/324 (26%), Positives = 145/324 (44%), Gaps = 44/324 (13%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
Y+ +G G++G V A TG +VA+K L R +++ ++ RE+++L+ H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 78 HIIRLYEVIETPS------DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVE 131
++I L +V D+Y+V + G + IV+ +L +D + QI+ G++
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 191
Y H ++HRDLKP NL ++ +KI DFGL+ + + Y APE++
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLNW 193
Query: 192 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL----------- 240
++ VD+WS G I+ LL G F + + K I + T + L
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 241 --------------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYL 279
+P A DL+ +ML++D KRIT + H +F Q H P
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 313
Query: 280 AVPPP-DTMQQAKKIDEEILKEVV 302
V P D +++ + + K +
Sbjct: 314 PVADPYDQSFESRDLLIDEWKSLT 337
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 7e-65
Identities = 71/275 (25%), Positives = 117/275 (42%), Gaps = 19/275 (6%)
Query: 13 DMFLP--NYKLGKT-LGIGSFGKVKIAEHALTGHK--VAIKILNRRKIKNMEMEEKVRRE 67
+FL N + LG G+FG V+ + + + VAIK+L ++ E++ RE
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMRE 59
Query: 68 IKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQI 126
+I+ +P+I+RL V + + + +VME G L ++V K + Q+
Sbjct: 60 AQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 118
Query: 127 ISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS----CGSPNY 182
G++Y VHRDL N+LL ++ KI+DFGLS + T+ +
Sbjct: 119 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 178
Query: 183 AAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIY-TLPSHL 240
APE I+ + + DVWS GV ++ L G P+ P + I+ G P
Sbjct: 179 YAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 237
Query: 241 SPGARDLIPRMLIVDPMKRITIPEIRQ---HPWFQ 272
P L+ I R + Q ++
Sbjct: 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (532), Expect = 2e-64
Identities = 69/290 (23%), Positives = 124/290 (42%), Gaps = 26/290 (8%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+ + LG G +G+V VA+K L ++ E+ +E +++ HP
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHP 73
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHR 135
++++L V Y++ E++ G L DY+ E R + QI S +EY +
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLY 193
+HRDL N L+ VK+ADFGLS +M + + + APE ++ +
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 194 AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM 251
+ DVW+ GV+L+ + G P+ ++ +++ ++ P +L+
Sbjct: 194 -SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 252
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEV 301
+P R + EI Q F+ TM Q I +E+ KE+
Sbjct: 253 WQWNPSDRPSFAEIHQ--AFE-------------TMFQESSISDEVEKEL 287
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 2e-64
Identities = 68/304 (22%), Positives = 126/304 (41%), Gaps = 10/304 (3%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR--RKIKNMEMEEKVRREIKILRLFMH 76
+K K LG G+FG V G KV I + + R+ + + +++ E ++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
PH+ RL + T + + L K + N+ QI G+ Y
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLY 193
+VHRDL N+L+ + +VKI DFGL+ ++ + + + A E I ++Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 194 AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRM 251
+ DVWS GV ++ L+ G+ P+D + ++ G P + ++ +
Sbjct: 191 -THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249
Query: 252 LIVDPMKRITIPEIRQHPWFQAHLP-RYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQ 310
++D R E+ A P RYL + + M D + ++ D +
Sbjct: 250 WMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEE-DMDD 308
Query: 311 LVES 314
+V++
Sbjct: 309 VVDA 312
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 2e-64
Identities = 61/256 (23%), Positives = 109/256 (42%), Gaps = 11/256 (4%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
+ +G G FG V + L KVAIK + + EE E +++ HP
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHP 60
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQ-EDEARNFFQQIISGVEYCHRN 136
+++LY V + I +V E+++ G L DY+ + L + + G+ Y
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSCGSPNYAAPEVISGKLYA 194
V+HRDL N L+ +K++DFG++ + D + +A+PEV S Y
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY- 179
Query: 195 GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRML 252
+ DVWS GV+++ + G +P+++ + + + I G P S ++
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239
Query: 253 IVDPMKRITIPEIRQH 268
P R + +
Sbjct: 240 KERPEDRPAFSRLLRQ 255
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 3e-64
Identities = 75/292 (25%), Positives = 127/292 (43%), Gaps = 39/292 (13%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHK-VAIKILNRRKIKNMEMEEKVRREIKILRL--- 73
Y+ +G G++GKV A G + VA+K + + + M RE+ +LR
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLET 66
Query: 74 FMHPHIIRLYEVIETPSD-----IYVVMEYVKSGEL-FDYIVEKGRLQEDEARNFFQQII 127
F HP+++RL++V + +V E+V + V + + + ++ Q++
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 128 SGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187
G+++ H + VVHRDLKP+N+L+ S +K+ADFGL+ I L + + Y APEV
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 186
Query: 188 ISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------ 235
+ Y VD+WS G I + F + + KI I
Sbjct: 187 LLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 236 ---------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
+ + +DL+ + L +P KRI+ HP+FQ
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 210 bits (534), Expect = 3e-64
Identities = 71/297 (23%), Positives = 129/297 (43%), Gaps = 51/297 (17%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMH 76
+Y+L + LG G + +V A + KV +KIL K ++K++REIKIL L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGG 89
Query: 77 PHIIRLYEVIETPSD--IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH 134
P+II L ++++ P +V E+V + + L + + R + +I+ ++YCH
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146
Query: 135 RNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 193
++HRD+KP N+++D + +++ D+GL+ G S + PE++
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206
Query: 194 AGPEVDVWSCGVILYALLCGTLPFDDEN--------------IPNLFKKIKGGIYTLP-- 237
+D+WS G +L +++ PF + +L+ I L
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 238 ----------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272
+SP A D + ++L D R+T E +HP+F
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 4e-64
Identities = 67/264 (25%), Positives = 121/264 (45%), Gaps = 15/264 (5%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
KL + LG G FG+V + + KVA+K L + + + E +++ H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQ 68
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHR 135
++RLY V+ T IY++ EY+++G L D++ +L ++ + QI G+ +
Sbjct: 69 RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSCGSPNYAAPEVISGKLY 193
+HRDL+ N+L+ + KIADFGL+ ++ D + + + APE I+
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-T 186
Query: 194 AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRM 251
+ DVWS G++L ++ G +P+ P + + ++ G P + L+
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246
Query: 252 LIVDPMKRITIPEIRQ--HPWFQA 273
P R T +R +F A
Sbjct: 247 WKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 6e-64
Identities = 73/290 (25%), Positives = 130/290 (44%), Gaps = 32/290 (11%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
Y+ + +G G++G V A++ T VA+K + R + + REI +L+ H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 61
Query: 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
+I+RL++V+ + + +V E+ + G L + ++F Q++ G+ +CH
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGP 196
V+HRDLKP+NLL++ +K+A+FGL+ + Y P+V+ G
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 197 EVDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYT-------------------- 235
+D+WS G I L P F ++ + K+I + T
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 236 ---------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276
+ L+ RDL+ +L +P++RI+ E QHP+F P
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (526), Expect = 2e-63
Identities = 62/263 (23%), Positives = 111/263 (42%), Gaps = 15/263 (5%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLF 74
K+ + +G G FG+V L G + VAIK L + + E I+ F
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQF 84
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYC 133
HP++I L V+ + + ++ E++++G L ++ + G+ + + I +G++Y
Sbjct: 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS------CGSPNYAAPEV 187
VHRDL N+L++S K++DFGLS + D T + APE
Sbjct: 145 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204
Query: 188 ISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGAR 245
I + + DVWS G++++ ++ G P+ D ++ I+ P
Sbjct: 205 IQYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH 263
Query: 246 DLIPRMLIVDPMKRITIPEIRQH 268
L+ D R +I
Sbjct: 264 QLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 2e-62
Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 12/259 (4%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLF 74
+LG+ +G G FG V + VAIK + + + EK +E +R F
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQF 65
Query: 75 MHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYC 133
HPHI++L VI T + ++++ME GEL ++ + L + Q+ + + Y
Sbjct: 66 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC--GSPNYAAPEVISGK 191
VHRD+ N+L+ S VK+ DFGLS M D + K S + APE I+ +
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 192 LYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIP 249
+ DVW GV ++ +L G PF ++ +I G +P + P L+
Sbjct: 185 RF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 243
Query: 250 RMLIVDPMKRITIPEIRQH 268
+ DP +R E++
Sbjct: 244 KCWAYDPSRRPRFTELKAQ 262
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-60
Identities = 84/337 (24%), Positives = 139/337 (41%), Gaps = 57/337 (16%)
Query: 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
L Y+ K +G G+ G V A A+ VAIK L R +N ++ RE+ +++
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVN 74
Query: 76 HPHIIRLYEVIETPS------DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISG 129
H +II L V D+Y+VME + + + L + Q++ G
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCG 131
Query: 130 VEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 189
+++ H ++HRDLKP N+++ S +KI DFGL+ + + Y APEVI
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 190 GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH---------- 239
G VD+WS G I+ ++ + F + + + K+ + T
Sbjct: 192 GM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 240 --------------------------------LSPGARDLIPRMLIVDPMKRITIPEIRQ 267
+ ARDL+ +ML++DP KRI++ + Q
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
Query: 268 HPWFQ-AHLPRYLAVPPP---DTMQQAKKIDEEILKE 300
HP+ + P + PPP D ++ E KE
Sbjct: 311 HPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKE 347
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (504), Expect = 3e-60
Identities = 65/284 (22%), Positives = 112/284 (39%), Gaps = 37/284 (13%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
N + + +G G+FG+V A VA+K+L ++ + +M+ +RE ++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMA 71
Query: 73 LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR------------------- 113
F +P+I++L V + ++ EY+ G+L +++
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 114 -----LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168
L E +Q+ +G+ Y VHRDL N L+ VKIADFGLS +
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 169 DGHFLKTS---CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL-PFDDENIPN 224
+ K + PE I Y E DVW+ GV+L+ + L P+
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 225 LFKKI-KGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
+ + G I P + +L+ P R + I +
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (489), Expect = 5e-58
Identities = 59/277 (21%), Positives = 97/277 (35%), Gaps = 29/277 (10%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78
Y+LG+ +G GSFG + + G +VAIK+ + ++ E KI ++
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGV 63
Query: 79 IIRLYEVIETPSD-IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM 137
I D +VME + + + Q+IS +EY H
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123
Query: 138 VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDG--------HFLKTSCGSPNYAAPE 186
+HRD+KP+N L+ V I DFGL+ RD K G+ YA+
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 187 VISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--------IYTLPS 238
G D+ S G +L G+LP+ +K + I L
Sbjct: 184 THLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQ---HPWFQ 272
+ + + +RQ + + +
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-57
Identities = 66/261 (25%), Positives = 113/261 (43%), Gaps = 14/261 (5%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRL 73
K +G G FG+V + K VAIK L + ++ E I+
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD--FLGEAGIMGQ 65
Query: 74 FMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEY 132
F H +IIRL VI + ++ EY+++G L ++ EK G + + I +G++Y
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG----HFLKTSCGSPNYAAPEVI 188
VHRDL N+L++S K++DFGLS ++ D + + APE I
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 189 SGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARD 246
S + + DVWS G++++ ++ G P+ + + + K I G P
Sbjct: 186 SYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQ 244
Query: 247 LIPRMLIVDPMKRITIPEIRQ 267
L+ + + +R +I
Sbjct: 245 LMMQCWQQERARRPKFADIVS 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 5e-57
Identities = 65/262 (24%), Positives = 114/262 (43%), Gaps = 15/262 (5%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHK---VAIKILNRRKIKNMEMEEKVRREIKILRLFM 75
+ +G G FG V K A+K LN +I ++ + E I++ F
Sbjct: 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFS 86
Query: 76 HPHIIRLYEV-IETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYC 133
HP+++ L + + + VV+ Y+K G+L ++I E + F Q+ G+++
Sbjct: 87 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 146
Query: 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-----HFLKTSCGSPNYAAPEVI 188
VHRDL N +LD K+ VK+ADFGL+ M D H + + A E +
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 189 SGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARD 246
+ + DVWS GV+L+ L+ G P+ D N ++ + +G P + +
Sbjct: 207 QTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 265
Query: 247 LIPRMLIVDPMKRITIPEIRQH 268
++ + R + E+
Sbjct: 266 VMLKCWHPKAEMRPSFSELVSR 287
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 5e-57
Identities = 73/280 (26%), Positives = 110/280 (39%), Gaps = 33/280 (11%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKIL- 71
GKTLG G+FGKV A VA+K+L + ++ E + E+K+L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKVLS 81
Query: 72 RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG------------------R 113
L H +I+ L V+ EY G+L +++ K
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 114 LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173
L ++ +F Q+ G+ + +HRDL N+LL KI DFGL+ +++
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 174 KTS---CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN--LFKK 228
+ APE I E DVWS G+ L+ L + +K
Sbjct: 202 VVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 229 IKGGIYTL-PSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
IK G L P H D++ DP+KR T +I Q
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-56
Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 32/280 (11%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALT-------GHKVAIKILNRRKIKNMEMEEKVRREIKI 70
LGK LG G+FG+V +AE KVA+K+L + + + E+++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEM 71
Query: 71 L-RLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI----------------VEKGR 113
+ + H +II L +YV++EY G L +Y+ + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 114 LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173
L + + Q+ G+EY +HRDL N+L+ +KIADFGL+ + +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 174 KTS---CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKI 229
K + + APE + ++Y + DVWS GV+L+ + G P+ + LFK +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 230 KGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
K G PS+ + ++ P +R T ++ +
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 5e-55
Identities = 61/281 (21%), Positives = 112/281 (39%), Gaps = 29/281 (10%)
Query: 18 NYKLGKTLGIGSFGKVKIAEH-----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
+ + LG GSFG V +VAIK +N + +M + E +++
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMK 78
Query: 73 LFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGR----------LQEDEARNF 122
F H++RL V+ V+ME + G+L Y+ +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 123 FQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS---CGS 179
+I G+ Y + N VHRDL N ++ + VKI DFG++ + + + +
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT-LPFDDENIPNLFKKI-KGGIYTLP 237
+ +PE + ++ DVWS GV+L+ + P+ + + + + +GG+ P
Sbjct: 199 VRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQ------HPWFQ 272
+ +L+ +P R + EI P F+
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 184 bits (467), Expect = 6e-55
Identities = 48/272 (17%), Positives = 96/272 (35%), Gaps = 28/272 (10%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH- 76
+YK+G+ +G GSFG + + L +VAIK RR ++R E + +L
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGC 60
Query: 77 PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136
I +Y + +V++ + + + +Q+++ V+ H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 137 MVVHRDLKPENLLLDSKW-----NVKIADFGLSNIMRDG--------HFLKTSCGSPNYA 183
+V+RD+KP+N L+ + + DFG+ RD K G+ Y
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK--------GGIYT 235
+ G+ D+ + G + L G+LP+ +K + +
Sbjct: 181 SINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239
Query: 236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
L + + + ++
Sbjct: 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 4e-53
Identities = 71/280 (25%), Positives = 112/280 (40%), Gaps = 32/280 (11%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILR 72
KLGK LG G+FG+V A+ T VA+K+L + E+KIL
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILI 71
Query: 73 LFMHPHIIRLYE--VIETPSDIYVVMEYVKSGELFDYIVEKGR----------------L 114
H + + + V++E+ K G L Y+ K L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 115 QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR---DGH 171
+ + Q+ G+E+ +HRDL N+LL K VKI DFGL+ + D
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT-LPFDDENIPNLFKKI- 229
+ + APE I ++Y + DVWS GV+L+ + P+ I F +
Sbjct: 192 RKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250
Query: 230 -KGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268
+G P + +P + +P +R T E+ +H
Sbjct: 251 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 2e-52
Identities = 53/294 (18%), Positives = 106/294 (36%), Gaps = 51/294 (17%)
Query: 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP 77
L +++G G FG+V + G +VA+KI + R+ ++ E EI + H
Sbjct: 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFRE----AEIYQTVMLRHE 57
Query: 78 HIIRLYEVIE----TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133
+I+ T + +++V +Y + G LFDY+ + + + SG+ +
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHL 116
Query: 134 H--------RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-----HFLKTSCGSP 180
H + + HRDLK +N+L+ IAD GL+ G+
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 181 NYAAPEVISGKLY-----AGPEVDVWSCGVILYALLCGTLPFD---------------DE 220
Y APEV+ + + D+++ G++ + + D
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 221 NIPNLFKKIKGGIY-------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267
++ + K + ++ + R+T I++
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (405), Expect = 4e-45
Identities = 75/354 (21%), Positives = 127/354 (35%), Gaps = 75/354 (21%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP- 77
Y L + LG G F V +A+ + VA+KI+ K+ E EIK+L+
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDAD 70
Query: 78 ----------HIIRLYEVIET--PSDIYVVMEYVKSG---ELFDYIVEKGRLQEDEARNF 122
HI++L + P+ ++VVM + G E + +
Sbjct: 71 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 123 FQQIISGVEYCH-RNMVVHRDLKPENLLLDS----KWNVKIADFGLSNIMRDGHFLKTSC 177
+Q++ G++Y H R ++H D+KPEN+L++ + ++I L N S
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE----------------- 220
+ Y +PEV+ G + G D+WS +++ L+ G F+ +
Sbjct: 191 QTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 221 ---------------------------NIPNL----FKKIKGGIYTLPSHLSPGARDLIP 249
NI L + + Y + D +
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309
Query: 250 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVK 303
ML +DP KR + HPW + L + PD D E V+
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGM-EEIRVPDRELYGSGSDIPGWFEEVR 362
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} Length = 127 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Score = 110 bits (277), Expect = 1e-29
Identities = 29/150 (19%), Positives = 44/150 (29%), Gaps = 55/150 (36%)
Query: 391 KWALGLQSRAHPREIMTEVLKALQELNVGWKKIGH---------YNMKCRWIPGISGHHE 441
KW G++ R EI+ V +ALQ + Y +K RW
Sbjct: 2 KWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKRE- 60
Query: 442 GMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQ------RVQ 495
E+QLY+ ++LD++
Sbjct: 61 --------------------------GKNTYAYIELQLYEVMPGCFMLDVKSNGYKDIYS 94
Query: 496 GPQ-------------FLFLDLCAAFLAQL 512
P+ F FLDLCA + +L
Sbjct: 95 HPERTADHGMDDLKSSFPFLDLCAMLVCKL 124
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (274), Expect = 6e-29
Identities = 23/107 (21%), Positives = 42/107 (39%), Gaps = 32/107 (29%)
Query: 392 WALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSN 451
W LG++S++ P +IM EV +A+++L+ WK + Y ++ R ++
Sbjct: 1 WHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTF----------- 49
Query: 452 HYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQ 498
K +QLY+ YLLD + +
Sbjct: 50 ---------------------SKMSLQLYQVDSRTYLLDFRSIDDEI 75
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} Length = 171 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Score = 107 bits (268), Expect = 8e-28
Identities = 41/186 (22%), Positives = 67/186 (36%), Gaps = 57/186 (30%)
Query: 360 IEPAVSPVAHRAPGFMDYQG-MGLRGQLPYE-----RKWALGLQSRAHPREIMTEVLKAL 413
I P P HRA M QG P +W G++SR++P ++M E+ AL
Sbjct: 10 ILPTSLPQIHRA--NMLAQGSPAASKISPLVTKKSKTRWHFGIRSRSYPLDVMGEIYIAL 67
Query: 414 QELNVGWKKIGH---YNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSP 470
+ L W K + +K RW + N ++N K P
Sbjct: 68 KNLGAEWAKPSEEDLWTIKLRWKYD--------IGNKTNTNE---------------KIP 104
Query: 471 NVVKFEVQLYKTRDEKYLLDLQRVQGPQ----------------------FLFLDLCAAF 508
+++K +QL++ YL+D + G + + FL L
Sbjct: 105 DLMKMVIQLFQIETNNYLVDF-KFDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKL 163
Query: 509 LAQLRV 514
+ +L V
Sbjct: 164 IMELAV 169
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.4 bits (226), Expect = 5e-22
Identities = 33/203 (16%), Positives = 64/203 (31%), Gaps = 39/203 (19%)
Query: 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKIL-----NRRKIKNMEMEEKVR-------- 65
+GK +G G V + +K + +K+K +
Sbjct: 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 66 --REIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFF 123
E + L+ + ++Y V+ME + + EL+ + +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRV-------RVENPDEVL 109
Query: 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYA 183
I+ V + +VH DL N+L+ + + I DF S + +
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG-------WREIL 161
Query: 184 APEVISGKLYA----GPEVDVWS 202
+V + Y E D+ S
Sbjct: 162 ERDVRNIITYFSRTYRTEKDINS 184
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 81.3 bits (201), Expect = 2e-19
Identities = 18/125 (14%), Positives = 44/125 (35%), Gaps = 33/125 (26%)
Query: 391 KWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHS 450
W++ S P ++M E+ K L N +++ + + C G
Sbjct: 10 TWSMKTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDG--------------- 54
Query: 451 NHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRD-EKYLLDLQRVQGPQFLFLDLCAAFL 509
+ N+V++E+++ K + +R+ G F ++ +
Sbjct: 55 -----------------HAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASKIA 97
Query: 510 AQLRV 514
+L++
Sbjct: 98 NELKL 102
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 515 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 100.0 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.57 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.15 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.09 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.95 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.84 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.87 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-64 Score=493.34 Aligned_cols=257 Identities=34% Similarity=0.709 Sum_probs=241.4
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
+++|++++.||+|+||+||+|+++.+|+.||+|++.+....+....+.+.+|+++++.++||||+++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999876555445567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
||||+||+|.+++.+.+.+++.+++.++.||++||+|||++||+||||||+|||++.++.+||+|||+|...... ...+
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~ 163 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTT 163 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCEE
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-cccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999876543 3456
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~d 255 (515)
.+||+.|+|||++.+..| ++++|||||||++|+|++|..||.+.+..++..++....+.+|..+|+++++||.+||+.|
T Consensus 164 ~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d 242 (263)
T d2j4za1 164 LCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 242 (263)
T ss_dssp TTEEGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred cCCCCcccCHHHHcCCCC-CchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCC
Confidence 789999999999999877 7999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHhcCcccccc
Q 010214 256 PMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 256 P~~Rpt~~eil~hp~f~~~ 274 (515)
|.+|||++|+++||||+..
T Consensus 243 p~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 243 PSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp GGGSCCHHHHHTCHHHHHH
T ss_pred HhHCcCHHHHHcCcCcCCc
Confidence 9999999999999999754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-63 Score=487.98 Aligned_cols=260 Identities=35% Similarity=0.676 Sum_probs=226.8
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
++++|++++.||+|+||+||+|+++.+|+.||||++++.... +..+.+.+|+++|++++||||+++++++.+++.+|+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 478999999999999999999999999999999999865432 234678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC---
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--- 171 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~--- 171 (515)
|||||+||+|.+++.+++.+++.+++.++.||++||+|||++||+||||||+|||++.++++||+|||+|.......
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999998765432
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH-HHHHHHhcCccC--CCCCCChhHHHHh
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYT--LPSHLSPGARDLI 248 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~-~~~~~i~~~~~~--~p~~~s~~~~~li 248 (515)
...+.+||+.|||||++.+..+++.++|||||||++|+|++|..||...+.. .....+...... .+..+|+++++||
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 3456789999999999998888778899999999999999999999775443 333333333322 2357899999999
Q ss_pred cccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 249 PRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
.+||+.||.+|||++|+++||||++.++
T Consensus 241 ~~~L~~dP~~R~t~~eil~hpwf~~~l~ 268 (271)
T d1nvra_ 241 HKILVENPSARITIPDIKKDRWYNKPLK 268 (271)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence 9999999999999999999999987654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-62 Score=490.07 Aligned_cols=257 Identities=34% Similarity=0.639 Sum_probs=236.4
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++++.||+|+||+||+|.++.+|+.||||++.+.........+.+.+|+++|++++||||+++++++++++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999998765544445678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC---Ccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFL 173 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~---~~~ 173 (515)
|||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... ...
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~ 167 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999876532 234
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCC
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~ 253 (515)
.+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..+++.+|..+.+.+|..+|+++++||.+||+
T Consensus 168 ~~~~GT~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 246 (288)
T d1uu3a_ 168 NSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 246 (288)
T ss_dssp --CCCCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSC
T ss_pred ccccCCccccCceeeccCCC-CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHcc
Confidence 56789999999999998887 78999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCHHH------HhcCcccccc
Q 010214 254 VDPMKRITIPE------IRQHPWFQAH 274 (515)
Q Consensus 254 ~dP~~Rpt~~e------il~hp~f~~~ 274 (515)
.||.+|||++| +++||||+..
T Consensus 247 ~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 247 LDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp SSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred CCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 99999999987 6889999865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-61 Score=492.87 Aligned_cols=258 Identities=36% Similarity=0.606 Sum_probs=242.7
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
+++|++++.||+|+||+||+|+++.||+.||||++.+.........+.+.+|+.+|+.++||||+++++++++++.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 57899999999999999999999999999999999876654445567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~~~ 174 (515)
||||+||+|.+++.+.+.++|..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... +....
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~ 163 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999987543 45566
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCC
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~ 254 (515)
+.+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+..++++.+..+.+.+|..+|+++++||.+||++
T Consensus 164 ~~~GT~~Y~aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~ 242 (337)
T d1o6la_ 164 TFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 242 (337)
T ss_dssp CCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred cceeCHHHhhhhhccCCCC-ChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhccC
Confidence 7899999999999999988 789999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCC-----HHHHhcCcccccc
Q 010214 255 DPMKRIT-----IPEIRQHPWFQAH 274 (515)
Q Consensus 255 dP~~Rpt-----~~eil~hp~f~~~ 274 (515)
||.+|++ ++|+++||||+..
T Consensus 243 dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 243 DPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp STTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred CchhhcccccccHHHHHcCcccccC
Confidence 9999994 8999999999753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-61 Score=485.90 Aligned_cols=259 Identities=41% Similarity=0.701 Sum_probs=218.5
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
+.+.+.|++.+.||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+.+|+.++||||+++++++++++.+
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 82 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHL 82 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 456788999999999999999999999999999999998765433 346788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC---CCCceEEeeccccccccc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD---SKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~---~~~~vKL~DFGls~~~~~ 169 (515)
|+|||||+||+|.++|.+++.+++.+++.++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|.....
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999999999999999999999999999999999999999999999999999995 578999999999998877
Q ss_pred CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCCChhHH
Q 010214 170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGAR 245 (515)
Q Consensus 170 ~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 245 (515)
+....+.+||+.|+|||++.+..| ++++|||||||++|+|++|..||.+.+..++...+..+...++ ..+|++++
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp ----------CTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CCeeeeeeeCccccCcHHHcCCCC-CcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 777788899999999999999887 7899999999999999999999999999999999988776554 57899999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+||.+||++||.+|||++|+++||||+..
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999999753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-60 Score=476.91 Aligned_cols=254 Identities=31% Similarity=0.504 Sum_probs=228.7
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||+||+|.++.+|+.||||++.+..... .+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 468999999999999999999999999999999997655433 46789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Cccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~~ 174 (515)
||||+||+|.+++.+ +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|...... ....
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence 999999999998754 57999999999999999999999999999999999999999999999999999877543 3456
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC---ccCCCCCCChhHHHHhccc
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~m 251 (515)
+.+||+.|+|||++.+..| ++++||||+||++|+|++|..||.+.+.......+... ....|..+|+++++||.+|
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 253 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHH
T ss_pred ccccCCCccChhhhcCCCC-CchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHH
Confidence 7789999999999999877 78999999999999999999999988876665555433 2345678999999999999
Q ss_pred CCCCCCCCCCHHHHhcCcccccc
Q 010214 252 LIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|+.||.+|||+.|+++||||+..
T Consensus 254 L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 254 LDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp TCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ccCChhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-60 Score=474.12 Aligned_cols=261 Identities=38% Similarity=0.665 Sum_probs=240.6
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh---HHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---EMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 89 (515)
+.+.++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|++++|||||+++++++++
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 85 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3456789999999999999999999999999999999987654332 2357899999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC----ceEEeeccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW----NVKIADFGLSN 165 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~----~vKL~DFGls~ 165 (515)
+.+|+|||||+||+|.++|.+++.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999998876 59999999999
Q ss_pred ccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCCC
Q 010214 166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLS 241 (515)
Q Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 241 (515)
....+....+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+..+....+......++ ..+|
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred hcCCCccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence 8887777788899999999999998877 7999999999999999999999999999999999988877655 5789
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+++++||++||+.||.+|||++|+++||||+..
T Consensus 245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-60 Score=481.40 Aligned_cols=256 Identities=33% Similarity=0.688 Sum_probs=240.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.+++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 57899999999999999999999999999999999876544444567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
||||+||+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..... ...+
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--~~~~ 160 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYT 160 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CBCC
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc--cccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999987654 3457
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~d 255 (515)
.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..++..++..+...+|+.+|++++++|.+||..|
T Consensus 161 ~~Gt~~Y~APE~l~~~~y-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d 239 (316)
T d1fota_ 161 LCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239 (316)
T ss_dssp CCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSC
T ss_pred ccCcccccCHHHHcCCCC-CchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhC
Confidence 899999999999998887 6899999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCC-----CHHHHhcCcccccc
Q 010214 256 PMKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 256 P~~Rp-----t~~eil~hp~f~~~ 274 (515)
|.+|+ |++++++||||+..
T Consensus 240 p~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 240 LSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp TTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHhccccchhhHHHHHcCcccccC
Confidence 99996 99999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-60 Score=468.30 Aligned_cols=254 Identities=32% Similarity=0.585 Sum_probs=219.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CCeEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--PSDIY 93 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~ 93 (515)
.++|++.+.||+|+||+||+|+++.||+.||+|++.+.... ....+.+.+|+++|++++||||+++++++.+ .+.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 36899999999999999999999999999999999876654 3456789999999999999999999999854 56689
Q ss_pred EEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCcEEECCCCceEEeecccc
Q 010214 94 VVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNM-----VVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~g-----IvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
+|||||+||+|.+++.+ ++.+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999864 467999999999999999999999876 999999999999999999999999999
Q ss_pred cccccC-CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-CCCCCCCh
Q 010214 165 NIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSP 242 (515)
Q Consensus 165 ~~~~~~-~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~ 242 (515)
.....+ ....+.+||+.|+|||++.+..| ++++|||||||++|+|+||..||.+.+..++..++..+.. .+|..+|+
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 240 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 240 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCH
T ss_pred eecccCCCccccCCCCcccCCHHHHcCCCC-ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCH
Confidence 887554 34567789999999999998877 7899999999999999999999999999999999887765 56788999
Q ss_pred hHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 243 GARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 243 ~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
++.+||.+||+.||.+|||++|+++|||+
T Consensus 241 ~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 241 ELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999999999999999999999999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-60 Score=471.68 Aligned_cols=253 Identities=28% Similarity=0.437 Sum_probs=227.1
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
+.|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+++|++++|||||++++++.+++.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 579999999999999999999999999999999976532 23467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Cccc
Q 010214 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~~ 174 (515)
|||+||+|.+++.+ .+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|...... ....
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence 99999999999876 456999999999999999999999999999999999999999999999999999765432 3345
Q ss_pred cCCCCCCccCCCccc-----CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---CCCCCCChhHHH
Q 010214 175 TSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGARD 246 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~-----~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~ 246 (515)
+.+||+.|+|||++. +..| +.++|||||||++|+|++|..||.+.+..+...++..+.. ..|..+|+++++
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred ccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 678999999999984 3334 7899999999999999999999999888888888877643 345688999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
||.+||+.||.+|||++|+++||||+.
T Consensus 248 li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 248 FLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHccCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999974
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3e-59 Score=463.44 Aligned_cols=260 Identities=39% Similarity=0.650 Sum_probs=237.2
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCC------hHHHHHHHHHHHHHHhCC-CCCccEEEEEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN------MEMEEKVRREIKILRLFM-HPHIIRLYEVIE 87 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~------~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~ 87 (515)
+.++|++.+.||+|+||+||+|+++.+|+.||||++.+..... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 4689999999999999999999999999999999998765432 123467889999999997 999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 88 ~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
+++.+|+|||||+||+|.++|..++++++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred ccCCccccCCCCCCccCCCcccC-----CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCC----
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS---- 238 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~-----~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~---- 238 (515)
..+......+||+.|+|||++.+ ....++++||||+||++|+|++|+.||.+.+.......+..+...++.
T Consensus 161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (277)
T d1phka_ 161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240 (277)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence 77766777899999999999863 223478999999999999999999999999999988888888765543
Q ss_pred CCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 239 ~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.+|+++++||.+||+.||.+|||++|+++||||++.
T Consensus 241 ~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 789999999999999999999999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.7e-60 Score=482.32 Aligned_cols=260 Identities=33% Similarity=0.621 Sum_probs=238.9
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.-+.++++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|++++|||||++++++++++
T Consensus 20 ~~~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 20 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp BCSCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred CCCCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 34567789999999999999999999999999999999997543 344678899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC--CCceEEeeccccccc
Q 010214 91 DIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS--KWNVKIADFGLSNIM 167 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~-~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~--~~~vKL~DFGls~~~ 167 (515)
.+|+|||||+||+|.+++. ..+++++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|...
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 9999999999999999995 4567999999999999999999999999999999999999964 578999999999988
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCCChh
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPG 243 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 243 (515)
.......+.+||+.|||||++.+..| +.++|||||||++|+|++|..||.+.+..+.+.+|....+.++ ..+|++
T Consensus 177 ~~~~~~~~~~gT~~Y~aPEv~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 255 (350)
T d1koaa2 177 DPKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255 (350)
T ss_dssp CTTSCEEEECSCTTTCCHHHHHTCCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred ccccccceecCcccccCHHHHcCCCC-ChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 77777788899999999999999887 7899999999999999999999999999999999988877665 368999
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+++||.+||+.||.+|||++|+++||||+..
T Consensus 256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-60 Score=477.72 Aligned_cols=258 Identities=35% Similarity=0.600 Sum_probs=236.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHH-hCCCCCccEEEEEEEcCCeEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~i 94 (515)
+++|++++.||+|+||+||+|.++.+|+.||||++.+.........+.+.+|+.++. .++||||+++++++.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 478999999999999999999999999999999998654433334456667777664 7899999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccc
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL 173 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~ 173 (515)
|||||+||+|.+++..++.+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||++...... ...
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~ 160 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 160 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999866543 344
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCC
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~ 253 (515)
...+||+.|+|||++.+..| ++++||||+||++|+|++|+.||.+.+..++..++..+.+.+|..+|+++++||.+||+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~ 239 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 239 (320)
T ss_dssp CCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSC
T ss_pred cccCCCCCcCCHHHHcCCCC-CchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhcc
Confidence 55789999999999999887 68999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCHH-HHhcCcccccc
Q 010214 254 VDPMKRITIP-EIRQHPWFQAH 274 (515)
Q Consensus 254 ~dP~~Rpt~~-eil~hp~f~~~ 274 (515)
+||.+|||+. |+++||||++.
T Consensus 240 ~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 240 REPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp SSGGGSBTTBSCGGGSGGGTTC
T ss_pred cCCCCCcCHHHHHHhCchhccC
Confidence 9999999995 89999999863
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-59 Score=479.85 Aligned_cols=258 Identities=31% Similarity=0.571 Sum_probs=237.8
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
.+.++|++++.||+|+||+||+|.++.+|+.||||++++.. ......+.+|+.+|++++|||||++++++++++.+|
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45678999999999999999999999999999999997653 234567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC--CCCceEEeecccccccccC
Q 010214 94 VVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD--SKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~--~~~~vKL~DFGls~~~~~~ 170 (515)
+|||||+||+|.+++.+.+ ++++.+++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|......
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999999999999886544 699999999999999999999999999999999999998 5789999999999998887
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCCChhHHH
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARD 246 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~ 246 (515)
....+.+||+.|+|||++.+..| +.++|||||||++|+|+||..||.+.+..+++..+..+.+.+| ..+|+++++
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred CceeeccCcccccCHHHHcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 77888899999999999998887 7899999999999999999999999999999999988876655 468999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
||.+||++||.+|||+.|+++||||+...
T Consensus 262 li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 99999999999999999999999998653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-59 Score=481.59 Aligned_cols=256 Identities=36% Similarity=0.653 Sum_probs=239.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
+++|++++.||+|+||+||+|+++.||+.||||++.+.........+.+.+|+++|+.++||||+++++++.+...+|+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 57999999999999999999999999999999999876554444567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
|||+.||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+..... ..+
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~ 197 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWT 197 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCC
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--ccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999876543 456
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~d 255 (515)
.+||+.|||||++.+..| ++++|||||||++|+|++|..||.+.+...+..+|..+...+|..+|+++.+||++||++|
T Consensus 198 ~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d 276 (350)
T d1rdqe_ 198 LCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276 (350)
T ss_dssp CEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSC
T ss_pred ccCccccCCHHHHcCCCC-CccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhhC
Confidence 789999999999999887 7899999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCC-----CHHHHhcCcccccc
Q 010214 256 PMKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 256 P~~Rp-----t~~eil~hp~f~~~ 274 (515)
|.+|+ |++|+++||||+..
T Consensus 277 P~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 277 LTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp TTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHhccccccccHHHHHcCccccCC
Confidence 99995 99999999999753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-59 Score=459.65 Aligned_cols=250 Identities=27% Similarity=0.522 Sum_probs=222.1
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc----CCeEEE
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----PSDIYV 94 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~i 94 (515)
|++.+.||+|+||+||+|.++.+++.||+|++...... ....+.+.+|+++|++++|||||++++++++ ...+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 47888999999999999999999999999999876543 3456789999999999999999999999865 356899
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEC-CCCceEEeecccccccccCC
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDLkpeNILl~-~~~~vKL~DFGls~~~~~~~ 171 (515)
|||||+||+|.+++.+.+.+++.+++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+... ..
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~-~~ 168 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-AS 168 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-TT
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc-CC
Confidence 9999999999999999999999999999999999999999998 99999999999996 57899999999997653 34
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC-ChHHHHHHHhcCcc--CCCCCCChhHHHHh
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIY--TLPSHLSPGARDLI 248 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~s~~~~~li 248 (515)
...+.+||+.|+|||++.+. | +.++|||||||++|+|++|+.||.+. +...+.+.+..+.. .++...++++++||
T Consensus 169 ~~~~~~GT~~Y~aPE~~~~~-~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li 246 (270)
T d1t4ha_ 169 FAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246 (270)
T ss_dssp SBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred ccCCcccCccccCHHHhCCC-C-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHH
Confidence 45678999999999999865 5 79999999999999999999999764 45566677766543 34567899999999
Q ss_pred cccCCCCCCCCCCHHHHhcCcccc
Q 010214 249 PRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
.+||+.||++|||++|+++||||+
T Consensus 247 ~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 247 EGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999999996
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-59 Score=472.90 Aligned_cols=258 Identities=26% Similarity=0.520 Sum_probs=238.3
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
.+.++|++++.||+|+||+||+|.++.||+.||||++++.. .....+.+|+++|+.++||||+++++++++++.+|
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 46789999999999999999999999999999999997653 23456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC--CceEEeecccccccccC
Q 010214 94 VVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK--WNVKIADFGLSNIMRDG 170 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~--~~vKL~DFGls~~~~~~ 170 (515)
+|||||+||+|.++|.+.+ .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999999999998665 79999999999999999999999999999999999999854 58999999999988777
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCC----CCChhHHH
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARD 246 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~ 246 (515)
....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..+...+|..+.+.+|. .+|+++++
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~-~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred CcccccccccccccchhccCCCC-CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence 77778899999999999998877 78999999999999999999999999999999999998877763 78999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
||.+||+.||.+|||++|+++||||++..+
T Consensus 237 li~~~L~~dp~~R~s~~eil~hp~~~~~~~ 266 (321)
T d1tkia_ 237 FVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhccCcc
Confidence 999999999999999999999999986544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-59 Score=470.46 Aligned_cols=254 Identities=27% Similarity=0.346 Sum_probs=230.3
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
.|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|++++|||||++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999988776666677889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCC
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC 177 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~ 177 (515)
||.||+|..++..++++++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|..... ..+.+
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~~~~ 172 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFV 172 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCCC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CCccc
Confidence 999999988888888999999999999999999999999999999999999999999999999999986644 34678
Q ss_pred CCCCccCCCcccCC--ccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC--CCCCCChhHHHHhcccCC
Q 010214 178 GSPNYAAPEVISGK--LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT--LPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 178 gt~~Y~aPE~i~~~--~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~mL~ 253 (515)
||+.|||||++.+. ..++.++|||||||++|+|++|..||.+.+..+...++..+... .+..+|+++++||.+||+
T Consensus 173 GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~ 252 (309)
T d1u5ra_ 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 252 (309)
T ss_dssp SCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTC
T ss_pred cCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCc
Confidence 99999999998653 22378999999999999999999999998887777777665443 245689999999999999
Q ss_pred CCCCCCCCHHHHhcCcccccc
Q 010214 254 VDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.||.+|||++|+++||||...
T Consensus 253 ~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 253 KIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp SSGGGSCCHHHHTTCHHHHSC
T ss_pred CChhHCcCHHHHHhCHHhcCC
Confidence 999999999999999999754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-60 Score=477.18 Aligned_cols=257 Identities=25% Similarity=0.450 Sum_probs=221.8
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|++++.||+|+||+||+|+++.+|+.||+|++++.. .......+.+|+.+|+.++|||||++++++.+++.+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34678999999999999999999999999999999997653 2345678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|....+. .
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~ 159 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M 159 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-T
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-c
Confidence 999999999999999999999999999999999999999997 59999999999999999999999999999876443 3
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHH-------------------------
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFK------------------------- 227 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~------------------------- 227 (515)
..+.+||+.|+|||++.+..| ++++||||+||++|+|++|+.||.+.+......
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCC-CTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred cccccCCccccCchHHcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 456799999999999999887 789999999999999999999997755332111
Q ss_pred -----------------HHhcC-ccCCC-CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 228 -----------------KIKGG-IYTLP-SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 228 -----------------~i~~~-~~~~p-~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.+... ....| ..+|+++++||.+||+.||.+|||++|+++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 11111 01112 2368899999999999999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-58 Score=476.46 Aligned_cols=258 Identities=28% Similarity=0.477 Sum_probs=227.6
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHH---HHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKV---RREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i---~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
+++|++++.||+|+||+||+|+++.||+.||||++.+...........+ .+|+++++.++|||||++++++++++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 5799999999999999999999999999999999976554333223333 3456777788899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
|+|||||+||+|.++|.+++.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|...... .
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-~ 161 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-K 161 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-C
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-c
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999876544 3
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH---HHHHHHhcCccCCCCCCChhHHHHhc
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---NLFKKIKGGIYTLPSHLSPGARDLIP 249 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~---~~~~~i~~~~~~~p~~~s~~~~~li~ 249 (515)
..+.+||+.|+|||++.+...+++++|||||||++|+|+||..||.+.+.. .+...+......+|..+|+++++||.
T Consensus 162 ~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 241 (364)
T d1omwa3 162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241 (364)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHH
T ss_pred ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHH
Confidence 456789999999999976544489999999999999999999999875433 44555666677888899999999999
Q ss_pred ccCCCCCCCCCC-----HHHHhcCcccccc
Q 010214 250 RMLIVDPMKRIT-----IPEIRQHPWFQAH 274 (515)
Q Consensus 250 ~mL~~dP~~Rpt-----~~eil~hp~f~~~ 274 (515)
+||++||.+||| ++|+++||||+..
T Consensus 242 ~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 242 GLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 999999999999 7999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-58 Score=452.84 Aligned_cols=253 Identities=34% Similarity=0.624 Sum_probs=226.2
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChH---HHHHHHHHHHHHHhCC--CCCccEEEEEEEcC
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---MEEKVRREIKILRLFM--HPHIIRLYEVIETP 89 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~---~~~~i~~Ei~il~~l~--hpnIv~l~~~~~~~ 89 (515)
+.++|++.+.||+|+||+||+|+++.+|+.||||++.+....... ...++.+|+.+|++++ ||||++++++++++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 457899999999999999999999999999999999876544321 2244678999999987 89999999999999
Q ss_pred CeEEEEEeccCC-CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCceEEeeccccccc
Q 010214 90 SDIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIM 167 (515)
Q Consensus 90 ~~~~iVmEy~~g-g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-~~~vKL~DFGls~~~ 167 (515)
+.+|+||||+.+ +++.+++.+++.+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|...
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 999999999976 688999999999999999999999999999999999999999999999985 479999999999865
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHH
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDL 247 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 247 (515)
.. ....+.+||+.|+|||++.+..+.+.++||||+||++|+|++|..||... ..+..+...++..+|+++++|
T Consensus 162 ~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~~~s~~~~~l 234 (273)
T d1xwsa_ 162 KD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHL 234 (273)
T ss_dssp CS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCCCHHHHHH
T ss_pred cc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCCCCCHHHHHH
Confidence 43 34567789999999999988877778899999999999999999999763 346667788899999999999
Q ss_pred hcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|.+||+.||.+|||++|+++||||++.
T Consensus 235 i~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 235 IRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-57 Score=461.81 Aligned_cols=254 Identities=35% Similarity=0.617 Sum_probs=221.6
Q ss_pred ccccCCCceEee-eecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHH-hCCCCCccEEEEEEEc-
Q 010214 12 VDMFLPNYKLGK-TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR-LFMHPHIIRLYEVIET- 88 (515)
Q Consensus 12 ~~~~~~~Y~i~~-~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~-~l~hpnIv~l~~~~~~- 88 (515)
-+.++++|.+.. .||+|+||+||+|.++.||+.||||++++. ..+.+|+.++. ..+||||++++++|++
T Consensus 6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 345678999874 699999999999999999999999998642 45778999865 5589999999999976
Q ss_pred ---CCeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCceEEee
Q 010214 89 ---PSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIAD 160 (515)
Q Consensus 89 ---~~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~---~~~vKL~D 160 (515)
...+|+|||||+||+|.++|.++ .+++|.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence 46699999999999999999875 36999999999999999999999999999999999999985 46799999
Q ss_pred cccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHH----HHHHHhcCccCC
Q 010214 161 FGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN----LFKKIKGGIYTL 236 (515)
Q Consensus 161 FGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~----~~~~i~~~~~~~ 236 (515)
||+++.........+.+||+.|+|||++.+..| ++++|||||||++|+|+||..||.+.+... +...+..+.+.+
T Consensus 158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y-~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~ 236 (335)
T d2ozaa1 158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236 (335)
T ss_dssp CTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGG-SHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred cceeeeccCCCccccccCCcccCCcHHHcCCCC-CHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence 999998877777788899999999999998887 789999999999999999999998765443 344455556666
Q ss_pred CC----CCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 237 PS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 237 p~----~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|. .+|+++++||.+||+.||.+|||+.|+++||||++.
T Consensus 237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 53 589999999999999999999999999999999764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-57 Score=454.35 Aligned_cols=254 Identities=28% Similarity=0.405 Sum_probs=217.6
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh--HHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010214 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM--EMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~--~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy 98 (515)
.++.||+|+||+||+|+++.+|+.||||++++...... .....+.+|+.+|+.++|||||++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 46889999999999999999999999999976543321 2245788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-CccccCC
Q 010214 99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSC 177 (515)
Q Consensus 99 ~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~ 177 (515)
+.|+++..++..++.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ....+.+
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 161 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV 161 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence 999887777766778999999999999999999999999999999999999999999999999999876543 3445678
Q ss_pred CCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC----------------------
Q 010214 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT---------------------- 235 (515)
Q Consensus 178 gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~---------------------- 235 (515)
||+.|+|||++.+..+++.++||||+||++|+|++|..||.+.+..+...+|......
T Consensus 162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (299)
T d1ua2a_ 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241 (299)
T ss_dssp CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence 9999999999976655589999999999999999999999998888877776532111
Q ss_pred ------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 236 ------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 236 ------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
....+++++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 013568899999999999999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-56 Score=446.51 Aligned_cols=257 Identities=30% Similarity=0.522 Sum_probs=220.0
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
+++|++++.||+|+||+||+|.++.+|+.||||++...... ....+.+.+|+++|++++||||+++++++.+++.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 47999999999999999999999999999999999765432 23357888999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCc
Q 010214 96 MEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHF 172 (515)
Q Consensus 96 mEy~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~ 172 (515)
|||+.+ .+.+++.. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..... ...
T Consensus 80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 999976 55555543 45699999999999999999999999999999999999999999999999999987654 344
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-----------------
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT----------------- 235 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~----------------- 235 (515)
....+||+.|+|||++....+.+.++||||+||++|+|++|+.||.+.+......++......
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 556789999999999988887789999999999999999999999988877665554321100
Q ss_pred -C-----------CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 236 -L-----------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 236 -~-----------p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
. ...+|+++++||.+||+.||.+|||++|+++||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0 12567899999999999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-55 Score=437.78 Aligned_cols=257 Identities=25% Similarity=0.424 Sum_probs=221.8
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC----
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS---- 90 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~---- 90 (515)
+.++|++.+.||+|+||+||+|+++.+|+.||||++.+....+......+.+|+++|+.++||||+++++++.+.+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 4678999999999999999999999999999999998877777777888999999999999999999999997654
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.+|+|||||+|++|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+......
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 38999999999999999999999999999999999999999999999999999999999999999999999998755332
Q ss_pred ----CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCC----CCCCCh
Q 010214 171 ----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL----PSHLSP 242 (515)
Q Consensus 171 ----~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~ 242 (515)
....+.+||+.|+|||++.+..| ++++||||+||++|+|+||.+||.+.+..+...++....... +..+|+
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 243 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243 (277)
T ss_dssp --------------TTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCH
T ss_pred cccccccccccCcccccCHHHHcCCCC-CcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 23456689999999999998877 789999999999999999999999998888777776655433 357899
Q ss_pred hHHHHhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 243 ~~~~li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
++.+||.+||++||.+||+..+.+.|+|.+
T Consensus 244 ~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 244 DLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 999999999999999999555555677764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-55 Score=439.29 Aligned_cols=256 Identities=30% Similarity=0.487 Sum_probs=221.4
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++++.||+|+||+||+|+++ +|+.||||++...... ....+.+.+|+.+|++++||||+++++++.+++..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 479999999999999999999986 8899999999766432 23457889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~ 174 (515)
|||+.++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+....... ...
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 9999887777777778889999999999999999999999999999999999999999999999999998765433 344
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc--------------------
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-------------------- 234 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-------------------- 234 (515)
...|++.|+|||.+.+..+.++++||||+||++|+|++|+.||.+.+..+...++.....
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 557999999999998877778999999999999999999999999887776666532111
Q ss_pred ---------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 235 ---------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 235 ---------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
..+..+++++++||++||++||++|||++|+++||||++
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 123467899999999999999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-55 Score=439.66 Aligned_cols=257 Identities=28% Similarity=0.443 Sum_probs=218.6
Q ss_pred CCCceEeeeecccCceEEEEEEEcCC-CcEEEEEEecccccCChHHHHHHHHHHHHHHhC---CCCCccEEEEEEEc---
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALT-GHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIRLYEVIET--- 88 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~t-g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l~~~~~~--- 88 (515)
.++|++++.||+|+||+||+|++..+ ++.||||++....... .....+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 47999999999999999999999766 5679999997654332 1223455777776655 79999999999853
Q ss_pred --CCeEEEEEeccCCCCHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 89 --PSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 89 --~~~~~iVmEy~~gg~L~~~i~-~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
...+|++|||+.++.+..... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 346899999998876654443 34569999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc------------
Q 010214 166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------ 233 (515)
Q Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~------------ 233 (515)
.........+.+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+..+...++....
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hhcccccCCCcccChhhcCcchhcCCCC-ChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 8777777788899999999999998887 789999999999999999999999988877776664311
Q ss_pred ---------------cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 234 ---------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 234 ---------------~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..++..+++++++||.+||+.||.+|||+.|+++||||++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 12345678999999999999999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=440.57 Aligned_cols=252 Identities=30% Similarity=0.394 Sum_probs=216.1
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc------CCe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET------PSD 91 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------~~~ 91 (515)
+|+..++||+|+||+||+|+++.+|+.||||++.+.... ..+|+++|++++||||+++++++.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 699999999999999999999999999999999765422 2479999999999999999999853 335
Q ss_pred EEEEEeccCCCCHHHH---HHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-ceEEeeccccccc
Q 010214 92 IYVVMEYVKSGELFDY---IVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIM 167 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~---i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~-~vKL~DFGls~~~ 167 (515)
+|+|||||+++.+... ......+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 8999999977533322 23456799999999999999999999999999999999999999775 8999999999988
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--------------
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------- 233 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------------- 233 (515)
..+....+.+||+.|+|||++.+...++.++||||+||++|+|++|..||...+......++....
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 777777888999999999998876666899999999999999999999999888776665553210
Q ss_pred ---cC------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 234 ---YT------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 234 ---~~------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
.. ....+++++.+||.+||+.||.+|||+.|+++||||++...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 01 12357899999999999999999999999999999987543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=425.43 Aligned_cols=259 Identities=27% Similarity=0.474 Sum_probs=227.5
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... ......++.+|+.+|+.++||||+++++++.++..+++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 3689999999999999999999999999999999976553 345678899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~ 174 (515)
||++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.+....... ...
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence 9999999999999888899999999999999999999999999999999999999999999999999998775433 334
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCC-CCCChHHHHHHHhcCc--------------------
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGI-------------------- 233 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf-~~~~~~~~~~~i~~~~-------------------- 233 (515)
...+++.|+|||++.+..+.+.++||||+||++|+|++|..|| .+.+..+...++....
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence 4567889999999988776689999999999999999999885 5566666665543211
Q ss_pred ---------cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 234 ---------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 234 ---------~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
...+..+++++.+||++||+.||.+|||++|+|+||||++..
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 112345788999999999999999999999999999998753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-54 Score=435.28 Aligned_cols=258 Identities=28% Similarity=0.444 Sum_probs=217.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc-------
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET------- 88 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------- 88 (515)
+++|++++.||+|+||+||+|+++.+|+.||||++.+..... .....+.+|+++|+.++||||+++++++.+
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 689999999999999999999999999999999997665432 344678899999999999999999999855
Q ss_pred -CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 89 -PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 89 -~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
+..+|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 3468999999988777666666778999999999999999999999999999999999999999999999999999765
Q ss_pred ccC-----CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCC----
Q 010214 168 RDG-----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS---- 238 (515)
Q Consensus 168 ~~~-----~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~---- 238 (515)
... ....+.+||+.|+|||++.+....++++||||+||++|+|++|..||.+.+.......+.......+.
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 432 23455689999999999987765589999999999999999999999988877766665443322221
Q ss_pred ----------------------------CCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 239 ----------------------------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 239 ----------------------------~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..++++++||.+||+.||++|||++|+++||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 136788999999999999999999999999999853
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-54 Score=427.54 Aligned_cols=246 Identities=25% Similarity=0.416 Sum_probs=213.4
Q ss_pred eeecccCceEEEEEEEc--CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccC
Q 010214 23 KTLGIGSFGKVKIAEHA--LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVK 100 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~ 100 (515)
+.||+|+||+||+|.+. .+++.||||++..... +....+.+.+|+++|++++|||||+++++++++ ..|+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 57999999999999865 3567899999975543 345567899999999999999999999999765 5789999999
Q ss_pred CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc----cccC
Q 010214 101 SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTS 176 (515)
Q Consensus 101 gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~~ 176 (515)
+|+|.+++.+...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 999999999989999999999999999999999999999999999999999999999999999987654322 2345
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcccCCC
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~~ 254 (515)
.||+.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+..++...+..+. ...|..+|+++.+||.+||+.
T Consensus 171 ~gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 78999999999988777 789999999999999998 999999998888888887764 577889999999999999999
Q ss_pred CCCCCCCHHHHh---cCccc
Q 010214 255 DPMKRITIPEIR---QHPWF 271 (515)
Q Consensus 255 dP~~Rpt~~eil---~hp~f 271 (515)
||.+|||+++++ +|+|+
T Consensus 250 dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHh
Confidence 999999999984 56554
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=433.45 Aligned_cols=257 Identities=32% Similarity=0.529 Sum_probs=215.2
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC----
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS---- 90 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~---- 90 (515)
+.++|++++.||+|+||+||+|.++.+|+.||||++.+.. .....+.+.+|+.+|+.++||||+++++++..+.
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 4578999999999999999999999999999999997543 3455678899999999999999999999996653
Q ss_pred -eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 91 -DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 91 -~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
.+|++ +|+.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 84 KDVYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp CCEEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred ceEEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 35555 55668999999964 5799999999999999999999999999999999999999999999999999987644
Q ss_pred CC----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-----------
Q 010214 170 GH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY----------- 234 (515)
Q Consensus 170 ~~----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~----------- 234 (515)
.. .....+||+.|+|||++.....+++++||||+||++|+|++|..||.+.+.............
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 32 345678999999999997666668999999999999999999999998776544443321100
Q ss_pred --------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 235 --------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 235 --------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
.....+|+++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 11246788999999999999999999999999999998653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-54 Score=437.73 Aligned_cols=256 Identities=30% Similarity=0.490 Sum_probs=217.2
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC---
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS--- 90 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~--- 90 (515)
.+.++|++++.||+|+||+||+|.++.+|+.||||++.+.. ......+.+.+|+++|+.++|||||++++++...+
T Consensus 15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 93 (346)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence 36789999999999999999999999999999999997654 34456788999999999999999999999997654
Q ss_pred ---eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 91 ---DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 91 ---~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
.+|+||||| |++|..++ +++++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|...
T Consensus 94 ~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 94 DFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp TCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 579999999 55777665 5678999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-------------
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------------- 234 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~------------- 234 (515)
.. ...+.+||+.|+|||++.+..+.+.++||||+||++|+|++|+.||.+.+.......+.....
T Consensus 172 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 172 DS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp CS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred CC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 43 346678999999999998877778999999999999999999999998876655444332111
Q ss_pred ------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 ------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 ------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..+..+++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 1234678999999999999999999999999999999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-54 Score=422.71 Aligned_cols=246 Identities=24% Similarity=0.478 Sum_probs=210.4
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||+||+|.++ +++.||||++++.... .+.+.+|++++++++||||+++++++.+++.+|+||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 58999999999999999999986 5778999999764433 357899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc--c
Q 010214 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--L 173 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~--~ 173 (515)
|||++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999999999998754 5689999999999999999999999999999999999999999999999999987654432 2
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhccc
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~m 251 (515)
....||+.|+|||++.+..| +.++||||+||++|||+| |.+||...+..++...+..+. ...|...++++.+|+.+|
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 238 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238 (263)
T ss_dssp -----CTTSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHH
T ss_pred cceecCcccCChHHhcCCCC-CchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHH
Confidence 34578999999999998887 789999999999999999 678888888888888887764 456778899999999999
Q ss_pred CCCCCCCCCCHHHHhcC
Q 010214 252 LIVDPMKRITIPEIRQH 268 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~h 268 (515)
|+.||.+|||++|+++|
T Consensus 239 l~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 239 WKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCCHhHCcCHHHHHHH
Confidence 99999999999999886
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.8e-54 Score=429.47 Aligned_cols=250 Identities=24% Similarity=0.424 Sum_probs=210.5
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCc---EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
.++|++.+.||+|+||+||+|.++.+|+ .||||.+.... .....+.+.+|+++|++++|||||++++++.+++.+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 4789999999999999999999987765 58899876433 334567899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|+|||||+||+|.+++... +.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999999999988864 579999999999999999999999999999999999999999999999999998765433
Q ss_pred ccc------cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChh
Q 010214 172 FLK------TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPG 243 (515)
Q Consensus 172 ~~~------~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 243 (515)
... ...||+.|+|||++.+..| +.++|||||||++|||+| |..||.+.+..++...+..+. .+.|..++++
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 261 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSA 261 (299)
T ss_dssp -------------CGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CcceeeecccccCCccccCHHHHhcCCC-CcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHH
Confidence 221 2357899999999998877 789999999999999998 899999999888888887664 5677889999
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+.+|+.+||+.||.+|||+.|++++
T Consensus 262 l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 262 LHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-54 Score=427.94 Aligned_cols=248 Identities=23% Similarity=0.408 Sum_probs=218.9
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
-.++|++.+.||+|+||+||+|.++.+|+.||||++++.... .+.+.+|+++|++++|||||++++++.+++.+|+
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 357899999999999999999999999999999998765432 4678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 95 VMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
|||||++|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999999999764 5689999999999999999999999999999999999999999999999999987754432
Q ss_pred c--ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCC-CCCCChHHHHHHHhcC-ccCCCCCCChhHHHHh
Q 010214 173 L--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGG-IYTLPSHLSPGARDLI 248 (515)
Q Consensus 173 ~--~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~P-f~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li 248 (515)
. ....||+.|+|||++.+..| +.++||||+||++|+|++|..| |.+.+...+.+.+..+ ....|..+++++.+||
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~-~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 249 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 249 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eeeccccccccccChHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHH
Confidence 2 23458899999999988877 7899999999999999996555 5666666666666655 3567788999999999
Q ss_pred cccCCCCCCCCCCHHHHhc
Q 010214 249 PRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~ 267 (515)
.+||+.||.+|||++|+++
T Consensus 250 ~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 250 RACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999965
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-54 Score=436.83 Aligned_cols=249 Identities=27% Similarity=0.438 Sum_probs=214.4
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCc-----EEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGH-----KVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPS 90 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~-----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~ 90 (515)
++|++++.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+|+++ +|||||++++++.+++
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 689999999999999999999876554 69999986543 223456788999999988 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHh-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010214 91 DIYVVMEYVKSGELFDYIVEK-----------------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPEN 147 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~-----------------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeN 147 (515)
.+|+|||||+||+|.++|.++ +.+++.+++.++.||+.||+|||++||+||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 999999999999999999754 248999999999999999999999999999999999
Q ss_pred EEECCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChH
Q 010214 148 LLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP 223 (515)
Q Consensus 148 ILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~ 223 (515)
||++.++++||+|||+|+....... ..+.+||+.|||||++.+..| ++++|||||||++|+|+| |..||.+.+..
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC-CcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999987654432 335678999999999988877 789999999999999997 89999987666
Q ss_pred HHHHHHhcC--ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 224 NLFKKIKGG--IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 224 ~~~~~i~~~--~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..+.++... ....|..+|+++++||.+||+.||++|||++||++|
T Consensus 274 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 555555443 345678899999999999999999999999999876
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-54 Score=425.51 Aligned_cols=252 Identities=26% Similarity=0.440 Sum_probs=220.4
Q ss_pred CCceEeee-ecccCceEEEEEEEcCC--CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 17 PNYKLGKT-LGIGSFGKVKIAEHALT--GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 17 ~~Y~i~~~-LG~G~fg~Vy~a~~~~t--g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
++|.+.+. ||+|+||+||+|.++.+ +..||||++++.. .....+.+.+|+++|++++|||||+++++++++ .+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEE
Confidence 57888885 99999999999987644 4579999997543 345567899999999999999999999999764 589
Q ss_pred EEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 94 VVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
+|||||+||+|.+++.. ++.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 99999999999999865 46799999999999999999999999999999999999999999999999999987654322
Q ss_pred ----cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHH
Q 010214 173 ----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARD 246 (515)
Q Consensus 173 ----~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 246 (515)
....+||+.|+|||++.+..+ +.++||||+||++|||+| |..||.+.+..++...+..+. ...|+.+|+++.+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 243 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 243 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccccccccCccccChHHHhCCCC-CccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 234578999999999988777 789999999999999998 999999988888888888764 5678899999999
Q ss_pred HhcccCCCCCCCCCCHHHH---hcCcccc
Q 010214 247 LIPRMLIVDPMKRITIPEI---RQHPWFQ 272 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~ei---l~hp~f~ 272 (515)
||.+||+.||.+|||+.++ |+|+|+.
T Consensus 244 li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 244 LMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999887 5678764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-54 Score=424.41 Aligned_cols=251 Identities=26% Similarity=0.486 Sum_probs=220.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||+||+|.++ +++.||||+++..... .+.+.+|+++|++++|||||++++++.+ +.+|+|
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 478999999999999999999986 6788999999764432 3578999999999999999999998754 567999
Q ss_pred EeccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--
Q 010214 96 MEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-- 171 (515)
Q Consensus 96 mEy~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-- 171 (515)
||||++|+|.+++.. ..++++.++..++.||+.||.|||++||+||||||+|||+++++.+||+|||+|+...+..
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999999999998754 3369999999999999999999999999999999999999999999999999998876543
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhc
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIP 249 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 249 (515)
......||+.|+|||++.+..+ +.++||||+||++|+|+| |.+||...+..+....+..+. ...|..+++++.+|+.
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 244 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHH
Confidence 2345679999999999987777 789999999999999999 566677777778888887764 5667889999999999
Q ss_pred ccCCCCCCCCCCHHHHhc--Cccccc
Q 010214 250 RMLIVDPMKRITIPEIRQ--HPWFQA 273 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~--hp~f~~ 273 (515)
+||+.||.+|||++|+++ |+||..
T Consensus 245 ~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 245 LCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 999999999999999998 788853
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=418.64 Aligned_cols=246 Identities=24% Similarity=0.448 Sum_probs=222.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++++.||+|+||+||+|+++ +++.||||++++.... .+.+.+|++++++++||||+++++++.+++.+|+||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 68999999999999999999985 7889999999875543 357889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc--c
Q 010214 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--L 173 (515)
Q Consensus 97 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~--~ 173 (515)
||+++|+|.+++.. ...+++..+++++.||++||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 99999999999764 56799999999999999999999999999999999999999999999999999987654433 2
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhccc
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~m 251 (515)
....||+.|+|||++.+..+ +.++||||+||++|||+| |+.||.+.+..++..++..+. ...|...++++.+||.+|
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~-~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 237 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC 237 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred cccCCCCCcCCcHHhcCCCC-CcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHH
Confidence 34678999999999998877 689999999999999998 899999999999988888764 466788999999999999
Q ss_pred CCCCCCCCCCHHHHhcC
Q 010214 252 LIVDPMKRITIPEIRQH 268 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~h 268 (515)
|+.||.+|||++++++|
T Consensus 238 l~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 238 WHEKADERPTFKILLSN 254 (258)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCCHhHCcCHHHHHHH
Confidence 99999999999999987
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-54 Score=425.16 Aligned_cols=248 Identities=25% Similarity=0.403 Sum_probs=207.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||+||+|+++ ..||||+++...... ...+.+.+|+.+|++++|||||++++++. ...+|+|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEE
Confidence 478999999999999999999753 469999997654433 45678999999999999999999999864 4568999
Q ss_pred EeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC---C
Q 010214 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---H 171 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~---~ 171 (515)
||||+||+|.+++... +++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... .
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999999999999754 57999999999999999999999999999999999999999999999999999876432 2
Q ss_pred ccccCCCCCCccCCCcccCCc--cCCCcceeehhHHHHHHHHhCCCCCCCCChHHH-HHHHhcCcc-----CCCCCCChh
Q 010214 172 FLKTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVILYALLCGTLPFDDENIPNL-FKKIKGGIY-----TLPSHLSPG 243 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~--~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~-~~~i~~~~~-----~~p~~~s~~ 243 (515)
...+.+||+.|||||++.+.. ..+.++||||+||++|||+||+.||.+.+.... ...+..+.. ..+..++++
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 241 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHH
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHH
Confidence 345678999999999997532 237899999999999999999999988665443 344443322 345678999
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+.+|+.+||..||.+|||+.|++++
T Consensus 242 l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 242 MKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=431.06 Aligned_cols=258 Identities=33% Similarity=0.575 Sum_probs=225.7
Q ss_pred CCCceEeeeecccCceEEEEEEE---cCCCcEEEEEEecccccC-ChHHHHHHHHHHHHHHhCCC-CCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEH---ALTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLFMH-PHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~---~~tg~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l~h-pnIv~l~~~~~~~~ 90 (515)
+++|++++.||+|+||+||+|.+ +.+|+.||||++++.... +....+.+.+|+++|++++| |||++++++++++.
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 58899999999999999999997 447899999999765432 22234667899999999987 89999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD- 169 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~- 169 (515)
.+|++|||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+..
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999987643
Q ss_pred -CCccccCCCCCCccCCCcccCCc-cCCCcceeehhHHHHHHHHhCCCCCCCCChHH----HHHHHhcCccCCCCCCChh
Q 010214 170 -GHFLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENIPN----LFKKIKGGIYTLPSHLSPG 243 (515)
Q Consensus 170 -~~~~~~~~gt~~Y~aPE~i~~~~-~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~~ 243 (515)
.....+.+|++.|+|||.+.+.. +.+.++|||||||+||+|++|..||.+.+... +..........+|..+|++
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 262 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 262 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHH
Confidence 33345678999999999997654 34789999999999999999999998765443 3444455567788899999
Q ss_pred HHHHhcccCCCCCCCCC-----CHHHHhcCccccc
Q 010214 244 ARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQA 273 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rp-----t~~eil~hp~f~~ 273 (515)
+.+||++||++||.+|| |++|+++||||+.
T Consensus 263 ~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 99999999999999999 5899999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.4e-53 Score=427.43 Aligned_cols=250 Identities=27% Similarity=0.486 Sum_probs=214.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcC--CeE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETP--SDI 92 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~ 92 (515)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. .+++.+|+.+|+.++ ||||+++++++... ..+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 468999999999999999999999999999999986533 357889999999996 99999999999754 569
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-ceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~-~vKL~DFGls~~~~~~~ 171 (515)
|+|||||.+++|..+ .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.....+.
T Consensus 108 ~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 108 ALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999999999775 35799999999999999999999999999999999999998655 69999999999888777
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH-HHHHHHhc-------------Ccc---
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKG-------------GIY--- 234 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~-~~~~~i~~-------------~~~--- 234 (515)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..||...... .....+.. ...
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 7788899999999999987765689999999999999999999999765432 11111110 000
Q ss_pred ---------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 ---------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 ---------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.....+|+++.+||++||++||.+|||++|+|+||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 0112478899999999999999999999999999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-53 Score=432.77 Aligned_cols=255 Identities=31% Similarity=0.523 Sum_probs=207.3
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc------
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET------ 88 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------ 88 (515)
+.++|++++.||+|+||+||+|.++.||+.||||++.+... +.....++.+|+.+|++++||||+++++++..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 45889999999999999999999999999999999977654 44566789999999999999999999999953
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
.+.+|+|||||.|+ +.+.+ ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++....
T Consensus 94 ~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 94 FQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp CCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence 47899999999764 55544 4579999999999999999999999999999999999999999999999999998887
Q ss_pred cCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-------------
Q 010214 169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------- 235 (515)
Q Consensus 169 ~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~------------- 235 (515)
........+||+.|+|||++.+..+ ++++||||+||++|+|++|+.||.+.+......++......
T Consensus 171 ~~~~~~~~~~t~~y~aPE~l~~~~~-~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 171 TSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp ----------CCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred cccccccccccccccChhhhcCCCC-CCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 7777778899999999999998876 78999999999999999999999988766655554321110
Q ss_pred ---------C--------------C------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 236 ---------L--------------P------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 236 ---------~--------------p------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
. + ...|+++.+||++||..||.+|||++|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0 0 1236788999999999999999999999999999875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=428.76 Aligned_cols=255 Identities=28% Similarity=0.436 Sum_probs=218.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----C
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP-----S 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 90 (515)
-++|++++.||+|+||+||+|.++.+|+.||||++.+.. .+....+++.+|+.+|+.++||||+++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 578999999999999999999999999999999998654 3445567889999999999999999999998643 2
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
..+++|+|+.||+|.+++. .+++++.+++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-- 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-- 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT--
T ss_pred ceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC--
Confidence 3456677778999999885 4679999999999999999999999999999999999999999999999999987653
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCC--------------
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL-------------- 236 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~-------------- 236 (515)
....+.+||+.|+|||++.+..+.+.++||||+||++|+|++|..||.+.+.......+.......
T Consensus 173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 252 (348)
T d2gfsa1 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252 (348)
T ss_dssp GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence 334667899999999998887777899999999999999999999999988777666664432211
Q ss_pred -----------------CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 237 -----------------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 237 -----------------p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
...+++++++||.+||+.||.+|||+.|+|+||||++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 13578999999999999999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=414.55 Aligned_cols=249 Identities=28% Similarity=0.468 Sum_probs=209.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCC---cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
.++|++++.||+|+||+||+|.+..++ ..||||.+... ......+.+.+|+.+|++++||||+++++++. ++.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 368999999999999999999987554 46889987543 34455678999999999999999999999985 5678
Q ss_pred EEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|+||||+++|+|.+++.. .+.+++..++.++.||++||.|||++||+||||||+||+++.++.+||+|||+|+......
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 999999999999998765 4579999999999999999999999999999999999999999999999999998765433
Q ss_pred c--cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHH
Q 010214 172 F--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL 247 (515)
Q Consensus 172 ~--~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 247 (515)
. ....+||+.|+|||++.+..| +.++|||||||++|+|+| |.+||.+.+..++...+..+. .+.|+.+|+++.+|
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~-~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 241 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 241 (273)
T ss_dssp --------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceeccceecCcccchhhHhccCCC-CCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 2 334568999999999988777 789999999999999998 899999999988888888775 56788999999999
Q ss_pred hcccCCCCCCCCCCHHHHhcC
Q 010214 248 IPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~h 268 (515)
|.+||+.||.+|||+.|+++|
T Consensus 242 i~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 242 MTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-52 Score=413.02 Aligned_cols=256 Identities=27% Similarity=0.472 Sum_probs=217.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||+||+|.++.+ +.||||++...... .+.+.+|+.+|++++|||||++++++. .+.+|+|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv 89 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 89 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEE
Confidence 58999999999999999999999755 57999999755432 367899999999999999999999985 4568999
Q ss_pred EeccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--
Q 010214 96 MEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-- 171 (515)
Q Consensus 96 mEy~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-- 171 (515)
||||++|+|..++.. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....+.
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 999999999998854 4579999999999999999999999999999999999999999999999999998765433
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhC-CCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhc
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIP 249 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG-~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 249 (515)
.....+||+.|+|||++.+..+ +.++||||+||++|+|+|| .+||......++...+..+. .+.|..+++++++||.
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 248 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 248 (285)
T ss_dssp ------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred eeccccccccccChHHHhCCCC-CcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHH
Confidence 2334679999999999988777 7899999999999999994 56667777777888877653 5678899999999999
Q ss_pred ccCCCCCCCCCCHHHHhc--CcccccccCcc
Q 010214 250 RMLIVDPMKRITIPEIRQ--HPWFQAHLPRY 278 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~--hp~f~~~~~~~ 278 (515)
+||+.||++|||++++++ ++||....|.+
T Consensus 249 ~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~ 279 (285)
T d1fmka3 249 QCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 279 (285)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred HHcccCHhHCcCHHHHHHHHhhhhcCCCCCC
Confidence 999999999999999988 88887664443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=407.17 Aligned_cols=249 Identities=26% Similarity=0.399 Sum_probs=210.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCC----cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTG----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
-..|++.+.||+|+||+||+|.++.++ ..||||+++... .......+.+|+++|++++|||||++++++.+.+.
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 357999999999999999999987665 479999986543 33445678999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 92 IYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
+++|||||.+|+|.+++... +.+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999999999988754 57999999999999999999999999999999999999999999999999999876543
Q ss_pred C----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhC-CCCCCCCChHHHHHHHhcCc-cCCCCCCChhH
Q 010214 171 H----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGA 244 (515)
Q Consensus 171 ~----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG-~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 244 (515)
. ......||+.|+|||++.+..+ +.++|||||||++|||++| .+||...+..++...+..+. .+.|..+++++
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 242 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 242 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHH
T ss_pred CccceEeccCCCCccccCHHHHccCCC-CCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHH
Confidence 2 1223468999999999998877 7899999999999999995 55666677777777777663 46677899999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.+||.+||+.||.+|||+.|+++
T Consensus 243 ~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 243 YQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHCcCCHhHCcCHHHHHH
Confidence 99999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=416.82 Aligned_cols=249 Identities=25% Similarity=0.402 Sum_probs=213.8
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCc----EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
.+|++++.||+|+||+||+|.+..+|+ +||+|.+.... .....+.+.+|+++|++++|||||++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 579999999999999999999988886 57888775432 223457889999999999999999999999875 56
Q ss_pred EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
+++|||+.+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 7888999999999988764 579999999999999999999999999999999999999999999999999998765433
Q ss_pred c---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHH
Q 010214 172 F---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARD 246 (515)
Q Consensus 172 ~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 246 (515)
. .....||+.|+|||++.+..| +.++|||||||++|||+| |.+||.+.+..++...+..+. .+.|..+++++.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 2 234468999999999988877 789999999999999998 899999988888888887765 5678899999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHP 269 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp 269 (515)
|+.+||+.||.+|||+.|+++|.
T Consensus 245 li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHHH
Confidence 99999999999999999999884
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-52 Score=415.76 Aligned_cols=249 Identities=25% Similarity=0.426 Sum_probs=218.1
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcE--EEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHK--VAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~--vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 93 (515)
++|++.+.||+|+||+||+|+++.+|.. ||||.+.... ..+..+.+.+|+++|+++ +||||+++++++.+.+.+|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 6999999999999999999999988875 6677765332 333456789999999998 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceE
Q 010214 94 VVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK 157 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vK 157 (515)
+||||++||+|.++|..+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceE
Confidence 999999999999999754 5699999999999999999999999999999999999999999999
Q ss_pred EeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhC-CCCCCCCChHHHHHHHhcC-ccC
Q 010214 158 IADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPNLFKKIKGG-IYT 235 (515)
Q Consensus 158 L~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG-~~Pf~~~~~~~~~~~i~~~-~~~ 235 (515)
|+|||++............+||+.|+|||.+.+..| +.++|||||||++|+|++| .+||.+.+..++...+..+ ...
T Consensus 168 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~ 246 (309)
T d1fvra_ 168 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246 (309)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC
T ss_pred EccccccccccccccccceecCCcccchHHhccCCC-CccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 999999987766555566789999999999998877 7899999999999999996 5689999999988888775 456
Q ss_pred CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 236 ~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.|..+++++.+||.+||+.||++|||+.|+++|
T Consensus 247 ~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 778899999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-52 Score=408.47 Aligned_cols=249 Identities=27% Similarity=0.422 Sum_probs=207.4
Q ss_pred CCceEeeeecccCceEEEEEEEcC-CC--cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHAL-TG--HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~-tg--~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
++|++.+.||+|+||.||+|++.. ++ ..||||++.+.........+.+.+|+.+|++++||||+++++++.++ .++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 679999999999999999998653 33 36899999877766666778899999999999999999999999764 678
Q ss_pred EEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 94 VVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
+|||||++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence 99999999999998765 45799999999999999999999999999999999999999999999999999987644322
Q ss_pred ----cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCcc--CCCCCCChhHH
Q 010214 173 ----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY--TLPSHLSPGAR 245 (515)
Q Consensus 173 ----~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~ 245 (515)
.....|++.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+..+...++..... +.|..+|+++.
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 245 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY 245 (273)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHH
T ss_pred cceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHH
Confidence 234467889999999998876 789999999999999998 8999999999998888876644 55678999999
Q ss_pred HHhcccCCCCCCCCCCHHHHhc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+||.+||..||++|||+.||++
T Consensus 246 ~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 246 NVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-51 Score=409.37 Aligned_cols=249 Identities=25% Similarity=0.384 Sum_probs=220.0
Q ss_pred CCCceEeeeecccCceEEEEEEEc-----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.++|++.+.||+|+||+||+|+++ .+++.||||+++... .....+.+.+|+.+|+.++||||+++++++.+.+
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 468999999999999999999975 356789999987543 3445678999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG------------------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPE 146 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~------------------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpe 146 (515)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 9999999999999999997532 3889999999999999999999999999999999
Q ss_pred cEEECCCCceEEeecccccccccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCC-CCCCCCCh
Q 010214 147 NLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT-LPFDDENI 222 (515)
Q Consensus 147 NILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~-~Pf~~~~~ 222 (515)
|||++.++.+||+|||+|....+.. ...+.+||+.|+|||.+.+..| ++++|||||||++|||++|. +||.+.+.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCC-ChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 9999999999999999998764432 2345679999999999998877 68999999999999999985 78999999
Q ss_pred HHHHHHHhcCcc-CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 223 PNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 223 ~~~~~~i~~~~~-~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.++...+..+.. ..|..+++++.+||.+||+.||.+|||+.||++
T Consensus 249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 998888888764 467889999999999999999999999999954
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=402.34 Aligned_cols=243 Identities=26% Similarity=0.507 Sum_probs=208.6
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEE-cCCeEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE-TPSDIYV 94 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~i 94 (515)
.++|++.+.||+|+||.||+|.+ +|..||||+++++. ..+.+.+|++++++++||||+++++++. .++.+|+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence 57899999999999999999998 47899999986543 3467899999999999999999999884 4566899
Q ss_pred EEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 95 VMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
||||+++|+|.+++.+++ .+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.... .
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~--~ 156 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--T 156 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC--C
Confidence 999999999999997543 589999999999999999999999999999999999999999999999999986543 2
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhcc
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~ 250 (515)
..+..+|+.|+|||++.+..+ ++++|||||||++|||+| |.+||...+..++...+..+ ..++|..+++++.+||.+
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 235 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN 235 (262)
T ss_dssp -----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHH
T ss_pred CccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence 345678999999999988776 799999999999999998 89999999888888888765 457788899999999999
Q ss_pred cCCCCCCCCCCHHHHhcC
Q 010214 251 MLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~h 268 (515)
||..||.+|||+.+++++
T Consensus 236 cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 236 CWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcccCHhHCcCHHHHHHH
Confidence 999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=404.97 Aligned_cols=249 Identities=28% Similarity=0.478 Sum_probs=215.6
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCC-------cEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTG-------HKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIE 87 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg-------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~ 87 (515)
.++|++++.||+|+||.||+|++..++ ..||||++++.. .......+.+|...++++ +||||+++++++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 579999999999999999999986654 479999987543 234456788888888777 7999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC
Q 010214 88 TPSDIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD 151 (515)
Q Consensus 88 ~~~~~~iVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~ 151 (515)
++..+|+|||||++|+|.++|... ..+++.+++.++.||+.||+|||+++|+||||||+|||++
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 999999999999999999999754 3589999999999999999999999999999999999999
Q ss_pred CCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHH
Q 010214 152 SKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFK 227 (515)
Q Consensus 152 ~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~ 227 (515)
.++.+||+|||++........ ....+||+.|+|||.+.+..| ++++|||||||++|+|++ |.+||.+.+..+++.
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y-~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC-CchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 999999999999987755432 344679999999999988877 799999999999999998 799999999988888
Q ss_pred HHhcC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 228 KIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 228 ~i~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.+..+ ....|..+++++.+||.+||+.||.+|||+.|+++
T Consensus 249 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 88765 45678899999999999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-51 Score=406.27 Aligned_cols=250 Identities=29% Similarity=0.445 Sum_probs=202.5
Q ss_pred CCCceEeeeecccCceEEEEEEEcC-----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~ 89 (515)
.++|++++.||+|+||+||+|.+.. +++.||||++.... .......+.+|..++.++ +||||+++++++.++
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 3789999999999999999999754 45689999986543 233456677777777666 689999999997654
Q ss_pred -CeEEEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC
Q 010214 90 -SDIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS 152 (515)
Q Consensus 90 -~~~~iVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~ 152 (515)
..+++|||||++|+|.+++... ..+++.+++.++.||++||+|||++||+||||||+|||++.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 5689999999999999999753 24899999999999999999999999999999999999999
Q ss_pred CCceEEeecccccccccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhC-CCCCCCCChHH-HHH
Q 010214 153 KWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPN-LFK 227 (515)
Q Consensus 153 ~~~vKL~DFGls~~~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG-~~Pf~~~~~~~-~~~ 227 (515)
++++||+|||+|+...... ...+.+||+.|+|||++.+..+ +.++||||+||++|+|++| ..||.+..... ...
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999998654332 2345679999999999998877 7899999999999999986 57888765444 344
Q ss_pred HHhcC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 228 KIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 228 ~i~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.+..+ ....|..+++++.+||.+||+.||.+|||+.|+++|
T Consensus 249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44443 456778899999999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=400.72 Aligned_cols=249 Identities=23% Similarity=0.372 Sum_probs=220.7
Q ss_pred CCCceEeeeecccCceEEEEEEEcC-----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.++|++++.||+|+||+||+|.++. +++.||||++++.. .......+.+|+.++++++||||+++++++..+.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 4899999999999999999998853 45789999997543 3345567899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEee
Q 010214 91 DIYVVMEYVKSGELFDYIVEK----------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~----------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~D 160 (515)
..++|||||++|+|.+++... ..+++..+..++.|+++||.|||+++|+||||||+|||++.++++||+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEee
Confidence 999999999999999998743 2478999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhC-CCCCCCCChHHHHHHHhcCc-cC
Q 010214 161 FGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPNLFKKIKGGI-YT 235 (515)
Q Consensus 161 FGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG-~~Pf~~~~~~~~~~~i~~~~-~~ 235 (515)
||+++....... ....+||+.|+|||.+.+..+ +.++||||+||++|+|+|| .+||.+.+..+.+..+.++. ..
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~-~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~ 255 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCC-CcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 999987654322 344578999999999998877 6899999999999999997 58999999888888887765 45
Q ss_pred CCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 236 ~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.|..+++.+.+||.+||+.||.+|||+.++++
T Consensus 256 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 67889999999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=396.77 Aligned_cols=249 Identities=30% Similarity=0.470 Sum_probs=215.1
Q ss_pred CCCceEeeeecccCceEEEEEEEc-----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~ 89 (515)
.++|++++.||+|+||.||+|++. .+++.||||++++.. .......+.+|+.+++.+ +|||||++++++.++
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 489999999999999999999863 467799999997543 334567789999999999 699999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKG------------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD 151 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~------------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~ 151 (515)
..+|+|||||++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 99999999999999999997643 589999999999999999999999999999999999999
Q ss_pred CCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHH
Q 010214 152 SKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFK 227 (515)
Q Consensus 152 ~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~ 227 (515)
.++.+||+|||++........ ....+||+.|+|||++.+..+ +.++|||||||++|+|+| |.+||...+....+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999987654322 234578999999999987766 789999999999999998 677777766655544
Q ss_pred HH-hcC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 228 KI-KGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 228 ~i-~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
++ ..+ ....|..+++++.+||.+||+.||.+|||++||++
T Consensus 259 ~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 44 333 34556789999999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-48 Score=388.56 Aligned_cols=246 Identities=25% Similarity=0.369 Sum_probs=206.1
Q ss_pred eEeeeecccCceEEEEEEEcCCC---cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc-CCeEEEE
Q 010214 20 KLGKTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-PSDIYVV 95 (515)
Q Consensus 20 ~i~~~LG~G~fg~Vy~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~iV 95 (515)
.+.++||+|+||+||+|.+..++ ..||||++++ ..+....+.+.+|+++|++++||||+++++++.+ +..+++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECC--CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc--ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34678999999999999987654 3699999864 3355567889999999999999999999999764 5689999
Q ss_pred EeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc--
Q 010214 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-- 172 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~-- 172 (515)
||||++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999999998754 4578889999999999999999999999999999999999999999999999987654322
Q ss_pred ---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCC-CChHHHHHHHhcC-ccCCCCCCChhHHHH
Q 010214 173 ---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGG-IYTLPSHLSPGARDL 247 (515)
Q Consensus 173 ---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~-~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 247 (515)
.....||+.|+|||.+.+..+ +.++||||||+++|||+||..||.. .+..+....+..+ ....|..+++++.+|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence 223468999999999987776 7899999999999999997777654 3444455555554 345678899999999
Q ss_pred hcccCCCCCCCCCCHHHHhcC
Q 010214 248 IPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~h 268 (515)
|.+||+.||++|||+.|+++|
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-48 Score=386.75 Aligned_cols=251 Identities=23% Similarity=0.270 Sum_probs=203.7
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCC-ccEEEEEEEcCCeEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIRLYEVIETPSDIYV 94 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~i 94 (515)
.++|++++.||+|+||+||+|.+..+|+.||||++..+... ..+.+|+++++.++|+| |+.+..++.+.+..++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 36799999999999999999999999999999998765432 35778999999998776 5556666788889999
Q ss_pred EEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCceEEeecccccccccC
Q 010214 95 VMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~---~~~vKL~DFGls~~~~~~ 170 (515)
||||+. ++|.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|....+.
T Consensus 81 vme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 81 VMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 999995 566666654 567999999999999999999999999999999999999864 457999999999877543
Q ss_pred C--------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHH---hc-----Ccc
Q 010214 171 H--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI---KG-----GIY 234 (515)
Q Consensus 171 ~--------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i---~~-----~~~ 234 (515)
. ...+.+||+.|+|||++.+..+ ++++|||||||++|+|++|..||...........+ .. ...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCC-CHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCC-CChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 2 2345689999999999998877 79999999999999999999999875543322221 11 112
Q ss_pred CCCCCCChhHHHHhcccCCCCCCCCCCHHH---HhcCccccc
Q 010214 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPE---IRQHPWFQA 273 (515)
Q Consensus 235 ~~p~~~s~~~~~li~~mL~~dP~~Rpt~~e---il~hp~f~~ 273 (515)
..+..+|+++.+|+.+||+.||.+||++.+ +++|+|.+.
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 234678999999999999999999999874 567777654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.5e-47 Score=380.42 Aligned_cols=247 Identities=21% Similarity=0.288 Sum_probs=209.5
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC-CCccEEEEEEEcCCeE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH-PHIIRLYEVIETPSDI 92 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h-pnIv~l~~~~~~~~~~ 92 (515)
.+.++|++++.||+|+||+||+|++..+|+.||||+++..... ..+.+|++.++.+.| +|++.+++++.+....
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 4568999999999999999999999999999999998654322 346789999999986 8999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-----CCceEEeecccccc
Q 010214 93 YVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-----KWNVKIADFGLSNI 166 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-----~~~vKL~DFGls~~ 166 (515)
|+||||+ |++|.+++...+ .+++.++..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+.
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9999999 679999997654 6999999999999999999999999999999999999974 57899999999987
Q ss_pred cccC--------CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCc--
Q 010214 167 MRDG--------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI---PNLFKKIKGGI-- 233 (515)
Q Consensus 167 ~~~~--------~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~---~~~~~~i~~~~-- 233 (515)
.... ....+.+||+.|||||++.+..+ ++++|||||||++|+|++|..||.+... .....++....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCC-ChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 6432 12345689999999999998877 7999999999999999999999976433 22333333222
Q ss_pred ---cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 234 ---YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 234 ---~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
..++..+++++.+++..|+..+|++||+.+.+.+
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 2234678999999999999999999999877644
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-47 Score=378.22 Aligned_cols=246 Identities=21% Similarity=0.333 Sum_probs=194.3
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC----e
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS----D 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~----~ 91 (515)
..+|.+.+.||+|+||.||+|++ +|+.||||+++.+. ......++|+..++.++||||+++++++.+++ .
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 46799999999999999999986 68999999986433 12223345666667889999999999997643 5
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH--------CCceeccCCCCcEEECCCCceEEeeccc
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR--------NMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~--------~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
+|+|||||++|+|.+++.+. .+++.....++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 89999999999999999754 69999999999999999999996 5999999999999999999999999999
Q ss_pred ccccccCC-----ccccCCCCCCccCCCcccCCcc-----CCCcceeehhHHHHHHHHhCCCCCCCC-------------
Q 010214 164 SNIMRDGH-----FLKTSCGSPNYAAPEVISGKLY-----AGPEVDVWSCGVILYALLCGTLPFDDE------------- 220 (515)
Q Consensus 164 s~~~~~~~-----~~~~~~gt~~Y~aPE~i~~~~~-----~~~~~DIwSlGvily~lltG~~Pf~~~------------- 220 (515)
+....... .....+||+.|+|||++.+... .+.++|||||||++|||+||..||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 98775432 2345689999999999876531 256899999999999999998887431
Q ss_pred --ChHHHHHHHhcCcc--CCCCC-----CChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 221 --NIPNLFKKIKGGIY--TLPSH-----LSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 221 --~~~~~~~~i~~~~~--~~p~~-----~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
........+..... .+|.. ....+.+|+.+||+.||.+|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 12223333333222 22222 12358899999999999999999999763
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-45 Score=378.52 Aligned_cols=252 Identities=29% Similarity=0.509 Sum_probs=199.0
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-----------CCCccEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-----------HPHIIRLYEV 85 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----------hpnIv~l~~~ 85 (515)
++|+++++||+|+||+||+|+++.+|+.||||+++++. ...+.+.+|+++++.++ ||||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 46999999999999999999999999999999997543 23467788999988875 5789999988
Q ss_pred EE--cCCeEEEEEeccCCCCHHHHH-H--HhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCC-----
Q 010214 86 IE--TPSDIYVVMEYVKSGELFDYI-V--EKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKW----- 154 (515)
Q Consensus 86 ~~--~~~~~~iVmEy~~gg~L~~~i-~--~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~----- 154 (515)
+. .....+++|+++..+...... . ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 75 456777788777655433332 2 24579999999999999999999998 8999999999999998665
Q ss_pred -ceEEeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH------HHHH
Q 010214 155 -NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP------NLFK 227 (515)
Q Consensus 155 -~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~------~~~~ 227 (515)
.++++|||.+..... .....+||+.|+|||++.+..| ++++||||+||++++|++|+.||...... ....
T Consensus 169 ~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred ceeeEeeccccccccc--ccccccccccccChhhccccCC-CccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 399999999876543 3456789999999999998877 78999999999999999999999754321 1111
Q ss_pred HHh---c---------------------------------------CccCCCCCCChhHHHHhcccCCCCCCCCCCHHHH
Q 010214 228 KIK---G---------------------------------------GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEI 265 (515)
Q Consensus 228 ~i~---~---------------------------------------~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~ei 265 (515)
.+. . .....+...++++.+||.+||.+||.+|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 100 0 0011122346789999999999999999999999
Q ss_pred hcCccccccc
Q 010214 266 RQHPWFQAHL 275 (515)
Q Consensus 266 l~hp~f~~~~ 275 (515)
|+||||++..
T Consensus 326 L~Hp~f~~~~ 335 (362)
T d1q8ya_ 326 VNHPWLKDTL 335 (362)
T ss_dssp HTCGGGTTCT
T ss_pred hcCcccCCCC
Confidence 9999998653
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-40 Score=281.80 Aligned_cols=74 Identities=31% Similarity=0.712 Sum_probs=69.8
Q ss_pred eeEeecccCCHHHHHHHHHHHHHhcCcEEEEecceeEEEEeecCCCCCCCCccCCCCCCCCCCCCcccccccCCccCCCc
Q 010214 392 WALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPN 471 (515)
Q Consensus 392 w~lgi~s~~~p~~im~ev~~~l~~l~~~wk~~~~y~~kcr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 471 (515)
||||||||++|.|||.|||||||+||+|||+++||||||||+++.. ++
T Consensus 1 WhlGIrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~--------------------------------~~ 48 (153)
T d2v8qa1 1 WHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVT--------------------------------ST 48 (153)
T ss_dssp EEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTT--------------------------------CC
T ss_pred CccccccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCC--------------------------------Cc
Confidence 9999999999999999999999999999999999999999998643 45
Q ss_pred eEEEEEEEeeecCCceeEEeecccCC
Q 010214 472 VVKFEVQLYKTRDEKYLLDLQRVQGP 497 (515)
Q Consensus 472 ~~k~~lQLyk~~~~~yllDf~~~~g~ 497 (515)
.+||+||||||++++||||||+++|+
T Consensus 49 ~~Km~lQLYqv~~~~YLLDfk~i~~~ 74 (153)
T d2v8qa1 49 FSKMSLQLYQVDSRTYLLDFRSIDDE 74 (153)
T ss_dssp EEEEEEEEEECSSSCEEEEEEEECCC
T ss_pred eeEEEEEEEEEcCCceEEEeeecCcc
Confidence 79999999999999999999999765
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=100.00 E-value=1.9e-40 Score=294.36 Aligned_cols=105 Identities=29% Similarity=0.580 Sum_probs=79.4
Q ss_pred CCCCceeEeecccCCHHHHHHHHHHHHHhcCcEEEEec---ceeEEEEeecCCCCCCCCccCCCCCCCCCCCCccccccc
Q 010214 387 PYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIG---HYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIEN 463 (515)
Q Consensus 387 ~~~~~w~lgi~s~~~p~~im~ev~~~l~~l~~~wk~~~---~y~~kcr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (515)
.+++|||||||||++|.|||.|||||||+||++||+++ +|+|||||+++..... ..|
T Consensus 41 ~~~~kWhfGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~---~~~----------------- 100 (171)
T d2qlva1 41 KSKTRWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKT---NTN----------------- 100 (171)
T ss_dssp ---CCCEESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC------------------------------
T ss_pred cccceeeeecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCccc---ccC-----------------
Confidence 35679999999999999999999999999999999986 6999999998642210 000
Q ss_pred CCccCCCceEEEEEEEeeecCCceeEEeecccC---------------------CceehHHHHHHHHHHHhc
Q 010214 464 DGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQG---------------------PQFLFLDLCAAFLAQLRV 514 (515)
Q Consensus 464 ~~~~~~~~~~k~~lQLyk~~~~~yllDf~~~~g---------------------~~~~f~~~c~~~i~~l~~ 514 (515)
...+++|||+||||||++++||||||+.++ ++|+|||+|++||+||+|
T Consensus 101 ---~~~~~~vk~~iQLYqv~~~~YLlDFK~~g~e~~~~~~~~~~~~~~~e~~~~Sp~pFldlca~LI~qLAv 169 (171)
T d2qlva1 101 ---EKIPDLMKMVIQLFQIETNNYLVDFKFDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMELAV 169 (171)
T ss_dssp -------CEEEEEEEEEC---CCEEEEEEEEEEEC--------------CHHHHTSHHHHHHHHHHHHHHHH
T ss_pred ---CCCCceEEEEEEEEEEcCCceEEEEecCCccccccccccccccCCCcccCcCCccHHHHHHHHHHHHhc
Confidence 122678999999999999999999997432 359999999999999997
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=100.00 E-value=4.5e-40 Score=277.96 Aligned_cols=98 Identities=29% Similarity=0.502 Sum_probs=84.7
Q ss_pred CceeEeecccCCHHHHHHHHHHHHHhcCcEEEEecc---------eeEEEEeecCCCCCCCCccCCCCCCCCCCCCcccc
Q 010214 390 RKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGH---------YNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAI 460 (515)
Q Consensus 390 ~~w~lgi~s~~~p~~im~ev~~~l~~l~~~wk~~~~---------y~~kcr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (515)
.|||||||||++|.|||.|||||||+||+|||+++| |||||||+++....
T Consensus 1 ~KWhfGIRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~--------------------- 59 (127)
T d2qrda1 1 NKWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKR--------------------- 59 (127)
T ss_dssp CCCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHH---------------------
T ss_pred CCceeccccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccc---------------------
Confidence 489999999999999999999999999999999997 99999999753210
Q ss_pred cccCCccCCCceEEEEEEEeeecCCceeEEeecc------cC-------------CceehHHHHHHHHHHHhc
Q 010214 461 IENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRV------QG-------------PQFLFLDLCAAFLAQLRV 514 (515)
Q Consensus 461 ~~~~~~~~~~~~~k~~lQLyk~~~~~yllDf~~~------~g-------------~~~~f~~~c~~~i~~l~~ 514 (515)
+..++.|||+||||||++++||||||+. ++ ++|+|||+|++||+||+.
T Consensus 60 ------~~~~~~vkm~iQLYqve~~~YLlDFK~dg~e~~~~~~~~~~~~~~~~~~s~~pFldl~a~LI~qL~~ 126 (127)
T d2qrda1 60 ------EGKNTYAYIELQLYEVMPGCFMLDVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLFS 126 (127)
T ss_dssp ------TTCCEEEEEEEEEEEEETTEEEEEEEEEEEEESCC-------------CCCTTHHHHHHHHHHHHHH
T ss_pred ------cCCCceEEEEEEEEEEcCCcEEEEEccCCcccccCCccccccCccccccCCccHHHHHHHHHHHHhc
Confidence 1225689999999999999999999953 22 359999999999999985
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=5.5e-24 Score=197.16 Aligned_cols=137 Identities=20% Similarity=0.257 Sum_probs=110.4
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccC-----C----------hHHHHHHHHHHHHHHhCCCCCccEEE
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-----N----------MEMEEKVRREIKILRLFMHPHIIRLY 83 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~-----~----------~~~~~~i~~Ei~il~~l~hpnIv~l~ 83 (515)
|.+++.||+|+||+||+|.+. +|+.||||++...... . ........+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568999999999999999985 7899999987532111 0 01124456789999999999999988
Q ss_pred EEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 84 EVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 84 ~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
++.. .+++|||+++..+. .+++..+..++.||+.+|.|||++||+||||||+|||++++ .++|+|||.
T Consensus 81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 7642 27999999886543 25667788999999999999999999999999999999965 599999999
Q ss_pred ccccc
Q 010214 164 SNIMR 168 (515)
Q Consensus 164 s~~~~ 168 (515)
|....
T Consensus 149 a~~~~ 153 (191)
T d1zara2 149 SVEVG 153 (191)
T ss_dssp CEETT
T ss_pred cccCC
Confidence 87654
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.86 E-value=2.2e-22 Score=165.33 Aligned_cols=95 Identities=19% Similarity=0.371 Sum_probs=87.1
Q ss_pred CCCceeEeecccCCHHHHHHHHHHHHHhcCcEEEEecceeEEEEeecCCCCCCCCccCCCCCCCCCCCCcccccccCCcc
Q 010214 388 YERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVV 467 (515)
Q Consensus 388 ~~~~w~lgi~s~~~p~~im~ev~~~l~~l~~~wk~~~~y~~kcr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (515)
-+..|++|+.|+.+|.|||.||++||+.+|++|++.++|.++|+|..+..
T Consensus 7 ~rf~wsv~tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~------------------------------ 56 (102)
T d1ul7a_ 7 GRFTWSMKTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHA------------------------------ 56 (102)
T ss_dssp CCCCCCCCCCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCG------------------------------
T ss_pred cceeeeeecCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCC------------------------------
Confidence 37799999999999999999999999999999999999999999976421
Q ss_pred CCCceEEEEEEEeeec-CCceeEEeecccCCceehHHHHHHHHHHHhc
Q 010214 468 KSPNVVKFEVQLYKTR-DEKYLLDLQRVQGPQFLFLDLCAAFLAQLRV 514 (515)
Q Consensus 468 ~~~~~~k~~lQLyk~~-~~~yllDf~~~~g~~~~f~~~c~~~i~~l~~ 514 (515)
...++||+|+||++ ..-|+|||||++|+++.|.++|+.|+++|++
T Consensus 57 --~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~l~~~il~~l~l 102 (102)
T d1ul7a_ 57 --ENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASKIANELKL 102 (102)
T ss_dssp --GGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHHHHHHHHHHCCC
T ss_pred --CceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHHHHHHHHHhccC
Confidence 24699999999996 6899999999999999999999999999974
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.57 E-value=1.3e-07 Score=89.28 Aligned_cols=145 Identities=14% Similarity=0.100 Sum_probs=100.2
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCC
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPS 90 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~ 90 (515)
....+..|+..+..+.++.+.||+.. .+++.+.+|+........ ...+.+|...++.+. +--+.+++.+.+.++
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 34456788888876666678999885 366778899876543322 234678888887765 334678888888889
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN---------------------------------- 136 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~---------------------------------- 136 (515)
..|+||++++|.++.+... +......++.++...+..||+.
T Consensus 84 ~~~lv~~~l~G~~~~~~~~-----~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEEEECCSSEEHHHHTT-----TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred ceEEEEEeccccccccccc-----ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999999987755331 1111223344444444444421
Q ss_pred -------------------------CceeccCCCCcEEECCCCceEEeecccccc
Q 010214 137 -------------------------MVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 137 -------------------------gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
.++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 178999999999999876667999997753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.15 E-value=3.3e-06 Score=78.73 Aligned_cols=82 Identities=12% Similarity=0.050 Sum_probs=55.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC--CCccEEEEEEEcCCeEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH--PHIIRLYEVIETPSDIY 93 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~ 93 (515)
...+.+...-+..+-+.||+... .++..+.+|....... ..+.+|...++.+.. -.+.+++.+..+++..|
T Consensus 10 l~g~~~~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~ 82 (255)
T d1nd4a_ 10 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 82 (255)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred ccCCceEEcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceE
Confidence 34555544333333468998874 4677789998654432 235677777776653 33677888888888999
Q ss_pred EEEeccCCCCH
Q 010214 94 VVMEYVKSGEL 104 (515)
Q Consensus 94 iVmEy~~gg~L 104 (515)
+|||+++|.++
T Consensus 83 ~v~~~i~G~~~ 93 (255)
T d1nd4a_ 83 LLLGEVPGQDL 93 (255)
T ss_dssp EEEECCSSEET
T ss_pred EEEEeeecccc
Confidence 99999988655
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.09 E-value=2.6e-06 Score=85.59 Aligned_cols=80 Identities=16% Similarity=0.046 Sum_probs=51.1
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccc-cC-C--hHHHHHHHHHHHHHHhCC-C--CCccEEEEEEEcCCeEEE
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRK-IK-N--MEMEEKVRREIKILRLFM-H--PHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~-~~-~--~~~~~~i~~Ei~il~~l~-h--pnIv~l~~~~~~~~~~~i 94 (515)
.+.||.|....||++....+++.|++|.-.... .. . .....+..+|.+.|+.+. + ..+.+++.+. +...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 567899999999999988788899999754311 00 0 012345667888887664 2 3566777653 344578
Q ss_pred EEeccCCCC
Q 010214 95 VMEYVKSGE 103 (515)
Q Consensus 95 VmEy~~gg~ 103 (515)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.95 E-value=0.0015 Score=64.70 Aligned_cols=75 Identities=17% Similarity=0.161 Sum_probs=51.8
Q ss_pred EeeeecccCceEEEEEEEcC-------CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeE
Q 010214 21 LGKTLGIGSFGKVKIAEHAL-------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDI 92 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~-------tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 92 (515)
-++.|+.|-.-.+|++.... ..+.|.+++.... .. .....+|..+++.+. +.-..++++++..
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 35678889999999998753 3467888887522 11 224568999988876 4334578887642
Q ss_pred EEEEeccCCCCH
Q 010214 93 YVVMEYVKSGEL 104 (515)
Q Consensus 93 ~iVmEy~~gg~L 104 (515)
++||||++|..|
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 589999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.84 E-value=0.0008 Score=64.86 Aligned_cols=67 Identities=7% Similarity=0.136 Sum_probs=43.5
Q ss_pred eEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc--cEEE-----EEEEcCCeEEEEEeccCCC
Q 010214 31 GKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI--IRLY-----EVIETPSDIYVVMEYVKSG 102 (515)
Q Consensus 31 g~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI--v~l~-----~~~~~~~~~~iVmEy~~gg 102 (515)
-.||++.. .+|..|++|+....... .+.+..|...+..|....+ +... ..++.....+.++++++|.
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 47999875 47889999998654322 3567778888776652221 1111 1234567789999999764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.87 E-value=0.0076 Score=57.05 Aligned_cols=30 Identities=23% Similarity=0.269 Sum_probs=26.8
Q ss_pred CCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 136 ~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
.|+||+|+.+.||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 469999999999999988777899999874
|